Psyllid ID: psy15039

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620--
Protein Sequence
METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSR
Secondary Structure (PSIPRED)
cccccccccccEEEccccccccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccccEEEEEEEEcccEEEEccccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccEEEEcccccccccccccccccccccccHHHHHcccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccccccccccccccccHHHHcccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccHHcccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccccEEEEEEEEcccEEEEccccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccEEEEcccccccccccccccccccccccHHHHHcccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccHHHcEEEEEccccccccEEEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEHccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccEEccccHHHEEEcccccEEEEcccHHHHHcccccccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccHHcccccccHHHHHHccccccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccHHcccccccccccccccHccccccccccccccccccccccccccccccccccccccHcEEEEEccccccccEEEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEHHccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccEEccccHHHEEEcccccEEEEcccHHHHccccccccccccccccccHHHccHHHHHcccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHcHHHHcccccccccccEcccc
Coil and Loop (DISEMBL)
metldnvpsnyKICSILGQCFNNLSSVYLSKHKVTNQLIAVKkfnldrmtdedLKSLHHEIVCMrhlrhpniicyissfldatdlhlvsplmgfgscKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLsglrymcpfsptkkkvhlfppstaynlnwlspevleqnldgydersdiysVGISccelangtvpfaetpTTLMLIEKLagatphlldcttyyvdtgqddgeenACSYISEQQTQVLTSRKFSDSFHSIVELClsrdvdkrplaCNLLQHAFFKQTKKCSVmlpellrpalslnesnvceINNELECMFNINdtfnssvetldnvpsnyKICSILGQCFNNLSSVYLSKHKVTNQLIAVKkfnldrmtdedLKSLHHEIVCMrhlrhpniicyissfldatdlhlvsplmgfgscKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLsglrymcpfsptkkkvhlfppstaynlnwlspevleqnldgydersdiysVGISccelangtvpfaetpTTLMLIEKLagatphlldcttyyvdtgqddgeenACSYISEQQTQVLTSR
Flexible Loop (DISEMBL)
metldnvpsnYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYiseqqtqvltsr
Low Complexity Region (SEG)
METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSR
Disordered region (IsUnstruct)
********SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG***********************
Disordered Region (DISOPRED)
******V**NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG******************RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC*******************************
Disordered Region (DISEMBL)
********SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE*********
Disordered Region (DISPRO)
****DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEI***********DTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI***********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	622	2.2.26 [Sep-21-2011]
Q3UUJ4	431	STE20-related kinase adap	yes	N/A	0.5	0.721	0.442	7e-70
Q7RTN6	431	STE20-related kinase adap	yes	N/A	0.5	0.721	0.445	1e-69
Q5ZK47	389	STE20-related kinase adap	yes	N/A	0.5	0.799	0.448	3e-69
Q5E9J9	373	STE20-related kinase adap	yes	N/A	0.5	0.833	0.445	7e-69
Q5RBJ6	431	STE20-related kinase adap	yes	N/A	0.5	0.721	0.442	1e-68
Q7TNZ6	393	STE20-related kinase adap	yes	N/A	0.498	0.788	0.442	2e-68
Q4R6X5	394	STE20-related kinase adap	N/A	N/A	0.5	0.789	0.442	2e-68
Q9C0K7	418	STE20-related kinase adap	no	N/A	0.509	0.758	0.373	8e-58
Q8K4T3	418	STE20-related kinase adap	no	N/A	0.540	0.803	0.373	1e-57
P83098	346	Putative serine/threonine	yes	N/A	0.482	0.867	0.375	6e-48

>sp|Q3UUJ4|STRAA_MOUSE STE20-related kinase adapter protein alpha OS=Mus musculus GN=Strada PE=2 SV=1

 Score =  265 bits (678), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 145/328 (44%), Positives = 202/328 (61%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +I+G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 69  YELLTIIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 128

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 129 NIVPYRATFIADNELWVVTSFMAYGSAKDLIGTHFMDGMNELAIAYILQGVLKALDYIHH 188

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 189 MGYVHRSVKASHILISTDGKVYLSGLRSNLSMISHGQRQRAVHDFPKYSIKVLPWLSPEV 248

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct: 249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 308

Query: 248 --------TGQDDGEENACSYISEQQTQVLTS-----RKFSDSFHSIVELCLSRDVDKRP 294
                   +  + G  ++ +  S + +   +      R FS  FH+ VE CL R+ D RP
Sbjct: 309 ELTMSPSRSIANPGLNDSLAAGSLRPSNGDSPSHPYHRTFSPHFHNFVEQCLQRNPDARP 368

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 369 NASTLLNHSFFKQIKRRASEALPELLRP 396

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.
Mus musculus (taxid: 10090)

>sp|Q7RTN6|STRAA_HUMAN STE20-related kinase adapter protein alpha OS=Homo sapiens GN=STRADA PE=1 SV=1

 Score =  264 bits (675), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 146/328 (44%), Positives = 197/328 (60%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 69  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 128

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 129 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 188

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 189 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 248

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct: 249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 308

Query: 248 T-GQDDGEENACSYISEQQTQVLTS------------RKFSDSFHSIVELCLSRDVDKRP 294
                     A S +S+  T                 R FS  FH  VE CL R+ D RP
Sbjct: 309 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 368

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 369 SASTLLNHSFFKQIKRRASEALPELLRP 396

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Homo sapiens (taxid: 9606)

>sp|Q5ZK47|STRAA_CHICK STE20-related kinase adapter protein alpha OS=Gallus gallus GN=STRADA PE=2 SV=1

 Score =  263 bits (672), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 147/328 (44%), Positives = 196/328 (59%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +I+G+ F +L  V L+++K + + + V++ NL+  T+E +  L  E+   +   HP
Sbjct: 11  YELLTIIGRGFEDLMVVNLARYKPSGEYVTVRRVNLEACTNEMVTFLQGELHVSKLFNHP 70

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 71  NIVPYKATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 130

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M       K VH FP  +   L WLSPEV
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLKVVHDFPKYSIKVLPWLSPEV 190

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYS+GI+ CELANG VPF + P+T ML+EKL G  P LLD TT   D
Sbjct: 191 LQQNLQGYDAKSDIYSIGITACELANGHVPFKDMPSTQMLLEKLNGTVPCLLDTTTIPAD 250

Query: 248 TGQDDGEENACSYISEQQTQVLTSRK-------------FSDSFHSIVELCLSRDVDKRP 294
                   ++ +Y   + T V   R              FS  FH+ V  CL R+ D RP
Sbjct: 251 ELTMKTSRSSANYGLGESTAVSNVRAANGESTLHPYLRTFSSCFHNFVGQCLQRNPDFRP 310

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H FFKQ K + S  LPELLRP
Sbjct: 311 SAGALLNHPFFKQIKRRASEALPELLRP 338

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Gallus gallus (taxid: 9031)

>sp|Q5E9J9|STRAA_BOVIN STE20-related kinase adapter protein alpha OS=Bos taurus GN=STRADA PE=2 SV=1

 Score =  262 bits (669), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 146/328 (44%), Positives = 198/328 (60%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 70

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ  L  L+YIH 
Sbjct: 71  NILPYGATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGALKALDYIHH 130

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASH+LIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 131 MGYVHRSVKASHVLISADGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSIKVLPWLSPEV 190

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct: 191 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 250

Query: 248 T-GQDDGEENACSYISEQ--QTQVLTS----------RKFSDSFHSIVELCLSRDVDKRP 294
                     A S +SE    +   TS          R FS  FH  VE CL R+ D RP
Sbjct: 251 ELTMSTSRSAANSGLSESLAPSTPRTSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDMRP 310

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 311 SASTLLNHSFFKQIKRRASEALPELLRP 338

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Bos taurus (taxid: 9913)

>sp|Q5RBJ6|STRAA_PONAB STE20-related kinase adapter protein alpha OS=Pongo abelii GN=STRADA PE=2 SV=1

 Score =  261 bits (667), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 145/328 (44%), Positives = 196/328 (59%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 69  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 128

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 129 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 188

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 189 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSIKVLPWLSPEV 248

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T  L+EKL G  P LLD +T   +
Sbjct: 249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQTLLEKLNGTVPCLLDTSTIPAE 308

Query: 248 T-GQDDGEENACSYISEQQTQVLTS------------RKFSDSFHSIVELCLSRDVDKRP 294
                     A S +S+  T                 R FS  FH  VE CL R+ D RP
Sbjct: 309 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 368

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 369 SASTLLNHSFFKQIKRRASEALPELLRP 396

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Pongo abelii (taxid: 9601)

>sp|Q7TNZ6|STRAA_RAT STE20-related kinase adapter protein alpha OS=Rattus norvegicus GN=Strada PE=1 SV=1

 Score =  260 bits (665), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 145/328 (44%), Positives = 199/328 (60%), Gaps = 18/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ S++G+ F +L +V  S++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 32  YELLSVIGKGFEDLMTVN-SRYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 90

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L  V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 91  NIVPYRATFIADNELWAVTSFMAYGSAKDLIGTHFMDGMSELAIAYILQGVLKALDYIHH 150

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 151 MGYVHRSVKASHILISTDGKVYLSGLRSNLSMISHGQRQRAVHDFPKYSIKVLPWLSPEV 210

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct: 211 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 270

Query: 248 --------TGQDDGEENACSYISEQQTQVLTS-----RKFSDSFHSIVELCLSRDVDKRP 294
                   +  + G  ++ +  S +     +      R FS  FH+ VE CL R+ D RP
Sbjct: 271 ELTMSPSRSIANPGLNDSLAAGSLRPANGDSPSHPYHRTFSPHFHNFVEQCLQRNPDARP 330

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 331 NASTLLNHSFFKQIKRRASEALPELLRP 358

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Rattus norvegicus (taxid: 10116)

>sp|Q4R6X5|STRAA_MACFA STE20-related kinase adapter protein alpha OS=Macaca fascicularis GN=STRADA PE=2 SV=1

 Score =  260 bits (664), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 145/328 (44%), Positives = 195/328 (59%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +++G+ F +L +V L+++K T + + V++ NL   ++E +  L  E+   +   HP
Sbjct: 32  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLGACSNEMVTFLQGELHVSKLFNHP 91

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 92  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 151

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 152 MGYVHRSVKASHILISLDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 211

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct: 212 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 271

Query: 248 T-GQDDGEENACSYISEQQTQVLTS------------RKFSDSFHSIVELCLSRDVDKRP 294
                     A S +S+  T                 R FS  FH  VE CL  + D RP
Sbjct: 272 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPYFHHFVEQCLQPNPDARP 331

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 332 SASTLLNHSFFKQIKRRASEALPELLRP 359

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Macaca fascicularis (taxid: 9541)

>sp|Q9C0K7|STRAB_HUMAN STE20-related kinase adapter protein beta OS=Homo sapiens GN=STRADB PE=1 SV=1

 Score =  225 bits (573), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 127/340 (37%), Positives = 194/340 (57%), Gaps = 23/340 (6%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S+Y++   +G+ F+NL+SV+L++H  T  L+ +K  NL+   +E LK+L   ++     R
Sbjct: 56  SHYELQVEIGRGFDNLTSVHLARHTPTGTLVTIKITNLENCNEERLKALQKAVILSHFFR 115

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI  Y + F   + L ++SP M +GS   L+  +F  G+ E +I +IL   + GL Y+
Sbjct: 116 HPNITTYWTVFTVGSWLWVISPFMAYGSASQLLRTYFPEGMSETLIRNILFGAVRGLNYL 175

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           H  G IHR++KASHILIS +G   LSGL +   +       + V+ FP  +     WLSP
Sbjct: 176 HQNGCIHRSIKASHILISGDGLVTLSGLSHLHSLVKHGQRHRAVYDFPQFSTSVQPWLSP 235

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY- 244
           E+L Q+L GY+ +SDIYSVGI+ CELA+G VPF +   T ML++KL G     LD + + 
Sbjct: 236 ELLRQDLHGYNVKSDIYSVGITACELASGQVPFQDMHRTQMLLQKLKGPPYSPLDISIFP 295

Query: 245 -------YVDTGQDDG------EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVD 291
                     +G D G        +    ++  +    +S+ FS +F S+V+LCL +D +
Sbjct: 296 QSESRMKNSQSGVDSGIGESVLVSSGTHTVNSDRLHTPSSKTFSPAFFSLVQLCLQQDPE 355

Query: 292 KRPLACNLLQHAFFKQTKK------CSVMLPELLRPALSL 325
           KRP A +LL H FFKQ K+       S++ P   +P++SL
Sbjct: 356 KRPSASSLLSHVFFKQMKEESQDSILSLLPPAYNKPSISL 395

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Homo sapiens (taxid: 9606)

>sp|Q8K4T3|STRAB_MOUSE STE20-related kinase adapter protein beta OS=Mus musculus GN=Stradb PE=2 SV=1

 Score =  224 bits (572), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 133/356 (37%), Positives = 200/356 (56%), Gaps = 20/356 (5%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S+Y++   +G+ F+NL+SV+L++H  T  L+ VK  NL+  T+E LK+L   ++     +
Sbjct: 56  SHYELQVEIGRGFDNLTSVHLARHTPTGTLVTVKITNLESCTEERLKALQRAVILSHFFQ 115

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI  Y + F   + L ++SP M +GS   L+  +F  G+ E +I +IL   + GL Y+
Sbjct: 116 HPNITTYWTVFTVGSWLWVISPFMAYGSASQLLRTYFPDGMSETLIRNILFGAVQGLNYL 175

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           H  G IHR+ KASHILIS +G   LSGL +   +       + V  FP  +     WLSP
Sbjct: 176 HQNGCIHRSFKASHILISGDGLVTLSGLSHLHSLLKHGQRHRAVFDFPQFSTSVQPWLSP 235

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY- 244
           E+L Q+L GY+ +SDIYSVGI+ CELA+G VPF +   T ML++KL G     LD + + 
Sbjct: 236 ELLRQDLHGYNVKSDIYSVGITACELASGQVPFQDMHRTQMLLQKLKGPPYSPLDVSIFP 295

Query: 245 YVDTGQDDGEENACSYISEQ-------------QTQVLTSRKFSDSFHSIVELCLSRDVD 291
             D+   + +    S I E              +    +++ FS +F S+V+LCL +D +
Sbjct: 296 QSDSRMRNSQSGVDSGIGESVLVSTGTHTVNSDRLHTPSTKTFSPAFFSLVQLCLQQDPE 355

Query: 292 KRPLACNLLQHAFFKQTKKCS--VMLPELLRPALSLNESNVCEINNELECMFNIND 345
           KRP A +LL H FFKQ K+ S   +LP LL PA +   +++  ++   E  F   D
Sbjct: 356 KRPSASSLLSHVFFKQMKEESQDSILP-LLPPAYNRPSASLQPVSPWSELEFQFPD 410

Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.

Mus musculus (taxid: 10090)

>sp|P83098|STLK_DROME Putative serine/threonine-protein kinase STE20-like OS=Drosophila melanogaster GN=Stlk PE=2 SV=2

 Score =  192 bits (489), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 117/312 (37%), Positives = 174/312 (55%), Gaps = 12/312 (3%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
           N  S+YK+  IL    N +         + N+ +AVKK ++D+   E L  L +E++ +R
Sbjct: 5   NNISDYKLLEILK---NGMIGTVYKAEDINNKCLAVKKVSMDQPM-EKLTLLFNEVLTVR 60

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L+H NI   +S FL    ++L    M FG+C+ L+   +  G PE+ I  IL+DVL+ L
Sbjct: 61  RLQHRNINTIVSCFLYKQYVYLTYKFMCFGNCEVLLKNVYTSGFPEVAIALILKDVLSAL 120

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTAYN--LNW 182
            YIH + ++H +V+A HIL+S   KA LS   Y   F S  +KK  +F  +      L W
Sbjct: 121 TYIHSEHYVHGSVRAKHILLSPR-KAVLSNFSYCQSFISQGEKKTFIFGSTVGIEKELYW 179

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
            +PEVL QNL GY E+ DIYS+GI+CCE+ANG  PF +T  T M IEK+ G+   LLD  
Sbjct: 180 TAPEVLYQNLSGYTEKIDIYSIGITCCEMANGFQPFKDTELTYMYIEKVRGSLQVLLDKN 239

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
           +   + G    E        +    V+ ++ FS++FH  VELCL+++   R  A  L+ H
Sbjct: 240 SLLENQGSLSLEHTNKRIARD----VIVNKSFSENFHQFVELCLNKNPLSRWAASKLMTH 295

Query: 303 AFFKQTKKCSVM 314
           +F KQ +  S++
Sbjct: 296 SFLKQCRNTSLL 307

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	622
193699951	369	PREDICTED: STE20-related kinase adapter	0.514	0.867	0.520	3e-93
156537884	361	PREDICTED: STE20-related kinase adapter	0.519	0.894	0.464	4e-80
242004275	360	cAMP-dependent protein kinase catalytic	0.509	0.880	0.474	2e-78
189238800	279	PREDICTED: similar to protein kinase LYK	0.409	0.913	0.513	5e-71
270010138	258	hypothetical protein TcasGA2_TC009500 [T	0.389	0.937	0.528	1e-70
387916078	372	STE20-related kinase adaptor alpha isofo	0.561	0.938	0.422	6e-70
348508994	399	PREDICTED: STE20-related kinase adapter	0.503	0.784	0.431	4e-69
224086205	431	PREDICTED: STE20-related kinase adapter	0.5	0.721	0.463	5e-69
449267457	391	STE20-related kinase adapter protein alp	0.5	0.795	0.463	1e-68
51858665	373	Lyk5 protein [Rattus norvegicus]	0.5	0.833	0.445	2e-68

>gi|193699951|ref|XP_001951624.1| PREDICTED: STE20-related kinase adapter protein alpha-like [Acyrthosiphon pisum]

 Score =  349 bits (895), Expect = 3e-93,   Method: Compositional matrix adjust.
 Identities = 175/336 (52%), Positives = 230/336 (68%), Gaps = 16/336 (4%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y +CS+LG CF++ + V+L KH  +  L+A+K FNLD M+  D + +  EI   R L HP
Sbjct: 10  YTMCSVLGSCFSDRAVVFLGKHNKSGNLVAMKNFNLDSMSKTDCQLIQDEIYNTRQLMHP 69

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           N+I Y++SFLD + L++V PLMG+GSC+DL+  HF  GLPE VI  +L+DVL GLEYIH 
Sbjct: 70  NLIPYVTSFLDKSQLYVVFPLMGYGSCRDLLRNHFVEGLPETVIAFVLKDVLQGLEYIHN 129

Query: 131 KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           KG +HRA+KA HILI  +G A LSGLR MCP    +  +H  P  +A NLNW SPE+LEQ
Sbjct: 130 KGLVHRAIKAGHILIRADGHASLSGLRSMCPID-KRSNLHSLPLQSANNLNWSSPEMLEQ 188

Query: 191 NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT--YYVDT 248
           NL GY+E+SDIYS+GI+ CELANG VPFAET TT ML +K+ G  PHLLDCTT   Y D 
Sbjct: 189 NLLGYNEKSDIYSIGITSCELANGFVPFAETDTTFMLTQKVKGLIPHLLDCTTCYPYEDN 248

Query: 249 GQDDGEENACSYISEQQTQV-------LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
             D+G      Y SE+   V       + +R F++ FH++VELC  RD + RP A NLL 
Sbjct: 249 AADNG------YQSEETIGVNATPVSNVYTRMFTEEFHNLVELCCQRDPESRPSASNLLA 302

Query: 302 HAFFKQTKKCSVMLPELLRPALSLNESNVCEINNEL 337
           H F KQ K+ +V + +LLRPA+ L ++NV EI+++L
Sbjct: 303 HTFTKQVKRVNVKVTDLLRPAVPLLKTNVAEISDDL 338

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|156537884|ref|XP_001608122.1| PREDICTED: STE20-related kinase adapter protein alpha [Nasonia vitripennis]

 Score =  305 bits (782), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 152/327 (46%), Positives = 214/327 (65%), Gaps = 4/327 (1%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           D+  ++Y     LG   +    V L+ HK TN  + +KK+ +D    ED   +  EIV  
Sbjct: 3   DSNLNSYSSGMALGVSSSGAGIVQLALHKTTNTYVVIKKYFIDDKDSEDYSLIQQEIVTT 62

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
           RHL+HPN++ Y+++F+   D++++SPLM +GSC +LI  HFN G PEL I  I++DVL G
Sbjct: 63  RHLQHPNVLPYLNAFVSGHDIYVISPLMAYGSCSNLIKEHFNEGFPELAIAFIIKDVLQG 122

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF---SPTKKKVHLFPPSTAYNLN 181
           L+YIH KGFIHRA++ASHILIS +G+AC+ G+RY C        ++ +  FP S+  NL 
Sbjct: 123 LDYIHKKGFIHRALRASHILISGSGQACICGMRYSCEMFKSGKWQRTIFDFPKSSINNLK 182

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC 241
           WLSPE+L+Q+L GY+E+SDIYS+GI+ CELANG VP+A+   TLML EK+ G TP+++D 
Sbjct: 183 WLSPELLQQDLRGYNEKSDIYSLGITICELANGVVPYADVQDTLMLTEKVRGCTPNIIDR 242

Query: 242 TTYYVDTGQ-DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL 300
           +TY +D       EE   +    Q T+V+++RKFS+ FH+I ELCL  D   RP    LL
Sbjct: 243 STYPLDMMDVKQSEEKVNNENPTQNTEVMSTRKFSEPFHAIAELCLECDPSNRPGINQLL 302

Query: 301 QHAFFKQTKKCSVMLPELLRPALSLNE 327
            H+FFKQ +K +  L  LL+    LNE
Sbjct: 303 AHSFFKQCRKANTTLLNLLKDIKPLNE 329

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242004275|ref|XP_002423030.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212505961|gb|EEB10292.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis]

 Score =  300 bits (768), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 155/327 (47%), Positives = 210/327 (64%), Gaps = 10/327 (3%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           P +Y + S+LG+C   +  V L+KHK    L+AVKKF+L++   +D+  +  EI+ MR L
Sbjct: 7   PKDYDVVSLLGRCCGQIGMVLLAKHK-KKTLVAVKKFDLEKADHKDVLQIQKEIIIMRQL 65

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           +H N++ Y   F+D   +++V+ L GFGSC DLI  HF  GLPEL IC IL+DVLN L Y
Sbjct: 66  KHNNVLSYEFCFVDNQSVYVVTQLCGFGSCTDLIANHFPVGLPELAICFILRDVLNALAY 125

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLS 184
           IH KG IHRA++ASHIL+S NGK+ ++G RY   M      KK +H FP S A NLNWLS
Sbjct: 126 IHKKGIIHRAIRASHILVSANGKSMITGFRYAVHMVEGGKRKKCIHCFPTSAAVNLNWLS 185

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY 244
           PE+LEQ+L+GY+E+SDIYS+GI+  ELANG VPF++ P TLML EK+ G  P L+D TTY
Sbjct: 186 PELLEQSLEGYNEKSDIYSLGITSAELANGCVPFSDVPATLMLTEKVRGCAPQLIDQTTY 245

Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
            +   + +     C   S        +R FS+SFH    +CL +D   RP A  LL H+F
Sbjct: 246 PLYESESENNLVNCIVSSNDHK---ATRLFSESFHQFTNICLQKDHRLRPSAQQLLSHSF 302

Query: 305 FKQTKKCS---VMLPELLRPALSLNES 328
           FKQ ++ S     + +LL P + L+ S
Sbjct: 303 FKQLRQKSNNPNFMGDLLHPVMPLSAS 329

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189238800|ref|XP_974908.2| PREDICTED: similar to protein kinase LYK5 [Tribolium castaneum]

 Score =  275 bits (703), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 133/259 (51%), Positives = 178/259 (68%), Gaps = 4/259 (1%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  S LGQCF  ++ V L+KHK++  ++ +K+FN+DR+  E    +  EI+  +  +
Sbjct: 9   SAYETISTLGQCFEGMAVVNLAKHKISGTMVTIKRFNMDRIKHEA-HLVEREIILTKQFQ 67

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNII Y  +F+   ++ +VSPLM FGSC+DL+N HFN GLPE  I  IL+DVL+ L+YI
Sbjct: 68  HPNIIKYFVAFVHLHEVCVVSPLMAFGSCRDLLNTHFNEGLPEHAIILILKDVLDALDYI 127

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPF---SPTKKKVHLFPPSTAYNLNWLSP 185
           H +GFIHR+V+A HILIS  GKA L+GLRY CP       ++++H FP ST  NLNWLSP
Sbjct: 128 HKRGFIHRSVRAGHILISATGKASLAGLRYACPIVLNGKWQRQIHSFPASTVRNLNWLSP 187

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 245
           E+LEQNL GY+++SDIYSVG+  CELANG  P+A   TTLML EK+ G  P LLDCTT  
Sbjct: 188 ELLEQNLQGYNQKSDIYSVGMLICELANGAEPYAGVSTTLMLTEKVRGCVPQLLDCTTVP 247

Query: 246 VDTGQDDGEENACSYISEQ 264
            D   +  +E A   + +Q
Sbjct: 248 TDENNEVHDEVANLDVVQQ 266

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270010138|gb|EFA06586.1| hypothetical protein TcasGA2_TC009500 [Tribolium castaneum]

 Score =  274 bits (700), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 130/246 (52%), Positives = 172/246 (69%), Gaps = 4/246 (1%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  S LGQCF  ++ V L+KHK++  ++ +K+FN+DR+  E    +  EI+  +  +
Sbjct: 9   SAYETISTLGQCFEGMAVVNLAKHKISGTMVTIKRFNMDRIKHEA-HLVEREIILTKQFQ 67

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNII Y  +F+   ++ +VSPLM FGSC+DL+N HFN GLPE  I  IL+DVL+ L+YI
Sbjct: 68  HPNIIKYFVAFVHLHEVCVVSPLMAFGSCRDLLNTHFNEGLPEHAIILILKDVLDALDYI 127

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPF---SPTKKKVHLFPPSTAYNLNWLSP 185
           H +GFIHR+V+A HILIS  GKA L+GLRY CP       ++++H FP ST  NLNWLSP
Sbjct: 128 HKRGFIHRSVRAGHILISATGKASLAGLRYACPIVLNGKWQRQIHSFPASTVRNLNWLSP 187

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 245
           E+LEQNL GY+++SDIYSVG+  CELANG  P+A   TTLML EK+ G  P LLDCTT  
Sbjct: 188 ELLEQNLQGYNQKSDIYSVGMLICELANGAEPYAGVSTTLMLTEKVRGCVPQLLDCTTVP 247

Query: 246 VDTGQD 251
            D   +
Sbjct: 248 TDENNE 253

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|387916078|gb|AFK11648.1| STE20-related kinase adaptor alpha isoform 1 [Callorhinchus milii]

 Score =  271 bits (694), Expect = 6e-70,   Method: Compositional matrix adjust.
 Identities = 157/372 (42%), Positives = 217/372 (58%), Gaps = 23/372 (6%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           M TL    S+Y++  ++G  F ++ +V L+++K T Q + V++ NLD  T+E    L  E
Sbjct: 1   MSTLPADSSSYELLQVIGTGFEDILTVSLARYKRTGQRVTVRRINLDYCTNEMFTLLQGE 60

Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +   +   HPNI+ Y ++ +   ++ +V+P M +GS KDL+N+HF  GL EL I +ILQ 
Sbjct: 61  LHICKLFHHPNILPYKATLIANNEVWVVTPFMEYGSAKDLMNSHFTDGLGELTIAYILQG 120

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTA 177
           VL  L+YIH  G++HR+VKASHILIS +G+  LSGLR    M       K VH FP  + 
Sbjct: 121 VLKALDYIHRMGYVHRSVKASHILISVDGQVYLSGLRSIFSMISHGKRLKVVHDFPKYSV 180

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH 237
             L WLSP++L+QNL GYD +SDIYS+GI+ CELANG VPF   P T ML+EKL G  P 
Sbjct: 181 KILPWLSPDLLQQNLQGYDAKSDIYSLGITACELANGHVPFKNMPATQMLLEKLNGTVPC 240

Query: 238 LLDCTTYYVD--------TGQDDGEENACSYISEQQT-----QVLTSRKFSDSFHSIVEL 284
           LLD TT   D        +G D G     +    + T     Q   +R FS  FH+ VEL
Sbjct: 241 LLDTTTIPEDELMMKNSRSGVDSGIVEGSAACGARATNGEHEQHPYNRTFSGLFHNFVEL 300

Query: 285 CLSRDVDKRPLACNLLQHAFFKQTK-KCSVMLPELLRPALSLNESNVCEINNELECMFNI 343
           CL R+ + RP A  LL H+F KQ K + + MLPELLRP   + + N  + ++        
Sbjct: 301 CLQREPEHRPSANALLNHSFIKQLKRRAAEMLPELLRPVAPMPDCNSSQGHDR------G 354

Query: 344 NDTFNSSVETLD 355
            D   +S+E LD
Sbjct: 355 MDEMEASLEELD 366

Source: Callorhinchus milii

Species: Callorhinchus milii

Genus: Callorhinchus

Family: Callorhinchidae

Order: Chimaeriformes

Class: Chondrichthyes

Phylum: Chordata

Superkingdom: Eukaryota

>gi|348508994|ref|XP_003442037.1| PREDICTED: STE20-related kinase adapter protein alpha-like [Oreochromis niloticus]

 Score =  269 bits (687), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 144/334 (43%), Positives = 205/334 (61%), Gaps = 21/334 (6%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S+Y++ +++G+  +NL +V L++++ T + +A+++ +L+  T++ +  L  E+   +   
Sbjct: 30  SSYELLAVIGRGLDNLMTVNLARYRPTGEHVAIRRIDLESCTNDMVTYLQGELHVSKLFH 89

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HP+I+ Y S F+   +L +++P M +GS +DLI  HF  G+ EL I +IL  +L  LEYI
Sbjct: 90  HPSILPYKSVFIAENELWVITPFMAYGSARDLICTHFTDGMSELTIAYILLGMLKALEYI 149

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPF---SPTKKKVHLFPPSTAYNLNWLSP 185
           H  G++HR+VKASH+LIS +G+ C+SGLR +          K VH FP  +   L WLSP
Sbjct: 150 HHMGYVHRSVKASHVLISADGQVCMSGLRSIFSLIRHGQRAKVVHDFPQYSVNVLPWLSP 209

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 245
           EVL+QNL GYD RSDIYS+GI+ CELANG VPF + P T ML+EKL G  P LLD TT  
Sbjct: 210 EVLQQNLQGYDSRSDIYSLGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 269

Query: 246 VD--------TGQDDG--EENACSYISEQQTQVLTS-------RKFSDSFHSIVELCLSR 288
            +        +G D G  E      +     +  +S       R FS  FH+ VELCL R
Sbjct: 270 PEELSMKPSRSGADSGICEGPGAGGVRHSNGEPSSSSGGHPYNRTFSPQFHAFVELCLQR 329

Query: 289 DVDKRPLACNLLQHAFFKQTK-KCSVMLPELLRP 321
           D +KRP A +L+ H FFKQ K + S  LPELLRP
Sbjct: 330 DPEKRPSATSLVGHPFFKQIKRRPSEALPELLRP 363

Source: Oreochromis niloticus

Species: Oreochromis niloticus

Genus: Oreochromis

Family: Cichlidae

Order: Perciformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|224086205|ref|XP_002193381.1| PREDICTED: STE20-related kinase adapter protein alpha isoform 2 [Taeniopygia guttata]

 Score =  268 bits (686), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 152/328 (46%), Positives = 198/328 (60%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +I+G+ F +L  V L+++K T + + V++ NL+  T+E +  L  E+   +   HP
Sbjct: 69  YELLTIIGRGFEDLMVVNLARYKPTGEYVTVRRVNLEACTNEMVTFLQGELHVSKLFNHP 128

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 129 NIVPYKATFVADNELWVVTSFMAYGSAKDLICTHFTDGMTELAIAYILQGVLKALDYIHH 188

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M       K VH FP  +   L WLSPEV
Sbjct: 189 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLKVVHDFPKYSIKVLPWLSPEV 248

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P+T ML+EKL G  P LLD TT   D
Sbjct: 249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPSTQMLLEKLNGTVPCLLDTTTIPAD 308

Query: 248 -----TGQDD-----GEENACSYISEQQTQVLTS---RKFSDSFHSIVELCLSRDVDKRP 294
                T +       GE  A S +     +       R FS  FH+ VE CL R+ D RP
Sbjct: 309 ELTMRTSRSSANYGMGESTATSNVRAANGEPALHPYLRTFSTYFHNFVEQCLQRNPDFRP 368

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H FFKQ K + S  LPELLRP
Sbjct: 369 SAGTLLSHPFFKQIKRRASEALPELLRP 396

Source: Taeniopygia guttata

Species: Taeniopygia guttata

Genus: Taeniopygia

Family: Estrildidae

Order: Passeriformes

Class: Aves

Phylum: Chordata

Superkingdom: Eukaryota

>gi|449267457|gb|EMC78400.1| STE20-related kinase adapter protein alpha, partial [Columba livia]

 Score =  267 bits (682), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 152/328 (46%), Positives = 198/328 (60%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +I+G+ F +L  V L+++K T + + V++ NL+  T+E +  L  E+   +   HP
Sbjct: 29  YELLTIIGRGFEDLMVVNLARYKPTGEYVTVRRVNLEACTNEMVTFLQGELHVSKLFNHP 88

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 89  NIVPYKATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 148

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M       K VH FP  +   L WLSPEV
Sbjct: 149 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLKVVHDFPKYSIKVLPWLSPEV 208

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P+T ML+EKL G  P LLD TT   D
Sbjct: 209 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPSTQMLLEKLNGTVPCLLDTTTIPAD 268

Query: 248 -----TGQDD-----GEENACSYISEQQTQVLTS---RKFSDSFHSIVELCLSRDVDKRP 294
                T +       GE  A S +     +       R FS  FH+ VE CL R+ D RP
Sbjct: 269 ELTMKTSRSSANYGVGESMAVSNVRAANGEPTLHPYLRTFSTYFHNFVEQCLQRNPDFRP 328

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H FFKQ K + S  LPELLRP
Sbjct: 329 SAGTLLNHPFFKQIKRRASEALPELLRP 356

Source: Columba livia

Species: Columba livia

Genus: Columba

Family: Columbidae

Order: Columbiformes

Class: Aves

Phylum: Chordata

Superkingdom: Eukaryota

>gi|51858665|gb|AAH81911.1| Lyk5 protein [Rattus norvegicus]

 Score =  266 bits (680), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 146/328 (44%), Positives = 197/328 (60%), Gaps = 17/328 (5%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ S++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 11  YELLSVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 70

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L  V+  M +GS KDLI  HF  G+ ELVI +ILQ VL  L+YIH 
Sbjct: 71  NIVPYRATFIADNELWAVTSFMAYGSAKDLIGTHFMDGMSELVIAYILQGVLKALDYIHH 130

Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 131 MGYVHRSVKASHILISTDGKVYLSGLRSNLSMISHGQRQRAVHDFPKYSIKVLPWLSPEV 190

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY--- 244
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T    
Sbjct: 191 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 250

Query: 245 ---------YVDTGQDDG-EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                      + G +D     +    +         R FS  FH+ VE CL R+ D RP
Sbjct: 251 ELTMSPSRSIANPGLNDSLAAGSLRPANGDSPSHPYHRTFSPHFHNFVEQCLQRNPDARP 310

Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 311 NASTLLNHSFFKQIKRRASEALPELLRP 338

Source: Rattus norvegicus

Species: Rattus norvegicus

Genus: Rattus

Family: Muridae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	622
ZFIN|ZDB-GENE-030131-6482	399	strada "ste20-related kinase a	0.377	0.588	0.457	1.4e-64
UNIPROTKB|E1C0N4	431	STRADA "STE20-related kinase a	0.496	0.716	0.442	1.3e-61
UNIPROTKB|F1NL91	388	STRADA "STE20-related kinase a	0.485	0.778	0.449	2.7e-61
UNIPROTKB|Q5ZK47	389	STRADA "STE20-related kinase a	0.485	0.776	0.449	2.7e-61
UNIPROTKB|E2RGK3	431	STRADA "Uncharacterized protei	0.482	0.696	0.446	7.1e-61
UNIPROTKB|F1PFF0	373	STRADA "Uncharacterized protei	0.482	0.804	0.446	7.1e-61
UNIPROTKB|Q7RTN6	431	STRADA "STE20-related kinase a	0.482	0.696	0.436	9e-61
UNIPROTKB|D4A6D6	431	Strada "Protein kinase LYK5, i	0.482	0.696	0.433	1.2e-60
UNIPROTKB|F1M341	394	Strada "STE20-related kinase a	0.482	0.761	0.433	1.2e-60
MGI|MGI:1919399	431	Strada "STE20-related kinase a	0.482	0.696	0.436	1.9e-60

ZFIN|ZDB-GENE-030131-6482 strada "ste20-related kinase adaptor alpha" [Danio rerio (taxid:7955)]

 Score = 522 (188.8 bits), Expect = 1.4e-64, Sum P(2) = 1.4e-64
 Identities = 109/238 (45%), Positives = 152/238 (63%)

Query:     9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
             S Y++ +++G+   +L +V L+ +K T + +A+++ +LD   ++ +  L  E+   +   
Sbjct:    30 SAYELRNVIGRGLESLMTVNLAVYKPTGEYVAIRRIDLDSCANDMVSYLQGELRVSKLFH 89

Query:    69 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
             HP I+ Y S F+   +L +++P M +GS +DLI  HF  GL E  I +IL  VL  LEYI
Sbjct:    90 HPCILPYKSVFIAENELWVITPFMAYGSARDLIITHFTDGLNEQTIAYILLGVLRALEYI 149

Query:   129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPF---SPTKKKVHLFPPSTAYNLNWLSP 185
             H  G++HR+VKASHILIS +G+  LSGLR +          + VH FP  +   L WLSP
Sbjct:   150 HQMGYVHRSVKASHILISADGQMFLSGLRSIFSLIRHGQRARVVHDFPQYSVKVLPWLSP 209

Query:   186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 243
             EVL+QNL GYD RSDIYS+GI+ CELANG VPF + P T ML+EKL G  P LLD TT
Sbjct:   210 EVLQQNLQGYDFRSDIYSLGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 267

GO:0005524 "ATP binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

UNIPROTKB|E1C0N4 STRADA "STE20-related kinase adapter protein alpha" [Gallus gallus (taxid:9031)]

 Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
 Identities = 145/328 (44%), Positives = 198/328 (60%)

Query:     2 ETLDN-VPSN--YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH 58
             +T+ N +P +  Y++ +I+G+ F +L  V L+++K + + + V++ NL+  T+E +  L 
Sbjct:    57 DTMSNFLPDSSCYELLTIIGRGFEDLMVVNLARYKPSGEYVTVRRVNLEACTNEMVTFLQ 116

Query:    59 HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
              E+   +   HPNI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +IL
Sbjct:   117 GELHVSKLFNHPNIVPYKATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYIL 176

Query:   119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPS 175
             Q VL  L+YIH  G++HR+VKASHILIS +GK  LSGLR    M       K VH FP  
Sbjct:   177 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLKVVHDFPKY 236

Query:   176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 235
             +   L WLSPEVL+QNL GYD +SDIYS+GI+ CELANG VPF + P+T ML+EKL G  
Sbjct:   237 SIKVLPWLSPEVLQQNLQGYDAKSDIYSIGITACELANGHVPFKDMPSTQMLLEKLNGTV 296

Query:   236 PHLLDCTTYYVD-----TGQDD-----GEENACSYI---SEQQTQVLTSRKFSDSFHSIV 282
             P LLD TT   D     T +       GE  A S +   + + T     R FS  FH+ V
Sbjct:   297 PCLLDTTTIPADELTMKTSRSSANYGLGESTAVSNVRAANGESTLHPYLRTFSSCFHNFV 356

Query:   283 ELCLSRDVDKRPLACNLLQHAFFKQTKK 310
               CL R+ D RP A  LL H FFKQ K+
Sbjct:   357 GQCLQRNPDFRPSAGALLNHPFFKQIKR 384

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0019900 "kinase binding" evidence=IEA

GO:0030295 "protein kinase activator activity" evidence=IEA

GO:0032147 "activation of protein kinase activity" evidence=IEA

UNIPROTKB|F1NL91 STRADA "STE20-related kinase adapter protein alpha" [Gallus gallus (taxid:9031)]

 Score = 627 (225.8 bits), Expect = 2.7e-61, P = 2.7e-61
 Identities = 143/318 (44%), Positives = 192/318 (60%)

Query:     9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
             S Y++ +I+G+ F +L  V L+++K + + + V++ NL+  T+E +  L  E+   +   
Sbjct:     9 SCYELLTIIGRGFEDLMVVNLARYKPSGEYVTVRRVNLEACTNEMVTFLQGELHVSKLFN 68

Query:    69 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
             HPNI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YI
Sbjct:    69 HPNIVPYKATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 128

Query:   129 HGKGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSP 185
             H  G++HR+VKASHILIS +GK  LSGLR    M       K VH FP  +   L WLSP
Sbjct:   129 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLKVVHDFPKYSIKVLPWLSP 188

Query:   186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 245
             EVL+QNL GYD +SDIYS+GI+ CELANG VPF + P+T ML+EKL G  P LLD TT  
Sbjct:   189 EVLQQNLQGYDAKSDIYSIGITACELANGHVPFKDMPSTQMLLEKLNGTVPCLLDTTTIP 248

Query:   246 VD-----TGQDD-----GEENACSYI---SEQQTQVLTSRKFSDSFHSIVELCLSRDVDK 292
              D     T +       GE  A S +   + + T     R FS  FH+ V  CL R+ D 
Sbjct:   249 ADELTMKTSRSSANYGLGESTAVSNVRAANGESTLHPYLRTFSSCFHNFVGQCLQRNPDF 308

Query:   293 RPLACNLLQHAFFKQTKK 310
             RP A  LL H FFKQ K+
Sbjct:   309 RPSAGALLNHPFFKQIKR 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q5ZK47 STRADA "STE20-related kinase adapter protein alpha" [Gallus gallus (taxid:9031)]

 Score = 627 (225.8 bits), Expect = 2.7e-61, P = 2.7e-61
 Identities = 143/318 (44%), Positives = 192/318 (60%)

Query:     9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
             S Y++ +I+G+ F +L  V L+++K + + + V++ NL+  T+E +  L  E+   +   
Sbjct:     9 SCYELLTIIGRGFEDLMVVNLARYKPSGEYVTVRRVNLEACTNEMVTFLQGELHVSKLFN 68

Query:    69 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
             HPNI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YI
Sbjct:    69 HPNIVPYKATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 128

Query:   129 HGKGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSP 185
             H  G++HR+VKASHILIS +GK  LSGLR    M       K VH FP  +   L WLSP
Sbjct:   129 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLKVVHDFPKYSIKVLPWLSP 188

Query:   186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 245
             EVL+QNL GYD +SDIYS+GI+ CELANG VPF + P+T ML+EKL G  P LLD TT  
Sbjct:   189 EVLQQNLQGYDAKSDIYSIGITACELANGHVPFKDMPSTQMLLEKLNGTVPCLLDTTTIP 248

Query:   246 VD-----TGQDD-----GEENACSYI---SEQQTQVLTSRKFSDSFHSIVELCLSRDVDK 292
              D     T +       GE  A S +   + + T     R FS  FH+ V  CL R+ D 
Sbjct:   249 ADELTMKTSRSSANYGLGESTAVSNVRAANGESTLHPYLRTFSSCFHNFVGQCLQRNPDF 308

Query:   293 RPLACNLLQHAFFKQTKK 310
             RP A  LL H FFKQ K+
Sbjct:   309 RPSAGALLNHPFFKQIKR 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0030295 "protein kinase activator activity" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0006611 "protein export from nucleus" evidence=ISS

GO:0032147 "activation of protein kinase activity" evidence=ISS

UNIPROTKB|E2RGK3 STRADA "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 623 (224.4 bits), Expect = 7.1e-61, P = 7.1e-61
 Identities = 141/316 (44%), Positives = 191/316 (60%)

Query:    11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
             Y++ +I+G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct:    69 YELLTIIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 128

Query:    71 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
             NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct:   129 NILPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 188

Query:   131 KGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
              G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct:   189 MGYVHRSVKASHILISSDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 248

Query:   188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
             L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct:   249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 308

Query:   248 T-GQDDGEENACSYISEQ-QTQV-LTS----------RKFSDSFHSIVELCLSRDVDKRP 294
                       A S +S+   T    TS          R FS  FH  VE CL R+ D RP
Sbjct:   309 ELTMSTSRSAANSGLSDSLATSTPRTSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDVRP 368

Query:   295 LACNLLQHAFFKQTKK 310
              A  LL H+FFKQ K+
Sbjct:   369 SASTLLNHSFFKQIKR 384

GO:0032147 "activation of protein kinase activity" evidence=IEA

GO:0030295 "protein kinase activator activity" evidence=IEA

GO:0019900 "kinase binding" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1PFF0 STRADA "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 623 (224.4 bits), Expect = 7.1e-61, P = 7.1e-61
 Identities = 141/316 (44%), Positives = 191/316 (60%)

Query:    11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
             Y++ +I+G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct:    11 YELLTIIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 70

Query:    71 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
             NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct:    71 NILPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130

Query:   131 KGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
              G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct:   131 MGYVHRSVKASHILISSDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 190

Query:   188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
             L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct:   191 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 250

Query:   248 T-GQDDGEENACSYISEQ-QTQV-LTS----------RKFSDSFHSIVELCLSRDVDKRP 294
                       A S +S+   T    TS          R FS  FH  VE CL R+ D RP
Sbjct:   251 ELTMSTSRSAANSGLSDSLATSTPRTSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDVRP 310

Query:   295 LACNLLQHAFFKQTKK 310
              A  LL H+FFKQ K+
Sbjct:   311 SASTLLNHSFFKQIKR 326

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|Q7RTN6 STRADA "STE20-related kinase adapter protein alpha" [Homo sapiens (taxid:9606)]

 Score = 622 (224.0 bits), Expect = 9.0e-61, P = 9.0e-61
 Identities = 138/316 (43%), Positives = 189/316 (59%)

Query:    11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
             Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct:    69 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 128

Query:    71 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
             NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct:   129 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 188

Query:   131 KGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
              G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct:   189 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 248

Query:   188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
             L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct:   249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 308

Query:   248 T-GQDDGEENACSYISEQQTQVLTS------------RKFSDSFHSIVELCLSRDVDKRP 294
                       A S +S+  T                 R FS  FH  VE CL R+ D RP
Sbjct:   309 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 368

Query:   295 LACNLLQHAFFKQTKK 310
              A  LL H+FFKQ K+
Sbjct:   369 SASTLLNHSFFKQIKR 384

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0032147 "activation of protein kinase activity" evidence=IDA

GO:0006611 "protein export from nucleus" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0030295 "protein kinase activator activity" evidence=IDA

GO:0005829 "cytosol" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0046320 "regulation of fatty acid oxidation" evidence=TAS

GO:0019900 "kinase binding" evidence=IPI

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

UNIPROTKB|D4A6D6 Strada "Protein kinase LYK5, isoform CRA_a" [Rattus norvegicus (taxid:10116)]

 Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
 Identities = 137/316 (43%), Positives = 188/316 (59%)

Query:    11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
             Y++ S++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct:    69 YELLSVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 128

Query:    71 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
             NI+ Y ++F+   +L  V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct:   129 NIVPYRATFIADNELWAVTSFMAYGSAKDLIGTHFMDGMSELAIAYILQGVLKALDYIHH 188

Query:   131 KGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
              G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct:   189 MGYVHRSVKASHILISTDGKVYLSGLRSNLSMISHGQRQRAVHDFPKYSIKVLPWLSPEV 248

Query:   188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY--- 244
             L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T    
Sbjct:   249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 308

Query:   245 ---------YVDTGQDDG-EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                        + G +D     +    +         R FS  FH+ VE CL R+ D RP
Sbjct:   309 ELTMSPSRSIANPGLNDSLAAGSLRPANGDSPSHPYHRTFSPHFHNFVEQCLQRNPDARP 368

Query:   295 LACNLLQHAFFKQTKK 310
              A  LL H+FFKQ K+
Sbjct:   369 NASTLLNHSFFKQIKR 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1M341 Strada "STE20-related kinase adapter protein alpha" [Rattus norvegicus (taxid:10116)]

 Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
 Identities = 137/316 (43%), Positives = 188/316 (59%)

Query:    11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
             Y++ S++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct:    32 YELLSVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 91

Query:    71 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
             NI+ Y ++F+   +L  V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct:    92 NIVPYRATFIADNELWAVTSFMAYGSAKDLIGTHFMDGMSELAIAYILQGVLKALDYIHH 151

Query:   131 KGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
              G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct:   152 MGYVHRSVKASHILISTDGKVYLSGLRSNLSMISHGQRQRAVHDFPKYSIKVLPWLSPEV 211

Query:   188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY--- 244
             L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T    
Sbjct:   212 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 271

Query:   245 ---------YVDTGQDDG-EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                        + G +D     +    +         R FS  FH+ VE CL R+ D RP
Sbjct:   272 ELTMSPSRSIANPGLNDSLAAGSLRPANGDSPSHPYHRTFSPHFHNFVEQCLQRNPDARP 331

Query:   295 LACNLLQHAFFKQTKK 310
              A  LL H+FFKQ K+
Sbjct:   332 NASTLLNHSFFKQIKR 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1919399 Strada "STE20-related kinase adaptor alpha" [Mus musculus (taxid:10090)]

 Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
 Identities = 138/316 (43%), Positives = 189/316 (59%)

Query:    11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
             Y++ +I+G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct:    69 YELLTIIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFSHP 128

Query:    71 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
             NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct:   129 NIVPYRATFIADNELWVVTSFMAYGSAKDLIGTHFMDGMNELAIAYILQGVLKALDYIHH 188

Query:   131 KGFIHRAVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
              G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct:   189 MGYVHRSVKASHILISTDGKVYLSGLRSNLSMISHGQRQRAVHDFPKYSIKVLPWLSPEV 248

Query:   188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY--- 244
             L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T    
Sbjct:   249 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 308

Query:   245 ---------YVDTGQDDGEENACSYISEQQTQVLT-SRKFSDSFHSIVELCLSRDVDKRP 294
                        + G +D         S   +      R FS  FH+ VE CL R+ D RP
Sbjct:   309 ELTMSPSRSIANPGLNDSLAAGSLRPSNGDSPSHPYHRTFSPHFHNFVEQCLQRNPDARP 368

Query:   295 LACNLLQHAFFKQTKK 310
              A  LL H+FFKQ K+
Sbjct:   369 NASTLLNHSFFKQIKR 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019900 "kinase binding" evidence=ISO

GO:0030295 "protein kinase activator activity" evidence=ISO

GO:0032147 "activation of protein kinase activity" evidence=ISO

GO:0043234 "protein complex" evidence=ISO

GO:0051291 "protein heterooligomerization" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	622
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-142
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-117
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-89
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-76
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-71
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-60
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-49
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-47
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-40
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-40
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-39
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-38
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-36
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-36
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-35
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-33
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-33
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-32
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-30
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-30
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-29
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-29
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-28
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-28
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-27
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-27
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-26
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-26
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-25
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-25
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-24
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-24
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-24
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-23
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-22
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-21
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-21
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-19
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-19
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-19
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-06
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-04
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-04
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-04
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	0.001
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.001
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.001
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.001
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.001
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.001
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	0.001
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	0.001
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.001
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.002
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.002
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.003
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.003
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.003
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.003
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.003
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.003
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.004
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.004
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.004
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.004

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  414 bits (1067), Expect = e-142
 Identities = 166/313 (53%), Positives = 213/313 (68%), Gaps = 6/313 (1%)

Query: 14  CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII 73
            +++G+CF +L  V+L+KHK TN L+AVKK NLD  + EDLK L  EI+  R L+HPNI+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 74  CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF 133
            Y++SF+  ++L++VSPLM +GSC+DL+  HF  GLPEL I  IL+DVLN L+YIH KGF
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122

Query: 134 IHRAVKASHILISHNGKACLSGLRYMCPF---SPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           IHR+VKASHIL+S +GK  LSGLRY          ++ VH FP S+  NL WLSPEVL+Q
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 191 NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY--YVDT 248
           NL GY+E+SDIYSVGI+ CELANG VPF + P T ML+EK+ G  P LLD +TY  Y D+
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242

Query: 249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT 308
                  N              +R FS+ FH  VELCL RD + RP A  LL H+FFKQ 
Sbjct: 243 MSQSRSSNEHPNNR-DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301

Query: 309 KKCSVMLPELLRP 321
           K+ +  L +LL+P
Sbjct: 302 KRRNTSLLDLLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  351 bits (903), Expect = e-117
 Identities = 136/239 (56%), Positives = 175/239 (73%), Gaps = 3/239 (1%)

Query: 364 CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII 423
            +++G+CF +L  V+L+KHK TN L+AVKK NLD  + EDLK L  EI+  R L+HPNI+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 424 CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF 483
            Y++SF+  ++L++VSPLM +GSC+DL+  HF  GLPEL I  IL+DVLN L+YIH KGF
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122

Query: 484 IHRAVKASHILISHNGKACLSGLRYMCPF---SPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           IHR+VKASHIL+S +GK  LSGLRY          ++ VH FP S+  NL WLSPEVL+Q
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 541 NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG 599
           NL GY+E+SDIYSVGI+ CELANG VPF + P T ML+EK+ G  P LLD +TY +   
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score =  280 bits (718), Expect = 1e-89
 Identities = 145/324 (44%), Positives = 195/324 (60%), Gaps = 17/324 (5%)

Query: 15  SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC 74
           +++G+ F +L +V L+++K T + + V++ NL+  T+E +  L  E+   +   HPNI+ 
Sbjct: 4   TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVP 63

Query: 75  YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI 134
           Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH  G++
Sbjct: 64  YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYV 123

Query: 135 HRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN 191
           HR+VKASHILIS +GK  LSGLR    M       + VH FP  +   L WLSPEVL+QN
Sbjct: 124 HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN 183

Query: 192 LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY------- 244
           L GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD TT        
Sbjct: 184 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTM 243

Query: 245 -----YVDTGQDDGEENACSYISEQQTQVLT-SRKFSDSFHSIVELCLSRDVDKRPLACN 298
                  ++G  +    +    S  ++     +R FS  FH  VE CL R+ D RP A  
Sbjct: 244 KPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST 303

Query: 299 LLQHAFFKQTKK-CSVMLPELLRP 321
           LL H+FFKQ K+  S  LPELLRP
Sbjct: 304 LLNHSFFKQIKRRASEALPELLRP 327

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score =  244 bits (625), Expect = 7e-76
 Identities = 130/311 (41%), Positives = 184/311 (59%), Gaps = 17/311 (5%)

Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYI 76
           +G+ F NL+SVYL++H  T  L+ V+  +L+  T+E LK+L +E+V     RHPNI+   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 77  SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 136
           + F   + L ++SP M +GS   L+  +F  G+ E +I +IL   L GL Y+H  G+IHR
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHR 125

Query: 137 AVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
            +KASHILIS +G   LSGL +   +       K V+ FP  +   L WLSPE+L Q+L 
Sbjct: 126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185

Query: 194 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD------ 247
           GY+ +SDIYSVGI+ CELA G VPF +   T ML++KL G     LD TT+  +      
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245

Query: 248 --TGQDDGEENACSYISEQQT------QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL 299
             +G D G   +       QT      +  +S+ FS +F ++VELCL +D +KRP A +L
Sbjct: 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305

Query: 300 LQHAFFKQTKK 310
           L HAFFKQ K+
Sbjct: 306 LSHAFFKQVKE 316

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score =  233 bits (595), Expect = 2e-71
 Identities = 113/232 (48%), Positives = 153/232 (65%), Gaps = 3/232 (1%)

Query: 365 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC 424
           +++G+ F +L +V L+++K T + + V++ NL+  T+E +  L  E+   +   HPNI+ 
Sbjct: 4   TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVP 63

Query: 425 YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI 484
           Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH  G++
Sbjct: 64  YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYV 123

Query: 485 HRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN 541
           HR+VKASHILIS +GK  LSGLR    M       + VH FP  +   L WLSPEVL+QN
Sbjct: 124 HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN 183

Query: 542 LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 593
           L GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD TT
Sbjct: 184 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score =  204 bits (519), Expect = 2e-60
 Identities = 102/231 (44%), Positives = 143/231 (61%), Gaps = 3/231 (1%)

Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYI 426
           +G+ F NL+SVYL++H  T  L+ V+  +L+  T+E LK+L +E+V     RHPNI+   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 427 SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 486
           + F   + L ++SP M +GS   L+  +F  G+ E +I +IL   L GL Y+H  G+IHR
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHR 125

Query: 487 AVKASHILISHNGKACLSGLRY---MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
            +KASHILIS +G   LSGL +   +       K V+ FP  +   L WLSPE+L Q+L 
Sbjct: 126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185

Query: 544 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY 594
           GY+ +SDIYSVGI+ CELA G VPF +   T ML++KL G     LD TT+
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  172 bits (438), Expect = 1e-49
 Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 42/280 (15%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            VY ++HK T + +A+K   L+  + E  + + +EI  ++  +HPNI+ Y  S+L   +L
Sbjct: 15  EVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V      GS KDL+    N  L E  I ++ +++L GLEY+H  G IHR +KA++IL+
Sbjct: 73  WIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
           + +G+  L         S TK +  +    T Y   W++PEV+      YD ++DI+S+G
Sbjct: 132 TSDGEVKLIDFGLSAQLSDTKARNTMV--GTPY---WMAPEVINGK--PYDYKADIWSLG 184

Query: 206 ISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
           I+  ELA G  P++E  P   +                 + + T                
Sbjct: 185 ITAIELAEGKPPYSELPPMKAL-----------------FKIAT--------------NG 213

Query: 265 QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
              +    K+SD F   ++ CL ++ +KRP A  LL+H F
Sbjct: 214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  171 bits (435), Expect = 5e-49
 Identities = 93/307 (30%), Positives = 148/307 (48%), Gaps = 50/307 (16%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            +Y++  ++G      + VY +     N+ +A+K+ +L++     +  L  E+  M    
Sbjct: 1   DDYELIEVIGV--GATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCN 57

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 127
           HPN++ Y +SF+   +L LV P +  GS  D++ + +  G L E +I  +L++VL GLEY
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 128 IHGKGFIHRAVKASHILISHNG---------KACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
           +H  G IHR +KA +IL+  +G          A L            +K     P     
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRKTFVGTP----- 170

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 238
              W++PEV+EQ + GYD ++DI+S GI+  ELA G  P+++ P   +L+  L    P L
Sbjct: 171 --CWMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSL 227

Query: 239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                   +TG D                     K+S SF  ++ LCL +D  KRP A  
Sbjct: 228 --------ETGADYK-------------------KYSKSFRKMISLCLQKDPSKRPTAEE 260

Query: 299 LLQHAFF 305
           LL+H FF
Sbjct: 261 LLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  167 bits (425), Expect = 1e-47
 Identities = 82/299 (27%), Positives = 124/299 (41%), Gaps = 49/299 (16%)

Query: 11  YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           Y+I   LG+  F     VYL++ K T +L+A+K     ++  +D + +  EI  ++ L+H
Sbjct: 1   YEILEKLGEGSF---GKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKH 56

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+     F D   L+LV      G   DL+       L E      L+ +L+ LEY+H
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH 114

Query: 130 GKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
            KG +HR +K  +IL+  +G   L+  GL R + P       V      T     +++PE
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-----GTPE---YMAPE 166

Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 246
           VL     GY +  DI+S+G+   EL  G  PF      L L +K+    P          
Sbjct: 167 VLLGK--GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP----- 219

Query: 247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                                       S     ++   L +D +KR  A   LQH FF
Sbjct: 220 ------------------------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 3e-45
 Identities = 100/312 (32%), Positives = 153/312 (49%), Gaps = 48/312 (15%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           + +   +G+   +   VY +  K TNQ++A+K  +L+   +++++ +  EI  +   R P
Sbjct: 3   FTLLECIGK--GSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSP 59

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
            I  Y  SFL  + L ++    G GSC DL+       L E  I  IL++VL GLEY+H 
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE 116

Query: 131 KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +G IHR +KA++IL+S  G   L+        + T  K + F   T +   W++PEV++Q
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPF---WMAPEVIKQ 172

Query: 191 NLDGYDERSDIYSVGISCCELANGTVPFAET-PT-TLMLIEKLAGATPHLLDCTTYYVDT 248
           +  GYDE++DI+S+GI+  ELA G  P ++  P   L LI K    +             
Sbjct: 173 S--GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS------------- 217

Query: 249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT 308
                               L   KFS  F   V LCL++D  +RP A  LL+H F K+ 
Sbjct: 218 --------------------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257

Query: 309 KKCSVMLPELLR 320
           KK S  L  L+ 
Sbjct: 258 KKTSY-LTLLIE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (393), Expect = 4e-43
 Identities = 72/245 (29%), Positives = 111/245 (45%), Gaps = 20/245 (8%)

Query: 361 YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           Y+I   LG+  F     VYL++ K T +L+A+K     ++  +D + +  EI  ++ L+H
Sbjct: 1   YEILEKLGEGSF---GKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKH 56

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+     F D   L+LV      G   DL+       L E      L+ +L+ LEY+H
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH 114

Query: 480 GKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
            KG +HR +K  +IL+  +G   L+  GL R + P       V      T     +++PE
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-----GTPE---YMAPE 166

Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 596
           VL     GY +  DI+S+G+   EL  G  PF      L L +K+    P          
Sbjct: 167 VLLGK--GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224

Query: 597 DTGQD 601
              +D
Sbjct: 225 PEAKD 229

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  153 bits (390), Expect = 1e-42
 Identities = 68/202 (33%), Positives = 112/202 (55%), Gaps = 11/202 (5%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            VY ++HK T + +A+K   L+  + E  + + +EI  ++  +HPNI+ Y  S+L   +L
Sbjct: 15  EVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V      GS KDL+    N  L E  I ++ +++L GLEY+H  G IHR +KA++IL+
Sbjct: 73  WIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
           + +G+  L         S TK +  +    T Y   W++PEV+      YD ++DI+S+G
Sbjct: 132 TSDGEVKLIDFGLSAQLSDTKARNTMV--GTPY---WMAPEVINGK--PYDYKADIWSLG 184

Query: 556 ISCCELANGTVPFAE-TPTTLM 576
           I+  ELA G  P++E  P   +
Sbjct: 185 ITAIELAEGKPPYSELPPMKAL 206

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  153 bits (390), Expect = 1e-42
 Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 49/289 (16%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +VY +KHK T +++AVK         +  ++   EI  +R L HPNI+  I +F D   
Sbjct: 13  GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L+LV      G   D ++        E     I   +L GLEY+H  G IHR +K  +IL
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGPL--SEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL 130

Query: 145 ISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDER 198
           +  NG   ++  GL           K  L   S+         +++PEVL    +GY  +
Sbjct: 131 LDENGVVKIADFGL----------AKKLLKSSSSLTTFVGTPWYMAPEVLLGG-NGYGPK 179

Query: 199 SDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEEN 256
            D++S+G+   EL  G  PF+       L LI ++ G                       
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF------------------ 221

Query: 257 ACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                             S+    +++ CL++D  KRP A  +LQH +F
Sbjct: 222 ----------DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  151 bits (383), Expect = 2e-41
 Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 50/298 (16%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            VY +  + T + +A+KK    R+  ++ + + +EI+ M+  +HPNI+ Y  S+L   +L
Sbjct: 34  EVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V   M  GS  D+I       + E  I ++ ++VL GLEY+H +  IHR +K+ +IL+
Sbjct: 91  WVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPS---TAYNLNWLSPEVLEQNLDGYDERSDIY 202
           S +G   L+   +    +  K K +    S   T Y   W++PEV+++    Y  + DI+
Sbjct: 150 SKDGSVKLADFGFAAQLTKEKSKRN----SVVGTPY---WMAPEVIKRKD--YGPKVDIW 200

Query: 203 SVGISCCELANGTVPFAETP--TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           S+GI C E+A G  P+   P    L LI       P L +                    
Sbjct: 201 SLGIMCIEMAEGEPPYLREPPLRALFLITT--KGIPPLKN-------------------- 238

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPEL 318
                       K+S  F   +  CL +D +KRP A  LLQH F K+        P +
Sbjct: 239 ----------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  147 bits (374), Expect = 2e-40
 Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 48/288 (16%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            SVYL+  K T +L+AVK   L   ++E+L++L  EI  +  L+HPNI+ Y  S  D   
Sbjct: 14  GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73

Query: 85  --LHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
             L++    +  GS   L+     FG LPE VI    + +L GL Y+H  G +HR +K +
Sbjct: 74  NTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGA 130

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKK----VHLFPPSTAYNLNWLSPEVLEQNLDGYDE 197
           +IL+  +G   L+       F   K+           S      W++PEV+    + Y  
Sbjct: 131 NILVDSDGVVKLAD------FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--EEYGR 182

Query: 198 RSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENA 257
            +DI+S+G +  E+A G  P++E    +  + K+  +                       
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------------- 222

Query: 258 CSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
              I E           S+     +  CL RD  KRP A  LLQH F 
Sbjct: 223 -PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  146 bits (370), Expect = 8e-40
 Identities = 74/246 (30%), Positives = 123/246 (50%), Gaps = 23/246 (9%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
            +Y++  ++G      + VY +     N+ +A+K+ +L++     +  L  E+  M    
Sbjct: 1   DDYELIEVIGV--GATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCN 57

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 477
           HPN++ Y +SF+   +L LV P +  GS  D++ + +  G L E +I  +L++VL GLEY
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 478 IHGKGFIHRAVKASHILISHNG---------KACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
           +H  G IHR +KA +IL+  +G          A L            +K     P     
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRKTFVGTP----- 170

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 588
              W++PEV+EQ + GYD ++DI+S GI+  ELA G  P+++ P   +L+  L    P L
Sbjct: 171 --CWMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSL 227

Query: 589 LDCTTY 594
                Y
Sbjct: 228 ETGADY 233

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  143 bits (364), Expect = 5e-39
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 19/200 (9%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            +VY +KHK T +++AVK         +  ++   EI  +R L HPNI+  I +F D   
Sbjct: 13  GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           L+LV      G   D ++        E     I   +L GLEY+H  G IHR +K  +IL
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGPL--SEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL 130

Query: 495 ISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDER 548
           +  NG   ++  GL           K  L   S+         +++PEVL    +GY  +
Sbjct: 131 LDENGVVKIADFGL----------AKKLLKSSSSLTTFVGTPWYMAPEVLLGG-NGYGPK 179

Query: 549 SDIYSVGISCCELANGTVPF 568
            D++S+G+   EL  G  PF
Sbjct: 180 VDVWSLGVILYELLTGKPPF 199

Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  142 bits (360), Expect = 2e-38
 Identities = 86/298 (28%), Positives = 139/298 (46%), Gaps = 49/298 (16%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           + I   LG+   +  SVY + HK T Q++A+K        +EDL+ +  EI  ++    P
Sbjct: 5   FDILEKLGE--GSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
            I+ Y  S+   TDL +V    G GS  D++    N  L E  I  IL   L GLEY+H 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 131 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
              IHR +KA +IL++  G+A L+  G+      +  K+   +    T +   W++PEV+
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPF---WMAPEVI 171

Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT 248
           ++   GY+ ++DI+S+GI+  E+A G  P+++      +                     
Sbjct: 172 QEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------------------- 210

Query: 249 GQDDGEENACSYISEQQTQVLTS-RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                       I  +    L+   K+S  F+  V+ CL +D ++RP A  LLQH F 
Sbjct: 211 ------------IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 4e-38
 Identities = 86/282 (30%), Positives = 128/282 (45%), Gaps = 40/282 (14%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            VY ++   T +L+A+K   L+    +D + +  EI  ++  RHPNI+ Y  S+L    L
Sbjct: 18  DVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V    G GS +D+        L EL I ++ ++ L GL Y+H  G IHR +K ++IL+
Sbjct: 76  WIVMEYCGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL 134

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSV 204
           + +G   L+        + T  K   F   T Y   W++PEV       GYD + DI+++
Sbjct: 135 TEDGDVKLADFGVSAQLTATIAKRKSF-IGTPY---WMAPEVAAVERKGGYDGKCDIWAL 190

Query: 205 GISCCELANGTVPFAET-PT-TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           GI+  ELA    P  +  P   L LI K     P L D                      
Sbjct: 191 GITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD---------------------- 228

Query: 263 EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                     K+S  FH  ++ CL++D  KRP A  LLQH F
Sbjct: 229 --------KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  135 bits (342), Expect = 2e-36
 Identities = 62/188 (32%), Positives = 93/188 (49%), Gaps = 8/188 (4%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +VYL++ K T + +A+K    +  +   L+ L  EI  ++ L HPNI+     F D   
Sbjct: 7   GTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH 65

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L+LV      GS KDL+  +    L E  I  IL  +L GLEY+H  G IHR +K  +IL
Sbjct: 66  LYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENIL 124

Query: 145 ISH-NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
           +   NGK  L+        +  K  +     +      +++PEVL      Y E+SDI+S
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLK----TIVGTPAYMAPEVLLGK-GYYSEKSDIWS 179

Query: 204 VGISCCEL 211
           +G+   EL
Sbjct: 180 LGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  135 bits (342), Expect = 2e-36
 Identities = 62/188 (32%), Positives = 93/188 (49%), Gaps = 8/188 (4%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            +VYL++ K T + +A+K    +  +   L+ L  EI  ++ L HPNI+     F D   
Sbjct: 7   GTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH 65

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           L+LV      GS KDL+  +    L E  I  IL  +L GLEY+H  G IHR +K  +IL
Sbjct: 66  LYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENIL 124

Query: 495 ISH-NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
           +   NGK  L+        +  K  +     +      +++PEVL      Y E+SDI+S
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLK----TIVGTPAYMAPEVLLGK-GYYSEKSDIWS 179

Query: 554 VGISCCEL 561
           +G+   EL
Sbjct: 180 LGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 3e-36
 Identities = 72/210 (34%), Positives = 118/210 (56%), Gaps = 12/210 (5%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           + +   +G+   +   VY +  K TNQ++A+K  +L+   +++++ +  EI  +   R P
Sbjct: 3   FTLLECIGK--GSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSP 59

Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 480
            I  Y  SFL  + L ++    G GSC DL+       L E  I  IL++VL GLEY+H 
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE 116

Query: 481 KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +G IHR +KA++IL+S  G   L+        + T  K + F   T +   W++PEV++Q
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPF---WMAPEVIKQ 172

Query: 541 NLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +  GYDE++DI+S+GI+  ELA G  P ++
Sbjct: 173 S--GYDEKADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  133 bits (336), Expect = 4e-35
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 18/220 (8%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            SVYL+  K T +L+AVK   L   ++E+L++L  EI  +  L+HPNI+ Y  S  D   
Sbjct: 14  GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73

Query: 435 --LHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
             L++    +  GS   L+     FG LPE VI    + +L GL Y+H  G +HR +K +
Sbjct: 74  NTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGA 130

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKK----VHLFPPSTAYNLNWLSPEVLEQNLDGYDE 547
           +IL+  +G   L+       F   K+           S      W++PEV+    + Y  
Sbjct: 131 NILVDSDGVVKLAD------FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--EEYGR 182

Query: 548 RSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH 587
            +DI+S+G +  E+A G  P++E    +  + K+  +   
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  131 bits (332), Expect = 2e-34
 Identities = 63/200 (31%), Positives = 108/200 (54%), Gaps = 16/200 (8%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            VY +  + T + +A+KK    R+  ++ + + +EI+ M+  +HPNI+ Y  S+L   +L
Sbjct: 34  EVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V   M  GS  D+I       + E  I ++ ++VL GLEY+H +  IHR +K+ +IL+
Sbjct: 91  WVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPS---TAYNLNWLSPEVLEQNLDGYDERSDIY 552
           S +G   L+   +    +  K K +    S   T Y   W++PEV+++    Y  + DI+
Sbjct: 150 SKDGSVKLADFGFAAQLTKEKSKRN----SVVGTPY---WMAPEVIKRKD--YGPKVDIW 200

Query: 553 SVGISCCELANGTVPFAETP 572
           S+GI C E+A G  P+   P
Sbjct: 201 SLGIMCIEMAEGEPPYLREP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 2e-33
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 50/285 (17%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            VY   +  T   +A+K+ +L+++ +E LKS+  EI  +++L+HPNI+ YI S   +  L
Sbjct: 15  VVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74

Query: 86  HLVSPLMGFGSCKDLINAHFNFG-LPE-LVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           +++      GS + +I     FG  PE LV  ++ Q VL GL Y+H +G IHR +KA++I
Sbjct: 75  YIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQ-VLQGLAYLHEQGVIHRDIKAANI 130

Query: 144 LISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           L + +G   L+  G+      +     V     S      W++PEV+E  + G    SDI
Sbjct: 131 LTTKDGVVKLADFGV------ATKLNDVSKDDASVVGTPYWMAPEVIE--MSGASTASDI 182

Query: 202 YSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           +S+G +  EL  G  P+ +  P   +                 + +   QDD        
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAAL-----------------FRI--VQDD-----HPP 218

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
           + E           S      +  C  +D + RP A  LL+H + 
Sbjct: 219 LPEG---------ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  127 bits (321), Expect = 4e-33
 Identities = 69/214 (32%), Positives = 113/214 (52%), Gaps = 17/214 (7%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           + I   LG+   +  SVY + HK T Q++A+K        +EDL+ +  EI  ++    P
Sbjct: 5   FDILEKLGE--GSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58

Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 480
            I+ Y  S+   TDL +V    G GS  D++    N  L E  I  IL   L GLEY+H 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 481 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
              IHR +KA +IL++  G+A L+  G+      +  K+   +    T +   W++PEV+
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPF---WMAPEVI 171

Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPFAETP 572
           ++   GY+ ++DI+S+GI+  E+A G  P+++  
Sbjct: 172 QEI--GYNNKADIWSLGITAIEMAEGKPPYSDIH 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 9e-33
 Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 17/206 (8%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            VY   +  T   +A+K+ +L+++ +E LKS+  EI  +++L+HPNI+ YI S   +  L
Sbjct: 15  VVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74

Query: 436 HLVSPLMGFGSCKDLINAHFNFG-LPE-LVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           +++      GS + +I     FG  PE LV  ++ Q VL GL Y+H +G IHR +KA++I
Sbjct: 75  YIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQ-VLQGLAYLHEQGVIHRDIKAANI 130

Query: 494 LISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           L + +G   L+  G+      +     V     S      W++PEV+E  + G    SDI
Sbjct: 131 LTTKDGVVKLADFGV------ATKLNDVSKDDASVVGTPYWMAPEVIE--MSGASTASDI 182

Query: 552 YSVGISCCELANGTVPFAE-TPTTLM 576
           +S+G +  EL  G  P+ +  P   +
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAAL 208

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 7e-32
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 10/218 (4%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            VY ++   T +L+A+K   L+    +D + +  EI  ++  RHPNI+ Y  S+L    L
Sbjct: 18  DVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V    G GS +D+        L EL I ++ ++ L GL Y+H  G IHR +K ++IL+
Sbjct: 76  WIVMEYCGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL 134

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSV 554
           + +G   L+        + T  K   F   T Y   W++PEV       GYD + DI+++
Sbjct: 135 TEDGDVKLADFGVSAQLTATIAKRKSF-IGTPY---WMAPEVAAVERKGGYDGKCDIWAL 190

Query: 555 GISCCELANGTVPFAET-PT-TLMLIEKLAGATPHLLD 590
           GI+  ELA    P  +  P   L LI K     P L D
Sbjct: 191 GITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 1e-30
 Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 53/292 (18%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL----- 80
           VY ++HK T QL+A+K  ++    +E++K    E   +R    HPNI  +  +F+     
Sbjct: 22  VYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSNHPNIATFYGAFIKKNPP 78

Query: 81  -DATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRA 137
            +   L LV  L G GS  DL+      G  L E  I +IL++ L GL Y+H    IHR 
Sbjct: 79  GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRD 138

Query: 138 VKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLD 193
           +K  +IL++ N   K    G+        T  + + F   T Y   W++PEV+  ++  D
Sbjct: 139 IKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNTF-IGTPY---WMAPEVIACDEQPD 192

Query: 194 -GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD 252
             YD RSD++S+GI+  ELA+G  P  +      L +      P L              
Sbjct: 193 ASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL-------------- 238

Query: 253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                            +   +S  F+  +  CL ++ ++RP    LL+H F
Sbjct: 239 ----------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  119 bits (298), Expect = 6e-30
 Identities = 86/281 (30%), Positives = 130/281 (46%), Gaps = 41/281 (14%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY +++  T +L A+K   L+    ED   +  EI+ M+  +H NI+ Y  S+L    L 
Sbjct: 25  VYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +     G GS +D+   H    L E  I ++ ++ L GL Y+H KG +HR +K ++IL++
Sbjct: 83  ICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140

Query: 147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVG 205
            NG   L+        + T  K   F   T Y   W++PEV   +   GY++  DI++VG
Sbjct: 141 DNGHVKLADFGVSAQITATIAKRKSF-IGTPY---WMAPEVAAVERKGGYNQLCDIWAVG 196

Query: 206 ISCCELANGTVP-FAETPT-TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           I+  ELA    P F   P   L L+ K     P L D                       
Sbjct: 197 ITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD----------------------- 233

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                    K+S+SFH  V++ L+++  KRP A  LLQH F
Sbjct: 234 -------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  117 bits (296), Expect = 2e-29
 Identities = 83/302 (27%), Positives = 138/302 (45%), Gaps = 54/302 (17%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           +VY ++   TN+++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L    
Sbjct: 30  AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89

Query: 85  LHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
             LV   M +  GS  D++  H    L E+ I  I    L GL Y+H    IHR +KA +
Sbjct: 90  AWLV---MEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGN 145

Query: 143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDI 201
           IL++  G   L+        SP    V      T Y   W++PEV+    +G YD + D+
Sbjct: 146 ILLTEPGTVKLADFGSASLVSPANSFV-----GTPY---WMAPEVILAMDEGQYDGKVDV 197

Query: 202 YSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS-- 259
           +S+GI+C ELA    P                                      NA S  
Sbjct: 198 WSLGITCIELAERKPPLFNM----------------------------------NAMSAL 223

Query: 260 -YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPEL 318
            +I++  +  L+S  +SD F + V+ CL +    RP +  LL+H F  + +  +V++ +L
Sbjct: 224 YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVII-DL 282

Query: 319 LR 320
           ++
Sbjct: 283 IQ 284

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  116 bits (292), Expect = 4e-29
 Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 42/285 (14%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T Q++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 28  TQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86

Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           GS  DL+ A       E  I  +L+++L GL+Y+H +  IHR +KA+++L+S  G   L+
Sbjct: 87  GSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLA 143

Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 144 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIQQS--AYDSKADIWSLGITAIELAKG 197

Query: 215 TVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKF 274
             P ++     +L        P L         TG+                       F
Sbjct: 198 EPPNSDMHPMRVLFLIPKNNPPTL---------TGE-----------------------F 225

Query: 275 SDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           S  F   ++ CL++D   RP A  LL+H F  +  K +  L EL+
Sbjct: 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELI 270

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  115 bits (290), Expect = 6e-29
 Identities = 85/297 (28%), Positives = 138/297 (46%), Gaps = 42/297 (14%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           +   VY      T +++A+K  +L+   DE ++ +  EI  +     P I  Y  S+L  
Sbjct: 16  SFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYGSYLKG 74

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           T L ++   +G GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA++
Sbjct: 75  TKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAAN 131

Query: 143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
           +L+S  G   L+        + T+ K + F   T +   W++PEV++Q+   YD ++DI+
Sbjct: 132 VLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDFKADIW 185

Query: 203 SVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           S+GI+  ELA G  P ++     +L      + P L          GQ            
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL---------EGQ------------ 224

Query: 263 EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
                      +S  F   VE CL++D   RP A  LL+H F  +  K +  L EL+
Sbjct: 225 -----------YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELI 270

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (285), Expect = 3e-28
 Identities = 80/287 (27%), Positives = 125/287 (43%), Gaps = 39/287 (13%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           N   V    H+ T +++AVK   L+ + +   K +  E+  +     P I+ +  +F + 
Sbjct: 13  NSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKAS 141
            D+ +    M  GS  D I       +PE ++  I   VL GL Y+H K   IHR VK S
Sbjct: 72  GDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS 130

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +IL++  G+  L      C F  + + V+    +     ++++PE ++ N   Y  +SDI
Sbjct: 131 NILVNSRGQIKL------CDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN--DYSVKSDI 182

Query: 202 YSVGISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           +S+G+S  ELA G  P+  E      + E L                            Y
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELL---------------------------QY 215

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
           I  +    L S KFS  F   V LCL +D  +RP    LL+H F K+
Sbjct: 216 IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  113 bits (284), Expect = 5e-28
 Identities = 83/315 (26%), Positives = 133/315 (42%), Gaps = 64/315 (20%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S+ +   +LGQ   +   VY  +HK T ++ A+KK ++D   +E  K L  E+  +R   
Sbjct: 1   SDLERVKVLGQ--GSSGVVYKVRHKPTGKIYALKKIHVD-GDEEFRKQLLRELKTLRSCE 57

Query: 69  HPNII-CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            P ++ CY  +F    ++ +V   M  GS  DL+        PE V+ +I + +L GL+Y
Sbjct: 58  SPYVVKCY-GAFYKEGEISIVLEYMDGGSLADLLKKVGKI--PEPVLAYIARQILKGLDY 114

Query: 128 IHGK-GFIHRAVKASHILISHNGK---------ACLSGLRYMCPFSPTKKKVHLFPPSTA 177
           +H K   IHR +K S++LI+  G+           L      C         + F  +  
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC---------NTFVGTVT 165

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGAT 235
           Y    +SPE ++     Y   +DI+S+G++  E A G  PF     P+   L++      
Sbjct: 166 Y----MSPERIQGESYSYA--ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ------ 213

Query: 236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL 295
                                    I +     L + +FS  F   +  CL +D  KRP 
Sbjct: 214 ------------------------AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249

Query: 296 ACNLLQHAFFKQTKK 310
           A  LLQH F K+   
Sbjct: 250 AAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  113 bits (285), Expect = 8e-28
 Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 43/307 (14%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
           +  +VY + +  TN+++AVKK +   + T+E  + +  E+  ++ L+HPN I Y   +L 
Sbjct: 33  SFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
                LV      GS  DL+  H    L E+ I  I    L GL Y+H    IHR +KA 
Sbjct: 93  EHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAG 150

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSD 200
           +IL++  G+  L+        SP    V      T Y   W++PEV+    +G YD + D
Sbjct: 151 NILLTEPGQVKLADFGSASKSSPANSFV-----GTPY---WMAPEVILAMDEGQYDGKVD 202

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           ++S+GI+C ELA                       P L +               +A  +
Sbjct: 203 VWSLGITCIELAE--------------------RKPPLFNMNAM-----------SALYH 231

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
           I++  +  L S +++DSF   V+ CL +   +RP +  LL+H F ++ +   V++  + R
Sbjct: 232 IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291

Query: 321 PALSLNE 327
              ++ E
Sbjct: 292 TKDAVRE 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  112 bits (283), Expect = 1e-27
 Identities = 80/294 (27%), Positives = 128/294 (43%), Gaps = 49/294 (16%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V ++  K T + +AVKK +L +    +L  L +E+V MR  +HPNI+   SS+L   +L 
Sbjct: 35  VCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMYSSYLVGDELW 92

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +V   +  G+  D++  H    + E  I  +   VL  L ++H +G IHR +K+  IL++
Sbjct: 93  VVMEFLEGGALTDIV-THTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT 149

Query: 147 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
            +G+  LS   +    S   P +K +      T Y   W++PEV+ +    Y    DI+S
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSL----VGTPY---WMAPEVISRLP--YGTEVDIWS 200

Query: 204 VGISCCELANGTVP-FAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           +GI   E+ +G  P F E P   M   +     P L +                      
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-PKLKN---------------------- 237

Query: 263 EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                     K S    S ++  L RD  +R  A  LL H F  +    S ++P
Sbjct: 238 --------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 87/302 (28%), Positives = 136/302 (45%), Gaps = 52/302 (17%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH---PNIICYISSFLDA 82
           +VY  KH  T +++A+K  NLD   D+D+  +  E+  +  LR    PNI  Y  S+L  
Sbjct: 16  AVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
             L ++      GS + L+ A     + E  I  I+++VL  L+YIH  G IHR +KA++
Sbjct: 75  PRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAAN 131

Query: 143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG--YDERSD 200
           IL+++ G   L         +    K   F   T Y   W++PEV+    +G  YD ++D
Sbjct: 132 ILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPY---WMAPEVI---TEGKYYDTKAD 184

Query: 201 IYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENAC 258
           I+S+GI+  E+A G  P+++      +MLI K     P L           +D+G     
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRL-----------EDNG----- 226

Query: 259 SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVM-LPE 317
                          +S      V  CL  +  +R  A  LL+  + K   K  V  L E
Sbjct: 227 ---------------YSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKE 271

Query: 318 LL 319
           L+
Sbjct: 272 LI 273

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  111 bits (280), Expect = 2e-27
 Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 43/295 (14%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           +VY +    T Q +A+K+ NL +   ++L  + +EI+ MR  +HPNI+ Y+ S+L   +L
Sbjct: 34  TVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDSYLVGDEL 91

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL+
Sbjct: 92  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY---WMAPEVVTRK--AYGPKVDIWSLG 202

Query: 206 ISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQ 265
           I                   M IE + G  P+L            ++    A   I+   
Sbjct: 203 I-------------------MAIEMVEGEPPYL------------NENPLRALYLIATNG 231

Query: 266 TQVLTSR-KFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           T  L +  K S  F   +  CL  DV+KR  A  LLQH F K  K  S + P + 
Sbjct: 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIA 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  110 bits (276), Expect = 4e-27
 Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 46/287 (16%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 28  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86

Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 87  GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 143

Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 144 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELAKG 197

Query: 215 TVPFAETP--TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSR 272
             P +E      L LI K     P  L+                                
Sbjct: 198 EPPHSELHPMKVLFLIPK---NNPPTLE-------------------------------G 223

Query: 273 KFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
            +S      VE CL+++   RP A  LL+H F  +  K +  L EL+
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELI 270

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  108 bits (270), Expect = 2e-26
 Identities = 87/282 (30%), Positives = 133/282 (47%), Gaps = 43/282 (15%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY +++  T +L AVK   L+    +D   +  EI  ++  +H NI+ Y  S+L    L 
Sbjct: 25  VYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +     G GS +D+   H    L EL I ++ ++ L GL Y+H KG +HR +K ++IL++
Sbjct: 83  ICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140

Query: 147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV--LEQNLDGYDERSDIYSV 204
            NG   L+        + T  K   F   T Y   W++PEV  +E+N  GY++  DI++V
Sbjct: 141 DNGDVKLADFGVAAKITATIAKRKSF-IGTPY---WMAPEVAAVEKN-GGYNQLCDIWAV 195

Query: 205 GISCCELANGTVP-FAETPT-TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           GI+  ELA    P F   P   L L+ K     P L D T                    
Sbjct: 196 GITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT-------------------- 235

Query: 263 EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                     K+S +FH+ V++ L+++  KRP A  LL H F
Sbjct: 236 ----------KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  108 bits (271), Expect = 3e-26
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 49/290 (16%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDED-------LKSLHHEIVCMRHLRHPNIICYISS 78
           SVYL  +  + +L+AVK+  L  ++          L +L  EI  ++ L+H NI+ Y+ S
Sbjct: 15  SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS 74

Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRA 137
            LDA  L++    +  GS   L+N   N+G   E ++ + ++ +L GL Y+H +G IHR 
Sbjct: 75  SLDADHLNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRD 131

Query: 138 VKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
           +K ++IL+ + G   +S  G+      +    K +   PS   ++ W++PEV++Q    Y
Sbjct: 132 IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS--Y 189

Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCTTYYVDTGQDDGE 254
             ++DI+S+G    E+  G  PF +  T L  I K+   A+P +                
Sbjct: 190 TRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIGENASPEI---------------- 232

Query: 255 ENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
               S IS +    L             E     D +KRP A  LL+H F
Sbjct: 233 ---PSNISSEAIDFL-------------EKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  107 bits (269), Expect = 3e-26
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 64/288 (22%)

Query: 35  TNQLIAVKKFNLDR----MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
             QLIAVK+  LD       +++ + L  E+  ++ L+H NI+ Y+ + LD   + +   
Sbjct: 23  QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82

Query: 91  LMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
            +  GS   ++N    FG LPE V C   + +L+G+ Y+H    +HR +K +++++  NG
Sbjct: 83  FVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG 139

Query: 150 -----------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
                      +    GL      S   K +H     T Y   W++PEV+ ++  GY  +
Sbjct: 140 IIKLIDFGCARRLAWVGLH--GTHSNMLKSMH----GTPY---WMAPEVINES--GYGRK 188

Query: 199 SDIYSVGISCCELANGTVPFAETP--TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEEN 256
           SDI+S+G +  E+A G  P A       +  I    G  P L D                
Sbjct: 189 SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPD---------------- 232

Query: 257 ACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                            FS +    V  CL+RD  +RP A  LL+H F
Sbjct: 233 ----------------SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (269), Expect = 4e-26
 Identities = 76/301 (25%), Positives = 125/301 (41%), Gaps = 56/301 (18%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y+I   +G+   +   VYL + K   +L  +K+ +L  M++++ +   +E+  ++ L H
Sbjct: 1   KYEIIKQIGK--GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH 58

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFG--LPELVICHILQDVLNG 124
           PNII Y  SF +   L +V   M +    DL   I      G   PE  I      +   
Sbjct: 59  PNIIKYYESFEEKGKLCIV---MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           L+Y+H +  +HR +K  +I ++ NG   L   G+  +   S T          T Y   +
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTV-VGTPY---Y 169

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPFAETPTTLMLIEKLAGATPHLLD 240
           LSPE+ +     Y+ +SDI+S+G  C   EL     PF E    L L  K          
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLG--CVLYELCTLKHPF-EGENLLELALK---------- 214

Query: 241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL 300
                               I + Q   + S+ +S    ++V   L +D ++RP    +L
Sbjct: 215 --------------------ILKGQYPPIPSQ-YSSELRNLVSSLLQKDPEERPSIAQIL 253

Query: 301 Q 301
           Q
Sbjct: 254 Q 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 6e-26
 Identities = 69/212 (32%), Positives = 110/212 (51%), Gaps = 18/212 (8%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH---PNIICYISSFLDA 432
           +VY  KH  T +++A+K  NLD   D+D+  +  E+  +  LR    PNI  Y  S+L  
Sbjct: 16  AVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
             L ++      GS + L+ A     + E  I  I+++VL  L+YIH  G IHR +KA++
Sbjct: 75  PRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAAN 131

Query: 493 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG--YDERSD 550
           IL+++ G   L         +    K   F   T Y   W++PEV+    +G  YD ++D
Sbjct: 132 ILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPY---WMAPEVI---TEGKYYDTKAD 184

Query: 551 IYSVGISCCELANGTVPFAETPT--TLMLIEK 580
           I+S+GI+  E+A G  P+++      +MLI K
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 6e-26
 Identities = 75/282 (26%), Positives = 123/282 (43%), Gaps = 40/282 (14%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY ++HK T    A K   ++  ++E+L+    EI  +   +HPNI+    ++     L 
Sbjct: 21  VYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           ++      G+   ++      GL E  I ++ + +L  L ++H    IHR +KA +IL++
Sbjct: 79  ILIEFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137

Query: 147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YDERSDIYS 203
            +G   L+          T +K   F   T Y   W++PEV+  E   D  YD ++DI+S
Sbjct: 138 LDGDVKLADFGVSAKNKSTLQKRDTF-IGTPY---WMAPEVVACETFKDNPYDYKADIWS 193

Query: 204 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           +GI+  ELA    P  E     +L++ L    P L                         
Sbjct: 194 LGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL------------------------- 228

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                    K+S SF+  ++ CL +D D RP A  LL+H F 
Sbjct: 229 -----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  108 bits (270), Expect = 6e-26
 Identities = 79/307 (25%), Positives = 135/307 (43%), Gaps = 43/307 (14%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
           +  +VY ++    ++++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L 
Sbjct: 27  SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
                LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA 
Sbjct: 87  EHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSD 200
           +IL+S  G   L         +P    V      T Y   W++PEV+    +G YD + D
Sbjct: 145 NILLSEPGLVKLGDFGSASIMAPANXFV-----GTPY---WMAPEVILAMDEGQYDGKVD 196

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           ++S+GI+C ELA    P                                      +A  +
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAM-------------------------------SALYH 225

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
           I++ ++  L S  +S+ F + V+ CL +    RP +  LL+H F  + +  +V++  + R
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR 285

Query: 321 PALSLNE 327
              ++ E
Sbjct: 286 TKDAVRE 292

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 9e-26
 Identities = 62/205 (30%), Positives = 109/205 (53%), Gaps = 15/205 (7%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDED-------LKSLHHEIVCMRHLRHPNIICYISS 428
           SVYL  +  + +L+AVK+  L  ++          L +L  EI  ++ L+H NI+ Y+ S
Sbjct: 15  SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS 74

Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRA 487
            LDA  L++    +  GS   L+N   N+G   E ++ + ++ +L GL Y+H +G IHR 
Sbjct: 75  SLDADHLNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRD 131

Query: 488 VKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
           +K ++IL+ + G   +S  G+      +    K +   PS   ++ W++PEV++Q    Y
Sbjct: 132 IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS--Y 189

Query: 546 DERSDIYSVGISCCELANGTVPFAE 570
             ++DI+S+G    E+  G  PF +
Sbjct: 190 TRKADIWSLGCLVVEMLTGKHPFPD 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 23/208 (11%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL----- 430
           VY ++HK T QL+A+K  ++    +E++K    E   +R    HPNI  +  +F+     
Sbjct: 22  VYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSNHPNIATFYGAFIKKNPP 78

Query: 431 -DATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRA 487
            +   L LV  L G GS  DL+      G  L E  I +IL++ L GL Y+H    IHR 
Sbjct: 79  GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRD 138

Query: 488 VKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLD 543
           +K  +IL++ N   K    G+        T  + + F   T Y   W++PEV+  ++  D
Sbjct: 139 IKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNTF-IGTPY---WMAPEVIACDEQPD 192

Query: 544 -GYDERSDIYSVGISCCELANGTVPFAE 570
             YD RSD++S+GI+  ELA+G  P  +
Sbjct: 193 ASYDARSDVWSLGITAIELADGKPPLCD 220

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (261), Expect = 5e-25
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 25/228 (10%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y+I   +G+   +   VYL + K   +L  +K+ +L  M++++ +   +E+  ++ L H
Sbjct: 1   KYEIIKQIGK--GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH 58

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFG--LPELVICHILQDVLNG 474
           PNII Y  SF +   L +V   M +    DL   I      G   PE  I      +   
Sbjct: 59  PNIIKYYESFEEKGKLCIV---MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           L+Y+H +  +HR +K  +I ++ NG   L   G+  +   S T          T Y   +
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTV-VGTPY---Y 169

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPF-AETPTTLML 577
           LSPE+ +     Y+ +SDI+S+G  C   EL     PF  E    L L
Sbjct: 170 LSPELCQN--KPYNYKSDIWSLG--CVLYELCTLKHPFEGENLLELAL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  107 bits (266), Expect = 5e-25
 Identities = 80/327 (24%), Positives = 127/327 (38%), Gaps = 32/327 (9%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLR 68
           +Y+I   LG+   +   VYL++     +L+A+K       +     +    EI  +  L 
Sbjct: 1   SYRILRKLGE--GSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLN 55

Query: 69  HPNIIC-YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLE 126
           HP  I      F D   L+LV   +  GS +DL+      G L E     IL  +L+ LE
Sbjct: 56  HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 127 YIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y+H KG IHR +K  +IL+  +G   K    GL  + P   +   +   P ++     ++
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 184 SPEVLEQNLDG-YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           +PEVL           SDI+S+GI+  EL  G  PF                       +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF------------------EGEKNS 217

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
           +    T +   E    S  S            S +   +++  L++D   R  + + L H
Sbjct: 218 SATSQTLKIILELPTPSLASPLSPSNPELI--SKAASDLLKKLLAKDPKNRLSSSSDLSH 275

Query: 303 AFFKQTKKCSVMLPELLRPALSLNESN 329
                 K     L +LL+P  S     
Sbjct: 276 DLLAHLKLKESDLSDLLKPDDSAPLRL 302

Length = 384

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  104 bits (261), Expect = 7e-25
 Identities = 79/305 (25%), Positives = 137/305 (44%), Gaps = 43/305 (14%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           +VY +    T Q +A+K+ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +L
Sbjct: 34  TVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDEL 91

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V   +  GS  D++       + E  I  + ++ L  L+++H    IHR +K+ +IL+
Sbjct: 92  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY---WMAPEVVTRK--AYGPKVDIWSLG 202

Query: 206 ISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
           I   E+  G  P+  E P   + +    G TP L +                        
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQN------------------------ 237

Query: 265 QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALS 324
                   + S  F   +  CL  DVD+R  A  LLQH F K  K  S + P ++    +
Sbjct: 238 ------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEA 291

Query: 325 LNESN 329
           +  S+
Sbjct: 292 IKNSS 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  104 bits (260), Expect = 1e-24
 Identities = 79/295 (26%), Positives = 134/295 (45%), Gaps = 43/295 (14%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           +V+ +    T Q +A+K+ NL +   ++L  + +EI+ M+ L++PNI+ ++ SFL   +L
Sbjct: 34  TVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLDSFLVGDEL 91

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ ++L+
Sbjct: 92  FVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY---WMAPEVVTRK--AYGPKVDIWSLG 202

Query: 206 ISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
           I   E+  G  P+  E P   + +    G TP L +                        
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQN------------------------ 237

Query: 265 QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
                   K S  F   +  CL  DV+KR  A  LLQH F K  K  S + P +L
Sbjct: 238 ------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLIL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  104 bits (259), Expect = 1e-24
 Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 43/292 (14%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +L
Sbjct: 35  TVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDEL 92

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL+
Sbjct: 93  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY---WMAPEVVTRK--AYGPKVDIWSLG 203

Query: 206 ISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
           I   E+  G  P+  E P   + +    G TP L +                        
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQN------------------------ 238

Query: 265 QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                   K S  F   +  CL  DV+KR  A  LLQH F K  K  S + P
Sbjct: 239 ------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (257), Expect = 2e-24
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 54/288 (18%)

Query: 26  SVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           SVY   +       AVK+ +L    +   E +K L  EI  +  L+HPNI+ Y+ +  + 
Sbjct: 15  SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE 74

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
            +L++   L+  GS   L+     +G  PE VI    + +L GLEY+H +  +HR +K +
Sbjct: 75  DNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGA 131

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL-FPPS---TAYNLNWLSPEVLEQNLDGYDE 197
           +IL+  NG   L+       F   K+ V   F  S   + Y   W++PEV+ Q   GY  
Sbjct: 132 NILVDTNGVVKLAD------FGMAKQVVEFSFAKSFKGSPY---WMAPEVIAQQ-GGYGL 181

Query: 198 RSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEEN 256
            +DI+S+G +  E+A G  P+++      +     +   P + D                
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD---------------- 225

Query: 257 ACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                             SD     +  CL RD   RP A  LL+H F
Sbjct: 226 ----------------HLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  103 bits (257), Expect = 3e-24
 Identities = 80/307 (26%), Positives = 139/307 (45%), Gaps = 43/307 (14%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
           +  +VY ++   TN+++A+KK +   + ++E  + +  E+  ++ ++HPN I Y   +L 
Sbjct: 37  SFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
                LV      GS  DL+  H    L E+ I  I    L GL Y+H    IHR +KA 
Sbjct: 97  EHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAG 154

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSD 200
           +IL++  G+  L+        SP    V      T Y   W++PEV+    +G YD + D
Sbjct: 155 NILLTEPGQVKLADFGSASIASPANSFV-----GTPY---WMAPEVILAMDEGQYDGKVD 206

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           ++S+GI+C ELA    P                                      +A  +
Sbjct: 207 VWSLGITCIELAERKPPLFNMNAM-------------------------------SALYH 235

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
           I++ ++  L S ++SD F + V+ CL +    RP +  LL+H F  + +  +V++  + R
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQR 295

Query: 321 PALSLNE 327
              ++ E
Sbjct: 296 TKDAVRE 302

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  102 bits (254), Expect = 4e-24
 Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 11/217 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY +++  T +L A+K   L+    ED   +  EI+ M+  +H NI+ Y  S+L    L 
Sbjct: 25  VYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +     G GS +D+   H    L E  I ++ ++ L GL Y+H KG +HR +K ++IL++
Sbjct: 83  ICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140

Query: 497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVG 555
            NG   L+        + T  K   F   T Y   W++PEV   +   GY++  DI++VG
Sbjct: 141 DNGHVKLADFGVSAQITATIAKRKSF-IGTPY---WMAPEVAAVERKGGYNQLCDIWAVG 196

Query: 556 ISCCELANGTVP-FAETPT-TLMLIEKLAGATPHLLD 590
           I+  ELA    P F   P   L L+ K     P L D
Sbjct: 197 ITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  102 bits (254), Expect = 5e-24
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 10/198 (5%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           +   VY      T +++A+K  +L+   DE ++ +  EI  +     P I  Y  S+L  
Sbjct: 16  SFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYGSYLKG 74

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           T L ++   +G GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA++
Sbjct: 75  TKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAAN 131

Query: 493 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
           +L+S  G   L+        + T+ K + F   T +   W++PEV++Q+   YD ++DI+
Sbjct: 132 VLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDFKADIW 185

Query: 553 SVGISCCELANGTVPFAE 570
           S+GI+  ELA G  P ++
Sbjct: 186 SLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  101 bits (253), Expect = 6e-24
 Identities = 59/183 (32%), Positives = 101/183 (55%), Gaps = 10/183 (5%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T Q++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 28  TQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86

Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           GS  DL+ A       E  I  +L+++L GL+Y+H +  IHR +KA+++L+S  G   L+
Sbjct: 87  GSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLA 143

Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 144 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIQQS--AYDSKADIWSLGITAIELAKG 197

Query: 565 TVP 567
             P
Sbjct: 198 EPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  101 bits (253), Expect = 6e-24
 Identities = 60/186 (32%), Positives = 105/186 (56%), Gaps = 10/186 (5%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 28  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86

Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 87  GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 143

Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 144 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELAKG 197

Query: 565 TVPFAE 570
             P +E
Sbjct: 198 EPPHSE 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 98.0 bits (245), Expect = 6e-23
 Identities = 47/201 (23%), Positives = 82/201 (40%), Gaps = 16/201 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
               K       +AVK    D   ++ ++    E   MR L HPN++  +    +   L+
Sbjct: 19  KLKGKGGKKKVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY 77

Query: 87  LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +V   M  G     L        L +L+       +  G+EY+  K FIHR + A + L+
Sbjct: 78  IVMEYMEGGDLLSYLRKNRPKLSLSDLL--SFALQIARGMEYLESKNFIHRDLAARNCLV 135

Query: 146 SHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
             N    +S  GL R +      +K+    P      + W++PE L++    +  +SD++
Sbjct: 136 GENLVVKISDFGLSRDLYDDDYYRKRGGKLP------IRWMAPESLKEGK--FTSKSDVW 187

Query: 203 SVGISCCELA-NGTVPFAETP 222
           S G+   E+   G  P+    
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 98.0 bits (245), Expect = 6e-23
 Identities = 47/201 (23%), Positives = 82/201 (40%), Gaps = 16/201 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
               K       +AVK    D   ++ ++    E   MR L HPN++  +    +   L+
Sbjct: 19  KLKGKGGKKKVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY 77

Query: 437 LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +V   M  G     L        L +L+       +  G+EY+  K FIHR + A + L+
Sbjct: 78  IVMEYMEGGDLLSYLRKNRPKLSLSDLL--SFALQIARGMEYLESKNFIHRDLAARNCLV 135

Query: 496 SHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
             N    +S  GL R +      +K+    P      + W++PE L++    +  +SD++
Sbjct: 136 GENLVVKISDFGLSRDLYDDDYYRKRGGKLP------IRWMAPESLKEGK--FTSKSDVW 187

Query: 553 SVGISCCELA-NGTVPFAETP 572
           S G+   E+   G  P+    
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 99.1 bits (247), Expect = 7e-23
 Identities = 62/191 (32%), Positives = 98/191 (51%), Gaps = 16/191 (8%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           +VY ++   TN+++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L    
Sbjct: 30  AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89

Query: 435 LHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
             LV   M +  GS  D++  H    L E+ I  I    L GL Y+H    IHR +KA +
Sbjct: 90  AWLV---MEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGN 145

Query: 493 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDI 551
           IL++  G   L+        SP    V      T Y   W++PEV+    +G YD + D+
Sbjct: 146 ILLTEPGTVKLADFGSASLVSPANSFV-----GTPY---WMAPEVILAMDEGQYDGKVDV 197

Query: 552 YSVGISCCELA 562
           +S+GI+C ELA
Sbjct: 198 WSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 59/307 (19%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTD--EDLKS--LHHEIVCMRHLRHPNII-CYISSFLD 81
           VY  + K T  ++AVK+    R T   E+ K   +  ++V   H   P I+ CY   F+ 
Sbjct: 31  VYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSH-DCPYIVKCY-GYFIT 85

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 140
            +D+ +   LM   +C D +       +PE ++  +   ++  L Y+  K G IHR VK 
Sbjct: 86  DSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKP 143

Query: 141 SHILISHNG--KAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN--LD 193
           S+IL+  +G  K C   +SG R +   + T+          AY    ++PE ++      
Sbjct: 144 SNILLDASGNVKLCDFGISG-RLVDSKAKTRSA-----GCAAY----MAPERIDPPDPNP 193

Query: 194 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG 253
            YD R+D++S+GIS  ELA G  P+    T   ++ K+    P  L              
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL------------PP 241

Query: 254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSV 313
            E                  FS  F S V+LCL++D  KRP    LLQH F ++ +   V
Sbjct: 242 NEG-----------------FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284

Query: 314 MLPELLR 320
            +    +
Sbjct: 285 DVAGWFQ 291

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)

Query: 376 SVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           SVY   +       AVK+ +L    +   E +K L  EI  +  L+HPNI+ Y+ +  + 
Sbjct: 15  SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE 74

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
            +L++   L+  GS   L+     +G  PE VI    + +L GLEY+H +  +HR +K +
Sbjct: 75  DNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGA 131

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL-FPPS---TAYNLNWLSPEVLEQNLDGYDE 547
           +IL+  NG   L+       F   K+ V   F  S   + Y   W++PEV+ Q   GY  
Sbjct: 132 NILVDTNGVVKLAD------FGMAKQVVEFSFAKSFKGSPY---WMAPEVIAQQ-GGYGL 181

Query: 548 RSDIYSVGISCCELANGTVPFAE 570
            +DI+S+G +  E+A G  P+++
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQ 204

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 18/204 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V ++  K T + +AVKK +L +    +L  L +E+V MR  +HPNI+   SS+L   +L 
Sbjct: 35  VCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMYSSYLVGDELW 92

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +V   +  G+  D++  H    + E  I  +   VL  L ++H +G IHR +K+  IL++
Sbjct: 93  VVMEFLEGGALTDIV-THTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT 149

Query: 497 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
            +G+  LS   +    S   P +K +      T Y   W++PEV+ +    Y    DI+S
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSL----VGTPY---WMAPEVISRLP--YGTEVDIWS 200

Query: 554 VGISCCELANGTVP-FAETPTTLM 576
           +GI   E+ +G  P F E P   M
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAM 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 99.0 bits (245), Expect = 2e-22
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 12/216 (5%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLR 418
           +Y+I   LG+   +   VYL++     +L+A+K       +     +    EI  +  L 
Sbjct: 1   SYRILRKLGE--GSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLN 55

Query: 419 HPNIIC-YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLE 476
           HP  I      F D   L+LV   +  GS +DL+      G L E     IL  +L+ LE
Sbjct: 56  HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 477 YIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y+H KG IHR +K  +IL+  +G   K    GL  + P   +   +   P ++     ++
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 534 SPEVLEQNLDG-YDERSDIYSVGISCCELANGTVPF 568
           +PEVL           SDI+S+GI+  EL  G  PF
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211

Length = 384

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 30/205 (14%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY ++ K+T +++A+KK  L   ++   K+   EI  ++ L HPNII  +  F    D
Sbjct: 13  GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD 72

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L+LV   M     K +       GLPE +I   L  +L GL + H  G +HR +K  ++L
Sbjct: 73  LYLVFEFMDTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL 130

Query: 145 ISHNG--KACLSGL--------RYMCPFSPTKKKVHLFPPSTAYNLNWL-SPEVLEQNLD 193
           I+  G  K    GL        R    +  T+               W  +PE+L     
Sbjct: 131 INTEGVLKLADFGLARSFGSPVRPYTHYVVTR---------------WYRAPELL-LGDK 174

Query: 194 GYDERSDIYSVGISCCELANGTVPF 218
           GY    DI+SVG    EL +   P 
Sbjct: 175 GYSTPVDIWSVGCIFAELLSR-RPL 198

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 30/205 (14%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY ++ K+T +++A+KK  L   ++   K+   EI  ++ L HPNII  +  F    D
Sbjct: 13  GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD 72

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           L+LV   M     K +       GLPE +I   L  +L GL + H  G +HR +K  ++L
Sbjct: 73  LYLVFEFMDTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL 130

Query: 495 ISHNG--KACLSGL--------RYMCPFSPTKKKVHLFPPSTAYNLNWL-SPEVLEQNLD 543
           I+  G  K    GL        R    +  T+               W  +PE+L     
Sbjct: 131 INTEGVLKLADFGLARSFGSPVRPYTHYVVTR---------------WYRAPELL-LGDK 174

Query: 544 GYDERSDIYSVGISCCELANGTVPF 568
           GY    DI+SVG    EL +   P 
Sbjct: 175 GYSTPVDIWSVGCIFAELLSR-RPL 198

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 17/202 (8%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
               K       +AVK    D   ++ ++    E   MR L HPNI+  +    +   L 
Sbjct: 19  TLKGKGDGKEVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77

Query: 87  LVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           +V   M  G   D +  N      L +L+       +  G+EY+  K FIHR + A + L
Sbjct: 78  IVMEYMPGGDLLDYLRKNRPKELSLSDLL--SFALQIARGMEYLESKNFIHRDLAARNCL 135

Query: 145 ISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N    +S  GL R +      K K    P      + W++PE L++    +  +SD+
Sbjct: 136 VGENLVVKISDFGLSRDLYDDDYYKVKGGKLP------IRWMAPESLKEGK--FTSKSDV 187

Query: 202 YSVGISCCELA-NGTVPFAETP 222
           +S G+   E+   G  P+    
Sbjct: 188 WSFGVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 17/202 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
               K       +AVK    D   ++ ++    E   MR L HPNI+  +    +   L 
Sbjct: 19  TLKGKGDGKEVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77

Query: 437 LVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           +V   M  G   D +  N      L +L+       +  G+EY+  K FIHR + A + L
Sbjct: 78  IVMEYMPGGDLLDYLRKNRPKELSLSDLL--SFALQIARGMEYLESKNFIHRDLAARNCL 135

Query: 495 ISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N    +S  GL R +      K K    P      + W++PE L++    +  +SD+
Sbjct: 136 VGENLVVKISDFGLSRDLYDDDYYKVKGGKLP------IRWMAPESLKEGK--FTSKSDV 187

Query: 552 YSVGISCCELA-NGTVPFAETP 572
           +S G+   E+   G  P+    
Sbjct: 188 WSFGVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 79/307 (25%), Positives = 125/307 (40%), Gaps = 53/307 (17%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCM 64
           P+N++   +LGQ       VYL     T + +AVK+   D     T +++ +L  EI  +
Sbjct: 1   PTNWRRGKLLGQ--GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
           ++L+H  I+ Y     D   L +    M  GS KD + A+    L E V     + +L G
Sbjct: 59  KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEG 116

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPSTAY 178
           +EY+H    +HR +K ++IL    G   L        L+ +C      K V   P     
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP----- 171

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 238
              W+SPEV+  + +GY  ++D++SVG +  E+     P+AE        E +A      
Sbjct: 172 --YWMSPEVI--SGEGYGRKADVWSVGCTVVEMLTEKPPWAE-------FEAMA------ 214

Query: 239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                             A   I+ Q T        S    + +      +  KRP A  
Sbjct: 215 ------------------AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEE 256

Query: 299 LLQHAFF 305
           LL+H F 
Sbjct: 257 LLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 95.6 bits (238), Expect = 5e-22
 Identities = 81/305 (26%), Positives = 134/305 (43%), Gaps = 56/305 (18%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----ED-LKSLHHEIVCM 64
           N+KI   +G+     S VY +   +  +++A+KK  +  M D    +D LK    EI  +
Sbjct: 3   NFKIEKKIGK--GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLL 56

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDV 121
           + L HPN+I Y++SF++  +L++V  L   G    +I  HF      +PE  I      +
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTIWKYFVQL 115

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAY 178
            + LE++H K  +HR +K +++ I+  G   L  L   R+   FS      H     T Y
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSL-VGTPY 171

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 238
              ++SPE + +N  GY+ +SDI+S+G    E+A    PF      L             
Sbjct: 172 ---YMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------ 214

Query: 239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                            + C  I +     L +  +S+    +V  C++ D +KRP    
Sbjct: 215 -----------------SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISY 257

Query: 299 LLQHA 303
           +LQ A
Sbjct: 258 VLQVA 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 96.2 bits (239), Expect = 5e-22
 Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 50/289 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT-- 83
           VY  +H  T QL A+K  ++    +E++K    EI +  ++  H NI  Y  +F+  +  
Sbjct: 32  VYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRNIATYYGAFIKKSPP 88

Query: 84  ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
                L LV    G GS  DL+       L E  I +I +++L GL ++H    IHR +K
Sbjct: 89  GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIK 148

Query: 140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YD 196
             ++L++ N +  L           T  + + F   T Y   W++PEV+  ++N D  YD
Sbjct: 149 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY---WMAPEVIACDENPDATYD 204

Query: 197 ERSDIYSVGISCCELANGTVPFAET-PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE 255
            RSDI+S+GI+  E+A G  P  +  P   + +                           
Sbjct: 205 YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--------------------------- 237

Query: 256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                I       L S+K+S  F   +E CL ++   RP    LL+H F
Sbjct: 238 -----IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 96.3 bits (239), Expect = 6e-22
 Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 54/303 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V +++ K + + +AVK  +L +    +L  L +E+V MR  +H N++    S+L   +L 
Sbjct: 37  VCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           ++   +  G+  D+++      L E  I  + + VL  L Y+H +G IHR +K+  IL++
Sbjct: 95  VLMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT 151

Query: 147 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
            +G+  LS   +    S   P +K +      T Y   W++PEV+ +    Y    DI+S
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKRKSL----VGTPY---WMAPEVISRTP--YGTEVDIWS 202

Query: 204 VGISCCELANGTVP-FAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           +GI   E+ +G  P F+++P   M  ++L  + P  L                       
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAM--KRLRDSPPPKLK---------------------- 238

Query: 263 EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPA 322
                   + K S      +E  L+R+  +R  A  LL H F  QT      LPE L P 
Sbjct: 239 -------NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG-----LPECLVPL 286

Query: 323 LSL 325
           +  
Sbjct: 287 IQQ 289

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 95.1 bits (236), Expect = 8e-22
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 13/222 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY +++  T +L AVK   L+    +D   +  EI  ++  +H NI+ Y  S+L    L 
Sbjct: 25  VYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +     G GS +D+   H    L EL I ++ ++ L GL Y+H KG +HR +K ++IL++
Sbjct: 83  ICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140

Query: 497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV--LEQNLDGYDERSDIYSV 554
            NG   L+        + T  K   F   T Y   W++PEV  +E+N  GY++  DI++V
Sbjct: 141 DNGDVKLADFGVAAKITATIAKRKSF-IGTPY---WMAPEVAAVEKN-GGYNQLCDIWAV 195

Query: 555 GISCCELANGTVP-FAETPT-TLMLIEKLAGATPHLLDCTTY 594
           GI+  ELA    P F   P   L L+ K     P L D T +
Sbjct: 196 GITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 1e-21
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 30/204 (14%)

Query: 385 TNQLIAVKKFNLDR----MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
             QLIAVK+  LD       +++ + L  E+  ++ L+H NI+ Y+ + LD   + +   
Sbjct: 23  QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82

Query: 441 LMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
            +  GS   ++N    FG LPE V C   + +L+G+ Y+H    +HR +K +++++  NG
Sbjct: 83  FVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG 139

Query: 500 -----------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
                      +    GL      S   K +H     T Y   W++PEV+ ++  GY  +
Sbjct: 140 IIKLIDFGCARRLAWVGLH--GTHSNMLKSMH----GTPY---WMAPEVINES--GYGRK 188

Query: 549 SDIYSVGISCCELANGTVPFAETP 572
           SDI+S+G +  E+A G  P A   
Sbjct: 189 SDIWSIGCTVFEMATGKPPLASMD 212

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 94.8 bits (235), Expect = 1e-21
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 50/289 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT-- 83
           VY  +H  T QL A+K  ++    +E++K    EI +  ++  H NI  Y  +F+     
Sbjct: 22  VYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRNIATYYGAFIKKNPP 78

Query: 84  ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
                L LV    G GS  DLI       L E  I +I +++L GL ++H    IHR +K
Sbjct: 79  GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 138

Query: 140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YD 196
             ++L++ N +  L           T  + + F   T Y   W++PEV+  ++N D  YD
Sbjct: 139 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY---WMAPEVIACDENPDATYD 194

Query: 197 ERSDIYSVGISCCELANGTVPFAET-PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE 255
            +SD++S+GI+  E+A G  P  +  P   + +                           
Sbjct: 195 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--------------------------- 227

Query: 256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                I       L S+K+S  F S +E CL ++  +RP    L++H F
Sbjct: 228 -----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 32/222 (14%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S+ +   +LGQ   +   VY  +HK T ++ A+KK ++D   +E  K L  E+  +R   
Sbjct: 1   SDLERVKVLGQ--GSSGVVYKVRHKPTGKIYALKKIHVD-GDEEFRKQLLRELKTLRSCE 57

Query: 419 HPNII-CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            P ++ CY  +F    ++ +V   M  GS  DL+        PE V+ +I + +L GL+Y
Sbjct: 58  SPYVVKCY-GAFYKEGEISIVLEYMDGGSLADLLKKVGKI--PEPVLAYIARQILKGLDY 114

Query: 478 IHGK-GFIHRAVKASHILISHNGK---------ACLSGLRYMCPFSPTKKKVHLFPPSTA 527
           +H K   IHR +K S++LI+  G+           L      C         + F  +  
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC---------NTFVGTVT 165

Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 569
           Y    +SPE ++     Y   +DI+S+G++  E A G  PF 
Sbjct: 166 Y----MSPERIQGESYSYA--ADIWSLGLTLLECALGKFPFL 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
           +  +VY + +  TN+++AVKK +   + T+E  + +  E+  ++ L+HPN I Y   +L 
Sbjct: 33  SFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
                LV      GS  DL+  H    L E+ I  I    L GL Y+H    IHR +KA 
Sbjct: 93  EHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAG 150

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSD 550
           +IL++  G+  L+        SP    V      T Y   W++PEV+    +G YD + D
Sbjct: 151 NILLTEPGQVKLADFGSASKSSPANSFV-----GTPY---WMAPEVILAMDEGQYDGKVD 202

Query: 551 IYSVGISCCELANGTVPF 568
           ++S+GI+C ELA    P 
Sbjct: 203 VWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 34/281 (12%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            VY + +  T +L+AVK+  +     + +K +  E+  +  L+HPN++ Y    +    +
Sbjct: 15  KVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           ++       G+ ++L        L E VI      +L GL Y+H  G +HR +K ++I +
Sbjct: 75  YIFMEYCSGGTLEEL--LEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV-LEQNLDGYDERSDIYSV 204
            HNG   L               +     S A    +++PEV       G+   +DI+S+
Sbjct: 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSL 192

Query: 205 GISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           G    E+A G  P++E      ++  + AG  P                           
Sbjct: 193 GCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP--------------------------- 225

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
               +  S + S      ++ CL  D  KRP A  LLQH F
Sbjct: 226 ---PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 82/317 (25%), Positives = 134/317 (42%), Gaps = 50/317 (15%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +E+L +    ++I   +G+       VY   +K    L AVK  +     DE++++   E
Sbjct: 14  LESLGDPTDTWEIIETIGK--GTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---E 68

Query: 61  IVCMRHL-RHPNIICYISSFLDAT-----DLHLVSPLMGFGSCKDLINAHFNFG--LPEL 112
              ++ L  HPN++ +   F  A       L LV  L   GS  +L+      G  L E 
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 113 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 172
           +I +IL   L GL+++H    IHR VK ++IL++  G   L         + T+ + +  
Sbjct: 129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN-- 186

Query: 173 PPSTAYNLNWLSPEVL--EQNLD-GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE 229
             ++     W++PEV+  EQ  D  YD R D++S+GI+  EL +G  P  +      L +
Sbjct: 187 --TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244

Query: 230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRD 289
                 P LL                                 K+  SF+  +  CL +D
Sbjct: 245 IPRNPPPTLLH------------------------------PEKWCRSFNHFISQCLIKD 274

Query: 290 VDKRPLACNLLQHAFFK 306
            + RP   +LL+H F K
Sbjct: 275 FEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.8 bits (233), Expect = 4e-21
 Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           +VY +    T Q +A+K+ NL +   ++L  + +EI+ MR  +HPNI+ Y+ S+L   +L
Sbjct: 34  TVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDSYLVGDEL 91

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL+
Sbjct: 92  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSLG 202

Query: 556 ISCCELANGTVPF 568
           I   E+  G  P+
Sbjct: 203 IMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 78/314 (24%), Positives = 137/314 (43%), Gaps = 51/314 (16%)

Query: 4   LDNVPS---NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
            D+ P     ++I   +G+       V+   +K      AVK  +     DE++++ ++ 
Sbjct: 10  FDSFPDPSDTWEIIETIGK--GTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI 67

Query: 61  IVCMRHLRHPNIICYISSFL-----DATDLHLVSPLMGFGSCKDLINAHFNFG--LPELV 113
           +  +    HPN++ +   +      +   L LV  L   GS  DL+      G  + E +
Sbjct: 68  LKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125

Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP 173
           I +IL + L GL+++H    IHR VK ++IL++  G   L         + T+ + +   
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN--- 182

Query: 174 PSTAYNLNWLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
            ++     W++PEV+  EQ LD  YD R D++S+GI+  EL +G  P A+      L + 
Sbjct: 183 -TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241

Query: 231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDV 290
                P L                          Q ++     +S+ F+  +  CL++D 
Sbjct: 242 PRNPPPTL-------------------------HQPEL-----WSNEFNDFIRKCLTKDY 271

Query: 291 DKRPLACNLLQHAF 304
           +KRP   +LLQH F
Sbjct: 272 EKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 92.2 bits (230), Expect = 6e-21
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 15/206 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
                 + T   +AVK       ++E+ +    E   M+ L HPNI+  +        L+
Sbjct: 19  TLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLY 77

Query: 87  LVSPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +V+  M  G   D +  H     L +L+   +   +  G+EY+  K F+HR + A + L+
Sbjct: 78  IVTEYMPGGDLLDFLRKHGEKLTLKDLL--QMALQIAKGMEYLESKNFVHRDLAARNCLV 135

Query: 146 SHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
           + N    +S  GL R +      +K+     P     + W++PE L+     +  +SD++
Sbjct: 136 TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP-----IKWMAPESLKDGK--FTSKSDVW 188

Query: 203 SVGISCCELA-NGTVPFAETPTTLML 227
           S G+   E+   G  P+       +L
Sbjct: 189 SFGVLLWEIFTLGEQPYPGMSNEEVL 214

Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 92.2 bits (230), Expect = 6e-21
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 15/206 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
                 + T   +AVK       ++E+ +    E   M+ L HPNI+  +        L+
Sbjct: 19  TLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLY 77

Query: 437 LVSPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +V+  M  G   D +  H     L +L+   +   +  G+EY+  K F+HR + A + L+
Sbjct: 78  IVTEYMPGGDLLDFLRKHGEKLTLKDLL--QMALQIAKGMEYLESKNFVHRDLAARNCLV 135

Query: 496 SHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
           + N    +S  GL R +      +K+     P     + W++PE L+     +  +SD++
Sbjct: 136 TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP-----IKWMAPESLKDGK--FTSKSDVW 188

Query: 553 SVGISCCELA-NGTVPFAETPTTLML 577
           S G+   E+   G  P+       +L
Sbjct: 189 SFGVLLWEIFTLGEQPYPGMSNEEVL 214

Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 9e-21
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 13/195 (6%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V L + K T +L A+K     ++     ++    E   +  + HP I+    +F     L
Sbjct: 9   VLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL 68

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +LV      G     ++    F   E        +++  LEY+H  G I+R +K  +IL+
Sbjct: 69  YLVLEYAPGGELFSHLSKEGRF--SEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126

Query: 146 SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
             +G   L+  GL      S    + + F  +  Y    L+PEVL     GY +  D +S
Sbjct: 127 DADGHIKLTDFGLAKE--LSSEGSRTNTFCGTPEY----LAPEVLLGK--GYGKAVDWWS 178

Query: 204 VGISCCELANGTVPF 218
           +G+   E+  G  PF
Sbjct: 179 LGVLLYEMLTGKPPF 193

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 9e-21
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 13/195 (6%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V L + K T +L A+K     ++     ++    E   +  + HP I+    +F     L
Sbjct: 9   VLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL 68

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +LV      G     ++    F   E        +++  LEY+H  G I+R +K  +IL+
Sbjct: 69  YLVLEYAPGGELFSHLSKEGRF--SEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126

Query: 496 SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
             +G   L+  GL      S    + + F  +  Y    L+PEVL     GY +  D +S
Sbjct: 127 DADGHIKLTDFGLAKE--LSSEGSRTNTFCGTPEY----LAPEVLLGK--GYGKAVDWWS 178

Query: 554 VGISCCELANGTVPF 568
           +G+   E+  G  PF
Sbjct: 179 LGVLLYEMLTGKPPF 193

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 74/308 (24%), Positives = 127/308 (41%), Gaps = 52/308 (16%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD- 84
           SV   + K T  + A+K    D    +  K +  E+   +  + P I+ Y  +FLD +  
Sbjct: 16  SVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74

Query: 85  -LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
            + +       GS   +       G  + E V+  I + VL GL Y+H +  IHR +K S
Sbjct: 75  SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPS 134

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS---TAYNLNWLSPEVLEQNLDGYDER 198
           +IL++  G+  L      C F  + + V+    +   T++   +++PE + Q    Y   
Sbjct: 135 NILLTRKGQVKL------CDFGVSGELVNSLAGTFTGTSF---YMAPERI-QGKP-YSIT 183

Query: 199 SDIYSVGISCCELANGTVPF-AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENA 257
           SD++S+G++  E+A    PF  E    L  IE L                          
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-------------------------- 217

Query: 258 CSYISEQQTQVL-----TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS 312
            SYI       L        K+S+ F   ++ CL +D  +RP   ++L+H + K   K  
Sbjct: 218 -SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276

Query: 313 VMLPELLR 320
           V + + + 
Sbjct: 277 VNMAKFVA 284

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
           +  +VY ++    ++++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L 
Sbjct: 27  SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
                LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA 
Sbjct: 87  EHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSD 550
           +IL+S  G   L         +P    V      T Y   W++PEV+    +G YD + D
Sbjct: 145 NILLSEPGLVKLGDFGSASIMAPANXFV-----GTPY---WMAPEVILAMDEGQYDGKVD 196

Query: 551 IYSVGISCCELANGTVPF 568
           ++S+GI+C ELA    P 
Sbjct: 197 VWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 79/297 (26%), Positives = 132/297 (44%), Gaps = 48/297 (16%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V ++  K T + +AVKK +L +    +L  L +E+V MR   H N++   +S+L   +L 
Sbjct: 38  VCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNSYLVGDELW 95

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +V   +  G+  D++    +  + E  I  +   VL  L Y+H +G IHR +K+  IL++
Sbjct: 96  VVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152

Query: 147 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
            +G+  LS   +    S   P +K +      T Y   W++PEV+ +    Y    DI+S
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKSL----VGTPY---WMAPEVISRL--PYGTEVDIWS 203

Query: 204 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           +GI   E+ +G  P+   P  L  + ++    P                           
Sbjct: 204 LGIMVIEMIDGEPPYFNEPP-LQAMRRIRDNLP--------------------------- 235

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
              +V  S K S      ++L L R+  +R  A  LLQH F K     S ++P L+R
Sbjct: 236 --PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVP-LMR 289

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 27/220 (12%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----ED-LKSLHHEIVCM 414
           N+KI   +G+     S VY +   +  +++A+KK  +  M D    +D LK    EI  +
Sbjct: 3   NFKIEKKIGK--GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLL 56

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDV 471
           + L HPN+I Y++SF++  +L++V  L   G    +I  HF      +PE  I      +
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTIWKYFVQL 115

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAY 528
            + LE++H K  +HR +K +++ I+  G   L  L   R+   FS      H     T Y
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSL-VGTPY 171

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
              ++SPE + +N  GY+ +SDI+S+G    E+A    PF
Sbjct: 172 ---YMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 18/214 (8%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           ++K+   LG+   +  SVY  K    NQ  A+K+ +L  M+ ++ +   +EI  +  + H
Sbjct: 1   DFKVLKKLGK--GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH 58

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-----LPELVICHILQDVLNG 124
           PNII Y  +FLD   L +V     FG   DL  A          +PE  I  I   +L G
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFG---DLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           L+ +H +  +HR +K+++IL+  N    +  L           K  +  P      ++++
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP------HYMA 169

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PEV +     Y  +SDI+S+G    E+A    PF
Sbjct: 170 PEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 18/214 (8%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           ++K+   LG+   +  SVY  K    NQ  A+K+ +L  M+ ++ +   +EI  +  + H
Sbjct: 1   DFKVLKKLGK--GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH 58

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-----LPELVICHILQDVLNG 474
           PNII Y  +FLD   L +V     FG   DL  A          +PE  I  I   +L G
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFG---DLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           L+ +H +  +HR +K+++IL+  N    +  L           K  +  P      ++++
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP------HYMA 169

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PEV +     Y  +SDI+S+G    E+A    PF
Sbjct: 170 PEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 77/297 (25%), Positives = 122/297 (41%), Gaps = 41/297 (13%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATD 84
            V   ++K T +++A+KKF  +   DED+K     E+  +R LRH NI+    +F     
Sbjct: 16  VVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74

Query: 85  LHLVSPLMGFGSCK--DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           L+LV     +      +L+ A    GLP   +   +  +L  + Y H    IHR +K  +
Sbjct: 75  LYLV---FEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPEN 130

Query: 143 ILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAY-NLNWL-SPEVLEQNLDGYDE 197
           IL+S +G  K C  G  R +      +    L    T Y    W  +PE+L  + + Y +
Sbjct: 131 ILVSESGVLKLCDFGFARAL----RARPASPL----TDYVATRWYRAPELLVGDTN-YGK 181

Query: 198 RSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATP----HLLDCTTYYVDTGQD 251
             D++++G    EL +G   F        L LI+K  G  P     L      +      
Sbjct: 182 PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF------ 235

Query: 252 DGEENACSYISEQQTQVLTSR---KFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                  ++    Q + L  R   K S      ++ CL  D  +R     LLQH +F
Sbjct: 236 ----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 22/222 (9%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCM 414
           P+N++   +LGQ       VYL     T + +AVK+   D     T +++ +L  EI  +
Sbjct: 1   PTNWRRGKLLGQ--GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
           ++L+H  I+ Y     D   L +    M  GS KD + A+    L E V     + +L G
Sbjct: 59  KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEG 116

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPSTAY 528
           +EY+H    +HR +K ++IL    G   L        L+ +C      K V   P     
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP----- 171

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
              W+SPEV+  + +GY  ++D++SVG +  E+     P+AE
Sbjct: 172 --YWMSPEVI--SGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 51/292 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDED--------LKSLHHEIVCMRHLRHPNIICYISS 78
           VYL+ +  T +++AVK+  L               +K+L  EI  ++ L H NI+ Y+  
Sbjct: 17  VYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76

Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
                 L +    +  GS    +  +  F   E ++    + VL GL Y+H KG +HR +
Sbjct: 77  ETTEEYLSIFLEYVPGGSIGSCLRTYGRF--EEQLVRFFTEQVLEGLAYLHSKGILHRDL 134

Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN----WLSPEVLEQNLDG 194
           KA ++L+  +G   +S       F  +KK   ++      ++     W++PEV+     G
Sbjct: 135 KADNLLVDADGICKISD------FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188

Query: 195 YDERSDIYSVGISCCELANGTVPFA--ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD 252
           Y  + DI+S+G    E+  G  P++  E    +  +     A P                
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI--------------- 233

Query: 253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
              +    +S      L +             C + + D RP A  LLQH F
Sbjct: 234 -PPDVSMNLSPVALDFLNA-------------CFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 12/211 (5%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           N   V    H+ T +++AVK   L+ + +   K +  E+  +     P I+ +  +F + 
Sbjct: 13  NSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKAS 491
            D+ +    M  GS  D I       +PE ++  I   VL GL Y+H K   IHR VK S
Sbjct: 72  GDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS 130

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +IL++  G+  L      C F  + + V+    +     ++++PE ++ N   Y  +SDI
Sbjct: 131 NILVNSRGQIKL------CDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN--DYSVKSDI 182

Query: 552 YSVGISCCELANGTVPFA-ETPTTLMLIEKL 581
           +S+G+S  ELA G  P+  E      + E L
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELL 213

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
           +  +VY ++   TN+++A+KK +   + ++E  + +  E+  ++ ++HPN I Y   +L 
Sbjct: 37  SFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
                LV      GS  DL+  H    L E+ I  I    L GL Y+H    IHR +KA 
Sbjct: 97  EHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAG 154

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSD 550
           +IL++  G+  L+        SP    V      T Y   W++PEV+    +G YD + D
Sbjct: 155 NILLTEPGQVKLADFGSASIASPANSFV-----GTPY---WMAPEVILAMDEGQYDGKVD 206

Query: 551 IYSVGISCCELANGTVPF 568
           ++S+GI+C ELA    P 
Sbjct: 207 VWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 13/214 (6%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           +VY +    T Q +A+K+ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +L
Sbjct: 34  TVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDEL 91

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V   +  GS  D++       + E  I  + ++ L  L+++H    IHR +K+ +IL+
Sbjct: 92  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSLG 202

Query: 556 ISCCELANGTVPFA-ETPTTLMLIEKLAGATPHL 588
           I   E+  G  P+  E P   + +    G TP L
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 21/200 (10%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGS--- 96
           AVK    D  ++E+ K    E   M+ L HPN++  +    +   L+LV   M  G    
Sbjct: 27  AVKTLKED-ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLD 85

Query: 97  ----CKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
                + +  +     L    +      +  G+EY+  K F+HR + A + L+  +    
Sbjct: 86  YLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVK 145

Query: 153 LS--GL-RYMCPFSPTKKKVHL-FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 208
           +S  GL R +      +KK     P      + W++PE L+  +  +  +SD++S G+  
Sbjct: 146 ISDFGLSRDVYDDDYYRKKTGGKLP------IRWMAPESLKDGI--FTSKSDVWSFGVLL 197

Query: 209 CEL-ANGTVPFAETPTTLML 227
            E+   G  P+       +L
Sbjct: 198 WEIFTLGATPYPGLSNEEVL 217

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 21/200 (10%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGS--- 446
           AVK    D  ++E+ K    E   M+ L HPN++  +    +   L+LV   M  G    
Sbjct: 27  AVKTLKED-ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLD 85

Query: 447 ----CKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
                + +  +     L    +      +  G+EY+  K F+HR + A + L+  +    
Sbjct: 86  YLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVK 145

Query: 503 LS--GL-RYMCPFSPTKKKVHL-FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 558
           +S  GL R +      +KK     P      + W++PE L+  +  +  +SD++S G+  
Sbjct: 146 ISDFGLSRDVYDDDYYRKKTGGKLP------IRWMAPESLKDGI--FTSKSDVWSFGVLL 197

Query: 559 CEL-ANGTVPFAETPTTLML 577
            E+   G  P+       +L
Sbjct: 198 WEIFTLGATPYPGLSNEEVL 217

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 13/214 (6%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +L
Sbjct: 35  TVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDEL 92

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL+
Sbjct: 93  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSLG 203

Query: 556 ISCCELANGTVPFA-ETPTTLMLIEKLAGATPHL 588
           I   E+  G  P+  E P   + +    G TP L
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL 236

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 17/204 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT-- 433
           VY  +H  T QL A+K  ++    +E++K    EI +  ++  H NI  Y  +F+  +  
Sbjct: 32  VYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRNIATYYGAFIKKSPP 88

Query: 434 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
                L LV    G GS  DL+       L E  I +I +++L GL ++H    IHR +K
Sbjct: 89  GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIK 148

Query: 490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YD 546
             ++L++ N +  L           T  + + F   T Y   W++PEV+  ++N D  YD
Sbjct: 149 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY---WMAPEVIACDENPDATYD 204

Query: 547 ERSDIYSVGISCCELANGTVPFAE 570
            RSDI+S+GI+  E+A G  P  +
Sbjct: 205 YRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 18/204 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V +++ K + + +AVK  +L +    +L  L +E+V MR  +H N++    S+L   +L 
Sbjct: 37  VCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           ++   +  G+  D+++      L E  I  + + VL  L Y+H +G IHR +K+  IL++
Sbjct: 95  VLMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT 151

Query: 497 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
            +G+  LS   +    S   P +K +      T Y   W++PEV+ +    Y    DI+S
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKRKSL----VGTPY---WMAPEVISRTP--YGTEVDIWS 202

Query: 554 VGISCCELANGTVP-FAETPTTLM 576
           +GI   E+ +G  P F+++P   M
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAM 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 10/216 (4%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY ++HK T    A K   ++  ++E+L+    EI  +   +HPNI+    ++     L 
Sbjct: 21  VYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           ++      G+   ++      GL E  I ++ + +L  L ++H    IHR +KA +IL++
Sbjct: 79  ILIEFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137

Query: 497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YDERSDIYS 553
            +G   L+          T +K   F   T Y   W++PEV+  E   D  YD ++DI+S
Sbjct: 138 LDGDVKLADFGVSAKNKSTLQKRDTF-IGTPY---WMAPEVVACETFKDNPYDYKADIWS 193

Query: 554 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 589
           +GI+  ELA    P  E     +L++ L    P L 
Sbjct: 194 LGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 26/229 (11%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   I+G+   + S+V L+K K TN+  A+K  +  ++  E  +K +  E   +  L
Sbjct: 1   DDFKFGKIIGE--GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58

Query: 68  -RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA-HFNFGLPELVICHILQDVLNGL 125
             HP II    +F D  +L+ V   + +    +L+        L E        ++L  L
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFV---LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL 115

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----- 180
           EY+H KG IHR +K  +IL+  +    ++         P          +T  +      
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 181 -----------NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
                       ++SPE+L +   G    SD++++G    ++  G  PF
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 26/229 (11%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   I+G+   + S+V L+K K TN+  A+K  +  ++  E  +K +  E   +  L
Sbjct: 1   DDFKFGKIIGE--GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58

Query: 418 -RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA-HFNFGLPELVICHILQDVLNGL 475
             HP II    +F D  +L+ V   + +    +L+        L E        ++L  L
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFV---LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL 115

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----- 530
           EY+H KG IHR +K  +IL+  +    ++         P          +T  +      
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 531 -----------NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                       ++SPE+L +   G    SD++++G    ++  G  PF
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 87.1 bits (215), Expect = 7e-19
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 13/214 (6%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           +V+ +    T Q +A+K+ NL +   ++L  + +EI+ M+ L++PNI+ ++ SFL   +L
Sbjct: 34  TVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLDSFLVGDEL 91

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ ++L+
Sbjct: 92  FVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSLG 202

Query: 556 ISCCELANGTVPFA-ETPTTLMLIEKLAGATPHL 588
           I   E+  G  P+  E P   + +    G TP L
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDED--------LKSLHHEIVCMRHLRHPNIICYISS 428
           VYL+ +  T +++AVK+  L               +K+L  EI  ++ L H NI+ Y+  
Sbjct: 17  VYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76

Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
                 L +    +  GS    +  +  F   E ++    + VL GL Y+H KG +HR +
Sbjct: 77  ETTEEYLSIFLEYVPGGSIGSCLRTYGRF--EEQLVRFFTEQVLEGLAYLHSKGILHRDL 134

Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN----WLSPEVLEQNLDG 544
           KA ++L+  +G   +S       F  +KK   ++      ++     W++PEV+     G
Sbjct: 135 KADNLLVDADGICKISD------FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188

Query: 545 YDERSDIYSVGISCCELANGTVPFA 569
           Y  + DI+S+G    E+  G  P++
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPWS 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 79/317 (24%), Positives = 129/317 (40%), Gaps = 71/317 (22%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMT--DEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT 83
           V   +H  T  ++AVK+    R T   ++ K L  ++ + MR +  P  + +  +     
Sbjct: 17  VDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL--PELVICHILQDVLNGLEYIHGK-GFIHRAVKA 140
           D+ +   +M   S        ++ GL  PE ++  I   ++  LEY+H K   IHR VK 
Sbjct: 74  DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKP 132

Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVL--EQNLD 193
           S++LI+ NG+        +C F  +   V     S A  ++     +++PE +  E N  
Sbjct: 133 SNVLINRNGQV------KLCDFGISGYLVD----SVAKTIDAGCKPYMAPERINPELNQK 182

Query: 194 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG 253
           GYD +SD++S+GI+  ELA G  P+    T                              
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPF---------------------------- 214

Query: 254 EENACSYISEQQTQV-------LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
                    +Q  QV       L + KFS  F   V  CL ++  +RP    LLQH FF+
Sbjct: 215 ---------QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265

Query: 307 QTKKCSVMLPELLRPAL 323
                +  +   +   L
Sbjct: 266 LHLSKNTDVASFVSLIL 282

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 22/213 (10%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
             V+L+K K T  + A+K      M  ++ +  +  E   +   + P ++    SF    
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           +L+LV   +  G    L+    N G L E V    + +++  LEY+H  G IHR +K  +
Sbjct: 67  NLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 143 ILISHNGKACLS--GLRYM-------CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
           ILI  NG   L+  GL  +             K+   +    T     +++PEV+     
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV--GTPD---YIAPEVILGQ-- 176

Query: 194 GYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
           G+ +  D +S+G    E   G  PF  ETP  +
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 22/213 (10%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
             V+L+K K T  + A+K      M  ++ +  +  E   +   + P ++    SF    
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           +L+LV   +  G    L+    N G L E V    + +++  LEY+H  G IHR +K  +
Sbjct: 67  NLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 493 ILISHNGKACLS--GLRYM-------CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
           ILI  NG   L+  GL  +             K+   +    T     +++PEV+     
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV--GTPD---YIAPEVILGQ-- 176

Query: 544 GYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
           G+ +  D +S+G    E   G  PF  ETP  +
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 48/297 (16%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V ++  K + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L 
Sbjct: 36  VCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELW 93

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +V   +  G+  D++    +  + E  I  +   VL  L  +H +G IHR +K+  IL++
Sbjct: 94  VVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT 150

Query: 147 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
           H+G+  LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKSL----VGTPY---WMAPELISRL--PYGPEVDIWS 201

Query: 204 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           +GI   E+ +G  P+   P  L  ++ +    P  L                        
Sbjct: 202 LGIMVIEMVDGEPPYFNEP-PLKAMKMIRDNLPPKLK----------------------- 237

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
                    K S S    ++  L RD  +R  A  LL+H F  +    S ++P L+R
Sbjct: 238 ------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP-LMR 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 10/197 (5%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY ++   T   IA+K+  +       ++ LH EI    +L+H NI+ Y+ S  +     
Sbjct: 24  VYAARDLSTQVRIAIKE--IPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81

Query: 87  LVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +    +  GS   L+ + +      E  I    + +L GL+Y+H    +HR +K  ++L+
Sbjct: 82  IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSDIYS 203
           +       SG+  +  F  +K+   + P +  +   L +++PEV+++   GY   +DI+S
Sbjct: 142 N-----TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196

Query: 204 VGISCCELANGTVPFAE 220
           +G +  E+A G  PF E
Sbjct: 197 LGCTIVEMATGKPPFIE 213

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 10/197 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY ++   T   IA+K+  +       ++ LH EI    +L+H NI+ Y+ S  +     
Sbjct: 24  VYAARDLSTQVRIAIKE--IPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81

Query: 437 LVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +    +  GS   L+ + +      E  I    + +L GL+Y+H    +HR +K  ++L+
Sbjct: 82  IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSDIYS 553
           +       SG+  +  F  +K+   + P +  +   L +++PEV+++   GY   +DI+S
Sbjct: 142 N-----TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196

Query: 554 VGISCCELANGTVPFAE 570
           +G +  E+A G  PF E
Sbjct: 197 LGCTIVEMATGKPPFIE 213

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 83.5 bits (206), Expect = 9e-18
 Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 42/290 (14%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 67
           +N++I   +G+     S VY +   +  + +A+KK  +  M D   +     EI  ++ L
Sbjct: 2   ANFQIEKKIGR--GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDVLNG 124
            HPN+I Y+ SF++  +L++V  L   G    +I  +F      +PE  +      + + 
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK-YFKKQKRLIPERTVWKYFVQLCSA 118

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +E++H +  +HR +K +++ I+  G   L  L     FS      H    +  Y    +S
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY----MS 174

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY 244
           PE + +N  GY+ +SDI+S+G    E+A    PF      L                   
Sbjct: 175 PERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF------------------ 214

Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                      + C  I +     L +  +S+    +V +C+  D D+RP
Sbjct: 215 -----------SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT-- 433
           VY  +H  T QL A+K  ++    +E++K    EI +  ++  H NI  Y  +F+     
Sbjct: 22  VYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRNIATYYGAFIKKNPP 78

Query: 434 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
                L LV    G GS  DLI       L E  I +I +++L GL ++H    IHR +K
Sbjct: 79  GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 138

Query: 490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YD 546
             ++L++ N +  L           T  + + F   T Y   W++PEV+  ++N D  YD
Sbjct: 139 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY---WMAPEVIACDENPDATYD 194

Query: 547 ERSDIYSVGISCCELANGTVPFAE 570
            +SD++S+GI+  E+A G  P  +
Sbjct: 195 FKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V ++  K T + +AVKK +L +    +L  L +E+V MR   H N++   +S+L   +L 
Sbjct: 38  VCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNSYLVGDELW 95

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +V   +  G+  D++    +  + E  I  +   VL  L Y+H +G IHR +K+  IL++
Sbjct: 96  VVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152

Query: 497 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
            +G+  LS   +    S   P +K +      T Y   W++PEV+ +    Y    DI+S
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKSL----VGTPY---WMAPEVISRL--PYGTEVDIWS 203

Query: 554 VGISCCELANGTVP-FAETPTTLM 576
           +GI   E+ +G  P F E P   M
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAM 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 18/204 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V ++  K + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L 
Sbjct: 36  VCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELW 93

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +V   +  G+  D++    +  + E  I  +   VL  L  +H +G IHR +K+  IL++
Sbjct: 94  VVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT 150

Query: 497 HNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
           H+G+  LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKSL----VGTPY---WMAPELISRL--PYGPEVDIWS 201

Query: 554 VGISCCELANGTVP-FAETPTTLM 576
           +GI   E+ +G  P F E P   M
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAM 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 14/191 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V+L + K   +L+ +K+  +++MT ++  +  +E   ++ L HPNII Y  +FL+   L 
Sbjct: 16  VHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +V      G+  + I    N  L E  I H    +L  L ++H K  +HR +K  +IL+ 
Sbjct: 76  IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135

Query: 147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDERSDIY 202
            +      G      F  +K    L   S AY +     ++SPE+ E     Y+++SDI+
Sbjct: 136 KHKMVVKIG-----DFGISKI---LSSKSKAYTVVGTPCYISPELCEGK--PYNQKSDIW 185

Query: 203 SVGISCCELAN 213
           ++G    ELA+
Sbjct: 186 ALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 14/191 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V+L + K   +L+ +K+  +++MT ++  +  +E   ++ L HPNII Y  +FL+   L 
Sbjct: 16  VHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +V      G+  + I    N  L E  I H    +L  L ++H K  +HR +K  +IL+ 
Sbjct: 76  IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135

Query: 497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDERSDIY 552
            +      G      F  +K    L   S AY +     ++SPE+ E     Y+++SDI+
Sbjct: 136 KHKMVVKIG-----DFGISKI---LSSKSKAYTVVGTPCYISPELCEGK--PYNQKSDIW 185

Query: 553 SVGISCCELAN 563
           ++G    ELA+
Sbjct: 186 ALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 23/257 (8%)

Query: 347 FNSSVETLDNVPS---NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED 403
           +NSS+  L+++      ++I   +G+       VY   +K    L AVK  +     DE+
Sbjct: 7   YNSSMLGLESLGDPTDTWEIIETIGK--GTYGKVYKVTNKKDGSLAAVKILDPISDVDEE 64

Query: 404 LKSLHHEIVCMRHL-RHPNIICYISSFLDAT-----DLHLVSPLMGFGSCKDLINAHFNF 457
           +++   E   ++ L  HPN++ +   F  A       L LV  L   GS  +L+      
Sbjct: 65  IEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121

Query: 458 G--LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT 515
           G  L E +I +IL   L GL+++H    IHR VK ++IL++  G   L         + T
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 516 KKKVHLFPPSTAYNLNWLSPEVL--EQNLD-GYDERSDIYSVGISCCELANGTVPFAETP 572
           + + +    ++     W++PEV+  EQ  D  YD R D++S+GI+  EL +G  P  +  
Sbjct: 182 RLRRN----TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237

Query: 573 TTLMLIEKLAGATPHLL 589
               L +      P LL
Sbjct: 238 PVKTLFKIPRNPPPTLL 254

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 22/197 (11%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATD 434
            V   ++K T +++A+KKF  +   DED+K     E+  +R LRH NI+    +F     
Sbjct: 16  VVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74

Query: 435 LHLVSPLMGFGSCK--DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           L+LV     +      +L+ A    GLP   +   +  +L  + Y H    IHR +K  +
Sbjct: 75  LYLV---FEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPEN 130

Query: 493 ILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAY-NLNWL-SPEVLEQNLDGYDE 547
           IL+S +G  K C  G  R +      +    L    T Y    W  +PE+L  + + Y +
Sbjct: 131 ILVSESGVLKLCDFGFARAL----RARPASPL----TDYVATRWYRAPELLVGDTN-YGK 181

Query: 548 RSDIYSVGISCCELANG 564
             D++++G    EL +G
Sbjct: 182 PVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 42/285 (14%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY +K+K T  L A K   ++  ++E+L+    EI  +    HP I+  + +F     L 
Sbjct: 28  VYKAKNKETGALAAAKV--IETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           ++      G+  D I    + GL E  I  I + +L  L+Y+H    IHR +KA ++L++
Sbjct: 86  IMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT 144

Query: 147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YDERSDIYS 203
            +G   L+          T ++   F   T Y   W++PEV+  E   D  YD ++DI+S
Sbjct: 145 LDGDIKLADFGVSAKNVKTLQRRDSF-IGTPY---WMAPEVVMCETMKDTPYDYKADIWS 200

Query: 204 VGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           +GI+  E+A    P  E  P  ++L  K+A + P  L   +                   
Sbjct: 201 LGITLIEMAQIEPPHHELNPMRVLL--KIAKSEPPTLSQPS------------------- 239

Query: 263 EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
                     K+S  F   ++  L +  + RP A  LL+H F   
Sbjct: 240 ----------KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 86/307 (28%), Positives = 126/307 (41%), Gaps = 54/307 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC-----YISSFLD 81
           V  +  K T + +A+KK +       D K +  EI  +RHLRH NII         S  D
Sbjct: 16  VCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75

Query: 82  ATDLHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 135
             D+++V+ LM         S + L + H         I + L  +L GL+Y+H    IH
Sbjct: 76  FNDVYIVTELMETDLHKVIKSPQPLTDDH---------IQYFLYQILRGLKYLHSANVIH 126

Query: 136 RAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLN-WL-SPEVLEQ 190
           R +K S+IL++ N   K C  GL R + P     +K  L    T Y +  W  +PE+L  
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDP--DEDEKGFL----TEYVVTRWYRAPELL-L 179

Query: 191 NLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDT 248
           +   Y +  DI+SVG    EL      F        L LI ++ G TP            
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG-TPSE---------- 228

Query: 249 GQDDGE---ENACSYISEQQTQ--VLTSRKFSDSFHSIVEL---CLSRDVDKRPLACNLL 300
            +D      E A +Y+     +     S+ F  +    ++L    L  D  KR  A   L
Sbjct: 229 -EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287

Query: 301 QHAFFKQ 307
            H +  Q
Sbjct: 288 AHPYLAQ 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 4/217 (1%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            VY + +  T +L+AVK+  +     + +K +  E+  +  L+HPN++ Y    +    +
Sbjct: 15  KVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           ++       G+ ++L        L E VI      +L GL Y+H  G +HR +K ++I +
Sbjct: 75  YIFMEYCSGGTLEEL--LEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV-LEQNLDGYDERSDIYSV 554
            HNG   L               +     S A    +++PEV       G+   +DI+S+
Sbjct: 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSL 192

Query: 555 GISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLD 590
           G    E+A G  P++E      ++  + AG  P + D
Sbjct: 193 GCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 21/230 (9%)

Query: 354 LDNVPS---NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
            D+ P     ++I   +G+       V+   +K      AVK  +     DE++++ ++ 
Sbjct: 10  FDSFPDPSDTWEIIETIGK--GTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI 67

Query: 411 IVCMRHLRHPNIICYISSFL-----DATDLHLVSPLMGFGSCKDLINAHFNFG--LPELV 463
           +  +    HPN++ +   +      +   L LV  L   GS  DL+      G  + E +
Sbjct: 68  LKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125

Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP 523
           I +IL + L GL+++H    IHR VK ++IL++  G   L         + T+ + +   
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN--- 182

Query: 524 PSTAYNLNWLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAE 570
            ++     W++PEV+  EQ LD  YD R D++S+GI+  EL +G  P A+
Sbjct: 183 -TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 71/290 (24%), Positives = 123/290 (42%), Gaps = 42/290 (14%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL-DRMTDEDLKSLHHEIVCMRHL 67
           +N++I   +G+     S VY +   +    +A+KK  + D M  +       EI  ++ L
Sbjct: 2   ANFRIEKKIGR--GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDVLNG 124
            HPN+I Y +SF++  +L++V  L   G    +I  HF      +PE  +      + + 
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           LE++H +  +HR +K +++ I+  G   L  L     FS      H    +  Y    +S
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY----MS 174

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY 244
           PE + +N  GY+ +SDI+S+G    E+A    PF      L                   
Sbjct: 175 PERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------------ 214

Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                      + C  I +     L S  +S+    +V +C++ D +KRP
Sbjct: 215 -----------SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 59/306 (19%)

Query: 11  YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           Y++   +G+  F    +V   + K   +++  K+ +   MT+++ + L  E+  +R L+H
Sbjct: 2   YEVLETIGKGSF---GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH 58

Query: 70  PNIICYISSFLD--ATDLHLVSPLMGFGSCKDLI-NAHFNFG-LPELVICHILQDVLNGL 125
           PNI+ Y    +D     L++V      G    LI         + E  I  IL  +L  L
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 126 EYIHGKG-----FIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAY 178
              H +       +HR +K ++I +  N    L   GL  +     +  K ++    T Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV---GTPY 175

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPFAETPTTLMLIEKLAGATP 236
              ++SPE L  N   YDE+SDI+S+G  C   EL   + PF      L L  K+     
Sbjct: 176 ---YMSPEQL--NHMSYDEKSDIWSLG--CLIYELCALSPPF-TARNQLQLASKIK---- 223

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
                          +G+     Y             +S   + +++  L+ D DKRP  
Sbjct: 224 ---------------EGKFRRIPYR------------YSSELNEVIKSMLNVDPDKRPST 256

Query: 297 CNLLQH 302
             LLQ 
Sbjct: 257 EELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 73/312 (23%), Positives = 125/312 (40%), Gaps = 50/312 (16%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRH 66
             + +  S LG    N  SV   KH  T  ++A K  ++       + K +  E+  M  
Sbjct: 4   NEDLETISDLGA--GNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHE 59

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGL 125
            R P I+ +  +FL+  +   +   M F  C  L   +   G +P  ++  I   V+ GL
Sbjct: 60  CRSPYIVSFYGAFLNENN---ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGL 116

Query: 126 EYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
            Y++     +HR +K S+IL++  G+  L      C F  + + ++    +      ++S
Sbjct: 117 TYLYNVHRIMHRDIKPSNILVNSRGQIKL------CDFGVSGELINSIADTFVGTSTYMS 170

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY 244
           PE ++     Y  +SD++S+GIS  ELA G  PFA +                       
Sbjct: 171 PERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSN---------------------- 206

Query: 245 YVDTGQDDGEENACS------YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                 DDG+++          I ++    L S  F +     V+ CL +D  +RP    
Sbjct: 207 ----IDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262

Query: 299 LLQHAFFKQTKK 310
           L     F Q  +
Sbjct: 263 LCAMPPFIQALR 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 80/303 (26%), Positives = 123/303 (40%), Gaps = 56/303 (18%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR----------HPNIICY 75
           SVYL+++K T +L+A+KK        +   S      CM  LR          HPNI+  
Sbjct: 14  SVYLARNKETGELVAIKKMK------KKFYSWEE---CMN-LREVKSLRKLNEHPNIVKL 63

Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 135
              F +  +L+ V   M  G+   L+         E VI  I+  +L GL +IH  GF H
Sbjct: 64  KEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122

Query: 136 RAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAY-NLNWL-SPEVLEQN 191
           R +K  ++L+S     K    GL          +++   PP T Y +  W  +PE+L ++
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGL---------AREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 192 LDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDTG 249
              Y    DI+++G    EL      F  +     L  I  + G TP           T 
Sbjct: 174 TS-YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG-TP-----------TK 220

Query: 250 QD--DGEE--NACSYISEQQTQVLTSRKFSDSFHSIVEL---CLSRDVDKRPLACNLLQH 302
           QD  +G +  +   +   Q       +   ++    ++L    L  D  KRP A   LQH
Sbjct: 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280

Query: 303 AFF 305
            +F
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 47/295 (15%)

Query: 16  ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           ILG    N  +VY + H +T +++AVK   LD +T E  K +  E+  +     P II +
Sbjct: 8   ILG--HGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 135
             +F     + + +  M  GS  D+        +PE V+  I   V+ GL Y+     +H
Sbjct: 65  YGAFFVENRISICTEFMDGGSL-DVYRK-----IPEHVLGRIAVAVVKGLTYLWSLKILH 118

Query: 136 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
           R VK S++L++  G+  L      C F  + + V+    +      +++PE +    + Y
Sbjct: 119 RDVKPSNMLVNTRGQVKL------CDFGVSTQLVNSIAKTYVGTNAYMAPERISG--EQY 170

Query: 196 DERSDIYSVGISCCELANGTVPFAE---TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD 252
              SD++S+GIS  ELA G  P+ +      +LM ++        LL C           
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ--------LLQC----------- 211

Query: 253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
                   I ++   VL   +FS+ F   +  C+ +   +RP   NL+ H F  Q
Sbjct: 212 --------IVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 23/204 (11%)

Query: 26  SVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRH-PNIICYISSFLD 81
           SVYL+K + T    A+K   K ++       + ++  E   M      P +     SF  
Sbjct: 11  SVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS 68

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
              L+LV   +  G C  LI      GLPE      + +V+ G+E +H +G IHR +K  
Sbjct: 69  KDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 142 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
           ++LI   G   L+  GL           +  L         ++L+PE +     G D+ S
Sbjct: 127 NLLIDQTGHLKLTDFGL----------SRNGLENKKFVGTPDYLAPETILGV--GDDKMS 174

Query: 200 DIYSVGISCCELANGTVPF-AETP 222
           D +S+G    E   G  PF AETP
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 23/204 (11%)

Query: 376 SVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRH-PNIICYISSFLD 431
           SVYL+K + T    A+K   K ++       + ++  E   M      P +     SF  
Sbjct: 11  SVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS 68

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
              L+LV   +  G C  LI      GLPE      + +V+ G+E +H +G IHR +K  
Sbjct: 69  KDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 492 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
           ++LI   G   L+  GL           +  L         ++L+PE +     G D+ S
Sbjct: 127 NLLIDQTGHLKLTDFGL----------SRNGLENKKFVGTPDYLAPETILGV--GDDKMS 174

Query: 550 DIYSVGISCCELANGTVPF-AETP 572
           D +S+G    E   G  PF AETP
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 13/214 (6%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 417
           +N++I   +G+     S VY +   +  + +A+KK  +  M D   +     EI  ++ L
Sbjct: 2   ANFQIEKKIGR--GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDVLNG 474
            HPN+I Y+ SF++  +L++V  L   G    +I  +F      +PE  +      + + 
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK-YFKKQKRLIPERTVWKYFVQLCSA 118

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +E++H +  +HR +K +++ I+  G   L  L     FS      H    +  Y    +S
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY----MS 174

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE + +N  GY+ +SDI+S+G    E+A    PF
Sbjct: 175 PERIHEN--GYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 77/308 (25%), Positives = 130/308 (42%), Gaps = 56/308 (18%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD---RMTDEDLKSLHHEIVCM 64
           P N+++  +LG+       VYL     T + +AVK+   D   + T +++ +L  EI  +
Sbjct: 1   PVNWRLGKLLGR--GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL 58

Query: 65  RHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
           ++LRH  I+ Y     D  +  L +    M  GS KD + A+    L E V     + +L
Sbjct: 59  KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQIL 116

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPST 176
            G+ Y+H    +HR +K ++IL    G   L        ++ +C      K V      T
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV----TGT 172

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP 236
            Y   W+SPEV+  + +GY  ++D++SV  +  E+     P+AE        E +A    
Sbjct: 173 PY---WMSPEVI--SGEGYGRKADVWSVACTVVEMLTEKPPWAE-------YEAMA---- 216

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
                               A   I+ Q T+ +     SD+    ++     +  +RP A
Sbjct: 217 --------------------AIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE-KRRPTA 255

Query: 297 CNLLQHAF 304
             LL+H F
Sbjct: 256 EFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 24/224 (10%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD---RMTDEDLKSLHHEIVCM 414
           P N+++  +LG+       VYL     T + +AVK+   D   + T +++ +L  EI  +
Sbjct: 1   PVNWRLGKLLGR--GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL 58

Query: 415 RHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
           ++LRH  I+ Y     D  +  L +    M  GS KD + A+    L E V     + +L
Sbjct: 59  KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQIL 116

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPST 526
            G+ Y+H    +HR +K ++IL    G   L        ++ +C      K V      T
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV----TGT 172

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            Y   W+SPEV+  + +GY  ++D++SV  +  E+     P+AE
Sbjct: 173 PY---WMSPEVI--SGEGYGRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 58/300 (19%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEI-VCMRHLRHPNIICYISSFL 80
              +V    HK +  ++AVK+       DE + K L  ++ V MR    P I+ +  +  
Sbjct: 16  AFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73

Query: 81  DATDLHLVSPLM--GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRA 137
              D  +   LM          +       +PE ++  I    +  L Y+  +   IHR 
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 138 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVLEQN- 191
           VK S+IL+  NG   L      C F  + + V     S A   +     +++PE ++ + 
Sbjct: 134 VKPSNILLDRNGNIKL------CDFGISGQLVD----SIAKTRDAGCRPYMAPERIDPSA 183

Query: 192 LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA----GATPHLLDCTTYYVD 247
            DGYD RSD++S+GI+  E+A G  P+   P    + ++L     G  P L         
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPY---PKWNSVFDQLTQVVKGDPPIL--------- 231

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
               +  E                  FS SF + + LCL +D  KRP    LL+H F K 
Sbjct: 232 -SNSEERE------------------FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 30/227 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTD--EDLKS--LHHEIVCMRHLRHPNII-CYISSFLD 431
           VY  + K T  ++AVK+    R T   E+ K   +  ++V   H   P I+ CY   F+ 
Sbjct: 31  VYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSH-DCPYIVKCY-GYFIT 85

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
            +D+ +   LM   +C D +       +PE ++  +   ++  L Y+  K G IHR VK 
Sbjct: 86  DSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKP 143

Query: 491 SHILISHNG--KAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN--LD 543
           S+IL+  +G  K C   +SG R +   + T+          AY    ++PE ++      
Sbjct: 144 SNILLDASGNVKLCDFGISG-RLVDSKAKTRSA-----GCAAY----MAPERIDPPDPNP 193

Query: 544 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD 590
            YD R+D++S+GIS  ELA G  P+    T   ++ K+    P  L 
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 78/318 (24%), Positives = 127/318 (39%), Gaps = 80/318 (25%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNII---CYISSFL 80
             VY +++K T +L+A+KK  ++   +   + ++  EI  ++ LRHPNI+     ++S  
Sbjct: 13  GQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSK- 70

Query: 81  DATDLHLVSP-----LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 135
               +++V       L G      L +    F   +  I   ++ +L GL+Y+H  G +H
Sbjct: 71  GKGSIYMVFEYMDHDLTGL-----LDSPEVKFTESQ--IKCYMKQLLEGLQYLHSNGILH 123

Query: 136 RAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN-----LNWLSPEV 187
           R +K S+ILI+++G   L+  GL R                 S  Y      L +  PE+
Sbjct: 124 RDIKGSNILINNDGVLKLADFGLARPYTK-----------RNSADYTNRVITLWYRPPEL 172

Query: 188 L--EQNLDGYDERSDIYSVGISCC---ELANGTVPF-AET-PTTLMLIEKLAGATPHLLD 240
           L        Y    D++SVG   C   EL  G   F   T    L  I +L G +P    
Sbjct: 173 LLGATR---YGPEVDMWSVG---CILAELFLGKPIFQGSTELEQLEKIFELCG-SPT--- 222

Query: 241 CTTYYVDTGQDDGEENACSYISEQQTQVLTS-----RKFSDSFHSI-----VELC---LS 287
                        +EN          + L       R+  + F  +     ++L    L+
Sbjct: 223 -------------DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLT 269

Query: 288 RDVDKRPLACNLLQHAFF 305
            D  KR  A   LQH +F
Sbjct: 270 LDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCM 64
           P+N+++  +LGQ       VYL     T + +AVK+   D     T +++ +L  EI  +
Sbjct: 1   PTNWRLGKLLGQ--GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLL 58

Query: 65  RHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
           ++L H  I+ Y     D  +  L +    M  GS KD + ++    L E V     + +L
Sbjct: 59  KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQIL 116

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPST 176
            G+ Y+H    +HR +K ++IL    G   L        L+ +C      K V      T
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV----TGT 172

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            Y   W+SPEV+    +GY  ++DI+SVG +  E+     P+AE
Sbjct: 173 PY---WMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCM 414
           P+N+++  +LGQ       VYL     T + +AVK+   D     T +++ +L  EI  +
Sbjct: 1   PTNWRLGKLLGQ--GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLL 58

Query: 415 RHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
           ++L H  I+ Y     D  +  L +    M  GS KD + ++    L E V     + +L
Sbjct: 59  KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQIL 116

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPST 526
            G+ Y+H    +HR +K ++IL    G   L        L+ +C      K V      T
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV----TGT 172

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            Y   W+SPEV+    +GY  ++DI+SVG +  E+     P+AE
Sbjct: 173 PY---WMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 86/325 (26%), Positives = 139/325 (42%), Gaps = 48/325 (14%)

Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   +  + S + +K   T + +A+KK +    +    K  + E
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQSAIHAKRTYRE 64

Query: 61  IVCMRHLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           +  ++H+ H N+I  +      SS  D  D++LV+ LMG     DL N      L +  I
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----ADLNNIVKCQKLSDDHI 120

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             ++  +L GL+YIH  G IHR +K S+I ++ +       L+ +  F   +        
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-----CELKIL-DFGLARHTDDEM-- 172

Query: 175 STAY-NLNW-LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEK 230
            T Y    W  +PE++  N   Y++  DI+SVG    EL  G   F  +     L  I  
Sbjct: 173 -TGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230

Query: 231 LAGA-TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF--HS-----IV 282
           L G     LL          Q    E+A +YI  Q    +  + F + F   +     ++
Sbjct: 231 LVGTPDEELL----------QKISSESARNYI--QSLPQMPKKDFKEVFSGANPLAIDLL 278

Query: 283 ELCLSRDVDKRPLACNLLQHAFFKQ 307
           E  L  D DKR  A   L H +  +
Sbjct: 279 EKMLVLDPDKRITAAEALAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 40/276 (14%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V+    K   ++ A+K+ +L +M   + +    E   +  L    II Y  SFLD   L+
Sbjct: 16  VFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLN 75

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +V      G    L+       LPE  +      +L GL ++H K  +HR +K+ ++ + 
Sbjct: 76  IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135

Query: 147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
                 +  L      S        F  +      +LSPE+ E     Y+E+SD++++G+
Sbjct: 136 AYDNVKIGDLGVAKLLSDNT----NFANTIVGTPYYLSPELCEDK--PYNEKSDVWALGV 189

Query: 207 SCCELANGTVPFAETPTTLMLIEKLA-GATPHLLDCTTYYVDTGQDDGEENACSYISEQQ 265
              E   G  PF +      LI K+  G  P +                           
Sbjct: 190 VLYECCTGKHPF-DANNQGALILKIIRGVFPPV--------------------------- 221

Query: 266 TQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                S+ +S     +++ CL++D  +RP    LL+
Sbjct: 222 -----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 82/289 (28%), Positives = 125/289 (43%), Gaps = 37/289 (12%)

Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVS 89
           KHK T Q++A+KKF L+   D+ +K +   EI  ++ LRH N++  I  F     L+LV 
Sbjct: 21  KHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79

Query: 90  PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
             +      DL    +  GL E  +   L  +L G+E+ H    IHR +K  +IL+S +G
Sbjct: 80  EFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG 137

Query: 150 --KACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL-SPEVLEQNLDGYDERSDIY 202
             K C  G      F+ T     L  P   Y       W  +PE+L  +   Y    DI+
Sbjct: 138 VVKLCDFG------FART-----LAAPGEVYTDYVATRWYRAPELLVGDTK-YGRAVDIW 185

Query: 203 SVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEEN----AC 258
           +VG    E+  G   F         I++L     H++ C    +   Q+  ++N      
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSD----IDQLY----HIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 259 SYISEQQTQVLTSR--KFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                ++ + L  R  K S     + + CL  D D RP +  LL H FF
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 13/214 (6%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL-DRMTDEDLKSLHHEIVCMRHL 417
           +N++I   +G+     S VY +   +    +A+KK  + D M  +       EI  ++ L
Sbjct: 2   ANFRIEKKIGR--GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDVLNG 474
            HPN+I Y +SF++  +L++V  L   G    +I  HF      +PE  +      + + 
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           LE++H +  +HR +K +++ I+  G   L  L     FS      H    +  Y    +S
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY----MS 174

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE + +N  GY+ +SDI+S+G    E+A    PF
Sbjct: 175 PERIHEN--GYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 48/216 (22%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNII---CYISSFL 430
             VY +++K T +L+A+KK  ++   +   + ++  EI  ++ LRHPNI+     ++S  
Sbjct: 13  GQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSK- 70

Query: 431 DATDLHLVSP-----LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 485
               +++V       L G      L +    F   +  I   ++ +L GL+Y+H  G +H
Sbjct: 71  GKGSIYMVFEYMDHDLTGL-----LDSPEVKFTESQ--IKCYMKQLLEGLQYLHSNGILH 123

Query: 486 RAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN-----LNWLSPEV 537
           R +K S+ILI+++G   L+  GL R                 S  Y      L +  PE+
Sbjct: 124 RDIKGSNILINNDGVLKLADFGLARPYTK-----------RNSADYTNRVITLWYRPPEL 172

Query: 538 L--EQNLDGYDERSDIYSVGISCC---ELANGTVPF 568
           L        Y    D++SVG   C   EL  G   F
Sbjct: 173 LLGATR---YGPEVDMWSVG---CILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 86/329 (26%), Positives = 142/329 (43%), Gaps = 56/329 (17%)

Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 66

Query: 61  IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 67  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 124

Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ + +     L+ +  F   +   
Sbjct: 125 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-----LKIL-DFGLAR--- 168

Query: 170 HLFPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
           H     T Y    W  +PE++  N   Y++  DI+SVG    EL  G   F  T     L
Sbjct: 169 HTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227

Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFH------ 279
            LI +L G     L          +    E+A +YI  Q    +    F++ F       
Sbjct: 228 KLILRLVGTPGAELL---------KKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 276

Query: 280 -SIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 277 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 305

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 35/206 (16%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY ++ K T +++A+KK  LD   +    +   EI  ++ L+HPNI+  +        L+
Sbjct: 15  VYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74

Query: 87  LVSPLMGFGSC----KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           LV     F  C    K  ++      L   +I  I+  +L GL Y H    +HR +K  +
Sbjct: 75  LV-----FEYCDMDLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQN 128

Query: 143 ILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAY-----NLNWLSPEVLEQNLDG 194
           ILI+ +G  K    GL R                P   Y      L + +PE+L      
Sbjct: 129 ILINRDGVLKLADFGLARA------------FGIPLRTYTHEVVTLWYRAPEIL-LGSKH 175

Query: 195 YDERSDIYSVGISCC--ELANGTVPF 218
           Y    DI+SVG  C   E+  G   F
Sbjct: 176 YSTAVDIWSVG--CIFAEMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 35/206 (16%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY ++ K T +++A+KK  LD   +    +   EI  ++ L+HPNI+  +        L+
Sbjct: 15  VYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74

Query: 437 LVSPLMGFGSC----KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           LV     F  C    K  ++      L   +I  I+  +L GL Y H    +HR +K  +
Sbjct: 75  LV-----FEYCDMDLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQN 128

Query: 493 ILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAY-----NLNWLSPEVLEQNLDG 544
           ILI+ +G  K    GL R                P   Y      L + +PE+L      
Sbjct: 129 ILINRDGVLKLADFGLARA------------FGIPLRTYTHEVVTLWYRAPEIL-LGSKH 175

Query: 545 YDERSDIYSVGISCC--ELANGTVPF 568
           Y    DI+SVG  C   E+  G   F
Sbjct: 176 YSTAVDIWSVG--CIFAEMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 20/200 (10%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
             V + + + T ++ A+K  N  +  ++  ++++ +E   ++ L HP ++    SF D  
Sbjct: 14  GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73

Query: 84  DLHLVSPLMGFGSCKDL-----INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           +++LV  L+  G   DL         F+    +  IC I   VL  LEY+H KG IHR +
Sbjct: 74  NMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEI---VL-ALEYLHSKGIIHRDI 126

Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  +IL+   G   ++        +P          ST+    +++PEVL +   GY   
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTT-----STSGTPGYMAPEVLCRQ--GYSVA 179

Query: 199 SDIYSVGISCCELANGTVPF 218
            D +S+G++  E   G  P+
Sbjct: 180 VDWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 20/200 (10%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
             V + + + T ++ A+K  N  +  ++  ++++ +E   ++ L HP ++    SF D  
Sbjct: 14  GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73

Query: 434 DLHLVSPLMGFGSCKDL-----INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           +++LV  L+  G   DL         F+    +  IC I   VL  LEY+H KG IHR +
Sbjct: 74  NMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEI---VL-ALEYLHSKGIIHRDI 126

Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  +IL+   G   ++        +P          ST+    +++PEVL +   GY   
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTT-----STSGTPGYMAPEVLCRQ--GYSVA 179

Query: 549 SDIYSVGISCCELANGTVPF 568
            D +S+G++  E   G  P+
Sbjct: 180 VDWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 35/223 (15%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y+I   +G+   +   +YL+K K  ++   +K+ +L +M  ++ ++   E++ +  ++H
Sbjct: 1   RYEIIKKIGE--GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPE-LVICHILQDVLNGLEYI 128
           PNI+ + +SF +   L +V      G     IN        E  ++   +Q  L GL++I
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL-GLKHI 117

Query: 129 HGKGFIHRAVKASHILISHNGKACLSG-------------LRYMCPFSPTKKKVHLFPPS 175
           H +  +HR +K+ +I +S NG     G             L Y C  +P           
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY---------- 167

Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
                 +LSPE+ +     Y+ ++DI+S+G    EL     PF
Sbjct: 168 ------YLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 35/223 (15%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y+I   +G+   +   +YL+K K  ++   +K+ +L +M  ++ ++   E++ +  ++H
Sbjct: 1   RYEIIKKIGE--GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPE-LVICHILQDVLNGLEYI 478
           PNI+ + +SF +   L +V      G     IN        E  ++   +Q  L GL++I
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL-GLKHI 117

Query: 479 HGKGFIHRAVKASHILISHNGKACLSG-------------LRYMCPFSPTKKKVHLFPPS 525
           H +  +HR +K+ +I +S NG     G             L Y C  +P           
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY---------- 167

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                 +LSPE+ +     Y+ ++DI+S+G    EL     PF
Sbjct: 168 ------YLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.4 bits (189), Expect = 4e-15
 Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 32/208 (15%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC-----YISSFLD 431
           V  +  K T + +A+KK +       D K +  EI  +RHLRH NII         S  D
Sbjct: 16  VCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75

Query: 432 ATDLHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 485
             D+++V+ LM         S + L + H         I + L  +L GL+Y+H    IH
Sbjct: 76  FNDVYIVTELMETDLHKVIKSPQPLTDDH---------IQYFLYQILRGLKYLHSANVIH 126

Query: 486 RAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLN-WL-SPEVLEQ 540
           R +K S+IL++ N   K C  GL R + P     +K  L    T Y +  W  +PE+L  
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDP--DEDEKGFL----TEYVVTRWYRAPELL-L 179

Query: 541 NLDGYDERSDIYSVGISCCELANGTVPF 568
           +   Y +  DI+SVG    EL      F
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLF 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 74/282 (26%), Positives = 123/282 (43%), Gaps = 42/282 (14%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY +++K T  L A K   +D  ++E+L+    EI  +    HPNI+  + +F    +L 
Sbjct: 21  VYKAQNKETGVLAAAKV--IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           ++      G+  D +       L E  I  + +  L  L Y+H    IHR +KA +IL +
Sbjct: 79  ILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT 137

Query: 147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLD-GYDERSDIYS 203
            +G   L+        + T ++   F   T Y   W++PEV+  E + D  YD ++D++S
Sbjct: 138 LDGDIKLADFGVSAKNTRTIQRRDSF-IGTPY---WMAPEVVMCETSKDRPYDYKADVWS 193

Query: 204 VGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           +GI+  E+A    P  E  P  ++L  K+A + P  L                       
Sbjct: 194 LGITLIEMAQIEPPHHELNPMRVLL--KIAKSEPPTL----------------------- 228

Query: 263 EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                     ++S  F   ++ CL ++VD R     LLQH F
Sbjct: 229 ------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 24/228 (10%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD- 434
           SV   + K T  + A+K    D    +  K +  E+   +  + P I+ Y  +FLD +  
Sbjct: 16  SVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74

Query: 435 -LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
            + +       GS   +       G  + E V+  I + VL GL Y+H +  IHR +K S
Sbjct: 75  SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPS 134

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS---TAYNLNWLSPEVLEQNLDGYDER 548
           +IL++  G+  L      C F  + + V+    +   T++   +++PE + Q    Y   
Sbjct: 135 NILLTRKGQVKL------CDFGVSGELVNSLAGTFTGTSF---YMAPERI-QGKP-YSIT 183

Query: 549 SDIYSVGISCCELANGTVPF-AETPTTLMLIEKLA----GATPHLLDC 591
           SD++S+G++  E+A    PF  E    L  IE L+       P L D 
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 27/222 (12%)

Query: 361 YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           Y++   +G+  F    +V   + K   +++  K+ +   MT+++ + L  E+  +R L+H
Sbjct: 2   YEVLETIGKGSF---GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH 58

Query: 420 PNIICYISSFLD--ATDLHLVSPLMGFGSCKDLI-NAHFNFG-LPELVICHILQDVLNGL 475
           PNI+ Y    +D     L++V      G    LI         + E  I  IL  +L  L
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 476 EYIHGKG-----FIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAY 528
              H +       +HR +K ++I +  N    L   GL  +     +  K ++    T Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV---GTPY 175

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPF 568
              ++SPE L  N   YDE+SDI+S+G  C   EL   + PF
Sbjct: 176 ---YMSPEQL--NHMSYDEKSDIWSLG--CLIYELCALSPPF 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 27/206 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMT--DEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT 433
           V   +H  T  ++AVK+    R T   ++ K L  ++ + MR +  P  + +  +     
Sbjct: 17  VDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL--PELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
           D+ +   +M   S        ++ GL  PE ++  I   ++  LEY+H K   IHR VK 
Sbjct: 74  DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKP 132

Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVL--EQNLD 543
           S++LI+ NG+        +C F  +   V     S A  ++     +++PE +  E N  
Sbjct: 133 SNVLINRNGQV------KLCDFGISGYLVD----SVAKTIDAGCKPYMAPERINPELNQK 182

Query: 544 GYDERSDIYSVGISCCELANGTVPFA 569
           GYD +SD++S+GI+  ELA G  P+ 
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 24/224 (10%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCM 64
           P N++   +LGQ       VYL     T + +A K+   D     T +++ +L  EI  +
Sbjct: 1   PINWRRGKLLGQ--GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLL 58

Query: 65  RHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
           ++L+H  I+ Y     D  +  L +    M  GS KD + A+    L E V     + +L
Sbjct: 59  KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQIL 116

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPST 176
            G+ Y+H    +HR +K ++IL    G   L        L+ +C      + V      T
Sbjct: 117 EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV----TGT 172

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            Y   W+SPEV+    +GY  ++D++S+G +  E+     P+AE
Sbjct: 173 PY---WMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 24/224 (10%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCM 414
           P N++   +LGQ       VYL     T + +A K+   D     T +++ +L  EI  +
Sbjct: 1   PINWRRGKLLGQ--GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLL 58

Query: 415 RHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
           ++L+H  I+ Y     D  +  L +    M  GS KD + A+    L E V     + +L
Sbjct: 59  KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQIL 116

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSG------LRYMCPFSPTKKKVHLFPPST 526
            G+ Y+H    +HR +K ++IL    G   L        L+ +C      + V      T
Sbjct: 117 EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV----TGT 172

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            Y   W+SPEV+    +GY  ++D++S+G +  E+     P+AE
Sbjct: 173 PY---WMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 35/202 (17%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR----------HPNIICY 425
           SVYL+++K T +L+A+KK        +   S      CM  LR          HPNI+  
Sbjct: 14  SVYLARNKETGELVAIKKMK------KKFYSWEE---CMN-LREVKSLRKLNEHPNIVKL 63

Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 485
              F +  +L+ V   M  G+   L+         E VI  I+  +L GL +IH  GF H
Sbjct: 64  KEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122

Query: 486 RAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAY-NLNWL-SPEVLEQN 541
           R +K  ++L+S     K    GL          +++   PP T Y +  W  +PE+L ++
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGL---------AREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 542 LDGYDERSDIYSVGISCCELAN 563
              Y    DI+++G    EL  
Sbjct: 174 TS-YSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)

Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   +  + S + +K   T + +A+KK +    +    K  + E
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQSAIHAKRTYRE 64

Query: 411 IVCMRHLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           +  ++H+ H N+I  +      SS  D  D++LV+ LMG     DL N      L +  I
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----ADLNNIVKCQKLSDDHI 120

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHI 493
             ++  +L GL+YIH  G IHR +K S+I
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNI 149

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            V+ +K + T + +A+KK  L R+          EI  ++  +HP ++  +  F   +  
Sbjct: 15  IVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            LV   M      +++       LPE  +   ++ +L G+ Y+H  G +HR +K +++LI
Sbjct: 75  VLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI 132

Query: 146 SHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
           S +G  K    GL R    FS  + +++    +T +   + +PE+L      YD   D++
Sbjct: 133 SADGVLKIADFGLAR---LFSEEEPRLYSHQVATRW---YRAPELLYGARK-YDPGVDLW 185

Query: 203 SVGISCCELANGTVPF 218
           +VG    EL NG  P 
Sbjct: 186 AVGCIFAELLNG-SPL 200

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            V+ +K + T + +A+KK  L R+          EI  ++  +HP ++  +  F   +  
Sbjct: 15  IVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            LV   M      +++       LPE  +   ++ +L G+ Y+H  G +HR +K +++LI
Sbjct: 75  VLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI 132

Query: 496 SHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
           S +G  K    GL R    FS  + +++    +T +   + +PE+L      YD   D++
Sbjct: 133 SADGVLKIADFGLAR---LFSEEEPRLYSHQVATRW---YRAPELLYGARK-YDPGVDLW 185

Query: 553 SVGISCCELANGTVPF 568
           +VG    EL NG  P 
Sbjct: 186 AVGCIFAELLNG-SPL 200

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 7/206 (3%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V+    K   ++ A+K+ +L +M   + +    E   +  L    II Y  SFLD   L+
Sbjct: 16  VFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLN 75

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +V      G    L+       LPE  +      +L GL ++H K  +HR +K+ ++ + 
Sbjct: 76  IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135

Query: 497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
                 +  L      S        F  +      +LSPE+ E     Y+E+SD++++G+
Sbjct: 136 AYDNVKIGDLGVAKLLSDNT----NFANTIVGTPYYLSPELCEDK--PYNEKSDVWALGV 189

Query: 557 SCCELANGTVPFAETPTTLMLIEKLA 582
              E   G  PF +      LI K+ 
Sbjct: 190 VLYECCTGKHPF-DANNQGALILKII 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 18/218 (8%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRH 416
             + +  S LG    N  SV   KH  T  ++A K  ++       + K +  E+  M  
Sbjct: 4   NEDLETISDLGA--GNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHE 59

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGL 475
            R P I+ +  +FL+  +   +   M F  C  L   +   G +P  ++  I   V+ GL
Sbjct: 60  CRSPYIVSFYGAFLNENN---ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGL 116

Query: 476 EYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
            Y++     +HR +K S+IL++  G+  L      C F  + + ++    +      ++S
Sbjct: 117 TYLYNVHRIMHRDIKPSNILVNSRGQIKL------CDFGVSGELINSIADTFVGTSTYMS 170

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP 572
           PE ++     Y  +SD++S+GIS  ELA G  PFA + 
Sbjct: 171 PERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 70/253 (27%), Positives = 108/253 (42%), Gaps = 59/253 (23%)

Query: 61  IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           IVCM +  H P+ +C+I   ++  DLH      G  S K++      F   E+++     
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIIL----- 108

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    +  Y 
Sbjct: 109 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGY- 161

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
              ++PEVL++    YD  +D +S+G    +L  G  PF +  T             H +
Sbjct: 162 ---MAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------DKHEI 207

Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-- 297
           D  T  V+    D                     FS    S++E  L RDV KR L C  
Sbjct: 208 DRMTLTVNVELPD--------------------SFSPELKSLLEGLLQRDVSKR-LGCLG 246

Query: 298 ----NLLQHAFFK 306
                + +H FFK
Sbjct: 247 RGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 13/219 (5%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHEIVCMRHLRHPNIICYISSFL 80
           SS Y ++   T  L+AVK+    R T    +E +++L  EI  M  L HP+II  + +  
Sbjct: 14  SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC 73

Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
           + +  +L    M  GS   L++    +G   E VI +  + +L GL Y+H    IHR VK
Sbjct: 74  EDSHFNLFVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK 130

Query: 140 ASHILISHNGKAC-LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
            +++LI   G+   ++        +        F       + +++PEVL    + Y   
Sbjct: 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRS 188

Query: 199 SDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGAT 235
            D++SVG    E+A    P+     +  L LI K+A AT
Sbjct: 189 CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 13/219 (5%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHEIVCMRHLRHPNIICYISSFL 430
           SS Y ++   T  L+AVK+    R T    +E +++L  EI  M  L HP+II  + +  
Sbjct: 14  SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC 73

Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
           + +  +L    M  GS   L++    +G   E VI +  + +L GL Y+H    IHR VK
Sbjct: 74  EDSHFNLFVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK 130

Query: 490 ASHILISHNGKAC-LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
            +++LI   G+   ++        +        F       + +++PEVL    + Y   
Sbjct: 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRS 188

Query: 549 SDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGAT 585
            D++SVG    E+A    P+     +  L LI K+A AT
Sbjct: 189 CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 13/219 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY +K+K T  L A K   ++  ++E+L+    EI  +    HP I+  + +F     L 
Sbjct: 28  VYKAKNKETGALAAAKV--IETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           ++      G+  D I    + GL E  I  I + +L  L+Y+H    IHR +KA ++L++
Sbjct: 86  IMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT 144

Query: 497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG-YDERSDIYS 553
            +G   L+          T ++   F   T Y   W++PEV+  E   D  YD ++DI+S
Sbjct: 145 LDGDIKLADFGVSAKNVKTLQRRDSF-IGTPY---WMAPEVVMCETMKDTPYDYKADIWS 200

Query: 554 VGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDC 591
           +GI+  E+A    P  E  P  ++L  K+A + P  L  
Sbjct: 201 LGITLIEMAQIEPPHHELNPMRVLL--KIAKSEPPTLSQ 237

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 18/211 (8%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            V L K K  N+  A+K      + +    + +  E   +    HP I+    +F D   
Sbjct: 8   RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY 67

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           ++++      G    ++     F          +  V+   EY+H +G I+R +K  ++L
Sbjct: 68  IYMLMEYCLGGELWTILRDRGLFDEYTARFY--IACVVLAFEYLHNRGIIYRDLKPENLL 125

Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDERSD 200
           +  NG         +  F   KK   L      +       +++PE++     GYD   D
Sbjct: 126 LDSNGYV------KLVDFGFAKK---LKSGQKTWTFCGTPEYVAPEIILNK--GYDFSVD 174

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKL 231
            +S+GI   EL  G  PF E     M I   
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYND 205

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 18/211 (8%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            V L K K  N+  A+K      + +    + +  E   +    HP I+    +F D   
Sbjct: 8   RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY 67

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           ++++      G    ++     F          +  V+   EY+H +G I+R +K  ++L
Sbjct: 68  IYMLMEYCLGGELWTILRDRGLFDEYTARFY--IACVVLAFEYLHNRGIIYRDLKPENLL 125

Query: 495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDERSD 550
           +  NG         +  F   KK   L      +       +++PE++     GYD   D
Sbjct: 126 LDSNGYV------KLVDFGFAKK---LKSGQKTWTFCGTPEYVAPEIILNK--GYDFSVD 174

Query: 551 IYSVGISCCELANGTVPFAETPTTLMLIEKL 581
            +S+GI   EL  G  PF E     M I   
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYND 205

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 77/287 (26%), Positives = 121/287 (42%), Gaps = 33/287 (11%)

Query: 30  SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-ATDLHLV 88
           ++ ++T Q +A+KK      T    K  + E+  ++HLRH NII     F+    D++ V
Sbjct: 29  ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88

Query: 89  SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
           + L+G     DL     +  L +  I + L  +L GL+Y+H  G +HR +K S+ILI+ N
Sbjct: 89  TELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144

Query: 149 GKACLSGLRYMCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              C   L+ +C F   + +        ST Y   + +PE++      YD   DI+S G 
Sbjct: 145 ---C--DLK-ICDFGLARIQDPQMTGYVSTRY---YRAPEIM-LTWQKYDVEVDIWSAGC 194

Query: 207 SCCELANGT--VPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS-- 262
              E+  G    P  +      +I  L G  P          D       EN   ++   
Sbjct: 195 IFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD---------DVINTICSENTLRFVQSL 245

Query: 263 EQQTQVLTSRKF---SDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
            ++  V  S KF     S   ++E  L  D  KR  A   L H +  
Sbjct: 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 37/307 (12%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLD-------RMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           N   V    H+ +  ++A K  +L+       ++  E LK LH    C      P I+ +
Sbjct: 13  NGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRE-LKVLHE---C----NSPYIVGF 64

Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFI 134
             +F    ++ +    M  GS  D +       +PE ++  I   VL GL Y+  K   +
Sbjct: 65  YGAFYSDGEISICMEHMDGGSL-DQVLKKAG-RIPENILGKISIAVLRGLTYLREKHKIM 122

Query: 135 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 194
           HR VK S+IL++  G+        +C F  + + +     S     +++SPE L+     
Sbjct: 123 HRDVKPSNILVNSRGEI------KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--H 174

Query: 195 YDERSDIYSVGISCCELANGTVPF-AETPTTLMLI---EKLAGATPHLLDCTTYYVDTGQ 250
           Y  +SDI+S+G+S  E+A G  P        L  +       G         + +     
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH---PP 231

Query: 251 DDGEENAC----SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
           D     A      YI  +    L S  FSD F   V+ CL ++  +R     L +H F K
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291

Query: 307 QTKKCSV 313
           + +   V
Sbjct: 292 RAELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 56/188 (29%), Positives = 91/188 (48%), Gaps = 17/188 (9%)

Query: 380 SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-ATDLHLV 438
           ++ ++T Q +A+KK      T    K  + E+  ++HLRH NII     F+    D++ V
Sbjct: 29  ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88

Query: 439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
           + L+G     DL     +  L +  I + L  +L GL+Y+H  G +HR +K S+ILI+ N
Sbjct: 89  TELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144

Query: 499 GKACLSGLRYMCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              C   L+ +C F   + +        ST Y   + +PE++      YD   DI+S G 
Sbjct: 145 ---C--DLK-ICDFGLARIQDPQMTGYVSTRY---YRAPEIM-LTWQKYDVEVDIWSAGC 194

Query: 557 SCCELANG 564
              E+  G
Sbjct: 195 IFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 43/125 (34%), Positives = 65/125 (52%), Gaps = 6/125 (4%)

Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVS 439
           KHK T Q++A+KKF L+   D+ +K +   EI  ++ LRH N++  I  F     L+LV 
Sbjct: 21  KHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79

Query: 440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
             +      DL    +  GL E  +   L  +L G+E+ H    IHR +K  +IL+S +G
Sbjct: 80  EFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG 137

Query: 500 --KAC 502
             K C
Sbjct: 138 VVKLC 142

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 31/200 (15%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 85
           V+  +++ T Q++A+KKF ++   D  +K +   EI  ++ L+HPN++  I  F     L
Sbjct: 17  VFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKL 75

Query: 86  HLVSPLMGFGSCK----DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           HLV     F  C     + +  +   G+PE +I  I+   L  + + H    IHR VK  
Sbjct: 76  HLV-----FEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPE 129

Query: 142 HILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL-SPEVLEQNLDG 194
           +ILI+  G  K C  G   +           L  P   Y       W  +PE+L  +   
Sbjct: 130 NILITKQGQIKLCDFGFARI-----------LTGPGDDYTDYVATRWYRAPELLVGDTQ- 177

Query: 195 YDERSDIYSVGISCCELANG 214
           Y    D++++G    EL  G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 31/200 (15%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 435
           V+  +++ T Q++A+KKF ++   D  +K +   EI  ++ L+HPN++  I  F     L
Sbjct: 17  VFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKL 75

Query: 436 HLVSPLMGFGSCK----DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           HLV     F  C     + +  +   G+PE +I  I+   L  + + H    IHR VK  
Sbjct: 76  HLV-----FEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPE 129

Query: 492 HILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL-SPEVLEQNLDG 544
           +ILI+  G  K C  G   +           L  P   Y       W  +PE+L  +   
Sbjct: 130 NILITKQGQIKLCDFGFARI-----------LTGPGDDYTDYVATRWYRAPELLVGDTQ- 177

Query: 545 YDERSDIYSVGISCCELANG 564
           Y    D++++G    EL  G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 7/128 (5%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH----HEIVCMRHLRHPNIICYISSFLDA 82
           VY ++ K T +++A+KK  L     E    ++     EI  ++ L+HPNII  +  F   
Sbjct: 16  VYKARDKETGRIVAIKKIKLGERK-EAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK 74

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           ++++LV   M     + +I        P  +  ++L   L GLEY+H    +HR +K ++
Sbjct: 75  SNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLM-TLRGLEYLHSNWILHRDLKPNN 132

Query: 143 ILISHNGK 150
           +LI+ +G 
Sbjct: 133 LLIASDGV 140

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 7/128 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH----HEIVCMRHLRHPNIICYISSFLDA 432
           VY ++ K T +++A+KK  L     E    ++     EI  ++ L+HPNII  +  F   
Sbjct: 16  VYKARDKETGRIVAIKKIKLGERK-EAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK 74

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           ++++LV   M     + +I        P  +  ++L   L GLEY+H    +HR +K ++
Sbjct: 75  SNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLM-TLRGLEYLHSNWILHRDLKPNN 132

Query: 493 ILISHNGK 500
           +LI+ +G 
Sbjct: 133 LLIASDGV 140

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 22/164 (13%)

Query: 411 IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           IVCM +  H P+ +C+I   ++  DLH      G  S K++      F   E+++     
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIIL----- 108

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    +  Y 
Sbjct: 109 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGY- 161

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
              ++PEVL++    YD  +D +S+G    +L  G  PF +  T
Sbjct: 162 ---MAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 63/272 (23%)

Query: 61  IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           IVCM +  H P+ + +I   ++  DLH      G  S  ++      F   E+++     
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR-----FYAAEIIL----- 108

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    +  Y 
Sbjct: 109 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGY- 161

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
              ++PEVL++ +  YD  +D +S+G    +L  G  PF +  T             H +
Sbjct: 162 ---MAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------DKHEI 207

Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN- 298
           D  T  +     D                     FS    S++E  L RDV++R L C  
Sbjct: 208 DRMTLTMAVELPD--------------------SFSPELRSLLEGLLQRDVNRR-LGCLG 246

Query: 299 -----LLQHAFFKQTKKCSVML----PELLRP 321
                + +H FF+      V L    P L+ P
Sbjct: 247 RGAQEVKEHPFFRSLDWQMVFLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 26/156 (16%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           + I   +G+       VY ++ K T +L+A+KK  LD   +    +   EI  +R L H 
Sbjct: 9   FDIIGQIGE--GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 71  NIICY---ISSFLDATD-------LHLVSPLMGFGSCKDLIN------AHFNFGLPELVI 114
           NI+     ++   DA D        +LV   M      DL+        HF+    E  I
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFS----EDHI 118

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK 150
              ++ +L GL Y H K F+HR +K S+IL+++ G+
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 26/156 (16%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           + I   +G+       VY ++ K T +L+A+KK  LD   +    +   EI  +R L H 
Sbjct: 9   FDIIGQIGE--GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 421 NIICY---ISSFLDATD-------LHLVSPLMGFGSCKDLIN------AHFNFGLPELVI 464
           NI+     ++   DA D        +LV   M      DL+        HF+    E  I
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFS----EDHI 118

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK 500
              ++ +L GL Y H K F+HR +K S+IL+++ G+
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 75/256 (29%), Positives = 117/256 (45%), Gaps = 29/256 (11%)

Query: 321 PALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLS 380
           PAL  N++    I+N L       DT N  +  L     +Y++  ++G+       V L 
Sbjct: 13  PALRKNKN----IDNFLN---RYKDTINK-IRDLRMKAEDYEVVKVIGR--GAFGEVQLV 62

Query: 381 KHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL 437
           +HK T ++ A+K   KF + + +D        +I  M     P ++    +F D   L++
Sbjct: 63  RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQLFYAFQDDRYLYM 120

Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V   M  G   DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+  
Sbjct: 121 VMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 177

Query: 498 NGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNL-NWLSPEVLE-QNLDGYDERS-DIY 552
           +G   L+       F    K  K  +    TA    +++SPEVL+ Q  DGY  R  D +
Sbjct: 178 SGHLKLAD------FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 553 SVGISCCELANGTVPF 568
           SVG+   E+  G  PF
Sbjct: 232 SVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 61/196 (31%), Positives = 88/196 (44%), Gaps = 11/196 (5%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V L +HK + Q+ A+K  +   M    D      E   M H     I+    +F D   L
Sbjct: 59  VQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           ++V   M  G   DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+
Sbjct: 119 YMVMEYMPGG---DLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLE-QNLDGYDERS-DIY 202
             +G   L+     C        V      TA    +++SPEVL+ Q  DGY  R  D +
Sbjct: 176 DKSGHLKLADFG-TCMKMDANGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 203 SVGISCCELANGTVPF 218
           SVG+   E+  G  PF
Sbjct: 232 SVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 61/196 (31%), Positives = 88/196 (44%), Gaps = 11/196 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V L +HK + Q+ A+K  +   M    D      E   M H     I+    +F D   L
Sbjct: 59  VQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           ++V   M  G   DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+
Sbjct: 119 YMVMEYMPGG---DLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLE-QNLDGYDERS-DIY 552
             +G   L+     C        V      TA    +++SPEVL+ Q  DGY  R  D +
Sbjct: 176 DKSGHLKLADFG-TCMKMDANGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 553 SVGISCCELANGTVPF 568
           SVG+   E+  G  PF
Sbjct: 232 SVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 13/217 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY +++K T  L A K   +D  ++E+L+    EI  +    HPNI+  + +F    +L 
Sbjct: 21  VYKAQNKETGVLAAAKV--IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           ++      G+  D +       L E  I  + +  L  L Y+H    IHR +KA +IL +
Sbjct: 79  ILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT 137

Query: 497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLD-GYDERSDIYS 553
            +G   L+        + T ++   F   T Y   W++PEV+  E + D  YD ++D++S
Sbjct: 138 LDGDIKLADFGVSAKNTRTIQRRDSF-IGTPY---WMAPEVVMCETSKDRPYDYKADVWS 193

Query: 554 VGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLL 589
           +GI+  E+A    P  E  P  ++L  K+A + P  L
Sbjct: 194 LGITLIEMAQIEPPHHELNPMRVLL--KIAKSEPPTL 228

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 25/194 (12%)

Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 95
            Q +AVK    D       ++   E   M  LRHPN++  +   L    L++V+  M  G
Sbjct: 29  GQKVAVKCLKDDSTA---AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85

Query: 96  SCKDLI----NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           S  D +     A       + +   +  DV  G+EY+  K F+HR + A ++L+S +  A
Sbjct: 86  SLVDYLRSRGRAVITLA--QQLGFAL--DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA 141

Query: 152 CLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +S  GL          K+      S    + W +PE L +    +  +SD++S GI   
Sbjct: 142 KVSDFGL---------AKEASQGQDSGKLPVKWTAPEALREKK--FSTKSDVWSFGILLW 190

Query: 210 EL-ANGTVPFAETP 222
           E+ + G VP+   P
Sbjct: 191 EIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 25/194 (12%)

Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 445
            Q +AVK    D       ++   E   M  LRHPN++  +   L    L++V+  M  G
Sbjct: 29  GQKVAVKCLKDDSTA---AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85

Query: 446 SCKDLI----NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           S  D +     A       + +   +  DV  G+EY+  K F+HR + A ++L+S +  A
Sbjct: 86  SLVDYLRSRGRAVITLA--QQLGFAL--DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA 141

Query: 502 CLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +S  GL          K+      S    + W +PE L +    +  +SD++S GI   
Sbjct: 142 KVSDFGL---------AKEASQGQDSGKLPVKWTAPEALREKK--FSTKSDVWSFGILLW 190

Query: 560 EL-ANGTVPFAETP 572
           E+ + G VP+   P
Sbjct: 191 EIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 68.2 bits (166), Expect = 8e-12
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 25/229 (10%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V+L KHK T +    K  +   + + +   L  E+  MR L+H NI+ YI  FL+  +  
Sbjct: 29  VFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88

Query: 87  LVSPLMGFGSCKDLI----NAHFNFG-LPELVICHILQDVLNGLEYIH-------GKGFI 134
           L   LM F    DL       +  FG + E  I  I + +L+ L Y H       G+  +
Sbjct: 89  LYI-LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVL 147

Query: 135 HRAVKASHILIS----HNGKAC-----LSG--LRYMCPFSPTKK-KVHLFPPSTAYNLNW 182
           HR +K  +I +S    H GK       L+G  +  +  F  +K   +     S      +
Sbjct: 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYY 207

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 231
            SPE+L      YD++SD++++G    EL +G  PF +      LI +L
Sbjct: 208 WSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL 256

Length = 1021

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 68.2 bits (166), Expect = 8e-12
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 25/229 (10%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V+L KHK T +    K  +   + + +   L  E+  MR L+H NI+ YI  FL+  +  
Sbjct: 29  VFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88

Query: 437 LVSPLMGFGSCKDLI----NAHFNFG-LPELVICHILQDVLNGLEYIH-------GKGFI 484
           L   LM F    DL       +  FG + E  I  I + +L+ L Y H       G+  +
Sbjct: 89  LYI-LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVL 147

Query: 485 HRAVKASHILIS----HNGKAC-----LSG--LRYMCPFSPTKK-KVHLFPPSTAYNLNW 532
           HR +K  +I +S    H GK       L+G  +  +  F  +K   +     S      +
Sbjct: 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYY 207

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
            SPE+L      YD++SD++++G    EL +G  PF +      LI +L
Sbjct: 208 WSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL 256

Length = 1021

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           ILG    N  +VY + H +T +++AVK   LD +T E  K +  E+  +     P II +
Sbjct: 8   ILG--HGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 485
             +F     + + +  M  GS  D+        +PE V+  I   V+ GL Y+     +H
Sbjct: 65  YGAFFVENRISICTEFMDGGSL-DVYRK-----IPEHVLGRIAVAVVKGLTYLWSLKILH 118

Query: 486 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
           R VK S++L++  G+  L      C F  + + V+    +      +++PE +    + Y
Sbjct: 119 RDVKPSNMLVNTRGQVKL------CDFGVSTQLVNSIAKTYVGTNAYMAPERISG--EQY 170

Query: 546 DERSDIYSVGISCCELANGTVPF 568
              SD++S+GIS  ELA G  P+
Sbjct: 171 GIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 81/329 (24%), Positives = 141/329 (42%), Gaps = 56/329 (17%)

Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  + +G   + ++ S Y ++     Q +AVKK +    +    +  + E
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQSLIHARRTYRE 64

Query: 61  IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  AT      +++LV+ LMG        C+ L + H  F  
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-- 122

Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH  G IHR +K S++ ++ + +     LR +  F   ++  
Sbjct: 123 -------LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-----LRIL-DFGLARQAD 169

Query: 170 HLFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTV--PFAETPTTLM 226
                  A    W  +PE++  N   Y++  DI+SVG    EL  G    P  +    L 
Sbjct: 170 DEMTGYVA--TRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226

Query: 227 LIEKLAGA-TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFH------ 279
            I ++ G  +P +L          +    E+A  YI  Q    +  +     F       
Sbjct: 227 RIMEVVGTPSPEVL----------KKISSEHARKYI--QSLPHMPQQDLKKIFRGANPLA 274

Query: 280 -SIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L H +F Q
Sbjct: 275 IDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 22/154 (14%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH-----EIVC 63
            +Y+I   LG+       VY ++   T +++A+KK     +   + K         EI  
Sbjct: 8   RDYEILGKLGE--GTFGEVYKARQIKTGRVVALKK-----ILMHNEKDGFPITALREIKI 60

Query: 64  MRHLRHPNIICYISSFLDATDLH--------LVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           ++ L+HPN++  I   ++  D          +V+P M       L N        + + C
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKC 119

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
           ++LQ +L G+ Y+H    +HR +KA++ILI + G
Sbjct: 120 YMLQ-LLEGINYLHENHILHRDIKAANILIDNQG 152

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 22/154 (14%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH-----EIVC 413
            +Y+I   LG+       VY ++   T +++A+KK     +   + K         EI  
Sbjct: 8   RDYEILGKLGE--GTFGEVYKARQIKTGRVVALKK-----ILMHNEKDGFPITALREIKI 60

Query: 414 MRHLRHPNIICYISSFLDATDLH--------LVSPLMGFGSCKDLINAHFNFGLPELVIC 465
           ++ L+HPN++  I   ++  D          +V+P M       L N        + + C
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKC 119

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
           ++LQ +L G+ Y+H    +HR +KA++ILI + G
Sbjct: 120 YMLQ-LLEGINYLHENHILHRDIKAANILIDNQG 152

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 69/289 (23%), Positives = 113/289 (39%), Gaps = 57/289 (19%)

Query: 26  SVYLSKHKVTNQLIAVKKF--NLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
           +VY   H+ T +L A+K    N +   D   + +  EI  +R + HPN++     F    
Sbjct: 89  TVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           ++ ++   M  GS   L   H      E  +  + + +L+G+ Y+H +  +HR +K S++
Sbjct: 146 EIQVLLEFMDGGS---LEGTHIA---DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199

Query: 144 LISHNGKACLSGLRY-MCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNL-----DGY 195
           LI+       S     +  F  ++       P  S+   + ++SPE +  +L     DGY
Sbjct: 200 LIN-------SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252

Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE 255
               DI+S+G+S  E   G  PF                               Q D   
Sbjct: 253 --AGDIWSLGVSILEFYLGRFPFGVGR---------------------------QGDWAS 283

Query: 256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
             C+    Q  +       S  F   +  CL R+  KR  A  LLQH F
Sbjct: 284 LMCAICMSQPPE--APATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 38/251 (15%)

Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 66

Query: 411 IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 67  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 124

Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ + +     L+ +  F   +   
Sbjct: 125 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-----LKIL-DFGLAR--- 168

Query: 520 HLFPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
           H     T Y    W  +PE++  N   Y++  DI+SVG    EL  G   F  T     L
Sbjct: 169 HTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227

Query: 576 MLIEKLAGATP 586
            LI +L G   
Sbjct: 228 KLILRLVGTPG 238

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)

Query: 411 IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           IVCM +  H P+ + +I   ++  DLH      G  S  ++      F   E+++     
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR-----FYAAEIIL----- 108

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    +  Y 
Sbjct: 109 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGY- 161

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
              ++PEVL++ +  YD  +D +S+G    +L  G  PF +  T
Sbjct: 162 ---MAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +Y++  ++G+       V L +HK T ++ A+K   KF + + +D        +I  M  
Sbjct: 44  DYEVVKVIGR--GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAF 99

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
              P ++    +F D   L++V   M  G   DL+N   N+ +PE        +V+  L+
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALD 156

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNL-NWL 183
            IH  GFIHR VK  ++L+  +G   L+       F    K  K  +    TA    +++
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLAD------FGTCMKMNKEGMVRCDTAVGTPDYI 210

Query: 184 SPEVLE-QNLDGYDERS-DIYSVGISCCELANGTVPF 218
           SPEVL+ Q  DGY  R  D +SVG+   E+  G  PF
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 32/285 (11%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLV 88
           T   +A+KK      ++   K  + E+  ++H++H N+I  +  F          D +LV
Sbjct: 39  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98

Query: 89  SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
            P MG     DL     +  L E  I  ++  +L GL+YIH  G IHR +K  ++ ++ +
Sbjct: 99  MPFMG----TDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154

Query: 149 G--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              K    GL        T   V  +  +    LNW+           Y +  DI+SVG 
Sbjct: 155 CELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMH----------YTQTVDIWSVGC 204

Query: 207 SCCELANGTVPF--AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
              E+  G   F   +    LM I K+ G TP     +  +V   Q +  +N    +   
Sbjct: 205 IMAEMLTGKPLFKGHDHLDQLMEIMKVTG-TP-----SKEFVQKLQSEDAKNYVKKLPRF 258

Query: 265 QTQVLTS--RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
           + +   S     +    +++E  L  D + R  A   L H +F++
Sbjct: 259 RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 48/289 (16%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
           V   + K T ++ A KK +  R+     E +     +I+     R   I+    +F    
Sbjct: 9   VCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSLAYAFETKD 66

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           DL LV  LM  G  K  I      G PE         ++ GLE++H +  ++R +K  ++
Sbjct: 67  DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENV 126

Query: 144 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
           L+  +G   +S L          KK+     +  Y    ++PEVL+  +  YD   D ++
Sbjct: 127 LLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGY----MAPEVLQGEV--YDFSVDWFA 179

Query: 204 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           +G +  E+  G  PF +       +EK        L   T                    
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEK---VEK------EELKRRT-------------------- 210

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC------NLLQHAFFK 306
            +  V    KFS     + E  L +D +KR L C       + +H  FK
Sbjct: 211 LEMAVEYPDKFSPEAKDLCEALLQKDPEKR-LGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 17/241 (7%)

Query: 334 NNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK- 392
           N  ++   N  +     +  L     +Y +  ++G+       V L +HK + ++ A+K 
Sbjct: 18  NKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGR--GAFGEVQLVRHKSSQKVYAMKL 75

Query: 393 --KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL 450
             KF + + +D        +I  M     P ++    +F D   L++V   M  G   DL
Sbjct: 76  LSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG---DL 130

Query: 451 INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC 510
           +N   N+ +PE        +V+  L+ IH  G IHR VK  ++L+  +G   L+     C
Sbjct: 131 VNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG-TC 189

Query: 511 PFSPTKKKVHLFPPSTAYNL-NWLSPEVLE-QNLDGYDERS-DIYSVGISCCELANGTVP 567
                   V      TA    +++SPEVL+ Q  DGY  R  D +SVG+   E+  G  P
Sbjct: 190 MKMDETGMVRC---DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Query: 568 F 568
           F
Sbjct: 247 F 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 71/311 (22%), Positives = 128/311 (41%), Gaps = 50/311 (16%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           N  SVY   H+ T   +A+K+  L+ + +     +  E+  +     P I+ +  +F   
Sbjct: 13  NYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 140
             +++    M  GS   L        G+PE V+  I   V+ GL+++  +   IHR VK 
Sbjct: 72  GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKP 131

Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-----QNLDGY 195
           +++L++ NG+        +C F  +   V     +     ++++PE ++     QN   Y
Sbjct: 132 TNVLVNGNGQV------KLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT-Y 184

Query: 196 DERSDIYSVGISCCELANGTVPF-AETPTTLM--LIEKLAGATPHLLDCTTYYVDTGQDD 252
             +SD++S+G+S  E+A G  P+  ET   +   L   + G  P L              
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS------------ 232

Query: 253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS 312
                                +SD     V  CL++  ++RP    LL+H +  + K   
Sbjct: 233 --------------------GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Query: 313 VMLPELLRPAL 323
           V + E +  AL
Sbjct: 273 VDMAEWVTGAL 283

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEI-VCMRHLRHPNIICYISSFL 430
              +V    HK +  ++AVK+       DE + K L  ++ V MR    P I+ +  +  
Sbjct: 16  AFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73

Query: 431 DATDLHLVSPLM--GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRA 487
              D  +   LM          +       +PE ++  I    +  L Y+  +   IHR 
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 488 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVLEQN- 541
           VK S+IL+  NG   L      C F  + + V     S A   +     +++PE ++ + 
Sbjct: 134 VKPSNILLDRNGNIKL------CDFGISGQLVD----SIAKTRDAGCRPYMAPERIDPSA 183

Query: 542 LDGYDERSDIYSVGISCCELANGTVPF 568
            DGYD RSD++S+GI+  E+A G  P+
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 28/187 (14%)

Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLV 88
             + + +A+KK           K    E+  +RH +H NII           D  D+++V
Sbjct: 27  TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86

Query: 89  SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
             LM       +I  H +  L E  I + L  +L GL+YIH    IHR +K S++L++ +
Sbjct: 87  MDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED 143

Query: 149 --------GKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDER 198
                   G A     R +   SPT+ K  +    T Y     + +PE+L  +L  Y   
Sbjct: 144 CELRIGDFGMA-----RGLSS-SPTEHKYFM----TEYVATRWYRAPELL-LSLPEYTTA 192

Query: 199 SDIYSVG 205
            D++SVG
Sbjct: 193 IDMWSVG 199

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 28/187 (14%)

Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLV 438
             + + +A+KK           K    E+  +RH +H NII           D  D+++V
Sbjct: 27  TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86

Query: 439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
             LM       +I  H +  L E  I + L  +L GL+YIH    IHR +K S++L++ +
Sbjct: 87  MDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED 143

Query: 499 --------GKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDER 548
                   G A     R +   SPT+ K  +    T Y     + +PE+L  +L  Y   
Sbjct: 144 CELRIGDFGMA-----RGLSS-SPTEHKYFM----TEYVATRWYRAPELL-LSLPEYTTA 192

Query: 549 SDIYSVG 555
            D++SVG
Sbjct: 193 IDMWSVG 199

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 34/230 (14%)

Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  + +G   + ++ S Y ++     Q +AVKK +    +    +  + E
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQSLIHARRTYRE 64

Query: 411 IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  AT      +++LV+ LMG        C+ L + H  F  
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-- 122

Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH  G IHR +K S++ ++ + +     LR +  F   ++  
Sbjct: 123 -------LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-----LRIL-DFGLARQAD 169

Query: 520 HLFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                  A    W  +PE++  N   Y++  DI+SVG    EL  G   F
Sbjct: 170 DEMTGYVA--TRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 17/215 (7%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +Y +  ++G+       V L +HK + ++ A+K   KF + + +D        +I  M  
Sbjct: 44  DYDVVKVIGR--GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAF 99

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
              P ++    +F D   L++V   M  G   DL+N   N+ +PE        +V+  L+
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWAKFYTAEVVLALD 156

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSP 185
            IH  G IHR VK  ++L+  +G   L+     C        V      TA    +++SP
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFG-TCMKMDETGMVRC---DTAVGTPDYISP 212

Query: 186 EVLE-QNLDGYDERS-DIYSVGISCCELANGTVPF 218
           EVL+ Q  DGY  R  D +SVG+   E+  G  PF
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 42/229 (18%)

Query: 16  ILGQCFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNI 72
           ILG+      SV    LS+   +   +AVK   LD  T  +++    E  CM+   HPN+
Sbjct: 6   ILGE--GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 73  ICYISSFLDATDLH------LVSPLMGFGSCKDLINAHFNFGLPELVICHIL----QDVL 122
           +  I    +A+ L       ++ P M  G     +      GLPE +    L     D+ 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAY-- 178
            G+EY+  + FIHR + A + ++  +   C++  GL          KK++    S  Y  
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL---------SKKIY----SGDYYR 170

Query: 179 -------NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFA 219
                   + W++ E L   +  Y  +SD+++ G++  E+A  G  P+ 
Sbjct: 171 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYP 217

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 42/229 (18%)

Query: 366 ILGQCFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNI 422
           ILG+      SV    LS+   +   +AVK   LD  T  +++    E  CM+   HPN+
Sbjct: 6   ILGE--GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 423 ICYISSFLDATDLH------LVSPLMGFGSCKDLINAHFNFGLPELVICHIL----QDVL 472
           +  I    +A+ L       ++ P M  G     +      GLPE +    L     D+ 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAY-- 528
            G+EY+  + FIHR + A + ++  +   C++  GL          KK++    S  Y  
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL---------SKKIY----SGDYYR 170

Query: 529 -------NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFA 569
                   + W++ E L   +  Y  +SD+++ G++  E+A  G  P+ 
Sbjct: 171 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYP 217

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 17/227 (7%)

Query: 23  NLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--I 76
           +   V L ++        + +AVK  N     ++       EI  +R L H NI+ Y  +
Sbjct: 16  HFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENIVKYKGV 74

Query: 77  SSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIH 135
                   L L+   +  GS +D +  H     L  L++      +  G++Y+  + +IH
Sbjct: 75  CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL--FSSQICKGMDYLGSQRYIH 132

Query: 136 RAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
           R + A +IL+       +S  GL  + P       V     S  +   W +PE L  +  
Sbjct: 133 RDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---WYAPECLRTSK- 188

Query: 194 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD 240
            +   SD++S G++  EL     P    P   + +  +A     +  
Sbjct: 189 -FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 17/227 (7%)

Query: 373 NLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--I 426
           +   V L ++        + +AVK  N     ++       EI  +R L H NI+ Y  +
Sbjct: 16  HFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENIVKYKGV 74

Query: 427 SSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIH 485
                   L L+   +  GS +D +  H     L  L++      +  G++Y+  + +IH
Sbjct: 75  CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL--FSSQICKGMDYLGSQRYIH 132

Query: 486 RAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
           R + A +IL+       +S  GL  + P       V     S  +   W +PE L  +  
Sbjct: 133 RDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---WYAPECLRTSK- 188

Query: 544 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD 590
            +   SD++S G++  EL     P    P   + +  +A     +  
Sbjct: 189 -FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 12/195 (6%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
           V   + K T ++ A KK +  R+     E +     +I+     R   I+    +F    
Sbjct: 9   VCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSLAYAFETKD 66

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           DL LV  LM  G  K  I      G PE         ++ GLE++H +  ++R +K  ++
Sbjct: 67  DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENV 126

Query: 494 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
           L+  +G   +S L          KK+     +  Y    ++PEVL+  +  YD   D ++
Sbjct: 127 LLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGY----MAPEVLQGEV--YDFSVDWFA 179

Query: 554 VGISCCELANGTVPF 568
           +G +  E+  G  PF
Sbjct: 180 LGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-H 69
           YKI   +G+     S V  ++ + T +  A+K       + E + +L  EI  +R L  H
Sbjct: 1   YKILGKIGE--GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPH 57

Query: 70  PNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           PNI+  I    D     L LV  LM   +  +LI       LPE  +   +  +L  L++
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDH 115

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY-NLNWL-SP 185
           +H  G  HR +K  +ILI  +    L     +  F  + + ++  PP T Y +  W  +P
Sbjct: 116 MHRNGIFHRDIKPENILIKDD---ILK----LADFG-SCRGIYSKPPYTEYISTRWYRAP 167

Query: 186 EVLEQNLDG-YDERSDIYSVGISCC 209
           E L    DG Y  + DI++VG  C 
Sbjct: 168 ECLLT--DGYYGPKMDIWAVG--CV 188

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-H 419
           YKI   +G+     S V  ++ + T +  A+K       + E + +L  EI  +R L  H
Sbjct: 1   YKILGKIGE--GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPH 57

Query: 420 PNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           PNI+  I    D     L LV  LM   +  +LI       LPE  +   +  +L  L++
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDH 115

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY-NLNWL-SP 535
           +H  G  HR +K  +ILI  +    L     +  F  + + ++  PP T Y +  W  +P
Sbjct: 116 MHRNGIFHRDIKPENILIKDD---ILK----LADFG-SCRGIYSKPPYTEYISTRWYRAP 167

Query: 536 EVLEQNLDG-YDERSDIYSVGISCC 559
           E L    DG Y  + DI++VG  C 
Sbjct: 168 ECLLT--DGYYGPKMDIWAVG--CV 188

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 22/228 (9%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V+L K +   + +A+K  N   M++ED      E   M  L HP ++           L+
Sbjct: 20  VHLGKWRAQIK-VAIKAINEGAMSEEDF---IEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +V+  M  G   + +         ++++  + QDV  G+EY+    FIHR + A + L+S
Sbjct: 76  IVTEFMENGCLLNYLRQRQGKLSKDMLLS-MCQDVCEGMEYLERNSFIHRDLAARNCLVS 134

Query: 147 HNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
             G   +S     RY+     T      FP      + W  PEV   N   Y  +SD++S
Sbjct: 135 STGVVKVSDFGMTRYVLDDEYTSSSGAKFP------VKWSPPEVF--NFSKYSSKSDVWS 186

Query: 204 VGISCCEL-ANGTVPFAETPTTLMLIEKLAGA----TPHLLDCTTYYV 246
            G+   E+   G +PF E  +   ++E ++       P L   T Y V
Sbjct: 187 FGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGFRLYRPKLASMTVYEV 233

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 22/228 (9%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V+L K +   + +A+K  N   M++ED      E   M  L HP ++           L+
Sbjct: 20  VHLGKWRAQIK-VAIKAINEGAMSEEDF---IEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +V+  M  G   + +         ++++  + QDV  G+EY+    FIHR + A + L+S
Sbjct: 76  IVTEFMENGCLLNYLRQRQGKLSKDMLLS-MCQDVCEGMEYLERNSFIHRDLAARNCLVS 134

Query: 497 HNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
             G   +S     RY+     T      FP      + W  PEV   N   Y  +SD++S
Sbjct: 135 STGVVKVSDFGMTRYVLDDEYTSSSGAKFP------VKWSPPEVF--NFSKYSSKSDVWS 186

Query: 554 VGISCCEL-ANGTVPFAETPTTLMLIEKLAGA----TPHLLDCTTYYV 596
            G+   E+   G +PF E  +   ++E ++       P L   T Y V
Sbjct: 187 FGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGFRLYRPKLASMTVYEV 233

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 29/219 (13%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y +  ++G+   +     L +H  ++Q  A+K+  L + +   ++    E V +  ++H
Sbjct: 1   QYNVLRVVGE--GSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKH 57

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+ +  SF     L++V      G     I        PE  I      +  G+++IH
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 130 GKGFIHRAVKASHILISHNGKACL----------SGLRYMCPFSPTKKKVHLFPPSTAYN 179
            K  +HR +K+ +I ++ NGK  L          S   Y C +  T   V   PP    N
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV---PPEIWEN 174

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +              Y+ +SDI+S+G    EL     PF
Sbjct: 175 MP-------------YNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 29/219 (13%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y +  ++G+   +     L +H  ++Q  A+K+  L + +   ++    E V +  ++H
Sbjct: 1   QYNVLRVVGE--GSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKH 57

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+ +  SF     L++V      G     I        PE  I      +  G+++IH
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 480 GKGFIHRAVKASHILISHNGKACL----------SGLRYMCPFSPTKKKVHLFPPSTAYN 529
            K  +HR +K+ +I ++ NGK  L          S   Y C +  T   V   PP    N
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV---PPEIWEN 174

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +              Y+ +SDI+S+G    EL     PF
Sbjct: 175 MP-------------YNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 11/165 (6%)

Query: 60  EIVCMRHLRHPNIICYISSFL-DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
           E   M  LRH N++  +   + +   L++V+  M  GS  D + +     L    +    
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
            DV   +EY+    F+HR + A ++L+S +  A +S        S T+    L       
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------- 161

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 162 PVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 11/165 (6%)

Query: 410 EIVCMRHLRHPNIICYISSFL-DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
           E   M  LRH N++  +   + +   L++V+  M  GS  D + +     L    +    
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
            DV   +EY+    F+HR + A ++L+S +  A +S        S T+    L       
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------- 161

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 162 PVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 10/179 (5%)

Query: 29  LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV 88
           L K K   +   +K+ N+ +M+ ++ +    E+  + +++HPNI+ Y  SF +  +L++V
Sbjct: 18  LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77

Query: 89  SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
                 G     INA      PE  I      +   L+++H +  +HR +K+ +I ++ +
Sbjct: 78  MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137

Query: 149 GKACLSGLRYMCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
           G   L         + T   V L      T Y   +LSPE+ E     Y+ +SDI+++G
Sbjct: 138 GTIKLGDFGIARVLNST---VELARTCIGTPY---YLSPEICENR--PYNNKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 10/179 (5%)

Query: 379 LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV 438
           L K K   +   +K+ N+ +M+ ++ +    E+  + +++HPNI+ Y  SF +  +L++V
Sbjct: 18  LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77

Query: 439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
                 G     INA      PE  I      +   L+++H +  +HR +K+ +I ++ +
Sbjct: 78  MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137

Query: 499 GKACLSGLRYMCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
           G   L         + T   V L      T Y   +LSPE+ E     Y+ +SDI+++G
Sbjct: 138 GTIKLGDFGIARVLNST---VELARTCIGTPY---YLSPEICENR--PYNNKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 44/196 (22%), Positives = 86/196 (43%), Gaps = 15/196 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +         +
Sbjct: 22  VYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L+ 
Sbjct: 79  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138

Query: 147 HNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
            N   K    GL R M          +       + + W +PE L  N   +  +SD+++
Sbjct: 139 ENHLVKVADFGLSRLM------TGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWA 190

Query: 204 VGISCCELAN-GTVPF 218
            G+   E+A  G  P+
Sbjct: 191 FGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 44/196 (22%), Positives = 86/196 (43%), Gaps = 15/196 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +         +
Sbjct: 22  VYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L+ 
Sbjct: 79  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138

Query: 497 HNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
            N   K    GL R M          +       + + W +PE L  N   +  +SD+++
Sbjct: 139 ENHLVKVADFGLSRLM------TGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWA 190

Query: 554 VGISCCELAN-GTVPF 568
            G+   E+A  G  P+
Sbjct: 191 FGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 22/154 (14%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +GQ       V+ ++HK T Q++A+KK  ++   +    +   EI  ++ L+
Sbjct: 12  SKYEKLAKIGQ--GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK 69

Query: 69  HPNI-----ICYISSFL---DATDLHLVSPLMGFGSCK-DLI----NAHFNFGLPELVIC 115
           H N+     IC   +          +LV     F  C+ DL     N +  F L E  I 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLV-----FEFCEHDLAGLLSNKNVKFTLSE--IK 122

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
            +++ +LNGL YIH    +HR +KA++ILI+ +G
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 22/154 (14%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +GQ       V+ ++HK T Q++A+KK  ++   +    +   EI  ++ L+
Sbjct: 12  SKYEKLAKIGQ--GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK 69

Query: 419 HPNI-----ICYISSFL---DATDLHLVSPLMGFGSCK-DLI----NAHFNFGLPELVIC 465
           H N+     IC   +          +LV     F  C+ DL     N +  F L E  I 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLV-----FEFCEHDLAGLLSNKNVKFTLSE--IK 122

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
            +++ +LNGL YIH    +HR +KA++ILI+ +G
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 25/195 (12%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-ATDL 85
           VY ++   + +++A+KK  +D   D    S   EI  + +LRHPNI+       +     
Sbjct: 23  VYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV----ELKEVVVGK 78

Query: 86  HLVSPLMGFGSC-KDLINAHFN----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           HL S  +    C +DL +   N    F   + V C +LQ +L GL+Y+H    IHR +K 
Sbjct: 79  HLDSIFLVMEYCEQDLASLLDNMPTPFSESQ-VKCLMLQ-LLRGLQYLHENFIIHRDLKV 136

Query: 141 SHILISHNG--KACLSGL--RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD 196
           S++L++  G  K    GL   Y  P  P   KV          L + +PE+L      Y 
Sbjct: 137 SNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV--------VTLWYRAPELL-LGCTTYT 187

Query: 197 ERSDIYSVGISCCEL 211
              D+++VG    EL
Sbjct: 188 TAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 25/195 (12%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-ATDL 435
           VY ++   + +++A+KK  +D   D    S   EI  + +LRHPNI+       +     
Sbjct: 23  VYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV----ELKEVVVGK 78

Query: 436 HLVSPLMGFGSC-KDLINAHFN----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           HL S  +    C +DL +   N    F   + V C +LQ +L GL+Y+H    IHR +K 
Sbjct: 79  HLDSIFLVMEYCEQDLASLLDNMPTPFSESQ-VKCLMLQ-LLRGLQYLHENFIIHRDLKV 136

Query: 491 SHILISHNG--KACLSGL--RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD 546
           S++L++  G  K    GL   Y  P  P   KV          L + +PE+L      Y 
Sbjct: 137 SNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV--------VTLWYRAPELL-LGCTTYT 187

Query: 547 ERSDIYSVGISCCEL 561
              D+++VG    EL
Sbjct: 188 TAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 21  FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 80
           F ++    L     + Q +AVK    D  +  D++    E  CM+   HPN+I  I   L
Sbjct: 12  FGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSL 71

Query: 81  DATDLH------LVSPLMGFGSCKDLINA----HFNFGLPELVICHILQDVLNGLEYIHG 130
            +          ++ P M  G     +         F LP   +   + D+ +G+EY+  
Sbjct: 72  RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS 131

Query: 131 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVH---LFPPSTAYNL--NWL 183
           K FIHR + A + +++ N   C++  GL          KK++    +    A  L   WL
Sbjct: 132 KNFIHRDLAARNCMLNENMTVCVADFGL---------SKKIYSGDYYRQGCASKLPVKWL 182

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFA 219
           + E L  N+  Y   SD+++ G++  E+   G  P+A
Sbjct: 183 ALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYA 217

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 371 FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 430
           F ++    L     + Q +AVK    D  +  D++    E  CM+   HPN+I  I   L
Sbjct: 12  FGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSL 71

Query: 431 DATDLH------LVSPLMGFGSCKDLINA----HFNFGLPELVICHILQDVLNGLEYIHG 480
            +          ++ P M  G     +         F LP   +   + D+ +G+EY+  
Sbjct: 72  RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS 131

Query: 481 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVH---LFPPSTAYNL--NWL 533
           K FIHR + A + +++ N   C++  GL          KK++    +    A  L   WL
Sbjct: 132 KNFIHRDLAARNCMLNENMTVCVADFGL---------SKKIYSGDYYRQGCASKLPVKWL 182

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFA 569
           + E L  N+  Y   SD+++ G++  E+   G  P+A
Sbjct: 183 ALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYA 217

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 8/180 (4%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY +++K+T +++A+KK  LD  T+    +   EI  ++ L HPNI+  +        L+
Sbjct: 16  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 75

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           LV   +     K  ++A    G+P  +I   L  +L GL + H    +HR +K  ++LI+
Sbjct: 76  LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 134

Query: 147 HNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             G   L+       F  P +   H         L + +PE+L      Y    DI+S+G
Sbjct: 135 TEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL-LGCKYYSTAVDIWSLG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 8/180 (4%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY +++K+T +++A+KK  LD  T+    +   EI  ++ L HPNI+  +        L+
Sbjct: 16  VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 75

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           LV   +     K  ++A    G+P  +I   L  +L GL + H    +HR +K  ++LI+
Sbjct: 76  LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 134

Query: 497 HNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             G   L+       F  P +   H         L + +PE+L      Y    DI+S+G
Sbjct: 135 TEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL-LGCKYYSTAVDIWSLG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 44/293 (15%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           +Y    +LG+         L +    + L+  K+ NL R+++++ +   +EIV +  L+H
Sbjct: 1   HYIPIRVLGK--GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNII Y + F+D   L +       G+  D I         E ++   L  +++ + YIH
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSPEV 187
             G +HR +K  +I ++       +GL  +  F  +K     +    +      ++SPE+
Sbjct: 119 KAGILHRDIKTLNIFLTK------AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
            +     Y+ +SDI+++G    EL             L L        P           
Sbjct: 173 CQGV--KYNFKSDIWALGCVLYEL-------------LTLKRTFDATNP----------- 206

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL 300
                   N    I +     + S  +S    S+V   L +D +KRP A  +L
Sbjct: 207 -------LNLVVKIVQGNYTPVVSV-YSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +Y    +LG+         L +    + L+  K+ NL R+++++ +   +EIV +  L+H
Sbjct: 1   HYIPIRVLGK--GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNII Y + F+D   L +       G+  D I         E ++   L  +++ + YIH
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSPEV 537
             G +HR +K  +I ++       +GL  +  F  +K     +    +      ++SPE+
Sbjct: 119 KAGILHRDIKTLNIFLTK------AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172

Query: 538 LEQNLDGYDERSDIYSVG 555
            +     Y+ +SDI+++G
Sbjct: 173 CQGV--KYNFKSDIWALG 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 72/317 (22%), Positives = 128/317 (40%), Gaps = 29/317 (9%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F    ++ 
Sbjct: 21  VFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILI 145
           +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK S+IL+
Sbjct: 80  ICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
           +  G+  L      C F  + + +     S     +++SPE L+     Y  +SDI+S+G
Sbjct: 138 NSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMG 189

Query: 206 ISCCELANGTVPFAETPTTLMLIEKLAGAT---------------PHLLDCTTYYVDTGQ 250
           +S  E+A G  P    P     +E + G                 P     ++Y  D+  
Sbjct: 190 LSLVEMAIGRYPIP--PPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRP 247

Query: 251 DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK 310
                    YI  +    L S  F   F   V  CL ++  +R     L+ HAF K+++ 
Sbjct: 248 PMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA 307

Query: 311 CSVMLPELLRPALSLNE 327
             V     L   + LN+
Sbjct: 308 EEVDFAGWLCSTIGLNQ 324

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 13/191 (6%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 85
           VY  ++K T Q++A+KK  L+   +E + S    EI  ++ L+HPNI+C     +  + L
Sbjct: 16  VYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +L+   +     K L +      +   ++   L  +L G+ + H +  +HR +K  ++LI
Sbjct: 75  YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134

Query: 146 SHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG--YDERSDIY 202
            + G   L+       F  P +   H         L + +PEVL   L    Y    DI+
Sbjct: 135 DNKGVIKLADFGLARAFGIPVRVYTH-----EVVTLWYRAPEVL---LGSPRYSTPVDIW 186

Query: 203 SVGISCCELAN 213
           S+G    E+A 
Sbjct: 187 SIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 13/191 (6%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 435
           VY  ++K T Q++A+KK  L+   +E + S    EI  ++ L+HPNI+C     +  + L
Sbjct: 16  VYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +L+   +     K L +      +   ++   L  +L G+ + H +  +HR +K  ++LI
Sbjct: 75  YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134

Query: 496 SHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG--YDERSDIY 552
            + G   L+       F  P +   H         L + +PEVL   L    Y    DI+
Sbjct: 135 DNKGVIKLADFGLARAFGIPVRVYTH-----EVVTLWYRAPEVL---LGSPRYSTPVDIW 186

Query: 553 SVGISCCELAN 563
           S+G    E+A 
Sbjct: 187 SIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 64/229 (27%), Positives = 95/229 (41%), Gaps = 51/229 (22%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
           +V   Y+  S +G+    +  V  + HK T   +A+KK          +    H+  C R
Sbjct: 2   DVGPRYQNLSYIGEGAYGM--VCSATHKPTGVKVAIKK----------ISPFEHQTFCQR 49

Query: 66  HLR---------HPNIICYI-----SSFLDATDLHLVSPLMGFGSCK-----DLINAHFN 106
            LR         H NII  +      SF    D+++V  LM     K      L N H  
Sbjct: 50  TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH-- 107

Query: 107 FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFS 163
                  I + L  +L GL+YIH    +HR +K S++L++ N   K C  GL R   P  
Sbjct: 108 -------IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160

Query: 164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 212
                +  +  +  Y     +PE++  N  GY +  DI+SVG   C LA
Sbjct: 161 DHTGFLTEYVATRWYR----APEIM-LNSKGYTKAIDIWSVG---CILA 201

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 64/229 (27%), Positives = 95/229 (41%), Gaps = 51/229 (22%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
           +V   Y+  S +G+    +  V  + HK T   +A+KK          +    H+  C R
Sbjct: 2   DVGPRYQNLSYIGEGAYGM--VCSATHKPTGVKVAIKK----------ISPFEHQTFCQR 49

Query: 416 HLR---------HPNIICYI-----SSFLDATDLHLVSPLMGFGSCK-----DLINAHFN 456
            LR         H NII  +      SF    D+++V  LM     K      L N H  
Sbjct: 50  TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH-- 107

Query: 457 FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFS 513
                  I + L  +L GL+YIH    +HR +K S++L++ N   K C  GL R   P  
Sbjct: 108 -------IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160

Query: 514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 562
                +  +  +  Y     +PE++  N  GY +  DI+SVG   C LA
Sbjct: 161 DHTGFLTEYVATRWYR----APEIM-LNSKGYTKAIDIWSVG---CILA 201

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 16/184 (8%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K      M+++D      E   M  L HPN++           + +V+  M  G   
Sbjct: 31  VAIKMIREGAMSEDDF---IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87

Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           + +         E ++  +  DV   +EY+   GFIHR + A + L+  +    +S  GL
Sbjct: 88  NYLRERKGKLGTEWLL-DMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL 146

Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL-ANG 214
            RY+     T  +   FP      + W  PEV + +   +  +SD++S G+   E+ + G
Sbjct: 147 ARYVLDDQYTSSQGTKFP------VKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEG 198

Query: 215 TVPF 218
            +P+
Sbjct: 199 KMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 16/184 (8%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K      M+++D      E   M  L HPN++           + +V+  M  G   
Sbjct: 31  VAIKMIREGAMSEDDF---IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87

Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           + +         E ++  +  DV   +EY+   GFIHR + A + L+  +    +S  GL
Sbjct: 88  NYLRERKGKLGTEWLL-DMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL 146

Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL-ANG 564
            RY+     T  +   FP      + W  PEV + +   +  +SD++S G+   E+ + G
Sbjct: 147 ARYVLDDQYTSSQGTKFP------VKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEG 198

Query: 565 TVPF 568
            +P+
Sbjct: 199 KMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 10/107 (9%)

Query: 112 LVICHIL---QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC-PFSPTKK 167
           + IC IL   + VL  ++Y+H    IHR +KA +I I+H G  CL      C P      
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238

Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
           K + +  + A N    +PE+L +  D Y    DI+S GI   E+A  
Sbjct: 239 KYYGWAGTIATN----APELLAR--DPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 10/107 (9%)

Query: 462 LVICHIL---QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC-PFSPTKK 517
           + IC IL   + VL  ++Y+H    IHR +KA +I I+H G  CL      C P      
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238

Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
           K + +  + A N    +PE+L +  D Y    DI+S GI   E+A  
Sbjct: 239 KYYGWAGTIATN----APELLAR--DPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 37/202 (18%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH------LVSPLM 92
           +AVK   +   T  +++    E VCM+   HPN++  I   L   +        ++ P M
Sbjct: 29  VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88

Query: 93  GFGSCKDLINAHFNFG-----LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
             G     +  +   G     LP  ++   + D+ +G+EY+  K FIHR + A + +++ 
Sbjct: 89  KHGDLHSFL-LYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147

Query: 148 NGKACLSGLRYMCPFSPTKK----------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 197
           N   C++       F  +KK          ++   P      + W++ E L   +  Y  
Sbjct: 148 NMNVCVAD------FGLSKKIYNGDYYRQGRIAKMP------VKWIAIESLADRV--YTT 193

Query: 198 RSDIYSVGISCCELAN-GTVPF 218
           +SD++S G++  E+A  G  P+
Sbjct: 194 KSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 37/202 (18%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH------LVSPLM 442
           +AVK   +   T  +++    E VCM+   HPN++  I   L   +        ++ P M
Sbjct: 29  VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88

Query: 443 GFGSCKDLINAHFNFG-----LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
             G     +  +   G     LP  ++   + D+ +G+EY+  K FIHR + A + +++ 
Sbjct: 89  KHGDLHSFL-LYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147

Query: 498 NGKACLSGLRYMCPFSPTKK----------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 547
           N   C++       F  +KK          ++   P      + W++ E L   +  Y  
Sbjct: 148 NMNVCVAD------FGLSKKIYNGDYYRQGRIAKMP------VKWIAIESLADRV--YTT 193

Query: 548 RSDIYSVGISCCELAN-GTVPF 568
           +SD++S G++  E+A  G  P+
Sbjct: 194 KSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 9/208 (4%)

Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           +HK T +++A+KKF      +E  ++   E+  +R L+  NI+    +F     L+LV  
Sbjct: 21  RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80

Query: 91  LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK 150
            +   +  +L+    N   PE V  +I Q ++  + + H    +HR +K  ++LISHN  
Sbjct: 81  YVE-KNMLELLEEMPNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHRDIKPENLLISHNDV 138

Query: 151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
             L    +    S      +    +T +   + SPE+L      Y +  D++SVG    E
Sbjct: 139 LKLCDFGFARNLSEGSNANYTEYVATRW---YRSPELLLGA--PYGKAVDMWSVGCILGE 193

Query: 211 LANGT--VPFAETPTTLMLIEKLAGATP 236
           L++G    P       L  I+K+ G  P
Sbjct: 194 LSDGQPLFPGESEIDQLFTIQKVLGPLP 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 9/208 (4%)

Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           +HK T +++A+KKF      +E  ++   E+  +R L+  NI+    +F     L+LV  
Sbjct: 21  RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80

Query: 441 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK 500
            +   +  +L+    N   PE V  +I Q ++  + + H    +HR +K  ++LISHN  
Sbjct: 81  YVE-KNMLELLEEMPNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHRDIKPENLLISHNDV 138

Query: 501 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
             L    +    S      +    +T +   + SPE+L      Y +  D++SVG    E
Sbjct: 139 LKLCDFGFARNLSEGSNANYTEYVATRW---YRSPELLLGA--PYGKAVDMWSVGCILGE 193

Query: 561 LANGT--VPFAETPTTLMLIEKLAGATP 586
           L++G    P       L  I+K+ G  P
Sbjct: 194 LSDGQPLFPGESEIDQLFTIQKVLGPLP 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 32/224 (14%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISSF 79
           ++  V+L + K T +L A+K   LD+        +     E   +  L HP +    +SF
Sbjct: 13  DVGRVFLVRLKGTGKLFALKV--LDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF 70

Query: 80  LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
              T L LV      G    L+       L E V      +VL  LEY+H  G ++R +K
Sbjct: 71  QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLK 130

Query: 140 ASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLN---------------- 181
             +IL+  +G   LS   L       P      L   S   ++N                
Sbjct: 131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSN 190

Query: 182 -------WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
                  +++PEV+  + DG+    D +++GI   E+  GT PF
Sbjct: 191 SFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 32/224 (14%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISSF 429
           ++  V+L + K T +L A+K   LD+        +     E   +  L HP +    +SF
Sbjct: 13  DVGRVFLVRLKGTGKLFALKV--LDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF 70

Query: 430 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
              T L LV      G    L+       L E V      +VL  LEY+H  G ++R +K
Sbjct: 71  QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLK 130

Query: 490 ASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLN---------------- 531
             +IL+  +G   LS   L       P      L   S   ++N                
Sbjct: 131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSN 190

Query: 532 -------WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                  +++PEV+  + DG+    D +++GI   E+  GT PF
Sbjct: 191 SFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 28/204 (13%)

Query: 376 SVYLSKHKVTNQLIAVKKF--NLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
           +VY   H+ T +L A+K    N +   D   + +  EI  +R + HPN++     F    
Sbjct: 89  TVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           ++ ++   M  GS   L   H      E  +  + + +L+G+ Y+H +  +HR +K S++
Sbjct: 146 EIQVLLEFMDGGS---LEGTHIA---DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199

Query: 494 LISHNGKACLSGLRY-MCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNL-----DGY 545
           LI+       S     +  F  ++       P  S+   + ++SPE +  +L     DGY
Sbjct: 200 LIN-------SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252

Query: 546 DERSDIYSVGISCCELANGTVPFA 569
               DI+S+G+S  E   G  PF 
Sbjct: 253 --AGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 62/307 (20%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLR---HPNI-----ICYIS 77
           VY ++   T + +A+KK  +  +++E +  S   EI  ++ L    HPNI     +C+  
Sbjct: 15  VYKARDLNTGRFVALKKVRV-PLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73

Query: 78  SFLDATDLHLVSPLMGFGSC-KDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGF 133
                  L LV     F    +DL   ++     GLP   I  +++ +L G++++H    
Sbjct: 74  RTDRELKLTLV-----FEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRI 128

Query: 134 IHRAVKASHILISHNGKACLS--GLR--YMCPFSPTKKKVHLFPPSTAYNLNWL-SPEVL 188
           +HR +K  +IL++ +G+  ++  GL   Y    + T   V L          W  +PEVL
Sbjct: 129 VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL----------WYRAPEVL 178

Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLLDCTTYY 245
            Q    Y    D++SVG    EL     P     +    L  I  + G  P         
Sbjct: 179 LQ--SSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVIG-LP--------- 225

Query: 246 VDTGQDDGEENA-------CSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
               +++   N         SY        +      +    +++  L+ +  KR  A  
Sbjct: 226 ---SEEEWPRNVSLPRSSFPSYTPRSFKSFVPE--ICEEGLDLLKKMLTFNPHKRISAFE 280

Query: 299 LLQHAFF 305
            LQH +F
Sbjct: 281 ALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 24/212 (11%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLV 438
           T   +A+KK      ++   K  + E+  ++H++H N+I  +  F          D +LV
Sbjct: 39  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98

Query: 439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
            P MG     DL     +  L E  I  ++  +L GL+YIH  G IHR +K  ++ ++ +
Sbjct: 99  MPFMG----TDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154

Query: 499 G--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              K    GL        T   V  +  +    LNW+           Y +  DI+SVG 
Sbjct: 155 CELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMH----------YTQTVDIWSVGC 204

Query: 557 SCCELANGTVPF--AETPTTLMLIEKLAGATP 586
              E+  G   F   +    LM I K+ G   
Sbjct: 205 IMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 35/209 (16%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDED---LKSLHH---EIVCMRHLRHPNIICYISSFL 80
           V L +HK + +  A+K      ++      LK + H   E   ++ +RHP ++    SF 
Sbjct: 17  VMLVRHKGSGKYYALK-----ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71

Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           D ++L+LV   +  G     +     F  PE V       V+  LEY+H    ++R +K 
Sbjct: 72  DDSNLYLVMEYVPGGELFSHLRKSGRF--PEPVARFYAAQVVLALEYLHSLDIVYRDLKP 129

Query: 141 SHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDG 194
            ++L+  +G   ++  G      F+   K+V        Y L     +L+PE++  +  G
Sbjct: 130 ENLLLDSDGYIKITDFG------FA---KRV----KGRTYTLCGTPEYLAPEII-LSK-G 174

Query: 195 YDERSDIYSVGISCCELANGTVPF-AETP 222
           Y +  D +++GI   E+  G  PF  + P
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 35/209 (16%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDED---LKSLHH---EIVCMRHLRHPNIICYISSFL 430
           V L +HK + +  A+K      ++      LK + H   E   ++ +RHP ++    SF 
Sbjct: 17  VMLVRHKGSGKYYALK-----ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71

Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           D ++L+LV   +  G     +     F  PE V       V+  LEY+H    ++R +K 
Sbjct: 72  DDSNLYLVMEYVPGGELFSHLRKSGRF--PEPVARFYAAQVVLALEYLHSLDIVYRDLKP 129

Query: 491 SHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDG 544
            ++L+  +G   ++  G      F+   K+V        Y L     +L+PE++  +  G
Sbjct: 130 ENLLLDSDGYIKITDFG------FA---KRV----KGRTYTLCGTPEYLAPEII-LSK-G 174

Query: 545 YDERSDIYSVGISCCELANGTVPF-AETP 572
           Y +  D +++GI   E+  G  PF  + P
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 19/187 (10%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T Q +AVK    D      L+    E   M  L H N++  +   L    L++V  LM  
Sbjct: 28  TGQKVAVKNIKCDVTAQAFLE----ETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82

Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           G+  + +       +  + +     DV  G+EY+  K  +HR + A +IL+S +G A +S
Sbjct: 83  GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVS 142

Query: 155 --GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL- 211
             GL  +               ++   + W +PE L+     +  +SD++S G+   E+ 
Sbjct: 143 DFGLARVGSMGVD---------NSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVF 191

Query: 212 ANGTVPF 218
           + G  P+
Sbjct: 192 SYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 19/187 (10%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T Q +AVK    D      L+    E   M  L H N++  +   L    L++V  LM  
Sbjct: 28  TGQKVAVKNIKCDVTAQAFLE----ETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82

Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           G+  + +       +  + +     DV  G+EY+  K  +HR + A +IL+S +G A +S
Sbjct: 83  GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVS 142

Query: 505 --GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL- 561
             GL  +               ++   + W +PE L+     +  +SD++S G+   E+ 
Sbjct: 143 DFGLARVGSMGVD---------NSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVF 191

Query: 562 ANGTVPF 568
           + G  P+
Sbjct: 192 SYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 17/219 (7%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE---IVCMRH 66
           ++ + S++G+   +   V + + K T  + A+K      +  ++  S   E   I+ + +
Sbjct: 2   DFDVKSLVGR--GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
              P I     +F D  +L+LV      G    L+N + +    E +    L +++  + 
Sbjct: 60  --SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIH 116

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
            +H  G++HR +K  ++LI   G   L+        +  K      P  T    ++++PE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP---DYIAPE 173

Query: 187 VLEQNLDG-----YDERSDIYSVGISCCELANGTVPFAE 220
           VL   ++G     Y    D +S+G+   E+  G  PF E
Sbjct: 174 VL-TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 17/219 (7%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE---IVCMRH 416
           ++ + S++G+   +   V + + K T  + A+K      +  ++  S   E   I+ + +
Sbjct: 2   DFDVKSLVGR--GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
              P I     +F D  +L+LV      G    L+N + +    E +    L +++  + 
Sbjct: 60  --SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIH 116

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
            +H  G++HR +K  ++LI   G   L+        +  K      P  T    ++++PE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP---DYIAPE 173

Query: 537 VLEQNLDG-----YDERSDIYSVGISCCELANGTVPFAE 570
           VL   ++G     Y    D +S+G+   E+  G  PF E
Sbjct: 174 VL-TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 75/299 (25%), Positives = 129/299 (43%), Gaps = 43/299 (14%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-- 83
           SV  +  K T + +A+KK +    ++   K  + E+  ++H++H N+I  +  F  A   
Sbjct: 30  SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89

Query: 84  ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
               D +LV P M     + ++    +    E  + +++  +L GL+YIH  G IHR +K
Sbjct: 90  DEFQDFYLVMPYM-QTDLQKIMGHPLS----EDKVQYLVYQMLCGLKYIHSAGIIHRDLK 144

Query: 140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-WL-SPEVLEQNLDGYDE 197
             ++ ++ + +     L+ +  F   +   H     T Y +  W  +PEV+  N   Y++
Sbjct: 145 PGNLAVNEDCE-----LKIL-DFGLAR---HADAEMTGYVVTRWYRAPEVI-LNWMHYNQ 194

Query: 198 RSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE 255
             DI+SVG    E+  G   F   +    L  I K+ G           +V   +D   +
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP------GPEFVQKLED---K 245

Query: 256 NACSYISEQQTQVLTSRKFSDSFHS-------IVELCLSRDVDKRPLACNLLQHAFFKQ 307
            A SYI  +       + FS  F         ++E  L  DVDKR  A   L+H +F  
Sbjct: 246 AAKSYI--KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 16/211 (7%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           N  SVY   H+ T   +A+K+  L+ + +     +  E+  +     P I+ +  +F   
Sbjct: 13  NYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             +++    M  GS   L        G+PE V+  I   V+ GL+++  +   IHR VK 
Sbjct: 72  GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKP 131

Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-----QNLDGY 545
           +++L++ NG+        +C F  +   V     +     ++++PE ++     QN   Y
Sbjct: 132 TNVLVNGNGQV------KLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT-Y 184

Query: 546 DERSDIYSVGISCCELANGTVPF-AETPTTL 575
             +SD++S+G+S  E+A G  P+  ET   +
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANI 215

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 38/201 (18%)

Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           VT Q +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 39  VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98

Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 99  VMELMDANLCQVI-----QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 153

Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD-GYDE 197
           +        G A  +G  + M P+  T+           Y   + +PEV+   L  GY E
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTR-----------Y---YRAPEVI---LGMGYKE 196

Query: 198 RSDIYSVGISCCELANGTVPF 218
             DI+SVG    E+  GTV F
Sbjct: 197 NVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 38/201 (18%)

Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           VT Q +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 39  VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98

Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 99  VMELMDANLCQVI-----QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 153

Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD-GYDE 547
           +        G A  +G  + M P+  T+           Y   + +PEV+   L  GY E
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTR-----------Y---YRAPEVI---LGMGYKE 196

Query: 548 RSDIYSVGISCCELANGTVPF 568
             DI+SVG    E+  GTV F
Sbjct: 197 NVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 40/207 (19%)

Query: 19  QCFNNLSS-----VYLSKHKVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLRH 69
           +  N +       VY ++ K T +++A+KK  +++   E     + SL  EI  +  L+H
Sbjct: 8   EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLR-EINILLKLQH 63

Query: 70  PNIICYISSFLDATDLHLVSPLMGF--GSCKDLI-NAHFNFGLPELVICHILQDVLNGLE 126
           PNI+  +   +  ++L  +  +M +     K L+      F   E V C +LQ +L+G+ 
Sbjct: 64  PNIV-TVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE-VKCLMLQ-LLSGVA 120

Query: 127 YIHGKGFIHRAVKASHILISHNG--KACLSGL--RYMCPFSP-TKKKVHLFPPSTAYNLN 181
           ++H    +HR +K S++L+++ G  K C  GL   Y  P  P T+  V L          
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL---------- 170

Query: 182 WL-SPEVLEQNLDG--YDERSDIYSVG 205
           W  +PE+L   L    Y    D++SVG
Sbjct: 171 WYRAPELL---LGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 40/207 (19%)

Query: 369 QCFNNLSS-----VYLSKHKVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLRH 419
           +  N +       VY ++ K T +++A+KK  +++   E     + SL  EI  +  L+H
Sbjct: 8   EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLR-EINILLKLQH 63

Query: 420 PNIICYISSFLDATDLHLVSPLMGF--GSCKDLI-NAHFNFGLPELVICHILQDVLNGLE 476
           PNI+  +   +  ++L  +  +M +     K L+      F   E V C +LQ +L+G+ 
Sbjct: 64  PNIV-TVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE-VKCLMLQ-LLSGVA 120

Query: 477 YIHGKGFIHRAVKASHILISHNG--KACLSGL--RYMCPFSP-TKKKVHLFPPSTAYNLN 531
           ++H    +HR +K S++L+++ G  K C  GL   Y  P  P T+  V L          
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL---------- 170

Query: 532 WL-SPEVLEQNLDG--YDERSDIYSVG 555
           W  +PE+L   L    Y    D++SVG
Sbjct: 171 WYRAPELL---LGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 23/235 (9%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLR 68
           N+K    LG+     ++VY  +++ T +++A+K+ +LD   +E   S    EI  M+ L+
Sbjct: 1   NFKQLEKLGE--GTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELK 56

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 127
           H NI+           L LV   M     K  ++ H   G L    +      +L G+ +
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL 183
            H    +HR +K  ++LI+  G+  L+       F          P +T  N    L + 
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFG--------IPVNTFSNEVVTLWYR 167

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATP 236
           +P+VL  +   Y    DI+SVG    E+  G   F  T     L+ I ++ G TP
Sbjct: 168 APDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TP 220

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 23/235 (9%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLR 418
           N+K    LG+     ++VY  +++ T +++A+K+ +LD   +E   S    EI  M+ L+
Sbjct: 1   NFKQLEKLGE--GTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELK 56

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 477
           H NI+           L LV   M     K  ++ H   G L    +      +L G+ +
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL 533
            H    +HR +K  ++LI+  G+  L+       F          P +T  N    L + 
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFG--------IPVNTFSNEVVTLWYR 167

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATP 586
           +P+VL  +   Y    DI+SVG    E+  G   F  T     L+ I ++ G TP
Sbjct: 168 APDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TP 220

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 36/205 (17%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLR---HPNI-----ICYIS 427
           VY ++   T + +A+KK  +  +++E +  S   EI  ++ L    HPNI     +C+  
Sbjct: 15  VYKARDLNTGRFVALKKVRV-PLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73

Query: 428 SFLDATDLHLVSPLMGFGSC-KDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGF 483
                  L LV     F    +DL   ++     GLP   I  +++ +L G++++H    
Sbjct: 74  RTDRELKLTLV-----FEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRI 128

Query: 484 IHRAVKASHILISHNGKACLS--GLR--YMCPFSPTKKKVHLFPPSTAYNLNWL-SPEVL 538
           +HR +K  +IL++ +G+  ++  GL   Y    + T   V L          W  +PEVL
Sbjct: 129 VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL----------WYRAPEVL 178

Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
            Q    Y    D++SVG    EL  
Sbjct: 179 LQ--SSYATPVDMWSVGCIFAELFR 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 81/321 (25%), Positives = 127/321 (39%), Gaps = 53/321 (16%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHHEIVCMRHLR 68
           YKI  ++G+   +   V  +    T + +A+KK N   + ++D     +  EI  +R LR
Sbjct: 2   YKIQEVIGK--GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA--TRILREIKLLRLLR 57

Query: 69  HPNI-----ICYISSFLDATDLHLVSPLMG------FGSCKDLINAHFNFGLPELVICHI 117
           HP+I     I    S  +  D+++V  LM         +  DL   H  F L +L     
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL----- 112

Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTA 177
               L  L+YIH     HR +K  +IL + + K     L+ +C F   +   +  P +  
Sbjct: 113 ----LRALKYIHTANVFHRDLKPKNILANADCK-----LK-ICDFGLARVAFNDTPTAIF 162

Query: 178 YN----LNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGT--VPFAETPTTLMLIEK 230
           +       W  +PE+       Y    DI+S+G    E+  G    P       L LI  
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222

Query: 231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQ--VLTSRKF--SDSFH-SIVELC 285
           L G             +T      E A  Y+S  + +  V  S+KF  +D     ++E  
Sbjct: 223 LLGTPS---------PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERL 273

Query: 286 LSRDVDKRPLACNLLQHAFFK 306
           L+ D   RP A   L   +FK
Sbjct: 274 LAFDPKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 29/219 (13%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL----RHPNIICYISSFLD 81
           +VYL +HK T Q  A+KK N   +    L++   ++   R +     +P ++    SF  
Sbjct: 16  AVYLVRHKETRQRFAMKKINKQNLI---LRNQIQQVFVERDILTFAENPFVVSMFCSFET 72

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFG-LP-ELVICHILQDVLNGLEYIHGKGFIHRAVK 139
              L +V   +  G C  L+    N G LP ++   +  + VL  LEY+H  G +HR +K
Sbjct: 73  KRHLCMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVL-ALEYLHNYGIVHRDLK 128

Query: 140 ASHILISHNGKACLS--GLRYMCPFSPT--------KKKVHLFPPSTAYNL-NWLSPEV- 187
             ++LI+  G   L+  GL  +   S T        +K    F          +++PEV 
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
           L Q   GY +  D +++GI   E   G VPF  +TP  L
Sbjct: 189 LRQ---GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 29/219 (13%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL----RHPNIICYISSFLD 431
           +VYL +HK T Q  A+KK N   +    L++   ++   R +     +P ++    SF  
Sbjct: 16  AVYLVRHKETRQRFAMKKINKQNLI---LRNQIQQVFVERDILTFAENPFVVSMFCSFET 72

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFG-LP-ELVICHILQDVLNGLEYIHGKGFIHRAVK 489
              L +V   +  G C  L+    N G LP ++   +  + VL  LEY+H  G +HR +K
Sbjct: 73  KRHLCMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVL-ALEYLHNYGIVHRDLK 128

Query: 490 ASHILISHNGKACLS--GLRYMCPFSPT--------KKKVHLFPPSTAYNL-NWLSPEV- 537
             ++LI+  G   L+  GL  +   S T        +K    F          +++PEV 
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
           L Q   GY +  D +++GI   E   G VPF  +TP  L
Sbjct: 189 LRQ---GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 3/125 (2%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 85
           VY ++ K+T +++A+KK  L+   DE + S    EI  ++ L HPNI+  +        L
Sbjct: 15  VYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +LV   +     K  +++    GL   +I   L  +L G+ Y H    +HR +K  ++LI
Sbjct: 74  YLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132

Query: 146 SHNGK 150
              G 
Sbjct: 133 DREGA 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 3/125 (2%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 435
           VY ++ K+T +++A+KK  L+   DE + S    EI  ++ L HPNI+  +        L
Sbjct: 15  VYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +LV   +     K  +++    GL   +I   L  +L G+ Y H    +HR +K  ++LI
Sbjct: 74  YLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132

Query: 496 SHNGK 500
              G 
Sbjct: 133 DREGA 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 66/295 (22%), Positives = 114/295 (38%), Gaps = 55/295 (18%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDE---DLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
           V   + + T +L A KK N  R+      +   +   I+   H R   I+    +F   T
Sbjct: 9   VSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF--IVSLAYAFQTKT 66

Query: 84  DLHLVSPLMGFGSCKDLINAHF------NFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
           DL LV  +M  G     +  H       N G PE   C     +++GLE++H +  I+R 
Sbjct: 67  DLCLVMTIMNGGD----LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRD 122

Query: 138 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 197
           +K  ++L+ ++G   +S L         + K   +  +  +    ++PE+L+   + YD 
Sbjct: 123 LKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGF----MAPELLQG--EEYDF 176

Query: 198 RSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENA 257
             D +++G++  E+     PF         +E        L D  TY             
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILNDSVTY------------- 220

Query: 258 CSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR----PLACNLLQ-HAFFKQ 307
                          KFS +  S  E  L++D +KR       C+ L+ H  F+ 
Sbjct: 221 -------------PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 47/204 (23%)

Query: 30  SKHKVTNQLIAVKKFN--LDRMTDEDLKSLHHEIVCMRHLRHPNII-------------- 73
           +K+  TN+ +A+KK     D   D   ++L  EI  +RHL H N+I              
Sbjct: 24  AKNSETNEKVAIKKIANAFDNRIDA-KRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAF 81

Query: 74  --CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK 131
              YI   L  TDLH +       S + L + H  + L +L         L GL+YIH  
Sbjct: 82  NDVYIVYELMDTDLHQI-----IRSSQTLSDDHCQYFLYQL---------LRGLKYIHSA 127

Query: 132 GFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN--WLSPEV 187
             +HR +K S++L++ N   K C  GL      + T  +   F   T Y +   + +PE+
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGL------ARTTSEKGDF--MTEYVVTRWYRAPEL 179

Query: 188 LEQNLDGYDERSDIYSVGISCCEL 211
           L  N   Y    D++SVG    EL
Sbjct: 180 L-LNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 47/204 (23%)

Query: 380 SKHKVTNQLIAVKKFN--LDRMTDEDLKSLHHEIVCMRHLRHPNII-------------- 423
           +K+  TN+ +A+KK     D   D   ++L  EI  +RHL H N+I              
Sbjct: 24  AKNSETNEKVAIKKIANAFDNRIDA-KRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAF 81

Query: 424 --CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK 481
              YI   L  TDLH +       S + L + H  + L +L         L GL+YIH  
Sbjct: 82  NDVYIVYELMDTDLHQI-----IRSSQTLSDDHCQYFLYQL---------LRGLKYIHSA 127

Query: 482 GFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN--WLSPEV 537
             +HR +K S++L++ N   K C  GL      + T  +   F   T Y +   + +PE+
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGL------ARTTSEKGDF--MTEYVVTRWYRAPEL 179

Query: 538 LEQNLDGYDERSDIYSVGISCCEL 561
           L  N   Y    D++SVG    EL
Sbjct: 180 L-LNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 36/198 (18%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +AVKK +         K  + E+V ++ + H NII  ++ F       +  D++LV  LM
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +     +  L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 109 DANLCQVI-----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163

Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +   + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRY--------------YRAPEVILGM--GYKENVDIWS 207

Query: 204 VGISCCELANGTVPFAET 221
           VG    EL  G+V F  T
Sbjct: 208 VGCIMGELVKGSVIFQGT 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 36/198 (18%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +AVKK +         K  + E+V ++ + H NII  ++ F       +  D++LV  LM
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +     +  L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 109 DANLCQVI-----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163

Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +   + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRY--------------YRAPEVILGM--GYKENVDIWS 207

Query: 554 VGISCCELANGTVPFAET 571
           VG    EL  G+V F  T
Sbjct: 208 VGCIMGELVKGSVIFQGT 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 64/294 (21%)

Query: 26  SVYL---SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           +VYL    K     +L  +K+  +  +   +    + E   +  L HP I+ + +SFL+ 
Sbjct: 15  TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER 74

Query: 83  TDLHLVSPLMGFGSCKDLINA-----HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
               +++    +   +DL        H    L E  +C     +L G+ Y+H +  +HR 
Sbjct: 75  DAFCIITE---YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRD 131

Query: 138 VKASHILISHN-------GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +KA +I + +N       G + L  L   C  + T          T Y   ++SPE L+ 
Sbjct: 132 LKAKNIFLKNNLLKIGDFGVSRL--LMGSCDLATTFT-------GTPY---YMSPEALKH 179

Query: 191 NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQ 250
              GYD +SDI+S+G    E+      F       +++  + G TP L +          
Sbjct: 180 Q--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPET--------- 228

Query: 251 DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                                  +S   +SI++  L++D   RP A  +L++ F
Sbjct: 229 -----------------------YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 30/286 (10%)

Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           E+  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +  
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSI 110

Query: 120 DVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
            VL GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S   
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVG 164

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL------- 231
             +++SPE L+     Y  +SDI+S+G+S  ELA G  P    P     +E +       
Sbjct: 165 TRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIP--PPDAKELEAIFGRPVVD 220

Query: 232 -AGATPHLLD---------CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSI 281
                PH +           + + +D+           YI  +    L +  F+  F   
Sbjct: 221 GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF 280

Query: 282 VELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNE 327
           V  CL ++  +R     L+ H F K+++   V     L   L LN+
Sbjct: 281 VNKCLIKNPAERADLKMLMNHTFIKRSEVEEVDFAGWLCKTLRLNQ 326

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 32/231 (13%)

Query: 376 SVYL---SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           +VYL    K     +L  +K+  +  +   +    + E   +  L HP I+ + +SFL+ 
Sbjct: 15  TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER 74

Query: 433 TDLHLVSPLMGFGSCKDLINA-----HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
               +++    +   +DL        H    L E  +C     +L G+ Y+H +  +HR 
Sbjct: 75  DAFCIITE---YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRD 131

Query: 488 VKASHILISHN-------GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +KA +I + +N       G + L  L   C  + T          T Y   ++SPE L+ 
Sbjct: 132 LKAKNIFLKNNLLKIGDFGVSRL--LMGSCDLATTFT-------GTPY---YMSPEALKH 179

Query: 541 NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC 591
              GYD +SDI+S+G    E+      F       +++  + G TP L + 
Sbjct: 180 Q--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPET 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 37/136 (27%), Positives = 64/136 (47%), Gaps = 13/136 (9%)

Query: 27  VYLSKHK--VTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRHPNIICYISSFLDAT 83
           VY +K K     +  A+KKF  D+     + +S   EI  +R L+H N++  +  FL+  
Sbjct: 16  VYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75

Query: 84  DLHLVSPLMGFGSCK-DL---INAHF---NFGLPELVICHILQDVLNGLEYIHGKGFIHR 136
           D  +    + F   + DL   I  H       +P  ++  +L  +LNG+ Y+H    +HR
Sbjct: 76  DKSV---YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHR 132

Query: 137 AVKASHILISHNGKAC 152
            +K ++IL+   G   
Sbjct: 133 DLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 37/136 (27%), Positives = 64/136 (47%), Gaps = 13/136 (9%)

Query: 377 VYLSKHK--VTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRHPNIICYISSFLDAT 433
           VY +K K     +  A+KKF  D+     + +S   EI  +R L+H N++  +  FL+  
Sbjct: 16  VYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75

Query: 434 DLHLVSPLMGFGSCK-DL---INAHF---NFGLPELVICHILQDVLNGLEYIHGKGFIHR 486
           D  +    + F   + DL   I  H       +P  ++  +L  +LNG+ Y+H    +HR
Sbjct: 76  DKSV---YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHR 132

Query: 487 AVKASHILISHNGKAC 502
            +K ++IL+   G   
Sbjct: 133 DLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 14  LGQGCF---GEVWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 65

Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 66  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 123

Query: 134 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 175

Query: 191 NLDG-YDERSDIYSVGISCCELAN-GTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 176 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 14  LGQGCF---GEVWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 65

Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 66  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 123

Query: 484 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 175

Query: 541 NLDG-YDERSDIYSVGISCCELAN-GTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 176 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 26/227 (11%)

Query: 10  NYKICSILGQCFNNLSSVY-LSKHKVTNQLIAVKKFNL--------DRMTDEDLKSLHHE 60
            Y +   LG        VY + K      L+A+K+ N+         R  D+ +  +  E
Sbjct: 1   EYAVLEHLGS--GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58

Query: 61  IVCMR-HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA----HFNFGLPELVIC 115
           +  ++  LRHPNI+ Y  +FL+   L++V  L+      +  N+       F   E  I 
Sbjct: 59  VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--TEERIW 116

Query: 116 HILQDVLNGLEYIHGKGFI-HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
           +I   ++  L Y+H +  I HR +  ++I++  + K  ++         P  K       
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT----- 171

Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET 221
           S    + +  PE++ +N   Y E++D+++ G    ++     PF  T
Sbjct: 172 SVVGTILYSCPEIV-KNEP-YGEKADVWAFGCILYQMCTLQPPFYST 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 26/227 (11%)

Query: 360 NYKICSILGQCFNNLSSVY-LSKHKVTNQLIAVKKFNL--------DRMTDEDLKSLHHE 410
            Y +   LG        VY + K      L+A+K+ N+         R  D+ +  +  E
Sbjct: 1   EYAVLEHLGS--GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58

Query: 411 IVCMR-HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA----HFNFGLPELVIC 465
           +  ++  LRHPNI+ Y  +FL+   L++V  L+      +  N+       F   E  I 
Sbjct: 59  VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--TEERIW 116

Query: 466 HILQDVLNGLEYIHGKGFI-HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 524
           +I   ++  L Y+H +  I HR +  ++I++  + K  ++         P  K       
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT----- 171

Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET 571
           S    + +  PE++ +N   Y E++D+++ G    ++     PF  T
Sbjct: 172 SVVGTILYSCPEIV-KNEP-YGEKADVWAFGCILYQMCTLQPPFYST 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 23/201 (11%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-- 433
           SV  +  K T + +A+KK +    ++   K  + E+  ++H++H N+I  +  F  A   
Sbjct: 30  SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89

Query: 434 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
               D +LV P M     + ++    +    E  + +++  +L GL+YIH  G IHR +K
Sbjct: 90  DEFQDFYLVMPYM-QTDLQKIMGHPLS----EDKVQYLVYQMLCGLKYIHSAGIIHRDLK 144

Query: 490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-WL-SPEVLEQNLDGYDE 547
             ++ ++ + +     L+ +  F   +   H     T Y +  W  +PEV+  N   Y++
Sbjct: 145 PGNLAVNEDCE-----LKIL-DFGLAR---HADAEMTGYVVTRWYRAPEVI-LNWMHYNQ 194

Query: 548 RSDIYSVGISCCELANGTVPF 568
             DI+SVG    E+  G   F
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 58/259 (22%), Positives = 108/259 (41%), Gaps = 58/259 (22%)

Query: 64  MRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
           + H+R  P ++    +F   T LHL+   +  G     ++    F   E+ I     +++
Sbjct: 58  LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI--YSGEIV 115

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYN- 179
             LE++H  G I+R +K  +IL+  NG   L+  GL          K+ H      AY+ 
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL---------SKEFHEDEVERAYSF 166

Query: 180 ---LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP 236
              + +++P+++     G+D+  D +S+G+   EL  G  PF                  
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV---------------- 210

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQ--QTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                          DGE+N+ + IS +  +++    ++ S     I++  L +D  KR 
Sbjct: 211 ---------------DGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR- 254

Query: 295 LAC------NLLQHAFFKQ 307
           L C       + +H FF++
Sbjct: 255 LGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 21/201 (10%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDE---DLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
           V   + + T +L A KK N  R+      +   +   I+   H R   I+    +F   T
Sbjct: 9   VSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF--IVSLAYAFQTKT 66

Query: 434 DLHLVSPLMGFGSCKDLINAHF------NFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
           DL LV  +M  G     +  H       N G PE   C     +++GLE++H +  I+R 
Sbjct: 67  DLCLVMTIMNGGD----LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRD 122

Query: 488 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 547
           +K  ++L+ ++G   +S L         + K   +  +  +    ++PE+L+   + YD 
Sbjct: 123 LKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGF----MAPELLQG--EEYDF 176

Query: 548 RSDIYSVGISCCELANGTVPF 568
             D +++G++  E+     PF
Sbjct: 177 SVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 17/186 (9%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M  +D  +   E   M+ LRHP +I   +       +++V+ LM +GS  
Sbjct: 33  VAVKTLKPGTMDPKDFLA---EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89

Query: 99  DLI--NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 154
           + +   A     LP+L+   +   V +G+ Y+  + +IHR + A ++L+  N   K    
Sbjct: 90  EYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADF 147

Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN- 213
           GL  +      K+ ++       + + W +PE      + +  +SD++S GI   E+   
Sbjct: 148 GLARV-----IKEDIYEAREGAKFPIKWTAPEAA--LYNRFSIKSDVWSFGILLTEIVTY 200

Query: 214 GTVPFA 219
           G +P+ 
Sbjct: 201 GRMPYP 206

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 17/186 (9%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M  +D  +   E   M+ LRHP +I   +       +++V+ LM +GS  
Sbjct: 33  VAVKTLKPGTMDPKDFLA---EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89

Query: 449 DLI--NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 504
           + +   A     LP+L+   +   V +G+ Y+  + +IHR + A ++L+  N   K    
Sbjct: 90  EYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADF 147

Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN- 563
           GL  +      K+ ++       + + W +PE      + +  +SD++S GI   E+   
Sbjct: 148 GLARV-----IKEDIYEAREGAKFPIKWTAPEAA--LYNRFSIKSDVWSFGILLTEIVTY 200

Query: 564 GTVPFA 569
           G +P+ 
Sbjct: 201 GRMPYP 206

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 21/219 (9%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATD 84
           +V+ +K++ T++++A+K+  LD   DE + S    EI  ++ L+H NI+           
Sbjct: 15  TVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73

Query: 85  LHLVSPLMGFGSCKDLINAHFNF--GLPELVICH-ILQDVLNGLEYIHGKGFIHRAVKAS 141
           L LV     F  C   +  +F+   G  +  I    +  +L GL + H    +HR +K  
Sbjct: 74  LTLV-----FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQ 128

Query: 142 HILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           ++LI+ NG+  L+       F  P +             L +  P+VL      Y    D
Sbjct: 129 NLLINKNGELKLADFGLARAFGIPVRCYSA-----EVVTLWYRPPDVL-FGAKLYSTSID 182

Query: 201 IYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATP 236
           ++S G    ELAN   P     +    L  I +L G TP
Sbjct: 183 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TP 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 21/219 (9%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATD 434
           +V+ +K++ T++++A+K+  LD   DE + S    EI  ++ L+H NI+           
Sbjct: 15  TVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73

Query: 435 LHLVSPLMGFGSCKDLINAHFNF--GLPELVICH-ILQDVLNGLEYIHGKGFIHRAVKAS 491
           L LV     F  C   +  +F+   G  +  I    +  +L GL + H    +HR +K  
Sbjct: 74  LTLV-----FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQ 128

Query: 492 HILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           ++LI+ NG+  L+       F  P +             L +  P+VL      Y    D
Sbjct: 129 NLLINKNGELKLADFGLARAFGIPVRCYSA-----EVVTLWYRPPDVL-FGAKLYSTSID 182

Query: 551 IYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATP 586
           ++S G    ELAN   P     +    L  I +L G TP
Sbjct: 183 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TP 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)

Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99

Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 100 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRY--------------YRAPEVILGM--GYKEN 198

Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 199 VDIWSVGCIMGEMVRHKILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)

Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99

Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 100 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRY--------------YRAPEVILGM--GYKEN 198

Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 199 VDIWSVGCIMGEMVRHKILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 26/210 (12%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKS--------LH----HEIVCMRHLRHPNIIC 74
           V  +   +T +++A+KK  +  ++++  K         +H     E+  M  ++H NI+ 
Sbjct: 25  VEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84

Query: 75  YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI 134
            +  +++   ++LV  +M     K +++        + V C IL  +LNGL  +H   F+
Sbjct: 85  LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQ-VKC-ILLQILNGLNVLHKWYFM 141

Query: 135 HRAVKASHILISHNGKACLS--GL--RYMCP--FSPTKKKVHLFP----PSTAYNLNWLS 184
           HR +  ++I I+  G   ++  GL  RY  P       K   +       S    L + +
Sbjct: 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRA 201

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANG 214
           PE+L    + Y    D++SVG    EL  G
Sbjct: 202 PELL-MGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 26/210 (12%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKS--------LH----HEIVCMRHLRHPNIIC 424
           V  +   +T +++A+KK  +  ++++  K         +H     E+  M  ++H NI+ 
Sbjct: 25  VEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84

Query: 425 YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI 484
            +  +++   ++LV  +M     K +++        + V C IL  +LNGL  +H   F+
Sbjct: 85  LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQ-VKC-ILLQILNGLNVLHKWYFM 141

Query: 485 HRAVKASHILISHNGKACLS--GL--RYMCP--FSPTKKKVHLFP----PSTAYNLNWLS 534
           HR +  ++I I+  G   ++  GL  RY  P       K   +       S    L + +
Sbjct: 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRA 201

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANG 564
           PE+L    + Y    D++SVG    EL  G
Sbjct: 202 PELL-MGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 50/202 (24%), Positives = 79/202 (39%), Gaps = 43/202 (21%)

Query: 39  IAVKK----FNLDRMTDEDLKSLHHEIVCMRHLR-HPNIIC---------------YISS 78
           +A+KK    F+   +    L+    E+  +RH R H NI C               Y+  
Sbjct: 30  VAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85

Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
            L   DLH +       S + L +AHF            +  +L GL+YIH    +HR +
Sbjct: 86  ELMEADLHQI-----IRSGQPLTDAHFQS---------FIYQILCGLKYIHSANVLHRDL 131

Query: 139 KASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD 196
           K  ++L++ +   K C  GL     FS    +   F         + +PE++      Y 
Sbjct: 132 KPGNLLVNADCELKICDFGL--ARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYT 188

Query: 197 ERSDIYSVGISCCELANGTVPF 218
           +  D++SVG    EL      F
Sbjct: 189 KAIDVWSVGCILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 50/202 (24%), Positives = 79/202 (39%), Gaps = 43/202 (21%)

Query: 389 IAVKK----FNLDRMTDEDLKSLHHEIVCMRHLR-HPNIIC---------------YISS 428
           +A+KK    F+   +    L+    E+  +RH R H NI C               Y+  
Sbjct: 30  VAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85

Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
            L   DLH +       S + L +AHF            +  +L GL+YIH    +HR +
Sbjct: 86  ELMEADLHQI-----IRSGQPLTDAHFQS---------FIYQILCGLKYIHSANVLHRDL 131

Query: 489 KASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD 546
           K  ++L++ +   K C  GL     FS    +   F         + +PE++      Y 
Sbjct: 132 KPGNLLVNADCELKICDFGL--ARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYT 188

Query: 547 ERSDIYSVGISCCELANGTVPF 568
           +  D++SVG    EL      F
Sbjct: 189 KAIDVWSVGCILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 36/195 (18%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

Query: 149 ----GKACLSGLRYMC-PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  +M  P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY--------------YRAPEVILGM--GYKENVDIWS 210

Query: 204 VGISCCELANGTVPF 218
           VG    E+  G V F
Sbjct: 211 VGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 36/195 (18%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

Query: 499 ----GKACLSGLRYMC-PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  +M  P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY--------------YRAPEVILGM--GYKENVDIWS 210

Query: 554 VGISCCELANGTVPF 568
           VG    E+  G V F
Sbjct: 211 VGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 11/159 (6%)

Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           E+  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +  
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSI 110

Query: 470 DVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
            VL GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S   
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVG 164

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVP 567
             +++SPE L+     Y  +SDI+S+G+S  ELA G  P
Sbjct: 165 TRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 13/193 (6%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLM 92
           T +++AVK    +    ++      EI  ++ L H NI+ Y     +     L L+   +
Sbjct: 32  TGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--K 150
             GS +D +  H    L +L++    Q +  G+ Y+H + +IHR + A ++L+ ++   K
Sbjct: 91  PLGSLRDYLPKH-KLNLAQLLL--FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147

Query: 151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
               GL    P      +V     S  +   W + E L++N   Y   SD++S G++  E
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAVECLKENKFSY--ASDVWSFGVTLYE 202

Query: 211 LANGTVPFAETPT 223
           L          P 
Sbjct: 203 LLTHCDSKQSPPK 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 13/193 (6%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLM 442
           T +++AVK    +    ++      EI  ++ L H NI+ Y     +     L L+   +
Sbjct: 32  TGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--K 500
             GS +D +  H    L +L++    Q +  G+ Y+H + +IHR + A ++L+ ++   K
Sbjct: 91  PLGSLRDYLPKH-KLNLAQLLL--FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147

Query: 501 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
               GL    P      +V     S  +   W + E L++N   Y   SD++S G++  E
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAVECLKENKFSY--ASDVWSFGVTLYE 202

Query: 561 LANGTVPFAETPT 573
           L          P 
Sbjct: 203 LLTHCDSKQSPPK 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M  E   +   E   M+ LRH  ++  
Sbjct: 14  LGQGCF---GEVWMGTWNGTTK-VAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVP- 65

Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  MG GS  D +         LP+LV   +   + +G+ YI    +
Sbjct: 66  LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERMNY 123

Query: 134 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           IHR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 175

Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 176 -LYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M  E   +   E   M+ LRH  ++  
Sbjct: 14  LGQGCF---GEVWMGTWNGTTK-VAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVP- 65

Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  MG GS  D +         LP+LV   +   + +G+ YI    +
Sbjct: 66  LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERMNY 123

Query: 484 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           IHR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 175

Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 176 -LYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 27/215 (12%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLD-------RMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           N   V    H+ +  ++A K  +L+       ++  E LK LH    C      P I+ +
Sbjct: 13  NGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRE-LKVLHE---C----NSPYIVGF 64

Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFI 484
             +F    ++ +    M  GS  D +       +PE ++  I   VL GL Y+  K   +
Sbjct: 65  YGAFYSDGEISICMEHMDGGSL-DQVLKKAG-RIPENILGKISIAVLRGLTYLREKHKIM 122

Query: 485 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 544
           HR VK S+IL++  G+        +C F  + + +     S     +++SPE L+     
Sbjct: 123 HRDVKPSNILVNSRGEI------KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--H 174

Query: 545 YDERSDIYSVGISCCELANGTVPF-AETPTTLMLI 578
           Y  +SDI+S+G+S  E+A G  P        L  +
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 12/192 (6%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F    ++ 
Sbjct: 21  VFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILI 495
           +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK S+IL+
Sbjct: 80  ICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
           +  G+  L      C F  + + +     S     +++SPE L+     Y  +SDI+S+G
Sbjct: 138 NSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMG 189

Query: 556 ISCCELANGTVP 567
           +S  E+A G  P
Sbjct: 190 LSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 33/110 (30%), Positives = 47/110 (42%), Gaps = 4/110 (3%)

Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK 168
           LP      I + +L  L Y+HG+G IHR VK  +I +     A L      C        
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
              +  S     N  SPE+L   LD Y  ++DI+S G+   E++   V  
Sbjct: 242 PQCYGWSGTLETN--SPELLA--LDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 33/110 (30%), Positives = 47/110 (42%), Gaps = 4/110 (3%)

Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK 518
           LP      I + +L  L Y+HG+G IHR VK  +I +     A L      C        
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
              +  S     N  SPE+L   LD Y  ++DI+S G+   E++   V  
Sbjct: 242 PQCYGWSGTLETN--SPELLA--LDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 56/245 (22%), Positives = 95/245 (38%), Gaps = 39/245 (15%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 65
            ++++  ++G+       V+L + K T Q+ A+K   K ++ +           +I  + 
Sbjct: 1   DDFEVIKVIGR--GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI--LA 56

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNG 124
               P I+    SF D   L+LV   M  G   DL+N        PE      + +++  
Sbjct: 57  DADSPWIVKLYYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETARFYIAELVLA 113

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL---------------RYMCPFSPTKK 167
           L+ +H  GFIHR +K  +ILI  +G   L+  GL                          
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 168 KVHLFPP--------STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF- 218
            V             ST    ++++PEVL      Y    D +S+G+   E+  G  PF 
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 219 AETPT 223
           ++T  
Sbjct: 232 SDTLQ 236

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 56/245 (22%), Positives = 95/245 (38%), Gaps = 39/245 (15%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 415
            ++++  ++G+       V+L + K T Q+ A+K   K ++ +           +I  + 
Sbjct: 1   DDFEVIKVIGR--GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI--LA 56

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNG 474
               P I+    SF D   L+LV   M  G   DL+N        PE      + +++  
Sbjct: 57  DADSPWIVKLYYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETARFYIAELVLA 113

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL---------------RYMCPFSPTKK 517
           L+ +H  GFIHR +K  +ILI  +G   L+  GL                          
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 518 KVHLFPP--------STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF- 568
            V             ST    ++++PEVL      Y    D +S+G+   E+  G  PF 
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 569 AETPT 573
           ++T  
Sbjct: 232 SDTLQ 236

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 37/192 (19%)

Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHF---- 105
           TD++ K    E   M +  HPNI+  +   L     +++  LM  G   DL+   +    
Sbjct: 39  TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGG---DLL--SYLRDA 93

Query: 106 ---NFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHILISHNGKAC------- 152
               FG P L +  +L    DV  G  Y+    FIHR + A + L+S  G          
Sbjct: 94  RVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153

Query: 153 ---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISC 208
              L+   Y   +   K+   L P      + W++PE L   LDG +  +SD++S G+  
Sbjct: 154 DFGLARDIYKSDYY-RKEGEGLLP------VRWMAPESL---LDGKFTTQSDVWSFGVLM 203

Query: 209 CE-LANGTVPFA 219
            E L  G  P+ 
Sbjct: 204 WEILTLGQQPYP 215

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 37/192 (19%)

Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHF---- 455
           TD++ K    E   M +  HPNI+  +   L     +++  LM  G   DL+   +    
Sbjct: 39  TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGG---DLL--SYLRDA 93

Query: 456 ---NFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHILISHNGKAC------- 502
               FG P L +  +L    DV  G  Y+    FIHR + A + L+S  G          
Sbjct: 94  RVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153

Query: 503 ---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISC 558
              L+   Y   +   K+   L P      + W++PE L   LDG +  +SD++S G+  
Sbjct: 154 DFGLARDIYKSDYY-RKEGEGLLP------VRWMAPESL---LDGKFTTQSDVWSFGVLM 203

Query: 559 CE-LANGTVPFA 569
            E L  G  P+ 
Sbjct: 204 WEILTLGQQPYP 215

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 26/153 (16%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHHEIVCMRHLR 418
           YKI  ++G+   +   V  +    T + +A+KK N   + ++D     +  EI  +R LR
Sbjct: 2   YKIQEVIGK--GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA--TRILREIKLLRLLR 57

Query: 419 HPNI-----ICYISSFLDATDLHLVSPLMG------FGSCKDLINAHFNFGLPELVICHI 467
           HP+I     I    S  +  D+++V  LM         +  DL   H  F L +L     
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL----- 112

Query: 468 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGK 500
               L  L+YIH     HR +K  +IL + + K
Sbjct: 113 ----LRALKYIHTANVFHRDLKPKNILANADCK 141

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 414 MRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
           + H+R  P ++    +F   T LHL+   +  G     ++    F   E+ I     +++
Sbjct: 58  LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI--YSGEIV 115

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYN- 529
             LE++H  G I+R +K  +IL+  NG   L+  GL          K+ H      AY+ 
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL---------SKEFHEDEVERAYSF 166

Query: 530 ---LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
              + +++P+++     G+D+  D +S+G+   EL  G  PF
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 22/204 (10%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           N   VY    K  N  +AVK      +  +  +    E   ++   HPNI+  I   +  
Sbjct: 7   NFGDVYKGVLK-GNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK 64

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
             +++V  L+  GS    +    N  L    +  +  D   G+EY+  K  IHR + A +
Sbjct: 65  QPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARN 123

Query: 143 ILISHNGKACLSGL-------RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
            L+  N    +S           +   S   K++   P      + W +PE L  N   Y
Sbjct: 124 CLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI---P------IKWTAPEAL--NYGRY 172

Query: 196 DERSDIYSVGISCCEL-ANGTVPF 218
              SD++S GI   E  + G  P+
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 22/204 (10%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           N   VY    K  N  +AVK      +  +  +    E   ++   HPNI+  I   +  
Sbjct: 7   NFGDVYKGVLK-GNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK 64

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
             +++V  L+  GS    +    N  L    +  +  D   G+EY+  K  IHR + A +
Sbjct: 65  QPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARN 123

Query: 493 ILISHNGKACLSGL-------RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
            L+  N    +S           +   S   K++   P      + W +PE L  N   Y
Sbjct: 124 CLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI---P------IKWTAPEAL--NYGRY 172

Query: 546 DERSDIYSVGISCCEL-ANGTVPF 568
              SD++S GI   E  + G  P+
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 47/219 (21%), Positives = 75/219 (34%), Gaps = 45/219 (20%)

Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
            S  D++       L E  I  +    L  L  +H      R  K+ +IL++ +G   L 
Sbjct: 1   VSLADILE-VRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTWDGLLKLD 53

Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
           G      F     +     P       +++PEV++     Y E++DIYS+GI+  E  + 
Sbjct: 54  GS---VAFKT--PEQSRPDPY------FMAPEVIQGQ--SYTEKADIYSLGITLYEALDY 100

Query: 215 TVP-FAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRK 273
            +P   E   + +L   L G             D    +G   A                
Sbjct: 101 ELPYNEERELSAILEILLNGMPADDPR------DRSNLEGVSAAR--------------- 139

Query: 274 FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS 312
              SF   + LC SR   +R  A + L H      +   
Sbjct: 140 ---SFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 29/194 (14%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-- 84
           V L +H+   +   +KK NL   +  + K+   E   +  L+HPNI+ Y  S+ +  D  
Sbjct: 16  VSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW-EGEDGL 74

Query: 85  LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           L++V   MGF    DL   +       LPE  +      +   L+Y+H K  +HR +K  
Sbjct: 75  LYIV---MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ 131

Query: 142 HILISHNG--KACLSG----LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
           ++ ++     K    G    L   C  + T          T Y   ++SPE+       Y
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLI-------GTPY---YMSPELFSNK--PY 179

Query: 196 DERSDIYSVGISCC 209
           + +SD++++G  CC
Sbjct: 180 NYKSDVWALG--CC 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 29/194 (14%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-- 434
           V L +H+   +   +KK NL   +  + K+   E   +  L+HPNI+ Y  S+ +  D  
Sbjct: 16  VSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW-EGEDGL 74

Query: 435 LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           L++V   MGF    DL   +       LPE  +      +   L+Y+H K  +HR +K  
Sbjct: 75  LYIV---MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ 131

Query: 492 HILISHNG--KACLSG----LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
           ++ ++     K    G    L   C  + T          T Y   ++SPE+       Y
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLI-------GTPY---YMSPELFSNK--PY 179

Query: 546 DERSDIYSVGISCC 559
           + +SD++++G  CC
Sbjct: 180 NYKSDVWALG--CC 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 32/203 (15%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V+L + +++    A+K   +  +   +  + +H+E   ++ + HP II    +  D   L
Sbjct: 17  VHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFL 76

Query: 86  HLVSPLMGFGSCKDLI----------NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 135
           ++   LM +    +L           N+   F   E+V C         LEY+H K  ++
Sbjct: 77  YM---LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV-C--------ALEYLHSKEIVY 124

Query: 136 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
           R +K  +IL+   G   L+   +        KK+     +      +L+PEV++    G+
Sbjct: 125 RDLKPENILLDKEGHIKLTDFGF-------AKKLRDRTWTLCGTPEYLAPEVIQSK--GH 175

Query: 196 DERSDIYSVGISCCELANGTVPF 218
           ++  D +++GI   E+  G  PF
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 32/203 (15%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V+L + +++    A+K   +  +   +  + +H+E   ++ + HP II    +  D   L
Sbjct: 17  VHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFL 76

Query: 436 HLVSPLMGFGSCKDLI----------NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 485
           ++   LM +    +L           N+   F   E+V C         LEY+H K  ++
Sbjct: 77  YM---LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV-C--------ALEYLHSKEIVY 124

Query: 486 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
           R +K  +IL+   G   L+   +        KK+     +      +L+PEV++    G+
Sbjct: 125 RDLKPENILLDKEGHIKLTDFGF-------AKKLRDRTWTLCGTPEYLAPEVIQSK--GH 175

Query: 546 DERSDIYSVGISCCELANGTVPF 568
           ++  D +++GI   E+  G  PF
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 43/189 (22%), Positives = 76/189 (40%), Gaps = 43/189 (22%)

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTAYNLNWL 183
           L+++H  G I+R +K  +IL+   G   L+       F +  +++ + F  +  Y    +
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY----M 173

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 243
           +PEV+     G+D+  D +S+G+   EL  G  PF                         
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV----------------------- 210

Query: 244 YYVDTGQDDGEENACSYISE--QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN--- 298
                   DGE+N+ S IS    +++    +  S      ++  L +D  KR L  N   
Sbjct: 211 --------DGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR-LGANGAD 261

Query: 299 -LLQHAFFK 306
            +  H FF+
Sbjct: 262 EIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 12  KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           K    LG+   N  SV L ++      T +++AVKK  L   T E L+    EI  ++ L
Sbjct: 7   KFIQQLGK--GNFGSVELCRYDPLQDNTGEVVAVKK--LQHSTAEHLRDFEREIEILKSL 62

Query: 68  RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNG 124
           +H NI+ Y  +       +L LV   + +GS +D L          +L+       +  G
Sbjct: 63  QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL--LYASQICKG 120

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           +EY+  K ++HR +   +IL+    +  +   GL  + P      KV     S  +   W
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---W 177

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCEL 211
            +PE L ++   +   SD++S G+   EL
Sbjct: 178 YAPESLTESK--FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 362 KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           K    LG+   N  SV L ++      T +++AVKK  L   T E L+    EI  ++ L
Sbjct: 7   KFIQQLGK--GNFGSVELCRYDPLQDNTGEVVAVKK--LQHSTAEHLRDFEREIEILKSL 62

Query: 418 RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNG 474
           +H NI+ Y  +       +L LV   + +GS +D L          +L+       +  G
Sbjct: 63  QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL--LYASQICKG 120

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           +EY+  K ++HR +   +IL+    +  +   GL  + P      KV     S  +   W
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---W 177

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCEL 561
            +PE L ++   +   SD++S G+   EL
Sbjct: 178 YAPESLTESK--FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 28/180 (15%)

Query: 56  SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-------- 107
           S  HE   +R L HP ++  +       D+ +V  L    +C  L     +         
Sbjct: 206 SSVHEARLLRRLSHPAVLALL-------DVRVVGGL----TCLVLPKYRSDLYTYLGARL 254

Query: 108 ---GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP 164
              GL +  +  + + +L+ ++YIHG+G IHR +K  ++L++     CL      C F+ 
Sbjct: 255 RPLGLAQ--VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC-FAR 311

Query: 165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT 224
                  F    A  ++  +PEVL    D Y    DI+S G+   E A  T         
Sbjct: 312 GSWSTP-FHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRG 368

Length = 461

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 28/180 (15%)

Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-------- 457
           S  HE   +R L HP ++  +       D+ +V  L    +C  L     +         
Sbjct: 206 SSVHEARLLRRLSHPAVLALL-------DVRVVGGL----TCLVLPKYRSDLYTYLGARL 254

Query: 458 ---GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP 514
              GL +  +  + + +L+ ++YIHG+G IHR +K  ++L++     CL      C F+ 
Sbjct: 255 RPLGLAQ--VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC-FAR 311

Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT 574
                  F    A  ++  +PEVL    D Y    DI+S G+   E A  T         
Sbjct: 312 GSWSTP-FHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRG 368

Length = 461

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 27/212 (12%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI------VCMRHLRHPNIICYISSFL 80
           VY  + K T ++ A+K  +   +  +  K + H I      V       P I+    SF 
Sbjct: 9   VYQVRKKDTRRIYAMKVLSKKEIVAK--KEVAHTIGERNILVRTLLDESPFIVGLKFSFQ 66

Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
             +DL+LV+  M  G     +     F   E      + +++  LE++H    ++R +K 
Sbjct: 67  TDSDLYLVTDYMSGGELFWHLQKEGRF--SEDRAKFYIAELVLALEHLHKYDIVYRDLKP 124

Query: 141 SHILISHNGKACLSGLRYMCPFSPTK------KKVHLFPPSTAYNLNWLSPEVLEQNLDG 194
            +IL+   G   L      C F  +K      K  + F  +T Y    L+PEVL     G
Sbjct: 125 ENILLDATGHIAL------CDFGLSKANLTDNKTTNTFCGTTEY----LAPEVLLDE-KG 173

Query: 195 YDERSDIYSVGISCCELANGTVPFAETPTTLM 226
           Y +  D +S+G+   E+  G  PF    T  M
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 27/212 (12%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI------VCMRHLRHPNIICYISSFL 430
           VY  + K T ++ A+K  +   +  +  K + H I      V       P I+    SF 
Sbjct: 9   VYQVRKKDTRRIYAMKVLSKKEIVAK--KEVAHTIGERNILVRTLLDESPFIVGLKFSFQ 66

Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
             +DL+LV+  M  G     +     F   E      + +++  LE++H    ++R +K 
Sbjct: 67  TDSDLYLVTDYMSGGELFWHLQKEGRF--SEDRAKFYIAELVLALEHLHKYDIVYRDLKP 124

Query: 491 SHILISHNGKACLSGLRYMCPFSPTK------KKVHLFPPSTAYNLNWLSPEVLEQNLDG 544
            +IL+   G   L      C F  +K      K  + F  +T Y    L+PEVL     G
Sbjct: 125 ENILLDATGHIAL------CDFGLSKANLTDNKTTNTFCGTTEY----LAPEVLLDE-KG 173

Query: 545 YDERSDIYSVGISCCELANGTVPFAETPTTLM 576
           Y +  D +S+G+   E+  G  PF    T  M
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 17/101 (16%)

Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPST 176
           I++ +L  +EYIH K  IHR +K  +I ++ +GK  L       PF              
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE---------KERE 322

Query: 177 AYNLNWL------SPEVLEQNLDGYDERSDIYSVGISCCEL 211
           A++  W+      SPE+L    DGY E +DI+S G+   ++
Sbjct: 323 AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 17/101 (16%)

Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPST 526
           I++ +L  +EYIH K  IHR +K  +I ++ +GK  L       PF              
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE---------KERE 322

Query: 527 AYNLNWL------SPEVLEQNLDGYDERSDIYSVGISCCEL 561
           A++  W+      SPE+L    DGY E +DI+S G+   ++
Sbjct: 323 AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 12/189 (6%)

Query: 33  KVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS 89
           K T ++ A KK +  R+   + E +  L  EI+    +  P I+    +F   T L LV 
Sbjct: 15  KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEK--VNSPFIVNLAYAFESKTHLCLVM 72

Query: 90  PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
            LM  G  K  I      GL    + H    +  G+ ++H    ++R +K  ++L+   G
Sbjct: 73  SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG 132

Query: 150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
              LS L         K          A    +++PE+L++  + Y    D +++G S  
Sbjct: 133 NCRLSDLGLAVELKDGKTITQ-----RAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIY 185

Query: 210 ELANGTVPF 218
           E+  G  PF
Sbjct: 186 EMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 12/189 (6%)

Query: 383 KVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS 439
           K T ++ A KK +  R+   + E +  L  EI+    +  P I+    +F   T L LV 
Sbjct: 15  KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEK--VNSPFIVNLAYAFESKTHLCLVM 72

Query: 440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
            LM  G  K  I      GL    + H    +  G+ ++H    ++R +K  ++L+   G
Sbjct: 73  SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG 132

Query: 500 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
              LS L         K          A    +++PE+L++  + Y    D +++G S  
Sbjct: 133 NCRLSDLGLAVELKDGKTITQ-----RAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIY 185

Query: 560 ELANGTVPF 568
           E+  G  PF
Sbjct: 186 EMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 29/191 (15%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ E       E   M+ LRH  ++   +   +   +++V+  M  GS  
Sbjct: 33  VAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89

Query: 99  DLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 154
           D + +       LP+LV   +   +  G+ Y+  + +IHR + A +IL+  N   K    
Sbjct: 90  DFLKSGEGKKLRLPQLV--DMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADF 147

Query: 155 GLRYM------CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 208
           GL  +            K     FP      + W +PE    N   +  +SD++S GI  
Sbjct: 148 GLARLIEDDEYTAREGAK-----FP------IKWTAPEAA--NYGRFTIKSDVWSFGILL 194

Query: 209 CELAN-GTVPF 218
            E+   G VP+
Sbjct: 195 TEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 29/191 (15%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ E       E   M+ LRH  ++   +   +   +++V+  M  GS  
Sbjct: 33  VAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89

Query: 449 DLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 504
           D + +       LP+LV   +   +  G+ Y+  + +IHR + A +IL+  N   K    
Sbjct: 90  DFLKSGEGKKLRLPQLV--DMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADF 147

Query: 505 GLRYM------CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 558
           GL  +            K     FP      + W +PE    N   +  +SD++S GI  
Sbjct: 148 GLARLIEDDEYTAREGAK-----FP------IKWTAPEAA--NYGRFTIKSDVWSFGILL 194

Query: 559 CELAN-GTVPF 568
            E+   G VP+
Sbjct: 195 TEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 24/191 (12%)

Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 95
           N  +AVK      M+ E   S   E   M+ LRH  ++  + + +    +++V+  M  G
Sbjct: 30  NTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLV-QLYAVVSEEPIYIVTEYMSKG 85

Query: 96  SCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL 153
           S  D +         LP LV   +   V  G+ YI    +IHR +++++IL+  +G  C 
Sbjct: 86  SLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVCK 142

Query: 154 S---GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISC 208
               GL R +     T ++   FP      + W +PE     L G +  +SD++S GI  
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA---LYGRFTIKSDVWSFGILL 193

Query: 209 CEL-ANGTVPF 218
            EL   G VP+
Sbjct: 194 TELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 24/191 (12%)

Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 445
           N  +AVK      M+ E   S   E   M+ LRH  ++  + + +    +++V+  M  G
Sbjct: 30  NTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLV-QLYAVVSEEPIYIVTEYMSKG 85

Query: 446 SCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL 503
           S  D +         LP LV   +   V  G+ YI    +IHR +++++IL+  +G  C 
Sbjct: 86  SLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVCK 142

Query: 504 S---GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISC 558
               GL R +     T ++   FP      + W +PE     L G +  +SD++S GI  
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA---LYGRFTIKSDVWSFGILL 193

Query: 559 CEL-ANGTVPF 568
            EL   G VP+
Sbjct: 194 TELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 3/120 (2%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 85
           VY ++ +VTN+ IA+KK  L++  DE + S    EI  ++ ++H NI+           L
Sbjct: 18  VYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRL 76

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +LV   +     K  +++  +F     +I   L  +L G+ Y H    +HR +K  ++LI
Sbjct: 77  YLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI 135

Length = 294

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 3/120 (2%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 435
           VY ++ +VTN+ IA+KK  L++  DE + S    EI  ++ ++H NI+           L
Sbjct: 18  VYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRL 76

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +LV   +     K  +++  +F     +I   L  +L G+ Y H    +HR +K  ++LI
Sbjct: 77  YLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI 135

Length = 294

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 38/185 (20%), Positives = 66/185 (35%), Gaps = 47/185 (25%)

Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI-----NAHFNFGLPELVI 114
           E + M    H NI+  I    +     ++  LM  G  K  +            L    +
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-------------------G 155
               +DV  G +Y+    FIHR + A + L++  G   ++                   G
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN- 213
            R M P                  + W+ PE     LDG +  ++D++S G+   E+ + 
Sbjct: 179 GRAMLP------------------IKWMPPEAF---LDGIFTSKTDVWSFGVLLWEIFSL 217

Query: 214 GTVPF 218
           G +P+
Sbjct: 218 GYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 38/185 (20%), Positives = 66/185 (35%), Gaps = 47/185 (25%)

Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI-----NAHFNFGLPELVI 464
           E + M    H NI+  I    +     ++  LM  G  K  +            L    +
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-------------------G 505
               +DV  G +Y+    FIHR + A + L++  G   ++                   G
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN- 563
            R M P                  + W+ PE     LDG +  ++D++S G+   E+ + 
Sbjct: 179 GRAMLP------------------IKWMPPEAF---LDGIFTSKTDVWSFGVLLWEIFSL 217

Query: 564 GTVPF 568
           G +P+
Sbjct: 218 GYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 12/111 (10%)

Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL-RYMCPF-SPTKKKVHLFPP 174
           I + +L GL Y+H +  IHR VK  +I I+   + C+  L     P  +P    +     
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----- 216

Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETPTT 224
             A  +   +PEVL +  D Y+ ++DI+S GI   E LA  +  F + P+T
Sbjct: 217 --AGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263

Length = 357

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 12/111 (10%)

Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL-RYMCPF-SPTKKKVHLFPP 524
           I + +L GL Y+H +  IHR VK  +I I+   + C+  L     P  +P    +     
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----- 216

Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETPTT 574
             A  +   +PEVL +  D Y+ ++DI+S GI   E LA  +  F + P+T
Sbjct: 217 --AGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263

Length = 357

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 16/187 (8%)

Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 95
           +  +A+K      M+ E   +   E   M+ L+HP ++  + + +    +++++  M  G
Sbjct: 30  HTKVAIKSLKQGSMSPE---AFLAEANLMKQLQHPRLV-RLYAVVTQEPIYIITEYMENG 85

Query: 96  SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACL 153
           S  D +       L    +  +   +  G+ +I  K +IHR ++A++IL+S     K   
Sbjct: 86  SLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIAD 145

Query: 154 SGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 212
            GL R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+ 
Sbjct: 146 FGLARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 197

Query: 213 N-GTVPF 218
             G +P+
Sbjct: 198 TYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 16/187 (8%)

Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 445
           +  +A+K      M+ E   +   E   M+ L+HP ++  + + +    +++++  M  G
Sbjct: 30  HTKVAIKSLKQGSMSPE---AFLAEANLMKQLQHPRLV-RLYAVVTQEPIYIITEYMENG 85

Query: 446 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACL 503
           S  D +       L    +  +   +  G+ +I  K +IHR ++A++IL+S     K   
Sbjct: 86  SLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIAD 145

Query: 504 SGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 562
            GL R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+ 
Sbjct: 146 FGLARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIV 197

Query: 563 N-GTVPF 568
             G +P+
Sbjct: 198 TYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 25/204 (12%)

Query: 27  VYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
           V ++KHK T +  A+K   K  + +M       +  E   +  L HP I+  + SF D  
Sbjct: 34  VRIAKHKGTGEYYAIKCLKKREILKMKQVQ--HVAQEKSILMELSHPFIVNMMCSFQDEN 91

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
            ++ +   +  G     +     F  P  V      +++   EY+H K  I+R +K  ++
Sbjct: 92  RVYFLLEFVVGGELFTHLRKAGRF--PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149

Query: 144 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDERS 199
           L+ + G   ++   +        KKV    P   + L     +L+PEV++    G+ +  
Sbjct: 150 LLDNKGHVKVTDFGF-------AKKV----PDRTFTLCGTPEYLAPEVIQSK--GHGKAV 196

Query: 200 DIYSVGISCCELANGTVPF-AETP 222
           D +++G+   E   G  PF  +TP
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTP 220

Length = 329

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 25/204 (12%)

Query: 377 VYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
           V ++KHK T +  A+K   K  + +M       +  E   +  L HP I+  + SF D  
Sbjct: 34  VRIAKHKGTGEYYAIKCLKKREILKMKQVQ--HVAQEKSILMELSHPFIVNMMCSFQDEN 91

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
            ++ +   +  G     +     F  P  V      +++   EY+H K  I+R +K  ++
Sbjct: 92  RVYFLLEFVVGGELFTHLRKAGRF--PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149

Query: 494 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYDERS 549
           L+ + G   ++   +        KKV    P   + L     +L+PEV++    G+ +  
Sbjct: 150 LLDNKGHVKVTDFGF-------AKKV----PDRTFTLCGTPEYLAPEVIQSK--GHGKAV 196

Query: 550 DIYSVGISCCELANGTVPF-AETP 572
           D +++G+   E   G  PF  +TP
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTP 220

Length = 329

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 5/96 (5%)

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTAYNLNWL 533
           L+++H  G I+R +K  +IL+   G   L+       F +  +++ + F  +  Y    +
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY----M 173

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 569
           +PEV+     G+D+  D +S+G+   EL  G  PF 
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           ++VY  + K+T+ L+A+K+  L+        ++  E+  ++ L+H NI+           
Sbjct: 20  ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKS 78

Query: 85  LHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           L LV   +          C + IN H N  L        L  +L GL Y H +  +HR +
Sbjct: 79  LTLVFEYLDKDLKQYLDDCGNSINMH-NVKL-------FLFQLLRGLNYCHRRKVLHRDL 130

Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWLSPEVLEQNLDG 194
           K  ++LI+  G+  L+       F   + K    P  T  N    L +  P++L  + D 
Sbjct: 131 KPQNLLINERGELKLAD------FGLARAKS--IPTKTYSNEVVTLWYRPPDILLGSTD- 181

Query: 195 YDERSDIYSVGISCCELANGT--VPFAETPTTLMLIEKLAGATP 236
           Y  + D++ VG    E++ G    P +     L  I ++ G TP
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-TP 224

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           ++VY  + K+T+ L+A+K+  L+        ++  E+  ++ L+H NI+           
Sbjct: 20  ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKS 78

Query: 435 LHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           L LV   +          C + IN H N  L        L  +L GL Y H +  +HR +
Sbjct: 79  LTLVFEYLDKDLKQYLDDCGNSINMH-NVKL-------FLFQLLRGLNYCHRRKVLHRDL 130

Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWLSPEVLEQNLDG 544
           K  ++LI+  G+  L+       F   + K    P  T  N    L +  P++L  + D 
Sbjct: 131 KPQNLLINERGELKLAD------FGLARAKS--IPTKTYSNEVVTLWYRPPDILLGSTD- 181

Query: 545 YDERSDIYSVGISCCELANGT--VPFAETPTTLMLIEKLAGATP 586
           Y  + D++ VG    E++ G    P +     L  I ++ G TP
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-TP 224

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 46/187 (24%)

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNFGL-PELVICHILQDVLNGLEYIHGKGFIHR 136
           SF D  +L+ V   M +    D+++     G+  E +    + ++   +E +H  GFIHR
Sbjct: 69  SFQDKDNLYFV---MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 137 AVKASHILISHNGKACLS------GLRYM----------------------------CPF 162
            +K  +ILI  +G   L+      G R+                             C  
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185

Query: 163 SPTKKK-VHLFPPSTAYNL----NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVP 217
            P +++         A++L    N+++PEVL +   GY +  D +SVG+   E+  G  P
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEMLVGQPP 243

Query: 218 F-AETPT 223
           F A+TP 
Sbjct: 244 FLADTPA 250

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 46/187 (24%)

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNFGL-PELVICHILQDVLNGLEYIHGKGFIHR 486
           SF D  +L+ V   M +    D+++     G+  E +    + ++   +E +H  GFIHR
Sbjct: 69  SFQDKDNLYFV---MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 487 AVKASHILISHNGKACLS------GLRYM----------------------------CPF 512
            +K  +ILI  +G   L+      G R+                             C  
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185

Query: 513 SPTKKK-VHLFPPSTAYNL----NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVP 567
            P +++         A++L    N+++PEVL +   GY +  D +SVG+   E+  G  P
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEMLVGQPP 243

Query: 568 F-AETPT 573
           F A+TP 
Sbjct: 244 FLADTPA 250

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 24/220 (10%)

Query: 20  CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISS 78
              + ++VY    ++  QL+A+K  ++   T+E +  +   E   ++ L+H NI+     
Sbjct: 14  GEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 79  FLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 136
                 L  V   M      DL         GL    +   +  +L GL YIHG+  +HR
Sbjct: 72  IHTKETLTFVFEYMH----TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN-----LNWLSPEVLEQN 191
            +K  ++LIS+ G+  L+       F   + K     PS  Y+     L +  P+VL   
Sbjct: 128 DLKPQNLLISYLGELKLAD------FGLARAKS---IPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 192 LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 231
            D Y    DI+  G    E+  G   F         +EK+
Sbjct: 179 TD-YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 24/220 (10%)

Query: 370 CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISS 428
              + ++VY    ++  QL+A+K  ++   T+E +  +   E   ++ L+H NI+     
Sbjct: 14  GEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 429 FLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 486
                 L  V   M      DL         GL    +   +  +L GL YIHG+  +HR
Sbjct: 72  IHTKETLTFVFEYMH----TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127

Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN-----LNWLSPEVLEQN 541
            +K  ++LIS+ G+  L+       F   + K     PS  Y+     L +  P+VL   
Sbjct: 128 DLKPQNLLISYLGELKLAD------FGLARAKS---IPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 542 LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
            D Y    DI+  G    E+  G   F         +EK+
Sbjct: 179 TD-YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 13/107 (12%)

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH----LFPPST 176
           V NG+E++  K  +HR + A ++LI      C   L  +C F   +  +     +   ST
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
              L W++PE +  NL  Y   SD++S GI   E+   G  P+ E P
Sbjct: 302 FLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPELP 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 13/107 (12%)

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH----LFPPST 526
           V NG+E++  K  +HR + A ++LI      C   L  +C F   +  +     +   ST
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
              L W++PE +  NL  Y   SD++S GI   E+   G  P+ E P
Sbjct: 302 FLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPELP 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 2/113 (1%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK    D+++D  +     E   M  L H N+I      L    L +V+ L   GS  
Sbjct: 26  VAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLL 83

Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           D +            +C     + NG+ Y+  K FIHR + A +IL++ + K 
Sbjct: 84  DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 2/113 (1%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK    D+++D  +     E   M  L H N+I      L    L +V+ L   GS  
Sbjct: 26  VAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLL 83

Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           D +            +C     + NG+ Y+  K FIHR + A +IL++ + K 
Sbjct: 84  DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 16/207 (7%)

Query: 47  DRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN 106
           DR   +  + +   ++ M  L H  I+  +        L LV+ L   GS  D +  H +
Sbjct: 46  DRSGRQTFQEITDHMLAMGSLDHAYIV-RLLGICPGASLQLVTQLSPLGSLLDHVRQHRD 104

Query: 107 FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK 166
              P+ ++   +Q +  G+ Y+     +HR + A +IL+  +    ++         P  
Sbjct: 105 SLDPQRLLNWCVQ-IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163

Query: 167 KKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN-GTVPFA----- 219
           KK   F       + W++   LE  L G Y  +SD++S G++  E+ + G  P+A     
Sbjct: 164 KK--YFYSEHKTPIKWMA---LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218

Query: 220 ETPTTLMLIEKLAGATPHLLDCTTYYV 246
           E P  L   E+L  A P +     Y V
Sbjct: 219 EVPDLLEKGERL--AQPQICTIDVYMV 243

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 16/207 (7%)

Query: 397 DRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN 456
           DR   +  + +   ++ M  L H  I+  +        L LV+ L   GS  D +  H +
Sbjct: 46  DRSGRQTFQEITDHMLAMGSLDHAYIV-RLLGICPGASLQLVTQLSPLGSLLDHVRQHRD 104

Query: 457 FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK 516
              P+ ++   +Q +  G+ Y+     +HR + A +IL+  +    ++         P  
Sbjct: 105 SLDPQRLLNWCVQ-IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163

Query: 517 KKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN-GTVPFA----- 569
           KK   F       + W++   LE  L G Y  +SD++S G++  E+ + G  P+A     
Sbjct: 164 KK--YFYSEHKTPIKWMA---LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218

Query: 570 ETPTTLMLIEKLAGATPHLLDCTTYYV 596
           E P  L   E+L  A P +     Y V
Sbjct: 219 EVPDLLEKGERL--AQPQICTIDVYMV 243

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 48/194 (24%), Positives = 76/194 (39%), Gaps = 28/194 (14%)

Query: 37  QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS------------FLDATD 84
           QL+A+K    D    +       E   M  L HPNI+C +              +L+  D
Sbjct: 35  QLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93

Query: 85  LH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           LH    + SP    G C    +      L      HI   +  G+EY+    F+H+ + A
Sbjct: 94  LHEFLIMRSPHSDVG-CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA 152

Query: 141 SHILISHNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 197
            +ILI       +S L   R +  +S    +V    P +   + W+ PE +      +  
Sbjct: 153 RNILIGEQLHVKISDLGLSREI--YSADYYRVQ---PKSLLPIRWMPPEAIMYG--KFSS 205

Query: 198 RSDIYSVGISCCEL 211
            SDI+S G+   E+
Sbjct: 206 DSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 48/194 (24%), Positives = 76/194 (39%), Gaps = 28/194 (14%)

Query: 387 QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS------------FLDATD 434
           QL+A+K    D    +       E   M  L HPNI+C +              +L+  D
Sbjct: 35  QLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93

Query: 435 LH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           LH    + SP    G C    +      L      HI   +  G+EY+    F+H+ + A
Sbjct: 94  LHEFLIMRSPHSDVG-CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA 152

Query: 491 SHILISHNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 547
            +ILI       +S L   R +  +S    +V    P +   + W+ PE +      +  
Sbjct: 153 RNILIGEQLHVKISDLGLSREI--YSADYYRVQ---PKSLLPIRWMPPEAIMYG--KFSS 205

Query: 548 RSDIYSVGISCCEL 561
            SDI+S G+   E+
Sbjct: 206 DSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 44/186 (23%), Positives = 86/186 (46%), Gaps = 19/186 (10%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+   +++   E   M+ L+H  ++   +       +++++  M  GS  
Sbjct: 33  VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89

Query: 99  DLI--NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLS 154
           D +  +      LP+L+       +  G+ YI  K +IHR ++A+++L+S +   K    
Sbjct: 90  DFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF 147

Query: 155 GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
           GL R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+  
Sbjct: 148 GLARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLYEIVT 199

Query: 214 -GTVPF 218
            G +P+
Sbjct: 200 YGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 44/186 (23%), Positives = 86/186 (46%), Gaps = 19/186 (10%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+   +++   E   M+ L+H  ++   +       +++++  M  GS  
Sbjct: 33  VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89

Query: 449 DLI--NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLS 504
           D +  +      LP+L+       +  G+ YI  K +IHR ++A+++L+S +   K    
Sbjct: 90  DFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF 147

Query: 505 GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
           GL R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+  
Sbjct: 148 GLARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLYEIVT 199

Query: 564 -GTVPF 568
            G +P+
Sbjct: 200 YGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 23/206 (11%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLD 81
           N   V+  + +  N  +AVK  +       DLK+    E   ++   HPNI+  I     
Sbjct: 7   NFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 64

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN---GLEYIHGKGFIHRAV 138
              +++V  L+  G   D +      G P L +  ++Q V N   G+EY+  K  IHR +
Sbjct: 65  KQPIYIVMELVQGG---DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTA----YNLNWLSPEVLEQNLDG 194
            A + L++      +S       F  ++++      ST       + W +PE L  N   
Sbjct: 121 AARNCLVTEKNVLKISD------FGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGR 172

Query: 195 YDERSDIYSVGISCCE-LANGTVPFA 219
           Y   SD++S GI   E  + G VP+A
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYA 198

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 23/206 (11%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLD 431
           N   V+  + +  N  +AVK  +       DLK+    E   ++   HPNI+  I     
Sbjct: 7   NFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 64

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN---GLEYIHGKGFIHRAV 488
              +++V  L+  G   D +      G P L +  ++Q V N   G+EY+  K  IHR +
Sbjct: 65  KQPIYIVMELVQGG---DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTA----YNLNWLSPEVLEQNLDG 544
            A + L++      +S       F  ++++      ST       + W +PE L  N   
Sbjct: 121 AARNCLVTEKNVLKISD------FGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGR 172

Query: 545 YDERSDIYSVGISCCE-LANGTVPFA 569
           Y   SD++S GI   E  + G VP+A
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYA 198

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           VY  + K  +  I V K   ++ + DE ++    E   M  L +P I+  I    +A  L
Sbjct: 15  VYKMRKKQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPYIVRMIG-VCEAEAL 69

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            LV  +   G     ++   +  +    +  ++  V  G++Y+ GK F+HR + A ++L+
Sbjct: 70  MLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL 128

Query: 146 SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
            +   A +S  GL        +  K         + L W +PE +  N   +  RSD++S
Sbjct: 129 VNQHYAKISDFGLSKALGADDSYYKARSA---GKWPLKWYAPECI--NFRKFSSRSDVWS 183

Query: 204 VGISCCE-LANGTVPFAET--PTTLMLIEK 230
            GI+  E  + G  P+ +   P  +  IE+
Sbjct: 184 YGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           VY  + K  +  I V K   ++ + DE ++    E   M  L +P I+  I    +A  L
Sbjct: 15  VYKMRKKQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPYIVRMIG-VCEAEAL 69

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            LV  +   G     ++   +  +    +  ++  V  G++Y+ GK F+HR + A ++L+
Sbjct: 70  MLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL 128

Query: 496 SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
            +   A +S  GL        +  K         + L W +PE +  N   +  RSD++S
Sbjct: 129 VNQHYAKISDFGLSKALGADDSYYKARSA---GKWPLKWYAPECI--NFRKFSSRSDVWS 183

Query: 554 VGISCCE-LANGTVPFAET--PTTLMLIEK 580
            GI+  E  + G  P+ +   P  +  IE+
Sbjct: 184 YGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 44/232 (18%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-----------LKSLH 58
            Y+    +G+       VY ++ K T +L+A+KK  L+ M +E            L+ L 
Sbjct: 2   AYEKLEKIGE--GTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLS 58

Query: 59  HEIVCMRHLR-------HPNIICYIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 110
             I  +R L        +     Y+   +LD +DL       G G  +          LP
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGR---------PLP 108

Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-LSGLRYMCPFS-PTKKK 168
              I   +  +L G+ + H  G +HR +K  ++L+        ++ L     FS P K  
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168

Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDG--YDERSDIYSVGISCCELANGTVPF 218
            H         L + +PEVL   L    Y    DI+SVG    E++     F
Sbjct: 169 TH-----EIVTLWYRAPEVL---LGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 44/232 (18%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-----------LKSLH 408
            Y+    +G+       VY ++ K T +L+A+KK  L+ M +E            L+ L 
Sbjct: 2   AYEKLEKIGE--GTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLS 58

Query: 409 HEIVCMRHLR-------HPNIICYIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 460
             I  +R L        +     Y+   +LD +DL       G G  +          LP
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGR---------PLP 108

Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-LSGLRYMCPFS-PTKKK 518
              I   +  +L G+ + H  G +HR +K  ++L+        ++ L     FS P K  
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168

Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDG--YDERSDIYSVGISCCELANGTVPF 568
            H         L + +PEVL   L    Y    DI+SVG    E++     F
Sbjct: 169 TH-----EIVTLWYRAPEVL---LGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 19/215 (8%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K      M++++      E   M  L H  ++           +++V+  M  G   
Sbjct: 31  VAIKMIKEGSMSEDEF---IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87

Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           + +  H         +  + +DV  G+ Y+  K FIHR + A + L+   G   +S  GL
Sbjct: 88  NYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGL 146

Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            RY+     T      FP      + W  PEVL  +   +  +SD+++ G+   E+ + G
Sbjct: 147 SRYVLDDEYTSSVGSKFP------VRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLG 198

Query: 215 TVP---FAETPTTLMLIEKLAGATPHLLDCTTYYV 246
            +P   F  + T   + + L    PHL     Y +
Sbjct: 199 KMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 19/215 (8%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K      M++++      E   M  L H  ++           +++V+  M  G   
Sbjct: 31  VAIKMIKEGSMSEDEF---IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87

Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           + +  H         +  + +DV  G+ Y+  K FIHR + A + L+   G   +S  GL
Sbjct: 88  NYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGL 146

Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            RY+     T      FP      + W  PEVL  +   +  +SD+++ G+   E+ + G
Sbjct: 147 SRYVLDDEYTSSVGSKFP------VRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLG 198

Query: 565 TVP---FAETPTTLMLIEKLAGATPHLLDCTTYYV 596
            +P   F  + T   + + L    PHL     Y +
Sbjct: 199 KMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 28/166 (16%)

Query: 60  EIVCMRHLR---HPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF---- 107
           E+  +RHL    HPN++     C +S     T L LV     F      +  + +     
Sbjct: 51  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV-----FEHVDQDLTTYLDKVPEP 105

Query: 108 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPT 165
           G+P   I  ++  +L GL+++H    +HR +K  +IL++ +G+  L+  GL  +  F   
Sbjct: 106 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 162

Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
                +   S    L + +PEVL Q+   Y    D++SVG    E+
Sbjct: 163 ----QMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 28/166 (16%)

Query: 410 EIVCMRHLR---HPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF---- 457
           E+  +RHL    HPN++     C +S     T L LV     F      +  + +     
Sbjct: 51  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV-----FEHVDQDLTTYLDKVPEP 105

Query: 458 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPT 515
           G+P   I  ++  +L GL+++H    +HR +K  +IL++ +G+  L+  GL  +  F   
Sbjct: 106 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 162

Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
                +   S    L + +PEVL Q+   Y    D++SVG    E+
Sbjct: 163 ----QMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 32/196 (16%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR---HLRHPNII-----CYIS 77
           +VY ++   +   +A+K   +    D    S   E+  ++      HPNI+     C  S
Sbjct: 15  TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGF 133
                T + LV     F      +  + +     GLP   I  +++  L GL+++H    
Sbjct: 75  RTDRETKVTLV-----FEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCI 129

Query: 134 IHRAVKASHILISHNGKACLS--GLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 189
           +HR +K  +IL++  G+  L+  GL   Y C  + T   V L+         + +PEVL 
Sbjct: 130 VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW---------YRAPEVLL 180

Query: 190 QNLDGYDERSDIYSVG 205
           Q+   Y    D++SVG
Sbjct: 181 QST--YATPVDMWSVG 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 32/196 (16%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR---HLRHPNII-----CYIS 427
           +VY ++   +   +A+K   +    D    S   E+  ++      HPNI+     C  S
Sbjct: 15  TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGF 483
                T + LV     F      +  + +     GLP   I  +++  L GL+++H    
Sbjct: 75  RTDRETKVTLV-----FEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCI 129

Query: 484 IHRAVKASHILISHNGKACLS--GLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 539
           +HR +K  +IL++  G+  L+  GL   Y C  + T   V L+         + +PEVL 
Sbjct: 130 VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW---------YRAPEVLL 180

Query: 540 QNLDGYDERSDIYSVG 555
           Q+   Y    D++SVG
Sbjct: 181 QST--YATPVDMWSVG 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 44.3 bits (105), Expect = 9e-05
 Identities = 44/185 (23%), Positives = 73/185 (39%), Gaps = 15/185 (8%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK       +    +    E   MR   HP+I+  I    +   + +V  L   G  +
Sbjct: 37  VAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELR 94

Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS--HNGKACLSGL 156
             +  +        +I +  Q +   L Y+  K F+HR + A ++L+S     K    GL
Sbjct: 95  SYLQVNKYSLDLASLILYSYQ-LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL 153

Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANG 214
            RY+   S  K      P      + W++PE +  N   +   SD++  G+   E L  G
Sbjct: 154 SRYLEDESYYKASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMLG 205

Query: 215 TVPFA 219
             PF 
Sbjct: 206 VKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 44.3 bits (105), Expect = 9e-05
 Identities = 44/185 (23%), Positives = 73/185 (39%), Gaps = 15/185 (8%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK       +    +    E   MR   HP+I+  I    +   + +V  L   G  +
Sbjct: 37  VAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELR 94

Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS--HNGKACLSGL 506
             +  +        +I +  Q +   L Y+  K F+HR + A ++L+S     K    GL
Sbjct: 95  SYLQVNKYSLDLASLILYSYQ-LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL 153

Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANG 564
            RY+   S  K      P      + W++PE +  N   +   SD++  G+   E L  G
Sbjct: 154 SRYLEDESYYKASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMLG 205

Query: 565 TVPFA 569
             PF 
Sbjct: 206 VKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.7 bits (105), Expect = 9e-05
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 18/199 (9%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           ++VY  K KV  +L+A+K   L         ++  E   ++ L+H NI+           
Sbjct: 19  ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKET 77

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L LV   +    C+  ++ H     PE V   + Q +L GL YIH +  +HR +K  ++L
Sbjct: 78  LTLVFEYVHTDLCQ-YMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRYILHRDLKPQNLL 135

Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN-----LNWLSPEVLEQNLDGYDERS 199
           IS  G+  L+       F   + K     PS  Y+     L +  P+VL  + + Y    
Sbjct: 136 ISDTGELKLAD------FGLARAKS---VPSHTYSNEVVTLWYRPPDVLLGSTE-YSTCL 185

Query: 200 DIYSVGISCCELANGTVPF 218
           D++ VG    E+  G   F
Sbjct: 186 DMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.7 bits (105), Expect = 9e-05
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 18/199 (9%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           ++VY  K KV  +L+A+K   L         ++  E   ++ L+H NI+           
Sbjct: 19  ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKET 77

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           L LV   +    C+  ++ H     PE V   + Q +L GL YIH +  +HR +K  ++L
Sbjct: 78  LTLVFEYVHTDLCQ-YMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRYILHRDLKPQNLL 135

Query: 495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN-----LNWLSPEVLEQNLDGYDERS 549
           IS  G+  L+       F   + K     PS  Y+     L +  P+VL  + + Y    
Sbjct: 136 ISDTGELKLAD------FGLARAKS---VPSHTYSNEVVTLWYRPPDVLLGSTE-YSTCL 185

Query: 550 DIYSVGISCCELANGTVPF 568
           D++ VG    E+  G   F
Sbjct: 186 DMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 22/168 (13%)

Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----------HLVSPLMGFGSCKDLINAHFNFGL 109
           EI  +R L+HPN+I     FL  +D           H +  ++ F              L
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ--L 105

Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYMCPF-SP 164
           P  ++  +L  +L+G+ Y+H    +HR +K ++IL+       G+  ++ + +   F SP
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 165 TKKKVHLFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCEL 211
            K    L P    +   W  +PE+L      Y +  DI+++G    EL
Sbjct: 166 LKPLADLDPVVVTF---WYRAPELL-LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 22/168 (13%)

Query: 410 EIVCMRHLRHPNIICYISSFLDATDL----------HLVSPLMGFGSCKDLINAHFNFGL 459
           EI  +R L+HPN+I     FL  +D           H +  ++ F              L
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ--L 105

Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYMCPF-SP 514
           P  ++  +L  +L+G+ Y+H    +HR +K ++IL+       G+  ++ + +   F SP
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 515 TKKKVHLFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCEL 561
            K    L P    +   W  +PE+L      Y +  DI+++G    EL
Sbjct: 166 LKPLADLDPVVVTF---WYRAPELL-LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 9/128 (7%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           ++VY  + K+T QL+A+K+  L+        ++  E   ++ L+H NI+           
Sbjct: 19  ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDIIHTKKT 77

Query: 85  LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           L LV   +      DL   ++          V   + Q +L GL Y H +  +HR +K  
Sbjct: 78  LTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQ-LLRGLAYCHQRRVLHRDLKPQ 132

Query: 142 HILISHNG 149
           ++LIS  G
Sbjct: 133 NLLISERG 140

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 9/128 (7%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           ++VY  + K+T QL+A+K+  L+        ++  E   ++ L+H NI+           
Sbjct: 19  ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDIIHTKKT 77

Query: 435 LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           L LV   +      DL   ++          V   + Q +L GL Y H +  +HR +K  
Sbjct: 78  LTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQ-LLRGLAYCHQRRVLHRDLKPQ 132

Query: 492 HILISHNG 499
           ++LIS  G
Sbjct: 133 NLLISERG 140

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 34/231 (14%)

Query: 17  LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 71
           LG+ CF  +    ++ + K K    +    K   D  TD+DL  L  E+  M+ + +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 72  IICYISSFLDATDLHLVSPLMGFGSCKDLINAH------FNFG---LPE-------LVIC 115
           II  + +      L+++      G+ ++ + A       ++F    LPE       LV C
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 172
                V  G+EY+  +  IHR + A ++L++ +   K    GL R +      KK  +  
Sbjct: 140 --AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 198 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 34/231 (14%)

Query: 367 LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 421
           LG+ CF  +    ++ + K K    +    K   D  TD+DL  L  E+  M+ + +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 422 IICYISSFLDATDLHLVSPLMGFGSCKDLINAH------FNFG---LPE-------LVIC 465
           II  + +      L+++      G+ ++ + A       ++F    LPE       LV C
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 522
                V  G+EY+  +  IHR + A ++L++ +   K    GL R +      KK  +  
Sbjct: 140 --AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 198 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 41/184 (22%), Positives = 85/184 (46%), Gaps = 16/184 (8%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+   +++   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 33  VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLV-KLHAVVTKEPIYIITEFMAKGSLL 88

Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGL 156
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S +   K    GL
Sbjct: 89  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 148

Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 149 ARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYG 200

Query: 215 TVPF 218
            +P+
Sbjct: 201 RIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 41/184 (22%), Positives = 85/184 (46%), Gaps = 16/184 (8%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+   +++   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 33  VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLV-KLHAVVTKEPIYIITEFMAKGSLL 88

Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGL 506
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S +   K    GL
Sbjct: 89  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 148

Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 149 ARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYG 200

Query: 565 TVPF 568
            +P+
Sbjct: 201 RIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 54/238 (22%), Positives = 99/238 (41%), Gaps = 33/238 (13%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKS-LHHEIV 62
           SN +  + LG+       V+L+K K         L+ VK     +  DE+L+S    E+ 
Sbjct: 5   SNLQEITTLGRG--EFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSEFRRELD 60

Query: 63  CMRHLRHPNII-----C------YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPE 111
             R L H N++     C      Y+   L+ TDL  +   +     KD           +
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118

Query: 112 LV-ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH 170
            V +C     +  G++++    F+HR + A + L+S   +  +S L  +        + +
Sbjct: 119 KVALCT---QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS-LSK-DVYNSEYY 173

Query: 171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLML 227
               +    L WL+PE +++  D +  +SD++S G+   E+   G +PF       +L
Sbjct: 174 KL-RNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 54/238 (22%), Positives = 99/238 (41%), Gaps = 33/238 (13%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKS-LHHEIV 412
           SN +  + LG+       V+L+K K         L+ VK     +  DE+L+S    E+ 
Sbjct: 5   SNLQEITTLGRG--EFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSEFRRELD 60

Query: 413 CMRHLRHPNII-----C------YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPE 461
             R L H N++     C      Y+   L+ TDL  +   +     KD           +
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118

Query: 462 LV-ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH 520
            V +C     +  G++++    F+HR + A + L+S   +  +S L  +        + +
Sbjct: 119 KVALCT---QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS-LSK-DVYNSEYY 173

Query: 521 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLML 577
               +    L WL+PE +++  D +  +SD++S G+   E+   G +PF       +L
Sbjct: 174 KL-RNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 12/195 (6%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATD 84
           V+L++ K TNQ  A+K    D  + D+D++ ++  + V      HP +     +F    +
Sbjct: 11  VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN 70

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L  V   +  G     I +   F LP         +++ GL+++H KG ++R +K  +IL
Sbjct: 71  LFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIVYRDLKLDNIL 128

Query: 145 ISHNGKACLSGLRYMCPFSPT-KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
           +  +G   ++    MC  +     K   F  +  Y    ++PE+L      Y+   D +S
Sbjct: 129 LDTDGHIKIADFG-MCKENMLGDAKTCTFCGTPDY----IAPEILLGQ--KYNTSVDWWS 181

Query: 204 VGISCCELANGTVPF 218
            G+   E+  G  PF
Sbjct: 182 FGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 12/195 (6%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATD 434
           V+L++ K TNQ  A+K    D  + D+D++ ++  + V      HP +     +F    +
Sbjct: 11  VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN 70

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           L  V   +  G     I +   F LP         +++ GL+++H KG ++R +K  +IL
Sbjct: 71  LFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIVYRDLKLDNIL 128

Query: 495 ISHNGKACLSGLRYMCPFSPT-KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
           +  +G   ++    MC  +     K   F  +  Y    ++PE+L      Y+   D +S
Sbjct: 129 LDTDGHIKIADFG-MCKENMLGDAKTCTFCGTPDY----IAPEILLGQ--KYNTSVDWWS 181

Query: 554 VGISCCELANGTVPF 568
            G+   E+  G  PF
Sbjct: 182 FGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 19/150 (12%)

Query: 78  SFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 135
           +F D  +L+LV   M +    DL+   + F   LPE +    L +++  ++ +H   ++H
Sbjct: 69  AFQDENNLYLV---MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 136 RAVKASHILISHNGKACL----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN 191
           R +K  +IL+  NG   L    S L+ M      +  V +  P      +++SPE+L+  
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTP------DYISPEILQAM 178

Query: 192 LDG---YDERSDIYSVGISCCELANGTVPF 218
            DG   Y    D +S+G+   E+  G  PF
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 19/150 (12%)

Query: 428 SFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIH 485
           +F D  +L+LV   M +    DL+   + F   LPE +    L +++  ++ +H   ++H
Sbjct: 69  AFQDENNLYLV---MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 486 RAVKASHILISHNGKACL----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN 541
           R +K  +IL+  NG   L    S L+ M      +  V +  P      +++SPE+L+  
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTP------DYISPEILQAM 178

Query: 542 LDG---YDERSDIYSVGISCCELANGTVPF 568
            DG   Y    D +S+G+   E+  G  PF
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 25/221 (11%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           ++V+  + K+T  L+A+K+  L+        ++  E+  ++ L+H NI+           
Sbjct: 20  ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIVHTDKS 78

Query: 85  LHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           L LV   +          C ++++ H N  +        L  +L GL Y H +  +HR +
Sbjct: 79  LTLVFEYLDKDLKQYMDDCGNIMSMH-NVKI-------FLYQILRGLAYCHRRKVLHRDL 130

Query: 139 KASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 197
           K  ++LI+  G+  L+        S PTK        +    L +  P+VL  + + Y  
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTY-----SNEVVTLWYRPPDVLLGSSE-YST 184

Query: 198 RSDIYSVGISCCELANGT--VPFAETPTTLMLIEKLAGATP 236
           + D++ VG    E+A+G    P +     L LI +L G TP
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-TP 224

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 25/221 (11%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           ++V+  + K+T  L+A+K+  L+        ++  E+  ++ L+H NI+           
Sbjct: 20  ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIVHTDKS 78

Query: 435 LHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           L LV   +          C ++++ H N  +        L  +L GL Y H +  +HR +
Sbjct: 79  LTLVFEYLDKDLKQYMDDCGNIMSMH-NVKI-------FLYQILRGLAYCHRRKVLHRDL 130

Query: 489 KASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 547
           K  ++LI+  G+  L+        S PTK        +    L +  P+VL  + + Y  
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSVPTKTY-----SNEVVTLWYRPPDVLLGSSE-YST 184

Query: 548 RSDIYSVGISCCELANGT--VPFAETPTTLMLIEKLAGATP 586
           + D++ VG    E+A+G    P +     L LI +L G TP
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-TP 224

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 31/122 (25%), Positives = 59/122 (48%), Gaps = 16/122 (13%)

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN---- 179
            L+++H  G I+R +K  +IL+   G   L+       F  +K+ +       AY+    
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTD------FGLSKESID--HEKKAYSFCGT 161

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPH 237
           + +++PEV+  N  G+ + +D +S G+   E+  G++PF   +   T+ +I K     P 
Sbjct: 162 VEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ 219

Query: 238 LL 239
            L
Sbjct: 220 FL 221

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 31/122 (25%), Positives = 59/122 (48%), Gaps = 16/122 (13%)

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN---- 529
            L+++H  G I+R +K  +IL+   G   L+       F  +K+ +       AY+    
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTD------FGLSKESID--HEKKAYSFCGT 161

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPH 587
           + +++PEV+  N  G+ + +D +S G+   E+  G++PF   +   T+ +I K     P 
Sbjct: 162 VEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ 219

Query: 588 LL 589
            L
Sbjct: 220 FL 221

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 17/205 (8%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE--IVCMRHLRHPNIICYISSFLDAT 83
           V L++ K + +L AVK    D  + D+D++    E  I+ +    HP +      F    
Sbjct: 11  VMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLYCCFQTPD 69

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
            L  V   +  G     I     F            ++ + L ++H KG I+R +K  ++
Sbjct: 70  RLFFVMEFVNGGDLMFHIQKSRRFDEAR--ARFYAAEITSALMFLHDKGIIYRDLKLDNV 127

Query: 144 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSDI 201
           L+ H G   L+    MC     K+ +     ++ +    ++++PE+L++ L G     D 
Sbjct: 128 LLDHEGHCKLADFG-MC-----KEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS--VDW 179

Query: 202 YSVGISCCELANGTVPF-AETPTTL 225
           +++G+   E+  G  PF AE    L
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 17/205 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE--IVCMRHLRHPNIICYISSFLDAT 433
           V L++ K + +L AVK    D  + D+D++    E  I+ +    HP +      F    
Sbjct: 11  VMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLYCCFQTPD 69

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
            L  V   +  G     I     F            ++ + L ++H KG I+R +K  ++
Sbjct: 70  RLFFVMEFVNGGDLMFHIQKSRRFDEAR--ARFYAAEITSALMFLHDKGIIYRDLKLDNV 127

Query: 494 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSDI 551
           L+ H G   L+    MC     K+ +     ++ +    ++++PE+L++ L G     D 
Sbjct: 128 LLDHEGHCKLADFG-MC-----KEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS--VDW 179

Query: 552 YSVGISCCELANGTVPF-AETPTTL 575
           +++G+   E+  G  PF AE    L
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 33/183 (18%), Positives = 76/183 (41%), Gaps = 10/183 (5%)

Query: 38  LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 97
            +A+        +D+  +    E + +    H NI+           + +V+  M  G+ 
Sbjct: 35  PVAIHTLR-AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93

Query: 98  KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
              +  H    L    +  +L  + +G++Y+   G++H+ + A  +L++ +    +SG R
Sbjct: 94  DSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Query: 158 YMCPFSPTKKKVHLFPPSTAYNLN-WLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGT 215
            +       K   ++   +  +   W +PE ++     +   SD++S GI   E ++ G 
Sbjct: 153 RL----QEDKSEAIYTTMSGKSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMSYGE 206

Query: 216 VPF 218
            P+
Sbjct: 207 RPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 33/183 (18%), Positives = 76/183 (41%), Gaps = 10/183 (5%)

Query: 388 LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 447
            +A+        +D+  +    E + +    H NI+           + +V+  M  G+ 
Sbjct: 35  PVAIHTLR-AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93

Query: 448 KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
              +  H    L    +  +L  + +G++Y+   G++H+ + A  +L++ +    +SG R
Sbjct: 94  DSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Query: 508 YMCPFSPTKKKVHLFPPSTAYNLN-WLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGT 565
            +       K   ++   +  +   W +PE ++     +   SD++S GI   E ++ G 
Sbjct: 153 RL----QEDKSEAIYTTMSGKSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMSYGE 206

Query: 566 VPF 568
            P+
Sbjct: 207 RPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 34/231 (14%)

Query: 17  LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 71
           LG+ CF  +    ++ + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 72  IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL----------------PELVIC 115
           II  + +      L+++      G+ ++ + A    G+                 +LV C
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 172
                V  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 143 --TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 201 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 34/231 (14%)

Query: 367 LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 421
           LG+ CF  +    ++ + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 422 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL----------------PELVIC 465
           II  + +      L+++      G+ ++ + A    G+                 +LV C
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 522
                V  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 143 --TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 201 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 40/228 (17%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           +++I  ++G+       V + K K T ++ A+K  N   M    LK    E  C R  R+
Sbjct: 2   DFEIIKVIGR--GAFGEVAVVKMKHTERIYAMKILNKWEM----LK--RAETACFREERN 53

Query: 70  P--NIIC-YISS----FLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQD 120
              N  C +I++    F D   L+LV   M +    DL+   + F   LPE +    + +
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLV---MDYYVGGDLLTLLSKFEDRLPEDMARFYIAE 110

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGK-------ACLSGLRYMCPFSPTKKKVHLFP 173
           ++  +  IH   ++HR +K  ++L+  NG        +CL     M      +  V +  
Sbjct: 111 MVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK----MNQDGTVQSSVAVGT 166

Query: 174 PSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPF 218
           P      +++SPE+L+   DG   Y    D +S+G+   E+  G  PF
Sbjct: 167 P------DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 40/228 (17%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +++I  ++G+       V + K K T ++ A+K  N   M    LK    E  C R  R+
Sbjct: 2   DFEIIKVIGR--GAFGEVAVVKMKHTERIYAMKILNKWEM----LK--RAETACFREERN 53

Query: 420 P--NIIC-YISS----FLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQD 470
              N  C +I++    F D   L+LV   M +    DL+   + F   LPE +    + +
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLV---MDYYVGGDLLTLLSKFEDRLPEDMARFYIAE 110

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGK-------ACLSGLRYMCPFSPTKKKVHLFP 523
           ++  +  IH   ++HR +K  ++L+  NG        +CL     M      +  V +  
Sbjct: 111 MVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK----MNQDGTVQSSVAVGT 166

Query: 524 PSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPF 568
           P      +++SPE+L+   DG   Y    D +S+G+   E+  G  PF
Sbjct: 167 P------DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 31/132 (23%), Positives = 48/132 (36%), Gaps = 34/132 (25%)

Query: 35  TNQLIAVKKFNLDRMTDEDL-KSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSPLM 92
           T   +A+K    D   +E        E  +C R L HPNI+  + S              
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCAR-LYHPNIVALLDS-------------- 46

Query: 93  GFGSCKD-LINAHFNF--------------GLPELVICHILQDVLNGLEYIHGKGFIHRA 137
             G     L+ A F +               LP      ++  VL+ L   H +G +HR 
Sbjct: 47  --GEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRD 104

Query: 138 VKASHILISHNG 149
           +K  +I++S  G
Sbjct: 105 LKPQNIMVSQTG 116

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 31/132 (23%), Positives = 48/132 (36%), Gaps = 34/132 (25%)

Query: 385 TNQLIAVKKFNLDRMTDEDL-KSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSPLM 442
           T   +A+K    D   +E        E  +C R L HPNI+  + S              
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCAR-LYHPNIVALLDS-------------- 46

Query: 443 GFGSCKD-LINAHFNF--------------GLPELVICHILQDVLNGLEYIHGKGFIHRA 487
             G     L+ A F +               LP      ++  VL+ L   H +G +HR 
Sbjct: 47  --GEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRD 104

Query: 488 VKASHILISHNG 499
           +K  +I++S  G
Sbjct: 105 LKPQNIMVSQTG 116

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 30/172 (17%)

Query: 60  EIVCMRHLRHPNIICYISSFLDATD--------------LHLVSPLMGFGSCKDLINAHF 105
           EI  +R L+HPN+I     FL   D               H++       + K  +    
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ--- 104

Query: 106 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYMCP 161
              LP  ++  +L  +L+G+ Y+H    +HR +K ++IL+       G+  ++ + +   
Sbjct: 105 ---LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 162 F-SPTKKKVHLFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCEL 211
           F SP K    L P    +   W  +PE+L      Y +  DI+++G    EL
Sbjct: 162 FNSPLKPLADLDPVVVTF---WYRAPELL-LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 30/172 (17%)

Query: 410 EIVCMRHLRHPNIICYISSFLDATD--------------LHLVSPLMGFGSCKDLINAHF 455
           EI  +R L+HPN+I     FL   D               H++       + K  +    
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ--- 104

Query: 456 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYMCP 511
              LP  ++  +L  +L+G+ Y+H    +HR +K ++IL+       G+  ++ + +   
Sbjct: 105 ---LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 512 F-SPTKKKVHLFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCEL 561
           F SP K    L P    +   W  +PE+L      Y +  DI+++G    EL
Sbjct: 162 FNSPLKPLADLDPVVVTF---WYRAPELL-LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 13/129 (10%)

Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
              K+L++   + GL  L +      V  G+E++  K  +HR + A ++L++  GK    
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ-GK---- 274

Query: 155 GLRYMCPFSPTKKKVH----LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
            +  +C F   +  +H    +   ST   + W++PE +  NL  Y   SD++S GI   E
Sbjct: 275 -IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWE 331

Query: 211 LAN-GTVPF 218
           + + G  P+
Sbjct: 332 IFSLGGTPY 340

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 13/129 (10%)

Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
              K+L++   + GL  L +      V  G+E++  K  +HR + A ++L++  GK    
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ-GK---- 274

Query: 505 GLRYMCPFSPTKKKVH----LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
            +  +C F   +  +H    +   ST   + W++PE +  NL  Y   SD++S GI   E
Sbjct: 275 -IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWE 331

Query: 561 LAN-GTVPF 568
           + + G  P+
Sbjct: 332 IFSLGGTPY 340

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 40/179 (22%), Positives = 66/179 (36%), Gaps = 40/179 (22%)

Query: 64  MRHLRHPNI--ICYISSFLDATDLHLVSPLMGFG-------SCKDL-INAHFNFGLPELV 113
           +  L H NI  I ++          ++ P M +G        C+    N        +LV
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHL 171
             H+   +  G+ Y+H +G IH+ + A + +I      K   + L              L
Sbjct: 121 --HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR-----------DL 167

Query: 172 FPPSTAYN---------LNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAE 220
           FP    Y+         + W++ E L      Y   SD++S G+   EL   G  P+ E
Sbjct: 168 FP--MDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 40/179 (22%), Positives = 66/179 (36%), Gaps = 40/179 (22%)

Query: 414 MRHLRHPNI--ICYISSFLDATDLHLVSPLMGFG-------SCKDL-INAHFNFGLPELV 463
           +  L H NI  I ++          ++ P M +G        C+    N        +LV
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHL 521
             H+   +  G+ Y+H +G IH+ + A + +I      K   + L              L
Sbjct: 121 --HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR-----------DL 167

Query: 522 FPPSTAYN---------LNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAE 570
           FP    Y+         + W++ E L      Y   SD++S G+   EL   G  P+ E
Sbjct: 168 FP--MDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 31/205 (15%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  TD+DL  L  E+  M+ + +H NII  +        L+++      G+ 
Sbjct: 47  VAVKMLK-DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105

Query: 98  KDLINAH------FNFGLPE----------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A       + F + +          LV C     V  G+EY+  +  IHR + A 
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC--AYQVARGMEYLESRRCIHRDLAAR 163

Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           ++L++ +   K    GL R +      KK  +   P     + W++PE L   +  Y  +
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP-----VKWMAPEALFDRV--YTHQ 216

Query: 199 SDIYSVGISCCELAN-GTVPFAETP 222
           SD++S GI   E+   G  P+   P
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGIP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 31/205 (15%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  TD+DL  L  E+  M+ + +H NII  +        L+++      G+ 
Sbjct: 47  VAVKMLK-DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105

Query: 448 KDLINAH------FNFGLPE----------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A       + F + +          LV C     V  G+EY+  +  IHR + A 
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC--AYQVARGMEYLESRRCIHRDLAAR 163

Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           ++L++ +   K    GL R +      KK  +   P     + W++PE L   +  Y  +
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP-----VKWMAPEALFDRV--YTHQ 216

Query: 549 SDIYSVGISCCELAN-GTVPFAETP 572
           SD++S GI   E+   G  P+   P
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGIP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 22/196 (11%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           + VK+       DE L  L  E+   R L HPN++  +   +++    LV      G  K
Sbjct: 25  VVVKELRASATPDEQLLFLQ-EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83

Query: 99  DLINA---HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-----GK 150
           + + +          + V+  +  +V +GL ++H   FIH  +   +  ++ +     G 
Sbjct: 84  NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGD 143

Query: 151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE---QNLDGYDE--RSDIYSVG 205
             L+  +Y   +  TK   H  P      L WL+PE++E   Q+L   D+  +S+I+S+G
Sbjct: 144 YGLALEQYPEDYYITKDC-HAVP------LRWLAPELVEIRGQDLLPKDQTKKSNIWSLG 196

Query: 206 ISCCELA-NGTVPFAE 220
           ++  EL      P+ +
Sbjct: 197 VTMWELFTAADQPYPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 22/196 (11%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           + VK+       DE L  L  E+   R L HPN++  +   +++    LV      G  K
Sbjct: 25  VVVKELRASATPDEQLLFLQ-EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83

Query: 449 DLINA---HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-----GK 500
           + + +          + V+  +  +V +GL ++H   FIH  +   +  ++ +     G 
Sbjct: 84  NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGD 143

Query: 501 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE---QNLDGYDE--RSDIYSVG 555
             L+  +Y   +  TK   H  P      L WL+PE++E   Q+L   D+  +S+I+S+G
Sbjct: 144 YGLALEQYPEDYYITKDC-HAVP------LRWLAPELVEIRGQDLLPKDQTKKSNIWSLG 196

Query: 556 ISCCELA-NGTVPFAE 570
           ++  EL      P+ +
Sbjct: 197 VTMWELFTAADQPYPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 48/215 (22%), Positives = 82/215 (38%), Gaps = 43/215 (20%)

Query: 24  LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV----CMRHLRHPNI-----IC 74
           +  VYL K     + +AVK      +  E + +   E +     M  L HP I     +C
Sbjct: 12  VKGVYLMKSGKEVE-VAVKT-----LKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65

Query: 75  YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI 134
                +      LV  L   G     +        P   +  +   V  G+ Y+  K F+
Sbjct: 66  KGEPLM------LVMELAPLGPLLKYLKKRREI--PVSDLKELAHQVAMGMAYLESKHFV 117

Query: 135 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN--------LNWLSPE 186
           HR + A ++L+ +  +A +S       F  ++    L   S  Y         L W +PE
Sbjct: 118 HRDLAARNVLLVNRHQAKISD------FGMSRA---LGAGSDYYRATTAGRWPLKWYAPE 168

Query: 187 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAE 220
            +  N   +  +SD++S G++  E  + G  P+ E
Sbjct: 169 CI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 48/215 (22%), Positives = 82/215 (38%), Gaps = 43/215 (20%)

Query: 374 LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV----CMRHLRHPNI-----IC 424
           +  VYL K     + +AVK      +  E + +   E +     M  L HP I     +C
Sbjct: 12  VKGVYLMKSGKEVE-VAVKT-----LKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65

Query: 425 YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI 484
                +      LV  L   G     +        P   +  +   V  G+ Y+  K F+
Sbjct: 66  KGEPLM------LVMELAPLGPLLKYLKKRREI--PVSDLKELAHQVAMGMAYLESKHFV 117

Query: 485 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN--------LNWLSPE 536
           HR + A ++L+ +  +A +S       F  ++    L   S  Y         L W +PE
Sbjct: 118 HRDLAARNVLLVNRHQAKISD------FGMSRA---LGAGSDYYRATTAGRWPLKWYAPE 168

Query: 537 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAE 570
            +  N   +  +SD++S G++  E  + G  P+ E
Sbjct: 169 CI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 34/190 (17%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  +        L++V      G+ 
Sbjct: 45  VAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL 103

Query: 98  KDLINAH------FNFGLPELVICHILQ--------DVLNGLEYIHGKGFIHRAVKASHI 143
           +D + A        +   P      + Q         V  G+E++  K  IHR + A ++
Sbjct: 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163

Query: 144 LISHNG--KACLSGLRYMCPFSPTKKKVH---LFPPSTAYNL--NWLSPEVLEQNLDGYD 196
           L++ +   K    GL          + +H    +  +T   L   W++PE L   +  Y 
Sbjct: 164 LVTEDHVMKIADFGL---------ARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YT 212

Query: 197 ERSDIYSVGI 206
            +SD++S G+
Sbjct: 213 HQSDVWSFGV 222

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 34/190 (17%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  +        L++V      G+ 
Sbjct: 45  VAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL 103

Query: 448 KDLINAH------FNFGLPELVICHILQ--------DVLNGLEYIHGKGFIHRAVKASHI 493
           +D + A        +   P      + Q         V  G+E++  K  IHR + A ++
Sbjct: 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163

Query: 494 LISHNG--KACLSGLRYMCPFSPTKKKVH---LFPPSTAYNL--NWLSPEVLEQNLDGYD 546
           L++ +   K    GL          + +H    +  +T   L   W++PE L   +  Y 
Sbjct: 164 LVTEDHVMKIADFGL---------ARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YT 212

Query: 547 ERSDIYSVGI 556
            +SD++S G+
Sbjct: 213 HQSDVWSFGV 222

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 41.3 bits (97), Expect = 9e-04
 Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 51/202 (25%)

Query: 40  AVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL-HLVSPLMGFG-- 95
           AVK  +L+R+TD E+++    E + M+   HPN++  +   L +     +V P M  G  
Sbjct: 27  AVK--SLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84

Query: 96  -----------SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
                      + KDLI     FGL           V  G+EY+  K F+HR + A + +
Sbjct: 85  RNFIRSETHNPTVKDLIG----FGL----------QVAKGMEYLASKKFVHRDLAARNCM 130

Query: 145 I--SHNGKACLSGL-------RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
           +  S   K    GL        Y   +S         P      + W++ E L+     +
Sbjct: 131 LDESFTVKVADFGLARDIYDKEY---YSVHNHTGAKLP------VKWMALESLQTQ--KF 179

Query: 196 DERSDIYSVGISCCELANGTVP 217
             +SD++S G+   EL     P
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 41.3 bits (97), Expect = 9e-04
 Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 51/202 (25%)

Query: 390 AVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL-HLVSPLMGFG-- 445
           AVK  +L+R+TD E+++    E + M+   HPN++  +   L +     +V P M  G  
Sbjct: 27  AVK--SLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84

Query: 446 -----------SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
                      + KDLI     FGL           V  G+EY+  K F+HR + A + +
Sbjct: 85  RNFIRSETHNPTVKDLIG----FGL----------QVAKGMEYLASKKFVHRDLAARNCM 130

Query: 495 I--SHNGKACLSGL-------RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
           +  S   K    GL        Y   +S         P      + W++ E L+     +
Sbjct: 131 LDESFTVKVADFGLARDIYDKEY---YSVHNHTGAKLP------VKWMALESLQTQ--KF 179

Query: 546 DERSDIYSVGISCCELANGTVP 567
             +SD++S G+   EL     P
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 38/189 (20%), Positives = 77/189 (40%), Gaps = 25/189 (13%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K    D +  +       E+  ++ LRH ++I   +       +++++ LM  GS  
Sbjct: 33  VAIKILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90

Query: 99  DLINA--HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL 156
             + +       +  L+   +   V  G+ Y+  +  IHR + A +IL+  +        
Sbjct: 91  AFLRSPEGQVLPVASLI--DMACQVAEGMAYLEEQNSIHRDLAARNILVGED-------- 140

Query: 157 RYMCPFSP------TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
             +C  +        K+ V+L          W +PE    +   +  +SD++S GI   E
Sbjct: 141 -LVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAA--SHGTFSTKSDVWSFGILLYE 196

Query: 211 L-ANGTVPF 218
           +   G VP+
Sbjct: 197 MFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 38/189 (20%), Positives = 77/189 (40%), Gaps = 25/189 (13%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K    D +  +       E+  ++ LRH ++I   +       +++++ LM  GS  
Sbjct: 33  VAIKILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90

Query: 449 DLINA--HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL 506
             + +       +  L+   +   V  G+ Y+  +  IHR + A +IL+  +        
Sbjct: 91  AFLRSPEGQVLPVASLI--DMACQVAEGMAYLEEQNSIHRDLAARNILVGED-------- 140

Query: 507 RYMCPFSP------TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
             +C  +        K+ V+L          W +PE    +   +  +SD++S GI   E
Sbjct: 141 -LVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAA--SHGTFSTKSDVWSFGILLYE 196

Query: 561 L-ANGTVPF 568
           +   G VP+
Sbjct: 197 MFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 19/150 (12%)

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIH 135
           +F D  +L+LV   M +    DL+     F   LPE +    L +++  ++ +H  G++H
Sbjct: 69  AFQDENNLYLV---MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 136 RAVKASHILISHNGKACL----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN 191
           R +K  ++L+  NG   L    S LR +      +  V +  P      +++SPE+L+  
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLR-LLADGTVQSNVAVGTP------DYISPEILQAM 178

Query: 192 LDG---YDERSDIYSVGISCCELANGTVPF 218
            DG   Y    D +S+G+   E+  G  PF
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 19/150 (12%)

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIH 485
           +F D  +L+LV   M +    DL+     F   LPE +    L +++  ++ +H  G++H
Sbjct: 69  AFQDENNLYLV---MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 486 RAVKASHILISHNGKACL----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN 541
           R +K  ++L+  NG   L    S LR +      +  V +  P      +++SPE+L+  
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLR-LLADGTVQSNVAVGTP------DYISPEILQAM 178

Query: 542 LDG---YDERSDIYSVGISCCELANGTVPF 568
            DG   Y    D +S+G+   E+  G  PF
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 41.4 bits (98), Expect = 0.001
 Identities = 39/132 (29%), Positives = 59/132 (44%), Gaps = 37/132 (28%)

Query: 33  KVTNQLIAVKK-FNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA------TD 84
           + T +++A+KK F+  R    D +    EI+ ++ L  HPNI+      L+        D
Sbjct: 29  RRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIV----KLLNVIKAENDKD 83

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICH-ILQDV---------LNGLEYIHGKGFI 134
           ++LV   M      DL            VI   IL+DV         L  L+YIH    I
Sbjct: 84  IYLVFEYME----TDLHA----------VIRANILEDVHKRYIMYQLLKALKYIHSGNVI 129

Query: 135 HRAVKASHILIS 146
           HR +K S+IL++
Sbjct: 130 HRDLKPSNILLN 141

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 41.4 bits (98), Expect = 0.001
 Identities = 39/132 (29%), Positives = 59/132 (44%), Gaps = 37/132 (28%)

Query: 383 KVTNQLIAVKK-FNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA------TD 434
           + T +++A+KK F+  R    D +    EI+ ++ L  HPNI+      L+        D
Sbjct: 29  RRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIV----KLLNVIKAENDKD 83

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICH-ILQDV---------LNGLEYIHGKGFI 484
           ++LV   M      DL            VI   IL+DV         L  L+YIH    I
Sbjct: 84  IYLVFEYME----TDLHA----------VIRANILEDVHKRYIMYQLLKALKYIHSGNVI 129

Query: 485 HRAVKASHILIS 496
           HR +K S+IL++
Sbjct: 130 HRDLKPSNILLN 141

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 50/195 (25%)

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNFGL-PELVICHILQDVLNGLEYIHGKGFIHR 136
           SF D  +L+ V   M +    D+++      + PE++    + ++   +E +H  GFIHR
Sbjct: 69  SFQDKDNLYFV---MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 137 AVKASHILISHNGKACLS------GLRYMCPFSPTKKKVHL----FPPST---------- 176
            +K  +ILI  +G   L+      G R+       +K  H+      PS           
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185

Query: 177 -------------------AYNL----NWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
                              A++L    N+++PEVL +   GY +  D +SVG+   E+  
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVILFEMLV 243

Query: 214 GTVPF-AETPTTLML 227
           G  PF A TPT   L
Sbjct: 244 GQPPFLAPTPTETQL 258

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 50/195 (25%)

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNFGL-PELVICHILQDVLNGLEYIHGKGFIHR 486
           SF D  +L+ V   M +    D+++      + PE++    + ++   +E +H  GFIHR
Sbjct: 69  SFQDKDNLYFV---MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 487 AVKASHILISHNGKACLS------GLRYMCPFSPTKKKVHL----FPPST---------- 526
            +K  +ILI  +G   L+      G R+       +K  H+      PS           
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185

Query: 527 -------------------AYNL----NWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
                              A++L    N+++PEVL +   GY +  D +SVG+   E+  
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVILFEMLV 243

Query: 564 GTVPF-AETPTTLML 577
           G  PF A TPT   L
Sbjct: 244 GQPPFLAPTPTETQL 258

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 23/181 (12%)

Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           T++  +    E   M    HPNII        +  + +V+  M  GS    +  H   F 
Sbjct: 45  TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT 104

Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-K 167
           + +LV   +L+ + +G++Y+   G++HR + A +IL++ N          +C  S     
Sbjct: 105 VIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILVNSN---------LVCKVSDFGLS 153

Query: 168 KVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 219
           +V    P  AY        + W +PE +      +   SD++S GI   E ++ G  P+ 
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYW 211

Query: 220 E 220
           E
Sbjct: 212 E 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 23/181 (12%)

Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           T++  +    E   M    HPNII        +  + +V+  M  GS    +  H   F 
Sbjct: 45  TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT 104

Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-K 517
           + +LV   +L+ + +G++Y+   G++HR + A +IL++ N          +C  S     
Sbjct: 105 VIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILVNSN---------LVCKVSDFGLS 153

Query: 518 KVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 569
           +V    P  AY        + W +PE +      +   SD++S GI   E ++ G  P+ 
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYW 211

Query: 570 E 570
           E
Sbjct: 212 E 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 33/206 (16%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 53  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111

Query: 98  KDLINAHF----------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A                       +LV C     V  G+EY+  K  IHR + A 
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC--AYQVARGMEYLASKKCIHRDLAAR 169

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 170 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 221

Query: 198 RSDIYSVGISCCELAN-GTVPFAETP 222
           +SD++S G+   E+   G  P+   P
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVP 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 33/206 (16%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 53  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111

Query: 448 KDLINAHF----------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A                       +LV C     V  G+EY+  K  IHR + A 
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC--AYQVARGMEYLASKKCIHRDLAAR 169

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 170 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 221

Query: 548 RSDIYSVGISCCELAN-GTVPFAETP 572
           +SD++S G+   E+   G  P+   P
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVP 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNI-----ICYISSF 79
           ++V+  + K+T  L+A+K+  L+        ++  E+  +++L+H NI     I +    
Sbjct: 19  ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDIIHTERC 77

Query: 80  LDATDLHLVSPLMGF-GSCKDLINAH----FNFGLPELVICHILQDVLNGLEYIHGKGFI 134
           L     +L S L  +  +C +L++ H    F F L            L GL Y H +  +
Sbjct: 78  LTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL------------LRGLSYCHKRKIL 125

Query: 135 HRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
           HR +K  ++LI+  G+  L+        S PTK        +    L +  P+VL  + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-----SNEVVTLWYRPPDVLLGSTE 180

Query: 194 GYDERSDIYSVGISCCELANG--TVPFAETPTTLMLIEKLAGATP 236
            Y    D++ VG    E+A G    P +     L LI +L G TP
Sbjct: 181 -YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG-TP 223

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNI-----ICYISSF 429
           ++V+  + K+T  L+A+K+  L+        ++  E+  +++L+H NI     I +    
Sbjct: 19  ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDIIHTERC 77

Query: 430 LDATDLHLVSPLMGF-GSCKDLINAH----FNFGLPELVICHILQDVLNGLEYIHGKGFI 484
           L     +L S L  +  +C +L++ H    F F L            L GL Y H +  +
Sbjct: 78  LTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL------------LRGLSYCHKRKIL 125

Query: 485 HRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
           HR +K  ++LI+  G+  L+        S PTK        +    L +  P+VL  + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-----SNEVVTLWYRPPDVLLGSTE 180

Query: 544 GYDERSDIYSVGISCCELANG--TVPFAETPTTLMLIEKLAGATP 586
            Y    D++ VG    E+A G    P +     L LI +L G TP
Sbjct: 181 -YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG-TP 223

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 36/177 (20%)

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
           SF D  +L+L+   +  G    L+         E    +I + VL  ++ IH  GFIHR 
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTL-TEEETQFYIAETVL-AIDSIHQLGFIHRD 126

Query: 138 VKASHILISHNGKACLS------GLRYMCPFSPTKKKVHLFPPS-TAYNLN--------- 181
           +K  ++L+   G   LS      GL+        +   H  P   T  N+N         
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186

Query: 182 ---------------WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETP 222
                          +++PEV  Q   GY++  D +S+G+   E+  G  PF +ETP
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 36/177 (20%)

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
           SF D  +L+L+   +  G    L+         E    +I + VL  ++ IH  GFIHR 
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTL-TEEETQFYIAETVL-AIDSIHQLGFIHRD 126

Query: 488 VKASHILISHNGKACLS------GLRYMCPFSPTKKKVHLFPPS-TAYNLN--------- 531
           +K  ++L+   G   LS      GL+        +   H  P   T  N+N         
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186

Query: 532 ---------------WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETP 572
                          +++PEV  Q   GY++  D +S+G+   E+  G  PF +ETP
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 31/195 (15%)

Query: 37  QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS------------SFLDATD 84
           Q +A+K    D+      +   HE +    L+HPNI+C +             S+   +D
Sbjct: 36  QAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94

Query: 85  LH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           LH    + SP    GS  D           + V  HI+  +  G+E++     +H+ +  
Sbjct: 95  LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV--HIVTQIAAGMEFLSSHHVVHKDLAT 152

Query: 141 SHILISHNGKACLSGL-RYMCPFSPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYD 196
            ++L+       +S L  +   ++    K+    L P      + W+SPE +       D
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP------IRWMSPEAIMYGKFSID 206

Query: 197 ERSDIYSVGISCCEL 211
             SDI+S G+   E+
Sbjct: 207 --SDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 31/195 (15%)

Query: 387 QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS------------SFLDATD 434
           Q +A+K    D+      +   HE +    L+HPNI+C +             S+   +D
Sbjct: 36  QAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94

Query: 435 LH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           LH    + SP    GS  D           + V  HI+  +  G+E++     +H+ +  
Sbjct: 95  LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV--HIVTQIAAGMEFLSSHHVVHKDLAT 152

Query: 491 SHILISHNGKACLSGL-RYMCPFSPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYD 546
            ++L+       +S L  +   ++    K+    L P      + W+SPE +       D
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP------IRWMSPEAIMYGKFSID 206

Query: 547 ERSDIYSVGISCCEL 561
             SDI+S G+   E+
Sbjct: 207 --SDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 44/190 (23%), Positives = 77/190 (40%), Gaps = 27/190 (14%)

Query: 38  LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           L+AVK   L   +D   K  H E   + +L+H +I+ +    ++   L +V   M  G  
Sbjct: 37  LVAVK--TLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 94

Query: 98  KDLINAH------FNFGLP--ELV---ICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
              + AH         G    EL    + HI Q +  G+ Y+  + F+HR +   + L+ 
Sbjct: 95  NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154

Query: 147 HN-----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
            N     G   +S   Y   +   +   H   P     + W+ PE +      +   SD+
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDY--YRVGGHTMLP-----IRWMPPESIMYR--KFTTESDV 205

Query: 202 YSVGISCCEL 211
           +S+G+   E+
Sbjct: 206 WSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 44/190 (23%), Positives = 77/190 (40%), Gaps = 27/190 (14%)

Query: 388 LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           L+AVK   L   +D   K  H E   + +L+H +I+ +    ++   L +V   M  G  
Sbjct: 37  LVAVK--TLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 94

Query: 448 KDLINAH------FNFGLP--ELV---ICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
              + AH         G    EL    + HI Q +  G+ Y+  + F+HR +   + L+ 
Sbjct: 95  NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154

Query: 497 HN-----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
            N     G   +S   Y   +   +   H   P     + W+ PE +      +   SD+
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDY--YRVGGHTMLP-----IRWMPPESIMYR--KFTTESDV 205

Query: 552 YSVGISCCEL 561
           +S+G+   E+
Sbjct: 206 WSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 64/310 (20%), Positives = 122/310 (39%), Gaps = 80/310 (25%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-----RHPNIICYISS 78
           + V L + K T ++ A+K    + +  DED+  +  E    +H+      HP ++   S 
Sbjct: 9   AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTE----KHVFETASNHPFLVGLHSC 64

Query: 79  FLDATDLHLVSPLMGFGSC-------KDLINAHFNFGLPELVICHILQDVLNGLEYIHGK 131
           F   + L  V   +  G         + L   H  F   E+ +          L ++H +
Sbjct: 65  FQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL---------ALNFLHER 115

Query: 132 GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEV 187
           G I+R +K  ++L+   G   L+    MC       K  + P  T        N+++PE+
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYG-MC-------KEGIRPGDTTSTFCGTPNYIAPEI 167

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L    + Y    D +++G+                   ++ E +AG +P       + + 
Sbjct: 168 LRG--EDYGFSVDWWALGV-------------------LMFEMMAGRSP-------FDIV 199

Query: 248 TGQDDGEENACSY----ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN----- 298
              D+ ++N   Y    I E+Q ++   R  S    S+++  L++D  +R L C+     
Sbjct: 200 GMSDNPDQNTEDYLFQVILEKQIRI--PRSLSVKASSVLKGFLNKDPKER-LGCHPQTGF 256

Query: 299 --LLQHAFFK 306
             +  H FF+
Sbjct: 257 RDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 50/190 (26%)

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNFGL-PELVICHILQDVLNGLEYIHGKGFIHR 136
           SF D  +L+ V   M +    D+++     G+ PE +    + ++   +E +H  GFIHR
Sbjct: 69  SFQDKDNLYFV---MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 137 AVKASHILISHNGKACL------SGLRYMCPFSPTKKKVHLFPPSTAYNLNW-------- 182
            +K  +ILI  +G   L      +G R+       +   H+   S  ++  W        
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185

Query: 183 -----------------------------LSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
                                        ++PEVL +   GY +  D +SVG+   E+  
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEMLV 243

Query: 214 GTVPF-AETP 222
           G  PF A+TP
Sbjct: 244 GQPPFLAQTP 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 50/190 (26%)

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNFGL-PELVICHILQDVLNGLEYIHGKGFIHR 486
           SF D  +L+ V   M +    D+++     G+ PE +    + ++   +E +H  GFIHR
Sbjct: 69  SFQDKDNLYFV---MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 487 AVKASHILISHNGKACL------SGLRYMCPFSPTKKKVHLFPPSTAYNLNW-------- 532
            +K  +ILI  +G   L      +G R+       +   H+   S  ++  W        
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185

Query: 533 -----------------------------LSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
                                        ++PEVL +   GY +  D +SVG+   E+  
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEMLV 243

Query: 564 GTVPF-AETP 572
           G  PF A+TP
Sbjct: 244 GQPPFLAQTP 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 9/157 (5%)

Query: 64  MRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
           + H+R  P ++    +F     LHL+   +  G     +    NF   E+       +++
Sbjct: 58  LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF--YSGEII 115

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTAYNLN 181
             LE++H  G ++R +K  +IL+   G   L+       F S  K++ + F  +  Y   
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY--- 172

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            ++PE++     G+ +  D +S+GI   EL  G  PF
Sbjct: 173 -MAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 9/157 (5%)

Query: 414 MRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
           + H+R  P ++    +F     LHL+   +  G     +    NF   E+       +++
Sbjct: 58  LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF--YSGEII 115

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTAYNLN 531
             LE++H  G ++R +K  +IL+   G   L+       F S  K++ + F  +  Y   
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY--- 172

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            ++PE++     G+ +  D +S+GI   EL  G  PF
Sbjct: 173 -MAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 16/114 (14%)

Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLR---YMCPFSPT 165
           E +IC+  Q V  G+E++  +  IHR + A +IL+S N   K C  GL    Y  P    
Sbjct: 174 EDLICYSFQ-VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232

Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           K    L        L W++PE +   +  Y  +SD++S G+   E+ + G  P+
Sbjct: 233 KGSARL-------PLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 16/114 (14%)

Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLR---YMCPFSPT 515
           E +IC+  Q V  G+E++  +  IHR + A +IL+S N   K C  GL    Y  P    
Sbjct: 174 EDLICYSFQ-VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232

Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           K    L        L W++PE +   +  Y  +SD++S G+   E+ + G  P+
Sbjct: 233 KGSARL-------PLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 9/127 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL----RHPNIICYISSFLDA 82
           VYL + K  ++L AVK      M +   K++ H++   R      + P I+    S   A
Sbjct: 20  VYLGRKKNNSKLYAVKVVKKADMIN---KNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
            +++LV   +  G  K L++ +  F   E+ + +I +  L  L+Y+H  G IHR +K  +
Sbjct: 77  NNVYLVMEYLIGGDVKSLLHIYGYFD-EEMAVKYISEVAL-ALDYLHRHGIIHRDLKPDN 134

Query: 143 ILISHNG 149
           +LIS+ G
Sbjct: 135 MLISNEG 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 9/127 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL----RHPNIICYISSFLDA 432
           VYL + K  ++L AVK      M +   K++ H++   R      + P I+    S   A
Sbjct: 20  VYLGRKKNNSKLYAVKVVKKADMIN---KNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
            +++LV   +  G  K L++ +  F   E+ + +I +  L  L+Y+H  G IHR +K  +
Sbjct: 77  NNVYLVMEYLIGGDVKSLLHIYGYFD-EEMAVKYISEVAL-ALDYLHRHGIIHRDLKPDN 134

Query: 493 ILISHNG 499
           +LIS+ G
Sbjct: 135 MLISNEG 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 16/114 (14%)

Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLR---YMCPFSPT 165
           E +IC+  Q V  G+E++  +  IHR + A +IL+S N   K C  GL    Y  P    
Sbjct: 179 EDLICYSFQ-VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237

Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           K    L        L W++PE +   +  Y  +SD++S G+   E+ + G  P+
Sbjct: 238 KGDARL-------PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 16/114 (14%)

Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLR---YMCPFSPT 515
           E +IC+  Q V  G+E++  +  IHR + A +IL+S N   K C  GL    Y  P    
Sbjct: 179 EDLICYSFQ-VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237

Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           K    L        L W++PE +   +  Y  +SD++S G+   E+ + G  P+
Sbjct: 238 KGDARL-------PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 11/114 (9%)

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLFPPSTAY 178
           DV  G++Y+  K FIHR + A ++L+  N  + ++       F  ++ ++V++       
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD------FGLSRGEEVYVKKTMGRL 180

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 231
            + W++ E L  N   Y  +SD++S G+   E+ + G  P+    T   L EKL
Sbjct: 181 PVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 11/114 (9%)

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLFPPSTAY 528
           DV  G++Y+  K FIHR + A ++L+  N  + ++       F  ++ ++V++       
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD------FGLSRGEEVYVKKTMGRL 180

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 581
            + W++ E L  N   Y  +SD++S G+   E+ + G  P+    T   L EKL
Sbjct: 181 PVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 19/148 (12%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVK----KFNLDRMTDEDLKSLHHEIVCMRH 66
           ++  ++LG+   +   V L+++K T +L A+K       + R   E L            
Sbjct: 1   FRCLAVLGR--GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS 58

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI-NAHFN-FGLPELVI---CHILQDV 121
            RHP ++   + F     +  V   M + +  DL+ + H + F  P  V    C     V
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFV---MEYAAGGDLMMHIHTDVFSEPRAVFYAAC-----V 110

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNG 149
           + GL+Y+H    ++R +K  ++L+   G
Sbjct: 111 VLGLQYLHENKIVYRDLKLDNLLLDTEG 138

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 19/148 (12%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVK----KFNLDRMTDEDLKSLHHEIVCMRH 416
           ++  ++LG+   +   V L+++K T +L A+K       + R   E L            
Sbjct: 1   FRCLAVLGR--GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS 58

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI-NAHFN-FGLPELVI---CHILQDV 471
            RHP ++   + F     +  V   M + +  DL+ + H + F  P  V    C     V
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFV---MEYAAGGDLMMHIHTDVFSEPRAVFYAAC-----V 110

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNG 499
           + GL+Y+H    ++R +K  ++L+   G
Sbjct: 111 VLGLQYLHENKIVYRDLKLDNLLLDTEG 138

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 36/177 (20%)

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
           SF D  +L+L+   +  G    L+              +I + VL  ++ IH  GFIHR 
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVL-AIDAIHQLGFIHRD 126

Query: 138 VKASHILISHNGKACLS------GL---------RYMCPFSPT----------------K 166
           +K  ++L+   G   LS      GL         R +    P+                K
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186

Query: 167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETP 222
           K       ST    ++++PEV  Q   GY++  D +S+G+   E+  G  PF +ETP
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 36/177 (20%)

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
           SF D  +L+L+   +  G    L+              +I + VL  ++ IH  GFIHR 
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVL-AIDAIHQLGFIHRD 126

Query: 488 VKASHILISHNGKACLS------GL---------RYMCPFSPT----------------K 516
           +K  ++L+   G   LS      GL         R +    P+                K
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186

Query: 517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETP 572
           K       ST    ++++PEV  Q   GY++  D +S+G+   E+  G  PF +ETP
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 11/114 (9%)

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLFPPSTAY 178
           DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++       
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD------FGLSRGQEVYVKKTMGRL 173

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 231
            + W++ E L  N   Y   SD++S G+   E+ + G  P+    T   L EKL
Sbjct: 174 PVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 11/114 (9%)

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLFPPSTAY 528
           DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++       
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD------FGLSRGQEVYVKKTMGRL 173

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 581
            + W++ E L  N   Y   SD++S G+   E+ + G  P+    T   L EKL
Sbjct: 174 PVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 41/127 (32%), Positives = 59/127 (46%), Gaps = 11/127 (8%)

Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPS 175
           L  +L GL+Y+H  G +HR +K  ++L++ N   K C  GL  +     +K         
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ--EVV 166

Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTT-LMLIEKLAG 233
           T Y   + +PE+L      Y    DI+SVG    EL    + F A++P   L LI  L G
Sbjct: 167 TQY---YRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222

Query: 234 ATPHLLD 240
            TP L  
Sbjct: 223 -TPSLEA 228

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 41/127 (32%), Positives = 59/127 (46%), Gaps = 11/127 (8%)

Query: 468 LQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPS 525
           L  +L GL+Y+H  G +HR +K  ++L++ N   K C  GL  +     +K         
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ--EVV 166

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTT-LMLIEKLAG 583
           T Y   + +PE+L      Y    DI+SVG    EL    + F A++P   L LI  L G
Sbjct: 167 TQY---YRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222

Query: 584 ATPHLLD 590
            TP L  
Sbjct: 223 -TPSLEA 228

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	622
KOG0603|consensus	612		100.0
KOG0582|consensus	516		100.0
KOG0615|consensus	475		100.0
KOG0581|consensus	364		100.0
KOG0575|consensus	592		100.0
KOG0593|consensus	396		100.0
KOG0600|consensus	560		100.0
KOG0598|consensus	357		100.0
KOG0659|consensus	318		100.0
KOG0595|consensus	429		100.0
KOG0591|consensus	375		100.0
KOG0595|consensus	429		100.0
KOG0661|consensus	538		100.0
KOG0592|consensus	604		100.0
KOG0033|consensus	355		100.0
KOG0663|consensus	419		100.0
KOG0588|consensus	786		100.0
KOG0578|consensus	550		100.0
KOG0583|consensus	370		100.0
KOG0660|consensus	359		100.0
KOG0616|consensus	355		100.0
KOG0198|consensus	313		100.0
KOG0201|consensus	467		100.0
KOG0605|consensus	550		100.0
KOG0597|consensus	808		100.0
KOG0598|consensus	357		100.0
KOG0585|consensus	576		100.0
KOG0594|consensus	323		100.0
KOG0599|consensus	411		100.0
KOG0580|consensus	281		100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0582|consensus	516		100.0
KOG0581|consensus	364		100.0
KOG0032|consensus	382		100.0
KOG1035|consensus	1351		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658|consensus	364		100.0
KOG0574|consensus	502		100.0
KOG0577|consensus	948		100.0
KOG0579|consensus	1187		100.0
KOG0591|consensus	375		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0610|consensus	459		100.0
KOG0611|consensus	668		100.0
KOG0589|consensus	426		100.0
KOG4717|consensus	864		100.0
KOG0592|consensus	604		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0616|consensus	355		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0192|consensus	362		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0593|consensus	396		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0576|consensus	829		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0694|consensus	694		100.0
KOG4279|consensus	1226		100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0597|consensus	808		100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0667|consensus	586		100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0033|consensus	355		100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0590|consensus	601		100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0192|consensus	362		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0600|consensus	560		100.0
KOG0659|consensus	318		100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0983|consensus	391		100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0588|consensus	786		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0605|consensus	550		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0578|consensus	550		100.0
KOG0198|consensus	313		100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0666|consensus	438		100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0583|consensus	370		100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0604|consensus	400		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0662|consensus	292		100.0
KOG0607|consensus	463		100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0197|consensus	468		100.0
KOG0596|consensus	677		100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG1989|consensus	738		100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986|consensus	591		100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0586|consensus	596		100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG2345|consensus	302		100.0
KOG4645|consensus	1509		100.0
KOG0585|consensus	576		100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0587|consensus	953		100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0663|consensus	419		100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0594|consensus	323		100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0201|consensus	467		100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0580|consensus	281		100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0610|consensus	459		100.0
KOG0660|consensus	359		100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0599|consensus	411		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0661|consensus	538		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0694|consensus	694		100.0
KOG0589|consensus	426		100.0
KOG0603|consensus	612		100.0
KOG4236|consensus	888		100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0669|consensus	376		100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4721|consensus	904		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4279|consensus	1226		100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0032|consensus	382		100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0584|consensus	632		100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0690|consensus	516		100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0611|consensus	668		100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0612|consensus	1317		100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0193|consensus	678		100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0577|consensus	948		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0574|consensus	502		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG4717|consensus	864		100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1006|consensus	361		100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0668|consensus	338		100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0197|consensus	468		100.0
KOG0194|consensus	474		100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG1035|consensus	1351		100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0579|consensus	1187		100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0667|consensus	586		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0658|consensus	364		100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4645|consensus	1509		100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1026|consensus	774		100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG4250|consensus	732		100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG4250|consensus	732		100.0
KOG0986|consensus	591		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0671|consensus	415		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0665|consensus	369		100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG1187|consensus	361		100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4721|consensus	904		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG1095|consensus	1025		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983|consensus	391		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0586|consensus	596		100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0587|consensus	953		100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0984|consensus	282		100.0
KOG0604|consensus	400		100.0
KOG4236|consensus	888		100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0

>KOG0603|consensus

Probab=100.00  E-value=4.4e-62  Score=504.92  Aligned_cols=522  Identities=21%  Similarity=0.327  Sum_probs=388.4

Q ss_pred             ecccccCCceeEEEEE---EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCcEEEEeec
Q psy15039         16 ILGQCFNNLSSVYLSK---HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        16 ~lG~g~g~~~~V~~~~---~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      ++|+  |.||.||+++   ....|+.||.|...+......+......|..++...+ ||.+|+++-+|..+..+++++++
T Consensus         1 vlg~--g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQ--GSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCc--CCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            4788  4466877665   5678999999998776543333335567888999997 99999999999999999999999


Q ss_pred             CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccc
Q psy15039         92 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        92 ~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      ..+|++...+....  ..++...+.+...++-|++++|+.+|++||+|++||+++.+|.+++.|||.....-..+.    
T Consensus        79 ~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            99999987775532  357888899999999999999999999999999999999999999999997644322211    


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQD  251 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  251 (622)
                          .++|..|||||++.    ++...+|.||+|+++|||++|..||..     .....|...                 
T Consensus       153 ----~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~-----------------  202 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKA-----------------  202 (612)
T ss_pred             ----cccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhh-----------------
Confidence                16677899999986    368899999999999999999999986     111221110                 


Q ss_pred             cCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCccccccccCCCc---ccccccccc
Q psy15039        252 DGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFFKQTKKCSVM---LPELLRPAL  323 (622)
Q Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~~~~~~~~~~---~~~~~~~~~  323 (622)
                                     ....+..++..+++++..++..+|..|..+     .++.+|+||....+....   .+....+. 
T Consensus       203 ---------------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~-  266 (612)
T KOG0603|consen  203 ---------------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPG-  266 (612)
T ss_pred             ---------------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCc-
Confidence                           112334578899999999999999999865     689999999876443110   01111110 


Q ss_pred             CCCccccccccccccc-----------------cccccccc-cccccc--cCCCCCCceEeeecccccCCeeEEEEEEEc
Q psy15039        324 SLNESNVCEINNELEC-----------------MFNINDTF-NSSVET--LDNVPSNYKICSILGQCFNNLSSVYLSKHK  383 (622)
Q Consensus       324 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~-~~~~~~--~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~  383 (622)
                      ...+..+...+.++..                 .+..-+.. ......  .......|++...+|.  |+|+.|-.+.+.
T Consensus       267 ~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~--gs~s~~~~~~~~  344 (612)
T KOG0603|consen  267 SITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGE--GSFSAVKYCESS  344 (612)
T ss_pred             ccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCC--CCccceeeeecc
Confidence            0111111111111100                 00000000 000011  1124677899889998  789999999999


Q ss_pred             cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh-CCCCccceeEEEEEeCCcEEEEeeccCCCCHHHHHHhccCCCCCHH
Q psy15039        384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH-LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPEL  462 (622)
Q Consensus       384 ~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~  462 (622)
                      .+++..++|++....      ....+|+.++.. -+||||+++.+.+.+..+.|+|||++.++.+.+-+.....+   ..
T Consensus       345 ~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~---~~  415 (612)
T KOG0603|consen  345 PTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEF---CS  415 (612)
T ss_pred             ccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchh---HH
Confidence            999999999997651      223456655544 48999999999999999999999999999998877665432   35


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccC
Q psy15039        463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILI-SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN  541 (622)
Q Consensus       463 ~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  541 (622)
                      .+..|++||+.|+.|||++|||||||||+|||+ ++.|.+++.+||+++.....       ..+.++|..|.|||++.. 
T Consensus       416 e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-------~~tp~~t~~y~APEvl~~-  487 (612)
T KOG0603|consen  416 EASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-------CDTPALTLQYVAPEVLAI-  487 (612)
T ss_pred             HHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-------hcccchhhcccChhhhcc-
Confidence            677899999999999999999999999999999 68999999999988654332       345688999999999975 


Q ss_pred             ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCcccccCCCCcCcccccchhhhhhhhhcc
Q psy15039        542 LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLT  620 (622)
Q Consensus       542 ~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (622)
                       ..|+.++||||||++||+||+|+.||...+.+..+..++..+.         +.+..++.++..+-+.+..++++|+|
T Consensus       488 -~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~---------~s~~vS~~AKdLl~~LL~~dP~~Rl~  556 (612)
T KOG0603|consen  488 -QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK---------FSECVSDEAKDLLQQLLQVDPALRLG  556 (612)
T ss_pred             -CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc---------cccccCHHHHHHHHHhccCChhhCcC
Confidence             6799999999999999999999999999988866666665442         12334444444455555566666654

>KOG0582|consensus

Probab=100.00  E-value=5.3e-56  Score=439.40  Aligned_cols=284  Identities=37%  Similarity=0.648  Sum_probs=248.8

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +.....+|++..+||.|+-  ++||+|+.+.+++.||||+++.++.+.+ ...+.+|++.|+.++|||||+++.+|+.+.
T Consensus        21 ~p~n~~~YeL~e~IG~G~s--a~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGAS--AVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             CCCCccceeEEEEEeccce--eEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            4566789999999999775  6999999999999999999999877554 778889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc-
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-  162 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~-  162 (622)
                      .+|+||.||.+|++.++++.....+++|..+..|++++++||.|||.+|-||||||+.||||+.+|.+++.|||.+..+ 
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999999999999999988888999999999999999999999999999999999999999999999999976433 


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ....+....+ .+..+|++|||||++.....+|+.|+||||||++..||++|+.||...++..++..++.+.+|.+.-..
T Consensus       178 ~~G~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  178 DSGDRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             ccCceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            3233333333 566889999999998888889999999999999999999999999999999999999999888653110


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCCCc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVM  314 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~~~  314 (622)
                              .+               .-....++..|+.+|..||.+||++||||.++|+|+||++.+.+...
T Consensus       257 --------~~---------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~  305 (516)
T KOG0582|consen  257 --------LD---------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL  305 (516)
T ss_pred             --------CC---------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence                    00               01234578899999999999999999999999999999987765443

>KOG0615|consensus

Probab=100.00  E-value=1e-55  Score=433.43  Aligned_cols=265  Identities=25%  Similarity=0.322  Sum_probs=219.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-----HHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-----EDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      +.+.|.+.+.||+  |+||.|-+|..++||+.||||++++.....     .......+|++||++|+|||||+++++|..
T Consensus       170 ~~d~yii~~~LGs--Gafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGS--GAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             hcceeEeeeeecC--CceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            6788999999999  778999999999999999999998765422     112335699999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CceEEcCCcc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---GKACLSGLRY  158 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~---~~~~i~~~~~  158 (622)
                      .+..|+||||+++|+|.+.+-...  .+.|..-+.+++|++.||.|||++||+||||||+|||+..+   ..+|++|||.
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999999997754  46788889999999999999999999999999999999876   5689999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccC-CCCCcchHHHHHHHHHHHhcCCCCCCCCchHH-HHHHHHhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD-GYDERSDIYSVGISCCELANGTVPFAETPTTL-MLIEKLAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~-~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~-~~~~~~~~~~p  236 (622)
                      +...+ ..    .+-.+.+||+.|.|||++..+.. .|..++||||+||+||-+++|.+||.+..... ..-+...|.++
T Consensus       326 AK~~g-~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  326 AKVSG-EG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             hhccc-cc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            75433 11    12235688999999999975433 34458999999999999999999998765444 33333445443


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..                             .+.+..+|+++.+||++||..||++|||++++|+||||+...
T Consensus       401 f~-----------------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  401 FG-----------------------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cc-----------------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            21                             123456899999999999999999999999999999998754

>KOG0581|consensus

Probab=100.00  E-value=1.9e-54  Score=422.21  Aligned_cols=258  Identities=28%  Similarity=0.474  Sum_probs=220.0

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc-EEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~lv   88 (622)
                      +.+.+++||+|.||  +||+++|+.|++.+|+|.+..+ .++...+++.||+++++..+||+||++||+|.+... ..++
T Consensus        80 dle~~~~lG~G~gG--~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   80 DLERLGVLGSGNGG--TVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HhhhhhhcccCCCc--EEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            66778899995554  9999999999999999999543 467778899999999999999999999999999985 9999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++|+|.++++..  +.++|..+..++.+|++||.|||+ ++||||||||+|||+++.|.+|++|||.+.....+  
T Consensus       157 mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             hhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            9999999999999875  358999999999999999999995 89999999999999999999999999986544332  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCC----chHHHHHHH-HhCCCCCCCccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET----PTTLMLIEK-LAGATPHLLDCT  242 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~----~~~~~~~~~-~~~~~p~~~~~~  242 (622)
                          ...+.+||..|||||.+.+.  .|+.++||||||+++.|+++|+.||...    .....+... +.+.+|.+    
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l----  302 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL----  302 (364)
T ss_pred             ----hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC----
Confidence                33456788899999999874  6999999999999999999999999763    122333333 33344432    


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                                 +...||++|++||+.||++||.+||++.|+++|||+++....
T Consensus       303 ---------------------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  303 ---------------------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             ---------------------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence                                       223589999999999999999999999999999999876553

>KOG0575|consensus

Probab=100.00  E-value=3.1e-52  Score=429.13  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=221.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..|+.+++||+  |||+.||.+++..||+.||+|++.+..+ .+...+.+.+||+|+++|+|||||+++++|++.++.|+
T Consensus        18 ~~Y~~g~~LGk--GgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGK--GGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeecc--CcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            45999999999  8899999999999999999999987553 45567788899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |.|+|..++|..++++..  .++|.+++.+++||+.||.|||+++|+|||||..|++|+.+.++||.|||++........
T Consensus        96 vLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999999998643  589999999999999999999999999999999999999999999999999876653322


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .-    .+.+||++|+|||++..  .+++..+||||+||++|-|+.|++||................             
T Consensus       174 rk----~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-------------  234 (592)
T KOG0575|consen  174 RK----KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-------------  234 (592)
T ss_pred             cc----ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-------------
Confidence            11    24588999999999974  579999999999999999999999998664433322221111             


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                          ...+..+|.++++||..+|+.||.+|||++++|.|+||++
T Consensus       235 --------------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  235 --------------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             --------------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence                                1123368999999999999999999999999999999954

>KOG0593|consensus

Probab=100.00  E-value=7e-53  Score=397.73  Aligned_cols=284  Identities=23%  Similarity=0.323  Sum_probs=220.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      +.|+.+.++|+  |+||+||+|+++.||+.||||++..+..++...+.+.|||++|++|+|||+|.++++|.....++||
T Consensus         2 ekYE~LgkvGE--GSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGE--GSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhcccc--CcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            36899999999  6688999999999999999999987777777778889999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      +|||+.--|..+ ... ..++++..++.++.|++.|+.|||++++|||||||+||||+.+|.+|++|||++..+......
T Consensus        80 FE~~dhTvL~eL-e~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   80 FEYCDHTVLHEL-ERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eeecchHHHHHH-Hhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            999996555444 333 347999999999999999999999999999999999999999999999999988655432211


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..    ..+-|.||+|||++.+.. .|+.++||||+||++.||++|.+.|.+.....++  +.+..|..++   ..+...
T Consensus       158 YT----DYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p---rhq~iF  229 (396)
T KOG0593|consen  158 YT----DYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP---RHQSIF  229 (396)
T ss_pred             hh----hhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH---HHHHHh
Confidence            11    123368999999998764 5999999999999999999999999877654443  3444443221   111111


Q ss_pred             cCCCCcCcccccccchhhhhccc---cCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVL---TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ...+....-.    +++.....+   ..+..|.-..||++.||+.||++|++.+|+|.|+||...
T Consensus       230 ~~N~~F~Gv~----lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  230 SSNPFFHGVR----LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             ccCCceeeee----cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            1111111000    111111111   113467789999999999999999999999999999543

>KOG0600|consensus

Probab=100.00  E-value=3.2e-51  Score=411.42  Aligned_cols=283  Identities=26%  Similarity=0.347  Sum_probs=224.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--CcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~   86 (622)
                      +.|+.++.||+  |.||.||+|++..||+.||+|++..+...++-...+.|||.||++|+|||||++.+.....  ..+|
T Consensus       117 ~~feki~kIGe--GTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  117 DSFEKIEKIGE--GTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             HHHHHHHHhcC--cchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            57999999999  6688999999999999999999988877777778889999999999999999999998876  6899


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ||+|||+ -+|..++... .-.+++.+++.+|+||+.||+|||++||+|||||.+|||||++|.+||.|||++..+....
T Consensus       195 lVFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  195 LVFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            9999998 4666666442 2357899999999999999999999999999999999999999999999999887554433


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHHHhCCCCCCCccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....   .+.+.|+||+|||+|.+. ..|+.++|+||+||||.||+.|++.|.+...  +...+.++.|.+..- .|.. 
T Consensus       273 ~~~~---T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~-~W~~-  346 (560)
T KOG0600|consen  273 SAPY---TSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED-YWPV-  346 (560)
T ss_pred             Cccc---ccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh-cccc-
Confidence            3221   134668999999999986 5799999999999999999999999988765  444566677754321 1110 


Q ss_pred             cccCCCCcC---cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        245 YVDTGQDDG---EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       245 ~~~~~~~~~---~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                       .+.+....   .......+.+      ....++....+|+..+|..||++|.||.++|+++||...
T Consensus       347 -~kLP~~~~~kp~~~y~r~l~E------~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  347 -SKLPHATIFKPQQPYKRRLRE------TFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             -ccCCcccccCCCCcccchHHH------HhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence             01110000   0000011111      135689999999999999999999999999999999543

>KOG0598|consensus

Probab=100.00  E-value=7.6e-51  Score=396.97  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=224.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +++|+++++||+  |+||+||.++.+.|++.||+|++++... ...+......|..||.+++||.||+++-.|.+.+.+|
T Consensus        24 ~~dF~~lkviGk--G~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   24 PDDFEILKVIGK--GSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             hhheeeeeeeec--cCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            679999999999  7788999999999999999999998764 3446778889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|+||+.||+|.-.|.+.  ..++|..++.++.+|+.||.|||++|||||||||+||||+.+|.++++|||+........
T Consensus       102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999999999999764  357899999999999999999999999999999999999999999999999865332222


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..    ..+.+||+.|||||++.+  .+|+..+|+|||||++|||++|.+||...+.....-..+.++.+          
T Consensus       180 ~~----t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~----------  243 (357)
T KOG0598|consen  180 DA----TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP----------  243 (357)
T ss_pred             Cc----cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC----------
Confidence            21    224588999999999987  47999999999999999999999999987765544444333211          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc----CHHhhhcCccccccccC
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP----LACNLLQHAFFKQTKKC  311 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----s~~~~l~h~~~~~~~~~  311 (622)
                                            ..+..+|.+++++++.+|.+||++|.    .+.++-+||||....+.
T Consensus       244 ----------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  244 ----------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             ----------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence                                  12234799999999999999999996    68889999999887653

>KOG0659|consensus

Probab=100.00  E-value=2.5e-50  Score=374.48  Aligned_cols=282  Identities=24%  Similarity=0.303  Sum_probs=225.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|+.+++||+  |.||.||+|++.+||+.||||+++..+..+..-..+.|||+.|+.++|||||.++++|-+.+.+.||
T Consensus         2 ~rY~~~~~lGE--G~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGE--GTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcC--cceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            57999999999  6688999999999999999999998877666667789999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      .|||+ .+|...++... ..++...++.|+.|+++||+|||++.|+||||||.|+|++.+|.+|+.|||..+.++.....
T Consensus        80 fEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            99998 68888887753 35789999999999999999999999999999999999999999999999998887654432


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..    ..+.|.+|+|||++.+. ..|+..+||||.||+++||+-|.+-|.+....+++  +-...|. |...+++.   
T Consensus       158 ~~----~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGT-P~~~~WP~---  228 (318)
T KOG0659|consen  158 QT----HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGT-PTPDQWPE---  228 (318)
T ss_pred             cc----cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCC-CCcccCcc---
Confidence            21    22568899999999876 56999999999999999999997767665543333  3333332 22111111   


Q ss_pred             cCCCCcCcccccccchhhhhccc----cCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVL----TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                             ....+.|..-...+.+    .....|+++.||+..||.+||.+|+++.|+|+|+||++...
T Consensus       229 -------~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  229 -------MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             -------ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence                   1111122111111111    22356888999999999999999999999999999987544

>KOG0595|consensus

Probab=100.00  E-value=9e-50  Score=392.41  Aligned_cols=263  Identities=22%  Similarity=0.386  Sum_probs=221.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ....+|++.+.||+  |.||+||+|+|++++..||||++.+.+..+...+.+..||++|+.|+|||||+++++..+++.+
T Consensus         7 ~~~~~y~~~~~iG~--GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    7 RVVGDYELSREIGS--GSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             cccccceehhhccC--cceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            44578999999999  6688999999999999999999999887888888899999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC------CceEEcCCccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN------GKACLSGLRYM  159 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~------~~~~i~~~~~~  159 (622)
                      |||||||.+|+|.++++.+.  .++|..++.++.||+.||++||+++||||||||.||||+..      -.+||+|||++
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999999998854  68999999999999999999999999999999999999875      24789999987


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  239 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~  239 (622)
                      ......     ....+.+|++.|||||++..  ..|+.|+|+||+|+++|+|++|++||........+...-.+..    
T Consensus       163 R~L~~~-----~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~----  231 (429)
T KOG0595|consen  163 RFLQPG-----SMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE----  231 (429)
T ss_pred             hhCCch-----hHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc----
Confidence            655422     22345688899999999964  4699999999999999999999999987655444332211100    


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                .........+.+..+++-..|+.+|..|.+..+.+.|++.....
T Consensus       232 --------------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  232 --------------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             --------------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                                      00011233567777899999999999999999999999886543

>KOG0591|consensus

Probab=100.00  E-value=1.9e-51  Score=384.31  Aligned_cols=247  Identities=26%  Similarity=0.463  Sum_probs=213.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEE-EEEeCCc-EEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-SFLDATD-LHL   87 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~-~~~~~~~-~~l   87 (622)
                      +|+|+++||+  |.||.||++.+..||..+|.|.++-..++....+.+..||.+|++|+|||||+|++ .|..+.. +++
T Consensus        20 ~y~Il~~IG~--GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   20 DYQILKKIGR--GSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHcC--CcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            6999999999  77889999999999999999999988888888999999999999999999999998 6666655 999


Q ss_pred             EeecCCCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         88 VSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHG--KG--FIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~--~~--IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      |||||+.|+|.++++.-.+  ..++|..+..++.|++.||.+||+  .+  |+||||||.||+|+.+|.+|+.|||+...
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999976432  347999999999999999999999  55  99999999999999999999999998876


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH-hCCCCCCCc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLD  240 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~-~~~~p~~~~  240 (622)
                      ++....    +..+.+||++||+||.+.+  .+|+.|+||||+||++|||+.-++||.+.. -..+.+++ .+..|++  
T Consensus       178 l~s~~t----fA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-~~~L~~KI~qgd~~~~--  248 (375)
T KOG0591|consen  178 LSSKTT----FAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDN-LLSLCKKIEQGDYPPL--  248 (375)
T ss_pred             hcchhH----HHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCccccc-HHHHHHHHHcCCCCCC--
Confidence            654332    3446688999999999986  469999999999999999999999999873 34444444 3333322  


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA  296 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~  296 (622)
                                                   +...+|.++..+|..|+..||+.||+.
T Consensus       249 -----------------------------p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  249 -----------------------------PDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             -----------------------------cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence                                         224689999999999999999999986

>KOG0595|consensus

Probab=100.00  E-value=1.3e-49  Score=391.32  Aligned_cols=213  Identities=23%  Similarity=0.424  Sum_probs=189.9

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ....+|.+.+.||.  |+||+||+|+++.++..||||.|.+.....+.++.+..||.+|+.|+|||||.+++++.+++.+
T Consensus         7 ~~~~~y~~~~~iG~--GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    7 RVVGDYELSREIGS--GSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             cccccceehhhccC--cceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            34578999999999  7799999999999999999999998887888888999999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC------CceEEcCcccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN------GKACLSGLRYM  509 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~------~~~~~~~~~~~  509 (622)
                      |+|||||.||+|.+++++++  .++|..++.++.|++.||++||+++||||||||+||||+..      -..||+|||++
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999999998865  58999999999999999999999999999999999999875      24789999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      ..+...     ....+.+|||.|||||++..  +.|+.|+|+||+|+|+|||++|++||...+..+.+..
T Consensus       163 R~L~~~-----~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~  225 (429)
T KOG0595|consen  163 RFLQPG-----SMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY  225 (429)
T ss_pred             hhCCch-----hHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence            655432     22345789999999999965  5799999999999999999999999988766665543

>KOG0661|consensus

Probab=100.00  E-value=1.6e-50  Score=403.50  Aligned_cols=280  Identities=28%  Similarity=0.356  Sum_probs=224.2

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCC-
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT-   83 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~-   83 (622)
                      .+-++|.+++.||.  |.||.||+|+.+.+|..||||+|++.-.+.++.-. .||++.|++|+ |||||++.+++.+.+ 
T Consensus         7 ~~m~RY~~i~klGD--GTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGD--GTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hHHHHHHHHHHhcC--CcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            35679999999999  66889999999999999999999887666665443 49999999998 999999999999988 


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+|+|||||+ .+|.++++.+ ...++|..++.||.||++||+|+|++|+.|||+||||||+..+..+||.|||+++...
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence            8999999997 7899999887 4568999999999999999999999999999999999999988899999999876543


Q ss_pred             CCCccccccCCC--CCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCCCCC
Q psy15039        164 PTKKKVHLFPPS--TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATPHLL  239 (622)
Q Consensus       164 ~~~~~~~~~~~~--~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p~~~  239 (622)
                      ..       ++-  .+-|.||+|||+|... ..|+.++||||+||+++|+.+-++.|.+.++.+++.+  .+.|.+ ...
T Consensus       162 Sk-------pPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP-~~~  232 (538)
T KOG0661|consen  162 SK-------PPYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP-DKD  232 (538)
T ss_pred             cC-------CCcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC-ccc
Confidence            21       222  2347899999999875 5799999999999999999999999998877665543  344432 211


Q ss_pred             ccccccccCCCCcCcccccccc---hh----hhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYI---SE----QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i---~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ++...          .+....+   .+    .....+. ...+.++.++|..||.+||++||||.|+|+||||.....
T Consensus       233 ~~~eg----------~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  233 SWPEG----------YNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             cchhH----------HHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            11110          0000000   00    0011111 237999999999999999999999999999999987554

>KOG0592|consensus

Probab=100.00  E-value=1.2e-49  Score=403.07  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=221.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHH-HHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~-~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      +.+|+.++.||+  |.||+|++|+.+.|++.||||++++.-...+. .+-+.+|-.+|.+| .||.||+|+.-|.|...+
T Consensus        72 ~~DF~Fg~~lGe--GSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   72 PNDFKFGKILGE--GSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             hhhcchhheecc--ccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            458999999999  66899999999999999999999876443332 34466899999999 899999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|+||+++|+|.++++..  +.++|...+.++.||+.||+|||++|||||||||+||||+.+|+++|+|||.+..+...
T Consensus       150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            9999999999999999885  46899999999999999999999999999999999999999999999999987655432


Q ss_pred             Ccc---------ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        166 KKK---------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       166 ~~~---------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      ...         ......+.+||..|++||+|..+  .-++.+|+|||||++|+|+.|++||...+.-....+++.-.+ 
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-
Confidence            221         01111446788899999999764  357889999999999999999999998765444433332211 


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                                      ..+..+++.++|||+++|..||.+|+|+.++.+||||....+
T Consensus       305 --------------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw  346 (604)
T KOG0592|consen  305 --------------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW  346 (604)
T ss_pred             --------------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence                                            123457899999999999999999999999999999988655

>KOG0033|consensus

Probab=100.00  E-value=5.8e-51  Score=373.67  Aligned_cols=264  Identities=25%  Similarity=0.318  Sum_probs=225.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      -+.++|++.++||+  |.||.|+++.++.||+.+|+|+++.+..+..+.+.+.||+.|-+.|+|||||++++.+......
T Consensus         8 ~f~d~y~l~e~igk--G~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHcc--CchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence            36789999999999  6699999999999999999999999888888889999999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCcccccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPF  162 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~~~~~~  162 (622)
                      |+|+|+|++++|..-+-.+.  -++|..+..+++||++||+|||.+||||||+||+|+|+.+..   -+|++|||.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999999875554432  368999999999999999999999999999999999997543   5899999998877


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      +...     ...+.++|+.|||||++..  ..|+..+||||+|++||-|+.|.+||.+.+......+.+.+....     
T Consensus       164 ~~g~-----~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~-----  231 (355)
T KOG0033|consen  164 NDGE-----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY-----  231 (355)
T ss_pred             CCcc-----ccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC-----
Confidence            6221     2356788999999999975  579999999999999999999999998865443333333443210     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                              +.+.+..+|+++++||++||..||.+|.|+.|+|+|||+.+..
T Consensus       232 ------------------------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  232 ------------------------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             ------------------------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence                                    1123466899999999999999999999999999999997743

>KOG0663|consensus

Probab=100.00  E-value=7.5e-49  Score=375.21  Aligned_cols=296  Identities=20%  Similarity=0.270  Sum_probs=224.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--CcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~   86 (622)
                      ++|+.++.|++  |.||.||+|++++|++.||+|+++.+.....-.-...|||.+|.+++|||||.+.++.+..  +..|
T Consensus        76 ~efe~lnrI~E--GtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEE--GTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhccc--CcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            47999999999  6688999999999999999999988764444344567999999999999999999998875  5799


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||+ -+|.+++.... .++.+.+++.++.|+++||+|||++.|+|||||++|+|+++.|-++++|||.+..++...
T Consensus       154 ~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            9999998 57888887654 357789999999999999999999999999999999999999999999999998877654


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCCCccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHLLDCTTY  244 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~~~~~~~  244 (622)
                      +.+.    ..+.|++|+|||+|.+. .-|+.++||||+|||+.||+++++-|.+.....++  +..+-|.+ .-..++.+
T Consensus       232 k~~T----~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP-te~iwpg~  305 (419)
T KOG0663|consen  232 KPYT----PLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP-SEAIWPGY  305 (419)
T ss_pred             ccCc----ceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC-ccccCCCc
Confidence            4331    23568999999999976 56999999999999999999999999887654443  33444432 21111110


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc--cCCCccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK--KCSVMLP  316 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~--~~~~~~~  316 (622)
                      -.-......  +....-.......+.....|+...+|+..+|.+||.+|.||.+.|+|.||....  .++..+|
T Consensus       306 ~~lp~~k~~--~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~P  377 (419)
T KOG0663|consen  306 SELPAVKKM--TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFP  377 (419)
T ss_pred             cccchhhcc--ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcC
Confidence            000000000  000000000011111112679999999999999999999999999999998843  3444444

>KOG0588|consensus

Probab=100.00  E-value=1.1e-48  Score=403.83  Aligned_cols=262  Identities=22%  Similarity=0.361  Sum_probs=222.9

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCC-CCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +--..|++++.||+  |+.|.|-+|+|..||+.+|||++.+. ..++.....+.|||.||+-|.||||+++|++|.++..
T Consensus         9 ~tiGpwkLgkTLG~--Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGK--GSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccceeccccccC--CCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            33457999999999  66779999999999999999999876 5556666778899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|||.||+++|.|++.+..+  ++++|.++..+++||+.|+.|||..+|+|||+||+|+||+.++.+||+|||-+.....
T Consensus        87 lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            99999999999999999775  4689999999999999999999999999999999999999999999999997643322


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ++     .-.+.+|++.|.|||++.+. .+.+.++||||+|||||.|++|+.||++.+....+.+.-.|.          
T Consensus       165 gk-----lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~----------  228 (786)
T KOG0588|consen  165 GK-----LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV----------  228 (786)
T ss_pred             Cc-----cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc----------
Confidence            21     12356889999999999874 344679999999999999999999999665544444333332          


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                             +-.+..+|.++++|+.+||..||.+|.|.+++++|||+.....
T Consensus       229 -----------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  229 -----------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             -----------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence                                   1233568999999999999999999999999999999976543

>KOG0578|consensus

Probab=100.00  E-value=5.3e-49  Score=402.18  Aligned_cols=262  Identities=29%  Similarity=0.533  Sum_probs=224.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      +-...|..-..||+|+  -|.||.|+.+.+++.||||+++.......  +.+..|+.+|+.++|+|||.|++.|.-++.+
T Consensus       270 dP~~~y~~~~kigqga--SG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGA--TGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             Chhhhhcchhhhcccc--ccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            3345788899999955  56999999999999999999998765544  4477999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|+|.|++...   .++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+|+.|||+...+...
T Consensus       346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999999998663   3899999999999999999999999999999999999999999999999986555433


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..    ...+.+||++|||||++..+  .|++++||||||+++.||+-|.+||...+....+........|.+       
T Consensus       423 ~~----KR~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l-------  489 (550)
T KOG0578|consen  423 QS----KRSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL-------  489 (550)
T ss_pred             cC----ccccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc-------
Confidence            22    23456889999999999764  699999999999999999999999998776665555544444332       


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                             -.+..+|+.+++|+.+||+.||++|++|.+||+||||+....
T Consensus       490 -----------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  490 -----------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             -----------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence                                   134568999999999999999999999999999999966543

>KOG0583|consensus

Probab=100.00  E-value=7.3e-48  Score=399.17  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=217.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC---HHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeC
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---DEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~   82 (622)
                      ....|++++.||+  |+||+|+.|++..||+.||||.++++...   ....+.+.||+.+|+.++ ||||+++++++...
T Consensus        15 ~~g~y~~~~~lG~--GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   15 SIGKYELGRTLGS--GSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccCceeeeeeecC--CCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            4569999999999  77889999999999999999988775322   123456779999999999 99999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CceEEcCCccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYMCP  161 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~-~~~~i~~~~~~~~  161 (622)
                      ..+|+|||||.+|+|.+.+...  ..+.|..++.+++|+++||+|||++||+||||||+|||++.+ +++|++|||.+..
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999999873  468899999999999999999999999999999999999999 9999999998754


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCC-CCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~-~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ....    .....+.+||+.|+|||++.+... | +.++||||+||+||.|++|..||..............+..     
T Consensus       171 ~~~~----~~~l~t~cGsp~Y~aPEvl~~~~~-Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-----  240 (370)
T KOG0583|consen  171 SPGE----DGLLKTFCGSPAYAAPEVLSGKGT-YSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-----  240 (370)
T ss_pred             cCCC----CCcccCCCCCcccCCHHHhCCCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-----
Confidence            4211    122345678899999999986432 5 4799999999999999999999987554443333222211     


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCC-cHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKF-SDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                                  ..+..+ |+++.+|+++||..||.+|+++.+++.||||+.
T Consensus       241 ----------------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  241 ----------------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ----------------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                        112334 999999999999999999999999999999987

>KOG0660|consensus

Probab=100.00  E-value=1.6e-48  Score=379.20  Aligned_cols=291  Identities=26%  Similarity=0.307  Sum_probs=226.5

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-   81 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-   81 (622)
                      +..+++..|..++.||+  |.||.|+.|.++.||+.||||++..-....-..+...||+++|+.++|+|||.+.+.+.. 
T Consensus        16 ~~~~i~~~y~~~~~iG~--GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGR--GAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             eEEeccceecccccccC--cceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            34678889988999999  557799999999999999999997544456678889999999999999999999999876 


Q ss_pred             ----CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         82 ----ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        82 ----~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                          -+.+|+|+|+|+ .+|.++++...  .+.+..++.++.|+++||+|+|+-+|+||||||+|+|++.+.++|++|||
T Consensus        94 ~~~~f~DvYiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cccccceeEEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccc
Confidence                256999999995 78888887642  48899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGAT  235 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~  235 (622)
                      .++..+.....  .+-....-|.+|+|||++... ..|+.++||||+|||++||++|++-|.+.+..  ..++..+.|.+
T Consensus       171 LAR~~~~~~~~--~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  171 LARYLDKFFED--GFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             ceeeccccCcc--cchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            88655432111  111233558899999999754 67999999999999999999999999887653  33444444433


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhh---cc--ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQT---QV--LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~---~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      +. .+        ...-..+....++...+.   ..  -..+..++.+.+|+.+||..||.+|+|++|+|+|||+.....
T Consensus       248 ~~-e~--------l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  248 SE-ED--------LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             CH-HH--------HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence            21 00        001111122223322111   00  012367899999999999999999999999999999987554

>KOG0616|consensus

Probab=100.00  E-value=4.2e-48  Score=364.83  Aligned_cols=257  Identities=19%  Similarity=0.331  Sum_probs=222.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -++|++++.||.  |+||.|.+++++.+|..||+|++++... .-.+.+...+|..+|+.+.||++|++++.|.+...+|
T Consensus        43 l~dfe~~~tlGt--GSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   43 LQDFERLKTLGT--GSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhhhheeeecc--CccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            368999999999  6688999999999999999999987653 4456677889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||.++|++.+++++..  +++|..++.++.||+.||+|||+++|++|||||+|||||.+|.+++.|||++...... 
T Consensus       121 mvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            9999999999999998753  5889999999999999999999999999999999999999999999999987544322 


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                            ..+.+||+.|+|||++..  .+|+.++|.|||||++|||+.|.+||....+......++.+..           
T Consensus       198 ------T~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-----------  258 (355)
T KOG0616|consen  198 ------TWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-----------  258 (355)
T ss_pred             ------EEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----------
Confidence                  235588999999999976  4699999999999999999999999998766433333333321           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                            -.++.+|.++++|++.+|+.|-.+|.     ..+++..||||+...+
T Consensus       259 ----------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  259 ----------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             ----------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence                                  13456899999999999999999993     5778999999987655

>KOG0198|consensus

Probab=100.00  E-value=6.1e-48  Score=383.87  Aligned_cols=264  Identities=30%  Similarity=0.464  Sum_probs=214.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC--cE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--DL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~   85 (622)
                      ..+|..++.||+  |.||.||++.++++|...|||.+.......  .+.+.+|+++|++|+|||||+++|.....+  .+
T Consensus        16 ~~~~~~~~~lG~--Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGR--GSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccC--ccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            567999999999  668899999999999999999987763222  677899999999999999999999866555  59


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCceEEcCCccccccCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSP  164 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~~~~  164 (622)
                      ++.|||+++|+|.++++.... .++|..++.+++||++||+|||++|||||||||+|||++. +|.++++|||.......
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999988654 6999999999999999999999999999999999999999 79999999998755442


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCC-CchHHHHHHHHhCC-CCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGA-TPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~-~~~~~~~~~~~~~~-~p~~~~~~  242 (622)
                       ............+|+.|||||++..+ ..-+.++||||+||++.||+||+.||.. ......+....... .|.     
T Consensus       171 -~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~-----  243 (313)
T KOG0198|consen  171 -KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPE-----  243 (313)
T ss_pred             -ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCC-----
Confidence             11111122345678899999999742 1123499999999999999999999976 22222222222111 111     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                                 .+..+|+++++|+..||..||++||||.++|.|||.++...
T Consensus       244 ---------------------------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  244 ---------------------------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ---------------------------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                                       12347999999999999999999999999999999977554

>KOG0201|consensus

Probab=100.00  E-value=1.7e-49  Score=393.31  Aligned_cols=264  Identities=32%  Similarity=0.545  Sum_probs=223.3

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -+..|..++.||+  |+||.||+|.+.+|++.||||+++.+.. +++.+.+.+|+.+|.+++++||.++|+.|..+..+|
T Consensus        11 ~~~~~~~~~~Igr--GsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   11 PELLYTKLELIGR--GSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             cccccccchhccc--cccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            3457888899999  7788999999999999999999998754 455678889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ++||||.+|++.++++..  ..++|..+..++++++.||.|+|.++.+|||||+.|||+..+|.+++.|||.+.......
T Consensus        88 iiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999999999999763  235899999999999999999999999999999999999999999999999876554332


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..    ..+..+|+.||||||+.+  .+|+.|+||||||++++||++|.+|+....++..+.......            
T Consensus       166 ~r----r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~------------  227 (467)
T KOG0201|consen  166 KR----RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA------------  227 (467)
T ss_pred             hc----cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC------------
Confidence            22    245678999999999974  579999999999999999999999997654432222111111            


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCCC
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSV  313 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~~  313 (622)
                                         .+.+. ..||+.+++||..||.+||+.||+|.++|+|+|++...+++.
T Consensus       228 -------------------PP~L~-~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~  274 (467)
T KOG0201|consen  228 -------------------PPRLD-GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSE  274 (467)
T ss_pred             -------------------CCccc-cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchH
Confidence                               12222 379999999999999999999999999999999998665543

>KOG0605|consensus

Probab=100.00  E-value=1.3e-47  Score=388.82  Aligned_cols=268  Identities=21%  Similarity=0.316  Sum_probs=223.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -++|+++.+||+  |+||.||+|+-+.||+.+|+|+++++.+ ...+...+..|-.+|..-++|+||+++-+|.+.+.+|
T Consensus       140 ~~DFe~Lk~Igk--GAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  140 LDDFELLKVIGK--GAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             cccchhheeecc--ccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            468999999999  7788999999999999999999998765 4556778889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC-
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT-  165 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~-  165 (622)
                      |||||++||++..+|...  ..|+|..++.++.+++.|++-+|+.|+|||||||+|+|||..|++|++|||+...+... 
T Consensus       218 LiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999999774  46899999999999999999999999999999999999999999999999975321100 


Q ss_pred             ----------------C------------ccc--------------cccCCCCCCCccccChhhhccccCCCCCcchHHH
Q psy15039        166 ----------------K------------KKV--------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS  203 (622)
Q Consensus       166 ----------------~------------~~~--------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWS  203 (622)
                                      .            ...              .....+++|||.|||||++.+.  +|+..+|+||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWS  373 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWS  373 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHH
Confidence                            0            000              0112346778999999999874  6999999999


Q ss_pred             HHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHH
Q psy15039        204 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVE  283 (622)
Q Consensus       204 lG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~  283 (622)
                      ||||+|||+.|.+||.+..+.......+.-.                             ....++.....|+++.|||.
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-----------------------------~~l~fP~~~~~s~eA~DLI~  424 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWR-----------------------------ETLKFPEEVDLSDEAKDLIT  424 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-----------------------------hhccCCCcCcccHHHHHHHH
Confidence            9999999999999998876654433332110                             11223344567899999999


Q ss_pred             HhhhcCCCCCcC---HHhhhcCccccccccC
Q psy15039        284 LCLSRDVDKRPL---ACNLLQHAFFKQTKKC  311 (622)
Q Consensus       284 ~~L~~dP~~Rps---~~~~l~h~~~~~~~~~  311 (622)
                      +||. ||++|..   ++|+-+||||+...+.
T Consensus       425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  425 RLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            9999 9999985   8899999999987663

>KOG0597|consensus

Probab=100.00  E-value=2.9e-47  Score=385.64  Aligned_cols=256  Identities=26%  Similarity=0.421  Sum_probs=221.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|.+.+.||+  |.||.||||+.|.|.+.||||.+.+..-.+.+.+.+.+|+.|++.|+|||||.++++|+....+|+|
T Consensus         2 e~yhv~e~iG~--Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGE--GSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcC--CccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            47889999999  6688999999999999999999999887888899999999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      .|||.+ +|..++....  .++|+.++.+..|++.||.|||+++|+|||+||.|||+...|.+|++|||++..++....-
T Consensus        80 te~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             ehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            999986 9999997643  5899999999999999999999999999999999999999999999999998766543322


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                      .    ....||+.|||||++.+  ..|+..+|+||+||++|||.+|++||.... ...+++.|...++            
T Consensus       157 l----tsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~s-i~~Lv~~I~~d~v------------  217 (808)
T KOG0597|consen  157 L----TSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARS-ITQLVKSILKDPV------------  217 (808)
T ss_pred             e----eeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHH-HHHHHHHHhcCCC------------
Confidence            1    23467888999999986  569999999999999999999999997543 2333444332211            


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                          ..+...|.+|.+|++.+|.+||.+|.+=.+++.|||++..
T Consensus       218 --------------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 --------------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             --------------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                                1223578999999999999999999999999999999753

>KOG0598|consensus

Probab=100.00  E-value=6.7e-47  Score=369.31  Aligned_cols=218  Identities=23%  Similarity=0.359  Sum_probs=190.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      -+.+|+++++||+  |+||.||.++.+.|++.+|+|++.+..... .+.+....|..+|..++||+||+++-+|++...+
T Consensus        23 ~~~dF~~lkviGk--G~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   23 GPDDFEILKVIGK--GSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             Chhheeeeeeeec--cCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            4678999999999  889999999999999999999998776544 4578899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+|+||+.||+|.-.|.+.+  .++|..++.|+.+|+.||.|||++|||||||||+||||+.+|.+++.|||++...-. 
T Consensus       101 ylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-  177 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-  177 (357)
T ss_pred             EEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence            99999999999999988754  368999999999999999999999999999999999999999999999997542211 


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                         ......+.+||+.|||||++.+  .+|+..+|+|||||++|||++|.+||...+..+....+..+.
T Consensus       178 ---~~~~t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k  241 (357)
T KOG0598|consen  178 ---DGDATRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK  241 (357)
T ss_pred             ---CCCccccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence               1122345789999999999987  479999999999999999999999999987766554455444

>KOG0585|consensus

Probab=100.00  E-value=1.3e-46  Score=374.95  Aligned_cols=267  Identities=22%  Similarity=0.361  Sum_probs=212.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH--------H----HHHHHHHHHHHHhhCCCCcceeEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--------E----DLKSLHHEIVCMRHLRHPNIICYI   76 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~--------~----~~~~~~~Ei~il~~l~HpnIv~~~   76 (622)
                      .+|++++.||+  |.||+|-+|++..+++.||||++++.....        .    ..+...+||.||++|+|||||+|+
T Consensus        97 Nqy~l~~eiG~--G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   97 NQYELIKEIGS--GQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             hheehhhhhcC--CccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            58999999999  778899999999999999999998653321        1    124678999999999999999999


Q ss_pred             EEEEeC--CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEc
Q psy15039         77 SSFLDA--TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  154 (622)
Q Consensus        77 ~~~~~~--~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~  154 (622)
                      ++..+.  +.+|||+|||..|.+...-..  ..-+++.+++.|+++++.||+|||.+|||||||||+|+||+.+|.+||.
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence            998775  579999999999987532211  1227899999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCC-ccccccCCCCCCCccccChhhhcccc-CCC-CCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH
Q psy15039        155 GLRYMCPFSPTK-KKVHLFPPSTAYNLNWLSPEVLEQNL-DGY-DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       155 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~y~aPE~l~~~~-~~~-~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~  231 (622)
                      |||....+.... ......-..++||+.|+|||.+.++. ..| +.+.||||+||+||.|+.|+.||.+... ..+..+|
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-~~l~~KI  331 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-LELFDKI  331 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-HHHHHHH
Confidence            999877553221 01111112368899999999997643 223 4688999999999999999999986543 3344444


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ...                              ...++..+....+++|||.+||++||++|.+..++-.|||.....+
T Consensus       332 vn~------------------------------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  332 VND------------------------------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             hcC------------------------------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            321                              1122334457889999999999999999999999999999977544

>KOG0594|consensus

Probab=100.00  E-value=4.4e-46  Score=363.72  Aligned_cols=290  Identities=23%  Similarity=0.314  Sum_probs=219.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc-ceeEEEEEEeCC---
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN-IICYISSFLDAT---   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~~~~~~~~~~---   83 (622)
                      ..+|+..+.||+  |.||+||+|+++.||+.||+|++..+...+.......||+.+|+.|+|+| ||++++++.+.+   
T Consensus        10 ~~~~~~~eklGe--Gtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGE--GTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCC--CCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            346888999999  66889999999999999999999887554344566789999999999999 999999999887   


Q ss_pred             ---cEEEEeecCCCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         84 ---DLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        84 ---~~~lv~e~~~~g~l~~~l~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                         .+++|+||++ -+|.+.++....  .+++...++.+|+||+.||+|||+++|+||||||.||||+++|.+|++|||.
T Consensus        88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccch
Confidence               8999999987 678888877653  3688899999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p  236 (622)
                      +..++......    ....+|.+|+|||++.+. ..|+..+||||+||+++||+++++-|.+.....++  +-.+.|.+ 
T Consensus       167 Ara~~ip~~~y----t~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP-  240 (323)
T KOG0594|consen  167 ARAFSIPMRTY----TPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP-  240 (323)
T ss_pred             HHHhcCCcccc----cccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC-
Confidence            87655332221    123568899999999976 45999999999999999999999999877654333  33333332 


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ....++...  ..++... ....+-..... .......+++..+++..||++||.+|.||..+|.||||.....
T Consensus       241 ~e~~Wp~v~--~~~~~k~-~f~~~~~~~~l-~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  241 NEKDWPGVS--SLPDYKA-PFPKWPGPKDL-SSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CccCCCCcc--ccccccc-cCcCCCCccch-HHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            211111000  0000000 00000000000 0011234578999999999999999999999999999987644

>KOG0599|consensus

Probab=100.00  E-value=3.8e-47  Score=353.61  Aligned_cols=263  Identities=27%  Similarity=0.387  Sum_probs=224.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC------CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM------TDEDLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~------~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      =..|+--++||.  |.-|+|-++.++.||+..|+|++....-      ..+..+...+|+.||+++ .|||||++.++|.
T Consensus        16 y~~y~pkeilgr--gvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   16 YAKYEPKEILGR--GVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             HhhcChHHHhcc--cchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            347888899999  6677999999999999999999975321      123345567999999999 7999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                      ++..+++|.|+|+.|+|.|.|....  .++|...+.||+|+++|+.|||.++||||||||+|||++++.+++++|||+++
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence            9999999999999999999997753  58999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhc----cccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~----~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      ......+..     ..+||+.|+|||.+.    .+..+|+..+|+||+|+++|.|+.|.+||.......++.-.+.|...
T Consensus       172 ~l~~GekLr-----elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  172 QLEPGEKLR-----ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             ccCCchhHH-----HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            876655433     347789999999884    34568999999999999999999999999987666665555555432


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      +                             ..+.+..+|...+|||++||+.||.+|.|+.|+|+||||.+.
T Consensus       247 F-----------------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  247 F-----------------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             c-----------------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            1                             123455689999999999999999999999999999999653

>KOG0580|consensus

Probab=100.00  E-value=3.9e-47  Score=348.37  Aligned_cols=258  Identities=21%  Similarity=0.355  Sum_probs=219.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHH-HHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .++|++++.||+  |.||.||.|+.++++-.||+|++-++...+.. .+++.||++|-+.|+||||+++|++|.+....|
T Consensus        21 l~dfeigr~Lgk--gkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   21 LDDFEIGRPLGK--GKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             hhhccccccccC--CccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            358999999999  88999999999999999999998776543333 456889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      |++||.+.|++...|.......++|.....+++|++.||.|||.++|+||||||+|+|++.+|..+++|||.+.....++
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k  178 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK  178 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence            99999999999999986555568899999999999999999999999999999999999999999999999875443222


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      +      .+.++|.-|.+||+..+  ..++..+|+|++|+++||++.|.+||.+.. ....++++...            
T Consensus       179 R------~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~------------  237 (281)
T KOG0580|consen  179 R------KTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV------------  237 (281)
T ss_pred             c------eeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc------------
Confidence            2      24477889999999975  468999999999999999999999998765 33334333211            


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                          ....+..+|.++.|+|.+||..+|.+|.+..|++.|||+...
T Consensus       238 --------------------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 --------------------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             --------------------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                                011225579999999999999999999999999999998653

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.5e-45  Score=380.67  Aligned_cols=298  Identities=45%  Similarity=0.744  Sum_probs=222.6

Q ss_pred             eEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeec
Q psy15039         12 KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        12 ~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      +++++||+|.++|++||+++++.+|+.||||+++.+.......+.+.+|+.+++.++|||||+++++|..++.+++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            46789999888999999999999999999999987655555566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC---CCcc
Q psy15039         92 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP---TKKK  168 (622)
Q Consensus        92 ~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~---~~~~  168 (622)
                      +++|++.+++......++++..+..++.|++.||+|||++||+||||||+|||++.++.+++.||+.......   ....
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999999765444588999999999999999999999999999999999999999999998875432211   1111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc-
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD-  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-  247 (622)
                      ....+.....+..|+|||++.++...|+.++||||+||++|||++|..||..............+..|...+....... 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence            1111222344567999999976545689999999999999999999999987655555555555544433221100000 


Q ss_pred             ----CCCCcCcccccccch-----h---hhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        248 ----TGQDDGEENACSYIS-----E---QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ----~~~~~~~~~~~~~i~-----~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                          ..........+....     .   ..........+++++.+|+..||+.||++|||++++++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                000000000000000     0   0000112234688999999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0582|consensus

Probab=100.00  E-value=1.2e-45  Score=365.80  Aligned_cols=230  Identities=36%  Similarity=0.632  Sum_probs=208.0

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ....+|++..+||.|+  -++||+|+...+++.||||+++.+..... .+.+.+|+..|+.++|||||+++.+|..+..+
T Consensus        23 ~n~~~YeL~e~IG~G~--sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGA--SAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCccceeEEEEEeccc--eeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            4567899999999955  59999999999999999999998877655 78899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||.||.+|++.++++.....+++|..+..++++++.||.|||++|-||||||+.||||+++|.++++|||+...+...
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999999999999888888999999999999999999999999999999999999999999999999985443333


Q ss_pred             CCc-eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCC
Q psy15039        516 KKK-VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  589 (622)
Q Consensus       516 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~  589 (622)
                      ... ...+ .+.++|+.|||||++.++..+|+.|+|||||||+.+||++|..||...++.+.++..+.+.+|.++
T Consensus       180 G~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  180 GDRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             CceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            222 2233 567889999999998777789999999999999999999999999999999999999999887655

>KOG0581|consensus

Probab=100.00  E-value=5e-46  Score=363.28  Aligned_cols=219  Identities=26%  Similarity=0.438  Sum_probs=187.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc-EEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~-~~l  437 (622)
                      ++.+.++.||+  |+.|+||+++|+.|++.+|+|+|.. ..+....+++.+|+++++..+||+||.+|++|..... +++
T Consensus        79 ~dle~~~~lG~--G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGS--GNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhccc--CCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            45677889999  6679999999999999999999954 3456667899999999999999999999999999995 999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||++|+|.++++..+  .++|....+++.+|++||.|||+ ++||||||||+|||+++.|.+||+|||.+..+..  
T Consensus       156 ~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--  231 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--  231 (364)
T ss_pred             ehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh--
Confidence            999999999999998753  47999999999999999999995 9999999999999999999999999997644332  


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC----CcHHHHHH-HHcCCCCCCCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET----PTTLMLIE-KLAGATPHLLD  590 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~----~~~~~~~~-~~~~~~p~~~~  590 (622)
                          ....+.+||..|||||.+.+  ..|+.++||||||++++||++|+.||...    .....++. ++.+.+|.+++
T Consensus       232 ----S~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~  304 (364)
T KOG0581|consen  232 ----SIANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE  304 (364)
T ss_pred             ----hhcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence                23456788999999999987  56999999999999999999999999874    23334444 55556555555

>KOG0032|consensus

Probab=100.00  E-value=6.3e-45  Score=376.86  Aligned_cols=264  Identities=24%  Similarity=0.395  Sum_probs=225.0

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA   82 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~   82 (622)
                      .++...|++++.||+  |+||.||+|+++.||+.+|+|.+++.... ......+.+|+++|++|. |||||+++++|.+.
T Consensus        31 ~~~~~~Y~l~~~lG~--G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGR--GQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCC--CCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            567789999999999  78999999999999999999999876553 234567889999999998 99999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CceEEcCCcc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN----GKACLSGLRY  158 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~----~~~~i~~~~~  158 (622)
                      +.+++|||+|.+|+|.+.+...   .++|..+..+++|++.|++|||+.||+||||||+|+|+...    +.+++.|||.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            9999999999999999999775   38999999999999999999999999999999999999753    4799999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      +..... ...    ..+.++|+.|+|||++..  ..|+..+||||+||++|.|++|.+||..............+.+.. 
T Consensus       186 a~~~~~-~~~----~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f-  257 (382)
T KOG0032|consen  186 AKFIKP-GER----LHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF-  257 (382)
T ss_pred             ceEccC-Cce----EeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC-
Confidence            765543 111    124577889999999975  469999999999999999999999999877655555554443211 


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                  ....+..+|..+++||+.||..||.+|+|+.++|+|||+....
T Consensus       258 ----------------------------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  258 ----------------------------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             ----------------------------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence                                        1124556799999999999999999999999999999987753

>KOG1035|consensus

Probab=100.00  E-value=3.7e-45  Score=399.99  Aligned_cols=496  Identities=18%  Similarity=0.286  Sum_probs=323.6

Q ss_pred             HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc----EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Q psy15039         52 EDLKSLHHEIVCMRHLRHPNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY  127 (622)
Q Consensus        52 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~----~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~y  127 (622)
                      .++....-|+..+..+.|+|+++++.+-.....    +.+..++|.+-++.+.+....  .++-..++.+..++++||+|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHH
Confidence            344556678889999999999999887655432    334468899999998887643  46778889999999999999


Q ss_pred             HHhCCcccCCCCCC---CEEEcCCCceEEc--CCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHH
Q psy15039        128 IHGKGFIHRAVKAS---HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY  202 (622)
Q Consensus       128 lH~~~IvHrDiKp~---NiLl~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiW  202 (622)
                      +|+....|.-+..+   +-..+.++.....  +++.+..+.......     +.....-|.|||.+..+........|+|
T Consensus       302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-----~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-----SDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccch-----hhcCccccccccccccccchhhhhhHHH
Confidence            99985444433322   1112222222222  444333322211111     1111234788888765433233456999


Q ss_pred             HHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHH
Q psy15039        203 SVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIV  282 (622)
Q Consensus       203 SlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  282 (622)
                      .+|..+..+..|..+-......           +.+                               ....+..+..++.
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~-----------~~~-------------------------------l~~~~~~~~~d~~  414 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVP-----------VSL-------------------------------LDVLSTSELLDAL  414 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccch-----------hhh-------------------------------hccccchhhhhhh
Confidence            9999999988875442110000           000                               0011112677888


Q ss_pred             HHhhhcCCCCCcCHHhhhcCccccccccCCCccccccccccCCCccccccccccccccccccccccccccccCCCCCCce
Q psy15039        283 ELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYK  362 (622)
Q Consensus       283 ~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  362 (622)
                      ..|+..|+++|+++.+++.|+|.+.........-...      .+..+.      .......+.+.....+...+..+|+
T Consensus       415 ~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~~~~~~~------~~~~~~------~~~~r~~~~~s~~~r~~SRY~~DFE  482 (1351)
T KOG1035|consen  415 PKCLDEDSEERLSALELLTHPFLRFPTDNESSEFAPN------DETSVP------QFRLRFSGAMSPLQRQFSRYLNDFE  482 (1351)
T ss_pred             hhhcchhhhhccchhhhhhchhcccccccccccccCc------cccccC------ccCCCCccccCccccchhhHhhhhH
Confidence            8999999999999999999999865443221000000      000000      0000001111111112245677899


Q ss_pred             EeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe-----------
Q psy15039        363 ICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-----------  431 (622)
Q Consensus       363 ~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----------  431 (622)
                      .+..||+  ||||.||+++++..|+.||||+|.... ++.....+.+|+++|++|+|||||+||.+|..           
T Consensus       483 EL~lLGk--GGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  483 ELELLGK--GGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             HHHHhcC--CCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            9999999  889999999999999999999998876 66667889999999999999999999876410           


Q ss_pred             -------------------------------------------------------------------C------------
Q psy15039        432 -------------------------------------------------------------------A------------  432 (622)
Q Consensus       432 -------------------------------------------------------------------~------------  432 (622)
                                                                                         .            
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                                               0            


Q ss_pred             -----------------------------CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy15039        433 -----------------------------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF  483 (622)
Q Consensus       433 -----------------------------~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~i  483 (622)
                                                   ..+||.||||+...+.++++++.... ....++.+++||++||+|+|+.||
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCce
Confidence                                         12689999999999999887754321 466788999999999999999999


Q ss_pred             eecCCCCCcEEEcCCCceEEcCcccccccC---CC----------CC-ceeccCCCCCCCCccccccccccCc-cCCCch
Q psy15039        484 IHRAVKASHILISHNGKACLSGLRYMCPFS---PT----------KK-KVHLFPPSTAYNLNWLSPEVLEQNL-DGYDER  548 (622)
Q Consensus       484 iHRDlKp~NILl~~~~~~~~~~~~~~~~~~---~~----------~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~  548 (622)
                      |||||||.||++++++.+||.|||.++...   ..          .. ......++.+||-.|+|||++.+.. ..|+.|
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999999999999999887611   00          00 0111234567888999999997542 269999


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCcccccCCCCcCcccccchhhhhhhhh
Q psy15039        549 SDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQV  618 (622)
Q Consensus       549 ~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  618 (622)
                      +||||||||++||+   +||............+..  +.++.. .-+++..-.+...-+--++++++++|
T Consensus       799 iDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~--g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kR  862 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEML---YPFGTSMERASILTNLRK--GSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKR  862 (1351)
T ss_pred             hhhHHHHHHHHHHh---ccCCchHHHHHHHHhccc--CCCCCC-cccccccchHHHHHHHHHhcCCCccC
Confidence            99999999999996   567544333333333332  222222 22333333333333444445555554

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.8e-45  Score=372.16  Aligned_cols=292  Identities=21%  Similarity=0.272  Sum_probs=213.6

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ...++|++.+.||+  |+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++||||+++++++.+....
T Consensus         2 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (303)
T cd07869           2 GKADSYEKLEKLGE--GSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETL   78 (303)
T ss_pred             CccccceEeeeEEe--cCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence            34679999999999  77999999999999999999998764322 2234567899999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+. +++.+.+.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||........
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            99999996 67777776532 35789999999999999999999999999999999999999999999999975432211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH---hCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL---AGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~---~~~~p~~~~~~  242 (622)
                      ..    ......+++.|+|||++.+. ..++.++||||+||++|+|++|..||.+..........+   .+. |....+.
T Consensus       157 ~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  230 (303)
T cd07869         157 SH----TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT-PNEDTWP  230 (303)
T ss_pred             Cc----cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC-CChhhcc
Confidence            11    11233457789999998653 457889999999999999999999998754332222222   121 1100000


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ... .... ......................+++++.+|++.||+.||.+|||+.++++||||+....
T Consensus       231 ~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         231 GVH-SLPH-FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             chh-hccc-cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            000 0000 00000000000011111222346788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0658|consensus

Probab=100.00  E-value=1.1e-45  Score=359.97  Aligned_cols=282  Identities=23%  Similarity=0.325  Sum_probs=213.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-----c
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----D   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~   84 (622)
                      .|+-.+++|.  |.||.||.|+-.++++.||||+.-.+.      +--.+|+++|+.++|||||++.-+|....     .
T Consensus        25 ~~~~~~liG~--GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGS--GSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEee--cccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            5888999999  668899999999999999999974432      11237999999999999999998886542     3


Q ss_pred             EEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~-~~~~i~~~~~~~~  161 (622)
                      +.+|||||+ .+|.+.++..  .+..++...++-++.||++||+|||+.||+||||||.|+|+|.+ |.+|++|||.+..
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            668999998 6788888742  23457888999999999999999999999999999999999976 8999999998765


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCCC
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHLL  239 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~~  239 (622)
                      ...+....     +...|..|+|||++.+. ..|+.++||||.||+++||+-|++-|.+.+...++  +.++.|.+ +..
T Consensus       176 L~~~epni-----SYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P-t~e  248 (364)
T KOG0658|consen  176 LVKGEPNI-----SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP-TRE  248 (364)
T ss_pred             eccCCCce-----eEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC-CHH
Confidence            54433322     22346789999999876 57999999999999999999999999987654444  44455543 211


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCC
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS  312 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~  312 (622)
                      +-..    ......+...+....... ........+++..+|+.++|+++|.+|.++.++|+||||...+...
T Consensus       249 ~I~~----mn~~y~~~~~p~ik~~~~-~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  249 DIKS----MNPNYTEFKFPQIKAHPW-HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             HHhh----cCcccccccCcccccccc-eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence            1110    000100111111111111 1123456789999999999999999999999999999998876653

>KOG0574|consensus

Probab=100.00  E-value=1.6e-47  Score=360.31  Aligned_cols=261  Identities=29%  Similarity=0.526  Sum_probs=219.4

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      .|.+.+.||+  |+||.||+|.|+++|+.+|||++.++    .+.+.+.+||.||++++.|.+|+|||.|.....+|+||
T Consensus        34 VFDi~~KLGE--GSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGE--GSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcC--CcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            5788899999  66889999999999999999998664    35677889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      |||..|++.|+++.+. ..|.|.++..+++.-++||+|||...-+|||||..|||++.+|.+++.|||....+...-.+ 
T Consensus       108 EYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-  185 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-  185 (502)
T ss_pred             hhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence            9999999999998764 36999999999999999999999999999999999999999999999999987554332211 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                         ..+..+|+.|||||++..  -+|+.++||||||++..||+.|++||....+...+.-.-..++|             
T Consensus       186 ---RNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP-------------  247 (502)
T KOG0574|consen  186 ---RNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP-------------  247 (502)
T ss_pred             ---hCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC-------------
Confidence               235577899999999975  46999999999999999999999999765433221111001111             


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCCC
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSV  313 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~~  313 (622)
                                       .+-.+..||++|-|||+.||-.+|++|-||.++++|||+++.+.|+.
T Consensus       248 -----------------TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I  294 (502)
T KOG0574|consen  248 -----------------TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDI  294 (502)
T ss_pred             -----------------CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccH
Confidence                             11123458999999999999999999999999999999999888753

>KOG0577|consensus

Probab=100.00  E-value=5.6e-46  Score=377.43  Aligned_cols=258  Identities=29%  Similarity=0.518  Sum_probs=225.6

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .|.-++.||.  |+||.||.|++..|.+.||||+++.+.. +.+.++++.+|+..|++|+|||+|.|.|+|......|||
T Consensus        27 lf~dLrEIGH--GSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   27 LFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHhcC--CccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            5777899999  6688999999999999999999998653 456688899999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||||- |+..|++.-+.+ ++.|..|..|+.+.+.||+|||+.+.||||||..|||++..|.+|+.|||.....++.   
T Consensus       105 MEYCl-GSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  105 MEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHHHh-ccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            99997 777888877654 6889999999999999999999999999999999999999999999999976544332   


Q ss_pred             ccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           .+.+||++||||||+.. .-+.|+.++|||||||++.||+..++|+++.+.+..++.+....+|.+         
T Consensus       180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL---------  245 (948)
T KOG0577|consen  180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---------  245 (948)
T ss_pred             -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC---------
Confidence                 24578899999999853 224689999999999999999999999999888877777666655543         


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                            ....||+.|+.||..||++-|.+|||.+++|.|+|+...+.
T Consensus       246 ----------------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  246 ----------------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             ----------------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence                                  45678999999999999999999999999999999977554

>KOG0579|consensus

Probab=100.00  E-value=2.4e-46  Score=382.18  Aligned_cols=262  Identities=27%  Similarity=0.426  Sum_probs=228.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+.|+|+..||.  |+||+||+|.++.|+...|.|.|...  ..++.+++.-||.||..++|||||+++++|...+.+|+
T Consensus        31 ~d~WeIiGELGD--GAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   31 RDHWEIIGELGD--GAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHHhhhcC--ccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            356889999999  66889999999999999999998664  46778889999999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ..|||+||.+..++.... ..|.|..+..+++|++.||+|||+++|||||||..|||++-+|++++.|||.+........
T Consensus       107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            999999999998887754 4689999999999999999999999999999999999999999999999998654332222


Q ss_pred             cccccCCCCCCCccccChhhhc---cccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLE---QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~---~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .    ..+..||++|||||+..   .+...|+.++||||||++|.||+.+.+|......+..++......+|++      
T Consensus       186 k----RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL------  255 (1187)
T KOG0579|consen  186 K----RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------  255 (1187)
T ss_pred             h----hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc------
Confidence            2    12446788999999874   2335799999999999999999999999988888888877777666654      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                              +.+..||..|.||++.||..||..||++.++|+||||.+.
T Consensus       256 ------------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  256 ------------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             ------------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                                    3456799999999999999999999999999999999853

>KOG0591|consensus

Probab=100.00  E-value=2e-46  Score=350.62  Aligned_cols=225  Identities=26%  Similarity=0.421  Sum_probs=194.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEE-EEEeCCc-
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-SFLDATD-  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~-~~~~~~~-  434 (622)
                      ...+|++.+.||+  |+||.||++.+..+|..+|.|++.-..++......+..|+.+|++|+|||||+|++ .|...+. 
T Consensus        17 ~l~~y~Il~~IG~--GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   17 TLADYQILKKIGR--GSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             cHHHHHHHHHHcC--CcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            3567999999999  78999999999999999999999988888888889999999999999999999998 7777776 


Q ss_pred             EEEEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHG--KG--FIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~--~~--iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                      +++|||+|+.|+|.++++..+  ..-++|..+++++.|++.||.++|+  .+  |+||||||.||+|+.+|.+|+.|||+
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence            999999999999999987432  3358999999999999999999999  44  99999999999999999999999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC-CCCC
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPH  587 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~-~~p~  587 (622)
                      +.-++...    .+..+.+|||.||+||++..  .+|+.+|||||+||++|||+.-++||.+.+ -..+.++|.. ..|+
T Consensus       175 ~r~l~s~~----tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-~~~L~~KI~qgd~~~  247 (375)
T KOG0591|consen  175 GRFLSSKT----TFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDN-LLSLCKKIEQGDYPP  247 (375)
T ss_pred             HhHhcchh----HHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCccccc-HHHHHHHHHcCCCCC
Confidence            76554332    34556789999999999987  579999999999999999999999999884 4445555544 5566


Q ss_pred             CCC
Q psy15039        588 LLD  590 (622)
Q Consensus       588 ~~~  590 (622)
                      +++
T Consensus       248 ~p~  250 (375)
T KOG0591|consen  248 LPD  250 (375)
T ss_pred             CcH
Confidence            663

>KOG0615|consensus

Probab=100.00  E-value=7.2e-46  Score=364.17  Aligned_cols=219  Identities=25%  Similarity=0.324  Sum_probs=183.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-----HHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-----DLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ..+.|.+.+.||+  |+||.|-+|..+.||+.||||++++......     ....+.+|+++|++|+|||||++++.|..
T Consensus       170 ~~d~yii~~~LGs--Gafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGS--GAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             hcceeEeeeeecC--CceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            4567889999999  7899999999999999999999987643321     12346799999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CceEEcCccc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---GKACLSGLRY  508 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~---~~~~~~~~~~  508 (622)
                      ....|+|||||+||+|.+.+-.++.  +.+.....++.|++.|+.|||++||+||||||+|||+..+   -.+|++|||+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999999887654  5677778899999999999999999999999999999877   5789999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccC-CCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      +...+.     ..+..+.||||.|.||||+...... |..++||||+||+||.+++|.+||.+...+..+.+.|..+
T Consensus       326 AK~~g~-----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G  397 (475)
T KOG0615|consen  326 AKVSGE-----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG  397 (475)
T ss_pred             hhcccc-----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence            654331     2344567999999999999653333 3458999999999999999999999887666566655443

>KOG0575|consensus

Probab=100.00  E-value=9e-45  Score=374.07  Aligned_cols=215  Identities=24%  Similarity=0.390  Sum_probs=188.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ..|+.++.||+  |||+.||.+++..+|+.||+|++.+... .....+.+.+||+|++.|+|||||+++++|++.+++|+
T Consensus        18 ~~Y~~g~~LGk--GgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGK--GGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeecc--CcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            56999999999  8899999999999999999999987543 34456789999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |.|+|+.++|..++++.  ..++|..++.+++||++||.|||+++|||||||..|++|+++.++||.|||+++.+.....
T Consensus        96 vLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            99999999999999854  3588999999999999999999999999999999999999999999999999886653322


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      .    ..+.||||.|.||||+..  .+++..+||||+||++|.||.|+|||...+-. ..+.+|...
T Consensus       174 r----k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-ety~~Ik~~  233 (592)
T KOG0575|consen  174 R----KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-ETYNKIKLN  233 (592)
T ss_pred             c----cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHH-HHHHHHHhc
Confidence            2    245789999999999975  57899999999999999999999999766433 344555443

>KOG0610|consensus

Probab=100.00  E-value=1.4e-44  Score=355.67  Aligned_cols=268  Identities=24%  Similarity=0.316  Sum_probs=222.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +.|++++.||+  |.-|+||+++.+.++...|+|+++++.+. .....++.-|-.||++++||.+..||+.|..++..+|
T Consensus        77 ~~f~llk~LG~--GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   77 RHFRLLKRLGC--GDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHcCC--CCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            36888999999  66889999999999999999999887654 3345667789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC---
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP---  164 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~---  164 (622)
                      +||||+||+|..+++.+....++|..++.++.+|+.||+|||-.|||.|||||+||||..+|++-++||.++.....   
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999999999887766789999999999999999999999999999999999999999999988875432110   


Q ss_pred             ------------------------------CCcc--------------c-----cccCCCCCCCccccChhhhccccCCC
Q psy15039        165 ------------------------------TKKK--------------V-----HLFPPSTAYNLNWLSPEVLEQNLDGY  195 (622)
Q Consensus       165 ------------------------------~~~~--------------~-----~~~~~~~~~~~~y~aPE~l~~~~~~~  195 (622)
                                                    ..+.              .     .....+.+||-.|+|||++.+  .++
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G--~GH  312 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG--EGH  312 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec--CCC
Confidence                                          0000              0     001113356677999999987  468


Q ss_pred             CCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCc
Q psy15039        196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFS  275 (622)
Q Consensus       196 ~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s  275 (622)
                      +.++|+|+|||++|||++|..||.+.....-+...+.. .+.                              ++.....|
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-~l~------------------------------Fp~~~~vs  361 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-PLK------------------------------FPEEPEVS  361 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-CCc------------------------------CCCCCcch
Confidence            99999999999999999999999987766555544432 221                              22334678


Q ss_pred             HHHHHHHHHhhhcCCCCCcC----HHhhhcCccccccccC
Q psy15039        276 DSFHSIVELCLSRDVDKRPL----ACNLLQHAFFKQTKKC  311 (622)
Q Consensus       276 ~~~~~li~~~L~~dP~~Rps----~~~~l~h~~~~~~~~~  311 (622)
                      ..++|||+.+|.+||.+|..    |.|+-+||||+..++.
T Consensus       362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence            89999999999999999998    9999999999987763

>KOG0611|consensus

Probab=100.00  E-value=4e-45  Score=356.54  Aligned_cols=258  Identities=21%  Similarity=0.338  Sum_probs=219.1

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      -|..-+|++.+.||+  |.||+|-+|+....|+.||||.+.++.. ++.+.-.+.|||+||+.|+|||||++|++|+..+
T Consensus        49 hnlkHRyE~~etLGk--GTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   49 HNLKHRYEITETLGK--GTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             cchhhHHHHHHHhcC--CcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            356678999999999  6688999999999999999999998775 4455778899999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ...+||||..+|+|.|.+....  .|+|.+++.+++||.+|+.|||+++++|||||.+|||+|.+++++|.|||++..+.
T Consensus       127 KIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999999998754  58999999999999999999999999999999999999999999999999876554


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ..+ ...    +.++++-|.+||++-+. .+-++.+|-||||++||.|+.|.+||++.+......+...|.+-       
T Consensus       205 ~~k-fLq----TFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------  271 (668)
T KOG0611|consen  205 DKK-FLQ----TFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------  271 (668)
T ss_pred             ccc-HHH----HhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-------
Confidence            322 222    34677889999999653 33468999999999999999999999988765554444444321       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                                 .+.-..++.-||++||..+|++|.|..++..|=|..
T Consensus       272 ---------------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  272 ---------------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ---------------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                       111244678899999999999999999999997764

>KOG0589|consensus

Probab=100.00  E-value=6.7e-45  Score=370.68  Aligned_cols=259  Identities=24%  Similarity=0.422  Sum_probs=229.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc-EEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~l   87 (622)
                      ++|+.++.+|+  |.||.+++++|+..+..|++|+++..+.++...+.+.+|+.++++++|||||.|++.|+.++. +++
T Consensus         4 ~~Ye~~~~iG~--GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGR--GAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCc--cccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            68999999999  668899999999999999999999998888888889999999999999999999999999888 999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||+||+||++.+.++.....-++|+.+..|+.|++.||+|||+++|+|||||+.||+++.++.+++.|||.+....... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-  160 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence            9999999999999987654457999999999999999999999999999999999999999999999999876554332 


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                         ....+..+|+.||.||++.+  ..|+.|+|||||||++|||++-+++|...+....+.++..+..+           
T Consensus       161 ---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-----------  224 (426)
T KOG0589|consen  161 ---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-----------  224 (426)
T ss_pred             ---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-----------
Confidence               12345678999999999986  46999999999999999999999999988777666665544321           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                           +.+..+|.+++.+|+.||+.+|+.||++.++|.+|....
T Consensus       225 ---------------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  225 ---------------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ---------------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                                 234568999999999999999999999999999987753

>KOG4717|consensus

Probab=100.00  E-value=1.2e-44  Score=362.34  Aligned_cols=261  Identities=25%  Similarity=0.419  Sum_probs=225.1

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      |-.-|.+.+.||+  |-|++|-+|+|.-||+.||||++++.+++....-++.+|+..|+-.+|||||++|++......+|
T Consensus        16 IAGLYDLekTlG~--GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   16 IAGLYDLEKTLGR--GHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             eeeeehhhhhhcC--CceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            3456999999999  77899999999999999999999998887777778889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCceEEcCCccccccCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~~~~~  165 (622)
                      ||+|+=++|+|+|++-.+.. ++.|...+.+++||+.|+.|||...||||||||+||++-. -|-+|+.|||+...|.+.
T Consensus        94 LiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999999977654 6999999999999999999999999999999999998865 588999999998887765


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCC-CcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~-~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ++..     +.++++.|-|||+|.+.  .|+ +++||||||||||.|++|++||...+...-+..        ++||..-
T Consensus       173 ~kL~-----TsCGSLAYSAPEILLGD--sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm--------ImDCKYt  237 (864)
T KOG4717|consen  173 KKLT-----TSCGSLAYSAPEILLGD--SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM--------IMDCKYT  237 (864)
T ss_pred             chhh-----cccchhhccCchhhhcC--ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh--------hhccccc
Confidence            5432     45778889999999874  465 789999999999999999999986554332222        2344311


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                               -+..+|.++++||..||.+||.+|.+.+++..|+|++....
T Consensus       238 -------------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  238 -------------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             -------------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                                     23467999999999999999999999999999999987654

>KOG0592|consensus

Probab=100.00  E-value=4.4e-45  Score=370.04  Aligned_cols=224  Identities=25%  Similarity=0.400  Sum_probs=191.1

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHH-HHHHHHHHHHHhhC-CCCccceeEEEEEeC
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL-RHPNIICYISSFLDA  432 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~  432 (622)
                      ..-+.+|++++.||.  |+|++|++|+.+.|++.||||++.+..+-.+. .+-+.+|-.+|.+| +||.||++|-.|.+.
T Consensus        69 kk~~~DF~Fg~~lGe--GSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGE--GSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             cCChhhcchhheecc--ccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            345788999999999  78999999999999999999999876543322 45678899999999 899999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  512 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~  512 (622)
                      ..+|+|+||+++|+|.+++++.+  .+++..++.|+.||+.||+|||++|||||||||+||||++||+++|.|||.+..+
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999999999999999865  4789999999999999999999999999999999999999999999999987665


Q ss_pred             CCCCCc---------eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        513 SPTKKK---------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       513 ~~~~~~---------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      +.....         ......+.+||-.|++||+|..  ...+..+|||+||||+|+|+.|+|||.+.+......+++.-
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            542221         1111255788999999999976  35688999999999999999999999998776655555444


Q ss_pred             C
Q psy15039        584 A  584 (622)
Q Consensus       584 ~  584 (622)
                      .
T Consensus       303 ~  303 (604)
T KOG0592|consen  303 D  303 (604)
T ss_pred             c
Confidence            3

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.9e-44  Score=370.51  Aligned_cols=257  Identities=20%  Similarity=0.323  Sum_probs=212.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus        16 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         16 KLSDFEMGETLGT--GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CchheEEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            3578999999999  7789999999999999999999876432 223456688999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+.+|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||........
T Consensus        94 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999999998764  35789999999999999999999999999999999999999999999999976443211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                             .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||.+..... ..+.+....+         
T Consensus       172 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~---------  232 (329)
T PTZ00263        172 -------TFTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAGRL---------  232 (329)
T ss_pred             -------cceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCCc---------
Confidence                   112356778999999975  357899999999999999999999998654432 2222221110         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTK  309 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~  309 (622)
                                             ..+..++.++.+|+..||+.||.+||+     +.+++.||||....
T Consensus       233 -----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        233 -----------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence                                   012236788999999999999999997     79999999998743

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-44  Score=364.99  Aligned_cols=256  Identities=19%  Similarity=0.278  Sum_probs=212.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+...+++
T Consensus         1 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGT--GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeec--CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            57999999999  7799999999999999999999976432 22345668899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+++.|||........  
T Consensus        79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          79 LMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999999999998764  35789999999999999999999999999999999999999999999999976433211  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||..............+..            
T Consensus       155 -----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------------  215 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL------------  215 (291)
T ss_pred             -----cccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------------
Confidence                 112346778999999875  3578999999999999999999999987654332222222211            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                           ..+..+++.+++|+++||+.||.+||+     +.++++||||.....
T Consensus       216 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         216 ---------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             ---------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence                                 012345788999999999999999995     999999999976543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0616|consensus

Probab=100.00  E-value=1.3e-44  Score=341.28  Aligned_cols=242  Identities=18%  Similarity=0.326  Sum_probs=200.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...+|++...||.  |+||.|.+++++.+|..+|+|++.+... .-.+.+...+|..+|+.+.||++|++++.|.+.+.+
T Consensus        42 ~l~dfe~~~tlGt--GSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   42 SLQDFERLKTLGT--GSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             chhhhhheeeecc--CccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            3567999999999  7899999999999999999999876542 234456788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||.+||+|..++++.+.  +++..++.|+.||+.||+|||+++|++|||||+|||||.+|.+++.|||++...+  
T Consensus       120 ymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--  195 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--  195 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence            999999999999999998654  6788899999999999999999999999999999999999999999999875332  


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCccc
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  595 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  595 (622)
                           ...-+.||||.|+|||++..  .+|+.++|.|||||++|||+.|.+||...++....-.++.+.    +.+|+++
T Consensus       196 -----~rT~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~----v~fP~~f  264 (355)
T KOG0616|consen  196 -----GRTWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK----VKFPSYF  264 (355)
T ss_pred             -----CcEEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc----ccCCccc
Confidence                 22345689999999999976  579999999999999999999999999987755433344443    3445555


Q ss_pred             ccCCCCcCcccccchhhhhhhhhc
Q psy15039        596 VDTGQDDGEENACSYISEQQTQVL  619 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~~~~~  619 (622)
                      ...    ..-.+...|..+.++|.
T Consensus       265 s~~----~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  265 SSD----AKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             CHH----HHHHHHHHHhhhhHhhh
Confidence            322    22334455555555554

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-44  Score=362.17  Aligned_cols=285  Identities=21%  Similarity=0.277  Sum_probs=211.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||.||+|+++.+++.||||++......+...+.+.+|+++|++++||||++++++|..++.+++|
T Consensus         1 ~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGE--GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecc--cCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            47999999999  7789999999999999999999987655455566788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||++++.+..+...  ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+++.|||...........
T Consensus        79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          79 FEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            999998776655433  235889999999999999999999999999999999999999999999999976543221111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HHHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~p~~~~~~~~~~  246 (622)
                         ......+++.|+|||++.+.  .++.++||||+||++|+|++|++||..........  ..+.+..|.... .....
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  230 (287)
T cd07848         157 ---NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM-KLFYS  230 (287)
T ss_pred             ---cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH-Hhhhc
Confidence               11123457789999999753  58899999999999999999999998765433322  222222221000 00000


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ........  .+...............+|+++.+|+++||+.||++|||++++++||||
T Consensus       231 ~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLR--FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccc--cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00000000  0000000000001123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-43  Score=359.99  Aligned_cols=280  Identities=21%  Similarity=0.293  Sum_probs=210.0

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      -++|++.+.||+  |+||.||+|+++.+++.||+|+++.... ......+.+|+.+|++++||||+++++++.+....++
T Consensus         4 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           4 LETYVKLDKLGE--GTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             cccceEeeEEec--CCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            357999999999  7799999999999999999999875432 2223456789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++ |++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        81 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          81 VFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            999998 58888876543 2478899999999999999999999999999999999999999999999997643321111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCCCCCcccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATPHLLDCTTYY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p~~~~~~~~~  245 (622)
                          ......+++.|+|||++.+. ..++.++||||+||++|+|++|+.||.+......+..  ...+.++.. .+.   
T Consensus       159 ----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~---  229 (288)
T cd07871         159 ----TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE-TWP---  229 (288)
T ss_pred             ----cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH-Hhh---
Confidence                11223457789999998653 4588999999999999999999999987654333322  222222110 000   


Q ss_pred             ccCCCCcCcccccccchhhh---hccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        246 VDTGQDDGEENACSYISEQQ---TQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                       ..   ...........+..   .........++++.+|+++||+.||.+|||+.|+++||||
T Consensus       230 -~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         230 -GI---TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             -cc---ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             00   00000000000000   0001123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0192|consensus

Probab=100.00  E-value=3.7e-43  Score=360.59  Aligned_cols=253  Identities=28%  Similarity=0.458  Sum_probs=207.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcE-EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-cEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQL-IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-DLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~-vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~   86 (622)
                      +..++.+.||+  |+||+||+|..+.+  . ||||+++.........+.+.+|+.+|++|+|||||+|+|++.... .+.
T Consensus        41 ~~l~~~~~iG~--G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   41 DELPIEEVLGS--GSFGTVYKGKWRGT--DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             HHhhhhhhccc--CCceeEEEEEeCCc--eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            34556677898  77889999998844  5 999999887666565788999999999999999999999999887 799


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCEEEcCCC-ceEEcCCccccccCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG-FIHRAVKASHILISHNG-KACLSGLRYMCPFSP  164 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~-IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~~~  164 (622)
                      +|||||++|+|.+++.......++...+..++.||++|+.|||+++ ||||||||+|||++.++ .+||+|||.+.....
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9999999999999997743446899999999999999999999999 99999999999999998 999999998755433


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh-CCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA-GATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~-~~~p~~~~~~~  243 (622)
                      ..    .......+|..|||||++.+....|+.|+||||||+++|||+||..||............+. +..|.+     
T Consensus       197 ~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~-----  267 (362)
T KOG0192|consen  197 SK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI-----  267 (362)
T ss_pred             cc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC-----
Confidence            22    11122577889999999984334699999999999999999999999998776433333332 222221     


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                 +....+.+..++..||..||.+||+..+++.
T Consensus       268 ---------------------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  268 ---------------------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ---------------------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                       1226788999999999999999999998775

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-43  Score=358.26  Aligned_cols=260  Identities=20%  Similarity=0.304  Sum_probs=210.7

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .|++.+.||+  |+||.||+|.++.+|+.||||++....... .....+.+|+.+|++++|+||++++++|.+.+.+++|
T Consensus         1 ~f~~~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGK--GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEec--CCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            4889999999  889999999999999999999987654322 2334577899999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++|+|.+.+.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.......... 
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-  157 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence            9999999999887654444588999999999999999999999999999999999999999999999997644321111 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH---HHHHHHhCCCCCCCcccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL---MLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~p~~~~~~~~~  245 (622)
                          .....++..|+|||++.+  ..|+.++||||+||++|+|++|+.||.......   .....+...           
T Consensus       158 ----~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (285)
T cd05631         158 ----VRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-----------  220 (285)
T ss_pred             ----ecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------
Confidence                112356788999999975  358899999999999999999999997643321   111111000           


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                           .......+++++.+|+.+||+.||++||+     ++++++||||.....
T Consensus       221 ---------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         221 ---------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             ---------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                                 00112357899999999999999999997     899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0593|consensus

Probab=100.00  E-value=9.2e-45  Score=342.78  Aligned_cols=213  Identities=23%  Similarity=0.334  Sum_probs=183.0

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      .|+.+..+|.  |+||+||+|+++.||+.||||+|..+..++...+..+|||+.|++|+|||+|.++.+|.....+++|+
T Consensus         3 kYE~LgkvGE--GSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    3 KYEKLGKVGE--GSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             HHhhhhcccc--CcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            5788889999  78999999999999999999999877766666678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      |||+..-|. .|.+. ..++++..+.+|+.|++.|+.|+|+++||||||||+|||++.+|.+|++|||++..++......
T Consensus        81 E~~dhTvL~-eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   81 EYCDHTVLH-ELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eecchHHHH-HHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999964444 44444 3468999999999999999999999999999999999999999999999999976554322111


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                          +..+-|.+|.|||++.+. ..|+.++||||+||++.||++|.+-|.+.++.++++.+.
T Consensus       159 ----TDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~  215 (396)
T KOG0593|consen  159 ----TDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR  215 (396)
T ss_pred             ----hhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence                112336789999999764 369999999999999999999999999999888876543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-42  Score=360.21  Aligned_cols=288  Identities=23%  Similarity=0.337  Sum_probs=216.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+++++.+|..||+|.+..+. .+...+.+.+|+++|++++||||+++++++.+++..++
T Consensus         4 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGA--GNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecC--CCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            479999999999  778899999999999999999987643 34556678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ||||+++|+|.+++....  .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+++.|||.........
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             EeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            999999999999987643  478999999999999999999986 69999999999999999999999999764332111


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                            .....++..|+|||++.+  ..++.++|||||||++|+|++|+.||....... +...+ +... .......+.
T Consensus       159 ------~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~-~~~~-~~~~~~~~~  227 (331)
T cd06649         159 ------ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIF-GRPV-VDGEEGEPH  227 (331)
T ss_pred             ------cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHh-cccc-cccccCCcc
Confidence                  122356778999999975  358899999999999999999999997654322 21111 1110 000000000


Q ss_pred             cCCCC-------------cC-----cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        247 DTGQD-------------DG-----EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       247 ~~~~~-------------~~-----~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      .....             +.     ......++.....+......+++++++||.+||+.||++|||+.++++||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence            00000             00     0000011111111222233578999999999999999999999999999999875


Q ss_pred             ccC
Q psy15039        309 KKC  311 (622)
Q Consensus       309 ~~~  311 (622)
                      ...
T Consensus       308 ~~~  310 (331)
T cd06649         308 EVE  310 (331)
T ss_pred             ccc
Confidence            443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0576|consensus

Probab=100.00  E-value=1.6e-45  Score=379.84  Aligned_cols=416  Identities=28%  Similarity=0.419  Sum_probs=325.5

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      |=.++|+++..+|.  |.||.||+++++.++++.|+|.++....  ++.+-+..||-+++..+|||||-|++.|...+.+
T Consensus        12 nP~ddyellqrvgs--gTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGS--GTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecC--CcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            44679999999999  6688999999999999999999988643  3456677899999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |++||||.+|+++|+-...  ++++|.++..+.+..+.||+|+|+.|=+|||||-.|||++..|++++.|||........
T Consensus        88 wicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999999999986443  46899999999999999999999999999999999999999999999999987666544


Q ss_pred             CccccccCCCCCCCccccChhhhc-cccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~-~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~~~~~  242 (622)
                      ..+..    +..+|++|||||+-. +...+|+.++||||+|++..|+..-++|.+....+..+  +.+....+|.+.   
T Consensus       166 i~Krk----sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk---  238 (829)
T KOG0576|consen  166 IAKRK----SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK---  238 (829)
T ss_pred             hhhhh----cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc---
Confidence            33332    346788999999852 33457999999999999999999989897765443332  233333333322   


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCCCccccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPA  322 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~  322 (622)
                                                 ...+|++-|.+|++.+|..+|++||+++.+|+|||....              
T Consensus       239 ---------------------------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------------  277 (829)
T KOG0576|consen  239 ---------------------------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------------  277 (829)
T ss_pred             ---------------------------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------------
Confidence                                       234689999999999999999999999999999876331              


Q ss_pred             cCCCccccccccccccccccccccccccccccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH
Q psy15039        323 LSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE  402 (622)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~  402 (622)
                                                                                                      
T Consensus       278 --------------------------------------------------------------------------------  277 (829)
T KOG0576|consen  278 --------------------------------------------------------------------------------  277 (829)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHHHHHHHHHhhCCCCc-cceeEEEEEeCCcEEEEeeccCCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy15039        403 DLKSLHHEIVCMRHLRHPN-IICYISSFLDATDLHLVSPLMGFG-SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG  480 (622)
Q Consensus       403 ~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~lv~e~~~~g-~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~  480 (622)
                        ....-++++|.+.+||| .|.+++.+......++.++++.++ +..+.... ....+.+.....+.+.-..+|+++|+
T Consensus       278 --l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~  354 (829)
T KOG0576|consen  278 --LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHS  354 (829)
T ss_pred             --hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccc
Confidence              01122567888999999 788888888888899999999877 22221111 01112334455666777889999999


Q ss_pred             CCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHH
Q psy15039        481 KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE  560 (622)
Q Consensus       481 ~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e  560 (622)
                      .-=+|||    ||+.++ +..+..+++....+....     .+.+..+++.|+|||+...+  .++...|.||+|+-..+
T Consensus       355 ~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-----~~~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~  422 (829)
T KOG0576|consen  355 SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-----KPRTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQ  422 (829)
T ss_pred             ccccCcc----cccccc-cccccccccCCcccCccc-----ccccCCCCCCCCCchhhccc--ccccCCCccCCCcchhh
Confidence            8889999    888765 555666766544333221     34456778999999998763  58888999999999999


Q ss_pred             HHcCCCCCCC
Q psy15039        561 LANGTVPFAE  570 (622)
Q Consensus       561 ~ltg~~Pf~~  570 (622)
                      |.-|.+|-..
T Consensus       423 ~ap~~pPr~~  432 (829)
T KOG0576|consen  423 MAPGLPPRSS  432 (829)
T ss_pred             cCCCCCCCCC
Confidence            9999888644

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=371.17  Aligned_cols=265  Identities=20%  Similarity=0.320  Sum_probs=212.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus         1 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGR--GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEe--cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            48999999999  7799999999999999999999976432 23445667899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+++.|||....+.....
T Consensus        79 v~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          79 IMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999999999998764  3588999999999999999999999999999999999999999999999997543221100


Q ss_pred             ccc----------------------------------ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc
Q psy15039        168 KVH----------------------------------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN  213 (622)
Q Consensus       168 ~~~----------------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~  213 (622)
                      ...                                  ....+..+|+.|+|||++..  ..|+.++|||||||++|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhhc
Confidence            000                                  00112357889999999865  458999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCC
Q psy15039        214 GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR  293 (622)
Q Consensus       214 g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  293 (622)
                      |..||............+....                             ....+....+++++.+||.+||. ||.+|
T Consensus       235 G~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R  284 (364)
T cd05599         235 GYPPFCSDNPQETYRKIINWKE-----------------------------TLQFPDEVPLSPEAKDLIKRLCC-EAERR  284 (364)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCC-----------------------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhc
Confidence            9999987654433222221110                             00111223578999999999997 99999


Q ss_pred             cC---HHhhhcCccccccc
Q psy15039        294 PL---ACNLLQHAFFKQTK  309 (622)
Q Consensus       294 ps---~~~~l~h~~~~~~~  309 (622)
                      ++   +.++++||||+...
T Consensus       285 ~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         285 LGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCCCCHHHHhcCCCcCCCC
Confidence            98   99999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.9e-43  Score=366.02  Aligned_cols=289  Identities=23%  Similarity=0.270  Sum_probs=210.8

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-----c
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----D   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~   84 (622)
                      +|++.+.||+  |+||.||+|+++.+|+.||||+++...........+.+|+.+|++++||||+++++++....     .
T Consensus         1 ry~i~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGK--GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEee--cCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            5999999999  77899999999999999999998754333444567889999999999999999999886542     4


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+|||||+ +++.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.......
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          79 IYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            899999996 6888888653  3478999999999999999999999999999999999999999999999997643221


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH--HHHHHHhCCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL--MLIEKLAGATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~--~~~~~~~~~~p~~~~~~  242 (622)
                      ..... .......++..|+|||++.+....++.++|||||||++|+|++|++||.......  ..+....+.++....  
T Consensus       156 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  232 (338)
T cd07859         156 DTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI--  232 (338)
T ss_pred             ccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH--
Confidence            11110 1112335678899999986533468899999999999999999999997654322  222222332221000  


Q ss_pred             cccccCCCCcCcccccccchhhh-hcc-ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQ-TQV-LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~-~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ..   ........ ....+.... ... ......++++.+++.+||+.||++||++.++++||||+....
T Consensus       233 ~~---i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         233 SR---VRNEKARR-YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HH---hhhhhHHH-HHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            00   00000000 000000000 000 011246788999999999999999999999999999977544

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.4e-43  Score=365.11  Aligned_cols=252  Identities=19%  Similarity=0.279  Sum_probs=206.5

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      ++||+  |+||.||+|+++.+|+.||||++..... .......+.+|+.+|++++||||++++++|...+.+++||||++
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGK--GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            36898  7799999999999999999999876432 33445667899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccC
Q psy15039         94 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  173 (622)
Q Consensus        94 ~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~  173 (622)
                      +|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    ..
T Consensus        79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----~~  152 (323)
T cd05571          79 GGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----TM  152 (323)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC----cc
Confidence            99999988763  3578999999999999999999999999999999999999999999999997543211111    11


Q ss_pred             CCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       174 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      ....+|+.|+|||++.+  ..|+.++||||+||++|||++|..||..............+. +                 
T Consensus       153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~-----------------  212 (323)
T cd05571         153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-I-----------------  212 (323)
T ss_pred             cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-C-----------------
Confidence            22356788999999875  358899999999999999999999998655433222222111 0                 


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                     ..+..+++++.+|+..||+.||++||     ++.++++||||....
T Consensus       213 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                           01234788999999999999999999     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694|consensus

Probab=100.00  E-value=1.6e-43  Score=368.67  Aligned_cols=258  Identities=21%  Similarity=0.319  Sum_probs=218.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~   86 (622)
                      ++|.++++||+  |+||+|+++..+.|++.||||.+++... ..++.+....|..|+.... ||.+++++.+|.+.+.+|
T Consensus       368 ~~F~~l~vLGk--GsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  368 DDFRLLAVLGR--GSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cceEEEEEecc--CcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            58999999999  7788999999999999999999998763 5667888889999998884 999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      .||||+.||++..+.+.   ..++|..++.|+..|+.||+|||++|||+||||.+|||||.+|.++|+|||.....- ..
T Consensus       446 fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~~  521 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-GQ  521 (694)
T ss_pred             EEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC-CC
Confidence            99999999994433322   358999999999999999999999999999999999999999999999999653321 11


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .   ....+.+||+.|||||++.+  ..|+.++|+|||||+||||+.|++||.+.+.....-.++...            
T Consensus       522 g---~~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~------------  584 (694)
T KOG0694|consen  522 G---DRTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE------------  584 (694)
T ss_pred             C---CccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------
Confidence            1   12345688999999999987  469999999999999999999999999877665443333211            


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~~~~~~  310 (622)
                                           ...+..+|.++.++++++|.+||++|..+     .++.+||||+...+
T Consensus       585 ---------------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w  632 (694)
T KOG0694|consen  585 ---------------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW  632 (694)
T ss_pred             ---------------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence                                 12345679999999999999999999975     68999999998764

>KOG4279|consensus

Probab=100.00  E-value=2.4e-44  Score=371.03  Aligned_cols=255  Identities=25%  Similarity=0.447  Sum_probs=214.5

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF   94 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~   94 (622)
                      -+||+  |.||+||.|+++.|...+|||.+...  .....+.+..||.+.++|+|.|||+|+|++..+..+.+.||-.+|
T Consensus       581 vVLGK--GTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  581 VVLGK--GTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EEeec--CceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            36999  66889999999999999999998654  245567788999999999999999999999888889999999999


Q ss_pred             CCHHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCceEEcCCccccccCCCCccccc
Q psy15039         95 GSCKDLINAHFNFGL--PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        95 g~l~~~l~~~~~~~l--~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      |+|.++++..|. ++  +|..+.++.+||++||.|||++.|||||||-.|||++. .|.+||+|||....+..-    .-
T Consensus       657 GSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----nP  731 (1226)
T KOG4279|consen  657 GSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----NP  731 (1226)
T ss_pred             CcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC----Cc
Confidence            999999999874 45  89999999999999999999999999999999999974 688999999976443211    11


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCCccccccccCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLLDCTTYYVDTG  249 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~~  249 (622)
                      ...+..||+.|||||++..+..+|+.++|||||||++.||+||++||.+.......+.++.  ..+|.            
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~------------  799 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPP------------  799 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCC------------
Confidence            1234577899999999999999999999999999999999999999987554444443332  12222            


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                          .+..+|.+++.||.+|+.+||.+||+|.++|+.||+....+
T Consensus       800 --------------------iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  800 --------------------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             --------------------CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence                                22347899999999999999999999999999999987643

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.2e-43  Score=369.76  Aligned_cols=267  Identities=22%  Similarity=0.289  Sum_probs=211.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.+++.||||++..... .......+.+|+.+|++++|||||+++++|.+.+.+++
T Consensus         1 ~~f~~~~~LG~--G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l   78 (381)
T cd05626           1 SMFVKIKTLGI--GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (381)
T ss_pred             CCceEEEEEee--cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence            47999999999  7799999999999999999999976543 33456678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||....+.....
T Consensus        79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          79 VMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999999999998764  3578999999999999999999999999999999999999999999999997532210000


Q ss_pred             c-------------------------------------------ccccCCCCCCCccccChhhhccccCCCCCcchHHHH
Q psy15039        168 K-------------------------------------------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV  204 (622)
Q Consensus       168 ~-------------------------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSl  204 (622)
                      .                                           ......+..+|+.|+|||++.+  ..|+.++||||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl  234 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence            0                                           0000112357889999999875  458899999999


Q ss_pred             HHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHH
Q psy15039        205 GISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL  284 (622)
Q Consensus       205 G~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~  284 (622)
                      ||++|||++|..||............+....                             ....+....+++++.+|+.+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~s~~~~dli~~  285 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN-----------------------------TLHIPPQVKLSPEAVDLITK  285 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc-----------------------------ccCCCCCCCCCHHHHHHHHH
Confidence            9999999999999986554333222221100                             00111223578999999999


Q ss_pred             hh--hcCCCCCcCHHhhhcCcccccccc
Q psy15039        285 CL--SRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       285 ~L--~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      |+  ..+|.+||++.++++||||.....
T Consensus       286 ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         286 LCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HccCcccccCCCCHHHHhcCcccCCCCh
Confidence            55  445556999999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.3e-43  Score=362.85  Aligned_cols=298  Identities=42%  Similarity=0.705  Sum_probs=219.9

Q ss_pred             EEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         13 ICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        13 ~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +...||+|.|+||+||+++++.+|+.||||++..........+.+.+|+.+++.++||||++++++|..++.+++++||+
T Consensus         2 ~~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             hHHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            45679999999999999999999999999999876666666788899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC---CCccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP---TKKKV  169 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~---~~~~~  169 (622)
                      .++++.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.+++.......   .....
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999999998775544689999999999999999999999999999999999999999999998865322111   11111


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc-C
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD-T  248 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~  248 (622)
                      ...+.....+..|+|||++.+....++.++||||+||++|+|++|..||............+.+......+....... .
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence            111111223456999999976545578999999999999999999999987665555444444322111100000000 0


Q ss_pred             CCCcCccccc-------------ccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        249 GQDDGEENAC-------------SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       249 ~~~~~~~~~~-------------~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ..........             ..+............+++++.+|++.||+.||++|||+.++++||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            0000000000             0000001111122346889999999999999999999999999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.8e-43  Score=366.78  Aligned_cols=266  Identities=19%  Similarity=0.279  Sum_probs=209.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.+|+.||||++..... .......+.+|+.+|++++||||+++++.+.+...+|+
T Consensus         1 ~~y~~~~~LG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGR--GAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEe--CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            48999999999  7799999999999999999999976432 23344667889999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+++.|||..........
T Consensus        79 v~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          79 IMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999999999998764  3588999999999999999999999999999999999999999999999997643221100


Q ss_pred             cc-------------------------------cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCC
Q psy15039        168 KV-------------------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV  216 (622)
Q Consensus       168 ~~-------------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~  216 (622)
                      ..                               .....+..+|+.|+|||++.+  ..|+.++|||||||++|||++|..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCCC
Confidence            00                               000113467889999999975  468999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCC---CC
Q psy15039        217 PFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVD---KR  293 (622)
Q Consensus       217 Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~R  293 (622)
                      ||.+................                             ...+....+|+++++++.+|+. +|.   .|
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r  284 (363)
T cd05628         235 PFCSETPQETYKKVMNWKET-----------------------------LIFPPEVPISEKAKDLILRFCC-EWEHRIGA  284 (363)
T ss_pred             CCCCCCHHHHHHHHHcCcCc-----------------------------ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence            99876543332222211100                             0011223478999999998765 444   56


Q ss_pred             cCHHhhhcCcccccccc
Q psy15039        294 PLACNLLQHAFFKQTKK  310 (622)
Q Consensus       294 ps~~~~l~h~~~~~~~~  310 (622)
                      |+++++++||||+....
T Consensus       285 ~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         285 PGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCHHHHhCCCCCCCCCH
Confidence            89999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-42  Score=357.82  Aligned_cols=298  Identities=54%  Similarity=0.892  Sum_probs=224.8

Q ss_pred             EEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         13 ICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        13 ~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +..+||+|.|+++.||+++++.+|+.||||+++...........+.+|+.+|++++||||++++++|...+..+++|||+
T Consensus         2 ~~~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             chhhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            44578888888889999999999999999999876555666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc---cc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK---KV  169 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~---~~  169 (622)
                      ++|++.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+++.+|+..........   ..
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999999999875545689999999999999999999999999999999999999999999999986543321111   11


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                      .........+..|+|||++......|+.++||||+||++|||++|..||...+......+.+.+..+...+.........
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            11122233456799999997654568899999999999999999999998776666666666555443332211111000


Q ss_pred             CCcC-cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        250 QDDG-EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       250 ~~~~-~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .... ....................++.++.+|+..||+.||++|||+.++++||||+..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence            0000 000000000011111223346789999999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.2e-42  Score=352.38  Aligned_cols=280  Identities=22%  Similarity=0.307  Sum_probs=205.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEcc-CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCcceeEEEEEEe---
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKV-TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFLD---   81 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~-t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~~~~~~~~---   81 (622)
                      .+|++.+.||+  |+||+||+|++.. +|+.||||.+......+.....+.+|+.+++.+   +||||+++++++..   
T Consensus         1 ~~Y~~~~~lg~--G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEecc--CCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            47999999999  7799999999865 578899999876544333334556788777766   69999999998852   


Q ss_pred             --CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         82 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        82 --~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                        ...+++||||++ +++.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence              356999999997 68888887654445899999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHL  238 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~  238 (622)
                      .......     ......+++.|+|||++.+  ..++.++||||+||++|||++|.+||........+...+.. ..|..
T Consensus       158 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         158 RIYSFQM-----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             EeccCCc-----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            4432211     1123356778999999865  35889999999999999999999999876554433333221 11111


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .++.... .....     ............ ....+++.+.+|+.+||+.||++|||+.++|+||||
T Consensus       231 ~~~~~~~-~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         231 EDWPRDV-ALPRQ-----AFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhchhhh-cccch-----hccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            1111000 00000     000000000000 113468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-43  Score=363.07  Aligned_cols=256  Identities=20%  Similarity=0.329  Sum_probs=210.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCC-cEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTN-QLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~-~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ++|++.+.||+  |+||.||+|.++.++ ..||+|++..... .....+.+.+|+.+|+.++|||||++++++.+...++
T Consensus        30 ~~y~~~~~ig~--G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         30 EDFNFIRTLGT--GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             hhcEEEEEEee--cCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            57999999999  778999999987665 6899999865432 2344566889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.+|.++++|||........ 
T Consensus       108 lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            9999999999999997643  5789999999999999999999999999999999999999999999999976433211 


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                            ..+..+|+.|+|||++.+  ..++.++||||+||++|||++|..||..............+. .          
T Consensus       185 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~----------  245 (340)
T PTZ00426        185 ------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-I----------  245 (340)
T ss_pred             ------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-C----------
Confidence                  123356788999999975  357899999999999999999999998765433222222111 0          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                            ..+..+++++.+++++||+.||.+|+     ++.++++||||....+
T Consensus       246 ----------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        246 ----------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                  01234678899999999999999995     8999999999987543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=361.27  Aligned_cols=263  Identities=20%  Similarity=0.298  Sum_probs=213.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+|++++.||+  |+||.||+|+++.+|+.||||+++..... ....+.+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus         1 ~~y~~~~~ig~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQ--GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEee--cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            47999999999  77899999999999999999999764322 2345668899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+++.|||.......   
T Consensus        79 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          79 AMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            99999999999999764  3578999999999999999999999999999999999999999999999997643321   


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                          ......+|+.|+|||++.+.  .|+.++|||||||++|||++|..||................ ..+ .       
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~-~-------  218 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETL-Q-------  218 (333)
T ss_pred             ----ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-ccc-c-------
Confidence                12234567889999999753  68999999999999999999999998665433222211110 000 0       


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                      ..........+++++.+|+..||..+|++||++.++++||||....
T Consensus       219 ----------------~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         219 ----------------RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             ----------------CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence                            0000001135689999999999999999999999999999998753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-42  Score=368.48  Aligned_cols=265  Identities=23%  Similarity=0.301  Sum_probs=211.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||.||+|+++.+++.||||++..... .......+.+|+.+|++++|||||+++++|.+++.+++
T Consensus         1 ~~f~~~~~LG~--G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l   78 (382)
T cd05625           1 SMFVKIKTLGI--GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF   78 (382)
T ss_pred             CCcEEEEEEEe--CCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence            46999999999  7799999999999999999999876432 23445678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||....+.....
T Consensus        79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          79 VMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999998764  3478999999999999999999999999999999999999999999999997532210000


Q ss_pred             -------------------------------------------cccccCCCCCCCccccChhhhccccCCCCCcchHHHH
Q psy15039        168 -------------------------------------------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV  204 (622)
Q Consensus       168 -------------------------------------------~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSl  204 (622)
                                                                 .......+..+|+.|+|||++.+  ..|+.++||||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl  234 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEec
Confidence                                                       00000112356888999999975  458999999999


Q ss_pred             HHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHH
Q psy15039        205 GISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL  284 (622)
Q Consensus       205 G~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~  284 (622)
                      ||++|||++|+.||............+.....                             ...+....+++++.+++.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~~~~s~~~~~li~~  285 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTS-----------------------------LHIPPQAKLSPEASDLIIK  285 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC-----------------------------cCCCCcccCCHHHHHHHHH
Confidence            99999999999999876554333333221100                             0111234578999999999


Q ss_pred             hhhcCCCCCcC---HHhhhcCccccccc
Q psy15039        285 CLSRDVDKRPL---ACNLLQHAFFKQTK  309 (622)
Q Consensus       285 ~L~~dP~~Rps---~~~~l~h~~~~~~~  309 (622)
                      |+ .||.+|++   ++++++||||+...
T Consensus       286 l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         286 LC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             Hc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            76 59999997   99999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0597|consensus

Probab=100.00  E-value=9.5e-44  Score=360.19  Aligned_cols=243  Identities=24%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|.+.+.||+  |+||.||||+.+.|.+.||+|.+.+..-++++++.+.+|++|++.|+|||||.+++.|....++|+|
T Consensus         2 e~yhv~e~iG~--Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGE--GSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcC--CccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            46888999999  7899999999999999999999998888888899999999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      .||+.| +|..++....  .++|..++.++.|++.||.|||+++|+|||+||+|||++..|.+|++|||++...+..+. 
T Consensus        80 te~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-  155 (808)
T ss_pred             ehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence            999997 9999998754  489999999999999999999999999999999999999999999999998766554322 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCcccccC
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  598 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  598 (622)
                         ...+..|||.|||||++.+  +.|+..+|+||+|||+|||.+|+|||...+- .++.+.|...++.-++       .
T Consensus       156 ---vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si-~~Lv~~I~~d~v~~p~-------~  222 (808)
T KOG0597|consen  156 ---VLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSI-TQLVKSILKDPVKPPS-------T  222 (808)
T ss_pred             ---eeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHH-HHHHHHHhcCCCCCcc-------c
Confidence               2234678999999999986  6799999999999999999999999987644 4455555554322222       4


Q ss_pred             CCCcCcccccchhhhhhhhhcc
Q psy15039        599 GQDDGEENACSYISEQQTQVLT  620 (622)
Q Consensus       599 ~~~~~~~~~~~~~~~~~~~~~~  620 (622)
                      ..++....+...+..++.+|+|
T Consensus       223 ~S~~f~nfl~gLL~kdP~~Rlt  244 (808)
T KOG0597|consen  223 ASSSFVNFLQGLLIKDPAQRLT  244 (808)
T ss_pred             ccHHHHHHHHHHhhcChhhccc
Confidence            4444445555566667777765

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-42  Score=364.76  Aligned_cols=266  Identities=22%  Similarity=0.297  Sum_probs=214.0

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..+|++.+.||+  |+||.||+++++.+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.+...++
T Consensus        42 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          42 AEDFDVIKVIGR--GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             HHHcEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            468999999999  7799999999999999999999975432 2233455778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.........
T Consensus       120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999998653   47899999999999999999999999999999999999999999999999764432211


Q ss_pred             ccccccCCCCCCCccccChhhhcccc--CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .   .......+|+.|+|||++....  ..++.++|||||||++|||++|..||................. .       
T Consensus       197 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~-------  265 (370)
T cd05596         197 M---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-S-------  265 (370)
T ss_pred             c---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-c-------
Confidence            1   1112345788899999986432  2478899999999999999999999987654332222221110 0       


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~~  310 (622)
                                           ...+....+|.++.+|+..||+.+|++  |+++.++++||||+....
T Consensus       266 ---------------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         266 ---------------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             ---------------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                                 011122357899999999999999988  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.6e-42  Score=371.07  Aligned_cols=283  Identities=19%  Similarity=0.257  Sum_probs=205.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-----   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----   82 (622)
                      ..+|++++.||+  |+||.||+|.++.+++.||||++....      ....+|+.+|+.++|||||+++++|...     
T Consensus        65 ~~~y~~~~~LG~--G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGN--GSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEe--CCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            347999999999  779999999999999999999985432      2234799999999999999999987542     


Q ss_pred             ---CcEEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCC
Q psy15039         83 ---TDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGL  156 (622)
Q Consensus        83 ---~~~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~  156 (622)
                         ..+++||||+++ ++.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .++++||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               247799999984 666666532  234588999999999999999999999999999999999999765 6999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~  234 (622)
                      |.+........     ..+..+|+.|+|||++.+. ..|+.++||||+||++|||++|.+||.+......+...+  .+.
T Consensus       216 Gla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAGQR-----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             ccchhccCCCC-----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            98754432211     1123557789999998653 468999999999999999999999998765544333322  222


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                      + ........    .........+. +.........+...++++.+|+++||+.||.+|||+.++|+||||......
T Consensus       290 p-~~~~~~~~----~~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        290 P-TEDQLKEM----NPNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             C-CHHHHHHh----chhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            1 10000000    00000000000 000001111123468899999999999999999999999999999876543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=357.39  Aligned_cols=250  Identities=20%  Similarity=0.258  Sum_probs=204.8

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG   95 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g   95 (622)
                      ||+  |+||.||+|+++.+++.||+|+++... ........+.+|+.+|++++|||||+++++|.+.+.+++||||+++|
T Consensus         1 lg~--G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGK--GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCc--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            677  889999999999999999999987543 23345567789999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCC
Q psy15039         96 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  175 (622)
Q Consensus        96 ~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  175 (622)
                      +|.+.+...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+++.|||..........    ....
T Consensus        79 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~~~  152 (312)
T cd05585          79 ELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD----KTNT  152 (312)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC----cccc
Confidence            999998764  3578999999999999999999999999999999999999999999999997543211111    1123


Q ss_pred             CCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcc
Q psy15039        176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE  255 (622)
Q Consensus       176 ~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  255 (622)
                      ..+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||..............+. +                   
T Consensus       153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~-------------------  210 (312)
T cd05585         153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-L-------------------  210 (312)
T ss_pred             ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-C-------------------
Confidence            356788999999975  458999999999999999999999998665443322222111 0                   


Q ss_pred             cccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc---CHHhhhcCccccccc
Q psy15039        256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP---LACNLLQHAFFKQTK  309 (622)
Q Consensus       256 ~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~h~~~~~~~  309 (622)
                                   ..+..+++++.+|+.+||+.||.+||   ++.+++.||||....
T Consensus       211 -------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         211 -------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             -------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                         11234688999999999999999997   589999999998753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=367.37  Aligned_cols=264  Identities=21%  Similarity=0.322  Sum_probs=209.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+|++++.||+  |+||.||+++++.+|+.||||++..... .....+.+.+|+++|++++|||||+++++|.+...+|+
T Consensus         1 ~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGK--GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEee--cCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            47999999999  7799999999999999999999865432 23445678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||....+.....
T Consensus        79 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          79 IMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999999999998763  3578999999999999999999999999999999999999999999999997642211000


Q ss_pred             c----------c---------------------------------cccCCCCCCCccccChhhhccccCCCCCcchHHHH
Q psy15039        168 K----------V---------------------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV  204 (622)
Q Consensus       168 ~----------~---------------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSl  204 (622)
                      .          .                                 ........+|+.|+|||++.+  ..|+.++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSl  234 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEec
Confidence            0          0                                 000012357888999999875  458999999999


Q ss_pred             HHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHH
Q psy15039        205 GISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL  284 (622)
Q Consensus       205 G~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~  284 (622)
                      ||++|||++|..||.................                             ....+....++.++.+|+.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~~p~~~~~s~~~~dli~~  285 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWRE-----------------------------TLYFPDDIHLSVEAEDLIRR  285 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccCC-----------------------------ccCCCCCCCCCHHHHHHHHH
Confidence            9999999999999976554332222211100                             00111223578999999999


Q ss_pred             hhhcCCCCC---cCHHhhhcCcccccc
Q psy15039        285 CLSRDVDKR---PLACNLLQHAFFKQT  308 (622)
Q Consensus       285 ~L~~dP~~R---ps~~~~l~h~~~~~~  308 (622)
                      ||+ +|.+|   +++.++++||||+..
T Consensus       286 lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         286 LIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             Hhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            998 77765   599999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0667|consensus

Probab=100.00  E-value=8.2e-43  Score=363.69  Aligned_cols=286  Identities=22%  Similarity=0.296  Sum_probs=216.6

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-C-----CcceeEEEEEEeCC
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-H-----PNIICYISSFLDAT   83 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~~~~~~~~~~   83 (622)
                      +|++.++||+  |.||.|.+|.+..|++.||||+++.+   +.-..+..-|+.||..|+ |     -|||+++++|...+
T Consensus       187 rY~V~e~LGk--GtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGK--GSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEecc--cccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            7899999999  66889999999999999999999664   445566778999999997 5     39999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC--ceEEcCCccccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCP  161 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~--~~~i~~~~~~~~  161 (622)
                      .++||.|+++ -+|.++++...-.+++-..++.++.||+.||.+||+.||||.|||||||||..-+  .+|+.|||.+|.
T Consensus       262 HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  262 HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999999887 6899999987666799999999999999999999999999999999999997644  789999999876


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCC-C
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPH-L  238 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~-~  238 (622)
                      .+...       .+...+..|+|||++.+  ..|+.++||||||||++||++|.+.|.+.+...++  +..+.|.+|. +
T Consensus       341 ~~q~v-------ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  341 ESQRV-------YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             cCCcc-------eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            54321       13345678999999997  46999999999999999999998888877664443  4445555442 2


Q ss_pred             Cccc---cccccC-C-------CCcCcccccccchh-------hhhccc-cC--------CCCcHHHHHHHHHhhhcCCC
Q psy15039        239 LDCT---TYYVDT-G-------QDDGEENACSYISE-------QQTQVL-TS--------RKFSDSFHSIVELCLSRDVD  291 (622)
Q Consensus       239 ~~~~---~~~~~~-~-------~~~~~~~~~~~i~~-------~~~~~~-~~--------~~~s~~~~~li~~~L~~dP~  291 (622)
                      ++..   ..+.+. .       ...........+..       .....+ ..        ..-...|.||+++||.+||.
T Consensus       412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~  491 (586)
T KOG0667|consen  412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA  491 (586)
T ss_pred             HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence            2210   111111 0       00000000000000       000011 00        12245789999999999999


Q ss_pred             CCcCHHhhhcCcccccccc
Q psy15039        292 KRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       292 ~Rps~~~~l~h~~~~~~~~  310 (622)
                      +|+|+.++|+|||+.....
T Consensus       492 ~R~tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  492 ERITPAQALNHPFLTGTSL  510 (586)
T ss_pred             hcCCHHHHhcCcccccccc
Confidence            9999999999999986544

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-42  Score=363.48  Aligned_cols=268  Identities=22%  Similarity=0.304  Sum_probs=213.3

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      .....+|++.+.||+  |+||.||+++++.+++.||+|.+.+... .....+.+.+|+.+++.++||||++++++|.+..
T Consensus        39 ~~~~~~y~~~~~lG~--G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          39 QMKAEDYDVVKVIGR--GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             CCCHHHCeEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            344578999999999  7799999999999999999999875332 2334456778999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+|+|||||++|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+....
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999999998653   47899999999999999999999999999999999999999999999999765432


Q ss_pred             CCCccccccCCCCCCCccccChhhhcccc--CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ....   ....+..+|+.|+|||++....  ..++.++||||+||++|+|++|..||............+....      
T Consensus       194 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~------  264 (370)
T cd05621         194 ETGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN------  264 (370)
T ss_pred             cCCc---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------
Confidence            2111   1112345788999999986432  2378899999999999999999999986654333222221110      


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTK  309 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~  309 (622)
                                             ....+....+++.+++++..||..++.+  |+++.++++||||+...
T Consensus       265 -----------------------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         265 -----------------------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             -----------------------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence                                   0011122346899999999999865544  89999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0033|consensus

Probab=100.00  E-value=5.5e-45  Score=334.40  Aligned_cols=250  Identities=25%  Similarity=0.324  Sum_probs=215.2

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...++|++.++||+  |.|+.||++.+..||+.+|+|.++...++....+.+.+|++|-+.|+|||||++.+.+......
T Consensus         8 ~f~d~y~l~e~igk--G~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHcc--CchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence            45678999999999  7799999999999999999999998888887888999999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~~~~~~~~~  512 (622)
                      |+|+|+|+|++|..-+-..  +-.+|..+..+++||++||.|+|.++|||||+||+|+|+.+..   -+|++|||.+..+
T Consensus        86 ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999999997544332  2357999999999999999999999999999999999997654   5899999998776


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  592 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  592 (622)
                      +.     .....+.+|||.|||||++..  ++|+.++||||.|||||-|+.|.+||.+.+.. .++++|..+.   -|.+
T Consensus       164 ~~-----g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g~---yd~~  232 (355)
T KOG0033|consen  164 ND-----GEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAGA---YDYP  232 (355)
T ss_pred             CC-----ccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhccc---cCCC
Confidence            62     223467889999999999976  68999999999999999999999999987544 4556554432   5677


Q ss_pred             cccccCCCCcCcccccchhhhhhhhhcc
Q psy15039        593 TYYVDTGQDDGEENACSYISEQQTQVLT  620 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (622)
                      +.+|+.....++..+..++..++++|||
T Consensus       233 ~~~w~~is~~Ak~LvrrML~~dP~kRIt  260 (355)
T KOG0033|consen  233 SPEWDTVTPEAKSLIRRMLTVNPKKRIT  260 (355)
T ss_pred             CcccCcCCHHHHHHHHHHhccChhhhcc
Confidence            7788888777777777888888888887

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=364.42  Aligned_cols=266  Identities=22%  Similarity=0.312  Sum_probs=215.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||||+++..... ......+.+|+.+|+.++||||++++++|.+++.+++
T Consensus         1 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGR--GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEe--CCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            47999999999  77999999999999999999999764332 2445668899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        79 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999999999999764  3588999999999999999999999999999999999999999999999997654332210


Q ss_pred             -------------------------cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc
Q psy15039        168 -------------------------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  222 (622)
Q Consensus       168 -------------------------~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~  222 (622)
                                               ..........+|+.|+|||++.+.  .++.++|||||||++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                     000112234567889999999764  68999999999999999999999998765


Q ss_pred             hHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-HHhhhc
Q psy15039        223 TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-ACNLLQ  301 (622)
Q Consensus       223 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~~~~l~  301 (622)
                      ............                             .....+....+++++.+||..||. ||.+||+ +.++++
T Consensus       235 ~~~~~~~i~~~~-----------------------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         235 LQETYNKIINWK-----------------------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HHHHHHHHhccC-----------------------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            433322221100                             000111223378999999999997 9999999 999999


Q ss_pred             Ccccccccc
Q psy15039        302 HAFFKQTKK  310 (622)
Q Consensus       302 h~~~~~~~~  310 (622)
                      ||||+....
T Consensus       285 hp~~~~~~~  293 (350)
T cd05573         285 HPFFKGIDW  293 (350)
T ss_pred             CCCcCCCCH
Confidence            999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-42  Score=366.86  Aligned_cols=265  Identities=22%  Similarity=0.283  Sum_probs=210.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|++++||||+++++.|.+++.+++
T Consensus         1 ~~y~~~~~lG~--G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGI--GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEe--CCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            57999999999  7799999999999999999999865322 22334567799999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||....+.....
T Consensus        79 v~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          79 VMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999999998764  3478999999999999999999999999999999999999999999999997532210000


Q ss_pred             ---------------------------------------cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHH
Q psy15039        168 ---------------------------------------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC  208 (622)
Q Consensus       168 ---------------------------------------~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il  208 (622)
                                                             .......+..+|+.|+|||++.+  ..++.++|||||||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil  234 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeecccee
Confidence                                                   00000112357889999999975  4588999999999999


Q ss_pred             HHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhc
Q psy15039        209 CELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR  288 (622)
Q Consensus       209 ~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~  288 (622)
                      |||++|+.||.................                             ....+....+++++.+++.+|+ .
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~s~~~~~li~~l~-~  284 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKVINWET-----------------------------TLHIPSQAKLSREASDLILRLC-C  284 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHHhccCc-----------------------------cccCCCCCCCCHHHHHHHHHHh-c
Confidence            999999999987654333222211100                             0011122357889999999976 5


Q ss_pred             CCCCCc---CHHhhhcCccccccc
Q psy15039        289 DVDKRP---LACNLLQHAFFKQTK  309 (622)
Q Consensus       289 dP~~Rp---s~~~~l~h~~~~~~~  309 (622)
                      ||.+|+   ++.++++||||+...
T Consensus       285 ~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         285 GAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             CHhhcCCCCCHHHHhCCCCcCCCC
Confidence            999999   999999999998743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-42  Score=360.05  Aligned_cols=266  Identities=20%  Similarity=0.278  Sum_probs=215.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||+||+++++.+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         1 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGR--GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEe--ccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            47999999999  7799999999999999999999976533 33445668899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||..........
T Consensus        79 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             EECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999997652 3589999999999999999999999999999999999999999999999997654432211


Q ss_pred             cccccCCCCCCCccccChhhhccc----cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN----LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~----~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .   ......+|+.|+|||++...    ...++.++|||||||++|+|++|..||.................        
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--------  226 (330)
T cd05601         158 V---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR--------  226 (330)
T ss_pred             e---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            1   11223567789999998631    23578899999999999999999999986654433222221100        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                           ....+....+++++.+|+..||+ ||.+||++.++++||||.....
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         227 ---------------------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             ---------------------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence                                 00111223578999999999998 9999999999999999987543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.1e-42  Score=357.37  Aligned_cols=252  Identities=19%  Similarity=0.301  Sum_probs=205.4

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      +.||+  |+||.||+++++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++...+.+++||||++
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGK--GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             Ceeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            36888  7799999999999999999999976432 33455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccC
Q psy15039         94 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  173 (622)
Q Consensus        94 ~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~  173 (622)
                      +|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    ..
T Consensus        79 ~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----~~  152 (328)
T cd05593          79 GGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----TM  152 (328)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----cc
Confidence            99999888653  3578999999999999999999999999999999999999999999999997543211111    11


Q ss_pred             CCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       174 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      ....+|+.|+|||++.+  ..++.++||||+||++|+|++|+.||......... ..+....+                 
T Consensus       153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~-----------------  212 (328)
T cd05593         153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEDI-----------------  212 (328)
T ss_pred             ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HHhccCCc-----------------
Confidence            12356788999999875  35889999999999999999999999765443222 22111000                 


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                     ..+..+++++.+|+.+||+.||++||     ++.++++||||....
T Consensus       213 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         213 ---------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             ---------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                           11234788999999999999999997     899999999997653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.6e-42  Score=356.19  Aligned_cols=252  Identities=19%  Similarity=0.295  Sum_probs=205.7

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      +.||+  |+||.||+++++.+|+.||+|++..... .+.....+.+|+.+|+.++||||++++++|...+.+++||||++
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             Ceeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            36888  7899999999999999999999976432 33455667899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccC
Q psy15039         94 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  173 (622)
Q Consensus        94 ~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~  173 (622)
                      +|+|...+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||...........    .
T Consensus        79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~----~  152 (323)
T cd05595          79 GGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----M  152 (323)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc----c
Confidence            99999888654  35789999999999999999999999999999999999999999999999975432111111    1


Q ss_pred             CCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       174 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      ....+++.|+|||++.+  ..++.++|||||||++|+|++|..||.................                  
T Consensus       153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------  212 (323)
T cd05595         153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------  212 (323)
T ss_pred             ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence            12356788999999865  3588999999999999999999999976544332222211100                  


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                     ..+..+++++.+++..||+.||++||     ++.++++|+||....
T Consensus       213 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                           01234789999999999999999998     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0590|consensus

Probab=100.00  E-value=1.1e-44  Score=395.44  Aligned_cols=544  Identities=18%  Similarity=0.236  Sum_probs=384.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEE-ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKH-KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~-~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   85 (622)
                      ...|.+.+.||+  |.|+.|-.... ..+...+|.|.++..........+...|..+-+.+. |+|++++++...+.+..
T Consensus        19 ~~~~~~~~~ig~--gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGK--GSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             cccccccccccc--cccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            457999999999  55778877776 445556888888765433444556667998888887 99999999999999999


Q ss_pred             EEEeecCCCCCHHHHH-HhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEEcCCC-ceEEcCCcccccc
Q psy15039         86 HLVSPLMGFGSCKDLI-NAHFNFGLPELVICHILQDVLNGLEYIH-GKGFIHRAVKASHILISHNG-KACLSGLRYMCPF  162 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l-~~~~~~~l~e~~~~~i~~qi~~aL~ylH-~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~  162 (622)
                      ++.++|..++++.+.+ .... .+.+......++.|+..|+.|+| ..++.||||||+|.+++..+ ..++.||+.+..+
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999999999888 3322 13556667789999999999999 99999999999999999999 8999999987666


Q ss_pred             CC-CCccccccCCCCCC-CccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        163 SP-TKKKVHLFPPSTAY-NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       163 ~~-~~~~~~~~~~~~~~-~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      .. .....  .....++ ++.|+|||...+. ....+..|+||+|+++..+++|..|+........              
T Consensus       176 ~~~~g~~~--~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------  238 (601)
T KOG0590|consen  176 RNKNGAER--SLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------  238 (601)
T ss_pred             cccCCcce--eeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence            54 21111  1122344 7889999998763 3456889999999999999999999864321110              


Q ss_pred             cccccccCCCCcCcccccccchhh-hhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc-cccCCCccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQ-QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ-TKKCSVMLPEL  318 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~-~~~~~~~~~~~  318 (622)
                                     ....++... ......+...+....+++..+|..+|..|.+.+++-.++|+.. .....      
T Consensus       239 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~------  297 (601)
T KOG0590|consen  239 ---------------RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFS------  297 (601)
T ss_pred             ---------------cceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccccccccc------
Confidence                           001111111 1123345667889999999999999999999999999999976 11100      


Q ss_pred             cccccCCCccccccccccccccccccccccccccccCCCCCCc-eEeeecccccCCeeEEEEEEEccCCcEEEEEEecCC
Q psy15039        319 LRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNY-KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD  397 (622)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y-~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~  397 (622)
                              ..+   .......          ...........| +...++|.  |.+|.|+.+......+.++.|.+...
T Consensus       298 --------~~n---~~~~~~~----------~~~~~~~~~~~y~~~~~~~g~--ga~g~~~~~~~~~~~~~~~~~~~r~~  354 (601)
T KOG0590|consen  298 --------KSN---PCADSLT----------IAKSPIGFSEKYGKPGRVLGS--GAYGSVRIAKRRSDLKSFPEKEFRVR  354 (601)
T ss_pred             --------ccc---ccccccc----------cccCccccccccCCccceeee--cccCceEEEEecCCCccchhhhhhcc
Confidence                    000   0000000          000011112223 34456777  66788888888888888888876531


Q ss_pred             ---CCCHHH-HHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy15039        398 ---RMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN  473 (622)
Q Consensus       398 ---~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~  473 (622)
                         ...... ...+..|.-+-..|.|||++.....+.+.....-.||||++ +|..++....  .+....+..++.|++.
T Consensus       355 ~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~  431 (601)
T KOG0590|consen  355 VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLR  431 (601)
T ss_pred             cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHH
Confidence               122222 23377888888999999998887766666666666999999 9999887642  2556667789999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCc-hhhHH
Q psy15039        474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE-RSDIY  552 (622)
Q Consensus       474 gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~Diw  552 (622)
                      ||+|+|+.||.||||||+|+|++.+|.+++.|||....+....+.......+.+|+-.|+|||++.+  ..|++ .+|||
T Consensus       432 Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiw  509 (601)
T KOG0590|consen  432 GVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVW  509 (601)
T ss_pred             HHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhh
Confidence            9999999999999999999999999999999999876655444332233456678888999999976  35775 58999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCcccccCCCCcCcccccchhhhhhhhhcc
Q psy15039        553 SVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLT  620 (622)
Q Consensus       553 SlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (622)
                      |.|++++.|.+|+.||.-....+..+..... ..=.+...+...+..-......-+...+..++++|+|
T Consensus       510 S~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t  578 (601)
T KOG0590|consen  510 SCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT  578 (601)
T ss_pred             hccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec
Confidence            9999999999999999654333222111111 1111222233333333344445556666666666665

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.3e-42  Score=354.21  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=205.3

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHH---hhCCCCcceeEEEEEEeCCcEE
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCM---RHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il---~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      |++.+.||+  |+||.||+|.++.+|+.||||+++.... .....+.+.+|+.++   +.++||||++++++|.+.+.+|
T Consensus         1 y~i~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGR--GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEee--cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            789999999  7789999999999999999999975432 223345566666554   6778999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|...+..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.........
T Consensus        79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999999887754   358899999999999999999999999999999999999999999999999653221111


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .    ......+++.|+|||++.+  ..++.++|||||||++|+|++|+.||..............+. +          
T Consensus       156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~----------  218 (324)
T cd05589         156 D----RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-V----------  218 (324)
T ss_pred             C----cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C----------
Confidence            1    1123356788999999875  358899999999999999999999998765443332222111 0          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                            ..+..+++++.+++.+||+.||.+||     ++.++++||||+...
T Consensus       219 ----------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         219 ----------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence                                  01234688999999999999999999     689999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-41  Score=345.12  Aligned_cols=278  Identities=22%  Similarity=0.302  Sum_probs=202.8

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCcceeEEEEEEeC----
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFLDA----   82 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~~~~~~~~~----   82 (622)
                      +|++.+.||+  |+||+||+|+++.+|+.||+|.++.....+.....+.+|+.+++.+   +||||+++++++...    
T Consensus         1 ~y~~~~~lg~--g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGV--GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEee--cCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            5999999999  7789999999999999999999876533322233455677777665   799999999988653    


Q ss_pred             -CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         83 -TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        83 -~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                       ...+++|||+. +++.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||....
T Consensus        79 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          79 ETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             CceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence             45899999998 5888888765444589999999999999999999999999999999999999999999999997644


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCC
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLL  239 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~  239 (622)
                      ......     .....++..|+|||++.+  ..++.++||||+||++|+|++|.+||........+....  .+.++. .
T Consensus       158 ~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~-~  229 (288)
T cd07863         158 YSCQMA-----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE-D  229 (288)
T ss_pred             ccCccc-----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh-h
Confidence            321111     112345678999999875  358899999999999999999999997665443332221  111110 0


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .+.... ...    .........  .........++.++.+++.+||+.||++|||+.+++.||||
T Consensus       230 ~~~~~~-~~~----~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         230 DWPRDV-TLP----RGAFSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             hCcccc-ccc----ccccCCCCC--CchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            000000 000    000000000  00001123568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-41  Score=352.04  Aligned_cols=257  Identities=19%  Similarity=0.285  Sum_probs=208.7

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCC-cceeEEEEEEeCCcEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHP-NIICYISSFLDATDLHL   87 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~Hp-nIv~~~~~~~~~~~~~l   87 (622)
                      +|++++.||+  |+||.||+|+++.+++.||||++..... .+...+.+.+|+.+++.++|+ +|++++++|...+.+|+
T Consensus         1 ~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGK--GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEee--ccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            6999999999  7799999999999999999999876432 234456778899999999775 58889999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||..........
T Consensus        79 v~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          79 VMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            99999999999988664  3478999999999999999999999999999999999999999999999997533211111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    .....+|+.|+|||++.+  ..++.++||||+||++|+|++|+.||................ +           
T Consensus       157 ~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~-----------  218 (324)
T cd05587         157 T----TRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-V-----------  218 (324)
T ss_pred             c----eeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-C-----------
Confidence            1    112346788999999975  357899999999999999999999998665443322222111 0           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~~~~~  309 (622)
                                           ..+..++.++.+++.+||..||.+|++.     +++++||||....
T Consensus       219 ---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         219 ---------------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                                 0123468899999999999999999986     8999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.6e-41  Score=351.25  Aligned_cols=289  Identities=23%  Similarity=0.349  Sum_probs=213.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..++|++.+.||+  |+||.||++.++.+|+.||+|.+.... .+.....+.+|+++|++++|||||+++++|.+++.++
T Consensus         3 ~~~~y~~~~~lg~--g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGA--GNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             chhhhheeccccC--CCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            3579999999999  778999999999999999999987653 3445567889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+++.|||........
T Consensus        80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999999998764  2478999999999999999999975 7999999999999999999999999975433211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh----CCCCCCCcc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA----GATPHLLDC  241 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~----~~~p~~~~~  241 (622)
                            ......++..|+|||++.+  ..++.++|+|||||++|+|++|+.||........ ...+.    +..+.....
T Consensus       158 ------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (333)
T cd06650         158 ------MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETS  228 (333)
T ss_pred             ------ccccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccC
Confidence                  1112345678999999875  3588999999999999999999999975433211 11111    110000000


Q ss_pred             ccccc----------cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        242 TTYYV----------DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       242 ~~~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .....          +..+.........++.....+......+++++++|+.+||+.||++|||+.+++.||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            00000          000000000000011111111122234688999999999999999999999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.6e-42  Score=359.77  Aligned_cols=266  Identities=20%  Similarity=0.294  Sum_probs=211.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||++.++.+|+.||||++..... .......+.+|+.+|.+++||||+++++.|.+.+.+++
T Consensus         1 ~~f~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGR--GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            57999999999  7799999999999999999999975322 23345667889999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+++.|||..........
T Consensus        79 v~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          79 IMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999999999998764  3588999999999999999999999999999999999999999999999997543211100


Q ss_pred             c-------------------------------ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCC
Q psy15039        168 K-------------------------------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV  216 (622)
Q Consensus       168 ~-------------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~  216 (622)
                      .                               ......+..+|+.|+|||++.+  ..|+.++|||||||++|||++|..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCCC
Confidence            0                               0000113457889999999975  468999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-
Q psy15039        217 PFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-  295 (622)
Q Consensus       217 Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-  295 (622)
                      ||.................                             ....+....+++++++|+.+|+ .||.+|++ 
T Consensus       235 Pf~~~~~~~~~~~i~~~~~-----------------------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  284 (360)
T cd05627         235 PFCSETPQETYRKVMNWKE-----------------------------TLVFPPEVPISEKAKDLILRFC-TDSENRIGS  284 (360)
T ss_pred             CCCCCCHHHHHHHHHcCCC-----------------------------ceecCCCCCCCHHHHHHHHHhc-cChhhcCCC
Confidence            9987654433222221100                             0001122347889999999977 49999994 


Q ss_pred             --HHhhhcCcccccccc
Q psy15039        296 --ACNLLQHAFFKQTKK  310 (622)
Q Consensus       296 --~~~~l~h~~~~~~~~  310 (622)
                        +.++++||||....+
T Consensus       285 ~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         285 NGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCHHHHhcCCCCCCCCH
Confidence              799999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-41  Score=348.31  Aligned_cols=289  Identities=20%  Similarity=0.291  Sum_probs=212.1

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .-.+|++.+.||+  |+||.||+|+++.+++.||||+++..... .....+.+|+.++++++||||+++++++..++..+
T Consensus         4 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           4 KMETYIKLEKLGE--GTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCCceEEEEEecc--cCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            3468999999999  78999999999999999999998764322 22345678999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++ ++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.........
T Consensus        81 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            99999984 7777775532 347889999999999999999999999999999999999999999999999764332211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCCCccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHLLDCTTY  244 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~~~~~~~  244 (622)
                      ..    .....+++.|+|||++.+. ..++.++||||+||++|+|++|+.||.........  +....+.++.. .+.. 
T Consensus       159 ~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~-  231 (309)
T cd07872         159 KT----YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE-TWPG-  231 (309)
T ss_pred             cc----cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-HHhh-
Confidence            11    1122446789999998653 35788999999999999999999999876543322  22222222110 0000 


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                       ..............+...  ........+++++.+|+.+||+.||.+|||+.++++||||+....
T Consensus       232 -~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         232 -ISSNDEFKNYNFPKYKPQ--PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             -hcchhhhhhhhcCccCCC--chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence             000000000000000000  000112347889999999999999999999999999999987544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-41  Score=357.54  Aligned_cols=266  Identities=22%  Similarity=0.307  Sum_probs=211.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..+|++.+.||+  |+||.||+|+++.+++.||+|.+..... .....+.+.+|+.+|+.++||||+++++++.+...++
T Consensus        42 ~~~y~i~~~lG~--G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          42 AEDYEVVKVIGR--GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             hhhcEEEEEEee--cCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            469999999999  7799999999999999999999865332 2333456778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.........
T Consensus       120 lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            999999999999998653   47899999999999999999999999999999999999999999999999765432211


Q ss_pred             ccccccCCCCCCCccccChhhhcccc--CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .   .......+|+.|+|||++....  ..|+.++||||+||++|||++|..||...+.............         
T Consensus       197 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------  264 (371)
T cd05622         197 M---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---------  264 (371)
T ss_pred             c---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            1   1112345788899999986432  2378899999999999999999999987654332222221110         


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~~  310 (622)
                                          ....+....++.+++++|..||..++.+  |+++.++++|+||++...
T Consensus       265 --------------------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         265 --------------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             --------------------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                                0011223457999999999999844433  789999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.3e-41  Score=353.69  Aligned_cols=261  Identities=21%  Similarity=0.334  Sum_probs=208.1

Q ss_pred             CceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCC
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT   83 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~   83 (622)
                      +|++++.||+  |+||+||++++.   .+|+.||+|++.....  .....+.+.+|+.+|+++ +||||++++++|....
T Consensus         1 ~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGT--GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEee--cCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            6999999999  779999999864   5899999999875322  223345677899999999 5899999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++||||+++|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||....+.
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999999999988654  347899999999999999999999999999999999999999999999999765432


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc---hHHHHHHHHhCCCCCCCc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP---TTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~---~~~~~~~~~~~~~p~~~~  240 (622)
                      ......   .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||....   ........+....|    
T Consensus       157 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----  228 (332)
T cd05614         157 SEEKER---TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP----  228 (332)
T ss_pred             ccCCCc---cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC----
Confidence            221111   1123567889999998743 347889999999999999999999996432   12222222211111    


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                                  .....+++.+.+++.+||+.||++||     +++++++||||+....
T Consensus       229 ----------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         229 ----------------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ----------------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                        11234688999999999999999999     7889999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-41  Score=352.18  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=204.1

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ++||+  |+||.||+|+++.+++.||||++..... .+...+.+.+|+.+++.+ +||||++++++|.+.+.+|+||||+
T Consensus         1 ~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGK--GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             Ceeee--CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            36888  7789999999999999999999875432 233455677899998877 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~----~  152 (320)
T cd05590          79 NGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----T  152 (320)
T ss_pred             CCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC----c
Confidence            999999888664  3588999999999999999999999999999999999999999999999997543211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|+.||......... ..+....+                
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~i~~~~~----------------  213 (320)
T cd05590         153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-EAILNDEV----------------  213 (320)
T ss_pred             ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-HHHhcCCC----------------
Confidence            123356788999999875  45889999999999999999999999866543332 22221110                


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH------HhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA------CNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~~l~h~~~~~~~  309 (622)
                                      ..+..+++++.++++.||+.||.+||++      .++++||||....
T Consensus       214 ----------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         214 ----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence                            1123468899999999999999999998      8999999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=345.09  Aligned_cols=259  Identities=21%  Similarity=0.302  Sum_probs=210.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      +|++.+.||+  |+||.||++.+..+++.||||++..+..... ....+.+|+.+|++++||||+++++.+..++.+++|
T Consensus         1 ~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGK--GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEec--CCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            5899999999  7789999999999999999999976543322 234567899999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.......... 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-  157 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence            9999999999888654444589999999999999999999999999999999999999999999999997543321111 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH---HHHHhCCCCCCCcccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML---IEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~---~~~~~~~~p~~~~~~~~~  245 (622)
                          .....+++.|+|||++.+  ..++.++||||+||++|+|++|..||.+.......   ...+....          
T Consensus       158 ----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  221 (285)
T cd05605         158 ----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----------  221 (285)
T ss_pred             ----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----------
Confidence                112345778999999865  35788999999999999999999999865432211   11111100          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                            ......+++.+.+|+..||..||.+||     ++.++++||||....
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         222 ----------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             ----------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence                                  011234788999999999999999999     899999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0192|consensus

Probab=100.00  E-value=5.3e-42  Score=352.00  Aligned_cols=234  Identities=28%  Similarity=0.442  Sum_probs=191.2

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcE-EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-cEEEE
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQL-IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-DLHLV  438 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~-vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-~~~lv  438 (622)
                      ..+.+.+|+  |+||.||++..+  |+. ||||++.....+....+.+.+|+.+|++|+|||||+|+|++.... .+.+|
T Consensus        43 l~~~~~iG~--G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   43 LPIEEVLGS--GSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             hhhhhhccc--CCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            345556888  789999988775  566 999999877766666789999999999999999999999999987 79999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcCCC-ceEEcCcccccccCCCC
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG-FIHRAVKASHILISHNG-KACLSGLRYMCPFSPTK  516 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~-iiHRDlKp~NILl~~~~-~~~~~~~~~~~~~~~~~  516 (622)
                      ||||++|+|.+++.......++...+..++.||+.|+.|||+++ ||||||||+|||++.++ .+||+|||.+.......
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999999999998743456899999999999999999999999 99999999999999998 99999999865433221


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH-cCCCCCCCC-CCcc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLD-CTTY  594 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~-~~~~p~~~~-~~~~  594 (622)
                          ......+||+.|||||++.+....|+.|+|||||||++|||+||+.||............. .+.+|.++. ++..
T Consensus       199 ----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~  274 (362)
T KOG0192|consen  199 ----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH  274 (362)
T ss_pred             ----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence                1223367899999999998422469999999999999999999999999988744333333 556677666 5544


Q ss_pred             cccCCCCc
Q psy15039        595 YVDTGQDD  602 (622)
Q Consensus       595 ~~~~~~~~  602 (622)
                      ......+|
T Consensus       275 l~~l~~~C  282 (362)
T KOG0192|consen  275 LSSLMERC  282 (362)
T ss_pred             HHHHHHHh
Confidence            44333333

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-42  Score=361.02  Aligned_cols=277  Identities=22%  Similarity=0.272  Sum_probs=203.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ...|++++.||+  |+||.||+|.++.+++.||||....        ..+.+|+++|++|+|||||+++++|......++
T Consensus        91 ~~~y~~~~~lg~--G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTP--GAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcC--CCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            357999999999  7788999999999999999997532        345689999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |+|++. +++...+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus       161 v~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            999986 6888877653  3578999999999999999999999999999999999999999999999997642211110


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc---------hHHHHHHHHhCCCCCC
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP---------TTLMLIEKLAGATPHL  238 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~---------~~~~~~~~~~~~~p~~  238 (622)
                      .   ......+|+.|+|||++.+  ..|+.++||||+||++|||++|..||....         .....+....+..|..
T Consensus       238 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        238 N---KYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             c---ccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            0   1113356788999999875  358999999999999999999998886432         1112222222332211


Q ss_pred             CccccccccCCCCcCcccc---cccchhhhhccc---cCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENA---CSYISEQQTQVL---TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~---~~~i~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ...     .. ........   ...........+   .....+.++.+|+.+||+.||.+|||+.++|+||||...
T Consensus       313 ~~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        313 FPI-----DA-QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             cCc-----ch-hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            000     00 00000000   000000000000   011346689999999999999999999999999999764

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.9e-41  Score=367.20  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=218.2

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ......+|++.+.||+  |+||+||+|+++.+|+.||||+++....+..+...+.+|+.+|..++|+||+++++.|....
T Consensus        27 ~~~~~~rY~i~~~LG~--G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         27 AKEQAKKYWISRVLGS--GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccCCCEEEEEEEec--CCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            3445679999999999  78999999999999999999999887777777778889999999999999999998876532


Q ss_pred             --------cEEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEE
Q psy15039         84 --------DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        84 --------~~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                              .+++||||+++|+|.+.++...  ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence                    3789999999999999986542  235789999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  233 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~  233 (622)
                      .|||....+......  .......+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||............+.+
T Consensus       185 ~DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~  260 (496)
T PTZ00283        185 GDFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG  260 (496)
T ss_pred             EecccCeeccccccc--cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            999976543221111  11123456788999999975  35899999999999999999999999876544333333322


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ..+                                ..+..+++++.+++..||+.||.+||++.++++|||++..
T Consensus       261 ~~~--------------------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        261 RYD--------------------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCC--------------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            211                                1123468899999999999999999999999999998653

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-42  Score=357.83  Aligned_cols=286  Identities=22%  Similarity=0.299  Sum_probs=211.5

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ...+++++|++++.||+  |+||.||+|.+..+++.||||++..........+.+.+|+.+|++++|||||+++++|...
T Consensus         9 ~~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07878           9 TVWEVPERYQNLTPVGS--GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA   86 (343)
T ss_pred             HHhhhhhhhhhheeccc--CCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence            34568899999999999  7799999999999999999999876543334456677999999999999999999988643


Q ss_pred             ------CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         83 ------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        83 ------~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                            ...+++++++ ++++.++++.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||
T Consensus        87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          87 TSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCC
Confidence                  3578999987 6788887753   35889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~  234 (622)
                      |........       ..+..+|+.|+|||++.+. ..++.++||||+||++|+|++|+.||........+...  ..+.
T Consensus       163 g~~~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07878         163 GLARQADDE-------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT  234 (343)
T ss_pred             ccceecCCC-------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            976543211       1123557789999998753 35789999999999999999999999765543322222  1121


Q ss_pred             CCCCCccccccccCCCCcCcccccc---cchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACS---YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~---~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .+.  +..    .............   ........ ......++.+.+|+.+||+.||.+|||+.++++||||....
T Consensus       235 ~~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         235 PSP--EVL----KKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             CCH--HHH----HhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            110  000    0000000000000   00000000 00123567889999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0600|consensus

Probab=100.00  E-value=2.1e-42  Score=347.93  Aligned_cols=213  Identities=25%  Similarity=0.369  Sum_probs=186.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC--Cc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--~~  434 (622)
                      ..+.|+.++.||+  |.||.||+|++..||+.||+|++..+...++......|||.||++|+|||||++.+...+.  ..
T Consensus       115 ~~~~feki~kIGe--GTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  115 RADSFEKIEKIGE--GTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             chHHHHHHHHhcC--cchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            3567899999999  7799999999999999999999998877777778899999999999999999999988876  68


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|||+|||++ +|..++.. ....+++.++..|+.|++.||+|||++||+|||||.+|||||.+|.+||+|||++.-+..
T Consensus       193 iYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            9999999995 77777654 234578899999999999999999999999999999999999999999999998765544


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      .....   -++.+-|++|.|||+|.+. ..|+.++|+||+|||+.||++|++.|.+.+..+++
T Consensus       271 ~~~~~---~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl  329 (560)
T KOG0600|consen  271 SGSAP---YTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL  329 (560)
T ss_pred             CCCcc---cccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence            33221   2345678999999999876 47999999999999999999999999999877765

>KOG0659|consensus

Probab=100.00  E-value=4.4e-42  Score=319.56  Aligned_cols=213  Identities=25%  Similarity=0.348  Sum_probs=187.0

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ..|...+.+|+  |.||.||+|++..||+.||||+|......+..-....|||+.|+.++|||||.++++|-..+.+.+|
T Consensus         2 ~rY~~~~~lGE--G~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGE--GTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcC--cceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            35788899999  7799999999999999999999998766665566889999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      +|||+ .+|...++.. ...+++..+..|+.|++.||+|||++.|+||||||.|+|++++|.+|++|||.++.++.....
T Consensus        80 fEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            99999 5888888764 345889999999999999999999999999999999999999999999999998877643321


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      .    ...+.|..|.|||++-+. ..|+..+||||.|||+.||+-|.|-|.+.++.+++..+
T Consensus       158 ~----~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I  214 (318)
T KOG0659|consen  158 Q----THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI  214 (318)
T ss_pred             c----ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence            1    122568899999999865 57999999999999999999999999999888887554

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.8e-41  Score=342.41  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=202.5

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG   95 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g   95 (622)
                      ||+  |+||+||++.++.+|+.||||++....... ...+.+.+|+.+|++++||||+++.++|.....+++||||+++|
T Consensus         1 lg~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGK--GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCC--CCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            577  889999999999999999999987654322 23456778999999999999999999999999999999999999


Q ss_pred             CHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccC
Q psy15039         96 SCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  173 (622)
Q Consensus        96 ~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~  173 (622)
                      +|.+.+...  ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||...........    .
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~----~  154 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK----T  154 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc----c
Confidence            998877432  2235889999999999999999999999999999999999999999999999976443222111    1


Q ss_pred             CCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH---HHHHHHhCCCCCCCccccccccCCC
Q psy15039        174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL---MLIEKLAGATPHLLDCTTYYVDTGQ  250 (622)
Q Consensus       174 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~  250 (622)
                      ....+++.|+|||++.+.  .++.++||||+||++|+|++|+.||.......   .....+...                
T Consensus       155 ~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         155 KGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             cccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            123567789999999753  58899999999999999999999997543211   111111000                


Q ss_pred             CcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        251 DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       251 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                      .......+++++.+++..||+.||++||     +++++++||||+...
T Consensus       217 ----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         217 ----------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             ----------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence                            0011235789999999999999999999     889999999998744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.2e-41  Score=356.25  Aligned_cols=281  Identities=20%  Similarity=0.261  Sum_probs=211.0

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-----c
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----D   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~   84 (622)
                      +|++++.||+  |+||.||+++++.+|+.||||++..........+.+.+|+.+|+.++||||+++++++...+     .
T Consensus         1 ~~~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGY--GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeee--CCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            5899999999  77999999999999999999998654444455667889999999999999999999998876     7


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+||||+. +++.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||.......
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            999999997 5777777543  3588999999999999999999999999999999999999999999999997643322


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HHHhCCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EKLAGATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~p~~~~~~  242 (622)
                      ....   ......++..|+|||++.+. ..|+.++||||+||++|||++|+.||.+.+....+.  ....+.++ ..+..
T Consensus       156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~-~~~~~  230 (372)
T cd07853         156 DESK---HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS-LEAMR  230 (372)
T ss_pred             Cccc---cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC-HHHHH
Confidence            1111   11122456789999998753 357899999999999999999999998765443322  22222211 10000


Q ss_pred             cccccCCCCcCcccccccchhh-------hhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQ-------QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..         .......+...       ..........++++.+||.+||+.||.+|||+.++++||||....
T Consensus       231 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         231 SA---------CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             Hh---------hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            00         00000000000       000011234588999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0983|consensus

Probab=100.00  E-value=2.9e-42  Score=321.32  Aligned_cols=264  Identities=27%  Similarity=0.454  Sum_probs=213.8

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      +-++++.||.  |.-|+|++++++.||...|||.+.... ++++.+++.+.+.++.+- +.|.||+.+|+|..+..+++.
T Consensus        93 dl~~l~dlGs--GtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   93 DLENLGDLGS--GTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             HhhhHHhhcC--CCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            3455667777  556799999999999999999997764 466677888888877765 479999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||.|.  .+.+.|....+.++||..+..+...+++||.||.+ ++|+|||+||+|||+|..|.+|++|||.+..+..+..
T Consensus       170 MelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  170 MELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            99885  45555545455679999999999999999999986 5999999999999999999999999998755543332


Q ss_pred             cccccCCCCCCCccccChhhhccc-cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..     ..++-+.|||||.+.-. ...|+-.+||||||++++||+||+.||.+.++......++....|+.++      
T Consensus       248 ht-----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~------  316 (391)
T KOG0983|consen  248 HT-----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP------  316 (391)
T ss_pred             cc-----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC------
Confidence            21     23555679999998533 4679999999999999999999999999987766555555443332221      


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCC
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS  312 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~  312 (622)
                                             ....||++|++|+..||++|+.+||.-.++|+|||+......+
T Consensus       317 -----------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  317 -----------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             -----------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence                                   2234899999999999999999999999999999998765543

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.6e-42  Score=353.48  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=204.3

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      +.||+  |+||.||+++++.+|+.||+|++..... .......+.+|+++++.++||||++++++|...+.+++||||++
T Consensus         1 ~~lG~--G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGK--GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             Ceeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            36888  7799999999999999999999976432 23445667789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         94 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        94 ~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      +|+|.+.+...  ..+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+++.|||...........    
T Consensus        79 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~----  152 (325)
T cd05594          79 GGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----  152 (325)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc----
Confidence            99999888653  357899999999999999999997 79999999999999999999999999975332111111    


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||......... ..+.....                
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~~i~~~~~----------------  213 (325)
T cd05594         153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEEI----------------  213 (325)
T ss_pred             cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHH-HHHhcCCC----------------
Confidence            112356788999999975  35889999999999999999999999765443222 22211100                


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                      ..+..+++++.+|+.+||+.||++|+     ++.++++||||....
T Consensus       214 ----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         214 ----------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence                            01234688999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-41  Score=350.58  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=204.7

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ++||+  |+||.||+|+++.+|+.||||++..+.. .......+..|+.+++.+ +||||++++++|.+...+|+||||+
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGK--GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             Ccccc--CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            36898  7789999999999999999999876432 234455677899999876 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~----~  152 (321)
T cd05591          79 NGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----T  152 (321)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc----c
Confidence            999999888654  3578999999999999999999999999999999999999999999999997543211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+++.|+|||++.+  ..|+.++||||+||++|+|++|+.||..............+..                 
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-----------------  213 (321)
T cd05591         153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-----------------  213 (321)
T ss_pred             ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            122346778999999865  3588999999999999999999999987655443332221110                 


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-------CHHhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-------LACNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-------s~~~~l~h~~~~~~~  309 (622)
                                      ..+..++.++.+++..||+.||++||       ++.++++||||....
T Consensus       214 ----------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         214 ----------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence                            11224688999999999999999999       899999999997643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-41  Score=355.08  Aligned_cols=286  Identities=23%  Similarity=0.276  Sum_probs=207.6

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC--
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--   83 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--   83 (622)
                      .+.++|++.+.||+  |+||.||+++++.+|+.||||++............+.+|+.+|+.++||||++++++|....  
T Consensus        18 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGS--GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeec--CCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            46789999999999  77999999999999999999999765545555667889999999999999999999987553  


Q ss_pred             ----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         84 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        84 ----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                          .+++||||+++ ++.+.+..    .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||..
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence                47999999985 45555432    3788899999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPH  237 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~  237 (622)
                      .......     ......+|..|+|||++.+  ..|+.++||||+||++|+|++|+.||.+.+.........  .+.++.
T Consensus       171 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         171 RTACTNF-----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             cccccCc-----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            4322111     1112355778999999975  358899999999999999999999998765433222111  111100


Q ss_pred             -CCcc----c-cccccCCCCc---CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        238 -LLDC----T-TYYVDTGQDD---GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       238 -~~~~----~-~~~~~~~~~~---~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                       +.+.    . .+....+...   ..+..+.++...  ........++++++|+.+||+.||++|||+.|+|+||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPS--ESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccc--ccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence             0000    0 0000000000   000000000000  00011234778999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.7e-41  Score=354.24  Aligned_cols=259  Identities=23%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++.... .+...+.+.+|+++|+.++||||++++++|.....+++|
T Consensus        74 ~~~~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGS--GAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccC--CCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            57899999999  778899999999999999999986543 344456788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++|+|.+..      ..++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.......... 
T Consensus       151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            9999999875421      256788889999999999999999999999999999999999999999997644322111 


Q ss_pred             ccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCCCCCCcccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~p~~~~~~~  243 (622)
                         ......++..|+|||++...   ...++.++|||||||++|||++|+.||......  ......+....        
T Consensus       224 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------  292 (353)
T PLN00034        224 ---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ--------  292 (353)
T ss_pred             ---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC--------
Confidence               11233567889999987431   123356899999999999999999999743211  11111111000        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                             .......++.++.+||..||..||++||++.++++||||.....+
T Consensus       293 -----------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        293 -----------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             -----------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence                                   001123468899999999999999999999999999999886544

>KOG0588|consensus

Probab=100.00  E-value=1.7e-42  Score=358.07  Aligned_cols=245  Identities=22%  Similarity=0.355  Sum_probs=202.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCC-CCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..+-|++++.||+  |+-|.|-+|+|..|||.+|||+|.+. ..++.....+.+||.+|+.|.||||+++|++|....++
T Consensus        10 tiGpwkLgkTLG~--Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   10 TIGPWKLGKTLGK--GSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cccceeccccccC--CCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            4466999999999  77999999999999999999999876 55666667899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+|.||+++|+|.+++.+++  ++++..+.++++||+.|+.|+|..+|+||||||+|+||+..+++||+|||.+..-..+
T Consensus        88 ylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999999998765  4789999999999999999999999999999999999999999999999986532222


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCcc
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  594 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  594 (622)
                           ..-.+.||+|.|.|||++.+  ..| +.++||||.|||||.||||+.||.+.+. ..+..++..+.   +++|.+
T Consensus       166 -----klLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-r~LLlKV~~G~---f~MPs~  234 (786)
T KOG0588|consen  166 -----KLLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-RVLLLKVQRGV---FEMPSN  234 (786)
T ss_pred             -----ccccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccH-HHHHHHHHcCc---ccCCCc
Confidence                 22345689999999999987  456 5799999999999999999999986654 44555554443   445544


Q ss_pred             cccCCCCcCcccccchhhhhhhhhcc
Q psy15039        595 YVDTGQDDGEENACSYISEQQTQVLT  620 (622)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (622)
                      .....|+.    +-.+++.+...|+|
T Consensus       235 Is~eaQdL----Lr~ml~VDp~~RiT  256 (786)
T KOG0588|consen  235 ISSEAQDL----LRRMLDVDPSTRIT  256 (786)
T ss_pred             CCHHHHHH----HHHHhccCcccccc
Confidence            44343333    44555666666665

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-41  Score=350.05  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=202.4

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ++||+  |+||.||+|+++.+++.||||+++.+... ......+.+|+.+++++ +||||++++++|.+...+|+|||||
T Consensus         1 ~~lG~--G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGR--GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            36888  77999999999999999999999765432 33456678999999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~----~  152 (329)
T cd05588          79 SGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----T  152 (329)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC----c
Confidence            999999888653  3589999999999999999999999999999999999999999999999997532111110    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--------HHHHHHHHhCCCCCCCccccc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--------TLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--------~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .....+|+.|+|||++.+  ..|+.++|+||+||++|+|++|+.||.....        .......+..           
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------  219 (329)
T cd05588         153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-----------  219 (329)
T ss_pred             cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------
Confidence            123356788999999975  4588999999999999999999999963211        0111111111           


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC------HHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL------ACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps------~~~~l~h~~~~~~~  309 (622)
                                         .  ....+..++.++.+++++||+.||.+||+      +.++++||||....
T Consensus       220 -------------------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         220 -------------------K--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             -------------------C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                               0  01122357889999999999999999997      78999999997643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0605|consensus

Probab=100.00  E-value=9e-42  Score=346.45  Aligned_cols=221  Identities=22%  Similarity=0.318  Sum_probs=189.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|+++.+||+  |+||.||+|+.+.||+.+|+|++.++.+-. .+++.+..|=.+|..-++|+||++|-+|.+...+
T Consensus       139 ~~~DFe~Lk~Igk--GAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  139 SLDDFELLKVIGK--GAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             Ccccchhheeecc--ccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            5678999999999  789999999999999999999998876543 4567888999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ||||||.+||++..+|.+..  .+++..++.|+.+++.|++-+|+.|+|||||||+|+|||..|++|++|||++..+...
T Consensus       217 YLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999999998743  5889999999999999999999999999999999999999999999999986432210


Q ss_pred             ---------------CC--cee--------------------------ccCCCCCCCCccccccccccCccCCCchhhHH
Q psy15039        516 ---------------KK--KVH--------------------------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY  552 (622)
Q Consensus       516 ---------------~~--~~~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw  552 (622)
                                     ..  ...                          ...-+++|||.||||||+.+  .+|+..+|+|
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDwW  372 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDWW  372 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccHH
Confidence                           00  000                          01124678999999999987  4699999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        553 SVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       553 SlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      |||||+||||.|.|||...++++....++.-
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw  403 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNW  403 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999999999999998877765554443

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.9e-41  Score=347.84  Aligned_cols=258  Identities=18%  Similarity=0.271  Sum_probs=209.2

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHL   87 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +|++++.||+  |+||.||+|+++.+++.||||.+..... .....+.+..|..++..+ +||||+++++++.+.+.+|+
T Consensus         1 df~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGK--GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            6999999999  7799999999999999999999976532 233345567788888887 58999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||..........
T Consensus        79 v~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          79 VMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999999999888664  3478999999999999999999999999999999999999999999999997543221111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                          ......+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||................ +           
T Consensus       157 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~-----------  218 (323)
T cd05616         157 ----TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-V-----------  218 (323)
T ss_pred             ----ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C-----------
Confidence                1123356788999999975  458999999999999999999999998765443332222111 0           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~~~~~~  310 (622)
                                           ..+..++.++.+++.+||+.||++|+++     .++++||||+...+
T Consensus       219 ---------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         219 ---------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence                                 0123468899999999999999999984     89999999986543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-41  Score=348.86  Aligned_cols=267  Identities=19%  Similarity=0.278  Sum_probs=209.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||.||+++++.+++.||||++++... .....+.+.+|+.+++.++||||++++++|.+...+|+
T Consensus         1 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGR--GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            47999999999  7789999999999999999999875322 23345667889999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        79 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             EEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999986532 3588999999999999999999999999999999999999999999999997644322111


Q ss_pred             cccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .   ......+|+.|+|||++..   +...++.++||||+||++|+|++|+.||................. ..      
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~------  227 (331)
T cd05597         158 V---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-HF------  227 (331)
T ss_pred             c---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-cc------
Confidence            1   0112346788999999863   123578899999999999999999999976544332222211100 00      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~  309 (622)
                                           ........+++++++++++||..++++  |+++.++++||||....
T Consensus       228 ---------------------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         228 ---------------------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             ---------------------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence                                 000112347899999999988765444  88999999999997653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-41  Score=349.88  Aligned_cols=252  Identities=19%  Similarity=0.307  Sum_probs=203.7

Q ss_pred             eecccccCCceeEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         15 SILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +.||+  |+||.||+++..   .+++.||||.+.....  .......+.+|+.+|++++||||++++++|..+..+|+||
T Consensus         2 ~~lg~--G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           2 KVLGK--GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             ceeee--cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            57899  889999999864   5899999999875432  2233455778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||..........  
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            999999999998764  3478889999999999999999999999999999999999999999999997543221111  


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                        ......+++.|+|||++.+  ..++.++|||||||++|||++|+.||..............+..              
T Consensus       156 --~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~--------------  217 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--------------  217 (323)
T ss_pred             --cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence              1122356788999999875  3578899999999999999999999987654433322222110              


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                         ..+..+++++.+|+.+||+.||++||     ++.++++||||....
T Consensus       218 -------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         218 -------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence                               01234688999999999999999999     899999999997653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0578|consensus

Probab=100.00  E-value=3.4e-42  Score=352.30  Aligned_cols=220  Identities=29%  Similarity=0.533  Sum_probs=193.0

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      +....|..-..+|+  |+-|.||.|+...+++.||||++.......+  +.+.+|+.+|+.++|+|||.|+++|...+.+
T Consensus       270 dP~~~y~~~~kigq--gaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQ--GATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             Chhhhhcchhhhcc--ccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            34556777889999  6689999999999999999999998766554  4588999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+|||||+||+|+|++...   .++|..+..+++++++||+|||.+||||||||.+|||++.+|.+|+.|||+...+...
T Consensus       346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999999998764   3789999999999999999999999999999999999999999999999997766654


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                      ..    ...+.+|||+|||||++..  ..|++++||||||++++||+-|++||...++-..++.+...+.|.+
T Consensus       423 ~~----KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l  489 (550)
T KOG0578|consen  423 QS----KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL  489 (550)
T ss_pred             cC----ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc
Confidence            32    2345789999999999976  4699999999999999999999999998877777766666565543

>KOG0198|consensus

Probab=100.00  E-value=4e-42  Score=342.25  Aligned_cols=217  Identities=29%  Similarity=0.440  Sum_probs=179.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC--cE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--DL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~--~~  435 (622)
                      ..+|..++.||+  |+||.||++.+..+|+.+|||.+......  ..+.+.+|+.+|++|+|||||++++......  .+
T Consensus        16 ~~~~~~~~~lG~--Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGR--GSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccC--ccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            566889999999  78999999999999999999998765322  2678999999999999999999999855555  58


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCceEEcCcccccccCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSP  514 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~-~~~~~~~~~~~~~~~~~  514 (622)
                      +++|||+++|+|.+++.+.+. ++++..++.+++||++||+|||++|||||||||+|||++. ++.+|++|||.+.....
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999998765 6999999999999999999999999999999999999999 79999999997654432


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC-CCcHHHHHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKL  581 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~-~~~~~~~~~~~  581 (622)
                       ............||+.|||||++..+ ...+.++|||||||++.||+||++||.. ......+..+.
T Consensus       171 -~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig  236 (313)
T KOG0198|consen  171 -KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG  236 (313)
T ss_pred             -ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh
Confidence             11111223456789999999999742 1223489999999999999999999987 33333344443

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.9e-41  Score=374.58  Aligned_cols=263  Identities=24%  Similarity=0.386  Sum_probs=214.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--Cc
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TD   84 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~   84 (622)
                      ...+|++++.||+  |+||+||+|+++.+++.||+|.+............+.+|+.+|++|+|||||+++++|.+.  ..
T Consensus        11 ~l~~YeIl~kLG~--GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         11 RLNEYEVIKKIGN--GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccCCEEEEEEEec--CCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            4568999999999  7799999999999999999999987766666777889999999999999999999998764  46


Q ss_pred             EEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCCEEEcCC-------
Q psy15039         85 LHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGK-------GFIHRAVKASHILISHN-------  148 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~-------~IvHrDiKp~NiLl~~~-------  148 (622)
                      +|+||||+++|+|.+++....  ...+++..++.|+.||+.||+|||+.       +||||||||+||||+..       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            999999999999999987532  23589999999999999999999984       59999999999999642       


Q ss_pred             ----------CceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy15039        149 ----------GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF  218 (622)
Q Consensus       149 ----------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf  218 (622)
                                +.++++|||.........     ......+|+.|+|||++.+....|+.++|||||||+||+|++|..||
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                      347889998764432211     11233567889999998755456889999999999999999999999


Q ss_pred             CCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHh
Q psy15039        219 AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN  298 (622)
Q Consensus       219 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  298 (622)
                      ........++..+...+ .                               +....++.++.+||..||..||.+||++.+
T Consensus       244 ~~~~~~~qli~~lk~~p-~-------------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Q  291 (1021)
T PTZ00266        244 HKANNFSQLISELKRGP-D-------------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQ  291 (1021)
T ss_pred             CcCCcHHHHHHHHhcCC-C-------------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence            86655444444332211 0                               111235788999999999999999999999


Q ss_pred             hhcCcccccc
Q psy15039        299 LLQHAFFKQT  308 (622)
Q Consensus       299 ~l~h~~~~~~  308 (622)
                      +|.|+|+...
T Consensus       292 lL~h~~ik~i  301 (1021)
T PTZ00266        292 CLGYQIIKNV  301 (1021)
T ss_pred             HhccHHHhhc
Confidence            9999999754

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.9e-41  Score=347.34  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ++||+  |+||.||+|+++.+|+.||||+++.+.. .+...+....|+.++..+ +||||++++++|.+++.+|+||||+
T Consensus         1 ~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGK--GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            46898  7789999999999999999999976432 123345566788888765 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      .+|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~  152 (316)
T cd05620          79 NGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN----R  152 (316)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC----c
Confidence            999999988664  3578999999999999999999999999999999999999999999999997543211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||...+... +.+.+....|.               
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~~~~~~~~---------------  214 (316)
T cd05620         153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFESIRVDTPH---------------  214 (316)
T ss_pred             eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC---------------
Confidence            123356788999999975  358899999999999999999999998665432 22222211111               


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-HhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-CNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-~~~l~h~~~~~~~  309 (622)
                                       .+..++.++.+++.+||+.||++||++ +++++||||....
T Consensus       215 -----------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         215 -----------------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             -----------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                             122468899999999999999999998 5899999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-41  Score=340.02  Aligned_cols=282  Identities=21%  Similarity=0.314  Sum_probs=209.9

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |++|.||+|+++.+|+.||||++..........+.+.+|+.+|++++||||+++++++.++..+++||
T Consensus         1 ~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGE--GTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecc--cCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            6999999999  77899999999999999999998765444444456778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         90 PLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||++ +++.+++..... ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+++.|||...........
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            9998 688888765332 35889999999999999999999999999999999999999999999999976433221111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~~~~~  246 (622)
                          .....+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+............  +..+. ..+.. ..
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~  230 (285)
T cd07861         158 ----YTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE-DVWPG-VT  230 (285)
T ss_pred             ----ccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh-hhhhc-ch
Confidence                1122346779999998653 3578899999999999999999999987654433332221  11100 00000 00


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      . .. +.....+.+...  ........+++++.++|.+||+.||++|||+.+++.||||
T Consensus       231 ~-~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         231 S-LP-DYKNTFPKWKKG--SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             h-hH-HHHhhccccCcc--hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0 00 000000000000  0001123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.9e-41  Score=354.30  Aligned_cols=289  Identities=20%  Similarity=0.252  Sum_probs=209.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC--
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--   83 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--   83 (622)
                      .+.++|++.+.||+  |+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++||||++++++|....  
T Consensus        14 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeee--cCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            46789999999999  77999999999999999999999775555556677889999999999999999999987543  


Q ss_pred             ----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         84 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        84 ----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                          ..++||||+++ ++.+.+..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||..
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence                47999999975 55555533    3788899999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh---CCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA---GATP  236 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~---~~~p  236 (622)
                      .......     ......+|..|+|||++.+  ..|+.++|||||||++|+|++|+.||.+..........+.   ...|
T Consensus       167 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         167 RTAGTSF-----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccCCCcc-----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            4432211     1122356778999999875  3588999999999999999999999987654433322221   1111


Q ss_pred             CCCcc----ccccccCCCCcCcccccccchhhhh--ccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        237 HLLDC----TTYYVDTGQDDGEENACSYISEQQT--QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       237 ~~~~~----~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      .....    ...+............+........  ........+.++++|+.+||+.||++|||+.|+|+||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            00000    0000000000000000000000000  000112346788999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-40  Score=333.22  Aligned_cols=266  Identities=32%  Similarity=0.617  Sum_probs=215.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||.||+|..+.+++.||+|+++...... ..+.+.+|+++|+.++||||+++++.+..++..+++
T Consensus         1 ~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGV--GATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecC--CCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            47999999999  778999999999999999999997655433 567788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||+++++++.+++..... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||..........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999999976433 3578999999999999999999999999999999999999999999999987644432221


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      ..........++..|+|||.+... ..++.++|+|||||++|+|++|+.||...+.............+.+..       
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  229 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLET-------  229 (267)
T ss_pred             ccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCC-------
Confidence            110111222456779999998754 357889999999999999999999998765544333333322211100       


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                          ......+++++.+++..||+.||++||++.++++||||
T Consensus       230 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         230 --------------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             --------------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                                00123578899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.9e-41  Score=352.25  Aligned_cols=289  Identities=20%  Similarity=0.230  Sum_probs=209.6

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      ..+.++|++.+.||+  |+||.||+|+++.+++.||||++..........+.+.+|+.+|+.++||||++++++|...  
T Consensus        20 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          20 FTVLKRYQNLKPIGS--GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hchhcceeEEEEeec--CCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence            346789999999999  7789999999999999999999976554455566788999999999999999999988654  


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ..+++||||+++ ++.+.+..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875          98 LEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             ccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence                357999999975 56666543    367889999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      ........     ......+|..|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+........+....+..
T Consensus       173 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         173 ARTAGTSF-----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             ccccCCCC-----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            64432211     1112355778999999975  4588999999999999999999999987665443333322111100


Q ss_pred             Ccccc--------ccccCCCCcCcccccccchhhhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        239 LDCTT--------YYVDTGQDDGEENACSYISEQQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       239 ~~~~~--------~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ++...        +....+.. ..............+  .......++++++|+.+||+.||.+|||+.++|+||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKY-AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCc-CCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            00000        00000000 000000000000000  00112246789999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.7e-41  Score=346.10  Aligned_cols=252  Identities=22%  Similarity=0.354  Sum_probs=202.2

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ++||+  |+||.||+|+++.+++.||||.++.... .+...+.+.+|..++..+ +||||+++++++.....+++||||+
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGK--GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            36898  7799999999999999999999876432 233345556677777654 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~----~  152 (316)
T cd05592          79 NGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG----K  152 (316)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC----c
Confidence            999999988764  3588999999999999999999999999999999999999999999999997643221111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||.+....... ..+....|.               
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-~~i~~~~~~---------------  214 (316)
T cd05592         153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-DSILNDRPH---------------  214 (316)
T ss_pred             cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCCCC---------------
Confidence            123356788999999975  35889999999999999999999999876543332 222221111               


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-HhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-CNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-~~~l~h~~~~~~~  309 (622)
                                       .+..++.++.+++..||+.||++||++ .++++||||....
T Consensus       215 -----------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         215 -----------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             -----------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                             123468889999999999999999986 5899999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0666|consensus

Probab=100.00  E-value=1.7e-42  Score=328.14  Aligned_cols=292  Identities=23%  Similarity=0.306  Sum_probs=214.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCc----EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-CC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQ----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-AT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~   83 (622)
                      ..|+++..||+  |.||.||+|..+.|+-    .+|||+++.++.-......+-|||.+++.|+|||||++..+|.. +.
T Consensus        24 ~~ye~ig~Ig~--GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGR--GTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecc--cccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            47999999999  6688999997766544    69999998775444455667899999999999999999999988 77


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CceEEcCC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF---NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN----GKACLSGL  156 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~----~~~~i~~~  156 (622)
                      .+|++.||.+ -+|..+++-+.   ...+|...++.|+.||+.|+.|||++=|+||||||+|||+..+    |.+||.|+
T Consensus       102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            8999999998 46777776442   2348999999999999999999999999999999999999988    89999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch-----------HH
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT-----------TL  225 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~-----------~~  225 (622)
                      |++..+...-+..... ...+.|.+|+|||+|.+. ..|+.++||||.|||+.||++-.+-|.+...           +.
T Consensus       181 GlaR~~~~plkpl~s~-d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASL-DPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cHHHHhhccccccccC-CceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            9887665444333222 234568899999999976 5799999999999999999999888875221           11


Q ss_pred             HHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhh-hc------cccCCCCcHHHHHHHHHhhhcCCCCCcCHHh
Q psy15039        226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQ-TQ------VLTSRKFSDSFHSIVELCLSRDVDKRPLACN  298 (622)
Q Consensus       226 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  298 (622)
                      ..+-.+.| .|...+++..    ...+......+.+.... ..      .-....-++...+|+..||.+||.+|.|+.+
T Consensus       259 ~rIf~vLG-~Pt~~~Wp~l----kk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q  333 (438)
T KOG0666|consen  259 DRIFEVLG-TPTDKDWPDL----KKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ  333 (438)
T ss_pred             HHHHHHcC-CCccccchhh----hhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence            12222333 2332222110    00000000000000000 00      0011123566999999999999999999999


Q ss_pred             hhcCcccccccc
Q psy15039        299 LLQHAFFKQTKK  310 (622)
Q Consensus       299 ~l~h~~~~~~~~  310 (622)
                      +|+|+||+....
T Consensus       334 Aleh~yF~~d~l  345 (438)
T KOG0666|consen  334 ALEHPYFTEDPL  345 (438)
T ss_pred             HhcccccccCCC
Confidence            999999988644

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-41  Score=350.55  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=204.4

Q ss_pred             eecccccCCceeEEEEEE---ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeec
Q psy15039         15 SILGQCFNNLSSVYLSKH---KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~---~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      +.||+  |+||.||++++   +.+|+.||+|++........+...+.+|+++|++++||||++++++|.+...+|+||||
T Consensus         2 ~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQ--GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeee--CCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            57899  77999999986   46899999999976544444455677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccc
Q psy15039         92 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        92 ~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      +++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||...........   
T Consensus        80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---  154 (318)
T cd05582          80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---  154 (318)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc---
Confidence            9999999988653  35889999999999999999999999999999999999999999999999976433221111   


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQD  251 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  251 (622)
                       .....+++.|+|||++.+  ..++.++|||||||++|+|++|+.||.................                
T Consensus       155 -~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~----------------  215 (318)
T cd05582         155 -AYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL----------------  215 (318)
T ss_pred             -eecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence             112356778999999875  3578899999999999999999999986554333222211110                


Q ss_pred             cCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCccccccc
Q psy15039        252 DGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTK  309 (622)
Q Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~  309 (622)
                                       ..+..+++++.+|++.||+.||++||+     ..+++.||||....
T Consensus       216 -----------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         216 -----------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence                             012346889999999999999999999     67799999998653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.7e-41  Score=346.50  Aligned_cols=252  Identities=21%  Similarity=0.311  Sum_probs=204.5

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|+++.+++.||||++..... .......+.+|+.+++.+ +||||+++++++.+.+.+++||||+
T Consensus         1 ~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGK--GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            36888  7799999999999999999999976432 233455677899999988 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~  152 (318)
T cd05570          79 NGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----T  152 (318)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----c
Confidence            999999888764  3588999999999999999999999999999999999999999999999997533211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....++..|+|||++.+  ..++.++||||+||++|+|++|+.||.......... .+....+                
T Consensus       153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~-~i~~~~~----------------  213 (318)
T cd05570         153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ-SILEDEV----------------  213 (318)
T ss_pred             ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH-HHHcCCC----------------
Confidence            112345778999999975  358899999999999999999999998655433222 2211110                


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~~~~~  309 (622)
                                      ..+..+++++.+|+.+||+.||++||++     .++++||||+...
T Consensus       214 ----------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         214 ----------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             ----------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                            0123468899999999999999999999     9999999998754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.8e-41  Score=345.47  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=202.4

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhh-CCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRH-LRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|+++.+++.||||.++.+.. .+.......+|..+++. ++||||+++++++.+.+.+++||||+
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGK--GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             Ceeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            36888  7799999999999999999999876432 12334556678888876 49999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||...........    
T Consensus        79 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----  152 (316)
T cd05619          79 NGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----  152 (316)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc----
Confidence            999999998763  34788899999999999999999999999999999999999999999999975432111111    


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|..|+|||++.+  ..|+.++||||+||++|+|++|..||........ ...+....|.               
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~i~~~~~~---------------  214 (316)
T cd05619         153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-FQSIRMDNPC---------------  214 (316)
T ss_pred             eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC---------------
Confidence            122356778999999875  3588999999999999999999999986654332 2222211110               


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHH-hhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-NLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~-~~l~h~~~~~~~  309 (622)
                                       .+..++.++.+++.+||+.||++||++. ++++||||....
T Consensus       215 -----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         215 -----------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             -----------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence                             1224688899999999999999999996 899999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-40  Score=360.86  Aligned_cols=260  Identities=18%  Similarity=0.329  Sum_probs=212.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccC-CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVT-NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..|.+.+.||+  |+||.||+|.+..+ ++.||+|.+...  .......+.+|+.+|+.++|||||+++++|...+.+++
T Consensus        67 ~~y~~~~~lg~--G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         67 HMYVLTTLVGR--NPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eeEEEEEEEEe--CCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34999999999  77889999999888 888999987543  23444567789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         88 VSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ||||+++|+|.+.+....  ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||....+...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            999999999998876432  235789999999999999999999999999999999999999999999999987544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...  .......+|+.|+|||++.+  ..|+.++||||+||++|+|++|+.||..............+..+.        
T Consensus       223 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--------  290 (478)
T PTZ00267        223 VSL--DVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP--------  290 (478)
T ss_pred             ccc--ccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            110  11223456888999999875  458999999999999999999999998665443333333322111        


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                              .+..+++++.++|..||..||++||++.+++.|+|++..
T Consensus       291 ------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        291 ------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                                    123468899999999999999999999999999998653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-40  Score=340.62  Aligned_cols=288  Identities=19%  Similarity=0.278  Sum_probs=211.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      -++|++.+.||+  |+||.||+|+++.+++.||+|.+...... .....+.+|+.+++.|+||||+++++++.....+++
T Consensus         5 ~~~y~~~~~lg~--g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGE--GTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccceEEeeEecc--CcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            467999999999  77999999999999999999998754322 223456689999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++ +++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        82 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            999998 58888876542 3578999999999999999999999999999999999999999999999997643221111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCCCCCcccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATPHLLDCTTYY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p~~~~~~~~~  245 (622)
                      .    ......++.|+|||++.+. ..++.++|||||||++|+|++|++||...+.......  ...+.++. ..+... 
T Consensus       160 ~----~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~-  232 (301)
T cd07873         160 T----YSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE-ETWPGI-  232 (301)
T ss_pred             c----ccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh-hhchhh-
Confidence            1    1122346789999998653 3578899999999999999999999987654332221  22221110 000000 


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ... ..........+....  .......+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus       233 ~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         233 LSN-EEFKSYNYPKYRADC--LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             hcc-ccccccccCcccccc--HHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            000 000000000000000  00112357889999999999999999999999999999976543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.9e-41  Score=337.88  Aligned_cols=252  Identities=23%  Similarity=0.329  Sum_probs=200.4

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG   95 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g   95 (622)
                      ||+  |+||.||+++++.+|+.||+|++..+.... ...+.+..|+++|++++||||++++++|.++..+++||||++++
T Consensus         1 lg~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGK--GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCC--CCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            577  889999999999999999999997644322 22344567999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCC
Q psy15039         96 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  175 (622)
Q Consensus        96 ~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  175 (622)
                      +|.+++......++++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........     ...
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-----~~~  153 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-----ITQ  153 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-----eec
Confidence            999888654444588999999999999999999999999999999999999999999999997644322111     112


Q ss_pred             CCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH---HHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL---MLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       176 ~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      ..++..|+|||++...  .++.++||||+||++|+|++|+.||.......   ..........                 
T Consensus       154 ~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------  214 (277)
T cd05607         154 RAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-----------------  214 (277)
T ss_pred             cCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-----------------
Confidence            3456789999998754  48899999999999999999999997543211   1111110000                 


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH----HhhhcCcccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA----CNLLQHAFFKQT  308 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~~~l~h~~~~~~  308 (622)
                                    .......+++++.+|++.||+.||++||++    ++++.|+||+..
T Consensus       215 --------------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         215 --------------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             --------------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence                          001123478899999999999999999999    678899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.8e-40  Score=329.49  Aligned_cols=256  Identities=20%  Similarity=0.372  Sum_probs=210.2

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-CcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-TDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lv   88 (622)
                      .|++++.||+  |++|.||+++++.+++.||+|++..........+.+.+|++++++++||||+++++.+... ..++++
T Consensus         1 ~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGK--GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecC--CCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            5999999999  7788999999999999999999987655556667788999999999999999999988754 468999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||++++++.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.||+.......... 
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-  157 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-  157 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence            9999999999999765444589999999999999999999999999999999999999999999999997543322111 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                         ......+++.|+|||++..  ..++.++|+||+||++|+|++|+.||...+..........+..|.           
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-----------  221 (257)
T cd08223         158 ---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP-----------  221 (257)
T ss_pred             ---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence               1112244667999999865  357889999999999999999999998655443333333222211           


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                           ....+++++.+++.+||+.||++||++.++++||||
T Consensus       222 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         222 ---------------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ---------------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                 123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0583|consensus

Probab=100.00  E-value=3.2e-41  Score=349.61  Aligned_cols=220  Identities=25%  Similarity=0.382  Sum_probs=185.4

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC---HHHHHHHHHHHHHHhhCC-CCccceeEEEEEe
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---DEDLKSLHHEIVCMRHLR-HPNIICYISSFLD  431 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~  431 (622)
                      ...+.|.+.+.||.  |+||.|++|++..+|+.||+|++..+...   ....+.+.+|+.+++.++ ||||+++++++..
T Consensus        14 ~~~g~y~~~~~lG~--GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   14 LSIGKYELGRTLGS--GSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             cccCceeeeeeecC--CCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            34678999999999  78999999999999999999987765222   123456779999999998 9999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CceEEcCccccc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYMC  510 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~-~~~~~~~~~~~~  510 (622)
                      ...+|+||||+.+|+|.+++...  ..+.|..++.+++|++.|++|||++||+||||||+|||++.+ +++|+.|||++.
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999999873  357889999999999999999999999999999999999999 999999999865


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCC-chhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ...    .......+.+||+.|+|||++.+.. .|+ .++||||+||+||.|++|+.||.+.+... +...+....
T Consensus       170 ~~~----~~~~~l~t~cGsp~Y~aPEvl~~~~-~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-l~~ki~~~~  239 (370)
T KOG0583|consen  170 ISP----GEDGLLKTFCGSPAYAAPEVLSGKG-TYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-LYRKIRKGE  239 (370)
T ss_pred             ccC----CCCCcccCCCCCcccCCHHHhCCCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-HHHHHhcCC
Confidence            432    1123345678999999999997632 275 78999999999999999999998865444 444455443

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-40  Score=346.15  Aligned_cols=253  Identities=21%  Similarity=0.330  Sum_probs=201.7

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|+++.+++.||+|++++... .......+.+|+.++.++ +|||||++++++...+.+++||||+
T Consensus         1 ~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGR--GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            46898  7799999999999999999999986533 334456677899998877 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~----~  152 (329)
T cd05618          79 NGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----T  152 (329)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC----c
Confidence            999998887653  3589999999999999999999999999999999999999999999999997532211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc--------hHHHHHHHHhCCCCCCCccccc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--------TTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~--------~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .....+|+.|+|||++.+  ..++.++|||||||++|+|++|..||....        ....+...+...          
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------  220 (329)
T cd05618         153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------  220 (329)
T ss_pred             cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------
Confidence            123356788999999975  357899999999999999999999995211        011111111110          


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH------HhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA------CNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~~l~h~~~~~~~  309 (622)
                                            ....+..++.++.+++++||+.||++||++      .++++||||....
T Consensus       221 ----------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         221 ----------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                                  011123568899999999999999999984      7999999997653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.4e-40  Score=328.08  Aligned_cols=256  Identities=23%  Similarity=0.432  Sum_probs=213.0

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |++|.||+|.++.+|+.||+|.+............+.+|+.++++++||||+++++++......+++|
T Consensus         1 ~~~~~~~l~~--g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGK--GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecC--CCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            6899999999  77889999999999999999999876666677778899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||........... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-  157 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-  157 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence            9999999999997754446889999999999999999999999999999999999999999999999865433221111 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                         .....++..|+|||++...  .++.++|+|||||++++|++|+.||..............+..|.            
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd08529         158 ---ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP------------  220 (256)
T ss_pred             ---hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence               1122345679999998753  47889999999999999999999998665443333222222111            


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                          ....++.++.+++.+||+.+|++||++.++++|||+
T Consensus       221 --------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         221 --------------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             --------------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                                112467889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.3e-40  Score=338.47  Aligned_cols=286  Identities=23%  Similarity=0.344  Sum_probs=212.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||.||+++++.+|..||+|.++... .......+.+|+++|++++||||++++++|..++.++++
T Consensus         1 ~~~~~~~~lg~--G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGA--GNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccC--CCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            47999999999  778899999999999999999987542 344556788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||+++++|.++++..  ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+++.|||........  
T Consensus        78 ~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             eeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            9999999999999764  357899999999999999999997 59999999999999999999999999865332111  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc--cc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT--YY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~--~~  245 (622)
                          ......++..|+|||++.+  ..++.++|+|||||++|+|++|..||....... .................  ..
T Consensus       154 ----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         154 ----MANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             ----ccccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccc
Confidence                1122345678999999865  347889999999999999999999997544221 11111111111100000  00


Q ss_pred             ccCCCCcCc----ccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        246 VDTGQDDGE----ENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       246 ~~~~~~~~~----~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      .........    ......+.....+......++.++.+|+.+||..||++||++.++++||||...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            000000000    000000111111112223478899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.9e-41  Score=346.32  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHH-HHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIV-CMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|+++.+|+.||||++..... .....+.+.+|.. +++.++||||++++++|...+.+++||||+
T Consensus         1 ~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGK--GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            36888  7799999999999999999999875432 2223344555554 568899999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~----~  152 (323)
T cd05575          79 NGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK----T  152 (323)
T ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC----c
Confidence            999999888663  3578999999999999999999999999999999999999999999999997543211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||...+..........+. .                
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~----------------  213 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-L----------------  213 (323)
T ss_pred             cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-C----------------
Confidence            122356778999999875  358899999999999999999999998765433222222111 0                


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH----HhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA----CNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~~~l~h~~~~~~~  309 (622)
                                      .....+++++.+++.+||+.||.+||++    .+++.||||....
T Consensus       214 ----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         214 ----------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                            0123468899999999999999999998    5999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0604|consensus

Probab=100.00  E-value=7.7e-42  Score=322.38  Aligned_cols=260  Identities=20%  Similarity=0.266  Sum_probs=206.0

Q ss_pred             CCCCceEE-eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC--
Q psy15039          7 VPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA--   82 (622)
Q Consensus         7 ~~~~y~~~-~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--   82 (622)
                      +.++|.|- .+||-|..  |+|-.|.++.||+.+|+|++.       +...+.||+.+.=+. .|||||+++++|...  
T Consensus        59 itedY~is~qvLG~Gin--GkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGIN--GKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             chhhheehhhhhccccC--CceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            56788885 45888664  599999999999999999972       224456788876555 699999999988653  


Q ss_pred             --CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCc
Q psy15039         83 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLR  157 (622)
Q Consensus        83 --~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~  157 (622)
                        ..+.+|||.|+||+|++.+..+....+.|.++..|++||..|+.|||+.+|.||||||+|+|...++   .+|++|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence              5688999999999999999887766689999999999999999999999999999999999997654   57899999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH----HHHHHHHhC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT----LMLIEKLAG  233 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~----~~~~~~~~~  233 (622)
                      ++..-..     ...-.+.++|++|.|||++-  .+.|+...|+||+||++|-|++|.+||.+....    -+..++..|
T Consensus       210 FAK~t~~-----~~~L~TPc~TPyYvaPevlg--~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g  282 (400)
T KOG0604|consen  210 FAKETQE-----PGDLMTPCFTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG  282 (400)
T ss_pred             cccccCC-----CccccCCcccccccCHHHhC--chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence            8643221     11123568899999999984  467999999999999999999999999864321    111111111


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                      .+                .             ++.+.+..+|++++|+|+.+|+.+|.+|.|+.+++.|||+.+....
T Consensus       283 qy----------------~-------------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v  331 (400)
T KOG0604|consen  283 QY----------------E-------------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV  331 (400)
T ss_pred             Cc----------------c-------------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence            11                1             1223445679999999999999999999999999999999876543

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7.9e-41  Score=339.77  Aligned_cols=281  Identities=20%  Similarity=0.288  Sum_probs=206.4

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||+|+++.+|+.||+|.+............+.+|+.+|++++||||+++++++.+...+++++
T Consensus         1 ~y~~~~~l~~--g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGE--GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecc--cCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            5999999999  77889999999999999999999765443333455778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||++ +++.+.+.... ..+++..+..++.||++||.|||++||+||||||+||+++.++.+++.|||....+...... 
T Consensus        79 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-  155 (284)
T cd07839          79 EYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-  155 (284)
T ss_pred             ecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence            9998 57777765532 35899999999999999999999999999999999999999999999999976543322111 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH---hCCCCCCCccccccc
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL---AGATPHLLDCTTYYV  246 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~---~~~~p~~~~~~~~~~  246 (622)
                         .....++..|+|||++.+. ..++.++||||+||++|+|++|..||............+   .+..+. ..+.. ..
T Consensus       156 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~  229 (284)
T cd07839         156 ---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE-ESWPG-VS  229 (284)
T ss_pred             ---cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh-HHhHH-hh
Confidence               1122446789999998653 357889999999999999999998875443322222221   111110 00000 00


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ......   ...... ...........+++++.+++.+||+.||.+|||+.+++.||||
T Consensus       230 ~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         230 KLPDYK---PYPMYP-ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hccccc---ccCCCC-CcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            000000   000000 0000000123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-40  Score=345.96  Aligned_cols=256  Identities=20%  Similarity=0.332  Sum_probs=198.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~   81 (622)
                      .++|++.++||+  |+||.||+|.+     +.+++.||||++.... .....+.+.+|+.+|+++ +|||||++++++..
T Consensus         6 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           6 RDRLRLGKVLGH--GAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hhHceeeeEecc--CCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            368999999999  77999999985     3456789999987543 344556788999999999 89999999998876


Q ss_pred             C-CcEEEEeecCCCCCHHHHHHhhc-------------------------------------------------------
Q psy15039         82 A-TDLHLVSPLMGFGSCKDLINAHF-------------------------------------------------------  105 (622)
Q Consensus        82 ~-~~~~lv~e~~~~g~l~~~l~~~~-------------------------------------------------------  105 (622)
                      . ..++++|||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 45899999999999999986531                                                       


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCc
Q psy15039        106 -----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL  180 (622)
Q Consensus       106 -----~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (622)
                           ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||...........  .......+++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCCc
Confidence                 123667788899999999999999999999999999999999999999999976543211111  1112223456


Q ss_pred             cccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccc
Q psy15039        181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS  259 (622)
Q Consensus       181 ~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  259 (622)
                      .|+|||++.+  ..|+.++|||||||++|||++ |..||............+....+                       
T Consensus       241 ~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------  295 (338)
T cd05102         241 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-----------------------  295 (338)
T ss_pred             cccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-----------------------
Confidence            7999999865  358899999999999999996 99999765433222222211100                       


Q ss_pred             cchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       260 ~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                              .......++++.+++.+||+.||++|||+.++++
T Consensus       296 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 --------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    0012345788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-40  Score=336.95  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=209.0

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .|++.+.||+  |+||.||++.++.+++.||||.+....... .....+.+|+.+|++++|+||+.+++.+.+.+..++|
T Consensus         1 ~f~~~~~ig~--G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGK--GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeec--CCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            4889999999  789999999999999999999987654332 2234567899999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.......... 
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            9999999999988654444688999999999999999999999999999999999999999999999997643321111 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH--HHHHHHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL--MLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~--~~~~~~~~~~p~~~~~~~~~~  246 (622)
                          .....++..|+|||++.+  ..++.++||||+||++|+|++|+.||.......  .........            
T Consensus       158 ----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------  219 (285)
T cd05630         158 ----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------  219 (285)
T ss_pred             ----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence                112356778999999975  358899999999999999999999997543211  001110000            


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~  309 (622)
                                         ........+++++.+|+..||+.||++|||     +.++++||||+...
T Consensus       220 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         220 -------------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             -------------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence                               000112347889999999999999999999     99999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-40  Score=342.87  Aligned_cols=257  Identities=18%  Similarity=0.284  Sum_probs=207.6

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCC-CcceeEEEEEEeCCcEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRH-PNIICYISSFLDATDLHL   87 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~l   87 (622)
                      +|+..+.||+  |+||.||+|+++.+|+.||||++..... .....+.+.+|+.+++.+.| ++|++++++|.+.+.+|+
T Consensus         1 ~f~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGK--GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            5889999999  7789999999999999999999876432 23345567789999998865 678889999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        79 v~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          79 VMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            99999999999988664  3488999999999999999999999999999999999999999999999997543221111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                          ......+|+.|+|||++.+  ..++.++||||+||++|+|++|..||.................            
T Consensus       157 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------  218 (323)
T cd05615         157 ----TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------  218 (323)
T ss_pred             ----cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence                1122346788999999875  3588999999999999999999999987654433222221110            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~  309 (622)
                                           ..+..++.++.+++.+||+.||.+|++     ..++++||||....
T Consensus       219 ---------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         219 ---------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             ---------------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                                 012346888999999999999999997     47899999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0662|consensus

Probab=100.00  E-value=3e-41  Score=295.98  Aligned_cols=280  Identities=21%  Similarity=0.307  Sum_probs=214.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|+-.+.||+  |.||+||+|+++.|++.||+|.+..+..++.......|||-+|+.|+|.|||+++++...+..+-+|
T Consensus         2 ~~ydkmekige--gtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    2 QKYDKMEKIGE--GTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             cchHHHHhhcC--CcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            46777899999  6688999999999999999999988766666667788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      .|||. -+|..+.... ++.++.+.++.+|-|+++||.|||+++++|||+||.|+||+.+|..++.|||.+..|+...+.
T Consensus        80 fe~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   80 FEFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            99997 3455555443 345889999999999999999999999999999999999999999999999998877654332


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHH--HHHhCCCCCCCcccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI--EKLAGATPHLLDCTTYY  245 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~--~~~~~~~p~~~~~~~~~  245 (622)
                      .    .....|++|++|.++.+. .-|+...|+||.||++.|+.. |.+.|.+.+...++.  ..+.|.+ .-..++.  
T Consensus       158 y----saevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p-~ed~wps--  229 (292)
T KOG0662|consen  158 Y----SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEDQWPS--  229 (292)
T ss_pred             e----eceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC-ccccCCc--
Confidence            2    123457899999999865 569999999999999999986 766677766544443  3333322 1111110  


Q ss_pred             ccCCCCcCcccccccchhhhhc-cc----cCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQ-VL----TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~-~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                              -...+.|..-...+ ..    .-++++..-+|+++++|.-+|.+|.+|+.+++||||...
T Consensus       230 --------~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  230 --------MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             --------cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                    00000110000000 00    012345667899999999999999999999999999763

>KOG0607|consensus

Probab=100.00  E-value=1.8e-41  Score=322.28  Aligned_cols=266  Identities=22%  Similarity=0.310  Sum_probs=208.5

Q ss_pred             CCCCceEE-eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCc
Q psy15039          7 VPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD   84 (622)
Q Consensus         7 ~~~~y~~~-~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~   84 (622)
                      |.+-|++. +.||+  |+|+.|--|.+..||+.||||++++..  -..+.+..||++++.+. .|+||++++++|++++.
T Consensus        75 F~d~YkLt~e~LGe--GAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   75 FEDMYKLTSELLGE--GAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             HHHHHHhHHHHhcC--ccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            44567774 56999  558899999999999999999998763  34567788999999999 69999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCccc--
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYM--  159 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~~~--  159 (622)
                      +|||||-|.+|++.+.+..+..  ++|.++..++++|+.||+|||.+||.|||+||+|||-.+..   .+||+||.+.  
T Consensus       151 FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999999999999999877653  68999999999999999999999999999999999987654   3566666543  


Q ss_pred             cccCCCCccccccC--CCCCCCccccChhhh---ccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch-----------
Q psy15039        160 CPFSPTKKKVHLFP--PSTAYNLNWLSPEVL---EQNLDGYDERSDIYSVGISCCELANGTVPFAETPT-----------  223 (622)
Q Consensus       160 ~~~~~~~~~~~~~~--~~~~~~~~y~aPE~l---~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~-----------  223 (622)
                      ..+...... ..++  .+.+++..|||||+.   .+....|+.+.|.||||++||-|++|.+||.+.-.           
T Consensus       229 ~k~~~~~sp-astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  229 IKLNNDCSP-ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             cccCCCCCC-CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            222222211 1111  144667789999976   34445799999999999999999999999975321           


Q ss_pred             ---HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhcc--ccCCCCcHHHHHHHHHhhhcCCCCCcCHHh
Q psy15039        224 ---TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQV--LTSRKFSDSFHSIVELCLSRDVDKRPLACN  298 (622)
Q Consensus       224 ---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  298 (622)
                         +..+.+.|                              .+....+  -.+..+|.+++++++.+|.+|+.+|.++.+
T Consensus       308 r~CQ~~LFesI------------------------------QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~  357 (463)
T KOG0607|consen  308 RVCQNKLFESI------------------------------QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ  357 (463)
T ss_pred             HHHHHHHHHHH------------------------------hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence               12222222                              1222222  234568999999999999999999999999


Q ss_pred             hhcCccccccc
Q psy15039        299 LLQHAFFKQTK  309 (622)
Q Consensus       299 ~l~h~~~~~~~  309 (622)
                      +++|||+....
T Consensus       358 vlnhPw~~~~~  368 (463)
T KOG0607|consen  358 VLNHPWVQRCA  368 (463)
T ss_pred             ccCCccccccc
Confidence            99999997643

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-40  Score=344.19  Aligned_cols=266  Identities=18%  Similarity=0.268  Sum_probs=209.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||+++++.+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         1 ~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGR--GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEe--CCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            47999999999  7799999999999999999999865322 22334557789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        79 v~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             EEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999997642 3578999999999999999999999999999999999999999999999997643321111


Q ss_pred             cccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .   ......+|+.|+|||++..   +...|+.++|||||||++|||++|+.||................. .       
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~-------  226 (332)
T cd05623         158 V---QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-R-------  226 (332)
T ss_pred             c---eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-c-------
Confidence            1   1112356788999999863   123578899999999999999999999987654433322221110 0       


Q ss_pred             cccCCCCcCcccccccchhhhhcc-ccCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQV-LTSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~  309 (622)
                                           ... .....+++++.+|+++||..++++  |+++.++++||||....
T Consensus       227 ---------------------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         227 ---------------------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             ---------------------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence                                 000 011346899999999999665544  78999999999998653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.7e-40  Score=358.09  Aligned_cols=285  Identities=19%  Similarity=0.225  Sum_probs=201.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCC------cceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP------NIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~~~~~~~   80 (622)
                      ...+|++++.||+  |+||+||+|.++.+++.||||+++...   ...+...+|+++|+.++|.      ||++++++|.
T Consensus       127 ~~~~y~i~~~lG~--G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        127 STQRFKILSLLGE--GTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CCCcEEEEEEEEe--ccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            4578999999999  779999999999999999999986421   2233455688888877654      5888988887


Q ss_pred             eC-CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCC---------
Q psy15039         81 DA-TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNG---------  149 (622)
Q Consensus        81 ~~-~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~---------  149 (622)
                      .. ..+++|||++ ++++.+++...  ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++         
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence            65 4688999987 57788877653  358899999999999999999998 5999999999999998765         


Q ss_pred             -------ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc
Q psy15039        150 -------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  222 (622)
Q Consensus       150 -------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~  222 (622)
                             .+++.|||........       .....+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||....
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~~~-------~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDERHS-------RTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccCCCCceEEECCCCccccCccc-------cccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   3889999965432111       123456788999999975  358999999999999999999999998765


Q ss_pred             hHH--HHHHHHhCCCCCCCccc-------cccccCCCCcCcccccccchhhh-hccccCCCCcHHHHHHHHHhhhcCCCC
Q psy15039        223 TTL--MLIEKLAGATPHLLDCT-------TYYVDTGQDDGEENACSYISEQQ-TQVLTSRKFSDSFHSIVELCLSRDVDK  292 (622)
Q Consensus       223 ~~~--~~~~~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~  292 (622)
                      ...  ..+....+..|......       ..+...+...... ....+.... .........++.+.+||..||++||++
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCT-DPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccC-CHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            432  23344444433211000       0000000000000 000000000 000000112567889999999999999


Q ss_pred             CcCHHhhhcCccccccc
Q psy15039        293 RPLACNLLQHAFFKQTK  309 (622)
Q Consensus       293 Rps~~~~l~h~~~~~~~  309 (622)
                      |||+.|+|+||||.+..
T Consensus       429 R~ta~e~L~Hp~~~~~~  445 (467)
T PTZ00284        429 RLNARQMTTHPYVLKYY  445 (467)
T ss_pred             CCCHHHHhcCccccccC
Confidence            99999999999998743

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=334.00  Aligned_cols=263  Identities=28%  Similarity=0.462  Sum_probs=213.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+++++.+++.||+|.+...  .....+.+.+|+.+|++++||||+++++++..+...++
T Consensus         4 ~~~~~i~~~l~~--g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGD--GAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcC--CCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            357999999999  77889999999999999999998654  34556778899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||..........
T Consensus        80 v~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          80 LIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             EeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999999987643 3588999999999999999999999999999999999999999999999986543221111


Q ss_pred             cccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .    .....++..|+|||++..+   ...++.++|+||+||++|+|++|+.||..............+..|.+      
T Consensus       159 ~----~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------  228 (280)
T cd06611         159 K----RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL------  228 (280)
T ss_pred             c----cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc------
Confidence            1    1122456679999998532   23467799999999999999999999986654433333222221111      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                              ..+..++.++.+++..||+.||++||++.++++||||.+..
T Consensus       229 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         229 ------------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             ------------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                                    11234688999999999999999999999999999997753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0197|consensus

Probab=100.00  E-value=9.1e-41  Score=341.34  Aligned_cols=248  Identities=21%  Similarity=0.338  Sum_probs=202.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      .+++++.||+  |.||.|+.|+.+.+ ..||+|.++...+.++   .|.+|+++|++|+|+|||+|++++..+..+||||
T Consensus       207 ~l~l~~~LG~--G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~---~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGS--GQFGEVWLGKWNGS-TKVAVKTIKEGSMSPE---AFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcC--CccceEEEEEEcCC-CcccceEEeccccChh---HHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3456788999  88999999999854 3789999987655444   4668999999999999999999999988999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      |||+.|+|.++|+......++-.....++.||++|++||+++++|||||-+.||||+++..+||+|||.......+   .
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~---~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD---E  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC---c
Confidence            9999999999998755556778888999999999999999999999999999999999999999999988633221   1


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                      .....+......|+|||.+..+  .|+.|+|||||||+|+||+| |+.|+...+....+...-.|               
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~--~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G---------------  420 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYG--KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG---------------  420 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhC--CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc---------------
Confidence            1112222334579999999764  59999999999999999997 99999876554443322222               


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhh
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL  300 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l  300 (622)
                                       .+.+.+..+++++.+++..||+.+|++|||.+.+.
T Consensus       421 -----------------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 -----------------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -----------------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                             12234556899999999999999999999998654

>KOG0596|consensus

Probab=100.00  E-value=3.4e-41  Score=341.70  Aligned_cols=266  Identities=21%  Similarity=0.338  Sum_probs=209.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      ....|++++.||.  ||-|+||++..-. .+.||+|++.....++....-+..||.+|.+| .|.+||+++++-+.+..+
T Consensus       359 kg~~Yeilk~iG~--GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  359 KGREYEILKQIGS--GGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             CcchhhHHHhhcC--CCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            3468999999999  8889999999764 45789998877666777788899999999999 689999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+||| |+..+|..+|+..+. ..+.-.++.++.||+.|++++|..||||-||||.|+|+- .|.+|+.|||.+......
T Consensus       436 YmvmE-~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  436 YMVME-CGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEee-cccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            99999 566889999987653 234348999999999999999999999999999999986 489999999987554333


Q ss_pred             CccccccCCCCCCCccccChhhhccccC---------CCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLD---------GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~---------~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      ..  .+...+.+||++||+||.+.....         ..+.++||||||||||+|++|++||.........+..+..+.-
T Consensus       513 TT--sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  513 TT--SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             cc--ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            22  233446789999999999854321         1356899999999999999999999876555444444432110


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .+                          .++..++   ..++.++++.||.+||++||+..++|+|||..-..
T Consensus       591 ~I--------------------------efp~~~~---~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  591 EI--------------------------EFPDIPE---NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             cc--------------------------cccCCCC---chHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            00                          0001111   12389999999999999999999999999996643

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=328.73  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=208.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +.+|++.+.||+  |++|.||+|.+..+++.||+|.+......   ....+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~~~lg~--g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   78 (263)
T cd06625           1 PTNWRRGKLLGQ--GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET   78 (263)
T ss_pred             CCcccccceecC--CCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence            368999999999  77889999999999999999998754332   2234568899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++++||++++++.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+++.|||.......
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999999987642  478999999999999999999999999999999999999999999999997543221


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ...... ......++..|+|||++.+.  .++.++||||+||++|+|++|+.||.................+        
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------  225 (263)
T cd06625         157 ICSSGT-GMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--------  225 (263)
T ss_pred             cccccc-cccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--------
Confidence            111100 00122345679999998753  4789999999999999999999999765443322222111000        


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                             ......+++++.+++++||..||++||++.++++|+||
T Consensus       226 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         226 -----------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             -----------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                   00123468889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG1989|consensus

Probab=100.00  E-value=5.8e-41  Score=360.68  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=206.5

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEE-EEeC-----
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISS-FLDA-----   82 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~-~~~~-----   82 (622)
                      +++|.++|.+  |||+.||+|.....|..||+|++-..  ++...+.+.+||.+|++|+ |+|||.|++. ....     
T Consensus        38 ~v~V~~vLAE--GGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   38 RVTVEKVLAE--GGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEcc--CCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            6788999999  99999999999999999999998554  5677888999999999997 9999999993 3221     


Q ss_pred             -CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         83 -TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        83 -~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                       -.+.|.||||.+|.|-|++..+.+.++.|.++..|+.|+++||.+||...  |||||||-|||||+.+|..|++|||..
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence             34788999999999999998877777999999999999999999999987  999999999999999999999999986


Q ss_pred             cccCCCCc---ccc--ccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC
Q psy15039        160 CPFSPTKK---KVH--LFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  233 (622)
Q Consensus       160 ~~~~~~~~---~~~--~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~  233 (622)
                      +.-...-.   .+.  -......-|+.|+|||++.- .....++|+|||||||+||.||....||......         
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------  264 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------  264 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence            53221110   000  00111223577999999842 2235688999999999999999999999754111         


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                                                .|......++....+|+.+++||..||+.||++||.+.|++.+-+
T Consensus       265 --------------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  265 --------------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             --------------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                                      122233445566789999999999999999999999999887543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.1e-40  Score=333.53  Aligned_cols=263  Identities=21%  Similarity=0.315  Sum_probs=210.9

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .|+..+.||+  |+||+||++.+..+|+.||+|++........ ....+.+|+++|++++|+||+.++++|..++..+++
T Consensus         1 ~~~~~~~lg~--G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGK--GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEec--CCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            3788899999  7799999999999999999999976544322 345577899999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+.++++.+++......++++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.......... 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            9999999999888654444689999999999999999999999999999999999999999999999997643221111 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                          .....++..|+|||++.+  ..++.++|+||+||++|+|++|..||........... +......           
T Consensus       158 ----~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-~~~~~~~-----------  219 (285)
T cd05632         158 ----IRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-VDRRVLE-----------  219 (285)
T ss_pred             ----ccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhhc-----------
Confidence                112345778999999865  3588999999999999999999999986543221111 1000000           


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                       ........++.++.+|+..||+.||++||+     +.+++.|+||+....
T Consensus       220 -----------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         220 -----------------TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             -----------------cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence                             000112346888999999999999999999     889999999988644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-41  Score=347.44  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=201.0

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC---CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL---RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l---~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ||+  |+||+||+|+++.+|+.||||++..... .........+|..++.++   +||||++++++|...+.+|+||||+
T Consensus         1 lG~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGK--GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCC--CCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            677  8899999999999999999999865432 223344556777777766   6999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~----~  152 (330)
T cd05586          79 SGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK----T  152 (330)
T ss_pred             CCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC----C
Confidence            999999888653  3588999999999999999999999999999999999999999999999997643211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|..||..............+..                 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  214 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-----------------  214 (330)
T ss_pred             ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            1233567889999998643 3578999999999999999999999987654433222221110                 


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc----CHHhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP----LACNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----s~~~~l~h~~~~~~~  309 (622)
                                     .+....+++++.+|++.||+.||.+||    ++.++++||||....
T Consensus       215 ---------------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         215 ---------------RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             ---------------CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence                           011224688999999999999999998    689999999998643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.1e-40  Score=340.12  Aligned_cols=282  Identities=21%  Similarity=0.297  Sum_probs=193.0

Q ss_pred             EeecccccCCceeEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--CcEEEEe
Q psy15039         14 CSILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVS   89 (622)
Q Consensus        14 ~~~lG~g~g~~~~V~~~~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lv~   89 (622)
                      +..||+  |+||+||+|+++  .+++.||+|.+......    ..+.+|+++|++++|||||+++++|...  ..++++|
T Consensus         6 ~~~lG~--G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGR--GTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             cccccc--CCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            467999  779999999976  47889999998665432    3356899999999999999999998653  5689999


Q ss_pred             ecCCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc----CCCceEEcCCcc
Q psy15039         90 PLMGFGSCKDLINAHF-------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS----HNGKACLSGLRY  158 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~----~~~~~~i~~~~~  158 (622)
                      ||++ +++.+++....       ...+++..++.++.||+.||+|||++||+||||||+|||++    .++.+++.|||.
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9987 57777765321       12478999999999999999999999999999999999994    557899999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-----------HHH
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-----------LML  227 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-----------~~~  227 (622)
                      +........... ......+|+.|+|||++.+. ..|+.++||||+||++|+|++|++||......           ...
T Consensus       159 a~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         159 ARLFNSPLKPLA-DLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             eeccCCCCcccc-ccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            754432211111 11233557889999998753 35889999999999999999999999643211           111


Q ss_pred             HHHHhCCCCCCCccccc--cccCCC--CcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        228 IEKLAGATPHLLDCTTY--YVDTGQ--DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       228 ~~~~~~~~p~~~~~~~~--~~~~~~--~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                      +..+.+.++. .++...  ......  ........................+.++.+|+.+||+.||.+|||++|+|+||
T Consensus       237 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         237 IFNVMGFPAD-KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             HHHhcCCCCh-HHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            1111221110 000000  000000  00000000000000000001123467789999999999999999999999999


Q ss_pred             cc
Q psy15039        304 FF  305 (622)
Q Consensus       304 ~~  305 (622)
                      ||
T Consensus       316 ~f  317 (317)
T cd07868         316 YF  317 (317)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-40  Score=344.44  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=200.7

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHH-HHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIV-CMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|+++.+|+.||||++..... .......+.+|.. +++.++||||++++++|...+.+|+||||+
T Consensus         1 ~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGK--GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             Cceee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            36888  7799999999999999999999875432 2233344555654 578899999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|...+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||..........    .
T Consensus        79 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~----~  152 (325)
T cd05604          79 NGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD----T  152 (325)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC----C
Confidence            999999888653  3588999999999999999999999999999999999999999999999997543211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+++.|+|||++.+  ..|+.++|||||||++|+|++|..||...+.............                 
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-----------------  213 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-----------------  213 (325)
T ss_pred             cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-----------------
Confidence            122356778999999975  3588999999999999999999999987654433222221110                 


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH----HhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA----CNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~~~l~h~~~~~~~  309 (622)
                                      ......+.++.+++++||+.||.+||++    .+++.||||....
T Consensus       214 ----------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         214 ----------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             ----------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence                            1123468889999999999999999987    4899999998643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=336.78  Aligned_cols=267  Identities=25%  Similarity=0.328  Sum_probs=215.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+|++.+.||+  |+||.||+|.+..+++.||||.+....... ...+.+.+|+++|++++||||+++++.+......++
T Consensus         1 ~~y~~~~~ig~--g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGK--GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecC--CccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            47999999999  788999999999999999999998765433 355678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.||+..........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999999998764444689999999999999999999999999999999999999999999999986543221110


Q ss_pred             ccc-------------------------ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc
Q psy15039        168 KVH-------------------------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  222 (622)
Q Consensus       168 ~~~-------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~  222 (622)
                      ...                         .......++..|+|||++.+.  .++.++|||||||++|+|++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            000                         001112456679999999753  47889999999999999999999998665


Q ss_pred             hHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC----HHh
Q psy15039        223 TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL----ACN  298 (622)
Q Consensus       223 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~~  298 (622)
                      .............                               ........++++.+++.+||..||++||+    +.+
T Consensus       237 ~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~  285 (316)
T cd05574         237 RDETFSNILKKEV-------------------------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE  285 (316)
T ss_pred             hHHHHHHHhcCCc-------------------------------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence            4433332221110                               00111226889999999999999999999    999


Q ss_pred             hhcCcccccccc
Q psy15039        299 LLQHAFFKQTKK  310 (622)
Q Consensus       299 ~l~h~~~~~~~~  310 (622)
                      +++||||++..+
T Consensus       286 ll~~~~~~~~~~  297 (316)
T cd05574         286 IKQHPFFRGVNW  297 (316)
T ss_pred             HHcCchhhcCCh
Confidence            999999987654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.3e-39  Score=332.41  Aligned_cols=265  Identities=26%  Similarity=0.392  Sum_probs=212.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ...++|++++.||+  |+||.||+|+++.+++.||+|.+...  +....+.+.+|+.++++++||||+++++++..+...
T Consensus         9 ~~~~~y~i~~~lg~--g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (292)
T cd06644           9 DPNEVWEIIGELGD--GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL   84 (292)
T ss_pred             CcchhhhhhheecC--CCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence            34578999999999  77899999999999999999998654  355667788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||++++++..++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||........
T Consensus        85 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            99999999999988876543 35889999999999999999999999999999999999999999999999865332111


Q ss_pred             CccccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...    .....++..|+|||++...   ...++.++|+|||||++|+|++|..||.................|.     
T Consensus       164 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----  234 (292)
T cd06644         164 LQR----RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-----  234 (292)
T ss_pred             ccc----cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-----
Confidence            110    1122345679999998531   2346789999999999999999999997654333222222111111     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                               ......++.++.+++.+||..||++||++.++++||||....
T Consensus       235 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         235 -------------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             -------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                                     012235688899999999999999999999999999997644

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-40  Score=330.61  Aligned_cols=257  Identities=32%  Similarity=0.517  Sum_probs=206.9

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEee
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP   90 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e   90 (622)
                      |++++.||+  |+||+||+++++.+++.||+|++..............+|+.++++++||||+++++++.+....+++||
T Consensus         1 y~~~~~lg~--G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGS--GGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEE--ESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEe--CCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            899999999  678899999999999999999998876555555555679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccc
Q psy15039         91 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH  170 (622)
Q Consensus        91 ~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~  170 (622)
                      +++++++.+++...  ..+++..+..++.|+++||+|||++||+||||||+||+++.++.+++.|||..........   
T Consensus        79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~---  153 (260)
T PF00069_consen   79 YCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE---  153 (260)
T ss_dssp             EETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS---
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence            99999999999843  3478999999999999999999999999999999999999999999999998653211111   


Q ss_pred             ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHH-HhCCCCCCCcccccccc
Q psy15039        171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEK-LAGATPHLLDCTTYYVD  247 (622)
Q Consensus       171 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~-~~~~~p~~~~~~~~~~~  247 (622)
                       ......++..|+|||++..+ ..++.++|+||+|+++|+|++|..||.....  ....... .....            
T Consensus       154 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------------  219 (260)
T PF00069_consen  154 -NFNPFVGTPEYMAPEVLQQG-KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL------------  219 (260)
T ss_dssp             -EBSSSSSSGGGSCHHHHTTT-SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH------------
T ss_pred             -cccccccccccccccccccc-ccccccccccccccccccccccccccccccchhhhhhhhhcccccc------------
Confidence             11233557789999998622 4578999999999999999999999987621  2222211 11100            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                       ..........+.++.+++..||+.||++||++.++++||||
T Consensus       220 -----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  220 -----------------PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             00000111124789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.5e-40  Score=342.27  Aligned_cols=252  Identities=20%  Similarity=0.291  Sum_probs=200.0

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHH-HHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei-~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ++||+  |+||.||+|+++.+|+.||+|++..... .....+.+.+|+ .+++.++|||||+++++|.+.+..|+||||+
T Consensus         1 ~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGK--GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             Ceeee--CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            46888  7799999999999999999999876432 223334455555 4688999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||..........    .
T Consensus        79 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----~  152 (321)
T cd05603          79 NGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----T  152 (321)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----c
Confidence            999998888653  3478999999999999999999999999999999999999999999999997543211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+++.|+|||++.+  ..|+.++|||||||++|||++|..||...+.... ...+.....                
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~----------------  213 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNILHKPL----------------  213 (321)
T ss_pred             cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHHhcCCC----------------
Confidence            122356778999999865  3588999999999999999999999987654332 222221110                


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHH----hhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC----NLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~----~~l~h~~~~~~~  309 (622)
                                      ..+...+.++.+++..||+.||.+||++.    ++++|+||....
T Consensus       214 ----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         214 ----------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence                            01234578899999999999999999864    899999997644

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.9e-40  Score=342.16  Aligned_cols=266  Identities=18%  Similarity=0.260  Sum_probs=209.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||+++++.+++.||+|.++... ........+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         1 d~y~i~~~lG~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGR--GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEee--CCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            58999999999  779999999999999999999986532 223344557789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        79 v~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             EEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999997632 3588999999999999999999999999999999999999999999999997644322111


Q ss_pred             cccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .   ......+++.|+|||++.+.   ...++.++||||+||++|+|++|+.||..................        
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------  226 (331)
T cd05624         158 V---QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER--------  226 (331)
T ss_pred             e---eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc--------
Confidence            0   11123567889999998642   134778999999999999999999999865543322222211000        


Q ss_pred             cccCCCCcCcccccccchhhhhccc-cCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVL-TSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~  309 (622)
                                           .+.+ ....+++++.+++.+||+.++.+  |++++++++|+||....
T Consensus       227 ---------------------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         227 ---------------------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             ---------------------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence                                 0000 11246889999999999876654  56899999999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-39  Score=331.34  Aligned_cols=280  Identities=23%  Similarity=0.361  Sum_probs=208.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.....+++|
T Consensus         1 ~~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGE--GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             Cceeeeeeecc--cCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            47999999999  7788999999999999999999876543333445678999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||++++.+..++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||...........
T Consensus        79 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          79 FEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            9999998887776543  35889999999999999999999999999999999999999999999999876443222111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCC-CCC---CCccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGA-TPH---LLDCT  242 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~-~p~---~~~~~  242 (622)
                      .    ....++..|+|||++.++ ..++.++||||+||++|+|++|..||.+..........  ..+. .+.   ..+..
T Consensus       157 ~----~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         157 Y----TDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             c----cCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            0    112345679999998653 35788999999999999999999999876543332221  1111 100   00000


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .++.........       ... ........++..+.+|+.+||+.||++||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~-------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPE-------TRE-PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcc-------ccc-CHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000000000000       000 0000123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.8e-40  Score=342.53  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=200.2

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHH-HHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei-~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||.||+|+++.+++.||+|++...... ......+.+|. .+++.++||||++++++|...+.+|+||||+
T Consensus         1 ~~lg~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGK--GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            36888  78999999999999999999998764321 22223344444 4678899999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~----~  152 (325)
T cd05602          79 NGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----T  152 (325)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----C
Confidence            999999988763  3478889999999999999999999999999999999999999999999997643211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||.................                 
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-----------------  213 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-----------------  213 (325)
T ss_pred             cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-----------------
Confidence            123356788999999975  4588999999999999999999999987654433222221110                 


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHH----hhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC----NLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~----~~l~h~~~~~~~  309 (622)
                                      .....+++++.+++.+||+.||.+||++.    ++++|+||....
T Consensus       214 ----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         214 ----------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence                            01235688999999999999999999876    799999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0986|consensus

Probab=100.00  E-value=9.4e-42  Score=338.00  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=219.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHH-HHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~-~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ...|..-++||+  ||||.||-+..+.||++||.|++++.+.....-+ -...|-+||.+.+.|.||.+--+|.+++.++
T Consensus       184 ~n~F~~~RvlGk--GGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  184 KNTFRVYRVLGK--GGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccceeeeEEEec--ccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            346778899999  9999999999999999999999988766544433 3568999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|+..|.||+|.-.|-.....+++|..+..++.+|+.||++||+.+||.||+||+|||+|+.|+++|+|+|+++.+...+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            99999999999888877666789999999999999999999999999999999999999999999999999998775443


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH---HHHHHhCCCCCCCcccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM---LIEKLAGATPHLLDCTT  243 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~---~~~~~~~~~p~~~~~~~  243 (622)
                      ..     .+.++|..|||||++...  .|+..+|.||+||++|||+.|+.||........   +-+.+..          
T Consensus       342 ~~-----~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----------  404 (591)
T KOG0986|consen  342 PI-----RGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----------  404 (591)
T ss_pred             cc-----ccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----------
Confidence            21     234788899999999764  599999999999999999999999975432111   1111110          


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                          .  +.-.+.+||++++++...+|++||.+|..     ++++-+||||+...+
T Consensus       405 --------------------~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  405 --------------------D--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             --------------------c--hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence                                0  11123679999999999999999999985     568999999998654

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.1e-39  Score=331.48  Aligned_cols=264  Identities=28%  Similarity=0.507  Sum_probs=213.5

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +.+...+|++.+.||+  |+||.||+|.++.+++.||+|.+..+...  ..+.+.+|+.+++.++||||+++++.|....
T Consensus        15 ~~~~~~~y~~~~~lg~--g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          15 VGDPKKKYTRFEKIGQ--GASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             cCCcccceeeEEEecC--CCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            4566779999999999  77889999999999999999998765433  3456789999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999999999988642   36788999999999999999999999999999999999999999999999754332


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .....    .....++..|+|||.+.+  ..++.++|||||||++|+|++|+.||.................|.      
T Consensus       168 ~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  235 (296)
T cd06654         168 PEQSK----RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE------  235 (296)
T ss_pred             ccccc----cCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC------
Confidence            21111    112245668999999875  347889999999999999999999997654433222221111110      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                              ......++..+.+++.+||..||++||++.++++||||...+.
T Consensus       236 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         236 ------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             ------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence                                    0112346788999999999999999999999999999987544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.2e-40  Score=340.67  Aligned_cols=253  Identities=20%  Similarity=0.313  Sum_probs=203.0

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|+++.+++.||||++..... .....+.+.+|+.++.++ +||||++++++|.+.+.+++||||+
T Consensus         1 ~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGR--GSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            36898  7799999999999999999999976543 234456688999999988 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||..........    .
T Consensus        79 ~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~  152 (327)
T cd05617          79 NGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----T  152 (327)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC----c
Confidence            999999888653  3589999999999999999999999999999999999999999999999997543211111    1


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc------hHHHHHHHHhCCCCCCCccccccc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP------TTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~------~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||....      ....+...+....           
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------  219 (327)
T cd05617         153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-----------  219 (327)
T ss_pred             eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-----------
Confidence            123356788999999975  458899999999999999999999996321      1111222221110           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH------HhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA------CNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~~l~h~~~~~~~  309 (622)
                                           ...+..++..+.+++.+||..||.+|+++      .++++||||....
T Consensus       220 ---------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         220 ---------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence                                 01123468889999999999999999985      6999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.8e-39  Score=323.12  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=213.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.++||+  |+||.||.+++..+++.||+|.++....++...+.+.+|+.+|++++||||+++++++.....++++|
T Consensus         1 ~y~~~~~ig~--g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGK--GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecc--cCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            6999999999  66889999999999999999999877666677778889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+++.||+..........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--  156 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--  156 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence            999999999999765444578999999999999999999999999999999999999999999999987644322211  


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                        ......++..|+|||++.+.  .++.++|+||+||++|+|++|..||..............+..+.            
T Consensus       157 --~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP------------  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence              11223456789999998653  46789999999999999999999997655443333322222110            


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                          ....++.++.+++..||+.||++||++.++++|+|+
T Consensus       221 --------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         221 --------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                                113467889999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-39  Score=325.05  Aligned_cols=256  Identities=22%  Similarity=0.391  Sum_probs=212.2

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||+++++.+|+.||+|.++.........+.+.+|+.++++++||||+++++++......++|+
T Consensus         1 ~y~~~~~lg~--g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGE--GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEecc--CCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            5999999999  77999999999999999999999876555556677889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+.++++.+.+.......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+++.|||........... 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  157 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-  157 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence            9999999999887644445789999999999999999999999999999999999999999999999876433221110 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                         .....+++.|+|||++.+.  .++.++|+|||||++|+|++|..||............+.+..|.            
T Consensus       158 ---~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------  220 (256)
T cd08218         158 ---ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP------------  220 (256)
T ss_pred             ---hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC------------
Confidence               0112345679999998653  46789999999999999999999998665544433333332211            


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                          ....++.++.+++.+||+.||++||++.++++||||
T Consensus       221 --------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         221 --------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             --------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                                123468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-39  Score=328.65  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=206.3

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC---
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA---   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~---   82 (622)
                      -...|++.+.||+  |+||.||+|+.+.+++.||+|++.....   ....+.+|+.+++++ +||||++++++|...   
T Consensus         4 ~~~~y~~~~~lg~--g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           4 PAGIFELVELVGN--GTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhhHHHheee--cCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            3457999999999  7789999999999999999999876532   224567899999998 799999999998763   


Q ss_pred             ---CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         83 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        83 ---~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                         ..+|++|||++++++.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+++.|||..
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence               45899999999999999987654445889999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      ........    ......++..|+|||++...   ...|+.++||||+||++|+|++|..||................  
T Consensus       159 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--  232 (272)
T cd06637         159 AQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--  232 (272)
T ss_pred             eecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--
Confidence            43321111    11223456779999998632   2357889999999999999999999997544332222111100  


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                                   ........++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       233 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 -----------------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -----------------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                                         0111223568899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.4e-39  Score=328.58  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=210.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      +.|++.+.||+  |+||.||++.+..++..+|+|.+...  .....+.+.+|+++++.++||||++++++|..+...++|
T Consensus         5 ~~~~i~~~lg~--g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGD--GAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhccc--CCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            34789999999  77999999999999999999998654  345567788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      +||++++++..++.... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+++.|||.......... 
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          81 IEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            99999999988875532 3588999999999999999999999999999999999999999999999997543321111 


Q ss_pred             ccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                         ......++..|+|||++..   ....++.++||||+||++|+|++|+.||.................+.+       
T Consensus       159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  228 (282)
T cd06643         159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-------  228 (282)
T ss_pred             ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-------
Confidence               1112345678999999842   123467899999999999999999999976554333333322211110       


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                             ..+..++.++.+++.+||..||++||++.++++||||+..
T Consensus       229 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         229 -----------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             -----------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                                   1123468899999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0586|consensus

Probab=100.00  E-value=1.3e-40  Score=343.52  Aligned_cols=259  Identities=21%  Similarity=0.298  Sum_probs=219.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      --..|.+...||+  |+|++|.+++|..||..||||.+++...+...++.+.||+++|+.|+|||||+++.+......+|
T Consensus        54 ~vg~y~i~~tig~--g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   54 SVGLYVIIKTIGK--GNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccceeeeeeecc--ceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            3458999999999  88999999999999999999999998887777777899999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+.+|++.+.+..+.  .+.|..++.++.|+.+|++|||+++|||||||++||||+.+.+++|+|||++..+....
T Consensus       132 lV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence            9999999999999998764  46678999999999999999999999999999999999999999999999876654221


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                           ...+.++++.|.|||++.+. .+-++.+|+||+|+++|.|++|..||.+.......-+.+.+.            
T Consensus       210 -----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk------------  271 (596)
T KOG0586|consen  210 -----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK------------  271 (596)
T ss_pred             -----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchheeee------------
Confidence                 22355778899999999864 344689999999999999999999998653322111111111            


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                           .-.+...|.+..++|+++|-.+|.+|++.++++.|.|....
T Consensus       272 ---------------------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  272 ---------------------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             ---------------------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence                                 01122368899999999999999999999999999998653

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-39  Score=328.57  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=205.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|+++++||+  |+||.||+|.+..+++.||+|.+..+. .....+.+.+|+.+|++++||||+++++++...+..++|
T Consensus         1 ~~~~~~~~lg~--g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGH--GNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             Ccchheeeecc--CCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            47899999999  778999999999999999999987653 344556788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||++++++....      .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.........  
T Consensus        78 ~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          78 TEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             EecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9999999886432      36788999999999999999999999999999999999999999999999765432211  


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH------HHHHHHHhCCCCCCCccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT------LMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~------~~~~~~~~~~~p~~~~~~  242 (622)
                          .....++..|+|||++.+.  .++.++|+||+||++|+|++|+.||......      ......+...        
T Consensus       150 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------  215 (279)
T cd06619         150 ----AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------  215 (279)
T ss_pred             ----ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------
Confidence                1123456789999998753  5789999999999999999999999642111      0111111000        


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                            .........+++++.+++.+||+.||++||++.++++||||.....
T Consensus       216 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         216 ----------------------DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             ----------------------CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence                                  0011122346889999999999999999999999999999977543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.1e-40  Score=333.81  Aligned_cols=282  Identities=22%  Similarity=0.329  Sum_probs=209.8

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |++|.||+|+++.+|+.||||++..+...+.....+.+|+++|++++||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecC--CCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            6999999999  77899999999999999999998765444444456789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+. +++.+++.......+++..+..++.|++.||+|||+++++||||+|+||+++.++.+++.|||........... 
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  156 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  156 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence            9996 67888886654456899999999999999999999999999999999999999999999999876433222111 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCCcccccccc
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLLDCTTYYVD  247 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~  247 (622)
                         .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||..........+...  +..+......  ...
T Consensus       157 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  230 (284)
T cd07860         157 ---YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG--VTS  230 (284)
T ss_pred             ---cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh--hhH
Confidence               1122345679999988653 3467899999999999999999999987654433333221  1111000000  000


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .  .........+.... .. .....++.++.++|.+||+.||++|||+.++++||||
T Consensus       231 ~--~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         231 L--PDYKPSFPKWARQD-FS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             H--HHHHhhcccccccC-HH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0  00000000000000 00 0113468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG2345|consensus

Probab=100.00  E-value=4.6e-41  Score=309.75  Aligned_cols=266  Identities=25%  Similarity=0.350  Sum_probs=206.5

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-   82 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-   82 (622)
                      .--...+|.|.+.||+  |||+-||++++..|++.||+|++....  .++.+...+||...++++||||++++++...+ 
T Consensus        16 v~In~~Ryri~~~Lge--GGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGE--GGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             EEEcCceEEEeeeecC--CCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            3445779999999999  999999999999999999999987654  56678889999999999999999998766544 


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCceEEc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLS  154 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~~~~~~i~  154 (622)
                          ...|++..|...|++.+.+....  +..++|.++..|+.+|++||++||+..  .+||||||.|||+++.+.+++.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                34999999999999999886543  224899999999999999999999998  9999999999999999999999


Q ss_pred             CCccccccCCCCcccc----c-cCCCCCCCccccChhhhcccc-CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH
Q psy15039        155 GLRYMCPFSPTKKKVH----L-FPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  228 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~----~-~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~  228 (622)
                      |||.++..........    . .......|..|+|||++.-.. .-.+.++|||||||+||+|+.|..||...      .
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~------~  245 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI------Y  245 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH------h
Confidence            9998765432111100    0 001123367799999984321 22467999999999999999999999621      1


Q ss_pred             HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       229 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      +  .|..                     ..-.+...+...+....+|..+.++|++||+.||.+||++.+++.+
T Consensus       246 ~--~GgS---------------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  246 Q--QGGS---------------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             h--cCCe---------------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1  1110                     0001111222334445589999999999999999999999999865

>KOG4645|consensus

Probab=100.00  E-value=3.3e-42  Score=378.51  Aligned_cols=271  Identities=24%  Similarity=0.382  Sum_probs=229.8

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .+.++..++.-+..||.  |.||.||-|-+..||+..|+|.++.........+.+.+|+.+|..|+|||+|+|||+-++.
T Consensus      1229 ~lsnV~~rWqrg~~Ig~--G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGG--GTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             HhccceeeeccccccCC--cceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence            46678889999999999  6688999999999999999999887655555567788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      +.+++.||||++|+|.+++...  .-.+|...+.+..|++.|++|||++|||||||||+||+|+.+|-+|+.|||.+...
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999999999763  23789999999999999999999999999999999999999999999999987554


Q ss_pred             CCCCccccccCCCCCCCccccChhhhcccc-CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCCCc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLD  240 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~~~  240 (622)
                      ....+.+..--.+..||+-|||||++.+.. .+...+.||||+||+..||+||+.||...+..-.++.++.. -.|.+  
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~-- 1462 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI-- 1462 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC--
Confidence            433222221122567899999999997654 56778999999999999999999999988777777766643 22322  


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                    +..+|++.++|+..||+.||++|-++.|++.|.|-+...
T Consensus      1463 ------------------------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1463 ------------------------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             ------------------------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence                                          123799999999999999999999999999999886643

>KOG0585|consensus

Probab=100.00  E-value=8.8e-41  Score=333.30  Aligned_cols=225  Identities=25%  Similarity=0.366  Sum_probs=180.6

Q ss_pred             cCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH------------HHHHHHHHHHHHHhhCCCCc
Q psy15039        354 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------------EDLKSLHHEIVCMRHLRHPN  421 (622)
Q Consensus       354 ~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~------------~~~~~~~~E~~~l~~l~Hpn  421 (622)
                      .....++|++.+.||+  |.||.|-+|++..+++.||||++++.....            ...+.+.+||.+|++|+|||
T Consensus        92 ~~k~lNqy~l~~eiG~--G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGS--GQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cceehhheehhhhhcC--CccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            3456788999999999  779999999999999999999998643211            11357899999999999999


Q ss_pred             cceeEEEEEeC--CcEEEEeeccCCCCHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q psy15039        422 IICYISSFLDA--TDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN  498 (622)
Q Consensus       422 Iv~~~~~~~~~--~~~~lv~e~~~~g~l~~~l~~~~~~~-~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~  498 (622)
                      ||+++.+.-++  +.+|||+|||..|++...-.   ... +++..+++|+++++.||+|||.+|||||||||+|+||+++
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence            99999998775  46999999999998764321   123 7899999999999999999999999999999999999999


Q ss_pred             CceEEcCcccccccCCCCC-ceeccCCCCCCCCccccccccccCc-cCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcHH
Q psy15039        499 GKACLSGLRYMCPFSPTKK-KVHLFPPSTAYNLNWLSPEVLEQNL-DGY-DERSDIYSVGISCCELANGTVPFAETPTTL  575 (622)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~-~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~  575 (622)
                      |.+||+|||.+..+..... .....-..++|||.|||||.+..+. ..| +.+.||||+||+||.|+.|+.||.+.. ..
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-~~  325 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-EL  325 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-HH
Confidence            9999999998765533211 1111223478999999999997532 223 467899999999999999999998764 34


Q ss_pred             HHHHHHcCC
Q psy15039        576 MLIEKLAGA  584 (622)
Q Consensus       576 ~~~~~~~~~  584 (622)
                      .++.+|...
T Consensus       326 ~l~~KIvn~  334 (576)
T KOG0585|consen  326 ELFDKIVND  334 (576)
T ss_pred             HHHHHHhcC
Confidence            455555553

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=330.49  Aligned_cols=284  Identities=21%  Similarity=0.272  Sum_probs=204.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      -++|++.+.||+  |++|.||+|+++.+++.||||.+...... .....+.+|+.+|++++||||+++++++.+++..++
T Consensus         4 ~~~y~~~~~lg~--g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGE--GSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEee--cCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            468999999999  77899999999999999999998754321 122345689999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++ ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+++.|||..........
T Consensus        81 v~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          81 VFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            999998 58988886543 3578999999999999999999999999999999999999999999999997543221111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH---HHhCCC-CCCCcccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE---KLAGAT-PHLLDCTT  243 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~---~~~~~~-p~~~~~~~  243 (622)
                          ......++..|+|||++.+. ..++.++||||+||++|+|++|..||...........   ...+.+ +.......
T Consensus       159 ----~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         159 ----TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             ----cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence                01112345679999998653 3578899999999999999999999976542222211   111111 10000000


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                         . ............................++.+++.+||+.||++|||+.++++||||
T Consensus       234 ---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 ---S-NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ---h-ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence               0 000000000000000000011111123788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.2e-39  Score=328.95  Aligned_cols=263  Identities=27%  Similarity=0.464  Sum_probs=205.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHH-HhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC-MRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||++.++.+|+.||||+++.....+.. ..+.+|+.+ ++.++|||||++++++..+...|+
T Consensus         1 ~~~~~~~~ig~--g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGR--GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecc--cCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            58999999999  77889999999999999999999776444333 344456654 777899999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         88 VSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|||++ |++.+++....  ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+++.|||.......
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999997 78888776532  23578999999999999999999998 999999999999999999999999997644321


Q ss_pred             CCccccccCCCCCCCccccChhhhccc--cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-HHHHHHHhCCCCCCCcc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQN--LDGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKLAGATPHLLDC  241 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-~~~~~~~~~~~p~~~~~  241 (622)
                      ...     .....++..|+|||.+.+.  ...++.++|+||+||++|+|++|+.||...... ..+.....+..+.    
T Consensus       157 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  227 (283)
T cd06617         157 SVA-----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ----  227 (283)
T ss_pred             ccc-----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCC----
Confidence            111     1112345679999988642  134688999999999999999999999753322 2222222221111    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                                 .....++.++.+++..||..||++||++.++++||||......
T Consensus       228 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         228 ---------------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             ---------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence                                       1123478899999999999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=327.11  Aligned_cols=259  Identities=36%  Similarity=0.628  Sum_probs=211.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||.  |++|.||+|++..+|+.||+|.+.... .......+.+|+++++.++||||+++++++.++..+++|
T Consensus         1 ~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGK--GSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcC--CCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            47999999999  788999999999999999999987653 234456678999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      +||+++++|.+++...   .+++..+..++.|++.||.|||+++|+||||+|+||+++.++.+++.|||...........
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          78 MEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             EEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            9999999999998753   5789999999999999999999999999999999999999999999999876444322111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                          .....++..|+|||.+.+.  .++.++||||+||++|+|++|+.||..............+..|.           
T Consensus       155 ----~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----------  217 (274)
T cd06609         155 ----RNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS-----------  217 (274)
T ss_pred             ----cccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCC-----------
Confidence                1122345679999999753  48899999999999999999999997654332222211111111           


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                          .....++.++.+++.+||..||++||+++++++||||.....
T Consensus       218 --------------------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         218 --------------------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             --------------------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                                111226888999999999999999999999999999977543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-39  Score=329.53  Aligned_cols=256  Identities=21%  Similarity=0.342  Sum_probs=212.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||++++..+++.||+|.+..... .......+.+|+++|++++||||+++++++.+....++
T Consensus         1 ~~y~~~~~ig~--g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGT--GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeec--CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            47999999999  7799999999999999999999876433 23445678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||+|+|||++.++.+++.|||........  
T Consensus        79 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          79 VMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999999999998764  35889999999999999999999999999999999999999999999999876543322  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           .....+++.|+|||.+...  .++.++||||||+++|+|++|..||..............+. +.          
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-VR----------  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cc----------
Confidence                 1123456789999998653  46789999999999999999999997655332222222111 10          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                            .+..++..+.+++.+||..||.+|+     +++++++||||....+
T Consensus       217 ----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         217 ----------------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             ----------------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence                                  1223578899999999999999999     9999999999977554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-39  Score=327.22  Aligned_cols=258  Identities=29%  Similarity=0.497  Sum_probs=206.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||.||+|++..+++.||+|.++...  ......+.+|+.+++.++||||+++++++...+..|++
T Consensus         9 ~~~~~~~~lg~--g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGS--GTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCC--CCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            58999999999  778899999999999999999987653  23345677899999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.......... 
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence            9999999999998654  3578999999999999999999999999999999999999999999999997543321111 


Q ss_pred             ccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                         ......++..|+|||++.. ....++.++|+||+||++|+|++|..||..................           
T Consensus       162 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----------  227 (267)
T cd06645         162 ---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-----------  227 (267)
T ss_pred             ---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC-----------
Confidence               1122345678999999742 1235788999999999999999999999754432222111111000           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                                       .........++..+.+++.+||..||++||++.++++|||
T Consensus       228 -----------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         228 -----------------PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -----------------CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                             0000112246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.4e-39  Score=331.20  Aligned_cols=264  Identities=28%  Similarity=0.507  Sum_probs=212.3

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +.+...+|++.+.||+  |+||.||++.++.+|+.||+|.+......  ..+.+.+|+.+++.++||||++++++|....
T Consensus        14 ~~~~~~~y~~~~~lg~--g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          14 VGDPKKKYTRFEKIGQ--GASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             cCChhhhceeeeeecc--CCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3566789999999999  77889999999999999999999765433  2355789999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++||||++++++.+++..   ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+++.|||......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            99999999999999998864   247888999999999999999999999999999999999999999999999764332


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .....    .....+++.|+|||.+.+  ..++.++|+||+||++|+|++|..||........+........|.      
T Consensus       167 ~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------  234 (297)
T cd06656         167 PEQSK----RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE------  234 (297)
T ss_pred             CCccC----cCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCC------
Confidence            21111    112245667999999875  357889999999999999999999997643322111111000000      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                              ......+++.+.+++.+||+.||++||++.++++||||...+.
T Consensus       235 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         235 ------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             ------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                                    0112346788999999999999999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-39  Score=329.38  Aligned_cols=265  Identities=28%  Similarity=0.516  Sum_probs=213.7

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .+.+...+|++.+.||.  |+||.||+|.+..+|+.||||.+......  ..+.+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~~~~~y~~~~~lg~--g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (296)
T cd06655          13 SIGDPKKKYTRYEKIGQ--GASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVG   88 (296)
T ss_pred             hcCCCcceEEEEEEEec--CCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence            34455668999999999  77889999999999999999998765432  345678899999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      +.+++|+||+++++|..++...   .+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.|||.....
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            9999999999999999988652   4789999999999999999999999999999999999999999999999975433


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......    .....++..|+|||.+..  ..++.++|+|||||++|+|++|..||.................|.     
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-----  234 (296)
T cd06655         166 TPEQSK----RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-----  234 (296)
T ss_pred             cccccc----CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-----
Confidence            221111    112244667999999865  347889999999999999999999998765433222221111111     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                               ......+++.+.+++.+||..||++||++.++++||||+....
T Consensus       235 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         235 -------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             -------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                                     0112346788999999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0587|consensus

Probab=100.00  E-value=3.5e-40  Score=350.80  Aligned_cols=267  Identities=27%  Similarity=0.497  Sum_probs=224.0

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      +++++=.+-|+|.++||+  |++|+||+++++.+|+.+|||+++.....+++.   +-|..+|+.+ +|||++.++++|.
T Consensus        12 ~~lpdp~d~~ei~evig~--Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEi---E~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGN--GTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEI---ELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             hhCCCCCCccEEEEEEee--ccceeEEEEeeeecCceeeeEeecCCccccHHH---HHHHHHHHhccCCCCcceEEEEEE
Confidence            455566678999999999  556799999999999999999998865544443   3477888877 7999999999987


Q ss_pred             eC-----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         81 DA-----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        81 ~~-----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                      ..     +.+|||||||.+|+..|+++......+.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.+|++|
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEee
Confidence            53     6799999999999999999887766799999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~  232 (622)
                      ||.+.....+...    ..+..+|+.|||||++...   ..-|+..+|+||||++..||.-|.+|+....+...+..+..
T Consensus       167 FGvSaQldsT~gr----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR  242 (953)
T KOG0587|consen  167 FGVSAQLDSTVGR----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  242 (953)
T ss_pred             eeeeeeeeccccc----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence            9988766544333    2345778999999999532   12466789999999999999999999998776666555544


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      .++|.+                              ..+.+|+.+|.+||+.||.+|-++||+..++|+|||++.
T Consensus       243 NPPPkL------------------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  243 NPPPKL------------------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             CCCccc------------------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            444432                              234578999999999999999999999999999999984

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-39  Score=325.38  Aligned_cols=262  Identities=28%  Similarity=0.521  Sum_probs=208.4

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~   83 (622)
                      .+-.++|++.+.||+  |++|.||+|+++.+++.||+|.+.....   ....+.+|+.+++++ +||||+++++++....
T Consensus         2 ~~~~~~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           2 PDPTGIFELVEVIGE--GTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             CCchhheeheeeecC--CCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            345689999999999  7788999999999999999999876532   335678999999999 7999999999997754


Q ss_pred             ------cEEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         84 ------DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        84 ------~~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                            .++++|||+++++|.+++....  ...+++..+..++.|++.||+|||++||+||||+|+||+++.++.+++.|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence                  4899999999999999987543  34578999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~  232 (622)
                      ||...........    .....++..|+|||++...   ...++.++||||+||++|+|++|+.||..............
T Consensus       157 ~~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  232 (275)
T cd06608         157 FGVSAQLDSTLGR----RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR  232 (275)
T ss_pred             Cccceecccchhh----hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence            9875432211111    1123456679999998532   23467899999999999999999999975543333332222


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      +..+.                              ......+++++.+|+.+||..||++|||+.++++|||+
T Consensus       233 ~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         233 NPPPT------------------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             cCCCC------------------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            21111                              01123478899999999999999999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.3e-39  Score=332.13  Aligned_cols=287  Identities=20%  Similarity=0.255  Sum_probs=210.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--Cc
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TD   84 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~   84 (622)
                      ..++|++.+.||+  |+||.||+|.++.+|+.||+|++..+.........+.+|+.+|++++||||+++++++.+.  +.
T Consensus         5 ~~~~y~~~~~ig~--g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           5 SVTEFEKLNRIGE--GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             cccceeEeeeeee--cCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            4578999999999  7789999999999999999999876543333333456899999999999999999999765  46


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||++ +++.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+++.|||.......
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            899999997 47888876532 3578999999999999999999999999999999999999999999999997654432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~  242 (622)
                      .....    .....+..|+|||++.+. ..++.++||||+||++|+|++|.+||........+.....  +..+.. .. 
T Consensus       161 ~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~-~~-  233 (309)
T cd07845         161 PAKPM----TPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES-IW-  233 (309)
T ss_pred             ccCCC----CcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh-hc-
Confidence            21110    111235679999998653 4578899999999999999999999987655443332221  111100 00 


Q ss_pred             cccccCCCCcCcccccccchhhhhcc--ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQV--LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                         ...........  ..+.......  .....+++++.++|++||+.||++|||+.++++||||+...
T Consensus       234 ---~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         234 ---PGFSDLPLVGK--FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ---hhhhccccccc--ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence               00000000000  0000000000  01123588999999999999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-39  Score=328.66  Aligned_cols=260  Identities=28%  Similarity=0.470  Sum_probs=206.7

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe---
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD---   81 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~---   81 (622)
                      .-...|++.+.||+  |+||.||+|+++.+++.||+|.+...   ......+.+|+.+++++ +||||++++++|..   
T Consensus        13 ~~~~~~~~~~~lg~--g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          13 DPAGIFELVEVVGN--GTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             Chhhhhhhheeecc--CCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            34578999999999  77999999999999999999998654   23345677899999998 79999999999863   


Q ss_pred             ---CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         82 ---ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        82 ---~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                         ....+++|||+++|++.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++.+++.|||.
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence               35689999999999999999765545588999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  235 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~  235 (622)
                      .........    ......++..|+|||++...   ...++.++|+|||||++|+|++|..||.................
T Consensus       168 ~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  243 (282)
T cd06636         168 SAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP  243 (282)
T ss_pred             hhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence            543321111    11223456779999998531   23578899999999999999999999975443222221111100


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                                     .......++.++.+||.+||..||.+||++.++++||||
T Consensus       244 -------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -------------------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -------------------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                           011223578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3e-39  Score=328.34  Aligned_cols=284  Identities=22%  Similarity=0.320  Sum_probs=211.8

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||+|+++.+|+.||||++......+.....+.+|+.++++++||||+++++++.....+++|+
T Consensus         1 ~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGE--GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeeccc--CCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            5999999999  77889999999999999999999876554555677889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.+++.|||........... 
T Consensus        79 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-  155 (286)
T cd07832          79 EYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-  155 (286)
T ss_pred             ccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-
Confidence            999 999999987643 45899999999999999999999999999999999999999999999999876544322111 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCCCccccccccC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCTTYYVDT  248 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~  248 (622)
                        ......++..|+|||.+.+. ..++.++||||+||++|+|++|.+||.+......+...+.. ..|....+... ...
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  231 (286)
T cd07832         156 --LYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL-TSL  231 (286)
T ss_pred             --ccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhc-cCc
Confidence              01123456789999998643 34688999999999999999998888765543332222211 00100000000 000


Q ss_pred             CCCcCcccccccchhhhhc-cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        249 GQDDGEENACSYISEQQTQ-VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                       .. . .... ........ .......+.++.+++.+||..||++||++.++++||||.
T Consensus       232 -~~-~-~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         232 -PD-Y-NKIT-FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             -ch-h-hccc-CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             00 0 0000 00000000 001124578999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.9e-39  Score=323.44  Aligned_cols=258  Identities=28%  Similarity=0.505  Sum_probs=206.4

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-------HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-------DEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +|.+++.||+  |+||.||+|.+..+++.||+|.+......       ....+.+.+|+.++++++||||+++++++...
T Consensus         1 ~~~~~~~ig~--g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (267)
T cd06628           1 KWIKGALIGS--GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA   78 (267)
T ss_pred             Cccccceeec--CCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Confidence            4788999999  77889999999999999999998654321       12235678999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ...+++|||+++++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.|||.....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          79 DHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             CccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999999764  34788999999999999999999999999999999999999999999999876443


Q ss_pred             CCCCc--cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        163 SPTKK--KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       163 ~~~~~--~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      .....  ..........++..|+|||.+.+.  .++.++|+||+||++|+|++|+.||.................|.   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  231 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---  231 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---
Confidence            21110  000011122356679999998753  47889999999999999999999998654433222221111110   


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                                   ....++.++.+++.+||+.||++||++.++++||||
T Consensus       232 -----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         232 -----------------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----------------------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                         123467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0663|consensus

Probab=100.00  E-value=1.3e-40  Score=318.67  Aligned_cols=214  Identities=20%  Similarity=0.304  Sum_probs=182.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC--CcE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--~~~  435 (622)
                      .++|+.+..|+.  |+||.||+|+++.|++.||+|++..+.......-.-.|||.+|.+++|||||.+-.+....  +.+
T Consensus        75 v~efe~lnrI~E--GtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEE--GTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhccc--CcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            456889999999  7799999999999999999999987654433334568999999999999999998877643  579


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+|||||+ .+|..++....+ ++.+..+.-++.|++.||+|||.+.|+||||||+|+|+++.|-+|++|||++..++..
T Consensus       153 y~VMe~~E-hDLksl~d~m~q-~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMKQ-PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            99999999 588888877543 4667778889999999999999999999999999999999999999999998877654


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      .+..    +..+-|++|.|||++.+. ..|++++||||+|||+.||++++|-|.+.+...++..+
T Consensus       231 ~k~~----T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I  290 (419)
T KOG0663|consen  231 LKPY----TPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI  290 (419)
T ss_pred             cccC----cceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH
Confidence            3322    123558899999999865 57999999999999999999999999999887776554

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.9e-39  Score=321.17  Aligned_cols=255  Identities=24%  Similarity=0.393  Sum_probs=210.8

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||++.++.+++.+|||.+..........+.+.+|+++|++++||||+++++.+......++||
T Consensus         1 ~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGR--GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecc--cCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            6999999999  77889999999999999999999877666666778899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCccccccCCCCcc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++ .+++.||+.......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-  157 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-  157 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence            999999999999775444588999999999999999999999999999999999998654 578899987644322111 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                          .....++..|+|||.+.+  ..++.++|+||+||++|+|++|+.||..............+..+.           
T Consensus       158 ----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd08220         158 ----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-----------  220 (256)
T ss_pred             ----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-----------
Confidence                112234567999999865  347889999999999999999999998765443333332221110           


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                           ....++.++.+++..||..||++|||+.++++||||
T Consensus       221 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         221 ---------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ---------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                                 112368889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.6e-39  Score=328.84  Aligned_cols=285  Identities=21%  Similarity=0.251  Sum_probs=204.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..+|.+.+.||+  |+||.||+|.++.+|+.||||.+..+.. +.....+.+|+.+|+.++|+||+++++++.+....++
T Consensus         4 ~~~y~~~~~ig~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGE--GSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEe--cCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            468999999999  7789999999999999999999865432 2222345689999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+. +++.+.+.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+++.|||..........
T Consensus        81 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            999996 67776665432 3477888999999999999999999999999999999999999999999997543221111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh---CCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA---GATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~---~~~p~~~~~~~~  244 (622)
                          ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||............+.   +.++.. .....
T Consensus       159 ----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  232 (291)
T cd07870         159 ----TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED-TWPGV  232 (291)
T ss_pred             ----CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh-hhhhh
Confidence                11122346789999998643 3478899999999999999999999986554333222221   111100 00000


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                       .. ..........................+.++.+++.+||..||.+|||+.+++.||||
T Consensus       233 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         233 -SK-LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             -hh-cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             00 000000000000000000111112236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-39  Score=348.59  Aligned_cols=280  Identities=22%  Similarity=0.269  Sum_probs=201.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ...|.+.+.||+  |+||.||+|.+..+++.||||....        ..+.+|+++|++|+|||||++++++......++
T Consensus       168 ~~gy~i~~~Lg~--G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTP--GSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEcc--CCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            347999999999  7789999999999999999996422        234579999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||++. +++.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||..........
T Consensus       238 v~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            999985 78888876533 3588999999999999999999999999999999999999999999999997654322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc-------hHHHHHHHHhCCCCCCCc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP-------TTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~-------~~~~~~~~~~~~~p~~~~  240 (622)
                      .  .......+|..|+|||++.+  ..++.++|||||||++|||++|..|+....       ....+.+.+........+
T Consensus       316 ~--~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        316 T--PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             c--ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            1  11123457889999999975  358999999999999999999887664321       112222222211000000


Q ss_pred             cccccccCCCCcCcccccccchhh---hhcccc---CCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQ---QTQVLT---SRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~---~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      ..    ..................   ......   ...++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       392 ~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        392 FP----QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CC----CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            00    000000000000000000   000000   1245678999999999999999999999999999964

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-39  Score=342.36  Aligned_cols=278  Identities=20%  Similarity=0.241  Sum_probs=198.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|++++.||+  |+||.||+|+++.+++.||+|......        ..+|+.+|++++|||||++++++......++|
T Consensus        66 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTP--GSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecC--CCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            36999999999  778899999999999999999853321        24699999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||++. +++.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||.........  
T Consensus       136 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             EEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            99986 67888776533 358899999999999999999999999999999999999999999999999754211111  


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCC-CCCchH---------HHHHHHH--hCCCC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTT---------LMLIEKL--AGATP  236 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf-~~~~~~---------~~~~~~~--~~~~p  236 (622)
                         ...+..+|..|+|||++.+  ..|+.++||||+||++|||+++..|+ ...+..         ..+...+  .+..|
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  286 (357)
T PHA03209        212 ---AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP  286 (357)
T ss_pred             ---ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence               1113356788999999875  35899999999999999999855444 332211         1111111  11111


Q ss_pred             C-CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        237 H-LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       237 ~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      . ++..........  ......................++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       287 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        287 EEFPRDPGSRLVRG--FIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             hhcCCCCccHHHHH--HHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            1 110000000000  00000000000000011122356788899999999999999999999999999975

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.1e-39  Score=330.60  Aligned_cols=292  Identities=22%  Similarity=0.268  Sum_probs=209.4

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   83 (622)
                      .+.-++|++.+.||+  |+||.||+|+++.+|+.||||++............+.+|++++++++||||+++++++.... 
T Consensus         8 ~~~~~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865           8 CDEVSKYEKLAKIGQ--GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             cchhhheEEEEEeec--CCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            345568999999999  77899999999999999999998764433333345668999999999999999999887654 


Q ss_pred             -------cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         84 -------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        84 -------~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                             ..++||||++ +++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                   3599999997 47777775532 35789999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~  234 (622)
                      |....................++..|+|||.+.+. ..++.++||||+||++|+|++|..||......  ...+..+.+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            97654432221111111123446679999998653 34678999999999999999999999765443  2233444443


Q ss_pred             CCCCC-ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        235 TPHLL-DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       235 ~p~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .|... +.... ...  ... ...+................++.+.++|..||..||.+|||++++++||||
T Consensus       243 ~~~~~~~~~~~-~~~--~~~-~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDK-LEL--FKK-MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccc-hhh--hhh-ccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            32210 00000 000  000 000000000001111122346788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0594|consensus

Probab=100.00  E-value=3.8e-40  Score=322.09  Aligned_cols=215  Identities=25%  Similarity=0.378  Sum_probs=185.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc-cceeEEEEEeCC---
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN-IICYISSFLDAT---  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~---  433 (622)
                      ...|+..+.||.  |.||+||+|+++.+|+.||+|++..+...+.......||+.+|+.|+|+| ||.+++++.+.+   
T Consensus        10 ~~~~~~~eklGe--Gtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGE--GTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCC--CCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            456888888999  77999999999999999999999876543333456789999999999999 999999999887   


Q ss_pred             ---cEEEEeeccCCCCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        434 ---DLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       434 ---~~~lv~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                         .+++|+||++ -+|.+++.....  .+++...+..+++||+.||+|||+++|+||||||+|||++++|.+|++|||.
T Consensus        88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccch
Confidence               7999999998 589998887553  3678888999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      +..++.....    -....+|..|.|||++.+. ..|+..+||||+|||++||+++++-|.+.+..+++..+
T Consensus       167 Ara~~ip~~~----yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I  233 (323)
T KOG0594|consen  167 ARAFSIPMRT----YTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI  233 (323)
T ss_pred             HHHhcCCccc----ccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence            8766543322    2234568889999999875 36999999999999999999999999999888777664

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-38  Score=325.41  Aligned_cols=267  Identities=28%  Similarity=0.478  Sum_probs=209.8

Q ss_pred             CCCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEE
Q psy15039          1 METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF   79 (622)
Q Consensus         1 ~~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~   79 (622)
                      |+++.+..++|++.+.||+  |+||.||++..+.+++.||+|.+.....   ....+.+|+.+++++ +||||+++++++
T Consensus        14 ~~~~~~~~~~y~~~~~l~~--g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          14 LESLGDPTDTWEIIETIGK--GTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             cccCCCCCCCeEEEEEeec--CCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            4566677889999999999  7789999999999999999999865432   234566899999999 899999999998


Q ss_pred             EeCC-----cEEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceE
Q psy15039         80 LDAT-----DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC  152 (622)
Q Consensus        80 ~~~~-----~~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~  152 (622)
                      ...+     ..++||||+++++|.++++...  ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence            7543     5899999999999999886421  23478999999999999999999999999999999999999999999


Q ss_pred             EcCCccccccCCCCccccccCCCCCCCccccChhhhcccc---CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH
Q psy15039        153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL---DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  229 (622)
Q Consensus       153 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~  229 (622)
                      +.|||..........    ......++..|+|||++....   ..++.++||||+||++|+|++|+.||........+..
T Consensus       169 l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~  244 (291)
T cd06639         169 LVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK  244 (291)
T ss_pred             Eeecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence            999997543321111    111234567799999985421   1367899999999999999999999986544333322


Q ss_pred             HHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       230 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                      ...+..+.+                              .....++.++.++|.+||+.||++||++.++++||||+
T Consensus       245 ~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         245 IPRNPPPTL------------------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HhcCCCCCC------------------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            222211110                              11234567899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.4e-39  Score=324.67  Aligned_cols=260  Identities=30%  Similarity=0.489  Sum_probs=204.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -..+|++.+.||+  |+||.||+|+++.+|+.||+|++.....  .....+.+|+.++++++||||+++++++.....++
T Consensus         7 ~~~~y~~~~~lg~--g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGS--GTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeec--CCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            3468999999999  7789999999999999999999865432  23355778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.........
T Consensus        83 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999999999988653  357899999999999999999999999999999999999999999999999764432111


Q ss_pred             ccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..    .....++..|+|||.+.. ....++.++|+||+||++|+|++|..||.................          
T Consensus       161 ~~----~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------  226 (267)
T cd06646         161 AK----RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF----------  226 (267)
T ss_pred             cc----cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC----------
Confidence            10    112245667999998742 123467899999999999999999999964432211100000000          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                                        ..........++.++.+++++||..||++||+++++++|+|
T Consensus       227 ------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         227 ------------------QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ------------------CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                              00000112346889999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-39  Score=344.41  Aligned_cols=279  Identities=21%  Similarity=0.285  Sum_probs=203.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..+|++++.||+  |+||.||+|...  .++..||+|.+....       ...+|+.+|++|+|||||+++++|.....+
T Consensus        91 ~~~y~i~~~Lg~--G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         91 RMQYNILSSLTP--GSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             cCceEEEEeecC--CCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            457999999999  778899999754  567889999975432       245799999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +++||++. +++.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||........
T Consensus       162 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            99999986 6788887442  35889999999999999999999999999999999999999999999999987544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch---HHHH--HHHHhCCCCCCCc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLML--IEKLAGATPHLLD  240 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~---~~~~--~~~~~~~~p~~~~  240 (622)
                      ....  ......+|+.|+|||++..  ..|+.++||||+||++|||++|+.||.+...   ...+  +....+..|...+
T Consensus       239 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        239 PDTP--QCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cccc--cccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            1111  1113356788999999975  3588999999999999999999999976432   1111  1111222111100


Q ss_pred             cccccccCCCCcCcccccccchhh-----hhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQ-----QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      .     . ...........+....     ....+....++.++.++|++||..||++|||+.++|+||||.+.
T Consensus       315 ~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        315 Q-----N-GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             C-----c-cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            0     0 0000000000000000     00011123467789999999999999999999999999999764

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-39  Score=324.34  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=205.9

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC----HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      +|+.++.||+  |+||.||+++++.+|+.||+|.+......    ....+.+.+|+++|++++||||+++++++.+.+.+
T Consensus         1 ~~~~~~~lg~--g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   78 (268)
T cd06630           1 EWLKGQQLGT--GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHF   78 (268)
T ss_pred             CccccceecC--cCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeE
Confidence            5899999999  77889999999999999999998754321    22356788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCccccccCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPFSP  164 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~~~  164 (622)
                      ++|+||+++++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .++++|||.......
T Consensus        79 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          79 NLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            9999999999999998764  3578999999999999999999999999999999999998776 589999987644432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~p~~~~~~  242 (622)
                      .............++..|+|||.+.+  ..++.++|+||+||++|+|++|..||......  ...........       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  227 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-------  227 (268)
T ss_pred             ccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-------
Confidence            21111111112345678999999865  35788999999999999999999999643321  11111110000       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                             ........+++++.+++.+||..||++||++.++++||||+
T Consensus       228 -----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 -----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                   00011234678999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-38  Score=319.71  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=205.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      +.+|++.+.||+  |+||.||+++++.+|+.||||++....   ......+.+.+|++++++++||||+++++++.+.  
T Consensus         1 ~~~~~~~~~l~~--g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   78 (265)
T cd06652           1 PTNWRLGKLLGQ--GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME   78 (265)
T ss_pred             CCcceEeeEEec--CCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence            578999999999  778899999999999999999986432   2234566788999999999999999999998764  


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..++++|||+++++|.+++....  .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+++.|||.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            46889999999999999987642  4788889999999999999999999999999999999999999999999976543


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ........ ......++..|+|||++.+  ..++.++|+|||||++|+|++|+.||.................       
T Consensus       157 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------  226 (265)
T cd06652         157 QTICLSGT-GMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-------  226 (265)
T ss_pred             cccccccc-ccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC-------
Confidence            21110000 0111235667999999865  3578899999999999999999999976544333322221100       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                              ....+..++..+.+++++|+. +|.+||+++++++|||+.
T Consensus       227 ------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                    001123467889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.9e-39  Score=321.27  Aligned_cols=253  Identities=18%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..+|++.+.||+  |+||.||+|.++   ..+..||+|.++... +......+.+|+.+|++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~--G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGT--GRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecc--cCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            457999999999  778999999875   467789999987643 34445678899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+++.|||.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999987643 3578999999999999999999999999999999999999999999999986543211


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ..  . ........+..|+|||++.+  ..++.++||||+||++||+++ |..||........ ...+....+       
T Consensus       160 ~~--~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-~~~~~~~~~-------  226 (266)
T cd05064         160 EA--I-YTTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVEDGFR-------  226 (266)
T ss_pred             cc--h-hcccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHHCCCC-------
Confidence            11  0 01112233457999999865  458899999999999999774 9999986554332 222221100       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              .+.+..++..+.+++..||+.||++||++.++++
T Consensus       227 ------------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 ------------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                    0112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.4e-39  Score=319.85  Aligned_cols=255  Identities=32%  Similarity=0.553  Sum_probs=207.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||+|.+....    ..+.+.+|+.++++++||||+++++.+.....+|+
T Consensus         2 ~~~y~~~~~i~~--g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGE--GSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcC--CCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            468999999999  778999999999999999999986532    25678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.+++.|||..........
T Consensus        76 ~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             EEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999999986533 3588999999999999999999999999999999999999999999999987654332211


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    .....++..|+|||.+.+  ..++.++||||+||++|+|++|+.||.................+           
T Consensus       155 ~----~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  217 (256)
T cd06612         155 K----RNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-----------  217 (256)
T ss_pred             c----cccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-----------
Confidence            1    112234567999999865  35789999999999999999999999765433221111000000           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                         .......++.++.+++.+||+.||++||++.++++||||
T Consensus       218 -------------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         218 -------------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -------------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                               001123467889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.9e-39  Score=339.79  Aligned_cols=255  Identities=17%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCC-----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTN-----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~   82 (622)
                      ++|++.+.||+  |+||.||+|.+..+|     +.||||+++.... .+....+.+|+++|+.+ +|||||++++++...
T Consensus        38 ~~~~~~~~LG~--G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          38 DNLQFGKTLGA--GAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHceehheecC--CCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            47999999999  779999999975544     5799999976543 34456788999999999 899999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhc---------------------------------------------------------
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHF---------------------------------------------------------  105 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~---------------------------------------------------------  105 (622)
                      ..+++|||||++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999999885421                                                         


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCC
Q psy15039        106 -----------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP  174 (622)
Q Consensus       106 -----------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  174 (622)
                                 ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||...........  ....
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~~  272 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVKG  272 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eecc
Confidence                       113677889999999999999999999999999999999999999999999976543221111  1111


Q ss_pred             CCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       175 ~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      +...+..|+|||++..  ..|+.++|||||||++|+|++ |+.||............+....+                 
T Consensus       273 ~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-----------------  333 (374)
T cd05106         273 NARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-----------------  333 (374)
T ss_pred             CCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-----------------
Confidence            2233456999999865  358999999999999999997 99999765433222222211100                 


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                    ...+...++++.+++..||+.||.+||++.++++
T Consensus       334 --------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         334 --------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             --------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          0112235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.1e-39  Score=337.31  Aligned_cols=292  Identities=23%  Similarity=0.270  Sum_probs=214.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe----
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----   81 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----   81 (622)
                      .+.++|++.+.||+  |+||.||+|.++.+|+.||+|++..........+.+.+|+.+|++++||||++++++|..    
T Consensus         2 ~~~~~y~~~~~lg~--g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   79 (334)
T cd07855           2 DVGSRYKPIENIGS--GAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD   79 (334)
T ss_pred             chhhceeeeeeeec--CCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence            35689999999999  778899999999999999999997654444455677789999999999999999988764    


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ...+++||||+. |++.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+++.|||....
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          80 FKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             CceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            346899999996 6888887653  3488999999999999999999999999999999999999999999999997644


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCC-C
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPH-L  238 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~-~  238 (622)
                      ................++..|+|||.+... ..++.++||||+||++|+|++|+.||........+  +....+.+|. +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            322211111111223556789999998643 34789999999999999999999999876543222  2222332221 1


Q ss_pred             CccccccccCCCCcCcccccccchhhhhcc--ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQV--LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .+..       ..+................  ......++++.++|++||+.||++||++.++++||||.+...
T Consensus       236 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         236 LNRI-------GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhhh-------chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence            1000       0000000000000000000  011346889999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.4e-39  Score=325.02  Aligned_cols=243  Identities=19%  Similarity=0.239  Sum_probs=193.8

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEe----CCcEEEEe
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLD----ATDLHLVS   89 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~lv~   89 (622)
                      ..||+  |+++.||+|+.  +|+.||||.++..... +...+.+.+|+.+|++++|||||++++++.+    ...+++||
T Consensus        26 ~~i~~--g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKE--NDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEee--CCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            56777  88899999987  6899999999765432 3335678899999999999999999999977    35789999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||+++|+|.+++....  .+++.....++.|++.||.|||+. +++||||||+|||++.++.+++.|||........   
T Consensus       102 Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---  176 (283)
T PHA02988        102 EYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---  176 (283)
T ss_pred             EeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence            9999999999997643  477888889999999999999985 9999999999999999999999999975433211   


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                          .....++..|+|||++.+....|+.++|||||||++|||++|+.||............+....+            
T Consensus       177 ----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------  240 (283)
T PHA02988        177 ----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS------------  240 (283)
T ss_pred             ----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence                1123456789999999753346899999999999999999999999876543322222211110            


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                         ...+...++++.+++.+||+.||++|||+.++++
T Consensus       241 -------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 -------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                               0011246788999999999999999999999886

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-38  Score=317.75  Aligned_cols=252  Identities=22%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||+++++.+++.||+|.++.... ....+.+.+|+.+++.++||||++++++|.+...++++|
T Consensus         1 ~y~~~~~lg~--g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGE--GSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeec--cCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            6999999999  7788999999999999999999876432 345567789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++|++.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.+++.|||....+.....  
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999999988764444578999999999999999999999999999999999999999999999997644322111  


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                        ......++..|+|||++..  ..++.++|+||+|+++|+|++|..||...+..........+..+             
T Consensus       156 --~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  218 (255)
T cd08219         156 --YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-------------  218 (255)
T ss_pred             --ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-------------
Confidence              1112345667999999865  34788999999999999999999999876544333222222111             


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                         .....++.++.+++.+||+.||++||++.+++.-
T Consensus       219 -------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 -------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                               0123467889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.4e-39  Score=327.90  Aligned_cols=286  Identities=19%  Similarity=0.281  Sum_probs=209.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--CcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~   85 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||||.++.....+.....+.+|+.+|++++||||+++++++...  ...
T Consensus         4 ~~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           4 VDEYEKLNRIEE--GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhhcC--CCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            458999999999  7789999999999999999999987654444445567899999999999999999999887  889


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+++.|||........
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99999998 58888886643 25889999999999999999999999999999999999999999999999976544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCcccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDCTT  243 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~~  243 (622)
                      ....    .....+..|+|||.+.+. ..++.++|+||+||++|+|++|..||.............  .+.++. ..+..
T Consensus       160 ~~~~----~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~  233 (293)
T cd07843         160 LKPY----TQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE-KIWPG  233 (293)
T ss_pred             cccc----ccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch-HHHHH
Confidence            1111    122345679999998653 346789999999999999999999998765443322221  111110 00000


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      . .... .......................+++.+.++|+.||+.||++|||+.|+++||||
T Consensus       234 ~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         234 F-SELP-GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             h-hccc-hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            0 0000 0000000000000001111111258889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-39  Score=327.45  Aligned_cols=262  Identities=23%  Similarity=0.423  Sum_probs=210.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||.||+++++.+|+.||+|.+.... .+.....+.+|+.++++++||||+++++++......++|
T Consensus         1 ~~~~~~~~ig~--g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGK--GNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             Chhhhhhhhcc--cCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            47999999999  778999999999999999999986542 344556788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         89 SPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      |||++++++.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+++.|||.........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999998886531 1257899999999999999999997 599999999999999999999999999754332111


Q ss_pred             ccccccCCCCCCCccccChhhhcccc----CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHH-HhCCCCCCC
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNL----DGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEK-LAGATPHLL  239 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~----~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~-~~~~~p~~~  239 (622)
                            .....++..|+|||.+.+..    ..++.++|+||+||++|+|++|+.||.........  ... ..+..+.  
T Consensus       158 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  229 (286)
T cd06622         158 ------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT--  229 (286)
T ss_pred             ------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC--
Confidence                  11223456799999985432    23578999999999999999999999754332211  111 1111111  


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                                    ....+++++.+++.+||+.||++||++.++++||||......
T Consensus       230 ------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         230 ------------------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             ------------------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                                          122378899999999999999999999999999999876544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-38  Score=321.75  Aligned_cols=262  Identities=24%  Similarity=0.396  Sum_probs=206.7

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC--------HHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT--------DEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      +|.+.+.||+  |+||.||+|.++.+|+.||||.+......        ....+.+.+|+.+|++++||||+++++++..
T Consensus         2 ~~~~~~~lg~--g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   79 (272)
T cd06629           2 KWVKGELIGK--GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT   79 (272)
T ss_pred             ceeecceecc--cCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence            6899999999  77899999999999999999998643211        1123467789999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      .+..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+++.||+....
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            99999999999999999998764  3578999999999999999999999999999999999999999999999987643


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCC-CCCCCc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA-TPHLLD  240 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~-~p~~~~  240 (622)
                      .......  .......++..|+|||++......++.++|+||+||++|+|++|..||................ .+.+. 
T Consensus       158 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  234 (272)
T cd06629         158 SDDIYDN--DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP-  234 (272)
T ss_pred             ccccccc--cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC-
Confidence            3211111  0111234566799999987543357889999999999999999999997554433222211110 00000 


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                                 ......++.++.+++..||..||++||++.++++|||+
T Consensus       235 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         235 ---------------------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ---------------------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                       00123468899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0201|consensus

Probab=100.00  E-value=1.6e-41  Score=336.64  Aligned_cols=220  Identities=32%  Similarity=0.541  Sum_probs=189.7

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ..|...+.||+  |+||.||+|.+..|++.||||+++.+...+ +...+.+|+.+|..+++|||.++|++|..+..+|++
T Consensus        13 ~~~~~~~~Igr--GsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGR--GSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccchhccc--cccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            34667789999  789999999999999999999999876544 357889999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      ||||.||++.++++...  .+++..+.-++++++.||.|||+++.+|||||+.|||+..+|.++++|||.+.........
T Consensus        90 Mey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999999997643  2477778889999999999999999999999999999999999999999987655443322


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  590 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~  590 (622)
                          ..+.+|||.||||||+.+  ..|+.++||||||++.+||++|.||+....+...++-+.... |+.++
T Consensus       168 ----r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~  232 (467)
T KOG0201|consen  168 ----RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLD  232 (467)
T ss_pred             ----cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccc
Confidence                246789999999999985  579999999999999999999999999888766555555554 44444

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.6e-39  Score=319.57  Aligned_cols=256  Identities=23%  Similarity=0.407  Sum_probs=209.0

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||++..+.+|..||+|.+........+.+.+.+|++++++++||||+++++.+......++++
T Consensus         1 ~~~~~~~l~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGE--GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecC--CCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            6999999999  77889999999999999999999776544455567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-eEEcCCccccccCCCCcc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-ACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~-~~i~~~~~~~~~~~~~~~  168 (622)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.++. +++.||+...........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            9999999999987654445789999999999999999999999999999999999998864 588998866443322111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                          .....++..|+|||++...  .++.++|+||+||++++|++|..||..............+..+.           
T Consensus       159 ----~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  221 (257)
T cd08225         159 ----AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP-----------  221 (257)
T ss_pred             ----ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC-----------
Confidence                1112356679999998653  47889999999999999999999997654433333322221110           


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                           ....++.++.+++.+||..||++|||+.++++||||
T Consensus       222 ---------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         222 ---------------------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ---------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                                 123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-38  Score=325.91  Aligned_cols=265  Identities=20%  Similarity=0.328  Sum_probs=209.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||++.++.+++.||+|.++.... .......+.+|+.+++.++||||+++++.+..+..+++
T Consensus         1 ~~y~~~~~l~~--g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISN--GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CCceEeeEeec--CCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence            47999999999  7788999999999999999999876533 23345677899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........
T Consensus        79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          79 VMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999999999764  3578999999999999999999999999999999999999999999999986431100000


Q ss_pred             -c----------ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        168 -K----------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       168 -~----------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                       .          .........++..|+|||.+..  ..++.++|+|||||++|+|++|..||.+............+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  234 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence             0          0000111234567999999865  35789999999999999999999999866544333332222111


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC---HHhhhcCccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL---ACNLLQHAFFKQTK  309 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~h~~~~~~~  309 (622)
                      ..                              .....+++++.+++.+||+.||++||+   +.++++||||....
T Consensus       235 ~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         235 WP------------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             CC------------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            00                              011246889999999999999999998   78999999996643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.7e-39  Score=338.84  Aligned_cols=256  Identities=18%  Similarity=0.284  Sum_probs=201.0

Q ss_pred             CCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~   82 (622)
                      ++|++++.||+  |+||.||+|++     ..++..||||+++.... ....+.+.+|+++|+.+ +|||||++++++...
T Consensus        35 ~~~~~~~~LG~--G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          35 NRLSFGKTLGA--GAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             HHeehhheecC--CccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            37999999999  77999999974     45778999999875432 34456788999999999 899999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhc---------------------------------------------------------
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHF---------------------------------------------------------  105 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~---------------------------------------------------------  105 (622)
                      ...++|||||++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886421                                                         


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039        106 ----------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus       106 ----------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                                      ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||........... 
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-  270 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY-  270 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc-
Confidence                            113678889999999999999999999999999999999999999999999976543322111 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                       ........+..|+|||++.+  ..++.++|||||||++|||++ |..||............+.....            
T Consensus       271 -~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------  335 (375)
T cd05104         271 -VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR------------  335 (375)
T ss_pred             -cccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc------------
Confidence             11112233456999999975  358899999999999999997 89999765443333333221110            


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                         ...+...+.++.+|+..||+.||++||++.++++.
T Consensus       336 -------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 -------------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                               00112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.5e-39  Score=322.91  Aligned_cols=253  Identities=23%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      +|++.+.||+  |+||.||+|+++.+++.||+|.+...... ....+.+.+|++++++++||||+++++.+.....+++|
T Consensus         1 ~y~~~~~i~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGK--GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEecc--CCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            6999999999  77889999999999999999999765433 24567788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      +||+++++|.+.+...  ..+++..+..++.|+++||.|||++|++|+||||+||+++.++.+++.||+.......... 
T Consensus        79 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  155 (258)
T cd05578          79 VDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-  155 (258)
T ss_pred             EeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence            9999999999998764  3588999999999999999999999999999999999999999999999997654332211 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHHHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                          .....++..|+|||.+...  .++.++|+||+||++|+|++|..||.....  ............           
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  218 (258)
T cd05578         156 ----TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD-----------  218 (258)
T ss_pred             ----ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccc-----------
Confidence                1123445679999998653  478999999999999999999999986543  222222211100           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH--HhhhcCccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA--CNLLQHAFF  305 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~--~~~l~h~~~  305 (622)
                                           ...+..++.++.+++.+||+.||++||++  .++++||||
T Consensus       219 ---------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         219 ---------------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ---------------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                                 01123467899999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0580|consensus

Probab=100.00  E-value=1.7e-40  Score=304.72  Aligned_cols=217  Identities=24%  Similarity=0.384  Sum_probs=189.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHH-HHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++++.||+  |-||.||+|+.+.++-.||+|++.++...... ..++.||+.|.++|+||||+++|++|.+...+
T Consensus        20 ~l~dfeigr~Lgk--gkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   20 TLDDFEIGRPLGK--GKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             chhhccccccccC--CccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            3567999999999  77999999999999999999999876544333 35789999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+++||.+.|++...|........++.....|..|++.||.|+|.++||||||||+|+|++.+|..+++|||++..-..+
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            99999999999999998655555788889999999999999999999999999999999999999999999986543322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      +      ..+.|||..|.+||++.+  ..++..+|+|++|+.+||++.|.+||...+ ....+++|...
T Consensus       178 k------R~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~  237 (281)
T KOG0580|consen  178 K------RKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV  237 (281)
T ss_pred             C------ceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc
Confidence            2      234678999999999976  579999999999999999999999998776 55566666664

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-39  Score=325.89  Aligned_cols=286  Identities=22%  Similarity=0.307  Sum_probs=211.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|++.+.||+  |+||.||+|.++.+++.||||+++.........+.+.+|+++|++++||||+++++++..++..+++
T Consensus         1 ~~y~~~~~i~~--g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGE--GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecc--cCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            47999999999  7788999999999999999999876554455567788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||++++.+..+....  .++++..+..++.||+.||.|||+++|+||||||+||+++.++.+++.|||...........
T Consensus        79 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          79 FEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9999987776665442  34789999999999999999999999999999999999999999999999976443222110


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p~~~~~~~~~~  246 (622)
                         ......++..|+|||++... ..++.++|+||+||++|+|++|+.||........+..  ...+..+....   ...
T Consensus       157 ---~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  229 (288)
T cd07833         157 ---PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ---ELF  229 (288)
T ss_pred             ---cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh---hhc
Confidence               01122345679999998753 2578999999999999999999999986554433322  22221111000   000


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ...........................++.++.+|+++||..||++||++.++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00000000000000000000111223458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-38  Score=318.66  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=205.2

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM----TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      +|++++.||+  |+||.||+|.. .+|+.||||.+.....    .......+.+|+.+|++++|+||+++++++.+....
T Consensus         1 ~~~~~~~ig~--g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (265)
T cd06631           1 EWTKGEVLGK--GAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI   77 (265)
T ss_pred             CccccceEec--cCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence            5899999999  77889999986 4899999999875432    223346688999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++++||+++++|.+++....  .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+++.|||........
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          78 SIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999999987643  4789999999999999999999999999999999999999999999999876433211


Q ss_pred             Cc--cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        166 KK--KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       166 ~~--~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ..  ..........++..|+|||++.+  ..++.++|+||+||++|+|++|..||.................+       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-------  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-------
Confidence            00  00011112345677999999865  35789999999999999999999999765433322221111000       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                            . ......++.++.+++++||+.||++||++.++++||||
T Consensus       227 ----------------------~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ----------------------M-PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ----------------------C-CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                  0 00123478899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.4e-39  Score=335.01  Aligned_cols=290  Identities=22%  Similarity=0.262  Sum_probs=208.8

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      ..+..+|++.+.||+  |+||.||+|+++.+|+.||||.+............+.+|+.++++++||||++++++|...  
T Consensus        12 ~~~~~~y~~~~~lg~--g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (353)
T cd07850          12 FTVLKRYQNLKPIGS--GAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS   89 (353)
T ss_pred             hhhhcceEEEEEecc--CCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence            356789999999999  7799999999999999999999876544445556678999999999999999999998654  


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ...++||||+. +++.+.+..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        90 ~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          90 LEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             ccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence                34799999997 577777643    278889999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p  236 (622)
                      .........     .....++..|+|||.+.+  ..++.++||||+||++|+|++|+.||...+........+  .+.++
T Consensus       165 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (353)
T cd07850         165 ARTAGTSFM-----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS  237 (353)
T ss_pred             ceeCCCCCC-----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            644322111     112234667999999875  458899999999999999999999998665432222111  11111


Q ss_pred             C-CCcc----ccccccCCCCcCcccccccchhhhhc---cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        237 H-LLDC----TTYYVDTGQDDGEENACSYISEQQTQ---VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       237 ~-~~~~----~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      . +.+.    ...+......................   .......++.+.+++.+||+.||++|||+.++|.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence            0 0000    00000000000000000000000000   00012346778999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-38  Score=324.35  Aligned_cols=282  Identities=22%  Similarity=0.306  Sum_probs=209.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |++|.||+|+++.+|+.||||++............+.+|++++++++||||+++++++.+....++|
T Consensus         2 ~~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGE--GTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecC--CCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            47999999999  7788999999999999999999876544434445677899999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~-~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||++ +++.+.+........++..+..++.||+.||+|||+++|+||||||+||+++.+ +.+++.|||..........
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            99997 577777765444446788999999999999999999999999999999999864 5689999987643322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCcccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDCTTYY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~~~~  245 (622)
                      .    .....+++.|+|||++.+. ..++.++||||+||++|+|++|..||........+....  .+..+.. .+    
T Consensus       159 ~----~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----  228 (294)
T PLN00009        159 T----FTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE-TW----  228 (294)
T ss_pred             c----cccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh-hc----
Confidence            1    1122345679999998653 357889999999999999999999998655443333221  1111000 00    


Q ss_pred             ccCCCCcCcccccccchhh-----hhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQ-----QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                            ........+....     .........+++++.+++.+||..||++||++.++++||||....
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        229 ------PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ------cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                  0000000000000     000011235788999999999999999999999999999997643

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3e-38  Score=317.03  Aligned_cols=262  Identities=25%  Similarity=0.429  Sum_probs=211.5

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||++....+++.||+|.+......+...+.+.+|+.++++++||||+++++++...+.+++|+
T Consensus         1 ~y~~~~~lg~--G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGG--GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeec--CCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            5999999999  77889999999999999999999877655566788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||............
T Consensus        79 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          79 EYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             ecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999999998763  236888999999999999999999999999999999999999999999999765443222111


Q ss_pred             cccCCCCCCCccccChhhhcccc-CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh-CCCCCCCcccccccc
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA-GATPHLLDCTTYYVD  247 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~  247 (622)
                      ........++..|+|||.+.... ..++.++||||+||++|+|++|..||............+. +..|.          
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  226 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP----------  226 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC----------
Confidence            11011234567899999987542 2367899999999999999999999976533222222221 11111          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                          .+.....++.+.+++.+||+.||++||++.+++.|||+
T Consensus       227 --------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         227 --------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             --------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                                11223357889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0610|consensus

Probab=100.00  E-value=1.7e-39  Score=319.79  Aligned_cols=222  Identities=24%  Similarity=0.318  Sum_probs=190.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++++.||+  |..|+||+++.+.++..+|+|++.++.+.. ....++..|-.||+.++||.++.+|..|..+...+
T Consensus        76 l~~f~llk~LG~--GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   76 LRHFRLLKRLGC--GDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             HHHHHHHHHcCC--CCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            467899999999  779999999999999999999998776543 33578889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC--
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP--  514 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~--  514 (622)
                      ++||||+||+|..+++++....+++..++.|+.+|+.||+|||-.|||-|||||+||||-++|++.+.||.++.....  
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999999999988877899999999999999999999999999999999999999999999998865432110  


Q ss_pred             ---------------------------C---C-Cc-------------------eeccCCCCCCCCccccccccccCccC
Q psy15039        515 ---------------------------T---K-KK-------------------VHLFPPSTAYNLNWLSPEVLEQNLDG  544 (622)
Q Consensus       515 ---------------------------~---~-~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~~~  544 (622)
                                                 .   . +.                   ......+.+||..|+|||++.+  ++
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G--~G  311 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG--EG  311 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec--CC
Confidence                                       0   0 00                   0011134578899999999987  56


Q ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        545 YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       545 ~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .+.++|+|+|||.+|||+.|+.||.+.+..+.+..++..
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~  350 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ  350 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC
Confidence            899999999999999999999999999888776655544

>KOG0660|consensus

Probab=100.00  E-value=9.5e-40  Score=317.94  Aligned_cols=218  Identities=26%  Similarity=0.324  Sum_probs=183.5

Q ss_pred             cCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe--
Q psy15039        354 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--  431 (622)
Q Consensus       354 ~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--  431 (622)
                      ...++..|...+.||+  |+||.|+.|.++.||+.||||++...-......++..||+++|++++|+|||.+++.+..  
T Consensus        17 ~~~i~~~y~~~~~iG~--GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGR--GAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             EEeccceecccccccC--cceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            3456677877899999  779999999999999999999997544455667899999999999999999999999876  


Q ss_pred             ---CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        432 ---ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       432 ---~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                         -+++|+|+|+|+ .+|.++++...  .+++..++.++.|++.||.|+|+.+|+||||||+|+|++.+...|+.|||+
T Consensus        95 ~~~f~DvYiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   95 RDKFNDVYLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ccccceeEEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccc
Confidence               357999999995 68888887643  378899999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      +...+..  .....-+.-+-|.+|.|||++.. ...|+.++||||+|||+.||++|++-|.+.+...++..
T Consensus       172 AR~~~~~--~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l  239 (359)
T KOG0660|consen  172 ARYLDKF--FEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL  239 (359)
T ss_pred             eeecccc--CcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH
Confidence            7655432  11122233455889999999964 36799999999999999999999999999877665433

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=317.64  Aligned_cols=260  Identities=31%  Similarity=0.535  Sum_probs=208.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|.++.+++.+|+|.+.....  ...+.+.+|+.++++++||||+++++++.+...+++
T Consensus         2 ~~~~~~~~~l~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGS--GTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecC--CCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            368999999999  7788999999999999999999976532  355778899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||++++++.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........
T Consensus        78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            999999999999887642 3588999999999999999999999999999999999999999999999997644322110


Q ss_pred             cccccCCCCCCCccccChhhhccc-cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .    .....++..|+|||.+... ...++.++|+||+||++|+|++|..||.................+..        
T Consensus       157 ~----~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  224 (262)
T cd06613         157 K----RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--------  224 (262)
T ss_pred             c----cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc--------
Confidence            0    1122445679999998642 12577899999999999999999999986554332222211110000        


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                                          .......++.++.+++.+||..||.+||++.+++.|+|
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 --------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             --------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                                00012245788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-38  Score=323.19  Aligned_cols=264  Identities=26%  Similarity=0.449  Sum_probs=205.6

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE-
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL-   80 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~-   80 (622)
                      .+.....+|++.+.||+  |+||.||+++++.+++.||+|+++....   ....+.+|+.+++.+ +||||+++++++. 
T Consensus        12 ~~~~~~~~~~~~~~lg~--g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          12 SFPDPSDTWEIIETIGK--GTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             cCCCcccceeeeeeecc--CCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34567789999999999  7788999999999999999999765322   224566899999999 7999999999884 


Q ss_pred             ----eCCcEEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEc
Q psy15039         81 ----DATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  154 (622)
Q Consensus        81 ----~~~~~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~  154 (622)
                          .+...++||||+++++|.+++...  ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+++.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence                345689999999999999987643  22347899999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCccccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH
Q psy15039        155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~  231 (622)
                      |||..........    ......++..|+|||++...   ...|+.++||||+||++|+|++|+.||........+....
T Consensus       167 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~  242 (286)
T cd06638         167 DFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP  242 (286)
T ss_pred             cCCceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence            9997543321111    11223456789999998532   1347889999999999999999999997654332221111


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ....+                              .......++.++.+++.+||+.||++||++.++++|+||
T Consensus       243 ~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         243 RNPPP------------------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCC------------------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            11000                              001122357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-38  Score=318.43  Aligned_cols=259  Identities=26%  Similarity=0.425  Sum_probs=203.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      +-+|++.+.||+  |+||.||+|.++.+|..||+|++.....   .....+.+.+|+.++++++||||+++++++...  
T Consensus         1 ~~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (266)
T cd06651           1 PINWRRGKLLGQ--GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE   78 (266)
T ss_pred             CCCccccceecC--CCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence            458999999999  7789999999999999999999875432   234456788999999999999999999998763  


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+++++||+++++|.+++....  .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+++.|||.....
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            56889999999999999987643  4788899999999999999999999999999999999999999999999875432


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCC-CCCCCcc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA-TPHLLDC  241 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~-~p~~~~~  241 (622)
                      ....... .......++..|+|||.+.+  ..++.++|+||+||++|+|++|+.||................ .|.    
T Consensus       157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----  229 (266)
T cd06651         157 QTICMSG-TGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ----  229 (266)
T ss_pred             ccccccC-CccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCC----
Confidence            2110000 00111234667999999865  357889999999999999999999997654333222211110 000    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                                  ....+++.+.+++ .||..||++||++.++++||||.
T Consensus       230 ----------------------------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         230 ----------------------------LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ----------------------------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                        1123577888998 67788999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0599|consensus

Probab=100.00  E-value=1.7e-40  Score=309.17  Aligned_cols=252  Identities=24%  Similarity=0.356  Sum_probs=213.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC------CHHHHHHHHHHHHHHhhC-CCCccceeEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM------TDEDLKSLHHEIVCMRHL-RHPNIICYISSF  429 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~------~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~  429 (622)
                      .-.+|..-++||+  |..++|-++-++.||+.+|+|+|.....      ..+.++.-.+|+.||+++ .||||+++.++|
T Consensus        15 fy~~y~pkeilgr--gvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   15 FYAKYEPKEILGR--GVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             HHhhcChHHHhcc--cchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3456778889999  6678899999999999999999975321      122245567899999997 799999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                      .++..+++|+|+|+.|+|.|+|...  ..+++...+.+++|+++|++|||.++||||||||+|||++++.+++++|||++
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence            9999999999999999999999874  35899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccc----cCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      |.+....+.     ...||||.|+|||.+.    .+..+|+..+|+||+|||+|.++.|.+||-......++-.+..|. 
T Consensus       171 ~~l~~GekL-----relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk-  244 (411)
T KOG0599|consen  171 CQLEPGEKL-----RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK-  244 (411)
T ss_pred             eccCCchhH-----HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc-
Confidence            987665432     2357899999999984    344679999999999999999999999998765445555556665 


Q ss_pred             CCCCCCCcccccCCCCcCcccccchhhhhhhhhccc
Q psy15039        586 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTS  621 (622)
Q Consensus       586 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (622)
                         ..+.+.-|+...+..+..+.+++-.++++|+|+
T Consensus       245 ---yqF~speWadis~~~KdLIsrlLqVdp~~Rita  277 (411)
T KOG0599|consen  245 ---YQFRSPEWADISATVKDLISRLLQVDPTKRITA  277 (411)
T ss_pred             ---cccCCcchhhccccHHHHHHHHHeeCchhcccH
Confidence               456777888888888888889999999999985

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-38  Score=325.40  Aligned_cols=282  Identities=23%  Similarity=0.300  Sum_probs=210.6

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +|++++.||+  |+||.||+|.++.+|+.||||++......   ......+.+|++++++++||||+++++++.+.+..+
T Consensus         1 ~y~~~~~lg~--g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   78 (298)
T cd07841           1 RYEKGKKLGE--GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN   78 (298)
T ss_pred             Cceeeeeeee--ccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEE
Confidence            5899999999  77889999999999999999999765433   333455778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+ +|+|.+++.... ..+++..+..++.||++||.|||++||+||||||+||+++.++.+++.|||.........
T Consensus        79 lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          79 LVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             EEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            999999 899999987643 258899999999999999999999999999999999999999999999999765433221


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~~~~  245 (622)
                      ..    ......++.|+|||.+.+. ..++.++|+||+||++|+|++|.+||........+...... ..|.....    
T Consensus       157 ~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  227 (298)
T cd07841         157 RK----MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW----  227 (298)
T ss_pred             cc----ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh----
Confidence            11    1112345679999998543 35788999999999999999998888765443222221111 01100000    


Q ss_pred             ccCCCCcCcccccccchhhhh----ccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQT----QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ....      ....+......    ........+.++.++|.+||+.||++|||+.+++.|+||++...
T Consensus       228 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         228 PGVT------SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             hhcc------cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence            0000      00000000000    00012345789999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0661|consensus

Probab=100.00  E-value=2e-40  Score=331.29  Aligned_cols=217  Identities=28%  Similarity=0.354  Sum_probs=186.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCccceeEEEEEeCC-c
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT-D  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~-~  434 (622)
                      +-+.|.+.+.||.  |.||.||+|+.+.+|+.||||++.....+-++. .-.||++.|++|+ |||||++.+++.+.+ .
T Consensus         8 ~m~RY~~i~klGD--GTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    8 FMDRYTVIRKLGD--GTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             HHHHHHHHHHhcC--CcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            3467999999999  779999999999999999999997765554332 3579999999999 999999999999988 8


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+|||||+ ..|+++++.. ...+++..++.|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||++.....
T Consensus        85 L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   85 LYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             EeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            999999998 7999999876 56789999999999999999999999999999999999999999999999998754321


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH--HcCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGA  584 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~--~~~~  584 (622)
                       +..    -+..+.|.+|.|||++.+. ..|+.++||||+|||++|+.+-++-|.+.+..+++..+  +.|.
T Consensus       163 -kpP----YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt  228 (538)
T KOG0661|consen  163 -KPP----YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT  228 (538)
T ss_pred             -CCC----cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence             100    0123447889999999865 46999999999999999999999999999998888664  5554

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-38  Score=328.19  Aligned_cols=282  Identities=22%  Similarity=0.289  Sum_probs=192.1

Q ss_pred             EeecccccCCceeEEEEEEcc--CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--CCcEEEEe
Q psy15039         14 CSILGQCFNNLSSVYLSKHKV--TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--ATDLHLVS   89 (622)
Q Consensus        14 ~~~lG~g~g~~~~V~~~~~~~--t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lv~   89 (622)
                      +..||+  |+||.||+|+++.  ++..||+|.+......    ..+.+|+++|++++|||||++++++..  +..++++|
T Consensus         6 g~~lG~--G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGR--GTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEecc--CCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            457999  7799999999764  6789999998654332    346689999999999999999999865  45689999


Q ss_pred             ecCCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCceEEcCCcc
Q psy15039         90 PLMGFGSCKDLINAHF-------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRY  158 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl----~~~~~~~i~~~~~  158 (622)
                      ||++ +++.+++....       ...+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+++.|||.
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            9987 46777664321       1247899999999999999999999999999999999999    4567899999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-----------HHH
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-----------LML  227 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-----------~~~  227 (622)
                      ............ ......+|+.|+|||++.+. ..++.++||||+||++|||++|++||......           ...
T Consensus       159 a~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         159 ARLFNSPLKPLA-DLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             eeccCCCccccc-ccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            754432211111 11223557789999998753 35789999999999999999999999743221           111


Q ss_pred             HHHHhCCCCCCCcccccccc----CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        228 IEKLAGATPHLLDCTTYYVD----TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       228 ~~~~~~~~p~~~~~~~~~~~----~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                      +....+.+ ...++......    ...........................+..+.+|+.+||+.||.+|||+.|+|+||
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp  315 (317)
T cd07867         237 IFSVMGFP-ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP  315 (317)
T ss_pred             HHHhcCCC-ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence            11111111 10011000000    00000000000000000000011223467799999999999999999999999999


Q ss_pred             cc
Q psy15039        304 FF  305 (622)
Q Consensus       304 ~~  305 (622)
                      ||
T Consensus       316 ~f  317 (317)
T cd07867         316 YF  317 (317)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-38  Score=323.00  Aligned_cols=260  Identities=28%  Similarity=0.528  Sum_probs=210.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ...|+.++.||+  |+||.||+|.++.+++.||||.+..+. .......+.+|+.++++++||||+++++++.++...++
T Consensus         3 ~~~y~~~~~lg~--g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           3 EELFTKLERIGK--GSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HHhhhhhhhccc--CCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            457899999999  778999999999999999999987653 24456778899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++..   ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.+++.|||..........
T Consensus        80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999999998864   2478899999999999999999999999999999999999999999999997644322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    .....++..|+|||++.+.  .++.++|+|||||++|+|++|..||..............+..|           
T Consensus       157 ~----~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------  219 (277)
T cd06640         157 K----RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP-----------  219 (277)
T ss_pred             c----cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC-----------
Confidence            1    1112345679999998753  4788999999999999999999999765433221111111111           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                           .....++.++.+++.+||+.||++||++.++++|+||.+...+
T Consensus       220 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         220 ---------------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             ---------------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence                                 0112356789999999999999999999999999999776543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-39  Score=332.78  Aligned_cols=290  Identities=22%  Similarity=0.264  Sum_probs=209.0

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC---
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA---   82 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~---   82 (622)
                      ++.++|++.+.||+  |+||.||+|.++.+|+.||||+++... .......+.+|+.+|++++||||+++++++...   
T Consensus         2 ~~~~~y~i~~~lg~--G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           2 DVGPRYQNLSYIGE--GAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             ccccceEEEEEEEe--cCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            57789999999999  778999999999999999999986432 223445677899999999999999999887654   


Q ss_pred             --CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         83 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        83 --~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                        ...++++||++ +++.+.+..   ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||...
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          79 SFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             ccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence              35899999997 477777654   358899999999999999999999999999999999999999999999999765


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHL  238 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~  238 (622)
                      .......... ......++..|+|||++.+. ..++.++||||+||++|+|++|+.||...+.....  +..+.+.++. 
T Consensus       155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~-  231 (336)
T cd07849         155 IADPEHDHTG-FLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ-  231 (336)
T ss_pred             eccccccccC-CcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH-
Confidence            4322211111 11223456789999987643 35788999999999999999999999765432221  1111121110 


Q ss_pred             CccccccccCCCCcCcccccccchhhhhcc--ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQV--LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .+..     .....................  ......++++.+++.+||+.||++|||+.++++||||.....
T Consensus       232 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         232 EDLN-----CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHH-----HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0000     000000000000000000000  011245888999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.7e-39  Score=326.39  Aligned_cols=286  Identities=24%  Similarity=0.338  Sum_probs=209.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|++.+.||+  |+||.||+|.++.+|+.||+|++..........+.+.+|+.+|+.++||||+++++++.++...++|
T Consensus         1 ~~y~~~~~lg~--g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGE--GSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeecc--CCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            47999999999  7799999999999999999999876554444456678999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      +||++++.+..+....  .++++..+..++.||+.||+|||++||+||||+|+||+++.++.+++.|||...........
T Consensus        79 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          79 FEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            9999998888776542  24789999999999999999999999999999999999999999999999875433222111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccC
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT  248 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  248 (622)
                      .    ....++..|+|||++.+. ..++.++|||||||++|+|++|.+||............. .....+..........
T Consensus       157 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  230 (286)
T cd07846         157 Y----TDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII-KCLGNLIPRHQEIFQK  230 (286)
T ss_pred             c----CcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-HHhCCCchhhHHHhcc
Confidence            1    112345679999998643 347789999999999999999999997654332222211 1000000000000000


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .........+. .............++..+.+|+.+||..||++||++.++++|+||
T Consensus       231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         231 NPLFAGMRLPE-VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chHhhcccccc-ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00000000000 000000001123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.5e-38  Score=316.30  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=209.4

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--CCcEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--ATDLHL   87 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l   87 (622)
                      +|++.+.||+  |+||.||++.+..+|+.||+|.++.+...+...+.+.+|+++|++++||||+++++.+..  ...+++
T Consensus         1 ~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGK--GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             Cceeeeeecc--CCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            5999999999  789999999999999999999998776667777788999999999999999999998865  356899


Q ss_pred             EeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         88 VSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIH-----GKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH-----~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                      +|||+++++|.+++....  ...+++..+..++.||+.||+|||     +.+|+||||||+||+++.++.+++.|||...
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence            999999999999987642  235789999999999999999999     9999999999999999999999999999765


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh-CCCCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA-GATPHLL  239 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~-~~~p~~~  239 (622)
                      ........    .....++..|+|||.+...  .++.++|+||||+++|+|++|+.||....... ....+. +..+   
T Consensus       159 ~~~~~~~~----~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---  228 (265)
T cd08217         159 ILGHDSSF----AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LASKIKEGKFR---  228 (265)
T ss_pred             cccCCccc----ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHHHHhcCCCC---
Confidence            44322110    1122456779999998653  47889999999999999999999998655322 222221 1111   


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                                   .....++.++.+++.+||..||++||++.++++|||+
T Consensus       229 -----------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         229 -----------------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                         1123468899999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=320.47  Aligned_cols=260  Identities=29%  Similarity=0.522  Sum_probs=209.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC---CCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~~~~~~~~~~~~   85 (622)
                      ..|++.+.||+  |+||.||+|.++.+|+.||||.++... .......+.+|+.++++++   ||||+++++++......
T Consensus         1 ~~y~~~~~l~~--g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           1 SLYQRLELIGR--GAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             Chhhhhhheec--cCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            36899999999  778899999999999999999987643 3344566889999999997   99999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +++|||+++++|.+++...   .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+++.|||........
T Consensus        78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999999988652   5889999999999999999999999999999999999999999999999976544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...    .....++..|+|||.+..+ ..++.++|+|||||++|+|++|..||.......... .+...           
T Consensus       155 ~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~-----------  217 (277)
T cd06917         155 SSK----RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-LIPKS-----------  217 (277)
T ss_pred             ccc----cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-ccccC-----------
Confidence            211    1122456679999998643 457889999999999999999999997654322111 11000           


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                         ..+.+....++.++.+++.+||+.||++||++.+++.|+||++...
T Consensus       218 -------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         218 -------------------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             -------------------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence                               0001112236789999999999999999999999999999977554

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0694|consensus

Probab=100.00  E-value=1.5e-39  Score=339.04  Aligned_cols=216  Identities=20%  Similarity=0.328  Sum_probs=184.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCC-CCccceeEEEEEeCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~  434 (622)
                      ...+|.++++||+  |+||+|+++..+.+++.+|||++.+... ...+++..+.|.+|+...+ ||.+++++.+|.+.++
T Consensus       366 ~l~~F~~l~vLGk--GsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  366 TLDDFRLLAVLGR--GSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccceEEEEEecc--CcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3578999999999  8899999999999999999999987754 3455788999999998875 9999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+||||..||++..+.+   ...+++..++.|+..|+.||+|||++|||+||||.+|||||.+|.+||+|||....-. 
T Consensus       444 l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-  519 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-  519 (694)
T ss_pred             EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC-
Confidence            999999999999443322   2357899999999999999999999999999999999999999999999999743211 


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                         .......+.+|||.|||||++.+  ..|+.++|+|||||++||||.|++||.+.+.++ ++..|...
T Consensus       520 ---~~g~~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~FdsI~~d  583 (694)
T KOG0694|consen  520 ---GQGDRTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDSIVND  583 (694)
T ss_pred             ---CCCCccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhcC
Confidence               11223456799999999999987  579999999999999999999999999876555 44444443

>KOG0589|consensus

Probab=100.00  E-value=6.9e-40  Score=333.98  Aligned_cols=224  Identities=25%  Similarity=0.421  Sum_probs=200.3

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc-EEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~-~~l  437 (622)
                      ++|..++.+|+  |+||.+++++++..+..+++|+|.....++...+....|+.++++++|||||.|++.|...+. ++|
T Consensus         4 ~~Ye~~~~iG~--GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGR--GAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCc--cccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            57999999999  779999999999999999999999999888888899999999999999999999999999998 999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||+||+||++.+.+...+..-+++..+..|+.|++.|+.|||+++|+|||||++||+++.++.+++.|||.+....... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-  160 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence            9999999999999987765568999999999999999999999999999999999999999999999999876544322 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  590 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~  590 (622)
                         ....+..||+.||.||++.+  ..|+.|+|||||||++|||++-+++|...+....+.++..+..+++++
T Consensus       161 ---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~  228 (426)
T KOG0589|consen  161 ---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS  228 (426)
T ss_pred             ---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc
Confidence               23456789999999999976  679999999999999999999999999887776666666665455554

>KOG0603|consensus

Probab=100.00  E-value=1.1e-39  Score=338.63  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=209.4

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHh-hCCCCcceeEEEEEEeC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR-HLRHPNIICYISSFLDA   82 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~   82 (622)
                      ..++.+.|++...+|.  |+||.|-.+.++.|++..|+|++.....      +..+|+.++. .-+||||+++++.+.+.
T Consensus       317 ~~~~~~~y~~~~~~~~--gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  317 TAPFTESYEFREELGE--GSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             cCCcchhhccccccCC--CCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCC
Confidence            3457789999999999  6688999999999999999999977621      1224664444 44899999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-cCCCceEEcCCccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI-SHNGKACLSGLRYMCP  161 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl-~~~~~~~i~~~~~~~~  161 (622)
                      ...|+|||++.++.+.+.+.....   ....+..|++||+.|+.|||++||||||+||+|||+ ++.|.+++++||.+..
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            999999999999999988876432   236777899999999999999999999999999999 5889999999998865


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ....       ..+.++|..|.|||++..  .+|+.++||||||++||+|++|+.||...+....+..++....      
T Consensus       466 ~~~~-------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~------  530 (612)
T KOG0603|consen  466 LERS-------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK------  530 (612)
T ss_pred             Cchh-------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc------
Confidence            4332       235588999999999974  6799999999999999999999999998877766655543210      


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                                  .+..+|+++++|++.||+.||.+||++.+++.||||.
T Consensus       531 ----------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  531 ----------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             ----------------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence                                        1145799999999999999999999999999999993

>KOG4236|consensus

Probab=100.00  E-value=3e-40  Score=331.69  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=216.9

Q ss_pred             CCCCCceE--EeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          6 NVPSNYKI--CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         6 ~~~~~y~~--~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +|...|+|  -++||.  |.||+||-|+|++||+.||||.+++-+....+..++..|++||++++||.||.+...|++.+
T Consensus       559 d~stvYQif~devLGS--GQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e  636 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGS--GQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE  636 (888)
T ss_pred             hHHHHHHhhhHhhccC--CcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence            34456766  467998  88999999999999999999999998876666678889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCcccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMC  160 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~~~~  160 (622)
                      ..++|||-+. |+....+.....+.|+|...++++.||+.||.|||.+||+|.||||+|||+.+..   .+|++|||++.
T Consensus       637 rvFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  637 RVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             eEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccccee
Confidence            9999999886 5655555555566799999999999999999999999999999999999997653   68899999865


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ..+..     .+..+.++|+.|+|||+|..  .+|+...||||+|+++|--++|..||.+.......++...--+|    
T Consensus       716 iIgEk-----sFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyP----  784 (888)
T KOG4236|consen  716 IIGEK-----SFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYP----  784 (888)
T ss_pred             ecchh-----hhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccC----
Confidence            43321     23446688999999999985  47999999999999999999999999865432222221111111    


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                 .-++..+|+++.|||..+|+....+|-|.++.|.|||.+..+
T Consensus       785 ---------------------------p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  785 ---------------------------PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             ---------------------------CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence                                       113456899999999999999999999999999999998754

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.3e-39  Score=325.95  Aligned_cols=263  Identities=27%  Similarity=0.457  Sum_probs=210.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      +..+.|+....||+  |+||.||++.+..++..||||++....  ....+.+.+|+.++++++||||+++++.+...+..
T Consensus        19 ~~~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          19 DPREYLDSFIKIGE--GSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             chHHHHhhhhcccC--CCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            34467777888999  889999999999999999999986532  34456688999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||++++++.+++..   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+++.|||........
T Consensus        95 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999999999999998754   24788999999999999999999999999999999999999999999999975432211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...    .....++..|+|||.+.+  ..++.++|+||+||++|||++|..||.......... .+....+.        
T Consensus       172 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~--------  236 (292)
T cd06658         172 VPK----RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-RIRDNLPP--------  236 (292)
T ss_pred             ccc----CceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCC--------
Confidence            110    112245678999999865  357889999999999999999999998654432222 11111110        


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                           ........+..+.+++..||..||.+|||+.++++||||+.....
T Consensus       237 ---------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         237 ---------------------RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             ---------------------ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence                                 001122467889999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.4e-38  Score=323.47  Aligned_cols=261  Identities=29%  Similarity=0.507  Sum_probs=209.7

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .....|++.+.||+  |+||.||+|+++.+|+.||+|++.... ...+..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lg~--g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~   89 (307)
T cd06607          12 DPEKLFTDLREIGH--GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT   89 (307)
T ss_pred             CcchhhhhheeecC--CCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence            34567999999999  678899999999999999999986543 344556778899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++|+||+. |++.+++.... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+++.|||.......
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            999999997 67777765433 3588999999999999999999999999999999999999999999999986532211


Q ss_pred             CCccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .        ....++..|+|||++.. ....++.++|||||||++|+|++|..||.................|.      
T Consensus       168 ~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------  233 (307)
T cd06607         168 A--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT------  233 (307)
T ss_pred             C--------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC------
Confidence            1        12234567999998742 12357889999999999999999999998765443333222111111      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                               .....++.++.+++.+||..||++||++.+++.||||....
T Consensus       234 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         234 -------------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             -------------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                                     11223678899999999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-38  Score=322.66  Aligned_cols=284  Identities=21%  Similarity=0.248  Sum_probs=206.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCc---
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATD---   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~---   84 (622)
                      ++|++.+.||+  |+||.||+|.++.+|+.||||++............+.+|+.++++++ ||||+++++++...+.   
T Consensus         1 ~~y~~~~~lg~--g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGE--GTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecc--cCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            47999999999  77889999999999999999998765433334456788999999995 6999999999887665   


Q ss_pred             --EEEEeecCCCCCHHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCceEEcCCcc
Q psy15039         85 --LHLVSPLMGFGSCKDLINAHFN---FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRY  158 (622)
Q Consensus        85 --~~lv~e~~~~g~l~~~l~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-~~~~~i~~~~~  158 (622)
                        .|++|||+++ ++.+++.....   ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+++.|||.
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence              8999999985 78887765321   24789999999999999999999999999999999999998 88999999987


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPH  237 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~  237 (622)
                      ...+......    ......++.|+|||++.+. ..++.++|+||+||++|+|++|..||............... ..|.
T Consensus       158 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  232 (295)
T cd07837         158 GRAFSIPVKS----YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT  232 (295)
T ss_pred             ceecCCCccc----cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            5433221111    0112345679999998653 35788999999999999999999999876544333222211 0111


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                      ...+.    ...........+.+....  .......+++++.+||.+||..||.+||++.+++.||||+
T Consensus       233 ~~~~~----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         233 EQVWP----GVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhCc----chhhccchhhcCcccchh--HHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            00000    000000000000000000  0011234789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-38  Score=320.67  Aligned_cols=257  Identities=29%  Similarity=0.475  Sum_probs=209.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||.||++.++.+++.||+|.+..... +...+.+.+|++++++++||||+++++.+.....++++
T Consensus         1 ~~~~~~~~ig~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGA--GNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcC--CCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            47889999999  7788999999999999999999877543 35556788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +||+++++|.+++.... ..+++..+..++.|++.||+|+|+ .|++||||||+||+++.++.+++.|||..........
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999999987643 357899999999999999999999 9999999999999999999999999987543321111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc----hHHHHHHHHh-CCCCCCCccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP----TTLMLIEKLA-GATPHLLDCT  242 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~----~~~~~~~~~~-~~~p~~~~~~  242 (622)
                      .      ...++..|+|||.+.+.  .++.++||||+||++|+|++|..||....    ........+. +..|.     
T Consensus       157 ~------~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  223 (265)
T cd06605         157 K------TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR-----  223 (265)
T ss_pred             h------cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC-----
Confidence            0      13445679999998653  58899999999999999999999997542    1111222221 11111     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                .....+++++.++|..||..||++||++.+++.||||+..
T Consensus       224 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         224 --------------------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             --------------------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                                      1111278899999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-38  Score=324.30  Aligned_cols=263  Identities=26%  Similarity=0.424  Sum_probs=204.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|+..+.||+  |+||.||++.++.+|+.||||++...... .....+.+|+.++.++. |||||++++++..+...++
T Consensus         4 ~~~~~~~~lg~--G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           4 EDLKDLGEIGR--GAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHhHHHHHhCC--CCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            46778889999  77899999999999999999998765433 44567889999999996 9999999999999999999


Q ss_pred             EeecCCCCCHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         88 VSPLMGFGSCKDLINA---HFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      +|||++ +++.++...   .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+++.|||......
T Consensus        81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            999987 455554322   2224588999999999999999999975 99999999999999999999999998764332


Q ss_pred             CCCccccccCCCCCCCccccChhhhcccc-CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH-hCCCCCCCcc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLDC  241 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~-~~~~p~~~~~  241 (622)
                      ....     .....++..|+|||++.... ..++.++||||+||++|+|++|+.||............+ .+..|.+.  
T Consensus       160 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  232 (288)
T cd06616         160 DSIA-----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS--  232 (288)
T ss_pred             cCCc-----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC--
Confidence            1111     11224567799999986531 357899999999999999999999997654222222221 11111110  


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                ......++.++.+|+++||+.||++|||+.+++.||||+..
T Consensus       233 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         233 --------------------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             --------------------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence                                      00123478899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=333.07  Aligned_cols=286  Identities=24%  Similarity=0.305  Sum_probs=211.2

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      +++.+++++|++.+.||+  |+||.||+|.++.+|+.||+|+++.........+.+.+|+.++++++||||+++++++..
T Consensus        10 ~~~~~~~~~y~~~~~lg~--G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877          10 KTIWEVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHhhccCceEEEEEeee--cCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            456678999999999999  779999999999999999999997654333445667799999999999999999998865


Q ss_pred             C------CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         82 A------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        82 ~------~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                      .      ...+++++++ ++++.+++..   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEec
Confidence            3      3478888876 6788887754   2478999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAG  233 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~  233 (622)
                      ||........       .....++..|+|||++.+. ..++.++||||+||++|+|++|..||........+...  ..+
T Consensus       164 fg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         164 FGLARHTDDE-------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             cccccccccc-------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9976432211       1122446679999998642 35788999999999999999999999765443322221  112


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhh---hccc--cCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQ---TQVL--TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~---~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ..+.  +..   ....    ......++....   ....  .....++++.++|..||+.||++||++.+++.||||.+.
T Consensus       236 ~~~~--~~~---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         236 TPGA--ELL---KKIS----SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             CCCH--HHH---hhcc----cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence            1110  000   0000    000000000000   0000  011358889999999999999999999999999999875


Q ss_pred             cc
Q psy15039        309 KK  310 (622)
Q Consensus       309 ~~  310 (622)
                      ..
T Consensus       307 ~~  308 (345)
T cd07877         307 HD  308 (345)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-38  Score=331.44  Aligned_cols=288  Identities=21%  Similarity=0.274  Sum_probs=212.7

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   83 (622)
                      -.+.++|++.+.||+  |+||.||++.++.+|+.||||++..........+.+.+|+.+|++++||||++++++|.... 
T Consensus        11 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          11 WEVPDRYRDLKQVGS--GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hccccceEEEEEeee--cCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            457889999999999  77889999999999999999998765444444566789999999999999999999987654 


Q ss_pred             -----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         84 -----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        84 -----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                           .+++||||+ ++++.+++..   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence                 358999998 6788888754   3578999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      .......       .....+++.|+|||.+... ..++.++|+||+||++|+|++|..||............+....+..
T Consensus       165 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         165 ARQTDSE-------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             ccccccC-------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            6432211       1122446789999998643 3478899999999999999999999987654433333222111100


Q ss_pred             CccccccccCCCCcCcccccccchhhhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .+.    ...............+......  .......++++.+++.+||+.||++|||+.+++.||||+....
T Consensus       237 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         237 KEF----VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHH----HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            000    0000000000000000000000  0012357888999999999999999999999999999987644

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5e-38  Score=322.56  Aligned_cols=262  Identities=16%  Similarity=0.295  Sum_probs=197.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc----------------cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK----------------VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN   71 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~----------------~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn   71 (622)
                      ..+|++.+.||+  |+||.||+|...                .++..||||.+.... .......+.+|+.+|++++|||
T Consensus         4 ~~~~~~~~~lg~--G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGE--GQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhhCeeeeEecc--cCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence            368999999999  889999999853                245579999987643 3455667889999999999999


Q ss_pred             ceeEEEEEEeCCcEEEEeecCCCCCHHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy15039         72 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN-----------------FGLPELVICHILQDVLNGLEYIHGKGFI  134 (622)
Q Consensus        72 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~-----------------~~l~e~~~~~i~~qi~~aL~ylH~~~Iv  134 (622)
                      ||++++++.+.+..++||||+++|+|.+++.....                 ..+++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            99999999999999999999999999998865321                 1256778889999999999999999999


Q ss_pred             cCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-
Q psy15039        135 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-  213 (622)
Q Consensus       135 HrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-  213 (622)
                      ||||||+|||++.++.+++.|||..........  .........+..|+|||++..+  .++.++|||||||++|+|++ 
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHc
Confidence            999999999999999999999997654322111  0111122335679999998653  58899999999999999986 


Q ss_pred             -CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC
Q psy15039        214 -GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK  292 (622)
Q Consensus       214 -g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  292 (622)
                       +..||........+.. ........                        ........+...+..+.+|+.+||..||++
T Consensus       237 ~~~~p~~~~~~~~~~~~-~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~  291 (304)
T cd05096         237 CKEQPYGELTDEQVIEN-AGEFFRDQ------------------------GRQVYLFRPPPCPQGLYELMLQCWSRDCRE  291 (304)
T ss_pred             cCCCCCCcCCHHHHHHH-HHHHhhhc------------------------cccccccCCCCCCHHHHHHHHHHccCCchh
Confidence             6788876543322211 10000000                        000000112345788999999999999999


Q ss_pred             CcCHHhhhc
Q psy15039        293 RPLACNLLQ  301 (622)
Q Consensus       293 Rps~~~~l~  301 (622)
                      |||+.++.+
T Consensus       292 RPs~~~i~~  300 (304)
T cd05096         292 RPSFSDIHA  300 (304)
T ss_pred             CcCHHHHHH
Confidence            999999843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0669|consensus

Probab=100.00  E-value=7.9e-41  Score=308.19  Aligned_cols=287  Identities=23%  Similarity=0.295  Sum_probs=212.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC----
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA----   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----   82 (622)
                      ..+.|+-...||+  |.||.||+|+++.+|+.||+|++-.+.....-.....||+.+|..|+|+|++.+++.+...    
T Consensus        15 ~~~~yek~~kigq--GtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQ--GTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             cchHHHHHHhcCC--chHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            3456777889999  6688999999999999999998655433333345677999999999999999888765432    


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ..+|+|+.+|+ -+|..++.... ..++-.+++.+|.+++.||.|+|+..|+|||+||+|+||+.+|.+|+.|||.
T Consensus        93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ccccceeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence                24999999998 46777775432 3467788999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCC-
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGAT-  235 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~-  235 (622)
                      ...|+..+....-.-...+.|++|++||.+.+. ..|+++.|||..||++.||.+|.+-|.+...+  ..++..+.|.. 
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            887776543321111123457899999999876 56999999999999999999998888765543  34455666643 


Q ss_pred             CCCCccccccccCCCCcCcccccccch-----hhhhccc----cCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYIS-----EQQTQVL----TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                      |...+..          ..-.+++.|.     +...+..    .+---.+++.+|+..+|..||.+|+.+++++.|.||.
T Consensus       250 kevWP~~----------d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  250 KEVWPNV----------DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             cccCCCc----------ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            2211110          0001111110     0000000    0111267899999999999999999999999999996


Q ss_pred             cc
Q psy15039        307 QT  308 (622)
Q Consensus       307 ~~  308 (622)
                      ..
T Consensus       320 kd  321 (376)
T KOG0669|consen  320 KD  321 (376)
T ss_pred             cC
Confidence            64

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-38  Score=330.26  Aligned_cols=285  Identities=24%  Similarity=0.290  Sum_probs=211.9

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC---
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA---   82 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~---   82 (622)
                      ++...|++.+.||+  |+||.||+|+++.+|+.||||.+............+.+|+.+|+.++||||+++++++...   
T Consensus         2 ~~~~~y~~~~~lg~--G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           2 EVDTKYVPIKPIGR--GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             ccccceeEEEEecc--CCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence            56789999999999  7789999999999999999999876543344455677899999999999999999987654   


Q ss_pred             --CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         83 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        83 --~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                        ...++++||+. +++.+++...  ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+++.|||...
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          80 AFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             ccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence              34899999997 6888887653  358899999999999999999999999999999999999999999999999765


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH--HHHHHhCCCC-C
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM--LIEKLAGATP-H  237 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~--~~~~~~~~~p-~  237 (622)
                      .......    ......++..|+|||.+... ..++.++|||||||++|+|++|+.||.+.+....  .+....+..+ .
T Consensus       157 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         157 TTSEKGD----FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE  231 (337)
T ss_pred             ccCCCcc----cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            4322111    11123446789999998643 3478899999999999999999999976543221  1222222211 0


Q ss_pred             CCccccccccCCCCcCcccccccch---hhhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYIS---EQQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~---~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ...   ..       .......++.   .....  ......+++++.+++.+||+.||.+|||+.++++||||.....
T Consensus       232 ~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         232 DLG---FI-------RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             Hhh---hc-------CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            000   00       0000000000   00000  0112357899999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4721|consensus

Probab=100.00  E-value=6.5e-40  Score=332.12  Aligned_cols=237  Identities=23%  Similarity=0.418  Sum_probs=192.2

Q ss_pred             EeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         14 CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        14 ~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      +++||.|+  -|.||+|+-+  ++.||||+++.-  +       .-+|+-|++|+|||||.|.|++....-+++|||||.
T Consensus       129 LeWlGSGa--QGAVF~Grl~--netVAVKKV~el--k-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGA--QGAVFLGRLH--NETVAVKKVREL--K-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCc--ccceeeeecc--CceehhHHHhhh--h-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            56788855  5699999976  789999997331  1       137888999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccC
Q psy15039         94 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  173 (622)
Q Consensus        94 ~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~  173 (622)
                      +|.|..+|+...  .+....+..|..+|+.|++|||.+.|||||||.-||||+.+..+||+|||.+........     .
T Consensus       196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-----k  268 (904)
T KOG4721|consen  196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-----K  268 (904)
T ss_pred             cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh-----h
Confidence            999999998743  466778889999999999999999999999999999999999999999997654433222     2


Q ss_pred             CCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       174 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      .+.++|..|||||++..  +.-+.|+|||||||+||||+||..||...+....    |-|.              +.   
T Consensus       269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGV--------------Gs---  325 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGV--------------GS---  325 (904)
T ss_pred             hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchhee----EEec--------------cC---
Confidence            24578889999999975  4578999999999999999999999986543221    1110              00   


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                                .....+.+....+.|+-|++.||+..|..||+..++|.|-
T Consensus       326 ----------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  326 ----------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             ----------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence                      0011233456788999999999999999999999999983

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.7e-39  Score=323.63  Aligned_cols=259  Identities=29%  Similarity=0.527  Sum_probs=208.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..-|++.+.||+  |+||.||+|.+..+++.||+|.++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~y~~~~~l~~--g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           3 EELFTKLERIGK--GSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHHhcC--CCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            346888899999  7789999999999999999999875532 3455678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++++++.+++..   ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+++.|||..........
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999999999988854   3478999999999999999999999999999999999999999999999997644332111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    .....++..|+|||.+.+.  .++.++|+|||||++|||++|+.||..............+..|           
T Consensus       157 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------  219 (277)
T cd06642         157 K----RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP-----------  219 (277)
T ss_pred             h----hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC-----------
Confidence            1    1112345679999998653  5788999999999999999999999754332211111000000           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                           .....++.++.+++.+||+.+|++||++.++++||||.....
T Consensus       220 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         220 ---------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             ---------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence                                 011245788999999999999999999999999999976543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.9e-38  Score=319.07  Aligned_cols=255  Identities=18%  Similarity=0.307  Sum_probs=203.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCC-----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTN-----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ++|++.+.||+  |+||.||+|....++     ..||+|.+.... .......+.+|+.+|++++||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGE--GAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccC--ccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            47999999999  778899999987655     789999987543 3445567889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  149 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~  149 (622)
                      ..+++|||+++|+|.+++.....              ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            99999999999999999875421              3477888999999999999999999999999999999999999


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI  228 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~  228 (622)
                      .+++.|||..........  .........++.|+|||.+..+  .++.++|||||||++|||++ |..||.+..... ..
T Consensus       162 ~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-~~  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VI  236 (283)
T ss_pred             cEEECCCcceeecccccc--ccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HH
Confidence            999999997643322111  0111122345679999998653  57899999999999999997 999998654432 22


Q ss_pred             HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       229 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ..+....+                               ......+++++.+|+..||..||.+||++.+++++
T Consensus       237 ~~i~~~~~-------------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQL-------------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCc-------------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            22221110                               01123568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.3e-38  Score=315.91  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=204.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||+|+++.+++.||||+++... ........+.+|+.+|+.++||||+++++++.+....++
T Consensus         2 ~~~~i~~~l~~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGR--GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeecc--CCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            58999999999  778899999999999999999987543 344555678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         88 VSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||+++|+|.+++....  ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+++.|||........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            999999999999886432  234789999999999999999999999999999999999999999999999875433221


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-HHHHHHHhC-CCCCCCcccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKLAG-ATPHLLDCTT  243 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-~~~~~~~~~-~~p~~~~~~~  243 (622)
                      ...    .....+++.|+|||.+.+.  .++.++|+||+||++|+|++|..||...... ......+.. ..|.      
T Consensus       160 ~~~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         160 TTA----AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             hHH----HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            111    1122456679999998653  4788999999999999999999999754322 222222211 1110      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               .....++..+.+++.+||..||++||++.++++.
T Consensus       228 -------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 -------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                                     1122467889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.7e-38  Score=315.50  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=200.5

Q ss_pred             EEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         13 ICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        13 ~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      ....||+  |+||.||+|+++.+++.||+|.+....  ....+.+.+|+.++++++||||+++++++...+..++++||+
T Consensus        12 ~~~~lg~--g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          12 ERVVLGK--GTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             ceEEEec--CCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            4467999  778899999999999999999986543  345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCceEEcCCccccccCCCCccc
Q psy15039         93 GFGSCKDLINAHFNFGL--PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l--~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ++++|.+++..... .+  ++..+..++.||+.||+|||++||+||||||+||+++. ++.+++.|||........... 
T Consensus        88 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-  165 (268)
T cd06624          88 PGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-  165 (268)
T ss_pred             CCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-
Confidence            99999999876432 24  78889999999999999999999999999999999976 678999999875433211111 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCcccccccc
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDCTTYYVD  247 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~  247 (622)
                         .....++..|+|||++..+...++.++|+||+||++|+|++|..||.............  ....|           
T Consensus       166 ---~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  231 (268)
T cd06624         166 ---TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP-----------  231 (268)
T ss_pred             ---cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC-----------
Confidence               11123466799999987654457889999999999999999999997543221111110  00000           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                           ..+..+++++.+++.+||..+|++||++.+++.||||
T Consensus       232 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         232 ---------------------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ---------------------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                                 0123467889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4279|consensus

Probab=100.00  E-value=3e-40  Score=340.83  Aligned_cols=240  Identities=24%  Similarity=0.394  Sum_probs=194.9

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCCC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG  445 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g  445 (622)
                      +||+  |.||+||-|++..|...+|||.|...  .+...+-+..||.+.++|+|.|||+|+|++...+.+.++||-.+||
T Consensus       582 VLGK--GTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGK--GTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             Eeec--CceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            6899  77999999999999999999998754  2344567899999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCceEEcCcccccccCCCCCceecc
Q psy15039        446 SCKDLINAHFNFGL--PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSPTKKKVHLF  522 (622)
Q Consensus       446 ~l~~~l~~~~~~~~--~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~~~  522 (622)
                      +|.++|+..++ ++  .|..+..|.+||++||.|||++.|||||||.+|||++. .|.+||+|||....+    ......
T Consensus       658 SLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL----AginP~  732 (1226)
T KOG4279|consen  658 SLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL----AGINPC  732 (1226)
T ss_pred             cHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh----ccCCcc
Confidence            99999988654 44  78889999999999999999999999999999999965 789999999854222    112233


Q ss_pred             CCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH--HcCCCCCCCCCCccccc-CC
Q psy15039        523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATPHLLDCTTYYVD-TG  599 (622)
Q Consensus       523 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~-~~  599 (622)
                      ..+.+||+.|||||++.++..+|+.++|||||||++.||+||+|||.+......-+-+  +....|+++...+.-+. ..
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence            3456789999999999998899999999999999999999999999988766544333  45566776663322211 13


Q ss_pred             CCcCcccccchhhhh
Q psy15039        600 QDDGEENACSYISEQ  614 (622)
Q Consensus       600 ~~~~~~~~~~~~~~~  614 (622)
                      .+|.++++|.+.|-+
T Consensus       813 lrcFepd~~~R~sA~  827 (1226)
T KOG4279|consen  813 LRCFEPDPCDRPSAK  827 (1226)
T ss_pred             HHHcCCCcccCccHH
Confidence            455666666666544

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-37  Score=313.37  Aligned_cols=254  Identities=18%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ...+|++.+.||+  |+||.||+|..+.+++.||+|.+..+.   .....+.+|+.+|++++||||+++++++.....++
T Consensus         4 ~~~~~~~~~~ig~--g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           4 ERTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             chHHeEEeeecCC--cccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            3457999999999  778899999999999999999986532   33456789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ++|||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.++.+++.|||.........
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            99999999999999876544458899999999999999999999999999999999999999999999999764432211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..   ......++..|+|||.+.+  ..++.++|||||||++|||++ |..||....... ....+....+         
T Consensus       159 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~---------  223 (263)
T cd05052         159 YT---AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYR---------  223 (263)
T ss_pred             ee---ccCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCC---------
Confidence            10   1112233457999999865  357889999999999999998 999997654332 2222211100         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                            ......++.++.+++.+||+.||++||++.++++.
T Consensus       224 ----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         224 ----------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence                                  01123467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-37  Score=316.64  Aligned_cols=265  Identities=24%  Similarity=0.394  Sum_probs=207.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--CcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~   86 (622)
                      ++|+..+.||+  |++|.||++.++.+++.||+|.+..... ......+.+|+++|++++||||++++++|...  ..++
T Consensus         1 ~~~~~~~~lg~--g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGE--GAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEecc--CCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            47899999999  7788999999999999999999876533 34456688999999999999999999998654  4689


Q ss_pred             EEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         87 LVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +||||+++++|.+++....  ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+++.|||.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999998875432  23478999999999999999999999999999999999999999999999997543321


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc----hHHHHHHHHhC-CCCCCC
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP----TTLMLIEKLAG-ATPHLL  239 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~----~~~~~~~~~~~-~~p~~~  239 (622)
                      ...      ....++..|+|||.+.+  ..++.++||||+||++|+|++|..||....    ........+.. ..|.+.
T Consensus       158 ~~~------~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd06621         158 SLA------GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK  229 (287)
T ss_pred             ccc------ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence            111      11234567999999865  357889999999999999999999997542    11122222211 111000


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                                ........+++.+.+++.+||+.||++|||+.|++.||||++...
T Consensus       230 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         230 --------------------------DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             --------------------------cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence                                      000111346788999999999999999999999999999966443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0032|consensus

Probab=100.00  E-value=1.2e-38  Score=330.17  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=210.9

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCC-CCccceeEEEEEeC
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLR-HPNIICYISSFLDA  432 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~  432 (622)
                      ......|++.+.||+  |.||.||+|+++.||+.+|+|.+.+..... .....+.+|+.+|++|. |||||.++++|.+.
T Consensus        31 ~~~~~~Y~l~~~lG~--G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGR--GQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCC--CCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            446678999999999  789999999999999999999998765533 24568899999999998 99999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CceEEcCccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN----GKACLSGLRY  508 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~----~~~~~~~~~~  508 (622)
                      ...++|||++.||+|.+.+...   ..++..+..+++|++.|++|||+.||+||||||+|+|+...    +.+++.|||.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            9999999999999999998775   27899999999999999999999999999999999999654    4799999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                      +..... ..    .....+||+.|+|||++.+  ..|+..+||||+||++|.|++|.+||.+.+..........+..   
T Consensus       186 a~~~~~-~~----~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---  255 (382)
T KOG0032|consen  186 AKFIKP-GE----RLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---  255 (382)
T ss_pred             ceEccC-Cc----eEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---
Confidence            765443 11    1234688999999999975  5799999999999999999999999999887776666666653   


Q ss_pred             CCCCcccccCCCCcCcccccchhhhhhhhhcc
Q psy15039        589 LDCTTYYVDTGQDDGEENACSYISEQQTQVLT  620 (622)
Q Consensus       589 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (622)
                       +....+|+......+..+...+..++..|+|
T Consensus       256 -~f~~~~w~~is~~akd~i~~ll~~dp~~R~t  286 (382)
T KOG0032|consen  256 -DFTSEPWDDISESAKDFIRKLLEFDPRKRLT  286 (382)
T ss_pred             -CCCCCCccccCHHHHHHHHHhcccCcccCCC
Confidence             5555566666666777777777777777766

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.1e-38  Score=319.02  Aligned_cols=282  Identities=22%  Similarity=0.294  Sum_probs=207.0

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |++|.||+|+++.+|+.||||++..... +.....+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGE--GTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeecc--CCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            6999999999  7788999999999999999999876532 223345678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         90 PLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||++ +++.+++.... ...+++..+..++.|++.||+|||++||+||||||+||++++++.+++.|||....+......
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          78 EYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             ecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            9998 47888776543 234789999999999999999999999999999999999999999999999876433221110


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~  247 (622)
                          .....++..|+|||++.+. ..++.++|+||+||++|+|++|+.||............... ..|....+. ....
T Consensus       157 ----~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  230 (284)
T cd07836         157 ----FSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQ  230 (284)
T ss_pred             ----cccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH-HHhc
Confidence                1122346679999998654 35788999999999999999999999876544333322211 111100000 0000


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ...  .....+.... .... ......++++.+++..||+.||.+||++.++++||||
T Consensus       231 ~~~--~~~~~~~~~~-~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         231 LPE--YKPTFPRYPP-QDLQ-QLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             Cch--hcccccCCCh-HHHH-HHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000  0000000000 0000 0112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0584|consensus

Probab=100.00  E-value=3.9e-39  Score=332.94  Aligned_cols=255  Identities=23%  Similarity=0.439  Sum_probs=215.1

Q ss_pred             eEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc--EEE
Q psy15039         12 KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHL   87 (622)
Q Consensus        12 ~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~--~~l   87 (622)
                      +...+||+|+  |-+||+|.+..+|..||.-.++.+..  ++...+.+..|+.+|+.|+|||||++|.+|.+...  ..+
T Consensus        43 k~~evLGrGa--fKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   43 KFDEVLGRGA--FKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             ehhhhccccc--ceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            3466799955  66999999999999999988765543  46667899999999999999999999999998766  889


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCCEEEcC-CCceEEcCCccccccCC
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK--GFIHRAVKASHILISH-NGKACLSGLRYMCPFSP  164 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--~IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~~~~  164 (622)
                      |+|++..|+|...+++..  .++...++.|++||++||.|||++  .|||||||+.||+|+. .|.+||.|+|++.....
T Consensus       121 iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999998864  478899999999999999999998  5999999999999986 48999999998754322


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~~  243 (622)
                      ..      ..+..||+.|||||+...   .|+..+||||||+.+.||+|+..||..+....++++++.. ..|.-+    
T Consensus       199 s~------aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl----  265 (632)
T KOG0584|consen  199 SH------AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL----  265 (632)
T ss_pred             cc------cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh----
Confidence            21      223578999999999974   6999999999999999999999999999988888888644 333110    


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                                . .--.+++++||.+||.. .++|||+.|+|.||||.....+
T Consensus       266 --------------------------~-kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g~  305 (632)
T KOG0584|consen  266 --------------------------S-KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGGI  305 (632)
T ss_pred             --------------------------h-ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccccc
Confidence                                      0 11267899999999999 9999999999999999886543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-37  Score=310.42  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=213.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||++.+..+++.||+|++......+...+.+.+|++++++++|||++++++.+......++++
T Consensus         1 ~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGK--GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeecc--CCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            6999999999  78899999999999999999999877666667778889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         90 PLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |++++++|.+.+....  ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+++.||+..........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            9999999999987643  24588999999999999999999999999999999999999999999999987654432211


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                          ......+++.|+|||.+..  ..++.++|+||+|+++++|++|..||.................+.          
T Consensus       159 ----~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  222 (258)
T cd08215         159 ----LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP----------  222 (258)
T ss_pred             ----eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC----------
Confidence                1112345667999999865  347889999999999999999999997655433322222221111          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                            .+..++.++.+++.+||..||++||++.++++||||
T Consensus       223 ----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         223 ----------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                                  112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-37  Score=311.63  Aligned_cols=254  Identities=29%  Similarity=0.473  Sum_probs=206.9

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +|+..+.||+  |+||+||+|..+.+++.||+|.+.....   .++..+.+.+|+.+++.++||||+++++++.++..++
T Consensus         1 ~~~~~~~ig~--g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   78 (258)
T cd06632           1 RWRKGELLGS--GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY   78 (258)
T ss_pred             Cccccceeee--cCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEE
Confidence            4788899999  7788999999999999999999875432   2445677889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +++||+++++|.+++....  .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+++.|||.........
T Consensus        79 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          79 IFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999999987642  47899999999999999999999999999999999999999999999998754332211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh-CCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA-GATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~-~~~p~~~~~~~~~  245 (622)
                           ......++..|+|||.+.... .++.++|+||+||++|+|++|+.||.............. ...|         
T Consensus       157 -----~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  221 (258)
T cd06632         157 -----FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------  221 (258)
T ss_pred             -----cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC---------
Confidence                 011234566799999986532 378899999999999999999999976553332222211 0000         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                             ..+..+++++.+++.+||+.||++||++.+++.|||+
T Consensus       222 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         222 -----------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -----------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                                   0123467889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=325.69  Aligned_cols=289  Identities=22%  Similarity=0.297  Sum_probs=203.7

Q ss_pred             CceEEeecccccCCceeEEEEEEcc--CCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--Cc
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKV--TNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TD   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~--t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~   84 (622)
                      .|++.+.||+  |+||.||+|+++.  +++.||||.+..... .+...+.+.+|+.++++++||||+++++++.+.  ..
T Consensus         1 ~y~~~~~ig~--g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGR--GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEecc--CCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            4899999999  7789999999998  899999999877431 122345677899999999999999999999988  78


Q ss_pred             EEEEeecCCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC----CCceEEcCCc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHF---NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH----NGKACLSGLR  157 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~----~~~~~i~~~~  157 (622)
                      +++||||+++ ++.+++....   ...+++..+..++.||+.||+|||+++|+||||||+|||++.    ++.+++.|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999985 6666665432   125789999999999999999999999999999999999999    8899999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH------------
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL------------  225 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~------------  225 (622)
                      ........... ........++..|+|||++.+. ..++.++|||||||++|+|++|.+||.......            
T Consensus       158 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         158 LARLFNAPLKP-LADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             cccccCCCccc-ccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            76543322211 1111223456789999998653 357889999999999999999999997543221            


Q ss_pred             HHHHHHhCCCCCCCccccccccCCC---CcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        226 MLIEKLAGATPHLLDCTTYYVDTGQ---DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       226 ~~~~~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .+...+....+..............   .........  .............+.++.+++.+||+.||++|||+.++++|
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS--NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCC--ccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0111111110000000000000000   000000000  00000000112568899999999999999999999999999


Q ss_pred             ccc
Q psy15039        303 AFF  305 (622)
Q Consensus       303 ~~~  305 (622)
                      |||
T Consensus       314 ~~f  316 (316)
T cd07842         314 PYF  316 (316)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.2e-38  Score=350.74  Aligned_cols=260  Identities=20%  Similarity=0.276  Sum_probs=202.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+|++.+.||+  |+||.||+|+++.+|+.||||++..+.. .+...+.+.+|++++++++|||||++++++.+.+..++
T Consensus         2 grYeIi~~LGk--GgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGK--GGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEec--CCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            58999999999  8899999999999999999999976432 23445678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         88 VSPLMGFGSCKDLINAHFN---------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~---------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                      +|||+++|+|.+++.....         ..++...+..++.||++||+|||++||+||||||+|||++.+|.+++.|||.
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            9999999999999865321         1245567788999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCc--------------cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH
Q psy15039        159 MCPFSPTKK--------------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  224 (622)
Q Consensus       159 ~~~~~~~~~--------------~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~  224 (622)
                      .........              .....+....+|+.|+|||++.+.  .++.++||||+||++|||++|..||......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            654311000              000111234578899999998753  5789999999999999999999999764332


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .......... |                             ........+++.+.+++.+||+.||++||+..+.+.+
T Consensus       238 ki~~~~~i~~-P-----------------------------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILS-P-----------------------------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccC-h-----------------------------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2111110000 0                             0011123567889999999999999999887765544

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-38  Score=331.16  Aligned_cols=290  Identities=21%  Similarity=0.284  Sum_probs=215.9

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      |++.++.++|++.+.||+  |++|.||+|++..+++.||||++..........+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~y~~~~~ig~--g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851           8 KTVWEVPDRYQNLSPVGS--GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             cceecccCceEEEEEecc--CCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            456788999999999999  778899999999999999999987654444455667899999999999999999988876


Q ss_pred             CCc------EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         82 ATD------LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        82 ~~~------~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                      .+.      +++|+||+ +++|.+++..   ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+++.|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcc
Confidence            654      89999998 4688888865   3588999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--C
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--G  233 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~  233 (622)
                      ||........       .....++..|+|||++.+. ..++.++||||+||++|+|++|+.||........+...+.  +
T Consensus       162 fg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~  233 (343)
T cd07851         162 FGLARHTDDE-------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG  233 (343)
T ss_pred             cccccccccc-------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence            9976543221       1122446679999998643 3578899999999999999999999986654433222221  1


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhcc--ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQV--LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                      ..+.  ...   .... .+........+.......  .....+++++.+++.+||..||++|||+.++++||||.+....
T Consensus       234 ~~~~--~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         234 TPDE--ELL---QKIS-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             CCCH--HHH---hhcc-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            1110  000   0000 000000000000000000  0012358899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7e-38  Score=323.30  Aligned_cols=254  Identities=18%  Similarity=0.345  Sum_probs=200.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcE----EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL----IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~----vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..+|++.+.||+  |+||.||+|+++.+|+.    ||||.++... .....+.+.+|+.+|+.++||||+++++++... 
T Consensus         6 ~~~f~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           6 ETEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhhceeeeeeec--CCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            457999999999  77899999998777665    8999986532 344556788999999999999999999998765 


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++++||+.+|++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||......
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            5788999999999999987643 347888899999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......  ...+...+..|+|||.+..  ..++.++|||||||++|||++ |..||.+.+.... ...+....       
T Consensus       161 ~~~~~~--~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~-------  228 (316)
T cd05108         161 ADEKEY--HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGE-------  228 (316)
T ss_pred             CCCcce--eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCC-------
Confidence            222111  1112233567999999865  358899999999999999997 9999976543321 22211100       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ..+.....+.++.+++..||..||++||++.+++.+
T Consensus       229 ------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 ------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    011123457789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0690|consensus

Probab=100.00  E-value=1.1e-39  Score=310.45  Aligned_cols=259  Identities=20%  Similarity=0.302  Sum_probs=215.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+|+.+++||+  |.||+|-+++.|.||+.||||+++++.. .+++.-...-|-.+|+..+||.+..+.-.|...+.+++
T Consensus       168 ~dFdfLKvLGk--GTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  168 EDFDFLKVLGK--GTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             chhhHHHHhcC--CccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            37888999999  6688999999999999999999988653 45556667789999999999999999989999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||..+|+|.-.|.+.  ..++|...+.+-.+|+.||.|||+++||.||||.+|+|+|.+|.+|+.|||+-..- ..-.
T Consensus       246 VMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc-cccc
Confidence            99999999998777653  34789999999999999999999999999999999999999999999999964221 1111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                         ....+.++|+.|+|||++..+  .|+.++|.|.+||++|||++|+.||.+.+.....-.++...             
T Consensus       323 ---~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-------------  384 (516)
T KOG0690|consen  323 ---DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-------------  384 (516)
T ss_pred             ---ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-------------
Confidence               112345789999999999875  58999999999999999999999998776543322222111             


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                          .-.++.+|++++.|++.+|.+||.+|..     |.++++|+||....+
T Consensus       385 --------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  385 --------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             --------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence                                1123568999999999999999999985     678999999987654

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-38  Score=320.65  Aligned_cols=262  Identities=29%  Similarity=0.517  Sum_probs=210.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      +..++|++.+.||+  |+||.||++..+.+++.||+|.++....  ...+.+.+|+.++++++||||+++++.+...+..
T Consensus        16 ~~~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          16 DPKKKYTRFEKIGQ--GASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             CchhhceeeeEecC--CCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            34468999999999  7788999999999999999999865432  2345678999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|+||++++++.+++...   .+++..+..++.|++.||.|||++|++||||||+||+++.++.+++.|||........
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            9999999999999988653   4678889999999999999999999999999999999999999999999976443322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...    .....+++.|+|||.+..+  .++.++|+||+||++|+|++|..||..............+..|         
T Consensus       169 ~~~----~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------  233 (293)
T cd06647         169 QSK----RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP---------  233 (293)
T ss_pred             ccc----cccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCC---------
Confidence            111    1122455679999998653  5788999999999999999999999765432221111111000         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                           .......++..+.+++.+||..||++||++.+++.|+||+..+.
T Consensus       234 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         234 ---------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             ---------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                                 01112345778999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=311.26  Aligned_cols=259  Identities=26%  Similarity=0.418  Sum_probs=205.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      +.+|++.+.||+  |+||.||+|+++.+|+.||+|.+....   ........+.+|+.++++++||||+++++++.+.  
T Consensus         1 ~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   78 (264)
T cd06653           1 PVNWRLGKLLGR--GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE   78 (264)
T ss_pred             CCceeeeeeEcc--CCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence            468999999999  778899999999999999999976432   2334556788999999999999999999998775  


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+++++||+++++|.+.+....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            45889999999999999987542  4788999999999999999999999999999999999999999999999976543


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ....... .......++..|+|||.+.+  ..++.++|+|||||++|+|++|+.||.................+      
T Consensus       157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  227 (264)
T cd06653         157 QTICMSG-TGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK------  227 (264)
T ss_pred             ccccccC-ccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC------
Confidence            2110000 00011234667999999875  34788999999999999999999999865444433332211110      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                               ...+..+++.+.++++.||. +|.+||++.+++.|||.
T Consensus       228 -------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 -------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             -------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                     01134578899999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.3e-38  Score=327.38  Aligned_cols=256  Identities=20%  Similarity=0.311  Sum_probs=198.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~   82 (622)
                      ++|++.++||+  |+||.||+|...     .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus         7 ~~~~i~~~lG~--G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           7 DRLKLGKPLGR--GAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHhhhhccccc--CcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            58999999999  778999999743     456899999987543 344556788999999999 899999999987654


Q ss_pred             -CcEEEEeecCCCCCHHHHHHhhcC-------------------------------------------------------
Q psy15039         83 -TDLHLVSPLMGFGSCKDLINAHFN-------------------------------------------------------  106 (622)
Q Consensus        83 -~~~~lv~e~~~~g~l~~~l~~~~~-------------------------------------------------------  106 (622)
                       ..++++|||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             568999999999999999864321                                                       


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccc
Q psy15039        107 ----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW  182 (622)
Q Consensus       107 ----~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  182 (622)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||............  .......+..|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--~~~~~~~~~~y  241 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGDARLPLKW  241 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh--hccCCCCCccc
Confidence                147888899999999999999999999999999999999999999999999765432211111  11122334579


Q ss_pred             cChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccc
Q psy15039        183 LSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI  261 (622)
Q Consensus       183 ~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i  261 (622)
                      +|||++.+  ..++.++||||+||++|||++ |..||............+.....                         
T Consensus       242 ~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------------  294 (337)
T cd05054         242 MAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-------------------------  294 (337)
T ss_pred             cCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-------------------------
Confidence            99999875  358899999999999999997 99999754322222222211100                         


Q ss_pred             hhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        262 SEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                            .......++++.+++.+||+.+|++||++.++++|
T Consensus       295 ------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 ------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  01123467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-37  Score=312.12  Aligned_cols=258  Identities=29%  Similarity=0.502  Sum_probs=211.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|++.+.||+  |++|.||+|+++.+|+.||||++...... ...+.+.+|+..+++++||||+++++++.....++++
T Consensus         1 ~~~~~~~~i~~--g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQ--GSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             Ccceeeeeeee--cCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            47999999999  77889999999999999999999775432 4567788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||+++++|.+++...  ..+++..+..++.|+++||+|||+ ++++||||+|+||+++.++.+++.||+..........
T Consensus        78 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          78 LEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999999764  358899999999999999999999 9999999999999999999999999987654322211


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc--hHHHHHHHHhCCCCCCCcccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~--~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..    ....++..|+|||.+...  .++.++|+||||+++|+|++|+.||....  ........+.....         
T Consensus       156 ~~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  220 (264)
T cd06623         156 QC----NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---------  220 (264)
T ss_pred             cc----cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---------
Confidence            11    122345679999998653  57889999999999999999999997653  22222222221100         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCC-CcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRK-FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                           .. .... ++..+.+++..||..+|++||++.++++|||++..
T Consensus       221 ---------------------~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         221 ---------------------PS-LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             ---------------------CC-CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence                                 00 1122 78899999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-38  Score=318.53  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=207.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||+||++.+..+|+.||+|++.... .....+.+.+|+++++.++||||+++++++.....+++|
T Consensus         5 ~~~~~~~~ig~--g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGA--GNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCC--CCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            68999999999  778999999999999999999986543 234456788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+++.|||......... 
T Consensus        82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          82 MEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            9999999999988663  347899999999999999999997 599999999999999999999999999653321111 


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH----------HHHHHHhCCCCC
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL----------MLIEKLAGATPH  237 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~----------~~~~~~~~~~p~  237 (622)
                           .....++..|+|||++...  .++.++|+||+||++|+|++|..||.......          .....+...   
T Consensus       159 -----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  228 (284)
T cd06620         159 -----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE---  228 (284)
T ss_pred             -----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---
Confidence                 1123456789999998653  57889999999999999999999997543210          001111000   


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                 ..+.+....++.++.+|+.+||+.||++||++.++++|+||.+.
T Consensus       229 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 ---------------------------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             ---------------------------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                                       00011122367789999999999999999999999999999664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-38  Score=319.63  Aligned_cols=281  Identities=22%  Similarity=0.312  Sum_probs=208.1

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEee
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP   90 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e   90 (622)
                      |++.+.||+  |++|.||+|.++.+|+.||||++..+.........+.+|+.++++++||||+++++++.+....++++|
T Consensus         1 y~~~~~l~~--g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGE--GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecC--CCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            788999999  778899999999999999999997664444444567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccc
Q psy15039         91 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH  170 (622)
Q Consensus        91 ~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~  170 (622)
                      |++ +++.+++.......+++..+..++.|++.||+|||+++++||||+|+||+++.++.+++.||+...........  
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--  155 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--  155 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--
Confidence            996 68888887654335889999999999999999999999999999999999999999999999876433221111  


Q ss_pred             ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCCccccccccC
Q psy15039        171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLLDCTTYYVDT  248 (622)
Q Consensus       171 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~  248 (622)
                        .....++..|+|||++.+. ..++.++||||+||++|+|++|+.||..............  +.++......  ....
T Consensus       156 --~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  230 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG--VTSL  230 (283)
T ss_pred             --cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh--hhhc
Confidence              0112335679999988653 3468899999999999999999999986654333322221  1111000000  0000


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                       . ........+...  ........++.++.+++.+||+.||.+||++.+++.||||
T Consensus       231 -~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         231 -P-DYKPTFPKWARQ--DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             -h-hhhhhccccccc--chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence             0 000000000000  0001124578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.9e-38  Score=316.25  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=196.5

Q ss_pred             ecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHH---HHhhCCCCcceeEEEEEEeCCcEEEEeec
Q psy15039         16 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIV---CMRHLRHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        16 ~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~-~~~~~~~Ei~---il~~l~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      +||+  |+||.||+++++.+|+.||||.+........ ....+.+|..   ++...+||||+++++++...+..++||||
T Consensus         1 ~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             Cccc--CCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            4788  7799999999999999999999876543222 1222334443   44445899999999999999999999999


Q ss_pred             CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccc
Q psy15039         92 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        92 ~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      +++|+|.+.+...  ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.........     
T Consensus        79 ~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-----  151 (279)
T cd05633          79 MNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----  151 (279)
T ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-----
Confidence            9999999888654  348999999999999999999999999999999999999999999999999765443211     


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-HHHHHHHhCCCCCCCccccccccCCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKLAGATPHLLDCTTYYVDTGQ  250 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~  250 (622)
                       .....++..|+|||.+..+ ..++.++|+||+||++|+|++|..||...... ...........               
T Consensus       152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------  214 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV---------------  214 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC---------------
Confidence             1123467789999998643 45789999999999999999999999753221 11111110000               


Q ss_pred             CcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        251 DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       251 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                      ....+..+++++.+++..||..||.+||     ++.++++||||+....
T Consensus       215 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         215 ----------------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             ----------------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence                            0011234788999999999999999999     6999999999987553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=314.02  Aligned_cols=254  Identities=21%  Similarity=0.374  Sum_probs=199.9

Q ss_pred             ceEEeecccccCCceeEEEEEEcc---CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc---
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD---   84 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~---   84 (622)
                      |++++.||+  |+||.||+|....   ++..||||++..+.........+.+|+.+|+.++||||+++++++.....   
T Consensus         1 ~~~~~~lg~--G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGE--GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCc--CCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            678999999  7789999999765   44889999998766666667788999999999999999999998866544   


Q ss_pred             ---EEEEeecCCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         85 ---LHLVSPLMGFGSCKDLINAHF----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        85 ---~~lv~e~~~~g~l~~~l~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                         .++++||+++|++.+++....    ...+++..+..++.|++.||+|||+++|+||||||+||++++++.+++.|||
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence               799999999999998885432    1247899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      ...........  ........+..|+|||.+..  ..++.++|||||||++|||++ |..||.+............+..+
T Consensus       159 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  234 (273)
T cd05035         159 LSKKIYSGDYY--RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL  234 (273)
T ss_pred             ceeeccccccc--cccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            76433221110  00111123457999999864  457899999999999999998 89999765443322222211111


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                      ..+..+++++.+++.+||+.||++||++.+++++
T Consensus       235 --------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 --------------------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --------------------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                            0123467899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-37  Score=315.57  Aligned_cols=263  Identities=16%  Similarity=0.283  Sum_probs=202.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      ..++|++.+.||+  |+||.||+|+++.     ++..||+|.++... .......+.+|+.+|+.++||||+++++++..
T Consensus         4 ~~~~~~i~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQ--GSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecC--CCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4578999999999  7788999998653     35689999986543 23334457789999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEE
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFN--------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                      ....++||||+++|+|.+++.....        ...+...+..++.|++.||.|||+++|+||||||+|||++.++.+++
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999999975321        12356678899999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHh
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~  232 (622)
                      .|||............  ......++..|+|||.+..  ..++.++|+|||||++|||++ |..||..............
T Consensus       161 ~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         161 GDFGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             CcCCcccccccccccc--ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9998754322111100  0111123456999999875  357899999999999999998 7899976544332222222


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc------Ccccc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ------HAFFK  306 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~------h~~~~  306 (622)
                      +..+.                                .....++++.+++..||+.||++||++.++++      ||||+
T Consensus       237 ~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         237 GGYLD--------------------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             CCCCC--------------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence            21110                                11234678999999999999999999999987      88886


Q ss_pred             cc
Q psy15039        307 QT  308 (622)
Q Consensus       307 ~~  308 (622)
                      ..
T Consensus       285 ~~  286 (288)
T cd05061         285 EV  286 (288)
T ss_pred             CC
Confidence            53

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0611|consensus

Probab=100.00  E-value=2.2e-39  Score=316.40  Aligned_cols=216  Identities=24%  Similarity=0.391  Sum_probs=187.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..-.|++.+.||+  |.||.|-+|+....|+.||||.|.++...++ ++-.+.|||+||+.|+||||+++|.+|...+.+
T Consensus        51 lkHRyE~~etLGk--GTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   51 LKHRYEITETLGK--GTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhhHHHHHHHhcC--CcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            3456899999999  7799999999999999999999998876554 456789999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      .+||||..+|+|+|++.+.+  .+++..++.+++||+.|+.|+|.++++|||||.+|||||.+++++|+|||++--+...
T Consensus       129 vivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999999998754  4899999999999999999999999999999999999999999999999975443322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                           .+-.+.||+|.|.+||++.+  ..| ++.+|-|||||+||-|+.|..||.+.+-...+.++-.|
T Consensus       207 -----kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G  268 (668)
T KOG0611|consen  207 -----KFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG  268 (668)
T ss_pred             -----cHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc
Confidence                 23345788999999999976  456 67899999999999999999999988655544444444

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.8e-38  Score=316.67  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=202.3

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG   95 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g   95 (622)
                      ||+  |+||+||+|.++.+|+.||+|.+...... ....+.+.+|+.+|++++||||++++++|...+..++||||++++
T Consensus         1 lg~--g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGK--GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCC--CCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            577  78999999999999999999998764432 223455678999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCC
Q psy15039         96 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  175 (622)
Q Consensus        96 ~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  175 (622)
                      +|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.........     ....
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~  153 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KIKG  153 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----cccc
Confidence            99999876544468999999999999999999999999999999999999999999999998764332211     1112


Q ss_pred             CCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH---HHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       176 ~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      ..++..|+|||++.++  .++.++||||+||++|+|++|+.||......   ..+......                   
T Consensus       154 ~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  212 (277)
T cd05577         154 RAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------------------  212 (277)
T ss_pred             ccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-------------------
Confidence            2345679999998753  4788999999999999999999999754321   111111100                   


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                   .....+..+++++.+++.+||+.||++||     ++.++++||||....+
T Consensus       213 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         213 -------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             -------------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence                         00112234689999999999999999999     8999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-37  Score=314.05  Aligned_cols=258  Identities=16%  Similarity=0.267  Sum_probs=200.9

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      ...++|++.+.||+  |+||.||+|.++     .++..||||+++... .......+.+|+.+++.++||||+++++++.
T Consensus         3 ~~~~~~~~~~~ig~--G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           3 VAREKITMSRELGQ--GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             ccHHHceeeeeecc--ccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            35678999999999  778999999865     346789999986543 2344556889999999999999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceE
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFN--------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC  152 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~  152 (622)
                      .....++||||+++|+|.+++.....        ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            98999999999999999999865321        1246778889999999999999999999999999999999999999


Q ss_pred             EcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHH
Q psy15039        153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       153 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~  231 (622)
                      +.|||............  ......++..|+|||.+.+  ..++.++|||||||++|||++ |..||.............
T Consensus       160 l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         160 IGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             ECCCCCccccCCcceee--cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999754322111110  1111233567999999875  357899999999999999998 789997665443322222


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .+..+.                                .....++++.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EGGLLD--------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCcCC--------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            221110                                112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=307.57  Aligned_cols=254  Identities=29%  Similarity=0.532  Sum_probs=210.9

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |++|.||+++++.+++.||+|.+......+.....+.+|++++++++||||+++++++.+....+++|
T Consensus         1 ~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGR--GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcc--cCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            5899999999  67889999999999999999999877655566778899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.||+........... 
T Consensus        79 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          79 EYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             ecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            999999999998764  35889999999999999999999999999999999999999999999999876544322211 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                         .....++..|+|||.+...  .++.++|+||+|+++|+|++|..||.................+.            
T Consensus       156 ---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------  218 (254)
T cd06627         156 ---DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP------------  218 (254)
T ss_pred             ---ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC------------
Confidence               1122345679999998653  37889999999999999999999997654332222222111110            


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                          .+...++++.+++.+||..||++||++.+++.||||
T Consensus       219 --------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         219 --------------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             --------------------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                                123467889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-38  Score=329.25  Aligned_cols=290  Identities=22%  Similarity=0.278  Sum_probs=207.5

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +..+.++|++.+.||+  |+||.||+|.++.+|+.||||++......+.....+.+|+.++++++||||++++++|....
T Consensus        10 ~~~~~~~y~~~~~ig~--g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879          10 VWELPERYTSLKQVGS--GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             hhccccceEEEEEeee--cCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            3456789999999999  77889999999999999999998765433334456789999999999999999999987643


Q ss_pred             ------cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         84 ------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        84 ------~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                            .+++|+||+. .++.++..    ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          88 SGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             cCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence                  4699999986 36655542    247899999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  237 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~  237 (622)
                      ........       .....++..|+|||++.+. ..++.++||||+||++|+|++|+.||............+....+.
T Consensus       163 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (342)
T cd07879         163 LARHADAE-------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  234 (342)
T ss_pred             CCcCCCCC-------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            75432111       1122346679999998653 347889999999999999999999998765433332222111000


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .+..................+ ........ ......++++.+||..||+.||++||++.+++.||||...+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLP-KYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcC-CcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000000000000000000 00000000 011246788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.7e-38  Score=327.00  Aligned_cols=284  Identities=19%  Similarity=0.220  Sum_probs=207.0

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC---
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA---   82 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~---   82 (622)
                      ++..+|++.+.||+  |+||.||+|.++.+|+.||+|++.....  ...+.+.+|+.+|++++||||+++++++...   
T Consensus         2 ~~~~~y~~~~~Lg~--g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           2 DLGSRYMDLRPLGC--GSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcCcceEEEEEecC--CCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            57899999999999  7789999999999999999999876543  3456678999999999999999999876553   


Q ss_pred             -----------CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-Cc
Q psy15039         83 -----------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GK  150 (622)
Q Consensus        83 -----------~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~-~~  150 (622)
                                 ..+++||||++ +++.+++..   ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~  153 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCce
Confidence                       35799999997 588777753   347899999999999999999999999999999999999854 56


Q ss_pred             eEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH
Q psy15039        151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  230 (622)
Q Consensus       151 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~  230 (622)
                      +++.|||............ .......++..|+|||++... ..++.++|||||||++|+|++|..||............
T Consensus       154 ~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             EEECCcccceecCCccccc-cccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7899998764332111100 011112346679999987543 45788999999999999999999999766554433333


Q ss_pred             HhCCCCCCCc-cccccccCCCCcCcccccccch----hhhhc-cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        231 LAGATPHLLD-CTTYYVDTGQDDGEENACSYIS----EQQTQ-VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       231 ~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~i~----~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                      +.. .|...+ .......        .....+.    ..... ......++.++.+|+..||+.||.+|||+.++++|||
T Consensus       232 ~~~-~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~  302 (342)
T cd07854         232 LES-VPVVREEDRNELLN--------VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY  302 (342)
T ss_pred             HHh-cCCCChHHhhhhhh--------hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence            322 111100 0000000        0000000    00000 0012347889999999999999999999999999999


Q ss_pred             cccc
Q psy15039        305 FKQT  308 (622)
Q Consensus       305 ~~~~  308 (622)
                      |+..
T Consensus       303 ~~~~  306 (342)
T cd07854         303 MSCY  306 (342)
T ss_pred             cccc
Confidence            9754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.4e-37  Score=314.44  Aligned_cols=261  Identities=28%  Similarity=0.460  Sum_probs=208.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ....|.-.+.||+  |++|.||++.++.+++.||+|+++...  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        17 ~~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~   92 (285)
T cd06648          17 PRSYLDNFVKIGE--GSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELW   92 (285)
T ss_pred             chHhhhcceEecc--CCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEE
Confidence            3456777889999  778899999999999999999986542  233456789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +++||+++++|.+++..   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.........
T Consensus        93 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          93 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             EEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999999998866   247889999999999999999999999999999999999999999999998653322111


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..    .....++..|+|||.+.+.  .++.++|+||+||++|+|++|..||..............+..|..        
T Consensus       170 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--------  235 (285)
T cd06648         170 PR----RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL--------  235 (285)
T ss_pred             cc----cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC--------
Confidence            10    1122356679999998653  478899999999999999999999976543322222111111100        


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                            .....++..+.+++.+||..||++||++.++++|+||+....
T Consensus       236 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         236 ----------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ----------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                                  011236788999999999999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.6e-38  Score=316.33  Aligned_cols=255  Identities=17%  Similarity=0.272  Sum_probs=202.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .++|.+.+.||+  |+||.||+|++.     .+++.||||.++... ..+..+.+.+|+++|+.++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~--g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           4 RDTIVLKRELGE--GAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhHHhhccc--cCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            357999999999  778899999875     457899999986543 233456788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHF------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK  150 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~  150 (622)
                      ...+++|||+++++|.+++....            ...+++..+..++.|++.||+|||++||+||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999987542            123688899999999999999999999999999999999999999


Q ss_pred             eEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHH
Q psy15039        151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIE  229 (622)
Q Consensus       151 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~  229 (622)
                      +++.|||.........  ..........+..|+|||++.+  ..++.++|||||||++|||++ |..||...........
T Consensus       161 ~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTD--YYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             EEECCcccceecccCc--ceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999998764321111  0111122334567999999875  358899999999999999998 9999976554332222


Q ss_pred             HHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       230 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ...+..+                                .....++.++.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQGRLL--------------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcCCcC--------------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2211111                                112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-37  Score=315.10  Aligned_cols=277  Identities=23%  Similarity=0.260  Sum_probs=200.6

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeC--CcEEE
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA--TDLHL   87 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~--~~~~l   87 (622)
                      |++.+.||+  |+||.||+|+++.+++.||+|+++........ ....+|+.+|+++. ||||+++++++.+.  ..+++
T Consensus         1 y~~~~~lg~--g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGE--GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccc--cccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            789999999  77889999999999999999998764332222 23457999999995 99999999999987  88999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++ |++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+||+++. +.+++.|||..........
T Consensus        78 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          78 VFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            999997 57777776533 35789999999999999999999999999999999999999 9999999997643321111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HHHhCCCCCCCcccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EKLAGATPHLLDCTTYY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~p~~~~~~~~~  245 (622)
                      .     .....+..|+|||++..+ ..++.++||||+||++|||++|..||...+......  ....+..+...  ....
T Consensus       155 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  226 (282)
T cd07831         155 Y-----TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV--LKKF  226 (282)
T ss_pred             c-----CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH--HHhh
Confidence            0     112345679999987543 346889999999999999999999997655432221  11122111100  0000


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .....  ............  .......++.++.++|.+||.+||++||++.++++||||
T Consensus       227 ~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         227 RKSRH--MNYNFPSKKGTG--LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccc--ccccCccccccc--HHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00000  000000000000  000123468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-37  Score=310.04  Aligned_cols=251  Identities=19%  Similarity=0.322  Sum_probs=199.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +.+|++++.||+  |+||.||+|+.+. +..||||.+.......   ..+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~--G~~~~vy~~~~~~-~~~~aik~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           3 PKDLTFLKELGT--GQFGVVKYGKWRG-QYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             hHHeEEeeEecC--cccceEEEEEecC-CCcEEEEEcCCCcccH---HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            467999999999  7788999998764 4469999987544332   457789999999999999999999999889999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||+.+|++.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+++.|||..........
T Consensus        77 v~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            9999999999999876432 578999999999999999999999999999999999999999999999987543322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                         .......++..|+|||.+..  ..++.++|||||||++|+|++ |..||..............+..+          
T Consensus       156 ---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  220 (256)
T cd05113         156 ---TSSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------  220 (256)
T ss_pred             ---eecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------
Confidence               01112234567999999865  347889999999999999998 99999765543322222221111          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                            ......++.+.+++.+||+.||++||++.+++.+
T Consensus       221 ----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ----------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                                  0112357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.6e-38  Score=320.02  Aligned_cols=259  Identities=27%  Similarity=0.465  Sum_probs=207.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ...|+....||+  |+||.||++.++.+++.||||.++....  ...+.+.+|+.+++.++||||++++++|...+..++
T Consensus        20 ~~~~~~~~~ig~--g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          20 RSLLENYIKIGE--GSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             hhhHHhhhhcCC--CCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            356677778999  7789999999999999999999876433  234567899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ++||++++++.+++..   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........
T Consensus        96 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          96 LMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999999999988754   2478999999999999999999999999999999999999999999999997643322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    .....++..|+|||++.+.  .++.++||||+||++|||++|+.||......... ..+....+.          
T Consensus       173 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~----------  235 (297)
T cd06659         173 K----RKSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPPP----------  235 (297)
T ss_pred             c----ccceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhccCCC----------
Confidence            1    1123456789999998653  5788999999999999999999999865433322 222211100          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                         .......+++++.+++..||+.||++||++.++++||||.+..
T Consensus       236 -------------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         236 -------------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             -------------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence                               0011234678899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-37  Score=315.26  Aligned_cols=254  Identities=20%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ..+|.+.+.||+  |+||+||++..     ..++..||+|.+...  .+...+.+.+|+.+|++++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~--G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGE--GAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCC--cCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            468999999999  77999999986     345677999998653  345566788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFN-----------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~-----------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      +..+++|||+++++|.+++.....           ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            999999999999999999875421           237899999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  230 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~  230 (622)
                      ++.|||..........  ........++..|+|||++.+  ..++.++|||||||++|+|++ |..||............
T Consensus       160 kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         160 KIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             EeccCCccccccCCce--eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999997643322111  111112233567999999865  357899999999999999998 99999766543332222


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ..+..+                                .....++.++.+++.+||+.||.+|||+.+++.
T Consensus       236 ~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         236 TQGRVL--------------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HcCCcC--------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            222111                                012246788999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-37  Score=314.45  Aligned_cols=255  Identities=20%  Similarity=0.336  Sum_probs=200.9

Q ss_pred             CCceEEeecccccCCceeEEEEEE----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKH----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ++|++.+.||+  |+||+||+|..    ..+++.||+|.+.... .......+.+|+.+|++++|||||++++++.....
T Consensus         5 ~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGE--CAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccc--cCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            57999999999  77889999985    4566899999987543 34455678899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHF---------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  149 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~---------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~  149 (622)
                      .|++|||+++++|.+++....               ...+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            999999999999999985321               12367888999999999999999999999999999999999999


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI  228 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~  228 (622)
                      .+++.|||...........  ........+..|+|||.+.+.  .++.++|+|||||++|||++ |..||.+.... .+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVI  236 (283)
T ss_pred             cEEeccccccccccCCcce--ecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Confidence            9999999976443221110  111222334569999998653  47899999999999999998 99999765432 223


Q ss_pred             HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       229 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      +.+.....                               ......+++++.+++.+||+.||.+||++.+++++
T Consensus       237 ~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKRQL-------------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCc-------------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            32221110                               01123467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-37  Score=309.14  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=198.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +++|++.+.||+  |+||.||++..+. +..+|+|.+.......   ..+.+|+.+|++++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~--G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           3 PSELTFMKELGS--GQFGVVHLGKWRA-QIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             HHHcEEeeEecC--CcCceEEEEEecc-CceEEEEecccCCccH---HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            467999999999  7788999998864 5679999986544332   456789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999999999886533 3478999999999999999999999999999999999999999999999996543321111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .   ......++..|+|||++.+  ..++.++|+||+||++|+|++ |+.||..............+..+          
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------  220 (256)
T cd05114         156 T---SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------  220 (256)
T ss_pred             e---ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------
Confidence            0   1112233457999999864  357889999999999999999 99999766543332222221111          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                            ..+...+.++.+++.+||..||++||++.++++
T Consensus       221 ----------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 ----------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                  011234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5e-38  Score=330.62  Aligned_cols=217  Identities=21%  Similarity=0.329  Sum_probs=180.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus         1 ~~y~~~~~LG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGR--GAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEe--CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            47999999999  78999999999999999999998754322 2334678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..+.....
T Consensus        79 v~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999999987643  478999999999999999999999999999999999999999999999997643321100


Q ss_pred             c-------------------------------eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCC
Q psy15039        518 K-------------------------------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV  566 (622)
Q Consensus       518 ~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~  566 (622)
                      .                               ......+.+||+.|||||++.+  ..|+.++|||||||++|||++|++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCCC
Confidence            0                               0000123468999999999975  468999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHH
Q psy15039        567 PFAETPTTLMLIEKL  581 (622)
Q Consensus       567 Pf~~~~~~~~~~~~~  581 (622)
                      ||...+.........
T Consensus       235 Pf~~~~~~~~~~~i~  249 (363)
T cd05628         235 PFCSETPQETYKKVM  249 (363)
T ss_pred             CCCCCCHHHHHHHHH
Confidence            998776554443333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.7e-37  Score=312.72  Aligned_cols=255  Identities=18%  Similarity=0.313  Sum_probs=200.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      .+|++.+.||+  |+||.||+|.++.     ++..||+|.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus         6 ~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGH--GAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCC--CCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            57999999999  7788999999987     88999999986543 2333456888999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFN-----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSG  155 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~  155 (622)
                      ..+++|||+++++|.+++.....     ..+++..+..++.||+.||+|||+++++||||||+|||++.++   .+++.|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            99999999999999999876431     2478899999999999999999999999999999999998765   478999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGA  234 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~  234 (622)
                      ||..........  .........+..|+|||++.+  ..++.++|||||||++|||++ |..||........ ...+...
T Consensus       163 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~  237 (277)
T cd05036         163 FGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-MEFVTGG  237 (277)
T ss_pred             CccccccCCccc--eecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcC
Confidence            987644321110  000111122356999999865  358899999999999999996 9999986554332 2222111


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .+                               ...+..++.++.+++.+||+.||++||++.++++|
T Consensus       238 ~~-------------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 GR-------------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             Cc-------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00                               00123457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-38  Score=326.43  Aligned_cols=287  Identities=24%  Similarity=0.287  Sum_probs=215.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-----c
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----D   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~   84 (622)
                      +|++.+.||+  |++|.||+|++..+|+.||||++..........+.+.+|+.+|++++||||+++++++....     .
T Consensus         1 ~y~i~~~ig~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGS--GAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecC--CCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            5999999999  77899999999999999999998765444555677889999999999999999999988775     7


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|++|||++ +++.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.......
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            999999998 57888876532  588999999999999999999999999999999999999999999999997654433


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~  242 (622)
                      ..... .......++..|+|||++.+. ..++.++|+||+||++|+|++|.+||.+............  +.++.  +..
T Consensus       156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~  231 (330)
T cd07834         156 DEDEK-GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE--EDL  231 (330)
T ss_pred             ccccc-ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh--hHh
Confidence            22100 011122446789999998754 2578899999999999999999999987765443332221  21110  000


Q ss_pred             cccccCCCCcCcccccccchhhh---h--ccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQ---T--QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS  312 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~---~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~  312 (622)
                      ..       ........++....   .  .......++.++.+++..||+.||++||++.++++||||+..+..+
T Consensus       232 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         232 KF-------ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             hh-------ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence            00       00000000110000   0  0001233688999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.8e-37  Score=318.34  Aligned_cols=260  Identities=30%  Similarity=0.532  Sum_probs=208.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..+.|+..+.||+  |+||+||+|++..+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+....
T Consensus        19 ~~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          19 PEEIFVGLHEIGH--GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             HHHHhhcceeecc--CCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            3445888889999  7789999999999999999999876433 344556788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+||||+. |++.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||....... 
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence            99999996 67777775533 3588999999999999999999999999999999999999999999999986532111 


Q ss_pred             CccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                             .....++..|+|||++.. ....++.++|||||||++|+|++|..||.................|.       
T Consensus       174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------  239 (313)
T cd06633         174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT-------  239 (313)
T ss_pred             -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence                   112245667999999842 12347889999999999999999999998765433333222221111       


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                              .....++..+.+|+.+||+.||.+||++.+++.||||+...
T Consensus       240 ------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         240 ------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             ------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                                    11234677899999999999999999999999999998644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-37  Score=318.07  Aligned_cols=284  Identities=22%  Similarity=0.306  Sum_probs=205.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   83 (622)
                      -++|++.+.||+  |+||.||+|.++.+|+.||||.++.....+.....+.+|++++++++||||+++++++.+..    
T Consensus         6 ~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           6 VDKFDIIGQIGE--GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhheeeeecc--cCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            468999999999  77889999999999999999999765433333456778999999999999999999987655    


Q ss_pred             ------cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         84 ------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        84 ------~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                            .+++++||+++ ++.+.+... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+++.|||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                  79999999985 666766543 2357899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGAT  235 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~  235 (622)
                      ............   ......+..|+|||.+.+. ..++.++||||+||++|+|++|++||........+  +....+..
T Consensus       162 ~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         162 LARLYNSEESRP---YTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             ccccccCCcccc---cccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            764432221110   0111234579999988643 34688999999999999999999999765433222  22222221


Q ss_pred             -CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        236 -PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       236 -p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                       |...............+....    ..  .........++..+.+++..||+.||++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQ----YR--RRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             Chhhcccccccccccccccccc----cc--cchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence             110000000000000000000    00  00001122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-37  Score=310.69  Aligned_cols=250  Identities=20%  Similarity=0.305  Sum_probs=202.3

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG   95 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g   95 (622)
                      ||+  |++|.||+|+++.+++.||+|.+...... ....+.+.+|+++++.++||||+++++.+.++..+++++||++++
T Consensus         1 lg~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGV--GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCC--CCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            566  78999999999999999999999765433 344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCC
Q psy15039         96 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  175 (622)
Q Consensus        96 ~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  175 (622)
                      +|.+++....  .+++..+..++.|++.||+|+|+++++|+||||+||+++.++.+++.||+.........     ....
T Consensus        79 ~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~~~  151 (262)
T cd05572          79 ELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWT  151 (262)
T ss_pred             cHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----cccc
Confidence            9999997642  47899999999999999999999999999999999999999999999999765443221     1112


Q ss_pred             CCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch-HHHHHHHHh-CCCCCCCccccccccCCCCcC
Q psy15039        176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT-TLMLIEKLA-GATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       176 ~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~-~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      ..++..|+|||.+..  ..++.++|+||+||++|+|++|..||..... .......+. +...                 
T Consensus       152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------  212 (262)
T cd05572         152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-----------------  212 (262)
T ss_pred             ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-----------------
Confidence            245667999999864  3578899999999999999999999976541 222222211 1000                 


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQT  308 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~  308 (622)
                                    ...+...++++.+++.+||+.||++||+     +.|+++||||+..
T Consensus       213 --------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         213 --------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             --------------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence                          0011223788999999999999999999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.2e-37  Score=310.36  Aligned_cols=251  Identities=18%  Similarity=0.347  Sum_probs=200.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|... +++.||+|.+.....   ..+.+.+|+.++++++||||+++++++.+....++
T Consensus         5 ~~~~~~~~~lg~--g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGA--GQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCC--cCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            568999999999  778899999965 567899999865432   34567899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||+++++||||||+||+++.++.+++.|||..........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999998765444578888999999999999999999999999999999999999999999997654322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .   ......++..|+|||.+..  ..++.++|||||||++|+|++ |..||......... ..+....+          
T Consensus       159 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~~~----------  222 (261)
T cd05072         159 T---AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-SALQRGYR----------  222 (261)
T ss_pred             e---ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH-HHHHcCCC----------
Confidence            1   1112233557999999865  357889999999999999998 99999765443322 22221110          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           ......++.++.+++.+||..||++||+++++.+
T Consensus       223 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 ---------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                 0112346788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=310.02  Aligned_cols=255  Identities=18%  Similarity=0.329  Sum_probs=203.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +++|++.+.||+  |+||+||+|..+.+   ...||||.++... .......+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGG--GEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecC--CccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            568999999999  77899999998754   5689999986543 34455678899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999999987643 3578999999999999999999999999999999999999999999999997655431


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ......  ......+..|+|||.+..  ..++.++|||||||++|+|++ |..||....... ....+....+       
T Consensus       159 ~~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~-------  226 (266)
T cd05033         159 SEATYT--TKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-VIKAVEDGYR-------  226 (266)
T ss_pred             ccccee--ccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-HHHHHHcCCC-------
Confidence            111111  112233567999999865  357899999999999999997 999997654332 2222211100       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              .......++.+.+++..||+.||++||++.+++++
T Consensus       227 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         227 ------------------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    01123467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-37  Score=329.27  Aligned_cols=256  Identities=19%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEe
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLD   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~   81 (622)
                      .+.|.+++.||+  |+||.||+|.+..     ++..||||++.... .....+.+.+|+++|++++ |||||++++++..
T Consensus        36 ~~~~~~~~~LG~--G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          36 RDGLVLGRILGS--GAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             ccceehhheecC--CCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            568889999999  7899999998753     34579999996543 3444567889999999996 9999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhc--------------------------------------------------------
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHF--------------------------------------------------------  105 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~--------------------------------------------------------  105 (622)
                      ....++|||||++|+|.+++....                                                        
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            999999999999999998875421                                                        


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC
Q psy15039        106 --------------------------------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH  147 (622)
Q Consensus       106 --------------------------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~  147 (622)
                                                            ...+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                  113677888899999999999999999999999999999999


Q ss_pred             CCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHH
Q psy15039        148 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLM  226 (622)
Q Consensus       148 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~  226 (622)
                      ++.+++.|||...........  .......++..|+|||++.+  ..++.++|||||||++|||++ |..||........
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999976443221111  11122344567999999865  357899999999999999996 9999976543332


Q ss_pred             HHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        227 LIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       227 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ....+....+                               ......++.++.+++.+||+.||++||++.++.+
T Consensus       349 ~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         349 FYNKIKSGYR-------------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHhcCCC-------------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3222221110                               0112346788999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.9e-37  Score=307.81  Aligned_cols=247  Identities=20%  Similarity=0.309  Sum_probs=193.6

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF   94 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~   94 (622)
                      +.||+  |+||.||+|+++.+|+.||+|.+... ...+....+.+|+++|++++||||+++++++......++||||+++
T Consensus         1 ~~lg~--g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGR--GNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCc--ccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            36888  77889999999999999999997543 3344556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCC
Q psy15039         95 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP  174 (622)
Q Consensus        95 g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  174 (622)
                      ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.........  ......
T Consensus        78 ~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGG  154 (252)
T ss_pred             CcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc--ccccCC
Confidence            99999986532 347899999999999999999999999999999999999999999999998754322111  000011


Q ss_pred             CCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       175 ~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      ....+..|+|||.+.++  .++.++|||||||++|+|++ |..||......... ..+....+                 
T Consensus       155 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-~~~~~~~~-----------------  214 (252)
T cd05084         155 MKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-EAIEQGVR-----------------  214 (252)
T ss_pred             CCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-HHHHcCCC-----------------
Confidence            11223469999998653  47889999999999999997 99999754432221 11111000                 


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                    ......++..+.+++.+||+.||++||++.++++
T Consensus       215 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 --------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             --------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          0112245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.8e-38  Score=321.19  Aligned_cols=288  Identities=21%  Similarity=0.307  Sum_probs=203.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   83 (622)
                      .++|++.+.||+  |+||.||+|.++.+++.||||++......+.....+.+|+++|++++||||+++++++....    
T Consensus         7 ~~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGE--GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEecc--CCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            579999999999  77889999999999999999998765433333345678999999999999999999876543    


Q ss_pred             ----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         84 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        84 ----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                          .+++||||+.. ++.+.+... ...+++..+..++.|+++||+|||++||+||||||+||+++.++.+++.|||..
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                46999999874 566665442 235899999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCccccc-------cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HH
Q psy15039        160 CPFSPTKKKVHL-------FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EK  230 (622)
Q Consensus       160 ~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~  230 (622)
                      ............       ......++..|+|||.+.+. ..++.++||||+||++|+|++|++||..........  ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            433221111000       00112345679999998653 357889999999999999999999998655433222  12


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ..+.++.. .... +.......... .........  ......+++++.+++.+||+.||++|||+.+++.||||
T Consensus       242 ~~~~~~~~-~~~~-~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEE-TWPG-WRSLPGCEGVH-SFTNYPRTL--EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChh-hchh-hhhcccccccc-cCCCCCccH--HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            22211110 0000 00000000000 000000000  00123456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.7e-37  Score=314.17  Aligned_cols=263  Identities=32%  Similarity=0.574  Sum_probs=213.6

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .+...+|++...||+  |++|.||++.+..+++.||+|++.....   ..+.+.+|+.+|++++||||+++++++.....
T Consensus        15 ~~~~~~~~~~~~l~~--g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          15 GDPRELYKNLEKIGE--GASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             CCccccchHhHhccC--CCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            456778999999999  7788999999999999999999976532   44567899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .|+++||+++++|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+++.||+.......
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999999999997753 2578999999999999999999999999999999999999999999999987543322


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....    .....++..|+|||.+.+  ..++.++|+|||||++|+|++|..||...+.............+..      
T Consensus       169 ~~~~----~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------  236 (286)
T cd06614         169 EKSK----RNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL------  236 (286)
T ss_pred             chhh----hccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence            1111    111234567999999865  3478999999999999999999999986554433222222111110      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                              .....++.++.+++.+||+.||.+||++.+++.|+||+...
T Consensus       237 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         237 ------------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             ------------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                                    11223678899999999999999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-37  Score=312.97  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             ecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHH----HHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeec
Q psy15039         16 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        16 ~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      +||+  |+||.||+|++..+|+.||||.+.........    ......++++++...||||++++++|.+.+.+++||||
T Consensus         1 ~ig~--g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             Cccc--CCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence            4788  77899999999999999999998765432111    11122344566667899999999999999999999999


Q ss_pred             CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccc
Q psy15039         92 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        92 ~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      +.+|+|.+++...  ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.+++.|||....+....     
T Consensus        79 ~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-----  151 (278)
T cd05606          79 MNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----  151 (278)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-----
Confidence            9999999888653  358899999999999999999999999999999999999999999999999765443211     


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCCCCCCccccccccCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                       .....++..|+|||++..+ ..++.++||||+||++|+|++|+.||......  ...........+             
T Consensus       152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  216 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------  216 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC-------------
Confidence             1233567789999998643 34789999999999999999999999754221  111111111000             


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                         ..+..+|.++.+++.+||..||.+||     ++.++++||||+....
T Consensus       217 -------------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         217 -------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             -------------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence                               01223688999999999999999999     9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-37  Score=312.86  Aligned_cols=257  Identities=28%  Similarity=0.509  Sum_probs=207.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+-|++.+.||+  |+||.||+|.++.+++.||||.+..... ......+.+|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~ig~--G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           3 EELFTKLEKIGK--GSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             HHhhhhheeEee--cCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence            345888999999  7799999999999999999999865433 3445678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++++++.+++..   ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.+++.|||..........
T Consensus        80 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          80 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999999999988864   2478999999999999999999999999999999999999999999999986543321110


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                          ......++..|+|||.+..  ..++.++|+||+||++|+|++|..||..............+..|           
T Consensus       157 ----~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  219 (277)
T cd06641         157 ----KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP-----------  219 (277)
T ss_pred             ----hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC-----------
Confidence                0111234567999999864  34678999999999999999999999765433222211111111           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                           .....++.++.+++.+||+.||++||++.++++||||.+.
T Consensus       220 ---------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         220 ---------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ---------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                                 0122457889999999999999999999999999999774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.9e-37  Score=310.53  Aligned_cols=254  Identities=21%  Similarity=0.388  Sum_probs=197.5

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCc--EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC------
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQ--LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA------   82 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~------   82 (622)
                      |.+++.||+  |+||.||+|....+++  .||+|.++.....+...+.+.+|+++|+.++||||+++++++...      
T Consensus         1 ~~i~~~ig~--G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGE--GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCc--ccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            457889999  7789999999988876  599999887655667778889999999999999999999976432      


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHF----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                      ...+++|||+++|++.+++....    ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence            24789999999999998874321    12378999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPH  237 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~  237 (622)
                      ..........  ........+..|+|||.+.+  ..++.++|||||||++|+|++ |..||....... +...+..... 
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~~-  232 (272)
T cd05075         159 SKKIYNGDYY--RQGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNR-  232 (272)
T ss_pred             ccccCcccce--ecCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCC-
Confidence            6543322110  01111233457999999865  357899999999999999998 899997654332 2222211100 


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                    ......+++.+.+++.+||+.||++|||+.+++++
T Consensus       233 ------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 ------------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                          01123467889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.6e-37  Score=316.68  Aligned_cols=260  Identities=29%  Similarity=0.508  Sum_probs=209.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ....|+..+.||+  |+||.||+++++.+|+.||+|++..... ..+..+.+.+|+++|++++|||||++++++.+++..
T Consensus        23 ~~~~f~~~~~lg~--G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          23 PEKLFTDLREIGH--GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA  100 (317)
T ss_pred             chhhhhhhheecc--CCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence            3456899999999  7788999999999999999999876432 344556788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+. |++.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||....... 
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99999997 57777775533 3588999999999999999999999999999999999999999999999986532211 


Q ss_pred             CccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                             .....++..|+|||.+.. ....++.++||||+||++|+|++|..||..............+..+.       
T Consensus       178 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------  243 (317)
T cd06635         178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------  243 (317)
T ss_pred             -------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-------
Confidence                   112345667999999742 12347889999999999999999999998654433333332221110       


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                              .....+++.+.+++.+||+.||.+||++.++++|+|+....
T Consensus       244 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 ------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                                    11234678899999999999999999999999999996643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.8e-37  Score=315.69  Aligned_cols=256  Identities=18%  Similarity=0.285  Sum_probs=202.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~   81 (622)
                      .++|++.+.||+  |+||.||++.+     ..++..||||+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus        34 ~~~~~~~~~ig~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          34 RNNLSFGKTLGA--GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             HHHeEEcceeec--cCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            348999999999  77999999985     4567789999987543 344556788999999999 89999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      .+..+++|||+.+|+|.+++.......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||....
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999999998764433478999999999999999999999999999999999999999999999997644


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      .......  ........+..|+|||.+.+.  .++.++||||+||++|+|++ |..||............+....+    
T Consensus       191 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~----  262 (302)
T cd05055         191 IMNDSNY--VVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR----  262 (302)
T ss_pred             ccCCCce--eecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc----
Confidence            3221111  011122335679999998653  47889999999999999998 99999765544333333221100    


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                 .......++++.+++.+||..||++||++.++++
T Consensus       263 ---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 ---------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                       0112245788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-37  Score=317.14  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcE--EEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQL--IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~--vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      ++|++.+.||+  |+||.||+|.++.+|..  +|+|.+... ........+.+|+.++.++ +||||+++++++......
T Consensus         7 ~~~~~~~~lg~--G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           7 NDIKFQDVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhceeeeeecC--CCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            48999999999  77899999999888865  577776542 2344556788999999999 899999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         86 HLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      |+||||+++|+|.+++....              ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence            99999999999999986532              1247889999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  230 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~  230 (622)
                      ++.|||........   .  .......+..|+|||.+..  ..++.++|||||||++|+|++ |..||........ ...
T Consensus       164 kl~dfg~~~~~~~~---~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~  235 (303)
T cd05088         164 KIADFGLSRGQEVY---V--KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEK  235 (303)
T ss_pred             EeCccccCcccchh---h--hcccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-HHH
Confidence            99999975321110   0  0111122456999998864  357899999999999999998 9999976543322 222


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      +.....                               ......+++++.+++.+||+.||++||++.+++++
T Consensus       236 ~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         236 LPQGYR-------------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HhcCCc-------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            211000                               00112357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0612|consensus

Probab=100.00  E-value=4e-39  Score=350.12  Aligned_cols=266  Identities=21%  Similarity=0.311  Sum_probs=216.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .++|+|+++||+  |+||.|++++++.|++.||.|++++-.+- ..+.-.|..|-.+|..-+.+=||+++-+|.+..++|
T Consensus        74 ~~DfeilKvIGr--GaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   74 AEDFEILKVIGR--GAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             HHhhHHHHHhcc--cccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            579999999999  66889999999999999999999874332 333445667889999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||+||+|..++....  .+||..+++|+..|..||+-+|+.|.|||||||+|||||..|+++++|||.-..+....
T Consensus       152 lVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            9999999999999997643  59999999999999999999999999999999999999999999999999754443221


Q ss_pred             ccccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                       .+  .+...+|||-|++||+|..   +.+.|+..+|+||+||++|||++|..||....... .+.+|..-         
T Consensus       230 -~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve-TY~KIm~h---------  296 (1317)
T KOG0612|consen  230 -TV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE-TYGKIMNH---------  296 (1317)
T ss_pred             -cE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-HHHHHhch---------
Confidence             11  2345688999999999942   22568999999999999999999999997543221 11111100         


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC---HHhhhcCcccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL---ACNLLQHAFFKQTKK  310 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~h~~~~~~~~  310 (622)
                                         .....+|....+|.++++||...+. +|+.|..   ++++-.||||....+
T Consensus       297 -------------------k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  297 -------------------KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             -------------------hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence                               0112233334589999999999876 4888888   999999999998776

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-38  Score=343.80  Aligned_cols=286  Identities=19%  Similarity=0.264  Sum_probs=196.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccC-CcEEEEEEec--------------C-CCCCHHHHHHHHHHHHHHhhCCC
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVT-NQLIAVKKFN--------------L-DRMTDEDLKSLHHEIVCMRHLRH   69 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t-~~~vAiK~~~--------------~-~~~~~~~~~~~~~Ei~il~~l~H   69 (622)
                      .+..+|++++.||+  |+||+||+|..+.. +..+++|.++              + ..........+.+|+.+|++|+|
T Consensus       145 ~~~~~Y~ii~~LG~--G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        145 EFLAHFRVIDDLPA--GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhccEEEeEecC--CCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence            45578999999999  78999999986543 3333333111              0 01122334567899999999999


Q ss_pred             CcceeEEEEEEeCCcEEEEeecCCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q psy15039         70 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHF---NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS  146 (622)
Q Consensus        70 pnIv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~  146 (622)
                      ||||++++++.+.+..|++++++. +++.+++....   ........++.++.||+.||+|||++||+||||||+|||++
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            999999999999999999999986 45666553321   11223566788999999999999999999999999999999


Q ss_pred             CCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCC-CCCC--ch
Q psy15039        147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVP-FAET--PT  223 (622)
Q Consensus       147 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~P-f~~~--~~  223 (622)
                      .++.+++.|||....+......   ...+..+|..|+|||++.+  ..|+.++|||||||++|||++|..| |...  ..
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA---FDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc---ccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            9999999999987554322111   1123456788999999975  4589999999999999999998754 4322  22


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchh--------hhhccccCCCCcHHHHHHHHHhhhcCCCCCcC
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE--------QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL  295 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps  295 (622)
                      ...+...+........+.    .+     .......++..        .....+....++.++.+++.+||+.||.+|||
T Consensus       377 ~~~~~~~~~~~~~~~~~~----p~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps  447 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEF----PD-----PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG  447 (501)
T ss_pred             HHHHHHHHHhcccChhhc----CC-----cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence            223332222111000000    00     00000001100        00111122346778999999999999999999


Q ss_pred             HHhhhcCcccccc
Q psy15039        296 ACNLLQHAFFKQT  308 (622)
Q Consensus       296 ~~~~l~h~~~~~~  308 (622)
                      +.|+|+||||...
T Consensus       448 a~elL~hp~f~~~  460 (501)
T PHA03210        448 AAELLALPLFSAE  460 (501)
T ss_pred             HHHHhhChhhhcC
Confidence            9999999999764

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.7e-38  Score=332.98  Aligned_cols=217  Identities=24%  Similarity=0.330  Sum_probs=180.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      +.|++++.||+  |+||.||+|+++.+++.||||++..... .......+.+|+.+++.++|||||++++++.+.+.+++
T Consensus         1 ~~f~~~~~LG~--G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l   78 (381)
T cd05626           1 SMFVKIKTLGI--GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (381)
T ss_pred             CCceEEEEEee--cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence            36899999999  8899999999999999999999976443 23445678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||++..+.....
T Consensus        79 v~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          79 VMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999999987643  478888899999999999999999999999999999999999999999997543211000


Q ss_pred             c-------------------------------------------eeccCCCCCCCCccccccccccCccCCCchhhHHHH
Q psy15039        518 K-------------------------------------------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV  554 (622)
Q Consensus       518 ~-------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  554 (622)
                      .                                           ......+..||+.|||||++.+  ..|+.++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl  234 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence            0                                           0000123468899999999975  468999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        555 GISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       555 Gvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ||++|||+||++||............+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~  261 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVI  261 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            999999999999998766555444443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.8e-38  Score=333.20  Aligned_cols=217  Identities=23%  Similarity=0.317  Sum_probs=180.4

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      .|++++.||+  |+||.||+|+++.+++.||+|++..... .......+.+|+.+++.++|||||+++++|.+.+.+|+|
T Consensus         2 ~f~~~~~LG~--G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGI--GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEe--CCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            5899999999  7899999999999999999999875432 223456788999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC-
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK-  517 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~-  517 (622)
                      ||||++|+|.+++.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+..+..... 
T Consensus        80 ~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          80 MDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999999987643  468888999999999999999999999999999999999999999999997543210000 


Q ss_pred             ------------------------------------------ceeccCCCCCCCCccccccccccCccCCCchhhHHHHH
Q psy15039        518 ------------------------------------------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG  555 (622)
Q Consensus       518 ------------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG  555 (622)
                                                                .......+..||+.|||||++.+  ..|+.++||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlG  235 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEech
Confidence                                                      00001123468899999999975  4689999999999


Q ss_pred             HHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        556 ISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       556 vil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      |++|||++|++||...+........+.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~  262 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVIN  262 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            999999999999988766555545443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5e-37  Score=308.67  Aligned_cols=254  Identities=28%  Similarity=0.453  Sum_probs=203.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||+|.++.+|+.||+|.++.... .......+.+|++++++++|+||+++++++...+..++
T Consensus         2 ~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGK--GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             Cceeeeeeecc--CCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            58999999999  7788999999999999999999875433 33446778899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         88 VSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +|||+++|+|.+++....  ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+++.|||....+...
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            999999999999986532  234789999999999999999999999999999999999999999999999875433221


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-HHHHHHH-hCCCCCCCcccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKL-AGATPHLLDCTT  243 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-~~~~~~~-~~~~p~~~~~~~  243 (622)
                      ...    .....++..|+|||.+.+  ..++.++|+||+||++|+|++|+.||...... ......+ .+..+       
T Consensus       160 ~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  226 (267)
T cd08224         160 TTA----AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-------  226 (267)
T ss_pred             Ccc----cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC-------
Confidence            111    112234567999999865  35788999999999999999999999654322 1111111 11100       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              ......++.++.+++.+||..||++||++.++++
T Consensus       227 ------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         227 ------------------------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ------------------------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                    0112246788999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=321.45  Aligned_cols=212  Identities=19%  Similarity=0.302  Sum_probs=178.8

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         1 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGT--GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeec--CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            46899999999  88999999999999999999998754322 2334568899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.+|.+++.|||.+......  
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          79 LMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            999999999999987643  4788888999999999999999999999999999999999999999999975433211  


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                           .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||..............+
T Consensus       155 -----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~  213 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG  213 (291)
T ss_pred             -----cccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence                 123457888999999975  45889999999999999999999999877654433333333

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.4e-37  Score=320.06  Aligned_cols=293  Identities=19%  Similarity=0.265  Sum_probs=210.9

Q ss_pred             CCCCCCceE-EeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHH------------HHHHHHHHHHHhhCCCCc
Q psy15039          5 DNVPSNYKI-CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED------------LKSLHHEIVCMRHLRHPN   71 (622)
Q Consensus         5 ~~~~~~y~~-~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~------------~~~~~~Ei~il~~l~Hpn   71 (622)
                      .++..+|.. .+.||+  |+||+||+|.++.+|+.||||++.........            ...+.+|+.+|++++|||
T Consensus         4 ~~~~~ry~~~~~~ig~--G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   81 (335)
T PTZ00024          4 FSISERYIQKGAHLGE--GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN   81 (335)
T ss_pred             cccccchhhhhhcccC--CCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence            356677864 577999  77889999999999999999998654322110            124678999999999999


Q ss_pred             ceeEEEEEEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         72 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        72 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      |+++++++...+..+++|||++ |++.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus        82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence            9999999999999999999997 6888888653  347899999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCc----------cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCC
Q psy15039        152 CLSGLRYMCPFSPTKK----------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  221 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~  221 (622)
                      ++.|||..........          ..........++..|+|||.+.+. ..++.++|+||+||++|+|++|..||...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999997644331000          000001122346679999998653 34788999999999999999999999876


Q ss_pred             chHHHHHHHH--hCCCCCCCccccccccCCCCcCcccccccchhhhhc-cccCCCCcHHHHHHHHHhhhcCCCCCcCHHh
Q psy15039        222 PTTLMLIEKL--AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQ-VLTSRKFSDSFHSIVELCLSRDVDKRPLACN  298 (622)
Q Consensus       222 ~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  298 (622)
                      .....+....  .+.++. ..+.... ..+..      ..+....... .......++++.+++..||+.||++||++++
T Consensus       238 ~~~~~~~~i~~~~~~~~~-~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNE-DNWPQAK-KLPLY------TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             CHHHHHHHHHHHhCCCch-hhCcchh-hcccc------cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            5443322221  111111 0000000 00000      0000000000 0012346889999999999999999999999


Q ss_pred             hhcCccccccccC
Q psy15039        299 LLQHAFFKQTKKC  311 (622)
Q Consensus       299 ~l~h~~~~~~~~~  311 (622)
                      ++.||||+....+
T Consensus       310 ~l~~~~~~~~~~~  322 (335)
T PTZ00024        310 ALKHEYFKSDPLP  322 (335)
T ss_pred             HhcCcccCCCCCC
Confidence            9999999876554

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.6e-37  Score=311.05  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=194.8

Q ss_pred             CCCceEEeec--ccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSIL--GQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~l--G~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~   84 (622)
                      -++|++.+.+  |+  |+||.||+++++.+++.+|+|.+........       |+..+..+ +||||++++++|...+.
T Consensus        13 ~~~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         13 LKNCEIVKKLKLID--GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHhhccccceeecC--CCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            3577787776  88  7799999999999999999999876433221       22222222 79999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCccccccC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPFS  163 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~~  163 (622)
                      +++||||+++++|.+++....  .+++..+..++.|+++||.|||+.|++||||||+||+++.++ .+++.|||......
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999999997643  588999999999999999999999999999999999999988 89999998654332


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ..        ....++..|+|||++.+  ..++.++|+||+||++|+|++|..||........-........        
T Consensus       162 ~~--------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  223 (267)
T PHA03390        162 TP--------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--------  223 (267)
T ss_pred             CC--------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------
Confidence            11        12245678999999965  3578999999999999999999999975432211111110000        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-HHhhhcCccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-ACNLLQHAFFKQ  307 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~~~~l~h~~~~~  307 (622)
                                           .........+++.+.+|+..||+.||.+||+ .+++++||||..
T Consensus       224 ---------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        224 ---------------------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ---------------------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                                 0001112357899999999999999999997 599999999963

>KOG0193|consensus

Probab=100.00  E-value=1.8e-38  Score=325.82  Aligned_cols=256  Identities=20%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ...+++..||+  |.||+||+|++-.   .||||.++....++++.+.|.+|+..+|+-+|.||+-|+|++..+.. -+|
T Consensus       392 ~ev~l~~rIGs--GsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  392 EEVLLGERIGS--GSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             HHhhccceecc--ccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            45667889999  7788999999863   59999999998899999999999999999999999999999988765 888


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      +.+|++.+|+.+++... ..++-.....|++||++|+.|||.++|||||||..||++.++++++|.|||++..-..-.+.
T Consensus       466 TqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             ehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            99999999999986543 35778889999999999999999999999999999999999999999999976321110110


Q ss_pred             ccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      ..  -....+.+.|||||++.. ..-.|++.+|||||||++|||++|..||...... +++-.+...             
T Consensus       545 ~q--~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qIifmVGrG-------------  608 (678)
T KOG0193|consen  545 QQ--LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QIIFMVGRG-------------  608 (678)
T ss_pred             cc--cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-heEEEeccc-------------
Confidence            00  112345678999999852 2346899999999999999999999999843332 222111111             


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                  +.++..  .........++++|+..||..++++||...++|.
T Consensus       609 ------------~l~pd~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  609 ------------YLMPDL--SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------------ccCccc--hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                        111110  1112345679999999999999999999999887

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.7e-37  Score=313.63  Aligned_cols=252  Identities=19%  Similarity=0.299  Sum_probs=198.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCc--EEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQ--LIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      ++|++.++||+  |+||.||+|..+.++.  .+|+|.++.. ......+.+.+|+++++++ +||||+++++++......
T Consensus         2 ~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGE--GNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecC--CCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            68999999999  8899999999988875  4788887632 2344556788999999999 799999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         86 HLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      ++++||+++|+|.+++....              ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence            99999999999999986532              1237888999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  230 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~  230 (622)
                      ++.|||.........     .......+..|+|||++..  ..++.++|||||||++|||++ |..||............
T Consensus       159 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~  231 (297)
T cd05089         159 KIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL  231 (297)
T ss_pred             EECCcCCCcccccee-----ccCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999753211100     0011112346999999865  357899999999999999997 99999766543322222


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ..+..+                                .....+++++.+|+.+||+.||.+||+++++++.
T Consensus       232 ~~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         232 PQGYRM--------------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             hcCCCC--------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111100                                0123468899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-37  Score=320.94  Aligned_cols=228  Identities=48%  Similarity=0.808  Sum_probs=187.4

Q ss_pred             EeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeecc
Q psy15039        363 ICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM  442 (622)
Q Consensus       363 ~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~  442 (622)
                      ++++||+|.++|+.||+++++.+|+.||+|++..........+.+.+|+.+++.++|||||++++++...+..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789998778999999999999999999999776555555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC---CCce
Q psy15039        443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT---KKKV  519 (622)
Q Consensus       443 ~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~---~~~~  519 (622)
                      ++|+|.+++..+...++++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.||+........   ....
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            9999999997654456889999999999999999999999999999999999999999999998753322111   1111


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  590 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~  590 (622)
                      ........++..|||||++.++...|+.++|||||||++|||++|+.||...+..........+..|.+.+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            11222234566799999997644468999999999999999999999998877666666666665554443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.9e-37  Score=309.41  Aligned_cols=250  Identities=19%  Similarity=0.307  Sum_probs=201.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .+|++.+.||+  |+||.||+|.++. ++.||+|.+....  ......+.+|+.+|+.++||||+++++++......+++
T Consensus         6 ~~y~~~~~ig~--g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           6 EEFTLERKLGS--GYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHhhhhcc--CCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            47999999999  7788999999998 8899999987653  23345678999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.......... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            9999999999999765444578999999999999999999999999999999999999999999999987644321110 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                         ...+...+..|+|||.+..  ..++.++|||||||++|+|++ |+.||..............+..            
T Consensus       160 ---~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  222 (261)
T cd05148         160 ---LSSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR------------  222 (261)
T ss_pred             ---cccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc------------
Confidence               1112233457999999865  357889999999999999998 8999976554332222211110            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                          ...+...++++.+++.+||+.||++|||+.++++
T Consensus       223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 --------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                0112356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.9e-37  Score=306.55  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=209.3

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |+||.||+++++.+|+.+|+|.+......+.+...+.+|++++++++||||+++++++.+....++|+
T Consensus         1 ~y~~~~~i~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGK--GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecC--CCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            5999999999  77889999999999999999999876655666677889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         90 PLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||+++++|.+++....  ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+++.|||........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--  156 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence            9999999999886532  235789999999999999999999999999999999999999999999999875433221  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                          ......++..|+|||.+.+  ..++.++|+||+|+++|+|++|+.||..............+..|.          
T Consensus       157 ----~~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  220 (256)
T cd08530         157 ----MAKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP----------  220 (256)
T ss_pred             ----CcccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----------
Confidence                1112234567999999865  357889999999999999999999998665433222222221111          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                            ....++.++.+++.+||..||++||++.++++||+.
T Consensus       221 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         221 ----------------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----------------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                                  112467889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.8e-37  Score=312.14  Aligned_cols=254  Identities=19%  Similarity=0.278  Sum_probs=200.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      .+|.+.+.||+  |+||.||+|++.     .++..||+|.+....  ....+.+.+|++++++++||||+++++++....
T Consensus         5 ~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGE--GAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecc--cCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            47999999999  778899999864     456779999985532  344567889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  149 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~  149 (622)
                      ..++||||+++++|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            99999999999999999875321              2378899999999999999999999999999999999999999


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI  228 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~  228 (622)
                      .+++.|||..........  ........++..|+|||.+.+  ..++.++|||||||++|||++ |..||..........
T Consensus       161 ~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             cEEECCCCcccccCCCce--eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999997654322111  111222344567999999875  357889999999999999998 999997655433222


Q ss_pred             HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       229 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ....+..+.                                ....++..+.+++.+||+.||++||++.++++.
T Consensus       237 ~~~~~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         237 CITQGRVLE--------------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HHhCCCCCC--------------------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            221111110                                112357889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.2e-37  Score=307.01  Aligned_cols=250  Identities=18%  Similarity=0.357  Sum_probs=196.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..+|++.+.||+  |+||.||+|++..++ .||+|++.......   +.+.+|++++++++||||+++++.+. ....++
T Consensus         5 ~~~~~~~~~lg~--g~~~~v~~~~~~~~~-~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQ--GCFGEVWMGTWNGTT-RVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             hHHeeEeeecCC--CCCCcEEEEEecCCc-eEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            368999999999  778899999987664 59999987644332   45778999999999999999998874 456899


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|++.+++.......+++..+..++.|++.||+|+|+++|+||||||+||+++.++.+++.|||..........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999764444578899999999999999999999999999999999999999999999987643322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .   ......++..|+|||++..  ..++.++|+||+||++|+|++ |..||........ ...+....+          
T Consensus       158 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~----------  221 (262)
T cd05071         158 T---ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYR----------  221 (262)
T ss_pred             c---cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhcCCC----------
Confidence            1   1112234557999998864  357899999999999999999 8889976544332 222211100          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           .......+.++.+++.+||+.||++||++.++++
T Consensus       222 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ---------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                 0112345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.7e-37  Score=304.41  Aligned_cols=258  Identities=30%  Similarity=0.508  Sum_probs=210.5

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--CcEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHL   87 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~l   87 (622)
                      +|.+.+.||+  |++|.||+|.++.+++.||+|++......+...+.+.+|+.++++++||||+++++.+...  ..+++
T Consensus         1 ~~~~~~~i~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGR--GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeee--cCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            5889999999  7788999999999999999999987655556677889999999999999999999999988  88999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ++||++++++.+++....  .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+++.||+..........
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999999999987643  578999999999999999999999999999999999999999999999987654433221


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .  ........+..|+|||.+...  .++.++|+||+||++|+|++|..||............+....            
T Consensus       157 ~--~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  220 (260)
T cd06606         157 G--EGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG------------  220 (260)
T ss_pred             c--ccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC------------
Confidence            0  001123445679999998653  378899999999999999999999986653222222221100            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                        .....+..++.++.+++.+||..||++||++.++++||||
T Consensus       221 ------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         221 ------------------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ------------------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                              0001123357899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-36  Score=302.87  Aligned_cols=253  Identities=33%  Similarity=0.595  Sum_probs=207.3

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      +|++.+.||+  |++|.||++.++.+++.||+|++.....  ...+.+.+|+.++++++||||+++++.+..+...++++
T Consensus         1 ~y~~~~~l~~--g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGK--GGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             Cceeeeeecc--CCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            5899999999  7789999999999999999999876543  45567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+++.||+..........  
T Consensus        77 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             ecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999999999987643 3588999999999999999999999999999999999999999999999987644332211  


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                         .....++..|+|||.+...  .++.++|+||+||++|+|++|..||.................+.            
T Consensus       154 ---~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------  216 (253)
T cd05122         154 ---RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG------------  216 (253)
T ss_pred             ---ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC------------
Confidence               1122345679999998754  37889999999999999999999998664332222221111111            


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                                        ......++.++.+++..||+.||++|||+.++++|||
T Consensus       217 ------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ------------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ------------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                              1112235788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.5e-37  Score=313.05  Aligned_cols=257  Identities=19%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCC-----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTN-----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      -.++|++.+.||+  |+||.||++.++.+.     ..||+|.+.... .......+.+|+.+|+++ +||||+++++++.
T Consensus        10 ~~~~~~~~~~ig~--g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053          10 PRDRLTLGKPLGE--GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             CHhHeEEeeEecc--cccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3468999999999  778899999987544     789999987543 344556788999999999 8999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS  146 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~  146 (622)
                      ....++++|||+++|+|.+++....              ...+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            9999999999999999999986421              23478899999999999999999999999999999999999


Q ss_pred             CCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHH
Q psy15039        147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTL  225 (622)
Q Consensus       147 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~  225 (622)
                      .++.+++.|||...........  ........+..|+|||++..  ..++.++|||||||++|||++ |..||.......
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYY--RKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             CCCeEEeCccccccccccccce--eccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            9999999999976443221110  00111123456999999864  457899999999999999997 999997655433


Q ss_pred             HHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       226 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .......+..+                                ..+...+.++.+|+.+||..||++|||+.+++++
T Consensus       243 ~~~~~~~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYRM--------------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCcC--------------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            22221111100                                0122457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-37  Score=309.06  Aligned_cols=256  Identities=16%  Similarity=0.273  Sum_probs=201.3

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccC-----CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVT-----NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      ..++|++.+.||+  |+||.||+|..+..     +..||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus         4 ~~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           4 PREKITLIRELGQ--GSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             chHHeeEEeEecC--CCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4578999999999  77899999998754     4899999986543 33445667899999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEE
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFN--------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                      ....++||||+++|+|.+++.....        ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+++
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            9999999999999999999865321        13577889999999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHh
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~  232 (622)
                      .|||...........  .......++..|+|||.+..  ..++.++|||||||++|||++ |..||..............
T Consensus       161 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         161 GDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             CCcccchhhccCccc--ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            999976433221110  01112234567999999865  357889999999999999998 9999976544332222211


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      +..+.                                .+..++.++.+++..||+.||++|||+.++++
T Consensus       237 ~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 GGHLD--------------------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCC--------------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11110                                12235788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-37  Score=310.64  Aligned_cols=255  Identities=25%  Similarity=0.433  Sum_probs=202.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||.||+|.++.+|+.||||.+..... .......+.+|+.+++.++||||++++++|..++..++
T Consensus         2 ~~y~~~~~ig~--g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGR--GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcc--cCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            57999999999  7788999999999999999999876433 33445678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         88 VSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +|||+++++|.+++....  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            999999999999886432  234789999999999999999999999999999999999999999999999865433221


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH-HHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL-MLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~~~  244 (622)
                      ...    .....++..|+|||.+..  ..++.++|+||+||++|+|++|..||....... .....+...          
T Consensus       160 ~~~----~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (267)
T cd08229         160 TTA----AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----------  223 (267)
T ss_pred             Ccc----cccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC----------
Confidence            111    112345667999999865  357889999999999999999999997543321 111111100          


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                          ..+......+++++.+++.+||..||++|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         224 --------------------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             --------------------CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                                0001122347889999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-37  Score=305.83  Aligned_cols=251  Identities=20%  Similarity=0.332  Sum_probs=199.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |++|.||+|.... ++.||||.+......   .+.+.+|+.+|++++||||+++++++......++
T Consensus         5 ~~~~~~~~~lg~--g~~~~v~~~~~~~-~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGA--GQFGEVWEGLWNN-TTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecc--cCCccEEEEEecC-CeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            468999999999  7788999999764 568999998765432   3457789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||..........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999999999765434578999999999999999999999999999999999999999999999997654432111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .   ...+...+..|+|||++..  ..++.++|+|||||++|+|++ |+.||.+........ .+....+          
T Consensus       159 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~----------  222 (261)
T cd05068         159 E---AREGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-QVDQGYR----------  222 (261)
T ss_pred             c---ccCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCC----------
Confidence            0   1111222356999998864  357889999999999999998 999998655433222 2211110          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           .......+.++.+++.+||+.||++||++.++++
T Consensus       223 ---------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 ---------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ---------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                 0112235788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.9e-37  Score=307.56  Aligned_cols=255  Identities=20%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..+|++.+.||+  |+||.||+|+++.++.   .||+|.++... .....+.+.+|+.+|++++||||+++++++..++.
T Consensus         3 ~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGA--GEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecc--cCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            468999999999  7788999999875554   79999986643 34456778899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+++.|||.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999999987643 3478889999999999999999999999999999999999999999999987654332


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ....... ......+..|+|||.+.+  ..++.++|+|||||++|++++ |..||........ ...+....        
T Consensus       159 ~~~~~~~-~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-~~~~~~~~--------  226 (267)
T cd05066         159 DPEAAYT-TRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGY--------  226 (267)
T ss_pred             ccceeee-cCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-HHHHhCCC--------
Confidence            2111111 111222457999999875  357899999999999999886 9999976543322 22221110        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                             ..+.....++++.+++.+||+.+|++||++.++++
T Consensus       227 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         227 -----------------------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----------------------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                   00112345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0577|consensus

Probab=100.00  E-value=6.6e-39  Score=326.05  Aligned_cols=218  Identities=29%  Similarity=0.485  Sum_probs=187.9

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      |.-+..||.  |+||.||.|++..+.+.||||++.-+... .+....+..|++.|+.++|||+|.|.+||......|+||
T Consensus        28 f~dLrEIGH--GSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   28 FSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHhcC--CccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            556678999  88999999999999999999999866433 334567999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      |||- |+-.|++.-+. .++.+..+..|+.+.+.||+|||+++.||||||..|||+++.|.+|++|||.++...+     
T Consensus       106 EYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             HHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence            9997 68889887664 3688999999999999999999999999999999999999999999999997654332     


Q ss_pred             eccCCCCCCCCccccccccccCc-cCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  590 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~  590 (622)
                         ..+.+|||+||||||+.... +.|+-++|||||||++.||+-.+||.+..+....++.+.....|.+.+
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs  247 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS  247 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC
Confidence               24578999999999995311 369999999999999999999999999999988887766666555554

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-37  Score=316.24  Aligned_cols=205  Identities=19%  Similarity=0.300  Sum_probs=174.9

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      .|+..+.||+  |+||.||++.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~f~~~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGK--GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEec--CCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            3788899999  889999999999999999999987554332 2234578999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||+++|+||||||+|||+++++.+++.|||.+.......  
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            999999999988765444467899999999999999999999999999999999999999999999999765432211  


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                         ......+|+.|||||++.+  ..|+.++|||||||++|||++|++||.....
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~  206 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE  206 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence               1123457889999999975  4689999999999999999999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5e-37  Score=319.21  Aligned_cols=288  Identities=20%  Similarity=0.242  Sum_probs=205.6

Q ss_pred             CceEEeecccccCCceeEEEEEEccC--CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC----
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVT--NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA----   82 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~----   82 (622)
                      +|++.+.||+  |+||.||+++++.+  +..||||++..........+.+.+|+.+++++ +||||+++++.+...    
T Consensus         1 ~y~~~~~lg~--G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQ--GAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccc--cCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            5899999999  77899999999988  99999999875433334456678899999999 599999999875432    


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..++++++|++ ++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+++.|||.....
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            45889999887 6888887653  35789999999999999999999999999999999999999999999999976543


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLD  240 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~  240 (622)
                      ...............++..|+|||++.++ ..++.++||||+||++|+|++|.+||...+....+...+  .+.++.  +
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~  232 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE--E  232 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH--H
Confidence            32211111111123456789999988643 457899999999999999999999998655433222222  111110  0


Q ss_pred             cccccccCCCCcCcccccccchhhhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ...   .. ..................  .......+.++.+|+.+||+.||++|||+.+++.|||+++..
T Consensus       233 ~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         233 TLS---RI-GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             HHH---hh-hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            000   00 000000000000000000  011223578899999999999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.9e-37  Score=305.03  Aligned_cols=245  Identities=20%  Similarity=0.321  Sum_probs=192.8

Q ss_pred             ecccccCCceeEEEEE--EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         16 ILGQCFNNLSSVYLSK--HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        16 ~lG~g~g~~~~V~~~~--~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      .||+  |+||.||+|.  .+.+++.||+|+++.........+.+.+|+.+|+.++||||+++++++. .+..++||||++
T Consensus         2 ~lg~--G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGS--GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCC--cCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            5888  7789999996  4678899999998766555556677889999999999999999999875 456789999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccC
Q psy15039         94 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  173 (622)
Q Consensus        94 ~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~  173 (622)
                      +|+|.+++...  ..+++..+..++.|++.||+|+|++||+||||||+|||++.++.+++.|||............ ...
T Consensus        79 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  155 (257)
T cd05116          79 LGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-KAK  155 (257)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-eec
Confidence            99999998653  247899999999999999999999999999999999999999999999999765432221111 011


Q ss_pred             CCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhC-CCCCCCccccccccCCCC
Q psy15039        174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAG-ATPHLLDCTTYYVDTGQD  251 (622)
Q Consensus       174 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~  251 (622)
                      .....+..|+|||.+..  ..++.++|||||||++|||++ |..||....... ....+.. ..+               
T Consensus       156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~i~~~~~~---------------  217 (257)
T cd05116         156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-VTQMIESGERM---------------  217 (257)
T ss_pred             CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCC---------------
Confidence            11223467999999864  357889999999999999997 999997654332 2222221 111               


Q ss_pred             cCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        252 DGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                       ..+...++++.++|..||+.||++||+++++.+
T Consensus       218 -----------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 -----------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                             112346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=312.26  Aligned_cols=282  Identities=23%  Similarity=0.329  Sum_probs=207.2

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--CcEEEE
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLV   88 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lv   88 (622)
                      |++.+.||+  |+||.||+|+++.+|+.||+|++......+...+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         1 y~~~~~l~~--g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGE--GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEecc--CCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            789999999  7789999999999999999999987643444456678999999999999999999999988  789999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      +||++ +++.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+++.|||...........
T Consensus        79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          79 FEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             ecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            99998 47888776532 35889999999999999999999999999999999999999999999999976544332211


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~~~~~  246 (622)
                      .   .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.............  .+..+ .....    
T Consensus       157 ~---~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~----  227 (287)
T cd07840         157 D---YTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT-DENWP----  227 (287)
T ss_pred             c---ccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-hhhcc----
Confidence            1   1122345679999987643 357889999999999999999999998765443322221  11111 00000    


Q ss_pred             cCCCCcCcccc-cccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        247 DTGQDDGEENA-CSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       247 ~~~~~~~~~~~-~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ........... .................++++.+++..||..||++||++.++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            00000000000 000000000000111248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0574|consensus

Probab=100.00  E-value=5e-40  Score=309.70  Aligned_cols=215  Identities=30%  Similarity=0.524  Sum_probs=187.8

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ..|.++..||.  |+||.||+|.|+.+|+.+|||++..+    .+++.+..||.+|++++.|++|+||++|....++|+|
T Consensus        33 EVFDi~~KLGE--GSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   33 EVFDIVGKLGE--GSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHHhcC--CcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            34788889999  78999999999999999999998764    4567889999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      ||||.-|++.|+++.. ..++++..+..++++.+.||+|||...-||||||..|||++.+|.++++|||.+-.+.....+
T Consensus       107 MEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             hhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            9999999999998764 347899999999999999999999999999999999999999999999999986554432211


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCC
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  586 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p  586 (622)
                          ..+..|||.||||||+..  -+|+.++||||||++..||+.|++||.+-.+...++.+...++|
T Consensus       186 ----RNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP  247 (502)
T KOG0574|consen  186 ----RNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP  247 (502)
T ss_pred             ----hCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC
Confidence                245678999999999975  46999999999999999999999999988776666655555444

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.3e-38  Score=325.34  Aligned_cols=214  Identities=20%  Similarity=0.343  Sum_probs=181.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...+|++.+.||+  |+||.||+|+++.+++.||||++..... .....+.+.+|+.+++.++|||||++++++.+.+..
T Consensus        16 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         16 KLSDFEMGETLGT--GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CchheEEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            3578999999999  8899999999999999999999875432 223356788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999999987643  4688888899999999999999999999999999999999999999999976433221


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                             .....+|+.|+|||++.+  ..++.++|||||||++|||++|++||.+.+... +.+.+...
T Consensus       172 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~  230 (329)
T PTZ00263        172 -------TFTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAG  230 (329)
T ss_pred             -------cceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcC
Confidence                   123457889999999975  457899999999999999999999998765544 34444433

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-36  Score=308.68  Aligned_cols=253  Identities=17%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcE----EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL----IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~----vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.    ||+|.+.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus         6 ~~~~~~~~~lg~--G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGS--GAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCC--CCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            468999999999  77889999999888874    8999986543 44555678899999999999999999998875 4


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++++||+++|++.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||......
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            5789999999999999987642 347899999999999999999999999999999999999999999999999765443


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......  .......+..|+|||.+.+  ..++.++|||||||++|||++ |..||....... +...+....       
T Consensus       161 ~~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~-------  228 (279)
T cd05109         161 IDETEY--HADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLLEKGE-------  228 (279)
T ss_pred             ccccee--ecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCC-------
Confidence            221111  1112233567999999865  358899999999999999998 999997544322 122221100       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              .......++.++.+++..||..||++||++.+++.
T Consensus       229 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         229 ------------------------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ------------------------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    00112346788999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG4717|consensus

Probab=100.00  E-value=2.9e-38  Score=316.76  Aligned_cols=214  Identities=27%  Similarity=0.423  Sum_probs=190.2

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .+.+-|.+.+.||+  |-|++|-+|+|.-||+.||||+|.+..++.-....+..|++.|+..+|||||++|.+.-+...+
T Consensus        15 kIAGLYDLekTlG~--GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGR--GHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             ceeeeehhhhhhcC--CceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            35667999999999  7799999999999999999999999888877777899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCceEEcCcccccccCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~-~~~~~~~~~~~~~~~~~~  514 (622)
                      |||.|+=++|+|.|++-++. .++.|..+.+|++||+.|+.|+|+.++|||||||+||++- +-|-+|+.|||+.-.|.+
T Consensus        93 yLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999999998764 4799999999999999999999999999999999999875 458999999999777665


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCC-chhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      .+..     .+.+|++.|-|||++.+  ..|+ +++||||||||||.|+.|++||...++-+.+-.
T Consensus       172 G~kL-----~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm  230 (864)
T KOG4717|consen  172 GKKL-----TTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM  230 (864)
T ss_pred             cchh-----hcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh
Confidence            4432     34688999999999987  5687 578999999999999999999998877665533

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.9e-37  Score=309.45  Aligned_cols=254  Identities=18%  Similarity=0.278  Sum_probs=201.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ..+|.+.++||+  |+||.||++..     ..++..+|+|.+...  .......+.+|+++++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           4 RRDIVLKWELGE--GAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             hHhceeccccCC--ccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            357899999999  88999999974     346778999997643  345566788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFN-------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  149 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~-------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~  149 (622)
                      ...+++|||+++|+|.+++.....             ..+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            999999999999999999876431             2378899999999999999999999999999999999999999


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI  228 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~  228 (622)
                      .+++.|||..........  .........++.|+|||.+.+  ..++.++|||||||++|||++ |.+||..........
T Consensus       160 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             CEEECCCCceeEcCCCce--eecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            999999997654322111  111122233567999999875  357899999999999999998 999997654433322


Q ss_pred             HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       229 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ....+..+                                .....+++.+.+++.+||+.||.+||++.++++
T Consensus       236 ~~~~~~~~--------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         236 CITQGREL--------------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHcCccC--------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22222111                                112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-37  Score=305.77  Aligned_cols=251  Identities=20%  Similarity=0.365  Sum_probs=198.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..+|++.+.||+  |+||.||+++++ ++..+|+|.+.......   ..+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~--G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           3 PSELTFLKELGS--GQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             hHHcchhhhhcc--CCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            357899999999  778899999987 46789999987554433   346679999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++++|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........
T Consensus        77 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            9999999999999876432 578999999999999999999999999999999999999999999999986543221110


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                         .......++..|+|||.+.+  ..++.++|||||||++|+|++ |..||........ ...+....+          
T Consensus       156 ---~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~----------  219 (256)
T cd05059         156 ---TSSQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-VESVSAGYR----------  219 (256)
T ss_pred             ---cccCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-HHHHHcCCc----------
Confidence               11112233457999999875  358889999999999999998 8999976543322 222211100          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                           ...+...+.++.+++.+||..+|++|||+.++++.
T Consensus       220 ---------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ---------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                                 01123368899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.5e-37  Score=314.42  Aligned_cols=258  Identities=28%  Similarity=0.497  Sum_probs=206.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ...|+..+.||+  |+||.||+|+++.+++.||||.+.... ......+.+.+|+++++.++||||+++++++......+
T Consensus        14 ~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          14 EKLFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHHHHheee--CCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            346888999999  778899999999999999999987542 23445567889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+. |++.+++.... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+++.|||........ 
T Consensus        92 lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9999997 67777765433 34789999999999999999999999999999999999999999999999875432211 


Q ss_pred             ccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                             ....++..|+|||.+.. ....++.++|||||||++|+|++|..||..............+..|.        
T Consensus       169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  233 (308)
T cd06634         169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------  233 (308)
T ss_pred             -------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC--------
Confidence                   12234567999999752 12346789999999999999999999997654333222222211111        


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                             .....++..+.++|.+||..+|++||++.+++.|||+...
T Consensus       234 -----------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         234 -----------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -----------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                                   1123467889999999999999999999999999999774

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-37  Score=323.34  Aligned_cols=293  Identities=22%  Similarity=0.276  Sum_probs=211.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC--
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA--   82 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--   82 (622)
                      .+.++|++.+.||+  |+||.||+|.++.+|+.||||++............+.+|+.+++++ +||||+++++++...  
T Consensus         4 ~~~~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           4 HILRKYEILQKLGK--GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhhHHHHhHhhcC--CCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            56789999999999  7788999999999999999999865433344455677899999999 999999999998654  


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+++||||++ ++|.+.+...   .+++.....++.||+.||+|||++||+||||||+||+++.++.+++.|||.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            36899999997 5888887653   4778888999999999999999999999999999999999999999999876433


Q ss_pred             CCCCccc-cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCC
Q psy15039        163 SPTKKKV-HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLL  239 (622)
Q Consensus       163 ~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~  239 (622)
                      ....... ........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||..........+...  +..+. .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~  235 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA-E  235 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH-H
Confidence            2211100 0001122356789999988653 4578899999999999999999999976554433222211  11110 0


Q ss_pred             ccccccccCCCCcCcccccccchhhhh--ccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQT--QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                      +.     ..............+.....  .......++.++.+++..||+.||++|||+.++++|||+++....
T Consensus       236 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         236 DI-----ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HH-----HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence            00     00000000000000000000  000112368899999999999999999999999999999886543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-37  Score=309.11  Aligned_cols=251  Identities=29%  Similarity=0.458  Sum_probs=195.0

Q ss_pred             eEEeecccccCCceeEEEEEEc----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039         12 KICSILGQCFNNLSSVYLSKHK----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus        12 ~~~~~lG~g~g~~~~V~~~~~~----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++.+.||.  |.||.||+|...    ..+..||||.++.. ...+..+.+.+|+++|++++||||+++++++......++
T Consensus         2 ~~~~~ig~--G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGE--GSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEE--ESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEcc--CCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccc
Confidence            46788999  668899999988    56788999999553 455567889999999999999999999999998888999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |+|||++|+|.+.+.......+++..+..++.|++.||.|||+++|+|+||+++||+++.++.+|+.+||..........
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999886344688999999999999999999999999999999999999999999999987654421111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .  ...........|+|||.+...  .++.++||||||+++|||++ |+.||....... +...+...            
T Consensus       159 ~--~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-~~~~~~~~------------  221 (259)
T PF07714_consen  159 Y--KNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-IIEKLKQG------------  221 (259)
T ss_dssp             E--EESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-HHHHHHTT------------
T ss_pred             c--ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc-cccccccc------------
Confidence            1  111223345679999999764  37899999999999999999 789997764433 23332211            


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                         ........++..+.+++..||..||++||++.++++
T Consensus       222 -------------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  222 -------------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -------------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -------------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                               011123457889999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=328.83  Aligned_cols=217  Identities=21%  Similarity=0.349  Sum_probs=180.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus         1 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGR--GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEe--cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            47999999999  88999999999999999999999754322 2334668899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..+.....
T Consensus        79 v~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999999987643  478999999999999999999999999999999999999999999999997543321100


Q ss_pred             ce----------------------------------eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc
Q psy15039        518 KV----------------------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN  563 (622)
Q Consensus       518 ~~----------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt  563 (622)
                      ..                                  .....+..||+.|||||++..  ..|+.++|||||||++|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhhc
Confidence            00                                  001113468999999999965  468999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHH
Q psy15039        564 GTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       564 g~~Pf~~~~~~~~~~~~~  581 (622)
                      |.+||...+........+
T Consensus       235 G~~Pf~~~~~~~~~~~i~  252 (364)
T cd05599         235 GYPPFCSDNPQETYRKII  252 (364)
T ss_pred             CCCCCCCCCHHHHHHHHH
Confidence            999998876655443333

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.2e-37  Score=318.21  Aligned_cols=286  Identities=23%  Similarity=0.321  Sum_probs=209.9

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-CC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-AT   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~   83 (622)
                      ..+.++|++.+.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.++++++||||++++++|.. ..
T Consensus         6 ~~~~~~y~~~~~ig~--g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGM--GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecc--cCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            356789999999999  779999999999999999999987654444455677899999999999999999999876 46


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++++||++ +++.++++.   ..+++..+..++.|+++||+|||++||+||||||+|||++.++.+++.|||......
T Consensus        84 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          84 DIYFVTELLG-TDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             cEEEEeehhc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            7899999985 678877754   247888889999999999999999999999999999999999999999998754321


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH--HHHHHhCCCCCCCcc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM--LIEKLAGATPHLLDC  241 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~--~~~~~~~~~p~~~~~  241 (622)
                      ..       ..+..++..|+|||.+.+. ..++.++|+||+||++|+|++|+.||........  ......+..|.-  .
T Consensus       160 ~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~--~  229 (328)
T cd07856         160 PQ-------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD--V  229 (328)
T ss_pred             CC-------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH--H
Confidence            11       1122345679999987542 3578999999999999999999999976543221  122222222110  0


Q ss_pred             ccccccCCCCcCcccccccchhhhh-cc-ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQT-QV-LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~-~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                          ..................... +. .....+++++.++|++||+.||++||++.+++.||||...+.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         230 ----INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             ----HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence                000000000000000000000 00 011246789999999999999999999999999999976544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=306.42  Aligned_cols=252  Identities=25%  Similarity=0.315  Sum_probs=197.4

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHH-HhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVC-MRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||.||+|+++.+|+.||||.+...... ......+..|..+ .+.++||||+++++++...+..|+++||+
T Consensus         2 ~~l~~--g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISK--GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCc--CCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            56888  77889999999999999999998764332 2223334455544 45669999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||+|+||+++.++.+++.|||.......        
T Consensus        80 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--------  149 (260)
T cd05611          80 NGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--------  149 (260)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--------
Confidence            999999999764  3578999999999999999999999999999999999999999999999986533221        


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      .....++..|+|||.+.+.  .++.++||||+|+++|+|++|..||..............+...                
T Consensus       150 ~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------  211 (260)
T cd05611         150 NKKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN----------------  211 (260)
T ss_pred             cccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC----------------
Confidence            1122345679999998764  3789999999999999999999999765544332222111100                


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH---HhhhcCccccccc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA---CNLLQHAFFKQTK  309 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~---~~~l~h~~~~~~~  309 (622)
                                   .+......+++++.+++.+||..||++||++   .|++.||||++.+
T Consensus       212 -------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         212 -------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             -------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence                         0000112468899999999999999999955   7999999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.9e-37  Score=311.75  Aligned_cols=255  Identities=16%  Similarity=0.277  Sum_probs=199.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ++|++.+.||+  |+||.||+|++..     +++.||||+++... .......+.+|+.++++++|||||++++++....
T Consensus         5 ~~~~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGE--DRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCC--CCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            46889999999  7789999999764     36889999987543 3344566889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  149 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~  149 (622)
                      ..++++||+.++++.+++....              ...+++..+..++.|++.||+|+|++||+||||||+|||++.++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            9999999999999999985321              12367888999999999999999999999999999999999999


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI  228 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~  228 (622)
                      .+++.|||...........  ........++.|+|||.+..+  .++.++||||+||++|||++ |..||.+........
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05091         162 NVKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE  237 (283)
T ss_pred             ceEecccccccccccchhe--eeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999975443221111  011122335679999998653  47889999999999999998 888987654433222


Q ss_pred             HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       229 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ....+..+                                .....++.++.+++..||+.||++||++.++++.
T Consensus       238 ~i~~~~~~--------------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQVL--------------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCCcC--------------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            22221111                                1123467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-36  Score=305.11  Aligned_cols=251  Identities=20%  Similarity=0.351  Sum_probs=196.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..++|++.+.||+  |+||.||+|... ++..||+|.+.......   +.+.+|+.+|++++||||+++++++. ....+
T Consensus         4 ~~~~~~~~~~ig~--g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGN--GQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheecc--ccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            3568999999999  778899999876 56679999987654432   35778999999999999999999875 45689


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ++|||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||....+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999999999876544457899999999999999999999999999999999999999999999999764432211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..   ...+..++..|+|||.+..  ..++.++|||||||++|+|++ |..||......... ..+....+         
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-~~~~~~~~---------  221 (260)
T cd05070         157 YT---ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL-EQVERGYR---------  221 (260)
T ss_pred             cc---cccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCC---------
Confidence            10   0111223456999999864  347889999999999999999 89999765433322 22211100         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                            ...+...+..+.+++.+||..||++|||+.++.+
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 ----------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                  0112345788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.8e-37  Score=311.73  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=204.7

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      .|+....||+  |+||.||++.++.+|+.||||++....  ......+.+|+.+++.++||||+++++.|...+..+++|
T Consensus        21 ~~~~~~~lg~--g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          21 YLDNFIKIGE--GSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             HhhhHHHcCC--CCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence            3444567898  778899999999999999999985432  334566889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||++++++.+++..   ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.|||........... 
T Consensus        97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-  172 (292)
T cd06657          97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  172 (292)
T ss_pred             ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-
Confidence            99999999988754   24788999999999999999999999999999999999999999999999865433211100 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                         .....++..|+|||.+..  ..++.++|+||+||++|+|++|..||......... ..+....|.            
T Consensus       173 ---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~------------  234 (292)
T cd06657         173 ---RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPP------------  234 (292)
T ss_pred             ---ccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCCc------------
Confidence               112234667999999864  34788999999999999999999999765443222 111111110            


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                       ........+.++.+++.+||..||.+||++.+++.||||.....
T Consensus       235 -----------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         235 -----------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -----------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                             00012245788999999999999999999999999999988664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=312.68  Aligned_cols=280  Identities=25%  Similarity=0.334  Sum_probs=208.6

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEee
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP   90 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e   90 (622)
                      |++.+.||+  |++|.||+|++..+|+.+|+|+++.....+.....+.+|+++|++++||||+++++++.+....++++|
T Consensus         1 y~~~~~i~~--g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGE--GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             Cccceeeec--CCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            778899999  778899999999999999999997765544556678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccc
Q psy15039         91 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH  170 (622)
Q Consensus        91 ~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~  170 (622)
                      |+++ ++.+.+.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+++.||+...........  
T Consensus        79 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~--  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--  154 (283)
T ss_pred             ccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc--
Confidence            9985 8888776643 35889999999999999999999999999999999999999999999999876544332211  


Q ss_pred             ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH---hCCCCCCCcccccccc
Q psy15039        171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL---AGATPHLLDCTTYYVD  247 (622)
Q Consensus       171 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~  247 (622)
                        ......+..|+|||.+.+. ..++.++|+||+||++|+|++|+.||........+....   ....+......   ..
T Consensus       155 --~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  228 (283)
T cd05118         155 --YTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF---TS  228 (283)
T ss_pred             --ccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc---hh
Confidence              1112345679999998753 357889999999999999999999997665433332221   11111100000   00


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      . ..............  ........++.++.++|..||+.||.+||++.+++.||||
T Consensus       229 ~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         229 L-ARNYKFSFPKKAGM--PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             h-hhhhhhhhcccccc--CHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            0 00000000000000  0000123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=308.55  Aligned_cols=278  Identities=22%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCcceeEEEEEEeCCc---
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFLDATD---   84 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~~~~~~~~~~~---   84 (622)
                      |++.+.||+  |+||.||+|+++.+++.||||.+......+.....+.+|+.+++++   +||||+++++++...+.   
T Consensus         1 y~~~~~l~~--g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGE--GAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecc--cCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            789999999  7788999999999999999999976544444445566788877766   59999999999998876   


Q ss_pred             --EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         85 --LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        85 --~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                        .+++|||+. +++.+++.......+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+++.|||.....
T Consensus        79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence              999999998 47888886644345899999999999999999999999999999999999999999999999976443


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCC-CCCCCcc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA-TPHLLDC  241 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~-~p~~~~~  241 (622)
                      .....     .....++..|+|||++.+.  .++.++|+||+||++|+|++|.+||................ .+.....
T Consensus       158 ~~~~~-----~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         158 SFEMA-----LTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             cCCcc-----cccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence            22211     1122346679999998753  47889999999999999999999998665443332222110 0000000


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                          .... ...............  .......++.+.+++..||+.||++||++.++++||||
T Consensus       231 ----~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         231 ----PRNV-SLPRSSFPSYTPRSF--KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ----CCCc-ccchhhcccccccch--hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                0000 000000000000000  00112357888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.2e-36  Score=312.69  Aligned_cols=256  Identities=20%  Similarity=0.308  Sum_probs=200.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEcc-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKV-------TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF   79 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~   79 (622)
                      .++|.+++.||+  |+||.||+++++.       ++..||+|.++.+. .......+.+|+.+++++ +||||+++++++
T Consensus        17 ~~~~~i~~~lg~--G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          17 RDRLVLGKPLGE--GCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             hHHeEEeeeecc--CCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            378999999999  7799999998643       34679999987643 344556788999999999 899999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      ......|+||||+++|+|.+++.....              ..+++..+..++.|++.||+|||++|++||||||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            999999999999999999999976421              237788899999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.+++.|||............  .......+..|+|||.+.+  ..++.++|+||+||++|+|++ |..||...+..
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             cCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999999999999754332111000  0111122357999999865  357899999999999999998 88999765543


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      . ....+....+                               ...+...+.++.+++..||..+|++||++.+++++
T Consensus       250 ~-~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 E-LFKLLKEGHR-------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             H-HHHHHHcCCC-------------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            2 2222211100                               00123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1006|consensus

Probab=100.00  E-value=3.4e-39  Score=299.83  Aligned_cols=264  Identities=25%  Similarity=0.407  Sum_probs=206.7

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHH-HhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC-MRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      +-+-++.||.  |+||+|++..|+.+|+..|||++..... ..+.+++.+|... |+.=+-||||+|||+.-.....|+.
T Consensus        65 ~Lqdlg~iG~--G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   65 NLQDLGEIGN--GAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             hHHHHHHhcC--CcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            3444556777  7788999999999999999999987654 4455678888864 4555789999999999888999999


Q ss_pred             eecCCCCCHHHHHH---hhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         89 SPLMGFGSCKDLIN---AHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        89 ~e~~~~g~l~~~l~---~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      ||+|+ -++..+-+   ...+..++|+.+..|..-.+.||+||.+. .|||||+||+|||++..|.+|++|||....+..
T Consensus       142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            99987 44443322   22334589999999999999999999864 899999999999999999999999997644432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH-HhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK-LAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~-~~~~~p~~~~~~~  243 (622)
                      +..+.     .-++-..|||||.+.....+|+-++|+||||++|||++||..|+..-+.....+.. +.|.+|.+...  
T Consensus       221 SiAkT-----~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~--  293 (361)
T KOG1006|consen  221 SIAKT-----VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD--  293 (361)
T ss_pred             HHHhh-----hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc--
Confidence            22221     12444579999999876678999999999999999999999999875554444444 44544433211  


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                               .....+|..+..+|..||.+|-+.||.-.+++.+||++...
T Consensus       294 -------------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  294 -------------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             -------------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence                                     01245899999999999999999999999999999997643

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6e-37  Score=310.18  Aligned_cols=258  Identities=24%  Similarity=0.349  Sum_probs=208.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~   86 (622)
                      .+|++.+.||+  |+||.||+++.+.+|+.||+|.++.+.. .....+.+.+|+.++++++ ||||+++++++.+++..+
T Consensus         1 ~~y~~~~~lg~--g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGE--GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecC--CCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            47999999999  8899999999999999999999876433 2334466789999999998 999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ++||++++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+++.|||.........
T Consensus        79 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            9999999999999997643  58899999999999999999999999999999999999999999999999765433221


Q ss_pred             ccc----------------cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH
Q psy15039        167 KKV----------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  230 (622)
Q Consensus       167 ~~~----------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~  230 (622)
                      ...                ........++..|+|||++...  .++.++|+||+||+++++++|..||............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            100                0001112335679999998653  4788999999999999999999999865433222221


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH----HhhhcCccc
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA----CNLLQHAFF  305 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~~~l~h~~~  305 (622)
                      ....                                 ...+..+++.+.+++.+||+.||++||++    .++++||||
T Consensus       235 ~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         235 LKLE---------------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HhcC---------------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            1110                                 01123458889999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-37  Score=323.08  Aligned_cols=213  Identities=19%  Similarity=0.327  Sum_probs=178.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCC-cEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTN-QLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~-~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ...+|++.+.||+  |+||.||+|+++.++ ..||+|++..... .......+.+|+.+++.++|||||++++++.+.+.
T Consensus        28 ~~~~y~~~~~ig~--G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         28 KYEDFNFIRTLGT--GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             ChhhcEEEEEEee--cCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            3567999999999  889999999977665 6899999865432 22345678899999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999999987643  478888999999999999999999999999999999999999999999997643321


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                             ...+..||+.|||||++.+  ..++.++|||||||++|||++|.+||...+... +...+..
T Consensus       184 -------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~  242 (340)
T PTZ00426        184 -------RTYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILE  242 (340)
T ss_pred             -------CcceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHhc
Confidence                   1123467889999999975  458889999999999999999999998765443 3444443

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=302.75  Aligned_cols=249  Identities=21%  Similarity=0.328  Sum_probs=200.4

Q ss_pred             eecccccCCceeEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeec
Q psy15039         15 SILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      +.||+  |+||.||+|.....   +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++.....++++|||
T Consensus         1 ~~ig~--g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGE--GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             Ccccc--CCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46888  77899999999876   9999999997654433 567788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         92 MGFGSCKDLINAHF-------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        92 ~~~g~l~~~l~~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++++|.+++....       ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999999997641       23589999999999999999999999999999999999999999999999997654432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ...  .........+..|+|||.+...  .++.++||||+||++|+|++ |..||..............+..        
T Consensus       158 ~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------  225 (262)
T cd00192         158 DDY--YRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR--------  225 (262)
T ss_pred             ccc--cccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            211  0111223446679999998753  58899999999999999998 6999987644332222211110        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ......++.++.+++.+||+.||++||++.+++++
T Consensus       226 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         226 ------------------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ------------------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                    01123458899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-36  Score=309.54  Aligned_cols=262  Identities=16%  Similarity=0.277  Sum_probs=202.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCC----------------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTN----------------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN   71 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~----------------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn   71 (622)
                      ..+|++.+.||+  |+||.||+|++..++                ..||+|.+.... .....+.+.+|+++|++++|||
T Consensus         4 ~~~~~~~~~lg~--G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGE--GQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhhCcccccccC--CCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCC
Confidence            468999999999  778999999887655                568999987653 3455677889999999999999


Q ss_pred             ceeEEEEEEeCCcEEEEeecCCCCCHHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q psy15039         72 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN---------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH  142 (622)
Q Consensus        72 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~---------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~N  142 (622)
                      |+++++++..+...+++||++++++|.+++.....         ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            99999999999999999999999999999876431         147899999999999999999999999999999999


Q ss_pred             EEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc--CCCCCCC
Q psy15039        143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN--GTVPFAE  220 (622)
Q Consensus       143 iLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~--g~~Pf~~  220 (622)
                      |+++.++.+++.|||.........  .........++..|+|||.+...  .++.++|||||||++|||++  |..||..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSD--YYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             eeecCCCceEEccccceeecccCc--ceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999999764332111  11111223345679999998753  57899999999999999987  7788876


Q ss_pred             CchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhh
Q psy15039        221 TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL  300 (622)
Q Consensus       221 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l  300 (622)
                      ......+........           ...              ..........++.++.+++..||+.||++|||+.+++
T Consensus       237 ~~~~~~~~~~~~~~~-----------~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~  291 (296)
T cd05051         237 LTDQQVIENAGHFFR-----------DDG--------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH  291 (296)
T ss_pred             cChHHHHHHHHhccc-----------ccc--------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence            544332222111000           000              0000011234678999999999999999999999996


Q ss_pred             c
Q psy15039        301 Q  301 (622)
Q Consensus       301 ~  301 (622)
                      +
T Consensus       292 ~  292 (296)
T cd05051         292 L  292 (296)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.6e-36  Score=303.83  Aligned_cols=255  Identities=16%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +++|+..+.||+  |+||.||+|+.+.+++   .+|+|.+.... .....+.+.+|+.++++++||||+++.+++.+.+.
T Consensus         4 ~~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGA--GEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecC--CCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            458999999999  7788999999987765   79999986543 34455678899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999987643 3578899999999999999999999999999999999999999999999997644322


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ....... ......+..|+|||++..  ..++.++|||||||++|||++ |+.||....... ....+....        
T Consensus       160 ~~~~~~~-~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~~~--------  227 (268)
T cd05063         160 DPEGTYT-TSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAINDGF--------  227 (268)
T ss_pred             cccccee-ccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhcCC--------
Confidence            2111111 111112346999999865  357899999999999999997 999997654322 222221110        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                             ..+.....+.++.+++.+||+.||++||++.++++
T Consensus       228 -----------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         228 -----------------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                   00112235778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=320.26  Aligned_cols=201  Identities=19%  Similarity=0.259  Sum_probs=170.2

Q ss_pred             cccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCCC
Q psy15039        367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG  445 (622)
Q Consensus       367 lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g  445 (622)
                      ||+  |+||.||++++..+++.||+|++..... .......+.+|+.+++.++|||||++++++...+..++||||+++|
T Consensus         1 lg~--G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGK--GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCc--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            577  8899999999999999999999875432 2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCC
Q psy15039        446 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  525 (622)
Q Consensus       446 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (622)
                      +|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......    .....
T Consensus        79 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~  152 (312)
T cd05585          79 ELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKTNT  152 (312)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----Ccccc
Confidence            9999987643  47888899999999999999999999999999999999999999999999754321111    11223


Q ss_pred             CCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       526 ~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ..||+.|||||++.+  ..|+.++|||||||++|||++|++||...+.....
T Consensus       153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~  202 (312)
T cd05585         153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY  202 (312)
T ss_pred             ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH
Confidence            467889999999975  46899999999999999999999999877655443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.4e-36  Score=302.73  Aligned_cols=252  Identities=17%  Similarity=0.357  Sum_probs=198.5

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      -..++|++.++||+  |+||.||+|..+ +++.||+|.+.......   ..+.+|+.+|++++||||+++++++. ....
T Consensus         3 ~~~~~~~~~~~ig~--G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05067           3 VPRETLKLVKKLGA--GQFGEVWMGYYN-GHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVVT-QEPI   75 (260)
T ss_pred             cchHHceeeeeecc--CccceEEeeecC-CCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence            35678999999999  778899999865 57789999987655432   45778999999999999999998864 4678


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +++|||+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.|||........
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999999999987654446788999999999999999999999999999999999999999999999876443211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ...   ......++..|+|||++..  ..++.++|||||||++|+|++ |+.||......... ..+....+        
T Consensus       156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~--------  221 (260)
T cd05067         156 EYT---AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-QNLERGYR--------  221 (260)
T ss_pred             Ccc---cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-HHHHcCCC--------
Confidence            110   1112233457999999865  357889999999999999998 99999765443322 22211100        


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                             .......+.++.+++.+||..||++||++++++.
T Consensus       222 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 -----------------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                   0112335788999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-37  Score=322.24  Aligned_cols=202  Identities=18%  Similarity=0.288  Sum_probs=170.8

Q ss_pred             eecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        365 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      +.||+  |+||.||+|+++.+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+++||||++
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGK--GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            36888  8899999999999999999999875432 23345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~~~  152 (323)
T cd05571          79 GGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----ATM  152 (323)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----Ccc
Confidence            999999887643  47888899999999999999999999999999999999999999999999754221111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  576 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~  576 (622)
                      ....||+.|||||++.+  ..|+.++|||||||++|||++|+.||...+....
T Consensus       153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  203 (323)
T cd05571         153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL  203 (323)
T ss_pred             cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHH
Confidence            23467889999999975  4689999999999999999999999987655443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0668|consensus

Probab=100.00  E-value=1.7e-38  Score=289.05  Aligned_cols=283  Identities=22%  Similarity=0.320  Sum_probs=205.0

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCC-
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT-   83 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~-   83 (622)
                      ...++|++.+.+|+  |.||.||.|.+..+++.+.||.++.-     ..+.+.|||+||..|+ |||||++++...+.. 
T Consensus        35 g~~ddYeivrk~GR--GKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGR--GKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cccchHHHHHHHcC--ccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            35689999999999  88999999999999999999998542     3356789999999997 999999999988864 


Q ss_pred             -cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCccccc
Q psy15039         84 -DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCP  161 (622)
Q Consensus        84 -~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~  161 (622)
                       .-.||.||...-+...+-.     .++...++.++.|++.||.|||+.||+|||+||.|++|++.. ++++.|.|++.-
T Consensus       108 ktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             cCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence             3668899998877665542     466788999999999999999999999999999999999764 788999887643


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc---hHHHHHHHHhCCCCCC
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP---TTLMLIEKLAGATPHL  238 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~---~~~~~~~~~~~~~p~~  238 (622)
                      ..+. .....    ..-+..|-.||++.. ...|+...|+|||||+++.|+..+-||+...   .+...+.++.|.... 
T Consensus       183 YHp~-~eYnV----RVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el-  255 (338)
T KOG0668|consen  183 YHPG-KEYNV----RVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL-  255 (338)
T ss_pred             cCCC-ceeee----eeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH-
Confidence            3222 22211    122456889999864 4578999999999999999999999997543   234444444442210 


Q ss_pred             Cccc-cccccCCCCcCcccccccchh-hhhccccC---CCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        239 LDCT-TYYVDTGQDDGEENACSYISE-QQTQVLTS---RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       239 ~~~~-~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .... .+.+...+.  .....+..+. ....+..+   .-.++++.||+.++|.+|.++|+||.|++.||||....
T Consensus       256 ~~Yl~KY~i~Ldp~--~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQ--FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HHHHHHHccCCChh--HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence            0000 000000000  0000000000 01111111   12579999999999999999999999999999997643

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-36  Score=308.20  Aligned_cols=255  Identities=17%  Similarity=0.300  Sum_probs=199.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .++|++.+.||+  |+||.||+|+++     .++..||+|.+.... .....+.+.+|+.++++++||||+++++++..+
T Consensus         4 ~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQ--GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccc--cccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            458999999999  779999999975     378899999986543 344456788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFN--------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH  142 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~--------------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~N  142 (622)
                      ...++++||+++|+|.+++.....                    ..+++..+..++.|++.||+|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            999999999999999999864311                    236788889999999999999999999999999999


Q ss_pred             EEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCC
Q psy15039        143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAET  221 (622)
Q Consensus       143 iLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~  221 (622)
                      |+++.++.+++.|||..........  .........+..|+|||++.+  ..++.++|||||||++|+|++ |..||.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             eEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999997543221110  000111223456999999865  358899999999999999997 88899765


Q ss_pred             chHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        222 PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       222 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ...........+..+                                .....++.++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDGNVL--------------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcCCCC--------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            443322211111100                                012346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-36  Score=311.24  Aligned_cols=265  Identities=27%  Similarity=0.436  Sum_probs=205.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      .-++|++.+.||+  |+||.||+|+++.+|+.||||.++..... .....+.+|+.++.++ +||||+++++++.+...+
T Consensus        13 ~~~~~~~~~~lg~--g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          13 DLNDLENLGEIGS--GTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             CcchheeeeEeec--cCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            4478999999999  67889999999999999999999765432 3345566788777666 499999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++|||++ +++.+++.... ..+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+++.|||.......
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99999985 57777776533 358899999999999999999997 5999999999999999999999999997644322


Q ss_pred             CCccccccCCCCCCCccccChhhhcccc--CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH-HHHhCCCCCCCcc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI-EKLAGATPHLLDC  241 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~-~~~~~~~p~~~~~  241 (622)
                      ....     ....++..|+|||.+....  ..++.++|||||||++|+|++|+.||.......... .......+..   
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  239 (296)
T cd06618         168 SKAK-----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL---  239 (296)
T ss_pred             CCcc-----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC---
Confidence            1111     1123456799999986432  347889999999999999999999997543322222 2222211110   


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                                 .....++.++.+|+.+||..||++||++.++++|+||...+..
T Consensus       240 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         240 ---------------------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence                                       0112467889999999999999999999999999999875543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=327.31  Aligned_cols=213  Identities=23%  Similarity=0.360  Sum_probs=177.3

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||++++..+++.||||++..... .....+.+.+|+.+++.++|||||+++++|.+.+..|+
T Consensus         1 ~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGK--GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEee--cCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            46899999999  8899999999999999999999865432 23345678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..+.....
T Consensus        79 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999999987643  478888999999999999999999999999999999999999999999997642211000


Q ss_pred             ------------ce-------------------------------eccCCCCCCCCccccccccccCccCCCchhhHHHH
Q psy15039        518 ------------KV-------------------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV  554 (622)
Q Consensus       518 ------------~~-------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  554 (622)
                                  ..                               .....+.+||+.|||||++.+  ..|+.++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSl  234 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEec
Confidence                        00                               000012468899999999965  468999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        555 GISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       555 Gvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ||++|||++|.+||.........
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~  257 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETY  257 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHH
Confidence            99999999999999876654433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-36  Score=301.76  Aligned_cols=246  Identities=22%  Similarity=0.351  Sum_probs=193.2

Q ss_pred             eecccccCCceeEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeec
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      ++||+  |+||.||+|+...++   ..||+|.+..+... ...+.+.+|+++|++++|||||++++++. .+..+++|||
T Consensus         1 ~~ig~--G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGH--GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCc--cCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            46899  789999999876655   78999999766543 44567889999999999999999999876 4568999999


Q ss_pred             CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccc
Q psy15039         92 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        92 ~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      +++|+|.+++....  .+++..+..++.|++.||+|||+++++||||||+|||++.++.+++.||+............ .
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-~  153 (257)
T cd05060          77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-R  153 (257)
T ss_pred             CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-c
Confidence            99999999997643  57899999999999999999999999999999999999999999999998765443222111 1


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQ  250 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  250 (622)
                      ......++..|+|||.+..  ..++.++|||||||++|+|++ |..||........ ...+....+              
T Consensus       154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~-~~~~~~~~~--------------  216 (257)
T cd05060         154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-IAMLESGER--------------  216 (257)
T ss_pred             cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHHcCCc--------------
Confidence            1111223456999999865  358899999999999999997 9999976544322 222211100              


Q ss_pred             CcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        251 DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       251 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                       ......++..+.+++.+||..||++||++.++++
T Consensus       217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             0122346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-36  Score=305.46  Aligned_cols=251  Identities=19%  Similarity=0.305  Sum_probs=195.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcE----EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQL----IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~----vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .+|++++.||+  |+||+||+|....+|+.    ||+|.+.... .......+..|+.++++++||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~--G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGS--GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCc--cCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence            58999999999  77889999999888874    7777764322 23344667789999999999999999998754 56


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++++||+++|+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+++.|||.......
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            788999999999999997643 3578999999999999999999999999999999999999999999999997654332


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHh-CCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA-GATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~-~~~p~~~~~~  242 (622)
                      .....  ......++..|+|||.+..+  .|+.++|||||||++|||++ |..||.+...... ...+. +..+      
T Consensus       162 ~~~~~--~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~------  230 (279)
T cd05111         162 DDKKY--FYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERL------  230 (279)
T ss_pred             CCccc--ccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC------
Confidence            21111  11122344579999998653  58899999999999999998 9999976543321 11111 1100      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                ......+.+..+++..||..||.+|||+.++++
T Consensus       231 --------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         231 --------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                      011224667899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0197|consensus

Probab=100.00  E-value=1.3e-37  Score=318.18  Aligned_cols=289  Identities=20%  Similarity=0.292  Sum_probs=213.6

Q ss_pred             HHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCCCccccccccccCCCccccccccccccccccccccccccccccCC
Q psy15039        277 SFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDN  356 (622)
Q Consensus       277 ~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (622)
                      ...+.+..|....+.+++.....|..|=-.....    .|..         .       ++.     .+.       -..
T Consensus       156 ~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~----~p~~---------~-------~~~-----~d~-------wei  203 (468)
T KOG0197|consen  156 ELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHT----KPQT---------P-------DLA-----RDP-------WEI  203 (468)
T ss_pred             HhhhhHHHHHhhhhccCcchhhcccCchhccCCC----CCCC---------C-------ccc-----cCC-------eee
Confidence            4556778888999999998887777653221110    0000         0       000     000       011


Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++.+++++.||+  |-||.|+.++... ...||+|.+....++.   ..+.+|+.+|+.|+|+|||++++++.....+|
T Consensus       204 ~r~~l~l~~~LG~--G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  204 PREELKLIRELGS--GQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             cHHHHHHHHHhcC--CccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            2344678889999  7799999998863 3478999987655554   45779999999999999999999999988999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      ||||||+.|+|.++|+......+.....+.++.||++|++||+++++|||||-..|||++++..+||+|||++.....+.
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999999987545557778888999999999999999999999999999999999999999999877433322


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCC-CCCCCCCcc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGAT-PHLLDCTTY  594 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~-p~~~~~~~~  594 (622)
                      .   ....+......|.|||.+..  ..|+.+||||||||+||||+| |+.|+.+.+..+.+-..-.|-+ |.-..||..
T Consensus       358 Y---~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  358 Y---TASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE  432 (468)
T ss_pred             e---eecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence            1   11222333457999999976  469999999999999999999 9999999877666544444422 333346655


Q ss_pred             cccCCCCcCccccc
Q psy15039        595 YVDTGQDDGEENAC  608 (622)
Q Consensus       595 ~~~~~~~~~~~~~~  608 (622)
                      .-+....|=.+.+.
T Consensus       433 vY~lM~~CW~~~P~  446 (468)
T KOG0197|consen  433 VYELMKSCWHEDPE  446 (468)
T ss_pred             HHHHHHHHhhCCcc
Confidence            44444444333333

>KOG0194|consensus

Probab=100.00  E-value=3.2e-37  Score=320.53  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCc---E-EEEEEecC-CCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQ---L-IAVKKFNL-DRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~---~-vAiK~~~~-~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +=.+.+.||+  |+||.||+|+-+..+.   . ||||..+. .....++.+.+.+|+++|++++|||||++||+......
T Consensus       158 ~v~l~kkLGe--GaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  158 DIELGKKLGE--GAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             Cccccceeec--ccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3345689999  6688999999876533   3 89999886 34677888899999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++|||+|.+|+|.+.|+.... .++..+...++.+.++||+|||+++++||||-.+|+|++.++.+|++|||.+..-. 
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~-  313 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS-  313 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc-
Confidence            9999999999999999987543 58888888999999999999999999999999999999998899999999854321 


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                         .........--...|+|||.+...  -|+.++|||||||++||+++ |..||.+..........+....+..     
T Consensus       314 ---~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~-----  383 (474)
T KOG0194|consen  314 ---QYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP-----  383 (474)
T ss_pred             ---ceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC-----
Confidence               111111111223579999999764  69999999999999999987 8999998776655444434333211     


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                .+..-+.+...++..|+..||++||++.++.+
T Consensus       384 --------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  384 --------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             --------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                                      12234667888999999999999999998865

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=301.68  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=199.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..+|++.+.||+  |+||.||+|...  |+.||||.+.....   ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus         5 ~~~~~~~~~ig~--g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGK--GEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeec--CCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            458999999999  778999999875  88999999865432   45678899999999999999999999999899999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||..........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999999999999765433578999999999999999999999999999999999999999999999987644321111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                             ....+..|+|||.+..  ..++.++|||||||++|+|++ |..||...+.... ...+....+          
T Consensus       158 -------~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~----------  217 (256)
T cd05039         158 -------SGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEKGYR----------  217 (256)
T ss_pred             -------cCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhcCCC----------
Confidence                   1122456999999864  347889999999999999997 9999976544332 222211100          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           ......+++++.+++.+||..+|++||++.+++.
T Consensus       218 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         218 ---------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ---------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                                 0011246789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.7e-36  Score=304.01  Aligned_cols=254  Identities=19%  Similarity=0.332  Sum_probs=189.9

Q ss_pred             eecccccCCceeEEEEEEcc--CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHKV--TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~--t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|....  ....+|+|.+.... .......+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         1 ~~lg~--G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGN--GWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCc--cCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            35888  7788999997533  45679999876543 3444566789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         93 GFGSCKDLINAHFN---FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        93 ~~g~l~~~l~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ++|+|.+++.....   ...++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.........  .
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  155 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED--Y  155 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch--h
Confidence            99999999876432   124677888999999999999999999999999999999999999999999753321111  1


Q ss_pred             cccCCCCCCCccccChhhhccc-----cCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQN-----LDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .........+..|+|||++...     ...++.++||||+||++|||++ |..||........+...+....+.++.   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  232 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK---  232 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC---
Confidence            1111222335579999997531     1346789999999999999998 788987654443333333222111100   


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              ......+++.+.+++..|+ .||++||++.++++
T Consensus       233 ------------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 ------------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ------------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                    0012346788899999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-36  Score=309.01  Aligned_cols=261  Identities=21%  Similarity=0.344  Sum_probs=205.7

Q ss_pred             CceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCC
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT   83 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~   83 (622)
                      +|++.+.||+  |+||.||+++..   .+|+.||+|.+.....  .....+.+.+|+++|+++ +||||+.++++|..+.
T Consensus         1 ~y~~~~~lg~--G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (290)
T cd05613           1 NFELLKVLGT--GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT   78 (290)
T ss_pred             Cceeeeeecc--CCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence            6999999999  778899999975   5899999999865432  122345677899999999 6999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++|+||+++++|.+.+...  ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+++.|||......
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            999999999999999998764  357899999999999999999999999999999999999999999999998764432


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch---HHHHHHHHhCCCCCCCc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLLD  240 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~---~~~~~~~~~~~~p~~~~  240 (622)
                      .....   ......++..|+|||.+..+...++.++||||+||++|+|++|..||.....   .......+....+    
T Consensus       157 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----  229 (290)
T cd05613         157 EDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----  229 (290)
T ss_pred             ccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC----
Confidence            21111   0112235667999999875444577899999999999999999999964321   1111111111100    


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                                  ..+..+++.+.+++.+||..||++||     ++.+++.||||....
T Consensus       230 ----------------------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         230 ----------------------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             ----------------------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence                                        11234678899999999999999997     899999999997754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3e-36  Score=303.69  Aligned_cols=256  Identities=18%  Similarity=0.336  Sum_probs=201.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..+|++.+.||+  |+||.||+|..+.++.   .||||.++.. ..+...+.+.+|+.++++++||||+++++++..+..
T Consensus         3 ~~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           3 VSCVKIEEVIGA--GEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             hHHeEEEeEecC--CCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            356999999999  7788999999988775   5999998654 345566788999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.|||.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          80 VMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999999987643 3478899999999999999999999999999999999999999999999987543322


Q ss_pred             CCcccc-ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        165 TKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...... ....+...+..|+|||.+.+  ..++.++||||+||++|||++ |..||........ ...+....       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~-~~~i~~~~-------  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-INAIEQDY-------  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH-HHHHHcCC-------
Confidence            111110 11111122346999999865  357899999999999999886 9999976544322 22221110       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              ..+....++..+.+++..||+.||++||++.++++
T Consensus       229 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 ------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    00112345778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-37  Score=327.97  Aligned_cols=215  Identities=23%  Similarity=0.306  Sum_probs=178.2

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++++.||+  |+||.||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++.|.+.+.+++
T Consensus         1 ~~y~~~~~lG~--G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGI--GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEe--CCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            47999999999  78999999999999999999998643221 2234568899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||++..+.....
T Consensus        79 v~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          79 VMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999999987643  478888899999999999999999999999999999999999999999997543210000


Q ss_pred             ---------------------------------------ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHH
Q psy15039        518 ---------------------------------------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC  558 (622)
Q Consensus       518 ---------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil  558 (622)
                                                             .......+..||+.|||||++.+  ..++.++|||||||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil  234 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeecccee
Confidence                                                   00000123468899999999975  4689999999999999


Q ss_pred             HHHHcCCCCCCCCCcHHHHHH
Q psy15039        559 CELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       559 ~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      |||++|++||...........
T Consensus       235 yell~G~~Pf~~~~~~~~~~~  255 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLK  255 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHH
Confidence            999999999987765544333

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.8e-36  Score=300.89  Aligned_cols=246  Identities=19%  Similarity=0.297  Sum_probs=190.8

Q ss_pred             ecccccCCceeEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         16 ILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        16 ~lG~g~g~~~~V~~~~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      .||+  |+||.||+|..+  .++..||+|.+.... .....+.+.+|+.+|++++|||||++++++.. ...++||||++
T Consensus         2 ~ig~--G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGS--GNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCC--CCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            3788  779999999765  556679999986543 34445678899999999999999999998754 57899999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccC
Q psy15039         94 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  173 (622)
Q Consensus        94 ~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~  173 (622)
                      +++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+++.|||.............. .
T Consensus        78 ~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-~  155 (257)
T cd05115          78 GGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA-R  155 (257)
T ss_pred             CCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec-c
Confidence            999999986533 35889999999999999999999999999999999999999999999999976433222111111 1


Q ss_pred             CCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCc
Q psy15039        174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD  252 (622)
Q Consensus       174 ~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  252 (622)
                      ....++..|+|||.+..  ..++.++|||||||++|+|++ |..||..............+..+                
T Consensus       156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------  217 (257)
T cd05115         156 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL----------------  217 (257)
T ss_pred             CCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----------------
Confidence            11223457999999864  357889999999999999996 99999866543322222111111                


Q ss_pred             CcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                      ......++++.+++..||..||++||++.++.+
T Consensus       218 ----------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         218 ----------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            112345789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-36  Score=305.20  Aligned_cols=255  Identities=23%  Similarity=0.307  Sum_probs=201.8

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG   95 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g   95 (622)
                      ||+  |+||.||++.+..+|+.||+|.+..... .....+.+.+|+.++++++||||+++++.+......++++||++++
T Consensus         1 lg~--g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISK--GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCC--CCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            466  7899999999999999999999876543 2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc----cc
Q psy15039         96 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV----HL  171 (622)
Q Consensus        96 ~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~----~~  171 (622)
                      +|.+++....  .+++..+..++.||+.||+|||++|++||||+|+||+++.++.+++.|||............    ..
T Consensus        79 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          79 DLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            9999987643  57899999999999999999999999999999999999999999999998654322111100    00


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQD  251 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  251 (622)
                      ......++..|+|||.+...  .++.++|+|||||++|+|++|..||..............+..+               
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  219 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE---------------  219 (265)
T ss_pred             cccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC---------------
Confidence            11122345679999998653  3778999999999999999999999765543322222111110               


Q ss_pred             cCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH---HhhhcCcccccc
Q psy15039        252 DGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA---CNLLQHAFFKQT  308 (622)
Q Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~---~~~l~h~~~~~~  308 (622)
                                      .+....+++++.+++.+||+.||++||++   .+++.||||+..
T Consensus       220 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         220 ----------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             ----------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                            01111257899999999999999999999   999999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.3e-36  Score=302.56  Aligned_cols=254  Identities=17%  Similarity=0.269  Sum_probs=190.1

Q ss_pred             eecccccCCceeEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||.||+|...  .++..+|+|.+..... ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus         1 ~~lg~--G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGN--GWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             Ccccc--cCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            35888  778999999854  5677899999876543 333456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         93 GFGSCKDLINAHFN---FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        93 ~~g~l~~~l~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ++|+|.+++.....   ...++..+..++.|++.||+|||+++++||||||+||+++.++.+++.|||.........  .
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~--~  155 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED--Y  155 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc--e
Confidence            99999999865321   235677888899999999999999999999999999999999999999999764322111  1


Q ss_pred             cccCCCCCCCccccChhhhcccc-----CCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNL-----DGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~-----~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ........++..|+|||++....     ..++.++|||||||++|||++ |..||............+.+......    
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  231 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP----  231 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC----
Confidence            11112223456799999985321     135789999999999999996 99999765444333222221111000    


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                            . .......++.+.+++..|+ .||++|||+++++.
T Consensus       232 ----------------------~-~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         232 ----------------------K-PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ----------------------C-CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                                  0 0011235778999999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-36  Score=320.61  Aligned_cols=256  Identities=20%  Similarity=0.333  Sum_probs=199.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~   82 (622)
                      ++|.+++.||+  |+||.||+|++.     .+++.||||+++... .....+.+.+|+.+|.++. |||||++++++...
T Consensus        37 ~~~~~~~~lG~--G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          37 DNLVLGRTLGS--GAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHeehhhhccC--CCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            47889999999  778999999954     456789999997643 2344456889999999997 99999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcC--------------------------------------------------------
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFN--------------------------------------------------------  106 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~--------------------------------------------------------  106 (622)
                      ...++|||||++|+|.+++.....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999999864310                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q psy15039        107 ----------------------------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS  146 (622)
Q Consensus       107 ----------------------------------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~  146 (622)
                                                              ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence                                                    1245667888999999999999999999999999999999


Q ss_pred             CCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHH
Q psy15039        147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTL  225 (622)
Q Consensus       147 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~  225 (622)
                      .++.+++.|||...........  .......++..|+|||.+..  ..++.++|||||||++|||++ |..||...+...
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             CCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999976432211110  11122334567999999865  357889999999999999998 899997655444


Q ss_pred             HHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       226 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .....+....+                               ...+..++.++.+++.+||..||.+||++.++++.
T Consensus       350 ~~~~~~~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRGYR-------------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33333322110                               00123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-36  Score=309.66  Aligned_cols=257  Identities=19%  Similarity=0.306  Sum_probs=200.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEc-------cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHK-------VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISS   78 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~-------~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~   78 (622)
                      ..++|++++.||+  |+||.||+|++.       .++..||+|.+.... .....+.+.+|+.+|+.+ +||||++++++
T Consensus        13 ~~~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          13 SRDKLTLGKPLGE--GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cHHHeeecceeec--cCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3568999999999  779999999853       345689999986542 345567788999999999 89999999999


Q ss_pred             EEeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q psy15039         79 FLDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL  144 (622)
Q Consensus        79 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiL  144 (622)
                      +......+++|||+++|+|.+++.....              ..++...+..++.||+.||+|||++||+||||||+|||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence            9999999999999999999999876421              23677788999999999999999999999999999999


Q ss_pred             EcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCch
Q psy15039        145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT  223 (622)
Q Consensus       145 l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~  223 (622)
                      ++.++.+++.|||............  .......+..|+|||++.+  ..|+.++|||||||++|+|++ |..||...+.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999765432211110  1111223456999999865  358899999999999999998 8899976654


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ... ...+....+                               .......+.++.+++.+||..+|++||++.++++.
T Consensus       246 ~~~-~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EEL-FKLLKEGHR-------------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHH-HHHHHcCCc-------------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            332 222221110                               00123467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1035|consensus

Probab=100.00  E-value=1.5e-37  Score=340.44  Aligned_cols=262  Identities=23%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC------
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA------   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~------   82 (622)
                      .+|+.+++||+  ||||.||++++|-+|+.||||+|.... ++.....+.||+++|.+|+|||||+|+.+|+..      
T Consensus       479 ~DFEEL~lLGk--GGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  479 NDFEELELLGK--GGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhHHHHHhcC--CCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            47888999999  889999999999999999999998766 566677788999999999999999988653200      


Q ss_pred             --------------------------------------------------------------------------------
Q psy15039         83 --------------------------------------------------------------------------------   82 (622)
Q Consensus        83 --------------------------------------------------------------------------------   82 (622)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q psy15039         83 ---------------------------------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH  129 (622)
Q Consensus        83 ---------------------------------~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH  129 (622)
                                                       ..+|+-||||+...+.++++...... ....+..+++||++||.|+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence                                             12688899999999988887753221 46778899999999999999


Q ss_pred             hCCcccCCCCCCCEEEcCCCceEEcCCccccccC---C---C-------Cccccc-cCCCCCCCccccChhhhccccC-C
Q psy15039        130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS---P---T-------KKKVHL-FPPSTAYNLNWLSPEVLEQNLD-G  194 (622)
Q Consensus       130 ~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~---~---~-------~~~~~~-~~~~~~~~~~y~aPE~l~~~~~-~  194 (622)
                      +.|||||||||.||+++.++.+||.|||......   .   .       ...... ...+..||.-|+|||++.+... .
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999876511   0   0       000001 1223467788999999975432 6


Q ss_pred             CCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh-CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCC
Q psy15039        195 YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA-GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRK  273 (622)
Q Consensus       195 ~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  273 (622)
                      |+.|+|||||||++|||+.   ||.........+..+. +..|...+                            +. ..
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~----------------------------f~-~~  842 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPAD----------------------------FF-DP  842 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcc----------------------------cc-cc
Confidence            9999999999999999997   5765544444444432 22221100                            00 01


Q ss_pred             CcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        274 FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       274 ~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                      --+.-..+|.+||+.||.+||||.|+|++.||.
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            123456799999999999999999999999997

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=308.15  Aligned_cols=280  Identities=23%  Similarity=0.313  Sum_probs=207.6

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEee
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP   90 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e   90 (622)
                      |++.+.||+  |++|.||+|++..+++.||+|.+......+...+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus         1 y~~~~~ig~--g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGE--GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             Ceeehcccc--cCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            778899999  778899999999999999999998754334445667789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccc
Q psy15039         91 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH  170 (622)
Q Consensus        91 ~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~  170 (622)
                      |++ +++.+++.... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.+++.|||............ 
T Consensus        79 ~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-  155 (282)
T cd07829          79 YCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-  155 (282)
T ss_pred             CcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc-
Confidence            998 58999987643 358899999999999999999999999999999999999999999999998764433221111 


Q ss_pred             ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh--CCCCCCCccccccccC
Q psy15039        171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA--GATPHLLDCTTYYVDT  248 (622)
Q Consensus       171 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~  248 (622)
                         .....+..|+|||.+... ..++.++|+||+||++|||++|..||........+.....  +..+.. .+. .....
T Consensus       156 ---~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~  229 (282)
T cd07829         156 ---THEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE-SWP-GVTKL  229 (282)
T ss_pred             ---CccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHH-HHH-hhccc
Confidence               112335679999998653 3578899999999999999999999987654433322211  111000 000 00000


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .  ........+......  .....++.++.+++..||..||++||++.+++.||||
T Consensus       230 ~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         230 P--DYKPTFPKFPPKDLE--KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             c--cccccccccCccchH--HhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0  000000011100000  0112347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.5e-36  Score=300.80  Aligned_cols=244  Identities=22%  Similarity=0.380  Sum_probs=194.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE-eCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL-DATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~l   87 (622)
                      .+|++.+.||+  |+||.||++..+  |..||+|.+....    ..+.+.+|+.++++++||||+++++++. .....++
T Consensus         6 ~~~~~~~~lg~--g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecc--cCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            58999999999  778899999765  7889999985432    2356789999999999999999999765 4567999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||........  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  155 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  155 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--
Confidence            999999999999987654434789999999999999999999999999999999999999999999999975432211  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                           ......+..|+|||++..  ..++.++|||||||++|+|++ |+.||....... ....+....+          
T Consensus       156 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-~~~~~~~~~~----------  217 (256)
T cd05082         156 -----QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYK----------  217 (256)
T ss_pred             -----CCCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhcCCC----------
Confidence                 112233457999999865  357889999999999999997 999997654322 2222211100          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           .......++.+.+++.+||+.||++|||+.++++
T Consensus       218 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 ---------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                 0012345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-36  Score=317.30  Aligned_cols=256  Identities=19%  Similarity=0.307  Sum_probs=196.6

Q ss_pred             CCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~   82 (622)
                      ++|++.+.||+  |+||.||+|.+     ..+++.||||+++.+. .......+.+|+.+|+++ +|||||++++++...
T Consensus         7 ~~~~~~~~lG~--G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           7 DRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hHhcccccccC--CccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            58999999999  77899999984     4678899999997643 234456788999999999 689999999987654


Q ss_pred             -CcEEEEeecCCCCCHHHHHHhhcC-------------------------------------------------------
Q psy15039         83 -TDLHLVSPLMGFGSCKDLINAHFN-------------------------------------------------------  106 (622)
Q Consensus        83 -~~~~lv~e~~~~g~l~~~l~~~~~-------------------------------------------------------  106 (622)
                       ..++++||||++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             568999999999999999864310                                                       


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCC
Q psy15039        107 ----------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPST  176 (622)
Q Consensus       107 ----------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  176 (622)
                                ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||...........  ......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~  241 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDA  241 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch--hhcCCC
Confidence                      12567778889999999999999999999999999999999999999999976443211111  111122


Q ss_pred             CCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcc
Q psy15039        177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE  255 (622)
Q Consensus       177 ~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  255 (622)
                      .++..|+|||++..  ..++.++|||||||++|+|++ |..||............+.....                   
T Consensus       242 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  300 (343)
T cd05103         242 RLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-------------------  300 (343)
T ss_pred             CCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-------------------
Confidence            33456999999865  358899999999999999996 99999764433222222211100                   


Q ss_pred             cccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       256 ~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                  ...+...++++.+++..||+.||++||++.++++|
T Consensus       301 ------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 ------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        00112356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.8e-36  Score=304.01  Aligned_cols=257  Identities=18%  Similarity=0.314  Sum_probs=202.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEcc----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      -..++|++.++||+  |+||.||+|.++.    +++.||+|.+... ......+.+.+|+.+|++++||||+++++++..
T Consensus         3 ~~~~~~~~~~~i~~--g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           3 ISRDRVTLSDLLQE--GTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             cchhheEEeeeecc--cCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            34679999999999  7789999999887    3688999998643 345566778899999999999999999998766


Q ss_pred             -CCcEEEEeecCCCCCHHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEc
Q psy15039         82 -ATDLHLVSPLMGFGSCKDLINAHFN------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  154 (622)
Q Consensus        82 -~~~~~lv~e~~~~g~l~~~l~~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~  154 (622)
                       ....++++||++++++.+++.....      ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+++.
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             4678999999999999999866422      247899999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhC
Q psy15039        155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAG  233 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~  233 (622)
                      |||....+......  .......++..|+|||++..  ..++.++|||||||++||+++ |+.||....... +...+..
T Consensus       160 d~g~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~  234 (280)
T cd05043         160 DNALSRDLFPMDYH--CLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKD  234 (280)
T ss_pred             CCCCcccccCCceE--EeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHc
Confidence            99976543222111  11112233457999999865  357899999999999999998 999997654332 2222221


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ..+                               ......+++++.+++.+||..||++|||+.++++
T Consensus       235 ~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GYR-------------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCC-------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            110                               0011235788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=319.27  Aligned_cols=205  Identities=22%  Similarity=0.369  Sum_probs=177.6

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|++..+++.||||++....... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus         1 ~~y~~~~~ig~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQ--GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEee--cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            46999999999  789999999999999999999987543222 234678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.....   
T Consensus        79 v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             EEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            999999999999987643  478888999999999999999999999999999999999999999999997643322   


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  576 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~  576 (622)
                          ......+|+.|+|||++.+  ..++.++|||||||++|||++|++||...+....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  206 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET  206 (333)
T ss_pred             ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence                1234567888999999976  4689999999999999999999999987765543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-36  Score=303.01  Aligned_cols=253  Identities=17%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCc----EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..+|++.+.||+  |+||.||+|..+.+|+    .||+|.+..... ......+.+|+.+|++++||||+++++++.. .
T Consensus         6 ~~~~~~~~~ig~--g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           6 ETELEKIKVLGS--GAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHHcEEcceecC--CCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            468999999999  7789999999887776    589999866543 4455678899999999999999999999887 7


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..+++|||+++|+|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||......
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            8999999999999999987643 348899999999999999999999999999999999999999999999999765433


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......  .......+..|+|||.+..  ..++.++|+|||||++||+++ |..||..............+..       
T Consensus       161 ~~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  229 (279)
T cd05057         161 VDEKEY--HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-------  229 (279)
T ss_pred             Ccccce--ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-------
Confidence            221111  1111223457999999864  357889999999999999998 9999987654332221111111       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                               .......+.++.+++.+||..||++||++.++++
T Consensus       230 -------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 -------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                     1112335778999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.5e-37  Score=310.58  Aligned_cols=210  Identities=21%  Similarity=0.309  Sum_probs=174.9

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++.+.||.  |+||.||+|+++.+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGE--GTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEec--CCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            56999999999  88999999999999999999998754322 1234677999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||+++ +|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......  
T Consensus        82 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            999984 8988886543 246788889999999999999999999999999999999999999999999754322111  


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                        .......+|+.|+|||++.+. ..++.++||||+||++|||+||++||...+..+.+.
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~  214 (288)
T cd07871         158 --KTYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH  214 (288)
T ss_pred             --ccccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence              111234567889999998643 358899999999999999999999998876655443

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.8e-36  Score=308.71  Aligned_cols=257  Identities=19%  Similarity=0.300  Sum_probs=199.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEcc-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKV-------TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISS   78 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~   78 (622)
                      -.++|++++.||+  |+||.||++++..       .+..||+|.+.... .......+.+|+.+|+++ +|||||+++++
T Consensus        10 ~~~~~~~~~~lg~--G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099          10 PRDRLVLGKPLGE--GCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             cHHHeeeeeeecC--CCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            3468999999999  7789999998643       35579999986543 345566788999999999 69999999999


Q ss_pred             EEeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q psy15039         79 FLDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL  144 (622)
Q Consensus        79 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiL  144 (622)
                      +.+...++++|||+++|+|.+++.....              ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            9998899999999999999999865321              23778889999999999999999999999999999999


Q ss_pred             EcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCch
Q psy15039        145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT  223 (622)
Q Consensus       145 l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~  223 (622)
                      ++.++.+++.|||.............  ......+..|+|||++.+  ..++.++|||||||++|+|++ |..||...+.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999997643321110000  011122346999999865  358899999999999999998 8999976544


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .... ..+....+                               .......+.++.+++.+||..||++||++.++++.
T Consensus       243 ~~~~-~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         243 EELF-KLLREGHR-------------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHH-HHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3222 22211100                               00123457789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5e-36  Score=305.56  Aligned_cols=253  Identities=18%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             CceEEeecccccCCceeEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +|++.+.||+  |+||.||+|+...     ....+|+|.+.... .......+.+|+.+|+.++|||||++++.+...+.
T Consensus         1 ~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGE--GEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccC--cCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            5889999999  8899999998754     33579999886543 34455778899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHF----------------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH  142 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~----------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~N  142 (622)
                      .++++||+.+|+|.+++....                      ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            999999999999999886421                      1236788899999999999999999999999999999


Q ss_pred             EEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCC
Q psy15039        143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAET  221 (622)
Q Consensus       143 iLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~  221 (622)
                      ||++.++.+++.|||............  .......+..|+|||.+.+  ..++.++|||||||++|+|++ |..||.+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYV--KRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchh--cccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999764432211111  0111233457999999864  357899999999999999998 99999765


Q ss_pred             chHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        222 PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       222 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ..... ...+....                               .......++.++.+++..||+.||++||++.++++
T Consensus       234 ~~~~~-~~~~~~~~-------------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERL-FNLLKTGY-------------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHH-HHHHhCCC-------------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            43322 22221100                               00112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0579|consensus

Probab=100.00  E-value=1.8e-38  Score=324.56  Aligned_cols=245  Identities=24%  Similarity=0.337  Sum_probs=203.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..+.|+++..||.  |+||.||+|.++.|+-..|.|+|...  +.+++..++-||.||..++||+||+++++|+..+.+|
T Consensus        30 P~d~WeIiGELGD--GAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGD--GAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcC--ccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            3567889999999  77999999999999999999998644  4677889999999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +..|||+||-...++.... .++.+..+..+++|++.||.|||+++|||||||..|||++-+|.++++|||.+.......
T Consensus       106 iliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             EEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            9999999999988776653 468999999999999999999999999999999999999999999999999764322111


Q ss_pred             CceeccCCCCCCCCcccccccccc---CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  593 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  593 (622)
                          ....+..|||+||||||+.-   ...+|+.++|||||||+|.||+.+.||....++...++.+....+|.++-..-
T Consensus       185 ----qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~  260 (1187)
T KOG0579|consen  185 ----QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSH  260 (1187)
T ss_pred             ----hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcch
Confidence                11345788999999998831   12479999999999999999999999999999999888877777777766332


Q ss_pred             c---cccCCCCcCcccccch
Q psy15039        594 Y---YVDTGQDDGEENACSY  610 (622)
Q Consensus       594 ~---~~~~~~~~~~~~~~~~  610 (622)
                      |   |.|.-..|...|+.++
T Consensus       261 Ws~~F~DfLk~cL~Knp~~R  280 (1187)
T KOG0579|consen  261 WSRSFSDFLKRCLVKNPRNR  280 (1187)
T ss_pred             hhhHHHHHHHHHHhcCCccC
Confidence            2   3333444444444433

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-36  Score=299.42  Aligned_cols=252  Identities=19%  Similarity=0.333  Sum_probs=199.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..++|++.+.||+  |+||.||+|..+ .++.||||.+..+...   ...+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~--g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGA--GQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeecc--CcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            4579999999999  778999999976 4578999998765443   245778999999999999999999999988999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ++|||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.........
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999999999976544457899999999999999999999999999999999999999999999998754432211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      .   ........+..|+|||.+.+  ..++.++|+||+||++|+|++ |+.||.+............+..+         
T Consensus       158 ~---~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------  223 (261)
T cd05034         158 Y---TAREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---------  223 (261)
T ss_pred             h---hhhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            0   00111222457999999875  357889999999999999998 99999765443322222211100         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                             ......+.++.+++.+||..||++||++.++.+
T Consensus       224 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 -----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                   011234678999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0667|consensus

Probab=100.00  E-value=3.3e-37  Score=321.83  Aligned_cols=216  Identities=23%  Similarity=0.325  Sum_probs=185.2

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-C-----CccceeEEEEEeCC
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-H-----PNIICYISSFLDAT  433 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~~~~~~~~~~  433 (622)
                      .|++.+.||+  |+||+|.+|.+..|++.||||+++..   .....+...|+.+|..|+ |     -|+|+++++|...+
T Consensus       187 rY~V~e~LGk--GtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGK--GSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEecc--cccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            6899999999  77999999999999999999998643   344567889999999997 4     38999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--ceEEcCcccccc
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCP  511 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~--~~~~~~~~~~~~  511 (622)
                      ++|||+|+++ -+|.++++.+...+++...++.++.||+.||.+||+.+|||+||||+||||.+.+  .+|+.|||.+|.
T Consensus       262 HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  262 HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999999997 5999999988777899999999999999999999999999999999999997755  689999998875


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH--HcCCCC-CC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATP-HL  588 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~--~~~~~p-~~  588 (622)
                      .+...       .+..-+..|.||||+.+  ..|+.+.||||||||++||.+|.|-|.+.+..+++..+  +.|.+| .+
T Consensus       341 ~~q~v-------ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  341 ESQRV-------YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             cCCcc-------eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            43211       12344678999999987  57999999999999999999999999999888887554  455443 34


Q ss_pred             CC
Q psy15039        589 LD  590 (622)
Q Consensus       589 ~~  590 (622)
                      ++
T Consensus       412 L~  413 (586)
T KOG0667|consen  412 LD  413 (586)
T ss_pred             HH
Confidence            44

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.5e-37  Score=316.02  Aligned_cols=202  Identities=18%  Similarity=0.305  Sum_probs=170.1

Q ss_pred             eecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        365 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      +.||+  |+||.||+++++.+|+.||+|++..... .......+.+|+.+++.++||||++++++|...+.+|+||||++
T Consensus         1 ~~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             Ceeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            36788  8899999999999999999999875422 23345677899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~  152 (323)
T cd05595          79 GGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----ATM  152 (323)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC----Ccc
Confidence            999998887643  47888899999999999999999999999999999999999999999999754321111    111


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  576 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~  576 (622)
                      ....+|+.|||||++.+  ..++.++|||||||++|||++|+.||...+....
T Consensus       153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~  203 (323)
T cd05595         153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL  203 (323)
T ss_pred             ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence            23457889999999975  4689999999999999999999999987655443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7e-36  Score=299.41  Aligned_cols=249  Identities=21%  Similarity=0.377  Sum_probs=194.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||.||+|....++ .||+|.+......   .+.+.+|+.++++++||||+++++++. .+..+++
T Consensus         6 ~~~~~~~~ig~--g~~~~v~~~~~~~~~-~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQ--GCFGEVWMGTWNGTT-KVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecC--cCCCeEEEEEEcCCc-eEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            67999999999  778899999987664 5999998654332   245778999999999999999998875 4568899


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||...........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999999999997654344788899999999999999999999999999999999999999999999976443221111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                         .......+..|+|||.+.+  ..++.++|||||||++|+|++ |..||.+....... ..+....+           
T Consensus       159 ---~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~-----------  221 (260)
T cd05069         159 ---ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQVERGYR-----------  221 (260)
T ss_pred             ---ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCC-----------
Confidence               0111233456999998865  347889999999999999999 99999765443322 22221110           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                          ......++..+.+++++||..||++||+++++++
T Consensus       222 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 --------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                0012245788999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-36  Score=304.92  Aligned_cols=240  Identities=15%  Similarity=0.251  Sum_probs=185.2

Q ss_pred             eecccccCCceeEEEEEEccCCcE-------EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQL-------IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~-------vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +.||+  |+||.||+|.++.++..       ||+|.+....  ....+.+.+|+.+|+.++|||||++++++..+...++
T Consensus         1 ~~lg~--G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQ--GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCc--ccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence            36888  88999999998776654       8888875432  3344567789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--------eEEcCCccc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--------ACLSGLRYM  159 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~--------~~i~~~~~~  159 (622)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.        +++.|||..
T Consensus        77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999987643 25789999999999999999999999999999999999987765        466777654


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCC-CCCCCCchHHHHHHHHhCCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT-VPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~-~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      ......        ....+++.|+|||++.+. ..++.++|||||||++|+|++|. .||........ ...... .+  
T Consensus       156 ~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~-~~--  222 (258)
T cd05078         156 ITVLPK--------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYED-RH--  222 (258)
T ss_pred             cccCCc--------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHc-cc--
Confidence            322111        112345679999998753 35788999999999999999985 66654333221 111110 00  


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                    ..+...+.++.++++.||+.||++|||++++++.
T Consensus       223 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         223 ------------------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ------------------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                          0112345789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.6e-37  Score=322.21  Aligned_cols=214  Identities=23%  Similarity=0.335  Sum_probs=178.8

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ....+|++.+.||+  |+||.||+++++.+++.+|+|++..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        40 ~~~~~y~~~~~lG~--G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          40 MKAEDYDVVKVIGR--GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             CCHHHCeEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            34578999999999  8899999999999999999999864322 22334567899999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+||||+++|+|.+++...   .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||.+.....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            99999999999999988653   368888999999999999999999999999999999999999999999997654322


Q ss_pred             CCCceeccCCCCCCCCccccccccccCc--cCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ...   ....+..||+.|||||++....  ..++.++||||+||++|||++|++||...+.....
T Consensus       195 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~  256 (370)
T cd05621         195 TGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY  256 (370)
T ss_pred             CCc---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH
Confidence            111   1112456889999999996421  23788999999999999999999999876654443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.1e-36  Score=303.18  Aligned_cols=255  Identities=22%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCC---CCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD---RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +|++.+.||+  |+||.||++++..++..+++|.++..   .........+.+|+.++++++||||+++++++.+....+
T Consensus         1 ~y~i~~~ig~--g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (260)
T cd08222           1 RYILQQRLGK--GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFC   78 (260)
T ss_pred             CceeeeeecC--CCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceE
Confidence            5999999999  77889999999988888877776542   223344456778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         87 LVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+||++++++.+++....  ...+++..+..++.|++.||.|||++|++||||||+||+++. +.+++.|||.......
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            9999999999999886432  235889999999999999999999999999999999999975 6689999986543321


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ...    ......++..|+|||.+..  ..++.++|+||+|+++|+|++|..||..............+..|.       
T Consensus       158 ~~~----~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------  224 (260)
T cd08222         158 SCD----LATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS-------  224 (260)
T ss_pred             Ccc----cccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC-------
Confidence            111    0112234567999999864  357889999999999999999999997654433333222222211       


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                               ....++.++.++|.+||+.||++||++.++++||||
T Consensus       225 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         225 -------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -------------------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                                     123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.2e-36  Score=298.74  Aligned_cols=249  Identities=19%  Similarity=0.321  Sum_probs=187.2

Q ss_pred             eecccccCCceeEEEEEEcc---CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE-eCCcEEEEee
Q psy15039         15 SILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL-DATDLHLVSP   90 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~lv~e   90 (622)
                      +.||+  |+||.||+|....   ++..||||.+... ......+.+.+|+.+++.++||||+++++++. .+...+++||
T Consensus         1 ~~lg~--g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGK--GHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             Ccccc--cCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            36888  7788999999654   4567999998543 23445677889999999999999999999765 4556889999


Q ss_pred             cCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccc
Q psy15039         91 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH  170 (622)
Q Consensus        91 ~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~  170 (622)
                      |+.+|+|.+++.... ...++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.............
T Consensus        78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999987543 2356777888999999999999999999999999999999999999999997643321110000


Q ss_pred             ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHH-hCCCCCCCccccccccC
Q psy15039        171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL-AGATPHLLDCTTYYVDT  248 (622)
Q Consensus       171 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~  248 (622)
                      ........+..|+|||.+..  ..++.++|||||||++|||++ |.+||....... +...+ .+..+            
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~------------  221 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-ITVYLLQGRRL------------  221 (262)
T ss_pred             cccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCC------------
Confidence            11112233457999999865  357889999999999999999 466665543322 22222 11110            


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                          .....+++.+.+++..||..||++||++.++++.
T Consensus       222 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         222 --------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             --------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                1122357789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5e-36  Score=304.39  Aligned_cols=267  Identities=19%  Similarity=0.331  Sum_probs=195.5

Q ss_pred             CCc-eEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-
Q psy15039          9 SNY-KICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-   82 (622)
Q Consensus         9 ~~y-~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-   82 (622)
                      .+| ++.+.||+  |+||+||++.    ...+++.||+|.+.... .+.....+.+|+++|++++||||+++++++... 
T Consensus         3 ~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGE--GHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceeccc--CCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            455 99999999  7788998765    45688999999986643 334456678999999999999999999987654 


Q ss_pred             -CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         83 -TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        83 -~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                       ..++++|||+++++|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||....
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence             4589999999999999998652   488999999999999999999999999999999999999999999999997654


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ......... .......+..|+|||.+...  .++.++|||||||++|+|++|..||...+....  ...........  
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~--  229 (283)
T cd05080         157 VPEGHEYYR-VREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQMT--  229 (283)
T ss_pred             cCCcchhhc-cCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhcccccccc--
Confidence            322111110 01111234569999998653  478899999999999999999999865432211  00000000000  


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                 . ......+ ........+..++.++.+++..||+.||++||++.++++
T Consensus       230 -----------~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 -----------V-VRLIELL-ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             -----------h-hhhhhhh-hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       0 0000000 000011123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-36  Score=306.90  Aligned_cols=261  Identities=16%  Similarity=0.281  Sum_probs=197.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCC--------------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccee
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTN--------------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC   74 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~--------------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~   74 (622)
                      ++|++.+.||+  |+||.||+|++..++              ..||+|.+.... .......+.+|+++|++++||||++
T Consensus         5 ~~~~~~~~lg~--G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGE--GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             HhCeehhccCC--CCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            58999999999  778999999876543              359999987543 4455667889999999999999999


Q ss_pred             EEEEEEeCCcEEEEeecCCCCCHHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q psy15039         75 YISSFLDATDLHLVSPLMGFGSCKDLINAHFN----------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL  144 (622)
Q Consensus        75 ~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~----------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiL  144 (622)
                      +++++......++||||+++++|.+++.....          ..+++..+..++.|++.||+|||++|++||||||+|||
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            99999999999999999999999999864321          13578888999999999999999999999999999999


Q ss_pred             EcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc--CCCCCCCCc
Q psy15039        145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN--GTVPFAETP  222 (622)
Q Consensus       145 l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~--g~~Pf~~~~  222 (622)
                      ++.++.+++.|||..........  .........+..|+|||.+..+  .++.++|+|||||++|+|++  |..||....
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             EcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99999999999997643322111  0111122334579999998653  47899999999999999987  778887644


Q ss_pred             hHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        223 TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       223 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ....+. .+.......          .              ...........++.+.+|+.+||..||++||++.++++
T Consensus       238 ~~~~~~-~~~~~~~~~----------~--------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 DEQVIE-NTGEFFRNQ----------G--------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             hHHHHH-HHHHhhhhc----------c--------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            332211 111000000          0              00000112235789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7e-36  Score=298.70  Aligned_cols=249  Identities=20%  Similarity=0.359  Sum_probs=195.1

Q ss_pred             eecccccCCceeEEEEEEcc-CC--cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeec
Q psy15039         15 SILGQCFNNLSSVYLSKHKV-TN--QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~-t~--~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      +.||+  |++|.||+|.+.. .+  ..||||.+...... ...+.+.+|+.+|++++||||+++++.+.. ..++++|||
T Consensus         1 ~~ig~--g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGD--GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCc--cCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            36788  7788999999866 33  36999999776543 556788899999999999999999999988 889999999


Q ss_pred             CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccc
Q psy15039         92 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        92 ~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      +++++|.+.+.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.|||........... ..
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~  155 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-YV  155 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc-ee
Confidence            99999999987654235789999999999999999999999999999999999999999999999976544322111 11


Q ss_pred             cCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCC
Q psy15039        172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQ  250 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  250 (622)
                      ......++..|+|||.+..  ..++.++|||||||++|+|++ |..||........ ...+....+.             
T Consensus       156 ~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-------------  219 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-LKKIDKEGER-------------  219 (257)
T ss_pred             cccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCc-------------
Confidence            1112234567999999864  357889999999999999998 9999976544332 2222111000             


Q ss_pred             CcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        251 DDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       251 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                       .......+.++.+++..||+.+|++||++.++++
T Consensus       220 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                             0011235788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.5e-37  Score=322.44  Aligned_cols=216  Identities=21%  Similarity=0.338  Sum_probs=179.5

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+++++.+++.||+|++..... .......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus         1 ~~f~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGR--GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            46899999999  8899999999999999999999875322 22345678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.+|.+++.|||.+..+.....
T Consensus        79 v~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999999987643  478888999999999999999999999999999999999999999999997543321100


Q ss_pred             c-------------------------------eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCC
Q psy15039        518 K-------------------------------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV  566 (622)
Q Consensus       518 ~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~  566 (622)
                      .                               ......+.+||+.|||||++.+  ..|+.++|||||||++|||++|++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCCC
Confidence            0                               0001123468899999999975  468999999999999999999999


Q ss_pred             CCCCCCcHHHHHHH
Q psy15039        567 PFAETPTTLMLIEK  580 (622)
Q Consensus       567 Pf~~~~~~~~~~~~  580 (622)
                      ||...+........
T Consensus       235 Pf~~~~~~~~~~~i  248 (360)
T cd05627         235 PFCSETPQETYRKV  248 (360)
T ss_pred             CCCCCCHHHHHHHH
Confidence            99877665543333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-36  Score=304.18  Aligned_cols=270  Identities=18%  Similarity=0.280  Sum_probs=198.9

Q ss_pred             CCceEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      ..|++++.||+  |+||.||+|+    ++.++..||+|.+.... .......+.+|+++|++++||||+++++++...  
T Consensus         4 ~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           4 RFLKRIRDLGE--GHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhceecCC--CCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            35799999999  7799999998    46789999999986543 344456788999999999999999999998875  


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.....
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            56899999999999999986543 24788999999999999999999999999999999999999999999999976544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ....... .......++..|+|||++.+.  .++.++||||+||++|+|+++..|+......  ... ..+..+.     
T Consensus       160 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~--~~~-~~~~~~~-----  228 (284)
T cd05079         160 ETDKEYY-TVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTL--FLK-MIGPTHG-----  228 (284)
T ss_pred             ccCccce-eecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccch--hhh-hcccccc-----
Confidence            3222111 111123345579999998753  4788999999999999999988776432111  011 1110000     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                             ... .......+. ..........++.++.+|+.+||+.||++||++.+++++
T Consensus       229 -------~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         229 -------QMT-VTRLVRVLE-EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             -------ccc-HHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                   000 000000000 001111234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0658|consensus

Probab=100.00  E-value=1.4e-37  Score=303.34  Aligned_cols=207  Identities=26%  Similarity=0.389  Sum_probs=170.7

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-----c
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----D  434 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-----~  434 (622)
                      .|.-.+++|.  |+||.||.|.-..+++.||||++-.+.      +---+|+.+|+.++|||||++.-+|....     .
T Consensus        25 ~~~~~~liG~--GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGS--GSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEee--cccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            4778889999  789999999999999999999986432      12247999999999999999988887543     3


Q ss_pred             EEEEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CceEEcCcccccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYMCP  511 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~-~~~~~~~~~~~~~  511 (622)
                      +.+|||||+ -+|.+.++..  .+..++...+.-|+.||.+||+|||+.||+||||||+|+|+|.+ |..||+|||.+..
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            579999999 4888888742  23357777788899999999999999999999999999999987 8999999997654


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      +......     .+-..|..|.|||.+.+. ..|+.+.||||.||++.||+-|++-|.+.+...++..++
T Consensus       176 L~~~epn-----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi  239 (364)
T KOG0658|consen  176 LVKGEPN-----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII  239 (364)
T ss_pred             eccCCCc-----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH
Confidence            4332221     123347789999999876 479999999999999999999999999998888876653

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.9e-36  Score=301.98  Aligned_cols=255  Identities=20%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ++|++...||+  |+||.||+|+.+.     +.+.||+|.+.... .....+.+.+|+++|++++||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGR--GEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             Hhceeeeeecc--cceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            68999999999  7799999999765     45679999986543 2334567889999999999999999999999989


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFN-------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~-------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                      ..++||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999999876431       14789999999999999999999999999999999999999999999988


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGAT  235 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~  235 (622)
                      +..........   ........+..|+|||.+.+.  .++.++|||||||++|+|++ |..||..............+..
T Consensus       162 ~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~  236 (275)
T cd05046         162 SLSKDVYNSEY---YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL  236 (275)
T ss_pred             ccccccCcccc---cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence            86532211110   001112334569999998653  46789999999999999998 8899976544332222211111


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      +                               ......++..+.+++.+||+.||++||++.+++++
T Consensus       237 ~-------------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         237 E-------------------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             C-------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            0                               01123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.9e-36  Score=306.01  Aligned_cols=261  Identities=18%  Similarity=0.315  Sum_probs=196.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEcc----------------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKV----------------TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNI   72 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~----------------t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI   72 (622)
                      .+|++.+.||+  |+||.||++++..                ++..||+|.+.... .+.....+.+|+++|+.++||||
T Consensus         5 ~~~~~~~~lg~--G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           5 KRLTFKEKLGE--GQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhceeeeeccC--CCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence            46999999999  8899999996442                45579999986543 34556778899999999999999


Q ss_pred             eeEEEEEEeCCcEEEEeecCCCCCHHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q psy15039         73 ICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN---------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI  143 (622)
Q Consensus        73 v~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~---------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~Ni  143 (622)
                      +++++++......+++|||+++|+|.+++.....         ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            9999999999999999999999999999865421         1256778999999999999999999999999999999


Q ss_pred             EEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc--CCCCCCCC
Q psy15039        144 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN--GTVPFAET  221 (622)
Q Consensus       144 Ll~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~--g~~Pf~~~  221 (622)
                      |++.++.+++.|||...........  ........+..|+|||+...+  .++.++|+|||||++|||++  |..||...
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999976443221110  011112224579999987653  58899999999999999997  78999754


Q ss_pred             chHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        222 PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       222 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ...... .......          ....              .....+....+++.+.+|+..||+.||++||++.++++
T Consensus       238 ~~~~~~-~~~~~~~----------~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVI-ENTGEFF----------RDQG--------------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHH-HHHHHHH----------hhcc--------------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            432221 1110000          0000              00001112346788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-35  Score=297.22  Aligned_cols=251  Identities=21%  Similarity=0.331  Sum_probs=200.3

Q ss_pred             ceEEeecccccCCceeEEEEEEccCC----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +++.+.||+  |+||.||++++..++    ..||+|.+..... ....+.+.+|+.+|+.++||||+++++++.+....+
T Consensus         1 ~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGE--GAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             Ccccceecc--CCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            467889999  789999999999877    9999999965533 335677889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ++|||++++++.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+++.|||.........
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999999876543238899999999999999999999999999999999999999999999999764432221


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..   ......++..|+|||.+..  ..++.++||||+||++|+|++ |..||..............+..+         
T Consensus       158 ~~---~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  223 (258)
T smart00219      158 YY---KKKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL---------  223 (258)
T ss_pred             cc---ccccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---------
Confidence            10   0101224567999999854  457899999999999999998 88998765443332222211110         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                             ......+.++.+++.+||..||++|||+.++++
T Consensus       224 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      224 -----------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -----------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                   112236889999999999999999999999876

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=305.64  Aligned_cols=280  Identities=25%  Similarity=0.326  Sum_probs=204.8

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCcEEEEe
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      |++.+.||+  |++|+||+|+.+.+++.||||++.......+ .....+|+..+++++ ||||+++++++.+++..++||
T Consensus         1 y~~~~~ig~--g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGD--GTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             Ceeheeecc--CCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            788999999  7799999999999999999999876433222 233457999999999 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+ +|++.+.+.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+++.|||..........  
T Consensus        78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence            999 78998888765434578999999999999999999999999999999999999999999999987643321111  


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCcccccccc
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDCTTYYVD  247 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~  247 (622)
                         .....++..|+|||++..+ ..++.++|+||||+++++|++|++||.............  .+..+.. .+......
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  229 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ-DWPEGYKL  229 (283)
T ss_pred             ---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh-hhhhHhhh
Confidence               0112345679999998654 347889999999999999999999997665443333222  2211110 00000000


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .  ............... ... ....+.++.+++.+||+.||++||++.|++.||||
T Consensus       230 ~--~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         230 A--SKLGFRFPQFAPTSL-HQL-IPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             h--ccccccccccccccH-HHH-cccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0  000000000000000 001 11237889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=299.83  Aligned_cols=245  Identities=22%  Similarity=0.339  Sum_probs=190.7

Q ss_pred             eecccccCCceeEEEEEEccCCcE--EEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEEEeec
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQL--IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPL   91 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~--vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~   91 (622)
                      ++||+  |+||.||+|+.+.+|..  +|+|.++.. ......+.+.+|+++++++ +||||+++++++......+++|||
T Consensus         1 ~~lg~--g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCC--CCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            36888  88999999999988864  688887643 2344556788999999999 899999999999999999999999


Q ss_pred             CCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         92 MGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        92 ~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                      +++|+|.+++....              ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+++.|||
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999999986532              1236788999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      ........     ........+..|+|||++..  ..++.++|||||||++|||++ |..||...+..... ..+.....
T Consensus       158 l~~~~~~~-----~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~  229 (270)
T cd05047         158 LSRGQEVY-----VKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLPQGYR  229 (270)
T ss_pred             Cccccchh-----hhccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-HHHhCCCC
Confidence            75321110     00111122456999999864  457899999999999999996 99999765433222 22111000


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                     .......+.++.+++.+||..||.+|||+.++++
T Consensus       230 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         230 -------------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                           0011235778999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7e-36  Score=303.48  Aligned_cols=269  Identities=21%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             CCceEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--C
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--A   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~   82 (622)
                      .+|++.+.||+  |+||.||+|.    +..+++.||||++...  .....+.+.+|+++|++++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGK--GNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccC--CCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            48999999999  7889999998    4568999999998654  34556778899999999999999999998754  3


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            46899999999999999986542 34789999999999999999999999999999999999999999999999976543


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......... ......+..|+|||.+.++  .++.++||||+||++|||++|..|+......  ....+....+..    
T Consensus       159 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~----  229 (284)
T cd05081         159 PQDKEYYKV-REPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQ----  229 (284)
T ss_pred             cCCCcceee-cCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccc----
Confidence            221111100 0111223459999998653  5788999999999999999988776543221  111111100000    


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                               .........+ ...........++.++.+|+.+||..||++|||+.++++
T Consensus       230 ---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         230 ---------MIVYHLIELL-KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             ---------cchHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                     0000000000 001111223457889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-36  Score=316.00  Aligned_cols=200  Identities=18%  Similarity=0.300  Sum_probs=169.6

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF  444 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~  444 (622)
                      .||+  |+||.||++++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+++||||+++
T Consensus         2 ~lG~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           2 LLGK--GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             eeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            5788  8899999999999999999999875432 233456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCC
Q psy15039        445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP  524 (622)
Q Consensus       445 g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  524 (622)
                      |+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ....
T Consensus        80 g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~~  153 (328)
T cd05593          80 GELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----ATMK  153 (328)
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----cccc
Confidence            99998886643  47888899999999999999999999999999999999999999999999754221111    1112


Q ss_pred             CCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHH
Q psy15039        525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL  575 (622)
Q Consensus       525 ~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~  575 (622)
                      ...+|+.|||||++.+  ..++.++|||||||++|||++|+.||...+...
T Consensus       154 ~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~  202 (328)
T cd05593         154 TFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK  202 (328)
T ss_pred             cccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHH
Confidence            3457889999999975  468899999999999999999999998765444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-36  Score=314.17  Aligned_cols=212  Identities=18%  Similarity=0.293  Sum_probs=175.9

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~l  437 (622)
                      +|++.+.||+  |+||.||+|+++.+++.||+|++..... .....+....|..++..+ +||||+++++++.+.+.+|+
T Consensus         1 df~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGK--GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            5889999999  8899999999999999999999875432 223345677888888877 58999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+.+....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....... 
T Consensus        79 v~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             EEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            999999999999887643  47788899999999999999999999999999999999999999999999754322111 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                         .......||+.|||||++.+  ..++.++|||||||++|||+||++||...+.........
T Consensus       156 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~  214 (323)
T cd05616         156 ---VTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  214 (323)
T ss_pred             ---CccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence               11223467889999999975  468999999999999999999999998876554433333

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-36  Score=314.29  Aligned_cols=213  Identities=19%  Similarity=0.290  Sum_probs=175.7

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCC-ccceeEEEEEeCCcEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHP-NIICYISSFLDATDLHL  437 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~Hp-nIv~~~~~~~~~~~~~l  437 (622)
                      +|++.+.||+  |+||.||+|++..+++.||||++..... .....+.+..|+.++..++|+ +|+.+++++...+.+|+
T Consensus         1 ~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGK--GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEee--ccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            5889999999  8899999999999999999999875432 233456788999999999765 58889999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus        79 v~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            999999999999887643  467888999999999999999999999999999999999999999999997542211111


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                          ......||+.|+|||++.+  ..++.++||||+||++|||+||++||...+.... ...+..
T Consensus       157 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~  215 (324)
T cd05587         157 ----TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQSIME  215 (324)
T ss_pred             ----ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHc
Confidence                1123457889999999975  4588999999999999999999999987765443 333333

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.5e-36  Score=307.89  Aligned_cols=208  Identities=24%  Similarity=0.333  Sum_probs=173.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||||++....... ....+.+|+.+++.++||||+++++++.+....++
T Consensus         4 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGE--GSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEe--cCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            467999999999  789999999999999999999987543221 23457789999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||++ +++.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.+....... 
T Consensus        81 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             EEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            999996 67877776543 347888899999999999999999999999999999999999999999999754322111 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL  575 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~  575 (622)
                         .......+|+.|+|||++.+. ..++.++||||+||++|||++|++||.+..+..
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  211 (303)
T cd07869         158 ---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ  211 (303)
T ss_pred             ---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence               112234568889999998643 357889999999999999999999998765543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.5e-36  Score=299.60  Aligned_cols=240  Identities=16%  Similarity=0.294  Sum_probs=183.7

Q ss_pred             eecccccCCceeEEEEEEcc------------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039         15 SILGQCFNNLSSVYLSKHKV------------TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~------------t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +.||+  |+||.||+|+...            ....||+|.++...  ......+.+|+.+++.++|||||++++++..+
T Consensus         1 ~~lg~--G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGR--GTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             Ccccc--CCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            35888  7789999998542            23468999876532  33445678899999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-------eEEcC
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-------ACLSG  155 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~-------~~i~~  155 (622)
                      ...+++|||+++|++..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       +++.+
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999999988876532 34789999999999999999999999999999999999987664       67778


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHh-cCCCCCCCCchHHHHHHHHhCC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA-NGTVPFAETPTTLMLIEKLAGA  234 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~-~g~~Pf~~~~~~~~~~~~~~~~  234 (622)
                      ||.......        .....++..|+|||.+... ..++.++|||||||++|||+ .|..||......... ....+.
T Consensus       156 ~g~~~~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~  225 (262)
T cd05077         156 PGIPITVLS--------RQECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ  225 (262)
T ss_pred             CCCCccccC--------cccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC
Confidence            876533211        1122345679999988633 45888999999999999997 588888654322111 100100


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .                                 ......++++.+|+.+||+.||++||+..+++++
T Consensus       226 ~---------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 C---------------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             c---------------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            0                                 0112235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-35  Score=295.40  Aligned_cols=251  Identities=21%  Similarity=0.376  Sum_probs=198.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +++|++.+.||+  |+||.||++.+. .+..+|+|.+.......   ..+.+|++++++++||||+++++++......++
T Consensus         3 ~~~~~~~~~ig~--g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           3 PSELTLVQEIGS--GQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             hhHeEEEeeecC--cccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            458999999999  778899999886 46789999987654433   346789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      +|||+++++|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+++.|||..........
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999999999886543 3478899999999999999999999999999999999999999999999986543321111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .   ......++..|+|||.+.+  ..++.++||||+||++|+|++ |..||......... ..+....           
T Consensus       156 ~---~~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~-----------  218 (256)
T cd05112         156 T---SSTGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-ETINAGF-----------  218 (256)
T ss_pred             c---ccCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-HHHhCCC-----------
Confidence            0   1112234567999999875  357889999999999999998 99999765433222 2211100           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                          ........++++.+|+.+||..||++||++.+++++
T Consensus       219 --------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 --------------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                                001122357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-36  Score=326.97  Aligned_cols=231  Identities=22%  Similarity=0.331  Sum_probs=189.8

Q ss_pred             cccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        352 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       352 ~~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      .+......+|++.+.||+  |+||.||+|++..+|+.||||++.....+......+.+|+.++..++|+||++++..+..
T Consensus        25 ~~~~~~~~rY~i~~~LG~--G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGS--GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             ccccccCCCEEEEEEEec--CCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            344455679999999999  889999999999999999999998777777777788999999999999999999887764


Q ss_pred             CC--------cEEEEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCce
Q psy15039        432 AT--------DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  501 (622)
Q Consensus       432 ~~--------~~~lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~  501 (622)
                      ..        .+++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence            32        3689999999999999886532  2357899999999999999999999999999999999999999999


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ++.|||.+..+.....  ........||+.|||||++.+  ..|+.++|||||||++|||++|+.||...+....+...+
T Consensus       183 kL~DFGls~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~  258 (496)
T PTZ00283        183 KLGDFGFSKMYAATVS--DDVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL  258 (496)
T ss_pred             EEEecccCeecccccc--ccccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            9999997644322111  112234567889999999975  468999999999999999999999998876655555555


Q ss_pred             cCCCCCC
Q psy15039        582 AGATPHL  588 (622)
Q Consensus       582 ~~~~p~~  588 (622)
                      .+..+++
T Consensus       259 ~~~~~~~  265 (496)
T PTZ00283        259 AGRYDPL  265 (496)
T ss_pred             cCCCCCC
Confidence            5544433

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-36  Score=318.14  Aligned_cols=212  Identities=24%  Similarity=0.345  Sum_probs=177.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+++++.+++.+|+|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        41 ~~~~y~i~~~lG~--G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          41 KAEDYEVVKVIGR--GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             chhhcEEEEEEee--cCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            3578999999999  8899999999999999999999864322 222345678999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            9999999999999988653   3688888899999999999999999999999999999999999999999976543221


Q ss_pred             CCceeccCCCCCCCCccccccccccCc--cCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLM  576 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~  576 (622)
                      ..   .......||+.|||||++....  ..++.++|||||||++|||++|++||...+....
T Consensus       196 ~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  255 (371)
T cd05622         196 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT  255 (371)
T ss_pred             Cc---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence            11   1112456889999999996421  2378899999999999999999999987665443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.4e-36  Score=301.29  Aligned_cols=239  Identities=16%  Similarity=0.260  Sum_probs=183.1

Q ss_pred             ecccccCCceeEEEEEEccCC------------------------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc
Q psy15039         16 ILGQCFNNLSSVYLSKHKVTN------------------------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN   71 (622)
Q Consensus        16 ~lG~g~g~~~~V~~~~~~~t~------------------------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn   71 (622)
                      .||+  |+||.||+|....++                        ..||+|.++...  ......+.+|+.++++++|||
T Consensus         2 ~lG~--G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQ--GTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCc--ccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCC
Confidence            5899  779999999864332                        458999986532  233456778999999999999


Q ss_pred             ceeEEEEEEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC--
Q psy15039         72 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--  149 (622)
Q Consensus        72 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~--  149 (622)
                      |+++++++......++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+  
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999998886532 3578899999999999999999999999999999999998654  


Q ss_pred             -----ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHh-cCCCCCCCCch
Q psy15039        150 -----KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA-NGTVPFAETPT  223 (622)
Q Consensus       150 -----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~-~g~~Pf~~~~~  223 (622)
                           .+++.|||........        ....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             cCccceeeecCCccccccccc--------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence                 2677787754322111        112345679999998653 45789999999999999995 79999976433


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ..... ......                                 ......++++.+++.+||+.||++||++.+++++
T Consensus       228 ~~~~~-~~~~~~---------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         228 SEKER-FYEKKH---------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHH-HHHhcc---------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22111 110000                                 0011235679999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-35  Score=309.29  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=199.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEcc-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKV-------TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF   79 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~   79 (622)
                      ..+|++++.||+  |+||.||+|++..       ++..||+|.++.. ......+.+.+|+++++++ +||||+++++++
T Consensus        11 ~~~~~i~~~ig~--G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGE--GCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceecc--ccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            347999999999  7789999998653       2347999988653 3445567788999999999 899999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      ......++++||+++|+|.+++.....              ..++...+..++.|++.||+|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            999999999999999999999875321              136677888999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.+++.|||............  .......+..|+|||++.+  ..++.++|||||||++|||++ |..||...+..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYK--KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             cCCCcEEECCcccceecccccccc--cccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999764432211100  0111122346999999865  357889999999999999998 89999876544


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ........+..+                                ......+.++.+++.+||+.+|++||++.+++++
T Consensus       244 ~~~~~~~~~~~~--------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ELFKLLKEGHRM--------------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHcCCCC--------------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            322221111100                                0122457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2e-36  Score=315.58  Aligned_cols=218  Identities=20%  Similarity=0.341  Sum_probs=172.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~  431 (622)
                      .++|++.+.||+  |+||.||+|.+     ..+++.||+|++... ......+.+.+|+.+++.+ +|||||++++++..
T Consensus         6 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           6 RDRLRLGKVLGH--GAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hhHceeeeEecc--CCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            357999999999  88999999975     345678999998643 2344456789999999999 89999999998876


Q ss_pred             CC-cEEEEeeccCCCCHHHHHHhccC------------------------------------------------------
Q psy15039        432 AT-DLHLVSPLMGFGSCKDLINAHFN------------------------------------------------------  456 (622)
Q Consensus       432 ~~-~~~lv~e~~~~g~l~~~l~~~~~------------------------------------------------------  456 (622)
                      .+ .++++|||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            54 58999999999999999875321                                                      


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCC
Q psy15039        457 ------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL  530 (622)
Q Consensus       457 ------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~  530 (622)
                            ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.........  .......+++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCCc
Confidence                  23566778889999999999999999999999999999999999999999976543221111  1112233456


Q ss_pred             ccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHc
Q psy15039        531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       531 ~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~  582 (622)
                      .|||||++.+  ..|+.++|||||||++|||++ |.+||........+...+.
T Consensus       241 ~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~  291 (338)
T cd05102         241 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK  291 (338)
T ss_pred             cccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh
Confidence            7999999965  468999999999999999997 9999987655444444443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.1e-36  Score=304.59  Aligned_cols=262  Identities=20%  Similarity=0.319  Sum_probs=204.5

Q ss_pred             CceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCC
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT   83 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~   83 (622)
                      +|++.+.||+  |+||.||++++.   .+++.||||.+.....  .....+.+.+|+++++++ +||||+++++.+....
T Consensus         1 ~~~~~~~ig~--G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~   78 (288)
T cd05583           1 NFELLRVLGT--GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT   78 (288)
T ss_pred             CceEEEEecc--CCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence            5899999999  778899999864   5788999999865432  123345678999999999 5999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++||||+++|+|.+.+...  ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+++.|||....+.
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999999999888653  347899999999999999999999999999999999999999999999998754432


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch---HHHHHHHHhCCCCCCCc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLLD  240 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~---~~~~~~~~~~~~p~~~~  240 (622)
                      .....   ......++..|+|||.+.+....++.++|+||+|+++|+|++|..||.....   ...+...+....     
T Consensus       157 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  228 (288)
T cd05583         157 AEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-----  228 (288)
T ss_pred             ccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-----
Confidence            22111   1112245678999999865433467899999999999999999999964321   111111111110     


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC---HHhhhcCcccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL---ACNLLQHAFFKQTKK  310 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~h~~~~~~~~  310 (622)
                                                 ...+..++.++.+++.+||+.||++|||   +.++|+||||+...+
T Consensus       229 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         229 ---------------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             ---------------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence                                       0112346788999999999999999998   567799999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-35  Score=295.17  Aligned_cols=251  Identities=16%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ....|++.+.||+  |+||.||++... .+..||+|.+...   +.....+.+|+.+|++++|+||+++++.+.. ...+
T Consensus         4 ~~~~~~~~~~lg~--g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGA--GQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecC--ccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            4578999999999  778999999865 4567999987653   2234568889999999999999999999887 7789


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      ++|||++++++.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+++.||+....+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999999999976544457888899999999999999999999999999999999999999999998764432211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..   ......++..|+|||++..  ..++.++|+|||||++|+|++ |+.||......... ..+....+         
T Consensus       157 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~~~---------  221 (260)
T cd05073         157 YT---AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYR---------  221 (260)
T ss_pred             cc---cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhCCCC---------
Confidence            11   1112233456999999865  357889999999999999998 99999765443322 22211110         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                            .......+.++.+++.+||+.||++||++.++++
T Consensus       222 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 ----------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ----------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                  0112346788999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4645|consensus

Probab=100.00  E-value=1.5e-38  Score=349.80  Aligned_cols=235  Identities=23%  Similarity=0.376  Sum_probs=198.2

Q ss_pred             cccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        352 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       352 ~~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ..+.+++-+++-+..||.  |.||.||.|.+..||+..|+|.|..........+.+.+|+.++..|+|||+|+||++-.+
T Consensus      1228 ~~lsnV~~rWqrg~~Ig~--G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1228 SSLSNVTFRWQRGNFIGG--GTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred             HHhccceeeeccccccCC--cceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence            445667778888889998  679999999999999999999987665555556788999999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                      +...+|+||||++|+|.+++...+  -.++...+.+..|++.||+|||++|||||||||+||+|+.+|.+|+.|||.+..
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeE
Confidence            999999999999999999987533  267888889999999999999999999999999999999999999999998765


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCc-cCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc-CCCCCCC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA-GATPHLL  589 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~-~~~p~~~  589 (622)
                      +......+..--.+..||+.|||||++.+.. .+...+.|||||||++.||+||+.||...+.+-+++.+++ |..|+++
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc
Confidence            5444322222223567899999999996543 4566789999999999999999999999998888877755 4556555


Q ss_pred             C
Q psy15039        590 D  590 (622)
Q Consensus       590 ~  590 (622)
                      .
T Consensus      1464 ~ 1464 (1509)
T KOG4645|consen 1464 E 1464 (1509)
T ss_pred             h
Confidence            4

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-36  Score=318.98  Aligned_cols=215  Identities=24%  Similarity=0.330  Sum_probs=178.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...+|++.+.||+  |+||.||++++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        41 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          41 KAEDFDVIKVIGR--GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CHHHcEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            3568999999999  88999999999999999999998653222 22345578999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++|+|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999999988653   3678888899999999999999999999999999999999999999999976543221


Q ss_pred             CCceeccCCCCCCCCccccccccccCc--cCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      ..   .......||+.|||||++....  ..++.++|||||||++|||++|++||...+.......
T Consensus       196 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  258 (370)
T cd05596         196 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK  258 (370)
T ss_pred             Cc---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH
Confidence            11   1112356789999999986421  2478899999999999999999999987765444333

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-36  Score=308.05  Aligned_cols=210  Identities=22%  Similarity=0.333  Sum_probs=176.2

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++.+.||+  |+||.||+++++.+++.||+|++..........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~--g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGE--GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecc--cCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            36999999999  7899999999999999999999976554444556788999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||++++.+..+...  ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+++.|||.+........ 
T Consensus        79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          79 FEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             EecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            999998877655433  23578888999999999999999999999999999999999999999999997654322111 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                        .......+|+.|+|||++.+  ..++.++|||||||++|||++|++||...+....+
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~  210 (287)
T cd07848         156 --ANYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL  210 (287)
T ss_pred             --ccccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence              11122456788999999975  45889999999999999999999999877654443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-36  Score=313.86  Aligned_cols=206  Identities=20%  Similarity=0.303  Sum_probs=170.5

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHH---hhCCCCccceeEEEEEeCCcEE
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCM---RHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l---~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      |++.+.||+  |+||.||++++..+++.||||++..... .....+.+.+|++++   +.++||||+++++++...+..|
T Consensus         1 y~i~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGR--GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEee--cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            678999999  7899999999999999999999875432 223345677776655   5678999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|..++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999999887754   247888999999999999999999999999999999999999999999999653221111


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                          .......+|+.|||||++.+  ..++.++|||||||++|||++|++||...+....+
T Consensus       156 ----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~  210 (324)
T cd05589         156 ----DRTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF  210 (324)
T ss_pred             ----CcccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                11223457889999999975  46889999999999999999999999876554443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-35  Score=333.78  Aligned_cols=148  Identities=24%  Similarity=0.349  Sum_probs=133.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -++|.+++.||+  |+||.||+|.+..+++.||||++..... .......+.+|+.+++.++|||||++++++.....+|
T Consensus         3 ~~~y~i~~~LG~--G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISR--GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEec--CCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            368999999999  7799999999999999999999976443 3444567889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                      +||||+.+++|.+++...  ..+++..++.++.||+.||+|||.++|+||||||+|||++.++.+++.|||..
T Consensus        81 lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            999999999999998753  24788999999999999999999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-37  Score=320.47  Aligned_cols=213  Identities=24%  Similarity=0.368  Sum_probs=180.0

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         1 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGR--GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEe--CCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            46999999999  889999999999999999999987543222 345678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus        79 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999999999998765  3578889999999999999999999999999999999999999999999997654432210


Q ss_pred             -------------------------ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        518 -------------------------KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       518 -------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                                               ..........||+.|+|||++.+  ..++.++|||||||++|||++|++||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                     00011223467889999999976  468999999999999999999999998876


Q ss_pred             cHHHH
Q psy15039        573 TTLML  577 (622)
Q Consensus       573 ~~~~~  577 (622)
                      .....
T Consensus       235 ~~~~~  239 (350)
T cd05573         235 LQETY  239 (350)
T ss_pred             HHHHH
Confidence            54443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-35  Score=297.45  Aligned_cols=254  Identities=18%  Similarity=0.294  Sum_probs=198.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      -+.+|.+.+.||+  |+||.||+|.+..+   ...||||...... .....+.+.+|+.++++++||||+++++++.+ .
T Consensus         4 ~~~~~~~~~~lg~--g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           4 QREDITLGRCIGE--GQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             chhhceeeeeeCC--ccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            3567999999999  77899999997654   4569999986543 34556678899999999999999999998876 4


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..+++|||+++|+|.+++.... ..+++..+..++.|++.||+|+|++|++||||||+||+++.++.+++.|||......
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            5789999999999999997643 347899999999999999999999999999999999999999999999998754332


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...  .. .......+..|+|||.+..  ..++.++|||||||++|||++ |..||..............+..+      
T Consensus       159 ~~~--~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------  227 (270)
T cd05056         159 DES--YY-KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------  227 (270)
T ss_pred             ccc--ce-ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence            211  11 0111122356999999864  357899999999999999985 99999766544333222111110      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                ......+.++.+++.+|+..||++|||+.+++..
T Consensus       228 --------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         228 --------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      1123467889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1026|consensus

Probab=100.00  E-value=1.5e-36  Score=325.02  Aligned_cols=253  Identities=19%  Similarity=0.329  Sum_probs=207.3

Q ss_pred             CceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +=+..+.||+  |.||+||+|+-.     .+-+.||||.++... +.+..++|.||+.+|..|+|||||+|+|++..++.
T Consensus       487 ~i~~~~eLGe--gaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGE--GAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcC--chhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            4566788999  668899999853     456789999996643 45577899999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceE
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFN------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC  152 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~  152 (622)
                      +++|+|||..|+|..+|+....            ..|+..+...|+.||+.|++||-++..|||||-..|+||..+-.+|
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence            9999999999999999986531            1277889999999999999999999999999999999999999999


Q ss_pred             EcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHH
Q psy15039        153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       153 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~  231 (622)
                      |+|||.+.+...+  .++.....+.-.++|||||.+..+  .|+.++||||+||+|||+++ |..|+.+...++.+...-
T Consensus       644 IsDfGLsRdiYss--DYYk~~~~t~lPIRWMppEsIly~--kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  644 ISDFGLSRDIYSS--DYYKVRGNTLLPIRWMPPESILYG--KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             ecccccchhhhhh--hhhcccCCceeeeecCCHHHhhcC--cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            9999987654322  122222233345689999999864  59999999999999999986 999999877666554443


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      .|..                                ...+...+.++.+|+..||+.+|.+||+..|+-.
T Consensus       720 ~g~l--------------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  720 AGQL--------------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             cCCc--------------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            3321                                1124567889999999999999999999998743

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-35  Score=298.38  Aligned_cols=254  Identities=22%  Similarity=0.401  Sum_probs=196.3

Q ss_pred             ceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC----
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----   83 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   83 (622)
                      |++.++||+  |+||.||+|..+   .+++.||||.+..+.......+.+.+|+++|++++||||+++++++....    
T Consensus         1 ~~~~~~ig~--g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGK--GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccC--CCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            778899999  778899999865   46899999999876666666778889999999999999999999887642    


Q ss_pred             --cEEEEeecCCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         84 --DLHLVSPLMGFGSCKDLINAHF----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        84 --~~~lv~e~~~~g~l~~~l~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                        ..+++++|+.+|++.+++....    ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence              2478889999999988764321    1247888999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      ...........  ........+..|++||.+..  ..++.++|||||||++|+|++ |..||..............+.. 
T Consensus       159 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  233 (273)
T cd05074         159 LSKKIYSGDYY--RQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-  233 (273)
T ss_pred             ccccccCCcce--ecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-
Confidence            76543221110  01111223456999999865  357889999999999999998 8999976544332222221110 


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                     ......+++.+.+++.+||..+|++||++.+++++
T Consensus       234 -------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 -------------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                           00112457889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=311.71  Aligned_cols=212  Identities=21%  Similarity=0.311  Sum_probs=176.6

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGR--GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            47999999999  8899999999999999999999874322 22334568899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||.+..+.....
T Consensus        79 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             EEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999987532 3578889999999999999999999999999999999999999999999997544332111


Q ss_pred             ceeccCCCCCCCCcccccccccc---CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  576 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~  576 (622)
                      .   ......+|+.|||||++..   +...++.++|||||||++|||++|+.||...+....
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~  216 (331)
T cd05597         158 V---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  216 (331)
T ss_pred             c---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH
Confidence            1   1112357889999999963   123478899999999999999999999987655443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-36  Score=312.73  Aligned_cols=194  Identities=21%  Similarity=0.333  Sum_probs=166.0

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      +||+  |+||.||++++..+++.||||++....... ...+.+.+|+.+++.+ +||||++++++|.+.+.+|+||||++
T Consensus         2 ~lG~--G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           2 VIGR--GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             eEee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            6788  889999999999999999999997654332 3456788999999988 79999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......    ....
T Consensus        80 ~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~  153 (329)
T cd05588          80 GGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----GDTT  153 (329)
T ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC----CCcc
Confidence            999998886543  5789999999999999999999999999999999999999999999999975321110    1112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA  569 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~  569 (622)
                      ....||+.|+|||++.+  ..++.++|+|||||++|||++|+.||.
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         154 STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcc
Confidence            23467889999999975  468899999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=295.42  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             cccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCC
Q psy15039         17 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG   95 (622)
Q Consensus        17 lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g   95 (622)
                      ||+  |+||.||++.+..+++.||+|.+...... ......+.+|+.++++++||||+++++.+..+...+++|||++++
T Consensus         1 lg~--G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGK--GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCC--CCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            566  88999999999999999999998775432 234567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCC
Q psy15039         96 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  175 (622)
Q Consensus        96 ~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  175 (622)
                      +|.+++....  .+++..+..++.|++.||.|+|+++++|+||||+||+++.++.+++.|||..........    ....
T Consensus        79 ~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~  152 (250)
T cd05123          79 ELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----RTNT  152 (250)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC----cccC
Confidence            9999987642  578999999999999999999999999999999999999999999999987654332211    1112


Q ss_pred             CCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcc
Q psy15039        176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE  255 (622)
Q Consensus       176 ~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  255 (622)
                      ..++..|+|||.+.+.  ..+.++|+|||||++|+|++|..||...+............                     
T Consensus       153 ~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  209 (250)
T cd05123         153 FCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP---------------------  209 (250)
T ss_pred             CcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---------------------
Confidence            3445679999998653  46789999999999999999999997665432222221110                     


Q ss_pred             cccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH---HhhhcCccc
Q psy15039        256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA---CNLLQHAFF  305 (622)
Q Consensus       256 ~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~---~~~l~h~~~  305 (622)
                                  ...+...++++.+++.+||..||++||++   .++++||||
T Consensus       210 ------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 ------------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                        01122347889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.6e-35  Score=291.50  Aligned_cols=246  Identities=21%  Similarity=0.303  Sum_probs=192.1

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF   94 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~   94 (622)
                      ++||+  |+||.||+|..+ ++..||+|.++... .+.....+.+|+.++++++||||+++++++......++||||+++
T Consensus         1 ~~ig~--g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGK--GNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCC--CCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            36888  888999999865 68899999986543 344445688999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCC
Q psy15039         95 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP  174 (622)
Q Consensus        95 g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  174 (622)
                      +++.+++.... ..+++..+..++.|++.||.|+|++|++||||||+||+++.++.+++.|||..........   ....
T Consensus        77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~  152 (250)
T cd05085          77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---SSSG  152 (250)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc---ccCC
Confidence            99999886543 3478999999999999999999999999999999999999999999999997543211110   0011


Q ss_pred             CCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       175 ~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      ....+..|+|||++..  ..++.++||||+||++|+|++ |..||......... ..+.....                 
T Consensus       153 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-~~~~~~~~-----------------  212 (250)
T cd05085         153 LKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-EQVEKGYR-----------------  212 (250)
T ss_pred             CCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHHcCCC-----------------
Confidence            1122356999999865  347889999999999999998 99999765433222 22211100                 


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                    ......++.++.+++.+||..||++||++.++++.
T Consensus       213 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         213 --------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence                          00122367889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.2e-36  Score=311.77  Aligned_cols=209  Identities=24%  Similarity=0.307  Sum_probs=171.9

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-----c
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----D  434 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-----~  434 (622)
                      .|++.+.||+  |+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++....     .
T Consensus         1 ry~i~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGK--GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEee--cCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            4889999999  78999999999999999999998754333444567889999999999999999999886543     4


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+|||||+ ++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          79 IYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            899999996 68988887643  478888999999999999999999999999999999999999999999997643221


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                      .... ........+|+.|+|||++.+....++.++|||||||++|||+||++||.+.+..
T Consensus       156 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~  214 (338)
T cd07859         156 DTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV  214 (338)
T ss_pred             ccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence            1111 1111234678899999998653346889999999999999999999999876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=293.07  Aligned_cols=246  Identities=20%  Similarity=0.303  Sum_probs=193.7

Q ss_pred             eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCC
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF   94 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~   94 (622)
                      +.||+  |+||.||++.... ++.||+|++..... ......+.+|+.++++++||||+++++++.+....++||||+.+
T Consensus         1 ~~lg~--g~~g~v~~~~~~~-~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGK--GNFGDVYKGVLKG-NTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             Ccccc--CCCceEEEEEEeC-CCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            36888  7788999999988 99999999876543 34556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCC
Q psy15039         95 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP  174 (622)
Q Consensus        95 g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  174 (622)
                      +++.+++.... ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+++.|||.........  ......
T Consensus        77 ~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI--YTVSDG  153 (251)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc--ceeccc
Confidence            99999986543 357888999999999999999999999999999999999999999999998764332111  001111


Q ss_pred             CCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcC
Q psy15039        175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG  253 (622)
Q Consensus       175 ~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  253 (622)
                      ....+..|+|||.+.++  .++.++|+|||||++|+|++ |..||......... ..+....                  
T Consensus       154 ~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~~~~~~~------------------  212 (251)
T cd05041         154 LKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERIESGY------------------  212 (251)
T ss_pred             cCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-HHHhcCC------------------
Confidence            11224569999998653  57899999999999999998 88998765432221 1111100                  


Q ss_pred             cccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       254 ~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                   ....+...+.++.+++.+||+.+|++||++.++++
T Consensus       213 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 -------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         00112345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=304.61  Aligned_cols=205  Identities=20%  Similarity=0.308  Sum_probs=174.7

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHH-HHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      +|++.+.||+  |+||.||++.+..+++.||||++..+...... ...+.+|+.+++.++||||+++++++...+.+++|
T Consensus         1 ~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGK--GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEec--CCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            4889999999  88999999999999999999998754433322 34577899999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||+++|+||||||+||++++++.+++.|||.+.......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            999999999988876544468899999999999999999999999999999999999999999999999754322111  


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                         ...+..+++.|||||++.+  ..++.++||||+||++|||++|+.||.....
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~  206 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE  206 (285)
T ss_pred             ---ccccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence               1123456788999999965  4588899999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.4e-36  Score=312.28  Aligned_cols=207  Identities=21%  Similarity=0.318  Sum_probs=171.0

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|+++.+++.||||++..... .....+.+.+|+.++..+ +||||+++++++...+.+|+||||++
T Consensus         2 ~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           2 VLGK--GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             eeee--CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            6788  8899999999999999999999875432 223345677888888876 79999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~----~~~  153 (320)
T cd05590          80 GGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTT  153 (320)
T ss_pred             CchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----Ccc
Confidence            999999887643  47888899999999999999999999999999999999999999999999754321111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ....||+.|||||++.+  ..++.++|||||||++|||++|+.||...+.... .+.+..
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~  210 (320)
T cd05590         154 STFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAILN  210 (320)
T ss_pred             cccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHhc
Confidence            23467889999999975  4688999999999999999999999987765443 444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.1e-36  Score=310.94  Aligned_cols=208  Identities=18%  Similarity=0.298  Sum_probs=173.3

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCC-CCccceeEEEEEeCCcEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHL  437 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~l  437 (622)
                      +|++.+.||+  |+||.||+|+++.+|+.||+|++..... .....+.+..|+.+++.++ ||+|+++++++.+.+.+|+
T Consensus         1 ~f~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGK--GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            4778899999  8899999999999999999999875422 2233466788999998885 5778889999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....... 
T Consensus        79 v~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            999999999999887643  47888999999999999999999999999999999999999999999999754322111 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                         .......||+.|||||++.+  ..++.++||||+||++|||++|++||...+.....
T Consensus       156 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~  210 (323)
T cd05615         156 ---VTTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF  210 (323)
T ss_pred             ---ccccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence               11223457889999999975  46899999999999999999999999877654433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-36  Score=312.60  Aligned_cols=207  Identities=20%  Similarity=0.294  Sum_probs=171.3

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|++..+++.||||++..... .......+..|+.+++.+ +||||+++++++.+.+.+|+||||++
T Consensus         2 ~lG~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           2 VLGK--GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             cccc--CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            5788  8899999999999999999999875432 223355677899998866 89999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----~~~  153 (321)
T cd05591          80 GGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTT  153 (321)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----ccc
Confidence            999998887643  47888889999999999999999999999999999999999999999999754321111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      ....+|+.|||||++.+  ..|+.++|||||||++|||++|++||...+....+.....
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~  210 (321)
T cd05591         154 TTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH  210 (321)
T ss_pred             cccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            23457889999999965  4689999999999999999999999988765554433333

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-36  Score=315.73  Aligned_cols=216  Identities=20%  Similarity=0.304  Sum_probs=180.5

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+++++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         1 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGR--GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEe--ccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            46999999999  7899999999999999999999875433 22345678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.+..+.....
T Consensus        79 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             EECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999987752 3578999999999999999999999999999999999999999999999997654432221


Q ss_pred             ceeccCCCCCCCCccccccccccC----ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQN----LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      .   ......+|+.|+|||++...    ...++.++|||||||++|||++|+.||...+....+...
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i  221 (330)
T cd05601         158 V---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI  221 (330)
T ss_pred             e---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH
Confidence            1   12234578899999998631    235788999999999999999999999877655544333

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.2e-36  Score=296.78  Aligned_cols=229  Identities=19%  Similarity=0.248  Sum_probs=183.0

Q ss_pred             CCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCCCCCHHHHH
Q psy15039         22 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI  101 (622)
Q Consensus        22 g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g~l~~~l  101 (622)
                      |.|++||+++++.+|+.||+|++.....       ..+|...+....||||+++++++.+.+..+++|||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            3477999999999999999999865421       224555566678999999999999999999999999999999998


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCcc
Q psy15039        102 NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN  181 (622)
Q Consensus       102 ~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (622)
                      ....  .+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.+||........       ..+...+..
T Consensus        77 ~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~  147 (237)
T cd05576          77 SKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------CDGEAVENM  147 (237)
T ss_pred             HHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-------cccCCcCcc
Confidence            6643  4889999999999999999999999999999999999999999999999865333221       112233456


Q ss_pred             ccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccc
Q psy15039        182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI  261 (622)
Q Consensus       182 y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i  261 (622)
                      |+|||.+..  ..++.++|+||+||++|+|++|..||...+....      .                            
T Consensus       148 y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------~----------------------------  191 (237)
T cd05576         148 YCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSGIN------T----------------------------  191 (237)
T ss_pred             ccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------c----------------------------
Confidence            999998854  3578899999999999999999988753221100      0                            


Q ss_pred             hhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCccc
Q psy15039        262 SEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFF  305 (622)
Q Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~  305 (622)
                         ......+..+++.+.+++.+||+.||++||++     +++++||||
T Consensus       192 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         192 ---HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ---ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence               00000123468899999999999999999996     899999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.3e-35  Score=295.12  Aligned_cols=253  Identities=15%  Similarity=0.254  Sum_probs=186.9

Q ss_pred             ecccccCCceeEEEEEEccC--CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecCC
Q psy15039         16 ILGQCFNNLSSVYLSKHKVT--NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG   93 (622)
Q Consensus        16 ~lG~g~g~~~~V~~~~~~~t--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~   93 (622)
                      .||+  |+||+||+++...+  ...+++|.+.... .....+.+.+|+.+++.++|||||++++.+.+....++||||++
T Consensus         2 ~lg~--G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGN--GWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCC--CcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            5888  77899999975433  3457788776543 23445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccc
Q psy15039         94 FGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  171 (622)
Q Consensus        94 ~g~l~~~l~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~  171 (622)
                      +|+|.+++.....  ...++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||........  ....
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~--~~~~  156 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE--DYIE  156 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc--hhhh
Confidence            9999999875421  23567788899999999999999999999999999999999999999999975321111  0001


Q ss_pred             cCCCCCCCccccChhhhccc-----cCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        172 FPPSTAYNLNWLSPEVLEQN-----LDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       172 ~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ......++..|+|||++...     ...++.++|||||||++|||++ |..||............+.+..+...+     
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----  231 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK-----  231 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC-----
Confidence            11223456789999997531     1235678999999999999986 677887554433332222221111000     


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                            ......+++.+.+++..|+ .||++||++.++++
T Consensus       232 ----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         232 ----------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ----------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                                  0011236788999999999 67999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.9e-35  Score=301.90  Aligned_cols=254  Identities=18%  Similarity=0.330  Sum_probs=197.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCc----EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..+|++.+.||+  |+||.||+|.++.+|+    .||+|.+..... ......+.+|+.+++.++||||+++++++... 
T Consensus         6 ~~~~~~~~~lg~--G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           6 ETELKRVKVLGS--GAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhhceecccccc--CCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            357899999999  7788999999988887    468898865433 33344678999999999999999999988764 


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++++||+++|++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||......
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence            4678899999999999987643 247889999999999999999999999999999999999999999999999775443


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      .....  ........+..|+|||.+.+  ..++.++|||||||++|||++ |..||.+...... ...+....       
T Consensus       161 ~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~-------  228 (303)
T cd05110         161 GDEKE--YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGE-------  228 (303)
T ss_pred             Ccccc--cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCC-------
Confidence            22111  11112234567999999864  457899999999999999997 9999976543221 11111100       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ..+.....+.++.+++..||..||++||++.++++.
T Consensus       229 ------------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 ------------------------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    001122356789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4250|consensus

Probab=100.00  E-value=8.7e-37  Score=319.29  Aligned_cols=204  Identities=25%  Similarity=0.405  Sum_probs=171.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   83 (622)
                      .-.++..+.||+  |+||.||+|++++||+.||||.++... .....+..-+|+++|++|+|||||+++++-.+..    
T Consensus        12 ~y~W~~~e~LG~--Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   12 NYLWEMDERLGK--GAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             CcceeehhhhcC--CccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            356788999999  778999999999999999999998743 2334455678999999999999999998765543    


Q ss_pred             --cEEEEeecCCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCc--eEEcCC
Q psy15039         84 --DLHLVSPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGK--ACLSGL  156 (622)
Q Consensus        84 --~~~lv~e~~~~g~l~~~l~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~--~~~--~~i~~~  156 (622)
                        .-.+|||||.+|+|...++.-. ..+|+|.++..++.++..||.|||++||+||||||.||++..  +|+  -|++||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence              3568999999999999997532 357999999999999999999999999999999999999853  454  488899


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  220 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~  220 (622)
                      |.+...+.+..     ..+.+||..|++||++... ..|+..+|.|||||++|+.+||..||..
T Consensus       169 G~Arel~d~s~-----~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  169 GAARELDDNSL-----FTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cccccCCCCCe-----eeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            98877665442     2345789999999999742 4689999999999999999999999964

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.5e-35  Score=294.32  Aligned_cols=243  Identities=22%  Similarity=0.358  Sum_probs=192.9

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||.||++.  .+++.||+|.+....    ..+.+.+|+.++++++||||+++++++... ..+++
T Consensus         6 ~~~~~~~~lg~--g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGE--GEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeecc--CCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            57999999999  7788999986  478899999985532    235678899999999999999999998764 57999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+++.|||.........  
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            999999999999976544457899999999999999999999999999999999999999999999999754321110  


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           .....+..|+|||.+..  ..++.++|+|||||++|+|++ |+.||..............+..            
T Consensus       155 -----~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  215 (254)
T cd05083         155 -----DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR------------  215 (254)
T ss_pred             -----CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC------------
Confidence                 11122346999999865  357889999999999999997 9999976544332221111100            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                          ......++.++.+++.+||+.+|++||++.+++.
T Consensus       216 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 --------------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                0012346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.1e-36  Score=309.91  Aligned_cols=211  Identities=22%  Similarity=0.362  Sum_probs=171.3

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhh-CCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRH-LRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|++..+++.||||++..... .....+....|..++.. ++||||+++++++...+..++||||++
T Consensus         2 ~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           2 VLGK--GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             eeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            5788  8899999999999999999999875432 22334556677777765 489999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----~~~  153 (316)
T cd05592          80 GGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKA  153 (316)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----Ccc
Confidence            999999887643  47888899999999999999999999999999999999999999999999764322111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  587 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~  587 (622)
                      ....||+.|||||++.+  ..++.++|||||||++|||++|+.||.+.+... +...+....|.
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~  214 (316)
T cd05592         154 STFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDSILNDRPH  214 (316)
T ss_pred             ccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCC
Confidence            23467889999999975  458899999999999999999999998776544 34444444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.1e-35  Score=296.20  Aligned_cols=253  Identities=22%  Similarity=0.408  Sum_probs=200.3

Q ss_pred             CceEEeecccccCCceeEEEEEEcc-CCcEEEEEEecCCC--------CCHHHHHHHHHHHHHHhh-CCCCcceeEEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKV-TNQLIAVKKFNLDR--------MTDEDLKSLHHEIVCMRH-LRHPNIICYISSF   79 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~-t~~~vAiK~~~~~~--------~~~~~~~~~~~Ei~il~~-l~HpnIv~~~~~~   79 (622)
                      +|++.+.||+  |+||.||++.++. +++.+|+|.+....        ..+.....+.+|+.++++ ++||||+++++++
T Consensus         1 ~y~~~~~ig~--G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   78 (269)
T cd08528           1 EYAVLEHLGS--GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF   78 (269)
T ss_pred             CchhhhhhcC--CCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence            5899999999  7789999999988 78899999986432        223445667789998875 7999999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                      ..+...+++|||++++++.+++...  ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+++.||
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999999987543  22357899999999999999999996 78999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      |......... .    .....++..|+|||.+.+  ..++.++|+||||+++|+|++|+.||..............+..+
T Consensus       159 g~~~~~~~~~-~----~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~  231 (269)
T cd08528         159 GLAKQKQPES-K----LTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE  231 (269)
T ss_pred             cceeeccccc-c----cccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence            9764432221 1    112345667999999975  34789999999999999999999999765443322222211110


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                     ......+++++.+++.+||+.||++||++.++.++
T Consensus       232 -------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 -------------------------------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -------------------------------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                           01122467899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=323.06  Aligned_cols=220  Identities=18%  Similarity=0.319  Sum_probs=181.7

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccC-CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVT-NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ..|.+.+.||+  |++|.||+|.+..+ ++.||+|++...  .......+.+|+.+|+.++|||||++++++...+..|+
T Consensus        67 ~~y~~~~~lg~--G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         67 HMYVLTTLVGR--NPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eeEEEEEEEEe--CCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34999999999  88999999999887 888999987543  23444567889999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        438 VSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ||||+++|+|.+++...  ...++++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||++..+...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999999987642  2335788889999999999999999999999999999999999999999999986654322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  586 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p  586 (622)
                      ..  .....+.+||+.|||||++.+  ..++.++|||||||++|||++|+.||...+....+...+.+..+
T Consensus       223 ~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  289 (478)
T PTZ00267        223 VS--LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD  289 (478)
T ss_pred             cc--cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            11  111234567889999999975  46899999999999999999999999877655554445555443

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.9e-35  Score=297.66  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=192.1

Q ss_pred             eecccccCCceeEEEEEEccCC------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTN------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      +.||+  |+||.||+|+++.++      +.||||.+.... .......+.+|+.+|+.++||||+++++++.+....+++
T Consensus         1 ~~lg~--g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGS--GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             Ccccc--ccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            35888  778999999987654      789999986542 234456788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-----ceEEcCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFN-----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGLRY  158 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-----~~~i~~~~~  158 (622)
                      |||+++++|.+.+.....     ..+++..+..++.|++.||+|||+++++||||||+||+++.++     .+++.|||.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999999865321     2367888999999999999999999999999999999999877     789999987


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPH  237 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~  237 (622)
                      ........  .........++..|+|||++..+  .++.++|||||||++|+|++ |+.||......... ..+....  
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~--  230 (269)
T cd05044         158 ARDIYKSD--YYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-QHVTAGG--  230 (269)
T ss_pred             cccccccc--ccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH-HHHhcCC--
Confidence            64332111  11111122345679999998753  57899999999999999998 99999765433222 1211100  


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                   ........+..+.+++.+||..+|++||++.++++
T Consensus       231 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -----------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -----------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                         00112346788999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.3e-36  Score=311.98  Aligned_cols=202  Identities=22%  Similarity=0.332  Sum_probs=165.5

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHH-HHHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|++..+++.||+|++...... ......+.+|. .+++.++||||+++++++...+..|+||||++
T Consensus         2 ~lg~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           2 VIGK--GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             eeee--CCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            5788  88999999999999999999998754321 12223444444 45788999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----~~~  153 (325)
T cd05602          80 GGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----GTT  153 (325)
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----CCc
Confidence            999999887643  46788888899999999999999999999999999999999999999999754321111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ....||+.|||||++.+  ..++.++|||||||++|||++|++||...+.....
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  205 (325)
T cd05602         154 STFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY  205 (325)
T ss_pred             ccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence            23457889999999975  46889999999999999999999999877655443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-35  Score=298.73  Aligned_cols=253  Identities=17%  Similarity=0.264  Sum_probs=194.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ..+|++.+.||+  |+||.||+|...   ..+..||+|.+.... +......+.+|+..++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~--G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGT--GRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecc--cCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            356899999999  889999999765   456789999987543 34445678999999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+++.|||.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999987643 2578888999999999999999999999999999999999999999999986543211


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCC-CCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLL-DCT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~-~~~  592 (622)
                      ...   .......++..|+|||++.+  ..++.++|||||||++||+++ |+.||...+....+.....+..++.+ .++
T Consensus       160 ~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (266)
T cd05064         160 EAI---YTTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCP  234 (266)
T ss_pred             cch---hcccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCC
Confidence            110   11112233567999999865  468999999999999999775 99999877655544333333332222 244


Q ss_pred             cccccCCCCcCcccccchhhhhhhhhc
Q psy15039        593 TYYVDTGQDDGEENACSYISEQQTQVL  619 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (622)
                      ....+....|..+++.++.+.++...+
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~~  261 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHSI  261 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHHH
Confidence            555555666666666677666555443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-36  Score=313.15  Aligned_cols=200  Identities=20%  Similarity=0.300  Sum_probs=168.5

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF  444 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~  444 (622)
                      .||+  |+||.||++++..+|+.||+|++..... .......+.+|+++++.++||||+++++++...+.+++||||+++
T Consensus         2 ~lG~--G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           2 LLGK--GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             eeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            5788  8899999999999999999999875432 223345678999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       445 g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      |+|.+++....  .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+++.|||.+........    ..
T Consensus        80 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~  153 (325)
T cd05594          80 GELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----TM  153 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----cc
Confidence            99998886543  47888999999999999999997 7999999999999999999999999997542211111    11


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHH
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL  575 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~  575 (622)
                      ....+|+.|||||++.+  ..++.++|||||||++|||++|+.||...+...
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~  203 (325)
T cd05594         154 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK  203 (325)
T ss_pred             ccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHH
Confidence            23457889999999965  468899999999999999999999998765443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.3e-36  Score=310.15  Aligned_cols=209  Identities=20%  Similarity=0.315  Sum_probs=170.6

Q ss_pred             eecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        365 SILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      +.||+  |+||.||++++.   .+++.||+|++.....  .......+.+|+.+|+.++||||++++++|...+..|+||
T Consensus         2 ~~lg~--G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           2 KVLGK--GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             ceeee--cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            57888  889999999863   5789999999875322  1223456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......   
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  154 (323)
T cd05584          80 EYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---  154 (323)
T ss_pred             eCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---
Confidence            9999999999887643  46788888999999999999999999999999999999999999999999754321111   


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                       .......+|+.|+|||++.+  ..++.++|||||||++|||++|++||...+....+.....+
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~  215 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG  215 (323)
T ss_pred             -CcccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence             11123457889999999975  45788999999999999999999999877655544443333

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.1e-36  Score=311.05  Aligned_cols=221  Identities=20%  Similarity=0.350  Sum_probs=177.1

Q ss_pred             CceEeeecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCC
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT  433 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~  433 (622)
                      +|++.+.||+  |+||.||++++.   .+++.||+|++.....  .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus         1 ~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGT--GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEee--cCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            5899999999  889999998874   5789999999865322  122345678999999999 5999999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      .+++||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||++..+.
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            9999999999999999887643  47888899999999999999999999999999999999999999999999765432


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC---CcHHHHHHHHcCCCCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET---PTTLMLIEKLAGATPHL  588 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~---~~~~~~~~~~~~~~p~~  588 (622)
                      .....   ......||+.|||||++.+. ..++.++|||||||++|||+||+.||...   .....+...+....|.+
T Consensus       157 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  230 (332)
T cd05614         157 SEEKE---RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF  230 (332)
T ss_pred             ccCCC---ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            21111   11234678899999999642 34788999999999999999999999643   23334444454444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-35  Score=302.64  Aligned_cols=212  Identities=23%  Similarity=0.360  Sum_probs=172.2

Q ss_pred             CceEeeecccccCCeeEEEEEEEcc-CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCccceeEEEEEe----
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKV-TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFLD----  431 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~----  431 (622)
                      +|++.+.||+  |+||.||+|++.. +++.||+|++............+.+|+.+++.+   +||||+++++++..    
T Consensus         2 ~Y~~~~~lg~--G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           2 QYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CcceeeEecc--CCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            6899999999  8899999999854 578899999876543333334566787777765   69999999998863    


Q ss_pred             -CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        432 -ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       432 -~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                       ...+++||||++ ++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence             346899999997 689998876544568899999999999999999999999999999999999999999999999764


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      .....     .......+|+.|+|||++.+  ..++.++|||||||++|||++|++||.+.+....+...+
T Consensus       159 ~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~  222 (290)
T cd07862         159 IYSFQ-----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  222 (290)
T ss_pred             eccCC-----cccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            43221     11223457889999999965  458899999999999999999999998877665554443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-35  Score=331.65  Aligned_cols=214  Identities=21%  Similarity=0.296  Sum_probs=176.1

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|++..+|+.||+|++..+... +...+++.+|+.+++.++|||||++++++.+.+..++
T Consensus         2 grYeIi~~LGk--GgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGK--GGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEec--CCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            57999999999  88999999999999999999999754322 3345678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        438 VSPLMGFGSCKDLINAHF---------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~---------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                      +|||+++|+|.+++....         ....+...+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            999999999999886421         11244566788999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCCc--------------eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        509 MCPFSPTKKK--------------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       509 ~~~~~~~~~~--------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                      +.........              ....+....||+.|||||++.+  ..++.++|||||||++|||+||++||......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            6544111000              0011123468999999999975  45899999999999999999999999876544


Q ss_pred             HH
Q psy15039        575 LM  576 (622)
Q Consensus       575 ~~  576 (622)
                      ..
T Consensus       238 ki  239 (932)
T PRK13184        238 KI  239 (932)
T ss_pred             hh
Confidence            33

>KOG4250|consensus

Probab=100.00  E-value=9.8e-37  Score=318.91  Aligned_cols=204  Identities=25%  Similarity=0.415  Sum_probs=172.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-----
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----  433 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-----  433 (622)
                      ..+...+.||+  |+||.||+++++.||+.||||.++... ....++++.+|+++|++|+|||||++++.-.+..     
T Consensus        13 y~W~~~e~LG~--Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   13 YLWEMDERLGK--GAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             cceeehhhhcC--CccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            45778889999  889999999999999999999997654 2344678899999999999999999998755433     


Q ss_pred             -cEEEEeeccCCCCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCc--eEEcCcc
Q psy15039        434 -DLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS--HNGK--ACLSGLR  507 (622)
Q Consensus       434 -~~~lv~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~--~~~~--~~~~~~~  507 (622)
                       ...+|||||.+|+|...+.+- ...++++..++.++.+++.||.|||++|||||||||.||++-  .+|+  -|+.|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             468999999999999998753 346899999999999999999999999999999999999984  3453  5788999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      .+..++...     ...+..||+.|.+||++... ..|+..+|.|||||++|+.+||..||...
T Consensus       170 ~Arel~d~s-----~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  170 AARELDDNS-----LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccccCCCCC-----eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            877665543     23457889999999999742 46888999999999999999999999543

>KOG0986|consensus

Probab=100.00  E-value=5.4e-37  Score=304.25  Aligned_cols=203  Identities=24%  Similarity=0.380  Sum_probs=180.6

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHH-HHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~-~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      .|..-.+||+  |+||.||-+.-+.||+.+|+|++.+.+.....- ...+.|-.+|..++.|.||.+--+|.+.+.+++|
T Consensus       186 ~F~~~RvlGk--GGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  186 TFRVYRVLGK--GGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ceeeeEEEec--ccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            4566679999  889999999999999999999998765544332 3467899999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      +.+|-||+|.-.|..+++.++++..++.|+.+|++||++||+.+||-|||||+|||||+.|+++|+|+|+++.+...+. 
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-  342 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-  342 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc-
Confidence            9999999998888887777899999999999999999999999999999999999999999999999999998876442 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                          -.+++||..|||||++..  +.|+...|.|||||++|||+.|+.||...
T Consensus       343 ----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  343 ----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             ----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhh
Confidence                234578899999999976  45999999999999999999999999754

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.1e-35  Score=293.29  Aligned_cols=238  Identities=16%  Similarity=0.269  Sum_probs=185.4

Q ss_pred             eecccccCCceeEEEEEEccCC----------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039         15 SILGQCFNNLSSVYLSKHKVTN----------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~~t~----------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +.||+  |+||.||+|.++.++          ..||+|.+......   ...+.+|+.+|++++||||+++++++.. ..
T Consensus         1 ~~lg~--G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQ--GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             Ccccc--cccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            46888  778899999999887          45888887554321   4667899999999999999999999888 77


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-------ceEEcCCc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-------KACLSGLR  157 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-------~~~i~~~~  157 (622)
                      .++||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++       .+++.|||
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            8999999999999999876432 578899999999999999999999999999999999999887       68999998


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      .......        ......+..|+|||++......++.++||||+||++|+|++ |..||......... ....... 
T Consensus       154 ~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-~~~~~~~-  223 (259)
T cd05037         154 IPITVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFYQDQH-  223 (259)
T ss_pred             ccccccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-HHHhcCC-
Confidence            7644321        11123345699999987643467889999999999999998 67888654322111 1100000 


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                      ......+.++.+++.+||..||++||++.++++
T Consensus       224 --------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 --------------------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --------------------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                            000112378999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-35  Score=308.87  Aligned_cols=217  Identities=20%  Similarity=0.287  Sum_probs=178.3

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+++++.+++.+|+|++..... .......+.+|+.++..++||||+++++++.+.+.+++
T Consensus         1 ~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGR--GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEe--CCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            46899999999  8899999999999999999999864321 22234457889999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+++.|||.+..+.....
T Consensus        79 v~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             EEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999997642 2478888999999999999999999999999999999999999999999997543322111


Q ss_pred             ceeccCCCCCCCCccccccccccC---ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      .   ......||+.|||||++...   ...++.++|||||||++|||++|+.||...+.........
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~  221 (332)
T cd05623         158 V---QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  221 (332)
T ss_pred             c---eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            1   11224678899999998531   2357889999999999999999999998776555443333

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-35  Score=300.40  Aligned_cols=198  Identities=24%  Similarity=0.390  Sum_probs=166.9

Q ss_pred             cccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCCC
Q psy15039        367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG  445 (622)
Q Consensus       367 lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g  445 (622)
                      ||+  |+||.||++.++.+++.||+|++....... ...+.+..|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 lg~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGK--GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCC--CCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            566  889999999999999999999987543332 23456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        446 SCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       446 ~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|.+++...  ....+++..+..++.||+.||+|||+++|+||||||+||+++.++.+++.|||.+..+.....    ..
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----~~  154 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----KT  154 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc----cc
Confidence            999877542  233578999999999999999999999999999999999999999999999997654332211    11


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      .+..+|+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         155 KGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             cccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            23457888999999975  468899999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.2e-36  Score=309.68  Aligned_cols=207  Identities=22%  Similarity=0.343  Sum_probs=168.1

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHH-HHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIV-CMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|+++.+|+.||||++...... ....+.+.+|.. +++.++||||+++++++...+..++||||++
T Consensus         2 ~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           2 VIGK--GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             eeee--CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            6788  88999999999999999999998754322 222345555555 5678999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~  153 (323)
T cd05575          80 GGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----KTT  153 (323)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----Ccc
Confidence            999999887643  47888899999999999999999999999999999999999999999999754321111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ....+|+.|||||++.+  ..++.++|||||||++|||++|++||...+.... ...+..
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~  210 (323)
T cd05575         154 STFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-YDNILN  210 (323)
T ss_pred             ccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHH-HHHHHc
Confidence            23457889999999975  4689999999999999999999999987655443 343333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-35  Score=330.34  Aligned_cols=222  Identities=25%  Similarity=0.414  Sum_probs=183.9

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC--C
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--T  433 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--~  433 (622)
                      .....|++++.||+  |+||.||+|++..+++.+|+|++............+.+|+.+|+.|+|||||+++++|...  .
T Consensus        10 ~~l~~YeIl~kLG~--GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         10 SRLNEYEVIKKIGN--GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             cccCCEEEEEEEec--CCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            34568999999999  7899999999999999999999987766666677899999999999999999999998754  4


Q ss_pred             cEEEEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEcCC------
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGK-------GFIHRAVKASHILISHN------  498 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~~-------~iiHRDlKp~NILl~~~------  498 (622)
                      .+|+||||+++|+|.+++....  ...+++..++.|+.||+.||+|||+.       +||||||||+||||+.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            5899999999999999987532  23588999999999999999999984       59999999999999642      


Q ss_pred             -----------CceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCC
Q psy15039        499 -----------GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVP  567 (622)
Q Consensus       499 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~P  567 (622)
                                 +.++|.|||++.......     ......+|+.|||||++.+....++.++||||||||+|||+||++|
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                       347899999765432211     1223467889999999965445688999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHcCC
Q psy15039        568 FAETPTTLMLIEKLAGA  584 (622)
Q Consensus       568 f~~~~~~~~~~~~~~~~  584 (622)
                      |...+....+...+...
T Consensus       243 F~~~~~~~qli~~lk~~  259 (1021)
T PTZ00266        243 FHKANNFSQLISELKRG  259 (1021)
T ss_pred             CCcCCcHHHHHHHHhcC
Confidence            98777666666655443

>KOG0671|consensus

Probab=100.00  E-value=1.2e-36  Score=297.21  Aligned_cols=289  Identities=20%  Similarity=0.284  Sum_probs=210.2

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCC--Cc----ceeEEEE
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH--PN----IICYISS   78 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H--pn----Iv~~~~~   78 (622)
                      +.+..+|++.+.+|+  |.||+|-.+.+.+++..||||+++.-   +.-.+...-||++|.+|.+  ||    +|++.++
T Consensus        85 D~l~~Ry~i~~~lGe--GtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGE--GTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             cccccceehhhhhcC--CcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            456789999999999  66889999999999999999998531   2334556679999999943  33    6788899


Q ss_pred             EEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---------
Q psy15039         79 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---------  149 (622)
Q Consensus        79 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---------  149 (622)
                      |......++|.|.++ .++.|+++.....+.|-..++.+.+|++++++|||+.+++|-||||+|||+.+..         
T Consensus       160 FdyrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  160 FDYRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             hhccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence            999999999999864 6899999887666788999999999999999999999999999999999996533         


Q ss_pred             -----------ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy15039        150 -----------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF  218 (622)
Q Consensus       150 -----------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf  218 (622)
                                 .+++.|||.+.- ...      .-.+.+.|..|+|||++.+  -+++.++||||+||||+|+.+|...|
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf-~~e------~hs~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATF-DHE------HHSTIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             ccceeccCCCcceEEEecCCcce-ecc------CcceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceec
Confidence                       234445554321 100      0122345778999999986  35889999999999999999999999


Q ss_pred             CCCc--hHHHHHHHHhCCCCCCCcc---ccccccCCCCcCccccc----ccchhhhhc----cccCCCCcHHHHHHHHHh
Q psy15039        219 AETP--TTLMLIEKLAGATPHLLDC---TTYYVDTGQDDGEENAC----SYISEQQTQ----VLTSRKFSDSFHSIVELC  285 (622)
Q Consensus       219 ~~~~--~~~~~~~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~----~~i~~~~~~----~~~~~~~s~~~~~li~~~  285 (622)
                      .+.+  .....++++.|+.|.-.-.   ...+...+.-++.+...    .+..+.+.+    ......--.++.||+..|
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            8765  3455678888877642211   12222222212111110    111111111    111112234688999999


Q ss_pred             hhcCCCCCcCHHhhhcCcccccc
Q psy15039        286 LSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       286 L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      |.+||.+|+|+.|+|.||||+..
T Consensus       390 L~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  390 LEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HccCccccccHHHHhcCHHhhcC
Confidence            99999999999999999999764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-35  Score=307.83  Aligned_cols=195  Identities=21%  Similarity=0.325  Sum_probs=166.2

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||++++..+++.||+|++...... ....+.+.+|+.++..+ +||||+++++++...+.+|+||||++
T Consensus         2 ~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           2 VIGR--GSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             eeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            6888  88999999999999999999999765332 23456788999999888 69999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~  153 (327)
T cd05617          80 GGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----DTT  153 (327)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----Cce
Confidence            999998886543  47899999999999999999999999999999999999999999999999754211111    111


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      ....||+.|+|||++.+  ..|+.++|||||||++|||++|++||..
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         154 STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            23467889999999975  4689999999999999999999999953

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0665|consensus

Probab=100.00  E-value=7e-37  Score=292.05  Aligned_cols=288  Identities=23%  Similarity=0.289  Sum_probs=210.2

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +++.++.+|.-++.+|.|+.   .|..|.+..+++.||||++..........++..||..+|..+.|+|||+++.+|...
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~---~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ---IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             cceeeeeeeeeecccCCCCc---eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            56678889999999999553   588899999999999999877655555567888999999999999999999999765


Q ss_pred             C------cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         83 T------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        83 ~------~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                      .      .+|+|||+|. ++|.+.+.    ..++...++.++.|+++|++|+|+.||+||||||+||++..++..|+.||
T Consensus        88 ~~l~~~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             ccHHHHHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccc
Confidence            3      5999999998 55555554    23678999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH---hC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL---AG  233 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~---~~  233 (622)
                      |........   ...  .....+..|.|||++.+-  +|...+||||+||++.||++|+.-|.+.+...+..+.+   ..
T Consensus       163 g~ar~e~~~---~~m--tpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt  235 (369)
T KOG0665|consen  163 GLARTEDTD---FMM--TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT  235 (369)
T ss_pred             hhhcccCcc---ccc--CchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence            987543322   111  122446789999999863  48999999999999999999999998776554433322   22


Q ss_pred             CCCCCCcc-----ccccccCCCCcCcccccccchhhhhcc-cc-CCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        234 ATPHLLDC-----TTYYVDTGQDDGEENACSYISEQQTQV-LT-SRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       234 ~~p~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~-~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                      +.|.+.+.     ..+....++..+ .+.....+....+. .. +..-+..+++++.+||-.||++|.+++++|+|||++
T Consensus       236 pd~~F~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  236 PDPSFMKQLQPTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             CCHHHHHHhhHHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            22211110     001111111111 00000000000000 00 112245689999999999999999999999999997

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.4e-36  Score=308.88  Aligned_cols=208  Identities=20%  Similarity=0.305  Sum_probs=168.4

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHH-HHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIV-CMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|++..+++.||+|++...... ......+.+|.. +++.++|||||++++++.+.+..|+||||++
T Consensus         2 ~lg~--G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           2 VIGK--GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             eeee--CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            6788  88999999999999999999998754321 222345555654 6788999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+......    ....
T Consensus        80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~  153 (321)
T cd05603          80 GGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----EETT  153 (321)
T ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC----CCcc
Confidence            999988876532  4678888899999999999999999999999999999999999999999975422111    1112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....+|+.|+|||++.+  ..++.++|||||||++|||++|++||...+... +...+...
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~  211 (321)
T cd05603         154 STFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-MYDNILHK  211 (321)
T ss_pred             ccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-HHHHHhcC
Confidence            23457889999999975  468899999999999999999999998775443 44444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-35  Score=307.75  Aligned_cols=194  Identities=22%  Similarity=0.340  Sum_probs=165.0

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+++++.+++.||+|++...... ....+.+.+|+.++..+ +|||||++++++...+..++||||++
T Consensus         2 ~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           2 VIGR--GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             eeee--CCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            6888  88999999999999999999999765332 33456688899988776 89999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----~~~  153 (329)
T cd05618          80 GGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTT  153 (329)
T ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----Ccc
Confidence            999998876543  47899999999999999999999999999999999999999999999999753211111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA  569 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~  569 (622)
                      ....||+.|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         154 STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCc
Confidence            23467889999999975  468899999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-36  Score=312.19  Aligned_cols=205  Identities=21%  Similarity=0.306  Sum_probs=171.0

Q ss_pred             eecccccCCeeEEEEEEE---ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeec
Q psy15039        365 SILGQCFNNLSSVYLSKH---KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL  441 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~---~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~  441 (622)
                      +.||+  |+||.||++++   ..+|+.||+|++............+.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus         2 ~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQ--GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeee--CCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            56888  88999999886   46899999999976544444455678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceec
Q psy15039        442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL  521 (622)
Q Consensus       442 ~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (622)
                      +++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+........    
T Consensus        80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----  153 (318)
T cd05582          80 LRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK----  153 (318)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC----
Confidence            99999999886543  478999999999999999999999999999999999999999999999997543322111    


Q ss_pred             cCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        522 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       522 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      ......+|+.|||||++.+  ..++.++|||||||++|||++|+.||........+..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~  209 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM  209 (318)
T ss_pred             ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH
Confidence            1123457888999999975  4578899999999999999999999987665444333

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-35  Score=306.63  Aligned_cols=213  Identities=20%  Similarity=0.308  Sum_probs=172.0

Q ss_pred             eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEEEeecc
Q psy15039        365 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLM  442 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~e~~  442 (622)
                      +.||+  |+||.||+|+++.+|+.||+|++...... +........|..++..+ +||||+++++++.+.+..|+||||+
T Consensus         1 ~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGK--GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             Ceeee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            36888  88999999999999999999998754221 22345667788888754 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceecc
Q psy15039        443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  522 (622)
Q Consensus       443 ~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (622)
                      ++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......    ..
T Consensus        79 ~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~  152 (316)
T cd05620          79 NGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----NR  152 (316)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----Cc
Confidence            9999999887643  46788889999999999999999999999999999999999999999999754221111    11


Q ss_pred             CCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       523 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                      .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||...+.. .+.+.+....|.+
T Consensus       153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~~~~~~~~~~~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELFESIRVDTPHY  215 (316)
T ss_pred             eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC
Confidence            223457889999999975  46899999999999999999999999876544 3444444444433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-36  Score=310.31  Aligned_cols=206  Identities=20%  Similarity=0.307  Sum_probs=168.0

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHH-HHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIV-CMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|+++.+|+.+|+|++..... .......+.+|.. +++.++||||+++++++...+..|+||||++
T Consensus         2 ~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           2 VIGK--GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             ceee--CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            5788  8899999999999999999999875422 2223345556654 5778999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~  153 (325)
T cd05604          80 GGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----DTT  153 (325)
T ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----CCc
Confidence            999998886543  57899999999999999999999999999999999999999999999999753221111    112


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ....+|+.|||||++.+  ..++.++|||||||++|||++|++||...+........+
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~  209 (325)
T cd05604         154 TTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL  209 (325)
T ss_pred             ccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence            23457889999999975  468899999999999999999999998776554433333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG1187|consensus

Probab=100.00  E-value=4.3e-35  Score=303.21  Aligned_cols=201  Identities=24%  Similarity=0.353  Sum_probs=167.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc-EEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~l   87 (622)
                      ++|.--..||+  ||||.||+|.-... ..||||+++......  .+.|.+|+.+|.+++|||+|+|+|+|.+.+. ..|
T Consensus        75 ~~Fs~~~~ig~--Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L  149 (361)
T KOG1187|consen   75 NNFSESNLIGE--GGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL  149 (361)
T ss_pred             hCCchhcceec--CCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence            46666789999  88999999998755 899999887654432  3448999999999999999999999999884 999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK---GFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      |.|||+.|+|.+.|.......++|.....|+.++++||+|||..   .||||||||+|||||.++.+|++|||.+.....
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            99999999999999764322689999999999999999999985   399999999999999999999999998743321


Q ss_pred             CCccccccCCCC-CCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCC
Q psy15039        165 TKKKVHLFPPST-AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  220 (622)
Q Consensus       165 ~~~~~~~~~~~~-~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~  220 (622)
                      ....    ..+. .+|..|+|||.+..  ...+.|+||||||++|.||++|+.|...
T Consensus       230 ~~~~----~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  230 GDTS----VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             cccc----eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCC
Confidence            0111    1111 67788999999865  3478999999999999999999988874

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.8e-35  Score=292.31  Aligned_cols=246  Identities=21%  Similarity=0.357  Sum_probs=196.3

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      +|++.+.||+  |++|.||++.+..+++.|++|.+.....+......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         1 ~~~~~~~l~~--g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGK--GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecC--CCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            5788899999  78999999999999999999999876666677788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      ||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........  
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--  156 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--  156 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--
Confidence            999999999999875445678888999999999999999999999999999999999999999999997544332111  


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC-CCcccccC
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD-CTTYYVDT  598 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~  598 (622)
                        ......+++.|+|||++..  ..++.++|+|||||++|||++|+.||...+..........+..|.+.. .+....+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd08529         157 --FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQL  232 (256)
T ss_pred             --hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHH
Confidence              1112345678999999975  457889999999999999999999998776555444445554444432 22233333


Q ss_pred             CCCcCcccccchhhh
Q psy15039        599 GQDDGEENACSYISE  613 (622)
Q Consensus       599 ~~~~~~~~~~~~~~~  613 (622)
                      ..++...+..++++-
T Consensus       233 i~~~l~~~p~~Rp~~  247 (256)
T cd08529         233 IDQCLTKDYRQRPDT  247 (256)
T ss_pred             HHHHccCCcccCcCH
Confidence            444444444444443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4721|consensus

Probab=100.00  E-value=9.1e-37  Score=309.35  Aligned_cols=188  Identities=24%  Similarity=0.424  Sum_probs=163.0

Q ss_pred             eeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        364 CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       364 ~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      ++.||.  |+-|.||+++..  ++.||||+++.         .-..+|+=|++|+|||||.|.++|.....++||||||.
T Consensus       129 LeWlGS--GaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGS--GAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhcc--Ccccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            357888  778999999875  78999999752         12357888999999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      .|.|..+|+...  .+.......|..+|+.|+.|||.+.|||||||.-||||+.+..+||.|||........     .+.
T Consensus       196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-----STk  268 (904)
T KOG4721|consen  196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-----STK  268 (904)
T ss_pred             cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-----hhh
Confidence            999999998743  4677788899999999999999999999999999999999999999999965433221     234


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      .+.+||..|||||++..  +..+.|+|||||||+|||||||..||.+.+.
T Consensus       269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds  316 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS  316 (904)
T ss_pred             hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccch
Confidence            56789999999999986  5789999999999999999999999987654

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-35  Score=296.98  Aligned_cols=270  Identities=20%  Similarity=0.324  Sum_probs=199.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--   81 (622)
                      ..+|++.+.||+  |+||.||+++..    .+++.||||.+...... ...+.+.+|+++++.++||||+++++++..  
T Consensus         3 ~~~~~~~~~ig~--g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGE--GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeecc--CCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            357889999999  779999999964    45899999999765433 345678899999999999999999998877  


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ....+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||....
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            567999999999999999987643 2478999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ......... .......+..|+|||.+...  .++.++|||||||++|+|++|..||.........   +.+..+.    
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~----  228 (284)
T cd05038         159 LPEDKDYYY-VKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQG----  228 (284)
T ss_pred             cccCCccee-ccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccc----
Confidence            432111111 11112234469999998653  5788999999999999999999998653321100   0000000    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                               ..........+.. .........++.++.+++.+||+.||++||++.++++
T Consensus       229 ---------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         229 ---------QMIVTRLLELLKE-GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ---------cccHHHHHHHHHc-CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                     0000000000000 0011112345688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.8e-35  Score=303.78  Aligned_cols=221  Identities=44%  Similarity=0.739  Sum_probs=182.1

Q ss_pred             eeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        364 CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       364 ~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      ...||+|+|+||+||++++..+|+.||+|++......+...+.+.+|+.+++.++||||++++++|...+..++++||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            35789988899999999999999999999988766666667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC---Ccee
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK---KKVH  520 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~---~~~~  520 (622)
                      ++++.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.+|+.........   ....
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            9999999887655568899999999999999999999999999999999999999999999987532221111   0011


Q ss_pred             ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        521 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       521 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ..+....++..|||||++.+....++.++|||||||++|||++|++||........+...+.+.
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  226 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP  226 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC
Confidence            1111123355799999997644457899999999999999999999998877666665555543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-35  Score=307.38  Aligned_cols=215  Identities=20%  Similarity=0.286  Sum_probs=177.6

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+++++.+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         1 d~y~i~~~lG~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGR--GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEee--CCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            47999999999  8899999999999999999999864321 22334567889999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus        79 v~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             EEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999997642 2578888999999999999999999999999999999999999999999997644322111


Q ss_pred             ceeccCCCCCCCCccccccccccC---ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      .   ......||+.|||||++.+.   ...++.++|||||||++|||++|+.||...+.......
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~  219 (331)
T cd05624         158 V---QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  219 (331)
T ss_pred             e---eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH
Confidence            1   11224578899999998641   12478899999999999999999999987765544333

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.8e-35  Score=305.08  Aligned_cols=207  Identities=21%  Similarity=0.333  Sum_probs=169.0

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhh-CCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRH-LRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+|++..+++.||||++..+.. .+........|..+++. ++||||+++++++.+.+.+++||||++
T Consensus         2 ~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           2 MLGK--GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             eeee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            5788  8899999999999999999999875422 12234556778888876 599999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........    ..
T Consensus        80 ~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~  153 (316)
T cd05619          80 GGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA----KT  153 (316)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----ce
Confidence            999999887643  467888889999999999999999999999999999999999999999997543211111    11


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .+..+|+.|||||++.+  ..++.++|||||||++|||++|+.||...+... +.+.+..
T Consensus       154 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~i~~  210 (316)
T cd05619         154 CTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-LFQSIRM  210 (316)
T ss_pred             eeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Confidence            23457888999999975  468999999999999999999999998765543 3444433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-35  Score=310.77  Aligned_cols=209  Identities=19%  Similarity=0.286  Sum_probs=172.9

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-----c
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----D  434 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-----~  434 (622)
                      +|++.+.||+  |+||.||++++..+|+.||||++..........+++.+|+.+++.++||||+++++++...+     .
T Consensus         1 ~~~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGY--GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeee--CCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            4788899999  88999999999999999999998654334445678899999999999999999999998776     7


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .|+|+||+. ++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            899999997 5777777543  3478888999999999999999999999999999999999999999999997643322


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ...   .......+|+.|+|||++.+. ..|+.++||||+||++|||++|++||...+....+
T Consensus       156 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  214 (372)
T cd07853         156 DES---KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL  214 (372)
T ss_pred             Ccc---ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            111   111223467789999998653 35788999999999999999999999877655443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-35  Score=305.44  Aligned_cols=208  Identities=21%  Similarity=0.320  Sum_probs=171.2

Q ss_pred             ecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        366 ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      .||+  |+||.||+++++.+++.||||++..... .......+.+|+.+++.+ +||||+++++++...+.+++||||++
T Consensus         2 ~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           2 VLGK--GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             eeee--CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            6788  7899999999999999999999875432 223356678899999888 79999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                      +|+|.+.+....  .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.+.......    ...
T Consensus        80 ~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~  153 (318)
T cd05570          80 GGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTT  153 (318)
T ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----Ccc
Confidence            999998887643  47899999999999999999999999999999999999999999999999753211111    111


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....+|+.|||||++.+  ..++.++|||||||++|||++|+.||...+... +...+...
T Consensus       154 ~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-~~~~i~~~  211 (318)
T cd05570         154 STFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-LFQSILED  211 (318)
T ss_pred             cceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcC
Confidence            22357888999999975  468999999999999999999999998765444 34444433

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG1095|consensus

Probab=100.00  E-value=5.3e-35  Score=324.18  Aligned_cols=255  Identities=19%  Similarity=0.342  Sum_probs=207.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccC-C----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVT-N----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t-~----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +.+=++++.||+  |.||.||.|.-..- |    ..||||.+.... +.++...|.+|..+|+.++|||||+++|+..+.
T Consensus       691 ~~~v~l~~~lG~--G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGK--GAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeecc--ccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            346678999999  66889999996543 3    249999987653 466678899999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHF-----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                      ...++++|||++|+|.++|+...     ...+.-..+..++.||++|.+||++++.|||||-++|+||+....+||.|||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999999998752     1247778889999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      .+.+....  .+........-...|||||.+..  ..|+.|+|||||||+|||+++ |..||.+......+...+.+.  
T Consensus       848 lArDiy~~--~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  848 LARDIYDK--DYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             hhHhhhhc--hheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            88754322  11111111223457999999986  469999999999999999998 999999877665554333321  


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                    +...+..+.+.+.++|..||+.||++||+...+++
T Consensus       922 ------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 ------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                          12234567788999999999999999999999887

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-34  Score=301.22  Aligned_cols=203  Identities=25%  Similarity=0.390  Sum_probs=175.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||++++..++..+|+|.+.... .......+.+|+.+|+.++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGA--GNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecC--CCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            467999999999  789999999999999999999987542 34445679999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      ||||+++|+|.+++....  .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+++.|||.+...... 
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999999987643  478888999999999999999986 6999999999999999999999999975433221 


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                           ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       158 -----~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~  207 (331)
T cd06649         158 -----MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDA  207 (331)
T ss_pred             -----ccccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                 1123457888999999975  4589999999999999999999999976544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.3e-35  Score=300.05  Aligned_cols=229  Identities=59%  Similarity=0.988  Sum_probs=190.1

Q ss_pred             eeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccC
Q psy15039        364 CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       364 ~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      ..++|+|.|+.+.||.+++..+++.||||++.....+....+.+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus         3 ~~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            34678877778889999998899999999998765566677889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC---cee
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK---KVH  520 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~---~~~  520 (622)
                      +|++.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+++.||+..........   ...
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99999999876555688999999999999999999999999999999999999999999999987554322111   111


Q ss_pred             ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q psy15039        521 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  592 (622)
Q Consensus       521 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  592 (622)
                      .......++..|+|||++......|+.++||||+||++|||++|+.||...+....+.+.+.+..|.+.+..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS  234 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence            222233456779999999764446889999999999999999999999988777777777777666655543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983|consensus

Probab=100.00  E-value=8.2e-36  Score=278.23  Aligned_cols=246  Identities=23%  Similarity=0.366  Sum_probs=193.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++.+.++.||.  |+-|.|++++.+.+|..+|||.+.+... .++.+++++.+.++... +.|.||+.+|+|..+.+.+
T Consensus        91 indl~~l~dlGs--GtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   91 INDLENLGDLGS--GTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             hHHhhhHHhhcC--CCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            344566778888  7789999999999999999999987654 45567888888877665 4899999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      +.||.|..+ +..++++. ..++||..+-++...++.||.||-+ ++|||||+||+|||+|+.|++|+.|||++-.+..+
T Consensus       168 IcMelMs~C-~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  168 ICMELMSTC-AEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHH-HHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            999999632 33445443 3468999999999999999999996 58999999999999999999999999975433332


Q ss_pred             CCceeccCCCCCCCCccccccccccC-ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCcc
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  594 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  594 (622)
                      +..     ...+|-+.|||||.+.-. ...|+.++|||||||+++||+||+.||.+..++...+.++....|+.++... 
T Consensus       246 kAh-----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-  319 (391)
T KOG0983|consen  246 KAH-----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-  319 (391)
T ss_pred             ccc-----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-
Confidence            221     123566789999999543 4579999999999999999999999999988887777777777777666322 


Q ss_pred             cccCCCCcCcccccchhhhhhhhhccc
Q psy15039        595 YVDTGQDDGEENACSYISEQQTQVLTS  621 (622)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (622)
                          |   .++..++|+..=+++-.+.
T Consensus       320 ----g---FSp~F~~fv~~CL~kd~r~  339 (391)
T KOG0983|consen  320 ----G---FSPDFQSFVKDCLTKDHRK  339 (391)
T ss_pred             ----C---cCHHHHHHHHHHhhcCccc
Confidence                2   2356677766655554443

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-35  Score=311.60  Aligned_cols=219  Identities=17%  Similarity=0.301  Sum_probs=175.3

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCC-----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTN-----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~-----~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~  431 (622)
                      .++|++.+.||+  |+||.||+|++..+|     +.||+|++..... ......+.+|+.+++.+ +|||||++++++..
T Consensus        37 ~~~~~~~~~LG~--G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          37 RDNLQFGKTLGA--GAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             HHHceehheecC--CCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            357999999999  889999999865444     5799999875443 33456789999999999 89999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhcc--------------------------------------------------------
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHF--------------------------------------------------------  455 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~--------------------------------------------------------  455 (622)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999886421                                                        


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccC
Q psy15039        456 ------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP  523 (622)
Q Consensus       456 ------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~  523 (622)
                                  ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+++.|||.+.........  ...
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~  271 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVK  271 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eec
Confidence                        113567778899999999999999999999999999999999999999999986543322111  111


Q ss_pred             CCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcC
Q psy15039        524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       524 ~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .+..+++.|||||++..  ..++.++|||||||++|||++ |++||........+...+..
T Consensus       272 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~  330 (374)
T cd05106         272 GNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR  330 (374)
T ss_pred             cCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc
Confidence            22234567999999965  458999999999999999997 99999876554444444433

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0586|consensus

Probab=100.00  E-value=9.7e-36  Score=307.58  Aligned_cols=206  Identities=25%  Similarity=0.400  Sum_probs=184.3

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      +...+|.+.+.||+  |+|+.|.++++..|+..||||.|++.......+..+.+|+++|+.|+|||||+++.+......+
T Consensus        53 ~~vg~y~i~~tig~--g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGK--GNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             ccccceeeeeeecc--ceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            45678999999999  8899999999999999999999999888777777799999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+.+|++.+++.++..  +.+..+..++.|++.|++|||+++|||||||.+||||+.+.+++|+|||++..+.. 
T Consensus       131 ylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-  207 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-  207 (596)
T ss_pred             EEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-
Confidence            999999999999999988754  45677889999999999999999999999999999999999999999998765532 


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                          .....+.+|++.|.|||++.+.  .| ++.+|+||+|+++|-|+.|..||.+..
T Consensus       208 ----~~~lqt~cgsppyAaPEl~~g~--~y~gpe~D~Wslgvvly~LV~GsLPFDG~~  259 (596)
T KOG0586|consen  208 ----GLMLQTFCGSPPYAAPELFNGK--KYDGPEVDIWSLGVVLYALVEGSLPFDGQN  259 (596)
T ss_pred             ----cccccccCCCCCccChHhhcCc--ccCCcceehhhhhhhheeeeecccccCCcc
Confidence                1223457889999999999763  35 578999999999999999999998664

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.3e-35  Score=295.41  Aligned_cols=197  Identities=24%  Similarity=0.346  Sum_probs=165.9

Q ss_pred             cccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCCC
Q psy15039        367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG  445 (622)
Q Consensus       367 lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~g  445 (622)
                      ||+  |+||.||+++++.+|+.||+|++..+..... ..+.+..|+.+++.++||||+++++++......++||||++++
T Consensus         1 lg~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGK--GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCC--CCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            566  8899999999999999999999875433221 2345567999999999999999999999999999999999999


Q ss_pred             CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCC
Q psy15039        446 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  525 (622)
Q Consensus       446 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (622)
                      +|.+++......++++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+........     ...
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-----~~~  153 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-----ITQ  153 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-----eec
Confidence            999888765555678888899999999999999999999999999999999999999999997644322111     112


Q ss_pred             CCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       526 ~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      ..+++.|+|||++.+  ..++.++||||+||++|||++|+.||....
T Consensus       154 ~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         154 RAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             cCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence            356788999999975  358999999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=293.75  Aligned_cols=265  Identities=17%  Similarity=0.179  Sum_probs=186.5

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccC---CcEEEEEEecCCCCCH--HH-------HHHHHHHHHHHhhCCCCcc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTD--ED-------LKSLHHEIVCMRHLRHPNI   72 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t---~~~vAiK~~~~~~~~~--~~-------~~~~~~Ei~il~~l~HpnI   72 (622)
                      +.+...|++.+.||+  |+||+||+|.+..+   +..+|+|.........  +.       ......+...+..++|+||
T Consensus         8 ~i~~~~y~i~~~LG~--G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          8 DITGKEWKIDKLIGC--GGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             ccCCCceEEeeEEec--CCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            445579999999999  88999999999888   7778888754332211  10       0112344556677899999


Q ss_pred             eeEEEEEEeCC----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q psy15039         73 ICYISSFLDAT----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN  148 (622)
Q Consensus        73 v~~~~~~~~~~----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~  148 (622)
                      ++++++.....    ..+++++++. .++.+++....  ..++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN  162 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence            99998766543    2356677654 45666665432  35788899999999999999999999999999999999999


Q ss_pred             CceEEcCCccccccCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH
Q psy15039        149 GKACLSGLRYMCPFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL  225 (622)
Q Consensus       149 ~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~  225 (622)
                      +.+++.|||.+..+........   .......+|+.|+|||+..+  ..|+.++||||+||++|||++|+.||.......
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999998755432211111   11112356788999999875  358999999999999999999999997653222


Q ss_pred             HHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       226 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ........                         ..+.............++.+.++++.|+..||++||+.+++++
T Consensus       241 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        241 NLIHAAKC-------------------------DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhHH-------------------------HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11111100                         0000000000112234788999999999999999999999865

>KOG0587|consensus

Probab=100.00  E-value=2.6e-35  Score=313.75  Aligned_cols=247  Identities=25%  Similarity=0.421  Sum_probs=205.7

Q ss_pred             cCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe-
Q psy15039        354 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD-  431 (622)
Q Consensus       354 ~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-  431 (622)
                      +....+.|++..++|+  |.+|.||+++++.+++..|+|+.+.....+   ..++.|.++|+.+ +|||++.+|++|.. 
T Consensus        14 lpdp~d~~ei~evig~--Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGN--GTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             CCCCCCccEEEEEEee--ccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3445667899999999  779999999999999999999987665444   3466788888877 79999999999875 


Q ss_pred             ----CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcc
Q psy15039        432 ----ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  507 (622)
Q Consensus       432 ----~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~  507 (622)
                          ++.+|||||||.+|+.+|+++......+.|..+..|++.++.||++||.+.+||||+|-.|||++.+|.+|++|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence                3579999999999999999987666678899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccC---ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      .+..+......    ..+..|||.||||||+.-.   ...|+.++|+|||||+..||.-|.||+.+.-+...++.+...+
T Consensus       169 vSaQldsT~gr----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP  244 (953)
T KOG0587|consen  169 VSAQLDSTVGR----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP  244 (953)
T ss_pred             eeeeeeccccc----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence            87665433222    2346789999999999421   1247789999999999999999999999999999999988888


Q ss_pred             CCCCCCCCcccccCCCCcCcccccchhhhhhhhh
Q psy15039        585 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQV  618 (622)
Q Consensus       585 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  618 (622)
                      +|.+..-..|.         +..-.|||..+++-
T Consensus       245 PPkLkrp~kWs---------~~FndFIs~cL~Kd  269 (953)
T KOG0587|consen  245 PPKLKRPKKWS---------KKFNDFISTCLVKD  269 (953)
T ss_pred             CccccchhhHH---------HHHHHHHHHHHhhc
Confidence            88777666665         55556666555443

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=308.21  Aligned_cols=202  Identities=22%  Similarity=0.299  Sum_probs=165.4

Q ss_pred             cccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC---CCCccceeEEEEEeCCcEEEEeecc
Q psy15039        367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL---RHPNIICYISSFLDATDLHLVSPLM  442 (622)
Q Consensus       367 lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~~~~~lv~e~~  442 (622)
                      ||+  |+||.||+|++..+++.||||++...... .........|..++..+   +||||+++++++...+..|+||||+
T Consensus         1 lG~--G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGK--GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCC--CCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            577  88999999999999999999998643222 22334556677777665   7999999999999999999999999


Q ss_pred             CCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceecc
Q psy15039        443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  522 (622)
Q Consensus       443 ~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (622)
                      ++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......    ..
T Consensus        79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~  152 (330)
T cd05586          79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN----KT  152 (330)
T ss_pred             CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----CC
Confidence            9999998887643  47889999999999999999999999999999999999999999999999754321111    11


Q ss_pred             CCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       523 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ....+||+.|||||++.+. ..++.++|||||||++|||++|+.||.........
T Consensus       153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~  206 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY  206 (330)
T ss_pred             ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHH
Confidence            2234678899999998643 34788999999999999999999999877655443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0984|consensus

Probab=100.00  E-value=2e-35  Score=265.19  Aligned_cols=226  Identities=23%  Similarity=0.343  Sum_probs=177.8

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh-CCCCccceeEEEEEeCCcEEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH-LRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      +..-+..||+  |+||.|-+.++..+|+.+|+|.+...-. ....+++.+|+.+..+ ...|.+|.||+++.+..+.|+.
T Consensus        47 ~L~~i~elGr--GayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   47 DLVGIEELGR--GAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhcC--CccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            3445567999  7799999999999999999999976554 4445678888886555 5899999999999999999999


Q ss_pred             eeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        439 SPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ||.|+ .+|..+-+..  ....++|..+-+|+..++.||.|||++ .|||||+||+|||++.+|++|++|||.+-.+..+
T Consensus       124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            99998 4666554321  234689999999999999999999986 8999999999999999999999999975433322


Q ss_pred             CCceeccCCCCCCCCccccccccccCc--cCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCCCc
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  593 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  593 (622)
                      ..+     .-.+|-..|||||.+..+.  .+|+.+|||||||+++.||++++.||....+..+....+...+|+-++..+
T Consensus       203 iAk-----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~~~  277 (282)
T KOG0984|consen  203 IAK-----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPADT  277 (282)
T ss_pred             hHH-----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcccc
Confidence            211     1123445799999995322  369999999999999999999999999887776666665555555454444


Q ss_pred             c
Q psy15039        594 Y  594 (622)
Q Consensus       594 ~  594 (622)
                      |
T Consensus       278 F  278 (282)
T KOG0984|consen  278 F  278 (282)
T ss_pred             c
Confidence            3

>KOG0604|consensus

Probab=100.00  E-value=1.7e-36  Score=286.29  Aligned_cols=245  Identities=18%  Similarity=0.246  Sum_probs=193.6

Q ss_pred             CCCCceEe-eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe---
Q psy15039        357 VPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD---  431 (622)
Q Consensus       357 ~~~~y~~~-~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---  431 (622)
                      ++++|.+- ++||-  |--|.|.-|.++.|++.+|+|++...       ....||+++.-.. .|||||+++++|..   
T Consensus        59 itedY~is~qvLG~--GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   59 ITEDYSISWQVLGA--GINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             chhhheehhhhhcc--ccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            56667665 46787  55799999999999999999987532       3456777766554 69999999998763   


Q ss_pred             -CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEcCcc
Q psy15039        432 -ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLR  507 (622)
Q Consensus       432 -~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~~~~  507 (622)
                       ...+.+|||.|+||+|...+..++....+|..+..|++||..|++|||+.+|.||||||+|+|.+..+   ..|+.|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             45689999999999999999888777789999999999999999999999999999999999997654   68899999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH---HHHHHHHcCC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGA  584 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~---~~~~~~~~~~  584 (622)
                      ++..-..     ...-.+.++||.|.|||++..  +.|+..+|+||+||++|-|+.|.+||....-.   ..+..+|..+
T Consensus       210 FAK~t~~-----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g  282 (400)
T KOG0604|consen  210 FAKETQE-----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG  282 (400)
T ss_pred             cccccCC-----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence            8643221     223356789999999999954  67999999999999999999999999754221   1123344333


Q ss_pred             CCCCCCCCcccccCCCCcCcccccchhhhhhhhhcc
Q psy15039        585 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLT  620 (622)
Q Consensus       585 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (622)
                      .   ..++...|+..+...+..+...+..++++|+|
T Consensus       283 q---y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT  315 (400)
T KOG0604|consen  283 Q---YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT  315 (400)
T ss_pred             C---ccCCChhHhHHHHHHHHHHHHHhcCCchhhee
Confidence            2   44566667777777777777778888888877

>KOG4236|consensus

Probab=100.00  E-value=4.1e-36  Score=302.03  Aligned_cols=199  Identities=25%  Similarity=0.416  Sum_probs=173.6

Q ss_pred             eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeeccCC
Q psy15039        365 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF  444 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~  444 (622)
                      ++||.  |.||.||-++++.||+.||||+|.+-+++...-.++..|+.||..++||.||.+...|.+.+.+++|||-+.|
T Consensus       570 evLGS--GQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  570 EVLGS--GQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             hhccC--CcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            57888  7799999999999999999999998887766667899999999999999999999999999999999999974


Q ss_pred             CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEcCcccccccCCCCCceec
Q psy15039        445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPFSPTKKKVHL  521 (622)
Q Consensus       445 g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~~~~~~~~~~~~~~~~~~  521 (622)
                       +..+.+.......+++.....++.||+.||.|||-++|+|+||||+|||+.+..   ++|+.|||++..++..     .
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-----s  721 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-----S  721 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-----h
Confidence             555555443344589999999999999999999999999999999999997654   7899999998766542     3


Q ss_pred             cCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        522 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       522 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      +..+.+|||.|+|||++..  .+|+..-||||+|||+|.-++|..||.+..+
T Consensus       722 FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd  771 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED  771 (888)
T ss_pred             hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccc
Confidence            4567889999999999976  5799999999999999999999999976543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.8e-35  Score=295.53  Aligned_cols=239  Identities=16%  Similarity=0.201  Sum_probs=184.6

Q ss_pred             eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEe----CCcEEEEe
Q psy15039        365 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLD----ATDLHLVS  439 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~~~~~lv~  439 (622)
                      ..+|+  |+++.||+|+.  +|+.||||++....... ...+.+.+|+.+|++++|||||++++++.+    ....++||
T Consensus        26 ~~i~~--g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKE--NDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEee--CCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            35677  78999999987  68999999987654333 235678899999999999999999999887    34689999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      ||+++|+|.+++....  .+++.....++.|++.||+|||+ .+++||||||+|||++.++.+++.|||.+...+..   
T Consensus       102 Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---  176 (283)
T PHA02988        102 EYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---  176 (283)
T ss_pred             EeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence            9999999999997643  46778888999999999999998 49999999999999999999999999975432211   


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC-CCCCCC-CCCcccc
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLL-DCTTYYV  596 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~-~~p~~~-~~~~~~~  596 (622)
                          .....+|+.|+|||++.+....|+.++|||||||++|||++|+.||...+........+.+ ..+++. +++..+.
T Consensus       177 ----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~  252 (283)
T PHA02988        177 ----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK  252 (283)
T ss_pred             ----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence                1223567789999999653346899999999999999999999999887655544333333 334433 4555555


Q ss_pred             cCCCCcCcccccchhhhhhh
Q psy15039        597 DTGQDDGEENACSYISEQQT  616 (622)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~~~  616 (622)
                      +....|...++.++.+-++.
T Consensus       253 ~li~~cl~~dp~~Rps~~el  272 (283)
T PHA02988        253 CIVEACTSHDSIKRPNIKEI  272 (283)
T ss_pred             HHHHHHhcCCcccCcCHHHH
Confidence            55555555566665554443

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=311.18  Aligned_cols=208  Identities=22%  Similarity=0.312  Sum_probs=168.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC-----
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-----  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-----  432 (622)
                      ...|++.+.||+  |+||.||+|.+..+++.||||++....      ....+|+.+|+.++|||||+++++|...     
T Consensus        65 ~~~y~~~~~LG~--G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGN--GSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEe--CCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            467999999999  889999999999999999999985432      2345799999999999999999887543     


Q ss_pred             ---CcEEEEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-ceEEcCc
Q psy15039        433 ---TDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGL  506 (622)
Q Consensus       433 ---~~~~lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~-~~~~~~~  506 (622)
                         ..+++||||+++ ++.+++...  ....+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+++.||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               136799999984 677766532  234578888999999999999999999999999999999998765 6999999


Q ss_pred             ccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        507 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      |.+..+.....     ..+..+|+.|||||++.+. ..|+.++|||||||++|||++|.+||.+.+....+...
T Consensus       216 Gla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  283 (440)
T PTZ00036        216 GSAKNLLAGQR-----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI  283 (440)
T ss_pred             ccchhccCCCC-----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            98654332111     1234568889999998643 36899999999999999999999999988766655544

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-34  Score=293.88  Aligned_cols=205  Identities=20%  Similarity=0.305  Sum_probs=174.4

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      |+..+.||+  |+||.||++.+..+++.+|+|++........ ....+.+|+.+|+.++|+||+.+++++...+..+++|
T Consensus         2 ~~~~~~lg~--G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGK--GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEec--CCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            677889999  8899999999999999999999876543332 2355788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      ||+++++|.+++......++++..+..++.|++.||+|||+++|+||||||+||++++++.+++.|||.........   
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---
Confidence            99999999988876544468899999999999999999999999999999999999999999999999754322111   


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                        ......+++.|+|||++.+  ..++.++|+|||||++|||++|++||......
T Consensus       157 --~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~  207 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK  207 (285)
T ss_pred             --cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence              1123457888999999965  46889999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-34  Score=287.53  Aligned_cols=219  Identities=23%  Similarity=0.373  Sum_probs=186.2

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      +|++.+.||.  |+||.||.+++..+++.+++|++.....+....+.+.+|+.++++++||||+++++++...+.++++|
T Consensus         1 ~y~~~~~ig~--g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGK--GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecc--cCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            5899999999  77999999999999999999999877666666778899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      ||+++++|.+++.......+++..+..++.|++.||+|||+++++||||||+||+++.++.+++.|||.+........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--  156 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--  156 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence            999999999999775444578889999999999999999999999999999999999999999999997654322221  


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCC
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  586 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p  586 (622)
                        ......+++.|+|||++.+  ..++.++|+|||||++|||++|..||..............+..+
T Consensus       157 --~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT  219 (256)
T ss_pred             --cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence              1223456788999999865  34788999999999999999999999877665555555555433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.3e-35  Score=295.78  Aligned_cols=210  Identities=22%  Similarity=0.356  Sum_probs=169.7

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCccceeEEEEEeC----
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFLDA----  432 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~----  432 (622)
                      .|++.+.||+  |+||.||+|+++.+++.||+|.+......+.......+|+.+++.+   +||||+++++++...    
T Consensus         1 ~y~~~~~lg~--g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGV--GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEee--cCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            4889999999  7899999999999999999999875433322223456677777665   799999999988653    


Q ss_pred             -CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        433 -TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       433 -~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                       ...++++|++. ++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..
T Consensus        79 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          79 ETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             CceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence             35899999998 4888888765444588999999999999999999999999999999999999999999999997654


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      .....     ......+|+.|+|||++.+  ..++.++||||+||++|||++|++||...+....+..
T Consensus       158 ~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~  218 (288)
T cd07863         158 YSCQM-----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK  218 (288)
T ss_pred             ccCcc-----cCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence            32211     1122356788999999975  4589999999999999999999999987766554433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	622
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-70
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-58
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-70
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-58
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-34
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-25
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-34
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-25
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-25
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-24
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-19
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-23
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-23
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-23
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-23
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-22
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-19
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-22
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-19
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-22
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-19
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-06
3soa_A	444	Full-Length Human Camkii Length = 444		4e-06
3soa_A	444	Full-Length Human Camkii Length = 444		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-05
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-05
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-05
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-05
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-04

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score =  263 bits (673), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 146/328 (44%), Positives = 197/328 (60%), Gaps = 17/328 (5%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 248 T-GQDDGEENACSYISEQQTQVLTS------------RKFSDSFHSIVELCLSRDVDKRP 294
                     A S +S+  T                 R FS  FH  VE CL R+ D RP
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 327 SASTLLNHSFFKQIKRRASEALPELLRP 354

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score =  223 bits (567), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 112/236 (47%), Positives = 157/236 (66%), Gaps = 3/236 (1%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 480
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 481 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 593
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score =  263 bits (673), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 146/328 (44%), Positives = 197/328 (60%), Gaps = 17/328 (5%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 131 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 190
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T   +
Sbjct: 191 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 250
Query: 248 T-GQDDGEENACSYISEQQTQVLTS------------RKFSDSFHSIVELCLSRDVDKRP 294
                     A S +S+  T                 R FS  FH  VE CL R+ D RP
Sbjct: 251 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 310
Query: 295 LACNLLQHAFFKQTK-KCSVMLPELLRP 321
            A  LL H+FFKQ K + S  LPELLRP
Sbjct: 311 SASTLLNHSFFKQIKRRASEALPELLRP 338

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score =  223 bits (567), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 112/236 (47%), Positives = 157/236 (66%), Gaps = 3/236 (1%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 480
           NI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ VL  L+YIH 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 481 KGFIHRAVKASHILISHNGKACLSGLR---YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
            G++HR+VKASHILIS +GK  LSGLR    M      ++ VH FP  +   L WLSPEV
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 190
Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 593
           L+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P LLD +T
Sbjct: 191 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 246

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 140/281 (49%), Gaps = 38/281 (13%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K+ NL++     +  L  EI  M    HPNI+ Y +SF+   +L LV  L+  GS  
Sbjct: 43  VAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 99  DLI------NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
           D+I        H +  L E  I  IL++VL GLEY+H  G IHR VKA +IL+  +G   
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161
Query: 153 LSGLRYMCPFSP----TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 208
           ++        +     T+ KV      T     W++PEV+EQ + GYD ++DI+S GI+ 
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPC---WMAPEVMEQ-VRGYDFKADIWSFGITA 217
Query: 209 CELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQV 268
            ELA G  P+ + P   +L+  L    P L        +TG  D E              
Sbjct: 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSL--------ETGVQDKE-------------- 255
Query: 269 LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK 309
              +K+  SF  ++ LCL +D +KRP A  LL+H FF++ K
Sbjct: 256 -MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/226 (34%), Positives = 114/226 (50%), Gaps = 23/226 (10%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K+ NL++     +  L  EI  M    HPNI+ Y +SF+   +L LV  L+  GS  
Sbjct: 43  VAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 449 DLI------NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
           D+I        H +  L E  I  IL++VL GLEY+H  G IHR VKA +IL+  +G   
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161
Query: 503 LSGLRYMCPFSP----TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 558
           ++        +     T+ KV      T     W++PEV+EQ + GYD ++DI+S GI+ 
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPC---WMAPEVMEQ-VRGYDFKADIWSFGITA 217
Query: 559 CELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGE 604
            ELA G  P+ + P   +L+  L    P L        +TG  D E
Sbjct: 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSL--------ETGVQDKE 255

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 38/284 (13%)
Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 95
            + +A+K+ NL++     +  L  EI  M    HPNI+ Y +SF+   +L LV  L+  G
Sbjct: 35  KEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 96  SCKDLI------NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
           S  D+I        H +  L E  I  IL++VL GLEY+H  G IHR VKA +IL+  +G
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG 153
Query: 150 KACLSGLRYMCPFSP----TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
              ++        +     T+ KV      T     W++PEV+EQ + GYD ++DI+S G
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPC---WMAPEVMEQ-VRGYDFKADIWSFG 209
Query: 206 ISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQ 265
           I+  ELA G  P+ + P   +L+  L    P L        +TG  D E           
Sbjct: 210 ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL--------ETGVQDKE----------- 250
Query: 266 TQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK 309
                 +K+  SF  ++ LCL +D +KRP A  LL+H FF++ K
Sbjct: 251 ----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/229 (34%), Positives = 115/229 (50%), Gaps = 23/229 (10%)
Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 445
            + +A+K+ NL++     +  L  EI  M    HPNI+ Y +SF+   +L LV  L+  G
Sbjct: 35  KEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 446 SCKDLI------NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
           S  D+I        H +  L E  I  IL++VL GLEY+H  G IHR VKA +IL+  +G
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG 153
Query: 500 KACLSGLRYMCPFSP----TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
              ++        +     T+ KV      T     W++PEV+EQ + GYD ++DI+S G
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPC---WMAPEVMEQ-VRGYDFKADIWSFG 209
Query: 556 ISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGE 604
           I+  ELA G  P+ + P   +L+  L    P L        +TG  D E
Sbjct: 210 ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL--------ETGVQDKE 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 141/309 (45%), Gaps = 53/309 (17%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           + +   LG+   +  SVY + HK T Q++A+K+  ++     DL+ +  EI  M+    P
Sbjct: 31  FDVLEKLGE--GSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSP 84
Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
           +++ Y  S+   TDL +V    G GS  D+I    N  L E  I  ILQ  L GLEY+H 
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF 143
Query: 131 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
              IHR +KA +IL++  G A L+  G+         K+   +  P       W++PEV+
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF------WMAPEVI 197
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT 248
           ++   GY+  +DI+S+GI+  E+A G  P+A+      +        P            
Sbjct: 198 QEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP------------ 243
Query: 249 GQDDGEENACSYISEQQTQVLTSRK---FSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                                T RK   +SD+F   V+ CL +  ++R  A  LLQH F 
Sbjct: 244 ---------------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282
Query: 306 KQTKKCSVM 314
           +  K  S++
Sbjct: 283 RSAKGVSIL 291

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 112/212 (52%), Gaps = 17/212 (8%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           + +   LG+   +  SVY + HK T Q++A+K+  ++     DL+ +  EI  M+    P
Sbjct: 31  FDVLEKLGE--GSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSP 84
Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 480
           +++ Y  S+   TDL +V    G GS  D+I    N  L E  I  ILQ  L GLEY+H 
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF 143
Query: 481 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
              IHR +KA +IL++  G A L+  G+         K+   +  P       W++PEV+
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF------WMAPEVI 197
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           ++   GY+  +DI+S+GI+  E+A G  P+A+
Sbjct: 198 QEI--GYNCVADIWSLGITAIEMAEGKPPYAD 227

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDE 91
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL
Sbjct: 92  LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
           +  +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPY---WMAPEVVTRK--AYGPKVDIWSL 202
Query: 205 GISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           GI   E+  G  P+  E P   + +    G TP L +                       
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQN----------------------- 238
Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                    K S  F   +  CL  DV+KR  A  LLQH F K  K  S + P
Sbjct: 239 -------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 350 SVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
           S+ ++ +    Y     +GQ  +   +VY +    T Q +A+++ NL +   ++L  + +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGAS--GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IIN 66
Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           EI+ MR  ++PNI+ Y+ S+L   +L +V   +  GS  D++       + E  I  + +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCR 123
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + L  LE++H    IHR +K+ +IL+  +G   L+   +    +P + K       T Y 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPY- 181
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             W++PEV+ +    Y  + DI+S+GI   E+  G  P+
Sbjct: 182 --WMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDE 91
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL
Sbjct: 92  LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
           +  +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY---WMAPEVVTRK--AYGPKVDIWSL 202
Query: 205 GISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           GI   E+  G  P+  E P   + +    G TP L +                       
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQN----------------------- 238
Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                    K S  F   +  CL  DV+KR  A  LLQH F K  K  S + P
Sbjct: 239 -------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 350 SVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
           S+ ++ +    Y     +GQ  +   +VY +    T Q +A+++ NL +   ++L  + +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGAS--GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IIN 66
Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           EI+ MR  ++PNI+ Y+ S+L   +L +V   +  GS  D++       + E  I  + +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCR 123
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + L  LE++H    IHR +K+ +IL+  +G   L+   +    +P + K       T Y 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY- 181
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             W++PEV+ +    Y  + DI+S+GI   E+  G  P+
Sbjct: 182 --WMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDE 91
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL
Sbjct: 92  LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
           +  +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPY---WMAPEVVTRK--AYGPKVDIWSL 202
Query: 205 GISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           GI   E+  G  P+  E P   + +    G TP L +                       
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQN----------------------- 238
Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                    K S  F   +  CL  DV+KR  A  LLQH F K  K  S + P
Sbjct: 239 -------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 350 SVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
           S+ ++ +    Y     +GQ  +   +VY +    T Q +A+++ NL +   ++L  + +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGAS--GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IIN 66
Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           EI+ MR  ++PNI+ Y+ S+L   +L +V   +  GS  D++       + E  I  + +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCR 123
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + L  LE++H    IHR +K+ +IL+  +G   L+   +    +P + K       T Y 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM-VGTPY- 181
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             W++PEV+ +    Y  + DI+S+GI   E+  G  P+
Sbjct: 182 --WMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +
Sbjct: 35  GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDE 92
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL
Sbjct: 93  LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNIL 149
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
           +  +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+
Sbjct: 150 LGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSL 203
Query: 205 GISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           GI   E+  G  P+  E P   + +    G TP L +                       
Sbjct: 204 GIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQN----------------------- 239
Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                    K S  F   +  CL  DV+KR  A  L+QH F K  K  S + P
Sbjct: 240 -------PEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTP 285

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +
Sbjct: 35  GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDE 92
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           L +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL
Sbjct: 93  LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNIL 149
Query: 495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
           +  +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+
Sbjct: 150 LGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSL 203
Query: 555 GISCCELANGTVPF 568
           GI   E+  G  P+
Sbjct: 204 GIMAIEMIEGEPPY 217

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +
Sbjct: 35  GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDE 92
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL
Sbjct: 93  LWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 149
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
           +  +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+
Sbjct: 150 LGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPY---WMAPEVVTRK--AYGPKVDIWSL 203
Query: 205 GISCCELANGTVPFA-ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           GI   E+  G  P+  E P   + +    G TP L +                       
Sbjct: 204 GIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQN----------------------- 239
Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                    K S  F   +  CL  DV+KR  A  L+QH F K  K  S + P
Sbjct: 240 -------PEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTP 285

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 350 SVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
           S+ ++ +    Y     +GQ  +   +VY +    T Q +A+++ NL +   ++L  + +
Sbjct: 12  SIVSVGDPKKKYTRFEKIGQGAS--GTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IIN 67
Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           EI+ MR  ++PNI+ Y+ S+L   +L +V   +  GS  D++       + E  I  + +
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCR 124
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + L  LE++H    IHR +K+ +IL+  +G   L+   +    +P + K       T Y 
Sbjct: 125 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPY- 182
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             W++PEV+ +    Y  + DI+S+GI   E+  G  P+
Sbjct: 183 --WMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 142/299 (47%), Gaps = 44/299 (14%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            +   VY      T +++A+K  +L+   DE ++ +  EI  +     P I  Y  S+L 
Sbjct: 30  GSFGEVYKGIDNHTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYFGSYLK 88
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           +T L ++   +G GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+
Sbjct: 89  STKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAA 145
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           ++L+S  G   L+        + T+ K + F   T +   W++PEV++Q+   YD ++DI
Sbjct: 146 NVLLSEQGDVKLADFGVAGQLTDTQIKRNXF-VGTPF---WMAPEVIKQS--AYDFKADI 199
Query: 202 YSVGISCCELANGTVPFAET-PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           +S+GI+  ELA G  P ++  P  ++ +  +   +P  L+        GQ          
Sbjct: 200 WSLGITAIELAKGEPPNSDLHPMRVLFL--IPKNSPPTLE--------GQH--------- 240
Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
                         S  F   VE CL++D   RP A  LL+H F  +  K +  L EL+
Sbjct: 241 --------------SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELI 285

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 10/196 (5%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            +   VY      T +++A+K  +L+   DE ++ +  EI  +     P I  Y  S+L 
Sbjct: 30  GSFGEVYKGIDNHTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYFGSYLK 88
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           +T L ++   +G GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+
Sbjct: 89  STKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAA 145
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           ++L+S  G   L+        + T+ K + F   T +   W++PEV++Q+   YD ++DI
Sbjct: 146 NVLLSEQGDVKLADFGVAGQLTDTQIKRNXF-VGTPF---WMAPEVIKQS--AYDFKADI 199
Query: 552 YSVGISCCELANGTVP 567
           +S+GI+  ELA G  P
Sbjct: 200 WSLGITAIELAKGEPP 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 136/287 (47%), Gaps = 46/287 (16%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T Q++A+K  +L+   DE ++ +  EI  +       +  Y  S+L  + L ++   +G 
Sbjct: 47  TQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGG 105
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           GS  DL+ A       E  I  +L+++L GL+Y+H +  IHR +KA+++L+S  G   L+
Sbjct: 106 GSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLA 162
Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 163 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIQQS--AYDSKADIWSLGITAIELAKG 216
Query: 215 TVPFAET--PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSR 272
             P ++      L LI K                         N  + + +         
Sbjct: 217 EPPNSDMHPMRVLFLIPK------------------------NNPPTLVGD--------- 243
Query: 273 KFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
            F+ SF   ++ CL++D   RP A  LL+H F  +  K +  L EL+
Sbjct: 244 -FTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLTELI 289

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 100/183 (54%), Gaps = 10/183 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T Q++A+K  +L+   DE ++ +  EI  +       +  Y  S+L  + L ++   +G 
Sbjct: 47  TQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGG 105
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           GS  DL+ A       E  I  +L+++L GL+Y+H +  IHR +KA+++L+S  G   L+
Sbjct: 106 GSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLA 162
Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 163 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIQQS--AYDSKADIWSLGITAIELAKG 216
Query: 565 TVP 567
             P
Sbjct: 217 EPP 219

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 44/286 (15%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 51  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 109
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 110 GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 166
Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 167 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 220
Query: 215 TVPFAET-PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRK 273
             P +E  P  ++ +  +    P  L+                                 
Sbjct: 221 EPPHSELHPMKVLFL--IPKNNPPTLEGN------------------------------- 247
Query: 274 FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           +S      VE CL+++   RP A  LL+H F  +  K +  L EL+
Sbjct: 248 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 293

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 105/186 (56%), Gaps = 10/186 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 51  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 109
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 110 GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 166
Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 167 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 220
Query: 565 TVPFAE 570
             P +E
Sbjct: 221 EPPHSE 226

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 44/286 (15%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 31  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 89
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 90  GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 146
Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 147 DFGVAGQLTDTQIKRNXF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 200
Query: 215 TVPFAET-PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRK 273
             P +E  P  ++ +  +    P  L+                                 
Sbjct: 201 EPPHSELHPMKVLFL--IPKNNPPTLEGN------------------------------- 227
Query: 274 FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           +S      VE CL+++   RP A  LL+H F  +  K +  L EL+
Sbjct: 228 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 273

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 105/186 (56%), Gaps = 10/186 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 31  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 89
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 90  GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 146
Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 147 DFGVAGQLTDTQIKRNXF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 200
Query: 565 TVPFAE 570
             P +E
Sbjct: 201 EPPHSE 206

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 44/286 (15%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 46  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 105 GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 161
Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 162 DFGVAGQLTDTQIKRNXF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 215
Query: 215 TVPFAET-PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRK 273
             P +E  P  ++ +  +    P  L+                                 
Sbjct: 216 EPPHSELHPMKVLFL--IPKNNPPTLEGN------------------------------- 242
Query: 274 FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           +S      VE CL+++   RP A  LL+H F  +  K +  L EL+
Sbjct: 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 288

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 105/186 (56%), Gaps = 10/186 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 46  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 105 GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 161
Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 162 DFGVAGQLTDTQIKRNXF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 215
Query: 565 TVPFAE 570
             P +E
Sbjct: 216 EPPHSE 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 44/286 (15%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 31  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 89
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 90  GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 146
Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 214
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 147 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 200
Query: 215 TVPFAET-PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRK 273
             P +E  P  ++ +  +    P  L+                                 
Sbjct: 201 EPPHSELHPMKVLFL--IPKNNPPTLEGN------------------------------- 227
Query: 274 FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           +S      VE CL+++   RP A  LL+H F  +  K +  L EL+
Sbjct: 228 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 273

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 105/186 (56%), Gaps = 10/186 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T +++A+K  +L+   DE ++ +  EI  +     P +  Y  S+L  T L ++   +G 
Sbjct: 31  TQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 89
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L+
Sbjct: 90  GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 146
Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                   + T+ K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G
Sbjct: 147 DFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARG 200
Query: 565 TVPFAE 570
             P +E
Sbjct: 201 EPPHSE 206

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 142/323 (43%), Gaps = 43/323 (13%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 80
            +  +VY ++    ++++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
                 LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERS 199
            +IL+S  G   L         +P    V      T Y   W++PEV+    +G YD + 
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPY---WMAPEVILAMDEGQYDGKV 234
Query: 200 DIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS 259
           D++S+GI+C ELA                       P L +               +A  
Sbjct: 235 DVWSLGITCIELAE--------------------RKPPLFNMNAM-----------SALY 263
Query: 260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           +I++ ++  L S  +S+ F + V+ CL +    RP +  LL+H F  + +  +V++  + 
Sbjct: 264 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 323
Query: 320 RPALSLNESNVCEINNELECMFN 342
           R   ++ E +  +     + +F 
Sbjct: 324 RTKDAVRELDNLQYRKMKKILFQ 346

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 430
            +  +VY ++    ++++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
                 LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERS 549
            +IL+S  G   L         +P    V      T Y   W++PEV+    +G YD + 
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPY---WMAPEVILAMDEGQYDGKV 234
Query: 550 DIYSVGISCCELANGTVPF 568
           D++S+GI+C ELA    P 
Sbjct: 235 DVWSLGITCIELAERKPPL 253

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 142/323 (43%), Gaps = 43/323 (13%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 80
            +  +VY ++    ++++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
                 LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA
Sbjct: 86  REHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERS 199
            +IL+S  G   L         +P    V      T Y   W++PEV+    +G YD + 
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPY---WMAPEVILAMDEGQYDGKV 195
Query: 200 DIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS 259
           D++S+GI+C ELA                       P L +               +A  
Sbjct: 196 DVWSLGITCIELAE--------------------RKPPLFNMNAM-----------SALY 224
Query: 260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           +I++ ++  L S  +S+ F + V+ CL +    RP +  LL+H F  + +  +V++  + 
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284
Query: 320 RPALSLNESNVCEINNELECMFN 342
           R   ++ E +  +     + +F 
Sbjct: 285 RTKDAVRELDNLQYRKMKKILFQ 307

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 430
            +  +VY ++    ++++A+KK +   + ++E  + +  E+  ++ LRHPN I Y   +L
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
                 LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA
Sbjct: 86  REHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERS 549
            +IL+S  G   L         +P    V      T Y   W++PEV+    +G YD + 
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPY---WMAPEVILAMDEGQYDGKV 195
Query: 550 DIYSVGISCCELANGTVPF 568
           D++S+GI+C ELA    P 
Sbjct: 196 DVWSLGITCIELAERKPPL 214

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 48/292 (16%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT 83
             VY  +H  T QL A+K  ++    +E++K    EI +  ++  H NI  Y  +F+   
Sbjct: 38  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRNIATYYGAFIKKN 94
Query: 84  ------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
                  L LV    G GS  DLI       L E  I +I +++L GL ++H    IHR 
Sbjct: 95  PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 154
Query: 138 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG- 194
           +K  ++L++ N +  L           T  + + F   T Y   W++PEV+  ++N D  
Sbjct: 155 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY---WMAPEVIACDENPDAT 210
Query: 195 YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGE 254
           YD +SD++S+GI+  E+A G  P                       C  + +        
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPL----------------------CDMHPM-------- 240
Query: 255 ENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
             A   I       L S+K+S  F S +E CL ++  +RP    L++H F +
Sbjct: 241 -RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDAT 433
             VY  +H  T QL A+K  ++    +E++K    EI +  ++  H NI  Y  +F+   
Sbjct: 38  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRNIATYYGAFIKKN 94
Query: 434 ------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
                  L LV    G GS  DLI       L E  I +I +++L GL ++H    IHR 
Sbjct: 95  PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 154
Query: 488 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL--EQNLDG- 544
           +K  ++L++ N +  L           T  + + F   T Y   W++PEV+  ++N D  
Sbjct: 155 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY---WMAPEVIACDENPDAT 210
Query: 545 YDERSDIYSVGISCCELANGTVPF 568
           YD +SD++S+GI+  E+A G  P 
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 140/309 (45%), Gaps = 56/309 (18%)
Query: 29  LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV 88
           L++ K + + +AVK  +L +    +L  L +E+V MR  +H N++    S+L   +L ++
Sbjct: 63  LAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 89  SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
              +  G+  D+++      L E  I  + + VL  L Y+H +G IHR +K+  IL++ +
Sbjct: 121 MEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 149 GKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
           G+  LS   +    S   P +K +      T Y   W++PEV+ ++L  Y    DI+S+G
Sbjct: 178 GRVKLSDFGFCAQISKDVPKRKXL----VGTPY---WMAPEVISRSL--YATEVDIWSLG 228
Query: 206 ISCCELANGTVP-FAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
           I   E+ +G  P F+++P   M  ++L  + P  L                         
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAM--KRLRDSPPPKLK------------------------ 262
Query: 265 QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALS 324
                 S K S      +E  L RD  +R  A  LL H F  QT      LPE L P + 
Sbjct: 263 -----NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG-----LPECLVPLIQ 312
Query: 325 L--NESNVC 331
           L   +++ C
Sbjct: 313 LYRKQTSTC 321

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 18/202 (8%)
Query: 379 LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV 438
           L++ K + + +AVK  +L +    +L  L +E+V MR  +H N++    S+L   +L ++
Sbjct: 63  LAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
              +  G+  D+++      L E  I  + + VL  L Y+H +G IHR +K+  IL++ +
Sbjct: 121 MEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 499 GKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
           G+  LS   +    S   P +K +      T Y   W++PEV+ ++L  Y    DI+S+G
Sbjct: 178 GRVKLSDFGFCAQISKDVPKRKXL----VGTPY---WMAPEVISRSL--YATEVDIWSLG 228
Query: 556 ISCCELANGTVP-FAETPTTLM 576
           I   E+ +G  P F+++P   M
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAM 250

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/309 (24%), Positives = 132/309 (42%), Gaps = 42/309 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             V+  + + T  +IAVK+       +E+ + L    V ++    P I+    +F+  TD
Sbjct: 39  GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHI 143
           + +   LMG  +C + +       +PE ++  +   ++  L Y+  K G IHR VK S+I
Sbjct: 99  VFIAMELMG--TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 144 LISHNGKACLSGLRYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQ---NLDGYDERS 199
           L+   G+  L      C F  + + V       +A    +++PE ++        YD R+
Sbjct: 157 LLDERGQIKL------CDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 200 DIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS 259
           D++S+GIS  ELA G  P+    T   ++ K+    P LL                    
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM---------------- 254
Query: 260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
                         FS  F S V+ CL++D  KRP    LL+H+F K+ +   V +    
Sbjct: 255 -------------GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWF 301
Query: 320 RPALSLNES 328
           +  ++  ES
Sbjct: 302 KDVMAKTES 310

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 13/220 (5%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             V+  + + T  +IAVK+       +E+ + L    V ++    P I+    +F+  TD
Sbjct: 39  GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHI 493
           + +   LMG  +C + +       +PE ++  +   ++  L Y+  K G IHR VK S+I
Sbjct: 99  VFIAMELMG--TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 494 LISHNGKACLSGLRYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQ---NLDGYDERS 549
           L+   G+  L      C F  + + V       +A    +++PE ++        YD R+
Sbjct: 157 LLDERGQIKL------CDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 550 DIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 589
           D++S+GIS  ELA G  P+    T   ++ K+    P LL
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 131/303 (43%), Gaps = 49/303 (16%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYI 76
           +G+    +  +   KH  T + +AVKK +L +    +L  L +E+V MR   H N++   
Sbjct: 53  IGEGSTGIVCIATEKH--TGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHDNVVDMY 108
Query: 77  SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 136
           SS+L   +L +V   +  G+  D++    +  + E  I  +   VL  L Y+H +G IHR
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHR 165
Query: 137 AVKASHILISHNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
            +K+  IL++ +G+  LS   +    S   P +K +      T Y   W++PEV+ +   
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL----VGTPY---WMAPEVISRL-- 216
Query: 194 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG 253
            Y    DI+S+GI   E+ +G  P+   P  L  + ++  + P                 
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPPYFNEP-PLQAMRRIRDSLP----------------- 258
Query: 254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSV 313
                        +V    K S      ++L L R+  +R  A  LL H F K     S 
Sbjct: 259 ------------PRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKLAGPPSC 306
Query: 314 MLP 316
           ++P
Sbjct: 307 IVP 309

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYI 426
           +G+    +  +   KH  T + +AVKK +L +    +L  L +E+V MR   H N++   
Sbjct: 53  IGEGSTGIVCIATEKH--TGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHDNVVDMY 108
Query: 427 SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 486
           SS+L   +L +V   +  G+  D++    +  + E  I  +   VL  L Y+H +G IHR
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHR 165
Query: 487 AVKASHILISHNGKACLSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
            +K+  IL++ +G+  LS   +    S   P +K +      T Y   W++PEV+ +   
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL----VGTPY---WMAPEVISRL-- 216
Query: 544 GYDERSDIYSVGISCCELANGTVP-FAETPTTLM 576
            Y    DI+S+GI   E+ +G  P F E P   M
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 250

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 47/287 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 92
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 53  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 110
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 111 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 167
Query: 153 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 168 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 218
Query: 210 ELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVL 269
           E+ +G  P+   P    +        P L +                             
Sbjct: 219 EMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL---------------------------- 250
Query: 270 TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
              K S S    ++  L RD  +R  A  LL+H F  +    + ++P
Sbjct: 251 --HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 295

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 442
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 53  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 110
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 111 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 167
Query: 503 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 168 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 218
Query: 560 ELANGTVP-FAETPTTLM 576
           E+ +G  P F E P   M
Sbjct: 219 EMVDGEPPYFNEPPLKAM 236

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 47/287 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 92
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 96  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 154 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 210
Query: 153 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 211 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 261
Query: 210 ELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVL 269
           E+ +G  P+   P    +        P L +                             
Sbjct: 262 EMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL---------------------------- 293
Query: 270 TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
              K S S    ++  L RD  +R  A  LL+H F  +    + ++P
Sbjct: 294 --HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 338

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 442
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 96  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 154 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 210
Query: 503 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 211 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 261
Query: 560 ELANGTVP-FAETPTTLM 576
           E+ +G  P F E P   M
Sbjct: 262 EMVDGEPPYFNEPPLKAM 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 47/287 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 92
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 51  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 108
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 109 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 165
Query: 153 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 166 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 216
Query: 210 ELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVL 269
           E+ +G  P+   P    +        P L +                             
Sbjct: 217 EMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL---------------------------- 248
Query: 270 TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
              K S S    ++  L RD  +R  A  LL+H F  +    + ++P
Sbjct: 249 --HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 293

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 442
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 51  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 108
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 109 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 165
Query: 503 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 166 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 216
Query: 560 ELANGTVP-FAETPTTLM 576
           E+ +G  P F E P   M
Sbjct: 217 EMVDGEPPYFNEPPLKAM 234

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 48/291 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 92
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 173 RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 231 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 287
Query: 153 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 288 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 338
Query: 210 ELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVL 269
           E+ +G  P+   P    +        P L +                             
Sbjct: 339 EMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL---------------------------- 370
Query: 270 TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
              K S S    ++  L RD  +R  A  LL+H F  +    + ++P L+R
Sbjct: 371 --HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP-LMR 418

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 442
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 173 RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 231 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 287
Query: 503 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 288 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 338
Query: 560 ELANGTVP-FAETPTTLM 576
           E+ +G  P F E P   M
Sbjct: 339 EMVDGEPPYFNEPPLKAM 356

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 49/288 (17%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 92
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 42  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 100 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 156
Query: 153 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 157 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 207
Query: 210 ELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVL 269
           E+ +G  P+   P                                  A   I +     L
Sbjct: 208 EMVDGEPPYFNEPPL-------------------------------KAMKMIRDNLPPRL 236
Query: 270 TS-RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
            +  K S S    ++  L RD  +R  A  LL+H F  +    + ++P
Sbjct: 237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 442
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 42  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             G+  D++  H      E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 100 EGGALTDIVT-HTRMN--EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 156
Query: 503 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 157 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 207
Query: 560 ELANGTVP-FAETPTTLM 576
           E+ +G  P F E P   M
Sbjct: 208 EMVDGEPPYFNEPPLKAM 225

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 49/288 (17%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 92
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 46  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 103
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             G+  D++    +  + E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 104 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 160
Query: 153 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 161 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 211
Query: 210 ELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVL 269
           E+ +G  P+   P                                  A   I +     L
Sbjct: 212 EMVDGEPPYFNEPPL-------------------------------KAMKMIRDNLPPRL 240
Query: 270 TS-RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
            +  K S S    ++  L RD  +R  A  LL+H F  +    + ++P
Sbjct: 241 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 288

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM 442
           + + +L+AVKK +L +    +L  L +E+V MR  +H N++   +S+L   +L +V   +
Sbjct: 46  RSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 103
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             G+  D++    +  + E  I  +   VL  L  +H +G IHR +K+  IL++H+G+  
Sbjct: 104 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 160
Query: 503 LSGLRYMCPFS---PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
           LS   +    S   P +K +      T Y   W++PE++ +    Y    DI+S+GI   
Sbjct: 161 LSDFGFCAQVSKEVPRRKXLV----GTPY---WMAPELISRL--PYGPEVDIWSLGIMVI 211
Query: 560 ELANGTVP-FAETPTTLM 576
           E+ +G  P F E P   M
Sbjct: 212 EMVDGEPPYFNEPPLKAM 229

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 42/269 (15%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELV 113
           + LH EI   +HL+H NI+ Y+ SF +   + +    +  GS   L+ + +      E  
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP 173
           I    + +L GL+Y+H    +HR +K  ++LI+       SG+  +  F  +K+   + P
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN-----TYSGVLKISDFGTSKRLAGINP 178
Query: 174 PSTAYN--LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE--TPTTLMLIE 229
            +  +   L +++PE++++   GY + +DI+S+G +  E+A G  PF E   P   M   
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 238
Query: 230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRD 289
            +    P + +  +                  +E +  +L               C   D
Sbjct: 239 GMFKVHPEIPESMS------------------AEAKAFILK--------------CFEPD 266
Query: 290 VDKRPLACNLLQHAFFKQTKKCSVMLPEL 318
            DKR  A +LL   F K + K     P+L
Sbjct: 267 PDKRACANDLLVDEFLKVSSKKKKTQPKL 295

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELV 463
           + LH EI   +HL+H NI+ Y+ SF +   + +    +  GS   L+ + +      E  
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP 523
           I    + +L GL+Y+H    +HR +K  ++LI+       SG+  +  F  +K+   + P
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN-----TYSGVLKISDFGTSKRLAGINP 178
Query: 524 PSTAYN--LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            +  +   L +++PE++++   GY + +DI+S+G +  E+A G  PF E
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 10  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 65
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 123
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   + C  +P+ ++  L     +  L++L PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSC-HAPSSRRTTL-----SGTLDYLPPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 178 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 10  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 65
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 123
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   + C  +P+ ++  L     +  L++L PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSC-HAPSSRRTTL-----SGTLDYLPPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 178 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELV 113
           + LH EI   +HL+H NI+ Y+ SF +   + +    +  GS   L+ + +      E  
Sbjct: 50  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP 173
           I    + +L GL+Y+H    +HR +K  ++LI+       SG+  +  F  +K+   + P
Sbjct: 110 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN-----TYSGVLKISDFGTSKRLAGINP 164
Query: 174 PSTAYN--LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            +  +   L +++PE++++   GY + +DI+S+G +  E+A G  PF E
Sbjct: 165 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 213

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELV 463
           + LH EI   +HL+H NI+ Y+ SF +   + +    +  GS   L+ + +      E  
Sbjct: 50  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP 523
           I    + +L GL+Y+H    +HR +K  ++LI+       SG+  +  F  +K+   + P
Sbjct: 110 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN-----TYSGVLKISDFGTSKRLAGINP 164
Query: 524 PSTAYN--LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            +  +   L +++PE++++   GY + +DI+S+G +  E+A G  PF E
Sbjct: 165 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 213

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 136/307 (44%), Gaps = 45/307 (14%)
Query: 3   TLDNVPSNYKICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           T D  P ++    I+G+  +     VY +++K T+ L A K   +D  ++E+L+    EI
Sbjct: 30  TRDLNPEDF--WEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEI 85
Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
             +    HPNI+  + +F    +L ++      G+  D +       L E  I  + +  
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 144
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L+ L Y+H    IHR +KA +IL + +G   L+        + T ++   F   T Y   
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPY--- 200
Query: 182 WLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPH 237
           W++PEV+  E + D  YD ++D++S+GI+  E+A    P  E  P  ++L  K+A + P 
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPP 258
Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
            L                                 ++S +F   ++ CL ++VD R    
Sbjct: 259 TL-----------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTS 289
Query: 298 NLLQHAF 304
            LLQH F
Sbjct: 290 QLLQHPF 296

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 16/242 (6%)
Query: 353 TLDNVPSNYKICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 411
           T D  P ++    I+G+  +     VY +++K T+ L A K   +D  ++E+L+    EI
Sbjct: 30  TRDLNPEDF--WEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEI 85
Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
             +    HPNI+  + +F    +L ++      G+  D +       L E  I  + +  
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 144
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L+ L Y+H    IHR +KA +IL + +G   L+        + T ++   F   T Y   
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPY--- 200
Query: 532 WLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPH 587
           W++PEV+  E + D  YD ++D++S+GI+  E+A    P  E  P  ++L  K+A + P 
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPP 258
Query: 588 LL 589
            L
Sbjct: 259 TL 260

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 3   TLDNVPSNYKICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           T D  P ++    I+G+  +     VY +++K T+ L A K   +D  ++E+L+    EI
Sbjct: 30  TRDLNPEDF--WEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEI 85
Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
             +    HPNI+  + +F    +L ++      G+  D +       L E  I  + +  
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 144
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L+ L Y+H    IHR +KA +IL + +G   L+        +   ++   F   T Y   
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXF-IGTPY--- 200
Query: 182 WLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPH 237
           W++PEV+  E + D  YD ++D++S+GI+  E+A    P  E  P  ++L  K+A + P 
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPP 258
Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
            L                                 ++S +F   ++ CL ++VD R    
Sbjct: 259 TL-----------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTS 289
Query: 298 NLLQHAF 304
            LLQH F
Sbjct: 290 QLLQHPF 296

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 16/242 (6%)
Query: 353 TLDNVPSNYKICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 411
           T D  P ++    I+G+  +     VY +++K T+ L A K   +D  ++E+L+    EI
Sbjct: 30  TRDLNPEDF--WEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEI 85
Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
             +    HPNI+  + +F    +L ++      G+  D +       L E  I  + +  
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 144
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L+ L Y+H    IHR +KA +IL + +G   L+        +   ++   F   T Y   
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXF-IGTPY--- 200
Query: 532 WLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPH 587
           W++PEV+  E + D  YD ++D++S+GI+  E+A    P  E  P  ++L  K+A + P 
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPP 258
Query: 588 LL 589
            L
Sbjct: 259 TL 260

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 47/300 (15%)
Query: 12  KICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           ++  I+G+  +     VY +K+K T  L A K   ++  ++E+L+    EI  +    HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAK--VIETKSEEELEDYIVEIEILATCDHP 76
Query: 71  NIICYISSFLDATDLHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
            I+  + ++     L +   ++ F  G   D I    + GL E  I  + + +L  L ++
Sbjct: 77  YIVKLLGAYYHDGKLWI---MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H K  IHR +KA ++L++  G   L+          T +K   F   T Y   W++PEV+
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPY---WMAPEVV 189
Query: 189 --EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTY 244
             E   D  YD ++DI+S+GI+  E+A    P  E  P  ++L  K+A + P  L     
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKSDPPTL----- 242
Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                                   LT  K+S  F   +++ L ++ + RP A  LL+H F
Sbjct: 243 ------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 114/242 (47%), Gaps = 15/242 (6%)
Query: 362 KICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           ++  I+G+  +     VY +K+K T  L A K   ++  ++E+L+    EI  +    HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAK--VIETKSEEELEDYIVEIEILATCDHP 76
Query: 421 NIICYISSFLDATDLHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
            I+  + ++     L +   ++ F  G   D I    + GL E  I  + + +L  L ++
Sbjct: 77  YIVKLLGAYYHDGKLWI---MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H K  IHR +KA ++L++  G   L+          T +K   F   T Y   W++PEV+
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPY---WMAPEVV 189
Query: 539 --EQNLDG-YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 595
             E   D  YD ++DI+S+GI+  E+A    P  E     +L++      P LL  + + 
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249
Query: 596 VD 597
           V+
Sbjct: 250 VE 251

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 47/300 (15%)
Query: 12  KICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           ++  I+G+  +     VY +K+K T  L A K   ++  ++E+L+    EI  +    HP
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAK--VIETKSEEELEDYIVEIEILATCDHP 68
Query: 71  NIICYISSFLDATDLHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
            I+  + ++     L +   ++ F  G   D I    + GL E  I  + + +L  L ++
Sbjct: 69  YIVKLLGAYYHDGKLWI---MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 125
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H K  IHR +KA ++L++  G   L+          T +K   F   T Y   W++PEV+
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPY---WMAPEVV 181
Query: 189 --EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTY 244
             E   D  YD ++DI+S+GI+  E+A    P  E  P  ++L  K+A + P  L     
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKSDPPTL----- 234
Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                                   LT  K+S  F   +++ L ++ + RP A  LL+H F
Sbjct: 235 ------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 270

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 114/242 (47%), Gaps = 15/242 (6%)
Query: 362 KICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           ++  I+G+  +     VY +K+K T  L A K   ++  ++E+L+    EI  +    HP
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAK--VIETKSEEELEDYIVEIEILATCDHP 68
Query: 421 NIICYISSFLDATDLHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
            I+  + ++     L +   ++ F  G   D I    + GL E  I  + + +L  L ++
Sbjct: 69  YIVKLLGAYYHDGKLWI---MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 125
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H K  IHR +KA ++L++  G   L+          T +K   F   T Y   W++PEV+
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPY---WMAPEVV 181
Query: 539 --EQNLDG-YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 595
             E   D  YD ++DI+S+GI+  E+A    P  E     +L++      P LL  + + 
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 241
Query: 596 VD 597
           V+
Sbjct: 242 VE 243

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 42/293 (14%)
Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCM 64
           N  +N++I   +G+     S VY +   +    +A+KK  +  + D   ++    EI  +
Sbjct: 29  NTLANFRIEKKIGR--GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 86
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDV 121
           + L HPN+I Y +SF++  +L++V  L   G    +I  HF      +PE  +      +
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQL 145
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
            + LE++H +  +HR +K +++ I+  G   L  L     FS      H    +  Y   
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY--- 202
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC 241
            +SPE + +N  GY+ +SDI+S+G    E+A    PF      L  +             
Sbjct: 203 -MSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------------- 246
Query: 242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                           C  I +     L S  +S+    +V +C++ D +KRP
Sbjct: 247 ----------------CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 283

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 13/217 (5%)
Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCM 414
           N  +N++I   +G+     S VY +   +    +A+KK  +  + D   ++    EI  +
Sbjct: 29  NTLANFRIEKKIGR--GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 86
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---LPELVICHILQDV 471
           + L HPN+I Y +SF++  +L++V  L   G    +I  HF      +PE  +      +
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQL 145
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
            + LE++H +  +HR +K +++ I+  G   L  L     FS      H    +  Y   
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY--- 202
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +SPE + +N  GY+ +SDI+S+G    E+A    PF
Sbjct: 203 -MSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 135/307 (43%), Gaps = 45/307 (14%)
Query: 3   TLDNVPSNYKICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           T D  P ++    I+G+  +     VY +++K T+ L A K   +D  ++E+L+    EI
Sbjct: 30  TRDLNPEDF--WEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEI 85
Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
             +    HPNI+  + +F    +L ++      G+  D +       L E  I  + +  
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 144
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L+ L Y+H    IHR +KA +IL + +G   L+        +   ++   F   T Y   
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF-IGTPY--- 200
Query: 182 WLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPH 237
           W++PEV+  E + D  YD ++D++S+GI+  E+A    P  E  P  ++L  K+A + P 
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPP 258
Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
            L                                 ++S +F   ++ CL ++VD R    
Sbjct: 259 TL-----------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTS 289
Query: 298 NLLQHAF 304
            LLQH F
Sbjct: 290 QLLQHPF 296

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 16/242 (6%)
Query: 353 TLDNVPSNYKICSILGQCFNN-LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 411
           T D  P ++    I+G+  +     VY +++K T+ L A K   +D  ++E+L+    EI
Sbjct: 30  TRDLNPEDF--WEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEI 85
Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
             +    HPNI+  + +F    +L ++      G+  D +       L E  I  + +  
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 144
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L+ L Y+H    IHR +KA +IL + +G   L+        +   ++   F   T Y   
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF-IGTPY--- 200
Query: 532 WLSPEVL--EQNLDG-YDERSDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPH 587
           W++PEV+  E + D  YD ++D++S+GI+  E+A    P  E  P  ++L  K+A + P 
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPP 258
Query: 588 LL 589
            L
Sbjct: 259 TL 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTEL-----CGTLDYLPPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTEL-----CGTLDYLPPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 35  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 90
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 148
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 202
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 203 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 35  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 90
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 148
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 202
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 203 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           ++ I   LG+      +VYL++ + +  ++A+K   K  L++   E    L  E+    H
Sbjct: 13  DFDIGRPLGK--GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH--QLRREVEIQSH 68
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD--EQRTATYITELANALS 126
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+  NG+  ++   +    +P+ ++  L        L++L PE
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 180
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 181 MIEGRM--HDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           ++ I   LG+      +VYL++ + +  ++A+K   K  L++   E    L  E+    H
Sbjct: 13  DFDIGRPLGK--GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH--QLRREVEIQSH 68
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD--EQRTATYITELANALS 126
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+  NG+  ++   +    +P+ ++  L        L++L PE
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 180
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 181 MIEGRM--HDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 65
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 8   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 63
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 121
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPP 175
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 415
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 8   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 63
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 121
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPP 175
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 65
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 8   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 63
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 121
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTXL-----CGTLDYLPP 175
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 415
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 8   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 63
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 121
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTXL-----CGTLDYLPP 175
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 11  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 66
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 124
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV-HAPSSRRTTL-----CGTLDYLPPE 178
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 11  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 66
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 124
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV-HAPSSRRTTL-----CGTLDYLPPE 178
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 90
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   ++LV+ 
Sbjct: 48  HKATNMEYAVK------VIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTE 101
Query: 91  LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 149
           LM  G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 102 LMRGGELLDKILRQKFFS--EREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESG 159
Query: 150 K-ACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              CL     +C F   K  +  +    +  Y  N+++PEVL++   GYDE  DI+S+GI
Sbjct: 160 NPECLR----ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGI 213
Query: 207 SCCELANGTVPFAETPT 223
               +  G  PFA  P+
Sbjct: 214 LLYTMLAGYTPFANGPS 230

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 440
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   ++LV+ 
Sbjct: 48  HKATNMEYAVK------VIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTE 101
Query: 441 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 499
           LM  G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 102 LMRGGELLDKILRQKFFS--EREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESG 159
Query: 500 K-ACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              CL     +C F   K  +  +    +  Y  N+++PEVL++   GYDE  DI+S+GI
Sbjct: 160 NPECLR----ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGI 213
Query: 557 SCCELANGTVPFAETPT 573
               +  G  PFA  P+
Sbjct: 214 LLYTMLAGYTPFANGPS 230

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 10  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 65
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 123
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 178 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 10  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 65
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 123
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 178 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV-HAPSSRRTTL-----CGTLDYLPPE 179
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV-HAPSSRRTTL-----CGTLDYLPPE 179
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAAL-----CGTLDYLPPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAAL-----CGTLDYLPPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 26  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 81
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 139
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 140 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 193
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 194 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 26  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 81
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 139
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 140 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 193
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 194 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAAL-----CGTLDYLPPE 179
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAAL-----CGTLDYLPPE 179
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 179
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 179
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 8   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 63
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 121
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 175
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 8   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 63
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 121
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 175
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 127
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPPE 181
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 127
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDL-----CGTLDYLPPE 181
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 11  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 66
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 124
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----CGTLDYLPPE 178
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 11  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 66
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 124
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----CGTLDYLPPE 178
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 13  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 68
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 126
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 180
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 181 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 13  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 68
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 126
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 180
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 181 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 127
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 181
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 127
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 181
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 65
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 8   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 63
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 121
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----CGTLDYLPP 175
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 415
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 8   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 63
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 121
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----CGTLDYLPP 175
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 176 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 90
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   ++LV+ 
Sbjct: 48  HKATNMEYAVK------VIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTE 101
Query: 91  LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 149
           LM  G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 102 LMRGGELLDKILRQKFFS--EREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESG 159
Query: 150 KA-CLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              CL     +C F   K  +  +    +  Y  N+++PEVL++   GYDE  DI+S+GI
Sbjct: 160 NPECLR----ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGI 213
Query: 207 SCCELANGTVPFAETPT 223
               +  G  PFA  P+
Sbjct: 214 LLYTMLAGYTPFANGPS 230

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 19/197 (9%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 440
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   ++LV+ 
Sbjct: 48  HKATNMEYAVK------VIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTE 101
Query: 441 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 499
           LM  G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 102 LMRGGELLDKILRQKFFS--EREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESG 159
Query: 500 KA-CLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              CL     +C F   K  +  +    +  Y  N+++PEVL++   GYDE  DI+S+GI
Sbjct: 160 NPECLR----ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGI 213
Query: 557 SCCELANGTVPFAETPT 573
               +  G  PFA  P+
Sbjct: 214 LLYTMLAGYTPFANGPS 230

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 65
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 11  EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 66
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 124
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPP 178
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 415
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 11  EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 66
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 124
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPP 178
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 35  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 90
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 148
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDDL-----CGTLDYLPPE 202
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 203 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 35  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 90
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 148
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDDL-----CGTLDYLPPE 202
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 203 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 65
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 11  EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 66
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 124
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----CGTLDYLPP 178
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 415
            +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    
Sbjct: 11  EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 66
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 124
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----CGTLDYLPP 178
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 179 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G     +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD--EQRTATYITELANALS 127
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----XGTLDYLPPE 181
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G     +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD--EQRTATYITELANALS 127
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRXXL-----XGTLDYLPPE 181
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           ++ I   LG+      +VYL++ + +  ++A+K   K  L++   E    L  E+    H
Sbjct: 13  DFDIGRPLGK--GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH--QLRREVEIQSH 68
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD--EQRTATYITELANALS 126
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+  NG+  ++   +    +P+ ++  L        L++L PE
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV-HAPSSRRDTL-----CGTLDYLPPE 180
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 181 MIEGRM--HDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           ++ I   LG+      +VYL++ + +  ++A+K   K  L++   E    L  E+    H
Sbjct: 13  DFDIGRPLGK--GKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH--QLRREVEIQSH 68
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD--EQRTATYITELANALS 126
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+  NG+  ++   +    +P+ ++  L        L++L PE
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV-HAPSSRRDTL-----CGTLDYLPPE 180
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 181 MIEGRM--HDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++ L H
Sbjct: 23  RYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+       D++  ++V  L   G   D I     F   E     I++ V +G+ Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMH 138
Query: 130 GKGFIHRAVKASHILISHNGKAC-----LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
               +HR +K  +IL+    K C       GL   C    TK K  +    TAY   +++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI---GTAY---YIA 191
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PEVL      YDE+ D++S G+    L +GT PF
Sbjct: 192 PEVLRGT---YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++ L H
Sbjct: 23  RYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+       D++  ++V  L   G   D I     F   E     I++ V +G+ Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMH 138
Query: 480 GKGFIHRAVKASHILISHNGKAC-----LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
               +HR +K  +IL+    K C       GL   C    TK K  +    TAY   +++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI---GTAY---YIA 191
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PEVL      YDE+ D++S G+    L +GT PF
Sbjct: 192 PEVLRGT---YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDDL-----CGTLDYLPPE 179
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 12  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 67
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 125
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDDL-----CGTLDYLPPE 179
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 180 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 65
            +++I   LG+      +VYL++ K    ++A+K   K  L++   E    L  E+    
Sbjct: 5   EDFEIGRPLGK--GKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 60
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 118
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 119 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPP 172
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 173 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMR 415
            +++I   LG+      +VYL++ K    ++A+K   K  L++   E    L  E+    
Sbjct: 5   EDFEIGRPLGK--GKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEH--QLRREVEIQS 60
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           HLRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANAL 118
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L P
Sbjct: 119 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPP 172
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 173 EMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G     +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD--EQRTATYITELANALS 127
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 181
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G     +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD--EQRTATYITELANALS 127
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 181
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 182 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 10  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 65
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 123
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDTL-----CGTLDYLPPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 178 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 10  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 65
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 123
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRDTL-----CGTLDYLPPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 178 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++ L H
Sbjct: 23  RYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+       D++  ++V  L   G   D I     F   E     I++ V +G+ Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMH 138
Query: 130 GKGFIHRAVKASHILISHNGKAC-----LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
               +HR +K  +IL+    K C       GL   C    TK K  +    TAY   +++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI---GTAY---YIA 191
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PEVL      YDE+ D++S G+    L +GT PF
Sbjct: 192 PEVLRGT---YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++ L H
Sbjct: 23  RYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+       D++  ++V  L   G   D I     F   E     I++ V +G+ Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMH 138
Query: 480 GKGFIHRAVKASHILISHNGKAC-----LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
               +HR +K  +IL+    K C       GL   C    TK K  +    TAY   +++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI---GTAY---YIA 191
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PEVL      YDE+ D++S G+    L +GT PF
Sbjct: 192 PEVLRGT---YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F D+T ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAAL-----CGTLDYLPPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 9   DFEIGRPLGK--GKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 64
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F D+T ++L+      G+    +     F   E      + ++ N L 
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 122
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRAAL-----CGTLDYLPPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++E  +  +DE+ D++S+G+ C E   G  PF
Sbjct: 177 MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++ L H
Sbjct: 23  RYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+       D++  ++V  L   G   D I     F   E     I++ V +G+ Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMH 138
Query: 130 GKGFIHRAVKASHILISHNGKAC-----LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
               +HR +K  +IL+    K C       GL   C    TK K  +    TAY   +++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI---GTAY---YIA 191
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PEVL      YDE+ D++S G+    L +GT PF
Sbjct: 192 PEVLRGT---YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++ L H
Sbjct: 23  RYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+       D++  ++V  L   G   D I     F   E     I++ V +G+ Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAARIIKQVFSGITYMH 138
Query: 480 GKGFIHRAVKASHILISHNGKAC-----LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
               +HR +K  +IL+    K C       GL   C    TK K  +    TAY   +++
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRI---GTAY---YIA 191
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PEVL      YDE+ D++S G+    L +GT PF
Sbjct: 192 PEVLRGT---YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 127
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 181
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +E     +DE+ D++S+G+ C E   G  PF
Sbjct: 182 XIEGRX--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
           +++I   LG+      +VYL++ K +  ++A+K   K  L++   E    L  E+    H
Sbjct: 14  DFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSH 69
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANALS 127
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y H K  IHR +K  ++L+   G+  ++   +    +P+ ++  L        L++L PE
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTL-----CGTLDYLPPE 181
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +E     +DE+ D++S+G+ C E   G  PF
Sbjct: 182 XIEGRX--HDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             F  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 AGFVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             F  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 AGFVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             F  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 AGFVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             F  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 AGFVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 125
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 126 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 175
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             F  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 176 AGFVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 231 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 279
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 125
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 126 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 175
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             F  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 176 AGFVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 231 ILRLVG-TP 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 41/281 (14%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           HK + Q++AVK+        E  + L    V MR    P I+ +  +     D  +   L
Sbjct: 43  HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 92  MG--FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHN 148
           M   F      + +  +  +PE ++  I    +  L ++      IHR +K S+IL+  +
Sbjct: 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162
Query: 149 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-WLSPEVLE--QNLDGYDERSDIYSVG 205
           G   L      C F  + + V     +       +++PE ++   +  GYD RSD++S+G
Sbjct: 163 GNIKL------CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
Query: 206 ISCCELANGTVPFAETPTTL-MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
           I+  ELA G  P+ +  +    L + + G  P L             + EE         
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL------------SNSEE--------- 255
Query: 265 QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                  R+FS SF + V LCL++D  KRP    LL+H F 
Sbjct: 256 -------REFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 13/214 (6%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           HK + Q++AVK+        E  + L    V MR    P I+ +  +     D  +   L
Sbjct: 43  HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 442 MG--FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHN 498
           M   F      + +  +  +PE ++  I    +  L ++      IHR +K S+IL+  +
Sbjct: 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162
Query: 499 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-WLSPEVLE--QNLDGYDERSDIYSVG 555
           G   L      C F  + + V     +       +++PE ++   +  GYD RSD++S+G
Sbjct: 163 GNIKL------CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
Query: 556 ISCCELANGTVPFAETPTTL-MLIEKLAGATPHL 588
           I+  ELA G  P+ +  +    L + + G  P L
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 90
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   +++V+ 
Sbjct: 43  HKATNMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96
Query: 91  LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 149
           LM  G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 97  LMKGGELLDKILRQKFFS--EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154
Query: 150 KACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 207
                 +R +C F   K  +  +    +  Y  N+++PEVLE+   GYD   DI+S+G+ 
Sbjct: 155 NP--ESIR-ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVL 209
Query: 208 CCELANGTVPFAETP 222
              +  G  PFA  P
Sbjct: 210 LYTMLTGYTPFANGP 224

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 440
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   +++V+ 
Sbjct: 43  HKATNMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96
Query: 441 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 499
           LM  G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 97  LMKGGELLDKILRQKFFS--EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154
Query: 500 KACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 557
                 +R +C F   K  +  +    +  Y  N+++PEVLE+   GYD   DI+S+G+ 
Sbjct: 155 NP--ESIR-ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVL 209
Query: 558 CCELANGTVPFAETP 572
              +  G  PFA  P
Sbjct: 210 LYTMLTGYTPFANGP 224

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 143/329 (43%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ + +  + G      F   +   
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILG------FGLAR--- 173
Query: 170 HLFPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
           H     T Y    W  +PE++  N   Y++  DI+SVG    EL  G   F  T     L
Sbjct: 174 HTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 233 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 281
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 282 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 114/251 (45%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ + +  + G      F   +   
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILG------FGLAR--- 173
Query: 520 HLFPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
           H     T Y    W  +PE++  N   Y++  DI+SVG    EL  G   F  T     L
Sbjct: 174 HTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 233 KLILRLVG-TP 242

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 115/254 (45%), Gaps = 25/254 (9%)
Query: 321 PALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLS 380
           PAL  N++    I+N L       DT N  +  L     +Y++  ++G+       V L 
Sbjct: 44  PALRKNKN----IDNFLS---RYKDTINK-IRDLRMKAEDYEVVKVIGR--GAFGEVQLV 93
Query: 381 KHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL 437
           +HK T ++ A+K   KF + + +D        E   M     P ++    +F D   L++
Sbjct: 94  RHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYM 151
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V   M  G   DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+  
Sbjct: 152 VMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 208
Query: 498 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLE-QNLDGYDERS-DIYSV 554
           +G   L+        +    K  +    TA    +++SPEVL+ Q  DGY  R  D +SV
Sbjct: 209 SGHLKLADFGTCMKMN----KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 264
Query: 555 GISCCELANGTVPF 568
           G+   E+  G  PF
Sbjct: 265 GVFLYEMLVGDTPF 278

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 51  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 106
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 107 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 164
Query: 127 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 165 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAY---YI 219
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 220 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 251

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 51  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 106
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 107 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 164
Query: 477 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 165 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAY---YI 219
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 220 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 251

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 27  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 82
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 140
Query: 127 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAY---YI 195
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 196 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 27  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 82
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 140
Query: 477 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAY---YI 195
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 196 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 50  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 105
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 106 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 163
Query: 127 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 164 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAY---YI 218
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 219 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 50  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 105
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 106 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 163
Query: 477 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 164 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAY---YI 218
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 219 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 139/329 (42%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K   +GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY 182
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 233 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 281
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 282 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 110/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K   +GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY 182
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 233 KLILRLVG-TP 242

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 144/327 (44%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ + +  +    Y+     T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF-YLA--RHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF-------HS 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ + +  +    Y+     T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF-YLA--RHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 188
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 189 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 238
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 239 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 287
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 288 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 188
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 189 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 238
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 239 KLILRLVG-TP 248

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 184
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 185 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 234
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 235 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 283
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 184
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 185 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 234
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 235 KLILRLVG-TP 244

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 115/254 (45%), Gaps = 25/254 (9%)
Query: 321 PALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLS 380
           PAL  N++    I+N L       DT N  +  L     +Y++  ++G+       V L 
Sbjct: 39  PALRKNKN----IDNFLS---RYKDTINK-IRDLRMKAEDYEVVKVIGR--GAFGEVQLV 88
Query: 381 KHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL 437
           +HK T ++ A+K   KF + + +D        E   M     P ++    +F D   L++
Sbjct: 89  RHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V   M  G   DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+  
Sbjct: 147 VMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 203
Query: 498 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLE-QNLDGYDERS-DIYSV 554
           +G   L+        +    K  +    TA    +++SPEVL+ Q  DGY  R  D +SV
Sbjct: 204 SGHLKLADFGTCMKMN----KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 555 GISCCELANGTVPF 568
           G+   E+  G  PF
Sbjct: 260 GVFLYEMLVGDTPF 273

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 91
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 149
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 150 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 199
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 200 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 255 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 303
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 304 LLEKMLVLDSDKRITAAQALAHAYFAQ 330

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 91
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 149
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 150 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 199
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 200 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 255 ILRLVG-TP 262

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 33  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 88
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 146
Query: 127 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 147 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAY---YI 201
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 202 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 233

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 33  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 88
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 146
Query: 477 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y+H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 147 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAY---YI 201
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 202 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 233

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 125
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 126 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 175
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 176 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 231 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 279
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 125
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 126 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 175
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 176 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 231 ILRLVG-TP 238

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 115/254 (45%), Gaps = 25/254 (9%)
Query: 321 PALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLS 380
           PAL  N++    I+N L       DT N  +  L     +Y++  ++G+       V L 
Sbjct: 44  PALRKNKN----IDNFLS---RYKDTINK-IRDLRMKAEDYEVVKVIGR--GAFGEVQLV 93
Query: 381 KHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL 437
           +HK T ++ A+K   KF + + +D        E   M     P ++    +F D   L++
Sbjct: 94  RHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYM 151
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V   M  G   DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+  
Sbjct: 152 VMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 208
Query: 498 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLE-QNLDGYDERS-DIYSV 554
           +G   L+        +    K  +    TA    +++SPEVL+ Q  DGY  R  D +SV
Sbjct: 209 SGHLKLADFGTCMKMN----KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 264
Query: 555 GISCCELANGTVPF 568
           G+   E+  G  PF
Sbjct: 265 GVFLYEMLVGDTPF 278

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 90
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 91  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 148
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 149 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 198
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 199 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 254 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 302
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 303 LLEKMLVLDSDKRITAAQALAHAYFAQ 329

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 90
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 91  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 148
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 149 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 198
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 199 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 254 ILRLVG-TP 261

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 188 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 237
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF------- 278
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 238 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 286
Query: 279 HSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 287 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 188 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 237
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 238 KLILRLVG-TP 247

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY 182
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 233 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 281
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 282 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY 182
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 233 KLILRLVG-TP 242

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 82
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 83  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 140
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 141 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 193
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 194 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 243
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 244 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 292
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 293 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 321

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 82
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 83  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 140
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 141 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 193
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 194 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 243
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 244 KLILRLVG-TP 253

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY 182
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 233 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 281
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 282 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY 182
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 233 KLILRLVG-TP 242

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 185
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 241 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 289
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 290 LLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 185
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 241 ILRLVG-TP 248

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 188 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 237
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF------- 278
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 238 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 286
Query: 279 HSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 287 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 188 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 237
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 238 KLILRLVG-TP 247

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 94
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 95  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 152
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 153 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 202
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 203 XGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 258 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 306
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 307 LLEKMLVLDSDKRITAAQALAHAYFAQ 333

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 94
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 95  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 152
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 153 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 202
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 203 XGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 258 ILRLVG-TP 265

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTADEM 186
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 242 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 290
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 291 LLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTADEM 186
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 242 ILRLVG-TP 249

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTADEM 186
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 242 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 290
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 291 LLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTADEM 186
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 242 ILRLVG-TP 249

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 87/327 (26%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ +  N    L  L Y      T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDYGLA-RHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF-------HS 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ +  N    L  L Y      T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDYGLA-RHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 184
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 185 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 240 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 288
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 289 LLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 184
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 185 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 240 ILRLVG-TP 247

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 94
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 95  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 152
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 153 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 202
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 203 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 258 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 306
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 307 LLEKMLVLDSDKRITAAQALAHAYFAQ 333

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 94
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 95  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 152
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 153 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 202
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 203 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 258 ILRLVG-TP 265

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 83
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 141
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 142 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 191
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 192 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 247 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 295
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 296 LLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 83
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 141
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 142 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 191
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 192 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 247 ILRLVG-TP 254

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 83
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 141
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 142 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 191
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 192 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 247 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 295
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 296 LLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 83
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 141
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 142 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 191
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 192 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 247 ILRLVG-TP 254

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 141/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C  L + H  F  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF-- 125
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 126 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 175
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 176 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 231 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 279
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 35/250 (14%)
Query: 351 VETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
            +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + 
Sbjct: 10  AKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYR 66
Query: 410 EIVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFG 458
           E+  ++H++H N+I  +  F  A       D++LV+ LMG        C  L + H  F 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF- 125
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK 518
                   ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  +
Sbjct: 126 --------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDE 174
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLM 576
           +  +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L 
Sbjct: 175 MTGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 577 LIEKLAGATP 586
           LI +L G TP
Sbjct: 230 LILRLVG-TP 238

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFG-----SCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 181
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 182 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 237 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 285
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 286 LLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFG-----SCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 181
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 182 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 237 ILRLVG-TP 244

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTADEM 186
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 242 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 290
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 291 LLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTADEM 186
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 242 ILRLVG-TP 249

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 125
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 126 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 175
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 176 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 231 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 279
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYFAQ 306

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 125
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 126 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 175
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 176 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 231 ILRLVG-TP 238

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 186
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 242 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 290
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 291 LLEKMLVLDSDKRITAAQALAHAYFAQ 317

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 136
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 137 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 186
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 187 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 242 ILRLVG-TP 249

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF-------HS 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 82
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 83  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 140
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 141 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 190
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 191 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 246 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 294
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 295 LLEKMLVLDSDKRITAAQALAHAYFAQ 321

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 82
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 83  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 140
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 141 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 190
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 191 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 246 ILRLVG-TP 253

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 138/329 (41%), Gaps = 56/329 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 167
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGX 182
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS----- 280
            LI +L G TP          +  +    E+A +YI  Q    +    F++ F       
Sbjct: 233 KLILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLA 281
Query: 281 --IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             ++E  L  D DKR  A   L HA+F Q
Sbjct: 282 VDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSPTKK 517
                  ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T  
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGX 182
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTL 575
               +  +    LNW+           Y++  DI+SVG    EL  G   F  T     L
Sbjct: 183 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 232
Query: 576 MLIEKLAGATP 586
            LI +L G TP
Sbjct: 233 KLILRLVG-TP 242

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 69
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 70  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 127
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 128 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 177
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 178 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 232
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 233 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 281
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 282 LLEKMLVLDSDKRITAAQALAHAYFAQ 308

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 69
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 70  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 127
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 128 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 177
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 178 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 232
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 233 ILRLVG-TP 240

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 68
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 69  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 126
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 127 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 176
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 177 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 232 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 280
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 281 LLEKMLVLDSDKRITAAQALAHAYFAQ 307

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 68
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 69  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 126
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 127 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 176
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 177 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 232 ILRLVG-TP 239

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 27  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 82
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HPNI      F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 83  LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 140
Query: 127 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 141 YXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI--GTAY---YI 195
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 196 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
            YK   +LG+   +   V L K K+T Q  AVK   K  + + TD++  SL  E+  ++ 
Sbjct: 27  RYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQ 82
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HPNI      F D    +LV  +   G   D I +   F   E+    I++ VL+G+ 
Sbjct: 83  LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGIT 140
Query: 477 YIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y H    +HR +K  ++L+    K     +        F  +KK        TAY   ++
Sbjct: 141 YXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI--GTAY---YI 195
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 196 APEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 184
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 185 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 240 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 288
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 289 LLEKMLVLDSDKRITAAQALAHAYFAQ 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 76
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 134
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 135 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 184
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 185 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 240 ILRLVG-TP 247

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 181
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 182 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 237 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 285
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 286 LLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 181
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 182 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 237 ILRLVG-TP 244

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 70
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 71  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 128
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 129 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 178
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 179 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 233
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 234 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 282
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 283 LLEKMLVLDSDKRITAAQALAHAYFAQ 309

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 70
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 71  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 128
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 129 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 178
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 179 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 233
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 234 ILRLVG-TP 241

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 181
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 182 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 237 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 285
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 286 LLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 73
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 131
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 132 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 181
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 182 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 237 ILRLVG-TP 244

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 68
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 69  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 126
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 127 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 176
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 177 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 232 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 280
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 281 LLEKMLVLDSDKRITAAQALAHAYFAQ 307

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 68
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 69  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 126
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 127 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 176
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 177 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 232 ILRLVG-TP 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 91
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 149
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 150 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 199
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 200 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 255 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 303
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 304 LLEKMLVLDSDKRITAAQALAHAYFAQ 330

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 91
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 149
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 150 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 199
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 200 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 255 ILRLVG-TP 262

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSKPFQSIIHAKRTYRE 83
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 141
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 142 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 191
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 192 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 247 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 295
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 296 LLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSKPFQSIIHAKRTYRE 83
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 141
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 142 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 191
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 192 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 247 ILRLVG-TP 254

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 90
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 91  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 148
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 149 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 198
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 199 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 254 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 302
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 303 LLEKMLVLDSDKRITAAQALAHAYFAQ 329

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 90
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 91  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 148
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 149 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 198
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 199 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 254 ILRLVG-TP 261

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 185
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 241 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 289
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 290 LLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 185
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 241 ILRLVG-TP 248

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  + +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 81
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 82  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 139
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 140 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 189
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 190 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 244
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF-------HS 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 245 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 293
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 294 LLEKMLVLDSDKRITAAQALAHAYFAQ 320

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  + +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 81
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 82  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 139
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 140 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 189
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 190 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 244
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 245 ILRLVG-TP 252

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 185
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 241 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 289
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 290 LLEKMLVLDSDKRITAAQALAHAYFAQ 316

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 77
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 135
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 136 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 185
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 TGYVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 241 ILRLVG-TP 248

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLR 68
           ++ I   LG+      +VYL++ K    ++A+K     ++  E ++  L  EI    HLR
Sbjct: 15  DFDIVRPLGK--GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+   + F D   ++L+      G     +  H  F   E      ++++ + L Y 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD--EQRSATFMEELADALHYC 130
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H +  IHR +K  ++L+ + G+  ++   +    +P+ ++  +        L++L PE++
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRXM-----CGTLDYLPPEMI 184
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E     +DE+ D++  G+ C E   G  PF
Sbjct: 185 EGKT--HDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLR 418
           ++ I   LG+      +VYL++ K    ++A+K     ++  E ++  L  EI    HLR
Sbjct: 15  DFDIVRPLGK--GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+   + F D   ++L+      G     +  H  F   E      ++++ + L Y 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD--EQRSATFMEELADALHYC 130
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H +  IHR +K  ++L+ + G+  ++   +    +P+ ++  +        L++L PE++
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRXM-----CGTLDYLPPEMI 184
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E     +DE+ D++  G+ C E   G  PF
Sbjct: 185 EGKT--HDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 136/327 (41%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ S Y  K  +    IAVKK +    +    K  + E
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLK---IAVKKLSRPFQSIIHAKRTYRE 100
Query: 61  IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMGFG-----SCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  AT      D++LV+ LMG        C+ L + H  F  
Sbjct: 101 LRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 158
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 159 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 208
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y+   DI+SVG    EL  G   F  T     L  
Sbjct: 209 TGYVATRWYR----APEIM-LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQ 263
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G  P  +                 A +YI+      +  R F+D F         
Sbjct: 264 IMRLTGTPPASVISRM---------PSHEARNYIN--SLPQMPKRNFADVFIGANPLAVD 312
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L H +F Q
Sbjct: 313 LLEKMLVLDTDKRITASEALAHPYFSQ 339

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 34/249 (13%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ S Y  K  +    IAVKK +    +    K  + E
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLK---IAVKKLSRPFQSIIHAKRTYRE 100
Query: 411 IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMGFG-----SCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  AT      D++LV+ LMG        C+ L + H  F  
Sbjct: 101 LRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 158
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 159 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 208
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y+   DI+SVG    EL  G   F  T     L  
Sbjct: 209 TGYVATRWYR----APEIM-LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQ 263
Query: 578 IEKLAGATP 586
           I +L G  P
Sbjct: 264 IMRLTGTPP 272

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 141/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 91
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 149
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 150 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 199
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
                +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 200 XGXVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 255 ILRLVG-TPG--------AELLKKISSESARNYI--QSLAQMPKMNFANVFIGANPLAVD 303
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 304 LLEKMLVLDSDKRITAAQALAHAYFAQ 330

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 112/249 (44%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGHRVAVKKLSRPFQSIIHAKRTYRE 91
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 149
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 150 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 199
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
                +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 200 XGXVATRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 255 ILRLVG-TP 262

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 142/327 (43%), Gaps = 52/327 (15%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 227
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP          +  +    E+A +YI  Q    +    F++ F         
Sbjct: 235 ILRLVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 283
Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 284 LLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 35/249 (14%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++H++H N+I  +  F  A       D++LV+ LMG        C+ L + H  F  
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-- 129
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
                  ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++
Sbjct: 130 -------LIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEM 179
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLML 577
             +  +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 180 TGYVATRWYR----APEIM-LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 235 ILRLVG-TP 242

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLR 68
           ++ I   LG+      +VYL++ K    ++A+K     ++  E ++  L  EI    HLR
Sbjct: 16  DFDIGRPLGK--GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+   + F D   ++L+      G     +  H  F   E      ++++ + L Y 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD--EQRSATFMEELADALHYC 131
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H +  IHR +K  ++L+ + G+  ++   +    +P+ ++  +        L++L PE++
Sbjct: 132 HERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRXM-----CGTLDYLPPEMI 185
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E     +DE+ D++  G+ C E   G  PF
Sbjct: 186 EGKT--HDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLR 418
           ++ I   LG+      +VYL++ K    ++A+K     ++  E ++  L  EI    HLR
Sbjct: 16  DFDIGRPLGK--GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+   + F D   ++L+      G     +  H  F   E      ++++ + L Y 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD--EQRSATFMEELADALHYC 131
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H +  IHR +K  ++L+ + G+  ++   +    +P+ ++  +        L++L PE++
Sbjct: 132 HERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRXM-----CGTLDYLPPEMI 185
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E     +DE+ D++  G+ C E   G  PF
Sbjct: 186 EGKT--HDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 105/224 (46%), Gaps = 14/224 (6%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
           NS     D  P   NY++   +G+   N + V L++H +T + +AVK  +  ++    L+
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGK--GNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQ 59
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+  M+ L HPNI+           L+LV      G   D + AH    + E    
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEAR 117
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 525
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S
Sbjct: 118 AKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFT-VGNKLDTFCGS 176
Query: 526 TAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
             Y     +PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 177 PPY----AAPELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 214

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
           PS+     +LG+ CF     V    H+ T +++ +K+  L R  +E  ++   E+  MR 
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKV---THRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRC 63
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HPN++ +I        L+ ++  +  G+ + +I +  +   P        +D+ +G+ 
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMA 122
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLS----------------GLRYMCPFSPTKKKVH 170
           Y+H    IHR + + + L+  N    ++                GLR +    P +KK +
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK--KPDRKKRY 180
Query: 171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
               +   N  W++PE++  N   YDE+ D++S GI  CE+
Sbjct: 181 ----TVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEI 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
           PS+     +LG+ CF     V    H+ T +++ +K+  L R  +E  ++   E+  MR 
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKV---THRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRC 63
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HPN++ +I        L+ ++  +  G+ + +I +  +   P        +D+ +G+ 
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMA 122
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLS----------------GLRYMCPFSPTKKKVH 520
           Y+H    IHR + + + L+  N    ++                GLR +    P +KK +
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK--KPDRKKRY 180
Query: 521 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
               +   N  W++PE++  N   YDE+ D++S GI  CE+
Sbjct: 181 ----TVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEI 215

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 145/322 (45%), Gaps = 42/322 (13%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           +  ++H++H N+I  +  F  A       D++LV+ LMG     DL N   +  L +  +
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKSQKLTDDHV 127
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             ++  +L GL+YIH    IHR +K S++ ++ + +  +     +C    T  ++  +  
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFG-LC--RHTDDEMTGYVA 184
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLA 232
           +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L LI +L 
Sbjct: 185 TRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS-------IVELC 285
           G TP          +  +    E+A +YI  Q    +    F++ F         ++E  
Sbjct: 240 G-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVDLLEKM 288
Query: 286 LSRDVDKRPLACNLLQHAFFKQ 307
           L  D DKR  A   L HA+F Q
Sbjct: 289 LVLDSDKRITAAQALAHAYFAQ 310

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 116/244 (47%), Gaps = 25/244 (10%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           +  ++H++H N+I  +  F  A       D++LV+ LMG     DL N   +  L +  +
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKSQKLTDDHV 127
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 524
             ++  +L GL+YIH    IHR +K S++ ++ + +  +     +C    T  ++  +  
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFG-LC--RHTDDEMTGYVA 184
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLA 582
           +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L LI +L 
Sbjct: 185 TRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 583 GATP 586
           G TP
Sbjct: 240 G-TP 242

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 90
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   +++V+ 
Sbjct: 43  HKATNXEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96
Query: 91  LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 149
           L   G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 97  LXKGGELLDKILRQKFFS--EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154
Query: 150 KACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 207
                 +R +C F   K  +  +    +  Y  N+++PEVLE+   GYD   DI+S+G+ 
Sbjct: 155 NP--ESIR-ICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQ--GYDAACDIWSLGVL 209
Query: 208 CCELANGTVPFAETP 222
                 G  PFA  P
Sbjct: 210 LYTXLTGYTPFANGP 224

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSP 440
           HK TN   AVK      + D+  +    EI + +R+ +HPNII     + D   +++V+ 
Sbjct: 43  HKATNXEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96
Query: 441 LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNG 499
           L   G   D I     F   E     +L  +   +EY+H +G +HR +K S+IL +  +G
Sbjct: 97  LXKGGELLDKILRQKFFS--EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154
Query: 500 KACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 557
                 +R +C F   K  +  +    +  Y  N+++PEVLE+   GYD   DI+S+G+ 
Sbjct: 155 NP--ESIR-ICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQ--GYDAACDIWSLGVL 209
Query: 558 CCELANGTVPFAETP 572
                 G  PFA  P
Sbjct: 210 LYTXLTGYTPFANGP 224

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y++   +G    N     L + K +N+L+AVK        DE++K    EI+  R LRH
Sbjct: 20  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRH 74
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 128
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 187
           H     HR +K  + L+  +    L     +C F  +K  V H  P ST     +++PEV
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLK----ICAFGYSKSSVLHSQPKSTVGTPAYIAPEV 187
Query: 188 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y++   +G    N     L + K +N+L+AVK        DE++K    EI+  R LRH
Sbjct: 20  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRH 74
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 478
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 537
           H     HR +K  + L+  +    L     +C F  +K  V H  P ST     +++PEV
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLK----ICAFGYSKSSVLHSQPKSTVGTPAYIAPEV 187
Query: 538 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
            +S  + D  P   NY++   +G+   N + V L++H +T + +AVK  +  ++    L+
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGK--GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ 58
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+  M+ L HPNI+           L+LV      G   D + AH    + E    
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEAR 116
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF--- 522
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F   
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDAFCGA 175
Query: 523 PPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
           PP  A       PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 176 PPYAA-------PELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 14/224 (6%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
            +S  + D  P   NY++   +G+   N + V L++H +T + +AVK  +  ++    L+
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGK--GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ 58
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+  M+ L HPNI+           L+LV      G   D + AH    + E    
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEAR 116
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 525
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGS 175
Query: 526 TAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
             Y     +PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 176 PPY----AAPELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y++   +G    N     L + K +N+L+AVK        DE++K    EI+  R LRH
Sbjct: 19  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRH 73
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 128
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 74  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 187
           H     HR +K  + L+  +    L     +C F  +K  V H  P ST     +++PEV
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 186
Query: 188 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 187 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 218

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y++   +G    N     L + K +N+L+AVK        DE++K    EI+  R LRH
Sbjct: 19  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRH 73
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 478
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 74  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 537
           H     HR +K  + L+  +    L     +C F  +K  V H  P ST     +++PEV
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 186
Query: 538 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 187 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 106/224 (47%), Gaps = 14/224 (6%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
            +S  + D  P   NY++   +G+   N + V L++H +T + +AVK  +  ++    L+
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGK--GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ 58
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+  M+ L HPNI+           L+LV      G   D + AH    + E    
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEAR 116
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 525
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGS 175
Query: 526 TAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
             Y     +PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 176 PPY----AAPELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 213

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            N     L + K+T +L+AVK        DE+++    EI+  R LRHPNI+ +    L 
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVILT 87
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
            T L ++   M + S  +L     N G   E       Q +L+G+ Y H     HR +K 
Sbjct: 88  PTHLAII---MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV-LEQNLDGYDER 198
            + L+  +    L     +C F  +K  V H  P ST     +++PEV L Q  DG  + 
Sbjct: 145 ENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG--KI 198
Query: 199 SDIYSVGISCCELANGTVPFAE 220
           +D++S G++   +  G  PF +
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFED 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N     L + K+T +L+AVK        DE+++    EI+  R LRHPNI+ +    L 
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVILT 87
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
            T L ++   M + S  +L     N G   E       Q +L+G+ Y H     HR +K 
Sbjct: 88  PTHLAII---MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV-LEQNLDGYDER 548
            + L+  +    L     +C F  +K  V H  P ST     +++PEV L Q  DG  + 
Sbjct: 145 ENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG--KI 198
Query: 549 SDIYSVGISCCELANGTVPFAE 570
           +D++S G++   +  G  PF +
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFED 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 51/285 (17%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           +H  + Q++AVK+      + E  + L    + MR +  P  + +  +     D+ +   
Sbjct: 71  RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 130
Query: 91  LMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH 147
           LM   S         + G  +PE ++  I   ++  LE++H K   IHR VK S++LI+ 
Sbjct: 131 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 189
Query: 148 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVL--EQNLDGYDERSD 200
            G+        MC F  +   V     S A  ++     +++PE +  E N  GY  +SD
Sbjct: 190 LGQV------KMCDFGISGYLVD----SVAKTIDAGCKPYMAPERINPELNQKGYSVKSD 239
Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           I+S+GI+  ELA    P+    T    ++++                             
Sbjct: 240 IWSLGITMIELAILRFPYDSWGTPFQQLKQVV---------------------------- 271
Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             E+ +  L + KFS  F      CL ++  +RP    L+QH FF
Sbjct: 272 --EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           +H  + Q++AVK+      + E  + L    + MR +  P  + +  +     D+ +   
Sbjct: 71  RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 130
Query: 441 LMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH 497
           LM   S         + G  +PE ++  I   ++  LE++H K   IHR VK S++LI+ 
Sbjct: 131 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 189
Query: 498 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVL--EQNLDGYDERSD 550
            G+        MC F  +   V     S A  ++     +++PE +  E N  GY  +SD
Sbjct: 190 LGQV------KMCDFGISGYLVD----SVAKTIDAGCKPYMAPERINPELNQKGYSVKSD 239
Query: 551 IYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           I+S+GI+  ELA    P+    T    ++++
Sbjct: 240 IWSLGITMIELAILRFPYDSWGTPFQQLKQV 270

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 15/240 (6%)
Query: 334 NNELECMFNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK- 392
           N  ++   N  +     +  L     +Y +  ++G+       V L +HK + ++ A+K 
Sbjct: 50  NKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGR--GAFGEVQLVRHKASQKVYAMKL 107
Query: 393 --KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL 450
             KF + + +D        E   M     P ++    +F D   L++V   M  G   DL
Sbjct: 108 LSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG---DL 162
Query: 451 INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC 510
           +N   N+ +PE        +V+  L+ IH  G IHR VK  ++L+  +G   L+     C
Sbjct: 163 VNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG-TC 221
Query: 511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERS-DIYSVGISCCELANGTVPF 568
                   VH    +     +++SPEVL+ Q  DGY  R  D +SVG+   E+  G  PF
Sbjct: 222 MKMDETGMVHC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 13/186 (6%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK         E +     E+  M+ LRHPNI+ ++ +     +L +V+  +  GS  
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 99  DLI-NAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILI--SHNGKACL 153
            L+  +     L E     +  DV  G+ Y+H +    +HR +K+ ++L+   +  K C 
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
            GL      S  K    L   S A    W++PEVL    +  +E+SD+YS G+   ELA 
Sbjct: 183 FGL------SRLKASTFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELAT 234
Query: 214 GTVPFA 219
              P+ 
Sbjct: 235 LQQPWG 240

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 13/186 (6%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK         E +     E+  M+ LRHPNI+ ++ +     +L +V+  +  GS  
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 449 DLI-NAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILI--SHNGKACL 503
            L+  +     L E     +  DV  G+ Y+H +    +HR +K+ ++L+   +  K C 
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 504 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
            GL      S  K    L   S A    W++PEVL    +  +E+SD+YS G+   ELA 
Sbjct: 183 FGL------SRLKASTFLSSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELAT 234
Query: 564 GTVPFA 569
              P+ 
Sbjct: 235 LQQPWG 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 138/324 (42%), Gaps = 46/324 (14%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           +  ++H++H N+I  +  F  A       D++LV+ LMG     DL N      L +  +
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKXQKLTDDHV 127
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLF 172
             ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T      +
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRW 187
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEK 230
             +    LNW+           Y++  DI+SVG    EL  G   F  T     L LI +
Sbjct: 188 YRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237
Query: 231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF-------HSIVE 283
           L G TP          +  +    E+A +YI  Q    +    F++ F         ++E
Sbjct: 238 LVG-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVDLLE 286
Query: 284 LCLSRDVDKRPLACNLLQHAFFKQ 307
             L  D DKR  A   L HA+F Q
Sbjct: 287 KMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 29/246 (11%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           +  ++H++H N+I  +  F  A       D++LV+ LMG     DL N      L +  +
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKXQKLTDDHV 127
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLF 522
             ++  +L GL+YIH    IHR +K S++ ++ +   K    GL        T      +
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRW 187
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEK 580
             +    LNW+           Y++  DI+SVG    EL  G   F  T     L LI +
Sbjct: 188 YRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237
Query: 581 LAGATP 586
           L G TP
Sbjct: 238 LVG-TP 242

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 14/224 (6%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
            +S  + D  P   NY++   +G+   N + V L++H +T + +AV+  +  ++    L+
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGK--GNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ 58
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+  M+ L HPNI+           L+LV      G   D + AH    + E    
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEAR 116
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 525
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGS 175
Query: 526 TAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
             Y     +PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 176 PPY----AAPELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
           NS     D  P   NY++   +G+   N + V L++H +T + +A+K  +  ++    L+
Sbjct: 2   NSIASCADEQPHIGNYRLLKTIGK--GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ 59
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+  M+ L HPNI+           L+L+      G   D + AH    + E    
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEAR 117
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF--- 522
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F   
Sbjct: 118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFCGA 176
Query: 523 PPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
           PP  A       PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 177 PPYAA-------PELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 214

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 127/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     KD ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 232
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 306 KQTKK 310
           +   K
Sbjct: 291 QDVTK 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     KD ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            NY++   +G+   N + V L++H +T + +AVK  +  ++    L+ L  E+  M+ L 
Sbjct: 7   GNYRLLKTIGK--GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+           L+LV      G   D + AH    + E       + +++ ++Y 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GWMKEKEARAKFRQIVSAVQYC 122
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S  Y     +PE+ 
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYA----APELF 177
Query: 189 E-QNLDGYDERSDIYSVGISCCELANGTVPF 218
           + +  DG +   D++S+G+    L +G++PF
Sbjct: 178 QGKKYDGPE--VDVWSLGVILYTLVSGSLPF 206

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
            NY++   +G+   N + V L++H +T + +AVK  +  ++    L+ L  E+  M+ L 
Sbjct: 7   GNYRLLKTIGK--GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+           L+LV      G   D + AH    + E       + +++ ++Y 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GWMKEKEARAKFRQIVSAVQYC 122
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S  Y     +PE+ 
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYA----APELF 177
Query: 539 E-QNLDGYDERSDIYSVGISCCELANGTVPF 568
           + +  DG +   D++S+G+    L +G++PF
Sbjct: 178 QGKKYDGPE--VDVWSLGVILYTLVSGSLPF 206

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y++   +G    N     L + K +N+L+AVK        DE++K    EI+  R LRH
Sbjct: 20  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRH 74
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 128
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 187
           H     HR +K  + L+  +    L     +C F  +K  V H  P  T     +++PEV
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLK----ICAFGYSKSSVLHSQPKDTVGTPAYIAPEV 187
Query: 188 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y++   +G    N     L + K +N+L+AVK        DE++K    EI+  R LRH
Sbjct: 20  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRH 74
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 478
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 537
           H     HR +K  + L+  +    L     +C F  +K  V H  P  T     +++PEV
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLK----ICAFGYSKSSVLHSQPKDTVGTPAYIAPEV 187
Query: 538 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 139/330 (42%), Gaps = 58/330 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP   +    +G   + ++ S Y ++ +   Q +AVKK +    +    +  + E
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR---QKVAVKKLSRPFQSLIHARRTYRE 77
Query: 61  IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++HL+H N+I  +  F  AT      +++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-- 135
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL--SGLRYMCPFSPTKK 167
                  ++  +L GL+YIH  G IHR +K S++ ++ + +  +   GL        T  
Sbjct: 136 -------LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY 188
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV--PFAETPTTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G    P ++    L
Sbjct: 189 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQL 238
Query: 226 MLIEKLAGA-TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
             I ++ G  +P +L   +           E+A +YI  Q    +  +  S  F     L
Sbjct: 239 KRIMEVVGTPSPEVLAKIS----------SEHARTYI--QSLPPMPQKDLSSIFRGANPL 286
Query: 285 C---LSR----DVDKRPLACNLLQHAFFKQ 307
               L R    D D+R  A   L HA+F Q
Sbjct: 287 AIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 316

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 36/231 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP   +    +G   + ++ S Y ++ +   Q +AVKK +    +    +  + E
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR---QKVAVKKLSRPFQSLIHARRTYRE 77
Query: 411 IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++HL+H N+I  +  F  AT      +++LV+ LMG        C+ L + H  F  
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-- 135
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL--SGLRYMCPFSPTKK 517
                  ++  +L GL+YIH  G IHR +K S++ ++ + +  +   GL        T  
Sbjct: 136 -------LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY 188
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
               +  +    LNW+           Y++  DI+SVG    EL  G   F
Sbjct: 189 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLQGKALF 229

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 14/224 (6%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
            +S  + D  P   NY++   +G+   N + V L++H +T + +AV+  +  ++    L+
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGK--GNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ 58
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+  M+ L HPNI+           L+LV      G   D + AH    + E    
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEAR 116
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 525
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S
Sbjct: 117 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDEFCGS 175
Query: 526 TAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
             Y     +PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 176 PPY----AAPELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 213

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            NY++   +G+   N + V L++H +T + +A+K  +  ++    L+ L  E+  M+ L 
Sbjct: 12  GNYRLLKTIGK--GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+           L+L+      G   D + AH    + E       + +++ ++Y 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYC 127
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S  Y     +PE+ 
Sbjct: 128 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDTFCGSPPYA----APELF 182
Query: 189 E-QNLDGYDERSDIYSVGISCCELANGTVPF 218
           + +  DG +   D++S+G+    L +G++PF
Sbjct: 183 QGKKYDGPE--VDVWSLGVILYTLVSGSLPF 211

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
            NY++   +G+   N + V L++H +T + +A+K  +  ++    L+ L  E+  M+ L 
Sbjct: 12  GNYRLLKTIGK--GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+           L+L+      G   D + AH    + E       + +++ ++Y 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYC 127
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H K  +HR +KA ++L+  +    ++   +   F+    K+  F  S  Y     +PE+ 
Sbjct: 128 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDTFCGSPPYA----APELF 182
Query: 539 E-QNLDGYDERSDIYSVGISCCELANGTVPF 568
           + +  DG +   D++S+G+    L +G++PF
Sbjct: 183 QGKKYDGPE--VDVWSLGVILYTLVSGSLPF 211

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 127/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     KD ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 231
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289
Query: 306 KQTKK 310
           +   K
Sbjct: 290 QDVTK 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     KD ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 142/322 (44%), Gaps = 42/322 (13%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 61  IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           +  ++H++H N+I  +  F  A       D++LV+ LMG     DL N      L +  +
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKXQKLTDDHV 127
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++  +  
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEMTGYVA 184
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLA 232
           +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L LI +L 
Sbjct: 185 TRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF-------HSIVELC 285
           G TP          +  +    E+A +YI  Q    +    F++ F         ++E  
Sbjct: 240 G-TPG--------AELLKKISSESARNYI--QSLTQMPKMNFANVFIGANPLAVDLLEKM 288
Query: 286 LSRDVDKRPLACNLLQHAFFKQ 307
           L  D DKR  A   L HA+F Q
Sbjct: 289 LVLDSDKRITAAQALAHAYFAQ 310

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 113/244 (46%), Gaps = 25/244 (10%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP  Y+  S +G   + ++ + + +K   T   +AVKK +    +    K  + E
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRE 71
Query: 411 IVCMRHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           +  ++H++H N+I  +  F  A       D++LV+ LMG     DL N      L +  +
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKXQKLTDDHV 127
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 524
             ++  +L GL+YIH    IHR +K S++ ++ +   C   +        T  ++  +  
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDDEMTGYVA 184
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLA 582
           +  Y     +PE++  N   Y++  DI+SVG    EL  G   F  T     L LI +L 
Sbjct: 185 TRWYR----APEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 239
Query: 583 GATP 586
           G TP
Sbjct: 240 G-TP 242

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 51/285 (17%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           +H  + Q++AVK+      + E  + L    + MR +  P  + +  +     D+ +   
Sbjct: 27  RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86
Query: 91  LMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH 147
           LM   S         + G  +PE ++  I   ++  LE++H K   IHR VK S++LI+ 
Sbjct: 87  LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 145
Query: 148 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVL--EQNLDGYDERSD 200
            G+        MC F  +   V       A +++     +++PE +  E N  GY  +SD
Sbjct: 146 LGQV------KMCDFGISGYLVD----DVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195
Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           I+S+GI+  ELA    P+    T    +++                              
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQ------------------------------ 225
Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
           + E+ +  L + KFS  F      CL ++  +RP    L+QH FF
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 21/212 (9%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           +H  + Q++AVK+      + E  + L    + MR +  P  + +  +     D+ +   
Sbjct: 27  RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86
Query: 441 LMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH 497
           LM   S         + G  +PE ++  I   ++  LE++H K   IHR VK S++LI+ 
Sbjct: 87  LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 145
Query: 498 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-----WLSPEVL--EQNLDGYDERSD 550
            G+        MC F  +   V       A +++     +++PE +  E N  GY  +SD
Sbjct: 146 LGQV------KMCDFGISGYLVD----DVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195
Query: 551 IYSVGISCCELANGTVPFAETPTTLMLIEKLA 582
           I+S+GI+  ELA    P+    T    ++++ 
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 6   NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 120
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 177 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 222

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 6   NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 120
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 177 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 222

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 7   NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 121
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 178 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 7   NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 121
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 178 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 30  NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 144
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 200
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 201 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 30  NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 144
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 200
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 201 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 140/325 (43%), Gaps = 48/325 (14%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP   +    +G   + ++ S Y ++ +   Q +AVKK +    +    +  + E
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR---QKVAVKKLSRPFQSLIHARRTYRE 77
Query: 61  IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           +  ++HL+H N+I  +  F  AT      +++LV+ LMG     DL N   +  L +  +
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG----ADLNNIVKSQALSDEHV 133
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL--SGLRYMCPFSPTKKKVHLF 172
             ++  +L GL+YIH  G IHR +K S++ ++ + +  +   GL        T      +
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRW 193
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV--PFAETPTTLMLIEK 230
             +    LNW+           Y++  DI+SVG    EL  G    P ++    L  I +
Sbjct: 194 YRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243
Query: 231 LAGA-TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELC---L 286
           + G  +P +L   +           E+A +YI  Q    +  +  S  F     L    L
Sbjct: 244 VVGTPSPEVLAKIS----------SEHARTYI--QSLPPMPQKDLSSIFRGANPLAIDLL 291
Query: 287 SR----DVDKRPLACNLLQHAFFKQ 307
            R    D D+R  A   L HA+F Q
Sbjct: 292 GRMLVLDSDQRVSAAEALAHAYFSQ 316

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP   +    +G   + ++ S Y ++ +   Q +AVKK +    +    +  + E
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR---QKVAVKKLSRPFQSLIHARRTYRE 77
Query: 411 IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           +  ++HL+H N+I  +  F  AT      +++LV+ LMG     DL N   +  L +  +
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG----ADLNNIVKSQALSDEHV 133
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL--SGLRYMCPFSPTKKKVHLF 522
             ++  +L GL+YIH  G IHR +K S++ ++ + +  +   GL        T      +
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRW 193
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             +    LNW+           Y++  DI+SVG    EL  G   F
Sbjct: 194 YRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 7   NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 121
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 178 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 14/228 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R L+H
Sbjct: 7   NYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           PNI+    S  + +  +LV  L+  G   +D++   F     E    H +Q +L  + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 121
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLR--YMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           H  G +HR +K  ++L++   K     L    +       +  H F  +  Y    LSPE
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY----LSPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           VL++  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 178 VLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 13/186 (6%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK         E +     E+  M+ LRHPNI+ ++ +     +L +V+  +  GS  
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 99  DLI-NAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILI--SHNGKACL 153
            L+  +     L E     +  DV  G+ Y+H +    +HR +K+ ++L+   +  K C 
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCD 182
Query: 154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
            GL      S  K    L     A    W++PEVL    +  +E+SD+YS G+   ELA 
Sbjct: 183 FGL------SRLKASXFLXSKXAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELAT 234
Query: 214 GTVPFA 219
              P+ 
Sbjct: 235 LQQPWG 240

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 13/186 (6%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK         E +     E+  M+ LRHPNI+ ++ +     +L +V+  +  GS  
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 449 DLI-NAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILI--SHNGKACL 503
            L+  +     L E     +  DV  G+ Y+H +    +HR +K+ ++L+   +  K C 
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCD 182
Query: 504 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
            GL      S  K    L     A    W++PEVL    +  +E+SD+YS G+   ELA 
Sbjct: 183 FGL------SRLKASXFLXSKXAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELAT 234
Query: 564 GTVPFA 569
              P+ 
Sbjct: 235 LQQPWG 240

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 127/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     KD ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     KD ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 33/288 (11%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVS 89
           ++K T +++A+KKF L+   D+ +K +   EI  ++ LRH N++  +         +LV 
Sbjct: 45  RNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103
Query: 90  PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
             +      DL    F  GL   V+   L  ++NG+ + H    IHR +K  +IL+S   
Sbjct: 104 EFVDHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ-- 159
Query: 150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL-SPEVLEQNLDGYDERSDIYSV 204
               SG+  +C F   +    L  P   Y+      W  +PE+L  ++  Y +  D++++
Sbjct: 160 ----SGVVKLCDFGFART---LAAPGEVYDDEVATRWYRAPELLVGDVK-YGKAVDVWAI 211
Query: 205 GISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEEN---ACSYI 261
           G    E+  G   F         I++L     H++ C    +   Q+   +N   A   +
Sbjct: 212 GCLVTEMFMGEPLFPGDSD----IDQLY----HIMMCLGNLIPRHQELFNKNPVFAGVRL 263
Query: 262 SEQQTQVLTSRKFSDSFHSIVEL---CLSRDVDKRPLACNLLQHAFFK 306
            E + +    R++      +++L   CL  D DKRP    LL H FF+
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 19/194 (9%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVS 439
           ++K T +++A+KKF L+   D+ +K +   EI  ++ LRH N++  +         +LV 
Sbjct: 45  RNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103
Query: 440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
             +      DL    F  GL   V+   L  ++NG+ + H    IHR +K  +IL+S   
Sbjct: 104 EFVDHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ-- 159
Query: 500 KACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL-SPEVLEQNLDGYDERSDIYSV 554
               SG+  +C F   +    L  P   Y+      W  +PE+L  ++  Y +  D++++
Sbjct: 160 ----SGVVKLCDFGFART---LAAPGEVYDDEVATRWYRAPELLVGDVK-YGKAVDVWAI 211
Query: 555 GISCCELANGTVPF 568
           G    E+  G   F
Sbjct: 212 GCLVTEMFMGEPLF 225

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 348 NSSVETLDNVP--SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK 405
            +S  + D  P   NY++   +G+   N + V L++H +T + +AVK  +  ++    L+
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGK--GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ 58
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
            L  E+   + L HPNI+           L+LV      G   D + AH      E    
Sbjct: 59  KLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAK 118
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF--- 522
              + +++ ++Y H K  +HR +KA ++L+  +    ++   +   F+    K+  F   
Sbjct: 119 --FRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFT-FGNKLDAFCGA 175
Query: 523 PPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
           PP  A       PE+ + +  DG +   D++S+G+    L +G++PF
Sbjct: 176 PPYAA-------PELFQGKKYDGPE--VDVWSLGVILYTLVSGSLPF 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 32  HKVTNQLIAVK--KFNLDRMTDEDLKSLH----HEIVCMRHLR-HPNIICYISSFLDATD 84
           H+ T    AVK  +   +R++ E L+ +      E   +R +  HP+II  I S+  ++ 
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           + LV  LM  G   D +       L E     I++ +L  + ++H    +HR +K  +IL
Sbjct: 175 MFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSD 200
           +  N +  LS   + C   P +K   L          +L+PE+L+ ++D    GY +  D
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLREL-----CGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 201 IYSVGISCCELANGTVPFAETPTTLML 227
           +++ G+    L  G+ PF      LML
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQILML 314

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 382 HKVTNQLIAVK--KFNLDRMTDEDLKSLH----HEIVCMRHLR-HPNIICYISSFLDATD 434
           H+ T    AVK  +   +R++ E L+ +      E   +R +  HP+II  I S+  ++ 
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           + LV  LM  G   D +       L E     I++ +L  + ++H    +HR +K  +IL
Sbjct: 175 MFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSD 550
           +  N +  LS   + C   P +K   L          +L+PE+L+ ++D    GY +  D
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLREL-----CGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 551 IYSVGISCCELANGTVPFAETPTTLML 577
           +++ G+    L  G+ PF      LML
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQILML 314

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 80/330 (24%), Positives = 138/330 (41%), Gaps = 58/330 (17%)
Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T+  VP   +    +G   + ++ S Y ++ +   Q +AVKK +    +    +  + E
Sbjct: 13  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR---QKVAVKKLSRPFQSLIHARRTYRE 69
Query: 61  IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 109
           +  ++HL+H N+I  +  F  AT      +++LV+ LMG        C+ L + H  F  
Sbjct: 70  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-- 127
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL--SGLRYMCPFSPTKK 167
                  ++  +L GL+YIH  G IHR +K S++ ++ + +  +   GL        T  
Sbjct: 128 -------LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY 180
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV--PFAETPTTL 225
               +  +    LNW+           Y++  DI+SVG    EL  G    P ++    L
Sbjct: 181 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQL 230
Query: 226 MLIEKLAGA-TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
             I ++ G  +P +L   +           E+A +YI  Q    +  +  S  F     L
Sbjct: 231 KRIMEVVGTPSPEVLAKIS----------SEHARTYI--QSLPPMPQKDLSSIFRGANPL 278
Query: 285 C-------LSRDVDKRPLACNLLQHAFFKQ 307
                   L  D D+R  A   L HA+F Q
Sbjct: 279 AIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 308

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 36/231 (15%)
Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T+  VP   +    +G   + ++ S Y ++ +   Q +AVKK +    +    +  + E
Sbjct: 13  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR---QKVAVKKLSRPFQSLIHARRTYRE 69
Query: 411 IVCMRHLRHPNIICYISSFLDAT------DLHLVSPLMG-----FGSCKDLINAHFNFGL 459
           +  ++HL+H N+I  +  F  AT      +++LV+ LMG        C+ L + H  F  
Sbjct: 70  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-- 127
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL--SGLRYMCPFSPTKK 517
                  ++  +L GL+YIH  G IHR +K S++ ++ + +  +   GL        T  
Sbjct: 128 -------LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY 180
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
               +  +    LNW+           Y++  DI+SVG    EL  G   F
Sbjct: 181 VATRWYRAPEIMLNWMH----------YNQTVDIWSVGCIMAELLQGKALF 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 39/307 (12%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 36  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 94
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 140
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 95  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 152
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 153 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 204
Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           I+S+G+S  E+A G  P      ++ + E        LLD                   Y
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSMAIFE--------LLD-------------------Y 237
Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
           I  +    L S  FS  F   V  CL ++  +R     L+ HAF K++    V     L 
Sbjct: 238 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC 297
Query: 321 PALSLNE 327
             + LN+
Sbjct: 298 STIGLNQ 304

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 36  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 94
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 95  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 152
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 153 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 204
Query: 551 IYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           I+S+G+S  E+A G  P      ++ + E L
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLR 68
           +++I   LG+      +VYL++ K ++ ++A+K     ++  E ++  L  EI    HL 
Sbjct: 24  DFEIGRPLGK--GKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+   + F D   ++L+      G     +     F   E     I++++ + L Y 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFD--EQRTATIMEELADALMYC 139
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           HGK  IHR +K  ++L+   G+  ++   +       ++K      +    L++L PE++
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK------TMCGTLDYLPPEMI 193
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E  +  ++E+ D++ +G+ C EL  G  PF
Sbjct: 194 EGRM--HNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLR 418
           +++I   LG+      +VYL++ K ++ ++A+K     ++  E ++  L  EI    HL 
Sbjct: 24  DFEIGRPLGK--GKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+   + F D   ++L+      G     +     F   E     I++++ + L Y 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFD--EQRTATIMEELADALMYC 139
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           HGK  IHR +K  ++L+   G+  ++   +       ++K      +    L++L PE++
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK------TMCGTLDYLPPEMI 193
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E  +  ++E+ D++ +G+ C EL  G  PF
Sbjct: 194 EGRM--HNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 232
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 306 KQTKK 310
           +   K
Sbjct: 291 QDVTK 295

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 11  NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 182
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 183 -LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 236
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 237 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294
Query: 306 KQTKK 310
           +   K
Sbjct: 295 QDVTK 299

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 11  NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 182
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 183 -LGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y++   +G    N     L + K  N+L+AVK        DE++K    EI+  R LRH
Sbjct: 20  RYELVKDIGA--GNFGVARLMRDKQANELVAVKYIERGEKIDENVK---REIINHRSLRH 74
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 128
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 187
           H     HR +K  + L+  +    L     +  F  +K  V H  P S      +++PEV
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLK----IADFGYSKASVLHSQPKSAVGTPAYIAPEV 187
Query: 188 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y++   +G    N     L + K  N+L+AVK        DE++K    EI+  R LRH
Sbjct: 20  RYELVKDIGA--GNFGVARLMRDKQANELVAVKYIERGEKIDENVK---REIINHRSLRH 74
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 478
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 537
           H     HR +K  + L+  +    L     +  F  +K  V H  P S      +++PEV
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLK----IADFGYSKASVLHSQPKSAVGTPAYIAPEV 187
Query: 538 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 176
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 230
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288
Query: 306 KQTKK 310
           +   K
Sbjct: 289 QDVTK 293

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 176
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 32/284 (11%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLV 88
           T   +A+KK      ++   K  + E+  ++H+RH N+I  +  F       D TD +LV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 89  SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
            P MG    K  +  H   G  E  I  ++  +L GL YIH  G IHR +K  ++ ++ +
Sbjct: 109 MPFMGTDLGK--LMKHEKLG--EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 164
Query: 149 --GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              K    GL            V  +  +    LNW+           Y +  DI+SVG 
Sbjct: 165 CELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMR----------YTQTVDIWSVGC 214
Query: 207 SCCELANGTVPFAETP--TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
              E+  G   F  +     L  I K+ G  P        +V   Q D  +N    + E 
Sbjct: 215 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP------AEFVQRLQSDEAKNYMKGLPEL 268
Query: 265 QTQVLTS--RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
           + +   S     S    +++E  L  D ++R  A   L H +F+
Sbjct: 269 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 24/212 (11%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLV 438
           T   +A+KK      ++   K  + E+  ++H+RH N+I  +  F       D TD +LV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
            P MG    K  +  H   G  E  I  ++  +L GL YIH  G IHR +K  ++ ++ +
Sbjct: 109 MPFMGTDLGK--LMKHEKLG--EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 164
Query: 499 --GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              K    GL            V  +  +    LNW+           Y +  DI+SVG 
Sbjct: 165 CELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMR----------YTQTVDIWSVGC 214
Query: 557 SCCELANGTVPFAETP--TTLMLIEKLAGATP 586
              E+  G   F  +     L  I K+ G  P
Sbjct: 215 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 45/292 (15%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT------DLH 86
           K + + +A+KK +    ++   K  + E++ ++H++H N+I  +  F  A+      D +
Sbjct: 64  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           LV P M     + ++   F+    E  I +++  +L GL+YIH  G +HR +K  ++ ++
Sbjct: 124 LVMPFMQ-TDLQKIMGMEFS----EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 178
Query: 147 HN--GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
            +   K    GL        T   V  +  +    L+W+           Y++  DI+SV
Sbjct: 179 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMH----------YNQTVDIWSV 228
Query: 205 GISCCELANGTVPF--AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           G    E+  G   F   +    L  I K+ G         T +V   Q   ++ A SYI 
Sbjct: 229 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP------GTEFV---QKLNDKAAKSYI- 278
Query: 263 EQQTQVLTSRK-FSDSF-------HSIVELCLSRDVDKRPLACNLLQHAFFK 306
             Q+   T RK F+  F         ++E  L  DVDKR  A   L H FF+
Sbjct: 279 --QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT------DLH 436
           K + + +A+KK +    ++   K  + E++ ++H++H N+I  +  F  A+      D +
Sbjct: 64  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           LV P M     + ++   F+    E  I +++  +L GL+YIH  G +HR +K  ++ ++
Sbjct: 124 LVMPFMQ-TDLQKIMGMEFS----EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 178
Query: 497 HN--GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
            +   K    GL        T   V  +  +    L+W+           Y++  DI+SV
Sbjct: 179 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMH----------YNQTVDIWSV 228
Query: 555 GISCCELANGTVPF 568
           G    E+  G   F
Sbjct: 229 GCIMAEMLTGKTLF 242

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 97
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +  A  L +V+    G    
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLY 107
Query: 98  KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             L  +   F + +L+   I +    G++Y+H K  IHR +K+++I + H       G  
Sbjct: 108 HHLHASETKFEMKKLI--DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDF 164
Query: 158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 216
            +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G +
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 217 PFAETPTTLMLIE 229
           P++       +IE
Sbjct: 224 PYSNINNRDQIIE 236

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 447
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +  A  L +V+    G    
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLY 107
Query: 448 KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             L  +   F + +L+   I +    G++Y+H K  IHR +K+++I + H       G  
Sbjct: 108 HHLHASETKFEMKKLI--DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDF 164
Query: 508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 566
            +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G +
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 567 PFAETPTTLMLIE 579
           P++       +IE
Sbjct: 224 PYSNINNRDQIIE 236

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 11  NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 182
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 183 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 236
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 237 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294
Query: 306 KQTKK 310
           +   K
Sbjct: 295 QDVTK 299

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 11  NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 182
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 183 -LGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 20/306 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L 
Sbjct: 7   ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEV 187
           H    +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEI 178
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTY 244
           L      Y    DI+S+G    E+      F   +E      +   L   TP   D   +
Sbjct: 179 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVW 232
Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
              T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H F
Sbjct: 233 PGVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290
Query: 305 FKQTKK 310
           F+   K
Sbjct: 291 FQDVTK 296

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
            N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L 
Sbjct: 7   ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEV 537
           H    +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEI 178
Query: 538 LEQNLDGYDERSDIYSVGISCCELAN 563
           L      Y    DI+S+G    E+  
Sbjct: 179 L-LGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 129/314 (41%), Gaps = 73/314 (23%)
Query: 61  IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 302
Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    ++   
Sbjct: 303 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPH----ASVGT 352
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T             H +
Sbjct: 353 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------DKHEI 401
Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-- 297
           D  T  +     D                     FS    S++E  L RDV++R L C  
Sbjct: 402 DRMTLTMAVELPDS--------------------FSPELRSLLEGLLQRDVNRR-LGCLG 440
Query: 298 ----NLLQHAFFKQTKKCSVML----PELLRPALSLNESNVCEINNELECMFNINDT--- 346
                + +  FF+      V L    P L+ P   +N ++  +I +     F+  DT   
Sbjct: 441 RGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGS-----FDEEDTKGI 495
Query: 347 --FNSSVETLDNVP 358
              +S  E   N P
Sbjct: 496 KLLDSDQELYRNFP 509

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 22/164 (13%)
Query: 411 IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 302
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    ++   
Sbjct: 303 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPH----ASVGT 352
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T
Sbjct: 353 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 73/314 (23%)
Query: 61  IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 303
Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  K      P ++   
Sbjct: 304 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGT 353
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T             H +
Sbjct: 354 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------DKHEI 402
Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-- 297
           D  T  +     D                     FS    S++E  L RDV++R L C  
Sbjct: 403 DRMTLTMAVELPDS--------------------FSPELRSLLEGLLQRDVNRR-LGCLG 441
Query: 298 ----NLLQHAFFKQTKKCSVML----PELLRPALSLNESNVCEINNELECMFNINDT--- 346
                + +  FF+      V L    P L+ P   +N ++  +I +     F+  DT   
Sbjct: 442 RGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGS-----FDEEDTKGI 496
Query: 347 --FNSSVETLDNVP 358
              +S  E   N P
Sbjct: 497 KLLDSDQELYRNFP 510

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 411 IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 303
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  K      P ++   
Sbjct: 304 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGT 353
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T
Sbjct: 354 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 73/314 (23%)
Query: 61  IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 303
Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  K      P ++   
Sbjct: 304 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGT 353
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T             H +
Sbjct: 354 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------DKHEI 402
Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-- 297
           D  T  +     D                     FS    S++E  L RDV++R L C  
Sbjct: 403 DRMTLTMAVELPDS--------------------FSPELRSLLEGLLQRDVNRR-LGCLG 441
Query: 298 ----NLLQHAFFKQTKKCSVML----PELLRPALSLNESNVCEINNELECMFNINDT--- 346
                + +  FF+      V L    P L+ P   +N ++  +I +     F+  DT   
Sbjct: 442 RGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGS-----FDEEDTKGI 496
Query: 347 --FNSSVETLDNVP 358
              +S  E   N P
Sbjct: 497 KLLDSDQELYRNFP 510

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 411 IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 303
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  K      P ++   
Sbjct: 304 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGT 353
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T
Sbjct: 354 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 228
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 306 KQTKK 310
           +   K
Sbjct: 287 QDVTK 291

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 129/314 (41%), Gaps = 73/314 (23%)
Query: 61  IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 303
Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    ++   
Sbjct: 304 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPH----ASVGT 353
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T             H +
Sbjct: 354 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------DKHEI 402
Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-- 297
           D  T  +     D                     FS    S++E  L RDV++R L C  
Sbjct: 403 DRMTLTMAVELPDS--------------------FSPELRSLLEGLLQRDVNRR-LGCLG 441
Query: 298 ----NLLQHAFFKQTKKCSVML----PELLRPALSLNESNVCEINNELECMFNINDT--- 346
                + +  FF+      V L    P L+ P   +N ++  +I +     F+  DT   
Sbjct: 442 RGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGS-----FDEEDTKGI 496
Query: 347 --FNSSVETLDNVP 358
              +S  E   N P
Sbjct: 497 KLLDSDQELYRNFP 510

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 22/164 (13%)
Query: 411 IVCMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           IVCM +  H P+ + +I   ++  DLH      G  S  D+      F   E+++     
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL----- 303
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
               GLE++H +  ++R +K ++IL+  +G   +S L   C FS  KKK H    ++   
Sbjct: 304 ----GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPH----ASVGT 353
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
             +++PEVL++ +  YD  +D +S+G    +L  G  PF +  T
Sbjct: 354 HGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 45/292 (15%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT------DLH 86
           K + + +A+KK +    ++   K  + E++ ++H++H N+I  +  F  A+      D +
Sbjct: 46  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           LV P M     + ++   F+    E  I +++  +L GL+YIH  G +HR +K  ++ ++
Sbjct: 106 LVMPFMQ-TDLQKIMGLKFS----EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160
Query: 147 HN--GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
            +   K    GL        T   V  +  +    L+W+           Y++  DI+SV
Sbjct: 161 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMH----------YNQTVDIWSV 210
Query: 205 GISCCELANGTVPF--AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS 262
           G    E+  G   F   +    L  I K+ G         T +V   Q   ++ A SYI 
Sbjct: 211 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP------GTEFV---QKLNDKAAKSYI- 260
Query: 263 EQQTQVLTSRK-FSDSF-------HSIVELCLSRDVDKRPLACNLLQHAFFK 306
             Q+   T RK F+  F         ++E  L  DVDKR  A   L H FF+
Sbjct: 261 --QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT------DLH 436
           K + + +A+KK +    ++   K  + E++ ++H++H N+I  +  F  A+      D +
Sbjct: 46  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           LV P M     + ++   F+    E  I +++  +L GL+YIH  G +HR +K  ++ ++
Sbjct: 106 LVMPFMQ-TDLQKIMGLKFS----EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160
Query: 497 HN--GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
            +   K    GL        T   V  +  +    L+W+           Y++  DI+SV
Sbjct: 161 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMH----------YNQTVDIWSV 210
Query: 555 GISCCELANGTVPF 568
           G    E+  G   F
Sbjct: 211 GCIMAEMLTGKTLF 224

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 228
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 306 KQTKK 310
           +   K
Sbjct: 287 QDVTK 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 20/306 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L 
Sbjct: 4   ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEV 187
           H    +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEI 175
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTY 244
           L      Y    DI+S+G    E+      F   +E      +   L   TP   D   +
Sbjct: 176 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVW 229
Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
              T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H F
Sbjct: 230 PGVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 305 FKQTKK 310
           F+   K
Sbjct: 288 FQDVTK 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
            N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L 
Sbjct: 4   ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEV 537
           H    +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEI 175
Query: 538 LEQNLDGYDERSDIYSVGISCCELAN 563
           L      Y    DI+S+G    E+  
Sbjct: 176 L-LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 176
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 230
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288
Query: 306 KQTKK 310
           +   K
Sbjct: 289 QDVTK 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 176
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 20/306 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L 
Sbjct: 2   ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEV 187
           H    +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEI 173
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTY 244
           L      Y    DI+S+G    E+      F   +E      +   L   TP   D   +
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVW 227
Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
              T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H F
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
Query: 305 FKQTKK 310
           F+   K
Sbjct: 286 FQDVTK 291

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
            N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L 
Sbjct: 2   ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEV 537
           H    +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEI 173
Query: 538 LEQNLDGYDERSDIYSVGISCCELAN 563
           L      Y    DI+S+G    E+  
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 176
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 230
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288
Query: 306 KQTKK 310
           +   K
Sbjct: 289 QDVTK 293

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 176
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 232
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 306 KQTKK 310
           +   K
Sbjct: 291 QDVTK 295

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 231
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289
Query: 306 KQTKK 310
           +   K
Sbjct: 290 QDVTK 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 8   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 179
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 180 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 233
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 234 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291
Query: 306 KQTKK 310
           +   K
Sbjct: 292 QDVTK 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 8   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 179
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 180 -LGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 232
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 306 KQTKK 310
           +   K
Sbjct: 291 QDVTK 295

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 231
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289
Query: 306 KQTKK 310
           +   K
Sbjct: 290 QDVTK 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 231
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 232 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289
Query: 306 KQTKK 310
           +   K
Sbjct: 290 QDVTK 294

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 6   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 177
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 174
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 228
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 306 KQTKK 310
           +   K
Sbjct: 287 QDVTK 291

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 174
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 176
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 230
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288
Query: 306 KQTKK 310
           +   K
Sbjct: 289 QDVTK 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 5   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 176
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 177 -LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y++   +G    N     L + K +N+L+AVK          ++K    EI+  R LRH
Sbjct: 20  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIAANVK---REIINHRSLRH 74
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 128
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 187
           H     HR +K  + L+  +    L     +C F  +K  V H  P ST     +++PEV
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 187
Query: 188 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y++   +G    N     L + K +N+L+AVK          ++K    EI+  R LRH
Sbjct: 20  RYELVKDIGS--GNFGVARLMRDKQSNELVAVKYIERGEKIAANVK---REIINHRSLRH 74
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 478
           PNI+ +    L  T L +V   M + S  +L     N G   E       Q +++G+ Y 
Sbjct: 75  PNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTAYNLNWLSPEV 537
           H     HR +K  + L+  +    L     +C F  +K  V H  P ST     +++PEV
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 187
Query: 538 -LEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
            L++  DG  + +D++S G++   +  G  PF +
Sbjct: 188 LLKKEYDG--KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D + AH    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 99  PYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 157
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 212
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 213 LFTYIEKSKSPPAEFM 228

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D + AH    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 99  PYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 157
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 212
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 213 LFTYIEKSKSPPAEFM 228

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 232
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 306 KQTKK 310
           +   K
Sbjct: 291 QDVTK 295

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 7/199 (3%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 97
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+    G    
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 95
Query: 98  KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             L  +   F + +L+   I +    G++Y+H K  IHR +K+++I + H       G  
Sbjct: 96  HHLHASETKFEMKKLI--DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDF 152
Query: 158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 216
            +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G +
Sbjct: 153 GLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 211
Query: 217 PFAETPTTLMLIEKLAGAT 235
           P++       +IE +   +
Sbjct: 212 PYSNINNRDQIIEMVGRGS 230

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 7/199 (3%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 447
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+    G    
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 95
Query: 448 KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             L  +   F + +L+   I +    G++Y+H K  IHR +K+++I + H       G  
Sbjct: 96  HHLHASETKFEMKKLI--DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDF 152
Query: 508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 566
            +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G +
Sbjct: 153 GLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 211
Query: 567 PFAETPTTLMLIEKLAGAT 585
           P++       +IE +   +
Sbjct: 212 PYSNINNRDQIIEMVGRGS 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 79/339 (23%), Positives = 139/339 (41%), Gaps = 28/339 (8%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           ME  D+   +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E
Sbjct: 1   MELKDD---DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRE 54
Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112
Query: 121 VLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           V+ GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S    
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGT 166
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATP 236
            +++SPE L+     Y  +SDI+S+G+S  E+A G  P          LM   ++ G   
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 237 HLLD--------CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
                        ++Y +D+           YI  +    L S  FS  F   V  CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 289 DVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNE 327
           +  +R     L+ HAF K++    V     L   + LN+
Sbjct: 285 NPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ 323

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 134 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 185
Query: 551 IYSVGISCCELANGTVPF 568
           I+S+G+S  E+A G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 79/339 (23%), Positives = 139/339 (41%), Gaps = 28/339 (8%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           ME  D+   +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E
Sbjct: 1   MELKDD---DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRE 54
Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112
Query: 121 VLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           V+ GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S    
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGT 166
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATP 236
            +++SPE L+     Y  +SDI+S+G+S  E+A G  P          LM   ++ G   
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 237 HLLD--------CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
                        ++Y +D+           YI  +    L S  FS  F   V  CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 289 DVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNE 327
           +  +R     L+ HAF K++    V     L   + LN+
Sbjct: 285 NPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ 323

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 134 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 185
Query: 551 IYSVGISCCELANGTVPF 568
           I+S+G+S  E+A G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 7/193 (3%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 97
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+    G    
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 107
Query: 98  KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             L  +   F + +L+   I +    G++Y+H K  IHR +K+++I + H       G  
Sbjct: 108 HHLHASETKFEMKKLI--DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDF 164
Query: 158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 216
            +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G +
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 217 PFAETPTTLMLIE 229
           P++       +IE
Sbjct: 224 PYSNINNRDQIIE 236

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 7/193 (3%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 447
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+    G    
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 107
Query: 448 KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             L  +   F + +L+   I +    G++Y+H K  IHR +K+++I + H       G  
Sbjct: 108 HHLHASETKFEMKKLI--DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDF 164
Query: 508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 566
            +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G +
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 567 PFAETPTTLMLIE 579
           P++       +IE
Sbjct: 224 PYSNINNRDQIIE 236

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 20/301 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 K 306
           +
Sbjct: 288 Q 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 10/210 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
                 Y    DI+S+G    E+      F
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/328 (24%), Positives = 134/328 (40%), Gaps = 38/328 (11%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           ME  D+   +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E
Sbjct: 1   MELKDD---DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRE 54
Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112
Query: 121 VLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           V+ GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S    
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGT 166
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
            +++SPE L+     Y  +SDI+S+G+S  E+A G  P    P       +   A   LL
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKEDSRPPMAIFELL 222
Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL 299
           D                   YI  +    L S  FS  F   V  CL ++  +R     L
Sbjct: 223 D-------------------YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 263
Query: 300 LQHAFFKQTKKCSVMLPELLRPALSLNE 327
           + HAF K++    V     L   + LN+
Sbjct: 264 MVHAFIKRSDAEEVDFAGWLCSTIGLNQ 291

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 134 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 185
Query: 551 IYSVGISCCELANGTVPF 568
           I+S+G+S  E+A G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/338 (23%), Positives = 138/338 (40%), Gaps = 28/338 (8%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           ME  D+   +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E
Sbjct: 1   MELKDD---DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRE 54
Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112
Query: 121 VLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           V+ GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S    
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGT 166
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATP 236
            +++SPE L+     Y  +SDI+S+G+S  E+A G  P          LM   ++ G   
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 237 HLLD--------CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
                        ++Y +D+           YI  +    L S  FS  F   V  CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 289 DVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLN 326
           +  +R     L+ HAF K++    V     L   + LN
Sbjct: 285 NPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLN 322

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 134 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 185
Query: 551 IYSVGISCCELANGTVPF 568
           I+S+G+S  E+A G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/338 (23%), Positives = 138/338 (40%), Gaps = 28/338 (8%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           ME  D+   +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E
Sbjct: 1   MELKDD---DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRE 54
Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112
Query: 121 VLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           V+ GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S    
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGT 166
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATP 236
            +++SPE L+     Y  +SDI+S+G+S  E+A G  P          LM   ++ G   
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 237 HLLD--------CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
                        ++Y +D+           YI  +    L S  FS  F   V  CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 289 DVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLN 326
           +  +R     L+ HAF K++    V     L   + LN
Sbjct: 285 NPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLN 322

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 76  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 133
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 134 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 185
Query: 551 IYSVGISCCELANGTVPF 568
           I+S+G+S  E+A G  P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 232
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 233 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 306 KQTKK 310
           +   K
Sbjct: 291 QDVTK 295

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 7   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH-----EVVTLWYRAPEIL 178
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 41  VKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL 100
           +K+ N+ RM+ ++ +    E+  + +++HPNI+ Y  SF +   L++V      G     
Sbjct: 54  IKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKR 113
Query: 101 INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC 160
           INA       E  I      +   L+++H +  +HR +K+ +I ++ +G   L       
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 161 PFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
             + T   V L      T Y   +LSPE+ E     Y+ +SDI+++G    EL      F
Sbjct: 174 VLNST---VELARACIGTPY---YLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAF 225
Query: 219 AETPTTLMLIEKLAGATP 236
                  ++++ ++G+ P
Sbjct: 226 EAGSMKNLVLKIISGSFP 243

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 391 VKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL 450
           +K+ N+ RM+ ++ +    E+  + +++HPNI+ Y  SF +   L++V      G     
Sbjct: 54  IKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKR 113
Query: 451 INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC 510
           INA       E  I      +   L+++H +  +HR +K+ +I ++ +G   L       
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 511 PFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             + T   V L      T Y   +LSPE+ E     Y+ +SDI+++G    EL      F
Sbjct: 174 VLNST---VELARACIGTPY---YLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAF 225
Query: 569 AETPTTLMLIEKLAGATP 586
                  ++++ ++G+ P
Sbjct: 226 EAGSMKNLVLKIISGSFP 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 37  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 94
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 95  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 153
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 154 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 208
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 209 LFTYIEKSKSPPAEFM 224

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 37  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 94
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 95  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 153
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 154 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 208
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 209 LFTYIEKSKSPPAEFM 224

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 36  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 93
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 94  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 152
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 153 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 207
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 208 LFTYIEKSKSPPAEFM 223

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 36  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 93
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 94  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 152
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 153 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 207
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 208 LFTYIEKSKSPPAEFM 223

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 125/305 (40%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+ K  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 229
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287
Query: 306 KQTKK 310
           +   K
Sbjct: 288 QDVTK 292

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+ K  LD  T+    +   EI  ++ L H
Sbjct: 4   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 175
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 125/305 (40%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+ K  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 228
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 306 KQTKK 310
           +   K
Sbjct: 287 QDVTK 291

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+ K  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 45  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 102
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 103 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 161
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 162 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 216
Query: 211 LANGTVPFAETPTTLMLI 228
           L          P   M +
Sbjct: 217 LFTYIEKSKSPPAEFMRM 234

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 45  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 102
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 103 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 161
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 162 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 216
Query: 561 LANGTVPFAETPTTLMLI 578
           L          P   M +
Sbjct: 217 LFTYIEKSKSPPAEFMRM 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 20/305 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 188
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPHLLDCTTYY 245
                 Y    DI+S+G    E+      F   +E      +   L   TP   D   + 
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTP---DEVVWP 228
Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
             T   D + +   +  +  ++V+      +   S++   L  D +KR  A   L H FF
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 306 KQTKK 310
           +   K
Sbjct: 287 QDVTK 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVL 538
               +HR +K  ++LI+  G   L+       F  P +   H         L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 174
Query: 539 EQNLDGYDERSDIYSVGISCCELAN 563
                 Y    DI+S+G    E+  
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 99  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 157
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 212
Query: 211 LANGTVPFAETPTTLMLI 228
           L          P   M +
Sbjct: 213 LFTYIEKSKSPPAEFMRM 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 99  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 157
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 212
Query: 561 LANGTVPFAETPTTLMLI 578
           L          P   M +
Sbjct: 213 LFTYIEKSKSPPAEFMRM 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 96  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 209
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 210 LFTYIEKSKSPPAEFM 225

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 96  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 209
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 210 LFTYIEKSKSPPAEFM 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +  A  L +V+      S  
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLY 91
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 92  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 146
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +  ++ W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSG-SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 215 TVPFA 219
            +P++
Sbjct: 206 QLPYS 210

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +  A  L +V+      S  
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLY 91
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 92  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 146
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +  ++ W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSG-SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 565 TVPFA 569
            +P++
Sbjct: 206 QLPYS 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 42  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 99
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 100 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 158
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 159 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 213
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 214 LFTYIEKSKSPPAEFM 229

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 42  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 99
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 100 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 158
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 159 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 213
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 214 LFTYIEKSKSPPAEFM 229

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 96  PYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 209
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 210 LFTYIEKSKSPPAEFM 225

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 96  PYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 209
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 210 LFTYIEKSKSPPAEFM 225

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 12/181 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 69  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 127 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 186 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 240
Query: 211 L 211
           L
Sbjct: 241 L 241

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 12/181 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 69  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 127 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 186 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 240
Query: 561 L 561
           L
Sbjct: 241 L 241

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 44  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 101
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 102 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 160
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 161 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 215
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 216 LFTYIEKSKSPPAEFM 231

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 44  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 101
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 102 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 160
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 161 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 215
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 216 LFTYIEKSKSPPAEFM 231

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 43  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 100
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 101 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 159
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 214
Query: 211 LANGTVPFAETPTTLMLI 228
           L          P   M +
Sbjct: 215 LFTYIEKSKSPPAEFMRM 232

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 43  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 100
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 101 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 159
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 214
Query: 561 LANGTVPFAETPTTLMLI 578
           L          P   M +
Sbjct: 215 LFTYIEKSKSPPAEFMRM 232

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 56  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 114 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 172
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 227
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 228 LFTYIEKSKSPPAEFM 243

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 56  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 114 PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 172
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 227
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 228 LFTYIEKSKSPPAEFM 243

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/330 (23%), Positives = 135/330 (40%), Gaps = 25/330 (7%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E+  +     
Sbjct: 69  DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 125
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   V+ GL Y+ 
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 183
Query: 130 GK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
            K   +HR VK S+IL++  G+  L      C F  + + +     S     +++SPE L
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERL 237
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATPHLLD----- 240
           +     Y  +SDI+S+G+S  E+A G  P          LM   ++ G            
Sbjct: 238 QGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 295
Query: 241 ---CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
               ++Y +D+           YI  +    L S  FS  F   V  CL ++  +R    
Sbjct: 296 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLK 355
Query: 298 NLLQHAFFKQTKKCSVMLPELLRPALSLNE 327
            L+ HAF K++    V     L   + LN+
Sbjct: 356 QLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ 385

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E+  +     
Sbjct: 69  DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 125
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   V+ GL Y+ 
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 183
Query: 480 GK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
            K   +HR VK S+IL++  G+  L      C F  + + +     S     +++SPE L
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERL 237
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +     Y  +SDI+S+G+S  E+A G  P 
Sbjct: 238 QGT--HYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V L + KVT+   A+K      ++      L  E+  ++ L HPNI+     F D  + +
Sbjct: 53  VLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           LV      G   D I     F   E+    I++ VL+G+ Y+H    +HR +K  ++L+ 
Sbjct: 113 LVMECYKGGELFDEIIHRMKFN--EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170
Query: 147 HNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
              K  L  +        F   KK        TAY   +++PEVL +    YDE+ D++S
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERL--GTAY---YIAPEVLRKK---YDEKCDVWS 222
Query: 204 VGISCCELANGTVPFA 219
           +G+    L  G  PF 
Sbjct: 223 IGVILFILLAGYPPFG 238

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V L + KVT+   A+K      ++      L  E+  ++ L HPNI+     F D  + +
Sbjct: 53  VLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           LV      G   D I     F   E+    I++ VL+G+ Y+H    +HR +K  ++L+ 
Sbjct: 113 LVMECYKGGELFDEIIHRMKFN--EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170
Query: 497 HNGKACLSGL---RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
              K  L  +        F   KK        TAY   +++PEVL +    YDE+ D++S
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERL--GTAY---YIAPEVLRKK---YDEKCDVWS 222
Query: 554 VGISCCELANGTVPFA 569
           +G+    L  G  PF 
Sbjct: 223 IGVILFILLAGYPPFG 238

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 56  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 114 PYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 172
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 227
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 228 LFTYIEKSKSPPAEFM 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 56  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 114 PYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 172
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 227
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 228 LFTYIEKSKSPPAEFM 243

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 7/183 (3%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 97
           +AVK   +   T E  ++  +E+  +R  RH NI+ ++  ++   +L +V+    G    
Sbjct: 61  VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG-YMTKDNLAIVTQWCEGSSLY 119
Query: 98  KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
           K L      F + +L+   I +    G++Y+H K  IHR +K+++I + H G     G  
Sbjct: 120 KHLHVQETKFQMFQLI--DIARQTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDF 176
Query: 158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 216
            +                T   L W++PEV+  Q+ + +  +SD+YS GI   EL  G +
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVL-WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235
Query: 217 PFA 219
           P++
Sbjct: 236 PYS 238

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 7/183 (3%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL-MGFGSC 447
           +AVK   +   T E  ++  +E+  +R  RH NI+ ++  ++   +L +V+    G    
Sbjct: 61  VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG-YMTKDNLAIVTQWCEGSSLY 119
Query: 448 KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
           K L      F + +L+   I +    G++Y+H K  IHR +K+++I + H G     G  
Sbjct: 120 KHLHVQETKFQMFQLI--DIARQTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDF 176
Query: 508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTV 566
            +                T   L W++PEV+  Q+ + +  +SD+YS GI   EL  G +
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVL-WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235
Query: 567 PFA 569
           P++
Sbjct: 236 PYS 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 39  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 96
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 97  PYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVK 155
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 156 IGDFGLTKVLPQDKEYYKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 210
Query: 211 LANGTVPFAETPTTLMLI 228
           L          P   M +
Sbjct: 211 LFTYIEKSKSPPAEFMRM 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 39  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 96
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 97  PYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVK 155
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 156 IGDFGLTKVLPQDKEYYKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 210
Query: 561 LANGTVPFAETPTTLMLI 578
           L          P   M +
Sbjct: 211 LFTYIEKSKSPPAEFMRM 228

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 38/301 (12%)
Query: 4   LDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHH 59
           L NV +N+  +  S+ G          + K  V N  +AVKK    +D  T+E  +    
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPEL---VICH 116
           EI  M   +H N++  +    D  DL LV   M  GS  D ++     G P L   + C 
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCK 137
Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFP 173
           I Q   NG+ ++H    IHR +K+++IL+     A +S  GL R    F+ T     +  
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIV- 196
Query: 174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG 233
            +TAY    ++PE L   +     +SDIYS G+   E+  G +P  +      L+  +  
Sbjct: 197 GTTAY----MAPEALRGEI---TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKE 248
Query: 234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR 293
                      Y+D   +D +  +                  ++ +S+   CL    +KR
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSV-----------------EAMYSVASQCLHEKKNKR 291
Query: 294 P 294
           P
Sbjct: 292 P 292

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 354 LDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHH 409
           L NV +N+  +  S+ G          + K  V N  +AVKK    +D  T+E  +    
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPEL---VICH 466
           EI  M   +H N++  +    D  DL LV   M  GS  D ++     G P L   + C 
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCK 137
Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFP 523
           I Q   NG+ ++H    IHR +K+++IL+     A +S  GL R    F+ T     +  
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIV- 196
Query: 524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
            +TAY    ++PE L   +     +SDIYS G+   E+  G
Sbjct: 197 GTTAY----MAPEALRGEI---TPKSDIYSFGVVLLEIITG 230

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFL 98
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS ++ +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 99  PYGSLREYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 157
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 212
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 213 LFTYIEKSKSPPAEFM 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFL 98
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS ++ +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 99  PYGSLREYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 157
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 212
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 213 LFTYIEKSKSPPAEFM 228

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN---LDRMTDEDLKSLHHEIVCMRHL 67
           + +  ILGQ     ++V+  +HK T  L A+K FN     R  D  ++    E   ++ L
Sbjct: 11  WLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGF---GSCKDLINAHFN-FGLPELVICHILQDVLN 123
            H NI+   +   + T  H V  +M F   GS   ++    N +GLPE     +L+DV+ 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVL-IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 124 GLEYIHGKGFIHRAVKASHIL--ISHNGKAC--LSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           G+ ++   G +HR +K  +I+  I  +G++   L+           ++ V L+       
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE---- 179
Query: 180 LNWLSPEVLEQNL------DGYDERSDIYSVGISCCELANGTVPF 218
             +L P++ E+ +        Y    D++S+G++    A G++PF
Sbjct: 180 -EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN---LDRMTDEDLKSLHHEIVCMRHL 417
           + +  ILGQ     ++V+  +HK T  L A+K FN     R  D  ++    E   ++ L
Sbjct: 11  WLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGF---GSCKDLINAHFN-FGLPELVICHILQDVLN 473
            H NI+   +   + T  H V  +M F   GS   ++    N +GLPE     +L+DV+ 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVL-IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 474 GLEYIHGKGFIHRAVKASHIL--ISHNGKAC--LSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           G+ ++   G +HR +K  +I+  I  +G++   L+           ++ V L+       
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE---- 179
Query: 530 LNWLSPEVLEQNL------DGYDERSDIYSVGISCCELANGTVPF 568
             +L P++ E+ +        Y    D++S+G++    A G++PF
Sbjct: 180 -EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 18/237 (7%)
Query: 7   VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKK-FNLDRMTDEDLKSLHHEIVCMR 65
           +   YKI   LG     +S+VYL++  + N  +A+K  F   R  +E LK    E+    
Sbjct: 9   INERYKIVDKLGG--GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 66  HLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
            L H NI+  I   +D  D   +LV   +   +  + I +H    +   +  +    +L+
Sbjct: 67  QLSHQNIVSMID--VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQILD 122
Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLN 181
           G+++ H    +HR +K  +ILI  N    +         S T   +  H+        + 
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG-----TVQ 177
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 238
           + SPE  +   +  DE +DIYS+GI   E+  G  PF       + I+ +  + P++
Sbjct: 178 YFSPE--QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 18/237 (7%)
Query: 357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKK-FNLDRMTDEDLKSLHHEIVCMR 415
           +   YKI   LG     +S+VYL++  + N  +A+K  F   R  +E LK    E+    
Sbjct: 9   INERYKIVDKLGG--GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 416 HLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
            L H NI+  I   +D  D   +LV   +   +  + I +H    +   +  +    +L+
Sbjct: 67  QLSHQNIVSMID--VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQILD 122
Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK--KKVHLFPPSTAYNLN 531
           G+++ H    +HR +K  +ILI  N    +         S T   +  H+        + 
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG-----TVQ 177
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 588
           + SPE  +   +  DE +DIYS+GI   E+  G  PF       + I+ +  + P++
Sbjct: 178 YFSPE--QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 38/301 (12%)
Query: 4   LDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHH 59
           L NV +N+  +  S+ G          + K  V N  +AVKK    +D  T+E  +    
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPEL---VICH 116
           EI  M   +H N++  +    D  DL LV   M  GS  D ++     G P L   + C 
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCK 137
Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFP 173
           I Q   NG+ ++H    IHR +K+++IL+     A +S  GL R    F+ T     +  
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIV- 196
Query: 174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG 233
            +TAY    ++PE L   +     +SDIYS G+   E+  G +P  +      L+  +  
Sbjct: 197 GTTAY----MAPEALRGEI---TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKE 248
Query: 234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR 293
                      Y+D   +D +  +                  ++ +S+   CL    +KR
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSV-----------------EAMYSVASQCLHEKKNKR 291
Query: 294 P 294
           P
Sbjct: 292 P 292

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 354 LDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHH 409
           L NV +N+  +  S+ G          + K  V N  +AVKK    +D  T+E  +    
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 79
Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPEL---VICH 466
           EI  M   +H N++  +    D  DL LV   M  GS  D ++     G P L   + C 
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCK 137
Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFP 523
           I Q   NG+ ++H    IHR +K+++IL+     A +S  GL R    F+ T     +  
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIV- 196
Query: 524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
            +TAY    ++PE L   +     +SDIYS G+   E+  G
Sbjct: 197 GTTAY----MAPEALRGEI---TPKSDIYSFGVVLLEIITG 230

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIK 190
Query: 199 SDIYSVGISCCELAN-GTVPF 218
           SD+++ G+   E+A  G  P+
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY 211

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIK 190
Query: 549 SDIYSVGISCCELAN-GTVPF 568
           SD+++ G+   E+A  G  P+
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY 211

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/245 (20%), Positives = 102/245 (41%), Gaps = 24/245 (9%)
Query: 341 FNINDTFNSSVETLDNVPSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRM 399
             I+D     +E +      + +  +LG+  F ++    L +   +   +AVK    D +
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL------HLVSPLMGFGSCKDLINA 453
              D++    E  CM+   HP++   +   L +          ++ P M  G     + A
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 454 HF----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM 509
                  F LP   +   + D+  G+EY+  + FIHR + A + +++ +   C++     
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD---- 180
Query: 510 CPFSPTKK----KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANG 564
             F  ++K      +    ++   + WL+ E L  NL  Y   SD+++ G++  E +  G
Sbjct: 181 --FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTRG 236
Query: 565 TVPFA 569
             P+A
Sbjct: 237 QTPYA 241

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN---LDRMTDEDLKSLHHEIVCMRHL 67
           + +  ILGQ     ++V+  +HK T  L A+K FN     R  D  ++    E   ++ L
Sbjct: 11  WLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGF---GSCKDLINAHFN-FGLPELVICHILQDVLN 123
            H NI+   +   + T  H V  +M F   GS   ++    N +GLPE     +L+DV+ 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVL-IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 124 GLEYIHGKGFIHRAVKASHIL--ISHNGKAC--LSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           G+ ++   G +HR +K  +I+  I  +G++   L+           ++ V L+       
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTE---- 179
Query: 180 LNWLSPEVLEQNL------DGYDERSDIYSVGISCCELANGTVPF 218
             +L P++ E+ +        Y    D++S+G++    A G++PF
Sbjct: 180 -EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN---LDRMTDEDLKSLHHEIVCMRHL 417
           + +  ILGQ     ++V+  +HK T  L A+K FN     R  D  ++    E   ++ L
Sbjct: 11  WLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EFEVLKKL 64
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGF---GSCKDLINAHFN-FGLPELVICHILQDVLN 473
            H NI+   +   + T  H V  +M F   GS   ++    N +GLPE     +L+DV+ 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVL-IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 474 GLEYIHGKGFIHRAVKASHIL--ISHNGKAC--LSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           G+ ++   G +HR +K  +I+  I  +G++   L+           ++ V L+       
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTE---- 179
Query: 530 LNWLSPEVLEQNL------DGYDERSDIYSVGISCCELANGTVPF 568
             +L P++ E+ +        Y    D++S+G++    A G++PF
Sbjct: 180 -EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 96
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 97  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 151
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 152 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210
Query: 215 TVPFA 219
            +P++
Sbjct: 211 QLPYS 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 96
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 97  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 151
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 152 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210
Query: 565 TVPFA 569
            +P++
Sbjct: 211 QLPYS 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 87/185 (47%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 91
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 92  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 146
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +  ++ W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSG-SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 215 TVPFA 219
            +P++
Sbjct: 206 QLPYS 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 87/185 (47%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 91
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 92  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 146
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +  ++ W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSG-SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 565 TVPFA 569
            +P++
Sbjct: 206 QLPYS 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 118
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 119 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 173
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 174 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 232
Query: 215 TVPFA 219
            +P++
Sbjct: 233 QLPYS 237

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 118
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 119 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 173
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 174 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 232
Query: 565 TVPFA 569
            +P++
Sbjct: 233 QLPYS 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 127/313 (40%), Gaps = 37/313 (11%)
Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 85
           V+  +++ T Q++A+KKF L+   D  +K +   EI  ++ L+HPN++  +  F     L
Sbjct: 19  VFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL 77
Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           HLV          +L    +  G+PE ++  I    L  + + H    IHR VK  +ILI
Sbjct: 78  HLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135
Query: 146 SHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL-SPEVLEQNLDGYDER 198
           + +   K C  G   +           L  PS  Y+      W  SPE+L  +   Y   
Sbjct: 136 TKHSVIKLCDFGFARL-----------LTGPSDYYDDEVATRWYRSPELLVGDTQ-YGPP 183
Query: 199 SDIYSVGISCCELANGT--VPFAETPTTLMLIEKLAG----ATPHLLDCTTYYVDTGQDD 252
            D++++G    EL +G    P       L LI K  G        +     Y+      D
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243
Query: 253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS 312
            E        + +   L     S     +++ CL  D  +R     LL H +F+  ++  
Sbjct: 244 PE--------DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295
Query: 313 VMLPELLRPALSL 325
            +  E  +PA +L
Sbjct: 296 DLAKEHDKPAENL 308

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 435
           V+  +++ T Q++A+KKF L+   D  +K +   EI  ++ L+HPN++  +  F     L
Sbjct: 19  VFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL 77
Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           HLV          +L    +  G+PE ++  I    L  + + H    IHR VK  +ILI
Sbjct: 78  HLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135
Query: 496 SHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWL-SPEVLEQNLDGYDER 548
           + +   K C  G   +           L  PS  Y+      W  SPE+L  +   Y   
Sbjct: 136 TKHSVIKLCDFGFARL-----------LTGPSDYYDDEVATRWYRSPELLVGDTQ-YGPP 183
Query: 549 SDIYSVGISCCELANGT--VPFAETPTTLMLIEKLAG 583
            D++++G    EL +G    P       L LI K  G
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 87/185 (47%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 93
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 94  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 148
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +  ++ W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 149 DFGLATVKSRWSGSHQFEQLSG-SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 207
Query: 215 TVPFA 219
            +P++
Sbjct: 208 QLPYS 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 87/185 (47%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 93
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 94  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 148
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +  ++ W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 149 DFGLATVKSRWSGSHQFEQLSG-SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 207
Query: 565 TVPFA 569
            +P++
Sbjct: 208 QLPYS 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 96  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 209
Query: 211 LANGTVPFAETPTTLM 226
           L          P   M
Sbjct: 210 LFTYIEKSKSPPAEFM 225

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y      A   +L L+   +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
            +GS +D +  H    +  + +      +  G+EY+  K +IHR +   +IL+ +  +  
Sbjct: 96  PYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL  + P      KV     S  +   W +PE L ++   +   SD++S G+   E
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIF---WYAPESLTES--KFSVASDVWSFGVVLYE 209
Query: 561 LANGTVPFAETPTTLM 576
           L          P   M
Sbjct: 210 LFTYIEKSKSPPAEFM 225

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 119
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 120 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 174
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 175 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233
Query: 215 TVPFA 219
            +P++
Sbjct: 234 QLPYS 238

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 119
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 120 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 174
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 175 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233
Query: 565 TVPFA 569
            +P++
Sbjct: 234 QLPYS 238

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 96
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 97  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 151
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 152 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210
Query: 215 TVPFA 219
            +P++
Sbjct: 211 QLPYS 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 96
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 97  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 151
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 152 DFGLATVKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210
Query: 565 TVPFA 569
            +P++
Sbjct: 211 QLPYS 215

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 122/307 (39%), Gaps = 43/307 (14%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 20  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 78
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 140
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 79  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 136
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           S+IL++  G+  L      C F  + + +           +++SPE L+     Y  +SD
Sbjct: 137 SNILVNSRGEIKL------CDFGVSGQLIDEMANEFVGTRSYMSPERLQGT--HYSVQSD 188
Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           I+S+G+S  E+A G  P    P  +            LLD                   Y
Sbjct: 189 IWSMGLSLVEMAVGRYP--RPPMAIF----------ELLD-------------------Y 217
Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
           I  +    L S  FS  F   V  CL ++  +R     L+ HAF K++    V     L 
Sbjct: 218 IVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC 277
Query: 321 PALSLNE 327
             + LN+
Sbjct: 278 STIGLNQ 284

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 20  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 78
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 79  DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 136
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +           +++SPE L+     Y  +SD
Sbjct: 137 SNILVNSRGEIKL------CDFGVSGQLIDEMANEFVGTRSYMSPERLQGT--HYSVQSD 188
Query: 551 IYSVGISCCELANGTVP 567
           I+S+G+S  E+A G  P
Sbjct: 189 IWSMGLSLVEMAVGRYP 205

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 84
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 85  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 144
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M          +  P    + + W +PE L  N   +  +SD+
Sbjct: 145 VGENHLVKVADFGLSRLMT------GDTYTAPAGAKFPIKWTAPESLAYN--KFSIKSDV 196
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 197 WAFGVLLWEIATYGMSPY 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 84
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 85  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 144
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M          +  P    + + W +PE L  N   +  +SD+
Sbjct: 145 VGENHLVKVADFGLSRLMT------GDTYTAPAGAKFPIKWTAPESLAYN--KFSIKSDV 196
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 197 WAFGVLLWEIATYGMSPY 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 51  DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 109
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 227 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 347 KL-------PVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 401 DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 459
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 227 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 347 KL-------PVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 51  DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 109
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 40  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 99
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 100 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 160 KL-------PVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 401 DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 459
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 40  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 99
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 100 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 160 KL-------PVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 51  DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 109
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 55  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 175 KL-------PVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 401 DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 459
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 55  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 175 KL-------PVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 51  DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 109
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 46  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 105
Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 169
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 106 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 165
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 166 KL-------PVKWTAPEALREA--AFSTKSDVWSFGILLWEIYSFGRVPYPRIP 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 401 DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGL 459
           D   ++   E   M  LRH N++  +   ++    L++V+  M  GS  D + +     L
Sbjct: 46  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 105
Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV 519
               +     DV   +EY+ G  F+HR + A ++L+S +  A +S        S T+   
Sbjct: 106 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 165
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            L        + W +PE L +    +  +SD++S GI   E+ + G VP+   P
Sbjct: 166 KL-------PVKWTAPEALREA--AFSTKSDVWSFGILLWEIYSFGRVPYPRIP 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 146 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIK 197
Query: 199 SDIYSVGISCCELAN-GTVPF 218
           SD+++ G+   E+A  G  P+
Sbjct: 198 SDVWAFGVLLWEIATYGMSPY 218

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 146 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIK 197
Query: 549 SDIYSVGISCCELAN-GTVPF 568
           SD+++ G+   E+A  G  P+
Sbjct: 198 SDVWAFGVLLWEIATYGMSPY 218

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 85
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 145
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M          +  P    + + W +PE L  N   +  +SD+
Sbjct: 146 VGENHLVKVADFGLSRLMT------GDTYTAPAGAKFPIKWTAPESLAYN--KFSIKSDV 197
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 85
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 145
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M          +  P    + + W +PE L  N   +  +SD+
Sbjct: 146 VGENHLVKVADFGLSRLMT------GDTYTAPAGAKFPIKWTAPESLAYN--KFSIKSDV 197
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 126/318 (39%), Gaps = 23/318 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 44  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 140
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 103 DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 161 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 212
Query: 201 IYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATPHLLDCTTYYVDT----GQDDG 253
           I+S+G+S  E+A G  P          LM   ++ G                   G D  
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 254 EENAC----SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK 309
              A      YI  +    L S  FS  F   V  CL ++  +R     L+ HAF K++ 
Sbjct: 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332
Query: 310 KCSVMLPELLRPALSLNE 327
              V     L   + LN+
Sbjct: 333 AEEVDFAGWLCSTIGLNQ 350

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F  
Sbjct: 44  GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKA 490
             ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K   +HR VK 
Sbjct: 103 DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           S+IL++  G+  L      C F  + + +     S     +++SPE L+     Y  +SD
Sbjct: 161 SNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSD 212
Query: 551 IYSVGISCCELANGTVPF 568
           I+S+G+S  E+A G  P 
Sbjct: 213 IWSMGLSLVEMAVGRYPI 230

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIK 192
Query: 199 SDIYSVGISCCELAN-GTVPF 218
           SD+++ G+   E+A  G  P+
Sbjct: 193 SDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIK 192
Query: 549 SDIYSVGISCCELAN-GTVPF 568
           SD+++ G+   E+A  G  P+
Sbjct: 193 SDVWAFGVLLWEIATYGMSPY 213

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 176 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 234
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 235 MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 292
Query: 152 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 195
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 293 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 335
Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 336 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 374

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 176 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 234
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 235 MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 292
Query: 502 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 545
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 293 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 335
Query: 546 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 336 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 374

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 111
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 112 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 166
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 167 DFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 225
Query: 215 TVPFA 219
            +P++
Sbjct: 226 QLPYS 230

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 111
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 112 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 166
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 167 DFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 225
Query: 565 TVPFA 569
            +P++
Sbjct: 226 QLPYS 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 91
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 92  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 146
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 147 DFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 215 TVPFA 219
            +P++
Sbjct: 206 QLPYS 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 91
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 92  HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 146
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 147 DFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 565 TVPFA 569
            +P++
Sbjct: 206 QLPYS 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
                VY+   K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
               ++V+  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 159
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 160 NCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYNT--FSIK 211
Query: 199 SDIYSVGISCCELAN-GTVPF 218
           SD+++ G+   E+A  G  P+
Sbjct: 212 SDVWAFGVLLWEIATYGMSPY 232

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
                VY+   K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
               ++V+  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 159
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 160 NCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYNT--FSIK 211
Query: 549 SDIYSVGISCCELAN-GTVPF 568
           SD+++ G+   E+A  G  P+
Sbjct: 212 SDVWAFGVLLWEIATYGMSPY 232

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRH 69
           ++I   +G+   +   V + +   T ++ A+K  N  +  +  +++++  E+  M+ L H
Sbjct: 17  FEILRAIGK--GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLNGLEY 127
           P ++    SF D  D+ +V  L+  G  +  +  N HF     +L IC ++      L+Y
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM----ALDY 130
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +  +  IHR +K  +IL+  +G   ++    +    P + ++     +  Y    ++PE+
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFN-IAAMLPRETQITTMAGTKPY----MAPEM 185
Query: 188 L-EQNLDGYDERSDIYSVGISCCELANGTVPF 218
              +   GY    D +S+G++  EL  G  P+
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRH 419
           ++I   +G+   +   V + +   T ++ A+K  N  +  +  +++++  E+  M+ L H
Sbjct: 17  FEILRAIGK--GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLNGLEY 477
           P ++    SF D  D+ +V  L+  G  +  +  N HF     +L IC ++      L+Y
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM----ALDY 130
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +  +  IHR +K  +IL+  +G   ++    +    P + ++     +  Y    ++PE+
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFN-IAAMLPRETQITTMAGTKPY----MAPEM 185
Query: 538 L-EQNLDGYDERSDIYSVGISCCELANGTVPF 568
              +   GY    D +S+G++  EL  G  P+
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 119
Query: 99  ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 155
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 120 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 174
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 214
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 175 DFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233
Query: 215 TVPFA 219
            +P++
Sbjct: 234 QLPYS 238

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK  N+   T + L++  +E+  +R  RH NI+ ++  +     L +V+      S  
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTKPQLAIVTQWCEGSSLY 119
Query: 449 ---DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG 505
               +I   F      + +  I +    G++Y+H K  IHR +K+++I + H       G
Sbjct: 120 HHLHIIETKFEM----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIG 174
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANG 564
              +          H F   +   L W++PEV+  Q+ + Y  +SD+Y+ GI   EL  G
Sbjct: 175 DFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233
Query: 565 TVPFA 569
            +P++
Sbjct: 234 QLPYS 238

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 220
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 221 MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278
Query: 152 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 195
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 321
Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 220
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 221 MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278
Query: 502 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 545
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 321
Query: 546 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/296 (22%), Positives = 121/296 (40%), Gaps = 56/296 (18%)
Query: 24  LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
              V+L + + +     +K  N DR +   ++ +  EI  ++ L HPNII     F D  
Sbjct: 35  FGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++++V      G   + I +    G  L E  +  +++ ++N L Y H +  +H+ +K  
Sbjct: 94  NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153
Query: 142 HILISHNGKACLSGLRYMCPFSPTK----KKVHLFPP-----STAYNLNWLSPEVLEQNL 192
           +IL                P SP K        LF       + A    +++PEV ++++
Sbjct: 154 NILFQDT-----------SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 193 DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDD 252
                + DI+S G+    L  G +PF  T T+L  +++ A               T ++ 
Sbjct: 203 TF---KCDIWSAGVVMYFLLTGCLPF--TGTSLEEVQQKA---------------TYKEP 242
Query: 253 GEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT 308
                C  ++ Q   +L                L++D ++RP A  +L H +FKQ 
Sbjct: 243 NYAVECRPLTPQAVDLLKQ-------------MLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 374 LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
              V+L + + +     +K  N DR +   ++ +  EI  ++ L HPNII     F D  
Sbjct: 35  FGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++++V      G   + I +    G  L E  +  +++ ++N L Y H +  +H+ +K  
Sbjct: 94  NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153
Query: 492 HILISHNGKACLSGLRYMCPFSPTK----KKVHLFPP-----STAYNLNWLSPEVLEQNL 542
           +IL                P SP K        LF       + A    +++PEV ++++
Sbjct: 154 NILFQDT-----------SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 543 DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA 582
                + DI+S G+    L  G +PF  T T+L  +++ A
Sbjct: 203 TF---KCDIWSAGVVMYFLLTGCLPF--TGTSLEEVQQKA 237

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 119/300 (39%), Gaps = 36/300 (12%)
Query: 4   LDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHH 59
           L NV +N+  +  S+ G          + K  V N  +AVKK    +D  T+E  +    
Sbjct: 14  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 73
Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPEL---VICH 116
           EI  M   +H N++  +    D  DL LV   M  GS  D ++     G P L   + C 
Sbjct: 74  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCK 131
Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPP 174
           I Q   NG+ ++H    IHR +K+++IL+     A +S  GL                  
Sbjct: 132 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVG 191
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +TAY    ++PE L   +     +SDIYS G+   E+  G +P  +      L+  +   
Sbjct: 192 TTAY----MAPEALRGEI---TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEE 243
Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                     Y+D   +D +  +                  ++ +S+   CL    +KRP
Sbjct: 244 IEDEEKTIEDYIDKKMNDADSTSV-----------------EAMYSVASQCLHEKKNKRP 286

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 20/233 (8%)
Query: 343 INDT-FNS-SVETLDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--L 396
           ++DT F+S S   L NV +N+  +  S+ G          + K  V N  +AVKK    +
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV 60
Query: 397 DRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN 456
           D  T+E  +    EI  M   +H N++  +    D  DL LV   M  GS  D ++    
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD- 119
Query: 457 FGLPEL---VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCP 511
            G P L   + C I Q   NG+ ++H    IHR +K+++IL+     A +S  GL     
Sbjct: 120 -GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
                        +TAY    ++PE L   +     +SDIYS G+   E+  G
Sbjct: 179 KFAQXVMXXRIVGTTAY----MAPEALRGEI---TPKSDIYSFGVVLLEIITG 224

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP------IKWTAPESLAYN--KFSIK 190
Query: 199 SDIYSVGISCCELAN-GTVPF 218
           SD+++ G+   E+A  G  P+
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
               ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP------IKWTAPESLAYN--KFSIK 190
Query: 549 SDIYSVGISCCELAN-GTVPF 568
           SD+++ G+   E+A  G  P+
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 20/232 (8%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 67
            +Y +   LG        V + +H++T   +AVK  N  ++   D+   +  EI  ++  
Sbjct: 11  GHYVLGDTLG--VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           RHP+II         TD  +V   +  G   D I  H    + E+    + Q +L+ ++Y
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDY 126
Query: 128 IHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            H    +HR +K  ++L+    N K    GL  M            F  ++  + N+ +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGSPNYAAP 179
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE--TPTTLMLIEKLAGAT 235
           EV+   L    E  DI+S G+    L  GT+PF +   PT   L +K+ G  
Sbjct: 180 EVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGV 227

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 20/232 (8%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 417
            +Y +   LG        V + +H++T   +AVK  N  ++   D+   +  EI  ++  
Sbjct: 11  GHYVLGDTLG--VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           RHP+II         TD  +V   +  G   D I  H    + E+    + Q +L+ ++Y
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDY 126
Query: 478 IHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            H    +HR +K  ++L+    N K    GL  M            F  ++  + N+ +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGSPNYAAP 179
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE--TPTTLMLIEKLAGAT 585
           EV+   L    E  DI+S G+    L  GT+PF +   PT   L +K+ G  
Sbjct: 180 EVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGV 227

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 40  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 96
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 97  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 156
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 157 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 208
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 209 WAFGVLLWEIATYGMSPY 226

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 40  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 96
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 97  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 156
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 157 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 208
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 209 WAFGVLLWEIATYGMSPY 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 85
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 145
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 146 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 197
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 85
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 145
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 146 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 197
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 88  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 148 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 199
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 200 WAFGVLLWEIATYGMSPY 217

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 88  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 148 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 199
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 200 WAFGVLLWEIATYGMSPY 217

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 95
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 96  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 152 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 195
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 196
Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 95
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 96  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 502 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 545
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 196
Query: 546 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 95
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 96  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 152 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 195
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 196
Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 95
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 96  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 502 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 545
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 196
Query: 546 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 36  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 94
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 95  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 152
Query: 152 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 195
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 153 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 195
Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 196 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 234

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 36  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 94
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 95  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 152
Query: 502 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 545
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 153 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 195
Query: 546 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 196 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 234

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 95
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 96  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 152 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 195
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 196
Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 95
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 96  MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 502 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 545
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 154 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 196
Query: 546 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           +   D +S+G+      +G  PF+E  T + L +++   
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +         +
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L+ 
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352
Query: 147 HNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
            N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+++
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDVWA 404
Query: 204 VGISCCELAN-GTVPF 218
            G+   E+A  G  P+
Sbjct: 405 FGVLLWEIATYGMSPY 420

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +         +
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L+ 
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352
Query: 497 HNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
            N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+++
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDVWA 404
Query: 554 VGISCCELAN-GTVPF 568
            G+   E+A  G  P+
Sbjct: 405 FGVLLWEIATYGMSPY 420

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 85
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 145
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 146 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 197
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 85
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            ++++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 145
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 146 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 197
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 198 WAFGVLLWEIATYGMSPY 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 13  ICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN 71
           +  ILG+  F ++    L +   T+  +AVK   LD  +  +++    E  CM+   HPN
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 72  IICYISSFLDATDLHL-----VSPLMGFGSCKD-LINAHFNFG---LPELVICHILQDVL 122
           +I  +   ++ +   +     + P M +G     L+ +    G   +P   +   + D+ 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK----------KVHLF 172
            G+EY+  + F+HR + A + ++  +   C++       F  +KK          ++   
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD------FGLSKKIYSGDYYRQGRIAKM 211
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA-NGTVPF 218
           P      + W++ E L   +  Y  +SD+++ G++  E+A  G  P+
Sbjct: 212 P------VKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 363 ICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN 421
           +  ILG+  F ++    L +   T+  +AVK   LD  +  +++    E  CM+   HPN
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 422 IICYISSFLDATDLHL-----VSPLMGFGSCKD-LINAHFNFG---LPELVICHILQDVL 472
           +I  +   ++ +   +     + P M +G     L+ +    G   +P   +   + D+ 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK----------KVHLF 522
            G+EY+  + F+HR + A + ++  +   C++       F  +KK          ++   
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD------FGLSKKIYSGDYYRQGRIAKM 211
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA-NGTVPF 568
           P      + W++ E L   +  Y  +SD+++ G++  E+A  G  P+
Sbjct: 212 P------VKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 43  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 101
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 102 MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 159
Query: 152 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 195
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 160 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 202
Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 231
           +   D +S+G+      +G  PF+E  T + L +++
Sbjct: 203 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 238

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLK-SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           KV  ++I+ +KF +    + D   ++  EI  ++ L HP II  I +F DA D ++V  L
Sbjct: 43  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-KIKNFFDAEDYYIVLEL 101
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           M  G   D +    N  L E         +L  ++Y+H  G IHR +K  ++L+S   + 
Sbjct: 102 MEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 159
Query: 502 CL---------------SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGY 545
           CL               S +R +C  +PT                +L+PEVL      GY
Sbjct: 160 CLIKITDFGHSKILGETSLMRTLCG-TPT----------------YLAPEVLVSVGTAGY 202
Query: 546 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           +   D +S+G+      +G  PF+E  T + L +++
Sbjct: 203 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 238

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 15/214 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---DEDLKSLHHEIVCMR 65
             Y+    LG+     ++VY ++ K TNQ++A+KK  L   +   D   ++   EI  ++
Sbjct: 10  KRYEKLDFLGE--GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L HPNII  + +F   +++ LV   M     + +I  +     P  +  ++L   L GL
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM-TLQGL 125
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTAYNLNWLS 184
           EY+H    +HR +K +++L+  NG   L+       F SP +   H           + +
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH-----QVVTRWYRA 180
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PE+L      Y    D+++VG    EL    VPF
Sbjct: 181 PELLF-GARMYGVGVDMWAVGCILAELLL-RVPF 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 15/214 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---DEDLKSLHHEIVCMR 415
             Y+    LG+     ++VY ++ K TNQ++A+KK  L   +   D   ++   EI  ++
Sbjct: 10  KRYEKLDFLGE--GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            L HPNII  + +F   +++ LV   M     + +I  +     P  +  ++L   L GL
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM-TLQGL 125
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTAYNLNWLS 534
           EY+H    +HR +K +++L+  NG   L+       F SP +   H           + +
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH-----QVVTRWYRA 180
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE+L      Y    D+++VG    EL    VPF
Sbjct: 181 PELLF-GARMYGVGVDMWAVGCILAELLL-RVPF 212

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 109/241 (45%), Gaps = 27/241 (11%)
Query: 12  KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN 71
           +I  ++G+       VY   H   +  +A++  +++R  ++ LK+   E++  R  RH N
Sbjct: 36  EIGELIGK--GRFGQVY---HGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 72  IICYISSFLDATDLHLVSPLMGFGSCKDLI-NAHFNFGLPELVICHILQDVLNGLEYIHG 130
           ++ ++ + +    L +++ L    +   ++ +A     + +     I Q+++ G+ Y+H 
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK--TRQIAQEIVKGMGYLHA 148
Query: 131 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKV-----------HLFPPSTA 177
           KG +H+ +K+ ++    NGK  ++  GL  +       ++            HL P    
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI-- 205
Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH 237
             +  LSP+  E  L  + + SD++++G    EL     PF   P   ++ +   G  P+
Sbjct: 206 --IRQLSPDTEEDKLP-FSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262
Query: 238 L 238
           L
Sbjct: 263 L 263

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 109/241 (45%), Gaps = 27/241 (11%)
Query: 362 KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN 421
           +I  ++G+       VY   H   +  +A++  +++R  ++ LK+   E++  R  RH N
Sbjct: 36  EIGELIGK--GRFGQVY---HGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 422 IICYISSFLDATDLHLVSPLMGFGSCKDLI-NAHFNFGLPELVICHILQDVLNGLEYIHG 480
           ++ ++ + +    L +++ L    +   ++ +A     + +     I Q+++ G+ Y+H 
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK--TRQIAQEIVKGMGYLHA 148
Query: 481 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKV-----------HLFPPSTA 527
           KG +H+ +K+ ++    NGK  ++  GL  +       ++            HL P    
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI-- 205
Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH 587
             +  LSP+  E  L  + + SD++++G    EL     PF   P   ++ +   G  P+
Sbjct: 206 --IRQLSPDTEEDKLP-FSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262
Query: 588 L 588
           L
Sbjct: 263 L 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
               +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIK 190
Query: 199 SDIYSVGISCCELAN-GTVPF 218
           SD+++ G+   E+A  G  P+
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY 211

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
                VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +     
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
               +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A 
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           + L+  N   K    GL R M   + T      FP      + W +PE L  N   +  +
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIK 190
Query: 549 SDIYSVGISCCELAN-GTVPF 568
           SD+++ G+   E+A  G  P+
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY 211

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 18/229 (7%)
Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
           N+   +    +LG      S V+L K ++T +L A+K         +   SL +EI  ++
Sbjct: 6   NIRKTFIFMEVLGS--GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLK 61
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            ++H NI+     +   T  +LV  L+  G   D I     +   +  +  ++Q VL+ +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQVLSAV 119
Query: 126 EYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           +Y+H  G +HR +K  ++L      N K  ++       F  +K + +    +      +
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITD------FGLSKMEQNGIMSTACGTPGY 173
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 231
           ++PEVL Q    Y +  D +S+G+    L  G  PF E  T   L EK+
Sbjct: 174 VAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEE-TESKLFEKI 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 18/229 (7%)
Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
           N+   +    +LG      S V+L K ++T +L A+K         +   SL +EI  ++
Sbjct: 6   NIRKTFIFMEVLGS--GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLK 61
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            ++H NI+     +   T  +LV  L+  G   D I     +   +  +  ++Q VL+ +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQVLSAV 119
Query: 476 EYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           +Y+H  G +HR +K  ++L      N K  ++       F  +K + +    +      +
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITD------FGLSKMEQNGIMSTACGTPGY 173
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           ++PEVL Q    Y +  D +S+G+    L  G  PF E  T   L EK+
Sbjct: 174 VAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEE-TESKLFEKI 219

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 20/232 (8%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 67
            +Y +   LG        V + +H++T   +AVK  N  ++   D+   +  EI  ++  
Sbjct: 11  GHYVLGDTLG--VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           RHP+II         TD  +V   +  G   D I  H    + E+    + Q +L+ ++Y
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDY 126
Query: 128 IHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            H    +HR +K  ++L+    N K    GL  M            F   +  + N+ +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRDSCGSPNYAAP 179
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE--TPTTLMLIEKLAGAT 235
           EV+   L    E  DI+S G+    L  GT+PF +   PT   L +K+ G  
Sbjct: 180 EVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGV 227

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 20/232 (8%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 417
            +Y +   LG        V + +H++T   +AVK  N  ++   D+   +  EI  ++  
Sbjct: 11  GHYVLGDTLG--VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           RHP+II         TD  +V   +  G   D I  H    + E+    + Q +L+ ++Y
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDY 126
Query: 478 IHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            H    +HR +K  ++L+    N K    GL  M            F   +  + N+ +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRDSCGSPNYAAP 179
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE--TPTTLMLIEKLAGAT 585
           EV+   L    E  DI+S G+    L  GT+PF +   PT   L +K+ G  
Sbjct: 180 EVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGV 227

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 91
           HK +NQ  AVK  +  RM     K +    +C  H   PNI+     F D     LV  L
Sbjct: 32  HKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGH---PNIVKLHEVFHDQLHTFLVMEL 87
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-- 149
           +  G   + I    +F   E    +I++ +++ + ++H  G +HR +K  ++L +     
Sbjct: 88  LNGGELFERIKKKKHFS--ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDN 145
Query: 150 ---KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              K    G   + P  P  + +     +  + L++ +PE+L QN  GYDE  D++S+G+
Sbjct: 146 LEIKIIDFGFARLKP--PDNQPL----KTPCFTLHYAAPELLNQN--GYDESCDLWSLGV 197
Query: 207 SCCELANGTVPFAETPTTL 225
               + +G VPF     +L
Sbjct: 198 ILYTMLSGQVPFQSHDRSL 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPL 441
           HK +NQ  AVK  +  RM     K +    +C  H   PNI+     F D     LV  L
Sbjct: 32  HKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGH---PNIVKLHEVFHDQLHTFLVMEL 87
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-- 499
           +  G   + I    +F   E    +I++ +++ + ++H  G +HR +K  ++L +     
Sbjct: 88  LNGGELFERIKKKKHFS--ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDN 145
Query: 500 ---KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              K    G   + P  P  + +     +  + L++ +PE+L QN  GYDE  D++S+G+
Sbjct: 146 LEIKIIDFGFARLKP--PDNQPL----KTPCFTLHYAAPELLNQN--GYDESCDLWSLGV 197
Query: 557 SCCELANGTVPFAETPTTL 575
               + +G VPF     +L
Sbjct: 198 ILYTMLSGQVPFQSHDRSL 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           +H  + Q+ AVK+      + E  + L    +  R +  P  + +  +     D+ +   
Sbjct: 54  RHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE 113
Query: 91  LMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH 147
           L    S         + G  +PE ++  I   ++  LE++H K   IHR VK S++LI+ 
Sbjct: 114 LXD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 172
Query: 148 NG--KACLSGLR-YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
            G  K C  G+  Y+             P      +N   PE+   N  GY  +SDI+S+
Sbjct: 173 LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERIN---PEL---NQKGYSVKSDIWSL 226
Query: 205 GISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ 264
           GI+  ELA    P+    T    +++                              + E+
Sbjct: 227 GITXIELAILRFPYDSWGTPFQQLKQ------------------------------VVEE 256
Query: 265 QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
            +  L + KFS  F      CL ++  +RP    L QH FF
Sbjct: 257 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           +H  + Q+ AVK+      + E  + L    +  R +  P  + +  +     D+ +   
Sbjct: 54  RHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE 113
Query: 441 LMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH 497
           L    S         + G  +PE ++  I   ++  LE++H K   IHR VK S++LI+ 
Sbjct: 114 LXD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 172
Query: 498 NG--KACLSGLR-YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
            G  K C  G+  Y+             P      +N   PE+   N  GY  +SDI+S+
Sbjct: 173 LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERIN---PEL---NQKGYSVKSDIWSL 226
Query: 555 GISCCELANGTVPFAETPTTLMLIEKL 581
           GI+  ELA    P+    T    ++++
Sbjct: 227 GITXIELAILRFPYDSWGTPFQQLKQV 253

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 17/235 (7%)
Query: 16  ILGQCFN--NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRHPNI 72
           ILG          V + KH++T   +AVK  N  ++   D+   +  EI  ++  RHP+I
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 73  ICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG 132
           I         +D+ +V   +  G   D I    N  L E     + Q +L+G++Y H   
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 133 FIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
            +HR +K  ++L+    N K    GL  M            F   +  + N+ +PEV+  
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRXSCGSPNYAAPEVISG 189
Query: 191 NLDGYDERSDIYSVGISCCELANGTVPFAE--TPTTLMLIEKLAGATPHLLDCTT 243
            L    E  DI+S G+    L  GT+PF +   PT    I      TP  L+ + 
Sbjct: 190 RLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 17/235 (7%)
Query: 366 ILGQCFN--NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRHPNI 422
           ILG          V + KH++T   +AVK  N  ++   D+   +  EI  ++  RHP+I
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 423 ICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG 482
           I         +D+ +V   +  G   D I    N  L E     + Q +L+G++Y H   
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 483 FIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
            +HR +K  ++L+    N K    GL  M            F   +  + N+ +PEV+  
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRXSCGSPNYAAPEVISG 189
Query: 541 NLDGYDERSDIYSVGISCCELANGTVPFAE--TPTTLMLIEKLAGATPHLLDCTT 593
            L    E  DI+S G+    L  GT+PF +   PT    I      TP  L+ + 
Sbjct: 190 RLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 84
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 85  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 144
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 145 VGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 196
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 197 WAFGVLLWEIATYGMSPY 214

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 84
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 85  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 144
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 145 VGENHLVKVADFGLSRLMTGDTXTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 196
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 197 WAFGVLLWEIATYGMSPY 214

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 195
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 196 WAFGVLLWEIATYGMSPY 213

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 37  QLIAVKKFNLDRMTDEDL------KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           ++I   +F+  R +D++       + +++EI  ++ L HPNII     F D    +LV+ 
Sbjct: 67  KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 91  LMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-- 147
               G   + +IN H      E    +I++ +L+G+ Y+H    +HR +K  +IL+ +  
Sbjct: 127 FYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 148 ---NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
              N K    GL     FS   K        TAY   +++PEVL++    Y+E+ D++S 
Sbjct: 184 SLLNIKIVDFGLSSF--FSKDYKLRDRL--GTAY---YIAPEVLKKK---YNEKCDVWSC 233
Query: 205 GISCCELANGTVPFA 219
           G+    L  G  PF 
Sbjct: 234 GVIMYILLCGYPPFG 248

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 387 QLIAVKKFNLDRMTDEDL------KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           ++I   +F+  R +D++       + +++EI  ++ L HPNII     F D    +LV+ 
Sbjct: 67  KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 441 LMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-- 497
               G   + +IN H      E    +I++ +L+G+ Y+H    +HR +K  +IL+ +  
Sbjct: 127 FYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 498 ---NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
              N K    GL     FS   K        TAY   +++PEVL++    Y+E+ D++S 
Sbjct: 184 SLLNIKIVDFGLSSF--FSKDYKLRDRL--GTAY---YIAPEVLKKK---YNEKCDVWSC 233
Query: 555 GISCCELANGTVPFA 569
           G+    L  G  PF 
Sbjct: 234 GVIMYILLCGYPPFG 248

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 145 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 202 YSVGISCCELAN-GTVPF 218
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             VY    K  +  +AVK    D M   +++    E   M+ ++HPN++  +        
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 88
Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            +++   M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L
Sbjct: 89  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 148
Query: 495 ISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +  N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+
Sbjct: 149 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDV 200
Query: 552 YSVGISCCELAN-GTVPF 568
           ++ G+   E+A  G  P+
Sbjct: 201 WAFGVLLWEIATYGMSPY 218

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 15/196 (7%)
Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY    K  +  +AVK    D M  E+      E   M+ ++HPN++  +         +
Sbjct: 275 VYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTREPPFY 331
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           +++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L+ 
Sbjct: 332 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 391
Query: 147 HNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
            N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+++
Sbjct: 392 ENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDVWA 443
Query: 204 VGISCCELAN-GTVPF 218
            G+   E+A  G  P+
Sbjct: 444 FGVLLWEIATYGMSPY 459

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 15/196 (7%)
Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY    K  +  +AVK    D M  E+      E   M+ ++HPN++  +         +
Sbjct: 275 VYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGVCTREPPFY 331
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           +++  M +G+  D +       +  +V+ ++   + + +EY+  K FIHR + A + L+ 
Sbjct: 332 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 391
Query: 497 HNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
            N   K    GL R M   + T      FP      + W +PE L  N   +  +SD+++
Sbjct: 392 ENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLAYN--KFSIKSDVWA 443
Query: 554 VGISCCELAN-GTVPF 568
            G+   E+A  G  P+
Sbjct: 444 FGVLLWEIATYGMSPY 459

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 77/336 (22%), Positives = 134/336 (39%), Gaps = 33/336 (9%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           +++  S LG    N   V   +H+ +  ++A K  +L+ +       +  E+  +     
Sbjct: 17  DFERISELGA--GNGGVVTKVQHRPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNS 73
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   VL GL Y+ 
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLR 131
Query: 130 GK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
            K   +HR VK S+IL++  G+  L      C F  + + +     S     ++++PE L
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMAPERL 185
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG--------ATPHLLD 240
           +     Y  +SDI+S+G+S  ELA G  P    P     +E + G          PH + 
Sbjct: 186 QGT--HYSVQSDIWSMGLSLVELAVGRYPIP--PPDAKELEAIFGRPVVDGEEGEPHSIS 241
Query: 241 CTTYYVDT-----GQDDGEENAC----SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVD 291
                        G D     A      YI  +    L +  F+  F   V  CL ++  
Sbjct: 242 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPA 301
Query: 292 KRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNE 327
           +R     L  H F K+++   V     L   L LN+
Sbjct: 302 ERADLKMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQ 337

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +++  S LG    N   V   +H+ +  ++A K  +L+ +       +  E+  +     
Sbjct: 17  DFERISELGA--GNGGVVTKVQHRPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNS 73
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   VL GL Y+ 
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLR 131
Query: 480 GK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
            K   +HR VK S+IL++  G+  L      C F  + + +     S     ++++PE L
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMAPERL 185
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +     Y  +SDI+S+G+S  ELA G  P 
Sbjct: 186 QGT--HYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 50/311 (16%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHH----EI 61
            NY+   ILG+  +  S V    HK T +  AVK  ++      + E+++ L      E+
Sbjct: 17  ENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 62  VCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
             +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ 
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRA 132
Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           +L  +  +H    +HR +K  +IL+  +    L+   + C   P +K       S     
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-----RSVCGTP 187
Query: 181 NWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP 236
           ++L+PE++E     N  GY +  D++S G+    L  G+ PF      LML   ++G   
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--- 244
Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
                  Y   + + D                     +SD+   +V   L     KR  A
Sbjct: 245 ------NYQFGSPEWD--------------------DYSDTVKDLVSRFLVVQPQKRYTA 278
Query: 297 CNLLQHAFFKQ 307
              L H FF+Q
Sbjct: 279 EEALAHPFFQQ 289

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 111/259 (42%), Gaps = 29/259 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHH----EI 411
            NY+   ILG+  +  S V    HK T +  AVK  ++      + E+++ L      E+
Sbjct: 17  ENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 412 VCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
             +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ 
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRA 132
Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           +L  +  +H    +HR +K  +IL+  +    L+   + C   P +K       S     
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-----RSVCGTP 187
Query: 531 NWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG--- 583
           ++L+PE++E     N  GY +  D++S G+    L  G+ PF      LML   ++G   
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247
Query: 584 -ATPHLLDCTTYYVDTGQD 601
             +P   D    Y DT +D
Sbjct: 248 FGSPEWDD----YSDTVKD 262

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
             V L K K+T    A+K      +T   +  +L  E+  ++ L HPNI+     F D  
Sbjct: 18  GEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR 77
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           + +LV  +   G   D I     F   E+    I++ VL+G  Y+H    +HR +K  ++
Sbjct: 78  NYYLVMEVYRGGELFDEIILRQKF--SEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENL 135
Query: 144 LISHNGKACL-----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           L+    +  L      GL          K+       TAY   +++PEVL +    YDE+
Sbjct: 136 LLESKSRDALIKIVDFGLSAHFEVGGKMKE----RLGTAY---YIAPEVLRKK---YDEK 185
Query: 199 SDIYSVGISCCELANGTVPFA 219
            D++S G+    L  G  PF 
Sbjct: 186 CDVWSCGVILYILLCGYPPFG 206

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
             V L K K+T    A+K      +T   +  +L  E+  ++ L HPNI+     F D  
Sbjct: 18  GEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR 77
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           + +LV  +   G   D I     F   E+    I++ VL+G  Y+H    +HR +K  ++
Sbjct: 78  NYYLVMEVYRGGELFDEIILRQKF--SEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENL 135
Query: 494 LISHNGKACL-----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           L+    +  L      GL          K+       TAY   +++PEVL +    YDE+
Sbjct: 136 LLESKSRDALIKIVDFGLSAHFEVGGKMKE----RLGTAY---YIAPEVLRKK---YDEK 185
Query: 549 SDIYSVGISCCELANGTVPFA 569
            D++S G+    L  G  PF 
Sbjct: 186 CDVWSCGVILYILLCGYPPFG 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 124/312 (39%), Gaps = 52/312 (16%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHH----EI 61
            NY+   ILG+  +  S V    HK T +  AVK  ++      + E+++ L      E+
Sbjct: 4   ENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 61
Query: 62  VCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
             +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ 
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRA 119
Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL-FPPSTAYN 179
           +L  +  +H    +HR +K  +IL+  +    L+   + C   P +K   +   PS    
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS---- 175
Query: 180 LNWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 235
             +L+PE++E     N  GY +  D++S G+    L  G+ PF      LML   ++G  
Sbjct: 176 --YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 231
Query: 236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL 295
                   Y   + + D                     +SD+   +V   L     KR  
Sbjct: 232 -------NYQFGSPEWD--------------------DYSDTVKDLVSRFLVVQPQKRYT 264
Query: 296 ACNLLQHAFFKQ 307
           A   L H FF+Q
Sbjct: 265 AEEALAHPFFQQ 276

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHH----EI 411
            NY+   ILG+  +  S V    HK T +  AVK  ++      + E+++ L      E+
Sbjct: 4   ENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 61
Query: 412 VCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
             +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ 
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRA 119
Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL-FPPSTAYN 529
           +L  +  +H    +HR +K  +IL+  +    L+   + C   P +K   +   PS    
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS---- 175
Query: 530 LNWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-- 583
             +L+PE++E     N  GY +  D++S G+    L  G+ PF      LML   ++G  
Sbjct: 176 --YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 233
Query: 584 --ATPHLLDCTTYYVDTGQD 601
              +P   D    Y DT +D
Sbjct: 234 QFGSPEWDD----YSDTVKD 249

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 66
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 6   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 121
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 184
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 122 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 177
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 178 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 416
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 6   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 121
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 534
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 122 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 177
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 178 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 30/236 (12%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----DLH 86
           K ++ N+ +AVK F +    D+      +E+  +  ++H NI+ +I +    T    DL 
Sbjct: 42  KAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH----------GKGFIHR 136
           L++     GS  D + A+      EL  CHI + +  GL Y+H               HR
Sbjct: 99  LITAFHEKGSLSDFLKANV-VSWNEL--CHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155
Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKK--VHLFPPSTAYNLNWLSPEVLEQNLDG 194
            +K+ ++L+ +N  AC++       F   K     H    +  Y    ++PEVLE  ++ 
Sbjct: 156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY----MAPEVLEGAINF 211
Query: 195 YDE---RSDIYSVGISCCELANG-TVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 246
             +   R D+Y++G+   ELA+  T         ++  E+  G  P L D     V
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 30/236 (12%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----DLH 436
           K ++ N+ +AVK F +    D+      +E+  +  ++H NI+ +I +    T    DL 
Sbjct: 42  KAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH----------GKGFIHR 486
           L++     GS  D + A+      EL  CHI + +  GL Y+H               HR
Sbjct: 99  LITAFHEKGSLSDFLKANV-VSWNEL--CHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155
Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKK--VHLFPPSTAYNLNWLSPEVLEQNLDG 544
            +K+ ++L+ +N  AC++       F   K     H    +  Y    ++PEVLE  ++ 
Sbjct: 156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY----MAPEVLEGAINF 211
Query: 545 YDE---RSDIYSVGISCCELANG-TVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 596
             +   R D+Y++G+   ELA+  T         ++  E+  G  P L D     V
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 66
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 7   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 122
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 184
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 178
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 179 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 416
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 7   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 122
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 534
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 178
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 179 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 66
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 9   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 124
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 184
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 125 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 180
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 181 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 416
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 9   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 124
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 534
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 125 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 180
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 181 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
             V L K K+T    A+K      +T   +  +L  E+  ++ L HPNI+     F D  
Sbjct: 35  GEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR 94
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           + +LV  +   G   D I     F   E+    I++ VL+G  Y+H    +HR +K  ++
Sbjct: 95  NYYLVMEVYRGGELFDEIILRQKFS--EVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENL 152
Query: 144 LISHNGKACL-----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           L+    +  L      GL         K K  L    TAY   +++PEVL +    YDE+
Sbjct: 153 LLESKSRDALIKIVDFGLSAHFEVG-GKMKERL---GTAY---YIAPEVLRKK---YDEK 202
Query: 199 SDIYSVGISCCELANGTVPFA 219
            D++S G+    L  G  PF 
Sbjct: 203 CDVWSCGVILYILLCGYPPFG 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
             V L K K+T    A+K      +T   +  +L  E+  ++ L HPNI+     F D  
Sbjct: 35  GEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR 94
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           + +LV  +   G   D I     F   E+    I++ VL+G  Y+H    +HR +K  ++
Sbjct: 95  NYYLVMEVYRGGELFDEIILRQKFS--EVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENL 152
Query: 494 LISHNGKACL-----SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           L+    +  L      GL         K K  L    TAY   +++PEVL +    YDE+
Sbjct: 153 LLESKSRDALIKIVDFGLSAHFEVG-GKMKERL---GTAY---YIAPEVLRKK---YDEK 202
Query: 549 SDIYSVGISCCELANGTVPFA 569
            D++S G+    L  G  PF 
Sbjct: 203 CDVWSCGVILYILLCGYPPFG 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 19  QCFNN--LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL--KSLHHEIVCMRHLRHPNIIC 74
           QC        V+ +K+KV +   A+K+    R+ + +L  + +  E+  +  L HP I+ 
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 75  YISSFLDATDLHLVSP------------LMGFGSCKDLINAHFNFGLPELVIC-HILQDV 121
           Y +++L+      + P            L    + KD +N        E  +C HI   +
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
              +E++H KG +HR +K S+I  + +    +     +      +++  +  P  AY  +
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 182 --------WLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
                   ++SPE +  N   Y  + DI+S+G+   EL
Sbjct: 188 TGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 369 QCFNN--LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL--KSLHHEIVCMRHLRHPNIIC 424
           QC        V+ +K+KV +   A+K+    R+ + +L  + +  E+  +  L HP I+ 
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 425 YISSFLDATDLHLVSP------------LMGFGSCKDLINAHFNFGLPELVIC-HILQDV 471
           Y +++L+      + P            L    + KD +N        E  +C HI   +
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
              +E++H KG +HR +K S+I  + +    +     +      +++  +  P  AY  +
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 532 --------WLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
                   ++SPE +  N   Y  + DI+S+G+   EL
Sbjct: 188 TGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 53/295 (17%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           VG+   E+  G V F  T        +IE+L   +P  +      V T      EN   Y
Sbjct: 211 VGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV----ENRPKY 266
Query: 261 ISEQQTQVLTSRKF-SDSFHSIVELCLSRDV---------DKRPLACNLLQHAFF 305
                 ++     F +DS H+ ++   +RD+          KR      LQH + 
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLL 589
           VG+   E+  G V F  T        +IE+L   +P  +
Sbjct: 211 VGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 66
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 8   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 123
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 184
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 124 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 179
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 180 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 416
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 8   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALE 123
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLS 534
           Y+HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +S
Sbjct: 124 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VS 179
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE+L +      + SD++++G    +L  G  PF
Sbjct: 180 PELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 124/312 (39%), Gaps = 52/312 (16%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHH----EI 61
            NY+   ILG+  +  S V    HK T +  AVK  ++      + E+++ L      E+
Sbjct: 17  ENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 62  VCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
             +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ 
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRA 132
Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL-FPPSTAYN 179
           +L  +  +H    +HR +K  +IL+  +    L+   + C   P +K   +   PS    
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS---- 188
Query: 180 LNWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 235
             +L+PE++E     N  GY +  D++S G+    L  G+ PF      LML   ++G  
Sbjct: 189 --YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 244
Query: 236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL 295
                   Y   + + D                     +SD+   +V   L     KR  
Sbjct: 245 -------NYQFGSPEWD--------------------DYSDTVKDLVSRFLVVQPQKRYT 277
Query: 296 ACNLLQHAFFKQ 307
           A   L H FF+Q
Sbjct: 278 AEEALAHPFFQQ 289

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 112/260 (43%), Gaps = 31/260 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNL---DRMTDEDLKSLHH----EI 411
            NY+   ILG+  +  S V    HK T +  AVK  ++      + E+++ L      E+
Sbjct: 17  ENYEPKEILGRGVS--SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 412 VCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
             +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ 
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRA 132
Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL-FPPSTAYN 529
           +L  +  +H    +HR +K  +IL+  +    L+   + C   P +K   +   PS    
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS---- 188
Query: 530 LNWLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-- 583
             +L+PE++E     N  GY +  D++S G+    L  G+ PF      LML   ++G  
Sbjct: 189 --YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 584 --ATPHLLDCTTYYVDTGQD 601
              +P   D    Y DT +D
Sbjct: 247 QFGSPEWDD----YSDTVKD 262

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 53/295 (17%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           VG+   E+  G V F  T        +IE+L   +P  +      V T      EN   Y
Sbjct: 211 VGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV----ENRPKY 266
Query: 261 ISEQQTQVLTSRKF-SDSFHSIVELCLSRDV---------DKRPLACNLLQHAFF 305
                 ++     F +DS H+ ++   +RD+          KR      LQH + 
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLL 589
           VG+   E+  G V F  T        +IE+L   +P  +
Sbjct: 211 VGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVC 63
           PS +++  +LGQ   +   V+L K K++     QL A+K      +   D      E   
Sbjct: 23  PSQFELLKVLGQ--GSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           +  + HP I+    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 137
Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
            L+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY----M 193
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 239
           +PEV+  N  G+ + +D +S G+   E+  GT+PF   +   T+ +I K     P  L
Sbjct: 194 APEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVC 413
           PS +++  +LGQ   +   V+L K K++     QL A+K      +   D      E   
Sbjct: 23  PSQFELLKVLGQ--GSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           +  + HP I+    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 137
Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
            L+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY----M 193
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 589
           +PEV+  N  G+ + +D +S G+   E+  GT+PF   +   T+ +I K     P  L
Sbjct: 194 APEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVC 63
           PS +++  +LGQ   +   V+L K K++     QL A+K      +   D      E   
Sbjct: 24  PSQFELLKVLGQ--GSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           +  + HP I+    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 138
Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
            L+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 139 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY----M 194
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 239
           +PEV+  N  G+ + +D +S G+   E+  GT+PF   +   T+ +I K     P  L
Sbjct: 195 APEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 250

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVC 413
           PS +++  +LGQ   +   V+L K K++     QL A+K      +   D      E   
Sbjct: 24  PSQFELLKVLGQ--GSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           +  + HP I+    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 138
Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
            L+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 139 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY----M 194
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 589
           +PEV+  N  G+ + +D +S G+   E+  GT+PF   +   T+ +I K     P  L
Sbjct: 195 APEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 250

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVT----NQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
           PS +++  +LGQ   +   V+L K K++     QL A+K      +   D      E   
Sbjct: 23  PSQFELLKVLGQ--GSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           +  + HP I+    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 137
Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
            L+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY----M 193
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 239
           +PEV+  N  G+ + +D +S G+   E+  GT+PF   +   T+ +I K     P  L
Sbjct: 194 APEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVT----NQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
           PS +++  +LGQ   +   V+L K K++     QL A+K      +   D      E   
Sbjct: 23  PSQFELLKVLGQ--GSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           +  + HP I+    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 137
Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
            L+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY----M 193
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 589
           +PEV+  N  G+ + +D +S G+   E+  GT+PF   +   T+ +I K     P  L
Sbjct: 194 APEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKM 61
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKM 61
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 18/242 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 18  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 69  HPNIICYIS---SFLDATDLHLVSPLMGFGSCKD-----LINAHFNFGLPELVICHILQD 120
           H N++  I    +     +    S  + F  C+      L N    F L E  I  ++Q 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQM 133
Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        +    L
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGA-TP 236
            +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L G+ TP
Sbjct: 194 WYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITP 251
Query: 237 HL 238
            +
Sbjct: 252 EV 253

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 18/242 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 18  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 419 HPNIICYIS---SFLDATDLHLVSPLMGFGSCKD-----LINAHFNFGLPELVICHILQD 470
           H N++  I    +     +    S  + F  C+      L N    F L E  I  ++Q 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQM 133
Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        +    L
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGA-TP 586
            +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L G+ TP
Sbjct: 194 WYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITP 251
Query: 587 HL 588
            +
Sbjct: 252 EV 253

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 13/181 (7%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 92
           T +++AVK    D    +       EI  +R L H +II Y     DA    L LV   +
Sbjct: 59  TGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             GS +D +  H + GL +L++    Q +  G+ Y+H + +IHR + A ++L+ ++    
Sbjct: 118 PLGSLRDYLPRH-SIGLAQLLL--FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVK 174
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  E
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVF---WYAPECLKEYKFYY--ASDVWSFGVTLYE 229
Query: 211 L 211
           L
Sbjct: 230 L 230

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 13/181 (7%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDLHLVSPLM 442
           T +++AVK    D    +       EI  +R L H +II Y     DA    L LV   +
Sbjct: 59  TGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             GS +D +  H + GL +L++    Q +  G+ Y+H + +IHR + A ++L+ ++    
Sbjct: 118 PLGSLRDYLPRH-SIGLAQLLL--FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVK 174
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  E
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVF---WYAPECLKEYKFYY--ASDVWSFGVTLYE 229
Query: 561 L 561
           L
Sbjct: 230 L 230

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMXGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMXGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 68
           ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L 
Sbjct: 33  DFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HP  +    +F D   L+        G     I    +F   E        ++++ LEY+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD--ETCTRFYTAEIVSALEYL 148
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE+L
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSPELL 206
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +      + SD++++G    +L  G  PF
Sbjct: 207 TEK--SASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 418
           ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L 
Sbjct: 33  DFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 90
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HP  +    +F D   L+        G     I    +F   E        ++++ LEY+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD--ETCTRFYTAEIVSALEYL 148
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE+L
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSPELL 206
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +      + SD++++G    +L  G  PF
Sbjct: 207 TEK--SASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVC 63
           PS++++  +LGQ   +   V+L + KVT      L A+K      +   D      E   
Sbjct: 27  PSHFELLKVLGQ--GSFGKVFLVR-KVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           +  + HP ++    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 141
Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           GL+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 142 GLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEY----M 197
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 239
           +PEV+  N  G+   +D +S G+   E+  G++PF   +   T+ LI K     P  L
Sbjct: 198 APEVV--NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVC 413
           PS++++  +LGQ   +   V+L + KVT      L A+K      +   D      E   
Sbjct: 27  PSHFELLKVLGQ--GSFGKVFLVR-KVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           +  + HP ++    +F     L+L+   +  G     ++    F   E  +   L ++  
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 141
Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           GL+++H  G I+R +K  +IL+   G   L+           +KK + F  +  Y    +
Sbjct: 142 GLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEY----M 197
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLL 589
           +PEV+  N  G+   +D +S G+   E+  G++PF   +   T+ LI K     P  L
Sbjct: 198 APEVV--NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 18  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF------GLPELV--------I 114
           H N++  I            SP   +  CK  I   F+F      GL   V        I
Sbjct: 76  HENVVNLIEICRTKA-----SP---YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             ++Q +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKL 231
           +    L +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L
Sbjct: 188 NRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQL 245
Query: 232 AGA-TPHL 238
            G+ TP +
Sbjct: 246 CGSITPEV 253

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 18  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF------GLPELV--------I 464
           H N++  I            SP   +  CK  I   F+F      GL   V        I
Sbjct: 76  HENVVNLIEICRTKA-----SP---YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 524
             ++Q +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKL 581
           +    L +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L
Sbjct: 188 NRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQL 245
Query: 582 AGA-TPHL 588
            G+ TP +
Sbjct: 246 CGSITPEV 253

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 115/281 (40%), Gaps = 29/281 (10%)
Query: 36  NQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
            +  A+KK  L++  DE + S    EI  ++ L+H NI+           L LV   +  
Sbjct: 26  GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
              K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++LI+  G+  ++
Sbjct: 84  QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142
Query: 155 GLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
                  F  P +K  H         L + +P+VL      Y    DI+SVG    E+ N
Sbjct: 143 DFGLARAFGIPVRKYTH-----EVVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 214 GT--VPFAETPTTLMLIEKLAGA-----TPHLLDCTTYYVDTGQDDGEENACSYISEQQT 266
           GT   P       LM I ++ G       P++ +   Y         + N   Y      
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY---------DPNFTVYEPLPWE 247
Query: 267 QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             L  +   +S   ++   L  D ++R  A   L+HA+FK+
Sbjct: 248 SFL--KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 386 NQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
            +  A+KK  L++  DE + S    EI  ++ L+H NI+           L LV   +  
Sbjct: 26  GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
              K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++LI+  G+  ++
Sbjct: 84  QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142
Query: 505 GLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
                  F  P +K  H         L + +P+VL      Y    DI+SVG    E+ N
Sbjct: 143 DFGLARAFGIPVRKYTH-----EVVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 564 GT--VPFAETPTTLMLIEKLAGATPH 587
           GT   P       LM I ++ G TP+
Sbjct: 197 GTPLFPGVSEADQLMRIFRILG-TPN 221

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMXGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 18  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF------GLPELV--------I 114
           H N++  I            SP   +  CK  I   F+F      GL   V        I
Sbjct: 76  HENVVNLIEICRTKA-----SP---YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             ++Q +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKL 231
           +    L +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L
Sbjct: 188 NRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQL 245
Query: 232 AGA-TPHL 238
            G+ TP +
Sbjct: 246 CGSITPEV 253

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 18  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 75
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF------GLPELV--------I 464
           H N++  I            SP   +  CK  I   F+F      GL   V        I
Sbjct: 76  HENVVNLIEICRTKA-----SP---YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 524
             ++Q +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKL 581
           +    L +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L
Sbjct: 188 NRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQL 245
Query: 582 AGA-TPHL 588
            G+ TP +
Sbjct: 246 CGSITPEV 253

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 39  IAVKKFNLDRMTDEDL----KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           +AVK    D   DED+    +++  E      L+HPNII      L   +L LV   M F
Sbjct: 33  VAVKAARHD--PDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV---MEF 87
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF---IHRAVKASHILI---SHN 148
                L        +P  ++ +    +  G+ Y+H +     IHR +K+S+ILI     N
Sbjct: 88  ARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147
Query: 149 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 208
           G      L+ +  F   ++       S A    W++PEV+  ++  + + SD++S G+  
Sbjct: 148 GDLSNKILK-ITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLL 204
Query: 209 CELANGTVPF 218
            EL  G VPF
Sbjct: 205 WELLTGEVPF 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 389 IAVKKFNLDRMTDEDL----KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           +AVK    D   DED+    +++  E      L+HPNII      L   +L LV   M F
Sbjct: 33  VAVKAARHD--PDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV---MEF 87
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF---IHRAVKASHILI---SHN 498
                L        +P  ++ +    +  G+ Y+H +     IHR +K+S+ILI     N
Sbjct: 88  ARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147
Query: 499 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 558
           G      L+ +  F   ++       S A    W++PEV+  ++  + + SD++S G+  
Sbjct: 148 GDLSNKILK-ITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLL 204
Query: 559 CELANGTVPF 568
            EL  G VPF
Sbjct: 205 WELLTGEVPF 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 17  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF------GLPELV--------I 114
           H N++  I            SP   +  CK  I   F+F      GL   V        I
Sbjct: 75  HENVVNLIEICRTKA-----SP---YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             ++Q +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKL 231
           +    L +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L
Sbjct: 187 NRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQL 244
Query: 232 AGA-TPHL 238
            G+ TP +
Sbjct: 245 CGSITPEV 252

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 17  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF------GLPELV--------I 464
           H N++  I            SP   +  CK  I   F+F      GL   V        I
Sbjct: 75  HENVVNLIEICRTKA-----SP---YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 524
             ++Q +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKL 581
           +    L +  PE+L    D Y    D++  G    E+   + P  +  T    L LI +L
Sbjct: 187 NRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQL 244
Query: 582 AGA-TPHL 588
            G+ TP +
Sbjct: 245 CGSITPEV 252

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 220
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +L++  + + E  D++S GI    +  G +P+ +
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 114 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 168
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M PF  T+               + +PEV+     GY E  DI+S
Sbjct: 169 ILDFGLARTAGTSFMMVPFVVTR--------------YYRAPEVILGM--GYKENVDIWS 212
Query: 204 VGISCCELANGTVPFAET 221
           VG    E+  G V F  T
Sbjct: 213 VGCIMGEMIKGGVLFPGT 230

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 114 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 168
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M PF  T+               + +PEV+     GY E  DI+S
Sbjct: 169 ILDFGLARTAGTSFMMVPFVVTR--------------YYRAPEVILGM--GYKENVDIWS 212
Query: 554 VGISCCELANGTVPFAET 571
           VG    E+  G V F  T
Sbjct: 213 VGCIMGEMIKGGVLFPGT 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 5   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 59
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 117
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 175
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 176 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 5   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 59
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 117
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 175
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 176 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 176
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 6   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 60
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 118
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 176
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 177 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +V+ +K++ T++++A+K+  LD   +    S   EI  ++ L+H NI+           
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 85  LHLVSPLMGFGSCKDLINAHF---NFGL-PELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           L LV     F  C   +  +F   N  L PE+V   + Q +L GL + H +  +HR +K 
Sbjct: 76  LTLV-----FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ-LLKGLGFCHSRNVLHRDLKP 129
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN----WLSPEVLEQNLDGYD 196
            ++LI+ NG+  L+       F           P   Y+      W  P  +      Y 
Sbjct: 130 QNLLINRNGELKLADFGLARAFG---------IPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 197 ERSDIYSVGISCCELANGTVPF 218
              D++S G    ELAN   P 
Sbjct: 181 TSIDMWSAGCIFAELANAARPL 202

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            +V+ +K++ T++++A+K+  LD   +    S   EI  ++ L+H NI+           
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 435 LHLVSPLMGFGSCKDLINAHF---NFGL-PELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           L LV     F  C   +  +F   N  L PE+V   + Q +L GL + H +  +HR +K 
Sbjct: 76  LTLV-----FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ-LLKGLGFCHSRNVLHRDLKP 129
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN----WLSPEVLEQNLDGYD 546
            ++LI+ NG+  L+       F           P   Y+      W  P  +      Y 
Sbjct: 130 QNLLINRNGELKLADFGLARAFG---------IPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 547 ERSDIYSVGISCCELANGTVPF 568
              D++S G    ELAN   P 
Sbjct: 181 TSIDMWSAGCIFAELANAARPL 202

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 115/281 (40%), Gaps = 29/281 (10%)
Query: 36  NQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
            +  A+KK  L++  DE + S    EI  ++ L+H NI+           L LV   +  
Sbjct: 26  GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
              K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++LI+  G+  ++
Sbjct: 84  QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142
Query: 155 GLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
                  F  P +K  H         L + +P+VL      Y    DI+SVG    E+ N
Sbjct: 143 DFGLARAFGIPVRKYTH-----EIVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 214 GT--VPFAETPTTLMLIEKLAGA-----TPHLLDCTTYYVDTGQDDGEENACSYISEQQT 266
           GT   P       LM I ++ G       P++ +   Y         + N   Y      
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY---------DPNFTVYEPLPWE 247
Query: 267 QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             L  +   +S   ++   L  D ++R  A   L+HA+FK+
Sbjct: 248 SFL--KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 386 NQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
            +  A+KK  L++  DE + S    EI  ++ L+H NI+           L LV   +  
Sbjct: 26  GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
              K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++LI+  G+  ++
Sbjct: 84  QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142
Query: 505 GLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
                  F  P +K  H         L + +P+VL      Y    DI+SVG    E+ N
Sbjct: 143 DFGLARAFGIPVRKYTH-----EIVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 564 GT--VPFAETPTTLMLIEKLAGATPH 587
           GT   P       LM I ++ G TP+
Sbjct: 197 GTPLFPGVSEADQLMRIFRILG-TPN 221

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + 
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKM 61
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 115/271 (42%), Gaps = 44/271 (16%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           VG    E+  G V F  T        +IE+L   +P  +      V T      EN   Y
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV----ENRPKY 266
Query: 261 ISEQQTQVLTSRKF-SDSFHSIVELCLSRDV 290
                 ++     F +DS H+ ++   +RD+
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDL 297

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLL 589
           VG    E+  G V F  T        +IE+L   +P  +
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 9/211 (4%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 29  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 144
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE+
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSPEL 202
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           L +      + SD++++G    +L  G  PF
Sbjct: 203 LTEK--SACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 9/211 (4%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 29  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 144
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE+
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSPEL 202
Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           L +      + SD++++G    +L  G  PF
Sbjct: 203 LTEK--SACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 27/233 (11%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMR 65
            +++I   LG    +   V+L + +   +  A+K    + +    LK + H   E + + 
Sbjct: 6   QDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLS 61
Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            + HP II    +F DA  + ++   +  G    L+     F  P  V      +V   L
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLAL 119
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----N 181
           EY+H K  I+R +K  +IL+  NG   ++   +             + P   Y L    +
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----------YVPDVTYXLCGTPD 168
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +++PEV+  +   Y++  D +S GI   E+  G  PF ++  T+   EK+  A
Sbjct: 169 YIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNA 218

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 27/233 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMR 415
            +++I   LG    +   V+L + +   +  A+K    + +    LK + H   E + + 
Sbjct: 6   QDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLS 61
Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            + HP II    +F DA  + ++   +  G    L+     F  P  V      +V   L
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLAL 119
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----N 531
           EY+H K  I+R +K  +IL+  NG   ++   +             + P   Y L    +
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----------YVPDVTYXLCGTPD 168
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           +++PEV+  +   Y++  D +S GI   E+  G  PF ++  T+   EK+  A
Sbjct: 169 YIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNA 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 17  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 68
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 69  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 126
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 177
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 17  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 68
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 69  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 126
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 177
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 68
           ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L 
Sbjct: 34  DFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 91
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HP  +    +F D   L+        G     I    +F   E        ++++ LEY+
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEYL 149
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE+L
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSPELL 207
Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +      + SD++++G    +L  G  PF
Sbjct: 208 TEK--SACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 418
           ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L 
Sbjct: 34  DFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 91
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HP  +    +F D   L+        G     I    +F   E        ++++ LEY+
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEYL 149
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE+L
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSPELL 207
Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +      + SD++++G    +L  G  PF
Sbjct: 208 TEK--SACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 193 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGNMSPE---AFLQEAQVMKKLRHEKLV-Q 244
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 245 LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 302
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP------IKWTAPEAA-- 354
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 355 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 193 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGNMSPE---AFLQEAQVMKKLRHEKLV-Q 244
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 245 LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 302
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP------IKWTAPEAA-- 354
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 355 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +V+ +K++ T++++A+K+  LD   +    S   EI  ++ L+H NI+           
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 85  LHLVSPLMGFGSCKDLINAHF---NFGL-PELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           L LV     F  C   +  +F   N  L PE+V   + Q +L GL + H +  +HR +K 
Sbjct: 76  LTLV-----FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ-LLKGLGFCHSRNVLHRDLKP 129
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN----WLSPEVLEQNLDGYD 196
            ++LI+ NG+  L+       F           P   Y+      W  P  +      Y 
Sbjct: 130 QNLLINRNGELKLANFGLARAFG---------IPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 197 ERSDIYSVGISCCELANGTVPF 218
              D++S G    ELAN   P 
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            +V+ +K++ T++++A+K+  LD   +    S   EI  ++ L+H NI+           
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 435 LHLVSPLMGFGSCKDLINAHF---NFGL-PELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           L LV     F  C   +  +F   N  L PE+V   + Q +L GL + H +  +HR +K 
Sbjct: 76  LTLV-----FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ-LLKGLGFCHSRNVLHRDLKP 129
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN----WLSPEVLEQNLDGYD 546
            ++LI+ NG+  L+       F           P   Y+      W  P  +      Y 
Sbjct: 130 QNLLINRNGELKLANFGLARAFG---------IPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 547 ERSDIYSVGISCCELANGTVPF 568
              D++S G    ELAN   P 
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRHL 67
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + L
Sbjct: 7   DWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 61
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            H N++ +     +    +L       G   D I    + G+PE         ++ G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVY 119
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +HG G  HR +K  ++L+       +S       F    ++  L        L +++PE+
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPEL 177
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRHL 417
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + L
Sbjct: 7   DWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 61
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            H N++ +     +    +L       G   D I    + G+PE         ++ G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVY 119
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +HG G  HR +K  ++L+       +S       F    ++  L        L +++PE+
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPEL 177
Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRHL 67
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + L
Sbjct: 8   DWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            H N++ +     +    +L       G   D I    + G+PE         ++ G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVY 120
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +HG G  HR +K  ++L+       +S       F    ++  L        L +++PE+
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPEL 178
Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           L++  + + E  D++S GI    +  G +P+
Sbjct: 179 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRHL 417
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI   + L
Sbjct: 8   DWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            H N++ +     +    +L       G   D I    + G+PE         ++ G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVY 120
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +HG G  HR +K  ++L+       +S       F    ++  L        L +++PE+
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPEL 178
Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           L++  + + E  D++S GI    +  G +P+
Sbjct: 179 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 15  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 66
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 67  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 124
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 175
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 15  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 66
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 67  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 124
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 175
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K+      + A+     ++SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR----ANAFVGTAQYVSP 201
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K+      + A+     ++SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR----ANAFVGTAQYVSP 201
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 9/213 (4%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFL 80
            N  SV    +++  + I V    L + T++ D + +  E   M  L +P I+  I    
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VC 79
Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
            A  L LV  + G G     +       +P   +  +L  V  G++Y+  K F+HR + A
Sbjct: 80  QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
            ++L+ +   A +S               +    +  + L W +PE +  N   +  RSD
Sbjct: 139 RNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSD 195
Query: 201 IYSVGISCCE-LANGTVPFAET--PTTLMLIEK 230
           ++S G++  E L+ G  P+ +   P  +  IE+
Sbjct: 196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 9/213 (4%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFL 430
            N  SV    +++  + I V    L + T++ D + +  E   M  L +P I+  I    
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VC 79
Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
            A  L LV  + G G     +       +P   +  +L  V  G++Y+  K F+HR + A
Sbjct: 80  QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
            ++L+ +   A +S               +    +  + L W +PE +  N   +  RSD
Sbjct: 139 RNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSD 195
Query: 551 IYSVGISCCE-LANGTVPFAET--PTTLMLIEK 580
           ++S G++  E L+ G  P+ +   P  +  IE+
Sbjct: 196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           +++   Y    +LG      S V L++ K T +L+A+K    + +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVL 70
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 125 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 180
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           +++   Y    +LG      S V L++ K T +L+A+K    + +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVL 70
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 475 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 530
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 16/224 (7%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------EDLKSLHHEIVCM 64
           Y++C ++G+     S V    ++ T Q  AVK  ++ + T       EDLK    E    
Sbjct: 26  YELCEVIGK--GAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK---REASIC 80
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLM-GFGSCKDLI-NAHFNFGLPELVICHILQDVL 122
             L+HP+I+  + ++     L++V   M G   C +++  A   F   E V  H ++ +L
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
             L Y H    IHR VK  ++L++    +    L      +    +  L         ++
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFG-VAIQLGESGLVAGGRVGTPHF 199
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM 226
           ++PEV+++  + Y +  D++  G+    L +G +PF  T   L 
Sbjct: 200 MAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 16/224 (7%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------EDLKSLHHEIVCM 414
           Y++C ++G+     S V    ++ T Q  AVK  ++ + T       EDLK    E    
Sbjct: 26  YELCEVIGK--GAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK---REASIC 80
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLM-GFGSCKDLI-NAHFNFGLPELVICHILQDVL 472
             L+HP+I+  + ++     L++V   M G   C +++  A   F   E V  H ++ +L
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
             L Y H    IHR VK  ++L++    +    L      +    +  L         ++
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFG-VAIQLGESGLVAGGRVGTPHF 199
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM 576
           ++PEV+++  + Y +  D++  G+    L +G +PF  T   L 
Sbjct: 200 MAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 13/231 (5%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHH 59
           M T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D         
Sbjct: 4   MTTPSHLSDRYELGEILG--FGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           E      L HP I+    +    T      ++V   +   + +D+++       P+  I 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAI- 119
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 175
            ++ D    L + H  G IHR VK ++ILIS      +         + +   V     +
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT-AA 178
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
                 +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 179 VIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 13/234 (5%)
Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-S 406
            S + T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D      
Sbjct: 1   GSHMTTPSHLSDRYELGEILG--FGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR 58
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPEL 462
              E      L HP I+    +    T      ++V   +   + +D+++       P+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKR 117
Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
            I  ++ D    L + H  G IHR VK ++ILIS      +         + +   V   
Sbjct: 118 AI-EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
             +      +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 177 -AAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 18/236 (7%)
Query: 3   TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
           T  ++   Y + + +G+   +   V ++  K T    A KK  + +   ED+     EI 
Sbjct: 20  TKGDINQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKK--IPKYFVEDVDRFKQEIE 75
Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
            M+ L HPNII    +F D TD++LV  L   G   + +     F   E     I++DVL
Sbjct: 76  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 133
Query: 123 NGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           + + Y H     HR +K  + L    S +    L        F P   K+      T Y 
Sbjct: 134 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPY- 190
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 235
             ++SP+VLE     Y    D +S G+    L  G  PF+  PT   ++ K+   T
Sbjct: 191 --YVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFS-APTDXEVMLKIREGT 240

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 18/236 (7%)
Query: 353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
           T  ++   Y + + +G+   +   V ++  K T    A KK  + +   ED+     EI 
Sbjct: 20  TKGDINQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKK--IPKYFVEDVDRFKQEIE 75
Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
            M+ L HPNII    +F D TD++LV  L   G   + +     F   E     I++DVL
Sbjct: 76  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 133
Query: 473 NGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + + Y H     HR +K  + L    S +    L        F P   K+      T Y 
Sbjct: 134 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPY- 190
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 585
             ++SP+VLE     Y    D +S G+    L  G  PF+  PT   ++ K+   T
Sbjct: 191 --YVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFS-APTDXEVMLKIREGT 240

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 192 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 243
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 301
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 353
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 354 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 192 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 243
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 301
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 353
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 354 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 192 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 243
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 301
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 353
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 354 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 192 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 243
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 244 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 301
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 353
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 354 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 18/236 (7%)
Query: 3   TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
           T  ++   Y + + +G+   +   V ++  K T    A KK  + +   ED+     EI 
Sbjct: 3   TKGDINQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKK--IPKYFVEDVDRFKQEIE 58
Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
            M+ L HPNII    +F D TD++LV  L   G   + +     F   E     I++DVL
Sbjct: 59  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 116
Query: 123 NGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           + + Y H     HR +K  + L    S +    L        F P   K+      T Y 
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPY- 173
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 235
             ++SP+VLE     Y    D +S G+    L  G  PF+  PT   ++ K+   T
Sbjct: 174 --YVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFS-APTDXEVMLKIREGT 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 18/236 (7%)
Query: 353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
           T  ++   Y + + +G+   +   V ++  K T    A KK  + +   ED+     EI 
Sbjct: 3   TKGDINQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKK--IPKYFVEDVDRFKQEIE 58
Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
            M+ L HPNII    +F D TD++LV  L   G   + +     F   E     I++DVL
Sbjct: 59  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 116
Query: 473 NGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + + Y H     HR +K  + L    S +    L        F P   K+      T Y 
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPY- 173
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 585
             ++SP+VLE     Y    D +S G+    L  G  PF+  PT   ++ K+   T
Sbjct: 174 --YVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFS-APTDXEVMLKIREGT 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 13/237 (5%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           M T      +Y++   LG+     S V     K   Q  A K  N  +++  D + L  E
Sbjct: 23  MATCTRFTDDYQLFEELGK--GAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLERE 80
Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
               R L+HPNI+    S  +    +LV  L+  G   + I A   +   E    H +  
Sbjct: 81  ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCIHQ 138
Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTA 177
           +L  + +IH    +HR +K  ++L++   K     L+           ++    F  +  
Sbjct: 139 ILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPG 198
Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           Y    LSPEVL +  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 199 Y----LSPEVLRK--DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGA 249

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +Y++   LG+     S V     K   Q  A K  N  +++  D + L  E    R L+H
Sbjct: 32  DYQLFEELGK--GAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+    S  +    +LV  L+  G   + I A   +   E    H +  +L  + +IH
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCIHQILESVNHIH 147
Query: 480 GKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
               +HR +K  ++L++   K     L+           ++    F  +  Y    LSPE
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGY----LSPE 203
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           VL +  D Y +  DI++ G+    L  G  PF +     +  +  AGA
Sbjct: 204 VLRK--DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGA 249

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------EDLKSLHHEIVCM 64
           Y++C ++G+     S V    ++ T Q  AVK  ++ + T       EDLK    E    
Sbjct: 26  YELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK---REASIC 80
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLM-GFGSCKDLI-NAHFNFGLPELVICHILQDVL 122
             L+HP+I+  + ++     L++V   M G   C +++  A   F   E V  H ++ +L
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 123 NGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
             L Y H    IHR VK   +L++   ++    L G         +     L        
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG----LVAGGRVGT 196
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM 226
            ++++PEV+++  + Y +  D++  G+    L +G +PF  T   L 
Sbjct: 197 PHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------EDLKSLHHEIVCM 414
           Y++C ++G+     S V    ++ T Q  AVK  ++ + T       EDLK    E    
Sbjct: 26  YELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK---REASIC 80
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLM-GFGSCKDLI-NAHFNFGLPELVICHILQDVL 472
             L+HP+I+  + ++     L++V   M G   C +++  A   F   E V  H ++ +L
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 473 NGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
             L Y H    IHR VK   +L++   ++    L G         +     L        
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG----LVAGGRVGT 196
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM 576
            ++++PEV+++  + Y +  D++  G+    L +G +PF  T   L 
Sbjct: 197 PHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           +++   Y    +LG      S V L++ K T +L+A+K    + +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVL 70
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 125 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 180
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           +++   Y    +LG      S V L++ K T +L+A+K    + +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVL 70
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 475 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 530
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           +++   Y    +LG      S V L++ K T +L+A+K    + +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVL 70
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 125 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 180
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           +++   Y    +LG      S V L++ K T +L+A+K    + +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVL 70
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 475 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 530
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 9/213 (4%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFL 80
            N  SV    +++  + I V    L + T++ D + +  E   M  L +P I+  I    
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VC 405
Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
            A  L LV  + G G     +       +P   +  +L  V  G++Y+  K F+HR + A
Sbjct: 406 QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
            ++L+ +   A +S               +    +  + L W +PE +  N   +  RSD
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSD 521
Query: 201 IYSVGISCCE-LANGTVPFAET--PTTLMLIEK 230
           ++S G++  E L+ G  P+ +   P  +  IE+
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 9/213 (4%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFL 430
            N  SV    +++  + I V    L + T++ D + +  E   M  L +P I+  I    
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VC 405
Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
            A  L LV  + G G     +       +P   +  +L  V  G++Y+  K F+HR + A
Sbjct: 406 QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
            ++L+ +   A +S               +    +  + L W +PE +  N   +  RSD
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSD 521
Query: 551 IYSVGISCCE-LANGTVPFAET--PTTLMLIEK 580
           ++S G++  E L+ G  P+ +   P  +  IE+
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 201
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 201
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 36/198 (18%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +AVKK +         K  + E+V ++ + H NII  ++ F       +  D++LV  LM
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +     +  L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 110 DANLCQVI-----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 164
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +   + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 165 ILDFGLARTASTNFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 208
Query: 204 VGISCCELANGTVPFAET 221
           VG    EL  G+V F  T
Sbjct: 209 VGCIMGELVKGSVIFQGT 226

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 36/198 (18%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +AVKK +         K  + E+V ++ + H NII  ++ F       +  D++LV  LM
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +     +  L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 110 DANLCQVI-----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 164
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +   + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 165 ILDFGLARTASTNFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 208
Query: 554 VGISCCELANGTVPFAET 571
           VG    EL  G+V F  T
Sbjct: 209 VGCIMGELVKGSVIFQGT 226

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 19  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 70
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 71  LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 128
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 179
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 180 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 19  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 70
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 71  LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 128
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 179
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 180 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 66
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI     
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINAM 61
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 177
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRH 416
            ++ +   LG+       V L+ ++VT + +AVK  ++ R  D  E++K    EI     
Sbjct: 7   EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINAM 61
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L H N++ +     +    +L       G   D I    + G+PE         ++ G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 119
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HG G  HR +K  ++L+       +S       F    ++  L        L +++PE
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPE 177
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L++  + + E  D++S GI    +  G +P+
Sbjct: 178 LLKRR-EFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 201
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 201
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 113 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 168 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 211
Query: 204 VGISCCELANGTVPFAET 221
           VG    E+  G V F  T
Sbjct: 212 VGCIMGEMIKGGVLFPGT 229

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 113 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 168 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 211
Query: 554 VGISCCELANGTVPFAET 571
           VG    E+  G V F  T
Sbjct: 212 VGCIMGEMIKGGVLFPGT 229

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 29  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 144
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 200
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 201 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 29  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 144
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 200
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 201 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 116/259 (44%), Gaps = 51/259 (19%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S+++  ++LGQ       V  +++ + ++  A+KK    R T+E L ++  E++ +  L 
Sbjct: 6   SDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLN 60
Query: 69  HPNIICYISSFLDATDLHLVSPLMGF---------------GSCKDLINAHFNFGLPELV 113
           H  ++ Y +++L+  +   V P+                  G+  DLI++  N       
Sbjct: 61  HQYVVRYYAAWLERRNF--VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDE 117
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGL-----RYMCPFSPTK 166
              + + +L  L YIH +G IHR +K  +I I  S N K    GL     R +       
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 167 KKVHLFPPSTAYNLN-------WLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTV 216
           + +    P ++ NL        +++ EV    LDG   Y+E+ D+YS+GI   E+     
Sbjct: 178 QNL----PGSSDNLTSAIGTAMYVATEV----LDGTGHYNEKIDMYSLGIIFFEM---IY 226
Query: 217 PFAETPTTLMLIEKLAGAT 235
           PF+     + +++KL   +
Sbjct: 227 PFSTGMERVNILKKLRSVS 245

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 116/259 (44%), Gaps = 51/259 (19%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S+++  ++LGQ       V  +++ + ++  A+KK    R T+E L ++  E++ +  L 
Sbjct: 6   SDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLN 60
Query: 419 HPNIICYISSFLDATDLHLVSPLMGF---------------GSCKDLINAHFNFGLPELV 463
           H  ++ Y +++L+  +   V P+                  G+  DLI++  N       
Sbjct: 61  HQYVVRYYAAWLERRNF--VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDE 117
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGL-----RYMCPFSPTK 516
              + + +L  L YIH +G IHR +K  +I I  S N K    GL     R +       
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 517 KKVHLFPPSTAYNLN-------WLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTV 566
           + +    P ++ NL        +++ EV    LDG   Y+E+ D+YS+GI   E+     
Sbjct: 178 QNL----PGSSDNLTSAIGTAMYVATEV----LDGTGHYNEKIDMYSLGIIFFEM---IY 226
Query: 567 PFAETPTTLMLIEKLAGAT 585
           PF+     + +++KL   +
Sbjct: 227 PFSTGMERVNILKKLRSVS 245

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/294 (20%), Positives = 115/294 (39%), Gaps = 50/294 (17%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            +  +VY      T   +A  +    ++T  + +    E   ++ L+HPNI+ +  S+  
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWES 96
Query: 82  ATD----LHLVSPLMGFGSCKDLINAHFNFGLPEL-VICHILQDVLNGLEYIHGKG--FI 134
                  + LV+ L   G+ K  +     F + ++ V+    + +L GL+++H +    I
Sbjct: 97  TVKGKKCIVLVTELXTSGTLKTYLK---RFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 135 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 194
           HR +K  +I I+    +   G   +        K   F  +      + +PE  E+    
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFXAPEXYEEK--- 205
Query: 195 YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLDCTTYYVDTGQDDG 253
           YDE  D+Y+ G    E A    P++E      +  ++ +G  P   D             
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKV----------- 254
Query: 254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
              A   + E                 I+E C+ ++ D+R    +LL HAFF++
Sbjct: 255 ---AIPEVKE-----------------IIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 93/227 (40%), Gaps = 19/227 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            +  +VY      T   +A  +    ++T  + +    E   ++ L+HPNI+ +  S+  
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWES 96
Query: 432 ATD----LHLVSPLMGFGSCKDLINAHFNFGLPEL-VICHILQDVLNGLEYIHGKG--FI 484
                  + LV+ L   G+ K  +     F + ++ V+    + +L GL+++H +    I
Sbjct: 97  TVKGKKCIVLVTELXTSGTLKTYLK---RFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 485 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 544
           HR +K  +I I+    +   G   +        K   F  +      + +PE  E+    
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIGTPEFXAPEXYEEK--- 205
Query: 545 YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLD 590
           YDE  D+Y+ G    E A    P++E      +  ++ +G  P   D
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFD 252

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T Q  A K  N  +++  D + L  E    R L+HPNI+    S  +    +LV  L+  
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-- 152
           G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K    
Sbjct: 88  GELFEDIVAREYYS--EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAV 145
Query: 153 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
            L+           ++    F  +  Y    LSPEVL +  D Y +  D+++ G+    L
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGY----LSPEVLRK--DPYGKPVDMWACGVILYIL 199
Query: 212 ANGTVPFAETPTTLMLIEKLAGA 234
             G  PF +     +  +  AGA
Sbjct: 200 LVGYPPFWDEDQHRLYQQIKAGA 222

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T Q  A K  N  +++  D + L  E    R L+HPNI+    S  +    +LV  L+  
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-- 502
           G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K    
Sbjct: 88  GELFEDIVAREYYS--EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAV 145
Query: 503 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
            L+           ++    F  +  Y    LSPEVL +  D Y +  D+++ G+    L
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGY----LSPEVLRK--DPYGKPVDMWACGVILYIL 199
Query: 562 ANGTVPFAETPTTLMLIEKLAGA 584
             G  PF +     +  +  AGA
Sbjct: 200 LVGYPPFWDEDQHRLYQQIKAGA 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET 221
           VG    E+  G V F  T
Sbjct: 211 VGCIMGEMIKGGVLFPGT 228

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET 571
           VG    E+  G V F  T
Sbjct: 211 VGCIMGEMIKGGVLFPGT 228

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------EDLKSLHHEIVCM 64
           Y++C ++G+     S V    ++ T Q  AVK  ++ + T       EDLK    E    
Sbjct: 28  YELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK---REASIC 82
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLM-GFGSCKDLI-NAHFNFGLPELVICHILQDVL 122
             L+HP+I+  + ++     L++V   M G   C +++  A   F   E V  H ++ +L
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 123 NGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
             L Y H    IHR VK   +L++   ++    L G         +     L        
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG----LVAGGRVGT 198
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM 226
            ++++PEV+++  + Y +  D++  G+    L +G +PF  T   L 
Sbjct: 199 PHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 243

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------EDLKSLHHEIVCM 414
           Y++C ++G+     S V    ++ T Q  AVK  ++ + T       EDLK    E    
Sbjct: 28  YELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK---REASIC 82
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLM-GFGSCKDLI-NAHFNFGLPELVICHILQDVL 472
             L+HP+I+  + ++     L++V   M G   C +++  A   F   E V  H ++ +L
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 473 NGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
             L Y H    IHR VK   +L++   ++    L G         +     L        
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG----LVAGGRVGT 198
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM 576
            ++++PEV+++  + Y +  D++  G+    L +G +PF  T   L 
Sbjct: 199 PHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 243

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T Q  A K  N  +++  D + L  E    R L+HPNI+    S  +    +LV  L+  
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-- 152
           G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K    
Sbjct: 88  GELFEDIVAREYYS--EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAV 145
Query: 153 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
            L+           ++    F  +  Y    LSPEVL +  D Y +  D+++ G+    L
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGY----LSPEVLRK--DPYGKPVDMWACGVILYIL 199
Query: 212 ANGTVPFAETPTTLMLIEKLAGA 234
             G  PF +     +  +  AGA
Sbjct: 200 LVGYPPFWDEDQHRLYQQIKAGA 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T Q  A K  N  +++  D + L  E    R L+HPNI+    S  +    +LV  L+  
Sbjct: 28  TGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-- 502
           G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K    
Sbjct: 88  GELFEDIVAREYYS--EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAV 145
Query: 503 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
            L+           ++    F  +  Y    LSPEVL +  D Y +  D+++ G+    L
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGY----LSPEVLRK--DPYGKPVDMWACGVILYIL 199
Query: 562 ANGTVPFAETPTTLMLIEKLAGA 584
             G  PF +     +  +  AGA
Sbjct: 200 LVGYPPFWDEDQHRLYQQIKAGA 222

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 29/281 (10%)
Query: 36  NQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
            +  A+KK  L++  DE + S    EI  ++ L+H NI+           L LV   +  
Sbjct: 26  GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
              K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++LI+  G+  ++
Sbjct: 84  QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142
Query: 155 GLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
                  F  P +K  H         L + +P+VL      Y    DI+SVG    E+ N
Sbjct: 143 DFGLARAFGIPVRKYTH-----EVVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 214 GT--VPFAETPTTLMLIEKLAGA-----TPHLLDCTTYYVDTGQDDGEENACSYISEQQT 266
           G    P       LM I ++ G       P++ +   Y         + N   Y      
Sbjct: 197 GAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY---------DPNFTVYEPLPWE 247
Query: 267 QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             L  +   +S   ++   L  D ++R  A   L+HA+FK+
Sbjct: 248 SFL--KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 386 NQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
            +  A+KK  L++  DE + S    EI  ++ L+H NI+           L LV   +  
Sbjct: 26  GETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
              K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++LI+  G+  ++
Sbjct: 84  QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142
Query: 505 GLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
                  F  P +K  H         L + +P+VL      Y    DI+SVG    E+ N
Sbjct: 143 DFGLARAFGIPVRKYTH-----EVVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 564 GT--VPFAETPTTLMLIEKLAGATPH 587
           G    P       LM I ++ G TP+
Sbjct: 197 GAPLFPGVSEADQLMRIFRILG-TPN 221

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 33  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 90
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 148
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 204
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 205 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 33  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 90
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 148
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 204
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 205 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 14  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 71
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 129
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 185
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 186 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 14  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 71
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 129
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 185
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 186 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLM 92
           T +++AVK    D    +       EI  +R L H +II Y     D  +  L LV   +
Sbjct: 42  TGEMVAVKALKAD-CGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             GS +D +  H + GL +L++    Q +  G+ Y+H + +IHR + A ++L+ ++    
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLL--FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVK 157
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  E
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKEYKFYY--ASDVWSFGVTLYE 212
Query: 211 LANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           L          PT  + +  +A     +L  T
Sbjct: 213 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 244

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLM 442
           T +++AVK    D    +       EI  +R L H +II Y     D  +  L LV   +
Sbjct: 42  TGEMVAVKALKAD-CGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             GS +D +  H + GL +L++    Q +  G+ Y+H + +IHR + A ++L+ ++    
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLL--FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVK 157
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  E
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKEYKFYY--ASDVWSFGVTLYE 212
Query: 561 LANGTVPFAETPTTLMLIEKLAGATPHLLDCT 592
           L          PT  + +  +A     +L  T
Sbjct: 213 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 244

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ +RH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKIRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ +RH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKIRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 53/295 (17%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           VG    E+  G V F  T        +IE+L   +P  +      V T      EN   Y
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV----ENRPKY 266
Query: 261 ISEQQTQVLTSRKF-SDSFHSIVELCLSRDV---------DKRPLACNLLQHAFF 305
                 ++     F +DS H+ ++   +RD+          KR      LQH + 
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLL 589
           VG    E+  G V F  T        +IE+L   +P  +
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 23  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 74
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 75  LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DMSAQIASGMAYVERMNY 132
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP------IKWTAPEA--- 183
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 23  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 74
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 75  LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DMSAQIASGMAYVERMNY 132
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP------IKWTAPEA--- 183
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 16  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 67
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    + +V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 68  LYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 125
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP------IKWTAPEA--- 176
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 16  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 67
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    + +V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 68  LYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 125
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP------IKWTAPEA--- 176
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/176 (21%), Positives = 77/176 (43%), Gaps = 22/176 (12%)
Query: 54  LKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV--------SPLMGFGSCKDLINAHF 105
           ++ ++ EI  ++ L HPN++  +    D  + HL          P+M   + K L     
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 106 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT 165
            F           QD++ G+EY+H +  IHR +K S++L+  +G   ++       F   
Sbjct: 140 RF---------YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--- 187
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS-DIYSVGISCCELANGTVPFAE 220
            K       +T     +++PE L +    +  ++ D++++G++      G  PF +
Sbjct: 188 -KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/176 (21%), Positives = 77/176 (43%), Gaps = 22/176 (12%)
Query: 404 LKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV--------SPLMGFGSCKDLINAHF 455
           ++ ++ EI  ++ L HPN++  +    D  + HL          P+M   + K L     
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 456 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT 515
            F           QD++ G+EY+H +  IHR +K S++L+  +G   ++       F   
Sbjct: 140 RF---------YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--- 187
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS-DIYSVGISCCELANGTVPFAE 570
            K       +T     +++PE L +    +  ++ D++++G++      G  PF +
Sbjct: 188 -KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 13/231 (5%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHH 59
           M T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D         
Sbjct: 4   MTTPSHLSDRYELGEILG--FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           E      L HP I+   ++    T      ++V   +   + +D+++       P+  I 
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAI- 119
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 175
            ++ D    L + H  G IHR VK ++I+IS      +         + +   V     +
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-A 178
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
                 +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 179 VIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 13/234 (5%)
Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-S 406
            S + T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D      
Sbjct: 1   GSHMTTPSHLSDRYELGEILG--FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR 58
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPEL 462
              E      L HP I+   ++    T      ++V   +   + +D+++       P+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKR 117
Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
            I  ++ D    L + H  G IHR VK ++I+IS      +         + +   V   
Sbjct: 118 AI-EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
             +      +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 177 A-AVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLM 92
           T +++AVK    D    +       EI  +R L H +II Y     D  +  L LV   +
Sbjct: 42  TGEMVAVKALKAD-CGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 152
             GS +D +  H + GL +L++    Q +  G+ Y+H + +IHR + A ++L+ ++    
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLL--FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVK 157
Query: 153 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  E
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKEYKFYY--ASDVWSFGVTLYE 212
Query: 211 LANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           L          PT  + +  +A     +L  T
Sbjct: 213 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 244

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLM 442
           T +++AVK    D    +       EI  +R L H +II Y     D  +  L LV   +
Sbjct: 42  TGEMVAVKALKAD-CGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC 502
             GS +D +  H + GL +L++    Q +  G+ Y+H + +IHR + A ++L+ ++    
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLL--FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVK 157
Query: 503 LS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  E
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKEYKFYY--ASDVWSFGVTLYE 212
Query: 561 LANGTVPFAETPTTLMLIEKLAGATPHLLDCT 592
           L          PT  + +  +A     +L  T
Sbjct: 213 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 244

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 32  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 147
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 203
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 192 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 243
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 244 LYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 301
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 353
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 354 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 192 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 243
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 244 LYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 301
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 353
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 354 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 68
           ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L 
Sbjct: 36  DFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 93
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HP  +    +F D   L+        G     I    +F   E        ++++ LEY+
Sbjct: 94  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEYL 151
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSPE 186
           HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SPE
Sbjct: 152 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSPE 207
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L +      + SD++++G    +L  G  PF
Sbjct: 208 LLTEK--SACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 418
           ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L 
Sbjct: 36  DFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 93
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HP  +    +F D   L+        G     I    +F   E        ++++ LEY+
Sbjct: 94  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEYL 151
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSPE 536
           HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SPE
Sbjct: 152 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSPE 207
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L +      + SD++++G    +L  G  PF
Sbjct: 208 LLTEK--SACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR + A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR + A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 275 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 326
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 327 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 384
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 436
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 437 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 275 LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 326
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 327 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNY 384
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEAA-- 436
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 437 -LYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 13/231 (5%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHH 59
           M T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D         
Sbjct: 4   MTTPSHLSDRYELGEILG--FGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           E      L HP I+    +    T      ++V   +   + +D+++       P+  I 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAI- 119
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 175
            ++ D    L + H  G IHR VK ++I+IS      +         + +   V     +
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-A 178
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
                 +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 179 VIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 13/234 (5%)
Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-S 406
            S + T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D      
Sbjct: 1   GSHMTTPSHLSDRYELGEILG--FGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR 58
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPEL 462
              E      L HP I+    +    T      ++V   +   + +D+++       P+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKR 117
Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
            I  ++ D    L + H  G IHR VK ++I+IS      +         + +   V   
Sbjct: 118 AI-EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
             +      +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 177 A-AVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 23  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 74
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 75  LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DMSAQIASGMAYVERMNY 132
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 183
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 23  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 74
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 75  LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DMSAQIASGMAYVERMNY 132
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 183
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   GF+HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGFVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   GF+HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGFVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 12/223 (5%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHH 59
           M T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D         
Sbjct: 4   MTTPSHLSDRYELGEILG--FGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           E      L HP I+    +    T      ++V   +   + +D+++       P+  I 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAI- 119
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 175
            ++ D    L + H  G IHR VK ++I+IS      +         + +   V     +
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-A 178
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
                 +LSPE  +   D  D RSD+YS+G    E+  G  PF
Sbjct: 179 VIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 12/226 (5%)
Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-S 406
            S + T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D      
Sbjct: 1   GSHMTTPSHLSDRYELGEILG--FGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR 58
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPEL 462
              E      L HP I+    +    T      ++V   +   + +D+++       P+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKR 117
Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
            I  ++ D    L + H  G IHR VK ++I+IS      +         + +   V   
Sbjct: 118 AI-EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             +      +LSPE  +   D  D RSD+YS+G    E+  G  PF
Sbjct: 177 A-AVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 121/295 (41%), Gaps = 53/295 (17%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           VG    E+  G V F  T        +IE+L   +P  +      V T      EN   Y
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV----ENRPKY 266
Query: 261 ISEQQTQVLTSRKF-SDSFHSIVELCLSRDV---------DKRPLACNLLQHAFF 305
                 ++     F +DS H+ ++   +RD+          KR      LQH + 
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
              +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 D-ANLSQVIQMELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLL 589
           VG    E+  G V F  T        +IE+L   +P  +
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/250 (21%), Positives = 94/250 (37%), Gaps = 46/250 (18%)
Query: 52  EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP- 110
           E  +    E+  M +L HPNI+       +   +     +M F  C DL +   +   P 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM-----VMEFVPCGDLYHRLLDKAHPI 119
Query: 111 -ELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS---HNGKACLSGLRYMCPFSP 164
              V   ++ D+  G+EY+  +    +HR +++ +I +     N   C      +  FS 
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK----VADFSL 175
Query: 165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT 224
           +++ VH        N  W++PE +    + Y E++D YS  +    +  G  PF      
Sbjct: 176 SQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF------ 228
Query: 225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
                          D  +Y        G+    + I E+  +            +++EL
Sbjct: 229 ---------------DEYSY--------GKIKFINMIREEGLRPTIPEDCPPRLRNVIEL 265
Query: 285 CLSRDVDKRP 294
           C S D  KRP
Sbjct: 266 CWSGDPKKRP 275

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 74/176 (42%), Gaps = 17/176 (9%)
Query: 402 EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP- 460
           E  +    E+  M +L HPNI+       +   +     +M F  C DL +   +   P 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM-----VMEFVPCGDLYHRLLDKAHPI 119
Query: 461 -ELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS---HNGKACLSGLRYMCPFSP 514
              V   ++ D+  G+EY+  +    +HR +++ +I +     N   C      +  FS 
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK----VADFSL 175
Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +++ VH        N  W++PE +    + Y E++D YS  +    +  G  PF E
Sbjct: 176 SQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 13/231 (5%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHH 59
           M T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D         
Sbjct: 4   MTTPSHLSDRYELGEILG--FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           E      L HP I+    +    T      ++V   +   + +D+++       P+  I 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAI- 119
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 175
            ++ D    L + H  G IHR VK ++I+IS      +         + +   V     +
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-A 178
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
                 +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 179 VIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 13/234 (5%)
Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-S 406
            S + T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D      
Sbjct: 1   GSHMTTPSHLSDRYELGEILG--FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR 58
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPEL 462
              E      L HP I+    +    T      ++V   +   + +D+++       P+ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKR 117
Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
            I  ++ D    L + H  G IHR VK ++I+IS      +         + +   V   
Sbjct: 118 AI-EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
             +      +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 177 A-AVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V   M  GS  D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 13/231 (5%)
Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-SLHH 59
           M T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D         
Sbjct: 21  MTTPSHLSDRYELGEILG--FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRR 78
Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           E      L HP I+    +    T      ++V   +   + +D+++       P+  I 
Sbjct: 79  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAI- 136
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 175
            ++ D    L + H  G IHR VK ++I+IS      +         + +   V     +
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-A 195
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
                 +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 196 VIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 244

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 13/234 (5%)
Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLK-S 406
            S + T  ++   Y++  ILG  F  +S V+L++    ++ +AVK    D   D      
Sbjct: 18  GSHMTTPSHLSDRYELGEILG--FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR 75
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDL----HLVSPLMGFGSCKDLINAHFNFGLPEL 462
              E      L HP I+    +    T      ++V   +   + +D+++       P+ 
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKR 134
Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
            I  ++ D    L + H  G IHR VK ++I+IS      +         + +   V   
Sbjct: 135 AI-EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
             +      +LSPE  +   D  D RSD+YS+G    E+  G  PF  ++P ++
Sbjct: 194 A-AVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 244

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 55/262 (20%)
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLE 126
           H N++  I  F +    +LV   M  GS    I+   HFN    EL    ++QDV + L+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQDVASALD 125
Query: 127 YIHGKGFIHRAVKASHILISHNGK---------ACLSGLRYMCPFSPTKKKVHLFPPSTA 177
           ++H KG  HR +K  +IL  H  +            SG++     SP      L P  +A
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 178 YNLNWLSPEVLE---QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
               +++PEV+E   +    YD+R D++S+G+                   +L   L+G 
Sbjct: 186 ---EYMAPEVVEAFSEEASIYDKRCDLWSLGV-------------------ILYILLSGY 223
Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKF----SDSFH------SIVEL 284
            P +  C +   D G D GE  AC        + +   K+     D  H       ++  
Sbjct: 224 PPFVGRCGS---DCGWDRGE--ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK 278
Query: 285 CLSRDVDKRPLACNLLQHAFFK 306
            L RD  +R  A  +LQH + +
Sbjct: 279 LLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 21/164 (12%)
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLE 476
           H N++  I  F +    +LV   M  GS    I+   HFN    EL    ++QDV + L+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQDVASALD 125
Query: 477 YIHGKGFIHRAVKASHILISHNGK---------ACLSGLRYMCPFSPTKKKVHLFPPSTA 527
           ++H KG  HR +K  +IL  H  +            SG++     SP      L P  +A
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 528 YNLNWLSPEVLE---QNLDGYDERSDIYSVGISCCELANGTVPF 568
               +++PEV+E   +    YD+R D++S+G+    L +G  PF
Sbjct: 186 ---EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 47  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 106 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 154
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 212
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 213 EVMSYGERPYWE 224

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 47  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 106 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 154
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 212
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 213 EVMSYGERPYWE 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 109/262 (41%), Gaps = 55/262 (20%)
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLE 126
           H N++  I  F +    +LV   M  GS    I+   HFN    EL    ++QDV + L+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQDVASALD 125
Query: 127 YIHGKGFIHRAVKASHILISHNG-----KAC----LSGLRYMCPFSPTKKKVHLFPPSTA 177
           ++H KG  HR +K  +IL  H       K C     SG++     SP      L P  +A
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 178 YNLNWLSPEVLE---QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
               +++PEV+E   +    YD+R D++S+G+                   +L   L+G 
Sbjct: 186 ---EYMAPEVVEAFSEEASIYDKRCDLWSLGV-------------------ILYILLSGY 223
Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKF----SDSFH------SIVEL 284
            P +  C +   D G D GE  AC        + +   K+     D  H       ++  
Sbjct: 224 PPFVGRCGS---DCGWDRGE--ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK 278
Query: 285 CLSRDVDKRPLACNLLQHAFFK 306
            L RD  +R  A  +LQH + +
Sbjct: 279 LLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLE 476
           H N++  I  F +    +LV   M  GS    I+   HFN    EL    ++QDV + L+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQDVASALD 125
Query: 477 YIHGKGFIHRAVKASHILISHNG-----KAC----LSGLRYMCPFSPTKKKVHLFPPSTA 527
           ++H KG  HR +K  +IL  H       K C     SG++     SP      L P  +A
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 528 YNLNWLSPEVLE---QNLDGYDERSDIYSVGISCCELANGTVPF 568
               +++PEV+E   +    YD+R D++S+G+    L +G  PF
Sbjct: 186 ---EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 47  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 106 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 154
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 212
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 213 EVMSYGERPYWE 224

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 47  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 106 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 154
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 155 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 212
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 213 EVMSYGERPYWE 224

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           +++   Y    +LG      S V L++ K T +L+A+K      +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVL 70
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 125 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 180
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           +++   Y    +LG      S V L++ K T +L+A+K      +  ++  S+ +EI  +
Sbjct: 14  EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVL 70
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 128
Query: 475 LEYIHGKGFIHRAVKASHIL---ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL- 530
           ++Y+H  G +HR +K  ++L   +  + K  +S       F  +K +      STA    
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD------FGLSKMEDPGSVLSTACGTP 182
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +++PEVL Q    Y +  D +S+G+    L  G  PF
Sbjct: 183 GYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 40/269 (14%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 149 ----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
               G A  +G  +M     T + V      T Y   + +PEV+     GY E  DI+SV
Sbjct: 167 ILDFGLARTAGTSFMM----TPEVV------TRY---YRAPEVILGM--GYKENVDIWSV 211
Query: 205 GISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI 261
           G    E+  G V F  T        +IE+L    P  +      V T  ++  + A    
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSF 271
Query: 262 SEQQTQVLTSRKFSDSFHSIVELCLSRDV 290
            +    VL     +DS H+ ++   +RD+
Sbjct: 272 EKLFPDVLFP---ADSEHNALKASQARDL 297

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 34/197 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 499 ----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
               G A  +G  +M     T + V      T Y   + +PEV+     GY E  DI+SV
Sbjct: 167 ILDFGLARTAGTSFMM----TPEVV------TRY---YRAPEVILGM--GYKENVDIWSV 211
Query: 555 GISCCELANGTVPFAET 571
           G    E+  G V F  T
Sbjct: 212 GCIMGEMIKGGVLFPGT 228

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 64  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 123 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 171
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 172 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 229
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 230 EVMSYGERPYWE 241

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 64  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 123 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 171
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 172 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 229
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 230 EVMSYGERPYWE 241

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 46/250 (18%)
Query: 52  EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP- 110
           E  +    E+  M +L HPNI+       +   +     +M F  C DL +   +   P 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM-----VMEFVPCGDLYHRLLDKAHPI 119
Query: 111 -ELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS---HNGKACLSGLRYMCPFSP 164
              V   ++ D+  G+EY+  +    +HR +++ +I +     N   C      +  F  
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK----VADFGT 175
Query: 165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT 224
           +++ VH        N  W++PE +    + Y E++D YS  +    +  G  PF      
Sbjct: 176 SQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF------ 228
Query: 225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
                          D  +Y        G+    + I E+  +            +++EL
Sbjct: 229 ---------------DEYSY--------GKIKFINMIREEGLRPTIPEDCPPRLRNVIEL 265
Query: 285 CLSRDVDKRP 294
           C S D  KRP
Sbjct: 266 CWSGDPKKRP 275

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/176 (22%), Positives = 73/176 (41%), Gaps = 17/176 (9%)
Query: 402 EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP- 460
           E  +    E+  M +L HPNI+       +   +     +M F  C DL +   +   P 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM-----VMEFVPCGDLYHRLLDKAHPI 119
Query: 461 -ELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS---HNGKACLSGLRYMCPFSP 514
              V   ++ D+  G+EY+  +    +HR +++ +I +     N   C      +  F  
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK----VADFGT 175
Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +++ VH        N  W++PE +    + Y E++D YS  +    +  G  PF E
Sbjct: 176 SQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 45/223 (20%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH---- 86
           K ++ N  +AVK F L    D+       EI     ++H N++ +I++    ++L     
Sbjct: 33  KAQLMNDFVAVKIFPLQ---DKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELW 89
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH-------GKG----FIH 135
           L++     GS  D +  +    +    +CH+ + +  GL Y+H       G+G      H
Sbjct: 90  LITAFHDKGSLTDYLKGNI---ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAH 146
Query: 136 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWLSPEVLEQN 191
           R  K+ ++L+  +  A L+       F P K      PP   +       +++PEVLE  
Sbjct: 147 RDFKSKNVLLKSDLTAVLADFGLAVRFEPGK------PPGDTHGQVGTRRYMAPEVLEGA 200
Query: 192 LDGYDE---RSDIYSVG------ISCCELANGTV-----PFAE 220
           ++   +   R D+Y++G      +S C+ A+G V     PF E
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEE 243

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 45/223 (20%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH---- 436
           K ++ N  +AVK F L    D+       EI     ++H N++ +I++    ++L     
Sbjct: 33  KAQLMNDFVAVKIFPLQ---DKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELW 89
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH-------GKG----FIH 485
           L++     GS  D +  +    +    +CH+ + +  GL Y+H       G+G      H
Sbjct: 90  LITAFHDKGSLTDYLKGNI---ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAH 146
Query: 486 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN----LNWLSPEVLEQN 541
           R  K+ ++L+  +  A L+       F P K      PP   +       +++PEVLE  
Sbjct: 147 RDFKSKNVLLKSDLTAVLADFGLAVRFEPGK------PPGDTHGQVGTRRYMAPEVLEGA 200
Query: 542 LDGYDE---RSDIYSVG------ISCCELANGTV-----PFAE 570
           ++   +   R D+Y++G      +S C+ A+G V     PF E
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEE 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 37  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 94
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +     F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 152
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 208
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 209 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 37  EDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 94
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +     F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 152
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 208
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 209 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 53/295 (17%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
                   ++      L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           VG    E+  G V F  T        +IE+L   +P  +      V T      EN   Y
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV----ENRPKY 266
Query: 261 ISEQQTQVLTSRKF-SDSFHSIVELCLSRDV---------DKRPLACNLLQHAFF 305
                 ++     F +DS H+ ++   +RD+          KR      LQH + 
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
                   ++      L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLL 589
           VG    E+  G V F  T        +IE+L   +P  +
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 67
            ++K   ILG+   + S+  L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 185
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 201
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHL 417
            ++K   ILG+   + S+  L++   T++  A+K      +  E+ +  +  E   M  L
Sbjct: 30  EDFKFGKILGE--GSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP  +    +F D   L+        G     I    +F   E        ++++ LEY
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVSALEY 145
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK--KVHLFPPSTAYNLNWLSP 535
           +HGKG IHR +K  +IL++ +    ++        SP  K  + + F  +  Y    +SP
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY----VSP 201
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           E+L +      + SD++++G    +L  G  PF
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 53/295 (17%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
                   ++      L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 204 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           VG    E+  G V F  T        +IE+L   +P  +      V T      EN   Y
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV----ENRPKY 266
Query: 261 ISEQQTQVLTSRKF-SDSFHSIVELCLSRDV---------DKRPLACNLLQHAFF 305
                 ++     F +DS H+ ++   +RD+          KR      LQH + 
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
                   ++      L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DAN-----LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  DI+S
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDIWS 210
Query: 554 VGISCCELANGTVPFAET---PTTLMLIEKLAGATPHLL 589
           VG    E+  G V F  T        +IE+L   +P  +
Sbjct: 211 VGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 115/300 (38%), Gaps = 36/300 (12%)
Query: 4   LDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHH 59
           L NV +N+  +  S+ G          + K  V N  +AVKK    +D  T+E  +    
Sbjct: 11  LKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 70
Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI---CH 116
           EI      +H N++  +    D  DL LV      GS  D ++     G P L     C 
Sbjct: 71  EIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD--GTPPLSWHXRCK 128
Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPP 174
           I Q   NG+ ++H    IHR +K+++IL+     A +S  GL                  
Sbjct: 129 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVG 188
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           +TAY     +PE L   +     +SDIYS G+   E+  G +P  +      L+  +   
Sbjct: 189 TTAY----XAPEALRGEI---TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEE 240
Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                     Y+D   +D +  +                  ++ +S+   CL    +KRP
Sbjct: 241 IEDEEKTIEDYIDKKXNDADSTSV-----------------EAXYSVASQCLHEKKNKRP 283

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 91/220 (41%), Gaps = 18/220 (8%)
Query: 354 LDNVPSNY--KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN--LDRMTDEDLKSLHH 409
           L NV +N+  +  S+ G          + K  V N  +AVKK    +D  T+E  +    
Sbjct: 11  LKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ 70
Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI---CH 466
           EI      +H N++  +    D  DL LV      GS  D ++     G P L     C 
Sbjct: 71  EIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD--GTPPLSWHXRCK 128
Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPP 524
           I Q   NG+ ++H    IHR +K+++IL+     A +S  GL                  
Sbjct: 129 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVG 188
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
           +TAY     +PE L   +     +SDIYS G+   E+  G
Sbjct: 189 TTAY----XAPEALRGEI---TPKSDIYSFGVVLLEIITG 221

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V+  M  G   D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V+  M  G   D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHN--GKACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 108 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 206
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 207 VDIWSVGCIMGEMVRHKILF 226

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 108 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 206
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 207 VDIWSVGCIMGEMVRHKILF 226

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 46  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 105
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 106 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 161 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 204
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 205 VDIWSVGCIMGEMVRHKILF 224

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 46  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 105
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 106 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 160
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 161 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 204
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 205 VDIWSVGCIMGEMVRHKILF 224

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 41  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 98
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D++LV+ LMG    K L   H    L    IC+ L  +
Sbjct: 99  RHENIIG-INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQI 153
Query: 122 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 211
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 212 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 241

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 41  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 98
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D++LV+ LMG    K L   H    L    IC+ L  +
Sbjct: 99  RHENIIG-INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQI 153
Query: 472 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 211
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 212 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 241

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 74  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 133 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 181
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 182 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 239
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 240 EVMSYGERPYWE 251

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 74  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 133 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 181
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 182 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 239
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 240 EVMSYGERPYWE 251

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 145 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 243
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 244 VDIWSVGCIMGEMVRHKILF 263

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 145 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 243
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 244 VDIWSVGCIMGEMVRHKILF 263

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 145 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 243
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 244 VDIWSVGCIMGEMVRHKILF 263

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 85  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 145 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 200 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 243
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 244 VDIWSVGCIMGEMVRHKILF 263

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 108 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 206
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 207 VDIWSVGCIMGEMVRHKILF 226

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 107
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 108 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 163 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 206
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 207 VDIWSVGCIMGEMVRHKILF 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 100 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 198
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 199 VDIWSVGCIMGEMVRHKILF 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 100 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 198
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 199 VDIWSVGCIMGEMVRHKILF 218

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 101 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 199
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 200 VDIWSVGCIMGEMVRHKILF 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 101 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 199
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 200 VDIWSVGCIMGEMVRHKILF 219

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 46/250 (18%)
Query: 52  EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP- 110
           E  +    E+  M +L HPNI+       +   +     +M F  C DL +   +   P 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM-----VMEFVPCGDLYHRLLDKAHPI 119
Query: 111 -ELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS---HNGKACLSGLRYMCPFSP 164
              V   ++ D+  G+EY+  +    +HR +++ +I +     N   C      +  F  
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK----VADFGL 175
Query: 165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT 224
           +++ VH        N  W++PE +    + Y E++D YS  +    +  G  PF      
Sbjct: 176 SQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF------ 228
Query: 225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
                          D  +Y        G+    + I E+  +            +++EL
Sbjct: 229 ---------------DEYSY--------GKIKFINMIREEGLRPTIPEDCPPRLRNVIEL 265
Query: 285 CLSRDVDKRP 294
           C S D  KRP
Sbjct: 266 CWSGDPKKRP 275

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/176 (22%), Positives = 73/176 (41%), Gaps = 17/176 (9%)
Query: 402 EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP- 460
           E  +    E+  M +L HPNI+       +   +     +M F  C DL +   +   P 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM-----VMEFVPCGDLYHRLLDKAHPI 119
Query: 461 -ELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS---HNGKACLSGLRYMCPFSP 514
              V   ++ D+  G+EY+  +    +HR +++ +I +     N   C      +  F  
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK----VADFGL 175
Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
           +++ VH        N  W++PE +    + Y E++D YS  +    +  G  PF E
Sbjct: 176 SQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 101 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 199
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 200 VDIWSVGCIMGEMVRHKILF 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 100
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM    C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 101 VMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 155
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 156 DCTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 199
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 200 VDIWSVGCIMGEMVRHKILF 219

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G++HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGYVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPL 91
           T +++AVK   L       L+S    EI  +R L H +I+ Y     D  +  + LV   
Sbjct: 36  TGEMVAVKA--LKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           +  GS +D +  H   GL +L++    Q +  G+ Y+H + +IHRA+ A ++L+ ++   
Sbjct: 94  VPLGSLRDYLPRH-CVGLAQLLL--FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLV 150
Query: 152 CLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKECKFYYA--SDVWSFGVTLY 205
Query: 210 EL 211
           EL
Sbjct: 206 EL 207

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPL 441
           T +++AVK   L       L+S    EI  +R L H +I+ Y     D  +  + LV   
Sbjct: 36  TGEMVAVKA--LKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           +  GS +D +  H   GL +L++    Q +  G+ Y+H + +IHRA+ A ++L+ ++   
Sbjct: 94  VPLGSLRDYLPRH-CVGLAQLLL--FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLV 150
Query: 502 CLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKECKFYYA--SDVWSFGVTLY 205
Query: 560 EL 561
           EL
Sbjct: 206 EL 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPL 91
           T +++AVK   L       L+S    EI  +R L H +I+ Y     D  +  + LV   
Sbjct: 37  TGEMVAVKA--LKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 92  MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 151
           +  GS +D +  H   GL +L++    Q +  G+ Y+H + +IHRA+ A ++L+ ++   
Sbjct: 95  VPLGSLRDYLPRH-CVGLAQLLL--FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLV 151
Query: 152 CLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKECKFYYA--SDVWSFGVTLY 206
Query: 210 EL 211
           EL
Sbjct: 207 EL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPL 441
           T +++AVK   L       L+S    EI  +R L H +I+ Y     D  +  + LV   
Sbjct: 37  TGEMVAVKA--LKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 442 MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA 501
           +  GS +D +  H   GL +L++    Q +  G+ Y+H + +IHRA+ A ++L+ ++   
Sbjct: 95  VPLGSLRDYLPRH-CVGLAQLLL--FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLV 151
Query: 502 CLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +   GL    P      +V     S  +   W +PE L++    Y   SD++S G++  
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVF---WYAPECLKECKFYYA--SDVWSFGVTLY 206
Query: 560 EL 561
           EL
Sbjct: 207 EL 208

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 9   SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCM 64
            N+++  +LG   +  +  V       T +L A+K      +  +  K+  H   E   +
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVL 112
Query: 65  RHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
            H+R  P ++    +F   T LHL+   +  G     ++    F   E+ I   + +++ 
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY--VGEIVL 170
Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN---- 179
            LE++H  G I+R +K  +IL+  NG   L+       F   + +        AY+    
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-------RAYDFCGT 223
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           + +++P+++     G+D+  D +S+G+   EL  G  PF
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 359 SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCM 414
            N+++  +LG   +  +  V       T +L A+K      +  +  K+  H   E   +
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVL 112
Query: 415 RHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
            H+R  P ++    +F   T LHL+   +  G     ++    F   E+ I   + +++ 
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY--VGEIVL 170
Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN---- 529
            LE++H  G I+R +K  +IL+  NG   L+       F   + +        AY+    
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-------RAYDFCGT 223
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           + +++P+++     G+D+  D +S+G+   EL  G  PF
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y++   LG+     S V      +  Q  A K  N  +++  D + L  E    R L+
Sbjct: 22  SMYQLFEELGK--GAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLK 79
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HPNI+    S  +    +L+  L+  G   + I A   +   E    H +Q +L  + + 
Sbjct: 80  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADASHCIQQILEAVLHC 137
Query: 129 HGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           H  G +HR +K  ++L++   K     L+           ++    F  +  Y    LSP
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY----LSP 193
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           EVL +  D Y +  D+++ G+    L  G  PF +     +  +  AGA
Sbjct: 194 EVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 240

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y++   LG+     S V      +  Q  A K  N  +++  D + L  E    R L+
Sbjct: 22  SMYQLFEELGK--GAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLK 79
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HPNI+    S  +    +L+  L+  G   + I A   +   E    H +Q +L  + + 
Sbjct: 80  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADASHCIQQILEAVLHC 137
Query: 479 HGKGFIHRAVKASHILISHNGKAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           H  G +HR +K  ++L++   K     L+           ++    F  +  Y    LSP
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY----LSP 193
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           EVL +  D Y +  D+++ G+    L  G  PF +     +  +  AGA
Sbjct: 194 EVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 240

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 24  LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
            S V L++ K T +L AVK      +  ++  S+ +EI  +R ++H NI+     +    
Sbjct: 35  FSEVVLAEEKATGKLFAVKCIPKKALKGKE-SSIENEIAVLRKIKHENIVALEDIYESPN 93
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
            L+LV  L+  G   D I     +   E     +++ VL+ + Y+H  G +HR +K  ++
Sbjct: 94  HLYLVMQLVSGGELFDRIVEKGFY--TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENL 151
Query: 144 L-ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLEQNLDGYDERSDI 201
           L  S + ++ +     +  F  +K +      STA     +++PEVL Q    Y +  D 
Sbjct: 152 LYYSQDEESKI----MISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQK--PYSKAVDC 205
Query: 202 YSVGISCCELANGTVPF 218
           +S+G+    L  G  PF
Sbjct: 206 WSIGVIAYILLCGYPPF 222

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 374 LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
            S V L++ K T +L AVK      +  ++  S+ +EI  +R ++H NI+     +    
Sbjct: 35  FSEVVLAEEKATGKLFAVKCIPKKALKGKE-SSIENEIAVLRKIKHENIVALEDIYESPN 93
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
            L+LV  L+  G   D I     +   E     +++ VL+ + Y+H  G +HR +K  ++
Sbjct: 94  HLYLVMQLVSGGELFDRIVEKGFY--TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENL 151
Query: 494 L-ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLEQNLDGYDERSDI 551
           L  S + ++ +     +  F  +K +      STA     +++PEVL Q    Y +  D 
Sbjct: 152 LYYSQDEESKI----MISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQK--PYSKAVDC 205
Query: 552 YSVGISCCELANGTVPF 568
           +S+G+    L  G  PF
Sbjct: 206 WSIGVIAYILLCGYPPF 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 113/250 (45%), Gaps = 32/250 (12%)
Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH--HEIVC 63
           N+ S++++ S+LG+       V  + HK T +++A+KK       D+ L +L    EI  
Sbjct: 8   NISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 64  MRHLRHPNIICYIS-----SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
           ++H +H NII   +     SF +  +++++  LM      DL        L +  I + +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFI 118
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFS------PTKKKVH 170
              L  ++ +HG   IHR +K S++LI+ N   K C  GL  +   S      PT ++  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 171 LFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCE--LANGTVPFAETPTTLML 227
           +   +      W  +PEV+  +   Y    D++S G    E  L     P  +    L+L
Sbjct: 179 M---TEXVATRWYRAPEVMLTSAK-YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 228 IEKLAGATPH 237
           I  + G TPH
Sbjct: 235 IFGIIG-TPH 243

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 113/250 (45%), Gaps = 32/250 (12%)
Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH--HEIVC 413
           N+ S++++ S+LG+       V  + HK T +++A+KK       D+ L +L    EI  
Sbjct: 8   NISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 414 MRHLRHPNIICYIS-----SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
           ++H +H NII   +     SF +  +++++  LM      DL        L +  I + +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFI 118
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFS------PTKKKVH 520
              L  ++ +HG   IHR +K S++LI+ N   K C  GL  +   S      PT ++  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 521 LFPPSTAYNLNWL-SPEVLEQNLDGYDERSDIYSVGISCCE--LANGTVPFAETPTTLML 577
           +   +      W  +PEV+  +   Y    D++S G    E  L     P  +    L+L
Sbjct: 179 M---TEXVATRWYRAPEVMLTSAK-YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 578 IEKLAGATPH 587
           I  + G TPH
Sbjct: 235 IFGIIG-TPH 243

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S+++  ++LGQ       V  +++ + ++  A+KK    R T+E L ++  E++ +  L 
Sbjct: 6   SDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLN 60
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFG---------------SCKDLINAHFNFGLPELV 113
           H  ++ Y +++L+  +   V P+                   +  DLI++  N       
Sbjct: 61  HQYVVRYYAAWLERRNF--VKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE-NLNQQRDE 117
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHL 171
              + + +L  L YIH +G IHR +K  +I I  S N K    GL      S    K+  
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 172 FP-PSTAYNLN-------WLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAE 220
              P ++ NL        +++ EV    LDG   Y+E+ D+YS+GI   E+     PF+ 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEV----LDGTGHYNEKIDMYSLGIIFFEM---IYPFST 230
Query: 221 TPTTLMLIEKLAGAT 235
               + +++KL   +
Sbjct: 231 GMERVNILKKLRSVS 245

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S+++  ++LGQ       V  +++ + ++  A+KK    R T+E L ++  E++ +  L 
Sbjct: 6   SDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLN 60
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFG---------------SCKDLINAHFNFGLPELV 463
           H  ++ Y +++L+  +   V P+                   +  DLI++  N       
Sbjct: 61  HQYVVRYYAAWLERRNF--VKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE-NLNQQRDE 117
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHL 521
              + + +L  L YIH +G IHR +K  +I I  S N K    GL      S    K+  
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 522 FP-PSTAYNLN-------WLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAE 570
              P ++ NL        +++ EV    LDG   Y+E+ D+YS+GI   E+     PF+ 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEV----LDGTGHYNEKIDMYSLGIIFFEM---IYPFST 230
Query: 571 TPTTLMLIEKLAGAT 585
               + +++KL   +
Sbjct: 231 GMERVNILKKLRSVS 245

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH--HEIVC 63
           N+ S++++ S+LG+       V  + HK T +++A+KK       D+ L +L    EI  
Sbjct: 8   NISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 64  MRHLRHPNIICYIS-----SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
           ++H +H NII   +     SF +  +++++  LM      DL        L +  I + +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFI 118
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFS------PTKKKVH 170
              L  ++ +HG   IHR +K S++LI+ N   K C  GL  +   S      PT ++  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 171 LFPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCE--LANGTVPFAETPTTLM 226
           +    T Y    W  +PEV+  +   Y    D++S G    E  L     P  +    L+
Sbjct: 179 M----TEYVATRWYRAPEVMLTSAK-YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 227 LIEKLAGATPH 237
           LI  + G TPH
Sbjct: 234 LIFGIIG-TPH 243

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH--HEIVC 413
           N+ S++++ S+LG+       V  + HK T +++A+KK       D+ L +L    EI  
Sbjct: 8   NISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 414 MRHLRHPNIICYIS-----SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
           ++H +H NII   +     SF +  +++++  LM      DL        L +  I + +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFI 118
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFS------PTKKKVH 520
              L  ++ +HG   IHR +K S++LI+ N   K C  GL  +   S      PT ++  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 521 LFPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCE--LANGTVPFAETPTTLM 576
           +    T Y    W  +PEV+  +   Y    D++S G    E  L     P  +    L+
Sbjct: 179 M----TEYVATRWYRAPEVMLTSAK-YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 577 LIEKLAGATPH 587
           LI  + G TPH
Sbjct: 234 LIFGIIG-TPH 243

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 17  LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 75
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 76  ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 133
           + + +    +++V   M  G   D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 134 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 191 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 218
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 367 LGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY 425
           LGQ CF     V++     T + +A+K      M+ E   +   E   M+ LRH  ++  
Sbjct: 26  LGQGCFGE---VWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLV-Q 77
Query: 426 ISSFLDATDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGF 483
           + + +    +++V   M  G   D +         LP+LV   +   + +G+ Y+    +
Sbjct: 78  LYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNY 135
Query: 484 IHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           +HR ++A++IL+  N   K    GL R +     T ++   FP      + W +PE    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWTAPEA--- 186
Query: 541 NLDG-YDERSDIYSVGISCCEL-ANGTVPF 568
            L G +  +SD++S GI   EL   G VP+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLVSPLMGF 94
           +AVK F+     DE       E+     LRH NI+ +I+S +     +T L L++     
Sbjct: 34  VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90
Query: 95  GSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIH-------GKGFI-HRAVKASHILI 145
           GS  D    +      + V C  I+  + +GL ++H       GK  I HR +K+ +IL+
Sbjct: 91  GSLYD----YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYD--ERSDI 201
             NG+ C++ L      S +  ++ +          +++PEVL++ +  D +D  +R DI
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 202 YSVGISCCELANGTV 216
           ++ G+   E+A   V
Sbjct: 207 WAFGLVLWEVARRMV 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLVSPLMGF 444
           +AVK F+     DE       E+     LRH NI+ +I+S +     +T L L++     
Sbjct: 34  VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90
Query: 445 GSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIH-------GKGFI-HRAVKASHILI 495
           GS  D    +      + V C  I+  + +GL ++H       GK  I HR +K+ +IL+
Sbjct: 91  GSLYD----YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYD--ERSDI 551
             NG+ C++ L      S +  ++ +          +++PEVL++ +  D +D  +R DI
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 552 YSVGISCCELANGTV 566
           ++ G+   E+A   V
Sbjct: 207 WAFGLVLWEVARRMV 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 31/282 (10%)
Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           D +   +++ S LG+   ++  VY  K K T +  A+K   L +  D+  K +  EI  +
Sbjct: 49  DALSDFFEVESELGRGATSI--VYRCKQKGTQKPYALK--VLKKTVDK--KIVRTEIGVL 102
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             L HPNII     F   T++ LV  L+  G   D I     +   E      ++ +L  
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS--ERDAADAVKQILEA 160
Query: 125 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           + Y+H  G +HR +K  ++L +        K    GL  +       K V   P      
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP------ 214
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 239
             + +PE+L      Y    D++SVGI    L  G  PF +      +  +       +L
Sbjct: 215 -GYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-------IL 264
Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSI 281
           +C  Y++    D+   NA   +  ++  VL  +K   +F ++
Sbjct: 265 NCEYYFISPWWDEVSLNAKDLV--RKLIVLDPKKRLTTFQAL 304

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 29/258 (11%)
Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           D +   +++ S LG+   ++  VY  K K T +  A+K   L +  D+  K +  EI  +
Sbjct: 49  DALSDFFEVESELGRGATSI--VYRCKQKGTQKPYALK--VLKKTVDK--KIVRTEIGVL 102
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             L HPNII     F   T++ LV  L+  G   D I     +   E      ++ +L  
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS--ERDAADAVKQILEA 160
Query: 475 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + Y+H  G +HR +K  ++L +        K    GL  +       K V   P      
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP------ 214
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL 589
             + +PE+L      Y    D++SVGI    L  G  PF +      +  +       +L
Sbjct: 215 -GYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-------IL 264
Query: 590 DCTTYYVDTGQDDGEENA 607
           +C  Y++    D+   NA
Sbjct: 265 NCEYYFISPWWDEVSLNA 282

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLVSPLMGF 94
           +AVK F+     DE       E+     LRH NI+ +I+S +     +T L L++     
Sbjct: 63  VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 119
Query: 95  GSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIH-------GKGFI-HRAVKASHILI 145
           GS  D    +      + V C  I+  + +GL ++H       GK  I HR +K+ +IL+
Sbjct: 120 GSLYD----YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 175
Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYD--ERSDI 201
             NG+ C++ L      S +  ++ +          +++PEVL++ +  D +D  +R DI
Sbjct: 176 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 235
Query: 202 YSVGISCCELANGTV 216
           ++ G+   E+A   V
Sbjct: 236 WAFGLVLWEVARRMV 250

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLVSPLMGF 444
           +AVK F+     DE       E+     LRH NI+ +I+S +     +T L L++     
Sbjct: 63  VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 119
Query: 445 GSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIH-------GKGFI-HRAVKASHILI 495
           GS  D    +      + V C  I+  + +GL ++H       GK  I HR +K+ +IL+
Sbjct: 120 GSLYD----YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 175
Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYD--ERSDI 551
             NG+ C++ L      S +  ++ +          +++PEVL++ +  D +D  +R DI
Sbjct: 176 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 235
Query: 552 YSVGISCCELANGTV 566
           ++ G+   E+A   V
Sbjct: 236 WAFGLVLWEVARRMV 250

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLVSPLMGF 94
           +AVK F+     DE       E+     LRH NI+ +I+S +     +T L L++     
Sbjct: 34  VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90
Query: 95  GSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIH-------GKGFI-HRAVKASHILI 145
           GS  D    +      + V C  I+  + +GL ++H       GK  I HR +K+ +IL+
Sbjct: 91  GSLYD----YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYD--ERSDI 201
             NG+ C++ L      S +  ++ +          +++PEVL++ +  D +D  +R DI
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 202 YSVGISCCELANGTV 216
           ++ G+   E+A   V
Sbjct: 207 WAFGLVLWEVARRMV 221

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----DATDLHLVSPLMGF 444
           +AVK F+     DE       E+     LRH NI+ +I+S +     +T L L++     
Sbjct: 34  VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM 90
Query: 445 GSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIH-------GKGFI-HRAVKASHILI 495
           GS  D    +      + V C  I+  + +GL ++H       GK  I HR +K+ +IL+
Sbjct: 91  GSLYD----YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL--DGYD--ERSDI 551
             NG+ C++ L      S +  ++ +          +++PEVL++ +  D +D  +R DI
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 552 YSVGISCCELANGTV 566
           ++ G+   E+A   V
Sbjct: 207 WAFGLVLWEVARRMV 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHE 60
           ++V  +Y++   LG      + V   + K T +  A K     R++        + +  E
Sbjct: 8   EDVEDHYEMGEELGS--GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 65
Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +R +RHPNII     F + TD+ L+  L+  G   D +    +  L E      L+ 
Sbjct: 66  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQ 123
Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKKVHLFPP 174
           +L+G+ Y+H K   H  +K  +I++          K    G+ +        K +   P 
Sbjct: 124 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP- 182
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
                  +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 183 ------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHE 410
           ++V  +Y++   LG      + V   + K T +  A K     R++        + +  E
Sbjct: 8   EDVEDHYEMGEELGS--GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 65
Query: 411 IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
           +  +R +RHPNII     F + TD+ L+  L+  G   D +    +  L E      L+ 
Sbjct: 66  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQ 123
Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKKVHLFPP 524
           +L+G+ Y+H K   H  +K  +I++          K    G+ +        K +   P 
Sbjct: 124 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP- 182
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                  +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 183 ------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH--HEIVC 63
           N+ S++++ S+LG+       V  + HK T +++A+KK       D+ L +L    EI  
Sbjct: 8   NISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 64  MRHLRHPNIICYIS-----SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
           ++H +H NII   +     SF +  +++++  LM      DL        L +  I + +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFI 118
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFS------PTKKKVH 170
              L  ++ +HG   IHR +K S++LI+ N   K C  GL  +   S      PT ++  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 171 L--FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE--LANGTVPFAETPTTLM 226
           +  F  +  Y     +PEV+  +   Y    D++S G    E  L     P  +    L+
Sbjct: 179 MVEFVATRWYR----APEVMLTSAK-YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 227 LIEKLAGATPH 237
           LI  + G TPH
Sbjct: 234 LIFGIIG-TPH 243

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH--HEIVC 413
           N+ S++++ S+LG+       V  + HK T +++A+KK       D+ L +L    EI  
Sbjct: 8   NISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 414 MRHLRHPNIICYIS-----SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
           ++H +H NII   +     SF +  +++++  LM      DL        L +  I + +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFI 118
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFS------PTKKKVH 520
              L  ++ +HG   IHR +K S++LI+ N   K C  GL  +   S      PT ++  
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 521 L--FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE--LANGTVPFAETPTTLM 576
           +  F  +  Y     +PEV+  +   Y    D++S G    E  L     P  +    L+
Sbjct: 179 MVEFVATRWYR----APEVMLTSAK-YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 577 LIEKLAGATPH 587
           LI  + G TPH
Sbjct: 234 LIFGIIG-TPH 243

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 100 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 155 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 198
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 199 VDIWSVGCIMGEMVRHKILF 218

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 100 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 155 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 198
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 199 VDIWSVGCIMGEMVRHKILF 218

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 87
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 88  VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 148 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 199 SDIYSVGISCCELANGTVPF 218
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 36/200 (18%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHL 437
           V ++ +A+KK +         K  + E+V M+ + H NII  ++ F       +  D++L
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           V  LM   +   +I    +       + ++L  +L G++++H  G IHR +K S+I++  
Sbjct: 107 VMELMD-ANLXQVIQMELDHER----MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 498 N--------GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +        G A  +G  + M P+  T+               + +PEV+     GY E 
Sbjct: 162 DXTLKILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKEN 205
Query: 549 SDIYSVGISCCELANGTVPF 568
            DI+SVG    E+    + F
Sbjct: 206 VDIWSVGCIMGEMVRHKILF 225

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/320 (22%), Positives = 131/320 (40%), Gaps = 48/320 (15%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNII-----CYISSFLDATD 84
           K   + +A+K+  +    +    S   E+  +RHL    HPN++     C +S     T 
Sbjct: 34  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 85  LHLVSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           L LV     F      +  + +     G+P   I  ++  +L GL+++H    +HR +K 
Sbjct: 94  LTLV-----FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148
Query: 141 SHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
            +IL++ +G+  L+  GL  +  F        +   S    L + +PEVL Q+   Y   
Sbjct: 149 QNILVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQS--SYATP 199
Query: 199 SDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENAC 258
            D++SVG    E+      F  +      +++L      +LD        G++D   +  
Sbjct: 200 VDLWSVGCIFAEMFRRKPLFRGSSD----VDQLG----KILDVIGL---PGEEDWPRDVA 248
Query: 259 SYISEQQTQVLTSRKFSDSFHSIVEL-------CLSRDVDKRPLACNLLQHAFFKQTKKC 311
             +  Q     +++        I EL       CL+ +  KR  A + L H +F+  ++C
Sbjct: 249 --LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306
Query: 312 SVMLPELLRPALSLNESNVC 331
              L   L P+ + +E N  
Sbjct: 307 KENLDSHLPPSQNTSELNTA 326

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 383 KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNII-----CYISSFLDATD 434
           K   + +A+K+  +    +    S   E+  +RHL    HPN++     C +S     T 
Sbjct: 34  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 435 LHLVSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           L LV     F      +  + +     G+P   I  ++  +L GL+++H    +HR +K 
Sbjct: 94  LTLV-----FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148
Query: 491 SHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
            +IL++ +G+  L+  GL  +  F        +   S    L + +PEVL Q+   Y   
Sbjct: 149 QNILVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQS--SYATP 199
Query: 549 SDIYSVGISCCEL 561
            D++SVG    E+
Sbjct: 200 VDLWSVGCIFAEM 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLR 68
           ++K+ ++LG+   + + VY ++   T   +A+K  +   M    + + + +E+     L+
Sbjct: 12  DFKVGNLLGK--GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HP+I+   + F D+  ++LV  +   G     +         E    H +  ++ G+ Y+
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYL 128
Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLS 184
           H  G +HR +  S++L++ N    ++                  P    Y L    N++S
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK--------MPHEKHYTLCGTPNYIS 180
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PE+  ++  G +  SD++S+G     L  G  PF
Sbjct: 181 PEIATRSAHGLE--SDVWSLGCMFYTLLIGRPPF 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLR 418
           ++K+ ++LG+   + + VY ++   T   +A+K  +   M    + + + +E+     L+
Sbjct: 12  DFKVGNLLGK--GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HP+I+   + F D+  ++LV  +   G     +         E    H +  ++ G+ Y+
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYL 128
Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLS 534
           H  G +HR +  S++L++ N    ++                  P    Y L    N++S
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK--------MPHEKHYTLCGTPNYIS 180
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE+  ++  G +  SD++S+G     L  G  PF
Sbjct: 181 PEIATRSAHGLE--SDVWSLGCMFYTLLIGRPPF 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ + +G++Y+   G +HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGAVHRDLAARNILINSN--------- 183
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 210 E-LANGTVPFAE 220
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 76  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ + +G++Y+   G +HR + A +ILI+ N         
Sbjct: 135 SFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGAVHRDLAARNILINSN--------- 183
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W SPE +      +   SD++S GI   
Sbjct: 184 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLW 241
Query: 560 E-LANGTVPFAE 570
           E ++ G  P+ E
Sbjct: 242 EVMSYGERPYWE 253

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/197 (21%), Positives = 83/197 (42%), Gaps = 14/197 (7%)
Query: 29  LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH-- 86
           L K +     I VK   +   +    +  + E   +R   HPN++  + +       H  
Sbjct: 26  LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHR-AVKASHIL 144
           L++  M +GS  ++++   NF + +        D+  G+ ++H  +  I R A+ +  ++
Sbjct: 86  LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS-DIYS 203
           I  +  A +S       F           P   Y   W++PE L++  +  + RS D++S
Sbjct: 146 IDEDMTARISMADVKFSFQ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWS 196
Query: 204 VGISCCELANGTVPFAE 220
             +   EL    VPFA+
Sbjct: 197 FAVLLWELVTREVPFAD 213

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/197 (21%), Positives = 83/197 (42%), Gaps = 14/197 (7%)
Query: 379 LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH-- 436
           L K +     I VK   +   +    +  + E   +R   HPN++  + +       H  
Sbjct: 26  LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHR-AVKASHIL 494
           L++  M +GS  ++++   NF + +        D+  G+ ++H  +  I R A+ +  ++
Sbjct: 86  LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145
Query: 495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS-DIYS 553
           I  +  A +S       F           P   Y   W++PE L++  +  + RS D++S
Sbjct: 146 IDEDMTARISMADVKFSFQ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWS 196
Query: 554 VGISCCELANGTVPFAE 570
             +   EL    VPFA+
Sbjct: 197 FAVLLWELVTREVPFAD 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLD 109
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXX 167
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLD 109
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXX 167
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 55/260 (21%)
Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLEYI 128
           NI+  I  F D T  +LV   +  GS    I    HFN    E     +++DV   L+++
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFN----EREASRVVRDVAAALDFL 127
Query: 129 HGKGFIHRAVKASHILISHNGKACL---------SGLRYMCPFSPTKKKVHLFPPSTAYN 179
           H KG  HR +K  +IL     K            SG++     +P        P  +A  
Sbjct: 128 HTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA-- 185
Query: 180 LNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP 236
             +++PEV+E   D    YD+R D++S+G+                   +L   L+G  P
Sbjct: 186 -EYMAPEVVEVFTDQATFYDKRCDLWSLGV-------------------VLYIMLSGYPP 225
Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKF----------SDSFHSIVELCL 286
            +  C     D G D GE   C     +  + +   K+          S     ++   L
Sbjct: 226 FVGHCGA---DCGWDRGE--VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLL 280
Query: 287 SRDVDKRPLACNLLQHAFFK 306
            RD  +R  A  +LQH + +
Sbjct: 281 VRDAKQRLSAAQVLQHPWVQ 300

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLEYI 478
           NI+  I  F D T  +LV   +  GS    I    HFN    E     +++DV   L+++
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFN----EREASRVVRDVAAALDFL 127
Query: 479 HGKGFIHRAVKASHILISHNGKACL---------SGLRYMCPFSPTKKKVHLFPPSTAYN 529
           H KG  HR +K  +IL     K            SG++     +P        P  +A  
Sbjct: 128 HTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA-- 185
Query: 530 LNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPF 568
             +++PEV+E   D    YD+R D++S+G+    + +G  PF
Sbjct: 186 -EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 40/200 (20%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +AVKK +         K  + E+V ++ + H NII  ++ F       +  D++LV  LM
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +     +  L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 149 -------GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
                    AC + +  M P+  T+               + +PEV+     GY    DI
Sbjct: 167 ILDFGLARTACTNFM--MTPYVVTR--------------YYRAPEVILGM--GYAANVDI 208
Query: 202 YSVGISCCELANGTVPFAET 221
           +SVG    EL  G V F  T
Sbjct: 209 WSVGCIMGELVKGCVIFQGT 228

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 40/200 (20%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +AVKK +         K  + E+V ++ + H NII  ++ F       +  D++LV  LM
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +     +  L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 499 -------GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
                    AC + +  M P+  T+               + +PEV+     GY    DI
Sbjct: 167 ILDFGLARTACTNFM--MTPYVVTR--------------YYRAPEVILGM--GYAANVDI 208
Query: 552 YSVGISCCELANGTVPFAET 571
           +SVG    EL  G V F  T
Sbjct: 209 WSVGCIMGELVKGCVIFQGT 228

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 86/186 (46%), Gaps = 19/186 (10%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+   +++   E   M+ L+H  ++   +       +++++  M  GS  
Sbjct: 40  VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLL 96
Query: 99  DLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 154
           D + +       LP+L+       +  G+ YI  K +IHR ++A+++L+S +   K    
Sbjct: 97  DFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF 154
Query: 155 GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
           GL R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+  
Sbjct: 155 GLARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGCFTIKSDVWSFGILLYEIVT 206
Query: 214 -GTVPF 218
            G +P+
Sbjct: 207 YGKIPY 212

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 86/186 (46%), Gaps = 19/186 (10%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+   +++   E   M+ L+H  ++   +       +++++  M  GS  
Sbjct: 40  VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLL 96
Query: 449 DLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 504
           D + +       LP+L+       +  G+ YI  K +IHR ++A+++L+S +   K    
Sbjct: 97  DFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF 154
Query: 505 GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
           GL R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+  
Sbjct: 155 GLARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGCFTIKSDVWSFGILLYEIVT 206
Query: 564 -GTVPF 568
            G +P+
Sbjct: 207 YGKIPY 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLK-SLHHEIVCMRH 66
            ++++  +LG+   +   V+L++ K TNQ  A+K    D  + D+D++ ++  + V    
Sbjct: 18  EDFELHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             HP +     +F    +L  V   +  G     I +   F L          +++ GL+
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQ 133
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           ++H KG ++R +K  +IL+  +G   ++             K + F  +  Y    ++PE
Sbjct: 134 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDY----IAPE 189
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L      Y+   D +S G+   E+  G  PF
Sbjct: 190 ILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLK-SLHHEIVCMRH 416
            ++++  +LG+   +   V+L++ K TNQ  A+K    D  + D+D++ ++  + V    
Sbjct: 18  EDFELHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
             HP +     +F    +L  V   +  G     I +   F L          +++ GL+
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQ 133
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           ++H KG ++R +K  +IL+  +G   ++             K + F  +  Y    ++PE
Sbjct: 134 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDY----IAPE 189
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L      Y+   D +S G+   E+  G  PF
Sbjct: 190 ILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 23/222 (10%)
Query: 7   VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHEIV 62
           V  +Y++   LG      + V   + K T +  A K     R++        + +  E+ 
Sbjct: 3   VEDHYEMGEELGS--GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
            +R +RHPNII     F + TD+ L+  L+  G   D +    +  L E      L+ +L
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQIL 118
Query: 123 NGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKKVHLFPPST 176
           +G+ Y+H K   H  +K  +I++          K    G+ +        K +   P   
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--- 175
Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
                +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 176 ----EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 23/222 (10%)
Query: 357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHEIV 412
           V  +Y++   LG      + V   + K T +  A K     R++        + +  E+ 
Sbjct: 3   VEDHYEMGEELGS--GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
            +R +RHPNII     F + TD+ L+  L+  G   D +    +  L E      L+ +L
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQIL 118
Query: 473 NGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKKVHLFPPST 526
           +G+ Y+H K   H  +K  +I++          K    G+ +        K +   P   
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--- 175
Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 176 ----EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 59  HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHI 117
            E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  L  L++   
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPP 174
              +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  K      P 
Sbjct: 499 --QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP- 555
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
                + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 556 -----IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 409 HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHI 467
            E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  L  L++   
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 468 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPP 524
              +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  K      P 
Sbjct: 499 --QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP- 555
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
                + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 556 -----IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 122 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 195
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 472 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 195
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           ++VY  K K+T+ L+A+K+  L+        ++  E+  ++ L+H NI+           
Sbjct: 16  ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKS 74
Query: 85  LHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           L LV   +          C ++IN H N  L        L  +L GL Y H +  +HR +
Sbjct: 75  LTLVFEYLDKDLKQYLDDCGNIINMH-NVKL-------FLFQLLRGLAYCHRQKVLHRDL 126
Query: 139 KASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 197
           K  ++LI+  G+  L+        S PTK        +    L +  P++L  + D Y  
Sbjct: 127 KPQNLLINERGELKLADFGLARAKSIPTKTY-----DNEVVTLWYRPPDILLGSTD-YST 180
Query: 198 RSDIYSVGISCCELANGTVPF 218
           + D++ VG    E+A G   F
Sbjct: 181 QIDMWGVGCIFYEMATGRPLF 201

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           ++VY  K K+T+ L+A+K+  L+        ++  E+  ++ L+H NI+           
Sbjct: 16  ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKS 74
Query: 435 LHLVSPLMG------FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           L LV   +          C ++IN H N  L        L  +L GL Y H +  +HR +
Sbjct: 75  LTLVFEYLDKDLKQYLDDCGNIINMH-NVKL-------FLFQLLRGLAYCHRQKVLHRDL 126
Query: 489 KASHILISHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 547
           K  ++LI+  G+  L+        S PTK        +    L +  P++L  + D Y  
Sbjct: 127 KPQNLLINERGELKLADFGLARAKSIPTKTY-----DNEVVTLWYRPPDILLGSTD-YST 180
Query: 548 RSDIYSVGISCCELANGTVPF 568
           + D++ VG    E+A G   F
Sbjct: 181 QIDMWGVGCIFYEMATGRPLF 201

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 11/204 (5%)
Query: 34  VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG 93
           +  Q  A    N  +++  D + L  E    R L+HPNI+    S  +    +L+  L+ 
Sbjct: 34  LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93
Query: 94  FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC- 152
            G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K   
Sbjct: 94  GGELFEDIVAREYYS--EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA 151
Query: 153 --LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
             L+           ++    F  +  Y    LSPEVL +  D Y +  D+++ G+    
Sbjct: 152 VKLADFGLAIEVEGEQQAWFGFAGTPGY----LSPEVLRK--DPYGKPVDLWACGVILYI 205
Query: 211 LANGTVPFAETPTTLMLIEKLAGA 234
           L  G  PF +     +  +  AGA
Sbjct: 206 LLVGYPPFWDEDQHRLYQQIKAGA 229

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 11/204 (5%)
Query: 384 VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG 443
           +  Q  A    N  +++  D + L  E    R L+HPNI+    S  +    +L+  L+ 
Sbjct: 34  LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93
Query: 444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC- 502
            G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K   
Sbjct: 94  GGELFEDIVAREYYS--EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA 151
Query: 503 --LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
             L+           ++    F  +  Y    LSPEVL +  D Y +  D+++ G+    
Sbjct: 152 VKLADFGLAIEVEGEQQAWFGFAGTPGY----LSPEVLRK--DPYGKPVDLWACGVILYI 205
Query: 561 LANGTVPFAETPTTLMLIEKLAGA 584
           L  G  PF +     +  +  AGA
Sbjct: 206 LLVGYPPFWDEDQHRLYQQIKAGA 229

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+   +++   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 215 VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLL 270
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL 156
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S +   K    GL
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 331 ARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 215 TVPFA--ETPTTLMLIEK 230
            +P+     P  +  +E+
Sbjct: 383 RIPYPGMSNPEVIRALER 400

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+   +++   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 215 VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLL 270
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL 506
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S +   K    GL
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 331 ARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 565 TVPFA--ETPTTLMLIEK 580
            +P+     P  +  +E+
Sbjct: 383 RIPYPGMSNPEVIRALER 400

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 67
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 14  GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 71
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 122
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 123
Query: 123 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 124 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 176
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           N+ +PEV+   L    E  D++S G+    +    +PF
Sbjct: 177 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPF 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 417
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 14  GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 71
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 472
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 123
Query: 473 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 124 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 176
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           N+ +PEV+   L    E  D++S G+    +    +PF
Sbjct: 177 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPF 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  +R +RHPNII     F + TD+ L+  L+  G   D +    +  L E   
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEA 131
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +L+G+ Y+H K   H  +K  +I++          K    G+ +        K 
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 192 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  +R +RHPNII     F + TD+ L+  L+  G   D +    +  L E   
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEA 131
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +L+G+ Y+H K   H  +K  +I++          K    G+ +        K 
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 192 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLM-----GFGSCKDLINAHFNFGLPELVICH 116
            H NII  I+  + A       D+++V  LM         C+ L N H         IC+
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDH---------ICY 132
Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPP 174
            L  +L GL+YIH    +HR +K S++L++   + K C  GL  +    P          
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTE 190
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             A    + +PE++  N  GY +  DI+SVG    E+
Sbjct: 191 YVATRW-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLM-----GFGSCKDLINAHFNFGLPELVICH 466
            H NII  I+  + A       D+++V  LM         C+ L N H         IC+
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDH---------ICY 132
Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPP 524
            L  +L GL+YIH    +HR +K S++L++   + K C  GL  +    P          
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTE 190
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             A    + +PE++  N  GY +  DI+SVG    E+
Sbjct: 191 YVATRW-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLV 88
           + K   +++  K+ +   MT+ + + L  E+  +R L+HPNI+ Y    +D T+  L++V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 89  SPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIH-----GKGFIHRAVKAS 141
                 G    +I         L E  +  ++  +   L+  H     G   +HR +K +
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 142 HILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
           ++ +    N K    GL  +     +  K  +  P       ++SPE  + N   Y+E+S
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY------YMSPE--QMNRMSYNEKS 197
Query: 200 DIYSVGISCCELANGTVPFA 219
           DI+S+G    EL     PF 
Sbjct: 198 DIWSLGCLLYELCALMPPFT 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLV 438
           + K   +++  K+ +   MT+ + + L  E+  +R L+HPNI+ Y    +D T+  L++V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 439 SPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIH-----GKGFIHRAVKAS 491
                 G    +I         L E  +  ++  +   L+  H     G   +HR +K +
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 492 HILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
           ++ +    N K    GL  +     +  K  +  P       ++SPE  + N   Y+E+S
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY------YMSPE--QMNRMSYNEKS 197
Query: 550 DIYSVGISCCELANGTVPFA 569
           DI+S+G    EL     PF 
Sbjct: 198 DIWSLGCLLYELCALMPPFT 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 12/212 (5%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLK-SLHHEIVCMRH 66
            ++ +  +LG+   +   V+L++ K TNQ  A+K    D  + D+D++ ++  + V    
Sbjct: 17  EDFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             HP +     +F    +L  V   +  G     I +   F L          +++ GL+
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQ 132
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           ++H KG ++R +K  +IL+  +G   ++             K + F  +  Y    ++PE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDY----IAPE 188
Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +L      Y+   D +S G+   E+  G  PF
Sbjct: 189 ILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 12/212 (5%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLK-SLHHEIVCMRH 416
            ++ +  +LG+   +   V+L++ K TNQ  A+K    D  + D+D++ ++  + V    
Sbjct: 17  EDFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
             HP +     +F    +L  V   +  G     I +   F L          +++ GL+
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQ 132
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           ++H KG ++R +K  +IL+  +G   ++             K + F  +  Y    ++PE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDY----IAPE 188
Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +L      Y+   D +S G+   E+  G  PF
Sbjct: 189 ILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 86
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 47  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 103
Query: 87  LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 136
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 104 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 158
Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 194
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 159 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 218
Query: 195 YD--ERSDIYSVGISCCELAN 213
           ++  +R+DIY++G+   E+A 
Sbjct: 219 FESFKRADIYAMGLVFWEIAR 239

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 436
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 47  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 103
Query: 437 LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 486
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 104 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 158
Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 544
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 159 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 218
Query: 545 YD--ERSDIYSVGISCCELAN 563
           ++  +R+DIY++G+   E+A 
Sbjct: 219 FESFKRADIYAMGLVFWEIAR 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLV 88
           + K   +++  K+ +   MT+ + + L  E+  +R L+HPNI+ Y    +D T+  L++V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 89  SPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIH-----GKGFIHRAVKAS 141
                 G    +I         L E  +  ++  +   L+  H     G   +HR +K +
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 142 HILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
           ++ +    N K    GL  +     +  K  +  P       ++SPE  + N   Y+E+S
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY------YMSPE--QMNRMSYNEKS 197
Query: 200 DIYSVGISCCELANGTVPFA 219
           DI+S+G    EL     PF 
Sbjct: 198 DIWSLGCLLYELCALMPPFT 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLV 438
           + K   +++  K+ +   MT+ + + L  E+  +R L+HPNI+ Y    +D T+  L++V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 439 SPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIH-----GKGFIHRAVKAS 491
                 G    +I         L E  +  ++  +   L+  H     G   +HR +K +
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 492 HILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
           ++ +    N K    GL  +     +  K  +  P       ++SPE  + N   Y+E+S
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY------YMSPE--QMNRMSYNEKS 197
Query: 550 DIYSVGISCCELANGTVPFA 569
           DI+S+G    EL     PF 
Sbjct: 198 DIWSLGCLLYELCALMPPFT 217

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 6   NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           +V   Y   S +G+  +  + S Y + +KV    +A+KK +         ++L  EI  +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYXQRTLR-EIKIL 79
Query: 65  RHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
              RH NII  I+  + A       D+++V  LM     K L   H    L    IC+ L
Sbjct: 80  LRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFL 134
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPST 176
             +L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYV 192
Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           A    + +PE++  N  GY +  DI+SVG    E+
Sbjct: 193 ATRW-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 356 NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           +V   Y   S +G+  +  + S Y + +KV    +A+KK +         ++L  EI  +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYXQRTLR-EIKIL 79
Query: 415 RHLRHPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
              RH NII  I+  + A       D+++V  LM     K L   H    L    IC+ L
Sbjct: 80  LRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFL 134
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPST 526
             +L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYV 192
Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           A    + +PE++  N  GY +  DI+SVG    E+
Sbjct: 193 ATRW-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 67
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 13  GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 70
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 122
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 122
Query: 123 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 123 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 175
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 227
           N+ +PEV+   L    E  D++S G+    +    +PF +    ++ 
Sbjct: 176 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFDDESIPVLF 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 417
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 13  GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 70
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 472
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 122
Query: 473 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 123 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 175
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 577
           N+ +PEV+   L    E  D++S G+    +    +PF +    ++ 
Sbjct: 176 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFDDESIPVLF 221

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 86
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 60  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116
Query: 87  LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 136
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 117 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 171
Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 194
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231
Query: 195 YD--ERSDIYSVGISCCELAN 213
           ++  +R+DIY++G+   E+A 
Sbjct: 232 FESFKRADIYAMGLVFWEIAR 252

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 436
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 60  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116
Query: 437 LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 486
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 117 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 171
Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 544
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231
Query: 545 YD--ERSDIYSVGISCCELAN 563
           ++  +R+DIY++G+   E+A 
Sbjct: 232 FESFKRADIYAMGLVFWEIAR 252

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/233 (20%), Positives = 98/233 (42%), Gaps = 29/233 (12%)
Query: 342 NINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD 401
           N++D +++  E    V +  K C          ++ ++ K +  +    V + +++R   
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQ-YAAKFIKKRRTKSSRRGVSREDIER--- 63
Query: 402 EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPE 461
                   E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E
Sbjct: 64  --------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTE 113
Query: 462 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPT 515
                 L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F   
Sbjct: 114 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            K +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 174 FKNIFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 67
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 8   GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 65
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 122
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 117
Query: 123 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 118 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 170
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           N+ +PEV+   L    E  D++S G+    +    +PF
Sbjct: 171 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPF 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 417
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 8   GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 65
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 472
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 117
Query: 473 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 118 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 170
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           N+ +PEV+   L    E  D++S G+    +    +PF
Sbjct: 171 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPF 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/184 (22%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ E   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 42  VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLL 97
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL 156
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S +   K    GL
Sbjct: 98  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 157
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 158 ARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYG 209
Query: 215 TVPF 218
            +P+
Sbjct: 210 RIPY 213

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/184 (22%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ E   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 42  VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLL 97
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL 506
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S +   K    GL
Sbjct: 98  DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 157
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 158 ARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYG 209
Query: 565 TVPF 568
            +P+
Sbjct: 210 RIPY 213

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 23  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAF 80
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 81  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 135
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++     K C  GL  +    P            A  
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVA--DPDHDHTGFLTEYVATR 193
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 194 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 23  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAF 80
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 81  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 135
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++     K C  GL  +    P            A  
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVA--DPDHDHTGFLTEYVATR 193
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 194 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 223

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 67
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 4   GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 61
Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 122
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 113
Query: 123 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 114 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 166
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           N+ +PEV+   L    E  D++S G+    +    +PF
Sbjct: 167 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPF 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHL 417
            NY+I   LG+   +   V L+ H  T Q +A+K  N   +   D++  +  EI  +R L
Sbjct: 4   GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 61
Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVL 472
           RHP+II          ++ +V    G        N  F++      + E       Q ++
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAG--------NELFDYIVQRDKMSEQEARRFFQQII 113
Query: 473 NGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           + +EY H    +HR +K  ++L+    N K    GL  +            F  ++  + 
Sbjct: 114 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-------FLKTSCGSP 166
Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           N+ +PEV+   L    E  D++S G+    +    +PF
Sbjct: 167 NYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPF 203

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 122 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 472 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 86
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 22  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 78
Query: 87  LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 136
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 79  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 133
Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 194
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 134 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 193
Query: 195 YD--ERSDIYSVGISCCELAN 213
           ++  +R+DIY++G+   E+A 
Sbjct: 194 FESFKRADIYAMGLVFWEIAR 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 436
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 22  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 78
Query: 437 LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 486
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 79  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 133
Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 544
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 134 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 193
Query: 545 YD--ERSDIYSVGISCCELAN 563
           ++  +R+DIY++G+   E+A 
Sbjct: 194 FESFKRADIYAMGLVFWEIAR 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 86
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 27  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 83
Query: 87  LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 136
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 84  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 138
Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 194
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 139 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 198
Query: 195 YD--ERSDIYSVGISCCELAN 213
           ++  +R+DIY++G+   E+A 
Sbjct: 199 FESFKRADIYAMGLVFWEIAR 219

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 436
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 27  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 83
Query: 437 LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 486
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 84  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 138
Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 544
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 139 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 198
Query: 545 YD--ERSDIYSVGISCCELAN 563
           ++  +R+DIY++G+   E+A 
Sbjct: 199 FESFKRADIYAMGLVFWEIAR 219

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 122 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 472 LNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L+  + + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 19/186 (10%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+   +++   E   M+ L+H  ++   +       +++++  M  GS  
Sbjct: 39  VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLL 95
Query: 99  DLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 154
           D + +       LP+L+       +  G+ YI  K +IHR ++A+++L+S +   K    
Sbjct: 96  DFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF 153
Query: 155 GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
           GL R +     T ++   FP      + W +PE +  N   +  +S+++S GI   E+  
Sbjct: 154 GLARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGCFTIKSNVWSFGILLYEIVT 205
Query: 214 -GTVPF 218
            G +P+
Sbjct: 206 YGKIPY 211

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 19/186 (10%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+   +++   E   M+ L+H  ++   +       +++++  M  GS  
Sbjct: 39  VAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLL 95
Query: 449 DLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLS 504
           D + +       LP+L+       +  G+ YI  K +IHR ++A+++L+S +   K    
Sbjct: 96  DFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADF 153
Query: 505 GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 563
           GL R +     T ++   FP      + W +PE +  N   +  +S+++S GI   E+  
Sbjct: 154 GLARVIEDNEYTAREGAKFP------IKWTAPEAI--NFGCFTIKSNVWSFGILLYEIVT 205
Query: 564 -GTVPF 568
            G +P+
Sbjct: 206 YGKIPY 211

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 86
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 21  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77
Query: 87  LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 136
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 78  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 132
Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 194
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192
Query: 195 YD--ERSDIYSVGISCCELAN 213
           ++  +R+DIY++G+   E+A 
Sbjct: 193 FESFKRADIYAMGLVFWEIAR 213

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 436
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 21  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77
Query: 437 LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 486
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 78  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 132
Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 544
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192
Query: 545 YD--ERSDIYSVGISCCELAN 563
           ++  +R+DIY++G+   E+A 
Sbjct: 193 FESFKRADIYAMGLVFWEIAR 213

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 52  EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLP 110
           +D + + +EI  M  L H N+I    +F    D+ LV   +  G   D +I+  +N  L 
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LT 185
Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNGKACLSGLRYMCPFSPTKKKV 169
           EL     ++ +  G+ ++H    +H  +K  +IL ++ + K        +  F   ++  
Sbjct: 186 ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI-----KIIDFGLARR-- 238
Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERS---DIYSVGISCCELANGTVPFAETPTTLM 226
             + P     +N+ +PE L   +  YD  S   D++SVG+    L +G  PF        
Sbjct: 239 --YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF-------- 288
Query: 227 LIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           L +  A    ++L C     D    D  E A  +IS+
Sbjct: 289 LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 402 EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLP 460
           +D + + +EI  M  L H N+I    +F    D+ LV   +  G   D +I+  +N  L 
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LT 185
Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL-ISHNGKACLSGLRYMCPFSPTKKKV 519
           EL     ++ +  G+ ++H    +H  +K  +IL ++ + K        +  F   ++  
Sbjct: 186 ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI-----KIIDFGLARR-- 238
Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERS---DIYSVGISCCELANGTVPFAETPTTLM 576
             + P     +N+ +PE L   +  YD  S   D++SVG+    L +G  PF        
Sbjct: 239 --YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF-------- 288
Query: 577 LIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 613
           L +  A    ++L C     D    D  E A  +IS+
Sbjct: 289 LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLXEXVATR 195
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLXEXVATR 195
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 26  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 83
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 84  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 138
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLXEXVATR 196
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 197 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 26  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 83
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 84  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 138
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLXEXVATR 196
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 197 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 19  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 76
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 77  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 131
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 189
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 190 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 219

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 19  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 76
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 77  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 131
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 189
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 190 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 219

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 86
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 24  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 80
Query: 87  LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 136
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 81  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 135
Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 194
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 136 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 195
Query: 195 YD--ERSDIYSVGISCCELAN 213
           ++  +R+DIY++G+   E+A 
Sbjct: 196 FESFKRADIYAMGLVFWEIAR 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISS----FLDATDLH 436
           + K   + +AVK F+     +E       EI     LRH NI+ +I++        T L 
Sbjct: 24  RGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 80
Query: 437 LVSPLMGFGSCKDLINAHFNF--GLPELVICHILQDVLNGLEYIH-------GKGFI-HR 486
           LVS     GS  D +N +     G+ +L +        +GL ++H       GK  I HR
Sbjct: 81  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-----TASGLAHLHMEIVGTQGKPAIAHR 135
Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDG 544
            +K+ +IL+  NG  C++ L            + + P        +++PEVL+   N+  
Sbjct: 136 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 195
Query: 545 YD--ERSDIYSVGISCCELAN 563
           ++  +R+DIY++G+   E+A 
Sbjct: 196 FESFKRADIYAMGLVFWEIAR 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V       A    +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLAGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V       A    +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLAGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 26  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 83
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 84  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 138
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 196
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 197 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 26  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 83
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 84  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 138
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 196
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 197 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 226

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 27  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 84
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 85  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 139
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 140 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 197
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 198 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 27  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 84
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 85  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 139
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 140 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 197
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 198 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 227

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 18  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 75
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 76  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 130
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 131 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 188
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 189 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 218

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 18  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 75
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 76  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 130
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 131 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 188
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 189 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 218

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 195
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 195
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 19  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 76
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 77  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 131
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 189
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 190 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 219

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 19  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 76
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 77  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 131
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 189
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 190 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 219

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            +   V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +
Sbjct: 83  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVRE 135
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
              +++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA
Sbjct: 136 GPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 141 SHILISHNG-KACLSGLRYMCPFSPTKKKVHL----FPPSTAYNLNWLSPEVLEQNLDGY 195
            ++L+S +G +A L    +     P      L    + P T  +   ++PEV+       
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH---MAPEVVMGKP--C 247
Query: 196 DERSDIYSVGISCC---ELANGTVPFAE 220
           D + DI+S   SCC    + NG  P+ +
Sbjct: 248 DAKVDIWS---SCCMMLHMLNGCHPWTQ 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            +   V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +
Sbjct: 83  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVRE 135
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
              +++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA
Sbjct: 136 GPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 491 SHILISHNG-KACLSGLRYMCPFSPTKKKVHL----FPPSTAYNLNWLSPEVLEQNLDGY 545
            ++L+S +G +A L    +     P      L    + P T  +   ++PEV+       
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH---MAPEVVMGKP--C 247
Query: 546 DERSDIYSVGISCC---ELANGTVPFAE 570
           D + DI+S   SCC    + NG  P+ +
Sbjct: 248 DAKVDIWS---SCCMMLHMLNGCHPWTQ 272

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 110/255 (43%), Gaps = 43/255 (16%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S+++  ++LGQ       V  +++ + ++  A+KK    R T+E L ++  E+  +  L 
Sbjct: 6   SDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVXLLASLN 60
Query: 69  HPNIICYISSFLDATDLHLVSPLMGFG---------------SCKDLINAHFNFGLPELV 113
           H  ++ Y +++L+  +   V P                    +  DLI++  N       
Sbjct: 61  HQYVVRYYAAWLERRNF--VKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQRDE 117
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHL 171
              + + +L  L YIH +G IHR +K  +I I  S N K    GL      S    K+  
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 172 FP-PSTAYNLN-------WLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAE 220
              P ++ NL        +++ EV    LDG   Y+E+ D YS+GI   E      PF+ 
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEV----LDGTGHYNEKIDXYSLGIIFFEX---IYPFST 230
Query: 221 TPTTLMLIEKLAGAT 235
               + +++KL   +
Sbjct: 231 GXERVNILKKLRSVS 245

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 110/255 (43%), Gaps = 43/255 (16%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S+++  ++LGQ       V  +++ + ++  A+KK    R T+E L ++  E+  +  L 
Sbjct: 6   SDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVXLLASLN 60
Query: 419 HPNIICYISSFLDATDLHLVSPLMGFG---------------SCKDLINAHFNFGLPELV 463
           H  ++ Y +++L+  +   V P                    +  DLI++  N       
Sbjct: 61  HQYVVRYYAAWLERRNF--VKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQRDE 117
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVHL 521
              + + +L  L YIH +G IHR +K  +I I  S N K    GL      S    K+  
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 522 FP-PSTAYNLN-------WLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAE 570
              P ++ NL        +++ EV    LDG   Y+E+ D YS+GI   E      PF+ 
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEV----LDGTGHYNEKIDXYSLGIIFFEX---IYPFST 230
Query: 571 TPTTLMLIEKLAGAT 585
               + +++KL   +
Sbjct: 231 GXERVNILKKLRSVS 245

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNII-----CYISSFLDATDLHL 87
            + +A+K+  +    +    S   E+  +RHL    HPN++     C +S     T L L
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 88  VSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           V     F      +  + +     G+P   I  ++  +L GL+++H    +HR +K  +I
Sbjct: 97  V-----FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 144 LISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           L++ +G+  L+  GL  +  F        +   S    L + +PEVL Q+   Y    D+
Sbjct: 152 LVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQS--SYATPVDL 202
Query: 202 YSVGISCCEL 211
           +SVG    E+
Sbjct: 203 WSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNII-----CYISSFLDATDLHL 437
            + +A+K+  +    +    S   E+  +RHL    HPN++     C +S     T L L
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 438 VSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           V     F      +  + +     G+P   I  ++  +L GL+++H    +HR +K  +I
Sbjct: 97  V-----FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 494 LISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           L++ +G+  L+  GL  +  F        +   S    L + +PEVL Q+   Y    D+
Sbjct: 152 LVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQS--SYATPVDL 202
Query: 552 YSVGISCCEL 561
           +SVG    E+
Sbjct: 203 WSVGCIFAEM 212

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 115
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 176 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 115
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 176 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+    +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRF 82
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 195
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+    +    H+  C R LR        
Sbjct: 25  VGPRYTNLS--YIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRF 82
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 83  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 137
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 195
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 196 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 225

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 115
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 176 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 115
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 176 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            +   V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +
Sbjct: 85  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVRE 137
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
              +++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA
Sbjct: 138 GPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 141 SHILISHNG-KACLSGLRYMCPFSPTKKKVHL----FPPSTAYNLNWLSPEVLEQNLDGY 195
            ++L+S +G +A L    +     P      L    + P T  +   ++PEV+       
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH---MAPEVVMGKP--C 249
Query: 196 DERSDIYSVGISCC---ELANGTVPFAE 220
           D + DI+S   SCC    + NG  P+ +
Sbjct: 250 DAKVDIWS---SCCMMLHMLNGCHPWTQ 274

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            +   V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +
Sbjct: 85  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVRE 137
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
              +++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA
Sbjct: 138 GPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 491 SHILISHNG-KACLSGLRYMCPFSPTKKKVHL----FPPSTAYNLNWLSPEVLEQNLDGY 545
            ++L+S +G +A L    +     P      L    + P T  +   ++PEV+       
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH---MAPEVVMGKP--C 249
Query: 546 DERSDIYSVGISCC---ELANGTVPFAE 570
           D + DI+S   SCC    + NG  P+ +
Sbjct: 250 DAKVDIWS---SCCMMLHMLNGCHPWTQ 274

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 23  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAF 80
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 81  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 135
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 193
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 194 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 23  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAF 80
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 81  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 135
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 193
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 194 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNII-----CYISSFLDATDLHL 87
            + +A+K+  +    +    S   E+  +RHL    HPN++     C +S     T L L
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 88  VSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           V     F      +  + +     G+P   I  ++  +L GL+++H    +HR +K  +I
Sbjct: 97  V-----FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 144 LISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           L++ +G+  L+  GL  +  F        +   S    L + +PEVL Q+   Y    D+
Sbjct: 152 LVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQS--SYATPVDL 202
Query: 202 YSVGISCCEL 211
           +SVG    E+
Sbjct: 203 WSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNII-----CYISSFLDATDLHL 437
            + +A+K+  +    +    S   E+  +RHL    HPN++     C +S     T L L
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 438 VSPLMGFGSCKDLINAHFNF----GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           V     F      +  + +     G+P   I  ++  +L GL+++H    +HR +K  +I
Sbjct: 97  V-----FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 494 LISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           L++ +G+  L+  GL  +  F        +   S    L + +PEVL Q+   Y    D+
Sbjct: 152 LVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQS--SYATPVDL 202
Query: 552 YSVGISCCEL 561
           +SVG    E+
Sbjct: 203 WSVGCIFAEM 212

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            +   V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVRE 121
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
              +++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA
Sbjct: 122 GPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 141 SHILISHNG-KACLSGLRYMCPFSPTKKKVHL----FPPSTAYNLNWLSPEVLEQNLDGY 195
            ++L+S +G +A L    +     P      L    + P T  +   ++PEV+       
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH---MAPEVVMGKP--C 233
Query: 196 DERSDIYSVGISCC---ELANGTVPFAE 220
           D + DI+S   SCC    + NG  P+ +
Sbjct: 234 DAKVDIWS---SCCMMLHMLNGCHPWTQ 258

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            +   V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVRE 121
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
              +++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA
Sbjct: 122 GPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 491 SHILISHNG-KACLSGLRYMCPFSPTKKKVHL----FPPSTAYNLNWLSPEVLEQNLDGY 545
            ++L+S +G +A L    +     P      L    + P T  +   ++PEV+       
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH---MAPEVVMGKP--C 233
Query: 546 DERSDIYSVGISCC---ELANGTVPFAE 570
           D + DI+S   SCC    + NG  P+ +
Sbjct: 234 DAKVDIWS---SCCMMLHMLNGCHPWTQ 258

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--- 83
           V++ K +   + +AVK F     T+E       EI     +RH NI+ +I++ +  T   
Sbjct: 53  VWMGKWR--GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 84  -DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF--------I 134
             L+L++     GS  D + +     L    +  +    ++GL ++H + F         
Sbjct: 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 135 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 194
           HR +K+ +IL+  NG  C++ L     F     +V + P +      ++ PEVL+++L+ 
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 195 YDERS----DIYSVGISCCELAN 213
              +S    D+YS G+   E+A 
Sbjct: 225 NHFQSYIMADMYSFGLILWEVAR 247

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--- 433
           V++ K +   + +AVK F     T+E       EI     +RH NI+ +I++ +  T   
Sbjct: 53  VWMGKWR--GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 434 -DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF--------I 484
             L+L++     GS  D + +     L    +  +    ++GL ++H + F         
Sbjct: 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 485 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 544
           HR +K+ +IL+  NG  C++ L     F     +V + P +      ++ PEVL+++L+ 
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 545 YDERS----DIYSVGISCCELAN 563
              +S    D+YS G+   E+A 
Sbjct: 225 NHFQSYIMADMYSFGLILWEVAR 247

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 50/229 (21%)
Query: 6   NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           +V   Y     +G+  +  +SS Y     V    +A+KK          +    H+  C 
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAY---DHVRKTRVAIKK----------ISPFEHQTYCQ 86
Query: 65  RHLR---------HPNIICYISSFLDAT------DLHLVSPLM-----GFGSCKDLINAH 104
           R LR         H N+I  I   L A+      D+++V  LM          + L N H
Sbjct: 87  RTLREIQILLRFRHENVIG-IRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDH 145
Query: 105 FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPF 162
                    IC+ L  +L GL+YIH    +HR +K S++LI+   + K C  GL  +   
Sbjct: 146 ---------ICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIA-- 194
Query: 163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
            P            A    + +PE++  N  GY +  DI+SVG    E+
Sbjct: 195 DPEHDHTGFLTEXVATRW-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 241

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 50/229 (21%)
Query: 356 NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           +V   Y     +G+  +  +SS Y     V    +A+KK          +    H+  C 
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAY---DHVRKTRVAIKK----------ISPFEHQTYCQ 86
Query: 415 RHLR---------HPNIICYISSFLDAT------DLHLVSPLM-----GFGSCKDLINAH 454
           R LR         H N+I  I   L A+      D+++V  LM          + L N H
Sbjct: 87  RTLREIQILLRFRHENVIG-IRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDH 145
Query: 455 FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPF 512
                    IC+ L  +L GL+YIH    +HR +K S++LI+   + K C  GL  +   
Sbjct: 146 ---------ICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIA-- 194
Query: 513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
            P            A    + +PE++  N  GY +  DI+SVG    E+
Sbjct: 195 DPEHDHTGFLTEXVATRW-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 241

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 36/189 (19%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 106 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 160
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  D++S
Sbjct: 161 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDLWS 204
Query: 204 VGISCCELA 212
           VG    E+ 
Sbjct: 205 VGCIMGEMV 213

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 36/189 (19%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 106 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 160
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  D++S
Sbjct: 161 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDLWS 204
Query: 554 VGISCCELA 562
           VG    E+ 
Sbjct: 205 VGCIMGEMV 213

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 29  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 86
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 87  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 141
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 142 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 199
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 200 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 29  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 86
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 87  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 141
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 142 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 199
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 200 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 229

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 191
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 192 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 36/189 (19%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 117 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 171
Query: 149 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
               G A  +G  + M P+  T+               + +PEV+     GY E  D++S
Sbjct: 172 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDLWS 215
Query: 204 VGISCCELA 212
           VG    E+ 
Sbjct: 216 VGCIMGEMV 224

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 36/189 (19%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 117 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 171
Query: 499 ----GKACLSGLRY-MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
               G A  +G  + M P+  T+               + +PEV+     GY E  D++S
Sbjct: 172 ILDFGLARTAGTSFMMTPYVVTR--------------YYRAPEVILGM--GYKENVDLWS 215
Query: 554 VGISCCELA 562
           VG    E+ 
Sbjct: 216 VGCIMGEMV 224

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTPA-------FVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTPA-------FVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 20/189 (10%)
Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 95
           N  +A+K      M+ E   S   E   M+ L+H  ++  + + +    +++V+  M  G
Sbjct: 33  NTKVAIKTLKPGTMSPE---SFLEEAQIMKKLKHDKLV-QLYAVVSEEPIYIVTEYMNKG 88
Query: 96  SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC--- 152
           S  D +       L    +  +   V  G+ YI    +IHR +++++IL+  NG  C   
Sbjct: 89  SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-NGLICKIA 147
Query: 153 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCE 210
                R +     T ++   FP      + W +PE     L G +  +SD++S GI   E
Sbjct: 148 DFGLARLIEDNEXTARQGAKFP------IKWTAPEA---ALYGRFTIKSDVWSFGILLTE 198
Query: 211 LA-NGTVPF 218
           L   G VP+
Sbjct: 199 LVTKGRVPY 207

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 20/189 (10%)
Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 445
           N  +A+K      M+ E   S   E   M+ L+H  ++  + + +    +++V+  M  G
Sbjct: 33  NTKVAIKTLKPGTMSPE---SFLEEAQIMKKLKHDKLV-QLYAVVSEEPIYIVTEYMNKG 88
Query: 446 SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC--- 502
           S  D +       L    +  +   V  G+ YI    +IHR +++++IL+  NG  C   
Sbjct: 89  SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-NGLICKIA 147
Query: 503 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCE 560
                R +     T ++   FP      + W +PE     L G +  +SD++S GI   E
Sbjct: 148 DFGLARLIEDNEXTARQGAKFP------IKWTAPEA---ALYGRFTIKSDVWSFGILLTE 198
Query: 561 LA-NGTVPF 568
           L   G VP+
Sbjct: 199 LVTKGRVPY 207

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 23  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 80
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 81  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 135
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 193
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 194 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 23  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 80
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 81  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 135
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 193
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 194 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 223

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T+EDL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T+EDL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +  L E   
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 116
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              L+ +LNG+ Y+H     H  +K  +I++          K    GL +   F    K 
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 177 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +G       +VY ++   +   +A+K   +    +    S   E+  +R L 
Sbjct: 4   SRYEPVAEIG--VGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 69  ---HPNIICYISS-FLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDV 121
              HPN++  +       TD  +   L+     +DL   ++     GLP   I  +++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L GL+++H    +HR +K  +IL++  G   L+       +S    ++ LFP      L 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFP--VVVTLW 176
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           + +PEVL Q+   Y    D++SVG    E+
Sbjct: 177 YRAPEVLLQST--YATPVDMWSVGCIFAEM 204

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +G       +VY ++   +   +A+K   +    +    S   E+  +R L 
Sbjct: 4   SRYEPVAEIG--VGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 419 ---HPNIICYISS-FLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDV 471
              HPN++  +       TD  +   L+     +DL   ++     GLP   I  +++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L GL+++H    +HR +K  +IL++  G   L+       +S    ++ LFP      L 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFP--VVVTLW 176
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           + +PEVL Q+   Y    D++SVG    E+
Sbjct: 177 YRAPEVLLQST--YATPVDMWSVGCIFAEM 204

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 41  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 98
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 99  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 153
Query: 122 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 211
Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 212 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 241

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 41  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 98
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 99  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 153
Query: 472 LNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           L GL+YIH    +HR +K S++L++   + K C  GL  +    P            A  
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHTGFLTEYVATR 211
Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
             + +PE++  N  GY +  DI+SVG    E+
Sbjct: 212 W-YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 241

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/195 (20%), Positives = 86/195 (44%), Gaps = 22/195 (11%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+   +++   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 209 VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLL 264
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY 158
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S    A L     
Sbjct: 265 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASL----- 315
Query: 159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP 217
           +C  +       L      + + W +PE +  N   +  +SD++S GI   E+   G +P
Sbjct: 316 VCKIA----DFGLARVGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIP 369
Query: 218 FA--ETPTTLMLIEK 230
           +     P  +  +E+
Sbjct: 370 YPGMSNPEVIRALER 384

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/195 (20%), Positives = 86/195 (44%), Gaps = 22/195 (11%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+   +++   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 209 VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLL 264
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY 508
           D + +      P   +      +  G+ +I  + +IHR ++A++IL+S    A L     
Sbjct: 265 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASL----- 315
Query: 509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP 567
           +C  +       L      + + W +PE +  N   +  +SD++S GI   E+   G +P
Sbjct: 316 VCKIA----DFGLARVGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIP 369
Query: 568 FA--ETPTTLMLIEK 580
           +     P  +  +E+
Sbjct: 370 YPGMSNPEVIRALER 384

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/216 (21%), Positives = 95/216 (43%), Gaps = 15/216 (6%)
Query: 8   PSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIVCM 64
           P  +++  +LG+  +  +  V       T ++ A+K  K  +     +D      E   +
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             ++HP I+  I +F     L+L+   +  G     +     F   E   C  L ++   
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLAEISMA 133
Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNW 182
           L ++H KG I+R +K  +I+++H G   L+       F   K+ +H    +  +   + +
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTD------FGLCKESIHDGTVTHTFCGTIEY 187
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++PE+L ++  G++   D +S+G    ++  G  PF
Sbjct: 188 MAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/216 (21%), Positives = 95/216 (43%), Gaps = 15/216 (6%)
Query: 358 PSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIVCM 414
           P  +++  +LG+  +  +  V       T ++ A+K  K  +     +D      E   +
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             ++HP I+  I +F     L+L+   +  G     +     F   E   C  L ++   
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLAEISMA 133
Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNW 532
           L ++H KG I+R +K  +I+++H G   L+       F   K+ +H    +  +   + +
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTD------FGLCKESIHDGTVTHTFCGTIEY 187
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++PE+L ++  G++   D +S+G    ++  G  PF
Sbjct: 188 MAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 11/203 (5%)
Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           T    A K  N  +++  D + L  E    R L+H NI+    S  +    +LV  L+  
Sbjct: 28  TGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-- 152
           G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K    
Sbjct: 88  GELFEDIVAREYYS--EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAV 145
Query: 153 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
            L+           ++    F  +  Y    LSPEVL +  + Y +  DI++ G+    L
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGY----LSPEVLRK--EAYGKPVDIWACGVILYIL 199
Query: 212 ANGTVPFAETPTTLMLIEKLAGA 234
             G  PF +     +  +  AGA
Sbjct: 200 LVGYPPFWDEDQHKLYQQIKAGA 222

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 11/203 (5%)
Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           T    A K  N  +++  D + L  E    R L+H NI+    S  +    +LV  L+  
Sbjct: 28  TGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTG 87
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC-- 502
           G   + I A   +   E    H +Q +L  + + H  G +HR +K  ++L++   K    
Sbjct: 88  GELFEDIVAREYYS--EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAV 145
Query: 503 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
            L+           ++    F  +  Y    LSPEVL +  + Y +  DI++ G+    L
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGY----LSPEVLRK--EAYGKPVDIWACGVILYIL 199
Query: 562 ANGTVPFAETPTTLMLIEKLAGA 584
             G  PF +     +  +  AGA
Sbjct: 200 LVGYPPFWDEDQHKLYQQIKAGA 222

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 32/237 (13%)
Query: 347 FNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS 406
           F   V+ +     +++I  ++G+       V + K K T ++ A+K  N   M    LK 
Sbjct: 78  FTQLVKEMQLHREDFEIIKVIGR--GAFGEVAVVKMKNTERIYAMKILNKWEM----LK- 130
Query: 407 LHHEIVCMRHLRH-------PNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNF 457
              E  C R  R          I     +F D   L+LV   M +    DL+   + F  
Sbjct: 131 -RAETACFREERDVLVNGDCQWITALHYAFQDENHLYLV---MDYYVGGDLLTLLSKFED 186
Query: 458 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR---YMCPFSP 514
            LPE +    + +++  ++ IH   ++HR +K  ++L+  NG   L+       M     
Sbjct: 187 KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT 246
Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPF 568
            +  V +  P      +++SPE+L+   DG   Y    D +S+G+   E+  G  PF
Sbjct: 247 VQSSVAVGTP------DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 79  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 137
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 138 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 195
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 196 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 79  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 137
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 138 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 195
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 196 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 32/237 (13%)
Query: 347 FNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS 406
           F   V+ +     +++I  ++G+       V + K K T ++ A+K  N   M    LK 
Sbjct: 62  FTQLVKEMQLHREDFEIIKVIGR--GAFGEVAVVKMKNTERIYAMKILNKWEM----LK- 114
Query: 407 LHHEIVCMRHLRH-------PNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNF 457
              E  C R  R          I     +F D   L+LV   M +    DL+   + F  
Sbjct: 115 -RAETACFREERDVLVNGDCQWITALHYAFQDENHLYLV---MDYYVGGDLLTLLSKFED 170
Query: 458 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR---YMCPFSP 514
            LPE +    + +++  ++ IH   ++HR +K  ++L+  NG   L+       M     
Sbjct: 171 KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT 230
Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPF 568
            +  V +  P      +++SPE+L+   DG   Y    D +S+G+   E+  G  PF
Sbjct: 231 VQSSVAVGTP------DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 53  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 111
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 112 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 169
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 170 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 53  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 111
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 112 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 169
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 170 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDAEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 215 TVPF 218
            +P+
Sbjct: 208 RIPY 211

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDAEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 565 TVPF 568
            +P+
Sbjct: 208 RIPY 211

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 48  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 106
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 107 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 165 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 48  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 106
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 107 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 165 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 17  LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 71
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 72  IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 115
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 172
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 209 TY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 267 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 367 LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 421
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 422 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 465
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 522
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 209 TY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 267 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 17  LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 71
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 72  IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 115
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 172
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 155 TY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 213 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 256

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 367 LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 421
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 422 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 465
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 522
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 155 TY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 213 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 109
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 167
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 109
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 167
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 109
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 167
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 109
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 167
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/216 (21%), Positives = 95/216 (43%), Gaps = 15/216 (6%)
Query: 8   PSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIVCM 64
           P  +++  +LG+  +  +  V       T ++ A+K  K  +     +D      E   +
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             ++HP I+  I +F     L+L+   +  G     +     F   E   C  L ++   
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLAEISMA 133
Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNW 182
           L ++H KG I+R +K  +I+++H G   L+       F   K+ +H    +  +   + +
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTD------FGLCKESIHDGTVTHXFCGTIEY 187
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++PE+L ++  G++   D +S+G    ++  G  PF
Sbjct: 188 MAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/216 (21%), Positives = 95/216 (43%), Gaps = 15/216 (6%)
Query: 358 PSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIVCM 414
           P  +++  +LG+  +  +  V       T ++ A+K  K  +     +D      E   +
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             ++HP I+  I +F     L+L+   +  G     +     F   E   C  L ++   
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLAEISMA 133
Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNW 532
           L ++H KG I+R +K  +I+++H G   L+       F   K+ +H    +  +   + +
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTD------FGLCKESIHDGTVTHXFCGTIEY 187
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++PE+L ++  G++   D +S+G    ++  G  PF
Sbjct: 188 MAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 17  LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 71
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 72  IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 115
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 172
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 152 TY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 210 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 367 LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 421
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 422 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 465
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 522
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 152 TY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 210 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 17  LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 71
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 72  IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 115
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 172
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 150 TY--QLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 208 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 251

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 367 LGQ-CFNNL---SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPN 421
           LG+ CF  +    +V + K K    +    K   D  T++DL  L  E+  M+ + +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 422 IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVIC 465
           II  + +      L+++      G+ ++ + A    G+         PE       LV C
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLF 522
                +  G+EY+  +  IHR + A ++L++ N   K    GL R +      KK  +  
Sbjct: 150 TY--QLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
            P     + W++PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 208 LP-----VKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 251

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 54  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 112
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 113 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 170
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 171 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 54  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 112
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 113 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 170
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 171 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 46  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 101
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 102 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 161
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 162 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 215 TVPF 218
            +P+
Sbjct: 214 RIPY 217

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 46  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 101
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 102 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 161
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 162 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 565 TVPF 568
            +P+
Sbjct: 214 RIPY 217

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 34/238 (14%)
Query: 347 FNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS 406
           F S V+ +     +++I  ++G+       V + K K  +++ A+K  N   M    LK 
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGR--GAFGEVAVVKLKNADKVFAMKILNKWEM----LK- 114
Query: 407 LHHEIVCMRHLRH-------PNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNF 457
              E  C R  R          I     +F D  +L+LV   M +    DL+   + F  
Sbjct: 115 -RAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV---MDYYVGGDLLTLLSKFED 170
Query: 458 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR---YMCPFSP 514
            LPE +    L +++  ++ +H   ++HR +K  +IL+  NG   L+       +     
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDG----YDERSDIYSVGISCCELANGTVPF 568
            +  V +  P      +++SPE+L Q ++G    Y    D +S+G+   E+  G  PF
Sbjct: 231 VQSSVAVGTP------DYISPEIL-QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 56  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 114
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 115 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 173 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    ++  
Sbjct: 56  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLD 114
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S N    L   GL RYM   +  
Sbjct: 115 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 173 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 85
           VY +K     +++A+K+  LD   DE + S    EI  ++ L HPNI+  I        L
Sbjct: 37  VYKAKDS-QGRIVALKRIRLD-AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            LV   M     K +++ +   GL +  I   L  +L G+ + H    +HR +K  ++LI
Sbjct: 95  TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152
Query: 146 SHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
           + +G   L+       F  P +   H         L + +P+VL      Y    DI+S+
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTH-----EVVTLWYRAPDVL-MGSKKYSTSVDIWSI 206
Query: 205 GISCCELANGTVPF 218
           G    E+  G   F
Sbjct: 207 GCIFAEMITGKPLF 220

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 435
           VY +K     +++A+K+  LD   DE + S    EI  ++ L HPNI+  I        L
Sbjct: 37  VYKAKDS-QGRIVALKRIRLD-AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            LV   M     K +++ +   GL +  I   L  +L G+ + H    +HR +K  ++LI
Sbjct: 95  TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152
Query: 496 SHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
           + +G   L+       F  P +   H         L + +P+VL      Y    DI+S+
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTH-----EVVTLWYRAPDVL-MGSKKYSTSVDIWSI 206
Query: 555 GISCCELANGTVPF 568
           G    E+  G   F
Sbjct: 207 GCIFAEMITGKPLF 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 85
           VY +K     +++A+K+  LD   DE + S    EI  ++ L HPNI+  I        L
Sbjct: 37  VYKAKDS-QGRIVALKRIRLD-AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            LV   M     K +++ +   GL +  I   L  +L G+ + H    +HR +K  ++LI
Sbjct: 95  TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152
Query: 146 SHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
           + +G   L+       F  P +   H         L + +P+VL      Y    DI+S+
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTH-----EVVTLWYRAPDVL-MGSKKYSTSVDIWSI 206
Query: 205 GISCCELANGTVPF 218
           G    E+  G   F
Sbjct: 207 GCIFAEMITGKPLF 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH-HEIVCMRHLRHPNIICYISSFLDATDL 435
           VY +K     +++A+K+  LD   DE + S    EI  ++ L HPNI+  I        L
Sbjct: 37  VYKAKDS-QGRIVALKRIRLD-AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            LV   M     K +++ +   GL +  I   L  +L G+ + H    +HR +K  ++LI
Sbjct: 95  TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152
Query: 496 SHNGKACLSGLRYMCPFS-PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
           + +G   L+       F  P +   H         L + +P+VL      Y    DI+S+
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTH-----EVVTLWYRAPDVL-MGSKKYSTSVDIWSI 206
Query: 555 GISCCELANGTVPF 568
           G    E+  G   F
Sbjct: 207 GCIFAEMITGKPLF 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/191 (20%), Positives = 86/191 (45%), Gaps = 16/191 (8%)
Query: 33  KVTNQLIAVKKFN----LDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV 88
           K T ++   K  N    LD+ T      + +EI  M  L HP +I    +F D  ++ L+
Sbjct: 73  KATGRVFVAKFINTPYPLDKYT------VKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126
Query: 89  SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
              +  G   D I A  ++ + E  + + ++    GL+++H    +H  +K  +I+    
Sbjct: 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185
Query: 149 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 208
             + +  + +         ++     +TA    + +PE++++   G+   +D++++G+  
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTTATA---EFAAPEIVDREPVGF--YTDMWAIGVLG 240
Query: 209 CELANGTVPFA 219
             L +G  PFA
Sbjct: 241 YVLLSGLSPFA 251

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/191 (20%), Positives = 86/191 (45%), Gaps = 16/191 (8%)
Query: 383 KVTNQLIAVKKFN----LDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV 438
           K T ++   K  N    LD+ T      + +EI  M  L HP +I    +F D  ++ L+
Sbjct: 73  KATGRVFVAKFINTPYPLDKYT------VKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126
Query: 439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
              +  G   D I A  ++ + E  + + ++    GL+++H    +H  +K  +I+    
Sbjct: 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185
Query: 499 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 558
             + +  + +         ++     +TA    + +PE++++   G+   +D++++G+  
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTTATA---EFAAPEIVDREPVGF--YTDMWAIGVLG 240
Query: 559 CELANGTVPFA 569
             L +G  PFA
Sbjct: 241 YVLLSGLSPFA 251

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 48  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 103
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S   + K    GL
Sbjct: 104 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 163
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 164 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 215
Query: 215 TVPF 218
            +P+
Sbjct: 216 RIPY 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 48  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 103
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S   + K    GL
Sbjct: 104 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 163
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 164 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 215
Query: 565 TVPF 568
            +P+
Sbjct: 216 RIPY 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 6   NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKF--NLDRMTDEDLKSLHHEIV 62
           +V   Y+I   +G   +  +SS   ++ ++T Q +A+KK     D +T+   K    E+ 
Sbjct: 51  DVGDEYEIIETIGNGAYGVVSS---ARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELK 105
Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK------DLINA------HFNFGLP 110
            ++H +H NII             ++ P + +G  K      DL+ +      H +  L 
Sbjct: 106 ILKHFKHDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLT 156
Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSPTKK 167
              + + L  +L GL+Y+H    IHR +K S++L++ N +  +      R +C    T  
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC----TSP 212
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             H +  +      W     L  +L  Y +  D++SVG
Sbjct: 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG 250

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 356 NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKF--NLDRMTDEDLKSLHHEIV 412
           +V   Y+I   +G   +  +SS   ++ ++T Q +A+KK     D +T+   K    E+ 
Sbjct: 51  DVGDEYEIIETIGNGAYGVVSS---ARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELK 105
Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK------DLINA------HFNFGLP 460
            ++H +H NII             ++ P + +G  K      DL+ +      H +  L 
Sbjct: 106 ILKHFKHDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLT 156
Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSPTKK 517
              + + L  +L GL+Y+H    IHR +K S++L++ N +  +      R +C    T  
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC----TSP 212
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             H +  +      W     L  +L  Y +  D++SVG
Sbjct: 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG 250

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLV 88
           + K   +++  K+ +   MT+ + + L  E+  +R L+HPNI+ Y    +D T+  L++V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 89  SPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIH-----GKGFIHRAVKAS 141
                 G    +I         L E  +  ++  +   L+  H     G   +HR +K +
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 142 HILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
           ++ +    N K    GL  +        K  +  P       ++SPE  + N   Y+E+S
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY------YMSPE--QMNRMSYNEKS 197
Query: 200 DIYSVGISCCELANGTVPFA 219
           DI+S+G    EL     PF 
Sbjct: 198 DIWSLGCLLYELCALMPPFT 217

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLV 438
           + K   +++  K+ +   MT+ + + L  E+  +R L+HPNI+ Y    +D T+  L++V
Sbjct: 26  RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85
Query: 439 SPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIH-----GKGFIHRAVKAS 491
                 G    +I         L E  +  ++  +   L+  H     G   +HR +K +
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 492 HILI--SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
           ++ +    N K    GL  +        K  +  P       ++SPE  + N   Y+E+S
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY------YMSPE--QMNRMSYNEKS 197
Query: 550 DIYSVGISCCELANGTVPFA 569
           DI+S+G    EL     PF 
Sbjct: 198 DIWSLGCLLYELCALMPPFT 217

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 41  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 96
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 97  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 156
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 157 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 208
Query: 215 TVPF 218
            +P+
Sbjct: 209 RIPY 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 41  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 96
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 97  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 156
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 157 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 208
Query: 565 TVPF 568
            +P+
Sbjct: 209 RIPY 212

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 12/179 (6%)
Query: 52  EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----DLHLVSPLMGFGSCKDLINAHFNF 107
           +D +    E    R   HPNI+  ++  L       +  L+ P    G+  + I    + 
Sbjct: 68  QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 108 G--LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM---CPF 162
           G  L E  I  +L  +  GLE IH KG+ HR +K ++IL+   G+  L  L  M   C  
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187
Query: 163 SPTKKKVHLFPPSTAYN--LNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 218
               ++        A    +++ +PE+   Q+    DER+D++S+G     +  G  P+
Sbjct: 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 12/179 (6%)
Query: 402 EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----DLHLVSPLMGFGSCKDLINAHFNF 457
           +D +    E    R   HPNI+  ++  L       +  L+ P    G+  + I    + 
Sbjct: 68  QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 458 G--LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM---CPF 512
           G  L E  I  +L  +  GLE IH KG+ HR +K ++IL+   G+  L  L  M   C  
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187
Query: 513 SPTKKKVHLFPPSTAYN--LNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
               ++        A    +++ +PE+   Q+    DER+D++S+G     +  G  P+
Sbjct: 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 215 TVPF 218
            +P+
Sbjct: 208 RIPY 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 565 TVPF 568
            +P+
Sbjct: 208 RIPY 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 215 TVPF 218
            +P+
Sbjct: 208 RIPY 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 565 TVPF 568
            +P+
Sbjct: 208 RIPY 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 49  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 104
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 105 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 164
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 165 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 216
Query: 215 TVPF 218
            +P+
Sbjct: 217 RIPY 220

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 49  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 104
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 105 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 164
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 165 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 216
Query: 565 TVPF 568
            +P+
Sbjct: 217 RIPY 220

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 222
           PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
           PE L   +  Y  +SD++S G+   E+   G  P+   P
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           ++L++ +   K    GL R +      KK  +   P     + W++PE L   +  Y  +
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLP-----VKWMAPEALFDRI--YTHQ 232
Query: 199 SDIYSVGISCCELAN-GTVPFAETPT 223
           SD++S G+   E+   G  P+   P 
Sbjct: 233 SDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           ++L++ +   K    GL R +      KK  +   P     + W++PE L   +  Y  +
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLP-----VKWMAPEALFDRI--YTHQ 232
Query: 549 SDIYSVGISCCELAN-GTVPFAETPT 573
           SD++S G+   E+   G  P+   P 
Sbjct: 233 SDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 42  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 97
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 98  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 157
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 158 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 209
Query: 215 TVPF 218
            +P+
Sbjct: 210 RIPY 213

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 42  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 97
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 98  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 157
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 158 ARLIEDNEXTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 209
Query: 565 TVPF 568
            +P+
Sbjct: 210 RIPY 213

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 34/181 (18%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 149 ----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
               G A  +G  +M              P       + +PEV+     GY E  DI+SV
Sbjct: 167 ILDFGLARTAGTSFM------------MEPEVVTRY-YRAPEVILGM--GYKENVDIWSV 211
Query: 205 G 205
           G
Sbjct: 212 G 212

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 34/181 (18%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 499 ----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
               G A  +G  +M              P       + +PEV+     GY E  DI+SV
Sbjct: 167 ILDFGLARTAGTSFM------------MEPEVVTRY-YRAPEVILGM--GYKENVDIWSV 211
Query: 555 G 555
           G
Sbjct: 212 G 212

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 16/165 (9%)
Query: 59  HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHI 117
            E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  L  L++   
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPP 174
              +   L Y+  K F+HR + A ++L+S      L   GL RYM   +  K      P 
Sbjct: 499 --QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP- 555
Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
                + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 556 -----IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 16/165 (9%)
Query: 409 HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHI 467
            E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  L  L++   
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 468 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPP 524
              +   L Y+  K F+HR + A ++L+S      L   GL RYM   +  K      P 
Sbjct: 499 --QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP- 555
Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
                + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 556 -----IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +       K +      +  Y    L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLXGTPEY----LAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +       K +      +  Y    L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLXGTPEY----LAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 24/192 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 53  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 111
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  +   F + +LV   +L+ +  G++Y+   G++HR + A +ILI+ N         
Sbjct: 112 TFLKKNDGQFTVIQLV--GMLRGISAGMKYLSDMGYVHRDLAARNILINSN--------- 160
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W +PE +      +   SD++S GI   
Sbjct: 161 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--FRKFTSASDVWSYGIVMW 218
Query: 210 ELAN-GTVPFAE 220
           E+ + G  P+ E
Sbjct: 219 EVVSYGERPYWE 230

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 24/192 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K   +   T++  +    E   M    HPNII        +  + +V+  M  GS  
Sbjct: 53  VAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 111
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  +   F + +LV   +L+ +  G++Y+   G++HR + A +ILI+ N         
Sbjct: 112 TFLKKNDGQFTVIQLV--GMLRGISAGMKYLSDMGYVHRDLAARNILINSN--------- 160
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W +PE +      +   SD++S GI   
Sbjct: 161 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--FRKFTSASDVWSYGIVMW 218
Query: 560 ELAN-GTVPFAE 570
           E+ + G  P+ E
Sbjct: 219 EVVSYGERPYWE 230

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 6   NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKF--NLDRMTDEDLKSLHHEIV 62
           +V   Y+I   +G   +  +SS   ++ ++T Q +A+KK     D +T+   K    E+ 
Sbjct: 52  DVGDEYEIIETIGNGAYGVVSS---ARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELK 106
Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK------DLINA------HFNFGLP 110
            ++H +H NII             ++ P + +G  K      DL+ +      H +  L 
Sbjct: 107 ILKHFKHDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLT 157
Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSPTKK 167
              + + L  +L GL+Y+H    IHR +K S++L++ N +  +      R +C    T  
Sbjct: 158 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC----TSP 213
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             H +  +      W     L  +L  Y +  D++SVG
Sbjct: 214 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG 251

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 356 NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKF--NLDRMTDEDLKSLHHEIV 412
           +V   Y+I   +G   +  +SS   ++ ++T Q +A+KK     D +T+   K    E+ 
Sbjct: 52  DVGDEYEIIETIGNGAYGVVSS---ARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELK 106
Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK------DLINA------HFNFGLP 460
            ++H +H NII             ++ P + +G  K      DL+ +      H +  L 
Sbjct: 107 ILKHFKHDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLT 157
Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSPTKK 517
              + + L  +L GL+Y+H    IHR +K S++L++ N +  +      R +C    T  
Sbjct: 158 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC----TSP 213
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             H +  +      W     L  +L  Y +  D++SVG
Sbjct: 214 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG 251

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/259 (21%), Positives = 100/259 (38%), Gaps = 45/259 (17%)
Query: 3   TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHH 59
           +L  +   Y +   +GQ   +   V ++    T  + A+K  N +++     +D++ +  
Sbjct: 20  SLLELQKKYHLKGAIGQ--GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 60  EIVCMRHLRHPNIICYISSFLDATDL----------HLVSPLMGF-----GSC------- 97
           E+  M+ L HPNI      + D   +          HL+  L  F     G C       
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 98  ---------KDLINAH-------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
                    ++ IN          +F   E +I +I++ + + L Y+H +G  HR +K  
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 142 HILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
           + L S N   +  L        F       +    + A    +++PEVL    + Y  + 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 200 DIYSVGISCCELANGTVPF 218
           D +S G+    L  G VPF
Sbjct: 258 DAWSAGVLLHLLLMGAVPF 276

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/259 (21%), Positives = 100/259 (38%), Gaps = 45/259 (17%)
Query: 353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHH 409
           +L  +   Y +   +GQ   +   V ++    T  + A+K  N +++     +D++ +  
Sbjct: 20  SLLELQKKYHLKGAIGQ--GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 410 EIVCMRHLRHPNIICYISSFLDATDL----------HLVSPLMGF-----GSC------- 447
           E+  M+ L HPNI      + D   +          HL+  L  F     G C       
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 448 ---------KDLINAH-------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
                    ++ IN          +F   E +I +I++ + + L Y+H +G  HR +K  
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 492 HILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
           + L S N   +  L        F       +    + A    +++PEVL    + Y  + 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 550 DIYSVGISCCELANGTVPF 568
           D +S G+    L  G VPF
Sbjct: 258 DAWSAGVLLHLLLMGAVPF 276

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 46  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 101
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 102 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 161
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 162 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 215 TVPF 218
            +P+
Sbjct: 214 RIPY 217

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 46  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 101
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 102 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 161
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 162 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 565 TVPF 568
            +P+
Sbjct: 214 RIPY 217

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 73  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 131 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 188
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V     +      +L+PE++     GY++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFA-------KRVKGATWTLCGTPEYLAPEIILSK--GYNKA 239
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 73  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 131 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 188
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V     +      +L+PE++     GY++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFA-------KRVKGATWTLCGTPEYLAPEIILSK--GYNKA 239
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 16/174 (9%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLD 109
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 165
           L  L++      +   L Y+  K F+HR + A ++L+S      L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY 167
Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 16/174 (9%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           +D   +    E + MR   HP+I+  I   +    + ++  L   G  +  +    F+  
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLD 109
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPT 515
           L  L++      +   L Y+  K F+HR + A ++L+S      L   GL RYM   +  
Sbjct: 110 LASLIL--YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY 167
Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           K      P      + W++PE +  N   +   SD++  G+   E L +G  PF
Sbjct: 168 KASKGKLP------IKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 215 TVPF 218
            +P+
Sbjct: 208 RIPY 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 40  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 95
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 156 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 565 TVPF 568
            +P+
Sbjct: 208 RIPY 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 45  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 100
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 101 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 160
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 161 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 212
Query: 215 TVPF 218
            +P+
Sbjct: 213 RIPY 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 45  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 100
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 101 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 160
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 161 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 212
Query: 565 TVPF 568
            +P+
Sbjct: 213 RIPY 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 50  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVR-LYAVVTQEPIYIITEYMENGSLV 105
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 106 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 165
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 166 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 217
Query: 215 TVPF 218
            +P+
Sbjct: 218 RIPY 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 50  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVR-LYAVVTQEPIYIITEYMENGSLV 105
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 106 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 165
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 166 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 217
Query: 565 TVPF 568
            +P+
Sbjct: 218 RIPY 221

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 35  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 90
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 91  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 150
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 151 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 202
Query: 215 TVPF 218
            +P+
Sbjct: 203 RIPY 206

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 35  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 90
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 91  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 150
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 151 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 202
Query: 565 TVPF 568
            +P+
Sbjct: 203 RIPY 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 36  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 91
Query: 99  DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 156
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 92  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGL 151
Query: 157 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 214
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 152 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 203
Query: 215 TVPF 218
            +P+
Sbjct: 204 RIPY 207

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +AVK      M+ +   +   E   M+ L+H  ++  + + +    +++++  M  GS  
Sbjct: 36  VAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV-RLYAVVTQEPIYIITEYMENGSLV 91
Query: 449 DLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL 506
           D +       L    +  +   +  G+ +I  + +IHR ++A++IL+S      ++  GL
Sbjct: 92  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGL 151
Query: 507 -RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
            R +     T ++   FP      + W +PE +  N   +  +SD++S GI   E+   G
Sbjct: 152 ARLIEDNEYTAREGAKFP------IKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHG 203
Query: 565 TVPF 568
            +P+
Sbjct: 204 RIPY 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T  +   FP  
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP-- 169
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 231
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 170 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 223
Query: 232 AGATPHLLDCTTYYV 246
               PHL     Y +
Sbjct: 224 RLYRPHLASEKVYTI 238

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T  +   FP  
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP-- 169
Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 581
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 170 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 223
Query: 582 AGATPHLLDCTTYYV 596
               PHL     Y +
Sbjct: 224 RLYRPHLASEKVYTI 238

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRH 69
           Y I   LG+   +   V L+ H  T Q +A+K  +   +   D+   +  EI  ++ LRH
Sbjct: 11  YIIRETLGE--GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           P+II         TD+ +V    G G   D I       + E       Q ++  +EY H
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCH 125
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 189
               +HR +K  ++L+  N    ++        +        F  ++  + N+ +PEV+ 
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-----FLKTSCGSPNYAAPEVIN 180
Query: 190 QNLDGYDERSDIYSVGISCCELANGTVPF 218
             L    E  D++S GI    +  G +PF
Sbjct: 181 GKLYAGPE-VDVWSCGIVLYVMLVGRLPF 208

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHLRH 419
           Y I   LG+   +   V L+ H  T Q +A+K  +   +   D+   +  EI  ++ LRH
Sbjct: 11  YIIRETLGE--GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           P+II         TD+ +V    G G   D I       + E       Q ++  +EY H
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCH 125
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 539
               +HR +K  ++L+  N    ++        +        F  ++  + N+ +PEV+ 
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-----FLKTSCGSPNYAAPEVIN 180
Query: 540 QNLDGYDERSDIYSVGISCCELANGTVPF 568
             L    E  D++S GI    +  G +PF
Sbjct: 181 GKLYAGPE-VDVWSCGIVLYVMLVGRLPF 208

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 24/210 (11%)
Query: 17  LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 68
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 69  -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L GL+YIH    +HR +K S++L++      +          P            A    
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW- 192
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           + +PE++  N  GY +  DI+SVG    E+
Sbjct: 193 YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 24/210 (11%)
Query: 367 LGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-------- 418
           +G  + NLS  Y+ +        A    N  R+  + +    H+  C R LR        
Sbjct: 21  VGPRYTNLS--YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 78
Query: 419 -HPNIICYISSFLDA------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            H NII  I+  + A       D+++V  LM     K L   H    L    IC+ L  +
Sbjct: 79  RHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQI 133
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L GL+YIH    +HR +K S++L++      +          P            A    
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW- 192
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           + +PE++  N  GY +  DI+SVG    E+
Sbjct: 193 YRAPEIM-LNSKGYTKSIDIWSVGCILAEM 221

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 48  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 164
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 165 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 216
Query: 198 RSDIYSVGISCCELAN-GTVPFAETPT 223
           +SD++S G+   E+   G  P+   P 
Sbjct: 217 QSDVWSFGVLLWEIFTLGGSPYPGVPV 243

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 48  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 164
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 165 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 216
Query: 548 RSDIYSVGISCCELAN-GTVPFAETPT 573
           +SD++S G+   E+   G  P+   P 
Sbjct: 217 QSDVWSFGVLLWEIFTLGGSPYPGVPV 243

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 180 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 231
Query: 198 RSDIYSVGISCCELAN-GTVPFAETPT 223
           +SD++S G+   E+   G  P+   P 
Sbjct: 232 QSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 180 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 231
Query: 548 RSDIYSVGISCCELAN-GTVPFAETPT 573
           +SD++S G+   E+   G  P+   P 
Sbjct: 232 QSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 52  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 168
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 169 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 220
Query: 198 RSDIYSVGISCCELAN-GTVPFAETPT 223
           +SD++S G+   E+   G  P+   P 
Sbjct: 221 QSDVWSFGVLLWEIFTLGGSPYPGVPV 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 52  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 168
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 169 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 220
Query: 548 RSDIYSVGISCCELAN-GTVPFAETPT 573
           +SD++S G+   E+   G  P+   P 
Sbjct: 221 QSDVWSFGVLLWEIFTLGGSPYPGVPV 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 55  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 171
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 172 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 223
Query: 198 RSDIYSVGISCCELAN-GTVPFAETPT 223
           +SD++S G+   E+   G  P+   P 
Sbjct: 224 QSDVWSFGVLLWEIFTLGGSPYPGVPV 250

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 55  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 171
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 172 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 223
Query: 548 RSDIYSVGISCCELAN-GTVPFAETPT 573
           +SD++S G+   E+   G  P+   P 
Sbjct: 224 QSDVWSFGVLLWEIFTLGGSPYPGVPV 250

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 104 VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 220
Query: 142 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           ++L++ +   K    GL R +      KK  +   P     + W++PE L   +  Y  +
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP-----VKWMAPEALFDRI--YTHQ 273
Query: 199 SDIYSVGISCCELAN-GTVPFAETPT 223
           SD++S G+   E+   G  P+   P 
Sbjct: 274 SDVWSFGVLLWEIFTLGGSPYPGVPV 299

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 104 VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 220
Query: 492 HILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           ++L++ +   K    GL R +      KK  +   P     + W++PE L   +  Y  +
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP-----VKWMAPEALFDRI--YTHQ 273
Query: 549 SDIYSVGISCCELAN-GTVPFAETPT 573
           SD++S G+   E+   G  P+   P 
Sbjct: 274 SDVWSFGVLLWEIFTLGGSPYPGVPV 299

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 56  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 114
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 172
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 173 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 224
Query: 198 RSDIYSVGISCCELAN-GTVPFAETPT 223
           +SD++S G+   E+   G  P+   P 
Sbjct: 225 QSDVWSFGVLLWEIFTLGGSPYPGVPV 251

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 56  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 114
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 172
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 173 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 224
Query: 548 RSDIYSVGISCCELAN-GTVPFAETPT 573
           +SD++S G+   E+   G  P+   P 
Sbjct: 225 QSDVWSFGVLLWEIFTLGGSPYPGVPV 251

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 81/202 (40%), Gaps = 15/202 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            N   V+  + +  N L+AVK        D   K L  E   ++   HPNI+  I     
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLIGVCTQ 183
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
              +++V  L+  G     +       L    +  ++ D   G+EY+  K  IHR + A 
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR 242
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVH-LFPPSTAYN---LNWLSPEVLEQNLDGYDE 197
           + L++      +S       F  ++++   ++  S       + W +PE L  N   Y  
Sbjct: 243 NCLVTEKNVLKISD------FGMSREEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSS 294
Query: 198 RSDIYSVGISCCE-LANGTVPF 218
            SD++S GI   E  + G  P+
Sbjct: 295 ESDVWSFGILLWETFSLGASPY 316

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 81/202 (40%), Gaps = 15/202 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+  + +  N L+AVK        D   K L  E   ++   HPNI+  I     
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLIGVCTQ 183
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
              +++V  L+  G     +       L    +  ++ D   G+EY+  K  IHR + A 
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR 242
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVH-LFPPSTAYN---LNWLSPEVLEQNLDGYDE 547
           + L++      +S       F  ++++   ++  S       + W +PE L  N   Y  
Sbjct: 243 NCLVTEKNVLKISD------FGMSREEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSS 294
Query: 548 RSDIYSVGISCCE-LANGTVPF 568
            SD++S GI   E  + G  P+
Sbjct: 295 ESDVWSFGILLWETFSLGASPY 316

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N    ++  GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N    ++  GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 45  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 102
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 103 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 160
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 211
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQI 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 45  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 102
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 103 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 160
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 211
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQI 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 180 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 231
Query: 198 RSDIYSVGISCCELAN-GTVPFAETPT 223
           +SD++S G+   E+   G  P+   P 
Sbjct: 232 QSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 180 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 231
Query: 548 RSDIYSVGISCCELAN-GTVPFAETPT 573
           +SD++S G+   E+   G  P+   P 
Sbjct: 232 QSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 15/202 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            N   V+  + +  N L+AVK        D   K L  E   ++   HPNI+  I     
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLIGVCTQ 183
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
              +++V  L+  G     +       L    +  ++ D   G+EY+  K  IHR + A 
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR 242
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTA----YNLNWLSPEVLEQNLDGYDE 197
           + L++      +S       F  ++++      ++       + W +PE L  N   Y  
Sbjct: 243 NCLVTEKNVLKISD------FGMSREEADGVXAASGGLRQVPVKWTAPEAL--NYGRYSS 294
Query: 198 RSDIYSVGISCCE-LANGTVPF 218
            SD++S GI   E  + G  P+
Sbjct: 295 ESDVWSFGILLWETFSLGASPY 316

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 15/202 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            N   V+  + +  N L+AVK        D   K L  E   ++   HPNI+  I     
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ-EARILKQYSHPNIVRLIGVCTQ 183
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
              +++V  L+  G     +       L    +  ++ D   G+EY+  K  IHR + A 
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR 242
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTA----YNLNWLSPEVLEQNLDGYDE 547
           + L++      +S       F  ++++      ++       + W +PE L  N   Y  
Sbjct: 243 NCLVTEKNVLKISD------FGMSREEADGVXAASGGLRQVPVKWTAPEAL--NYGRYSS 294
Query: 548 RSDIYSVGISCCE-LANGTVPF 568
            SD++S GI   E  + G  P+
Sbjct: 295 ESDVWSFGILLWETFSLGASPY 316

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 73  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 131 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 188
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 239
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 73  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 131 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 188
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 239
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHL 67
            N++   +LG+   +   V L++ K T  L AVK    D  + D+D++    E   +   
Sbjct: 23  DNFEFIRVLGK--GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 68  R-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           R HP +      F     L  V   +  G     I     F   E        ++++ L 
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIISALM 138
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV--HLFPPSTAYNLNWLS 184
           ++H KG I+R +K  ++L+ H G   L+    MC     K+ +   +   +     ++++
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFG-MC-----KEGICNGVTTATFCGTPDYIA 192
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PE+L++ L  Y    D +++G+   E+  G  PF
Sbjct: 193 PEILQEML--YGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHL 417
            N++   +LG+   +   V L++ K T  L AVK    D  + D+D++    E   +   
Sbjct: 23  DNFEFIRVLGK--GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 418 R-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           R HP +      F     L  V   +  G     I     F   E        ++++ L 
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIISALM 138
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV--HLFPPSTAYNLNWLS 534
           ++H KG I+R +K  ++L+ H G   L+    MC     K+ +   +   +     ++++
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFG-MC-----KEGICNGVTTATFCGTPDYIA 192
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PE+L++ L  Y    D +++G+   E+  G  PF
Sbjct: 193 PEILQEML--YGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQI 246

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQI 246

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 39  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 96
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 97  FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 154
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 155 KPENLLIDEQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 205
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTLMLIEKLAGA 234
            D +++G+   E+A G  P FA+ P  + + EK+   
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSG 240

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 39  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 96
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 97  FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 154
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 155 KPENLLIDEQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 205
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTLMLIEKLAGA 584
            D +++G+   E+A G  P FA+ P  + + EK+   
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSG 240

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 34/181 (18%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 92
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 93  GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 148
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 149 ----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 204
               G A  +G  +M              P       + +PEV+     GY E  D++SV
Sbjct: 167 ILDFGLARTAGTSFM------------MEPEVVTRY-YRAPEVILGM--GYKENVDLWSV 211
Query: 205 G 205
           G
Sbjct: 212 G 212

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 34/181 (18%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------DATDLHLVSPLM 442
           +A+KK +         K  + E+V M+ + H NII  ++ F       +  D+++V  LM
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---- 498
               C+ +        L    + ++L  +L G++++H  G IHR +K S+I++  +    
Sbjct: 112 DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 499 ----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSV 554
               G A  +G  +M              P       + +PEV+     GY E  D++SV
Sbjct: 167 ILDFGLARTAGTSFM------------MEPEVVTRY-YRAPEVILGM--GYKENVDLWSV 211
Query: 555 G 555
           G
Sbjct: 212 G 212

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 98  KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 197
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 180 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 231
Query: 198 RSDIYSVGISCCELAN-GTVPFAETPT 223
           +SD++S G+   E+   G  P+   P 
Sbjct: 232 QSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ 
Sbjct: 63  VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 121
Query: 448 KDLINAHFNFGL---------PE-------LVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           ++ + A    GL         PE       LV C     V  G+EY+  K  IHR + A 
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAY--QVARGMEYLASKKCIHRDLAAR 179
Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHL--FPPSTAYNL--NWLSPEVLEQNLDGYDE 547
           ++L++ +       +  +  F   +   H+  +  +T   L   W++PE L   +  Y  
Sbjct: 180 NVLVTED------NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTH 231
Query: 548 RSDIYSVGISCCELAN-GTVPFAETPT 573
           +SD++S G+   E+   G  P+   P 
Sbjct: 232 QSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 12  KICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           KI  ++G   F  + S +L         +A+K       T++  +    E   M    HP
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHP 68
Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIH 129
           N+I        +T + +++  M  GS    +  +   F + +LV   +L+ +  G++Y+ 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV--GMLRGIAAGMKYLA 126
Query: 130 GKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
              ++HRA+ A +IL++ N   K    GL R++     T    +         + W +PE
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLE--DDTSDPTYTSALGGKIPIRWTAPE 184
Query: 187 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAE 220
            ++     +   SD++S GI   E ++ G  P+ +
Sbjct: 185 AIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWD 217

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 362 KICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           KI  ++G   F  + S +L         +A+K       T++  +    E   M    HP
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHP 68
Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIH 479
           N+I        +T + +++  M  GS    +  +   F + +LV   +L+ +  G++Y+ 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV--GMLRGIAAGMKYLA 126
Query: 480 GKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
              ++HRA+ A +IL++ N   K    GL R++     T    +         + W +PE
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLE--DDTSDPTYTSALGGKIPIRWTAPE 184
Query: 537 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAE 570
            ++     +   SD++S GI   E ++ G  P+ +
Sbjct: 185 AIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWD 217

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 102
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 103 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 160
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 211
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQI 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 102
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 103 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 160
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 211
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQI 239

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 75/190 (39%), Gaps = 24/190 (12%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K       T+   +    E   M    HPNII             +V+  M  GS  
Sbjct: 80  VAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 157
             +  H   F + +LV   +L+ V  G+ Y+   G++HR + A ++L+  N         
Sbjct: 139 TFLRTHDGQFTIMQLV--GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN--------- 187
Query: 158 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 209
            +C  S     +V    P  AY        + W +PE +      +   SD++S G+   
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMW 245
Query: 210 E-LANGTVPF 218
           E LA G  P+
Sbjct: 246 EVLAYGERPY 255

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 75/190 (39%), Gaps = 24/190 (12%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K       T+   +    E   M    HPNII             +V+  M  GS  
Sbjct: 80  VAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR 507
             +  H   F + +LV   +L+ V  G+ Y+   G++HR + A ++L+  N         
Sbjct: 139 TFLRTHDGQFTIMQLV--GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN--------- 187
Query: 508 YMCPFSPTK-KKVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCC 559
            +C  S     +V    P  AY        + W +PE +      +   SD++S G+   
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMW 245
Query: 560 E-LANGTVPF 568
           E LA G  P+
Sbjct: 246 EVLAYGERPY 255

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 50/112 (44%), Gaps = 7/112 (6%)
Query: 109 LPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 167
           +P  VI  I++ VLN   YIH  K   HR VK S+IL+  NG+  LS       F  ++ 
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD------FGESEY 201
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 219
            V      +     ++ PE           + DI+S+GI    +    VPF+
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 50/112 (44%), Gaps = 7/112 (6%)
Query: 459 LPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 517
           +P  VI  I++ VLN   YIH  K   HR VK S+IL+  NG+  LS       F  ++ 
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD------FGESEY 201
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 569
            V      +     ++ PE           + DI+S+GI    +    VPF+
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           +  +  IHR + A ++L++ N   K    GL R +      KK  +   P     + W++
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VKWMA 227
Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           PE L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 228 PEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 51  DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 110
           + D +++  EI  M  LRHP ++    +F D  ++ ++   M  G   + +    N  + 
Sbjct: 89  ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMS 147
Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH 170
           E      ++ V  GL ++H   ++H  +K  +I+ +      L     +  F  T    H
Sbjct: 148 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELK----LIDFGLT---AH 200
Query: 171 LFPPS----TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 219
           L P      T     + +PEV E    GY   +D++SVG+    L +G  PF 
Sbjct: 201 LDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMWSVGVLSYILLSGLSPFG 251

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 401 DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 460
           + D +++  EI  M  LRHP ++    +F D  ++ ++   M  G   + +    N  + 
Sbjct: 89  ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMS 147
Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH 520
           E      ++ V  GL ++H   ++H  +K  +I+ +      L     +  F  T    H
Sbjct: 148 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELK----LIDFGLT---AH 200
Query: 521 LFPPS----TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 569
           L P      T     + +PEV E    GY   +D++SVG+    L +G  PF 
Sbjct: 201 LDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMWSVGVLSYILLSGLSPFG 251

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 47  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 104
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 105 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 162
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 163 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 213
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQI 241

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 47  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 104
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 105 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 162
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 163 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 213
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQI 241

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           K K   + +A+K+      ++ + K+   E+  +  + HPNI+    + L+   L     
Sbjct: 27  KAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCL----- 77
Query: 91  LMGFGSCKDLINA-HFNFGLPELVICHILQDVLN---GLEYIHG---KGFIHRAVKASHI 143
           +M +     L N  H    LP     H +   L    G+ Y+H    K  IHR +K  ++
Sbjct: 78  VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 137
Query: 144 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
           L+   G      +  +C F  T   +     +   +  W++PEV E +   Y E+ D++S
Sbjct: 138 LLVAGGT-----VLKICDFG-TACDIQTHMTNNKGSAAWMAPEVFEGS--NYSEKCDVFS 189
Query: 204 VGISCCELANGTVPFAET--PTTLMLIEKLAGATPHLL 239
            GI   E+     PF E   P   ++     G  P L+
Sbjct: 190 WGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 227

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           K K   + +A+K+      ++ + K+   E+  +  + HPNI+    + L+   L     
Sbjct: 27  KAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCL----- 77
Query: 441 LMGFGSCKDLINA-HFNFGLPELVICHILQDVLN---GLEYIHG---KGFIHRAVKASHI 493
           +M +     L N  H    LP     H +   L    G+ Y+H    K  IHR +K  ++
Sbjct: 78  VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 137
Query: 494 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
           L+   G      +  +C F  T   +     +   +  W++PEV E +   Y E+ D++S
Sbjct: 138 LLVAGGT-----VLKICDFG-TACDIQTHMTNNKGSAAWMAPEVFEGS--NYSEKCDVFS 189
Query: 554 VGISCCELANGTVPFAET--PTTLMLIEKLAGATPHLL 589
            GI   E+     PF E   P   ++     G  P L+
Sbjct: 190 WGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 227

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           K K   + +A+K+      ++ + K+   E+  +  + HPNI+    + L+   L     
Sbjct: 26  KAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCL----- 76
Query: 91  LMGFGSCKDLINA-HFNFGLPELVICHILQDVLN---GLEYIHG---KGFIHRAVKASHI 143
           +M +     L N  H    LP     H +   L    G+ Y+H    K  IHR +K  ++
Sbjct: 77  VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136
Query: 144 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 203
           L+   G      +  +C F  T   +     +   +  W++PEV E +   Y E+ D++S
Sbjct: 137 LLVAGGT-----VLKICDFG-TACDIQTHMTNNKGSAAWMAPEVFEGS--NYSEKCDVFS 188
Query: 204 VGISCCELANGTVPFAET--PTTLMLIEKLAGATPHLL 239
            GI   E+     PF E   P   ++     G  P L+
Sbjct: 189 WGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           K K   + +A+K+      ++ + K+   E+  +  + HPNI+    + L+   L     
Sbjct: 26  KAKWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCL----- 76
Query: 441 LMGFGSCKDLINA-HFNFGLPELVICHILQDVLN---GLEYIHG---KGFIHRAVKASHI 493
           +M +     L N  H    LP     H +   L    G+ Y+H    K  IHR +K  ++
Sbjct: 77  VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136
Query: 494 LISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS 553
           L+   G      +  +C F  T   +     +   +  W++PEV E +   Y E+ D++S
Sbjct: 137 LLVAGGT-----VLKICDFG-TACDIQTHMTNNKGSAAWMAPEVFEGS--NYSEKCDVFS 188
Query: 554 VGISCCELANGTVPFAET--PTTLMLIEKLAGATPHLL 589
            GI   E+     PF E   P   ++     G  P L+
Sbjct: 189 WGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 51  DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 110
           + D +++  EI  M  LRHP ++    +F D  ++ ++   M  G   + +    N  + 
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMS 253
Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH 170
           E      ++ V  GL ++H   ++H  +K  +I+ +      L     +  F  T    H
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELK----LIDFGLT---AH 306
Query: 171 LFPPS----TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 219
           L P      T     + +PEV E    GY   +D++SVG+    L +G  PF 
Sbjct: 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMWSVGVLSYILLSGLSPFG 357

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 401 DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 460
           + D +++  EI  M  LRHP ++    +F D  ++ ++   M  G   + +    N  + 
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMS 253
Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH 520
           E      ++ V  GL ++H   ++H  +K  +I+ +      L     +  F  T    H
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELK----LIDFGLT---AH 306
Query: 521 LFPPS----TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 569
           L P      T     + +PEV E    GY   +D++SVG+    L +G  PF 
Sbjct: 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGY--YTDMWSVGVLSYILLSGLSPFG 357

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 73  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 131 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 188
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 239
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 73  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 131 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 188
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 239
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQI 267

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 28/171 (16%)
Query: 60  EIVCMRHLRHPNIICYISSFLDATD--------------LHLVSPLMGFGSCKDLINAHF 105
           EI  +R L+HPN+I     FL   D               H++       + K  +    
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ--- 124
Query: 106 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYMCP 161
              LP  ++  +L  +L+G+ Y+H    +HR +K ++IL+       G+  ++ + +   
Sbjct: 125 ---LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 162 F-SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           F SP K    L P        + +PE+L      Y +  DI+++G    EL
Sbjct: 182 FNSPLKPLADLDP--VVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAEL 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 28/171 (16%)
Query: 410 EIVCMRHLRHPNIICYISSFLDATD--------------LHLVSPLMGFGSCKDLINAHF 455
           EI  +R L+HPN+I     FL   D               H++       + K  +    
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ--- 124
Query: 456 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYMCP 511
              LP  ++  +L  +L+G+ Y+H    +HR +K ++IL+       G+  ++ + +   
Sbjct: 125 ---LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 512 F-SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           F SP K    L P        + +PE+L      Y +  DI+++G    EL
Sbjct: 182 FNSPLKPLADLDP--VVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAEL 229

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 91/219 (41%), Gaps = 28/219 (12%)
Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 127
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL--NWLSP 185
           +  +  IHR + A ++L++ N    ++        +     +  +  +T   L   W++P
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFG----LARDINNIDYYKNTTNGRLPVKWMAP 228
Query: 186 EVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 223
           E L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 229 EALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 91/219 (41%), Gaps = 28/219 (12%)
Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
            +V + K K    +    K   D  T++DL  L  E+  M+ + +H NII  + +     
Sbjct: 55  EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114
Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGL---------PE-------LVICHILQDVLNGLEY 477
            L+++      G+ ++ + A    G+         PE       LV C     +  G+EY
Sbjct: 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY--QLARGMEY 172
Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL--NWLSP 535
           +  +  IHR + A ++L++ N    ++        +     +  +  +T   L   W++P
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFG----LARDINNIDYYKNTTNGRLPVKWMAP 228
Query: 536 EVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT 573
           E L   +  Y  +SD++S G+   E+   G  P+   P 
Sbjct: 229 EALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   M  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   M  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   M  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   M  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 12  KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 13  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 68
Query: 68  RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
               I+ Y  +S       L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 69  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 127
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           EY+  +  +HR + A +IL+       ++    +    P  K  ++        + W +P
Sbjct: 128 EYLGSRRCVHRDLAARNILVESEAHVKIADFG-LAKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 186 EVLEQNLDGYDERSDIYSVGISCCEL 211
           E L  N+  +  +SD++S G+   EL
Sbjct: 187 ESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 362 KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 13  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 68
Query: 418 RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
               I+ Y  +S       L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 69  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 127
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           EY+  +  +HR + A +IL+       ++    +    P  K  ++        + W +P
Sbjct: 128 EYLGSRRCVHRDLAARNILVESEAHVKIADFG-LAKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 536 EVLEQNLDGYDERSDIYSVGISCCEL 561
           E L  N+  +  +SD++S G+   EL
Sbjct: 187 ESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 12  KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 26  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 81
Query: 68  RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
               I+ Y  +S       L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 140
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           EY+  +  +HR + A +IL+       ++    +    P  K  ++        + W +P
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFG-LAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 186 EVLEQNLDGYDERSDIYSVGISCCEL 211
           E L  N+  +  +SD++S G+   EL
Sbjct: 200 ESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 362 KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 26  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 81
Query: 418 RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
               I+ Y  +S       L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 140
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           EY+  +  +HR + A +IL+       ++    +    P  K  ++        + W +P
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFG-LAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 536 EVLEQNLDGYDERSDIYSVGISCCEL 561
           E L  N+  +  +SD++S G+   EL
Sbjct: 200 ESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 12  KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 14  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 69
Query: 68  RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
               I+ Y  +S       L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 70  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 128
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           EY+  +  +HR + A +IL+       ++    +    P  K  ++        + W +P
Sbjct: 129 EYLGSRRCVHRDLAARNILVESEAHVKIADFG-LAKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 186 EVLEQNLDGYDERSDIYSVGISCCEL 211
           E L  N+  +  +SD++S G+   EL
Sbjct: 188 ESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 362 KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 14  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 69
Query: 418 RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
               I+ Y  +S       L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 70  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 128
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           EY+  +  +HR + A +IL+       ++    +    P  K  ++        + W +P
Sbjct: 129 EYLGSRRCVHRDLAARNILVESEAHVKIADFG-LAKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 536 EVLEQNLDGYDERSDIYSVGISCCEL 561
           E L  N+  +  +SD++S G+   EL
Sbjct: 188 ESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 9/128 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            +   V+  + K T    AVKK  L+    E+L      + C   L  P I+    +  +
Sbjct: 85  GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL------MACA-GLTSPRIVPLYGAVRE 137
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
              +++   L+  GS   L+       LPE    + L   L GLEY+H +  +H  VKA 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEGLEYLHSRRILHGDVKAD 195
Query: 142 HILISHNG 149
           ++L+S +G
Sbjct: 196 NVLLSSDG 203

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 9/128 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            +   V+  + K T    AVKK  L+    E+L      + C   L  P I+    +  +
Sbjct: 85  GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL------MACA-GLTSPRIVPLYGAVRE 137
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
              +++   L+  GS   L+       LPE    + L   L GLEY+H +  +H  VKA 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEGLEYLHSRRILHGDVKAD 195
Query: 492 HILISHNG 499
           ++L+S +G
Sbjct: 196 NVLLSSDG 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 12  KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 10  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 65
Query: 68  RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
               I+ Y  +S      +L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 66  HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 124
Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           EY+  +  +HR + A +IL+       ++  GL  + P       V     S  +   W 
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF---WY 181
Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCEL 211
           +PE L  N+  +  +SD++S G+   EL
Sbjct: 182 APESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 362 KICSILGQCFNNLSSVYLSKHKV----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           K  S LG+   N  SV L ++      T  L+AVK+  L     +  +    EI  ++ L
Sbjct: 10  KYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL 65
Query: 418 RHPNIICY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
               I+ Y  +S      +L LV   +  G  +D +  H        ++ +  Q +  G+
Sbjct: 66  HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ-ICKGM 124
Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           EY+  +  +HR + A +IL+       ++  GL  + P       V     S  +   W 
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF---WY 181
Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCEL 561
           +PE L  N+  +  +SD++S G+   EL
Sbjct: 182 APESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFP-- 184
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 231
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 185 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238
Query: 232 AGATPHLLDCTTYYV 246
               PHL     Y +
Sbjct: 239 RLYRPHLASEKVYTI 253

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFP-- 184
Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 581
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 185 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238
Query: 582 AGATPHLLDCTTYYV 596
               PHL     Y +
Sbjct: 239 RLYRPHLASEKVYTI 253

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 56  SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC--KDLINAHFNFGLPELV 113
           ++  EI  +R LRH N+I  +    +     +   +M +  C  ++++++      P   
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM-VMEYCVCGMQEMLDSVPEKRFPVCQ 110
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSP------ 164
                  +++GLEY+H +G +H+ +K  ++L++  G   +S L     + PF+       
Sbjct: 111 AHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++      PP  A  L+  S         G+  + DI+S G++   +  G  PF
Sbjct: 171 SQGSPAFQPPEIANGLDTFS---------GF--KVDIWSAGVTLYNITTGLYPF 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 406 SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC--KDLINAHFNFGLPELV 463
           ++  EI  +R LRH N+I  +    +     +   +M +  C  ++++++      P   
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM-VMEYCVCGMQEMLDSVPEKRFPVCQ 110
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL---RYMCPFSP------ 514
                  +++GLEY+H +G +H+ +K  ++L++  G   +S L     + PF+       
Sbjct: 111 AHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++      PP  A  L+  S         G+  + DI+S G++   +  G  PF
Sbjct: 171 SQGSPAFQPPEIANGLDTFS---------GF--KVDIWSAGVTLYNITTGLYPF 213

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLIIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIIISK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTLMLIEKL 231
            D +++G+   E+A G  P FA+ P  + + EK+
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQP--IQIYEKI 250

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLIIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIIISK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTLMLIEKL 581
            D +++G+   E+A G  P FA+ P  + + EK+
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQP--IQIYEKI 250

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 9/128 (7%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
            +   V+  + K T    AVKK  L+    E+L      + C   L  P I+    +  +
Sbjct: 104 GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL------MACA-GLTSPRIVPLYGAVRE 156
Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
              +++   L+  GS   L+       LPE    + L   L GLEY+H +  +H  VKA 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEGLEYLHSRRILHGDVKAD 214
Query: 142 HILISHNG 149
           ++L+S +G
Sbjct: 215 NVLLSSDG 222

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 9/128 (7%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
            +   V+  + K T    AVKK  L+    E+L      + C   L  P I+    +  +
Sbjct: 104 GSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL------MACA-GLTSPRIVPLYGAVRE 156
Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
              +++   L+  GS   L+       LPE    + L   L GLEY+H +  +H  VKA 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEGLEYLHSRRILHGDVKAD 214
Query: 492 HILISHNG 499
           ++L+S +G
Sbjct: 215 NVLLSSDG 222

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 164
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 231
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 165 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218
Query: 232 AGATPHLLDCTTYYV 246
               PHL     Y +
Sbjct: 219 RLYRPHLASEKVYTI 233

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 164
Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 581
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 165 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218
Query: 582 AGATPHLLDCTTYYV 596
               PHL     Y +
Sbjct: 219 RLYRPHLASEKVYTI 233

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 14/197 (7%)
Query: 29  LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH-- 86
           L K +     I VK   +   +    +  + E   +R   HPN++  + +       H  
Sbjct: 26  LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85
Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHR-AVKASHIL 144
           L++    +GS  ++++   NF + +        D   G  ++H  +  I R A+ +  + 
Sbjct: 86  LITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVX 145
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS-DIYS 203
           I  +  A +S       F           P   Y   W++PE L++  +  + RS D +S
Sbjct: 146 IDEDXTARISXADVKFSFQS---------PGRXYAPAWVAPEALQKKPEDTNRRSADXWS 196
Query: 204 VGISCCELANGTVPFAE 220
             +   EL    VPFA+
Sbjct: 197 FAVLLWELVTREVPFAD 213

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 14/197 (7%)
Query: 379 LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH-- 436
           L K +     I VK   +   +    +  + E   +R   HPN++  + +       H  
Sbjct: 26  LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85
Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHR-AVKASHIL 494
           L++    +GS  ++++   NF + +        D   G  ++H  +  I R A+ +  + 
Sbjct: 86  LITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVX 145
Query: 495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS-DIYS 553
           I  +  A +S       F           P   Y   W++PE L++  +  + RS D +S
Sbjct: 146 IDEDXTARISXADVKFSFQS---------PGRXYAPAWVAPEALQKKPEDTNRRSADXWS 196
Query: 554 VGISCCELANGTVPFAE 570
             +   EL    VPFA+
Sbjct: 197 FAVLLWELVTREVPFAD 213

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 168
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 231
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 169 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 222
Query: 232 AGATPHLLDCTTYYV 246
               PHL     Y +
Sbjct: 223 RLYRPHLASEKVYTI 237

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 168
Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 581
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 169 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 222
Query: 582 AGATPHLLDCTTYYV 596
               PHL     Y +
Sbjct: 223 RLYRPHLASEKVYTI 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +G       +VY ++   +   +A+K   +    +    S   E+  +R L 
Sbjct: 4   SRYEPVAEIG--VGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 69  ---HPNIICYISS-FLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDV 121
              HPN++  +       TD  +   L+     +DL   ++     GLP   I  +++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L GL+++H    +HR +K  +IL++  G   L+       +S    ++ L P      L 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAP--VVVTLW 176
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           + +PEVL Q+   Y    D++SVG    E+
Sbjct: 177 YRAPEVLLQST--YATPVDMWSVGCIFAEM 204

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +G       +VY ++   +   +A+K   +    +    S   E+  +R L 
Sbjct: 4   SRYEPVAEIG--VGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 419 ---HPNIICYISS-FLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDV 471
              HPN++  +       TD  +   L+     +DL   ++     GLP   I  +++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L GL+++H    +HR +K  +IL++  G   L+       +S    ++ L P      L 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAP--VVVTLW 176
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           + +PEVL Q+   Y    D++SVG    E+
Sbjct: 177 YRAPEVLLQST--YATPVDMWSVGCIFAEM 204

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   ++A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQI 246

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   ++A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQI 246

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 169
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 231
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 170 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 223
Query: 232 AGATPHLLDCTTYYV 246
               PHL     Y +
Sbjct: 224 RLYRPHLASEKVYTI 238

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 169
Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 581
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 170 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 223
Query: 582 AGATPHLLDCTTYYV 596
               PHL     Y +
Sbjct: 224 RLYRPHLASEKVYTI 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 38  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 95
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 96  FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 153
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V     +      +L+PE++     GY++ 
Sbjct: 154 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWTLCGTPEYLAPEIILSK--GYNKA 204
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQI 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 38  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 95
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 96  FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 153
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V     +      +L+PE++     GY++ 
Sbjct: 154 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWTLCGTPEYLAPEIILSK--GYNKA 204
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQI 232

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 12/184 (6%)
Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           +A+K       T+   +    E   M    HPNII             +V+  M  GS  
Sbjct: 80  VAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 99  DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSG 155
             +  H   F + +LV   +L+ V  G+ Y+   G++HR + A ++L+  N   K    G
Sbjct: 139 TFLRTHDGQFTIMQLV--GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANG 214
           L  +    P               + W +PE +      +   SD++S G+   E LA G
Sbjct: 197 LSRVLEDDPDAAXTTT---GGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYG 251
Query: 215 TVPF 218
             P+
Sbjct: 252 ERPY 255

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 12/184 (6%)
Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           +A+K       T+   +    E   M    HPNII             +V+  M  GS  
Sbjct: 80  VAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 449 DLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSG 505
             +  H   F + +LV   +L+ V  G+ Y+   G++HR + A ++L+  N   K    G
Sbjct: 139 TFLRTHDGQFTIMQLV--GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANG 564
           L  +    P               + W +PE +      +   SD++S G+   E LA G
Sbjct: 197 LSRVLEDDPDAAXTTT---GGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYG 251
Query: 565 TVPF 568
             P+
Sbjct: 252 ERPY 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 175
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 231
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 176 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 229
Query: 232 AGATPHLLDCTTYYV 246
               PHL     Y +
Sbjct: 230 RLYRPHLASEKVYTI 244

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 175
Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 581
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 176 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 229
Query: 582 AGATPHLLDCTTYYV 596
               PHL     Y +
Sbjct: 230 RLYRPHLASEKVYTI 244

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK T    A+K   LD+     LK + H   E    + +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK T    A+K   LD+     LK + H   E    + +  P ++    S
Sbjct: 53  GSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V     +      +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWTLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V     +      +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWTLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  +R + HPNII     + + TD+ L+  L+  G   D +       L E   
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEA 117
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 168
              ++ +L+G+ Y+H K   H  +K  +I++          K    GL +        K 
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 178 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +  E+  +R + HPNII     + + TD+ L+  L+  G   D +       L E   
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEA 117
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGLRYMCPFSPTKKK 518
              ++ +L+G+ Y+H K   H  +K  +I++          K    GL +        K 
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +   P        +++PE++  N +     +D++S+G+    L +G  PF
Sbjct: 178 IFGTP-------EFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 184
Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 231
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 185 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238
Query: 232 AGATPHLLDCTTYYV 246
               PHL     Y +
Sbjct: 239 RLYRPHLASEKVYTI 253

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           +DV   +EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP  
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-- 184
Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVP---FAETPTTLMLIEKL 581
               + W  PEVL      +  +SDI++ G+   E+ + G +P   F  + T   + + L
Sbjct: 185 ----VRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238
Query: 582 AGATPHLLDCTTYYV 596
               PHL     Y +
Sbjct: 239 RLYRPHLASEKVYTI 253

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +G       +VY ++   +   +A+K   +    +    S   E+  +R L 
Sbjct: 4   SRYEPVAEIG--VGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 69  ---HPNIICYISS-FLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDV 121
              HPN++  +       TD  +   L+     +DL   ++     GLP   I  +++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L GL+++H    +HR +K  +IL++  G   L+       +S    ++ L P      L 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDP--VVVTLW 176
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           + +PEVL Q+   Y    D++SVG    E+
Sbjct: 177 YRAPEVLLQST--YATPVDMWSVGCIFAEM 204

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +G       +VY ++   +   +A+K   +    +    S   E+  +R L 
Sbjct: 4   SRYEPVAEIG--VGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 419 ---HPNIICYISS-FLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDV 471
              HPN++  +       TD  +   L+     +DL   ++     GLP   I  +++  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L GL+++H    +HR +K  +IL++  G   L+       +S    ++ L P      L 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDP--VVVTLW 176
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           + +PEVL Q+   Y    D++SVG    E+
Sbjct: 177 YRAPEVLLQST--YATPVDMWSVGCIFAEM 204

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +          +   P +       L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-------LAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +          +   P +       L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-------LAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 127/308 (41%), Gaps = 32/308 (10%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y+  + LG+       VY +   VTN+ +A+K+  L+   +    +   E+  ++ L+H
Sbjct: 35  RYRRITKLGE--GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEY 127
            NII   S       LHL+     F   ++ +  +   N  +   VI   L  ++NG+ +
Sbjct: 93  RNIIELKSVIHHNHRLHLI-----FEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS-------PTKKKVHLFPPSTAYNL 180
            H +  +HR +K  ++L+S +  +    L+ +  F        P ++  H         L
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLK-IGDFGLARAFGIPIRQFTH-----EIITL 201
Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF---AETPTTLMLIEKLAGATPH 237
            +  PE+L  +   Y    DI+S+     E+   T  F   +E      + E L      
Sbjct: 202 WYRPPEILLGSRH-YSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG----- 255
Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
           L D TT+   T   D +++   +  +   +VL +    +    +  + L  D  KR  A 
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAM-LEMDPVKRISAK 314
Query: 298 NLLQHAFF 305
           N L+H +F
Sbjct: 315 NALEHPYF 322

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 7   VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE--DLKSLHHEIVCM 64
           VP NY+I  ++G+   +   VYL+  K  N+ +A+KK N  RM ++  D K +  EI  +
Sbjct: 26  VPDNYEIKHLIGR--GSYGYVYLAYDKNANKNVAIKKVN--RMFEDLIDCKRILREITIL 81
Query: 65  RHLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
             L+   II           L   +L++V  +      K      F   L E  +  IL 
Sbjct: 82  NRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEQHVKTILY 138
Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGL 156
           ++L G ++IH  G IHR +K ++ L++ +   K C  GL
Sbjct: 139 NLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGL 177

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE--DLKSLHHEIVCM 414
           VP NY+I  ++G+   +   VYL+  K  N+ +A+KK N  RM ++  D K +  EI  +
Sbjct: 26  VPDNYEIKHLIGR--GSYGYVYLAYDKNANKNVAIKKVN--RMFEDLIDCKRILREITIL 81
Query: 415 RHLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
             L+   II           L   +L++V  +      K      F   L E  +  IL 
Sbjct: 82  NRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEQHVKTILY 138
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGL 506
           ++L G ++IH  G IHR +K ++ L++ +   K C  GL
Sbjct: 139 NLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGL 177

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/342 (20%), Positives = 138/342 (40%), Gaps = 57/342 (16%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 66
            ++ +  ++G+   + + V L + K T+++ A+K    + + D ED+  +  E  V  + 
Sbjct: 9   QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 182
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSXFCGTPNY 176
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           ++PE+L     G+    D +++G+   E+  G  PF            + G++       
Sbjct: 177 IAPEILRGEDYGF--SVDWWALGVLMFEMMAGRSPF-----------DIVGSS------- 216
Query: 243 TYYVDTGQDDGEENACSYISEQ--QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC--- 297
                   D+ ++N   Y+ +   + Q+   R  S    S+++  L++D  +R L C   
Sbjct: 217 --------DNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER-LGCHPQ 267
Query: 298 ----NLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINN 335
               ++  H FF+      +M  + + P    N S    ++N
Sbjct: 268 TGFADIQGHPFFRNV-DWDMMEQKQVVPPFKPNISGEFGLDN 308

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 416
            ++ +  ++G+   + + V L + K T+++ A+K    + + D ED+  +  E  V  + 
Sbjct: 9   QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 532
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSXFCGTPNY 176
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++PE+L     G+    D +++G+   E+  G  PF
Sbjct: 177 IAPEILRGEDYGF--SVDWWALGVLMFEMMAGRSPF 210

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIKVADFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 66
            ++ +  ++G+   + + V L + K T+++ A+K    + + D ED+  +  E  V  + 
Sbjct: 20  QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 77
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 78  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 182
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 136 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSXFCGTPNY 187
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++PE+L     G+    D +++G+   E+  G  PF
Sbjct: 188 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 416
            ++ +  ++G+   + + V L + K T+++ A+K    + + D ED+  +  E  V  + 
Sbjct: 20  QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 77
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 78  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 532
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 136 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSXFCGTPNY 187
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++PE+L     G+    D +++G+   E+  G  PF
Sbjct: 188 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 221

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+P ++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPAIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KHK +    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+P ++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPAIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-----SFLDATDLH 86
           H+ T + +A+K+   + ++ ++ +    EI  M+ L HPN++           L   DL 
Sbjct: 36  HQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 94
Query: 87  LVSPLMGF---GSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           L++  M +   G  +  +N   N  GL E  I  +L D+ + L Y+H    IHR +K  +
Sbjct: 95  LLA--MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 152
Query: 143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSD 200
           I++    +  +  +  +       K++      T +   L +L+PE+LEQ    Y    D
Sbjct: 153 IVLQPGPQRLIHKIIDLG----YAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVD 206
Query: 201 IYSVGISCCELANGTVPF 218
            +S G    E   G  PF
Sbjct: 207 YWSFGTLAFECITGFRPF 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-----SFLDATDLH 436
           H+ T + +A+K+   + ++ ++ +    EI  M+ L HPN++           L   DL 
Sbjct: 36  HQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 94
Query: 437 LVSPLMGF---GSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           L++  M +   G  +  +N   N  GL E  I  +L D+ + L Y+H    IHR +K  +
Sbjct: 95  LLA--MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 152
Query: 493 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSD 550
           I++    +  +  +  +       K++      T +   L +L+PE+LEQ    Y    D
Sbjct: 153 IVLQPGPQRLIHKIIDLG----YAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVD 206
Query: 551 IYSVGISCCELANGTVPF 568
            +S G    E   G  PF
Sbjct: 207 YWSFGTLAFECITGFRPF 224

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 4   LDNVP-SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEI 61
           LD V  +++    +LG+   +   V L+  K T +L A+K    D  + D+D++    E 
Sbjct: 13  LDRVKLTDFNFLMVLGK--GSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEK 70
Query: 62  VCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
             +  L  P  +  + S     D L+ V   +  G     I     F  P+ V      +
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF--YAAE 128
Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           +  GL ++H +G I+R +K  ++++   G   ++    MC       K H+    T    
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFG-MC-------KEHMMDGVTTREF 180
Query: 181 ----NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
               ++++PE++      Y +  D ++ G+   E+  G  PF
Sbjct: 181 CGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 354 LDNVP-SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEI 411
           LD V  +++    +LG+   +   V L+  K T +L A+K    D  + D+D++    E 
Sbjct: 13  LDRVKLTDFNFLMVLGK--GSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEK 70
Query: 412 VCMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
             +  L  P  +  + S     D L+ V   +  G     I     F  P+ V      +
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF--YAAE 128
Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           +  GL ++H +G I+R +K  ++++   G   ++    MC       K H+    T    
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFG-MC-------KEHMMDGVTTREF 180
Query: 531 ----NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
               ++++PE++      Y +  D ++ G+   E+  G  PF
Sbjct: 181 CGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 57  LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 114
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 172
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 464
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 522
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 92/215 (42%), Gaps = 13/215 (6%)
Query: 12  KICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           KI  ++G   F  + S +L         +A+K       T++  +    E   M    HP
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHP 94
Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIH 129
           N+I        +T + +++  M  GS    +  +   F + +LV   +L+ +  G++Y+ 
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV--GMLRGIAAGMKYLA 152
Query: 130 GKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
              ++HR + A +IL++ N   K    GL R++     T    +         + W +PE
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE--DDTSDPTYTSALGGKIPIRWTAPE 210
Query: 187 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAE 220
            ++     +   SD++S GI   E ++ G  P+ +
Sbjct: 211 AIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 92/215 (42%), Gaps = 13/215 (6%)
Query: 362 KICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           KI  ++G   F  + S +L         +A+K       T++  +    E   M    HP
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHP 94
Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIH 479
           N+I        +T + +++  M  GS    +  +   F + +LV   +L+ +  G++Y+ 
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV--GMLRGIAAGMKYLA 152
Query: 480 GKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
              ++HR + A +IL++ N   K    GL R++     T    +         + W +PE
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE--DDTSDPTYTSALGGKIPIRWTAPE 210
Query: 537 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAE 570
            ++     +   SD++S GI   E ++ G  P+ +
Sbjct: 211 AIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 57  LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 114
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 172
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 464
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 522
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 32  HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-----SFLDATDLH 86
           H+ T + +A+K+   + ++ ++ +    EI  M+ L HPN++           L   DL 
Sbjct: 35  HQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93
Query: 87  LVSPLMGF---GSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           L++  M +   G  +  +N   N  GL E  I  +L D+ + L Y+H    IHR +K  +
Sbjct: 94  LLA--MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151
Query: 143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSD 200
           I++    +  +  +  +       K++      T +   L +L+PE+LEQ    Y    D
Sbjct: 152 IVLQPGPQRLIHKIIDLG----YAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVD 205
Query: 201 IYSVGISCCELANGTVPF 218
            +S G    E   G  PF
Sbjct: 206 YWSFGTLAFECITGFRPF 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 382 HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-----SFLDATDLH 436
           H+ T + +A+K+   + ++ ++ +    EI  M+ L HPN++           L   DL 
Sbjct: 35  HQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93
Query: 437 LVSPLMGF---GSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           L++  M +   G  +  +N   N  GL E  I  +L D+ + L Y+H    IHR +K  +
Sbjct: 94  LLA--MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151
Query: 493 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGYDERSD 550
           I++    +  +  +  +       K++      T +   L +L+PE+LEQ    Y    D
Sbjct: 152 IVLQPGPQRLIHKIIDLG----YAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVD 205
Query: 551 IYSVGISCCELANGTVPF 568
            +S G    E   G  PF
Sbjct: 206 YWSFGTLAFECITGFRPF 223

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 57  LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 114
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 172
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 464
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 522
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 15  SILGQCFNNLS--------SVYLSKHKVTNQLIAVKK----FNLDRMTDEDLKSL-HHEI 61
           S   Q F  LS         V+  + K   +L AVK+    F   +     L  +  HE 
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH---FNFGLPELVICHIL 118
           V     +HP  +    ++ +   L+L + L     C   +  H   +   LPE  +   L
Sbjct: 113 VG----QHPCCVRLEQAWEEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYL 163
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTA 177
           +D L  L ++H +G +H  VK ++I +   G+  L     +    +    +V    P   
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP--- 220
Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 212
               +++PE+L+ +   Y   +D++S+G++  E+A
Sbjct: 221 ---RYMAPELLQGS---YGTAADVFSLGLTILEVA 249

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 35/215 (16%)
Query: 365 SILGQCFNNLS--------SVYLSKHKVTNQLIAVKK----FNLDRMTDEDLKSL-HHEI 411
           S   Q F  LS         V+  + K   +L AVK+    F   +     L  +  HE 
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH---FNFGLPELVICHIL 468
           V     +HP  +    ++ +   L+L + L     C   +  H   +   LPE  +   L
Sbjct: 113 VG----QHPCCVRLEQAWEEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYL 163
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFPPSTA 527
           +D L  L ++H +G +H  VK ++I +   G+  L     +    +    +V    P   
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP--- 220
Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 562
               +++PE+L+ +   Y   +D++S+G++  E+A
Sbjct: 221 ---RYMAPELLQGS---YGTAADVFSLGLTILEVA 249

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 168
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 168
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 219
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQI 247

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 57  LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 114
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 172
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 407 LHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVI 464
           +  +I+   H R   I+    +F   TDL LV  +M  G  +  I      N G  E   
Sbjct: 234 VEKKILAKVHSRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLF 522
                 +++GLE++H +  I+R +K  ++L+  +G   +S  GL        TK K +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            P       +++PE+L    + YD   D +++G++  E+     PF
Sbjct: 352 TP------GFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 66
            ++ +  ++G+   + + V L + K T+++ A+K    + + D ED+  +  E  V  + 
Sbjct: 5   QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 182
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 121 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSXFCGTPNY 172
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++PE+L     G+    D +++G+   E+  G  PF
Sbjct: 173 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 416
            ++ +  ++G+   + + V L + K T+++ A+K    + + D ED+  +  E  V  + 
Sbjct: 5   QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 532
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 121 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSXFCGTPNY 172
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++PE+L     G+    D +++G+   E+  G  PF
Sbjct: 173 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 206

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V   +  G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  ++LI   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 66
            ++ +  ++G+   + + V L + K T+++ A++    + + D ED+  +  E  V  + 
Sbjct: 52  QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 182
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSTFCGTPNY 219
Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           ++PE+L     G+    D +++G+   E+  G  PF
Sbjct: 220 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 253

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI-VCMRH 416
            ++ +  ++G+   + + V L + K T+++ A++    + + D ED+  +  E  V  + 
Sbjct: 52  QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
             HP ++   S F   + L  V   +  G    + +      LPE        ++   L 
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NW 532
           Y+H +G I+R +K  ++L+   G   L+    MC       K  L P  T        N+
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG-MC-------KEGLRPGDTTSTFCGTPNY 219
Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++PE+L     G+    D +++G+   E+  G  PF
Sbjct: 220 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 253

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLF 172
           + H   DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++ 
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA------DFGLSRGQEVYVK 197
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
                  + W++ E L  N   Y   SD++S G+   E+ + G  P+
Sbjct: 198 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLF 522
           + H   DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++ 
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA------DFGLSRGQEVYVK 197
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
                  + W++ E L  N   Y   SD++S G+   E+ + G  P+
Sbjct: 198 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLF 172
           + H   DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++ 
Sbjct: 134 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA------DFGLSRGQEVYVK 187
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
                  + W++ E L  N   Y   SD++S G+   E+ + G  P+
Sbjct: 188 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLF 522
           + H   DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++ 
Sbjct: 134 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA------DFGLSRGQEVYVK 187
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
                  + W++ E L  N   Y   SD++S G+   E+ + G  P+
Sbjct: 188 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLF 172
           + H   DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++ 
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIA------DFGLSRGQEVYVK 194
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
                  + W++ E L  N   Y   SD++S G+   E+ + G  P+
Sbjct: 195 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLF 522
           + H   DV  G++Y+  K FIHR + A +IL+  N  A ++       F  ++ ++V++ 
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIA------DFGLSRGQEVYVK 194
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
                  + W++ E L  N   Y   SD++S G+   E+ + G  P+
Sbjct: 195 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 81/200 (40%), Gaps = 28/200 (14%)
Query: 38  LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           L+AVK   L   +D   K  H E   + +L+H +I+ +    ++   L +V   M  G  
Sbjct: 45  LVAVK--TLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 102
Query: 98  KDLINAH------FNFGLP--ELV---ICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
              + AH         G P  EL    + HI Q +  G+ Y+  + F+HR +   + L+ 
Sbjct: 103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162
Query: 147 HN-----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
            N     G   +S   Y   +       +     T   + W+ PE +      +   SD+
Sbjct: 163 ENLLVKIGDFGMSRDVYSTDY-------YRVGGHTMLPIRWMPPESIMYR--KFTTESDV 213
Query: 202 YSVGISCCEL-ANGTVPFAE 220
           +S+G+   E+   G  P+ +
Sbjct: 214 WSLGVVLWEIFTYGKQPWYQ 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 81/200 (40%), Gaps = 28/200 (14%)
Query: 388 LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           L+AVK   L   +D   K  H E   + +L+H +I+ +    ++   L +V   M  G  
Sbjct: 45  LVAVK--TLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 102
Query: 448 KDLINAH------FNFGLP--ELV---ICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
              + AH         G P  EL    + HI Q +  G+ Y+  + F+HR +   + L+ 
Sbjct: 103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162
Query: 497 HN-----GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
            N     G   +S   Y   +       +     T   + W+ PE +      +   SD+
Sbjct: 163 ENLLVKIGDFGMSRDVYSTDY-------YRVGGHTMLPIRWMPPESIMYR--KFTTESDV 213
Query: 552 YSVGISCCEL-ANGTVPFAE 570
           +S+G+   E+   G  P+ +
Sbjct: 214 WSLGVVLWEIFTYGKQPWYQ 233

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           +++I  ++G+     S V + K K T Q+ A+K  N   M    LK    E+ C R  R 
Sbjct: 62  DFEILKVIGR--GAFSEVAVVKMKQTGQVYAMKIMNKWDM----LK--RGEVSCFREER- 112
Query: 70  PNIIC-----YIS----SFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHIL 118
            +++      +I+    +F D   L+LV   M +    DL+     FG  +P  +    L
Sbjct: 113 -DVLVNGDRRWITQLHFAFQDENYLYLV---MEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
            +++  ++ +H  G++HR +K  +IL+   G   L+                L    T  
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP- 227
Query: 179 NLNWLSPEVLEQ-----NLDGYDERSDIYSVGISCCELANGTVPF 218
             ++LSPE+L+          Y    D +++G+   E+  G  PF
Sbjct: 228 --DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +++I  ++G+     S V + K K T Q+ A+K  N   M    LK    E+ C R  R 
Sbjct: 62  DFEILKVIGR--GAFSEVAVVKMKQTGQVYAMKIMNKWDM----LK--RGEVSCFREER- 112
Query: 420 PNIIC-----YIS----SFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHIL 468
            +++      +I+    +F D   L+LV   M +    DL+     FG  +P  +    L
Sbjct: 113 -DVLVNGDRRWITQLHFAFQDENYLYLV---MEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
            +++  ++ +H  G++HR +K  +IL+   G   L+                L    T  
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP- 227
Query: 529 NLNWLSPEVLEQ-----NLDGYDERSDIYSVGISCCELANGTVPF 568
             ++LSPE+L+          Y    D +++G+   E+  G  PF
Sbjct: 228 --DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/117 (21%), Positives = 51/117 (43%), Gaps = 7/117 (5%)
Query: 95  GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 154
           G+ +  I       L +++   + + +  G++YIH K  IHR +K S+I +    +  + 
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
               +       K+       +   L ++SPE +      Y +  D+Y++G+   EL
Sbjct: 179 DFGLVTSLKNDGKRTR-----SKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAEL 228

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/117 (21%), Positives = 51/117 (43%), Gaps = 7/117 (5%)
Query: 445 GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS 504
           G+ +  I       L +++   + + +  G++YIH K  IHR +K S+I +    +  + 
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
               +       K+       +   L ++SPE +      Y +  D+Y++G+   EL
Sbjct: 179 DFGLVTSLKNDGKRTR-----SKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAEL 228

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           TD+  +    E   M    HPNII           + +++  M  GS    +  +   F 
Sbjct: 55  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 114
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP-TKK 167
           + +LV   +L+ + +G++Y+    ++HR + A +IL++ N          +C  S     
Sbjct: 115 VIQLV--GMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN---------LVCKVSDFGMS 163
Query: 168 KVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 219
           +V    P  AY        + W +PE +      +   SD++S GI   E ++ G  P+ 
Sbjct: 164 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYW 221
Query: 220 E 220
           +
Sbjct: 222 D 222

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           TD+  +    E   M    HPNII           + +++  M  GS    +  +   F 
Sbjct: 55  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 114
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP-TKK 517
           + +LV   +L+ + +G++Y+    ++HR + A +IL++ N          +C  S     
Sbjct: 115 VIQLV--GMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN---------LVCKVSDFGMS 163
Query: 518 KVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 569
           +V    P  AY        + W +PE +      +   SD++S GI   E ++ G  P+ 
Sbjct: 164 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYW 221
Query: 570 E 570
           +
Sbjct: 222 D 222

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/219 (18%), Positives = 84/219 (38%), Gaps = 33/219 (15%)
Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           ++K   ++G        V+ +KH++  +   +K+   +    E       E+  +  L H
Sbjct: 12  DFKEIELIGS--GGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDH 63
Query: 70  PNIICYISSFLDATD-----------------LHLVSPLMGFGSCKDLINAHFNFGLPEL 112
            NI+ Y   + D  D                 L +       G+ +  I       L ++
Sbjct: 64  VNIVHYNGCW-DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 113 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 172
           +   + + +  G++YIH K  I+R +K S+I +    +  +     +       K+    
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR-- 180
Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
              +   L ++SPE +      Y +  D+Y++G+   EL
Sbjct: 181 ---SKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAEL 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/219 (18%), Positives = 84/219 (38%), Gaps = 33/219 (15%)
Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           ++K   ++G        V+ +KH++  +   +K+   +    E       E+  +  L H
Sbjct: 12  DFKEIELIGS--GGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDH 63
Query: 420 PNIICYISSFLDATD-----------------LHLVSPLMGFGSCKDLINAHFNFGLPEL 462
            NI+ Y   + D  D                 L +       G+ +  I       L ++
Sbjct: 64  VNIVHYNGCW-DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
           +   + + +  G++YIH K  I+R +K S+I +    +  +     +       K+    
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR-- 180
Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
              +   L ++SPE +      Y +  D+Y++G+   EL
Sbjct: 181 ---SKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAEL 214

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/301 (21%), Positives = 116/301 (38%), Gaps = 64/301 (21%)
Query: 33  KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH-PNIICYISSFLDATDLHLVSPL 91
           K T Q  A K     R   +    + HEI  +   +  P +I     + + +++ L+   
Sbjct: 51  KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY 110
Query: 92  MGFGSCKDLINAHFNFGLPELV-------ICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
              G         F+  LPEL        +  +++ +L G+ Y+H    +H  +K  +IL
Sbjct: 111 AAGGEI-------FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163
Query: 145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-NWLSPEVLEQNLDGYDERSDIYS 203
           +S      L  ++ +  F  ++K  H            +L+PE+L  N D     +D+++
Sbjct: 164 LS--SIYPLGDIK-IVDFGMSRKIGHACELREIMGTPEYLAPEIL--NYDPITTATDMWN 218
Query: 204 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           +GI    L   T PF                                  GE+N  +Y++ 
Sbjct: 219 IGIIAYMLLTHTSPFV---------------------------------GEDNQETYLNI 245
Query: 264 QQTQVLTSRKFSDSFHSIVELC-------LSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
            Q  V  S    ++F S+ +L        L ++ +KRP A   L H++ +Q    ++  P
Sbjct: 246 SQVNVDYSE---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302
Query: 317 E 317
           E
Sbjct: 303 E 303

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/123 (24%), Positives = 56/123 (45%), Gaps = 11/123 (8%)
Query: 98  KDLINAHFNFGLPELVIC-HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL 156
           KD +N   +    E  +C HI   +   +E++H KG +HR +K S+I  + +    +   
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 208
Query: 157 RYMCPFSPTKKKVHLFPPSTAYNLN--------WLSPEVLEQNLDGYDERSDIYSVGISC 208
             +      +++  +  P  AY  +        ++SPE +  N   Y  + DI+S+G+  
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLIL 266
Query: 209 CEL 211
            EL
Sbjct: 267 FEL 269

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/123 (24%), Positives = 56/123 (45%), Gaps = 11/123 (8%)
Query: 448 KDLINAHFNFGLPELVIC-HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL 506
           KD +N   +    E  +C HI   +   +E++H KG +HR +K S+I  + +    +   
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 208
Query: 507 RYMCPFSPTKKKVHLFPPSTAYNLN--------WLSPEVLEQNLDGYDERSDIYSVGISC 558
             +      +++  +  P  AY  +        ++SPE +  N   Y  + DI+S+G+  
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLIL 266
Query: 559 CEL 561
            EL
Sbjct: 267 FEL 269

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 7   VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE--DLKSLHHEIVCM 64
           VP NY I  ++G+   +   VYL+  K T + +A+KK N  RM ++  D K +  EI  +
Sbjct: 24  VPDNYIIKHLIGR--GSYGYVYLAYDKNTEKNVAIKKVN--RMFEDLIDCKRILREITIL 79
Query: 65  RHLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
             L+   II           L   +L++V  +      K      F   L E  I  IL 
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEEHIKTILY 136
Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGL 156
           ++L G  +IH  G IHR +K ++ L++ +   K C  GL
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE--DLKSLHHEIVCM 414
           VP NY I  ++G+   +   VYL+  K T + +A+KK N  RM ++  D K +  EI  +
Sbjct: 24  VPDNYIIKHLIGR--GSYGYVYLAYDKNTEKNVAIKKVN--RMFEDLIDCKRILREITIL 79
Query: 415 RHLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
             L+   II           L   +L++V  +      K      F   L E  I  IL 
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEEHIKTILY 136
Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGL 506
           ++L G  +IH  G IHR +K ++ L++ +   K C  GL
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 12  KICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           KI  ++G   F  + S  L      +  +A+K   +   T++  +    E   M    HP
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG-YTEKQRRDFLCEASIMGQFDHP 104
Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIH 129
           N++           + +V   M  G+    +  H   F + +LV   +L+ +  G+ Y+ 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLV--GMLRGIAAGMRYLA 162
Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLFPPSTAYN-------LN 181
             G++HR + A +IL++ N          +C  S     +V    P   Y        + 
Sbjct: 163 DMGYVHRDLAARNILVNSN---------LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR 213
Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 218
           W +PE ++     +   SD++S GI   E ++ G  P+
Sbjct: 214 WTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPY 249

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 362 KICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           KI  ++G   F  + S  L      +  +A+K   +   T++  +    E   M    HP
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG-YTEKQRRDFLCEASIMGQFDHP 104
Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIH 479
           N++           + +V   M  G+    +  H   F + +LV   +L+ +  G+ Y+ 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLV--GMLRGIAAGMRYLA 162
Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK-KKVHLFPPSTAYN-------LN 531
             G++HR + A +IL++ N          +C  S     +V    P   Y        + 
Sbjct: 163 DMGYVHRDLAARNILVNSN---------LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR 213
Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPF 568
           W +PE ++     +   SD++S GI   E ++ G  P+
Sbjct: 214 WTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPY 249

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 50  TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 108
           TD+  +    E   M    HPNII           + +++  M  GS    +  +   F 
Sbjct: 49  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 108
Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP-TKK 167
           + +LV   +L+ + +G++Y+    ++HR + A +IL++ N          +C  S     
Sbjct: 109 VIQLV--GMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN---------LVCKVSDFGMS 157
Query: 168 KVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 219
           +V    P  AY        + W +PE +      +   SD++S GI   E ++ G  P+ 
Sbjct: 158 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYW 215
Query: 220 E 220
           +
Sbjct: 216 D 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 400 TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFG 458
           TD+  +    E   M    HPNII           + +++  M  GS    +  +   F 
Sbjct: 49  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 108
Query: 459 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP-TKK 517
           + +LV   +L+ + +G++Y+    ++HR + A +IL++ N          +C  S     
Sbjct: 109 VIQLV--GMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN---------LVCKVSDFGMS 157
Query: 518 KVHLFPPSTAYN-------LNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 569
           +V    P  AY        + W +PE +      +   SD++S GI   E ++ G  P+ 
Sbjct: 158 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYW 215
Query: 570 E 570
           +
Sbjct: 216 D 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLMIDQQGYIQVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 108 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 167
           GLP   I  +++  L GL+++H    +HR +K  +IL++  G   L+       +S    
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---Y 172
Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           ++ L P      L + +PEVL Q+   Y    D++SVG    E+
Sbjct: 173 QMALTP--VVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEM 212

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 458 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 517
           GLP   I  +++  L GL+++H    +HR +K  +IL++  G   L+       +S    
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS---Y 172
Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           ++ L P      L + +PEVL Q+   Y    D++SVG    E+
Sbjct: 173 QMALTP--VVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEM 212

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 22  NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 78
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 139 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 199 SDIYSVGISCCELANGTVP-FAETPTTL 225
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 17/208 (8%)
Query: 372 NNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISS 428
            +   V L KH  T    A+K   LD+     LK + H   E   ++ +  P ++    S
Sbjct: 52  GSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
           F D ++L++V      G     +     F  P     +  Q VL   EY+H    I+R +
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH-ARFYAAQIVLT-FEYLHSLDLIYRDL 167
Query: 489 KASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           K  +++I   G   ++   +        K+V            +L+PE++     GY++ 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFA-------KRVKGRTWXLCGTPEYLAPEIILSK--GYNKA 218
Query: 549 SDIYSVGISCCELANGTVP-FAETPTTL 575
            D +++G+   E+A G  P FA+ P  +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQI 246

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	622
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-109
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-87
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-63
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-48
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-56
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-44
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-54
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-40
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-52
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-39
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-52
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-39
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-52
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-39
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-51
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-38
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-50
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-48
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-48
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-44
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-44
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-44
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-44
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-43
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-43
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-42
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-25
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-28
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-26
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-26
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-25
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-23
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-22
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-22
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-22
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-22
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-05
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-05
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-19
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-13
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-13
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-12
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-12
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-11
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-11
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-11
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-08
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-11
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-09
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-11
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-11
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-08
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-11
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-10
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-10
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-10
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-10
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-10
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-10
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-10
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-10
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-10
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-10
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-10
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-10
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-09
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-09
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-09
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-09
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-09
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-08
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-08
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-05
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-07
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-04
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-07
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-07
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-07
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-07
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-06
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-06
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-06
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-06
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-06
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-05
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-05
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-05
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-05
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-05
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-04
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-04
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-04

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  333 bits (854), Expect = e-109
 Identities = 141/346 (40%), Positives = 196/346 (56%), Gaps = 17/346 (4%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           M +       Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L  E
Sbjct: 17  MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76

Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +   +   HPNI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +ILQ 
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK---VHLFPPSTA 177
           VL  L+YIH  G++HR+VKASHILIS +GK  LSGLR         ++   VH FP  + 
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH 237
             L WLSPEVL+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  P 
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256

Query: 238 LLDCTTYYVDTGQDDGEENACSY-------------ISEQQTQVLTSRKFSDSFHSIVEL 284
           LLD +T   +        +  +               +         R FS  FH  VE 
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316

Query: 285 CLSRDVDKRPLACNLLQHAFFKQTKKCSV-MLPELLRPALSLNESN 329
           CL R+ D RP A  LL H+FFKQ K+ +   LPELLRP   +    
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  275 bits (704), Expect = 7e-87
 Identities = 113/277 (40%), Positives = 163/277 (58%), Gaps = 3/277 (1%)

Query: 349 SSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH 408
             + +       Y++ +++G+ F +L +V L+++K T + + V++ NL+  ++E +  L 
Sbjct: 15  QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74

Query: 409 HEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
            E+   +   HPNI+ Y ++F+   +L +V+  M +GS KDLI  HF  G+ EL I +IL
Sbjct: 75  GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134

Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK---VHLFPPS 525
           Q VL  L+YIH  G++HR+VKASHILIS +GK  LSGLR         ++   VH FP  
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT 585
           +   L WLSPEVL+QNL GYD +SDIYSVGI+ CELANG VPF + P T ML+EKL G  
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 586 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSR 622
           P LLD +T   +        +  +          T R
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  210 bits (536), Expect = 3e-63
 Identities = 96/326 (29%), Positives = 144/326 (44%), Gaps = 54/326 (16%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
               +Y++  ++G      + V  +      + +A+K+ NL++     +  L  EI  M 
Sbjct: 12  INRDDYELQEVIGS--GATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMS 68

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG------LPELVICHILQ 119
              HPNI+ Y +SF+   +L LV  L+  GS  D+I      G      L E  I  IL+
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGK---------ACLSGLRYMCPFSPTKKKVH 170
           +VL GLEY+H  G IHR VKA +IL+  +G          A L+    +       K   
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI----TRNKVRK 184

Query: 171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLI 228
            F   T     W++PEV+EQ   GYD ++DI+S GI+  ELA G  P+ + P    LML 
Sbjct: 185 TF-VGTPC---WMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239

Query: 229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
            +     P L                                 +K+  SF  ++ LCL +
Sbjct: 240 LQ--NDPPSL-----------------------ETGVQDKEMLKKYGKSFRKMISLCLQK 274

Query: 289 DVDKRPLACNLLQHAFFKQTKKCSVM 314
           D +KRP A  LL+H FF++ K    +
Sbjct: 275 DPEKRPTAAELLRHKFFQKAKNKEFL 300

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  170 bits (434), Expect = 1e-48
 Identities = 81/270 (30%), Positives = 121/270 (44%), Gaps = 31/270 (11%)

Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSL 407
           +SS         +Y++  ++G      + V  +      + +A+K+ NL++     +  L
Sbjct: 4   DSSALPWSINRDDYELQEVIGS--GATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDEL 60

Query: 408 HHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG------LPE 461
             EI  M    HPNI+ Y +SF+   +L LV  L+  GS  D+I      G      L E
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 462 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---------ACLSGLRYMCPF 512
             I  IL++VL GLEY+H  G IHR VKA +IL+  +G          A L+    +   
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI--- 177

Query: 513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP 572
               K    F   T     W++PEV+EQ   GYD ++DI+S GI+  ELA G  P+ + P
Sbjct: 178 -TRNKVRKTF-VGTPC---WMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYP 231

Query: 573 TT--LMLIEKLAGATPHLLDCTTYYVDTGQ 600
               LML  +     P L           +
Sbjct: 232 PMKVLMLTLQ--NDPPSLETGVQDKEMLKK 259

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  191 bits (488), Expect = 2e-56
 Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 58/302 (19%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            V+      T +++A+K  +L+   +++++ +  EI  +     P +  Y  S+L  T L
Sbjct: 37  EVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            ++   +G GS  DL+       L E  I  IL+++L GL+Y+H +  IHR +KA+++L+
Sbjct: 96  WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152

Query: 146 SHNGKACLSGLRYMCPF------SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
           S +G+  L        F      + T+ K + F   T +   W++PEV++Q+   YD ++
Sbjct: 153 SEHGEVKL------ADFGVAGQLTDTQIKRNTF-VGTPF---WMAPEVIKQS--AYDSKA 200

Query: 200 DIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENA 257
           DI+S+GI+  ELA G  P +E      L LI K     P L                   
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVLFLIPK--NNPPTLEG----------------- 241

Query: 258 CSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPE 317
                           +S      VE CL+++   RP A  LL+H F  +  K +  L E
Sbjct: 242 ---------------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286

Query: 318 LL 319
           L+
Sbjct: 287 LI 288

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  159 bits (403), Expect = 3e-44
 Identities = 65/246 (26%), Positives = 119/246 (48%), Gaps = 26/246 (10%)

Query: 343 INDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE 402
           +            +    +     +G+   +   V+      T +++A+K  +L+   ++
Sbjct: 6   VQSGLPGMQNLKADPEELFTKLEKIGK--GSFGEVFKGIDNRTQKVVAIKIIDLEE-AED 62

Query: 403 DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPEL 462
           +++ +  EI  +     P +  Y  S+L  T L ++   +G GS  DL+       L E 
Sbjct: 63  EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDET 119

Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF------SPTK 516
            I  IL+++L GL+Y+H +  IHR +KA+++L+S +G+  L        F      + T+
Sbjct: 120 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKL------ADFGVAGQLTDTQ 173

Query: 517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-- 574
            K + F   T +   W++PEV++Q+   YD ++DI+S+GI+  ELA G  P +E      
Sbjct: 174 IKRNTF-VGTPF---WMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMKV 227

Query: 575 LMLIEK 580
           L LI K
Sbjct: 228 LFLIPK 233

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  186 bits (474), Expect = 3e-54
 Identities = 89/328 (27%), Positives = 145/328 (44%), Gaps = 53/328 (16%)

Query: 1   METLDNVPSN------YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL 54
           ++ LD           + +   LG+   +  SVY + HK T Q++A+K+  ++     DL
Sbjct: 15  LKKLDEDSLTKQPEEVFDVLEKLGE--GSYGSVYKAIHKETGQIVAIKQVPVE----SDL 68

Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  EI  M+    P+++ Y  S+   TDL +V    G GS  D+I    N  L E  I
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEI 127

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             ILQ  L GLEY+H    IHR +KA +IL++  G A L+        + T  K +    
Sbjct: 128 ATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-I 186

Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLA 232
            T +   W++PEV+++   GY+  +DI+S+GI+  E+A G  P+A+      + +I    
Sbjct: 187 GTPF---WMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-- 239

Query: 233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK 292
              P                                     +SD+F   V+ CL +  ++
Sbjct: 240 NPPPTFRK------------------------------PELWSDNFTDFVKQCLVKSPEQ 269

Query: 293 RPLACNLLQHAFFKQTKKCSVMLPELLR 320
           R  A  LLQH F +  K  S++   +  
Sbjct: 270 RATATQLLQHPFVRSAKGVSILRDLINE 297

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  149 bits (377), Expect = 2e-40
 Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 15/223 (6%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            + +   LG+   +  SVY + HK T Q++A+K+  ++     DL+ +  EI  M+    
Sbjct: 30  VFDVLEKLGE--GSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDS 83

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           P+++ Y  S+   TDL +V    G GS  D+I    N  L E  I  ILQ  L GLEY+H
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH 142

Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 539
               IHR +KA +IL++  G A L+        + T  K +     T +   W++PEV++
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTPF---WMAPEVIQ 198

Query: 540 QNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEK 580
           +   GY+  +DI+S+GI+  E+A G  P+A+      + +I  
Sbjct: 199 EI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT 239

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  181 bits (462), Expect = 1e-52
 Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 45/293 (15%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +L
Sbjct: 35  TVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDEL 92

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL+
Sbjct: 93  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSLG 203

Query: 206 ISCCELANGTVPFAETP--TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           I   E+  G  P+        L LI      TP L +                       
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIAT--NGTPELQN----------------------- 238

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                    K S  F   +  CL  DV+KR  A  LLQH F K  K  S + P
Sbjct: 239 -------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  145 bits (369), Expect = 2e-39
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 13/207 (6%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           +VY +    T Q +A+++ NL +   ++L  + +EI+ MR  ++PNI+ Y+ S+L   +L
Sbjct: 35  TVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDEL 92

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            +V   +  GS  D++       + E  I  + ++ L  LE++H    IHR +K+ +IL+
Sbjct: 93  WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
             +G   L+   +    +P + K       T Y   W++PEV+ +    Y  + DI+S+G
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY---WMAPEVVTRK--AYGPKVDIWSLG 203

Query: 556 ISCCELANGTVPFAETP--TTLMLIEK 580
           I   E+  G  P+        L LI  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIAT 230

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  183 bits (465), Expect = 2e-52
 Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 51/301 (16%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           +VY ++    ++++A+KK +     ++E  + +  E+  ++ LRHPN I Y   +L    
Sbjct: 69  AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
             LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA +IL
Sbjct: 129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 145 ISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD-GYDERSDI 201
           +S  G   L   G       +      + F   T Y   W++PEV+    +  YD + D+
Sbjct: 187 LSEPGLVKLGDFG------SASIMAPANSF-VGTPY---WMAPEVILAMDEGQYDGKVDV 236

Query: 202 YSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS 259
           +S+GI+C ELA    P         L  I +                             
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQ----------------------------- 267

Query: 260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
                ++  L S  +S+ F + V+ CL +    RP +  LL+H F  + +  +V++  + 
Sbjct: 268 ----NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 323

Query: 320 R 320
           R
Sbjct: 324 R 324

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  145 bits (367), Expect = 8e-39
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           +VY ++    ++++A+KK +     ++E  + +  E+  ++ LRHPN I Y   +L    
Sbjct: 69  AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
             LV      GS  DL+  H    L E+ I  +    L GL Y+H    IHR VKA +IL
Sbjct: 129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 495 ISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD-GYDERSDI 551
           +S  G   L   G       +      + F   T Y   W++PEV+    +  YD + D+
Sbjct: 187 LSEPGLVKLGDFG------SASIMAPANSF-VGTPY---WMAPEVILAMDEGQYDGKVDV 236

Query: 552 YSVGISCCELANGTVPFAE 570
           +S+GI+C ELA    P   
Sbjct: 237 WSLGITCIELAERKPPLFN 255

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  179 bits (456), Expect = 8e-52
 Identities = 70/300 (23%), Positives = 118/300 (39%), Gaps = 44/300 (14%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            VY +K+K T  L A K       ++E+L+    EI  +    HP I+  + ++     L
Sbjct: 34  KVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            ++      G+   ++      GL E  I  + + +L  L ++H K  IHR +KA ++L+
Sbjct: 92  WIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM 150

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL---EQNLDGYDERSDIY 202
           +  G   L+          T +K   F   T Y   W++PEV+         YD ++DI+
Sbjct: 151 TLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPY---WMAPEVVMCETMKDTPYDYKADIW 206

Query: 203 SVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           S+GI+  E+A    P  E      L+ I K     P LL                     
Sbjct: 207 SLGITLIEMAQIEPPHHELNPMRVLLKIAK--SDPPTLLT-------------------- 244

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
                       K+S  F   +++ L ++ + RP A  LL+H F         +   +  
Sbjct: 245 ----------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAE 294

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  144 bits (365), Expect = 7e-39
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 10/198 (5%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            VY +K+K T  L A K       ++E+L+    EI  +    HP I+  + ++     L
Sbjct: 34  KVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            ++      G+   ++      GL E  I  + + +L  L ++H K  IHR +KA ++L+
Sbjct: 92  WIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM 150

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL---EQNLDGYDERSDIY 552
           +  G   L+          T +K   F   T Y   W++PEV+         YD ++DI+
Sbjct: 151 TLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPY---WMAPEVVMCETMKDTPYDYKADIW 206

Query: 553 SVGISCCELANGTVPFAE 570
           S+GI+  E+A    P  E
Sbjct: 207 SLGITLIEMAQIEPPHHE 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  179 bits (456), Expect = 2e-51
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 45/293 (15%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            V L++ K + + +AVK  +L +   +  + L +E+V MR  +H N++    S+L   +L
Sbjct: 60  IVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            ++   +  G+  D+++      L E  I  + + VL  L Y+H +G IHR +K+  IL+
Sbjct: 118 WVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174

Query: 146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 205
           + +G+  LS   +    S    K       T Y   W++PEV+ ++   Y    DI+S+G
Sbjct: 175 TLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPY---WMAPEVISRS--LYATEVDIWSLG 228

Query: 206 ISCCELANGTVPFAETP--TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 263
           I   E+ +G  P+        +  +       P L +                       
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRD--SPPPKLKN----------------------- 263

Query: 264 QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
                  S K S      +E  L RD  +R  A  LL H F  QT     ++P
Sbjct: 264 -------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  144 bits (364), Expect = 1e-38
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            V L++ K + + +AVK  +L +   +  + L +E+V MR  +H N++    S+L   +L
Sbjct: 60  IVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            ++   +  G+  D+++      L E  I  + + VL  L Y+H +G IHR +K+  IL+
Sbjct: 118 WVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174

Query: 496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG 555
           + +G+  LS   +    S    K       T Y   W++PEV+ ++   Y    DI+S+G
Sbjct: 175 TLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPY---WMAPEVISRS--LYATEVDIWSLG 228

Query: 556 ISCCELANGTVPFAETP--TTLMLIEKLAGATPHL 588
           I   E+ +G  P+        +  +       P L
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRD--SPPPKL 261

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  177 bits (450), Expect = 1e-50
 Identities = 78/337 (23%), Positives = 134/337 (39%), Gaps = 66/337 (19%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +  L +    +++  ++G        VY  +H  T QL A+K  ++     ++ + +  E
Sbjct: 16  LSALRDPAGIFELVELVGN--GTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQE 70

Query: 61  IVCMRHL-RHPNIICYISSFLDATDLHLVSPL------MGFGSCKDLINAHFNFGLPELV 113
           I  ++    H NI  Y  +F+      +   L       G GS  DLI       L E  
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130

Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF------SPTKK 167
           I +I +++L GL ++H    IHR +K  ++L++ N +  L        F        T  
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL------VDFGVSAQLDRTVG 184

Query: 168 KVHLFPPSTAYNLNWLSPEVL---EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT 224
           + + F   T Y   W++PEV+   E     YD +SD++S+GI+  E+A G  P  +    
Sbjct: 185 RRNTF-IGTPY---WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240

Query: 225 --LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIV 282
             L LI +                                      L S+K+S  F S +
Sbjct: 241 RALFLIPR---------------------------------NPAPRLKSKKWSKKFQSFI 267

Query: 283 ELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELL 319
           E CL ++  +RP    L++H F +       +  +L 
Sbjct: 268 ESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  140 bits (355), Expect = 2e-37
 Identities = 63/249 (25%), Positives = 108/249 (43%), Gaps = 33/249 (13%)

Query: 350 SVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
            +  L +    +++  ++G        VY  +H  T QL A+K  ++     ++ + +  
Sbjct: 15  DLSALRDPAGIFELVELVGN--GTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQ 69

Query: 410 EIVCMRHL-RHPNIICYISSFLDATDLHLVSPL------MGFGSCKDLINAHFNFGLPEL 462
           EI  ++    H NI  Y  +F+      +   L       G GS  DLI       L E 
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF------SPTK 516
            I +I +++L GL ++H    IHR +K  ++L++ N +  L        F        T 
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL------VDFGVSAQLDRTV 183

Query: 517 KKVHLFPPSTAYNLNWLSPEVL---EQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
            + + F   T Y   W++PEV+   E     YD +SD++S+GI+  E+A G  P  +   
Sbjct: 184 GRRNTF-IGTPY---WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239

Query: 574 T--LMLIEK 580
              L LI +
Sbjct: 240 MRALFLIPR 248

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  169 bits (430), Expect = 3e-48
 Identities = 51/317 (16%), Positives = 112/317 (35%), Gaps = 54/317 (17%)

Query: 9   SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           + +     +G   F    SV+    ++   + A+K+         D ++   E+     L
Sbjct: 11  TEFHELEKIGSGEF---GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 68  -RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNG 124
            +H +++ Y S++ +   + + +     GS  D I+ ++       E  +  +L  V  G
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK---KVHLFPPSTAYNLN 181
           L YIH    +H  +K S+I IS       +          + K   K+      T  +  
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187

Query: 182 --------WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG 233
                   +L+ EVL++N   +  ++DI+++ ++    A              + +   G
Sbjct: 188 QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ---G 243

Query: 234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR 293
             P +                                 +  S  F  ++++ +  D ++R
Sbjct: 244 RLPRI--------------------------------PQVLSQEFTELLKVMIHPDPERR 271

Query: 294 PLACNLLQHAFFKQTKK 310
           P A  L++H+      +
Sbjct: 272 PSAMALVKHSVLLSASR 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  149 bits (379), Expect = 6e-41
 Identities = 41/227 (18%), Positives = 87/227 (38%), Gaps = 19/227 (8%)

Query: 359 SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           + +     +G   F    SV+    ++   + A+K+         D ++   E+     L
Sbjct: 11  TEFHELEKIGSGEF---GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 418 -RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNG 474
            +H +++ Y S++ +   + + +     GS  D I+ ++       E  +  +L  V  G
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK---KVHLFPPSTAYNLN 531
           L YIH    +H  +K S+I IS       +          + K   K+      T  +  
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187

Query: 532 --------WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE 570
                   +L+ EVL++N   +  ++DI+++ ++    A        
Sbjct: 188 QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGAEPLPRN 233

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  170 bits (433), Expect = 8e-48
 Identities = 70/325 (21%), Positives = 123/325 (37%), Gaps = 35/325 (10%)

Query: 23  NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F   
Sbjct: 45  NGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI-HRAVKAS 141
            ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K  I HR VK S
Sbjct: 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161

Query: 142 HILISHNGKACLSGLRYMCPF------SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
           +IL++  G+  L      C F        +     +   S      ++SPE L+     Y
Sbjct: 162 NILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRS------YMSPERLQGT--HY 207

Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE 255
             +SDI+S+G+S  E+A G  P        + +           +        G+   + 
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 256 NAC-----------SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                          YI  +    L S  FS  F   V  CL ++  +R     L+ HAF
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327

Query: 305 FKQTKKCSVMLPELLRPALSLNESN 329
            K++    V     L   + LN+ +
Sbjct: 328 IKRSDAEEVDFAGWLCSTIGLNQPS 352

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (327), Expect = 3e-33
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 24/205 (11%)

Query: 373 NLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           N   V+   HK +  ++A K  +L+ +       +  E+  +     P I+ +  +F   
Sbjct: 45  NGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFI-HRAVKAS 491
            ++ +    M  GS   ++       +PE ++  +   V+ GL Y+  K  I HR VK S
Sbjct: 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161

Query: 492 HILISHNGKACLSGLRYMCPF------SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
           +IL++  G+  L      C F        +     +   S      ++SPE L+     Y
Sbjct: 162 NILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRS------YMSPERLQGT--HY 207

Query: 546 DERSDIYSVGISCCELANGTVPFAE 570
             +SDI+S+G+S  E+A G  P   
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPP 232

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  159 bits (404), Expect = 2e-44
 Identities = 71/332 (21%), Positives = 133/332 (40%), Gaps = 55/332 (16%)

Query: 3   TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI- 61
           +++    + +    LG+       V   +H  + Q++AVK+     +  ++ K L  ++ 
Sbjct: 1   SMEVKADDLEPIMELGR--GAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLD 57

Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQ 119
           + MR +  P  + +  +     D+ +   LM   S         + G  +PE ++  I  
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAV 116

Query: 120 DVLNGLEYIHGKG-FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
            ++  LE++H K   IHR VK S++LI+  G+  +      C F  +   V       A 
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKM------CDFGISGYLVD----DVAK 166

Query: 179 NLN-----WLSPEVL--EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 231
           +++     +++PE +  E N  GY  +SDI+S+GI+  ELA    P+    T    +   
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL--- 223

Query: 232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVD 291
                                        + E+ +  L + KFS  F      CL ++  
Sbjct: 224 ---------------------------KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSK 256

Query: 292 KRPLACNLLQHAFFKQTKKCSVMLPELLRPAL 323
           +RP    L+QH FF   +     +   ++  L
Sbjct: 257 ERPTYPELMQHPFFTLHESKGTDVASFVKLIL 288

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 8e-33
 Identities = 55/239 (23%), Positives = 107/239 (44%), Gaps = 25/239 (10%)

Query: 353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI- 411
           +++    + +    LG+       V   +H  + Q++AVK+     +  ++ K L  ++ 
Sbjct: 1   SMEVKADDLEPIMELGR--GAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLD 57

Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQ 469
           + MR +  P  + +  +     D+ +   LM   S         + G  +PE ++  I  
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAV 116

Query: 470 DVLNGLEYIHGKG-FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
            ++  LE++H K   IHR VK S++LI+  G+  +      C F  +   V       A 
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKM------CDFGISGYLVD----DVAK 166

Query: 529 NLN-----WLSPEVL--EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           +++     +++PE +  E N  GY  +SDI+S+GI+  ELA    P+    T    +++
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  160 bits (406), Expect = 2e-44
 Identities = 74/342 (21%), Positives = 134/342 (39%), Gaps = 62/342 (18%)

Query: 2   ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           +      ++ +    +G        V+  + + T  +IAVK+        E+ K +  ++
Sbjct: 18  QRYQAEINDLENLGEMGS--GTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDL 74

Query: 62  -VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
            V ++    P I+    +F+  TD+ +   LMG  +C + +       +PE ++  +   
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG--TCAEKLKKRMQGPIPERILGKMTVA 132

Query: 121 VLNGLEYIHGK-GFIHRAVKASHILISHNGK---------ACLSGLRYMCPFSPTKKKVH 170
           ++  L Y+  K G IHR VK S+IL+   G+           L   +     +       
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA---- 188

Query: 171 LFPPSTAYNLNWLSPEVLEQNLD---GYDERSDIYSVGISCCELANGTVPFAETPTTLML 227
                      +++PE ++        YD R+D++S+GIS  ELA G  P+    T   +
Sbjct: 189 ----------AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLS 287
           + K+    P LL                                  FS  F S V+ CL+
Sbjct: 239 LTKVLQEEPPLLP-----------------------------GHMGFSGDFQSFVKDCLT 269

Query: 288 RDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESN 329
           +D  KRP    LL+H+F K+ +   V +    +  ++  ES 
Sbjct: 270 KDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESP 311

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  129 bits (326), Expect = 2e-33
 Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 36/251 (14%)

Query: 345 DTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL 404
                  +      ++ +    +G        V+  + + T  +IAVK+        E+ 
Sbjct: 11  GYLTIGGQRYQAEINDLENLGEMGS--GTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEEN 67

Query: 405 KSLHHEI-VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELV 463
           K +  ++ V ++    P I+    +F+  TD+ +   LMG  +C + +       +PE +
Sbjct: 68  KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG--TCAEKLKKRMQGPIPERI 125

Query: 464 ICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGK---------ACLSGLRYMCPFS 513
           +  +   ++  L Y+  K G IHR VK S+IL+   G+           L   +     +
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185

Query: 514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLD---GYDERSDIYSVGISCCELANGTVPFAE 570
                             +++PE ++        YD R+D++S+GIS  ELA G  P+  
Sbjct: 186 GCA--------------AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

Query: 571 TPT---TLMLI 578
             T    L  +
Sbjct: 232 CKTDFEVLTKV 242

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  159 bits (403), Expect = 3e-44
 Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 46/299 (15%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            VY  +       IA+K+           + LH EI   +HL+H NI+ Y+ SF +   +
Sbjct: 37  IVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94

Query: 86  HLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
            +    +  GS   L+ + +      E  I    + +L GL+Y+H    +HR +K  ++L
Sbjct: 95  KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154

Query: 145 I-SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           I +++G   +S  G       S     ++    +    L +++PE++++   GY + +DI
Sbjct: 155 INTYSGVLKISDFGT------SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208

Query: 202 YSVGISCCELANGTVPFAE--TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS 259
           +S+G +  E+A G  PF E   P   M                 + V   +   E     
Sbjct: 209 WSLGCTIIEMATGKPPFYELGEPQAAM-----------------FKVGMFKVHPE----- 246

Query: 260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPEL 318
            I E           S    + +  C   D DKR  A +LL   F K + K     P+L
Sbjct: 247 -IPES---------MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (351), Expect = 4e-37
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            VY  +       IA+K+           + LH EI   +HL+H NI+ Y+ SF +   +
Sbjct: 37  IVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94

Query: 436 HLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
            +    +  GS   L+ + +      E  I    + +L GL+Y+H    +HR +K  ++L
Sbjct: 95  KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154

Query: 495 I-SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           I +++G   +S  G       S     ++    +    L +++PE++++   GY + +DI
Sbjct: 155 INTYSGVLKISDFGT------SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208

Query: 552 YSVGISCCELANGTVPFAE 570
           +S+G +  E+A G  PF E
Sbjct: 209 WSLGCTIIEMATGKPPFYE 227

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  159 bits (403), Expect = 5e-44
 Identities = 78/341 (22%), Positives = 138/341 (40%), Gaps = 55/341 (16%)

Query: 2   ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           +  D    + K    +G+      SV    HK + Q++AVK+     + +++ K L  ++
Sbjct: 15  QHWDFTAEDLKDLGEIGR--GAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDL 71

Query: 62  -VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF---GLPELVICHI 117
            V MR    P I+ +  +     D  +   LM   S        ++     +PE ++  I
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKI 130

Query: 118 LQDVLNGLEYIHGKG-FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPST 176
               +  L ++      IHR +K S+IL+  +G   L      C F  + + V     S 
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL------CDFGISGQLVD----SI 180

Query: 177 AYNLN-----WLSPEVL--EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE 229
           A   +     +++PE +    +  GYD RSD++S+GI+  ELA G  P+ +  +    + 
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240

Query: 230 K-LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
           + + G  P L +                               R+FS SF + V LCL++
Sbjct: 241 QVVKGDPPQLSNS----------------------------EEREFSPSFINFVNLCLTK 272

Query: 289 DVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESN 329
           D  KRP    LL+H F    ++ +V +   +   L    + 
Sbjct: 273 DESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPAT 313

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  126 bits (319), Expect = 2e-32
 Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 26/244 (10%)

Query: 349 SSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH 408
           S  +  D    + K    +G+      SV    HK + Q++AVK+     + +++ K L 
Sbjct: 12  SPEQHWDFTAEDLKDLGEIGR--GAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLL 68

Query: 409 HEI-VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF---GLPELVI 464
            ++ V MR    P I+ +  +     D  +   LM   S        ++     +PE ++
Sbjct: 69  MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEIL 127

Query: 465 CHILQDVLNGLEYIHGKG-FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFP 523
             I    +  L ++      IHR +K S+IL+  +G   L      C F  + + V    
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL------CDFGISGQLVD--- 178

Query: 524 PSTAYNLN-----WLSPEVL--EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM 576
            S A   +     +++PE +    +  GYD RSD++S+GI+  ELA G  P+ +  +   
Sbjct: 179 -SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237

Query: 577 LIEK 580
            + +
Sbjct: 238 QLTQ 241

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  159 bits (403), Expect = 7e-44
 Identities = 61/299 (20%), Positives = 100/299 (33%), Gaps = 55/299 (18%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
            V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +   +
Sbjct: 73  EVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWV 125

Query: 86  HLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           ++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA ++L
Sbjct: 126 NIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 182

Query: 145 ISHNGKAC------LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           +S +G          +          +        P T      ++PEV+       D +
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI-PGTET---HMAPEVVMG--KPCDAK 236

Query: 199 SDIYSVGISCCELANGTVPFAE-TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENA 257
            DI+S       + NG  P+ +     L L  K+A   P + +                 
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--KIASEPPPIRE----------------- 277

Query: 258 CSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLP 316
              I             +      ++  L ++   R  A  L +       +   +  P
Sbjct: 278 ---IPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (350), Expect = 1e-36
 Identities = 50/202 (24%), Positives = 78/202 (38%), Gaps = 23/202 (11%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
            V+  K K T    AVKK  L+    E       E+V    L  P I+    +  +   +
Sbjct: 73  EVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWV 125

Query: 436 HLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           ++   L+  GS   LI      G LPE    + L   L GLEY+H +  +H  VKA ++L
Sbjct: 126 NIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 182

Query: 495 ISHNGKAC------LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           +S +G          +          +        P T      ++PEV+       D +
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI-PGTET---HMAPEVVMG--KPCDAK 236

Query: 549 SDIYSVGISCCELANGTVPFAE 570
            DI+S       + NG  P+ +
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQ 258

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  157 bits (399), Expect = 4e-43
 Identities = 66/314 (21%), Positives = 123/314 (39%), Gaps = 66/314 (21%)

Query: 10  NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            Y     +G+  F       L K     +   +K+ N+ RM+ ++ +    E+  + +++
Sbjct: 25  KYVRLQKIGEGSF---GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81

Query: 69  HPNIICYISSFLDATDLHLVSPLMGF---GSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           HPNI+ Y  SF +   L++V   M +   G     INA       E  I      +   L
Sbjct: 82  HPNIVQYRESFEENGSLYIV---MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLF---PPSTAYN 179
           +++H +  +HR +K+ +I ++ +G   L   G+ R +   + T +        P      
Sbjct: 139 KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTP------ 189

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPFAETPTTLMLIEK-LAGATP 236
             +LSPE+ E     Y+ +SDI+++G  C   EL      F E  +   L+ K ++G+ P
Sbjct: 190 -YYLSPEICENK--PYNNKSDIWALG--CVLYELCTLKHAF-EAGSMKNLVLKIISGSFP 243

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
            +                                S  +S    S+V     R+   RP  
Sbjct: 244 PV--------------------------------SLHYSYDLRSLVSQLFKRNPRDRPSV 271

Query: 297 CNLLQHAFFKQTKK 310
            ++L+  F  +  +
Sbjct: 272 NSILEKGFIAKRIE 285

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  142 bits (361), Expect = 6e-38
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 37/248 (14%)

Query: 345 DTFNSSVETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED 403
            T N   ++++     Y     +G+  F       L K     +   +K+ N+ RM+ ++
Sbjct: 14  GTENLYFQSMEK----YVRLQKIGEGSF---GKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 404 LKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF---GSCKDLINAHFNFGLP 460
            +    E+  + +++HPNI+ Y  SF +   L++V   M +   G     INA       
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESFEENGSLYIV---MDYCEGGDLFKRINAQKGVLFQ 123

Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKK 517
           E  I      +   L+++H +  +HR +K+ +I ++ +G   L   G+ R +   + T +
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVE 180

Query: 518 KVHLF---PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPFAETP 572
                   P        +LSPE+ E     Y+ +SDI+++G  C   EL      F E  
Sbjct: 181 LARACIGTP-------YYLSPEICENK--PYNNKSDIWALG--CVLYELCTLKHAF-EAG 228

Query: 573 TTLMLIEK 580
           +   L+ K
Sbjct: 229 SMKNLVLK 236

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (391), Expect = 1e-42
 Identities = 59/289 (20%), Positives = 112/289 (38%), Gaps = 48/289 (16%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD- 84
           +VY      T   +A  +    ++T  + +    E   ++ L+HPNI+ +  S+      
Sbjct: 41  TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100

Query: 85  ---LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVK 139
              + LV+ LM  G+ K  +           V+    + +L GL+++H +    IHR +K
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKVM--KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158

Query: 140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
             +I I+       +G   +        K   F  +      +++PE+ E+    YDE  
Sbjct: 159 CDNIFITGP-----TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE---KYDESV 210

Query: 200 DIYSVGISCCELANGTVPFAETPTTLMLIEKLA-GATPHLLDCTTYYVDTGQDDGEENAC 258
           D+Y+ G+   E+A    P++E      +  ++  G  P   D                  
Sbjct: 211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD------------------ 252

Query: 259 SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
                        +        I+E C+ ++ D+R    +LL HAFF++
Sbjct: 253 -------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (338), Expect = 2e-35
 Identities = 45/201 (22%), Positives = 86/201 (42%), Gaps = 16/201 (7%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD- 434
           +VY      T   +A  +    ++T  + +    E   ++ L+HPNI+ +  S+      
Sbjct: 41  TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100

Query: 435 ---LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVK 489
              + LV+ LM  G+ K  +           V+    + +L GL+++H +    IHR +K
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKVM--KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158

Query: 490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
             +I I+       +G   +        K   F  +      +++PE+ E+    YDE  
Sbjct: 159 CDNIFITGP-----TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE---KYDESV 210

Query: 550 DIYSVGISCCELANGTVPFAE 570
           D+Y+ G+   E+A    P++E
Sbjct: 211 DVYAFGMCMLEMATSEYPYSE 231

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  153 bits (389), Expect = 4e-42
 Identities = 71/308 (23%), Positives = 127/308 (41%), Gaps = 52/308 (16%)

Query: 9   SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNL-DRMTDEDLKSLHHEIVCMRH 66
           +N++I   +G+  F   S VY +   +    +A+KK  + D M  +       EI  ++ 
Sbjct: 32  ANFRIEKKIGRGQF---SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNG 124
           L HPN+I Y +SF++  +L++V  L   G    +I         +PE  +      + + 
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL--RYMCPFSPTKKKVHLFPPSTAYNL 180
           LE++H +  +HR +K +++ I+  G   L   GL   +    +     V      T Y  
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTPY-- 201

Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLMLIEKLAGATPHLL 239
            ++SPE + +N  GY+ +SDI+S+G    E+A    PF  +      L +K         
Sbjct: 202 -YMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK--------- 249

Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL 299
                                I +     L S  +S+    +V +C++ D +KRP    +
Sbjct: 250 ---------------------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

Query: 300 LQHAFFKQ 307
              A    
Sbjct: 289 YDVAKRMH 296

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  137 bits (347), Expect = 3e-36
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 22/231 (9%)

Query: 359 SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNL-DRMTDEDLKSLHHEIVCMRH 416
           +N++I   +G+  F   S VY +   +    +A+KK  + D M  +       EI  ++ 
Sbjct: 32  ANFRIEKKIGRGQF---SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNG 474
           L HPN+I Y +SF++  +L++V  L   G    +I         +PE  +      + + 
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL--RYMCPFSPTKKKVHLFPPSTAYNL 530
           LE++H +  +HR +K +++ I+  G   L   GL   +    +     V      T Y  
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTPY-- 201

Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLMLIEK 580
            ++SPE + +N  GY+ +SDI+S+G    E+A    PF  +      L +K
Sbjct: 202 -YMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  152 bits (387), Expect = 8e-42
 Identities = 56/305 (18%), Positives = 105/305 (34%), Gaps = 55/305 (18%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
             +++  S LG   +     V+  + K   +L AVK+        +D      E+     
Sbjct: 56  QQSFQRLSRLGHGSY---GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 67  L-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           + +HP  +    ++ +   L+L + L G  S +    A     LPE  +   L+D L  L
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW-GASLPEAQVWGYLRDTLLAL 170

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 182
            ++H +G +H  VK ++I +   G+  L   GL   +      + +             +
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPR---Y 222

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           ++PE+L+     Y   +D++S+G++  E+A              L +      P      
Sbjct: 223 MAPELLQ---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY--LPPEFTA-- 275

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                                           S    S++ + L  D   R  A  LL  
Sbjct: 276 ------------------------------GLSSELRSVLVMMLEPDPKLRATAEALLAL 305

Query: 303 AFFKQ 307
              +Q
Sbjct: 306 PVLRQ 310

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  133 bits (337), Expect = 6e-35
 Identities = 46/228 (20%), Positives = 91/228 (39%), Gaps = 21/228 (9%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
             +++  S LG   +     V+  + K   +L AVK+        +D      E+     
Sbjct: 56  QQSFQRLSRLGHGSY---GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 417 L-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           + +HP  +    ++ +   L+L + L G  S +    A     LPE  +   L+D L  L
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW-GASLPEAQVWGYLRDTLLAL 170

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 532
            ++H +G +H  VK ++I +   G+  L   GL   +      + +             +
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPR---Y 222

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           ++PE+L+     Y   +D++S+G++  E+A              L + 
Sbjct: 223 MAPELLQ---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG 267

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (361), Expect = 2e-38
 Identities = 67/336 (19%), Positives = 127/336 (37%), Gaps = 64/336 (19%)

Query: 9   SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           S+++  ++LGQ  F     V  +++ + ++  A+KK    R T+E L ++  E++ +  L
Sbjct: 6   SDFEEIAVLGQGAF---GQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASL 59

Query: 68  RHPNIICYISSFLDATDLHLVSPL----------MGF---GSCKDLINAHFNFGLPELVI 114
            H  ++ Y +++L+  +                 M +   G+  DLI++  N        
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEY 118

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHL 171
             + + +L  L YIH +G IHR +K  +I I  +    +   GL + +       K    
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 172 FPPSTAYNLN-------WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT 224
             P ++ NL        +++ EVL      Y+E+ D+YS+GI   E+        E    
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVL-DGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237

Query: 225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
           L  +  ++   P                                            I+ L
Sbjct: 238 LKKLRSVSIEFPPDF-------------------------------DDNKMKVEKKIIRL 266

Query: 285 CLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLR 320
            +  D +KRP A  LL   +     +   ++ E L+
Sbjct: 267 LIDHDPNKRPGARTLLNSGWLPVKHQ-DEVIKEALK 301

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (314), Expect = 6e-32
 Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 32/222 (14%)

Query: 359 SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           S+++  ++LGQ  F     V  +++ + ++  A+KK    R T+E L ++  E++ +  L
Sbjct: 6   SDFEEIAVLGQGAF---GQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASL 59

Query: 418 RHPNIICYISSFLDATDLHLVSPL----------MGF---GSCKDLINAHFNFGLPELVI 464
            H  ++ Y +++L+  +                 M +   G+  DLI++  N        
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEY 118

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHL 521
             + + +L  L YIH +G IHR +K  +I I  +    +   GL + +       K    
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 522 FPPSTAYNLN-------WLSPEVLEQNLDGYDERSDIYSVGI 556
             P ++ NL        +++ EVL      Y+E+ D+YS+GI
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVL-DGTGHYNEKIDMYSLGI 219

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  137 bits (346), Expect = 1e-36
 Identities = 51/322 (15%), Positives = 105/322 (32%), Gaps = 76/322 (23%)

Query: 9   SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
            ++K   ++G   F     V+ +KH++  +   +K+   +            E+  +  L
Sbjct: 11  MDFKEIELIGSGGF---GQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKL 61

Query: 68  RHPNIICYISSFLDATDLHLVSP-------------LMGF---GSCKDLINAHFNFGLPE 111
            H NI+ Y   +         S               M F   G+ +  I       L +
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 112 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKK 168
           ++   + + +  G++YIH K  I+R +K S+I +    +  +   GL   +       + 
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI 228
                  T     ++SPE +      Y +  D+Y++G+   EL +      ET      +
Sbjct: 182 K-----GTLR---YMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

Query: 229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
                                           IS+          F     ++++  LS+
Sbjct: 232 RD----------------------------GIISDI---------FDKKEKTLLQKLLSK 254

Query: 289 DVDKRPLACNLLQHAFFKQTKK 310
             + RP    +L+     +   
Sbjct: 255 KPEDRPNTSEILRTLTVWKKSP 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (312), Expect = 8e-32
 Identities = 43/242 (17%), Positives = 87/242 (35%), Gaps = 39/242 (16%)

Query: 359 SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
            ++K   ++G   F     V+ +KH++  +   +K+   +            E+  +  L
Sbjct: 11  MDFKEIELIGSGGF---GQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKL 61

Query: 418 RHPNIICYISSFLDATDLHLVSP-------------LMGF---GSCKDLINAHFNFGLPE 461
            H NI+ Y   +         S               M F   G+ +  I       L +
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 462 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKK 518
           ++   + + +  G++YIH K  I+R +K S+I +    +  +   GL   +       + 
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI 578
                  T     ++SPE +      Y +  D+Y++G+   EL +      ET      +
Sbjct: 182 K-----GTLR---YMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

Query: 579 EK 580
             
Sbjct: 232 RD 233

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (344), Expect = 3e-36
 Identities = 63/314 (20%), Positives = 118/314 (37%), Gaps = 63/314 (20%)

Query: 10  NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           +Y++   +G   +         + K   +++  K+ +   MT+ + + L  E+  +R L+
Sbjct: 7   DYEVLYTIGTGSY---GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63

Query: 69  HPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNG 124
           HPNI+ Y    +D T+  L++V      G    +I         L E  +  ++  +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 125 LEYIHGKGF-----IHRAVKASHILISHNGKACLS--GL--RYMCPFSPTKKKVHLFPPS 175
           L+  H +       +HR +K +++ +       L   GL        S  K  V      
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-----G 178

Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPFAETPTTLMLIEKLAG 233
           T Y   ++SPE + +    Y+E+SDI+S+G  C   EL     PF    +   L  K   
Sbjct: 179 TPY---YMSPEQMNRM--SYNEKSDIWSLG--CLLYELCALMPPF-TAFSQKELAGK--- 227

Query: 234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR 293
                                      I E + + +  R +SD  + I+   L+     R
Sbjct: 228 ---------------------------IREGKFRRIPYR-YSDELNEIITRMLNLKDYHR 259

Query: 294 PLACNLLQHAFFKQ 307
           P    +L++    +
Sbjct: 260 PSVEEILENPLILE 273

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (310), Expect = 1e-31
 Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 32/237 (13%)

Query: 360 NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           +Y++   +G   +         + K   +++  K+ +   MT+ + + L  E+  +R L+
Sbjct: 7   DYEVLYTIGTGSY---GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63

Query: 419 HPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNG 474
           HPNI+ Y    +D T+  L++V      G    +I         L E  +  ++  +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 475 LEYIHGKGF-----IHRAVKASHILISHNGKACLS--GL--RYMCPFSPTKKKVHLFPPS 525
           L+  H +       +HR +K +++ +       L   GL        S  K  V      
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-----G 178

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCC--ELANGTVPFAETPTTLMLIEK 580
           T Y   ++SPE + +    Y+E+SDI+S+G  C   EL     PF    +   L  K
Sbjct: 179 TPY---YMSPEQMNRM--SYNEKSDIWSLG--CLLYELCALMPPF-TAFSQKELAGK 227

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  133 bits (336), Expect = 6e-35
 Identities = 59/325 (18%), Positives = 115/325 (35%), Gaps = 66/325 (20%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           ++++    LG+       V+ +K+KV +   A+K+  L        + +  E+  +  L 
Sbjct: 5   TDFEPIQCLGR--GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLE 61

Query: 69  HPNIICYISSFLDATDLHLVSP---------LMGF---GSCKDLINAHFNFGLPE-LVIC 115
           HP I+ Y +++L+      + P          M      + KD +N        E  V  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--------ACLSGLRYMCPFSPTKK 167
           HI   +   +E++H KG +HR +K S+I  + +               +           
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLT 179

Query: 168 KVHLFPPSTAYN--LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL 225
            +  +   T       ++SPE +  N   Y  + DI+S+G+   EL     PF+     +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELL---YPFSTQMERV 234

Query: 226 MLIEKL-AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
             +  +     P L                                  +     + +V+ 
Sbjct: 235 RTLTDVRNLKFPPLFT--------------------------------QKYPCEYVMVQD 262

Query: 285 CLSRDVDKRPLACNLLQHAFFKQTK 309
            LS    +RP A N++++A F+   
Sbjct: 263 MLSPSPMERPEAINIIENAVFEDLD 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  118 bits (298), Expect = 8e-30
 Identities = 48/246 (19%), Positives = 94/246 (38%), Gaps = 33/246 (13%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           ++++    LG+       V+ +K+KV +   A+K+  L        + +  E+  +  L 
Sbjct: 5   TDFEPIQCLGR--GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLE 61

Query: 419 HPNIICYISSFLDATDLHLVSP---------LMGF---GSCKDLINAHFNFGLPE-LVIC 465
           HP I+ Y +++L+      + P          M      + KD +N        E  V  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--------ACLSGLRYMCPFSPTKK 517
           HI   +   +E++H KG +HR +K S+I  + +               +           
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLT 179

Query: 518 KVHLFPPSTAYN--LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL 575
            +  +   T       ++SPE +  N   Y  + DI+S+G+   EL     PF+     +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELL---YPFSTQMERV 234

Query: 576 MLIEKL 581
             +  +
Sbjct: 235 RTLTDV 240

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (327), Expect = 1e-32
 Identities = 63/312 (20%), Positives = 112/312 (35%), Gaps = 55/312 (17%)

Query: 10  NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL- 67
           ++    +LG        ++   +    N+ +AVK     R+  E       E+  +R   
Sbjct: 25  SFCPKDVLGHGAE---GTIVY-RGMFDNRDVAVK-----RILPECFSFADREVQLLRESD 75

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HPN+I Y  +  D    ++   L    + ++ +    +F    L    +LQ   +GL +
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAH 133

Query: 128 IHGKGFIHRAVKASHILISHNG-----KACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL 180
           +H    +HR +K  +ILIS        KA +S  GL                 P T    
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG-- 191

Query: 181 NWLSPEVLEQNLD-GYDERSDIYSVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHL 238
            W++PE+L ++         DI+S G      ++ G+ PF ++      I   A +   L
Sbjct: 192 -WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250

Query: 239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                                            +        ++E  ++ D  KRP A +
Sbjct: 251 HP------------------------------EKHEDVIARELIEKMIAMDPQKRPSAKH 280

Query: 299 LLQHAFFKQTKK 310
           +L+H FF   +K
Sbjct: 281 VLKHPFFWSLEK 292

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  116 bits (293), Expect = 4e-28
 Identities = 52/240 (21%), Positives = 92/240 (38%), Gaps = 25/240 (10%)

Query: 360 NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL- 417
           ++    +LG        ++   +    N+ +AVK     R+  E       E+  +R   
Sbjct: 25  SFCPKDVLGHGAE---GTIVY-RGMFDNRDVAVK-----RILPECFSFADREVQLLRESD 75

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HPN+I Y  +  D    ++   L    + ++ +    +F    L    +LQ   +GL +
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAH 133

Query: 478 IHGKGFIHRAVKASHILISHNG-----KACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL 530
           +H    +HR +K  +ILIS        KA +S  GL                 P T    
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG-- 191

Query: 531 NWLSPEVLEQNLD-GYDERSDIYSVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHL 588
            W++PE+L ++         DI+S G      ++ G+ PF ++      I   A +   L
Sbjct: 192 -WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (307), Expect = 6e-31
 Identities = 63/311 (20%), Positives = 109/311 (35%), Gaps = 48/311 (15%)

Query: 10  NYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           +Y     LG+  F   S V L +        A+K+        +D +    E    R   
Sbjct: 30  HYLFIQKLGEGGF---SYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFN 84

Query: 69  HPNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVL 122
           HPNI+  ++  L          L+ P    G+  + I    + G  L E  I  +L  + 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN 179
            GLE IH KG+ HR +K ++IL+   G+  L   G     C      ++        A  
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 180 --LNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP 236
             +++ +PE+   Q+    DER+D++S+G     +  G  P+         +        
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL------ 258

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
                                     + Q  +  S + S +   ++   ++ D  +RP  
Sbjct: 259 ------------------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI 294

Query: 297 CNLLQHAFFKQ 307
             LL      Q
Sbjct: 295 PLLLSQLEALQ 305

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  113 bits (285), Expect = 5e-28
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 18/222 (8%)

Query: 360 NYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           +Y     LG+  F   S V L +        A+K+        +D +    E    R   
Sbjct: 30  HYLFIQKLGEGGF---SYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFN 84

Query: 419 HPNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVL 472
           HPNI+  ++  L          L+ P    G+  + I    + G  L E  I  +L  + 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN 529
            GLE IH KG+ HR +K ++IL+   G+  L   G     C      ++        A  
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 530 --LNWLSPEVLE-QNLDGYDERSDIYSVGISCCELANGTVPF 568
             +++ +PE+   Q+    DER+D++S+G     +  G  P+
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (307), Expect = 1e-30
 Identities = 53/342 (15%), Positives = 111/342 (32%), Gaps = 58/342 (16%)

Query: 10  NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            Y I   +G       S V+   ++   Q+ A+K  NL+   ++ L S  +EI  +  L+
Sbjct: 10  IYSILKQIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 69  HPN--IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             +  II      +    +++V            +    +            +++L  + 
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSI--DPWERKSYWKNMLEAVH 122

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 183
            IH  G +H  +K ++ LI  +G   L   G+   M    P    V     S    +N++
Sbjct: 123 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKD--SQVGTVNYM 176

Query: 184 SPEVLEQ---------NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
            PE ++          +      +SD++S+G     +  G  PF +    +  +      
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---- 232

Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                                     I +   ++            +++ CL RD  +R 
Sbjct: 233 --------------------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 266

Query: 295 LACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNE 336
               LL H + +        + +     +      +  +N+ 
Sbjct: 267 SIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSP 308

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  111 bits (280), Expect = 4e-27
 Identities = 43/236 (18%), Positives = 86/236 (36%), Gaps = 28/236 (11%)

Query: 360 NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
            Y I   +G       S V+   ++   Q+ A+K  NL+   ++ L S  +EI  +  L+
Sbjct: 10  IYSILKQIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 419 HPN--IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
             +  II      +    +++V            +    +            +++L  + 
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSI--DPWERKSYWKNMLEAVH 122

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 533
            IH  G +H  +K ++ LI  +G   L   G+   M    P    V     S    +N++
Sbjct: 123 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKD--SQVGTVNYM 176

Query: 534 SPEVLEQ---------NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
            PE ++          +      +SD++S+G     +  G  PF +    +  +  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  121 bits (305), Expect = 1e-30
 Identities = 52/313 (16%), Positives = 104/313 (33%), Gaps = 58/313 (18%)

Query: 10  NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            Y I   +G       S V+   ++   Q+ A+K  NL+   ++ L S  +EI  +  L+
Sbjct: 29  IYSILKQIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84

Query: 69  HPN--IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             +  II      +    +++V            +    +            +++L  + 
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSI--DPWERKSYWKNMLEAVH 141

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 183
            IH  G +H  +K ++ LI  +G   L   G+   M    P    V     S    +N++
Sbjct: 142 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKD--SQVGTVNYM 195

Query: 184 SPEVLEQ---------NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
            PE ++          +      +SD++S+G     +  G  PF +    +  +      
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---- 251

Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                                     I +   ++            +++ CL RD  +R 
Sbjct: 252 --------------------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

Query: 295 LACNLLQHAFFKQ 307
               LL H + + 
Sbjct: 286 SIPELLAHPYVQI 298

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  113 bits (286), Expect = 4e-28
 Identities = 44/248 (17%), Positives = 90/248 (36%), Gaps = 28/248 (11%)

Query: 348 NSSVETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS 406
           N   +++      Y I   +G       S V+   ++   Q+ A+K  NL+   ++ L S
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEADNQTLDS 72

Query: 407 LHHEIVCMRHLRHPN--IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
             +EI  +  L+  +  II      +    +++V            +    +        
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSI--DPWER 129

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHL 521
               +++L  +  IH  G +H  +K ++ LI  +G   L   G+   M    P    V  
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVK 185

Query: 522 FPPSTAYNLNWLSPEVLEQ---------NLDGYDERSDIYSVGISCCELANGTVPFAETP 572
              S    +N++ PE ++          +      +SD++S+G     +  G  PF +  
Sbjct: 186 D--SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

Query: 573 TTLMLIEK 580
             +  +  
Sbjct: 244 NQISKLHA 251

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (314), Expect = 3e-30
 Identities = 58/314 (18%), Positives = 102/314 (32%), Gaps = 35/314 (11%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            +++   LG        V    H+ T + +A+K+     ++ ++ +    EI  M+ L H
Sbjct: 15  PWEMKERLGT--GGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNH 71

Query: 70  PNIIC------YISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVL 122
           PN++        +          L       G  +  +N   N  GL E  I  +L D+ 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFPPST 176
           + L Y+H    IHR +K  +I++    +  +      G  + +       + V     + 
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG----TL 187

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP 236
            Y    L+PE+LEQ    Y    D +S G    E   G  PF      +    K+     
Sbjct: 188 QY----LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK-- 239

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
                          D    A  + S   T    S   +      ++  L     +R   
Sbjct: 240 -------SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292

Query: 297 CNLLQHAFFKQTKK 310
                   F+    
Sbjct: 293 PQNPNVGCFQALDS 306

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  113 bits (283), Expect = 2e-26
 Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 26/237 (10%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            +++   LG        V    H+ T + +A+K+     ++ ++ +    EI  M+ L H
Sbjct: 15  PWEMKERLGT--GGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNH 71

Query: 420 PNIIC------YISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVL 472
           PN++        +          L       G  +  +N   N  GL E  I  +L D+ 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFPPST 526
           + L Y+H    IHR +K  +I++    +  +      G  + +       + V     + 
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG----TL 187

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG 583
            Y    L+PE+LEQ    Y    D +S G    E   G  PF      +    K+  
Sbjct: 188 QY----LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  118 bits (299), Expect = 8e-30
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 19/222 (8%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
           PS+     +LG+ CF          H+ T +++ +K+  L R  +E  ++   E+  MR 
Sbjct: 9   PSDLIHGEVLGKGCF---GQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRC 63

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HPN++ +I        L+ ++  +  G+ + +I +  +   P        +D+ +G+ 
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMA 122

Query: 127 YIHGKGFIHRAVKASHILISHN--------GKACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
           Y+H    IHR + + + L+  N        G A L       P      K          
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182

Query: 179 --NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
             N  W++PE++      YDE+ D++S GI  CE+       
Sbjct: 183 VGNPYWMAPEMINGRS--YDEKVDVFSFGIVLCEIIGRVNAD 222

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  118 bits (299), Expect = 8e-30
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 19/222 (8%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
           PS+     +LG+ CF          H+ T +++ +K+  L R  +E  ++   E+  MR 
Sbjct: 9   PSDLIHGEVLGKGCF---GQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRC 63

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HPN++ +I        L+ ++  +  G+ + +I +  +   P        +D+ +G+ 
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMA 122

Query: 477 YIHGKGFIHRAVKASHILISHN--------GKACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
           Y+H    IHR + + + L+  N        G A L       P      K          
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182

Query: 529 --NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
             N  W++PE++      YDE+ D++S GI  CE+       
Sbjct: 183 VGNPYWMAPEMINGRS--YDEKVDVFSFGIVLCEIIGRVNAD 222

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (300), Expect = 2e-29
 Identities = 53/340 (15%), Positives = 111/340 (32%), Gaps = 58/340 (17%)

Query: 10  NYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
            Y I   +G       S V+   ++   Q+ A+K  NL+   ++ L S  +EI  +  L+
Sbjct: 57  IYSILKQIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112

Query: 69  HPN--IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
             +  II      +    +++V            +    +            +++L  + 
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSI--DPWERKSYWKNMLEAVH 169

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 183
            IH  G +H  +K ++ LI  +G   L   G+   M    P    V     S    +N++
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKD--SQVGAVNYM 223

Query: 184 SPEVLE---------QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
            PE ++         ++      +SD++S+G     +  G  PF +    +  +      
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---- 279

Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
                                     I +   ++            +++ CL RD  +R 
Sbjct: 280 --------------------------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

Query: 295 LACNLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEIN 334
               LL H + +        + +     +      +  +N
Sbjct: 314 SIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLN 353

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (273), Expect = 6e-26
 Identities = 45/248 (18%), Positives = 92/248 (37%), Gaps = 28/248 (11%)

Query: 348 NSSVETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS 406
           +S+ E +      Y I   +G       S V+   ++   Q+ A+K  NL+   ++ L S
Sbjct: 45  SSANECISVKGRIYSILKQIGSGGS---SKVFQVLNE-KKQIYAIKYVNLEEADNQTLDS 100

Query: 407 LHHEIVCMRHLRHPN--IICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
             +EI  +  L+  +  II      +    +++V            +    +        
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSI--DPWER 157

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHL 521
               +++L  +  IH  G +H  +K ++ LI  +G   L   G+   M    P    V  
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVK 213

Query: 522 FPPSTAYNLNWLSPEVLE---------QNLDGYDERSDIYSVGISCCELANGTVPFAETP 572
              S    +N++ PE ++         ++      +SD++S+G     +  G  PF +  
Sbjct: 214 D--SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

Query: 573 TTLMLIEK 580
             +  +  
Sbjct: 272 NQISKLHA 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (294), Expect = 4e-29
 Identities = 61/329 (18%), Positives = 112/329 (34%), Gaps = 37/329 (11%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           M +       + +  ILGQ     ++V+  +HK T  L A+K FN        +     E
Sbjct: 1   MGSQSTSNHLWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMRE 57

Query: 61  IVCMRHLRHPNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FGLPELVICHI 117
              ++ L H NI+   +   + T  H  L+      GS   ++    N +GLPE     +
Sbjct: 58  FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS------GL-RYMCPFSPTKKKVH 170
           L+DV+ G+ ++   G +HR +K  +I+                G  R +           
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177

Query: 171 LFPPSTAYNLNWLSPEVLEQNLD------GYDERSDIYSVGISCCELANGTVPF---AET 221
               +  Y    L P++ E+ +        Y    D++S+G++    A G++PF      
Sbjct: 178 ----TEEY----LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 222 PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSI 281
                ++ K+    P          + G  D       +  +       SR        +
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPID-------WSGDMPVSCSLSRGLQVLLTPV 282

Query: 282 VELCLSRDVDKRPLACNLLQHAFFKQTKK 310
           +   L  D +K                + 
Sbjct: 283 LANILEADQEKCWGFDQFFAETSDILHRG 311

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  105 bits (263), Expect = 5e-25
 Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 27/225 (12%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            + +  ILGQ     ++V+  +HK T  L A+K FN        +     E   ++ L H
Sbjct: 10  LWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNH 66

Query: 420 PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLE 476
            NI+   +   + T  H  L+      GS   ++    N +GLPE     +L+DV+ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLS------GL-RYMCPFSPTKKKVHLFPPSTAYN 529
           ++   G +HR +K  +I+                G  R +               +  Y 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG----TEEY- 181

Query: 530 LNWLSPEVLEQNLD------GYDERSDIYSVGISCCELANGTVPF 568
              L P++ E+ +        Y    D++S+G++    A G++PF
Sbjct: 182 ---LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  112 bits (282), Expect = 7e-28
 Identities = 36/192 (18%), Positives = 77/192 (40%), Gaps = 18/192 (9%)

Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--ATDLHLVSPLMG 93
              I VK   +   +    +  + E   +R   HPN++  + +     A    L++  M 
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92

Query: 94  FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF--IHRAVKASHILISHNG-- 149
           +GS  ++++   NF + +        D+  G+ ++H         A+ +  ++I  +   
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA 152

Query: 150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISC 208
           +  ++ ++    FS              Y   W++PE L+ +  D     +D++S  +  
Sbjct: 153 RISMADVK----FSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201

Query: 209 CELANGTVPFAE 220
            EL    VPFA+
Sbjct: 202 WELVTREVPFAD 213

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  112 bits (282), Expect = 7e-28
 Identities = 36/192 (18%), Positives = 77/192 (40%), Gaps = 18/192 (9%)

Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--ATDLHLVSPLMG 443
              I VK   +   +    +  + E   +R   HPN++  + +     A    L++  M 
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92

Query: 444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF--IHRAVKASHILISHNG-- 499
           +GS  ++++   NF + +        D+  G+ ++H         A+ +  ++I  +   
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA 152

Query: 500 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE-QNLDGYDERSDIYSVGISC 558
           +  ++ ++    FS              Y   W++PE L+ +  D     +D++S  +  
Sbjct: 153 RISMADVK----FSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201

Query: 559 CELANGTVPFAE 570
            EL    VPFA+
Sbjct: 202 WELVTREVPFAD 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (285), Expect = 2e-27
 Identities = 60/326 (18%), Positives = 111/326 (34%), Gaps = 31/326 (9%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           M +       + +  ILGQ     ++V+  +HK T  L A+K FN        +     E
Sbjct: 1   MGSQSTSNHLWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMRE 57

Query: 61  IVCMRHLRHPNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FGLPELVICHI 117
              ++ L H NI+   +   + T  H  L+      GS   ++    N +GLPE     +
Sbjct: 58  FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS------GL-RYMCPFSPTKKKVH 170
           L+DV+ G+ ++   G +HR +K  +I+                G  R +           
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177

Query: 171 LFPPSTAYNLNWLSPEVLEQNLD------GYDERSDIYSVGISCCELANGTVPFAETPTT 224
               +  Y    L P++ E+ +        Y    D++S+G++    A G++PF      
Sbjct: 178 ----TEEY----LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
               E +      ++        +G    E     +  +       SR        ++  
Sbjct: 230 RRNKEVMY----KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285

Query: 285 CLSRDVDKRPLACNLLQHAFFKQTKK 310
            L  D +K                + 
Sbjct: 286 ILEADQEKCWGFDQFFAETSDILHRM 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  104 bits (262), Expect = 2e-24
 Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 27/225 (12%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            + +  ILGQ     ++V+  +HK T  L A+K FN        +     E   ++ L H
Sbjct: 10  LWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNH 66

Query: 420 PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLE 476
            NI+   +   + T  H  L+      GS   ++    N +GLPE     +L+DV+ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLS------GL-RYMCPFSPTKKKVHLFPPSTAYN 529
           ++   G +HR +K  +I+                G  R +               +  Y 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG----TEEY- 181

Query: 530 LNWLSPEVLEQNLD------GYDERSDIYSVGISCCELANGTVPF 568
              L P++ E+ +        Y    D++S+G++    A G++PF
Sbjct: 182 ---LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (282), Expect = 3e-27
 Identities = 47/358 (13%), Positives = 93/358 (25%), Gaps = 79/358 (22%)

Query: 3   TLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHE 60
            L       K+   L        S V+L +     +  A+K F +       +L+ LH  
Sbjct: 56  LLSQGERKLKLVEPLRVGDR---SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112

Query: 61  IVCMRHLRHPNIICYISSF--------------------------LDATDLHLVSPLMGF 94
                 L   +                                      +  L+ P    
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS- 171

Query: 95  GSCKDLINA-----HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
              + L +       F      L +  +   ++     +  KG +H      ++ I  +G
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG 231

Query: 150 KACLSGLRYMCPFSPTKKKVHLFPPS--TAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 207
           +  L         S   K     P S        +   E L  +   +    + + +G+S
Sbjct: 232 RLMLGD------VSALWKVGTRGPASSVPVT---YAPREFLNASTATFTHALNAWQLGLS 282

Query: 208 CCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQ 267
              +    +PF      +    K                  G D     +C+ + +    
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRV-----------PGTDSLAFGSCTPLPD---- 327

Query: 268 VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSL 325
                       +++   L+ D  +R L    ++   F Q       L   +  +LS 
Sbjct: 328 ---------FVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ-------LQNEISSSLST 369

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.0 bits (241), Expect = 7e-22
 Identities = 35/269 (13%), Positives = 68/269 (25%), Gaps = 48/269 (17%)

Query: 353 TLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHE 410
            L       K+   L        S V+L +     +  A+K F +       +L+ LH  
Sbjct: 56  LLSQGERKLKLVEPLRVGDR---SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112

Query: 411 IVCMRHLRHPNIICYISSF--------------------------LDATDLHLVSPLMGF 444
                 L   +                                      +  L+ P    
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS- 171

Query: 445 GSCKDLINA-----HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
              + L +       F      L +  +   ++     +  KG +H      ++ I  +G
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG 231

Query: 500 KACLSGLRYMCPFSPTKKKVHLFPPS--TAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 557
           +  L         S   K     P S        +   E L  +   +    + + +G+S
Sbjct: 232 RLMLGD------VSALWKVGTRGPASSVPVT---YAPREFLNASTATFTHALNAWQLGLS 282

Query: 558 CCELANGTVPFAETPTTLMLIEKLAGATP 586
              +    +PF      +    K      
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  107 bits (270), Expect = 3e-26
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 18/225 (8%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 67
            +++I   LG+      +VYL++ K +  ++A+K     ++    +   L  E+    HL
Sbjct: 9   EDFEIGRPLGKG--KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           RHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSY 124

Query: 128 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            H K  IHR +K  ++L+   G+  ++  G     P S                L++L P
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--------DLCGTLDYLPP 176

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           E++E     +DE+ D++S+G+ C E   G  PF E  T     ++
Sbjct: 177 EMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKR 218

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  107 bits (270), Expect = 3e-26
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 18/225 (8%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 417
            +++I   LG+      +VYL++ K +  ++A+K     ++    +   L  E+    HL
Sbjct: 9   EDFEIGRPLGKG--KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           RHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSY 124

Query: 478 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            H K  IHR +K  ++L+   G+  ++  G     P S                L++L P
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--------DLCGTLDYLPP 176

Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           E++E     +DE+ D++S+G+ C E   G  PF E  T     ++
Sbjct: 177 EMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKR 218

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  107 bits (269), Expect = 8e-26
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 21/204 (10%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
            +V+ ++       +AVK         E +     E+  M+ LRHPNI+ ++ +     +
Sbjct: 51  GTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108

Query: 85  LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKAS 141
           L +V+  +  GS    L  +     L E     +  DV  G+ Y+H +    +HR +K+ 
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168

Query: 142 HILISHNG--KAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD 196
           ++L+      K C   LS L+     S           S A    W++PEVL       +
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSK---------SAAGTPEWMAPEVLRDEP--SN 217

Query: 197 ERSDIYSVGISCCELANGTVPFAE 220
           E+SD+YS G+   ELA    P+  
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGN 241

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  107 bits (269), Expect = 8e-26
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 21/204 (10%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
            +V+ ++       +AVK         E +     E+  M+ LRHPNI+ ++ +     +
Sbjct: 51  GTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108

Query: 435 LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKAS 491
           L +V+  +  GS    L  +     L E     +  DV  G+ Y+H +    +HR +K+ 
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168

Query: 492 HILISHNG--KAC---LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD 546
           ++L+      K C   LS L+     S           S A    W++PEVL       +
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSK---------SAAGTPEWMAPEVLRDEP--SN 217

Query: 547 ERSDIYSVGISCCELANGTVPFAE 570
           E+SD+YS G+   ELA    P+  
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGN 241

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  107 bits (269), Expect = 8e-26
 Identities = 37/197 (18%), Positives = 87/197 (44%), Gaps = 22/197 (11%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 99
           A++  +++R  ++ LK+   E++  R  RH N++ ++ + +    L +++ L    +   
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 100 LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-------GKAC 152
           ++       L       I Q+++ G+ Y+H KG +H+ +K+ ++   +        G   
Sbjct: 119 VVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFS 177

Query: 153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-------EQNLDGYDERSDIYSVG 205
           +SG+      +  ++            L  L+PE++       E++   + + SD++++G
Sbjct: 178 ISGVL----QAGRREDKLRIQNGW---LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230

Query: 206 ISCCELANGTVPFAETP 222
               EL     PF   P
Sbjct: 231 TIWYELHAREWPFKTQP 247

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  107 bits (269), Expect = 8e-26
 Identities = 37/197 (18%), Positives = 87/197 (44%), Gaps = 22/197 (11%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 449
           A++  +++R  ++ LK+   E++  R  RH N++ ++ + +    L +++ L    +   
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 450 LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-------GKAC 502
           ++       L       I Q+++ G+ Y+H KG +H+ +K+ ++   +        G   
Sbjct: 119 VVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFS 177

Query: 503 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-------EQNLDGYDERSDIYSVG 555
           +SG+      +  ++            L  L+PE++       E++   + + SD++++G
Sbjct: 178 ISGVL----QAGRREDKLRIQNGW---LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230

Query: 556 ISCCELANGTVPFAETP 572
               EL     PF   P
Sbjct: 231 TIWYELHAREWPFKTQP 247

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  108 bits (272), Expect = 1e-25
 Identities = 56/332 (16%), Positives = 108/332 (32%), Gaps = 64/332 (19%)

Query: 5   DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
            ++ +      ILG        +V   +     + +AVK+  +D            EI  
Sbjct: 11  QSLKNLVVSEKILGYGSS---GTVVF-QGSFQGRPVAVKRMLIDFC-----DIALMEIKL 61

Query: 64  MRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-----LPELVICHI 117
           +     HPN+I Y  S      L++   L    + +DL+ +            E     +
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP-------------FSP 164
           L+ + +G+ ++H    IHR +K  +IL+S + +                           
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLD-----GYDERSDIYSVG-ISCCELANGTVPF 218
            +        + +    W +PE+LE++ +           DI+S+G +    L+ G  PF
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 219 AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF 278
            +  +    I +   +   +                            + L  R      
Sbjct: 241 GDKYSRESNIIRGIFSLDEM----------------------------KCLHDRSLIAEA 272

Query: 279 HSIVELCLSRDVDKRPLACNLLQHAFFKQTKK 310
             ++   +  D  KRP A  +L+H  F    K
Sbjct: 273 TDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.2 bits (242), Expect = 1e-21
 Identities = 45/252 (17%), Positives = 89/252 (35%), Gaps = 36/252 (14%)

Query: 355 DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
            ++ +      ILG        +V   +     + +AVK+  +D            EI  
Sbjct: 11  QSLKNLVVSEKILGYGSS---GTVVF-QGSFQGRPVAVKRMLIDFC-----DIALMEIKL 61

Query: 414 MRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-----LPELVICHI 467
           +     HPN+I Y  S      L++   L    + +DL+ +            E     +
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 468 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP-------------FSP 514
           L+ + +G+ ++H    IHR +K  +IL+S + +                           
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLD-----GYDERSDIYSVG-ISCCELANGTVPF 568
            +        + +    W +PE+LE++ +           DI+S+G +    L+ G  PF
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 569 AETPTTLMLIEK 580
            +  +    I +
Sbjct: 241 GDKYSRESNIIR 252

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  105 bits (265), Expect = 2e-25
 Identities = 45/189 (23%), Positives = 86/189 (45%), Gaps = 21/189 (11%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT---DLHLVSPLMGFGS 96
           AVK  N+   T + L++  +E+  +R  RH NI+     F+  +    L +V+      S
Sbjct: 50  AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL----LFMGYSTAPQLAIVTQWCEGSS 105

Query: 97  CKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KAC-- 152
               ++A          +  I +    G++Y+H K  IHR +K+++I +  +   K    
Sbjct: 106 LYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDF 164

Query: 153 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGYDERSDIYSVGISCCE 210
            L+  +     S   +++            W++PEV+  Q+ + Y  +SD+Y+ GI   E
Sbjct: 165 GLATEKSRWSGSHQFEQLS-GSI------LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217

Query: 211 LANGTVPFA 219
           L  G +P++
Sbjct: 218 LMTGQLPYS 226

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  105 bits (265), Expect = 2e-25
 Identities = 45/189 (23%), Positives = 86/189 (45%), Gaps = 21/189 (11%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT---DLHLVSPLMGFGS 446
           AVK  N+   T + L++  +E+  +R  RH NI+     F+  +    L +V+      S
Sbjct: 50  AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL----LFMGYSTAPQLAIVTQWCEGSS 105

Query: 447 CKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KAC-- 502
               ++A          +  I +    G++Y+H K  IHR +K+++I +  +   K    
Sbjct: 106 LYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDF 164

Query: 503 -LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGYDERSDIYSVGISCCE 560
            L+  +     S   +++            W++PEV+  Q+ + Y  +SD+Y+ GI   E
Sbjct: 165 GLATEKSRWSGSHQFEQLS-GSI------LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217

Query: 561 LANGTVPFA 569
           L  G +P++
Sbjct: 218 LMTGQLPYS 226

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (262), Expect = 4e-25
 Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 18/225 (8%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 67
            ++ I   LG+      +VYL++ K    ++A+K     ++  E +   L  EI    HL
Sbjct: 14  DDFDIGRPLGKG--KFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           RHPNI+   + F D   ++L+      G     +  H  F   E      ++++ + L Y
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF--DEQRSATFMEELADALHY 129

Query: 128 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            H +  IHR +K  ++L+ + G+  ++  G     P    +        +    L++L P
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--------TMCGTLDYLPP 181

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           E++E     +DE+ D++  G+ C E   G  PF ++P+      +
Sbjct: 182 EMIEGK--THDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRR 223

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (262), Expect = 4e-25
 Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 18/225 (8%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 417
            ++ I   LG+      +VYL++ K    ++A+K     ++  E +   L  EI    HL
Sbjct: 14  DDFDIGRPLGKG--KFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           RHPNI+   + F D   ++L+      G     +  H  F   E      ++++ + L Y
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF--DEQRSATFMEELADALHY 129

Query: 478 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            H +  IHR +K  ++L+ + G+  ++  G     P    +        +    L++L P
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--------TMCGTLDYLPP 181

Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           E++E     +DE+ D++  G+ C E   G  PF ++P+      +
Sbjct: 182 EMIEGK--THDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRR 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  108 bits (271), Expect = 4e-25
 Identities = 69/312 (22%), Positives = 120/312 (38%), Gaps = 50/312 (16%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
            ++   Y+    LG        V L + KVT+   A+K      ++      L  E+  +
Sbjct: 33  GHLSEMYQRVKKLGS--GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
           + L HPNI+     F D  + +LV      G   D I     F   E+    I++ VL+G
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSG 148

Query: 125 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAY 178
           + Y+H    +HR +K  ++L+         K    GL          K+++      TAY
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-----GTAY 203

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 238
              +++PEVL +    YDE+ D++S+G+    L  G  PF       +L +         
Sbjct: 204 ---YIAPEVLRKK---YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK--------- 248

Query: 239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                  V+ G+   +      +SE       ++         ++  L  D  +R  A  
Sbjct: 249 -------VEKGKYTFDSPEWKNVSEG------AKDL-------IKQMLQFDSQRRISAQQ 288

Query: 299 LLQHAFFKQTKK 310
            L+H + K+   
Sbjct: 289 ALEHPWIKEMCS 300

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  105 bits (265), Expect = 2e-24
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 21/220 (9%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
            ++   Y+    LG        V L + KVT+   A+K      ++      L  E+  +
Sbjct: 33  GHLSEMYQRVKKLGS--GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
           + L HPNI+     F D  + +LV      G   D I     F   E+    I++ VL+G
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSG 148

Query: 475 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAY 528
           + Y+H    +HR +K  ++L+         K    GL          K+++      TAY
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-----GTAY 203

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
              +++PEVL +    YDE+ D++S+G+    L  G  PF
Sbjct: 204 ---YIAPEVLRKK---YDEKCDVWSIGVILFILLAGYPPF 237

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (260), Expect = 8e-25
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
                Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++
Sbjct: 19  TFAERYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L HPNI+       D++  ++V  L   G   D I     F   E     I++ V +G+
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGI 134

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFPPSTAYN 179
            Y+H    +HR +K  +IL+    K C       GL       +  K ++      TAY 
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-----GTAY- 188

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGI 206
             +++PEVL      YDE+ D++S G+
Sbjct: 189 --YIAPEVLRGT---YDEKCDVWSAGV 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (260), Expect = 8e-25
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
                Y I  +LG+   +   V   K ++T Q  AVK  N     ++D  ++  E+  ++
Sbjct: 19  TFAERYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            L HPNI+       D++  ++V  L   G   D I     F   E     I++ V +G+
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGI 134

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFPPSTAYN 529
            Y+H    +HR +K  +IL+    K C       GL       +  K ++      TAY 
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-----GTAY- 188

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGI 556
             +++PEVL      YDE+ D++S G+
Sbjct: 189 --YIAPEVLRGT---YDEKCDVWSAGV 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (259), Expect = 9e-25
 Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 29/232 (12%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
               NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R
Sbjct: 3   KFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L+HPNI+    S  + +  +LV  L+  G   + I A   +   E    H +Q +L  +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEADASHCIQQILESI 118

Query: 126 EYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYN 179
            Y H  G +HR +K  ++L++        K    GL   +                T   
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GTPG- 172

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVG----ISCCELANGTVPF-AETPTTLM 226
             +LSPEVL+++   Y +  DI++ G    I       G  PF  E    L 
Sbjct: 173 --YLSPEVLKKD--PYSKPVDIWACGVILYILLV----GYPPFWDEDQHRLY 216

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (259), Expect = 9e-25
 Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 29/232 (12%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
               NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R
Sbjct: 3   KFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            L+HPNI+    S  + +  +LV  L+  G   + I A   +   E    H +Q +L  +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEADASHCIQQILESI 118

Query: 476 EYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYN 529
            Y H  G +HR +K  ++L++        K    GL   +                T   
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GTPG- 172

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVG----ISCCELANGTVPF-AETPTTLM 576
             +LSPEVL+++   Y +  DI++ G    I       G  PF  E    L 
Sbjct: 173 --YLSPEVLKKD--PYSKPVDIWACGVILYILLV----GYPPFWDEDQHRLY 216

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (262), Expect = 1e-24
 Identities = 52/271 (19%), Positives = 95/271 (35%), Gaps = 56/271 (20%)

Query: 5   DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHE 60
             +   Y +   +GQ  +     V ++    T  + A+K   K  + ++  +D++ +  E
Sbjct: 22  LELQKKYHLKGAIGQGSY---GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH---------------- 104
           +  M+ L HPNI      + D   + LV  L   G   D +N                  
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 105 ----------------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
                                  +F   E +I +I++ + + L Y+H +G  HR +K  +
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198

Query: 143 ILISHNGKACLS----GLRYMCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYD 196
            L S N    +     GL          +   +     +  +    ++PEVL    + Y 
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF----VAPEVLNTTNESYG 254

Query: 197 ERSDIYSVGISCCELANGTVPF-AETPTTLM 226
            + D +S G+    L  G VPF        +
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (262), Expect = 1e-24
 Identities = 52/271 (19%), Positives = 95/271 (35%), Gaps = 56/271 (20%)

Query: 355 DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHE 410
             +   Y +   +GQ  +     V ++    T  + A+K   K  + ++  +D++ +  E
Sbjct: 22  LELQKKYHLKGAIGQGSY---GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 411 IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH---------------- 454
           +  M+ L HPNI      + D   + LV  L   G   D +N                  
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 455 ----------------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
                                  +F   E +I +I++ + + L Y+H +G  HR +K  +
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198

Query: 493 ILISHNGKACLS----GLRYMCPFSPTKKKVHLFPP--STAYNLNWLSPEVLEQNLDGYD 546
            L S N    +     GL          +   +     +  +    ++PEVL    + Y 
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF----VAPEVLNTTNESYG 254

Query: 547 ERSDIYSVGISCCELANGTVPF-AETPTTLM 576
            + D +S G+    L  G VPF        +
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (262), Expect = 1e-24
 Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 29/232 (12%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
               NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R
Sbjct: 26  KFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L+HPNI+    S  + +  +LV  L+  G   + I A   +   E    H +Q +L  +
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEADASHCIQQILESI 141

Query: 126 EYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYN 179
            Y H  G +HR +K  ++L++        K    GL   +                T   
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GTPG- 195

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVG----ISCCELANGTVPF-AETPTTLM 226
             +LSPEVL+++   Y +  DI++ G    I       G  PF  E    L 
Sbjct: 196 --YLSPEVLKKD--PYSKPVDIWACGVILYILLV----GYPPFWDEDQHRLY 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (262), Expect = 1e-24
 Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 29/232 (12%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
               NY +   LG+     S V    HK T    A K  N  +++  D + L  E    R
Sbjct: 26  KFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            L+HPNI+    S  + +  +LV  L+  G   + I A   +   E    H +Q +L  +
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEADASHCIQQILESI 141

Query: 476 EYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYN 529
            Y H  G +HR +K  ++L++        K    GL   +                T   
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GTPG- 195

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVG----ISCCELANGTVPF-AETPTTLM 576
             +LSPEVL+++   Y +  DI++ G    I       G  PF  E    L 
Sbjct: 196 --YLSPEVLKKD--PYSKPVDIWACGVILYILLV----GYPPFWDEDQHRLY 239

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  106 bits (266), Expect = 2e-24
 Identities = 76/330 (23%), Positives = 128/330 (38%), Gaps = 53/330 (16%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVC 63
                 YK   +LG+   +   V L K K+T Q  AVK  +  ++    D +SL  E+  
Sbjct: 22  AIFSDRYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           ++ L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLS 137

Query: 124 GLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTA 177
           G+ Y+H    +HR +K  ++L+         +    GL  +       K K+      TA
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-----GTA 192

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLMLIEKLAGATP 236
           Y   +++PEVL      YDE+ D++S G+    L +G  PF       ++  +K      
Sbjct: 193 Y---YIAPEVLHGT---YDEKCDVWSTGVILYILLSGCPPFNGANEYDIL--KK------ 238

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
                    V+ G+   E      +SE       ++         +   L+     R  A
Sbjct: 239 ---------VEKGKYTFELPQWKKVSES------AKDL-------IRKMLTYVPSMRISA 276

Query: 297 CNLLQHAFFKQTKKCSVMLPELLRPALSLN 326
            + L H + +   K  + +         LN
Sbjct: 277 RDALDHEWIQTYTKEQISVDVPSLDNAILN 306

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 3e-23
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 22/221 (9%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVC 413
                 YK   +LG+   +   V L K K+T Q  AVK  +  ++    D +SL  E+  
Sbjct: 22  AIFSDRYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           ++ L HPNI+     F D    +LV  +   G   D I +   F   E+    I++ VL+
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLS 137

Query: 474 GLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTA 527
           G+ Y+H    +HR +K  ++L+         +    GL  +       K K+      TA
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-----GTA 192

Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           Y   +++PEVL      YDE+ D++S G+    L +G  PF
Sbjct: 193 Y---YIAPEVLHGT---YDEKCDVWSTGVILYILLSGCPPF 227

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  104 bits (260), Expect = 2e-24
 Identities = 54/244 (22%), Positives = 96/244 (39%), Gaps = 28/244 (11%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYI----SSFL 80
             V++ K +   + +AVK F     T+E       EI     +RH NI+ +I        
Sbjct: 51  GEVWMGKWR--GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105

Query: 81  DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF------- 133
             T L+L++     GS  D + +     L    +  +    ++GL ++H + F       
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162

Query: 134 -IHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
             HR +K+ +IL+  NG  C++  GL     F     +V + P +      ++ PEVL++
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGL--AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220

Query: 191 NLDG----YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 246
           +L+         +D+YS G+   E+A   V         +    L  + P   D      
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC 280

Query: 247 DTGQ 250
               
Sbjct: 281 IKKL 284

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  104 bits (260), Expect = 2e-24
 Identities = 54/244 (22%), Positives = 96/244 (39%), Gaps = 28/244 (11%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYI----SSFL 430
             V++ K +   + +AVK F     T+E       EI     +RH NI+ +I        
Sbjct: 51  GEVWMGKWR--GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105

Query: 431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF------- 483
             T L+L++     GS  D + +     L    +  +    ++GL ++H + F       
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162

Query: 484 -IHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
             HR +K+ +IL+  NG  C++  GL     F     +V + P +      ++ PEVL++
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGL--AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220

Query: 541 NLDG----YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 596
           +L+         +D+YS G+   E+A   V         +    L  + P   D      
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC 280

Query: 597 DTGQ 600
               
Sbjct: 281 IKKL 284

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  103 bits (259), Expect = 3e-24
 Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 28/234 (11%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE--IVCMRHLRHPNIICYI----SS 78
             V+  K +   + +AVK F+       + +S   E  I     LRH NI+ +I      
Sbjct: 56  GEVWRGKWR--GEEVAVKIFS-----SREERSWFREAEIYQTVMLRHENILGFIAADNKD 108

Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK------- 131
               T L LVS     GS  D +N +    +    +  +     +GL ++H +       
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGK 165

Query: 132 -GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
               HR +K+ +IL+  NG  C++ L            + + P        +++PEVL+ 
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225

Query: 191 NLDG----YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD 240
           +++       +R+DIY++G+   E+A             +    L  + P + +
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  103 bits (259), Expect = 3e-24
 Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 28/234 (11%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE--IVCMRHLRHPNIICYI----SS 428
             V+  K +   + +AVK F+       + +S   E  I     LRH NI+ +I      
Sbjct: 56  GEVWRGKWR--GEEVAVKIFS-----SREERSWFREAEIYQTVMLRHENILGFIAADNKD 108

Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK------- 481
               T L LVS     GS  D +N +    +    +  +     +GL ++H +       
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGK 165

Query: 482 -GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
               HR +K+ +IL+  NG  C++ L            + + P        +++PEVL+ 
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225

Query: 541 NLDG----YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD 590
           +++       +R+DIY++G+   E+A             +    L  + P + +
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  102 bits (255), Expect = 3e-24
 Identities = 38/205 (18%), Positives = 79/205 (38%), Gaps = 16/205 (7%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDED-----LKSLHHEIVCMRHLRHPNIICYISSF 79
             V+  +      ++A+K   L     E       +    E+  M +L HPNI+      
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92

Query: 80  LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRA 137
            +     +V   +  G     +       +   V   ++ D+  G+EY+  +    +HR 
Sbjct: 93  HNP--PRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRD 149

Query: 138 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGY 195
           +++ +I +    +      + +  F  +++ VH     +    N  W++PE +    + Y
Sbjct: 150 LRSPNIFLQSLDENAPVCAK-VADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESY 205

Query: 196 DERSDIYSVGISCCELANGTVPFAE 220
            E++D YS  +    +  G  PF E
Sbjct: 206 TEKADTYSFAMILYTILTGEGPFDE 230

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  102 bits (255), Expect = 3e-24
 Identities = 38/205 (18%), Positives = 79/205 (38%), Gaps = 16/205 (7%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDED-----LKSLHHEIVCMRHLRHPNIICYISSF 429
             V+  +      ++A+K   L     E       +    E+  M +L HPNI+      
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92

Query: 430 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRA 487
            +     +V   +  G     +       +   V   ++ D+  G+EY+  +    +HR 
Sbjct: 93  HNP--PRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRD 149

Query: 488 VKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY--NLNWLSPEVLEQNLDGY 545
           +++ +I +    +      + +  F  +++ VH     +    N  W++PE +    + Y
Sbjct: 150 LRSPNIFLQSLDENAPVCAK-VADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESY 205

Query: 546 DERSDIYSVGISCCELANGTVPFAE 570
            E++D YS  +    +  G  PF E
Sbjct: 206 TEKADTYSFAMILYTILTGEGPFDE 230

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  104 bits (261), Expect = 8e-24
 Identities = 71/321 (22%), Positives = 127/321 (39%), Gaps = 54/321 (16%)

Query: 6   NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
                Y I  +LG+  F     V   K ++T Q  AVK  N     ++D  ++  E+  +
Sbjct: 19  TFAERYNIVCMLGKGSF---GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
           + L HPNI+       D++  ++V  L   G   D I     F   E     I++ V +G
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSG 133

Query: 125 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAY 178
           + Y+H    +HR +K  +IL+         K    GL       +  K ++      TAY
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-----GTAY 188

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLMLIEKLAGATPH 237
              +++PEVL      YDE+ D++S G+    L +GT PF  +    ++  ++       
Sbjct: 189 ---YIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL--KR------- 233

Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
                   V+TG+   +      IS+       ++         +   L+     R  A 
Sbjct: 234 --------VETGKYAFDLPQWRTISDD------AKDL-------IRKMLTFHPSLRITAT 272

Query: 298 NLLQHAFFKQTKKCSVMLPEL 318
             L+H + ++    +  + +L
Sbjct: 273 QCLEHPWIQKYSSETPTISDL 293

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  103 bits (259), Expect = 1e-23
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 356 NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
                Y I  +LG+  F     V   K ++T Q  AVK  N     ++D  ++  E+  +
Sbjct: 19  TFAERYNIVCMLGKGSF---GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
           + L HPNI+       D++  ++V  L   G   D I     F   E     I++ V +G
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSG 133

Query: 475 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAY 528
           + Y+H    +HR +K  +IL+         K    GL       +  K ++      TAY
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-----GTAY 188

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              +++PEVL      YDE+ D++S G+
Sbjct: 189 ---YIAPEVLRGT---YDEKCDVWSAGV 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =   99 bits (250), Expect = 1e-23
 Identities = 49/229 (21%), Positives = 100/229 (43%), Gaps = 25/229 (10%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 68
           ++K+ ++LG+   + + VY ++   T   +A+K  +   M    +   + +E+     L+
Sbjct: 12  DFKVGNLLGK--GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HP+I+   + F D+  ++LV  +   G     +         E    H +  ++ G+ Y+
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYL 128

Query: 129 HGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYN-----LN 181
           H  G +HR +  S++L++ N    ++  GL              L  P   +       N
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGL-----------ATQLKMPHEKHYTLCGTPN 177

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           ++SPE+  ++   +   SD++S+G     L  G  PF +T T    + K
Sbjct: 178 YISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNK 223

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =   99 bits (250), Expect = 1e-23
 Identities = 49/229 (21%), Positives = 100/229 (43%), Gaps = 25/229 (10%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 418
           ++K+ ++LG+   + + VY ++   T   +A+K  +   M    +   + +E+     L+
Sbjct: 12  DFKVGNLLGK--GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HP+I+   + F D+  ++LV  +   G     +         E    H +  ++ G+ Y+
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYL 128

Query: 479 HGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYN-----LN 531
           H  G +HR +  S++L++ N    ++  GL              L  P   +       N
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGL-----------ATQLKMPHEKHYTLCGTPN 177

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           ++SPE+  ++   +   SD++S+G     L  G  PF +T T    + K
Sbjct: 178 YISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNK 223

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (250), Expect = 2e-23
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE--IVCMRHLRHPNIICYI----SS 78
             V+    +   + +AVK F+       D KS   E  +     LRH NI+ +I    +S
Sbjct: 22  GEVWRGSWQ--GENVAVKIFS-----SRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74

Query: 79  FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF----- 133
              +T L L++     GS  D +       L  +    I+  + +GL ++H + F     
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131

Query: 134 ---IHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
               HR +K+ +IL+  NG+ C++  GL      S +  ++ +          +++PEVL
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGL--AVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 189 EQNLDG----YDERSDIYSVGISCCELANGTVPFAETP 222
           ++ +        +R DI++ G+   E+A   V      
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (250), Expect = 2e-23
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE--IVCMRHLRHPNIICYI----SS 428
             V+    +   + +AVK F+       D KS   E  +     LRH NI+ +I    +S
Sbjct: 22  GEVWRGSWQ--GENVAVKIFS-----SRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74

Query: 429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGF----- 483
              +T L L++     GS  D +       L  +    I+  + +GL ++H + F     
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131

Query: 484 ---IHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
               HR +K+ +IL+  NG+ C++  GL      S +  ++ +          +++PEVL
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGL--AVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 539 EQNLDG----YDERSDIYSVGISCCELANGTVPFAETP 572
           ++ +        +R DI++ G+   E+A   V      
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  100 bits (251), Expect = 3e-23
 Identities = 58/322 (18%), Positives = 115/322 (35%), Gaps = 49/322 (15%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHH------- 59
           +Y+I   L Q     + + L +    N+  A+K   K  L++  D    +          
Sbjct: 32  DYRIIRTLNQ--GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 60  -----EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG------ 108
                E+  +  +++   +       +  +++++   M   S        F         
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 109 LPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPT 165
           +P  VI  I++ VLN   YIH  K   HR VK S+IL+  NG+  LS  G          
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---- 203

Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL 225
            KK+     +  +    + PE           + DI+S+GI    +    VPF+   + +
Sbjct: 204 DKKIKGSRGTYEF----MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259

Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELC 285
            L   +            +++    +     + +++S +    L  + F           
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL--KLF----------- 306

Query: 286 LSRDVDKRPLACNLLQHAFFKQ 307
           L ++  +R  + + L+H +   
Sbjct: 307 LRKNPAERITSEDALKHEWLAD 328

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 55/292 (18%), Positives = 105/292 (35%), Gaps = 36/292 (12%)

Query: 346 TFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDE 402
             N  V+  D   ++Y+I   L Q     + + L +    N+  A+K   K  L++  D 
Sbjct: 18  YLNKYVKEKDKYINDYRIIRTLNQ--GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDF 73

Query: 403 DLKSLHH------------EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL 450
              +               E+  +  +++   +       +  +++++   M   S    
Sbjct: 74  TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133

Query: 451 INAHFNFG------LPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACL 503
               F         +P  VI  I++ VLN   YIH  K   HR VK S+IL+  NG+  L
Sbjct: 134 DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKL 193

Query: 504 S--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           S  G           KK+     +  +    + PE           + DI+S+GI    +
Sbjct: 194 SDFGESEYMV----DKKIKGSRGTYEF----MPPEFFSNESSYNGAKVDIWSLGICLYVM 245

Query: 562 ANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE 613
               VPF+   + + L   +            +++    +     + +++S 
Sbjct: 246 FYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN 297

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  100 bits (250), Expect = 6e-23
 Identities = 40/338 (11%), Positives = 89/338 (26%), Gaps = 84/338 (24%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNL-DRMTDEDLKSLHHEIVCMRHLR---HPNIICYISSFL 80
            +   +  + T +   V      +R     +K +  E++ +R LR   +         F+
Sbjct: 92  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151

Query: 81  DATDL------------------------HLVSPLMGFGSCKDLINAHFNFG-----LPE 111
              DL                          + P M   + +       +       L  
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVH 210

Query: 112 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG---LRYMCPFSPTKKK 168
                +   V+  L  +H  G +H  ++   I++   G   L+G   L      + +   
Sbjct: 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG 270

Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAETPTTL 225
               PP         +  +L              D +++G++   +    +P       L
Sbjct: 271 RGFAPPE------TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN-TDDAAL 323

Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELC 285
              E +  +  ++                                         +++E  
Sbjct: 324 GGSEWIFRSCKNI------------------------------------PQPVRALLEGF 347

Query: 286 LSRDVDKRPLACNLLQHAFFKQTKKC-SVMLPELLRPA 322
           L    + R L    ++   ++Q +   S  LP      
Sbjct: 348 LRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDG 385

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.1 bits (223), Expect = 2e-19
 Identities = 32/253 (12%), Positives = 72/253 (28%), Gaps = 47/253 (18%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNL-DRMTDEDLKSLHHEIVCMRHLR---HPNIICYISSFL 430
            +   +  + T +   V      +R     +K +  E++ +R LR   +         F+
Sbjct: 92  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151

Query: 431 DATDL------------------------HLVSPLMGFGSCKDLINAHFNFG-----LPE 461
              DL                          + P M   + +       +       L  
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVH 210

Query: 462 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG---LRYMCPFSPTKKK 518
                +   V+  L  +H  G +H  ++   I++   G   L+G   L      + +   
Sbjct: 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG 270

Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAETPTTL 575
               PP         +  +L              D +++G++   +    +P       L
Sbjct: 271 RGFAPPE------TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN-TDDAAL 323

Query: 576 MLIEKLAGATPHL 588
              E +  +  ++
Sbjct: 324 GGSEWIFRSCKNI 336

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 99.7 bits (248), Expect = 8e-23
 Identities = 40/343 (11%), Positives = 86/343 (25%), Gaps = 95/343 (27%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLR--------------- 68
            +   +  + T +   V       R     +K +  E++ +R LR               
Sbjct: 87  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146

Query: 69  ----------HPNIICYISSFLD--ATDLHLVSPLMGFGSCKDLINAHFNFG-----LPE 111
                        +I       D        + P M   + +       +       L  
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVH 205

Query: 112 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL 171
                +   V+  L  +H  G +H  ++   I++   G   L+G  ++           +
Sbjct: 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVV 261

Query: 172 FPPSTAYNLNWLSPEVLEQNLD---------GYDERSDIYSVGISCCELANGTVPFAETP 222
              S  +      PE+  +                  D +++G+    +    +P     
Sbjct: 262 SSVSRGF----EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI---- 313

Query: 223 TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIV 282
                                        D       +I        + +       +++
Sbjct: 314 ---------------------------TKDAALGGSEWIFR------SCKNIPQPVRALL 340

Query: 283 ELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSL 325
           E  L    + R L    ++   ++Q       L   L  AL L
Sbjct: 341 EGFLRYPKEDRLLPLQAMETPEYEQ-------LRTELSAALPL 376

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 30/256 (11%), Positives = 70/256 (27%), Gaps = 52/256 (20%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLD-RMTDEDLKSLHHEIVCMRHLR--------------- 418
            +   +  + T +   V       R     +K +  E++ +R LR               
Sbjct: 87  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146

Query: 419 ----------HPNIICYISSFLD--ATDLHLVSPLMGFGSCKDLINAHFNFG-----LPE 461
                        +I       D        + P M   + +       +       L  
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVH 205

Query: 462 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHL 521
                +   V+  L  +H  G +H  ++   I++   G   L+G  ++           +
Sbjct: 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVV 261

Query: 522 FPPSTAYNLNWLSPEVLEQNLD---------GYDERSDIYSVGISCCELANGTVPFAETP 572
              S  +      PE+  +                  D +++G+    +    +P  +  
Sbjct: 262 SSVSRGF----EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-D 316

Query: 573 TTLMLIEKLAGATPHL 588
             L   E +  +  ++
Sbjct: 317 AALGGSEWIFRSCKNI 332

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 99.1 bits (247), Expect = 8e-23
 Identities = 53/339 (15%), Positives = 117/339 (34%), Gaps = 60/339 (17%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR- 68
             ++  +L +     + VY ++   + +  A+K+  L    +E  +++  E+  M+ L  
Sbjct: 29  RLRVRRVLAEG--GFAFVYEAQDVGSGREYALKR--LLSNEEEKNRAIIQEVCFMKKLSG 84

Query: 69  HPNIICYISSFLDA-----TDLHLVSPLMGF--GSCKDLINAHFNFG-LPELVICHILQD 120
           HPNI+ + S+         T       L     G   + +    + G L    +  I   
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144

Query: 121 VLNGLEYIHGKG--FIHRAVKASHILISHNGKACL------SGLRYMCPFSPTKKKVHLF 172
               ++++H +    IHR +K  ++L+S+ G   L      + + +   +S + ++  L 
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 173 PPSTAYN--LNWLSPEVLEQNLD-GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE 229
                 N    + +PE+++   +    E+ DI+++G     L     PF           
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----------- 253

Query: 230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRD 289
                                   E+ A   I   +  +         FHS++   L  +
Sbjct: 254 ------------------------EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN 289

Query: 290 VDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNES 328
            ++R     ++         + +V     +   L  N  
Sbjct: 290 PEERLSIAEVVHQLQEIAAAR-NVNPKSPITELLEQNGG 327

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 42/229 (18%), Positives = 93/229 (40%), Gaps = 24/229 (10%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR- 418
             ++  +L +     + VY ++   + +  A+K+  L    +E  +++  E+  M+ L  
Sbjct: 29  RLRVRRVLAEG--GFAFVYEAQDVGSGREYALKR--LLSNEEEKNRAIIQEVCFMKKLSG 84

Query: 419 HPNIICYISSFLDA-----TDLHLVSPLMGF--GSCKDLINAHFNFG-LPELVICHILQD 470
           HPNI+ + S+         T       L     G   + +    + G L    +  I   
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144

Query: 471 VLNGLEYIHGKG--FIHRAVKASHILISHNGKACL------SGLRYMCPFSPTKKKVHLF 522
               ++++H +    IHR +K  ++L+S+ G   L      + + +   +S + ++  L 
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 523 PPSTAYN--LNWLSPEVLEQNLD-GYDERSDIYSVGISCCELANGTVPF 568
                 N    + +PE+++   +    E+ DI+++G     L     PF
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 50/248 (20%), Positives = 102/248 (41%), Gaps = 23/248 (9%)

Query: 332 EINNELECMFNINDTFNSSVETL--DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLI 389
           +IN+  +   +I   +      +   +V   Y I   LG        V+    K T ++ 
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG--AFGVVHRCVEKATGRVF 79

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 449
             K  N     D+   ++ +EI  M  L HP +I    +F D  ++ L+   +  G   D
Sbjct: 80  VAKFINTPYPLDKY--TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 137

Query: 450 LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS----G 505
            I A  ++ + E  + + ++    GL+++H    +H  +K  +I+      + +     G
Sbjct: 138 RIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 196

Query: 506 L-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG 564
           L   + P    K        +TA    + +PE++++  +     +D++++G+    L +G
Sbjct: 197 LATKLNPDEIVKVTT-----ATAE---FAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSG 246

Query: 565 TVPF-AET 571
             PF  E 
Sbjct: 247 LSPFAGED 254

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 21/223 (9%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
            +V   Y I   LG        V+    K T ++   K  N     D+   ++ +EI  M
Sbjct: 47  GSVYDYYDILEELGSG--AFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIM 102

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             L HP +I    +F D  ++ L+   +  G   D I A  ++ + E  + + ++    G
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEG 161

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPSTAYN 179
           L+++H    +H  +K  +I+      + +     GL   + P    K        +TA  
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-----ATAE- 215

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AET 221
             + +PE++++  +     +D++++G+    L +G  PF  E 
Sbjct: 216 --FAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (250), Expect = 2e-22
 Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 23/224 (10%)

Query: 5   DNVPSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
           D+V  +Y I   LG   F     V+    + T    A K       +D++  ++  EI  
Sbjct: 153 DHVLDHYDIHEELGTGAF---GVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQT 207

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           M  LRHP ++    +F D  ++ ++   M  G   + +    +  + E      ++ V  
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCK 266

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPSTAY 178
           GL ++H   ++H  +K  +I+ +      L     GL  ++ P    K         TA 
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-----GTAE 321

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AET 221
              + +PEV           +D++SVG+    L +G  PF  E 
Sbjct: 322 ---FAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (250), Expect = 2e-22
 Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 23/224 (10%)

Query: 355 DNVPSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
           D+V  +Y I   LG   F     V+    + T    A K       +D++  ++  EI  
Sbjct: 153 DHVLDHYDIHEELGTGAF---GVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQT 207

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           M  LRHP ++    +F D  ++ ++   M  G   + +    +  + E      ++ V  
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCK 266

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPSTAY 528
           GL ++H   ++H  +K  +I+ +      L     GL  ++ P    K         TA 
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-----GTAE 321

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AET 571
              + +PEV           +D++SVG+    L +G  PF  E 
Sbjct: 322 ---FAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 18/225 (8%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 68
            Y     LG+     +  +      T ++ A K      +     +  +  EI   R L 
Sbjct: 42  RYVRGRFLGKG--GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 127
           H +++ +   F D   + +V  L    S  +L         L E    + L+ ++ G +Y
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQY 156

Query: 128 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           +H    IHR +K  ++ ++ + +  +   GL     +   +KKV           N+++P
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV------LCGTPNYIAP 210

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           EVL +   G+    D++S+G     L  G  PF ET        +
Sbjct: 211 EVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLR 252

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 18/225 (8%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 418
            Y     LG+     +  +      T ++ A K      +     +  +  EI   R L 
Sbjct: 42  RYVRGRFLGKG--GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 477
           H +++ +   F D   + +V  L    S  +L         L E    + L+ ++ G +Y
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQY 156

Query: 478 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           +H    IHR +K  ++ ++ + +  +   GL     +   +KKV           N+++P
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV------LCGTPNYIAP 210

Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           EVL +   G+    D++S+G     L  G  PF ET        +
Sbjct: 211 EVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLR 252

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.1 bits (245), Expect = 6e-22
 Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 21/208 (10%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
                Y++   LG+     S V      +  Q  A    N  +++  D + L  E    R
Sbjct: 8   RFTEEYQLFEELGK--GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L+HPNI+    S  +    +L+  L+  G   + I A   +   E    H +Q +L  +
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY--SEADASHCIQQILEAV 123

Query: 126 EYIHGKGFIHRAVKASHILISHNG-----KACLSGL--RYMCPFSPTKKKVHLFPPSTAY 178
            + H  G +HR +K  ++L++        K    GL                     T  
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-----GTPG 178

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              +LSPEVL ++   Y +  D+++ G+
Sbjct: 179 ---YLSPEVLRKD--PYGKPVDLWACGV 201

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.1 bits (245), Expect = 6e-22
 Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 21/208 (10%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
                Y++   LG+     S V      +  Q  A    N  +++  D + L  E    R
Sbjct: 8   RFTEEYQLFEELGK--GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            L+HPNI+    S  +    +L+  L+  G   + I A   +   E    H +Q +L  +
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY--SEADASHCIQQILEAV 123

Query: 476 EYIHGKGFIHRAVKASHILISHNG-----KACLSGL--RYMCPFSPTKKKVHLFPPSTAY 528
            + H  G +HR +K  ++L++        K    GL                     T  
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-----GTPG 178

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              +LSPEVL ++   Y +  D+++ G+
Sbjct: 179 ---YLSPEVLRKD--PYGKPVDLWACGV 201

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 96.3 bits (240), Expect = 6e-22
 Identities = 62/314 (19%), Positives = 113/314 (35%), Gaps = 45/314 (14%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
            E L       ++  +  +       V+ ++    N+ +AVK F    + D+      +E
Sbjct: 16  TENLYFQSMPLQLLEVKAR--GRFGCVWKAQLL--NEYVAVKIFP---IQDKQSWQNEYE 68

Query: 61  IVCMRHLRHPNIICYI----SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICH 116
           +  +  ++H NI+ +I           DL L++     GS  D + A+    +    +CH
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCH 125

Query: 117 ILQDVLNGLEYIHGKGF----------IHRAVKASHILISHNGKACLS--GLRYMCPFSP 164
           I + +  GL Y+H               HR +K+ ++L+ +N  AC++  GL        
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPFAET 221
           +    H           +++PEVLE  ++       R D+Y++G+   ELA+        
Sbjct: 186 SAGDTH----GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 222 PTTLML-IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS 280
               ML  E+  G  P L D     V   +     +                        
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ-----------KHAGMAMLCE 290

Query: 281 IVELCLSRDVDKRP 294
            +E C   D + R 
Sbjct: 291 TIEECWDHDAEARL 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 52/249 (20%), Positives = 99/249 (39%), Gaps = 33/249 (13%)

Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSL 407
           +   E L       ++  +  +       V+ ++    N+ +AVK F    + D+     
Sbjct: 13  DLGTENLYFQSMPLQLLEVKAR--GRFGCVWKAQLL--NEYVAVKIFP---IQDKQSWQN 65

Query: 408 HHEIVCMRHLRHPNIICYI----SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELV 463
            +E+  +  ++H NI+ +I           DL L++     GS  D + A+    +    
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNE 122

Query: 464 ICHILQDVLNGLEYIHGKGF----------IHRAVKASHILISHNGKACLS--GLRYMCP 511
           +CHI + +  GL Y+H               HR +K+ ++L+ +N  AC++  GL     
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG---YDERSDIYSVGISCCELANGTVPF 568
              +    H           +++PEVLE  ++       R D+Y++G+   ELA+     
Sbjct: 183 AGKSAGDTH----GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 569 AETPTTLML 577
                  ML
Sbjct: 239 DGPVDEYML 247

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 18/225 (8%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 68
            Y     LG+     +  +      T ++ A K      +     +  +  EI   R L 
Sbjct: 16  RYVRGRFLGKG--GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 127
           H +++ +   F D   + +V  L    S  +L         L E    + L+ ++ G +Y
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQY 130

Query: 128 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           +H    IHR +K  ++ ++ + +  +   GL     +   +KKV           N+++P
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV------LCGTPNYIAP 184

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           EVL +   G+    D++S+G     L  G  PF ET        +
Sbjct: 185 EVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLR 226

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 18/225 (8%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 418
            Y     LG+     +  +      T ++ A K      +     +  +  EI   R L 
Sbjct: 16  RYVRGRFLGKG--GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 477
           H +++ +   F D   + +V  L    S  +L         L E    + L+ ++ G +Y
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQY 130

Query: 478 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           +H    IHR +K  ++ ++ + +  +   GL     +   +KKV           N+++P
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV------LCGTPNYIAP 184

Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           EVL +   G+    D++S+G     L  G  PF ET        +
Sbjct: 185 EVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLR 226

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 42/215 (19%), Positives = 79/215 (36%), Gaps = 32/215 (14%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
             V  +K +   + +A+K+      ++ + K+   E+  +  + HPNI+    + L+   
Sbjct: 22  GVVCKAKWR--AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNP-- 73

Query: 85  LHLVSPLMGFGSCKDLI-NAHFNFGLPELVICHILQDVLNGLEYIHG---KGFIHRAVKA 140
           + LV      GS  +++  A                    G+ Y+H    K  IHR +K 
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133

Query: 141 SHILISHNGKAC------LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 194
            ++L+   G          +              +     +   +  W++PEV E +   
Sbjct: 134 PNLLLVAGGTVLKICDFGTA------------CDIQTHMTNNKGSAAWMAPEVFEGS--N 179

Query: 195 YDERSDIYSVGISCCELANGTVPFAETPTTLMLIE 229
           Y E+ D++S GI   E+     PF E       I 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 42/215 (19%), Positives = 79/215 (36%), Gaps = 32/215 (14%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
             V  +K +   + +A+K+      ++ + K+   E+  +  + HPNI+    + L+   
Sbjct: 22  GVVCKAKWR--AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNP-- 73

Query: 435 LHLVSPLMGFGSCKDLI-NAHFNFGLPELVICHILQDVLNGLEYIHG---KGFIHRAVKA 490
           + LV      GS  +++  A                    G+ Y+H    K  IHR +K 
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133

Query: 491 SHILISHNGKAC------LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG 544
            ++L+   G          +              +     +   +  W++PEV E +   
Sbjct: 134 PNLLLVAGGTVLKICDFGTA------------CDIQTHMTNNKGSAAWMAPEVFEGS--N 179

Query: 545 YDERSDIYSVGISCCELANGTVPFAETPTTLMLIE 579
           Y E+ D++S GI   E+     PF E       I 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 12/192 (6%)

Query: 36  NQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG 93
              +AVK    D   D  + ++++  E      L+HPNII      L   +L LV     
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89

Query: 94  FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG---FIHRAVKASHILISHNGK 150
            G    +++      +P  ++ +    +  G+ Y+H +     IHR +K+S+ILI    +
Sbjct: 90  GGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146

Query: 151 ACLSGLRYM--CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 208
                 + +    F   ++       S A    W++PEV+  ++  + + SD++S G+  
Sbjct: 147 NGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLL 204

Query: 209 CELANGTVPFAE 220
            EL  G VPF  
Sbjct: 205 WELLTGEVPFRG 216

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 12/192 (6%)

Query: 386 NQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMG 443
              +AVK    D   D  + ++++  E      L+HPNII      L   +L LV     
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89

Query: 444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG---FIHRAVKASHILISHNGK 500
            G    +++      +P  ++ +    +  G+ Y+H +     IHR +K+S+ILI    +
Sbjct: 90  GGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146

Query: 501 ACLSGLRYM--CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISC 558
                 + +    F   ++       S A    W++PEV+  ++  + + SD++S G+  
Sbjct: 147 NGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLL 204

Query: 559 CELANGTVPFAE 570
            EL  G VPF  
Sbjct: 205 WELLTGEVPFRG 216

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 68/336 (20%), Positives = 128/336 (38%), Gaps = 63/336 (18%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-----------EDL 54
            +  +Y     LG        V L K K  +   A+K     +              +  
Sbjct: 33  KIGESYFKVRKLGS--GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +++EI  ++ L HPNII     F D    +LV+     G   + I     F   E   
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDA 148

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKK 168
            +I++ +L+G+ Y+H    +HR +K  +IL+ +       K    GL  +       + +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLML 227
           +      TAY   +++PEVL++    Y+E+ D++S G+    L  G  PF  +    ++ 
Sbjct: 209 LG-----TAY---YIAPEVLKKK---YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII- 256

Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLS 287
            +K               V+ G+   + N    IS++      +++        ++L L+
Sbjct: 257 -KK---------------VEKGKYYFDFNDWKNISDE------AKEL-------IKLMLT 287

Query: 288 RDVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPAL 323
            D +KR  A   L   + K+         +      
Sbjct: 288 YDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 32/218 (14%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-----------EDL 404
            +  +Y     LG        V L K K  +   A+K     +              +  
Sbjct: 33  KIGESYFKVRKLGS--GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
           + +++EI  ++ L HPNII     F D    +LV+     G   + I     F   E   
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDA 148

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKK 518
            +I++ +L+G+ Y+H    +HR +K  +IL+ +       K    GL  +       + +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
           +      TAY   +++PEVL++    Y+E+ D++S G+
Sbjct: 209 LG-----TAY---YIAPEVLKKK---YNEKCDVWSCGV 235

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 25/211 (11%)

Query: 3   TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI 61
           T  ++   Y + + +G+   +   V ++  K T    A KK     + D +  K    EI
Sbjct: 3   TKGDINQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EI 57

Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
             M+ L HPNII    +F D TD++LV  L   G   + +     F   E     I++DV
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF--RESDAARIMKDV 115

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPS 175
           L+ + Y H     HR +K  + L   +      K    GL     P    + KV      
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----G 170

Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
           T Y   ++SP+VLE     Y    D +S G+
Sbjct: 171 TPY---YVSPQVLEGL---YGPECDEWSAGV 195

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 25/211 (11%)

Query: 353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEI 411
           T  ++   Y + + +G+   +   V ++  K T    A KK     + D +  K    EI
Sbjct: 3   TKGDINQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EI 57

Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
             M+ L HPNII    +F D TD++LV  L   G   + +     F   E     I++DV
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF--RESDAARIMKDV 115

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPS 525
           L+ + Y H     HR +K  + L   +      K    GL     P    + KV      
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----G 170

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
           T Y   ++SP+VLE     Y    D +S G+
Sbjct: 171 TPY---YVSPQVLEGL---YGPECDEWSAGV 195

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 24/223 (10%)

Query: 6   NVPSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
            +   Y I   LG+  F     V+      + +    K   +       +K    EI  +
Sbjct: 2   ELYEKYMIAEDLGRGEF---GIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISIL 55

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
              RH NI+    SF    +L ++   +      + IN    F L E  I   +  V   
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEA 114

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPSTAYN 179
           L+++H     H  ++  +I+      + +     G  R + P    +        +    
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-----TAPE- 168

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AET 221
             + +PEV +   D     +D++S+G     L +G  PF AET
Sbjct: 169 --YYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAET 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 24/223 (10%)

Query: 356 NVPSNYKICSILGQC-FNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
            +   Y I   LG+  F     V+      + +    K   +       +K    EI  +
Sbjct: 2   ELYEKYMIAEDLGRGEF---GIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISIL 55

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
              RH NI+    SF    +L ++   +      + IN    F L E  I   +  V   
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEA 114

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPSTAYN 529
           L+++H     H  ++  +I+      + +     G  R + P    +        +    
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-----TAPE- 168

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AET 571
             + +PEV +   D     +D++S+G     L +G  PF AET
Sbjct: 169 --YYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAET 207

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.8 bits (233), Expect = 5e-21
 Identities = 49/285 (17%), Positives = 100/285 (35%), Gaps = 45/285 (15%)

Query: 31  KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 90
           + ++    +  +  +    +   + +   +I  M      N +  +        L++   
Sbjct: 82  QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQ 141

Query: 91  LMGFGSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 149
           L    + KD +N   +    E  +C HI   +   +E++H KG +HR +K S+I  + + 
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD 201

Query: 150 KACLS--GLRYMCPFSPTKKKVHLFPPSTAYN------LNWLSPEVLEQNLDGYDERSDI 201
              +   GL         ++ V    P+ A +        ++SPE +  N   Y  + DI
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDI 259

Query: 202 YSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI 261
           +S+G+   EL        E    +  +       P L                       
Sbjct: 260 FSLGLILFELLYSFSTQMERVRIITDVRN--LKFPLLFT--------------------- 296

Query: 262 SEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
                      +     H +V+  LS    +RP A +++++A F+
Sbjct: 297 -----------QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 38/209 (18%), Positives = 79/209 (37%), Gaps = 11/209 (5%)

Query: 381 KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP 440
           + ++    +  +  +    +   + +   +I  M      N +  +        L++   
Sbjct: 82  QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQ 141

Query: 441 LMGFGSCKDLINAHFNFGLPELVIC-HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG 499
           L    + KD +N   +    E  +C HI   +   +E++H KG +HR +K S+I  + + 
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD 201

Query: 500 KACLS--GLRYMCPFSPTKKKVHLFPPSTAYN------LNWLSPEVLEQNLDGYDERSDI 551
              +   GL         ++ V    P+ A +        ++SPE +  N   Y  + DI
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDI 259

Query: 552 YSVGISCCELANGTVPFAETPTTLMLIEK 580
           +S+G+   EL        E    +  +  
Sbjct: 260 FSLGLILFELLYSFSTQMERVRIITDVRN 288

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 16/74 (21%), Positives = 38/74 (51%), Gaps = 5/74 (6%)

Query: 9  SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
          ++++    +G+  F     V+ +K+KV +   A+K+  L    +   + +  E+  +  L
Sbjct: 6  TDFEPIQCMGRGGF---GVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKL 61

Query: 68 RHPNIICYISSFLD 81
           HP I+ Y +++L+
Sbjct: 62 EHPGIVRYFNAWLE 75

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 16/74 (21%), Positives = 38/74 (51%), Gaps = 5/74 (6%)

Query: 359 SNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           ++++    +G+  F     V+ +K+KV +   A+K+  L    +   + +  E+  +  L
Sbjct: 6   TDFEPIQCMGRGGF---GVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKL 61

Query: 418 RHPNIICYISSFLD 431
            HP I+ Y +++L+
Sbjct: 62  EHPGIVRYFNAWLE 75

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 45/234 (19%), Positives = 86/234 (36%), Gaps = 26/234 (11%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHE 60
             V   Y I   LG      + V   + K T    A K     +          + +  E
Sbjct: 8   QKVEDFYDIGEELGSG--QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65

Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +R + H N+I     + + TD+ L+  L+  G   D +    +    E      ++ 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEATSFIKQ 123

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKKKVHLFP 173
           +L+G+ Y+H K   H  +K  +I++          K    GL   +      K       
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---- 179

Query: 174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 226
             T     +++PE++    +     +D++S+G+    L +G  PF  +T    +
Sbjct: 180 -GTPE---FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 45/234 (19%), Positives = 86/234 (36%), Gaps = 26/234 (11%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHE 410
             V   Y I   LG      + V   + K T    A K     +          + +  E
Sbjct: 8   QKVEDFYDIGEELGSG--QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65

Query: 411 IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
           +  +R + H N+I     + + TD+ L+  L+  G   D +    +    E      ++ 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEATSFIKQ 123

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKKKVHLFP 523
           +L+G+ Y+H K   H  +K  +I++          K    GL   +      K       
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---- 179

Query: 524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 576
             T     +++PE++    +     +D++S+G+    L +G  PF  +T    +
Sbjct: 180 -GTPE---FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.4 bits (235), Expect = 7e-21
 Identities = 67/320 (20%), Positives = 120/320 (37%), Gaps = 62/320 (19%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHH 59
            +   Y +   LG        V L+  + T + +A++  +  +         +   ++  
Sbjct: 132 ALRDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189

Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           EI  ++ L HP II   + F DA D ++V  LM  G   D +  +      E        
Sbjct: 190 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL--KEATCKLYFY 246

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFP 173
            +L  ++Y+H  G IHR +K  ++L+S   + CL      G  + +   S  +       
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---- 302

Query: 174 PSTAYNLNWLSPEVLEQNLD-GYDERSDIYSVG----ISCCELANGTVPFAETPTTLMLI 228
             T     +L+PEVL      GY+   D +S+G    I       G  PF+E  T + L 
Sbjct: 303 -GTPT---YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS----GYPPFSEHRTQVSLK 354

Query: 229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
           ++               + +G+ +       +I E   +V      S+    +V+  L  
Sbjct: 355 DQ---------------ITSGKYN-------FIPEVWAEV------SEKALDLVKKLLVV 386

Query: 289 DVDKRPLACNLLQHAFFKQT 308
           D   R      L+H + +  
Sbjct: 387 DPKARFTTEEALRHPWLQDE 406

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 34/242 (14%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHH 409
            +   Y +   LG        V L+  + T + +A++  +  +         +   ++  
Sbjct: 132 ALRDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189

Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           EI  ++ L HP II   + F DA D ++V  LM  G   D +  +      E        
Sbjct: 190 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL--KEATCKLYFY 246

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFP 523
            +L  ++Y+H  G IHR +K  ++L+S   + CL      G  + +   S  +       
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---- 302

Query: 524 PSTAYNLNWLSPEVLEQNLD-GYDERSDIYSVG----ISCCELANGTVPFAETPTTLMLI 578
             T     +L+PEVL      GY+   D +S+G    I       G  PF+E  T + L 
Sbjct: 303 -GTPT---YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS----GYPPFSEHRTQVSLK 354

Query: 579 EK 580
           ++
Sbjct: 355 DQ 356

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.2 bits (230), Expect = 9e-21
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 26/229 (11%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
           N+   +    +LG      S V+L K ++T +L A+K         +   SL +EI  ++
Sbjct: 6   NIRKTFIFMEVLGSG--AFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLK 61

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLN 123
            ++H NI+     +   T  +LV  L+  G   D I     +     E     ++Q VL+
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYT----EKDASLVIQQVLS 117

Query: 124 GLEYIHGKGFIHRAVKASHILISHNG-----KACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
            ++Y+H  G +HR +K  ++L               GL  M                T  
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-----GTPG 172

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 226
              +++PEVL Q    Y +  D +S+G+    L  G  PF  ET + L 
Sbjct: 173 ---YVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.2 bits (230), Expect = 9e-21
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 26/229 (11%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
           N+   +    +LG      S V+L K ++T +L A+K         +   SL +EI  ++
Sbjct: 6   NIRKTFIFMEVLGSG--AFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLK 61

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLN 473
            ++H NI+     +   T  +LV  L+  G   D I     +     E     ++Q VL+
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYT----EKDASLVIQQVLS 117

Query: 474 GLEYIHGKGFIHRAVKASHILISHNG-----KACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
            ++Y+H  G +HR +K  ++L               GL  M                T  
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-----GTPG 172

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 576
              +++PEVL Q    Y +  D +S+G+    L  G  PF  ET + L 
Sbjct: 173 ---YVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 44/212 (20%), Positives = 86/212 (40%), Gaps = 25/212 (11%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHEI 61
            V  +Y++   LG      + V   + K T +  A K     R++        + +  E+
Sbjct: 2   MVEDHYEMGEELGSG--QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59

Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
             +R +RHPNII     F + TD+ L+  L+  G   D +    +    E      L+ +
Sbjct: 60  NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL--TEDEATQFLKQI 117

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKKKVHLFPP 174
           L+G+ Y+H K   H  +K  +I++          K    G+   +   +  K        
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----- 172

Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
            T     +++PE++    +     +D++S+G+
Sbjct: 173 GTPE---FVAPEIVNY--EPLGLEADMWSIGV 199

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 44/212 (20%), Positives = 86/212 (40%), Gaps = 25/212 (11%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHEI 411
            V  +Y++   LG      + V   + K T +  A K     R++        + +  E+
Sbjct: 2   MVEDHYEMGEELGSG--QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59

Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
             +R +RHPNII     F + TD+ L+  L+  G   D +    +    E      L+ +
Sbjct: 60  NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL--TEDEATQFLKQI 117

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKKKVHLFPP 524
           L+G+ Y+H K   H  +K  +I++          K    G+   +   +  K        
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----- 172

Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
            T     +++PE++    +     +D++S+G+
Sbjct: 173 GTPE---FVAPEIVNY--EPLGLEADMWSIGV 199

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 45/208 (21%), Positives = 80/208 (38%), Gaps = 24/208 (11%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHL 67
           Y++C ++G+     S V    ++ T Q  AVK               + L  E      L
Sbjct: 26  YELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGL 125
           +HP+I+  + ++     L++V   M        I       F   E V  H ++ +L  L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 126 EYIHGKGFIHRAVKASHIL-ISHNGKACLS----GL--RYMCPFSPTKKKVHLFPPSTAY 178
            Y H    IHR VK   +L  S    A +     G+  +          +V      T +
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-----GTPH 198

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              +++PEV+++    Y +  D++  G+
Sbjct: 199 ---FMAPEVVKRE--PYGKPVDVWGCGV 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 45/208 (21%), Positives = 80/208 (38%), Gaps = 24/208 (11%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHL 417
           Y++C ++G+     S V    ++ T Q  AVK               + L  E      L
Sbjct: 26  YELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGL 475
           +HP+I+  + ++     L++V   M        I       F   E V  H ++ +L  L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 476 EYIHGKGFIHRAVKASHIL-ISHNGKACLS----GL--RYMCPFSPTKKKVHLFPPSTAY 528
            Y H    IHR VK   +L  S    A +     G+  +          +V      T +
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-----GTPH 198

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              +++PEV+++    Y +  D++  G+
Sbjct: 199 ---FMAPEVVKRE--PYGKPVDVWGCGV 221

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 42/213 (19%), Positives = 81/213 (38%), Gaps = 25/213 (11%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHE 60
           +NV   Y     LG      + V   + K T    A K     R          + +  E
Sbjct: 7   ENVDDYYDTGEELGSG--QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64

Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +    E      L+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEEATEFLKQ 122

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKKKVHLFP 173
           +LNG+ Y+H     H  +K  +I++          K    GL   +   +  K       
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---- 178

Query: 174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
             T     +++PE++    +     +D++S+G+
Sbjct: 179 -GTPE---FVAPEIVNY--EPLGLEADMWSIGV 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 42/213 (19%), Positives = 81/213 (38%), Gaps = 25/213 (11%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHE 410
           +NV   Y     LG      + V   + K T    A K     R          + +  E
Sbjct: 7   ENVDDYYDTGEELGSG--QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64

Query: 411 IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
           +  ++ ++HPN+I     + + TD+ L+  L+  G   D +    +    E      L+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEEATEFLKQ 122

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKKKVHLFP 523
           +LNG+ Y+H     H  +K  +I++          K    GL   +   +  K       
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---- 178

Query: 524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
             T     +++PE++    +     +D++S+G+
Sbjct: 179 -GTPE---FVAPEIVNY--EPLGLEADMWSIGV 205

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 51/240 (21%), Positives = 91/240 (37%), Gaps = 28/240 (11%)

Query: 1   METL--DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DL 54
           MET     V   Y I   LG      + V   + K T    A K     +          
Sbjct: 2   METFKQQKVEDFYDIGEELGSG--QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR 59

Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           + +  E+  +R + HPNII     + + TD+ L+  L+  G   D +    +    E   
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEA 117

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKK 167
              ++ +L+G+ Y+H K   H  +K  +I++          K    GL   +      K 
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 226
                   T     +++PE++  N +     +D++S+G+    L +G  PF  +T    +
Sbjct: 178 IF-----GTPE---FVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 26/234 (11%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHE 410
             V   Y I   LG      + V   + K T    A K     +          + +  E
Sbjct: 8   QKVEDFYDIGEELGSG--QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65

Query: 411 IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
           +  +R + HPNII     + + TD+ L+  L+  G   D +    +    E      ++ 
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEATSFIKQ 123

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNG------KACLSGL-RYMCPFSPTKKKVHLFP 523
           +L+G+ Y+H K   H  +K  +I++          K    GL   +      K       
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---- 179

Query: 524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 576
             T     +++PE++  N +     +D++S+G+    L +G  PF  +T    +
Sbjct: 180 -GTPE---FVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 44/211 (20%), Positives = 86/211 (40%), Gaps = 24/211 (11%)

Query: 5   DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
             +   +     LG   F     V+L + + +     +K  N DR     ++ +  EI  
Sbjct: 18  GTIDDLFIFKRKLGSGAF---GDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEV 73

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDV 121
           ++ L HPNII     F D  ++++V      G   + I +    G  L E  +  +++ +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 122 LNGLEYIHGKGFIHRAVKASHIL-ISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPS 175
           +N L Y H +  +H+ +K  +IL    +  + +     GL         +          
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-----G 188

Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
           TA    +++PEV +++      + DI+S G+
Sbjct: 189 TAL---YMAPEVFKRD---VTFKCDIWSAGV 213

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 44/211 (20%), Positives = 86/211 (40%), Gaps = 24/211 (11%)

Query: 355 DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
             +   +     LG   F     V+L + + +     +K  N DR     ++ +  EI  
Sbjct: 18  GTIDDLFIFKRKLGSGAF---GDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEV 73

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDV 471
           ++ L HPNII     F D  ++++V      G   + I +    G  L E  +  +++ +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 472 LNGLEYIHGKGFIHRAVKASHIL-ISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPS 525
           +N L Y H +  +H+ +K  +IL    +  + +     GL         +          
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-----G 188

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
           TA    +++PEV +++      + DI+S G+
Sbjct: 189 TAL---YMAPEVFKRD---VTFKCDIWSAGV 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 22/211 (10%)

Query: 5   DNVPSNYKICS-ILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
           +N  + Y + S  LG+  F   + V     K T Q  A K     R   +    + HEI 
Sbjct: 24  ENFNNFYILTSKELGRGKF---AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80

Query: 63  CMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            +   +  P +I     + + +++ L+      G    L        + E  +  +++ +
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPS 175
           L G+ Y+H    +H  +K  +IL+S        K    G+ R +      ++ +      
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-----G 195

Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
           T     +L+PE+L    D     +D++++GI
Sbjct: 196 TPE---YLAPEILNY--DPITTATDMWNIGI 221

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 22/211 (10%)

Query: 355 DNVPSNYKICS-ILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
           +N  + Y + S  LG+  F   + V     K T Q  A K     R   +    + HEI 
Sbjct: 24  ENFNNFYILTSKELGRGKF---AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80

Query: 413 CMRHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            +   +  P +I     + + +++ L+      G    L        + E  +  +++ +
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPS 525
           L G+ Y+H    +H  +K  +IL+S        K    G+ R +      ++ +      
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-----G 195

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
           T     +L+PE+L    D     +D++++GI
Sbjct: 196 TPE---YLAPEILNY--DPITTATDMWNIGI 221

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 33/228 (14%)

Query: 345 DTFNSSVETLDNVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED 403
           D+F+   E        Y++   +LG+     + V    + +T+Q  AVK           
Sbjct: 4   DSFSGRFE------DVYQLQEDVLGE--GAHARVQTCINLITSQEYAVKIIEKQPGHIRS 55

Query: 404 LKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINA--HFNFGLP 460
              +  E+  +   + H N++  I  F +    +LV   M  GS    I+   HFN    
Sbjct: 56  --RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN---- 109

Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-----KAC---LS-GLRYMCP 511
           EL    ++QDV + L+++H KG  HR +K  +IL  H       K C   L  G++    
Sbjct: 110 ELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD---GYDERSDIYSVGI 556
            SP      L P  +A    +++PEV+E   +    YD+R D++S+G+
Sbjct: 170 CSPISTPELLTPCGSAE---YMAPEVVEAFSEEASIYDKRCDLWSLGV 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 24/197 (12%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT 83
           + V    + +T+Q  AVK              +  E+  +   + H N++  I  F +  
Sbjct: 27  ARVQTCINLITSQEYAVKIIEKQPGHIRS--RVFREVEMLYQCQGHRNVLELIEFFEEED 84

Query: 84  DLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
             +LV   M  GS    I+   HFN    EL    ++QDV + L+++H KG  HR +K  
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQDVASALDFLHNKGIAHRDLKPE 140

Query: 142 HILISHNG-----KAC---LS-GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL 192
           +IL  H       K C   L  G++     SP      L P  +A    +++PEV+E   
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE---YMAPEVVEAFS 197

Query: 193 D---GYDERSDIYSVGI 206
           +    YD+R D++S+G+
Sbjct: 198 EEASIYDKRCDLWSLGV 214

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 69/322 (21%), Positives = 119/322 (36%), Gaps = 64/322 (19%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHH 59
            +   Y +   LG        V L+  + T + +A+K  +  +         +   ++  
Sbjct: 7   ALRDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64

Query: 60  EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
           EI  ++ L HP II   + F DA D ++V  LM  G   D +  +      E        
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL--KEATCKLYFY 121

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFP 173
            +L  ++Y+H  G IHR +K  ++L+S   + CL      G  + +   S  +       
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---- 177

Query: 174 PSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVG----ISCCELANGTVPFAETPTTLMLI 228
             T     +L+PEVL      GY+   D +S+G    I       G  PF+E  T + L 
Sbjct: 178 -GTPT---YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS----GYPPFSEHRTQVSLK 229

Query: 229 EK-LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLS 287
           ++  +G          Y              ++I E   +V      S+    +V+  L 
Sbjct: 230 DQITSG---------KY--------------NFIPEVWAEV------SEKALDLVKKLLV 260

Query: 288 RDVDKRPLACNLLQHAFFKQTK 309
            D   R      L+H + +   
Sbjct: 261 VDPKARFTTEEALRHPWLQDED 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 26/214 (12%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHH 409
            +   Y +   LG        V L+  + T + +A+K  +  +         +   ++  
Sbjct: 7   ALRDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64

Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           EI  ++ L HP II   + F DA D ++V  LM  G   D +  +      E        
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL--KEATCKLYFY 121

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMCPFSPTKKKVHLFP 523
            +L  ++Y+H  G IHR +K  ++L+S   + CL      G  + +   S  +       
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---- 177

Query: 524 PSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGI 556
             T     +L+PEVL      GY+   D +S+G+
Sbjct: 178 -GTPT---YLAPEVLVSVGTAGYNRAVDCWSLGV 207

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 90.4 bits (224), Expect = 1e-19
 Identities = 34/242 (14%), Positives = 74/242 (30%), Gaps = 25/242 (10%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
                +  +LG+     + VY +           Q   +K          +       + 
Sbjct: 64  SKLVYVHHLLGE--GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--WEFYIGTQLME 119

Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF---GLPELVICHILQ 119
            ++       + + S+ L      LV  L  +G+  + IN + N     +P+ ++     
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR-----YMCPFSPTKKKVHLFPP 174
            +L  +E +H    IH  +K  + ++ +                +         + LFP 
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG-QSIDMKLFPK 238

Query: 175 STAYNLNW-----LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE 229
            T +            E+L      ++ + D + V  +   +  GT    +        E
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

Query: 230 KL 231
            L
Sbjct: 297 GL 298

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 90.4 bits (224), Expect = 1e-19
 Identities = 34/242 (14%), Positives = 74/242 (30%), Gaps = 25/242 (10%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
                +  +LG+     + VY +           Q   +K          +       + 
Sbjct: 64  SKLVYVHHLLGE--GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--WEFYIGTQLME 119

Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF---GLPELVICHILQ 469
            ++       + + S+ L      LV  L  +G+  + IN + N     +P+ ++     
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR-----YMCPFSPTKKKVHLFPP 524
            +L  +E +H    IH  +K  + ++ +                +         + LFP 
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG-QSIDMKLFPK 238

Query: 525 STAYNLNW-----LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE 579
            T +            E+L      ++ + D + V  +   +  GT    +        E
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

Query: 580 KL 581
            L
Sbjct: 297 GL 298

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 25/231 (10%)

Query: 5   DNVPSNYKICS--ILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
             V S Y +    ILG   F     V+  +   T   +A K      M D++   + +EI
Sbjct: 83  GAVNSFYTVSKTEILGGGRF---GQVHKCEETATGLKLAAKIIKTRGMKDKE--EVKNEI 137

Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
             M  L H N+I    +F    D+ LV   +  G   D I    ++ L EL     ++ +
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQI 196

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPST 176
             G+ ++H    +H  +K  +IL  +     +     GL R   P    K         T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-----GT 251

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 226
                +L+PEV+    D     +D++SVG+    L +G  PF  +     +
Sbjct: 252 PE---FLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 25/231 (10%)

Query: 355 DNVPSNYKICS--ILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 411
             V S Y +    ILG   F     V+  +   T   +A K      M D++   + +EI
Sbjct: 83  GAVNSFYTVSKTEILGGGRF---GQVHKCEETATGLKLAAKIIKTRGMKDKE--EVKNEI 137

Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
             M  L H N+I    +F    D+ LV   +  G   D I    ++ L EL     ++ +
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQI 196

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLS----GL-RYMCPFSPTKKKVHLFPPST 526
             G+ ++H    +H  +K  +IL  +     +     GL R   P    K         T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-----GT 251

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 576
                +L+PEV+    D     +D++SVG+    L +G  PF  +     +
Sbjct: 252 PE---FLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 57/316 (18%), Positives = 111/316 (35%), Gaps = 52/316 (16%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE--IVCM 64
             N K+  ++G+  +    +VY        + +AVK F     +  + ++  +E  I  +
Sbjct: 12  LDNLKLLELIGRGRY---GAVYKGSLD--ERPVAVKVF-----SFANRQNFINEKNIYRV 61

Query: 65  RHLRHPNIICYI-----SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
             + H NI  +I      +     +  LV      GS    ++ H       +  C +  
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAH 118

Query: 120 DVLNGLEYIHG---------KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKK 168
            V  GL Y+H              HR + + ++L+ ++G   +S  GL      +   + 
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 169 VHLFPPSTAY--NLNWLSPEVLE-----QNLDGYDERSDIYSVGISCCELANGT---VPF 218
                 + +    + +++PEVLE     ++ +   ++ D+Y++G+   E+        P 
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 219 AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSF 278
              P   M  +   G  P   D         Q      A    S      L  R   +  
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS------LAVRSLKE-- 290

Query: 279 HSIVELCLSRDVDKRP 294
              +E C  +D + R 
Sbjct: 291 --TIEDCWDQDAEARL 304

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 48/262 (18%), Positives = 98/262 (37%), Gaps = 42/262 (16%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE--IVCM 414
             N K+  ++G+  +    +VY        + +AVK F     +  + ++  +E  I  +
Sbjct: 12  LDNLKLLELIGRGRY---GAVYKGSLD--ERPVAVKVF-----SFANRQNFINEKNIYRV 61

Query: 415 RHLRHPNIICYI-----SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
             + H NI  +I      +     +  LV      GS    ++ H       +  C +  
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAH 118

Query: 470 DVLNGLEYIHG---------KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKK 518
            V  GL Y+H              HR + + ++L+ ++G   +S  GL      +   + 
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 519 VHLFPPSTAY--NLNWLSPEVLE-----QNLDGYDERSDIYSVGISCCELANGT---VPF 568
                 + +    + +++PEVLE     ++ +   ++ D+Y++G+   E+        P 
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 569 AETPTTLMLIEKLAGATPHLLD 590
              P   M  +   G  P   D
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFED 260

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 36/242 (14%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHH-- 59
                NY+   ILG+     S V    HK T +  AVK          + E+++ L    
Sbjct: 13  HGFYENYEPKEILGRG--VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 60  --EIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICH 116
             E+  +R +  HPNII    ++   T   LV  LM  G   D +         E     
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKETRK 128

Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFP 173
           I++ +L  +  +H    +HR +K  +IL+  +    L+  G    + P    ++      
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---- 184

Query: 174 PSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVG----ISCCELANGTVPF-AETPTT 224
             T     +L+PE++E +++    GY +  D++S G            G+ PF       
Sbjct: 185 -GTPS---YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA----GSPPFWHRKQML 236

Query: 225 LM 226
           ++
Sbjct: 237 ML 238

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 36/242 (14%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHH-- 409
                NY+   ILG+     S V    HK T +  AVK          + E+++ L    
Sbjct: 13  HGFYENYEPKEILGRG--VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 410 --EIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICH 466
             E+  +R +  HPNII    ++   T   LV  LM  G   D +         E     
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKETRK 128

Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFP 523
           I++ +L  +  +H    +HR +K  +IL+  +    L+  G    + P    ++      
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---- 184

Query: 524 PSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVG----ISCCELANGTVPF-AETPTT 574
             T     +L+PE++E +++    GY +  D++S G            G+ PF       
Sbjct: 185 -GTPS---YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA----GSPPFWHRKQML 236

Query: 575 LM 576
           ++
Sbjct: 237 ML 238

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 26/215 (12%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHH 59
                Y    ++G+     S V    H+ T    AVK   +          +E  ++   
Sbjct: 91  EFYQKYDPKDVIGRG--VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148

Query: 60  EIVCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
           E   +R +  HP+II  I S+  ++ + LV  LM  G   D +         E     I+
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--SEKETRSIM 206

Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 175
           + +L  + ++H    +HR +K  +IL+  N +  LS  G   ++ P    ++        
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-----G 261

Query: 176 TAYNLNWLSPEVLEQNLD----GYDERSDIYSVGI 206
           T     +L+PE+L+ ++D    GY +  D+++ G+
Sbjct: 262 TPG---YLAPEILKCSMDETHPGYGKEVDLWACGV 293

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 26/215 (12%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHH 409
                Y    ++G+     S V    H+ T    AVK   +          +E  ++   
Sbjct: 91  EFYQKYDPKDVIGRG--VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148

Query: 410 EIVCMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
           E   +R +  HP+II  I S+  ++ + LV  LM  G   D +         E     I+
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--SEKETRSIM 206

Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPS 525
           + +L  + ++H    +HR +K  +IL+  N +  LS  G   ++ P    ++        
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-----G 261

Query: 526 TAYNLNWLSPEVLEQNLD----GYDERSDIYSVGI 556
           T     +L+PE+L+ ++D    GY +  D+++ G+
Sbjct: 262 TPG---YLAPEILKCSMDETHPGYGKEVDLWACGV 293

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 24/208 (11%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           D +   +++ S LG+     S VY  K K T +  A+K          D K +  EI  +
Sbjct: 49  DALSDFFEVESELGR--GATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVL 102

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             L HPNII     F   T++ LV  L+  G   D I     +   E      ++ +L  
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY--SERDAADAVKQILEA 160

Query: 125 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAY 178
           + Y+H  G +HR +K  ++L +        K    GL + +      K         T  
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-----GTPG 215

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGI 206
              + +PE+L      Y    D++SVGI
Sbjct: 216 ---YCAPEILRG--CAYGPEVDMWSVGI 238

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 24/208 (11%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           D +   +++ S LG+     S VY  K K T +  A+K          D K +  EI  +
Sbjct: 49  DALSDFFEVESELGR--GATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVL 102

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             L HPNII     F   T++ LV  L+  G   D I     +   E      ++ +L  
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY--SERDAADAVKQILEA 160

Query: 475 LEYIHGKGFIHRAVKASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAY 528
           + Y+H  G +HR +K  ++L +        K    GL + +      K         T  
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-----GTPG 215

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGI 556
              + +PE+L      Y    D++SVGI
Sbjct: 216 ---YCAPEILRG--CAYGPEVDMWSVGI 238

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 43/235 (18%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRH 69
           YKI   LG     +S+VYL++  + N  +A+K   +     E+ LK    E+     L H
Sbjct: 13  YKIVDKLGG--GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 70  PNI-----------ICYIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHI 117
            NI             Y+   +++   L             + I +H    +   +  + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTL------------SEYIESHGPLSVDTAI--NF 116

Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPP 174
              +L+G+++ H    +HR +K  +ILI  N    +   G+ + +   S T+    L   
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL--G 174

Query: 175 STAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPF-AETPTTLML 227
           +  Y     SP   EQ      DE +DIYS+GI   E+  G  PF  ET  ++ +
Sbjct: 175 TVQY----FSP---EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 43/235 (18%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRH 419
           YKI   LG     +S+VYL++  + N  +A+K   +     E+ LK    E+     L H
Sbjct: 13  YKIVDKLGG--GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 420 PNI-----------ICYIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHI 467
            NI             Y+   +++   L             + I +H    +   +  + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTL------------SEYIESHGPLSVDTAI--NF 116

Query: 468 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPP 524
              +L+G+++ H    +HR +K  +ILI  N    +   G+ + +   S T+    L   
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL--G 174

Query: 525 STAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPF-AETPTTLML 577
           +  Y     SP   EQ      DE +DIYS+GI   E+  G  PF  ET  ++ +
Sbjct: 175 TVQY----FSP---EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.4 bits (207), Expect = 9e-18
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 10/127 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V+  +++ T Q++A+KKF          K    EI  ++ L+HPN++  +  F     LH
Sbjct: 19  VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78

Query: 87  LVSPLMGFGSC----KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           LV     F  C       ++ +   G+PE ++  I    L  + + H    IHR VK  +
Sbjct: 79  LV-----FEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPEN 132

Query: 143 ILISHNG 149
           ILI+ + 
Sbjct: 133 ILITKHS 139

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.4 bits (207), Expect = 9e-18
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 10/127 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V+  +++ T Q++A+KKF          K    EI  ++ L+HPN++  +  F     LH
Sbjct: 19  VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78

Query: 437 LVSPLMGFGSC----KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           LV     F  C       ++ +   G+PE ++  I    L  + + H    IHR VK  +
Sbjct: 79  LV-----FEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPEN 132

Query: 493 ILISHNG 499
           ILI+ + 
Sbjct: 133 ILITKHS 139

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 52/223 (23%), Positives = 104/223 (46%), Gaps = 15/223 (6%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           NY++   +G+   N + V L++H +T + +A+K  +  ++    L+ L  E+  M+ L H
Sbjct: 16  NYRLLKTIGK--GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 128
           PNI+           L+L+      G   D + AH   G + E       + +++ ++Y 
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYC 130

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H K  +HR +KA ++L+  +    ++   +   F+    K+  F  +  Y     +PE+ 
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYA----APELF 185

Query: 189 EQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           +     YD    D++S+G+    L +G++PF +      L E+
Sbjct: 186 QG--KKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRER 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 52/223 (23%), Positives = 104/223 (46%), Gaps = 15/223 (6%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           NY++   +G+   N + V L++H +T + +A+K  +  ++    L+ L  E+  M+ L H
Sbjct: 16  NYRLLKTIGK--GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEYI 478
           PNI+           L+L+      G   D + AH   G + E       + +++ ++Y 
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYC 130

Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H K  +HR +KA ++L+  +    ++   +   F+    K+  F  +  Y     +PE+ 
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYA----APELF 185

Query: 539 EQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           +     YD    D++S+G+    L +G++PF +      L E+
Sbjct: 186 QG--KKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRER 225

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 63/299 (21%), Positives = 111/299 (37%), Gaps = 53/299 (17%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT 83
           S      HK +NQ  AVK  +          +   EI  ++    HPNI+     F D  
Sbjct: 25  SICRKCVHKKSNQAFAVKIIS-----KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
              LV  L+  G   + I    +F   E    +I++ +++ + ++H  G +HR +K  ++
Sbjct: 80  HTFLVMELLNGGELFERIKKKKHF--SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137

Query: 144 LISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 197
           L +        K    G  R   P +   K          + L++ +PE+L QN  GYDE
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-------CFTLHYAAPELLNQN--GYDE 188

Query: 198 RSDIYSVG----ISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG 253
             D++S+G            G VPF     +         +   ++      +  G    
Sbjct: 189 SCDLWSLGVILYTMLS----GQVPFQSHDRS-----LTCTSAVEIMKK----IKKGDFSF 235

Query: 254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS 312
           E  A   +S+         K       +++  L+ D +KR     L  + + +   + S
Sbjct: 236 EGEAWKNVSQ-------EAK------DLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT 433
           S      HK +NQ  AVK  +          +   EI  ++    HPNI+     F D  
Sbjct: 25  SICRKCVHKKSNQAFAVKIIS-----KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
              LV  L+  G   + I    +F   E    +I++ +++ + ++H  G +HR +K  ++
Sbjct: 80  HTFLVMELLNGGELFERIKKKKHF--SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137

Query: 494 LISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE 547
           L +        K    G  R   P +   K          + L++ +PE+L QN  GYDE
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-------CFTLHYAAPELLNQN--GYDE 188

Query: 548 RSDIYSVGI 556
             D++S+G+
Sbjct: 189 SCDLWSLGV 197

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 27/221 (12%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHH---EIVC 63
            Y   S LG        V+ +  K  N+ + VK   K  +      +   L     EI  
Sbjct: 25  KYSTMSPLGS--GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQD 120
           +  + H NII  +  F +     LV      GS  DL   I+ H    L E +  +I + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEK--HGSGLDLFAFIDRHPR--LDEPLASYIFRQ 138

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAY 178
           +++ + Y+  K  IHR +K  +I+I+ +    L   G      +    K  + F  +  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS---AAYLERGKLFYTFCGTIEY 195

Query: 179 NLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPF 218
                +PEVL  N   Y     +++S+G++   L     PF
Sbjct: 196 ----CAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPF 230

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 27/221 (12%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHH---EIVC 413
            Y   S LG        V+ +  K  N+ + VK   K  +      +   L     EI  
Sbjct: 25  KYSTMSPLGS--GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQD 470
           +  + H NII  +  F +     LV      GS  DL   I+ H    L E +  +I + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEK--HGSGLDLFAFIDRHPR--LDEPLASYIFRQ 138

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAY 528
           +++ + Y+  K  IHR +K  +I+I+ +    L   G      +    K  + F  +  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS---AAYLERGKLFYTFCGTIEY 195

Query: 529 NLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPF 568
                +PEVL  N   Y     +++S+G++   L     PF
Sbjct: 196 ----CAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPF 230

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 74/322 (22%), Positives = 117/322 (36%), Gaps = 63/322 (19%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V   ++K T +++A+KKF          K    EI  ++ LRH N++  +         +
Sbjct: 41  VMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100

Query: 87  LVSPLMGFGSC----KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           LV     F        D +    N GL   V+   L  ++NG+ + H    IHR +K  +
Sbjct: 101 LV-----FEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPEN 154

Query: 143 ILISHNG--KACLSGL-RYMCPFSPTKKKVH----LFPPSTAYNLNWL-SPEVLEQNL-- 192
           IL+S +G  K C  G  R +   +P +                   W  +PE+L   +  
Sbjct: 155 ILVSQSGVVKLCDFGFARTLA--APGEVYDDEVATR----------WYRAPELL---VGD 199

Query: 193 DGYDERSDIYSVGISC--CELANGTVPFAETPTT-----LMLIEKLAGATPHLLDCTTYY 245
             Y +  D++++G  C   E+  G   F   P       L  I    G            
Sbjct: 200 VKYGKAVDVWAIG--CLVTEMFMGEPLF---PGDSDIDQLYHIMMCLG-NLI-------- 245

Query: 246 VDTGQDDGEEN----ACSYISEQQTQVLTSR--KFSDSFHSIVELCLSRDVDKRPLACNL 299
               Q+   +N           ++ + L  R  K S+    + + CL  D DKRP    L
Sbjct: 246 -PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304

Query: 300 LQHAFFKQTKKCSVMLPELLRP 321
           L H FF+          EL   
Sbjct: 305 LHHDFFQMDGFAERFSQELQLK 326

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 10/127 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V   ++K T +++A+KKF          K    EI  ++ LRH N++  +         +
Sbjct: 41  VMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100

Query: 437 LVSPLMGFGSC----KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           LV     F        D +    N GL   V+   L  ++NG+ + H    IHR +K  +
Sbjct: 101 LV-----FEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPEN 154

Query: 493 ILISHNG 499
           IL+S +G
Sbjct: 155 ILVSQSG 161

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 80/325 (24%), Positives = 130/325 (40%), Gaps = 57/325 (17%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
            +P  Y   + +G       SV  +  K + + +A+KK +    ++   K  + E++ ++
Sbjct: 21  ELPKTYVSPTHVGS--GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78

Query: 66  HLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICH 116
           H++H N+I  +      SS  +  D +LV P M      DL   +         E  I +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLK----FSEEKIQY 130

Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFP 173
           ++  +L GL+YIH  G +HR +K  ++ ++ +   K    GL R            H   
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR------------HADA 178

Query: 174 PSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIE 229
             T Y    W  +PEV+  +   Y++  DI+SVG    E+  G   F        L  I 
Sbjct: 179 EMTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS-------IV 282
           K+ G  P                 ++ A SYI  Q       + F+  F         ++
Sbjct: 238 KVTG-VPGTEFVQKL--------NDKAAKSYI--QSLPQTPRKDFTQLFPRASPQAADLL 286

Query: 283 ELCLSRDVDKRPLACNLLQHAFFKQ 307
           E  L  DVDKR  A   L H FF+ 
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEP 311

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 61/247 (24%), Positives = 104/247 (42%), Gaps = 40/247 (16%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
            +P  Y   + +G       SV  +  K + + +A+KK +    ++   K  + E++ ++
Sbjct: 21  ELPKTYVSPTHVGS--GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78

Query: 416 HLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICH 466
           H++H N+I  +      SS  +  D +LV P M      DL   +         E  I +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLK----FSEEKIQY 130

Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFP 523
           ++  +L GL+YIH  G +HR +K  ++ ++ +   K    GL R            H   
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR------------HADA 178

Query: 524 PSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIE 579
             T Y    W  +PEV+  +   Y++  DI+SVG    E+  G   F        L  I 
Sbjct: 179 EMTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 580 KLAGATP 586
           K+ G  P
Sbjct: 238 KVTG-VP 243

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 74/327 (22%), Positives = 122/327 (37%), Gaps = 60/327 (18%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
            V + Y+    +G       +V  +    T   +A+KK      ++   K  + E+  ++
Sbjct: 22  EVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79

Query: 66  HLRHPNIICYI------SSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGLPELVI 114
           H+RH N+I  +       +  D TD +LV P MG         + L             I
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR---------I 130

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 171
             ++  +L GL YIH  G IHR +K  ++ ++ +   K    GL R              
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------QA 178

Query: 172 FPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LML 227
               T Y    W  +PEV+  N   Y +  DI+SVG    E+  G   F  +     L  
Sbjct: 179 DSEMTGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237

Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I K+ G TP                  + A +Y+  +    L  + F+    +       
Sbjct: 238 IMKVTG-TPPAEFVQRL--------QSDEAKNYM--KGLPELEKKDFASILTNASPLAVN 286

Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D ++R  A   L H +F+ 
Sbjct: 287 LLEKMLVLDAEQRVTAGEALAHPYFES 313

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 62/249 (24%), Positives = 97/249 (38%), Gaps = 43/249 (17%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
            V + Y+    +G       +V  +    T   +A+KK      ++   K  + E+  ++
Sbjct: 22  EVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79

Query: 416 HLRHPNIICYI------SSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGLPELVI 464
           H+RH N+I  +       +  D TD +LV P MG         + L             I
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR---------I 130

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 521
             ++  +L GL YIH  G IHR +K  ++ ++ +   K    GL R              
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------QA 178

Query: 522 FPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LML 577
               T Y    W  +PEV+  N   Y +  DI+SVG    E+  G   F  +     L  
Sbjct: 179 DSEMTGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237

Query: 578 IEKLAGATP 586
           I K+ G TP
Sbjct: 238 IMKVTG-TP 245

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 41/238 (17%), Positives = 91/238 (38%), Gaps = 50/238 (21%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRH 69
           Y++  ++G+    +  VY ++  V  +++A+K  +    +D   ++ +  E      L+ 
Sbjct: 36  YRLRRLVGR--GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 70  PNIIC-----------YIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHI 117
           P+++            Y+    ++  DL              ++        P  V   I
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDL------------AAMLRRQGPLAPPRAV--AI 139

Query: 118 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-------SPTKKKVH 170
           ++ + + L+  H  G  HR VK  +IL+S +  A      Y+  F            ++ 
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFA------YLVDFGIASATTDEKLTQLG 193

Query: 171 LFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETPTTLML 227
               +  Y    ++P   E+  + +   R+DIY++     E   G+ P+     ++M 
Sbjct: 194 NTVGTLYY----MAP---ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 41/238 (17%), Positives = 91/238 (38%), Gaps = 50/238 (21%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRH 419
           Y++  ++G+    +  VY ++  V  +++A+K  +    +D   ++ +  E      L+ 
Sbjct: 36  YRLRRLVGR--GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 420 PNIIC-----------YIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHI 467
           P+++            Y+    ++  DL              ++        P  V   I
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDL------------AAMLRRQGPLAPPRAV--AI 139

Query: 468 LQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-------SPTKKKVH 520
           ++ + + L+  H  G  HR VK  +IL+S +  A      Y+  F            ++ 
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFA------YLVDFGIASATTDEKLTQLG 193

Query: 521 LFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETPTTLML 577
               +  Y    ++P   E+  + +   R+DIY++     E   G+ P+     ++M 
Sbjct: 194 NTVGTLYY----MAP---ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 27/209 (12%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
                Y++   +G    + S      HK TN   AVK  +  +    +      EI  + 
Sbjct: 19  QFTDGYEVKEDIGVG--SYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------EIEILL 70

Query: 66  HL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
              +HPNII     + D   +++V+ LM  G   D I     F   E     +L  +   
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF--SEREASAVLFTITKT 128

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS------GL-RYMCPFSPTKKKVHLFPPSTA 177
           +EY+H +G +HR +K S+IL         S      G  + +   +              
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-------C 181

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
           Y  N+++PEVLE+   GYD   DI+S+G+
Sbjct: 182 YTANFVAPEVLERQ--GYDAACDIWSLGV 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 27/209 (12%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
                Y++   +G    + S      HK TN   AVK  +  +    +      EI  + 
Sbjct: 19  QFTDGYEVKEDIGVG--SYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------EIEILL 70

Query: 416 HL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
              +HPNII     + D   +++V+ LM  G   D I     F   E     +L  +   
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF--SEREASAVLFTITKT 128

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS------GL-RYMCPFSPTKKKVHLFPPSTA 527
           +EY+H +G +HR +K S+IL         S      G  + +   +              
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-------C 181

Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
           Y  N+++PEVLE+   GYD   DI+S+G+
Sbjct: 182 YTANFVAPEVLERQ--GYDAACDIWSLGV 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 46/250 (18%), Positives = 101/250 (40%), Gaps = 41/250 (16%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-------------------- 49
            Y +   +G+   +   V L+ ++  N   A+K  +  ++                    
Sbjct: 14  QYTLKDEIGKG--SYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71

Query: 50  ----TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINA 103
                   ++ ++ EI  ++ L HPN++  +    D  +  L++V  L+  G   ++   
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131

Query: 104 HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCP 161
                L E       QD++ G+EY+H +  IHR +K S++L+  +G   ++  G+     
Sbjct: 132 K---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-- 186

Query: 162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAE 220
           F  +   +     + A+    ++PE L +    +  +  D++++G++      G  PF  
Sbjct: 187 FKGSDALLSNTVGTPAF----MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-M 241

Query: 221 TPTTLMLIEK 230
               + L  K
Sbjct: 242 DERIMCLHSK 251

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 46/250 (18%), Positives = 101/250 (40%), Gaps = 41/250 (16%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-------------------- 399
            Y +   +G+   +   V L+ ++  N   A+K  +  ++                    
Sbjct: 14  QYTLKDEIGKG--SYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71

Query: 400 ----TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINA 453
                   ++ ++ EI  ++ L HPN++  +    D  +  L++V  L+  G   ++   
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131

Query: 454 HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCP 511
                L E       QD++ G+EY+H +  IHR +K S++L+  +G   ++  G+     
Sbjct: 132 K---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-- 186

Query: 512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAE 570
           F  +   +     + A+    ++PE L +    +  +  D++++G++      G  PF  
Sbjct: 187 FKGSDALLSNTVGTPAF----MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-M 241

Query: 571 TPTTLMLIEK 580
               + L  K
Sbjct: 242 DERIMCLHSK 251

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 86/327 (26%), Positives = 133/327 (40%), Gaps = 60/327 (18%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
            VP  Y+  S +G       SV  +    T   +AVKK +    +    K  + E+  ++
Sbjct: 26  EVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83

Query: 66  HLRHPNIICYI------SSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGLPELVI 114
           H++H N+I  +       S  +  D++LV+ LMG        C+ L + H         +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---------V 134

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 171
             ++  +L GL+YIH    IHR +K S++ ++ +   K    GL R+             
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--------- 185

Query: 172 FPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LML 227
               T Y    W  +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 ---MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS------- 280
           I +L G TP                  E+A +YI  Q    +    F++ F         
Sbjct: 242 ILRLVG-TPGAELLKKI--------SSESARNYI--QSLTQMPKMNFANVFIGANPLAVD 290

Query: 281 IVELCLSRDVDKRPLACNLLQHAFFKQ 307
           ++E  L  D DKR  A   L HA+F Q
Sbjct: 291 LLEKMLVLDSDKRITAAQALAHAYFAQ 317

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 43/249 (17%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
            VP  Y+  S +G       SV  +    T   +AVKK +    +    K  + E+  ++
Sbjct: 26  EVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83

Query: 416 HLRHPNIICYI------SSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGLPELVI 464
           H++H N+I  +       S  +  D++LV+ LMG        C+ L + H         +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH---------V 134

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 521
             ++  +L GL+YIH    IHR +K S++ ++ +   K    GL R+             
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--------- 185

Query: 522 FPPSTAY-NLNWL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LML 577
               T Y    W  +PE++  N   Y++  DI+SVG    EL  G   F  T     L L
Sbjct: 186 ---MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

Query: 578 IEKLAGATP 586
           I +L G TP
Sbjct: 242 ILRLVG-TP 249

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 46/229 (20%), Positives = 101/229 (44%), Gaps = 24/229 (10%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D   +++  EI   + L H
Sbjct: 8   DWDLVQTLGEG--AYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVLNG 124
            N++ +     +    +L    + + S  +L    F+      G+PE         ++ G
Sbjct: 65  ENVVKFYGHRREGNIQYLF---LEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           + Y+HG G  HR +K  ++L+       +S  GL  +  ++  ++ ++    +  Y    
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY---- 173

Query: 183 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           ++PE+L++    +  E  D++S GI    +  G +P+ +   +      
Sbjct: 174 VAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 46/229 (20%), Positives = 101/229 (44%), Gaps = 24/229 (10%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D   +++  EI   + L H
Sbjct: 8   DWDLVQTLGEG--AYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVLNG 474
            N++ +     +    +L    + + S  +L    F+      G+PE         ++ G
Sbjct: 65  ENVVKFYGHRREGNIQYLF---LEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           + Y+HG G  HR +K  ++L+       +S  GL  +  ++  ++ ++    +  Y    
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY---- 173

Query: 533 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           ++PE+L++    +  E  D++S GI    +  G +P+ +   +      
Sbjct: 174 VAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 74/333 (22%), Positives = 131/333 (39%), Gaps = 52/333 (15%)

Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFN-LDRMTDEDLKSLHH 59
             + N+ S++++ S+LG+  +     V  + HK T +++A+KK    D+           
Sbjct: 4   RIVYNISSDFQLKSLLGEGAY---GVVCSATHKPTGEIVAIKKIEPFDKPLF--ALRTLR 58

Query: 60  EIVCMRHLRHPNIICYI-----SSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGL 109
           EI  ++H +H NII         SF +  +++++  LM        S + L + H     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH----- 113

Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTK 166
               I + +   L  ++ +HG   IHR +K S++LI+ N   K C  GL R +   +   
Sbjct: 114 ----IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 167 KKVHLFPPS-TAYNLN-WL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 223
            +          +    W  +PEV+      Y    D++S G    EL      F     
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

Query: 224 T--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHS- 280
              L+LI  + G TPH  D     +++        A  YI  +   +  +      F   
Sbjct: 229 RHQLLLIFGIIG-TPH-SDNDLRCIES------PRAREYI--KSLPMYPAAPLEKMFPRV 278

Query: 281 ------IVELCLSRDVDKRPLACNLLQHAFFKQ 307
                 +++  L  D  KR  A   L+H + + 
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 36/256 (14%)

Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFN-LDRMTDEDLKSLHH 409
             + N+ S++++ S+LG+  +     V  + HK T +++A+KK    D+           
Sbjct: 4   RIVYNISSDFQLKSLLGEGAY---GVVCSATHKPTGEIVAIKKIEPFDKPLF--ALRTLR 58

Query: 410 EIVCMRHLRHPNIICYI-----SSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGL 459
           EI  ++H +H NII         SF +  +++++  LM        S + L + H     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH----- 113

Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTK 516
               I + +   L  ++ +HG   IHR +K S++LI+ N   K C  GL R +   +   
Sbjct: 114 ----IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 517 KKVHLFPPS-TAYNLN-WL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
            +          +    W  +PEV+      Y    D++S G    EL      F     
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

Query: 574 T--LMLIEKLAGATPH 587
              L+LI  + G TPH
Sbjct: 229 RHQLLLIFGIIG-TPH 243

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 72/327 (22%), Positives = 117/327 (35%), Gaps = 56/327 (17%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN-LDRMTDEDLKSLHHEIVCM 64
           +V   Y   S +G+       V  +   +    +A+KK +  +  T    +    EI  +
Sbjct: 24  DVGPRYTNLSYIGE--GAYGMVCSAYDNLNKVRVAIKKISPFEHQTY--CQRTLREIKIL 79

Query: 65  RHLRHPNIIC-----YISSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGLPELVI 114
              RH NII         +     D+++V  LM          + L N H         I
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---------I 130

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 171
           C+ L  +L GL+YIH    +HR +K S++L++     K C  GL R   P          
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT----- 185

Query: 172 FPPSTAYNLN-WL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LML 227
               T Y    W  +PE++  N  GY +  DI+SVG    E+ +    F        L  
Sbjct: 186 -GFLTEYVATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243

Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSI------ 281
           I  + G +P   D                A +Y+            ++  F +       
Sbjct: 244 ILGILG-SPSQEDLNCI--------INLKARNYL--LSLPHKNKVPWNRLFPNADSKALD 292

Query: 282 -VELCLSRDVDKRPLACNLLQHAFFKQ 307
            ++  L+ +  KR      L H + +Q
Sbjct: 293 LLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 36/229 (15%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFN-LDRMTDEDLKSLHHEIVCM 414
           +V   Y   S +G+       V  +   +    +A+KK +  +  T    +    EI  +
Sbjct: 24  DVGPRYTNLSYIGE--GAYGMVCSAYDNLNKVRVAIKKISPFEHQTY--CQRTLREIKIL 79

Query: 415 RHLRHPNIIC-----YISSFLDATDLHLVSPLMGFG-----SCKDLINAHFNFGLPELVI 464
              RH NII         +     D+++V  LM          + L N H         I
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---------I 130

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 521
           C+ L  +L GL+YIH    +HR +K S++L++     K C  GL R   P          
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT----- 185

Query: 522 FPPSTAYNLN-WL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
               T Y    W  +PE++  N  GY +  DI+SVG    E+ +    F
Sbjct: 186 -GFLTEYVATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 22/231 (9%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 66
            Y +  +LG+   +   V       T    AVK   K  L R+ + +   +  EI  +R 
Sbjct: 6   KYLMGDLLGEG--SYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRR 62

Query: 67  LRHPNIICYISSFLDAT--DLHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVL 122
           LRH N+I  +    +     +++V   M +     ++++++      P          ++
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMV---MEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL 180
           +GLEY+H +G +H+ +K  ++L++  G   +S  G+                  S A+  
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF-- 177

Query: 181 NWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
               PE+    LD +   + DI+S G++   +  G  PF E      L E 
Sbjct: 178 --QPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFEN 224

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 22/231 (9%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRH 416
            Y +  +LG+   +   V       T    AVK   K  L R+ + +   +  EI  +R 
Sbjct: 6   KYLMGDLLGEG--SYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRR 62

Query: 417 LRHPNIICYISSFLDAT--DLHLVSPLMGF--GSCKDLINAHFNFGLPELVICHILQDVL 472
           LRH N+I  +    +     +++V   M +     ++++++      P          ++
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMV---MEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL 530
           +GLEY+H +G +H+ +K  ++L++  G   +S  G+                  S A+  
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF-- 177

Query: 531 NWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
               PE+    LD +   + DI+S G++   +  G  PF E      L E 
Sbjct: 178 --QPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFEN 224

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 64/338 (18%), Positives = 110/338 (32%), Gaps = 83/338 (24%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
               +Y++   LG+     S V+ + +   N+ + VK            K +  EI  + 
Sbjct: 33  GNQDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILE 85

Query: 66  HLR-HPNIIC--------------YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 110
           +LR  PNII                +   ++ TD   +                    L 
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----------------TLT 128

Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGL-RYMCPFSPTK 166
           +  I   + ++L  L+Y H  G +HR VK  +++I H     +    GL  +        
Sbjct: 129 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF-------- 180

Query: 167 KKVHLFPPSTAYN-----LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--- 218
                + P   YN       +  PE+L  +   YD   D++S+G     +     PF   
Sbjct: 181 -----YHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234

Query: 219 AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS---EQQTQVLTSRKFS 275
            +    L+ I K+ G T  L D    Y         E    +         +       S
Sbjct: 235 HDNYDQLVRIAKVLG-TEDLYDYIDKY-------NIELDPRFNDILGRHSRKRWERFVHS 286

Query: 276 DSFHSIVEL-------CLSRDVDKRPLACNLLQHAFFK 306
           ++ H +           L  D   R  A   ++H +F 
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 56/273 (20%), Positives = 94/273 (34%), Gaps = 66/273 (24%)

Query: 350 SVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
           S         +Y++   LG+     S V+ + +   N+ + VK            K +  
Sbjct: 27  SHVVEWGNQDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKR 79

Query: 410 EIVCMRHLR-HPNIIC--------------YISSFLDATDLHLVSPLMGFGSCKDLINAH 454
           EI  + +LR  PNII                +   ++ TD   +                
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------------- 125

Query: 455 FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGL-RYMC 510
               L +  I   + ++L  L+Y H  G +HR VK  +++I H     +    GL  +  
Sbjct: 126 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF-- 180

Query: 511 PFSPTKKKVHLFPPSTAYN-----LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT 565
                      + P   YN       +  PE+L  +   YD   D++S+G     +    
Sbjct: 181 -----------YHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRK 228

Query: 566 VPF---AETPTTLMLIEKLAGATPHLLDCTTYY 595
            PF    +    L+ I K+ G T  L D    Y
Sbjct: 229 EPFFHGHDNYDQLVRIAKVLG-TEDLYDYIDKY 260

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 54/239 (22%), Positives = 90/239 (37%), Gaps = 45/239 (18%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRH 69
           Y++  ILG     +S V+L++    ++ +AVK    D   D         E      L H
Sbjct: 14  YELGEILGF--GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 70  PNI---------------ICYIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELV 113
           P I               + YI   ++D   L            +D+++          +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------------RDIVHTEGPMTPKRAI 119

Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVH 170
              ++ D    L + H  G IHR VK ++I+IS      +   G+ R +     +  +  
Sbjct: 120 --EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 171 LFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPF-AETPTTLML 227
               +  Y    LSP   EQ      D RSD+YS+G    E+  G  PF  ++P ++  
Sbjct: 178 AVIGTAQY----LSP---EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 54/239 (22%), Positives = 90/239 (37%), Gaps = 45/239 (18%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRH 419
           Y++  ILG     +S V+L++    ++ +AVK    D   D         E      L H
Sbjct: 14  YELGEILGF--GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 420 PNI---------------ICYIS-SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELV 463
           P I               + YI   ++D   L            +D+++          +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------------RDIVHTEGPMTPKRAI 119

Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVH 520
              ++ D    L + H  G IHR VK ++I+IS      +   G+ R +     +  +  
Sbjct: 120 --EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 521 LFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPF-AETPTTLML 577
               +  Y    LSP   EQ      D RSD+YS+G    E+  G  PF  ++P ++  
Sbjct: 178 AVIGTAQY----LSP---EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 79.4 bits (196), Expect = 9e-16
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 23/218 (10%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
            ++  +   LG   +     VY    K  +  +AVK    D M  E+      E   M+ 
Sbjct: 219 RTDITMKHKLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKE 272

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNG 124
           ++HPN++  +         ++++  M +G+  D +            L+  ++   + + 
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSA 330

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLN 181
           +EY+  K FIHR + A + L+  N    ++  GL R M   + T      FP      + 
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IK 384

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELA-NGTVPF 218
           W +PE L  N   +  +SD+++ G+   E+A  G  P+
Sbjct: 385 WTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPY 420

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 79.4 bits (196), Expect = 9e-16
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 23/218 (10%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
            ++  +   LG   +     VY    K  +  +AVK    D M  E+      E   M+ 
Sbjct: 219 RTDITMKHKLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKE 272

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNG 474
           ++HPN++  +         ++++  M +G+  D +            L+  ++   + + 
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSA 330

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLN 531
           +EY+  K FIHR + A + L+  N    ++  GL R M   + T      FP      + 
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IK 384

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELA-NGTVPF 568
           W +PE L  N   +  +SD+++ G+   E+A  G  P+
Sbjct: 385 WTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPY 420

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 20/230 (8%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 68
           +Y +   LG        V + +H++T   +AVK  N  ++   D+   +  EI  ++  R
Sbjct: 12  HYVLGDTLGVG--TFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 127
           HP+II         TD  +V   +  G   D I  H   G + E+    + Q +L+ ++Y
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDY 126

Query: 128 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            H    +HR +K  ++L+  +  A ++  GL          + +     S  Y     +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---SNMMSDGEFLRTSCGSPNY----AAP 179

Query: 186 EVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
           EV+      Y     DI+S G+    L  GT+PF +      L +K+ G 
Sbjct: 180 EVISGR--LYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKIRGG 226

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 20/230 (8%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 418
           +Y +   LG        V + +H++T   +AVK  N  ++   D+   +  EI  ++  R
Sbjct: 12  HYVLGDTLGVG--TFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNGLEY 477
           HP+II         TD  +V   +  G   D I  H   G + E+    + Q +L+ ++Y
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDY 126

Query: 478 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            H    +HR +K  ++L+  +  A ++  GL          + +     S  Y     +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---SNMMSDGEFLRTSCGSPNY----AAP 179

Query: 536 EVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
           EV+      Y     DI+S G+    L  GT+PF +      L +K+ G 
Sbjct: 180 EVISGR--LYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKIRGG 226

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 17/198 (8%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           V+  + +  N L+AVK    + +  +       E   ++   HPNI+  I        ++
Sbjct: 130 VFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188

Query: 87  LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           +V  L+  G     L        +  L+   ++ D   G+EY+  K  IHR + A + L+
Sbjct: 189 IVMELVQGGDFLTFLRTEGARLRVKTLL--QMVGDAAAGMEYLESKCCIHRDLAARNCLV 246

Query: 146 SHNGKACLS--GL-RYMCPFSPTKK-KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           +      +S  G+ R            +   P      + W +PE L      Y   SD+
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVP------VKWTAPEALNYGR--YSSESDV 298

Query: 202 YSVGISCCELA-NGTVPF 218
           +S GI   E    G  P+
Sbjct: 299 WSFGILLWETFSLGASPY 316

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 17/198 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           V+  + +  N L+AVK    + +  +       E   ++   HPNI+  I        ++
Sbjct: 130 VFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188

Query: 437 LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           +V  L+  G     L        +  L+   ++ D   G+EY+  K  IHR + A + L+
Sbjct: 189 IVMELVQGGDFLTFLRTEGARLRVKTLL--QMVGDAAAGMEYLESKCCIHRDLAARNCLV 246

Query: 496 SHNGKACLS--GL-RYMCPFSPTKK-KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           +      +S  G+ R            +   P      + W +PE L      Y   SD+
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVP------VKWTAPEALNYGR--YSSESDV 298

Query: 552 YSVGISCCELA-NGTVPF 568
           +S GI   E    G  P+
Sbjct: 299 WSFGILLWETFSLGASPY 316

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 46/229 (20%), Positives = 100/229 (43%), Gaps = 24/229 (10%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D   +++  EI   + L H
Sbjct: 8   DWDLVQTLGEG--AYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVLNG 124
            N++ +     +    +L    + + S  +L    F+      G+PE         ++ G
Sbjct: 65  ENVVKFYGHRREGNIQYLF---LEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 125 LEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           + Y+HG G  HR +K  ++L+      K    GL  +  ++  ++ ++    +  Y    
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY---- 173

Query: 183 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           ++PE+L++    +  E  D++S GI    +  G +P+ +   +      
Sbjct: 174 VAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 46/229 (20%), Positives = 100/229 (43%), Gaps = 24/229 (10%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D   +++  EI   + L H
Sbjct: 8   DWDLVQTLGEG--AYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVLNG 474
            N++ +     +    +L    + + S  +L    F+      G+PE         ++ G
Sbjct: 65  ENVVKFYGHRREGNIQYLF---LEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 475 LEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           + Y+HG G  HR +K  ++L+      K    GL  +  ++  ++ ++    +  Y    
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY---- 173

Query: 533 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 580
           ++PE+L++    +  E  D++S GI    +  G +P+ +   +      
Sbjct: 174 VAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 9/127 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDE--DLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           VY +++K+T +++A+KK  LD    E     ++  EI  ++ L HPNI+  +        
Sbjct: 19  VYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENK 76

Query: 85  LHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
           L+LV     F     K  ++A    G+P  +I   L  +L GL + H    +HR +K  +
Sbjct: 77  LYLV---FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133

Query: 143 ILISHNG 149
           +LI+  G
Sbjct: 134 LLINTEG 140

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 9/127 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDE--DLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           VY +++K+T +++A+KK  LD    E     ++  EI  ++ L HPNI+  +        
Sbjct: 19  VYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENK 76

Query: 435 LHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
           L+LV     F     K  ++A    G+P  +I   L  +L GL + H    +HR +K  +
Sbjct: 77  LYLV---FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 133

Query: 493 ILISHNG 499
           +LI+  G
Sbjct: 134 LLINTEG 140

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 55/244 (22%)

Query: 6   NVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
            +P  Y+I  ++G       S   V  +  K+  +++A+KK         D K +  EI 
Sbjct: 50  QIPDRYEIRHLIGT-----GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA 104

Query: 63  CMRHLRHPNIIC-----YISSFLDATDLHLVSPLMG------FGSCKDLINAHFNFGLPE 111
            +  L H +++               +L++V  +        F +   L   H       
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELH------- 157

Query: 112 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKK 168
             I  +L ++L G++Y+H  G +HR +K ++ L++ +   K C  GL R +        +
Sbjct: 158 --IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 169 VHLFPPSTAYNLNWLS--------------------PEVLEQNLDGYDERSDIYSVGISC 208
           + + P     NL                        PE++    + Y E  D++S+G   
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIG--- 271

Query: 209 CELA 212
           C  A
Sbjct: 272 CIFA 275

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 55/244 (22%)

Query: 356 NVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
            +P  Y+I  ++G       S   V  +  K+  +++A+KK         D K +  EI 
Sbjct: 50  QIPDRYEIRHLIGT-----GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA 104

Query: 413 CMRHLRHPNIIC-----YISSFLDATDLHLVSPLMG------FGSCKDLINAHFNFGLPE 461
            +  L H +++               +L++V  +        F +   L   H       
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELH------- 157

Query: 462 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKK 518
             I  +L ++L G++Y+H  G +HR +K ++ L++ +   K C  GL R +        +
Sbjct: 158 --IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 519 VHLFPPSTAYNLNWLS--------------------PEVLEQNLDGYDERSDIYSVGISC 558
           + + P     NL                        PE++    + Y E  D++S+G   
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIG--- 271

Query: 559 CELA 562
           C  A
Sbjct: 272 CIFA 275

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 59/337 (17%), Positives = 113/337 (33%), Gaps = 68/337 (20%)

Query: 6   NVPSNYKICSILGQ------CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 59
            + S Y +   +        C         +        +A+K+          +  L  
Sbjct: 19  AMQSPYTVQRFISSGSYGAVC---------AGVDSEGIPVAIKRVFNTVSDGRTVNILSD 69

Query: 60  ---------EIVCMRHLRHPNIICYI-----SSFLDATDLHLVSPLMGFGSCKDL---IN 102
                    EI  + H  HPNI+                L+LV+ LM      DL   I+
Sbjct: 70  SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIH 125

Query: 103 AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYM 159
                 +    I + +  +L GL  +H  G +HR +   +IL++ N     C   L R  
Sbjct: 126 DQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 219
              +     V     +  +   + +PE++     G+ +  D++S G    E+ N    F 
Sbjct: 185 TADANKTHYV-----THRW---YRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

Query: 220 ETPTT--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDS 277
            +     L  I ++ G TP + D   +           +A  Y+       + +R ++  
Sbjct: 236 GSTFYNQLNKIVEVVG-TPKIEDVVMF--------SSPSARDYL-RNSLSNVPARAWTAV 285

Query: 278 FHS-------IVELCLSRDVDKRPLACNLLQHAFFKQ 307
             +       ++   L  +  +R      L+H +F+ 
Sbjct: 286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 50/259 (19%), Positives = 88/259 (33%), Gaps = 52/259 (20%)

Query: 356 NVPSNYKICSILGQ------CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
            + S Y +   +        C         +        +A+K+          +  L  
Sbjct: 19  AMQSPYTVQRFISSGSYGAVC---------AGVDSEGIPVAIKRVFNTVSDGRTVNILSD 69

Query: 410 ---------EIVCMRHLRHPNIICYI-----SSFLDATDLHLVSPLMGFGSCKDL---IN 452
                    EI  + H  HPNI+                L+LV+ LM      DL   I+
Sbjct: 70  SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIH 125

Query: 453 AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYM 509
                 +    I + +  +L GL  +H  G +HR +   +IL++ N     C   L R  
Sbjct: 126 DQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 569
              +     V     +  +   + +PE++     G+ +  D++S G    E+ N    F 
Sbjct: 185 TADANKTHYV-----THRW---YRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

Query: 570 ETPTT--LMLIEKLAGATP 586
            +     L  I ++ G TP
Sbjct: 236 GSTFYNQLNKIVEVVG-TP 253

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 38/235 (16%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y     +G    N     L + K+T +L+AVK        DE+++    EI+  R LRH
Sbjct: 21  RYDFVKDIGSG--NFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRH 75

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVLNG 124
           PNI+ +    L  T L ++   M + S  +L    +          E       Q +L+G
Sbjct: 76  PNIVRFKEVILTPTHLAII---MEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG 128

Query: 125 LEYIHGKGFIHRAVKASHILISHNG----KAC---LSGLRYMCPFSPTKKKVHLFPPSTA 177
           + Y H     HR +K  + L+  +     K C    S              +H  P ST 
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----------SVLHSQPKSTV 178

Query: 178 YNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 231
               +++PEVL +    YD + +D++S G++   +  G  PF E P       K 
Sbjct: 179 GTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKT 230

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 38/235 (16%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y     +G    N     L + K+T +L+AVK        DE+++    EI+  R LRH
Sbjct: 21  RYDFVKDIGSG--NFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRH 75

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVICHILQDVLNG 474
           PNI+ +    L  T L ++   M + S  +L    +          E       Q +L+G
Sbjct: 76  PNIVRFKEVILTPTHLAII---MEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG 128

Query: 475 LEYIHGKGFIHRAVKASHILISHNG----KAC---LSGLRYMCPFSPTKKKVHLFPPSTA 527
           + Y H     HR +K  + L+  +     K C    S              +H  P ST 
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----------SVLHSQPKSTV 178

Query: 528 YNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
               +++PEVL +    YD + +D++S G++   +  G  PF E P       K 
Sbjct: 179 GTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKT 230

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 27/233 (11%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 68
            Y I   LG+   +   V L+ H  T Q +A+K  +   +   D+   +  EI  ++ LR
Sbjct: 10  PYIIRETLGEG--SFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67

Query: 69  HPNII-CY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNG 124
           HP+II  Y  I++    TD+ +V    G G   D I        + E       Q ++  
Sbjct: 68  HPHIIKLYDVITT---PTDIVMVIEYAG-GELFDYIVEK---KRMTEDEGRRFFQQIICA 120

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           +EY H    +HR +K  ++L+  N    ++  GL            +     S  Y    
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL---SNIMTDGNFLKTSCGSPNY---- 173

Query: 183 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
            +PEV+      Y     D++S GI    +  G +PF +      L +K+   
Sbjct: 174 AAPEVINGK--LYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSC 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 27/233 (11%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 418
            Y I   LG+   +   V L+ H  T Q +A+K  +   +   D+   +  EI  ++ LR
Sbjct: 10  PYIIRETLGEG--SFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67

Query: 419 HPNII-CY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNG 474
           HP+II  Y  I++    TD+ +V    G G   D I        + E       Q ++  
Sbjct: 68  HPHIIKLYDVITT---PTDIVMVIEYAG-GELFDYIVEK---KRMTEDEGRRFFQQIICA 120

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           +EY H    +HR +K  ++L+  N    ++  GL            +     S  Y    
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL---SNIMTDGNFLKTSCGSPNY---- 173

Query: 533 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
            +PEV+      Y     D++S GI    +  G +PF +      L +K+   
Sbjct: 174 AAPEVINGK--LYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSC 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 42/212 (19%), Positives = 78/212 (36%), Gaps = 30/212 (14%)

Query: 6   NVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
            V  +Y++   +LG   N    V    H+ T Q  A+K          D      E+   
Sbjct: 25  AVTDDYQLSKQVLGLGVN--GKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHH 75

Query: 65  RHL-RHPNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
                 P+I+C +  + +       L ++   M  G     I    +    E     I++
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGLRYMCPFSPTKKKVHLFPP 174
           D+   ++++H     HR VK  ++L +        K    G       +  +        
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----- 190

Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 206
            T Y   +++PEVL    + YD+  D++S+G+
Sbjct: 191 YTPY---YVAPEVLGP--EKYDKSCDMWSLGV 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 42/212 (19%), Positives = 78/212 (36%), Gaps = 30/212 (14%)

Query: 356 NVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
            V  +Y++   +LG   N    V    H+ T Q  A+K          D      E+   
Sbjct: 25  AVTDDYQLSKQVLGLGVN--GKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHH 75

Query: 415 RHL-RHPNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
                 P+I+C +  + +       L ++   M  G     I    +    E     I++
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNG-----KACLSGLRYMCPFSPTKKKVHLFPP 524
           D+   ++++H     HR VK  ++L +        K    G       +  +        
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----- 190

Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGI 556
            T Y   +++PEVL    + YD+  D++S+G+
Sbjct: 191 YTPY---YVAPEVLGP--EKYDKSCDMWSLGV 217

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 23/218 (10%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
            ++  +   LG   +     VY    K  +  +AVK    D M  E+      E   M+ 
Sbjct: 12  RTDITMKHKLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKE 65

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNG 124
           ++HPN++  +         ++++  M +G+  D +            L+  ++   + + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSA 123

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLN 181
           +EY+  K FIHR + A + L+  N    ++  GL R M   + T      FP      + 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IK 177

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           W +PE L  N   +  +SD+++ G+   E+A  G  P+
Sbjct: 178 WTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPY 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 23/218 (10%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
            ++  +   LG   +     VY    K  +  +AVK    D M  E+      E   M+ 
Sbjct: 12  RTDITMKHKLGGGQY---GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKE 65

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNG 474
           ++HPN++  +         ++++  M +G+  D +            L+  ++   + + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSA 123

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLN 531
           +EY+  K FIHR + A + L+  N    ++  GL R M   + T      FP      + 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IK 177

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           W +PE L  N   +  +SD+++ G+   E+A  G  P+
Sbjct: 178 WTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPY 213

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 75.9 bits (187), Expect = 8e-15
 Identities = 35/193 (18%), Positives = 69/193 (35%), Gaps = 28/193 (14%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
             V    +K T +  A+K         +D      E+       + P+I+  +  + +  
Sbjct: 76  GKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLY 128

Query: 84  D----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
                L +V   +  G     I    +    E     I++ +   ++Y+H     HR VK
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 188

Query: 140 ASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
             ++L +        K    G  +     +            T Y   +++PEVL    +
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-----YTPY---YVAPEVLGP--E 238

Query: 194 GYDERSDIYSVGI 206
            YD+  D++S+G+
Sbjct: 239 KYDKSCDMWSLGV 251

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 75.9 bits (187), Expect = 8e-15
 Identities = 35/193 (18%), Positives = 69/193 (35%), Gaps = 28/193 (14%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
             V    +K T +  A+K         +D      E+       + P+I+  +  + +  
Sbjct: 76  GKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLY 128

Query: 434 D----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
                L +V   +  G     I    +    E     I++ +   ++Y+H     HR VK
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 188

Query: 490 ASHILISHNG-----KACLSGL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
             ++L +        K    G  +     +            T Y   +++PEVL    +
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-----YTPY---YVAPEVLGP--E 238

Query: 544 GYDERSDIYSVGI 556
            YD+  D++S+G+
Sbjct: 239 KYDKSCDMWSLGV 251

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 70/337 (20%), Positives = 118/337 (35%), Gaps = 59/337 (17%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
            ++   V   Y+    +G        V  +   +  + +A+KK +         K  + E
Sbjct: 17  GDSTFTVLKRYQNLKPIGSGAQ--GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE 74

Query: 61  IVCMRHLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
           +V M+ + H NII  +       S  +  D+++V  LM    C+ +I       L    +
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQME----LDHERM 129

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 171
            ++L  +L G++++H  G IHR +K S+I++  +   K    GL R           V  
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-- 187

Query: 172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIE 229
               T Y   + +PEV+     GY E  DI+SVG    E+  G V F  T        + 
Sbjct: 188 ---VTRY---YRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239

Query: 230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR- 288
           +  G TP                 +    +Y+  +         F   F  ++    S  
Sbjct: 240 EQLG-TPCPEFMKKL---------QPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEH 287

Query: 289 ------------------DVDKRPLACNLLQHAFFKQ 307
                             D  KR      LQH +   
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 29/242 (11%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
            V   Y+    +G        V  +   +  + +A+KK +         K  + E+V M+
Sbjct: 22  TVLKRYQNLKPIGSGAQ--GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 79

Query: 416 HLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
            + H NII  +       S  +  D+++V  LM    C+ +I       L    + ++L 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-VIQME----LDHERMSYLLY 134

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPST 526
            +L G++++H  G IHR +K S+I++  +   K    GL R           V      T
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-----VT 189

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGA 584
            Y   + +PEV+     GY E  DI+SVG    E+  G V F  T        + +  G 
Sbjct: 190 RY---YRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG- 243

Query: 585 TP 586
           TP
Sbjct: 244 TP 245

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 59/239 (24%), Positives = 90/239 (37%), Gaps = 50/239 (20%)

Query: 6   NVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
           +VP NY I  ++G+      S   VYL+  K T + +A+KK N       D K +  EI 
Sbjct: 23  HVPDNYIIKHLIGR-----GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT 77

Query: 63  CMRHLRHPNIICYI-----SSFLDATDLHLVSPLMG------FGSCKDLINAHFNFGLPE 111
            +  L+   II           L   +L++V  +        F +   L   H       
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEH------- 130

Query: 112 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKK 168
             I  IL ++L G  +IH  G IHR +K ++ L++ +   K C  GL R +     T   
Sbjct: 131 --IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 169 VHLFPPSTAYNLNWLS---------------PEVLEQNLDGYDERSDIYSVGISCCELA 212
             L         N                  PE++    + Y +  DI+S G   C  A
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG---CIFA 243

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 59/239 (24%), Positives = 90/239 (37%), Gaps = 50/239 (20%)

Query: 356 NVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
           +VP NY I  ++G+      S   VYL+  K T + +A+KK N       D K +  EI 
Sbjct: 23  HVPDNYIIKHLIGR-----GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT 77

Query: 413 CMRHLRHPNIICYI-----SSFLDATDLHLVSPLMG------FGSCKDLINAHFNFGLPE 461
            +  L+   II           L   +L++V  +        F +   L   H       
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEH------- 130

Query: 462 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKK 518
             I  IL ++L G  +IH  G IHR +K ++ L++ +   K C  GL R +     T   
Sbjct: 131 --IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 519 VHLFPPSTAYNLNWLS---------------PEVLEQNLDGYDERSDIYSVGISCCELA 562
             L         N                  PE++    + Y +  DI+S G   C  A
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG---CIFA 243

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 64/336 (19%), Positives = 109/336 (32%), Gaps = 66/336 (19%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
           ++ S Y     LG   N L  V+ +     ++ +A+KK  L       +K    EI  +R
Sbjct: 8   DLGSRYMDLKPLGCGGNGL--VFSAVDNDCDKRVAIKKIVLTDPQS--VKHALREIKIIR 63

Query: 66  HLRHPNIIC--------------YISSFLDATDLHLVSPLMGFG-----SCKDLINAHFN 106
            L H NI+                + S  +   +++V   M            L+  H  
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-- 121

Query: 107 FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMC 160
                      +  +L GL+YIH    +HR +K +++ I  N +  +      GL R M 
Sbjct: 122 -------ARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMD 172

Query: 161 PFSPTKKKVHLFPPSTAYNLN-WL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           P    K         +   +  W  SP +L  + + Y +  D+++ G    E+  G   F
Sbjct: 173 PHYSHK------GHLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

Query: 219 AETPTT--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISE--QQTQVLTSRKF 274
           A       + LI +      H  D                   YI     +     ++  
Sbjct: 226 AGAHELEQMQLILESIP-VVHEEDRQEL---------LSVIPVYIRNDMTEPHKPLTQLL 275

Query: 275 SDSFHSIVEL---CLSRDVDKRPLACNLLQHAFFKQ 307
                  V+     L+     R  A   L H +   
Sbjct: 276 PGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 54/260 (20%), Positives = 93/260 (35%), Gaps = 52/260 (20%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
           ++ S Y     LG   N L  V+ +     ++ +A+KK  L       +K    EI  +R
Sbjct: 8   DLGSRYMDLKPLGCGGNGL--VFSAVDNDCDKRVAIKKIVLTDPQS--VKHALREIKIIR 63

Query: 416 HLRHPNIIC--------------YISSFLDATDLHLVSPLMGFG-----SCKDLINAHFN 456
            L H NI+                + S  +   +++V   M            L+  H  
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-- 121

Query: 457 FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-----GL-RYMC 510
                      +  +L GL+YIH    +HR +K +++ I  N +  +      GL R M 
Sbjct: 122 -------ARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMD 172

Query: 511 PFSPTKKKVHLFPPSTAYNLN-WL-SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           P    K         +   +  W  SP +L  + + Y +  D+++ G    E+  G   F
Sbjct: 173 PHYSHK------GHLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

Query: 569 AETPTT--LMLIEKLAGATP 586
           A       + LI +      
Sbjct: 226 AGAHELEQMQLILESIP-VV 244

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 34/155 (21%), Positives = 61/155 (39%), Gaps = 25/155 (16%)

Query: 6   NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
               +Y    ++G   F     VY +K   + +L+A+KK   D+      +  + E+  M
Sbjct: 51  PQEVSYTDTKVIGNGSF---GVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIM 101

Query: 65  RHLRHPNIICYISSFL------DATDLHLVSPLMGFGSCKDL-----INAHFNFGLPELV 113
           R L H NI+     F       D   L+LV   +     + +       +     LP + 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIY 157

Query: 114 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 148
           +   +  +   L YIH  G  HR +K  ++L+  +
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 34/155 (21%), Positives = 61/155 (39%), Gaps = 25/155 (16%)

Query: 356 NVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
               +Y    ++G   F     VY +K   + +L+A+KK   D+      +  + E+  M
Sbjct: 51  PQEVSYTDTKVIGNGSF---GVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIM 101

Query: 415 RHLRHPNIICYISSFL------DATDLHLVSPLMGFGSCKDL-----INAHFNFGLPELV 463
           R L H NI+     F       D   L+LV   +     + +       +     LP + 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIY 157

Query: 464 ICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN 498
           +   +  +   L YIH  G  HR +K  ++L+  +
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 30/131 (22%), Positives = 55/131 (41%), Gaps = 14/131 (10%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDED---LKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
           VY   +K T   +A+K+    ++  E+     ++  EI  M+ L+H NI+          
Sbjct: 21  VYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIR-EISLMKELKHENIVRLYDVIHTEN 76

Query: 84  DLHLV-----SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
            L LV     + L  +         +   GL   ++ +    +L GL + H    +HR +
Sbjct: 77  KLTLVFEFMDNDLKKY--MDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134

Query: 139 KASHILISHNG 149
           K  ++LI+  G
Sbjct: 135 KPQNLLINKRG 145

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 30/131 (22%), Positives = 55/131 (41%), Gaps = 14/131 (10%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDED---LKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
           VY   +K T   +A+K+    ++  E+     ++  EI  M+ L+H NI+          
Sbjct: 21  VYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIR-EISLMKELKHENIVRLYDVIHTEN 76

Query: 434 DLHLV-----SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
            L LV     + L  +         +   GL   ++ +    +L GL + H    +HR +
Sbjct: 77  KLTLVFEFMDNDLKKY--MDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134

Query: 489 KASHILISHNG 499
           K  ++LI+  G
Sbjct: 135 KPQNLLINKRG 145

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 26/233 (11%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 68
           +Y +   LG        V + KH++T   +AVK  N  ++   D+   +  EI  ++  R
Sbjct: 17  HYILGDTLGVG--TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 69  HPNII-CY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNG 124
           HP+II  Y  IS+    +D+ +V   +  G   D I  +   G L E     + Q +L+G
Sbjct: 75  HPHIIKLYQVIST---PSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSG 128

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           ++Y H    +HR +K  ++L+  +  A ++  GL          + +     S  Y    
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL---SNMMSDGEFLRTSCGSPNY---- 181

Query: 183 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
            +PEV+      Y     DI+S G+    L  GT+PF +      L +K+   
Sbjct: 182 AAPEVISGR--LYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDG 231

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 26/233 (11%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 418
           +Y +   LG        V + KH++T   +AVK  N  ++   D+   +  EI  ++  R
Sbjct: 17  HYILGDTLGVG--TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 419 HPNII-CY--ISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG-LPELVICHILQDVLNG 474
           HP+II  Y  IS+    +D+ +V   +  G   D I  +   G L E     + Q +L+G
Sbjct: 75  HPHIIKLYQVIST---PSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSG 128

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           ++Y H    +HR +K  ++L+  +  A ++  GL          + +     S  Y    
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL---SNMMSDGEFLRTSCGSPNY---- 181

Query: 533 LSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 584
            +PEV+      Y     DI+S G+    L  GT+PF +      L +K+   
Sbjct: 182 AAPEVISGR--LYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDG 231

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 28/137 (20%), Positives = 55/137 (40%), Gaps = 18/137 (13%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLK----SLHHEIVCMRHLR---HPNI-----IC 74
           VY ++   +   +A+K   +             ++  E+  +R L    HPN+     +C
Sbjct: 25  VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVC 83

Query: 75  YISSFLDATDLHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG 132
             S       + LV           +  ++     GLP   I  +++  L GL+++H   
Sbjct: 84  ATSRTDREIKVTLV---FEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 140

Query: 133 FIHRAVKASHILISHNG 149
            +HR +K  +IL++  G
Sbjct: 141 IVHRDLKPENILVTSGG 157

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 28/137 (20%), Positives = 55/137 (40%), Gaps = 18/137 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLK----SLHHEIVCMRHLR---HPNI-----IC 424
           VY ++   +   +A+K   +             ++  E+  +R L    HPN+     +C
Sbjct: 25  VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVC 83

Query: 425 YISSFLDATDLHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG 482
             S       + LV           +  ++     GLP   I  +++  L GL+++H   
Sbjct: 84  ATSRTDREIKVTLV---FEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 140

Query: 483 FIHRAVKASHILISHNG 499
            +HR +K  +IL++  G
Sbjct: 141 IVHRDLKPENILVTSGG 157

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 72.6 bits (179), Expect = 4e-14
 Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 7/125 (5%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           VY  K K+T+ L+A+K+  L+        ++  E+  ++ L+H NI+           L 
Sbjct: 18  VYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLT 76

Query: 87  LVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           LV     +     K  ++      +    +   L  +L GL Y H +  +HR +K  ++L
Sbjct: 77  LV---FEYLDKDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLL 132

Query: 145 ISHNG 149
           I+  G
Sbjct: 133 INERG 137

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 72.6 bits (179), Expect = 4e-14
 Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 7/125 (5%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           VY  K K+T+ L+A+K+  L+        ++  E+  ++ L+H NI+           L 
Sbjct: 18  VYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLT 76

Query: 437 LVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           LV     +     K  ++      +    +   L  +L GL Y H +  +HR +K  ++L
Sbjct: 77  LV---FEYLDKDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLL 132

Query: 495 ISHNG 499
           I+  G
Sbjct: 133 INERG 137

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 8/126 (6%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V+ +K++ T++++A+K+  LD   +     +L  EI  ++ L+H NI+           L
Sbjct: 18  VFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKL 76

Query: 86  HLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
            LV     F     K   ++  N  L   ++   L  +L GL + H +  +HR +K  ++
Sbjct: 77  TLV---FEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132

Query: 144 LISHNG 149
           LI+ NG
Sbjct: 133 LINRNG 138

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 8/126 (6%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V+ +K++ T++++A+K+  LD   +     +L  EI  ++ L+H NI+           L
Sbjct: 18  VFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKL 76

Query: 436 HLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
            LV     F     K   ++  N  L   ++   L  +L GL + H +  +HR +K  ++
Sbjct: 77  TLV---FEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132

Query: 494 LISHNG 499
           LI+ NG
Sbjct: 133 LINRNG 138

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 28/142 (19%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLRHPNIIC------ 74
             V+ ++H+ T Q +A+KK     M +E     + +L  EI  ++ L+H N++       
Sbjct: 31  GEVFKARHRKTGQKVALKKV---LMENEKEGFPITALR-EIKILQLLKHENVVNLIEICR 86

Query: 75  --YISSFLDATDLHLVSP-----LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
                       ++LV       L G      L N    F L E  I  ++Q +LNGL Y
Sbjct: 87  TKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSE--IKRVMQMLLNGLYY 139

Query: 128 IHGKGFIHRAVKASHILISHNG 149
           IH    +HR +KA+++LI+ +G
Sbjct: 140 IHRNKILHRDMKAANVLITRDG 161

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 28/142 (19%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLRHPNIIC------ 424
             V+ ++H+ T Q +A+KK     M +E     + +L  EI  ++ L+H N++       
Sbjct: 31  GEVFKARHRKTGQKVALKKV---LMENEKEGFPITALR-EIKILQLLKHENVVNLIEICR 86

Query: 425 --YISSFLDATDLHLVSP-----LMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
                       ++LV       L G      L N    F L E  I  ++Q +LNGL Y
Sbjct: 87  TKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSE--IKRVMQMLLNGLYY 139

Query: 478 IHGKGFIHRAVKASHILISHNG 499
           IH    +HR +KA+++LI+ +G
Sbjct: 140 IHRNKILHRDMKAANVLITRDG 161

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 68/330 (20%), Positives = 115/330 (34%), Gaps = 55/330 (16%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
            V   Y+    +G        V  +   V ++ +A+KK +         K  + E+V M+
Sbjct: 59  TVLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116

Query: 66  HLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 119
            + H NII  +       +  +  D++LV  LM      +L        L    + ++L 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANL-CQVIQMELDHERMSYLLY 171

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPST 176
            +L G++++H  G IHR +K S+I++  +   K    GL R           V      T
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-----VT 226

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGA 234
            Y   + +PEV+     GY E  DI+SVG    E+    + F           + +  G 
Sbjct: 227 RY---YRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG- 280

Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISE--QQTQVLTSRKFSDSFHSIVEL-------- 284
           TP                 +    +Y+    +   +   + F DS               
Sbjct: 281 TPCPEFMKKL---------QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 331

Query: 285 -------CLSRDVDKRPLACNLLQHAFFKQ 307
                   L  D  KR    + LQH +   
Sbjct: 332 ARDLLSKMLVIDPAKRISVDDALQHPYINV 361

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.3 bits (180), Expect = 6e-14
 Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 29/242 (11%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
            V   Y+    +G        V  +   V ++ +A+KK +         K  + E+V M+
Sbjct: 59  TVLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116

Query: 416 HLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
            + H NII  +       +  +  D++LV  LM      +L        L    + ++L 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANL-CQVIQMELDHERMSYLLY 171

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHLFPPST 526
            +L G++++H  G IHR +K S+I++  +   K    GL R           V      T
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-----VT 226

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGA 584
            Y   + +PEV+     GY E  DI+SVG    E+    + F           + +  G 
Sbjct: 227 RY---YRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG- 280

Query: 585 TP 586
           TP
Sbjct: 281 TP 282

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 30/131 (22%), Positives = 62/131 (47%), Gaps = 15/131 (11%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLRHPNIICYISSFLDA 82
           VY +   VTN+ +A+K+    R+  E+      ++  E+  ++ L+H NII   S     
Sbjct: 50  VYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHN 105

Query: 83  TDLHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
             LHL+     +     K  ++ + +  +    I   L  ++NG+ + H +  +HR +K 
Sbjct: 106 HRLHLI---FEYAENDLKKYMDKNPDVSMRV--IKSFLYQLINGVNFCHSRRCLHRDLKP 160

Query: 141 SHILISHNGKA 151
            ++L+S +  +
Sbjct: 161 QNLLLSVSDAS 171

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 30/131 (22%), Positives = 62/131 (47%), Gaps = 15/131 (11%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLRHPNIICYISSFLDA 432
           VY +   VTN+ +A+K+    R+  E+      ++  E+  ++ L+H NII   S     
Sbjct: 50  VYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHN 105

Query: 433 TDLHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
             LHL+     +     K  ++ + +  +    I   L  ++NG+ + H +  +HR +K 
Sbjct: 106 HRLHLI---FEYAENDLKKYMDKNPDVSMRV--IKSFLYQLINGVNFCHSRRCLHRDLKP 160

Query: 491 SHILISHNGKA 501
            ++L+S +  +
Sbjct: 161 QNLLLSVSDAS 171

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 48/224 (21%), Positives = 94/224 (41%), Gaps = 32/224 (14%)

Query: 8   PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
            +   +  ILG+  F    SV    L +   T+  +AVK   LD  +  +++    E  C
Sbjct: 33  RNLLILGKILGEGEF---GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89

Query: 64  MRHLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAH------FNFGLPEL 112
           M+   HPN+I     C   S        ++ P M +G     +          +  L  L
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 113 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKV 169
           +    + D+  G+EY+  + F+HR + A + ++  +   C++  GL + +      ++  
Sbjct: 150 L--KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207

Query: 170 H-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 212
               P      + W++ E L   +  Y  +SD+++ G++  E+A
Sbjct: 208 IAKMP------VKWIAIESLADRV--YTSKSDVWAFGVTMWEIA 243

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 48/224 (21%), Positives = 94/224 (41%), Gaps = 32/224 (14%)

Query: 358 PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
            +   +  ILG+  F    SV    L +   T+  +AVK   LD  +  +++    E  C
Sbjct: 33  RNLLILGKILGEGEF---GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89

Query: 414 MRHLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAH------FNFGLPEL 462
           M+   HPN+I     C   S        ++ P M +G     +          +  L  L
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKV 519
           +    + D+  G+EY+  + F+HR + A + ++  +   C++  GL + +      ++  
Sbjct: 150 L--KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207

Query: 520 H-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELA 562
               P      + W++ E L   +  Y  +SD+++ G++  E+A
Sbjct: 208 IAKMP------VKWIAIESLADRV--YTSKSDVWAFGVTMWEIA 243

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 30/187 (16%), Positives = 63/187 (33%), Gaps = 37/187 (19%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 83
             V    +K T +  A+K         +D      E+       + P+I+  +  + +  
Sbjct: 32  GKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLY 84

Query: 84  D----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
                L +V   +  G     I    +    E     I++ +   ++Y+H     HR VK
Sbjct: 85  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144

Query: 140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
             ++L +       + L+ +  F                     + E   +    YD+  
Sbjct: 145 PENLLYTSKRPN--AILK-LTDFG-------------------FAKETTGEK---YDKSC 179

Query: 200 DIYSVGI 206
           D++S+G+
Sbjct: 180 DMWSLGV 186

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 30/187 (16%), Positives = 63/187 (33%), Gaps = 37/187 (19%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT 433
             V    +K T +  A+K         +D      E+       + P+I+  +  + +  
Sbjct: 32  GKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLY 84

Query: 434 D----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
                L +V   +  G     I    +    E     I++ +   ++Y+H     HR VK
Sbjct: 85  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144

Query: 490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
             ++L +       + L+ +  F                     + E   +    YD+  
Sbjct: 145 PENLLYTSKRPN--AILK-LTDFG-------------------FAKETTGEK---YDKSC 179

Query: 550 DIYSVGI 556
           D++S+G+
Sbjct: 180 DMWSLGV 186

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 40/129 (31%), Positives = 63/129 (48%), Gaps = 11/129 (8%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH----EIVCMRHLRHPNIICYISSFLDA 82
           VY ++ K TNQ++A+KK  L     E    ++     EI  ++ L HPNII  + +F   
Sbjct: 26  VYKARDKNTNQIVAIKKIKLG-HRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84

Query: 83  TDLHLVSPLMGFGSCKDL--INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           +++ LV   M      DL  I    +  L    I   +   L GLEY+H    +HR +K 
Sbjct: 85  SNISLVFDFM----ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140

Query: 141 SHILISHNG 149
           +++L+  NG
Sbjct: 141 NNLLLDENG 149

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 40/129 (31%), Positives = 63/129 (48%), Gaps = 11/129 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH----EIVCMRHLRHPNIICYISSFLDA 432
           VY ++ K TNQ++A+KK  L     E    ++     EI  ++ L HPNII  + +F   
Sbjct: 26  VYKARDKNTNQIVAIKKIKLG-HRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84

Query: 433 TDLHLVSPLMGFGSCKDL--INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           +++ LV   M      DL  I    +  L    I   +   L GLEY+H    +HR +K 
Sbjct: 85  SNISLVFDFM----ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140

Query: 491 SHILISHNG 499
           +++L+  NG
Sbjct: 141 NNLLLDENG 149

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 68/360 (18%), Positives = 124/360 (34%), Gaps = 81/360 (22%)

Query: 2   ETLDNVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFN--LDRMTDEDLKS 56
               +V   Y++   LG+      +   V+ S  + T +++AVKK        TD   + 
Sbjct: 2   RVDRHVLRKYELVKKLGK-----GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD--AQR 54

Query: 57  LHHEIVCMRHLR-HPNIICYISSFL--DATDLHLVSPLMGFGSCKDL---INAHFNFGLP 110
              EI+ +  L  H NI+  ++     +  D++LV   M      DL   I A+    L 
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANI---LE 107

Query: 111 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKK 167
            +   +++  ++  ++Y+H  G +HR +K S+IL++     K    GL R          
Sbjct: 108 PVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 168 KVHLFPPSTAYNLNWLS--------------PEVLEQNLDGYDERSDIYSVGISCC---E 210
            + L       N +                 PE+L      Y +  D++S+G   C   E
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEIL-LGSTKYTKGIDMWSLG---CILGE 223

Query: 211 LANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI------- 261
           +  G   F  + T   L  I  +    P   D  +             A + I       
Sbjct: 224 ILCGKPIFPGSSTMNQLERIIGVID-FPSNEDVESI--------QSPFAKTMIESLKEKV 274

Query: 262 -----SEQQTQVLTSRKFSDSFHS---------IVELCLSRDVDKRPLACNLLQHAFFKQ 307
                +++                         +++  L  + +KR  A + L+H F   
Sbjct: 275 EIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 52/239 (21%), Positives = 93/239 (38%), Gaps = 46/239 (19%)

Query: 352 ETLDNVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFN--LDRMTDEDLKS 406
               +V   Y++   LG+      +   V+ S  + T +++AVKK        TD   + 
Sbjct: 2   RVDRHVLRKYELVKKLGK-----GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD--AQR 54

Query: 407 LHHEIVCMRHLR-HPNIICYISSFL--DATDLHLVSPLMGFGSCKDL---INAHFNFGLP 460
              EI+ +  L  H NI+  ++     +  D++LV   M      DL   I A+    L 
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANI---LE 107

Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKK 517
            +   +++  ++  ++Y+H  G +HR +K S+IL++     K    GL R          
Sbjct: 108 PVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 518 KVHLFPPSTAYNLNWLS--------------PEVLEQNLDGYDERSDIYSVGISCCELA 562
            + L       N +                 PE+L      Y +  D++S+G   C L 
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEIL-LGSTKYTKGIDMWSLG---CILG 222

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 34/231 (14%)

Query: 9   SNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
             + +  +LG+  F    SV    L +   +   +AVK    D +   D++    E  CM
Sbjct: 23  QQFTLGRMLGKGEF---GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79

Query: 65  RHLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAH------FNFGLPEL 112
           +   HP++   +       +        ++ P M  G     + A       FN  L  L
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 113 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKV 169
           V    + D+  G+EY+  + FIHR + A + +++ +   C++  GL R +      ++  
Sbjct: 140 V--RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197

Query: 170 H-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
               P      + WL+ E L  NL  Y   SD+++ G++  E+   G  P+
Sbjct: 198 ASKLP------VKWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPY 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 34/231 (14%)

Query: 359 SNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
             + +  +LG+  F    SV    L +   +   +AVK    D +   D++    E  CM
Sbjct: 23  QQFTLGRMLGKGEF---GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79

Query: 415 RHLRHPNIICYI------SSFLDATDLHLVSPLMGFGSCKDLINAH------FNFGLPEL 462
           +   HP++   +       +        ++ P M  G     + A       FN  L  L
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKV 519
           V    + D+  G+EY+  + FIHR + A + +++ +   C++  GL R +      ++  
Sbjct: 140 V--RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197

Query: 520 H-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
               P      + WL+ E L  NL  Y   SD+++ G++  E+   G  P+
Sbjct: 198 ASKLP------VKWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPY 240

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 27/219 (12%), Positives = 61/219 (27%), Gaps = 48/219 (21%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLDAT 83
              + +     ++ +A+   +   +  +D+        + +  +  P +       LD  
Sbjct: 45  LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA----RVLDVV 100

Query: 84  DLH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
                  +V+  +  GS +++ +         +     +Q +    +  H  G       
Sbjct: 101 HTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDH 156

Query: 140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
            S + +S +G   L+    M   +P                                 + 
Sbjct: 157 PSRVRVSIDGDVVLAYPATMPDANP---------------------------------QD 183

Query: 200 DIYSVGISCCELANGTVPFAET--PTTLMLIEKLAGATP 236
           DI  +G S   L     P  E    + L   E+     P
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 27/219 (12%), Positives = 61/219 (27%), Gaps = 48/219 (21%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLRHPNIICYISSFLDAT 433
              + +     ++ +A+   +   +  +D+        + +  +  P +       LD  
Sbjct: 45  LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA----RVLDVV 100

Query: 434 DLH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
                  +V+  +  GS +++ +         +     +Q +    +  H  G       
Sbjct: 101 HTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDH 156

Query: 490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
            S + +S +G   L+    M   +P                                 + 
Sbjct: 157 PSRVRVSIDGDVVLAYPATMPDANP---------------------------------QD 183

Query: 550 DIYSVGISCCELANGTVPFAET--PTTLMLIEKLAGATP 586
           DI  +G S   L     P  E    + L   E+     P
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 71.1 bits (174), Expect = 4e-13
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 21/216 (9%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
             + ++   LGQ CF     V++         +A+K      M+ E       E   M+ 
Sbjct: 266 RESLRLEVKLGQGCF---GEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQ---EAQVMKK 318

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRH  ++   +   +   +++V+  M  GS  D +       L    +  +   + +G+ 
Sbjct: 319 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y+    ++HR ++A++IL+  N    ++  GL R +     T ++   FP      + W 
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWT 431

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           +PE        +  +SD++S GI   EL   G VP+
Sbjct: 432 APEAALYGR--FTIKSDVWSFGILLTELTTKGRVPY 465

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 71.1 bits (174), Expect = 4e-13
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 21/216 (9%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
             + ++   LGQ CF     V++         +A+K      M+ E       E   M+ 
Sbjct: 266 RESLRLEVKLGQGCF---GEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQ---EAQVMKK 318

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRH  ++   +   +   +++V+  M  GS  D +       L    +  +   + +G+ 
Sbjct: 319 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y+    ++HR ++A++IL+  N    ++  GL R +     T ++   FP      + W 
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWT 431

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           +PE        +  +SD++S GI   EL   G VP+
Sbjct: 432 APEAALYGR--FTIKSDVWSFGILLTELTTKGRVPY 465

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 9/126 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           VY +K     +++A+K+  LD   +     ++  EI  ++ L HPNI+  I        L
Sbjct: 37  VYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCL 94

Query: 86  HLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
            LV     F     K +++ +   GL +  I   L  +L G+ + H    +HR +K  ++
Sbjct: 95  TLV---FEFMEKDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150

Query: 144 LISHNG 149
           LI+ +G
Sbjct: 151 LINSDG 156

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 9/126 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           VY +K     +++A+K+  LD   +     ++  EI  ++ L HPNI+  I        L
Sbjct: 37  VYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCL 94

Query: 436 HLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
            LV     F     K +++ +   GL +  I   L  +L G+ + H    +HR +K  ++
Sbjct: 95  TLV---FEFMEKDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150

Query: 494 LISHNG 499
           LI+ +G
Sbjct: 151 LINSDG 156

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 14/133 (10%)

Query: 27  VY--LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           VY    K    ++  A+K+     ++    +    EI  +R L+HPN+I     FL   D
Sbjct: 37  VYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLRELKHPNVISLQKVFLSHAD 92

Query: 85  --LHLVSP-----LMGF-GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 136
             + L+       L       +          LP  ++  +L  +L+G+ Y+H    +HR
Sbjct: 93  RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152

Query: 137 AVKASHILISHNG 149
            +K ++IL+   G
Sbjct: 153 DLKPANILVMGEG 165

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 14/133 (10%)

Query: 377 VY--LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           VY    K    ++  A+K+     ++    +    EI  +R L+HPN+I     FL   D
Sbjct: 37  VYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLRELKHPNVISLQKVFLSHAD 92

Query: 435 --LHLVSP-----LMGF-GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 486
             + L+       L       +          LP  ++  +L  +L+G+ Y+H    +HR
Sbjct: 93  RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152

Query: 487 AVKASHILISHNG 499
            +K ++IL+   G
Sbjct: 153 DLKPANILVMGEG 165

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 21/216 (9%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
             + ++   LGQ CF     V++     T + +A+K      M+ E       E   M+ 
Sbjct: 183 RESLRLEVKLGQGCF---GEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ---EAQVMKK 235

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           LRH  ++   +   +   +++V+  M  GS  D +       L    +  +   + +G+ 
Sbjct: 236 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           Y+    ++HR ++A++IL+  N    ++  GL R +     T ++   FP      + W 
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWT 348

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           +PE        +  +SD++S GI   EL   G VP+
Sbjct: 349 APEAALYGR--FTIKSDVWSFGILLTELTTKGRVPY 382

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 21/216 (9%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
             + ++   LGQ CF     V++     T + +A+K      M+ E       E   M+ 
Sbjct: 183 RESLRLEVKLGQGCF---GEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ---EAQVMKK 235

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           LRH  ++   +   +   +++V+  M  GS  D +       L    +  +   + +G+ 
Sbjct: 236 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           Y+    ++HR ++A++IL+  N    ++  GL R +     T ++   FP      + W 
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP------IKWT 348

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           +PE        +  +SD++S GI   EL   G VP+
Sbjct: 349 APEAALYGR--FTIKSDVWSFGILLTELTTKGRVPY 382

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 68.7 bits (169), Expect = 7e-13
 Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 9/126 (7%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           VY +++    +  A+KK  L++  +     ++  EI  ++ L+H NI+           L
Sbjct: 18  VYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRL 75

Query: 86  HLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
            LV           K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++
Sbjct: 76  VLV---FEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131

Query: 144 LISHNG 149
           LI+  G
Sbjct: 132 LINREG 137

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 68.7 bits (169), Expect = 7e-13
 Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 9/126 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           VY +++    +  A+KK  L++  +     ++  EI  ++ L+H NI+           L
Sbjct: 18  VYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRL 75

Query: 436 HLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
            LV           K L++     GL  +     L  +LNG+ Y H +  +HR +K  ++
Sbjct: 76  VLV---FEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131

Query: 494 LISHNG 499
           LI+  G
Sbjct: 132 LINREG 137

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 70.2 bits (172), Expect = 8e-13
 Identities = 57/292 (19%), Positives = 104/292 (35%), Gaps = 54/292 (18%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V   + + T ++ A KK    R    +      +E   +  +    ++    ++     L
Sbjct: 200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259

Query: 86  HLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
            LV  LM  G   DL   I      G PE        ++  GLE +H +  ++R +K  +
Sbjct: 260 CLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316

Query: 143 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           IL+  +G   +S  G   +    P  + +     +  Y    ++PEV++     Y    D
Sbjct: 317 ILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGY----MAPEVVKNE--RYTFSPD 367

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
            +++G                    +L E +AG +P       +     +   EE     
Sbjct: 368 WWALGC-------------------LLYEMIAGQSP-------FQQRKKKIKREE---VE 398

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN------LLQHAFFK 306
              ++     S +FS    S+    L +D  +R L C       + +H  FK
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAER-LGCRGGSAREVKEHPLFK 449

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 42/198 (21%), Positives = 77/198 (38%), Gaps = 18/198 (9%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V   + + T ++ A KK    R    +      +E   +  +    ++    ++     L
Sbjct: 200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259

Query: 436 HLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
            LV  LM  G   DL   I      G PE        ++  GLE +H +  ++R +K  +
Sbjct: 260 CLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316

Query: 493 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           IL+  +G   +S  G   +    P  + +     +  Y    ++PEV++     Y    D
Sbjct: 317 ILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGY----MAPEVVKNE--RYTFSPD 367

Query: 551 IYSVGISCCELANGTVPF 568
            +++G    E+  G  PF
Sbjct: 368 WWALGCLLYEMIAGQSPF 385

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.6 bits (170), Expect = 9e-13
 Identities = 73/373 (19%), Positives = 118/373 (31%), Gaps = 80/373 (21%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           D     Y +   LG  + + S+V+LS      + +A+K         E   +   EI  +
Sbjct: 33  DLFNGRYHVIRKLG--WGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE---TALDEIRLL 87

Query: 65  RHLR-----HPNIICYISSFLDATDLH--------LVSPLMGFGSCKDLINAHFNFGLPE 111
           + +R      PN    +   LD   +         +V  ++G       I      GLP 
Sbjct: 88  KSVRNSDPNDPNR-EMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPL 145

Query: 112 LVICHILQDVLNGLEYIHGK-GFIHRAVKASHILIS------------------HNGKAC 152
             +  I+Q VL GL+Y+H K   IH  +K  +IL+S                        
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205

Query: 153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNW------------------------LSPEVL 188
                   P +     V+   P  A  L                           S EVL
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL 265

Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--------LMLIEKLAGATP-HLL 239
             +  GY+  +DI+S      ELA G   F              + LI +L G  P  L+
Sbjct: 266 IGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323

Query: 240 D----CTTYYVDTGQDDGEENACSYISEQQ--TQVLTSRKFSDSFHSIVELCLSRDVDKR 293
                   ++   G          +   +    +   S++ +  F   +   L    +KR
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383

Query: 294 PLACNLLQHAFFK 306
             A   L+H +  
Sbjct: 384 ATAAECLRHPWLN 396

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 61/284 (21%), Positives = 91/284 (32%), Gaps = 75/284 (26%)

Query: 341 FNINDTFNSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT 400
             I D FN            Y +   LG  + + S+V+LS      + +A+K        
Sbjct: 29  VKIGDLFNG----------RYHVIRKLG--WGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76

Query: 401 DEDLKSLHHEIVCMRHLR-----HPNIICYISSFLDATDLH--------LVSPLMGFGSC 447
            E   +   EI  ++ +R      PN    +   LD   +         +V  ++G    
Sbjct: 77  TE---TALDEIRLLKSVRNSDPNDPNR-EMVVQLLDDFKISGVNGTHICMVFEVLG-HHL 131

Query: 448 KDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILIS---------- 496
              I      GLP   +  I+Q VL GL+Y+H K   IH  +K  +IL+S          
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

Query: 497 --------HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW---------------- 532
                                 P +     V+   P  A  L                  
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251

Query: 533 --------LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                    S EVL  +  GY+  +DI+S      ELA G   F
Sbjct: 252 EDIQTRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLF 293

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 56/332 (16%), Positives = 109/332 (32%), Gaps = 76/332 (22%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHEIVCM 64
           + Y++  +LG+      +V+          +A+K    +R+       D  +   E+  +
Sbjct: 31  AEYRLGPLLGK--GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88

Query: 65  RHLR----HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVIC 115
             +     HP +I  +  F       LV         +DL    F++      L E    
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL--PAQDL----FDYITEKGPLGEGPSR 142

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILI-SHNGKACLS--GL-RYMCPFSPTKKKVHL 171
                V+  +++ H +G +HR +K  +ILI    G A L   G    +       +    
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-----HDEPYTD 197

Query: 172 FPPSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPFAETPTTLMLIEK 230
           F  +  Y      PE + ++   Y    + ++S+GI   ++  G +PF            
Sbjct: 198 FDGTRVY----SPPEWISRH--QYHALPATVWSLGILLYDMVCGDIPF------------ 239

Query: 231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDV 290
                               +  +E     I E +         S    +++  CL+   
Sbjct: 240 --------------------ERDQE-----ILEAELHF--PAHVSPDCCALIRRCLAPKP 272

Query: 291 DKRPLACNLLQHAFFKQTKKCSVMLPELLRPA 322
             RP    +L   + +   +   + P    PA
Sbjct: 273 SSRPSLEEILLDPWMQTPAEDVPLNPSKGGPA 304

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 44/228 (19%), Positives = 85/228 (37%), Gaps = 37/228 (16%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHEIVCM 414
           + Y++  +LG+      +V+          +A+K    +R+       D  +   E+  +
Sbjct: 31  AEYRLGPLLGK--GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88

Query: 415 RHLR----HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF-----GLPELVIC 465
             +     HP +I  +  F       LV         +DL    F++      L E    
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL--PAQDL----FDYITEKGPLGEGPSR 142

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILI-SHNGKACLS--GL-RYMCPFSPTKKKVHL 521
                V+  +++ H +G +HR +K  +ILI    G A L   G    +       +    
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-----HDEPYTD 197

Query: 522 FPPSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPF 568
           F  +  Y      PE + ++   Y    + ++S+GI   ++  G +PF
Sbjct: 198 FDGTRVY----SPPEWISRH--QYHALPATVWSLGILLYDMVCGDIPF 239

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 76/337 (22%), Positives = 130/337 (38%), Gaps = 73/337 (21%)

Query: 27  VYLSKH-KVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLR---HPNI-----I 73
           V+ ++  K   + +A+K+    R+   +    L ++  E+  +RHL    HPN+     +
Sbjct: 27  VFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDV 82

Query: 74  CYISSFLDATDLHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGK 131
           C +S     T L LV              ++     G+P   I  ++  +L GL+++H  
Sbjct: 83  CTVSRTDRETKLTLV---FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 139

Query: 132 GFIHRAVKASHILISHNG--KACLSGL--RYMCPFSPTKKKVHLFPPSTAYNLNWL-SPE 186
             +HR +K  +IL++ +G  K    GL   Y    + T   V L          W  +PE
Sbjct: 140 RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL----------WYRAPE 189

Query: 187 VLEQNLDGYDERSDIYSVGISCC---ELANGTVPFAET--PTTLMLIEKLAGATPHLLDC 241
           VL Q    Y    D++SVG   C   E+      F  +     L  I  + G  P     
Sbjct: 190 VLLQ--SSYATPVDLWSVG---CIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPG---- 239

Query: 242 TTYYVDTGQDDGEEN--ACSYISEQQTQVLTSRKFSDSFHSI----VEL---CLSRDVDK 292
                       EE+      +  Q     +++        I     +L   CL+ +  K
Sbjct: 240 ------------EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287

Query: 293 RPLACNLLQHAFFKQTKKCSVMLPELLRPALSLNESN 329
           R  A + L H +F+  ++C   L   L P+ + +E N
Sbjct: 288 RISAYSALSHPYFQDLERCKENLDSHLPPSQNTSELN 324

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.8 bits (164), Expect = 4e-12
 Identities = 32/138 (23%), Positives = 63/138 (45%), Gaps = 22/138 (15%)

Query: 377 VYLSKH-KVTNQLIAVKKFNLDRMTDED----LKSLHHEIVCMRHLR---HPNI-----I 423
           V+ ++  K   + +A+K+    R+   +    L ++  E+  +RHL    HPN+     +
Sbjct: 27  VFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDV 82

Query: 424 CYISSFLDATDLHLVSPLMGFGSC--KDLINAHFNFGLPELVICHILQDVLNGLEYIHGK 481
           C +S     T L LV              ++     G+P   I  ++  +L GL+++H  
Sbjct: 83  CTVSRTDRETKLTLV---FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 139

Query: 482 GFIHRAVKASHILISHNG 499
             +HR +K  +IL++ +G
Sbjct: 140 RVVHRDLKPQNILVTSSG 157

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 23/217 (10%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
           PS       +G   F     V+L      ++ +A+K      M++ED      E   M  
Sbjct: 7   PSELTFVQEIGSGQF---GLVHLGYWLNKDK-VAIKTIREGAMSEEDFIE---EAEVMMK 59

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGL 125
           L HP ++      L+   + LV+  M  G   D L      F    L+   +  DV  G+
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL--GMCLDVCEGM 117

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 182
            Y+     IHR + A + L+  N    +S  G+ R++     T      FP      + W
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP------VKW 171

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
            SPEV   +   Y  +SD++S G+   E+ + G +P+
Sbjct: 172 ASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPY 206

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 23/217 (10%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
           PS       +G   F     V+L      ++ +A+K      M++ED      E   M  
Sbjct: 7   PSELTFVQEIGSGQF---GLVHLGYWLNKDK-VAIKTIREGAMSEEDFIE---EAEVMMK 59

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGL 475
           L HP ++      L+   + LV+  M  G   D L      F    L+   +  DV  G+
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL--GMCLDVCEGM 117

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 532
            Y+     IHR + A + L+  N    +S  G+ R++     T      FP      + W
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP------VKW 171

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
            SPEV   +   Y  +SD++S G+   E+ + G +P+
Sbjct: 172 ASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPY 206

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 29/244 (11%)

Query: 340 MFNINDTFNSSVETLDNVPSNYKI--CSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKK 393
           +  +N     +V+ +   PS+  +    ++G+  F     VY   L  +       AVK 
Sbjct: 4   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHF---GCVYHGTLLDNDGKKIHCAVKS 60

Query: 394 FNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYI-SSFLDATDLHLVSPLMGFGSCKD-LI 451
            N       ++     E + M+   HPN++  +           +V P M  G  ++ + 
Sbjct: 61  LN-RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 119

Query: 452 NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RY 508
           N   N  + +L+       V  G++Y+  K F+HR + A + ++       ++  GL R 
Sbjct: 120 NETHNPTVKDLI--GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177

Query: 509 M---CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-G 564
           M     +S   K     P      + W++ E L+     +  +SD++S G+   EL   G
Sbjct: 178 MYDKEYYSVHNKTGAKLP------VKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRG 229

Query: 565 TVPF 568
             P+
Sbjct: 230 APPY 233

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 27/220 (12%)

Query: 12  KICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
               ++G+  F     VY   L  +       AVK  N       ++     E + M+  
Sbjct: 28  HFNEVIGRGHF---GCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDF 83

Query: 68  RHPNIICYI-SSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGL 125
            HPN++  +           +V P M  G  ++ + N   N  + +L+       V  G+
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGM 141

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYM---CPFSPTKKKVHLFPPSTAYN 179
           +Y+  K F+HR + A + ++       ++  GL R M     +S   K     P      
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP------ 195

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           + W++ E L+     +  +SD++S G+   EL   G  P+
Sbjct: 196 VKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPY 233

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 26/156 (16%)

Query: 2   ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           +T +     Y  C ++G   F     V+ +K   +++ +A+KK   D+      +  + E
Sbjct: 33  KTGEQREIAYTNCKVIGNGSF---GVVFQAKLVESDE-VAIKKVLQDK------RFKNRE 82

Query: 61  IVCMRHLRHPNIIC--YI----SSFLDATDLHLVSPLMGFGSCKDL--INAHF---NFGL 109
           +  MR ++HPN++             D   L+LV   +     + +   + H+      +
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTM 138

Query: 110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           P L+I   +  +L  L YIH  G  HR +K  ++L+
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 26/156 (16%)

Query: 352 ETLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           +T +     Y  C ++G   F     V+ +K   +++ +A+KK   D+      +  + E
Sbjct: 33  KTGEQREIAYTNCKVIGNGSF---GVVFQAKLVESDE-VAIKKVLQDK------RFKNRE 82

Query: 411 IVCMRHLRHPNIIC--YI----SSFLDATDLHLVSPLMGFGSCKDL--INAHF---NFGL 459
           +  MR ++HPN++             D   L+LV   +     + +   + H+      +
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTM 138

Query: 460 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           P L+I   +  +L  L YIH  G  HR +K  ++L+
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 40/189 (21%), Positives = 80/189 (42%), Gaps = 20/189 (10%)

Query: 39  IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-SFLDATDLHLVSPLMGFGSC 97
            A+K  +      + +++   E + MR L HPN++  I          H++ P M  G  
Sbjct: 52  CAIKSLS-RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL 110

Query: 98  KD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-- 154
              + +   N  + +L+       V  G+EY+  + F+HR + A + ++  +    ++  
Sbjct: 111 LQFIRSPQRNPTVKDLI--SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168

Query: 155 GL-RYMC---PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 210
           GL R +     +S  + +    P      + W + E L+     +  +SD++S G+   E
Sbjct: 169 GLARDILDREYYSVQQHRHARLP------VKWTALESLQTYR--FTTKSDVWSFGVLLWE 220

Query: 211 LAN-GTVPF 218
           L   G  P+
Sbjct: 221 LLTRGAPPY 229

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 40/189 (21%), Positives = 80/189 (42%), Gaps = 20/189 (10%)

Query: 389 IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYIS-SFLDATDLHLVSPLMGFGSC 447
            A+K  +      + +++   E + MR L HPN++  I          H++ P M  G  
Sbjct: 52  CAIKSLS-RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL 110

Query: 448 KD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-- 504
              + +   N  + +L+       V  G+EY+  + F+HR + A + ++  +    ++  
Sbjct: 111 LQFIRSPQRNPTVKDLI--SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168

Query: 505 GL-RYMC---PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
           GL R +     +S  + +    P      + W + E L+     +  +SD++S G+   E
Sbjct: 169 GLARDILDREYYSVQQHRHARLP------VKWTALESLQTYR--FTTKSDVWSFGVLLWE 220

Query: 561 LAN-GTVPF 568
           L   G  P+
Sbjct: 221 LLTRGAPPY 229

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 23/217 (10%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
                +   LG   F     V L K K     +AVK      M++++      E   M  
Sbjct: 7   REEITLLKELGSGQF---GVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQ---EAQTMMK 59

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGL 125
           L HP ++ +         +++V+  +  G   + + +H       +L+   +  DV  G+
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--EMCYDVCEGM 117

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 182
            ++    FIHR + A + L+  +    +S  G+ RY+            FP      + W
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP------VKW 171

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
            +PEV       Y  +SD+++ GI   E+ + G +P+
Sbjct: 172 SAPEVFHYFK--YSSKSDVWAFGILMWEVFSLGKMPY 206

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 23/217 (10%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
                +   LG   F     V L K K     +AVK      M++++      E   M  
Sbjct: 7   REEITLLKELGSGQF---GVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQ---EAQTMMK 59

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGL 475
           L HP ++ +         +++V+  +  G   + + +H       +L+   +  DV  G+
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--EMCYDVCEGM 117

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 532
            ++    FIHR + A + L+  +    +S  G+ RY+            FP      + W
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP------VKW 171

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
            +PEV       Y  +SD+++ GI   E+ + G +P+
Sbjct: 172 SAPEVFHYFK--YSSKSDVWAFGILMWEVFSLGKMPY 206

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 40/212 (18%), Positives = 90/212 (42%), Gaps = 20/212 (9%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           +++ + +     +A+K+        +  K +  E   M  + +P++   +   L +T + 
Sbjct: 35  LWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92

Query: 87  LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           L++ LM FG   D +     N G   L+  +    +  G+ Y+  +  +HR + A ++L+
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 146 SHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
                  ++  GL + +              P      + W++ E +   +  Y  +SD+
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMALESILHRI--YTHQSDV 202

Query: 202 YSVGISCCELAN-GTVPFAETPTT--LMLIEK 230
           +S G++  EL   G+ P+   P +    ++EK
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 40/212 (18%), Positives = 90/212 (42%), Gaps = 20/212 (9%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           +++ + +     +A+K+        +  K +  E   M  + +P++   +   L +T + 
Sbjct: 35  LWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92

Query: 437 LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           L++ LM FG   D +     N G   L+  +    +  G+ Y+  +  +HR + A ++L+
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 496 SHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
                  ++  GL + +              P      + W++ E +   +  Y  +SD+
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMALESILHRI--YTHQSDV 202

Query: 552 YSVGISCCELAN-GTVPFAETPTT--LMLIEK 580
           +S G++  EL   G+ P+   P +    ++EK
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 22/209 (10%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V L +HK T ++ A+K  +   M    D      E   M     P ++    +F D   L
Sbjct: 85  VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144

Query: 86  HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           ++V   M +    DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+
Sbjct: 145 YMV---MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201

Query: 146 SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQ--NLDGYDE 197
             +G   L+  G    C       K++              +++SPEVL+       Y  
Sbjct: 202 DKSGHLKLADFGT---C------MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252

Query: 198 RSDIYSVGISCCELANGTVPF-AETPTTL 225
             D +SVG+   E+  G  PF A++    
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPFYADSLVGT 281

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 22/209 (10%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V L +HK T ++ A+K  +   M    D      E   M     P ++    +F D   L
Sbjct: 85  VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144

Query: 436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           ++V   M +    DL+N   N+ +PE        +V+  L+ IH  GFIHR VK  ++L+
Sbjct: 145 YMV---MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201

Query: 496 SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQ--NLDGYDE 547
             +G   L+  G    C       K++              +++SPEVL+       Y  
Sbjct: 202 DKSGHLKLADFGT---C------MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252

Query: 548 RSDIYSVGISCCELANGTVPF-AETPTTL 575
             D +SVG+   E+  G  PF A++    
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPFYADSLVGT 281

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 45/226 (19%), Positives = 77/226 (34%), Gaps = 37/226 (16%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMR 65
            Y++  +LG       SVY       N  +A+K    DR++D     +   +  E+V ++
Sbjct: 44  QYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101

Query: 66  HLRH--PNIICYISSFLDATDLHLVSPL-MGFGSCKDLINAHFNFGLPELVICHILQDVL 122
            +      +I  +  F       L+           D I       L E +       VL
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVL 159

Query: 123 NGLEYIHGKGFIHRAVKASHILISHN---------GKACLSGLRYMCPFSPTKKKVHLFP 173
             + + H  G +HR +K  +ILI  N         G      L               F 
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGAL-------LKDTVYTDFD 209

Query: 174 PSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPF 218
            +  Y      PE +  +   Y    + ++S+GI   ++  G +PF
Sbjct: 210 GTRVY----SPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPF 249

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 45/226 (19%), Positives = 77/226 (34%), Gaps = 37/226 (16%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMR 415
            Y++  +LG       SVY       N  +A+K    DR++D     +   +  E+V ++
Sbjct: 44  QYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101

Query: 416 HLRH--PNIICYISSFLDATDLHLVSPL-MGFGSCKDLINAHFNFGLPELVICHILQDVL 472
            +      +I  +  F       L+           D I       L E +       VL
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVL 159

Query: 473 NGLEYIHGKGFIHRAVKASHILISHN---------GKACLSGLRYMCPFSPTKKKVHLFP 523
             + + H  G +HR +K  +ILI  N         G      L               F 
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGAL-------LKDTVYTDFD 209

Query: 524 PSTAYNLNWLSPEVLEQNLDGYD-ERSDIYSVGISCCELANGTVPF 568
            +  Y      PE +  +   Y    + ++S+GI   ++  G +PF
Sbjct: 210 GTRVY----SPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPF 249

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 65/292 (22%), Positives = 113/292 (38%), Gaps = 54/292 (18%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE---IVCMRHLRHPNIICYISSFLDA 82
           VY  +   T ++ A+K  +  R    +      +E   +  +     P I+C   +F   
Sbjct: 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
             L  +  LM  G     ++ H  F   E  +     +++ GLE++H +  ++R +K ++
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322

Query: 143 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           IL+  +G   +S  GL         KKK H    +  Y    ++PEVL++    YD  +D
Sbjct: 323 ILLDEHGHVRISDLGL---ACDFS-KKKPHASVGTHGY----MAPEVLQKG-VAYDSSAD 373

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
            +S+G                    ML + L G +P       +     +D  E      
Sbjct: 374 WFSLGC-------------------MLFKLLRGHSP-------FRQHKTKDKHEI----D 403

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN------LLQHAFFK 306
                  V     FS    S++E  L RDV++R L C       + +  FF+
Sbjct: 404 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR-LGCLGRGAQEVKESPFFR 454

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 17/198 (8%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE---IVCMRHLRHPNIICYISSFLDA 432
           VY  +   T ++ A+K  +  R    +      +E   +  +     P I+C   +F   
Sbjct: 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
             L  +  LM  G     ++ H  F   E  +     +++ GLE++H +  ++R +K ++
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322

Query: 493 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           IL+  +G   +S  GL         KKK H    +  Y    ++PEVL++    YD  +D
Sbjct: 323 ILLDEHGHVRISDLGL---ACDFS-KKKPHASVGTHGY----MAPEVLQKG-VAYDSSAD 373

Query: 551 IYSVGISCCELANGTVPF 568
            +S+G    +L  G  PF
Sbjct: 374 WFSLGCMLFKLLRGHSPF 391

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 27/220 (12%)

Query: 12  KICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
               ++G+  F     VY   L  +       AVK  N       ++     E + M+  
Sbjct: 92  HFNEVIGRGHF---GCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDF 147

Query: 68  RHPNIICYISSFLDATD-LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGL 125
            HPN++  +   L +     +V P M  G  ++ + N   N  + +L+       V  G+
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGM 205

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMC---PFSPTKKKVHLFPPSTAYN 179
           +++  K F+HR + A + ++       ++  GL R M      S   K     P      
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP------ 259

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           + W++ E L+     +  +SD++S G+   EL   G  P+
Sbjct: 260 VKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPY 297

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 27/220 (12%)

Query: 362 KICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
               ++G+  F     VY   L  +       AVK  N       ++     E + M+  
Sbjct: 92  HFNEVIGRGHF---GCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDF 147

Query: 418 RHPNIICYISSFLDATD-LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGL 475
            HPN++  +   L +     +V P M  G  ++ + N   N  + +L+       V  G+
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GFGLQVAKGM 205

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMC---PFSPTKKKVHLFPPSTAYN 529
           +++  K F+HR + A + ++       ++  GL R M      S   K     P      
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP------ 259

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           + W++ E L+     +  +SD++S G+   EL   G  P+
Sbjct: 260 VKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPY 297

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 40/212 (18%), Positives = 90/212 (42%), Gaps = 20/212 (9%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 86
           +++ + +     +A+K+        +  K +  E   M  + +P++   +   L +T + 
Sbjct: 35  LWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92

Query: 87  LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
           L++ LM FG   D +     N G   L+  +    +  G+ Y+  +  +HR + A ++L+
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 146 SHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
                  ++  GL + +              P      + W++ E +   +  Y  +SD+
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMALESILHRI--YTHQSDV 202

Query: 202 YSVGISCCELAN-GTVPFAETPTT--LMLIEK 230
           +S G++  EL   G+ P+   P +    ++EK
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 40/212 (18%), Positives = 90/212 (42%), Gaps = 20/212 (9%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH 436
           +++ + +     +A+K+        +  K +  E   M  + +P++   +   L +T + 
Sbjct: 35  LWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92

Query: 437 LVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
           L++ LM FG   D +     N G   L+  +    +  G+ Y+  +  +HR + A ++L+
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150

Query: 496 SHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
                  ++  GL + +              P      + W++ E +   +  Y  +SD+
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMALESILHRI--YTHQSDV 202

Query: 552 YSVGISCCELAN-GTVPFAETPTT--LMLIEK 580
           +S G++  EL   G+ P+   P +    ++EK
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 69/336 (20%), Positives = 121/336 (36%), Gaps = 52/336 (15%)

Query: 11  YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKF-NLDRMTDEDLKSLHHEIVCMRHLR 68
           Y +   LG   F   S+V+L+K  V N  +A+K        T+        EI  ++ + 
Sbjct: 21  YILVRKLGWGHF---STVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVN 73

Query: 69  -----------HPNIICYISSFL--DATDLH--LVSPLMGFGSCKDLINAHFNFGLPELV 113
                        +I+  +  F       +H  +V  ++G  +   LI  + + G+P + 
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG-ENLLALIKKYEHRGIPLIY 132

Query: 114 ICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHL 171
           +  I + +L GL+Y+H + G IH  +K  ++L+             +    +      H 
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 172 FPP--STAYNLNWLSPEVLEQNLD-GYDERSDIYSVGISCCELANGTVPF-AETPTT--- 224
                +  Y     SPEVL   L   +   +DI+S      EL  G   F  +   +   
Sbjct: 193 TNSIQTREYR----SPEVL---LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245

Query: 225 ----LMLIEKLAGATP-HLLD----CTTYYVDTGQDDGEENACSYISEQ--QTQVLTSRK 273
               +  I +L G  P +LL       T++   G          +  E     +   S+ 
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305

Query: 274 FSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK 309
            +      +   L  D  KR  A  L+ H + K T 
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 37/230 (16%)

Query: 361 YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKF-NLDRMTDEDLKSLHHEIVCMRHLR 418
           Y +   LG   F   S+V+L+K  V N  +A+K        T+        EI  ++ + 
Sbjct: 21  YILVRKLGWGHF---STVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVN 73

Query: 419 -----------HPNIICYISSFL--DATDLH--LVSPLMGFGSCKDLINAHFNFGLPELV 463
                        +I+  +  F       +H  +V  ++G  +   LI  + + G+P + 
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG-ENLLALIKKYEHRGIPLIY 132

Query: 464 ICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHL 521
           +  I + +L GL+Y+H + G IH  +K  ++L+             +    +      H 
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 522 FPP--STAYNLNWLSPEVLEQNLD-GYDERSDIYSVGISCCELANGTVPF 568
                +  Y     SPEVL   L   +   +DI+S      EL  G   F
Sbjct: 193 TNSIQTREYR----SPEVL---LGAPWGCGADIWSTACLIFELITGDFLF 235

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 23/217 (10%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
           P +      LG   F     V   K +     +A+K      M++++      E   M +
Sbjct: 23  PKDLTFLKELGTGQF---GVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIE---EAKVMMN 75

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGL 125
           L H  ++           + +++  M  G   + L      F   +L+   + +DV   +
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCKDVCEAM 133

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 182
           EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP      + W
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP------VRW 187

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
             PEVL  +   +  +SDI++ G+   E+ + G +P+
Sbjct: 188 SPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPY 222

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 23/217 (10%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
           P +      LG   F     V   K +     +A+K      M++++      E   M +
Sbjct: 23  PKDLTFLKELGTGQF---GVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIE---EAKVMMN 75

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGL 475
           L H  ++           + +++  M  G   + L      F   +L+   + +DV   +
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCKDVCEAM 133

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLNW 532
           EY+  K F+HR + A + L++  G   +S  GL RY+     T      FP      + W
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP------VRW 187

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
             PEVL  +   +  +SDI++ G+   E+ + G +P+
Sbjct: 188 SPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPY 222

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 44/221 (19%), Positives = 80/221 (36%), Gaps = 39/221 (17%)

Query: 11  YKICSILGQCFNNLSSVYLSK-HKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 68
           Y++   +      L  +YL+    V  + + +K   L    D + ++    E   +  + 
Sbjct: 82  YEVKGCIAH--GGLGWIYLALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVV 137

Query: 69  HPNIICYISSFLDATDLH------LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
           HP+I+  I +F++ TD H      +V   +G  S K          LP       L ++L
Sbjct: 138 HPSIVQ-IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEIL 192

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNG-KACLSGL-RYMCPFSP---TKKKVHLFPPSTA 177
             L Y+H  G ++  +K  +I+++    K    G    +  F     T            
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTP----------G 242

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           +     +P   E    G    +DIY+VG +   L       
Sbjct: 243 F----QAP---EIVRTGPTVATDIYTVGRTLAALTLDLPTR 276

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 44/221 (19%), Positives = 80/221 (36%), Gaps = 39/221 (17%)

Query: 361 YKICSILGQCFNNLSSVYLSK-HKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIVCMRHLR 418
           Y++   +      L  +YL+    V  + + +K   L    D + ++    E   +  + 
Sbjct: 82  YEVKGCIAH--GGLGWIYLALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVV 137

Query: 419 HPNIICYISSFLDATDLH------LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
           HP+I+  I +F++ TD H      +V   +G  S K          LP       L ++L
Sbjct: 138 HPSIVQ-IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEIL 192

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNG-KACLSGL-RYMCPFSP---TKKKVHLFPPSTA 527
             L Y+H  G ++  +K  +I+++    K    G    +  F     T            
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTP----------G 242

Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +     +P   E    G    +DIY+VG +   L       
Sbjct: 243 F----QAP---EIVRTGPTVATDIYTVGRTLAALTLDLPTR 276

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 52/289 (17%), Positives = 115/289 (39%), Gaps = 52/289 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V + +   T ++ A+K  N  + +   +++++  E+  M+ L HP ++    SF D  D+
Sbjct: 31  VCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90

Query: 86  HLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
            +V  L+  G   DL   +  + +F   E  +   + +++  L+Y+  +  IHR +K  +
Sbjct: 91  FMVVDLLLGG---DLRYHLQQNVHF--KEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 143 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGYDERS 199
           IL+  +G   ++   +       P + ++     +  Y    ++PE+   +   GY    
Sbjct: 146 ILLDEHGHVHITDFNI---AAMLPRETQITTMAGTKPY----MAPEMFSSRKGAGYSFAV 198

Query: 200 DIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS 259
           D +S+G+                      E L G  P       Y++ +     E     
Sbjct: 199 DWWSLGV-------------------TAYELLRGRRP-------YHIRSSTSSKE----I 228

Query: 260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC--NLLQHAFFK 306
             + + T V     +S    S+++  L  + D+R  +   ++    +  
Sbjct: 229 VHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR-FSQLSDVQNFPYMN 276

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 43/199 (21%), Positives = 93/199 (46%), Gaps = 19/199 (9%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V + +   T ++ A+K  N  + +   +++++  E+  M+ L HP ++    SF D  D+
Sbjct: 31  VCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90

Query: 436 HLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
            +V  L+  G   DL   +  + +F   E  +   + +++  L+Y+  +  IHR +K  +
Sbjct: 91  FMVVDLLLGG---DLRYHLQQNVHF--KEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 493 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL-EQNLDGYDERS 549
           IL+  +G   ++   +       P + ++     +  Y    ++PE+   +   GY    
Sbjct: 146 ILLDEHGHVHITDFNI---AAMLPRETQITTMAGTKPY----MAPEMFSSRKGAGYSFAV 198

Query: 550 DIYSVGISCCELANGTVPF 568
           D +S+G++  EL  G  P+
Sbjct: 199 DWWSLGVTAYELLRGRRPY 217

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 47/228 (20%), Positives = 91/228 (39%), Gaps = 45/228 (19%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
               K+   LG   F     V++  +   +  +AVK      M+ +   +   E   M+ 
Sbjct: 12  RETLKLVERLGAGQF---GEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLA---EANLMKQ 64

Query: 67  LRHPNII-----C-----YISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVI 114
           L+H  ++           YI           ++  M  GS  D +   +     + +L+ 
Sbjct: 65  LQHQRLVRLYAVVTQEPIYI-----------ITEYMENGSLVDFLKTPSGIKLTINKLL- 112

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 171
             +   +  G+ +I  + +IHR ++A++IL+S     K    GL R +     T ++   
Sbjct: 113 -DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171

Query: 172 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           FP      + W +PE +      +  +SD++S GI   E+   G +P+
Sbjct: 172 FP------IKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPY 211

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 47/228 (20%), Positives = 91/228 (39%), Gaps = 45/228 (19%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
               K+   LG   F     V++  +   +  +AVK      M+ +   +   E   M+ 
Sbjct: 12  RETLKLVERLGAGQF---GEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLA---EANLMKQ 64

Query: 417 LRHPNII-----C-----YISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVI 464
           L+H  ++           YI           ++  M  GS  D +   +     + +L+ 
Sbjct: 65  LQHQRLVRLYAVVTQEPIYI-----------ITEYMENGSLVDFLKTPSGIKLTINKLL- 112

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGL-RYMCPFSPTKKKVHL 521
             +   +  G+ +I  + +IHR ++A++IL+S     K    GL R +     T ++   
Sbjct: 113 -DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171

Query: 522 FPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           FP      + W +PE +      +  +SD++S GI   E+   G +P+
Sbjct: 172 FP------IKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPY 211

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 39/201 (19%), Positives = 80/201 (39%), Gaps = 19/201 (9%)

Query: 26  SVYLSKHKVTNQLI--AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 83
           +V    +++   +   AVK    +         L  E   M+ L +P I+  I    +A 
Sbjct: 32  TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAE 90

Query: 84  DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
              LV  +   G     +  + +     ++   ++  V  G++Y+    F+HR + A ++
Sbjct: 91  SWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEESNFVHRDLAARNV 148

Query: 144 LISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           L+     A +S  GL + +         +    +P      + W +PE +  N   +  +
Sbjct: 149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP------VKWYAPECI--NYYKFSSK 200

Query: 199 SDIYSVGISCCELAN-GTVPF 218
           SD++S G+   E  + G  P+
Sbjct: 201 SDVWSFGVLMWEAFSYGQKPY 221

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 39/201 (19%), Positives = 80/201 (39%), Gaps = 19/201 (9%)

Query: 376 SVYLSKHKVTNQLI--AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT 433
           +V    +++   +   AVK    +         L  E   M+ L +P I+  I    +A 
Sbjct: 32  TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAE 90

Query: 434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
              LV  +   G     +  + +     ++   ++  V  G++Y+    F+HR + A ++
Sbjct: 91  SWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEESNFVHRDLAARNV 148

Query: 494 LISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           L+     A +S  GL + +         +    +P      + W +PE +  N   +  +
Sbjct: 149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP------VKWYAPECI--NYYKFSSK 200

Query: 549 SDIYSVGISCCELAN-GTVPF 568
           SD++S G+   E  + G  P+
Sbjct: 201 SDVWSFGVLMWEAFSYGQKPY 221

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 60/292 (20%), Positives = 105/292 (35%), Gaps = 51/292 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V+  + K T +L A KK N  R    +  +    E   +  +    I+    +F   TDL
Sbjct: 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260

Query: 86  HLVSPLMGFGSCKDL-----INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
            LV  +M  G   D+          N G  E         +++GLE++H +  I+R +K 
Sbjct: 261 CLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317

Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
            ++L+  +G   +S L         + K   +  +  +    ++PE+L      YD   D
Sbjct: 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF----MAPELLLGE--EYDFSVD 371

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
            +++G+                    L E +A   P       +     + + +E     
Sbjct: 372 YFALGV-------------------TLYEMIAARGP-------FRARGEKVENKEL---K 402

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN------LLQHAFFK 306
               +  V    KFS +     E  L +D +KR L         L  H  F+
Sbjct: 403 QRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR-LGFRDGSCDGLRTHPLFR 453

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 15/198 (7%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V+  + K T +L A KK N  R    +  +    E   +  +    I+    +F   TDL
Sbjct: 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260

Query: 436 HLVSPLMGFGSCKDL-----INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
            LV  +M  G   D+          N G  E         +++GLE++H +  I+R +K 
Sbjct: 261 CLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317

Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
            ++L+  +G   +S L         + K   +  +  +    ++PE+L      YD   D
Sbjct: 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF----MAPELLLGE--EYDFSVD 371

Query: 551 IYSVGISCCELANGTVPF 568
            +++G++  E+     PF
Sbjct: 372 YFALGVTLYEMIAARGPF 389

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 39/214 (18%), Positives = 86/214 (40%), Gaps = 24/214 (11%)

Query: 27  VYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 84
           V++ + +     + +K  +    R + + +      ++ +  L H +I+  +     ++ 
Sbjct: 33  VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAIGSLDHAHIVRLLGLCPGSS- 88

Query: 85  LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           L LV+  +  GS  D +       G   L+  +    +  G+ Y+   G +HR + A ++
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQLLL--NWGVQIAKGMYYLEEHGMVHRNLAARNV 146

Query: 144 LISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERS 199
           L+    +  ++  G+   + P            P      + W++ E +      Y  +S
Sbjct: 147 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------IKWMALESIHFGK--YTHQS 198

Query: 200 DIYSVGISCCELAN-GTVPFAETPTT--LMLIEK 230
           D++S G++  EL   G  P+A         L+EK
Sbjct: 199 DVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 39/214 (18%), Positives = 86/214 (40%), Gaps = 24/214 (11%)

Query: 377 VYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD 434
           V++ + +     + +K  +    R + + +      ++ +  L H +I+  +     ++ 
Sbjct: 33  VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAIGSLDHAHIVRLLGLCPGSS- 88

Query: 435 LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           L LV+  +  GS  D +       G   L+  +    +  G+ Y+   G +HR + A ++
Sbjct: 89  LQLVTQYLPLGSLLDHVRQHRGALGPQLLL--NWGVQIAKGMYYLEEHGMVHRNLAARNV 146

Query: 494 LISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERS 549
           L+    +  ++  G+   + P            P      + W++ E +      Y  +S
Sbjct: 147 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------IKWMALESIHFGK--YTHQS 198

Query: 550 DIYSVGISCCELAN-GTVPFAETPTT--LMLIEK 580
           D++S G++  EL   G  P+A         L+EK
Sbjct: 199 DVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 66/313 (21%), Positives = 114/313 (36%), Gaps = 62/313 (19%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMR 65
           P ++K   ILG+  F   S+V L++   T++  A+K      +  E+ +  +  E   M 
Sbjct: 29  PEDFKFGKILGEGSF---STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L HP  +    +F D   L+        G     I    +F   E        ++++ L
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSAL 143

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----N 181
           EY+HGKG IHR +K  +IL++ +    +        F   K        + A +      
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQI------TDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK-LAGATPHLLD 240
           ++SPE+L +      + SD++++G    +L  G  PF       ++ +K +         
Sbjct: 198 YVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL------- 247

Query: 241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL 300
                                     +     KF      +VE  L  D  KR L C  +
Sbjct: 248 --------------------------EYDFPEKFFPKARDLVEKLLVLDATKR-LGCEEM 280

Query: 301 -------QHAFFK 306
                   H FF+
Sbjct: 281 EGYGPLKAHPFFE 293

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 19/217 (8%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMR 415
           P ++K   ILG+  F   S+V L++   T++  A+K      +  E+ +  +  E   M 
Sbjct: 29  PEDFKFGKILGEGSF---STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            L HP  +    +F D   L+        G     I    +F   E        ++++ L
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSAL 143

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----N 531
           EY+HGKG IHR +K  +IL++ +    +        F   K        + A +      
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQI------TDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++SPE+L +      + SD++++G    +L  G  PF
Sbjct: 198 YVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPF 232

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 39/220 (17%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR-------HLRHPNIICYISSF 79
           V + K K T Q+ A+K  N   M          E+ C R       +     I     +F
Sbjct: 77  VAVVKMKQTGQVYAMKIMNKWDMLKRG------EVSCFREERDVLVNGDRRWITQLHFAF 130

Query: 80  LDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRA 137
            D   L+LV   M +    DL+     FG  +P  +    L +++  ++ +H  G++HR 
Sbjct: 131 QDENYLYLV---MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187

Query: 138 VKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQ- 190
           +K  +IL+   G   L+  G    C       K+       +       ++LSPE+L+  
Sbjct: 188 IKPDNILLDRCGHIRLADFGS---C------LKLRADGTVRSLVAVGTPDYLSPEILQAV 238

Query: 191 ----NLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 225
                   Y    D +++G+   E+  G  PF A++    
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 39/220 (17%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR-------HLRHPNIICYISSF 429
           V + K K T Q+ A+K  N   M          E+ C R       +     I     +F
Sbjct: 77  VAVVKMKQTGQVYAMKIMNKWDMLKRG------EVSCFREERDVLVNGDRRWITQLHFAF 130

Query: 430 LDATDLHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRA 487
            D   L+LV   M +    DL+     FG  +P  +    L +++  ++ +H  G++HR 
Sbjct: 131 QDENYLYLV---MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187

Query: 488 VKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQ- 540
           +K  +IL+   G   L+  G    C       K+       +       ++LSPE+L+  
Sbjct: 188 IKPDNILLDRCGHIRLADFGS---C------LKLRADGTVRSLVAVGTPDYLSPEILQAV 238

Query: 541 ----NLDGYDERSDIYSVGISCCELANGTVPF-AETPTTL 575
                   Y    D +++G+   E+  G  PF A++    
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 35/221 (15%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
               K+   +G+  F     V L  ++     +AVK    D      L     E   M  
Sbjct: 192 MKELKLLQTIGKGEF---GDVMLGDYR--GNKVAVKCIKNDATAQAFLA----EASVMTQ 242

Query: 67  LRHPNIIC-YISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLN 123
           LRH N++        +   L++V+  M  GS  D +        G   L+      DV  
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCE 300

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLS--GL---RYMCPFSPTKKKVHLFPPSTAY 178
            +EY+ G  F+HR + A ++L+S +  A +S  GL           + +     P     
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLP----- 349

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
            + W +PE L +    +  +SD++S GI   E+ + G VP+
Sbjct: 350 -VKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPY 387

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 35/221 (15%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
               K+   +G+  F     V L  ++     +AVK    D      L     E   M  
Sbjct: 192 MKELKLLQTIGKGEF---GDVMLGDYR--GNKVAVKCIKNDATAQAFLA----EASVMTQ 242

Query: 417 LRHPNIIC-YISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLN 473
           LRH N++        +   L++V+  M  GS  D +        G   L+      DV  
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCE 300

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLS--GL---RYMCPFSPTKKKVHLFPPSTAY 528
            +EY+ G  F+HR + A ++L+S +  A +S  GL           + +     P     
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLP----- 349

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
            + W +PE L +    +  +SD++S GI   E+ + G VP+
Sbjct: 350 -VKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPY 387

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 26/221 (11%)

Query: 8   PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
               ++   +G+  F     V+       +     +A+K        D   +    E + 
Sbjct: 14  RERIELGRCIGEGQF---GDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALT 69

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVL 122
           MR   HP+I+  I    +   + ++  L   G  +  L    ++  L  L+       + 
Sbjct: 70  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLI--LYAYQLS 126

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN 179
             L Y+  K F+HR + A ++L+S N    L   GL RYM   +  K      P      
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP------ 180

Query: 180 LNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN-GTVPF 218
           + W++PE +       +   SD++  G+   E+   G  PF
Sbjct: 181 IKWMAPESI---NFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 26/221 (11%)

Query: 358 PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
               ++   +G+  F     V+       +     +A+K        D   +    E + 
Sbjct: 14  RERIELGRCIGEGQF---GDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALT 69

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVL 472
           MR   HP+I+  I    +   + ++  L   G  +  L    ++  L  L+       + 
Sbjct: 70  MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLI--LYAYQLS 126

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN 529
             L Y+  K F+HR + A ++L+S N    L   GL RYM   +  K      P      
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP------ 180

Query: 530 LNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN-GTVPF 568
           + W++PE +       +   SD++  G+   E+   G  PF
Sbjct: 181 IKWMAPESI---NFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 66/368 (17%), Positives = 117/368 (31%), Gaps = 106/368 (28%)

Query: 4   LDNVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           L+     Y +   LG       S   V       + +  A+KK   D          + E
Sbjct: 2   LETSSKKYSLGKTLGT-----GSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRE 50

Query: 61  IVCMRHLRHPNIIC--------------------------------------YISSFLDA 82
           +  M+ L H NII                                        I +    
Sbjct: 51  LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110

Query: 83  TDLHLVSPLMGFGSCKDL---INAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRA 137
             L+++   +       L   + +    G  +P  +I   +  +   + +IH  G  HR 
Sbjct: 111 KYLNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRD 166

Query: 138 VKASHILI---SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN-WL-SPEVLEQNL 192
           +K  ++L+    +  K C  G           KK+    PS AY  + +  +PE++    
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGS---------AKKLIPSEPSVAYICSRFYRAPELM-LGA 216

Query: 193 DGYDERSDIYSVGISCC---ELANGTVPFAETPTT--LMLIEKLAGATPHLLDCTTYYVD 247
             Y    D++S+G   C   EL  G   F+   +   L+ I ++ G TP           
Sbjct: 217 TEYTPSIDLWSIG---CVFGELILGKPLFSGETSIDQLVRIIQIMG-TP----------- 261

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHS--------IVELCLSRDVDKRPLACNL 299
           T +     N   + +E +   L ++ +              ++E  L  + D R      
Sbjct: 262 TKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319

Query: 300 LQHAFFKQ 307
           + H FF  
Sbjct: 320 MAHPFFDH 327

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 30/188 (15%), Positives = 55/188 (29%), Gaps = 61/188 (32%)

Query: 354 LDNVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 410
           L+     Y +   LG       S   V       + +  A+KK   D          + E
Sbjct: 2   LETSSKKYSLGKTLGT-----GSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRE 50

Query: 411 IVCMRHLRHPNIIC--------------------------------------YISSFLDA 432
           +  M+ L H NII                                        I +    
Sbjct: 51  LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110

Query: 433 TDLHLVSPLMGFGSCKDL---INAHFNFG--LPELVICHILQDVLNGLEYIHGKGFIHRA 487
             L+++   +       L   + +    G  +P  +I   +  +   + +IH  G  HR 
Sbjct: 111 KYLNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRD 166

Query: 488 VKASHILI 495
           +K  ++L+
Sbjct: 167 IKPQNLLV 174

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 43/225 (19%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
               K+   +G+  F     V L  ++     +AVK    D      L     E   M  
Sbjct: 20  MKELKLLQTIGKGEF---GDVMLGDYR--GNKVAVKCIKNDATAQAFLA----EASVMTQ 70

Query: 67  LRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQ 119
           LRH N++            +   L++V+  M  GS  D +        G   L+      
Sbjct: 71  LRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSL 124

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-R--YMCPFSPTKKKVHLFPP 174
           DV   +EY+ G  F+HR + A ++L+S +  A +S  GL +         + +     P 
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLP- 177

Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
                + W +PE L +    +  +SD++S GI   E+ + G VP+
Sbjct: 178 -----VKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPY 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 43/225 (19%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
               K+   +G+  F     V L  ++     +AVK    D      L     E   M  
Sbjct: 20  MKELKLLQTIGKGEF---GDVMLGDYR--GNKVAVKCIKNDATAQAFLA----EASVMTQ 70

Query: 417 LRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQ 469
           LRH N++            +   L++V+  M  GS  D +        G   L+      
Sbjct: 71  LRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSL 124

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-R--YMCPFSPTKKKVHLFPP 524
           DV   +EY+ G  F+HR + A ++L+S +  A +S  GL +         + +     P 
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLP- 177

Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
                + W +PE L +    +  +SD++S GI   E+ + G VP+
Sbjct: 178 -----VKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPY 215

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 47/218 (21%), Positives = 97/218 (44%), Gaps = 25/218 (11%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
             + K+   LG   F     V+++ +    + +AVK      M+ E   +   E   M+ 
Sbjct: 187 RESLKLEKKLGAGQF---GEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA---EANVMKT 239

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLNG 124
           L+H  ++   +       +++++  M  GS  D +  +      LP+L+       +  G
Sbjct: 240 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEG 296

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLN 181
           + +I  + +IHR ++A++IL+S +    ++  GL R +     T ++   FP      + 
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP------IK 350

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           W +PE +      +  +SD++S GI   E+   G +P+
Sbjct: 351 WTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPY 386

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 47/218 (21%), Positives = 97/218 (44%), Gaps = 25/218 (11%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
             + K+   LG   F     V+++ +    + +AVK      M+ E   +   E   M+ 
Sbjct: 187 RESLKLEKKLGAGQF---GEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA---EANVMKT 239

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI--NAHFNFGLPELVICHILQDVLNG 474
           L+H  ++   +       +++++  M  GS  D +  +      LP+L+       +  G
Sbjct: 240 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEG 296

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYNLN 531
           + +I  + +IHR ++A++IL+S +    ++  GL R +     T ++   FP      + 
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP------IK 350

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           W +PE +      +  +SD++S GI   E+   G +P+
Sbjct: 351 WTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPY 386

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 19/219 (8%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
            +N  I  ++G   F  + S  L         +A+K   +    ++  +    E   M  
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQ 102

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGL 125
             HPNII        +  + +V+  M  GS    +  H   F + +LV   +L+ + +G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGM 160

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYM--CPFSPTKKKVHLFPPSTAYNL 180
           +Y+   G++HR + A +ILI+ N    +S  GL R +   P +    +    P      +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP------I 214

Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
            W SPE +      +   SD++S GI   E+ + G  P+
Sbjct: 215 RWTSPEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPY 251

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 19/219 (8%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
            +N  I  ++G   F  + S  L         +A+K   +    ++  +    E   M  
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQ 102

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGL 475
             HPNII        +  + +V+  M  GS    +  H   F + +LV   +L+ + +G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGM 160

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYM--CPFSPTKKKVHLFPPSTAYNL 530
           +Y+   G++HR + A +ILI+ N    +S  GL R +   P +    +    P      +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP------I 214

Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
            W SPE +      +   SD++S GI   E+ + G  P+
Sbjct: 215 RWTSPEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPY 251

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 6/124 (4%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 84
            Y   +  T +++AVK    D    +       EI  +R L H +II Y        A  
Sbjct: 51  CYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109

Query: 85  LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 144
           L LV   +  GS +D +  H + GL +L+     Q +  G+ Y+H + +IHR + A ++L
Sbjct: 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLL--LFAQQICEGMAYLHAQHYIHRDLAARNVL 166

Query: 145 ISHN 148
           + ++
Sbjct: 167 LDND 170

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 6/124 (4%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 434
            Y   +  T +++AVK    D    +       EI  +R L H +II Y        A  
Sbjct: 51  CYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109

Query: 435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL 494
           L LV   +  GS +D +  H + GL +L+     Q +  G+ Y+H + +IHR + A ++L
Sbjct: 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLL--LFAQQICEGMAYLHAQHYIHRDLAARNVL 166

Query: 495 ISHN 498
           + ++
Sbjct: 167 LDND 170

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 30/198 (15%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 84
            Y      T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y  +       +
Sbjct: 30  RYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87

Query: 85  LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           L L+   + +GS +D L          +L+       +  G+EY+  K +IHR +   +I
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLL--QYTSQICKGMEYLGTKRYIHRDLATRNI 145

Query: 144 LISHNG----------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
           L+ +            K       +     P +      P      + W +PE L ++  
Sbjct: 146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE-----SP------IFWYAPESLTESK- 193

Query: 194 GYDERSDIYSVGISCCEL 211
            +   SD++S G+   EL
Sbjct: 194 -FSVASDVWSFGVVLYEL 210

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 30/198 (15%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 434
            Y      T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y  +       +
Sbjct: 30  RYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87

Query: 435 LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           L L+   + +GS +D L          +L+       +  G+EY+  K +IHR +   +I
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLL--QYTSQICKGMEYLGTKRYIHRDLATRNI 145

Query: 494 LISHNG----------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
           L+ +            K       +     P +      P      + W +PE L ++  
Sbjct: 146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE-----SP------IFWYAPESLTESK- 193

Query: 544 GYDERSDIYSVGISCCEL 561
            +   SD++S G+   EL
Sbjct: 194 -FSVASDVWSFGVVLYEL 210

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 51/237 (21%), Positives = 85/237 (35%), Gaps = 28/237 (11%)

Query: 8   PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIV 62
             + ++   LG   F     V              +AVK    D ++  +       E+ 
Sbjct: 17  EKDLRLLEKLGDGSF---GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDV 121
            M  L H N+I      L    + +V+ L   GS  D L     +F L  L        V
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQV 130

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPST 176
             G+ Y+  K FIHR + A ++L++      +   GL R +         ++    P   
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--- 187

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT--LMLIEK 230
                W +PE L+     +   SD +  G++  E+   G  P+     +  L  I+K
Sbjct: 188 ---FAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 51/237 (21%), Positives = 85/237 (35%), Gaps = 28/237 (11%)

Query: 358 PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKS-LHHEIV 412
             + ++   LG   F     V              +AVK    D ++  +       E+ 
Sbjct: 17  EKDLRLLEKLGDGSF---GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDV 471
            M  L H N+I      L    + +V+ L   GS  D L     +F L  L        V
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQV 130

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPST 526
             G+ Y+  K FIHR + A ++L++      +   GL R +         ++    P   
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP--- 187

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT--LMLIEK 580
                W +PE L+     +   SD +  G++  E+   G  P+     +  L  I+K
Sbjct: 188 ---FAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 19/193 (9%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 84
            Y  +   T + +AVK           +  L  EI  +R+L H NI+ Y  I +      
Sbjct: 41  RYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99

Query: 85  LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           + L+   +  GS K+ L        L + +       +  G++Y+  + ++HR + A ++
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQL--KYAVQICKGMDYLGSRQYVHRDLAARNV 157

Query: 144 LISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           L+    +  +   GL + +       T K     P      + W +PE L Q+   +   
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP------VFWYAPECLMQSK--FYIA 209

Query: 199 SDIYSVGISCCEL 211
           SD++S G++  EL
Sbjct: 210 SDVWSFGVTLHEL 222

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 19/193 (9%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 434
            Y  +   T + +AVK           +  L  EI  +R+L H NI+ Y  I +      
Sbjct: 41  RYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99

Query: 435 LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           + L+   +  GS K+ L        L + +       +  G++Y+  + ++HR + A ++
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQL--KYAVQICKGMDYLGSRQYVHRDLAARNV 157

Query: 494 LISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           L+    +  +   GL + +       T K     P      + W +PE L Q+   +   
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP------VFWYAPECLMQSK--FYIA 209

Query: 549 SDIYSVGISCCEL 561
           SD++S G++  EL
Sbjct: 210 SDVWSFGVTLHEL 222

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 30/198 (15%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 84
            Y      T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y  +       +
Sbjct: 61  RYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118

Query: 85  LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           L L+   + +GS +D L          +L+       +  G+EY+  K +IHR +   +I
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLL--QYTSQICKGMEYLGTKRYIHRDLATRNI 176

Query: 144 LISHNG----------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
           L+ +            K       Y     P +      P      + W +PE L ++  
Sbjct: 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE-----SP------IFWYAPESLTESK- 224

Query: 194 GYDERSDIYSVGISCCEL 211
            +   SD++S G+   EL
Sbjct: 225 -FSVASDVWSFGVVLYEL 241

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 30/198 (15%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 434
            Y      T +++AVKK  L   T+E L+    EI  ++ L+H NI+ Y  +       +
Sbjct: 61  RYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118

Query: 435 LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           L L+   + +GS +D L          +L+       +  G+EY+  K +IHR +   +I
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLL--QYTSQICKGMEYLGTKRYIHRDLATRNI 176

Query: 494 LISHNG----------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
           L+ +            K       Y     P +      P      + W +PE L ++  
Sbjct: 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE-----SP------IFWYAPESLTESK- 224

Query: 544 GYDERSDIYSVGISCCEL 561
            +   SD++S G+   EL
Sbjct: 225 -FSVASDVWSFGVVLYEL 241

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 24/220 (10%)

Query: 8   PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
               ++   +G+  F     V+       +     +A+K        D   +    E + 
Sbjct: 389 RERIELGRCIGEGQF---GDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALT 444

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVL 122
           MR   HP+I+  I    +   + ++  L   G  +  L    F+  L  L+       + 
Sbjct: 445 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLI--LYAYQLS 501

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN 179
             L Y+  K F+HR + A ++L+S N    L   GL RYM   +  K      P      
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP------ 555

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
           + W++PE +      +   SD++  G+   E+   G  PF
Sbjct: 556 IKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPF 593

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 24/220 (10%)

Query: 358 PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
               ++   +G+  F     V+       +     +A+K        D   +    E + 
Sbjct: 389 RERIELGRCIGEGQF---GDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALT 444

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVL 472
           MR   HP+I+  I    +   + ++  L   G  +  L    F+  L  L+       + 
Sbjct: 445 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLI--LYAYQLS 501

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTAYN 529
             L Y+  K F+HR + A ++L+S N    L   GL RYM   +  K      P      
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP------ 555

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
           + W++PE +      +   SD++  G+   E+   G  PF
Sbjct: 556 IKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPF 593

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 49/222 (22%), Positives = 81/222 (36%), Gaps = 25/222 (11%)

Query: 8   PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
            S   I  I+G         V    L      +  +A+K        +   +    E   
Sbjct: 48  ASRIHIEKIIGSGDS---GEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASI 103

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVL 122
           M    HPNII             +V+  M  GS    L      F + +LV   +L+ V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV--GMLRGVG 161

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMC--PFSPTKKKVHLFPPSTA 177
            G+ Y+   G++HR + A ++L+  N    +S  GL R +   P +         P    
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP---- 217

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
             + W +PE +      +   SD++S G+   E+   G  P+
Sbjct: 218 --IRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPY 255

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 49/222 (22%), Positives = 81/222 (36%), Gaps = 25/222 (11%)

Query: 358 PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
            S   I  I+G         V    L      +  +A+K        +   +    E   
Sbjct: 48  ASRIHIEKIIGSGDS---GEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASI 103

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVL 472
           M    HPNII             +V+  M  GS    L      F + +LV   +L+ V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV--GMLRGVG 161

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMC--PFSPTKKKVHLFPPSTA 527
            G+ Y+   G++HR + A ++L+  N    +S  GL R +   P +         P    
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP---- 217

Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
             + W +PE +      +   SD++S G+   E+   G  P+
Sbjct: 218 --IRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPY 255

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 60.3 bits (146), Expect = 9e-10
 Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 25/204 (12%)

Query: 26  SVYLSKHKVTNQLI--AVK--KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
           SV    +++  + I  A+K  K   ++   E++     E   M  L +P I+  I     
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVRLIGVCQA 407

Query: 82  ATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
              L LV  + G G     +        +  +    +L  V  G++Y+  K F+HR + A
Sbjct: 408 EA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVA--ELLHQVSMGMKYLEEKNFVHRNLAA 464

Query: 141 SHILISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 195
            ++L+ +   A +S  GL + +       T +    +P      L W +PE +      +
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP------LKWYAPECINFRK--F 516

Query: 196 DERSDIYSVGISCCELAN-GTVPF 218
             RSD++S G++  E  + G  P+
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPY 540

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 60.3 bits (146), Expect = 9e-10
 Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 25/204 (12%)

Query: 376 SVYLSKHKVTNQLI--AVK--KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
           SV    +++  + I  A+K  K   ++   E++     E   M  L +P I+  I     
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVRLIGVCQA 407

Query: 432 ATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
              L LV  + G G     +        +  +    +L  V  G++Y+  K F+HR + A
Sbjct: 408 EA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVA--ELLHQVSMGMKYLEEKNFVHRNLAA 464

Query: 491 SHILISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGY 545
            ++L+ +   A +S  GL + +       T +    +P      L W +PE +      +
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP------LKWYAPECINFRK--F 516

Query: 546 DERSDIYSVGISCCELAN-GTVPF 568
             RSD++S G++  E  + G  P+
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPY 540

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 23/188 (12%)

Query: 40  AVK--KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 97
           A+K  K   ++   E++     E   M  L +P I+  I        L LV  + G G  
Sbjct: 41  AIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPL 96

Query: 98  KD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-- 154
              L+       +  +    +L  V  G++Y+  K F+HR + A ++L+ +   A +S  
Sbjct: 97  HKFLVGKREEIPVSNVA--ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154

Query: 155 GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 211
           GL + +       T +    +P      L W +PE +      +  RSD++S G++  E 
Sbjct: 155 GLSKALGADDSYYTARSAGKWP------LKWYAPECINFRK--FSSRSDVWSYGVTMWEA 206

Query: 212 AN-GTVPF 218
            + G  P+
Sbjct: 207 LSYGQKPY 214

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 23/188 (12%)

Query: 390 AVK--KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSC 447
           A+K  K   ++   E++     E   M  L +P I+  I        L LV  + G G  
Sbjct: 41  AIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPL 96

Query: 448 KD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS-- 504
              L+       +  +    +L  V  G++Y+  K F+HR + A ++L+ +   A +S  
Sbjct: 97  HKFLVGKREEIPVSNVA--ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154

Query: 505 GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCEL 561
           GL + +       T +    +P      L W +PE +      +  RSD++S G++  E 
Sbjct: 155 GLSKALGADDSYYTARSAGKWP------LKWYAPECINFRK--FSSRSDVWSYGVTMWEA 206

Query: 562 AN-GTVPF 568
            + G  P+
Sbjct: 207 LSYGQKPY 214

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR-------HLRHPNIICYISSF 79
           V + K K  +++ A+K  N   M          E  C R       +     I     +F
Sbjct: 90  VAVVKLKNADKVFAMKILNKWEMLKRA------ETACFREERDVLVNGDSKWITTLHYAF 143

Query: 80  LDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
            D  +L+LV   M +    DL+   + F   LPE +    L +++  ++ +H   ++HR 
Sbjct: 144 QDDNNLYLV---MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200

Query: 138 VKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQN 191
           +K  +IL+  NG   L+  G    C       K+       +       +++SPE+L+  
Sbjct: 201 IKPDNILMDMNGHIRLADFGS---C------LKLMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 192 LD---GYDERSDIYSVGISCCELANGTVPF-AETPTTLM 226
                 Y    D +S+G+   E+  G  PF AE+     
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR-------HLRHPNIICYISSF 429
           V + K K  +++ A+K  N   M          E  C R       +     I     +F
Sbjct: 90  VAVVKLKNADKVFAMKILNKWEMLKRA------ETACFREERDVLVNGDSKWITTLHYAF 143

Query: 430 LDATDLHLVSPLMGFGSCKDLIN--AHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
            D  +L+LV   M +    DL+   + F   LPE +    L +++  ++ +H   ++HR 
Sbjct: 144 QDDNNLYLV---MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200

Query: 488 VKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQN 541
           +K  +IL+  NG   L+  G    C       K+       +       +++SPE+L+  
Sbjct: 201 IKPDNILMDMNGHIRLADFGS---C------LKLMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 542 LD---GYDERSDIYSVGISCCELANGTVPF-AETPTTLM 576
                 Y    D +S+G+   E+  G  PF AE+     
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 37/200 (18%), Positives = 81/200 (40%), Gaps = 25/200 (12%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
               +A+K  N +  +  +     +E   M+     +++  +          ++  LM  
Sbjct: 54  PETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 112

Query: 95  GSCKDLINAH-----FNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHILIS 146
           G  K  + +       N  L    +  ++Q   ++ +G+ Y++   F+HR + A + +++
Sbjct: 113 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172

Query: 147 HNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
            +    +   G+ R +      +K    L P      + W+SPE L+  +  +   SD++
Sbjct: 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLP------VRWMSPESLKDGV--FTTYSDVW 224

Query: 203 SVGISCCELANGTVPFAETP 222
           S G+   E+A      AE P
Sbjct: 225 SFGVVLWEIAT----LAEQP 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 37/200 (18%), Positives = 81/200 (40%), Gaps = 25/200 (12%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
               +A+K  N +  +  +     +E   M+     +++  +          ++  LM  
Sbjct: 54  PETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 112

Query: 445 GSCKDLINAH-----FNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHILIS 496
           G  K  + +       N  L    +  ++Q   ++ +G+ Y++   F+HR + A + +++
Sbjct: 113 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172

Query: 497 HNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
            +    +   G+ R +      +K    L P      + W+SPE L+  +  +   SD++
Sbjct: 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLP------VRWMSPESLKDGV--FTTYSDVW 224

Query: 553 SVGISCCELANGTVPFAETP 572
           S G+   E+A      AE P
Sbjct: 225 SFGVVLWEIAT----LAEQP 240

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 26/223 (11%)

Query: 8   PSNYKICSILGQ-CFNNLSSVYL----SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
           PS      ++G   F     VY     +        +A+K        ++       E  
Sbjct: 43  PSCVTRQKVIGAGEF---GEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAG 98

Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDV 121
            M    H NII           + +++  M  G+    L      F + +LV   +L+ +
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV--GMLRGI 156

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMC--PFSPTKKKVHLFPPST 176
             G++Y+    ++HR + A +IL++ N    +S  GL R +   P +         P   
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP--- 213

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 218
              + W +PE +      +   SD++S GI   E+   G  P+
Sbjct: 214 ---IRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPY 251

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 26/223 (11%)

Query: 358 PSNYKICSILGQ-CFNNLSSVYL----SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
           PS      ++G   F     VY     +        +A+K        ++       E  
Sbjct: 43  PSCVTRQKVIGAGEF---GEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAG 98

Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDV 471
            M    H NII           + +++  M  G+    L      F + +LV   +L+ +
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV--GMLRGI 156

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMC--PFSPTKKKVHLFPPST 526
             G++Y+    ++HR + A +IL++ N    +S  GL R +   P +         P   
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP--- 213

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF 568
              + W +PE +      +   SD++S GI   E+   G  P+
Sbjct: 214 ---IRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPY 251

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 32/161 (19%), Positives = 56/161 (34%), Gaps = 29/161 (18%)

Query: 2   ETLDNVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH 58
           E        +++  + GQ      +   V L K K T   +A+KK   D       + L 
Sbjct: 16  ERSRKEMDRFQVERMAGQ-----GTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNREL- 67

Query: 59  HEIVCMRHLRHPNIIC-----YISSFLDATD--LHLVSPLMGFGSCKDL-----INAHFN 106
             +  +  L HPNI+      Y     D  D  L++V   +       L           
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQ 123

Query: 107 FGLPELVICHILQDVLNGLEYIHGK--GFIHRAVKASHILI 145
              P ++I   L  ++  +  +H       HR +K  ++L+
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 32/161 (19%), Positives = 56/161 (34%), Gaps = 29/161 (18%)

Query: 352 ETLDNVPSNYKICSILGQCFNNLSS---VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH 408
           E        +++  + GQ      +   V L K K T   +A+KK   D       + L 
Sbjct: 16  ERSRKEMDRFQVERMAGQ-----GTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNREL- 67

Query: 409 HEIVCMRHLRHPNIIC-----YISSFLDATD--LHLVSPLMGFGSCKDL-----INAHFN 456
             +  +  L HPNI+      Y     D  D  L++V   +       L           
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQ 123

Query: 457 FGLPELVICHILQDVLNGLEYIHGK--GFIHRAVKASHILI 495
              P ++I   L  ++  +  +H       HR +K  ++L+
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 61/349 (17%), Positives = 117/349 (33%), Gaps = 80/349 (22%)

Query: 11  YKICSILGQ--------CFNNLSSVYLSKHKVTNQLIAVK------KFN---------LD 47
           Y+I   LG+        C +         H      +A+K      K+          L 
Sbjct: 21  YEIVGNLGEGTFGKVVECLD---------HARGKSQVALKIIRNVGKYREAARLEINVLK 71

Query: 48  RMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF 107
           ++ ++D ++    ++          +C            +   L+G  +  + +  +   
Sbjct: 72  KIKEKDKENKFLCVLMSDWFNFHGHMC------------IAFELLGK-NTFEFLKENNFQ 118

Query: 108 GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 167
             P   + H+   + + L ++H     H  +K  +IL  ++    L      C     K 
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178

Query: 168 ---KVHLFPPSTAYNLNWL----------SPEVLEQNLD-GYDERSDIYSVGISCCELAN 213
              +V  F  S  ++               PEV+   L+ G+ +  D++S+G    E   
Sbjct: 179 TSIRVADFG-SATFDHEHHTTIVATRHYRPPEVI---LELGWAQPCDVWSIGCILFEYYR 234

Query: 214 GTVPFAETPTT-----LMLIEKLAGATP-HLLDCTT---YYVDTGQDDGEENACSYISEQ 264
           G   F    T      L+++EK+ G  P H++  T    Y+   G    E ++     ++
Sbjct: 235 GFTLF---QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291

Query: 265 QTQVLTSRKFSDS-----FHSIVELCLSRDVDKRPLACNLLQHAFFKQT 308
             + L S    DS        ++   L  D  +R      L H FF   
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 46/231 (19%)

Query: 8   PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 63
             +  +  ILG+  F     VY    + HK     +AVK    D   D   K +  E V 
Sbjct: 11  REDVVLNRILGEGFF---GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS-EAVI 66

Query: 64  MRHLRHPNIIC----------YISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPEL 112
           M++L HP+I+           +I           +  L  +G     L     +  +  L
Sbjct: 67  MKNLDHPHIVKLIGIIEEEPTWI-----------IMELYPYGELGHYLERNKNSLKVLTL 115

Query: 113 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKV 169
           V       +   + Y+     +HR +   +IL++      L   GL RY+      K  V
Sbjct: 116 V--LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173

Query: 170 HLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN-GTVPF 218
              P      + W+SPE +       +   SD++   +   E+ + G  PF
Sbjct: 174 TRLP------IKWMSPESI---NFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 46/231 (19%)

Query: 358 PSNYKICSILGQ-CFNNLSSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVC 413
             +  +  ILG+  F     VY    + HK     +AVK    D   D   K +  E V 
Sbjct: 11  REDVVLNRILGEGFF---GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS-EAVI 66

Query: 414 MRHLRHPNIIC----------YISSFLDATDLHLVSPLMGFGSCKD-LINAHFNFGLPEL 462
           M++L HP+I+           +I           +  L  +G     L     +  +  L
Sbjct: 67  MKNLDHPHIVKLIGIIEEEPTWI-----------IMELYPYGELGHYLERNKNSLKVLTL 115

Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKV 519
           V       +   + Y+     +HR +   +IL++      L   GL RY+      K  V
Sbjct: 116 V--LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173

Query: 520 HLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELAN-GTVPF 568
              P      + W+SPE +       +   SD++   +   E+ + G  PF
Sbjct: 174 TRLP------IKWMSPESI---NFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 70/357 (19%), Positives = 122/357 (34%), Gaps = 80/357 (22%)

Query: 5   DNVPSNYKICSILGQ--------CFNNLSSVYLSKHKVTNQLIAVK------KFN----- 45
           D + + Y+I   LG+        C +         HK   + +AVK      ++      
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECID---------HKAGGRHVAVKIVKNVDRYCEAARS 60

Query: 46  ----LDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLI 101
               L+ +   D  S    +  +    H   IC            +V  L+G  S  D I
Sbjct: 61  EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC------------IVFELLGL-STYDFI 107

Query: 102 NAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP 161
             +         I  +   +   + ++H     H  +K  +IL   +        +    
Sbjct: 108 KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167

Query: 162 FSPTKK---KVHLFPPSTAYNLNWLS----------PEVLEQNLD-GYDERSDIYSVGIS 207
                    KV  F  S  Y+    S          PEV+   L  G+ +  D++S+G  
Sbjct: 168 ERTLINPDIKVVDFG-SATYDDEHHSTLVSTRHYRAPEVI---LALGWSQPCDVWSIGCI 223

Query: 208 CCELANGTVPFAETPTT-----LMLIEKLAGATP-HLLDCTTY--YVDTGQDDGEENACS 259
             E   G   F   PT      L ++E++ G  P H++  T    Y    + D +E++ +
Sbjct: 224 LIEYYLGFTVF---PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280

Query: 260 --YISEQ----QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK 310
             Y+S      +  +L+     +    +++  L  D  KR      L+H FF   KK
Sbjct: 281 GRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.8 bits (136), Expect = 2e-08
 Identities = 79/496 (15%), Positives = 132/496 (26%), Gaps = 180/496 (36%)

Query: 110 PELVICHILQDVLNGL---EYI--HG-KGFIHRAVKASHILISHNGKACL--SGLRYMCP 161
            +      L+  L  L   + +   G  G                GK  +          
Sbjct: 134 LQPY--LKLRQALLELRPAKNVLIDGVLGS---------------GKTWVALDVCL---- 172

Query: 162 FSPTKKKVHLFPPSTAYNLNWLS------PE-VLE--QNL-----DGYDERSDIYSVGIS 207
                 KV        +   WL+      PE VLE  Q L       +  RSD  S    
Sbjct: 173 ----SYKVQCKMDFKIF---WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 208 CCELANGTVP--FAETPTTLMLIEKLAGATPHLLD--------------CTTYYVDTGQD 251
                   +       P    L+         +L               C    + T + 
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLL---------VLLNVQNAKAWNAFNLSCKI--LLTTRF 274

Query: 252 DGEENACSYISEQQTQVLTSRKFSDSFH-----SIVELCLSRDVDKRP---LACNLLQHA 303
               +    +S   T  ++    S +       S++   L       P   L  N  + +
Sbjct: 275 KQVTDF---LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331

Query: 304 FFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPSNYKI 363
                     ++ E +R  L+  + N   +N +      +     SS+  L+  P+ Y+ 
Sbjct: 332 ----------IIAESIRDGLATWD-NWKHVNCD-----KLTTIIESSLNVLE--PAEYR- 372

Query: 364 CSILGQCFNNLS----SVYLSKH---------------KVTNQLI---AVKKFN------ 395
                + F+ LS    S ++                   V N+L     V+K        
Sbjct: 373 -----KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427

Query: 396 -----LD-RMTDEDLKSLHHEIV---------CMRHLRHPNIICYISSFLDATDLHLVSP 440
                L+ ++  E+  +LH  IV             L  P +  Y  S +     HL + 
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI---GHHLKNI 484

Query: 441 LMGFGSCKDLINAHFNFGLPELVICHI---------LQDVLNGLE-YIHGKGFI------ 484
                          +F   E  I H          + + L  L+ Y   K +I      
Sbjct: 485 EHP-ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY---KPYICDNDPK 540

Query: 485 -HRAVKA-SHILISHN 498
             R V A    L    
Sbjct: 541 YERLVNAILDFLPKIE 556

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 6e-04
 Identities = 52/317 (16%), Positives = 84/317 (26%), Gaps = 84/317 (26%)

Query: 258 CSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCSVMLPE 317
           C  + +    +L+  +       I+    S+D     L   L      KQ +     + E
Sbjct: 35  CKDVQDMPKSILSKEEIDH----IIM---SKDAVSGTLR--LFWTLLSKQEEMVQKFVEE 85

Query: 318 LLRPALS-LNESNVCEINNELECMFNINDTFNSSVETLDNVP---SNYKICSI-----LG 368
           +LR     L       I  E      +   +    + L N     + Y +  +     L 
Sbjct: 86  VLRINYKFLMSP----IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141

Query: 369 QCFNNLSS-----VY--------------LSKHKVTNQL------IAVKKFNLDRMTDED 403
           Q    L       +                  +KV  ++      + +K  N      E 
Sbjct: 142 QALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM 201

Query: 404 LKSLHHEIVCM---RHLRHPNIICYISSFLDATDLHLVSPLMGFGSC---------KDLI 451
           L+ L ++I      R     NI   I S        L S    + +C             
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP--YENCLLVLLNVQNAKAW 259

Query: 452 NAHFNFGLPELVICHIL--------QDVLNGLEYIH------GKGFIHRAVKASHILISH 497
           NA FN        C IL         D L+     H              VK+  +    
Sbjct: 260 NA-FNLS------CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312

Query: 498 NGKACLSGLRYMCPFSP 514
                L   R +   +P
Sbjct: 313 CRPQDLP--REVLTTNP 327

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 40/188 (21%), Positives = 73/188 (38%), Gaps = 20/188 (10%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 84
            Y      T  L+AVK+  L     +  +    EI  ++ L    I+ Y  +S       
Sbjct: 43  RYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100

Query: 85  LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 143
           L LV   +  G  +D L           L+       +  G+EY+  +  +HR + A +I
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLL--LYSSQICKGMEYLGSRRCVHRDLAARNI 158

Query: 144 LISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 198
           L+       ++  GL + +         ++    P      + W +PE L  N+  +  +
Sbjct: 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP------IFWYAPESLSDNI--FSRQ 210

Query: 199 SDIYSVGI 206
           SD++S G+
Sbjct: 211 SDVWSFGV 218

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 40/188 (21%), Positives = 73/188 (38%), Gaps = 20/188 (10%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICY--ISSFLDATD 434
            Y      T  L+AVK+  L     +  +    EI  ++ L    I+ Y  +S       
Sbjct: 43  RYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100

Query: 435 LHLVSPLMGFGSCKD-LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI 493
           L LV   +  G  +D L           L+       +  G+EY+  +  +HR + A +I
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLL--LYSSQICKGMEYLGSRRCVHRDLAARNI 158

Query: 494 LISHNGKACLS--GL-RYMCPFSP--TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER 548
           L+       ++  GL + +         ++    P      + W +PE L  N+  +  +
Sbjct: 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP------IFWYAPESLSDNI--FSRQ 210

Query: 549 SDIYSVGI 556
           SD++S G+
Sbjct: 211 SDVWSFGV 218

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 31/192 (16%), Positives = 64/192 (33%), Gaps = 29/192 (15%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 99
            +K   LD+      +S       M  L H +++      +   +  LV   + FGS   
Sbjct: 44  LLKV--LDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101

Query: 100 -LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS---- 154
            L        +   +   + + +   + ++     IH  V A +IL+             
Sbjct: 102 YLKKNKNCINILWKL--EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159

Query: 155 ------GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 207
                 G+   + P    ++++            W+ PE + +N    +  +D +S G +
Sbjct: 160 IKLSDPGISITVLPKDILQERI-----------PWVPPECI-ENPKNLNLATDKWSFGTT 207

Query: 208 CCELA-NGTVPF 218
             E+   G  P 
Sbjct: 208 LWEICSGGDKPL 219

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 31/192 (16%), Positives = 64/192 (33%), Gaps = 29/192 (15%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 449
            +K   LD+      +S       M  L H +++      +   +  LV   + FGS   
Sbjct: 44  LLKV--LDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101

Query: 450 -LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS---- 504
            L        +   +   + + +   + ++     IH  V A +IL+             
Sbjct: 102 YLKKNKNCINILWKL--EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159

Query: 505 ------GL-RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGIS 557
                 G+   + P    ++++            W+ PE + +N    +  +D +S G +
Sbjct: 160 IKLSDPGISITVLPKDILQERI-----------PWVPPECI-ENPKNLNLATDKWSFGTT 207

Query: 558 CCELA-NGTVPF 568
             E+   G  P 
Sbjct: 208 LWEICSGGDKPL 219

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 42/200 (21%), Positives = 85/200 (42%), Gaps = 28/200 (14%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 94
           +   +AVK    +  +++D      E + +    H NI+  I   L +    ++  LM  
Sbjct: 59  SPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG 117

Query: 95  GSCKDLINAH-------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 147
           G  K  +           +  + +L+  H+ +D+  G +Y+    FIHR + A + L++ 
Sbjct: 118 GDLKSFLRETRPRPSQPSSLAMLDLL--HVARDIACGCQYLEENHFIHRDIAARNCLLTC 175

Query: 148 NGK---ACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG-YDERS 199
            G    A +   G+ R +   S  +K    + P      + W+ PE     ++G +  ++
Sbjct: 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP------VKWMPPEAF---MEGIFTSKT 226

Query: 200 DIYSVGISCCELA-NGTVPF 218
           D +S G+   E+   G +P+
Sbjct: 227 DTWSFGVLLWEIFSLGYMPY 246

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 42/200 (21%), Positives = 85/200 (42%), Gaps = 28/200 (14%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGF 444
           +   +AVK    +  +++D      E + +    H NI+  I   L +    ++  LM  
Sbjct: 59  SPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG 117

Query: 445 GSCKDLINAH-------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH 497
           G  K  +           +  + +L+  H+ +D+  G +Y+    FIHR + A + L++ 
Sbjct: 118 GDLKSFLRETRPRPSQPSSLAMLDLL--HVARDIACGCQYLEENHFIHRDIAARNCLLTC 175

Query: 498 NGK---ACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG-YDERS 549
            G    A +   G+ R +   S  +K    + P      + W+ PE     ++G +  ++
Sbjct: 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP------VKWMPPEAF---MEGIFTSKT 226

Query: 550 DIYSVGISCCELA-NGTVPF 568
           D +S G+   E+   G +P+
Sbjct: 227 DTWSFGVLLWEIFSLGYMPY 246

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 63/345 (18%), Positives = 117/345 (33%), Gaps = 77/345 (22%)

Query: 11  YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVK------KFN---------LDRMTDEDL 54
           Y++  ++G+  F     V  +     +Q +A+K      +F+         L+ +  +D 
Sbjct: 99  YEVLKVIGKGSF---GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 55  KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
            +  + I  + +    N IC            +   L+   +  +LI  +   G    ++
Sbjct: 156 DNTMNVIHMLENFTFRNHIC------------MTFELLSM-NLYELIKKNKFQGFSLPLV 202

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFP 173
                 +L  L+ +H    IH  +K  +IL+   G+   SG++ +  F S   +   ++ 
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR---SGIK-VIDFGSSCYEHQRVYT 258

Query: 174 --PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-----LM 226
              S  Y     +PEV+      Y    D++S+G    EL  G       P       L 
Sbjct: 259 YIQSRFYR----APEVILGA--RYGMPIDMWSLGCILAELLTGYPLL---PGEDEGDQLA 309

Query: 227 LIEKLAGATP-HLLDCTT-------------YYVDTGQDDGEE---------NACSYISE 263
            + +L G     LLD +              Y   T   DG                  E
Sbjct: 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPE 369

Query: 264 QQTQVLTSRKFSD-SFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
            +      +   D  F   ++ CL  D   R      L+H + ++
Sbjct: 370 SREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 50/255 (19%), Positives = 95/255 (37%), Gaps = 54/255 (21%)

Query: 361 YKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVK------KFN---------LDRMTDEDL 404
           Y++  ++G+  F     V  +     +Q +A+K      +F+         L+ +  +D 
Sbjct: 99  YEVLKVIGKGSF---GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 405 KSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 464
            +  + I  + +    N IC            +   L+   +  +LI  +   G    ++
Sbjct: 156 DNTMNVIHMLENFTFRNHIC------------MTFELLSM-NLYELIKKNKFQGFSLPLV 202

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFP 523
                 +L  L+ +H    IH  +K  +IL+   G+   SG++ +  F S   +   ++ 
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR---SGIK-VIDFGSSCYEHQRVYT 258

Query: 524 --PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-----LM 576
              S  Y     +PEV+      Y    D++S+G    EL  G       P       L 
Sbjct: 259 YIQSRFYR----APEVILGA--RYGMPIDMWSLGCILAELLTGYPLL---PGEDEGDQLA 309

Query: 577 LIEKLAGATP-HLLD 590
            + +L G     LLD
Sbjct: 310 CMIELLGMPSQKLLD 324

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 40/198 (20%), Positives = 80/198 (40%), Gaps = 31/198 (15%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 99
           AVK    +  +++D      E + +    H NI+  I   L +    ++  LM  G  K 
Sbjct: 105 AVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163

Query: 100 LINAH-------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-- 150
            +           +  + +L+  H+ +D+  G +Y+    FIHR + A + L++  G   
Sbjct: 164 FLRETRPRPSQPSSLAMLDLL--HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221

Query: 151 -ACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSV 204
            A +   G+ R +      +K    + P      + W+ PE     ++G +  ++D +S 
Sbjct: 222 VAKIGDFGMARDIYRAGYYRKGGCAMLP------VKWMPPEAF---MEGIFTSKTDTWSF 272

Query: 205 GISCCELANGTVPFAETP 222
           G+   E+ +        P
Sbjct: 273 GVLLWEIFS----LGYMP 286

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 40/198 (20%), Positives = 80/198 (40%), Gaps = 31/198 (15%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 449
           AVK    +  +++D      E + +    H NI+  I   L +    ++  LM  G  K 
Sbjct: 105 AVKTLP-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163

Query: 450 LINAH-------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-- 500
            +           +  + +L+  H+ +D+  G +Y+    FIHR + A + L++  G   
Sbjct: 164 FLRETRPRPSQPSSLAMLDLL--HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221

Query: 501 -ACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSV 554
            A +   G+ R +      +K    + P      + W+ PE     ++G +  ++D +S 
Sbjct: 222 VAKIGDFGMARDIYRAGYYRKGGCAMLP------VKWMPPEAF---MEGIFTSKTDTWSF 272

Query: 555 GISCCELANGTVPFAETP 572
           G+   E+ +        P
Sbjct: 273 GVLLWEIFS----LGYMP 286

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 44/219 (20%), Positives = 83/219 (37%), Gaps = 42/219 (19%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYI-SSFLDATDLHLVSPLMGFGSC 97
           AVK    +  T  + ++L  E+  + H+  H N++  + +       L ++     FG+ 
Sbjct: 61  AVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119

Query: 98  KD-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHI 143
                           A  +     L + H++     V  G+E++  +  IHR + A +I
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179

Query: 144 LISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 193
           L+S      +   GL R       Y       +K     P      L W++PE +   + 
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLP------LKWMAPETIFDRV- 226

Query: 194 GYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 231
            Y  +SD++S G+   E+ + G  P+           +L
Sbjct: 227 -YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 44/219 (20%), Positives = 83/219 (37%), Gaps = 42/219 (19%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYI-SSFLDATDLHLVSPLMGFGSC 447
           AVK    +  T  + ++L  E+  + H+  H N++  + +       L ++     FG+ 
Sbjct: 61  AVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119

Query: 448 KD-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHI 493
                           A  +     L + H++     V  G+E++  +  IHR + A +I
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179

Query: 494 LISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD 543
           L+S      +   GL R       Y       +K     P      L W++PE +   + 
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLP------LKWMAPETIFDRV- 226

Query: 544 GYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 581
            Y  +SD++S G+   E+ + G  P+           +L
Sbjct: 227 -YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 45/206 (21%), Positives = 82/206 (39%), Gaps = 38/206 (18%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISSFLDAT 83
           V L KHK +    A+K  +  ++    LK + H   E   ++ +  P ++    SF D +
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 84  DLHLVSPLMGFG-------SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 136
           +L++V   +  G               H  F   ++V+           EY+H    I+R
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---------TFEYLHSLDLIYR 165

Query: 137 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNL 192
            +K  ++LI   G   +        F   K+          + L      L+PE++    
Sbjct: 166 DLKPENLLIDQQGYIQV------TDFGFAKR-----VKGRTWTLCGTPEALAPEIILSK- 213

Query: 193 DGYDERSDIYSVGISCCELANGTVPF 218
            GY++  D +++G+   E+A G  PF
Sbjct: 214 -GYNKAVDWWALGVLIYEMAAGYPPF 238

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 45/206 (21%), Positives = 82/206 (39%), Gaps = 38/206 (18%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH---EIVCMRHLRHPNIICYISSFLDAT 433
           V L KHK +    A+K  +  ++    LK + H   E   ++ +  P ++    SF D +
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 434 DLHLVSPLMGFG-------SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHR 486
           +L++V   +  G               H  F   ++V+           EY+H    I+R
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---------TFEYLHSLDLIYR 165

Query: 487 AVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNL 542
            +K  ++LI   G   +        F   K+          + L      L+PE++    
Sbjct: 166 DLKPENLLIDQQGYIQV------TDFGFAKR-----VKGRTWTLCGTPEALAPEIILSK- 213

Query: 543 DGYDERSDIYSVGISCCELANGTVPF 568
            GY++  D +++G+   E+A G  PF
Sbjct: 214 -GYNKAVDWWALGVLIYEMAAGYPPF 238

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 59/345 (17%), Positives = 111/345 (32%), Gaps = 58/345 (16%)

Query: 5   DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEI 61
             + + + +   +G   F     V L +H    +  AVK  + N+ + T         E 
Sbjct: 31  MLLNNAFLVIRKMGDGTF---GRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKI----EA 82

Query: 62  VCMRHLRH-----PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICH 116
             ++ +++      NI+ Y   F+    + L+   +G  S  ++I  +   G     I  
Sbjct: 83  DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKL 141

Query: 117 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP-- 174
              ++L  L Y+      H  +K  +IL+                     +         
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 175 ------STAYNLNWLS----------PEVLEQNLD-GYDERSDIYSVGISCCELANGTVP 217
                    +  ++            PEV+   L+ G+D  SD++S G    EL  G++ 
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTGSLL 258

Query: 218 FAETPTT-----LMLIEKLAGATP-HLLD-----CTTYYVDTGQDDGEENACSYISEQQT 266
           F    T      L ++E +    P ++L        + YV+  +        +       
Sbjct: 259 F---RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315

Query: 267 QVLTSRKFSD-----SFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
            V              F   +   L  D   RP    LL+H F +
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 40.8 bits (96), Expect = 9e-04
 Identities = 47/269 (17%), Positives = 92/269 (34%), Gaps = 48/269 (17%)

Query: 355 DNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEI 411
             + + + +   +G   F     V L +H    +  AVK  + N+ + T         E 
Sbjct: 31  MLLNNAFLVIRKMGDGTF---GRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKI----EA 82

Query: 412 VCMRHLRH-----PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICH 466
             ++ +++      NI+ Y   F+    + L+   +G  S  ++I  +   G     I  
Sbjct: 83  DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKL 141

Query: 467 ILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP-- 524
              ++L  L Y+      H  +K  +IL+                     +         
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 525 ------STAYNLNWLS----------PEVLEQNLD-GYDERSDIYSVGISCCELANGTVP 567
                    +  ++            PEV+   L+ G+D  SD++S G    EL  G++ 
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTGSLL 258

Query: 568 FAETPTT-----LMLIEKLAGATP-HLLD 590
           F    T      L ++E +    P ++L 
Sbjct: 259 F---RTHEHMEHLAMMESIIQPIPKNMLY 284

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 65/352 (18%), Positives = 125/352 (35%), Gaps = 70/352 (19%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIV 62
           +     Y+I S++G+   +   V  +  +V  + +A+K  K N     ++       E+ 
Sbjct: 50  EKWMDRYEIDSLIGK--GSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQI----EVR 102

Query: 63  CMRHLRHP------NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICH 116
            +  +          I+     F+    L LV  ++ + +  DL+      G+   +   
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK 161

Query: 117 ILQDVLNGLEYIHGK--GFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFP 173
             Q +   L ++       IH  +K  +IL+ +  +   S ++ +  F S  +    ++ 
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR---SAIK-IVDFGSSCQLGQRIYQ 217

Query: 174 --PSTAYNLNWLSPEVLEQNLD-GYDERSDIYSVGISCCELANGTVPFAETPTT-----L 225
              S  Y     SPEVL   L   YD   D++S+G    E+  G   F           +
Sbjct: 218 YIQSRFYR----SPEVL---LGMPYDLAIDMWSLGCILVEMHTGEPLF---SGANEVDQM 267

Query: 226 MLIEKLAGATP-HLLDC---TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSD----- 276
             I ++ G  P H+LD       + +   D       +   +++ +   +RK  +     
Sbjct: 268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVE 327

Query: 277 --------------------SFHSIVELCLSRDVDKRPLACNLLQHAFFKQT 308
                                F  ++   L  D   R      LQH+FFK+T
Sbjct: 328 TGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 51/256 (19%), Positives = 98/256 (38%), Gaps = 42/256 (16%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVK--KFNLDRMTDEDLKSLHHEIV 412
           +     Y+I S++G+   +   V  +  +V  + +A+K  K N     ++       E+ 
Sbjct: 50  EKWMDRYEIDSLIGK--GSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQI----EVR 102

Query: 413 CMRHLRHP------NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICH 466
            +  +          I+     F+    L LV  ++ + +  DL+      G+   +   
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK 161

Query: 467 ILQDVLNGLEYIHGK--GFIHRAVKASHILISHNGKACLSGLRYMCPF-SPTKKKVHLFP 523
             Q +   L ++       IH  +K  +IL+ +  +   S ++ +  F S  +    ++ 
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR---SAIK-IVDFGSSCQLGQRIYQ 217

Query: 524 --PSTAYNLNWLSPEVLEQNLD-GYDERSDIYSVGISCCELANGTVPFAETPTT-----L 575
              S  Y     SPEVL   L   YD   D++S+G    E+  G   F           +
Sbjct: 218 YIQSRFYR----SPEVL---LGMPYDLAIDMWSLGCILVEMHTGEPLF---SGANEVDQM 267

Query: 576 MLIEKLAGATP-HLLD 590
             I ++ G  P H+LD
Sbjct: 268 NKIVEVLGIPPAHILD 283

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 40/186 (21%), Positives = 79/186 (42%), Gaps = 28/186 (15%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ +
Sbjct: 71  AVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129

Query: 99  D-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHIL 144
           +                      ++    ++     +  G+EY+  +  IHR + A ++L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189

Query: 145 ISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           ++ N    ++  GL R +      KK  +   P      + W++PE L   +  Y  +SD
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLP------VKWMAPEALFDRV--YTHQSD 241

Query: 201 IYSVGI 206
           ++S G+
Sbjct: 242 VWSFGV 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 40/186 (21%), Positives = 79/186 (42%), Gaps = 28/186 (15%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++      G+ +
Sbjct: 71  AVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129

Query: 449 D-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHIL 494
           +                      ++    ++     +  G+EY+  +  IHR + A ++L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189

Query: 495 ISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           ++ N    ++  GL R +      KK  +   P      + W++PE L   +  Y  +SD
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLP------VKWMAPEALFDRV--YTHQSD 241

Query: 551 IYSVGI 556
           ++S G+
Sbjct: 242 VWSFGV 247

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 37/199 (18%), Positives = 76/199 (38%), Gaps = 47/199 (23%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 99
           AVK    +  +  +L+ L  E   ++ + HP++I    +      L L+     +GS + 
Sbjct: 57  AVKMLK-ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115

Query: 100 -------------------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRA 137
                                ++  +     L +  ++     +  G++Y+     +HR 
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175

Query: 138 VKASHILISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           + A +IL++   K  +S  GL R       Y       K+     P      + W++ E 
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY------VKRSQGRIP------VKWMAIES 223

Query: 188 LEQNLDGYDERSDIYSVGI 206
           L  ++  Y  +SD++S G+
Sbjct: 224 LFDHI--YTTQSDVWSFGV 240

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 37/199 (18%), Positives = 76/199 (38%), Gaps = 47/199 (23%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKD 449
           AVK    +  +  +L+ L  E   ++ + HP++I    +      L L+     +GS + 
Sbjct: 57  AVKMLK-ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115

Query: 450 -------------------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRA 487
                                ++  +     L +  ++     +  G++Y+     +HR 
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175

Query: 488 VKASHILISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           + A +IL++   K  +S  GL R       Y       K+     P      + W++ E 
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY------VKRSQGRIP------VKWMAIES 223

Query: 538 LEQNLDGYDERSDIYSVGI 556
           L  ++  Y  +SD++S G+
Sbjct: 224 LFDHI--YTTQSDVWSFGV 240

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 40/191 (20%), Positives = 80/191 (41%), Gaps = 28/191 (14%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG 93
               +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++     
Sbjct: 112 EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 170

Query: 94  FGSCKD-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVK 139
            G+ ++                      ++    ++     +  G+EY+  +  IHR + 
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230

Query: 140 ASHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGY 195
           A ++L++ N    ++  GL R +      KK  +   P      + W++PE L   +  Y
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP------VKWMAPEALFDRV--Y 282

Query: 196 DERSDIYSVGI 206
             +SD++S G+
Sbjct: 283 THQSDVWSFGV 293

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 40/191 (20%), Positives = 80/191 (41%), Gaps = 28/191 (14%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG 443
               +AVK    D  T++DL  L  E+  M+ + +H NII  + +      L+++     
Sbjct: 112 EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 170

Query: 444 FGSCKD-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVK 489
            G+ ++                      ++    ++     +  G+EY+  +  IHR + 
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230

Query: 490 ASHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGY 545
           A ++L++ N    ++  GL R +      KK  +   P      + W++PE L   +  Y
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP------VKWMAPEALFDRV--Y 282

Query: 546 DERSDIYSVGI 556
             +SD++S G+
Sbjct: 283 THQSDVWSFGV 293

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 50.7 bits (122), Expect = 6e-07
 Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 41/196 (20%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG 93
                A+K+   +  + +D +    E+  +  L  HPNII  + +      L+L      
Sbjct: 51  LRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109

Query: 94  FGSCKD----------------LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
            G+  D                  +        +L+  H   DV  G++Y+  K FIHR 
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL--HFAADVARGMDYLSQKQFIHRD 167

Query: 138 VKASHILISHNGKACLS--GL-R----YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
           + A +IL+  N  A ++  GL R    Y       KK +   P      + W++ E L  
Sbjct: 168 LAARNILVGENYVAKIADFGLSRGQEVY------VKKTMGRLP------VRWMAIESLNY 215

Query: 191 NLDGYDERSDIYSVGI 206
           ++  Y   SD++S G+
Sbjct: 216 SV--YTTNSDVWSYGV 229

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 50.7 bits (122), Expect = 6e-07
 Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 41/196 (20%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMG 443
                A+K+   +  + +D +    E+  +  L  HPNII  + +      L+L      
Sbjct: 51  LRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109

Query: 444 FGSCKD----------------LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
            G+  D                  +        +L+  H   DV  G++Y+  K FIHR 
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL--HFAADVARGMDYLSQKQFIHRD 167

Query: 488 VKASHILISHNGKACLS--GL-R----YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
           + A +IL+  N  A ++  GL R    Y       KK +   P      + W++ E L  
Sbjct: 168 LAARNILVGENYVAKIADFGLSRGQEVY------VKKTMGRLP------VRWMAIESLNY 215

Query: 541 NLDGYDERSDIYSVGI 556
           ++  Y   SD++S G+
Sbjct: 216 SV--YTTNSDVWSYGV 229

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 41/186 (22%), Positives = 79/186 (42%), Gaps = 28/186 (15%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           AVK       T++DL  L  E+  M+ + +H NII  + +      L+++      G+ +
Sbjct: 105 AVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163

Query: 99  D-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHIL 144
           +                 +    +L    ++     V  G+EY+  K  IHR + A ++L
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223

Query: 145 ISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
           ++ +    ++  GL R +      KK  +   P      + W++PE L   +  Y  +SD
Sbjct: 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP------VKWMAPEALFDRI--YTHQSD 275

Query: 201 IYSVGI 206
           ++S G+
Sbjct: 276 VWSFGV 281

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 41/186 (22%), Positives = 79/186 (42%), Gaps = 28/186 (15%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           AVK       T++DL  L  E+  M+ + +H NII  + +      L+++      G+ +
Sbjct: 105 AVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163

Query: 449 D-----------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHIL 494
           +                 +    +L    ++     V  G+EY+  K  IHR + A ++L
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223

Query: 495 ISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
           ++ +    ++  GL R +      KK  +   P      + W++PE L   +  Y  +SD
Sbjct: 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP------VKWMAPEALFDRI--YTHQSD 275

Query: 551 IYSVGI 556
           ++S G+
Sbjct: 276 VWSFGV 281

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 36/191 (18%), Positives = 70/191 (36%), Gaps = 33/191 (17%)

Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 95
             L+AVK   L   ++   +    E   +  L+H +I+ +     +   L +V   M  G
Sbjct: 71  KMLVAVKA--LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 128

Query: 96  SCKDLINAH---------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
                + +H                  GL +L+   +   V  G+ Y+ G  F+HR +  
Sbjct: 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL--AVASQVAAGMVYLAGLHFVHRDLAT 186

Query: 141 SHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG-Y 195
            + L+       +   G+ R +      +     + P      + W+ PE +   L   +
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP------IRWMPPESI---LYRKF 237

Query: 196 DERSDIYSVGI 206
              SD++S G+
Sbjct: 238 TTESDVWSFGV 248

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 36/191 (18%), Positives = 70/191 (36%), Gaps = 33/191 (17%)

Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 445
             L+AVK   L   ++   +    E   +  L+H +I+ +     +   L +V   M  G
Sbjct: 71  KMLVAVKA--LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 128

Query: 446 SCKDLINAH---------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
                + +H                  GL +L+   +   V  G+ Y+ G  F+HR +  
Sbjct: 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL--AVASQVAAGMVYLAGLHFVHRDLAT 186

Query: 491 SHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG-Y 545
            + L+       +   G+ R +      +     + P      + W+ PE +   L   +
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP------IRWMPPESI---LYRKF 237

Query: 546 DERSDIYSVGI 556
              SD++S G+
Sbjct: 238 TTESDVWSFGV 248

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 43/225 (19%), Positives = 82/225 (36%), Gaps = 48/225 (21%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIIC-----------YI----------S 77
           AVK    ++    + ++L  E+  M  L  H NI+            Y+           
Sbjct: 79  AVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137

Query: 78  SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 137
           ++L +         + + + K L        L    +      V  G+E++  K  +HR 
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197

Query: 138 VKASHILISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           + A ++L++H     +   GL R       Y        +     P      + W++PE 
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLP------VKWMAPES 245

Query: 188 LEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 231
           L + +  Y  +SD++S GI   E+ + G  P+   P      + +
Sbjct: 246 LFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 43/225 (19%), Positives = 82/225 (36%), Gaps = 48/225 (21%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIIC-----------YI----------S 427
           AVK    ++    + ++L  E+  M  L  H NI+            Y+           
Sbjct: 79  AVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137

Query: 428 SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRA 487
           ++L +         + + + K L        L    +      V  G+E++  K  +HR 
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197

Query: 488 VKASHILISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           + A ++L++H     +   GL R       Y        +     P      + W++PE 
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLP------VKWMAPES 245

Query: 538 LEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 581
           L + +  Y  +SD++S GI   E+ + G  P+   P      + +
Sbjct: 246 LFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 48.3 bits (116), Expect = 3e-06
 Identities = 56/205 (27%), Positives = 78/205 (38%), Gaps = 52/205 (25%)

Query: 26  SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH----EIVCMRHLRHPNI-----ICYI 76
            VY  K  V N  +AVKK  L  M D   + L      EI  M   +H N+         
Sbjct: 46  VVY--KGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-- 99

Query: 77  SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI------CHILQDVLNGLEYIHG 130
               D  DL LV   M  GS   L        L           C I Q   NG+ ++H 
Sbjct: 100 ---SDGDDLCLVYVYMPNGS---L--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151

Query: 131 KGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTA------YNLN 181
              IHR +K+++IL+     A +S  GL R     S    +  +   ++       Y   
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQTVM---TSRIVGTTAY--- 201

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGI 206
            ++PE L   +     +SDIYS G+
Sbjct: 202 -MAPEALRGEI---TPKSDIYSFGV 222

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 48.3 bits (116), Expect = 3e-06
 Identities = 56/205 (27%), Positives = 78/205 (38%), Gaps = 52/205 (25%)

Query: 376 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH----EIVCMRHLRHPNI-----ICYI 426
            VY  K  V N  +AVKK  L  M D   + L      EI  M   +H N+         
Sbjct: 46  VVY--KGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-- 99

Query: 427 SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI------CHILQDVLNGLEYIHG 480
               D  DL LV   M  GS   L        L           C I Q   NG+ ++H 
Sbjct: 100 ---SDGDDLCLVYVYMPNGS---L--LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151

Query: 481 KGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSPTKKKVHLFPPSTA------YNLN 531
              IHR +K+++IL+     A +S  GL R     S    +  +   ++       Y   
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQTVM---TSRIVGTTAY--- 201

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGI 556
            ++PE L   +     +SDIYS G+
Sbjct: 202 -MAPEALRGEI---TPKSDIYSFGV 222

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 60/298 (20%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 84
           V L + K T+++ A+K    +    DED+  +  E  V  +   HP ++   S F   + 
Sbjct: 25  VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84

Query: 85  LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           L  V   + + +  DL   +        PE        ++   L Y+H +G I+R +K  
Sbjct: 85  LFFV---IEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISLALNYLHERGIIYRDLKLD 139

Query: 142 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 195
           ++L+   G   L+  G   MC       K  L P  T        N+++PE+L      Y
Sbjct: 140 NVLLDSEGHIKLTDYG---MC-------KEGLRPGDTTSTFCGTPNYIAPEILRGE--DY 187

Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE 255
               D +++G+   E+  G  PF    ++                      D    + E+
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSS----------------------DNPDQNTED 225

Query: 256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN-------LLQHAFFK 306
                I E+  Q+   R  S    S+++  L++D  +R L C+       +  H FF+
Sbjct: 226 YLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKER-LGCHPQTGFADIQGHPFFR 280

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 44.9 bits (107), Expect = 5e-05
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 28/203 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 434
           V L + K T+++ A+K    +    DED+  +  E  V  +   HP ++   S F   + 
Sbjct: 25  VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84

Query: 435 LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           L  V   + + +  DL   +        PE        ++   L Y+H +G I+R +K  
Sbjct: 85  LFFV---IEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISLALNYLHERGIIYRDLKLD 139

Query: 492 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 545
           ++L+   G   L+  G   MC       K  L P  T        N+++PE+L      Y
Sbjct: 140 NVLLDSEGHIKLTDYG---MC-------KEGLRPGDTTSTFCGTPNYIAPEILRGE--DY 187

Query: 546 DERSDIYSVGISCCELANGTVPF 568
               D +++G+   E+  G  PF
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPF 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 60/298 (20%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 84
           V L + K T+++ A++    +    DED+  +  E  V  +   HP ++   S F   + 
Sbjct: 68  VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127

Query: 85  LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           L  V   + + +  DL   +        PE        ++   L Y+H +G I+R +K  
Sbjct: 128 LFFV---IEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISLALNYLHERGIIYRDLKLD 182

Query: 142 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 195
           ++L+   G   L+  G   MC       K  L P  T        N+++PE+L      Y
Sbjct: 183 NVLLDSEGHIKLTDYG---MC-------KEGLRPGDTTSTFCGTPNYIAPEILRGE--DY 230

Query: 196 DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEE 255
               D +++G+   E+  G  PF    ++                      D    + E+
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSS----------------------DNPDQNTED 268

Query: 256 NACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN-------LLQHAFFK 306
                I E+  Q+   R  S    S+++  L++D  +R L C+       +  H FF+
Sbjct: 269 YLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKER-LGCHPQTGFADIQGHPFFR 323

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 28/203 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 434
           V L + K T+++ A++    +    DED+  +  E  V  +   HP ++   S F   + 
Sbjct: 68  VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127

Query: 435 LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           L  V   + + +  DL   +        PE        ++   L Y+H +G I+R +K  
Sbjct: 128 LFFV---IEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISLALNYLHERGIIYRDLKLD 182

Query: 492 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 545
           ++L+   G   L+  G   MC       K  L P  T        N+++PE+L      Y
Sbjct: 183 NVLLDSEGHIKLTDYG---MC-------KEGLRPGDTTSTFCGTPNYIAPEILRGE--DY 230

Query: 546 DERSDIYSVGISCCELANGTVPF 568
               D +++G+   E+  G  PF
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPF 253

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 36/179 (20%)

Query: 1   METLDNVPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS--- 56
           ME    V + +++   +G   F     +YL  +  TN+ +A+K         E++K+   
Sbjct: 1   MEPR--VGNKFRLGRKIGSGSF---GEIYLGTNIQTNEEVAIKL--------ENVKTKHP 47

Query: 57  -LHHEIVCMRHLRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FG 108
            L +E    R L+     PN+  +          +  LV  L+G  S +DL N       
Sbjct: 48  QLLYESKIYRILQGGTGIPNVRWFGV-----EGDYNVLVMDLLGP-SLEDLFNFCSRKLS 101

Query: 109 LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 167
           L    +  +   ++N +E++H K F+HR +K  + L+   G    +   Y+  F   KK
Sbjct: 102 LK--TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKK 155

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 34/173 (19%)

Query: 357 VPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS----LHHEI 411
           V + +++   +G   F     +YL  +  TN+ +A+K         E++K+    L +E 
Sbjct: 5   VGNKFRLGRKIGSGSF---GEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYES 53

Query: 412 VCMRHLRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FGLPELVI 464
              R L+     PN+  +          +  LV  L+G  S +DL N       L    +
Sbjct: 54  KIYRILQGGTGIPNVRWFGV-----EGDYNVLVMDLLGP-SLEDLFNFCSRKLSLK--TV 105

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 517
             +   ++N +E++H K F+HR +K  + L+   G    +   Y+  F   KK
Sbjct: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKK 155

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 32/172 (18%)

Query: 7   VPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS----LHHEI 61
           V + Y++   +G   F     +YL       + +A+K         E +K+    LH E 
Sbjct: 7   VGNRYRLGRKIGSGSF---GDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIES 55

Query: 62  VCMRHLRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFNFGLPELVIC 115
              + ++     P I    +        +  +V  L+G  S +DL N   +       + 
Sbjct: 56  KIYKMMQGGVGIPTIRWCGA-----EGDYNVMVMELLGP-SLEDLFNFC-SRKFSLKTVL 108

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 167
            +   +++ +EYIH K FIHR VK  + L+    K  L    Y+  F   KK
Sbjct: 109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV---YIIDFGLAKK 157

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 32/172 (18%)

Query: 357 VPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKS----LHHEI 411
           V + Y++   +G   F     +YL       + +A+K         E +K+    LH E 
Sbjct: 7   VGNRYRLGRKIGSGSF---GDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIES 55

Query: 412 VCMRHLRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFNFGLPELVIC 465
              + ++     P I    +        +  +V  L+G  S +DL N   +       + 
Sbjct: 56  KIYKMMQGGVGIPTIRWCGA-----EGDYNVMVMELLGP-SLEDLFNFC-SRKFSLKTVL 108

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 517
            +   +++ +EYIH K FIHR VK  + L+    K  L    Y+  F   KK
Sbjct: 109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV---YIIDFGLAKK 157

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 46.8 bits (112), Expect = 9e-06
 Identities = 40/192 (20%), Positives = 74/192 (38%), Gaps = 34/192 (17%)

Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 95
             L+AVK   L   T    K    E   + +L+H +I+ +     D   L +V   M  G
Sbjct: 45  KMLVAVKA--LKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 102

Query: 96  SCKDLINAH----------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
                + AH                   GL +++  HI   + +G+ Y+  + F+HR + 
Sbjct: 103 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML--HIASQIASGMVYLASQHFVHRDLA 160

Query: 140 ASHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG- 194
             + L+  N    +   G+ R +      +   H + P      + W+ PE +   +   
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP------IRWMPPESI---MYRK 211

Query: 195 YDERSDIYSVGI 206
           +   SD++S G+
Sbjct: 212 FTTESDVWSFGV 223

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 46.8 bits (112), Expect = 9e-06
 Identities = 40/192 (20%), Positives = 74/192 (38%), Gaps = 34/192 (17%)

Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFG 445
             L+AVK   L   T    K    E   + +L+H +I+ +     D   L +V   M  G
Sbjct: 45  KMLVAVKA--LKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 102

Query: 446 SCKDLINAH----------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
                + AH                   GL +++  HI   + +G+ Y+  + F+HR + 
Sbjct: 103 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML--HIASQIASGMVYLASQHFVHRDLA 160

Query: 490 ASHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG- 544
             + L+  N    +   G+ R +      +   H + P      + W+ PE +   +   
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP------IRWMPPESI---MYRK 211

Query: 545 YDERSDIYSVGI 556
           +   SD++S G+
Sbjct: 212 FTTESDVWSFGV 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 59/295 (20%), Positives = 106/295 (35%), Gaps = 68/295 (23%)

Query: 27  VYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDA 82
           V+L++ K TNQ  A+K   K  +  + D+D++    E  V      HP +     +F   
Sbjct: 33  VFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90

Query: 83  TDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
            +L  V   M + +  DL   I +   F            +++ GL+++H KG ++R +K
Sbjct: 91  ENLFFV---MEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQFLHSKGIVYRDLK 145

Query: 140 ASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLD 193
             +IL+  +G   ++  G   MC       K ++   +         ++++PE+L     
Sbjct: 146 LDNILLDKDGHIKIADFG---MC-------KENMLGDAKTNTFCGTPDYIAPEILLGQ-- 193

Query: 194 GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDG 253
            Y+   D +S G+   E+  G  PF                                   
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPF-------------------------------HGQD 222

Query: 254 EENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN--LLQHAFFK 306
           EE     I          R        ++     R+ +KR L     + QH  F+
Sbjct: 223 EEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKR-LGVRGDIRQHPLFR 274

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 32/205 (15%)

Query: 377 VYLSKHKVTNQLIAVK---KFNLDRMTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDA 432
           V+L++ K TNQ  A+K   K  +  + D+D++    E  V      HP +     +F   
Sbjct: 33  VFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90

Query: 433 TDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
            +L  V   M + +  DL   I +   F            +++ GL+++H KG ++R +K
Sbjct: 91  ENLFFV---MEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQFLHSKGIVYRDLK 145

Query: 490 ASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLD 543
             +IL+  +G   ++  G   MC       K ++   +         ++++PE+L     
Sbjct: 146 LDNILLDKDGHIKIADFG---MC-------KENMLGDAKTNTFCGTPDYIAPEILLGQ-- 193

Query: 544 GYDERSDIYSVGISCCELANGTVPF 568
            Y+   D +S G+   E+  G  PF
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPF 218

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 42/210 (20%), Positives = 82/210 (39%), Gaps = 27/210 (12%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           AVK         ++ ++L  E+  M HL +H NI+  + +      + +++    +G   
Sbjct: 80  AVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138

Query: 99  D---------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHILIS 146
           +           +  F           +L     V  G+ ++  K  IHR V A ++L++
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198

Query: 147 HNG--KACLSGL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
           +    K    GL R +   S    K +   P      + W++PE +   +  Y  +SD++
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLP------VKWMAPESIFDCV--YTVQSDVW 250

Query: 203 SVGISCCELAN-GTVPFAETPTTLMLIEKL 231
           S GI   E+ + G  P+          + +
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 42/210 (20%), Positives = 82/210 (39%), Gaps = 27/210 (12%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           AVK         ++ ++L  E+  M HL +H NI+  + +      + +++    +G   
Sbjct: 80  AVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138

Query: 449 D---------LINAHFNFGLPELVICHILQ---DVLNGLEYIHGKGFIHRAVKASHILIS 496
           +           +  F           +L     V  G+ ++  K  IHR V A ++L++
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198

Query: 497 HNG--KACLSGL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
           +    K    GL R +   S    K +   P      + W++PE +   +  Y  +SD++
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLP------VKWMAPESIFDCV--YTVQSDVW 250

Query: 553 SVGISCCELAN-GTVPFAETPTTLMLIEKL 581
           S GI   E+ + G  P+          + +
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 45/220 (20%), Positives = 92/220 (41%), Gaps = 26/220 (11%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRH 66
            + ++   +LG+       V L K K T +  A+K    +  +  +++     E   +++
Sbjct: 147 MNEFEYLKLLGK--GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLN 123
            RHP +     SF     L  V   M + +  +L   ++    F   E        ++++
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFV---MEYANGGELFFHLSRERVF--SEDRARFYGAEIVS 259

Query: 124 GLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-- 180
            L+Y+H  K  ++R +K  ++++  +G   ++    +C       K  +   +T      
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG-LC-------KEGIKDGATMKTFCG 311

Query: 181 --NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
              +L+PEVLE N   Y    D + +G+   E+  G +PF
Sbjct: 312 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF 349

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 45/220 (20%), Positives = 92/220 (41%), Gaps = 26/220 (11%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRH 416
            + ++   +LG+       V L K K T +  A+K    +  +  +++     E   +++
Sbjct: 147 MNEFEYLKLLGK--GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLN 473
            RHP +     SF     L  V   M + +  +L   ++    F   E        ++++
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFV---MEYANGGELFFHLSRERVF--SEDRARFYGAEIVS 259

Query: 474 GLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL-- 530
            L+Y+H  K  ++R +K  ++++  +G   ++    +C       K  +   +T      
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG-LC-------KEGIKDGATMKTFCG 311

Query: 531 --NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
              +L+PEVLE N   Y    D + +G+   E+  G +PF
Sbjct: 312 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 39/242 (16%), Positives = 86/242 (35%), Gaps = 19/242 (7%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSV-----YLSKHKVTNQLIAVKKFNLDRMTDEDLK 55
           ++ L ++  +  + ++LG C      +     +     ++  L + +   +   T     
Sbjct: 76  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 135

Query: 56  SLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI 114
               + V    +     +    SS   A+   +    +     ++     +   L    +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSP-TKKKVH 170
                 V  G+E++  +  IHR + A +IL+S      +   GL R +       +K   
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255

Query: 171 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIE 229
             P      L W++PE +   +  Y  +SD++S G+   E+ + G  P+           
Sbjct: 256 RLP------LKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

Query: 230 KL 231
           +L
Sbjct: 308 RL 309

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 40/246 (16%), Positives = 87/246 (35%), Gaps = 19/246 (7%)

Query: 347 FNSSVETLDNVPSNYKICSILGQCFNNLSSV-----YLSKHKVTNQLIAVKKFNLDRMTD 401
             S ++ L ++  +  + ++LG C      +     +     ++  L + +   +   T 
Sbjct: 72  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131

Query: 402 EDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLP 460
                   + V    +     +    SS   A+   +    +     ++     +   L 
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191

Query: 461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS--GL-RYMCPFSP-TK 516
              +      V  G+E++  +  IHR + A +IL+S      +   GL R +       +
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251

Query: 517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTL 575
           K     P      L W++PE +   +  Y  +SD++S G+   E+ + G  P+       
Sbjct: 252 KGDARLP------LKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 576 MLIEKL 581
               +L
Sbjct: 304 EFCRRL 309

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 44/192 (22%), Positives = 77/192 (40%), Gaps = 33/192 (17%)

Query: 36  NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII------------CYISSFLDAT 83
            Q +A+K    D+      +   HE +    L+HPN++              I S+    
Sbjct: 39  TQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHG 97

Query: 84  DLH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 139
           DLH    + SP    GS  D          P+ V  H++  +  G+EY+     +H+ + 
Sbjct: 98  DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV--HLVAQIAAGMEYLSSHHVVHKDLA 155

Query: 140 ASHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG- 194
             ++L+       +S  GL R +      K   + L P      + W++PE +   + G 
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP------IRWMAPEAI---MYGK 206

Query: 195 YDERSDIYSVGI 206
           +   SDI+S G+
Sbjct: 207 FSIDSDIWSYGV 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 44/192 (22%), Positives = 77/192 (40%), Gaps = 33/192 (17%)

Query: 386 NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII------------CYISSFLDAT 433
            Q +A+K    D+      +   HE +    L+HPN++              I S+    
Sbjct: 39  TQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHG 97

Query: 434 DLH----LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK 489
           DLH    + SP    GS  D          P+ V  H++  +  G+EY+     +H+ + 
Sbjct: 98  DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV--HLVAQIAAGMEYLSSHHVVHKDLA 155

Query: 490 ASHILISHNGKACLS--GL-RYMCPFSPTKKKVH-LFPPSTAYNLNWLSPEVLEQNLDG- 544
             ++L+       +S  GL R +      K   + L P      + W++PE +   + G 
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP------IRWMAPEAI---MYGK 206

Query: 545 YDERSDIYSVGI 556
           +   SDI+S G+
Sbjct: 207 FSIDSDIWSYGV 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 42/202 (20%), Positives = 86/202 (42%), Gaps = 27/202 (13%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V L + K T +  A+K    +  +  +++     E   +++ RHP +     +F     L
Sbjct: 21  VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80

Query: 86  HLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
             V   M + +  +L   ++    F   E        ++++ LEY+H +  ++R +K  +
Sbjct: 81  CFV---MEYANGGELFFHLSRERVF--TEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135

Query: 143 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYD 196
           +++  +G   ++  G   +C       K  +   +T         +L+PEVLE N   Y 
Sbjct: 136 LMLDKDGHIKITDFG---LC-------KEGISDGATMKTFCGTPEYLAPEVLEDN--DYG 183

Query: 197 ERSDIYSVGISCCELANGTVPF 218
              D + +G+   E+  G +PF
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 42/202 (20%), Positives = 86/202 (42%), Gaps = 27/202 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V L + K T +  A+K    +  +  +++     E   +++ RHP +     +F     L
Sbjct: 21  VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80

Query: 436 HLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
             V   M + +  +L   ++    F   E        ++++ LEY+H +  ++R +K  +
Sbjct: 81  CFV---MEYANGGELFFHLSRERVF--TEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135

Query: 493 ILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGYD 546
           +++  +G   ++  G   +C       K  +   +T         +L+PEVLE N   Y 
Sbjct: 136 LMLDKDGHIKITDFG---LC-------KEGISDGATMKTFCGTPEYLAPEVLEDN--DYG 183

Query: 547 ERSDIYSVGISCCELANGTVPF 568
              D + +G+   E+  G +PF
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 35/207 (16%), Positives = 64/207 (30%), Gaps = 53/207 (25%)

Query: 35  TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC-----------YI------- 76
              ++AVK    +  + +       E   M    +PNI+             +       
Sbjct: 76  PFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY 134

Query: 77  ---SSFLDATDLHLVSPLMGFGSCKDLINAHFN---FGLPELVICHILQDVLNGLEYIHG 130
              + FL +   H V  L           +          E +   I + V  G+ Y+  
Sbjct: 135 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL--CIARQVAAGMAYLSE 192

Query: 131 KGFIHRAVKASHILISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNL 180
           + F+HR +   + L+  N    ++  GL R       Y              P      +
Sbjct: 193 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY------KADGNDAIP------I 240

Query: 181 NWLSPEVLEQNLDG-YDERSDIYSVGI 206
            W+ PE +       Y   SD+++ G+
Sbjct: 241 RWMPPESI---FYNRYTTESDVWAYGV 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 35/207 (16%), Positives = 64/207 (30%), Gaps = 53/207 (25%)

Query: 385 TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC-----------YI------- 426
              ++AVK    +  + +       E   M    +PNI+             +       
Sbjct: 76  PFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY 134

Query: 427 ---SSFLDATDLHLVSPLMGFGSCKDLINAHFN---FGLPELVICHILQDVLNGLEYIHG 480
              + FL +   H V  L           +          E +   I + V  G+ Y+  
Sbjct: 135 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL--CIARQVAAGMAYLSE 192

Query: 481 KGFIHRAVKASHILISHNGKACLS--GL-R-------YMCPFSPTKKKVHLFPPSTAYNL 530
           + F+HR +   + L+  N    ++  GL R       Y              P      +
Sbjct: 193 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY------KADGNDAIP------I 240

Query: 531 NWLSPEVLEQNLDG-YDERSDIYSVGI 556
            W+ PE +       Y   SD+++ G+
Sbjct: 241 RWMPPESI---FYNRYTTESDVWAYGV 264

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 22/160 (13%), Positives = 54/160 (33%), Gaps = 27/160 (16%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           D   + + +   +G        +YL+      +  A     ++    ++   L  E+   
Sbjct: 33  DMEGNQWVLGKKIGS--GGFGLIYLAFPTNKPEKDARHVVKVEY---QENGPLFSELKFY 87

Query: 65  RHLRHPNIICYISSFLDATDL-------------------HLVSPLMGFGSCKDLINAHF 105
           + +   + I           L                    +V   +G    + +   + 
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG-IDLQKISGQNG 146

Query: 106 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
            F   +  +  +   +L+ LEYIH   ++H  +KA+++L+
Sbjct: 147 TF--KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 22/160 (13%), Positives = 54/160 (33%), Gaps = 27/160 (16%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           D   + + +   +G        +YL+      +  A     ++    ++   L  E+   
Sbjct: 33  DMEGNQWVLGKKIGS--GGFGLIYLAFPTNKPEKDARHVVKVEY---QENGPLFSELKFY 87

Query: 415 RHLRHPNIICYISSFLDATDL-------------------HLVSPLMGFGSCKDLINAHF 455
           + +   + I           L                    +V   +G    + +   + 
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG-IDLQKISGQNG 146

Query: 456 NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
            F   +  +  +   +L+ LEYIH   ++H  +KA+++L+
Sbjct: 147 TF--KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 45.2 bits (108), Expect = 3e-05
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 38/206 (18%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 85
           V+L + +   +  A+K    +  +  + ++  + E + +  + HP II    +F DA  +
Sbjct: 22  VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81

Query: 86  HLVSPLMGFG-------SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 138
            ++   +  G         +   N    F   E+ +          LEY+H K  I+R +
Sbjct: 82  FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL---------ALEYLHSKDIIYRDL 132

Query: 139 KASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNL 192
           K  +IL+  NG   ++  G           K V    P   Y L    ++++PEV+    
Sbjct: 133 KPENILLDKNGHIKITDFGF---A------KYV----PDVTYTLCGTPDYIAPEVVSTK- 178

Query: 193 DGYDERSDIYSVGISCCELANGTVPF 218
             Y++  D +S GI   E+  G  PF
Sbjct: 179 -PYNKSIDWWSFGILIYEMLAGYTPF 203

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 45.2 bits (108), Expect = 3e-05
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 38/206 (18%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL 435
           V+L + +   +  A+K    +  +  + ++  + E + +  + HP II    +F DA  +
Sbjct: 22  VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81

Query: 436 HLVSPLMGFG-------SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAV 488
            ++   +  G         +   N    F   E+ +          LEY+H K  I+R +
Sbjct: 82  FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL---------ALEYLHSKDIIYRDL 132

Query: 489 KASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNL 542
           K  +IL+  NG   ++  G           K V    P   Y L    ++++PEV+    
Sbjct: 133 KPENILLDKNGHIKITDFGF---A------KYV----PDVTYTLCGTPDYIAPEVVSTK- 178

Query: 543 DGYDERSDIYSVGISCCELANGTVPF 568
             Y++  D +S GI   E+  G  PF
Sbjct: 179 -PYNKSIDWWSFGILIYEMLAGYTPF 203

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 44.9 bits (107), Expect = 4e-05
 Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 47/222 (21%)

Query: 40  AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 98
           AVK          + ++L  E+  + +L  H NI+  + +        +++    +G   
Sbjct: 57  AVKMLK-PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115

Query: 99  D------------------LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           +                  + +      L +L+       V  G+ ++  K  IHR + A
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLL--SFSYQVAKGMAFLASKNCIHRDLAA 173

Query: 141 SHILISHNG--KACLSGL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 190
            +IL++H    K C  GL R       Y        K     P      + W++PE +  
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLP------VKWMAPESIFN 221

Query: 191 NLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 231
            +  Y   SD++S GI   EL + G+ P+   P      + +
Sbjct: 222 CV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 44.9 bits (107), Expect = 4e-05
 Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 47/222 (21%)

Query: 390 AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCK 448
           AVK          + ++L  E+  + +L  H NI+  + +        +++    +G   
Sbjct: 57  AVKMLK-PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115

Query: 449 D------------------LINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           +                  + +      L +L+       V  G+ ++  K  IHR + A
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLL--SFSYQVAKGMAFLASKNCIHRDLAA 173

Query: 491 SHILISHNG--KACLSGL-R-------YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ 540
            +IL++H    K C  GL R       Y        K     P      + W++PE +  
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLP------VKWMAPESIFN 221

Query: 541 NLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL 581
            +  Y   SD++S GI   EL + G+ P+   P      + +
Sbjct: 222 CV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 42/210 (20%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 84
           V L++HK      AVK       +  ++ K +  E  V +++++HP ++    SF  A  
Sbjct: 54  VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113

Query: 85  LHLVSPLMGFGSCKDL---INAHFNFGLP-------ELVICHILQDVLNGLEYIHGKGFI 134
           L+ V   + + +  +L   +     F  P       E+            L Y+H    +
Sbjct: 114 LYFV---LDYINGGELFYHLQRERCFLEPRARFYAAEIAS---------ALGYLHSLNIV 161

Query: 135 HRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVL 188
           +R +K  +IL+   G   L+  G   +C       K ++   ST         +L+PEVL
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFG---LC-------KENIEHNSTTSTFCGTPEYLAPEVL 211

Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPF 218
            +    YD   D + +G    E+  G  PF
Sbjct: 212 HKQ--PYDRTVDWWCLGAVLYEMLYGLPPF 239

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 42/210 (20%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 434
           V L++HK      AVK       +  ++ K +  E  V +++++HP ++    SF  A  
Sbjct: 54  VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113

Query: 435 LHLVSPLMGFGSCKDL---INAHFNFGLP-------ELVICHILQDVLNGLEYIHGKGFI 484
           L+ V   + + +  +L   +     F  P       E+            L Y+H    +
Sbjct: 114 LYFV---LDYINGGELFYHLQRERCFLEPRARFYAAEIAS---------ALGYLHSLNIV 161

Query: 485 HRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVL 538
           +R +K  +IL+   G   L+  G   +C       K ++   ST         +L+PEVL
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFG---LC-------KENIEHNSTTSTFCGTPEYLAPEVL 211

Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +    YD   D + +G    E+  G  PF
Sbjct: 212 HKQ--PYDRTVDWWCLGAVLYEMLYGLPPF 239

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 30/222 (13%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMR 65
            +++    +LG+   +   V LS+ K T++L AVK    D  + D+D++    E  V   
Sbjct: 340 LTDFNFLMVLGK--GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVL 122
             + P +    S F     L+ V   M + +  DL   I     F   E        ++ 
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFV---MEYVNGGDLMYHIQQVGRF--KEPHAVFYAAEIA 452

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL 180
            GL ++  KG I+R +K  ++++   G   ++  G   MC       K +++   T    
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG---MC-------KENIWDGVTTKTF 502

Query: 181 ----NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
               ++++PE++      Y +  D ++ G+   E+  G  PF
Sbjct: 503 CGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPF 542

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 30/222 (13%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMR 415
            +++    +LG+   +   V LS+ K T++L AVK    D  + D+D++    E  V   
Sbjct: 340 LTDFNFLMVLGK--GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVL 472
             + P +    S F     L+ V   M + +  DL   I     F   E        ++ 
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFV---MEYVNGGDLMYHIQQVGRF--KEPHAVFYAAEIA 452

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL 530
            GL ++  KG I+R +K  ++++   G   ++  G   MC       K +++   T    
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG---MC-------KENIWDGVTTKTF 502

Query: 531 ----NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
               ++++PE++      Y +  D ++ G+   E+  G  PF
Sbjct: 503 CGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPF 542

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 28/203 (13%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 84
           V L++ K T  L AVK    D  + D+D++    E  +      HP +      F     
Sbjct: 39  VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98

Query: 85  LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           L  V   M F +  DL   I     F   E        ++++ L ++H KG I+R +K  
Sbjct: 99  LFFV---MEFVNGGDLMFHIQKSRRF--DEARARFYAAEIISALMFLHDKGIIYRDLKLD 153

Query: 142 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 195
           ++L+ H G   L+  G   MC       K  +    T        ++++PE+L++    Y
Sbjct: 154 NVLLDHEGHCKLADFG---MC-------KEGICNGVTTATFCGTPDYIAPEILQEM--LY 201

Query: 196 DERSDIYSVGISCCELANGTVPF 218
               D +++G+   E+  G  PF
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPF 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 28/203 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 434
           V L++ K T  L AVK    D  + D+D++    E  +      HP +      F     
Sbjct: 39  VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98

Query: 435 LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           L  V   M F +  DL   I     F   E        ++++ L ++H KG I+R +K  
Sbjct: 99  LFFV---MEFVNGGDLMFHIQKSRRF--DEARARFYAAEIISALMFLHDKGIIYRDLKLD 153

Query: 492 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 545
           ++L+ H G   L+  G   MC       K  +    T        ++++PE+L++    Y
Sbjct: 154 NVLLDHEGHCKLADFG---MC-------KEGICNGVTTATFCGTPDYIAPEILQEM--LY 201

Query: 546 DERSDIYSVGISCCELANGTVPF 568
               D +++G+   E+  G  PF
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPF 224

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 24/154 (15%)

Query: 1   METLDN-VPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLH 58
           M   +N V  +YK+   +G+  F     ++   + + NQ +A+K          D   L 
Sbjct: 1   MSGQNNVVGVHYKVGRRIGEGSF---GVIFEGTNLLNNQQVAIK----FEPRRSDAPQLR 53

Query: 59  HEIVCMRHLRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FGLPE 111
            E    + L      PN+  +         LH  LV  L+G  S +DL++     F +  
Sbjct: 54  DEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLVIDLLGP-SLEDLLDLCGRKFSVK- 106

Query: 112 LVICHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
             +    + +L  ++ IH K  ++R +K  + LI
Sbjct: 107 -TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 33/147 (22%), Positives = 60/147 (40%), Gaps = 23/147 (15%)

Query: 357 VPSNYKICSILGQ-CFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
           V  +YK+   +G+  F     ++   + + NQ +A+K          D   L  E    +
Sbjct: 8   VGVHYKVGRRIGEGSF---GVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYK 60

Query: 416 HLRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINAHFN-FGLPELVICHIL 468
            L      PN+  +         LH  LV  L+G  S +DL++     F +    +    
Sbjct: 61  LLAGCTGIPNVYYFGQ-----EGLHNVLVIDLLGP-SLEDLLDLCGRKFSVK--TVAMAA 112

Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILI 495
           + +L  ++ IH K  ++R +K  + LI
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLI 139

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 28/203 (13%)

Query: 27  VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 84
           V LS+ K T++L AVK    D  + D+D++    E  V     + P +    S F     
Sbjct: 36  VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95

Query: 85  LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
           L+ V   M + +  DL   I     F   E        ++  GL ++  KG I+R +K  
Sbjct: 96  LYFV---MEYVNGGDLMYHIQQVGRF--KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150

Query: 142 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 195
           ++++   G   ++  G   MC       K +++   T        ++++PE++      Y
Sbjct: 151 NVMLDSEGHIKIADFG---MC-------KENIWDGVTTKTFCGTPDYIAPEIIAYQ--PY 198

Query: 196 DERSDIYSVGISCCELANGTVPF 218
            +  D ++ G+   E+  G  PF
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPF 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 28/203 (13%)

Query: 377 VYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHE-IVCMRHLRHPNIICYISSFLDATD 434
           V LS+ K T++L AVK    D  + D+D++    E  V     + P +    S F     
Sbjct: 36  VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95

Query: 435 LHLVSPLMGFGSCKDL---INAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
           L+ V   M + +  DL   I     F   E        ++  GL ++  KG I+R +K  
Sbjct: 96  LYFV---MEYVNGGDLMYHIQQVGRF--KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150

Query: 492 HILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLSPEVLEQNLDGY 545
           ++++   G   ++  G   MC       K +++   T        ++++PE++      Y
Sbjct: 151 NVMLDSEGHIKIADFG---MC-------KENIWDGVTTKTFCGTPDYIAPEIIAYQ--PY 198

Query: 546 DERSDIYSVGISCCELANGTVPF 568
            +  D ++ G+   E+  G  PF
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPF 221

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 37/196 (18%), Positives = 64/196 (32%), Gaps = 70/196 (35%)

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTA---- 177
           GL Y+H +  IHR VK+ +IL+  N    ++  G+           + HL   ST     
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI---SKKGTELDQTHL---STVVKGT 204

Query: 178 --YNLNWLSPE-VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
             Y    + PE  ++  L    E+SD+YS G+                   +L E L   
Sbjct: 205 LGY----IDPEYFIKGRL---TEKSDVYSFGV-------------------VLFEVLCAR 238

Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKF-------------SDSFHSI 281
           +          +         N    ++E   +   + +               +S    
Sbjct: 239 SA---------IVQSLPREMVN----LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKF 285

Query: 282 VEL---CLSRDVDKRP 294
            +    CL+   + RP
Sbjct: 286 GDTAVKCLALSSEDRP 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 42.2 bits (100), Expect = 4e-04
 Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 22/92 (23%)

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTA---- 527
           GL Y+H +  IHR VK+ +IL+  N    ++  G+           + HL   ST     
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI---SKKGTELDQTHL---STVVKGT 204

Query: 528 --YNLNWLSPE-VLEQNLDGYDERSDIYSVGI 556
             Y    + PE  ++  L    E+SD+YS G+
Sbjct: 205 LGY----IDPEYFIKGRL---TEKSDVYSFGV 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 22/168 (13%)

Query: 7   VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 66
           V  N+++   +G    N   + L K+  TN+ +A+K   L+         LH E    + 
Sbjct: 7   VGPNFRVGKKIGC--GNFGELRLGKNLYTNEYVAIK---LEP-MKSRAPQLHLEYRFYKQ 60

Query: 67  LRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINA-HFNFGLPELVICHILQ 119
           L      P +  +          +  +V  L+G  S +DL +     F L    +  I  
Sbjct: 61  LGSGDGIPQVYYFGP-----CGKYNAMVLELLGP-SLEDLFDLCDRTFSLK--TVLMIAI 112

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 167
            +++ +EY+H K  I+R VK  + LI   G      + ++  F+  K+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKE 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 22/168 (13%)

Query: 357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH 416
           V  N+++   +G    N   + L K+  TN+ +A+K   L+         LH E    + 
Sbjct: 7   VGPNFRVGKKIGC--GNFGELRLGKNLYTNEYVAIK---LEP-MKSRAPQLHLEYRFYKQ 60

Query: 417 LRH----PNIICYISSFLDATDLH--LVSPLMGFGSCKDLINA-HFNFGLPELVICHILQ 469
           L      P +  +          +  +V  L+G  S +DL +     F L    +  I  
Sbjct: 61  LGSGDGIPQVYYFGP-----CGKYNAMVLELLGP-SLEDLFDLCDRTFSLK--TVLMIAI 112

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 517
            +++ +EY+H K  I+R VK  + LI   G      + ++  F+  K+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKE 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 27/164 (16%), Positives = 55/164 (33%), Gaps = 32/164 (19%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           D   + +K+   +GQ       +YL+    +++ +      + ++   D   L  E+   
Sbjct: 31  DMAAAAWKVGLPIGQ--GGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFY 87

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI---------- 114
           +    P  I              V    G G   D     + F    +++          
Sbjct: 88  QRAAKPEQI-QKWIRTRKLKYLGVPKYWGSGLH-DKNGKSYRF----MIMDRFGSDLQKI 141

Query: 115 -------------CHILQDVLNGLEYIHGKGFIHRAVKASHILI 145
                          +   +L+ LEYIH   ++H  +KAS++L+
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 27/164 (16%), Positives = 55/164 (33%), Gaps = 32/164 (19%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           D   + +K+   +GQ       +YL+    +++ +      + ++   D   L  E+   
Sbjct: 31  DMAAAAWKVGLPIGQ--GGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFY 87

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVI---------- 464
           +    P  I              V    G G   D     + F    +++          
Sbjct: 88  QRAAKPEQI-QKWIRTRKLKYLGVPKYWGSGLH-DKNGKSYRF----MIMDRFGSDLQKI 141

Query: 465 -------------CHILQDVLNGLEYIHGKGFIHRAVKASHILI 495
                          +   +L+ LEYIH   ++H  +KAS++L+
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 1/64 (1%)

Query: 87  LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 146
           LV P +G  S +  ++      L E  +  +   +L+ LE++H   ++H  V A +I + 
Sbjct: 135 LVLPSLG-RSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193

Query: 147 HNGK 150
              +
Sbjct: 194 PEDQ 197

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 1/64 (1%)

Query: 437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS 496
           LV P +G  S +  ++      L E  +  +   +L+ LE++H   ++H  V A +I + 
Sbjct: 135 LVLPSLG-RSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193

Query: 497 HNGK 500
              +
Sbjct: 194 PEDQ 197

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 62/311 (19%), Positives = 121/311 (38%), Gaps = 85/311 (27%)

Query: 27  VYLSKH---KVTNQLIAVKKFNLDRMTDEDLKSLHHEI----VCMRHLRHPNIICYISSF 79
           V+L +      T +L A+K      +  +  K+  H      V     + P ++    +F
Sbjct: 70  VFLVRKISGHDTGKLYAMKVLKKATIVQKA-KTTEHTRTERQVLEHIRQSPFLVTLHYAF 128

Query: 80  LDATDLHLVSPLMGFGSCKDL---INAHFNFGLP-------ELVICHILQDVLNGLEYIH 129
              T LHL+   + + +  +L   ++    F          E+V+          LE++H
Sbjct: 129 QTETKLHLI---LDYINGGELFTHLSQRERFTEHEVQIYVGEIVL---------ALEHLH 176

Query: 130 GKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWL 183
             G I+R +K  +IL+  NG   L+  GL          K+        AY+      ++
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGL---S------KEFVADETERAYDFCGTIEYM 227

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 243
           +P+++     G+D+  D +S+G+                   ++ E L GA+P       
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGV-------------------LMYELLTGASP------- 261

Query: 244 YYVDTGQDDGEENACSYISEQ--QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN--- 298
           + VD  ++   E     IS +  +++    ++ S     +++  L +D  KR L C    
Sbjct: 262 FTVDGEKNSQAE-----ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR-LGCGPRD 315

Query: 299 ---LLQHAFFK 306
              + +H FF+
Sbjct: 316 ADEIKEHLFFQ 326

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.0 bits (97), Expect = 9e-04
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 49/214 (22%)

Query: 27  VYLSKH---KVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 80
           V+L K        QL A+K   K  L        K    E   +  + HP I+    +F 
Sbjct: 40  VFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILVEVNHPFIVKLHYAFQ 96

Query: 81  DATDLHLVSPLMGFGSCKDL---INAHFNFGLP-------ELVICHILQDVLNGLEYIHG 130
               L+L+   + F    DL   ++    F          EL +          L+++H 
Sbjct: 97  TEGKLYLI---LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL---------ALDHLHS 144

Query: 131 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLS 184
            G I+R +K  +IL+   G   L+  GL           K  +     AY+      +++
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGL---S-------KESIDHEKKAYSFCGTVEYMA 194

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 218
           PEV+ +   G+ + +D +S G+   E+  GT+PF
Sbjct: 195 PEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPF 226

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.0 bits (97), Expect = 9e-04
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 49/214 (22%)

Query: 377 VYLSKH---KVTNQLIAVK---KFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL 430
           V+L K        QL A+K   K  L        K    E   +  + HP I+    +F 
Sbjct: 40  VFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILVEVNHPFIVKLHYAFQ 96

Query: 431 DATDLHLVSPLMGFGSCKDL---INAHFNFGLP-------ELVICHILQDVLNGLEYIHG 480
               L+L+   + F    DL   ++    F          EL +          L+++H 
Sbjct: 97  TEGKLYLI---LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL---------ALDHLHS 144

Query: 481 KGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNL----NWLS 534
            G I+R +K  +IL+   G   L+  GL           K  +     AY+      +++
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGL---S-------KESIDHEKKAYSFCGTVEYMA 194

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           PEV+ +   G+ + +D +S G+   E+  GT+PF
Sbjct: 195 PEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPF 226

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	622
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.9e-60  Score=486.84  Aligned_cols=261  Identities=22%  Similarity=0.371  Sum_probs=222.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      -++|++++.||+  |+||+||+|+++.||+.||||++++......+.+.+.+|+++|++|+|||||+++++|.+++.+|+
T Consensus        23 me~Y~~~~~lG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           23 MEKYVRLQKIGE--GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCEEEEEEC--------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEeEEEec--CCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            368999999999  779999999999999999999999888778888889999999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.......++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+|++|||.+........
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999876555679999999999999999999999999999999999999999999999998765432211


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      ..    .+.+||+.|||||++.+  ..|+.++|||||||++|||++|+.||.+.+....+...+.+..|.          
T Consensus       181 ~~----~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------  244 (350)
T 4b9d_A          181 LA----RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP----------  244 (350)
T ss_dssp             HH----HHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----------
T ss_pred             cc----cccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------
Confidence            11    12357889999999975  469999999999999999999999998876665555555554332          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                            .+..+|+++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       245 ----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          245 ----------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             ----------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                                  123578999999999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-59  Score=480.24  Aligned_cols=260  Identities=26%  Similarity=0.441  Sum_probs=220.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ...|++++.||+  |+||+||+|+++.||+.||||+++.....  ..+.+.+|+.+|++|+|||||+++++|.+++.+|+
T Consensus        73 ~~~y~~~~~iG~--G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           73 RSYLDNFIKIGE--GSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGTEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEEeEEeec--CcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            457999999999  77899999999999999999999765432  23457799999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++..   .+++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+|++|||.+........
T Consensus       149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            9999999999999875   3589999999999999999999999999999999999999999999999998765443222


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    ..+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+....+.....+..|.+         
T Consensus       226 ~----~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------  290 (346)
T 4fih_A          226 R----RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------  290 (346)
T ss_dssp             C----BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC---------
T ss_pred             c----ccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---------
Confidence            1    124578999999999975  4699999999999999999999999987665444333333222211         


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                           .....+|+++++||.+||+.||++|||+.|+|+||||++...
T Consensus       291 ---------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          291 ---------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             ---------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ---------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence                                 122457999999999999999999999999999999987543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-59  Score=475.93  Aligned_cols=262  Identities=24%  Similarity=0.347  Sum_probs=221.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +++|++++.||+  |+||+||+|+++.||+.||||++++.... ....+.+.+|+++|++|+|||||+++++|.+++.+|
T Consensus        31 ~~dy~i~~~lG~--G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           31 PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEec--ccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            467999999999  77999999999999999999999764321 223467889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.++++...  .++|..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||.+..+....
T Consensus       109 ivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999999998753  58999999999999999999999999999999999999999999999999876553322


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ...  ...+.+||+.|||||++.+  ..|+.++||||+||++|||++|++||.+.+..........+..+          
T Consensus       187 ~~~--~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------  252 (311)
T 4aw0_A          187 KQA--RANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----------  252 (311)
T ss_dssp             TCC--CBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------
T ss_pred             Ccc--cccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            111  1234578999999999976  46899999999999999999999999876655444444333211          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHh------hhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN------LLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~------~l~h~~~~~~~~  310 (622)
                                             .+..+|+++++||++||+.||++|||++|      +++||||+...+
T Consensus       253 -----------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw  299 (311)
T 4aw0_A          253 -----------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  299 (311)
T ss_dssp             -----------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             -----------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence                                   12347899999999999999999999998      588999987543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-58  Score=459.35  Aligned_cols=255  Identities=20%  Similarity=0.305  Sum_probs=204.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||++++....+. ..+.+.+|+++|++|+|||||+++++|.+++.+|+
T Consensus        13 g~Y~i~~~lG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC-----CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             eCeEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            58999999999  7789999999999999999999987654433 35678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||| +|+|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+....... 
T Consensus        91 vmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             EEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            99999 58999998764  358999999999999999999999999999999999999999999999999875432211 


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                          ...+.+||+.|||||++.+. ..++.++||||+||++|+|++|+.||.+.+..........+.. .          
T Consensus       167 ----~~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~----------  230 (275)
T 3hyh_A          167 ----FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-T----------  230 (275)
T ss_dssp             ------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-C----------
T ss_pred             ----ccCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence                12245789999999999763 3346899999999999999999999987655443333222221 1          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                            .+..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus       231 ----------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 ----------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ----------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                                  12347899999999999999999999999999999965

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.3e-58  Score=481.70  Aligned_cols=260  Identities=26%  Similarity=0.439  Sum_probs=220.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -...|++++.||+  |+||+||+|+++.||+.||||+++.....  ..+.+.+|+.+|++|+|||||+++++|.+.+.+|
T Consensus       149 p~~~y~~~~~iG~--G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGE--GSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEecc--CcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            3457999999999  77889999999999999999999876433  2355789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.++++.   ..++|..++.|+.||+.||+|||++|||||||||+||||+.+|.+|++|||.+..+....
T Consensus       225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            99999999999999965   258999999999999999999999999999999999999999999999999876543322


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..    ..+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+......+.....+..|.+        
T Consensus       302 ~~----~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--------  367 (423)
T 4fie_A          302 PR----RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--------  367 (423)
T ss_dssp             CC----BCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------
T ss_pred             cc----ccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--------
Confidence            21    124578999999999975  4699999999999999999999999987765544433333322211        


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                            .....+|+++++||.+||+.||++|||+.|+|+||||++..
T Consensus       368 ----------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          368 ----------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             ----------------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                                  12345799999999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-57  Score=457.38  Aligned_cols=254  Identities=22%  Similarity=0.395  Sum_probs=215.3

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe----CCcEE
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----ATDLH   86 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~   86 (622)
                      |++.++||+  |+||+||+|.++.||+.||||++......+...+.+.+|+.+|++|+|||||+++++|.+    ...+|
T Consensus        28 ~~~~~~iG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEec--CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            488889999  789999999999999999999998877777778889999999999999999999999976    24589


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcC-CCceEEcCCccccccC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISH-NGKACLSGLRYMCPFS  163 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~~~  163 (622)
                      +|||||++|+|.+++....  .+++..++.|+.||+.||+|||++|  ||||||||+||||+. +|.+|++|||.+....
T Consensus       106 lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999999998753  5899999999999999999999998  999999999999985 7899999999875332


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ...      ..+.+||+.|||||++.+   .|+.++|||||||++|||++|+.||.+......+...+....+.      
T Consensus       184 ~~~------~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~------  248 (290)
T 3fpq_A          184 ASF------AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------  248 (290)
T ss_dssp             TTS------BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------
T ss_pred             CCc------cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC------
Confidence            211      123468899999999864   49999999999999999999999998766555555555332110      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                              ...+...++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       249 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                                    0112346789999999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-58  Score=467.53  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=212.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +++|++++.||+  |+||+||+|++.   .+++.||||++++......+...+.+|+.+|++|+|||||+++++|.+++.
T Consensus        23 p~~Y~i~~~lG~--G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           23 PSQFELLKVLGQ--GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGGEEEEEEEEC--GGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             ccccEEEEEEec--CCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            468999999999  779999999984   578999999998654333333457789999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+|||||++|+|.+++....  .++|..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||.+.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999999998753  589999999999999999999999999999999999999999999999998754332


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ...    ...+.+||+.|||||++.+  ..|+.++||||+||++|||++|+.||.+.+..........+..+        
T Consensus       179 ~~~----~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------  244 (304)
T 3ubd_A          179 HEK----KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG--------  244 (304)
T ss_dssp             --C----CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred             CCc----cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence            221    1234578999999999975  46999999999999999999999999877655544444333211        


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~~~~~  309 (622)
                                               .+..+|+++++||++||+.||++|||+     +|+++||||+...
T Consensus       245 -------------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          245 -------------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             -------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -------------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                                     123478999999999999999999995     7999999998754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-56  Score=469.46  Aligned_cols=291  Identities=20%  Similarity=0.260  Sum_probs=224.3

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-   82 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-   82 (622)
                      ..++.++|++++.||+  |+||+||+|+++.||+.||||+++.........+.+.+|+++|++|+|||||++++++... 
T Consensus        49 ~~~i~~~Y~~~~~lG~--G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           49 TFDVGDEYEIIETIGN--GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CCCCCSSEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCCCCCeEEEEEEec--ccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            3467789999999999  7788999999999999999999987766677778899999999999999999999998643 


Q ss_pred             -----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         83 -----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        83 -----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                           ..+|+|||||+ |+|.+++...  ..+++..++.+++||+.||+|||++|||||||||+|||++.+|.++++|||
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecc
Confidence                 57999999997 6799988653  368999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HHHhCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EKLAGAT  235 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~  235 (622)
                      .+..+............+.++|+.|||||++.+. .+|+.++||||+||++|||++|++||.+.+....+.  ....+.+
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            8765543322222223356789999999998754 467999999999999999999999998876544433  3333433


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhc-----cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQ-----VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      +... ..        .........++......     ......+|+++.+||++||+.||++|||+.|+|+||||++..
T Consensus       283 ~~~~-~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          283 SPAV-IQ--------AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             CGGG-TC-------------CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             ChHH-hh--------hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            2110 00        00000000000000000     001235789999999999999999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.1e-56  Score=455.81  Aligned_cols=258  Identities=22%  Similarity=0.254  Sum_probs=210.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ..|++.+.||+  |+||+||+|+++.||+.||||+++.+...       .+|+.+|++|+|||||+++++|.+++.+|+|
T Consensus        58 ~~~~~~~~lG~--G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGR--GSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEecc--CCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56899999999  77999999999999999999999875432       3699999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCccccccCCCCc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++|+|.++++...  .++|..++.|+.||+.||+|||++|||||||||+||||+.+| .+|++|||.+..+.....
T Consensus       129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999999998753  589999999999999999999999999999999999999998 699999998765433211


Q ss_pred             c-ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 K-VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~-~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      . ........+||+.|||||++.+  ..|+.++||||+||++|||++|++||.+............+..|.         
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~---------  275 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI---------  275 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG---------
T ss_pred             ccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc---------
Confidence            1 1112233478999999999976  469999999999999999999999998654332222222222110         


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhh-------------hcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL-------------LQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~-------------l~h~~~~~~~  309 (622)
                                           ...+..+|+++.+||.+||+.||++|||+.|+             |+|||+...+
T Consensus       276 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          276 ---------------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             ---------------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             ---------------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence                                 01234579999999999999999999999997             5688886543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-54  Score=440.90  Aligned_cols=261  Identities=21%  Similarity=0.362  Sum_probs=201.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-----
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----   83 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||+++... .+...+.+.+|+++|++|+|||||+++++|.+.+     
T Consensus         5 ~dy~~~~~lG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGR--GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEE--CC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEec--CCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            46999999999  779999999999999999999997654 4555677899999999999999999999998654     


Q ss_pred             -------cEEEEeecCCCCCHHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         84 -------DLHLVSPLMGFGSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        84 -------~~~lv~e~~~~g~l~~~l~~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                             .+|+|||||++|+|.+++...... ..++..+..++.||++||+|||++||+||||||+|||++.+|.+|++|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   379999999999999999765322 245677889999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCcccc--------ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH
Q psy15039        156 LRYMCPFSPTKKKVH--------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  227 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~  227 (622)
                      ||.+...........        ....+.+||+.|||||++.+  ..|+.++|||||||++|||++   ||.........
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            998765433221110        01123468999999999975  469999999999999999996   88654333333


Q ss_pred             HHHHhC-CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        228 IEKLAG-ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       228 ~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                      ...+.. ..|.                                .....++...+||.+||+.||++|||+.|+++||||+
T Consensus       237 ~~~~~~~~~p~--------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~  284 (299)
T 4g31_A          237 LTDVRNLKFPP--------------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE  284 (299)
T ss_dssp             HHHHHTTCCCH--------------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHhcCCCCC--------------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            333221 1110                                1122466788999999999999999999999999998


Q ss_pred             ccc
Q psy15039        307 QTK  309 (622)
Q Consensus       307 ~~~  309 (622)
                      ...
T Consensus       285 ~~~  287 (299)
T 4g31_A          285 DLD  287 (299)
T ss_dssp             CC-
T ss_pred             CCC
Confidence            754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.2e-54  Score=447.00  Aligned_cols=294  Identities=21%  Similarity=0.291  Sum_probs=213.3

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEE
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISS   78 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~   78 (622)
                      .++++.++|++++.||+  |+||+||+|+++   .+++.||||++.....    ...+.+|+++|+.+ +|||||+++++
T Consensus        15 ~~p~l~~~Y~i~~~lG~--G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~   88 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGE--GTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYC   88 (361)
T ss_dssp             HSGGGGGTCEEEEEEEE--CSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred             hcCCccCcEEEEEEEec--ccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            45677889999999999  779999999986   4788999999866432    24567899999999 69999999999


Q ss_pred             EEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CceEEcCCc
Q psy15039         79 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLR  157 (622)
Q Consensus        79 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~-~~~~i~~~~  157 (622)
                      |.+.+.+|+|||||++|+|.++++     ++++..++.++.||+.||+|||++||+||||||+|||++.+ +.++++|||
T Consensus        89 ~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           89 FRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            999999999999999999999983     37899999999999999999999999999999999999876 799999999


Q ss_pred             cccccCCCCcccc------------------------ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc
Q psy15039        158 YMCPFSPTKKKVH------------------------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN  213 (622)
Q Consensus       158 ~~~~~~~~~~~~~------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~  213 (622)
                      .+...........                        ....+.++|+.|||||++.+. ..|+.++||||+||++|||++
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHH
Confidence            8754332211100                        001234689999999999754 468999999999999999999


Q ss_pred             CCCCCCCCchHHHH---HHHHhCCCCCCCccccc------cccCCCCcC-------------cccccccchhhhhccccC
Q psy15039        214 GTVPFAETPTTLML---IEKLAGATPHLLDCTTY------YVDTGQDDG-------------EENACSYISEQQTQVLTS  271 (622)
Q Consensus       214 g~~Pf~~~~~~~~~---~~~~~~~~p~~~~~~~~------~~~~~~~~~-------------~~~~~~~i~~~~~~~~~~  271 (622)
                      |+.||.........   +..+.|..+........      ....+..+.             .......+.........+
T Consensus       243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  322 (361)
T 4f9c_A          243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW  322 (361)
T ss_dssp             TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence            99999765433222   22222211000000000      000000000             000000000000111223


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        272 RKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       272 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ..+|+++.|||++||+.||++||||+|+|+||||++.
T Consensus       323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            4579999999999999999999999999999999763

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-53  Score=426.86  Aligned_cols=257  Identities=21%  Similarity=0.353  Sum_probs=207.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+++++++.||+  |+||+||+|+++.   .||||+++....+++..+.+.+|+.+|++|+|||||++++++. .+.+++
T Consensus        35 ~~~l~l~~~iG~--G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~i  108 (307)
T 3omv_A           35 ASEVMLSTRIGS--GSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAI  108 (307)
T ss_dssp             TTSCCEEEECCC--CSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEeeEEee--CCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEE
Confidence            468899999999  7799999998753   5999999877667778889999999999999999999999865 467899


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.... ..+++..+..|+.||++||+|||+++||||||||+||||+.++.+|++|||.+........
T Consensus       109 VmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999997643 4589999999999999999999999999999999999999999999999998754332111


Q ss_pred             cccccCCCCCCCccccChhhhccc-cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCC--CCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT--PHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~--p~~~~~~~~  244 (622)
                      .  ....+.++|+.|||||++.+. ...|+.++|||||||++|||+||+.||.+......+...+....  |.+.     
T Consensus       188 ~--~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~-----  260 (307)
T 3omv_A          188 S--QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS-----  260 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST-----
T ss_pred             c--eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc-----
Confidence            1  112234788999999999642 23589999999999999999999999987665544444443221  1110     


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              .....+++++.+|+.+||+.||++|||+.+++++
T Consensus       261 ------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          261 ------------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ------------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ------------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                    0123578899999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-53  Score=430.35  Aligned_cols=258  Identities=20%  Similarity=0.333  Sum_probs=211.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ++|.+.+.||+  |+||+||+|+++     .+|+.||||+++..  +....+.+.+|+++|++|+|||||++++++.+++
T Consensus        13 ~~~~l~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGE--GAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC----CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEee--CCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            58999999999  779999999975     47889999999653  4566778999999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceE
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF-----------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC  152 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~-----------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~  152 (622)
                      .+++|||||++|+|.+++....           ...+++..+..++.||++||+|||+++||||||||+||||+.++.+|
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999999997632           23589999999999999999999999999999999999999999999


Q ss_pred             EcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHH
Q psy15039        153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       153 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~  231 (622)
                      ++|||.+........  ........+|+.|||||++.+  ..|+.++|||||||++|||+| |+.||.+...........
T Consensus       169 i~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          169 IGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             ECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             ECCcccceecCCCCc--eeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999998754332211  112223457889999999976  469999999999999999998 999998876554444443


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      .+..+.                                .+..+++++.+|+.+||+.||++|||+.++  ++|+++.
T Consensus       245 ~~~~~~--------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          245 QGRVLQ--------------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HTCCCC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             cCCCCC--------------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            333221                                123478899999999999999999999999  4566543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5e-53  Score=434.03  Aligned_cols=224  Identities=21%  Similarity=0.362  Sum_probs=193.1

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++.....+....+.+.+|+.+|+.|+|||||+++++|.+.+.+|+|
T Consensus        24 e~Y~~~~~lG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGE--GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC--------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEec--CCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            57999999999  8899999999999999999999998888888888999999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      ||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+..... 
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  180 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-  180 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence            9999999999999876555678999999999999999999999999999999999999999999999998754432111 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  590 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~  590 (622)
                         ...+.+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+..++.+..|++.+
T Consensus       181 ---~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~  247 (350)
T 4b9d_A          181 ---LARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL  247 (350)
T ss_dssp             ---HHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             ---cccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc
Confidence               1123568999999999976  569999999999999999999999999887777777777776665443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.9e-52  Score=428.14  Aligned_cols=254  Identities=18%  Similarity=0.279  Sum_probs=205.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ++|.+.++||+  |+||+||+|+++     .+++.||||+++..  +....+.|.+|+++|++|+|||||++++++.+..
T Consensus        41 ~d~~l~~~LG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGE--GAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEcc--CCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            57899999999  789999999865     47899999999653  4566788999999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF-------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK  150 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~-------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~  150 (622)
                      .+++|||||++|+|.++++...             ...+++..+..|+.||++||+|||+++||||||||+||||+.++.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence            9999999999999999997542             234889999999999999999999999999999999999999999


Q ss_pred             eEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHH
Q psy15039        151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIE  229 (622)
Q Consensus       151 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~  229 (622)
                      +|++|||.+........  ........+|+.|||||++.+  ..|+.++|||||||++|||+| |+.||.+......+..
T Consensus       197 ~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             EEECCCC------------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             EEEcccccceeccCCCc--ceecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999998754432211  111234467889999999975  468999999999999999998 8999987665544433


Q ss_pred             HHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       230 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ...+..+.                                .+..+++++.+|+.+||+.||++|||+.+++++
T Consensus       273 i~~g~~~~--------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGRELE--------------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCCCC--------------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCCCC--------------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            33332211                                123578899999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.5e-52  Score=454.90  Aligned_cols=259  Identities=23%  Similarity=0.368  Sum_probs=215.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM----TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ++|+++++||+  |+||+||+|+++.||+.||||++++...    .........+|+.+++.++|||||+++++|.+.+.
T Consensus       189 ddf~i~k~LG~--G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          189 NDFSVHRIIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             HHeEEEEEEec--ccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            58999999999  7799999999999999999999975422    22223334456788899999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+|||||++|+|.+++....  .++|..++.|+.||+.||+|||++|||||||||+||||+.+|.++++|||.+..+..
T Consensus       267 lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            999999999999999998753  589999999999999999999999999999999999999999999999998865543


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHHHhCCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~~~~~~p~~~~~~  242 (622)
                      ..      ..+.+||+.|||||++..+ .+|+.++|||||||++|||++|.+||.+...  ...+...+....+      
T Consensus       345 ~~------~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~------  411 (689)
T 3v5w_A          345 KK------PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------  411 (689)
T ss_dssp             CC------CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC------
T ss_pred             CC------CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC------
Confidence            22      2345789999999999643 4699999999999999999999999975322  2222222211111      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                                ..+..+|+++++||..||+.||.+|++     ++++++||||+...+
T Consensus       412 --------------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          412 --------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             --------------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             --------------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence                                      123457999999999999999999998     799999999988654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5e-52  Score=422.45  Aligned_cols=255  Identities=16%  Similarity=0.284  Sum_probs=207.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +++++++.||+  |+||+||+|+..     .+++.||||+++... .....+.|.+|+.+|++|+|||||+++|++.++.
T Consensus        26 ~~~~~~~~lG~--G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGE--DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEE--CSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHCeEeeEecc--CCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            47899999999  779999999863     578899999997543 3344567889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  149 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~  149 (622)
                      .+++|||||++|+|.++|....              ...+++..+..++.||++||+|||+++||||||||+||||+.++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence            9999999999999999996532              13488999999999999999999999999999999999999999


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI  228 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~  228 (622)
                      .+|++|||.+.......  ......+..+|+.|||||++.+  ..|+.++|||||||++|||+| |..||.+........
T Consensus       183 ~~Ki~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          183 NVKISDLGLFREVYAAD--YYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CEEECCSCCBCGGGGGG--CBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CEEECCcccceeccCCC--ceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999875432211  1112234567889999999976  369999999999999999998 899998776544333


Q ss_pred             HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        229 EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       229 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ....+..+                                +.+..+++++.+|+..||+.||++|||+.+++++
T Consensus       259 ~i~~~~~~--------------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVL--------------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCC--------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCC--------------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33222211                                1223568899999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-52  Score=422.62  Aligned_cols=218  Identities=23%  Similarity=0.361  Sum_probs=187.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +++|++++.||+  |+||.||+|+++.+|+.||||++.+....+ ...+.+.+|+.+|+.|+|||||+++++|.+.+.+|
T Consensus        31 ~~dy~i~~~lG~--G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           31 PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEec--ccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            467999999999  789999999999999999999997543211 22467899999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +|||||+||+|.+++.+..  .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++..+....
T Consensus       109 ivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999999998754  47899999999999999999999999999999999999999999999999876554322


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ..  ....+.+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+..+..+
T Consensus       187 ~~--~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~  249 (311)
T 4aw0_A          187 KQ--ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL  249 (311)
T ss_dssp             TC--CCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             Cc--ccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            11  12235689999999999976  56999999999999999999999999887655544444444

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-51  Score=454.82  Aligned_cols=262  Identities=19%  Similarity=0.269  Sum_probs=220.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +-++|++++.||+  |+||+||+|+++.||+.||||++....  ..+.+.+.+|+.+|++|+|||||+++++|.+...+|
T Consensus       155 il~~Y~i~~~lG~--G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          155 VLDHYDIHEELGT--GAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEee--ccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3468999999999  779999999999999999999997653  445577889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC--CceEEcCCccccccCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSP  164 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~--~~~~i~~~~~~~~~~~  164 (622)
                      +|||||++|+|.+++.... ..++|..++.+++||+.||+|||++||+||||||+|||++.+  |.++++|||.+..+..
T Consensus       231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            9999999999999986432 358999999999999999999999999999999999999864  7999999998766543


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....     .+.++|+.|||||++.+  ..|+.++||||+||++|||++|.+||.+......+.....+..+.       
T Consensus       310 ~~~~-----~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~-------  375 (573)
T 3uto_A          310 KQSV-----KVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-------  375 (573)
T ss_dssp             TSEE-----EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-------
T ss_pred             CCce-----eeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC-------
Confidence            3211     12367899999999976  468999999999999999999999998776655444333322110       


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                            .......+|+++++||++||+.||.+|||+.|+|+||||+...
T Consensus       376 ----------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          376 ----------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             ----------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             ----------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence                                  0012345799999999999999999999999999999998643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.9e-51  Score=419.37  Aligned_cols=216  Identities=25%  Similarity=0.445  Sum_probs=186.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ...|++.+.||+  |+||.||+|+++.||+.||||++.......  .+.+.+|+.+|+.|+|||||+++++|.+.+.+|+
T Consensus        73 ~~~y~~~~~iG~--G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           73 RSYLDNFIKIGE--GSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGTEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEEeEEeec--CcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            356999999999  889999999999999999999997654332  3568899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++...   .+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+.....
T Consensus       149 vmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             EECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            99999999999998753   488999999999999999999999999999999999999999999999998765543221


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  586 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p  586 (622)
                      .    ..+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+....+........|
T Consensus       226 ~----~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~  288 (346)
T 4fih_A          226 R----RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP  288 (346)
T ss_dssp             C----BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC
T ss_pred             c----ccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence            1    234689999999999975  56999999999999999999999999987766655444444333

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.5e-51  Score=420.24  Aligned_cols=255  Identities=18%  Similarity=0.292  Sum_probs=209.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccC-----CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVT-----NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH-PNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~   82 (622)
                      ++|++++.||+  |+||+||+|+++.+     ++.||||+++... ...+.+.+.+|+++|++|+| ||||+++++|...
T Consensus        64 ~~~~l~~~LG~--G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           64 DRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHeEEeeEEec--CCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            58999999999  77999999998754     4689999997653 45566789999999999976 8999999998764


Q ss_pred             -CcEEEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC
Q psy15039         83 -TDLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH  147 (622)
Q Consensus        83 -~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~  147 (622)
                       ..+++|||||++|+|.++|+...              ...+++..+..++.||++||+|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence             56999999999999999997532              124789999999999999999999999999999999999999


Q ss_pred             CCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHH
Q psy15039        148 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLM  226 (622)
Q Consensus       148 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~  226 (622)
                      ++.+|++|||.+..........  ...+..+|+.|||||++.+  ..|+.++|||||||++|||+| |..||.+......
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCEEECcchhhhhcccCCCce--eeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999886543322111  1223456888999999976  469999999999999999998 9999987654444


Q ss_pred             HHHHHh-CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        227 LIEKLA-GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       227 ~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      +...+. +..|.                                .+..+++++.+++..||+.||++|||+.++++|
T Consensus       297 ~~~~i~~g~~~~--------------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRMR--------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCCC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCC--------------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            443332 21111                                123468899999999999999999999999987

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.7e-50  Score=402.68  Aligned_cols=212  Identities=22%  Similarity=0.406  Sum_probs=184.8

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe----CCcEE
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----ATDLH  436 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~~~~~  436 (622)
                      |++.+.||+  |+||.||+|+++.+++.||+|++.....+....+++.+|+.+|+.|+|||||+++++|.+    ...+|
T Consensus        28 ~~~~~~iG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEec--CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            478889999  889999999999999999999998777777778889999999999999999999999976    24589


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcC-CCceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISH-NGKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~--iiHRDlKp~NILl~~-~~~~~~~~~~~~~~~~  513 (622)
                      +|||||++|+|.+++.+..  .+++..+..++.||+.||+|||+++  ||||||||+||||+. +|.+||+|||++....
T Consensus       106 lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999999998754  4789999999999999999999998  999999999999985 7899999999875322


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ..      ...+.+||+.|||||++.+   .|+.++|||||||++|||+||++||.+......+...+....
T Consensus       184 ~~------~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~  246 (290)
T 3fpq_A          184 AS------FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV  246 (290)
T ss_dssp             TT------SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred             CC------ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC
Confidence            11      1224578999999999864   599999999999999999999999988777777777766543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-50  Score=401.18  Aligned_cols=217  Identities=22%  Similarity=0.366  Sum_probs=172.5

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHH-HHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||||++......+.. .+++.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus        13 g~Y~i~~~lG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGE--GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC-----CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             eCeEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999  88999999999999999999999876554433 5678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||| +|+|.+++....  .+++..+..++.||+.||+|||++|||||||||+|||++.+|.+|++|||++......  
T Consensus        91 vmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  165 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--  165 (275)
T ss_dssp             EEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence            99999 589999987653  5899999999999999999999999999999999999999999999999986543221  


Q ss_pred             ceeccCCCCCCCCccccccccccCccCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                         ....+.+||+.|||||++.+  ..| +.++||||+||++|||+||++||.+.+... +.+.+....+.+
T Consensus       166 ---~~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~~~~~  231 (275)
T 3hyh_A          166 ---NFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGVYTL  231 (275)
T ss_dssp             ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC
T ss_pred             ---CccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCC
Confidence               11234678999999999976  344 679999999999999999999998875544 445554444443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.2e-51  Score=414.96  Aligned_cols=217  Identities=22%  Similarity=0.309  Sum_probs=179.3

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      +++|++++.||+  |+||.||+|++.   .+++.||||++...........++.+|+.+|+.|+|||||+++++|.+.+.
T Consensus        23 p~~Y~i~~~lG~--G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           23 PSQFELLKVLGQ--GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGGEEEEEEEEC--GGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             ccccEEEEEEec--CCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            468999999999  789999999984   578999999997654333333467899999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+|||||+||+|.+++.+..  .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+|++|||++.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999999998754  478999999999999999999999999999999999999999999999998754322


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ..    ....+.+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+..+.+..+..+.
T Consensus       179 ~~----~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~  242 (304)
T 3ubd_A          179 HE----KKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK  242 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             CC----ccccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence            11    12345679999999999976  569999999999999999999999999877666555555443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.3e-50  Score=419.44  Aligned_cols=216  Identities=25%  Similarity=0.435  Sum_probs=187.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ...|++.+.||+  |+||.||+|+++.||+.||||++.......  .+.+.+|+.+|+.|+|||||+++++|.+.+.+|+
T Consensus       150 ~~~y~~~~~iG~--G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          150 RSYLDNFIKIGE--GSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GGTEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEeeeEecc--CcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            467999999999  889999999999999999999998654332  3568899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||+||+|.+++...   .+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+.....
T Consensus       226 VmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             EEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             EEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            99999999999998753   488999999999999999999999999999999999999999999999998765543221


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  586 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p  586 (622)
                          ...+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+....+..+.....|
T Consensus       303 ----~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~  365 (423)
T 4fie_A          303 ----RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP  365 (423)
T ss_dssp             ----CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             ----cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence                1234678999999999976  56999999999999999999999999988766655444444433

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.7e-50  Score=409.51  Aligned_cols=214  Identities=24%  Similarity=0.278  Sum_probs=180.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ...|++.+.||+  |+||.||+|+++.+|+.||||+++.+...       .+|+.+|+.|+|||||+++++|.+.+.+|+
T Consensus        57 ~~~~~~~~~lG~--G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           57 VHWMTHQPRVGR--GSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhheEeCcEecc--CCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456899999999  78999999999999999999999865432       469999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-ceEEcCcccccccCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPFSPTK  516 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~-~~~~~~~~~~~~~~~~~  516 (622)
                      |||||+||+|.++++...  .+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||++..+....
T Consensus       128 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999999998754  488999999999999999999999999999999999999998 69999999876554322


Q ss_pred             Cc-eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        517 KK-VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       517 ~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      .. ........+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+..+..+.
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~  272 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP  272 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC
T ss_pred             cccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC
Confidence            11 1112234579999999999976  569999999999999999999999998876655444444443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.4e-49  Score=416.24  Aligned_cols=309  Identities=43%  Similarity=0.716  Sum_probs=228.9

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      .++.....+|++++.||+|+++||.||+|+++.+|+.||||+++.........+.+.+|+.+|++++|||||+++++|.+
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            35566778999999999966589999999999999999999998876667777888999999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ...+++|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||....
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999999999876545689999999999999999999999999999999999999999999999987543


Q ss_pred             cCCC---CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        162 FSPT---KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       162 ~~~~---~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      ....   .......+....+|+.|+|||++.++...|+.++|||||||++|+|++|+.||.+..........+.+..|.+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            2111   1111122333467888999999986545689999999999999999999999987665555544444443332


Q ss_pred             CccccccccCCC-----CcCcccccccch--------hhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        239 LDCTTYYVDTGQ-----DDGEENACSYIS--------EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       239 ~~~~~~~~~~~~-----~~~~~~~~~~i~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .+..........     ............        ...........+++++.+||.+||+.||++|||+.++|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence            221100000000     000000000000        0000111234578999999999999999999999999999999


Q ss_pred             ccccc
Q psy15039        306 KQTKK  310 (622)
Q Consensus       306 ~~~~~  310 (622)
                      +....
T Consensus       338 ~~~~~  342 (389)
T 3gni_B          338 KQIKR  342 (389)
T ss_dssp             GGC--
T ss_pred             HHHhh
Confidence            87654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-49  Score=402.40  Aligned_cols=250  Identities=19%  Similarity=0.288  Sum_probs=201.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      .++|.+.+.||+  |+||.||+|++.     .+++.||||++...  +....+.+.+|+.+|++|+|||||++++++.+.
T Consensus        12 r~~~~l~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGE--GAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC----CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEee--CCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            357999999999  889999999865     46889999998743  455677899999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCce
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHF-----------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  501 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~-----------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~  501 (622)
                      +.+++|||||++|+|.++++.+.           ...+++..+..++.||+.||+|||+++||||||||+|||++.++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence            99999999999999999997642           2358999999999999999999999999999999999999999999


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHH
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  580 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~  580 (622)
                      ||+|||++.......  .........||+.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+..+.+...
T Consensus       168 Ki~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          168 KIGDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             EECCCSCHHHHTGGG--CEEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             EECCcccceecCCCC--ceeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999875433221  1122334568899999999976  469999999999999999999 89999998777766666


Q ss_pred             HcCCCCCCCC-CCcccccCCCCcCcccccchhhhhh
Q psy15039        581 LAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       581 ~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      ..+..|+.++ ++....+....|...++.++++-++
T Consensus       244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~  279 (299)
T 4asz_A          244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKG  279 (299)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            6666655544 4444555555565556555555443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.8e-48  Score=400.01  Aligned_cols=260  Identities=20%  Similarity=0.318  Sum_probs=221.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ...+|++++.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+++|+.++||||+++++++.+...+|
T Consensus        13 ~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           13 HIGNYRLLKTIGK--GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             EETTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            3468999999999  77999999999999999999999887667777888999999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        91 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999999997653  58899999999999999999999999999999999999999999999999875443322


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .     .....+|+.|+|||++.+. ..++.++||||+||++|+|++|+.||.+............+..+          
T Consensus       169 ~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  232 (328)
T 3fe3_A          169 K-----LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR----------  232 (328)
T ss_dssp             G-----GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------
T ss_pred             c-----cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence            1     1234678899999999754 23357999999999999999999999877655444333333211          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                             .+..+++++.+|+++||..||.+|||+.++++||||....
T Consensus       233 -----------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          233 -----------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             -----------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                                   1234688999999999999999999999999999997643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.2e-50  Score=406.49  Aligned_cols=258  Identities=21%  Similarity=0.283  Sum_probs=192.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   83 (622)
                      ..+|.+.+.||+  |+||+||+|++  +|+.||||+++...   .......+|+..+.+|+|||||++++++..++    
T Consensus         2 ar~i~L~~~iG~--G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGK--GRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEE--CSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEee--CCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            457999999999  77999999987  58999999996532   22223456888888999999999999998754    


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEEcCCCceEEcC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK--------GFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--------~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                      .+|||||||++|+|.++++..   ++++..+..++.|++.||+|||++        +||||||||+||||+.++.+|++|
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            589999999999999999763   478899999999999999999987        999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhcccc----CCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-------
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL----DGYDERSDIYSVGISCCELANGTVPFAETPTT-------  224 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~----~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-------  224 (622)
                      ||.+...............+..+|+.|||||++.+..    ..|+.++|||||||++|||+||.+||......       
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            9987544333222222233457899999999996531    13567999999999999999998877532110       


Q ss_pred             -------HHHHHHHhCC--CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC
Q psy15039        225 -------LMLIEKLAGA--TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL  295 (622)
Q Consensus       225 -------~~~~~~~~~~--~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps  295 (622)
                             ..+...+...  .|.+                           .........++.+.+|+.+||+.||++|||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~rp~~---------------------------p~~~~~~~~~~~l~~li~~cl~~dP~~RPt  284 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCEQKLRPNI---------------------------PNRWQSCEALRVMAKIMRECWYANGAARLT  284 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCC---------------------------CGGGGSSHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred             ccccchHHHHHHHHhcccCCCCC---------------------------CccccchHHHHHHHHHHHHHcccCHhHCcC
Confidence                   1111111000  0000                           000111223457889999999999999999


Q ss_pred             HHhhhcC
Q psy15039        296 ACNLLQH  302 (622)
Q Consensus       296 ~~~~l~h  302 (622)
                      +.++++.
T Consensus       285 ~~ei~~~  291 (303)
T 3hmm_A          285 ALRIKKT  291 (303)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=398.67  Aligned_cols=250  Identities=17%  Similarity=0.241  Sum_probs=196.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ..++.+.+.||+  |+||.||+|+.+     .+++.||||++...  +....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus        40 ~~d~~l~~~LG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           40 RRDIVLKWELGE--GAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEEEEEcc--CCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            357889999999  889999999864     46899999998643  455677899999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHF-------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  499 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~-------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~  499 (622)
                      +.+++|||||++|+|.++++.+.             ..++++..+..++.||+.||+|||+++||||||||+||||+.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            99999999999999999997642             13478999999999999999999999999999999999999999


Q ss_pred             ceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHH
Q psy15039        500 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLI  578 (622)
Q Consensus       500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~  578 (622)
                      .+||+|||++.......  .........||+.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+..+.+.
T Consensus       196 ~~Ki~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTD--YYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             EEEECCCC------------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             cEEEcccccceeccCCC--cceecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999875443221  1112234578999999999976  569999999999999999999 899999887776666


Q ss_pred             HHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhhh
Q psy15039        579 EKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       579 ~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      ....+..|+.++ ++....+....|...++.++.+-++
T Consensus       272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e  309 (329)
T 4aoj_A          272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKD  309 (329)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHH
Confidence            666666555544 4444445555555555555554433

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-48  Score=392.44  Aligned_cols=217  Identities=21%  Similarity=0.350  Sum_probs=180.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .+++++.+.||+  |+||.||+|+.+   ..||||++.....+....+.+.+|+.+|++|+|||||++++++. .+.+++
T Consensus        35 ~~~l~l~~~iG~--G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~i  108 (307)
T 3omv_A           35 ASEVMLSTRIGS--GSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAI  108 (307)
T ss_dssp             TTSCCEEEECCC--CSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEeeEEee--CCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEE
Confidence            467889999999  889999999864   35999999877777777889999999999999999999999875 467899


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+||||++++.+||+|||++........
T Consensus       109 VmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999997643 3588999999999999999999999999999999999999999999999998754332111


Q ss_pred             ceeccCCCCCCCCccccccccccC-ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                        .....+.+||+.|||||++... ...|+.++|||||||++|||+||++||.+.+....+...+..
T Consensus       188 --~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~  252 (307)
T 3omv_A          188 --SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR  252 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT
T ss_pred             --ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence              1112345789999999999642 235899999999999999999999999988776666665544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-48  Score=396.85  Aligned_cols=251  Identities=16%  Similarity=0.273  Sum_probs=200.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      .+++++.+.||+  |+||.||+|+.     ..+++.||||++.... +....+.+.+|+.+|++|+|||||++++++.+.
T Consensus        25 ~~~~~~~~~lG~--G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           25 LSAVRFMEELGE--DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHCeEeeEecc--CCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            346789999999  88999999985     3467899999987543 233356799999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN  498 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~--------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~  498 (622)
                      +.+++|||||++|+|.++|....              ...+++..+..++.||+.||+|||+++||||||||+||||+++
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK  181 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence            99999999999999999996532              1347899999999999999999999999999999999999999


Q ss_pred             CceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHH
Q psy15039        499 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLML  577 (622)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~  577 (622)
                      +.+||+|||++.......  ......+..||+.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+..+.+
T Consensus       182 ~~~Ki~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAAD--YYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             GCEEECCSCCBCGGGGGG--CBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             CCEEECCcccceeccCCC--ceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999865432211  1122334578999999999976  469999999999999999998 89999988776655


Q ss_pred             HHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhhh
Q psy15039        578 IEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       578 ~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .....+..++.++ ++....+...+|-..++.++.+-.+
T Consensus       258 ~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~e  296 (308)
T 4gt4_A          258 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD  296 (308)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            5555665555544 5666666666776666666665444

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-47  Score=388.55  Aligned_cols=264  Identities=28%  Similarity=0.509  Sum_probs=220.3

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..+...+|++.+.||+  |+||+||+|+++.+|+.||||++.......  .+.+.+|+.+|++++|||||+++++|...+
T Consensus        15 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQ--GASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             SSCGGGTBCCCEEEEE--ETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCChhhceeeeeeecc--CCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence            3456679999999999  779999999999999999999987654332  345779999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++||||+++|+|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999999999999999763   48899999999999999999999999999999999999999999999999765443


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .....    .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||.................+..     
T Consensus       168 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----  236 (297)
T 3fxz_A          168 PEQSK----RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----  236 (297)
T ss_dssp             STTCC----BCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----
T ss_pred             Ccccc----cCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            32211    123467888999999975  3589999999999999999999999987665444433322221110     


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                               ..+..+++.+.+|+.+||+.||++|||+.++++||||+..+.
T Consensus       237 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          237 -------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             -------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             -------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence                                     112357889999999999999999999999999999987654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=404.15  Aligned_cols=219  Identities=21%  Similarity=0.293  Sum_probs=186.1

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC---
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA---  432 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~---  432 (622)
                      .+.++|++++.||+  |+||.||+|+++.||+.||||++..........+++.+|+.+|+.|+|||||++++++...   
T Consensus        51 ~i~~~Y~~~~~lG~--G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGN--GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEec--ccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence            34568999999999  8899999999999999999999987766677778899999999999999999999987643   


Q ss_pred             ---CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        433 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       433 ---~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                         +.+|+|||||+ |+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+|++|||++
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence               57899999997 6799988764  35899999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ..+............+.+||+.|||||++.+. ..|+.++||||+||++|||++|++||.+.+...++..+
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I  275 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI  275 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            65543322222334567899999999998753 35799999999999999999999999988776665443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-47  Score=397.73  Aligned_cols=264  Identities=19%  Similarity=0.261  Sum_probs=219.2

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      .++.++|++++.||+  |+||.||+|+++.+|+.||||.++......    ...+.+.+|+.+|++++|||||+++++|.
T Consensus         8 ~~~~~~y~~~~~LG~--G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   85 (361)
T 2yab_A            8 QKVEDFYDIGEELGS--GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE   85 (361)
T ss_dssp             SCGGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CChhhceEEeeEEee--CcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence            467789999999999  779999999999999999999998754321    12456889999999999999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----ceEEcCC
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGL  156 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~----~~~i~~~  156 (622)
                      +...+++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++    .+++.||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999999999653  3589999999999999999999999999999999999998876    7999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      |.+........     .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||.+............+..+
T Consensus       164 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~  236 (361)
T 2yab_A          164 GLAHEIEDGVE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD  236 (361)
T ss_dssp             SSCEECCTTCC-----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             CCceEcCCCCc-----cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence            98755432211     123467889999999975  45899999999999999999999999876655444333322211


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ..                             ...+..+++++.+||..||..||.+|||+.++++||||...
T Consensus       237 ~~-----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          237 FD-----------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             CC-----------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             CC-----------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            00                             00124578999999999999999999999999999999754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=406.87  Aligned_cols=265  Identities=22%  Similarity=0.278  Sum_probs=222.1

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..+.++|++++.||+  |+||.||+|.++.+|+.||+|+++.......+.+.+.+|+.+|++|+|||||+++++|.+...
T Consensus         7 ~~~~~~Y~i~~~LG~--G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            7 TRFTEEYQLFEELGK--GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             CHHHHHEEEEEEEEE--C--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             ccccCCeEEEEEecc--CCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            456679999999999  779999999999999999999998877766777889999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~~~~~~~  161 (622)
                      .|+|||||++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+++.|||.+..
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999999998764  35899999999999999999999999999999999999984   57899999998755


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      .......    ..+..+|+.|+|||++.+  ..|+.++||||+||++|+|++|.+||..............+..+.    
T Consensus       163 ~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----  232 (444)
T 3soa_A          163 VEGEQQA----WFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF----  232 (444)
T ss_dssp             CCTTCCB----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----
T ss_pred             ecCCCce----eecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC----
Confidence            4332211    123467889999999975  358999999999999999999999998766554444433332211    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                               .......+++++.+||..||+.||++|||+.++|+||||...
T Consensus       233 -------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          233 -------------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             -------------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             -------------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                     011234578999999999999999999999999999999763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.3e-47  Score=397.05  Aligned_cols=264  Identities=25%  Similarity=0.316  Sum_probs=221.2

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..+.++|++.+.||+  |+||.||+|.++.+|+.||||+++.......+.+.+.+|+.+|++|+|||||+++++|.+...
T Consensus        25 ~~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           25 TKFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             CHHHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCcccCeEEeeEEec--CCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            345568999999999  779999999999999999999998877777778889999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~~~~~  161 (622)
                      .|+|||||++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++   .+++.|||....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999999988653  3578999999999999999999999999999999999998654   599999998755


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ......     .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||..............+..+.    
T Consensus       181 ~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----  249 (362)
T 2bdw_A          181 VNDSEA-----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY----  249 (362)
T ss_dssp             CTTCCS-----CCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----
T ss_pred             ecCCcc-----cccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----
Confidence            432211     123467889999999975  358999999999999999999999998765544333333332110    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                               +...+..+++++.+||.+||..||++||++.++|+||||...
T Consensus       250 -------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          250 -------------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             -------------------------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             -------------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                     001123568999999999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.7e-47  Score=390.67  Aligned_cols=258  Identities=19%  Similarity=0.297  Sum_probs=215.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||++++++|.+.+.+++
T Consensus         5 ~~y~~~~~lG~--G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            5 NDFDYLKLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHeEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            58999999999  7799999999999999999999865321 11234567799999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||..........
T Consensus        83 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999999999987643  478999999999999999999999999999999999999999999999997654221111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    ..+.++|+.|+|||++.+  ..|+.++|||||||++|||++|..||..............+..            
T Consensus       161 ~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------  222 (337)
T 1o6l_A          161 T----MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------  222 (337)
T ss_dssp             C----BCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred             c----ccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            1    123467889999999975  4689999999999999999999999987655433332222211            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                           ..+..+++++.+||.+||+.||.+||     ++.++++||||....
T Consensus       223 ---------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          223 ---------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence                                 01235789999999999999999999     899999999998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-47  Score=387.92  Aligned_cols=206  Identities=22%  Similarity=0.409  Sum_probs=165.2

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-----
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-----  433 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-----  433 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++.... .+...+++.+|+.+|+.|+|||||+++++|.+.+     
T Consensus         5 ~dy~~~~~lG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGR--GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEE--CC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEec--CCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            46999999999  889999999999999999999997654 4455678999999999999999999999998654     


Q ss_pred             -------cEEEEeeccCCCCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcC
Q psy15039        434 -------DLHLVSPLMGFGSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  505 (622)
Q Consensus       434 -------~~~lv~e~~~~g~l~~~l~~~~~~-~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~  505 (622)
                             .+|+|||||++|+|.+++...... ..++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   379999999999999999865332 245667889999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCcee--------ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        506 LRYMCPFSPTKKKVH--------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       506 ~~~~~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      ||++..+........        ....+.+||+.|||||++.+  ..|+.++|||||||++|||++   ||....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            998765443221110        11234579999999999976  569999999999999999996   886543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.4e-46  Score=380.49  Aligned_cols=285  Identities=21%  Similarity=0.293  Sum_probs=214.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++.+.||+  |+||+||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+...+++|
T Consensus         2 ~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGE--GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecC--CCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            57999999999  7788999999999999999999987766556667788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++ ++.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.........
T Consensus        80 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            999985 555555443 245899999999999999999999999999999999999999999999999987554322111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH---HhCCCCCCCcccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK---LAGATPHLLDCTTYY  245 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~---~~~~~p~~~~~~~~~  245 (622)
                          .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|..||............   ..+.++. ..+....
T Consensus       158 ----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~  231 (292)
T 3o0g_A          158 ----YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE-EQWPSMT  231 (292)
T ss_dssp             ----CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT-TTCTTGG
T ss_pred             ----ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh-hhhhhhc
Confidence                1233567889999999753 34899999999999999999988886544333222222   2222211 1110000


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                       ......   .... .............+++++.+|+..||+.||++|||+.|+++||||++.
T Consensus       232 -~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          232 -KLPDYK---PYPM-YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             -GSTTCC---CCCC-CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             -cccccc---cccc-ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence             000000   0000 000000111223578999999999999999999999999999999763

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.2e-47  Score=394.19  Aligned_cols=260  Identities=20%  Similarity=0.309  Sum_probs=214.0

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      .++|+++++||+  |+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.+ +|||||+++++|.+.+.+
T Consensus        22 ~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           22 IDNFEFIRVLGK--GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             -CCEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEee--CCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            368999999999  7799999999999999999999875422 122345677999999998 799999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+......
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999997753  5899999999999999999999999999999999999999999999999976532211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..    ...+.++|+.|+|||++.+.  .|+.++|||||||++|||++|..||..............+...         
T Consensus       178 ~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------  242 (353)
T 3txo_A          178 GV----TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---------  242 (353)
T ss_dssp             ------------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred             Cc----cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            11    12234678899999999753  5899999999999999999999999877655444333332211         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH------HhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA------CNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~~l~h~~~~~~~~  310 (622)
                                              .+..+++++.+|++.||+.||.+||++      .++++||||+...+
T Consensus       243 ------------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          243 ------------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             ------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             ------------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                                    123478999999999999999999999      89999999987643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-46  Score=383.98  Aligned_cols=290  Identities=22%  Similarity=0.308  Sum_probs=215.1

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..++.++|++++.||+  |+||+||+|+++ +|+.||||++..........+.+.+|+.+|++++|||||++++++.+..
T Consensus        16 ~q~l~~~y~~~~~lG~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGE--GTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             EECSSCEEEEEEEEEE--CSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             ecchHhhhHhhhhccC--CCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            4578899999999999  778899999996 5999999999766544445567889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++||||++ |++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        93 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           93 CLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             CEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            9999999998 47777776543 358999999999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH--HHHHHhCCC-CCCCc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM--LIEKLAGAT-PHLLD  240 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~--~~~~~~~~~-p~~~~  240 (622)
                      .....    .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.+......  .+....+.. |....
T Consensus       171 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          171 IPVRS----YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             SCCC-------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             CCccc----ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            22211    1123557889999998753 4589999999999999999999999986543322  222223322 21110


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ............     .... +..........+++++.+|+.+||+.||++|||+.++++||||++..
T Consensus       246 ~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          246 QVQELPLWKQRT-----FQVF-EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             GGTTSHHHHSCC-----CCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhhccchhhhcc-----cccc-cCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            000000000000     0000 00000011235789999999999999999999999999999998743

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=387.55  Aligned_cols=261  Identities=18%  Similarity=0.243  Sum_probs=218.0

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ++.++|++++.||+  |+||.||+|+++.+|+.||+|.+...   ......+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGR--GEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEec--CCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            57889999999999  77999999999999999999998654   34456688999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCceEEcCCccccccC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFS  163 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~--~~~~~i~~~~~~~~~~  163 (622)
                      ++|||||++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.  ++.+++.|||.+....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999999999986532 35899999999999999999999999999999999999987  7899999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .....     ....+|+.|+|||++.+.  .++.++||||+||++|+|++|..||..............+..+..     
T Consensus       156 ~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----  223 (321)
T 1tki_A          156 PGDNF-----RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-----  223 (321)
T ss_dssp             TTCEE-----EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----
T ss_pred             CCCcc-----ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-----
Confidence            32211     122457789999999753  478999999999999999999999987665544433333322110     


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                              ......+++++.+|+.+||..||.+|||+.++|+||||++.
T Consensus       224 ------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          224 ------------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ------------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                                    01123578999999999999999999999999999999764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-46  Score=383.69  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=215.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .++|++++.||+  |+||+||+|+++.+|+.||||+++..... ....+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus         5 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            368999999999  77889999999999999999998653211 122456778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+...... 
T Consensus        83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            999999999999999764  35889999999999999999999999999999999999999999999999987543221 


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                            ..+..+|+.|+|||++.+  ..|+.++|||||||++|||++|..||............+.+..+          
T Consensus       160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  221 (318)
T 1fot_A          160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR----------  221 (318)
T ss_dssp             ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------
T ss_pred             ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence                  123467888999999975  45899999999999999999999999876554443333332110          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                             .+..+++++.+++++||+.||.+||     +++++++||||+...+
T Consensus       222 -----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          222 -----------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             -----------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence                                   1234789999999999999999999     8999999999987543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.8e-46  Score=381.37  Aligned_cols=291  Identities=22%  Similarity=0.292  Sum_probs=204.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++++.||+  |+||.||+|.++.+|+.||||+++.... ....+.+.+|+.+|++++|||||++++++.+.+.+++
T Consensus         4 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGN--GTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             -----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECC--CCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            568999999999  7788999999999999999999976542 2223557789999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         88 VSPLMGFGSCKDLINAHF----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ||||++ |+|.+++....    ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||......
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999999 68998886542    1348899999999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HHHhCCCCCC-Cc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EKLAGATPHL-LD  240 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~p~~-~~  240 (622)
                      .....    .....+|+.|+|||++.+. ..|+.++|||||||++|+|++|+.||........+.  ....+.++.. ..
T Consensus       160 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPVNT----FSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCCCC----CCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             CCccc----CCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            22111    1233567889999998753 358999999999999999999999998766543332  2223332211 10


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .......... .........+. ..........+++++.+|+..||+.||++|||+.++++||||++..
T Consensus       235 ~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          235 SVTKLPKYNP-NIQQRPPRDLR-QVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GGGGCTTCCT-TCCCCCCCCSH-HHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhhhhccc-ccccccchhHH-HhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            0000000000 00000000000 0011122345789999999999999999999999999999998744

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4e-46  Score=393.25  Aligned_cols=260  Identities=20%  Similarity=0.329  Sum_probs=212.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~   86 (622)
                      ++|+++++||+  |+||+||+|+++.+++.||||++++.... ....+.+.+|+.+|+++ +|||||+++++|.+...+|
T Consensus        52 ~~y~~~~~LG~--G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           52 QDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             hHcEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            58999999999  77999999999999999999999875433 33445677899999887 8999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+.......
T Consensus       130 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999999987653  58999999999999999999999999999999999999999999999999765322111


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--------HHHHHHHHhCCCCCC
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--------TLMLIEKLAGATPHL  238 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--------~~~~~~~~~~~~p~~  238 (622)
                      .    ...+.++|+.|+|||++.+  ..|+.++|||||||++|||++|+.||.....        ...+...+...    
T Consensus       208 ~----~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----  277 (396)
T 4dc2_A          208 D----TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----  277 (396)
T ss_dssp             C----CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred             C----ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence            1    1224467889999999976  4689999999999999999999999964211        11111221111    


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH------HhhhcCcccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA------CNLLQHAFFKQTKK  310 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~~l~h~~~~~~~~  310 (622)
                                                  ....+..+|+++.+||+.||+.||.+||++      .++++||||+...+
T Consensus       278 ----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          278 ----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             ----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             ----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence                                        111234578999999999999999999995      79999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-46  Score=387.41  Aligned_cols=261  Identities=20%  Similarity=0.326  Sum_probs=215.3

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCc
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD   84 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~   84 (622)
                      ..++|++++.||+  |+||+||+|+++.+|+.||||+++.... .....+.+.+|..+|+.+ +||||++++++|.+.+.
T Consensus        15 ~~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             -CTTEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChHHeEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            3579999999999  7788999999999999999999975321 112245567899999887 99999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.++++|||.+.....
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            999999999999999997643  488999999999999999999999999999999999999999999999997654322


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....    ..+.++|+.|+|||++.+  ..|+.++||||+||++|||++|..||.+............+. +.       
T Consensus       171 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~-------  236 (345)
T 1xjd_A          171 GDAK----TNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PF-------  236 (345)
T ss_dssp             TTCC----BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CC-------
T ss_pred             CCCc----ccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CC-------
Confidence            1111    223467889999999975  358999999999999999999999998765544333322221 11       


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHH-hhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-NLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~-~~l~h~~~~~~~~  310 (622)
                                               .+..+++++.+||.+||+.||++||++. ++++||||+...+
T Consensus       237 -------------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          237 -------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             -------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             -------------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                                     1234789999999999999999999998 9999999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-45  Score=383.01  Aligned_cols=260  Identities=20%  Similarity=0.331  Sum_probs=214.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      .++|++++.||+  |+||.||+|+++.+|+.||||++++... .....+.+.+|+.+|+++ +|||||+++++|.+...+
T Consensus         8 ~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            358999999999  7799999999999999999999987543 445567788999999998 899999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||........
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999997643  5899999999999999999999999999999999999999999999999986542211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--------HHHHHHHHhCCCCC
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--------TLMLIEKLAGATPH  237 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--------~~~~~~~~~~~~p~  237 (622)
                      ..    ...+..+|+.|+|||++.+  ..|+.++|||||||++|||++|..||.....        ...+...+...   
T Consensus       164 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---  234 (345)
T 3a8x_A          164 GD----TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---  234 (345)
T ss_dssp             TC----CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---
T ss_pred             CC----cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---
Confidence            11    1123467889999999975  4689999999999999999999999964211        11111111110   


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH------HhhhcCccccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA------CNLLQHAFFKQTK  309 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~~l~h~~~~~~~  309 (622)
                                                   ....+..+++++.+|+.+||+.||.+||++      .++++||||+...
T Consensus       235 -----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          235 -----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             -----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             -----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence                                         011123578999999999999999999996      7999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.6e-46  Score=375.66  Aligned_cols=283  Identities=23%  Similarity=0.326  Sum_probs=212.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||+||+|++ .+|+.||||++..........+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lg~--G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGE--GTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEE--ETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhccc--CCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            58999999999  77999999999 6899999999976543333345677999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||+++ ++.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.........
T Consensus        79 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            999985 8888886542 45899999999999999999999999999999999999999999999999987544322111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~~p~~~~~~~~~~  246 (622)
                          .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|..||.+......+...  ..+..+.. .+... .
T Consensus       157 ----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~  229 (288)
T 1ob3_A          157 ----YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK-NWPNV-T  229 (288)
T ss_dssp             ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT-TSTTG-G
T ss_pred             ----cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChh-hchhh-h
Confidence                1123557889999998653 35899999999999999999999999876654443332  22222110 00000 0


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      .....  ......+..  .........+++++.+|+.+||+.||++|||+.++++||||++
T Consensus       230 ~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          230 ELPKY--DPNFTVYEP--LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             GSTTC--CTTCCCCCC--CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccc--ccccccccC--ccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            00000  000000000  0000112357899999999999999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=384.37  Aligned_cols=264  Identities=20%  Similarity=0.280  Sum_probs=217.2

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      .++.++|++.+.||+  |+||.||+|+++.+|+.||||.++......    ...+.+.+|+.+|++|+|||||+++++|.
T Consensus         7 ~~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   84 (326)
T 2y0a_A            7 ENVDDYYDTGEELGS--GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE   84 (326)
T ss_dssp             SCHHHHEEEEEEEEC--CSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCcccceEeceEEee--CCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            456678999999999  779999999999999999999997654321    12466889999999999999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----ceEEcCC
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGL  156 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~----~~~i~~~  156 (622)
                      +...+++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++    .+++.||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           85 NKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999999999653  3589999999999999999999999999999999999999877    7999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      |.+........     .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||.................+
T Consensus       163 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  235 (326)
T 2y0a_A          163 GLAHKIDFGNE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE  235 (326)
T ss_dssp             TTCEECCTTSC-----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CCCeECCCCCc-----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence            98755432211     123456888999999965  45899999999999999999999999876554433333222111


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      .                             .......+++++.+|+..||..||++|||+.++++||||+..
T Consensus       236 ~-----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          236 F-----------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             C-----------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             c-----------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            0                             000123568899999999999999999999999999999764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.7e-45  Score=369.95  Aligned_cols=266  Identities=25%  Similarity=0.323  Sum_probs=223.3

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..+.++|++.+.||+  |+||.||+|.++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus         2 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            2 TKFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             CTTTTTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             chhhhhhhhhhhhcC--cCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence            467899999999999  779999999999999999999998877777778889999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---eEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~---~~i~~~~~~~~  161 (622)
                      .++||||++++++.+.+....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.   +++.|||....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999999998887653  4789999999999999999999999999999999999987665   99999998754


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ......     .....+|+.|+|||++.+  ..++.++||||+||++|+|++|..||..............+....    
T Consensus       158 ~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  226 (284)
T 3kk8_A          158 VNDSEA-----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY----  226 (284)
T ss_dssp             CCSSCB-----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----
T ss_pred             cccCcc-----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC----
Confidence            432211     123456788999999975  357899999999999999999999998766544433333222110    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                               +......+++++.+|+..||+.||++|||+.++++||||.....
T Consensus       227 -------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          227 -------------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             -------------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             -------------------------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence                                     01122457899999999999999999999999999999987554

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-46  Score=395.86  Aligned_cols=268  Identities=22%  Similarity=0.303  Sum_probs=216.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..++|+++++||+  |+||+||+|+++.+|+.||+|++++.... ......+.+|+.+|+.++|||||+++++|.+...+
T Consensus        67 ~~~~y~~~~~LG~--G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           67 KAEDYEVVKVIGR--GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEc--CCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            3468999999999  77999999999999999999998652110 01123467899999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+......
T Consensus       145 ~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            9999999999999998652   5899999999999999999999999999999999999999999999999987544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccC--CCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLD--GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~--~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ..   ....+.++|+.|+|||++.....  .|+.++|||||||++|||++|+.||............+.+.         
T Consensus       222 ~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------  289 (410)
T 3v8s_A          222 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---------  289 (410)
T ss_dssp             SE---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---------
T ss_pred             Cc---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc---------
Confidence            11   11224567889999999975321  27789999999999999999999998765543333322110         


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCccccccccC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~~~  311 (622)
                                          .....+....+|+++++||..||+.+|.+  ||+++++++||||+...+.
T Consensus       290 --------------------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          290 --------------------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             --------------------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             --------------------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence                                00111223457999999999999999988  9999999999999886543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-45  Score=389.70  Aligned_cols=294  Identities=19%  Similarity=0.268  Sum_probs=211.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCC--
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT--   83 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~--   83 (622)
                      +.++|++++.||+  |+||.||+|.++.+|+.||||++..........+.+.+|+.+|+++. |||||+++++|...+  
T Consensus         7 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            7 VLRKYELVKKLGK--GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHTTEEEEEC---------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             ccCceEEEEEeee--CCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            4578999999999  77889999999999999999999766566777788889999999997 999999999998654  


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+|+|||||+ |+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+..+.
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            6999999998 6888888762   47899999999999999999999999999999999999999999999999875432


Q ss_pred             CCCccc-----------------cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH
Q psy15039        164 PTKKKV-----------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  226 (622)
Q Consensus       164 ~~~~~~-----------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~  226 (622)
                      ......                 ........+|+.|+|||++.+. ..|+.++||||+||++|||++|++||.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            211000                 0011234678899999999753 4689999999999999999999999988765444


Q ss_pred             HHHHH--hCCCCCCCccccc-------ccc-------CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCC
Q psy15039        227 LIEKL--AGATPHLLDCTTY-------YVD-------TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDV  290 (622)
Q Consensus       227 ~~~~~--~~~~p~~~~~~~~-------~~~-------~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP  290 (622)
                      +...+  .+.+ ...+....       +..       ............+ .............++++.+|+.+||+.||
T Consensus       240 ~~~i~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          240 LERIIGVIDFP-SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW-KNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHCCC-CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHH-HHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhcCCC-CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcch-hhhcccccccccCCHHHHHHHHHhhccCc
Confidence            33322  2221 10000000       000       0000000000000 00001111233678999999999999999


Q ss_pred             CCCcCHHhhhcCccccccc
Q psy15039        291 DKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       291 ~~Rps~~~~l~h~~~~~~~  309 (622)
                      ++|||+.++|+||||+...
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTC
T ss_pred             ccCCCHHHHhCCHHHHHhc
Confidence            9999999999999997643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.6e-46  Score=385.76  Aligned_cols=257  Identities=19%  Similarity=0.288  Sum_probs=216.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .++|++++.||+  |+||.||+|+++.+|+.||||+++.... .....+.+.+|+.+|++++||||++++++|.+...+|
T Consensus        40 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           40 LDQFDRIKTLGT--GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHCEEEEEeec--CcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            468999999999  7788999999999999999999865321 1123456789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||........ 
T Consensus       118 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999999997753  4889999999999999999999999999999999999999999999999987544321 


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                            ..+..+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||..............+..+          
T Consensus       195 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------  256 (350)
T 1rdq_E          195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----------  256 (350)
T ss_dssp             ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------
T ss_pred             ------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence                  123467889999999975  45899999999999999999999999876554433333332211          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                             .+..+++++.+||.+||+.||.+||+     ++++++||||....+
T Consensus       257 -----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          257 -----------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -----------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -----------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                                   12357899999999999999999998     999999999987543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-46  Score=377.18  Aligned_cols=259  Identities=18%  Similarity=0.337  Sum_probs=206.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH------------------------HHHHHHHHHHHHH
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------------------------EDLKSLHHEIVCM   64 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~------------------------~~~~~~~~Ei~il   64 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||||++.......                        ...+.+.+|+++|
T Consensus        13 ~~y~~~~~lG~--G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           13 NQYTLKDEIGK--GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             TTEEEEEEEEC----CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             cceEEEeEEee--cCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            68999999999  778899999999999999999997654211                        1235678999999


Q ss_pred             hhCCCCcceeEEEEEEe--CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q psy15039         65 RHLRHPNIICYISSFLD--ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH  142 (622)
Q Consensus        65 ~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~N  142 (622)
                      ++|+||||+++++++.+  ...+++||||+++++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            99999999999999987  5679999999999998876432   358999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCC-CCCcchHHHHHHHHHHHhcCCCCCCCC
Q psy15039        143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELANGTVPFAET  221 (622)
Q Consensus       143 iLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~-~~~~~DiWSlG~il~el~~g~~Pf~~~  221 (622)
                      ||++.++.+++.|||.+.........    .....+|+.|+|||++.+.... ++.++|||||||++|+|++|..||...
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDAL----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCE----ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEECCCCCEEEecCCCcccccccccc----ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999987554332211    1234678899999998754221 367899999999999999999999876


Q ss_pred             chHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        222 PTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       222 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ..............                               ..+....+++++.+|+.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIMCLHSKIKSQAL-------------------------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHHHHHHHHHHCCC-------------------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHHHHHHHHhcccC-------------------------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            54332222211111                               01122457899999999999999999999999999


Q ss_pred             Cccccc
Q psy15039        302 HAFFKQ  307 (622)
Q Consensus       302 h~~~~~  307 (622)
                      ||||++
T Consensus       293 hp~~~~  298 (298)
T 2zv2_A          293 HPWVTR  298 (298)
T ss_dssp             CHHHHC
T ss_pred             CccccC
Confidence            999953

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3e-46  Score=389.99  Aligned_cols=264  Identities=22%  Similarity=0.342  Sum_probs=212.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +.++|++++.||+  |+||+||+|+++.+|+.||||+++....   .....+.+.+|+.+|++|+|||||+++++|.+..
T Consensus        22 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           22 FEDVYELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG   99 (351)
T ss_dssp             HHHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEEeeEEee--CCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            4568999999999  7799999999999999999999864211   1112456789999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---eEEcCCcc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLRY  158 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~---~~i~~~~~  158 (622)
                      .+|+|||||++|+|.+.+....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.   +++.|||.
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999999988875432  234789999999999999999999999999999999999987654   99999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      .........    ......+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||...... .......+..+..
T Consensus       180 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~~  252 (351)
T 3c0i_A          180 AIQLGESGL----VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMN  252 (351)
T ss_dssp             CEECCTTSC----BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCCC
T ss_pred             eeEecCCCe----eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCCC
Confidence            765433211    1223467889999999975  35899999999999999999999999875322 2222222221100


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                   ......+++++.+||.+||..||++|||+.++++||||+..
T Consensus       253 -----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          253 -----------------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             -----------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             -----------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                                         00123578999999999999999999999999999999764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-45  Score=397.68  Aligned_cols=291  Identities=21%  Similarity=0.310  Sum_probs=205.5

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      ..+.++|++++.||+  |+||+||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||+++++|...  
T Consensus        49 ~~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGT--GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CCSCTTEEECCC---------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             CccCCCeEEeeEeee--cCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            356789999999999  7788999999999999999999977666667778899999999999999999999999554  


Q ss_pred             ---CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         83 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        83 ---~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                         ..+|+||||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+
T Consensus       127 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          127 EKFDELYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccCceEEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence               46999999985 7888888653  35899999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCccc-----------------------cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc---
Q psy15039        160 CPFSPTKKKV-----------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN---  213 (622)
Q Consensus       160 ~~~~~~~~~~-----------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~---  213 (622)
                      ..........                       .....+..+|+.|+|||++... ..|+.++|||||||++|||++   
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcc
Confidence            5543211100                       0011234668899999987543 468999999999999999998   


Q ss_pred             --------CCCCCCCCch----------------------HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccch-
Q psy15039        214 --------GTVPFAETPT----------------------TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYIS-  262 (622)
Q Consensus       214 --------g~~Pf~~~~~----------------------~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~-  262 (622)
                              |.+||.+...                      +...+..+.|.++. .+.     ....   ......++. 
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~-~~~-----~~~~---~~~~~~~~~~  353 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE-EDI-----EALE---KEDAKRYIRI  353 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCH-HHH-----HTSS---CHHHHHHHTT
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCH-HHH-----hhcC---CHHHHHHHHh
Confidence                    6667754321                      11122222332211 000     0000   000000000 


Q ss_pred             --hhh--hccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        263 --EQQ--TQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       263 --~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                        ...  .........++++.+||.+||..||.+|||+.|+|+||||+....
T Consensus       354 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             SCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             cCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence              000  000112346899999999999999999999999999999987654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.1e-46  Score=381.76  Aligned_cols=266  Identities=18%  Similarity=0.313  Sum_probs=213.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      .+-++|++.+.||+  |+||+||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++|||||++++++.+....
T Consensus         4 ~~~~~y~i~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            4 PFVEDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTTCEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cHhhhceeeeEEec--CCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            46789999999999  7799999999999999999999976543 22335678999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++|||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||....+...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999999988653  35899999999999999999999999999999999999999999999999987543221


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...  .......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||..................         
T Consensus       159 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------  226 (323)
T 3tki_A          159 NRE--RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------  226 (323)
T ss_dssp             TEE--CCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------
T ss_pred             Ccc--cccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------
Confidence            111  111234678889999999753 33467899999999999999999999765433222222211100         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                           .......+++++.+|+.+||+.||++|||+.|+++||||....
T Consensus       227 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          227 ---------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             ---------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ---------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                                 0112245789999999999999999999999999999997643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-45  Score=384.49  Aligned_cols=260  Identities=18%  Similarity=0.266  Sum_probs=215.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      .++|+++++||+  |+||+||+|+++.+|+.||||+++.... .....+.+.+|..+|+.+ +||||++++++|.+.+.+
T Consensus        19 ~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           19 LTDFNFLMVLGK--GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             CTTEEEEEEEEE--ETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             hHHcEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            468999999999  7799999999999999999999875421 112345677899999988 899999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||........
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999997653  4889999999999999999999999999999999999999999999999976542211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..    ...+.++|+.|+|||++.+  ..|+.++|||||||++|||++|..||..............+..+         
T Consensus       175 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------  239 (353)
T 2i0e_A          175 GV----TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---------  239 (353)
T ss_dssp             TC----CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred             Cc----ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            11    1223467889999999975  45899999999999999999999999876554433333322110         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                              .+..+++++.+||..||+.||.+||+     +.++++||||+...+
T Consensus       240 ------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          240 ------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             ------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             ------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence                                    12357899999999999999999994     699999999987543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=375.33  Aligned_cols=285  Identities=20%  Similarity=0.280  Sum_probs=208.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC---HHHHHHHHHHHHHHhhCC---CCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---DEDLKSLHHEIVCMRHLR---HPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~---HpnIv~~~~~~~   80 (622)
                      +.++|++.+.||+  |+||+||+|+++.+|+.||||++......   ......+.+|+.++++++   ||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            7 ATSRYEPVAEIGV--GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             ---CCEEEEEECC--SSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccceEEEEEEec--CCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            4679999999999  77889999999999999999998743211   111234557777777664   999999999998


Q ss_pred             eCC-----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         81 DAT-----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        81 ~~~-----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                      ...     .+++||||++ |+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            865     4899999998 6999999876544589999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAG  233 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~  233 (622)
                      ||.+........     .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||............  ..+
T Consensus       164 fg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (308)
T 3g33_A          164 FGLARIYSYQMA-----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  236 (308)
T ss_dssp             CSCTTTSTTCCC-----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CccccccCCCcc-----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            998754432211     112356788999999975  35899999999999999999999999876654433322  223


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..|.. ++....     ............  .........+++++.+|+.+||+.||++|||+.++|+||||++..
T Consensus       237 ~~~~~-~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          237 LPPED-DWPRDV-----SLPRGAFPPRGP--RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CCCTT-TSCSSC-----SSCGGGSCCCCC--CCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             CCChh-hccchh-----hccccccCCCCC--CcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            22211 110000     000000000000  000011245789999999999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=375.89  Aligned_cols=291  Identities=21%  Similarity=0.292  Sum_probs=216.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      -++|++++.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+|++++||||+++++++.+....++
T Consensus         2 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGE--GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEee--cCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence            468999999999  779999999999999999999997776666667778899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||++++++.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus        80 v~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            99999999999888653  3589999999999999999999999999999999999999999999999998754432211


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HHHhCCCCCCCcccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EKLAGATPHLLDCTTYY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~p~~~~~~~~~  245 (622)
                      .    .....+|..|+|||++.+. ..++.++||||+||++|+|++|..||.+........  ....+..+.  ..... 
T Consensus       158 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~-  229 (311)
T 4agu_A          158 Y----YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP--RHQQV-  229 (311)
T ss_dssp             ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH--HHHHH-
T ss_pred             c----cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc--ccccc-
Confidence            1    1223567789999998753 458899999999999999999999998765543332  222221110  00000 


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                      ............+.. ............+++++.+|+..||+.||++|||+.++++||||++.+..
T Consensus       230 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          230 FSTNQYFSGVKIPDP-EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             HHTCGGGTTCCCCCC-SSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cccccccccCcCCCc-cccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            000000000000000 00000011124578999999999999999999999999999999886543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=387.02  Aligned_cols=261  Identities=18%  Similarity=0.361  Sum_probs=214.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||+++.... .....+.+.+|+.+|++++|||||+++++|.+...+++
T Consensus        15 ~~y~i~~~LG~--G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           15 DHFEILRAIGK--GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             GGEEEEEEEEC--CTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHeEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            58999999999  7788999999999999999999865321 11234567899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++++|||.+........
T Consensus        93 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            99999999999999764  3589999999999999999999999999999999999999999999999998754432211


Q ss_pred             cccccCCCCCCCccccChhhhccc-cCCCCCcchHHHHHHHHHHHhcCCCCCCCCc--hHHHHHHHHhCCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~--~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                           ..+..+|+.|+|||++... ...|+.++|||||||++|+|++|..||....  ........+....         
T Consensus       171 -----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------  236 (384)
T 4fr4_A          171 -----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV---------  236 (384)
T ss_dssp             -----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC---------
T ss_pred             -----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc---------
Confidence                 1234678899999998642 2358899999999999999999999997432  2222222221111         


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-HHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-ACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~~~~l~h~~~~~~~~  310 (622)
                                             ...+..+++++.+||..||+.||.+||+ ++++++||||....+
T Consensus       237 -----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          237 -----------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             -----------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                                   1122457899999999999999999998 899999999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-45  Score=381.31  Aligned_cols=288  Identities=20%  Similarity=0.275  Sum_probs=210.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..++|++++.||+  |+||+||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+...++
T Consensus        32 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGE--GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhEEEEEEEEe--cCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            4468999999999  77889999999999999999999876555555667789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-----CCceEEcCCccccc
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-----NGKACLSGLRYMCP  161 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-----~~~~~i~~~~~~~~  161 (622)
                      +||||++ |+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.     ++.+++.|||.+..
T Consensus       110 lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999998 59999987643  5889999999999999999999999999999999999954     44599999998754


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCC
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLL  239 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~  239 (622)
                      .......    .....+|+.|+|||++.+. ..|+.++|||||||++|+|++|..||........+....  .+.++. .
T Consensus       187 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~  260 (329)
T 3gbz_A          187 FGIPIRQ----FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD-T  260 (329)
T ss_dssp             HC---------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT-T
T ss_pred             cCCcccc----cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch-h
Confidence            4322111    1123457789999999753 358999999999999999999999998776544433322  222211 1


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .+.... ..  ........... ...........+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       261 ~~~~~~-~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          261 TWPGVT-AL--PDWKQSFPKFR-GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TSTTGG-GS--TTCCTTCCCCC-CCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhh-hh--hhhhhhhhhhc-cccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            110000 00  00000000000 00001111233789999999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.8e-46  Score=405.84  Aligned_cols=218  Identities=22%  Similarity=0.358  Sum_probs=181.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM----TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      .++|+++++||+  |+||.||+|+++.||+.||||++.+...    .........+++.+++.++|||||+++++|.+.+
T Consensus       188 lddf~i~k~LG~--G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          188 MNDFSVHRIIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             hHHeEEEEEEec--ccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            467999999999  8899999999999999999999975321    2222233345577888889999999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      .+|+|||||+||+|.+++....  .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+.
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999999998754  47899999999999999999999999999999999999999999999999876554


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC--cHHHHHHHHcCCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLAGATP  586 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~--~~~~~~~~~~~~~p  586 (622)
                      ...      ..+.+||+.|||||++..+ ..|+.++|||||||++|||++|++||.+.+  ....+...+....+
T Consensus       344 ~~~------~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~  411 (689)
T 3v5w_A          344 KKK------PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV  411 (689)
T ss_dssp             SCC------CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC
T ss_pred             CCC------CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Confidence            322      2456899999999999643 469999999999999999999999997543  23334444444433

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.3e-46  Score=384.72  Aligned_cols=249  Identities=18%  Similarity=0.248  Sum_probs=195.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccC-----CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVT-----NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH-PNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~  431 (622)
                      .++|++++.||+  |+||.||+|++..+     ++.||||++.... .....+.+.+|+.+|++++| ||||+++++|..
T Consensus        63 ~~~~~l~~~LG~--G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           63 RDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             HHHeEEeeEEec--CCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            467999999999  88999999997654     4689999987543 45556789999999999965 999999999976


Q ss_pred             C-CcEEEEeeccCCCCHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q psy15039        432 A-TDLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS  496 (622)
Q Consensus       432 ~-~~~~lv~e~~~~g~l~~~l~~~~--------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~  496 (622)
                      . +.+++|||||++|+|.++|+...              ...+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  219 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence            5 56899999999999999997532              12478889999999999999999999999999999999999


Q ss_pred             CCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHH
Q psy15039        497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTL  575 (622)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~  575 (622)
                      +++.+||+|||++..+.......  ...+.++|+.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+...
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             CCCCEEECcchhhhhcccCCCce--eeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999876543322211  1234567889999999976  569999999999999999998 999999877655


Q ss_pred             HHHHHH-cCCCCCCCC-CCcccccCCCCcCcccccchhhh
Q psy15039        576 MLIEKL-AGATPHLLD-CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       576 ~~~~~~-~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      .+...+ .+..|..++ ++....+....|...++.++++-
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~  335 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF  335 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH
Confidence            555544 445555544 33333344444444444444443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.7e-45  Score=392.42  Aligned_cols=292  Identities=24%  Similarity=0.296  Sum_probs=215.9

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-   82 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-   82 (622)
                      ..++.++|++++.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||++++++... 
T Consensus        21 ~~~i~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGR--GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GCCCCTTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cceecCCEEEEEEEee--cCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3568899999999999  7789999999999999999999987656667778899999999999999999999999876 


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ..+|+||||++ |+|.++++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence                56999999987 5999998763  3589999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccc------------------cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCC-
Q psy15039        159 MCPFSPTKKKV------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA-  219 (622)
Q Consensus       159 ~~~~~~~~~~~------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~-  219 (622)
                      +..........                  ........+|++|+|||++... ..|+.++||||+||++|||++|..||. 
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccc
Confidence            75443221100                  0011344678899999997543 468999999999999999998544443 


Q ss_pred             ----------CCc-------------------hHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhcc--
Q psy15039        220 ----------ETP-------------------TTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQV--  268 (622)
Q Consensus       220 ----------~~~-------------------~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--  268 (622)
                                +..                   .+...+..+.|.++. .+.     .   .........++.......  
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~-~~~-----~---~~~~~~~~~~~~~~~~~~~~  325 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE-DDL-----K---NINKPEVIKYIKLFPHRKPI  325 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCH-HHH-----H---TCCCHHHHHHHHTSCCCCCC
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCH-HHH-----H---hccCHHHHHHHHhCCCCCCC
Confidence                      221                   111122222232211 000     0   000000000000000000  


Q ss_pred             ---ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        269 ---LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       269 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                         .....+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       326 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             CHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence               011357999999999999999999999999999999988654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-46  Score=388.70  Aligned_cols=273  Identities=24%  Similarity=0.347  Sum_probs=216.2

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ++.++|++.+.||+  |+||.||+|.++.+++.||||++....   ......+.+.+|+.+|++++|||||++++++.+.
T Consensus        23 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           23 ELQKKYHLKGAIGQ--GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhheeecceeee--cCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            45568999999999  778899999999999999999986532   2344567788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhc--------------------------------------CCCCCHHHHHHHHHHHHHH
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHF--------------------------------------NFGLPELVICHILQDVLNG  124 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~--------------------------------------~~~l~e~~~~~i~~qi~~a  124 (622)
                      ...++|||||++|+|.+++....                                      ...+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                      1113678889999999999


Q ss_pred             HHHHHhCCcccCCCCCCCEEEcCCC--ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHH
Q psy15039        125 LEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY  202 (622)
Q Consensus       125 L~ylH~~~IvHrDiKp~NiLl~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiW  202 (622)
                      |+|||++||+||||||+|||++.++  .+++.|||....+...............+|+.|+|||++.+....|+.++|||
T Consensus       181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            9999999999999999999998776  89999999875432211111111223467888999999975445689999999


Q ss_pred             HHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHH
Q psy15039        203 SVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIV  282 (622)
Q Consensus       203 SlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  282 (622)
                      ||||++|+|++|..||..............+..+.                             .......+++++.+||
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li  311 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF-----------------------------ENPNYNVLSPLARDLL  311 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT-----------------------------TSGGGGGSCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc-----------------------------CCcccccCCHHHHHHH
Confidence            99999999999999998776655554444332211                             0111234689999999


Q ss_pred             HHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        283 ELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       283 ~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..||+.||.+||++.++++||||++..
T Consensus       312 ~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          312 SNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHcCCChhHCCCHHHHhcChhhccCh
Confidence            999999999999999999999998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-45  Score=399.56  Aligned_cols=290  Identities=20%  Similarity=0.253  Sum_probs=210.2

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   83 (622)
                      ..+.++|++++.||+  |+||+||+|+++.+|+.||||++..........+.+.+|+.+|+.++|||||+++++|.... 
T Consensus        58 ~~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           58 FTVLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEEETTEEEEEEEEE--CSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             eeecCCeEEEEEeec--CCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence            345679999999999  77889999999999999999999876556677788899999999999999999999997653 


Q ss_pred             -----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         84 -----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        84 -----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                           .+|+|||||+++ +.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus       136 ~~~~~~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             cccCCeEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence                 579999999865 5555532    478999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCC-
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGAT-  235 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~-  235 (622)
                      +.......     ......+|+.|+|||++.+  ..|+.++||||+||++|||++|+.||.+.+....+...+  .+.+ 
T Consensus       211 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          211 ARTAGTSF-----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             C-----CC-----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             eeecCCCc-----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            75443211     1123466889999999976  368999999999999999999999998876544433322  2221 


Q ss_pred             CCCCcccc----ccccCCCCcCcccccccchhhhhccc--cCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        236 PHLLDCTT----YYVDTGQDDGEENACSYISEQQTQVL--TSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       236 p~~~~~~~----~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      |.......    .+....+................+..  .....++++.+|+.+||..||++|||+.|+|+||||...
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            11000000    00000000000000000000000000  000126789999999999999999999999999999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.9e-45  Score=376.41  Aligned_cols=259  Identities=19%  Similarity=0.311  Sum_probs=206.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMT--DEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .++|++++.||+  |+||.||+|++.   .+|+.||||+++.....  ......+.+|+.+|++++|||||+++++|.+.
T Consensus        16 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           16 PECFELLRVLGK--GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HHHeEEEEEEEe--CCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            468999999999  779999999985   79999999999775432  23345677999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+|+||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999997643  4789999999999999999999999999999999999999999999999976432


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      .....    ......+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||.................+      
T Consensus       172 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------  239 (327)
T 3a62_A          172 IHDGT----VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN------  239 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------
T ss_pred             ccCCc----cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC------
Confidence            21111    1123456888999999975  45899999999999999999999999876554433333322110      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                                 .+..+++++.+|+.+||+.||.+||     ++.++++||||+...
T Consensus       240 ---------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          240 ---------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             ---------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence                                       1234688999999999999999999     889999999998654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3e-45  Score=383.71  Aligned_cols=259  Identities=22%  Similarity=0.341  Sum_probs=203.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ...++|++.+.||+  |+||+||+|+++.+|+.||||++.......   +.+.+|+.+++.++|||||++++++.+...+
T Consensus        17 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           17 HDSDRYDFVKDIGS--GNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CCTTTEEEEEEESS--STTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCCcEEEEEEecc--CCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            34679999999999  778899999999999999999997654322   3467899999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--eEEcCCccccccC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--ACLSGLRYMCPFS  163 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~--~~i~~~~~~~~~~  163 (622)
                      ++|||||++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.  +++.|||.+....
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999999999987643  5889999999999999999999999999999999999987765  9999999764221


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCC-cchHHHHHHHHHHHhcCCCCCCCCch---HHHHHHHHhCCCCCCC
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE-RSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLL  239 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~-~~DiWSlG~il~el~~g~~Pf~~~~~---~~~~~~~~~~~~p~~~  239 (622)
                      ...     ......+|+.|+|||++.+.  .++. ++||||+||++|+|++|+.||.....   .......+.....   
T Consensus       170 ~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~---  239 (361)
T 3uc3_A          170 LHS-----QPKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY---  239 (361)
T ss_dssp             ----------------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC---
T ss_pred             ccC-----CCCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC---
Confidence            111     12234578899999999753  3544 48999999999999999999975432   1222222221110   


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                 ..+....+++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       240 ---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          240 ---------------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ---------------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ---------------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                                       111233578999999999999999999999999999999654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-45  Score=384.88  Aligned_cols=262  Identities=19%  Similarity=0.285  Sum_probs=216.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      .+.++|++++.||+  |+||.||+|.++.+|+.||+|.++...  ..+...+.+|+.+|++|+|||||+++++|.+...+
T Consensus        48 ~~~~~y~i~~~LG~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           48 SVYDYYDILEELGS--GAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             CGGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEec--CCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            34568999999999  779999999999999999999997643  34456788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCceEEcCCccccccC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFS  163 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~--~~~~~i~~~~~~~~~~  163 (622)
                      ++|||||++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.  ++.++++|||.+....
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999999999886532 35899999999999999999999999999999999999974  4679999999876543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .....     ....+|+.|+|||++.+  ..++.++|||||||++|+|++|..||.+......+........+.      
T Consensus       203 ~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~------  269 (387)
T 1kob_A          203 PDEIV-----KVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF------  269 (387)
T ss_dssp             TTSCE-----EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred             CCcce-----eeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence            32111     12256788999999975  458899999999999999999999998765544333332221110      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                             .......+++++.+||..||..||++|||+.++++||||+..
T Consensus       270 -----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          270 -----------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             -----------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                                   001123578999999999999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.6e-46  Score=387.10  Aligned_cols=259  Identities=20%  Similarity=0.285  Sum_probs=209.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ....+|++.+.||+  |+||+||+|.++.+|+.||||++....... ...+.+.+|+.+|+.++|||||++++++.+...
T Consensus         6 ~~i~~Y~i~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            6 RHIGPYIIRETLGE--GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             SEETTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCCEEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            34578999999999  779999999999999999999986532111 112467899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||+ +|++.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            99999999 688888886643  588999999999999999999999999999999999999999999999998654332


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ..     ......+|+.|+|||++.+. ..++.++||||+||++|+|++|..||.......            +..    
T Consensus       161 ~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------~~~----  218 (336)
T 3h4j_B          161 GN-----FLKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------LFK----  218 (336)
T ss_dssp             SB-----TTCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------CBC----
T ss_pred             Cc-----ccccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------HHH----
Confidence            21     11234678899999999753 223689999999999999999999997532110            000    


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                     .+..  .....+..+++++.+|+.+||+.||.+|||+.++++||||+..
T Consensus       219 ---------------~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          219 ---------------KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             ---------------CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ---------------HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                           0000  0011234578999999999999999999999999999999753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-44  Score=377.05  Aligned_cols=260  Identities=28%  Similarity=0.496  Sum_probs=217.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ...|++.+.||+  |+||.||+|+++.+|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+....+
T Consensus        53 ~~~y~~~~~lG~--G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           53 EKLFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhheeeeeEEcc--CCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            346999999999  77999999999999999999999876433 444577889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+. |++.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||........ 
T Consensus       131 lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9999998 67888876543 35899999999999999999999999999999999999999999999999976543221 


Q ss_pred             ccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                             ....+|+.|+|||++.. ....|+.++|||||||++|||++|..||........+.....+..|.        
T Consensus       208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------  272 (348)
T 1u5q_A          208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------  272 (348)
T ss_dssp             -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Confidence                   13356888999999853 12458899999999999999999999998766554444444332221        


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                             .....+++.+.+||..||+.||++|||+.++++||||.....
T Consensus       273 -----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          273 -----------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence                                   122457889999999999999999999999999999976543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=386.75  Aligned_cols=285  Identities=24%  Similarity=0.306  Sum_probs=216.3

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +..++.++|++++.||+  |+||.||+|.++.+|+.||||++..........+.+.+|+.+|++++|||||++++++...
T Consensus        19 ~~~~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           19 TAWEVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             SEECCBSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             ceeeecceEEEeEEeee--cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            34567889999999999  7788999999999999999999977655666677889999999999999999999999876


Q ss_pred             C------cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         83 T------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        83 ~------~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                      .      .+|+||||+ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEee
Confidence            3      469999999 7899999876   25889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~  234 (622)
                      |.+......       .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.+......+..  ...+.
T Consensus       173 g~a~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          173 GLARQADSE-------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  244 (367)
T ss_dssp             TTCEECCSS-------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ecccccccc-------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            987543221       1234568899999998753 4589999999999999999999999987765443332  23333


Q ss_pred             CCCCCccccccccCCCCcCcccccccchh---hhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISE---QQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~---~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      +|.-.      .......   ....++..   ....  .......++++.+|+.+||+.||++|||+.++|+||||....
T Consensus       245 ~~~~~------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          245 PPAEF------VQRLQSD---EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CCHHH------HHTCSCH---HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCHHH------HHHhhhH---HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            32100      0000000   00000000   0000  001235689999999999999999999999999999998754


Q ss_pred             c
Q psy15039        310 K  310 (622)
Q Consensus       310 ~  310 (622)
                      .
T Consensus       316 ~  316 (367)
T 1cm8_A          316 D  316 (367)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.1e-45  Score=382.72  Aligned_cols=260  Identities=22%  Similarity=0.318  Sum_probs=207.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHH-HhhCCCCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVC-MRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      .++|+++++||+  |+||+||+|+++.+++.||||++++... .......+.+|..+ ++.++|||||+++++|.+.+.+
T Consensus        37 ~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           37 PSDFHFLKVIGK--GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             GGGEEEEEEEEC--CTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEee--CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            468999999999  7788999999999999999999987543 23344556678876 5789999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||........
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999997643  4789999999999999999999999999999999999999999999999976532211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..    ...+.++|+.|+|||++.+  ..|+.++|||||||++|||++|..||............+.+..          
T Consensus       193 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------  256 (373)
T 2r5t_A          193 NS----TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------  256 (373)
T ss_dssp             CC----CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC----------
T ss_pred             CC----ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------
Confidence            11    1224467889999999975  4689999999999999999999999987665444333332211          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH----HhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA----CNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~~~l~h~~~~~~~~  310 (622)
                                             .....+++++.+||..||+.||.+||++    .++++||||+...+
T Consensus       257 -----------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          257 -----------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             -----------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence                                   0123578999999999999999999997    58999999987543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.8e-45  Score=399.31  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=212.7

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      .+.+.|++++.||+  |+||+||+|+++.+++.||||++............+.+|+.+|+.|+|||||+++++|.+...+
T Consensus        34 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           34 HLSEMYQRVKKLGS--GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             CHHHHEEEEEEEEC--C---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             chhcCeEEeeEEec--CCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34457999999999  7789999999999999999999987654444456688999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCcccccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPF  162 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~~~~~~  162 (622)
                      |+|||||++|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++..+   .+++.|||.+...
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999999999887653  488999999999999999999999999999999999997644   5999999976544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      .....     .....+|+.|+|||++.+   .|+.++||||+||++|+|++|..||..............+..+..    
T Consensus       190 ~~~~~-----~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  257 (494)
T 3lij_A          190 ENQKK-----MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD----  257 (494)
T ss_dssp             BTTBC-----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred             CCCcc-----ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Confidence            32211     123457888999999863   489999999999999999999999987766544444433322110    


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                               ...+..+|+++.+||..||+.||.+|||+.++|+||||+..
T Consensus       258 -------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          258 -------------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -------------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -------------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                     11234578999999999999999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.6e-45  Score=393.70  Aligned_cols=269  Identities=18%  Similarity=0.256  Sum_probs=216.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..++|+++++||+  |+||+||+|+++.+|+.||||++++.... ......+.+|+.+|+.++|||||+++++|.+...+
T Consensus        72 ~~~~y~~~~~LG~--G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           72 HREDFEILKVIGR--GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEEe--CCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            3568999999999  77999999999999999999998652211 11122377899999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            99999999999999997632 35899999999999999999999999999999999999999999999999976544322


Q ss_pred             CccccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...   .....++|+.|+|||++..   +...|+.++|||||||++|||++|+.||............+...        
T Consensus       229 ~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------  297 (437)
T 4aw2_A          229 GTV---QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------  297 (437)
T ss_dssp             SCE---ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------
T ss_pred             CCc---ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--------
Confidence            211   1223467889999999862   12458899999999999999999999998765544333222110        


Q ss_pred             cccccCCCCcCcccccccchhhhhccc-cCCCCcHHHHHHHHHhhhcCCCC--CcCHHhhhcCcccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVL-TSRKFSDSFHSIVELCLSRDVDK--RPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~--Rps~~~~l~h~~~~~~~~  310 (622)
                                           .....+ ....+|+++++||++||+.+|++  ||+++++++||||+...+
T Consensus       298 ---------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          298 ---------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             ---------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             ---------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence                                 000011 11347999999999999998888  999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-44  Score=370.84  Aligned_cols=257  Identities=28%  Similarity=0.449  Sum_probs=213.4

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEe
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS   89 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~   89 (622)
                      .|+..+.||+  |+||.||+|+++.+|+.||||++......  ..+.+.+|+.+|++++|||||++++++...+..++||
T Consensus        46 ~~~~~~~lg~--G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGE--GSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEecc--CCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            4888999999  77999999999999999999999765432  3456779999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      ||+++++|.+++..   ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||........... 
T Consensus       122 e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  197 (321)
T 2c30_A          122 EFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-  197 (321)
T ss_dssp             CCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred             ecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-
Confidence            99999999999864   35899999999999999999999999999999999999999999999999976544322111 


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG  249 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  249 (622)
                         .....+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||.................|..           
T Consensus       198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  261 (321)
T 2c30_A          198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-----------  261 (321)
T ss_dssp             ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-----------
T ss_pred             ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-----------
Confidence               123457888999999975  3588999999999999999999999987654433332222222111           


Q ss_pred             CCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                         .....+++++.+++.+||+.||++|||+.++++||||.+..
T Consensus       262 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          262 -------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                               11234688999999999999999999999999999997643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-45  Score=395.48  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=214.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..+|++++.||+  |+||.||+|+++.+|+.||||+++...... +....+.+|+.+|+.++|||||++++++.+...++
T Consensus        15 ~~~Y~l~~~LG~--G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           15 IGHYILGDTLGV--GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             ETTEEEEEEEEC--CSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            468999999999  778899999999999999999986532211 22456889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        93 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999998653  358999999999999999999999999999999999999999999999999875543221


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .     ..+.++|+.|+|||++.+. ..++.++||||+||++|+|++|..||..............+..           
T Consensus       171 ~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------  233 (476)
T 2y94_A          171 F-----LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-----------  233 (476)
T ss_dssp             C-----BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-----------
T ss_pred             c-----ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence            1     1234678899999999753 2346899999999999999999999987655443333222211           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                            ..+..+++++.+|+..||+.||.+|||+.++++||||+..
T Consensus       234 ----------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 ----------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ----------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                                  1123468899999999999999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=377.98  Aligned_cols=262  Identities=23%  Similarity=0.287  Sum_probs=203.9

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +.+.++|++.+.||+  |+||.||+|+++.+++.||||+++...    ..+.+.+|+.+|++|+|||||+++++|.+...
T Consensus        49 ~~~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           49 DALSDFFEVESELGR--GATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             SCGGGTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccccCcEEEeeEEee--CCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            345668999999999  779999999999999999999997643    23457789999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~~~~~~~  161 (622)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+++.|||....
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999999998653  34789999999999999999999999999999999999975   78999999997654


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      .....     ......+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||............+.......   
T Consensus       201 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~---  270 (349)
T 2w4o_A          201 VEHQV-----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF---  270 (349)
T ss_dssp             -----------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC---
T ss_pred             cCccc-----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc---
Confidence            32211     1123456788999999975  3589999999999999999999999987655443444433211100   


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                               .......++.++.+|+.+||+.||++|||+.++++||||....
T Consensus       271 -------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          271 -------------------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -------------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -------------------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                                     0011235789999999999999999999999999999997643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-45  Score=399.69  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=216.6

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ++.++|++.+.||+  |+||+||+|+++.+|+.||||++............+.+|+.+|++|+|||||++++++.+...+
T Consensus        19 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           19 TFAERYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHHEEEEEEEEC--CSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ChhcceEEeEEEee--cCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            35568999999999  7788999999999999999999865322222346678999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcCCcccccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCPF  162 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~~~~~~~~  162 (622)
                      ++|||||++|+|.+.+....  .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+++.|||.+...
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999999999887653  5889999999999999999999999999999999999954   457999999987544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      .....     .....+|+.|+|||++.+   .|+.++||||+||++|+|++|..||.+......+.....+..+.     
T Consensus       175 ~~~~~-----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----  241 (486)
T 3mwu_A          175 QQNTK-----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF-----  241 (486)
T ss_dssp             CCC---------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-----
T ss_pred             CCCCc-----cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----
Confidence            32211     123457889999999864   48999999999999999999999998776554444443332211     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                              ..+.+..+|+++.+||..||+.||.+|||+.++|+||||+...
T Consensus       242 ------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          242 ------------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ------------------------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ------------------------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                                    0112345789999999999999999999999999999998754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-44  Score=375.46  Aligned_cols=294  Identities=21%  Similarity=0.261  Sum_probs=216.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC----
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA----   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----   82 (622)
                      ..++|++++.||+  |+||.||+|+++.+|+.||||++............+.+|+.+|++++||||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           15 EVSKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             BGGGEEEEEECSS--CSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             cccceeEEEEEec--CCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            4568999999999  7788999999999999999999876654444445677999999999999999999999874    


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ..+++||||+++ ++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                468999999985 6777765532 3589999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p  236 (622)
                      +..................+|+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+.......  +....+..+
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            755432222111122334668889999998753 45899999999999999999999999876554332  333334332


Q ss_pred             C-CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        237 H-LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       237 ~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      . ....................    .............++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQ----KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSC----CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hhhccccccchhhccccccccc----ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            2 11100000000000000000    000000001112377899999999999999999999999999997643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.5e-45  Score=367.80  Aligned_cols=261  Identities=21%  Similarity=0.354  Sum_probs=210.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ++.++|++.+.||+  |+||.||+|+++.+|+.||+|++..... ....+.+.+|+++|++++||||+++++++.+...+
T Consensus        19 ~i~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           19 TIDDLFIFKRKLGS--GAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             CHHHHEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             Chhhheeecceecc--CCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            35568999999999  7789999999999999999999876542 22345678999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCceEEcCCcccc
Q psy15039         86 HLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMC  160 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~---~~~~~~i~~~~~~~  160 (622)
                      ++||||+++|+|.+.+...  ....+++..+..++.||+.||+|||++||+||||||+|||++   .++.+++.|||.+.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999988543  224589999999999999999999999999999999999994   45789999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      .......     .....+|+.|+|||++.+   .++.++|||||||++|+|++|..||...................   
T Consensus       176 ~~~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---  244 (285)
T 3is5_A          176 LFKSDEH-----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY---  244 (285)
T ss_dssp             C---------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---
T ss_pred             ecCCccc-----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---
Confidence            4332211     123356788999999853   47899999999999999999999998765544333332221110   


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                                 ......+++++.+|+..||+.||++|||+.|+++||||++
T Consensus       245 ---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          245 ---------------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ---------------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ---------------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                                       0112236889999999999999999999999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=388.06  Aligned_cols=268  Identities=19%  Similarity=0.252  Sum_probs=215.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..++|+++++||+  |+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus        59 ~~~~f~~~~~lG~--G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGR--GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            3578999999999  7788999999999999999999865321 112234477899999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||........
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999999999997643 35899999999999999999999999999999999999999999999999987544322


Q ss_pred             CccccccCCCCCCCccccChhhhccc-----cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQN-----LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ...   .....++|+.|+|||++...     ...|+.++|||||||++|||++|+.||............+...      
T Consensus       216 ~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------  286 (412)
T 2vd5_A          216 GTV---RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK------  286 (412)
T ss_dssp             SCE---ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH------
T ss_pred             Ccc---ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------
Confidence            211   11234678899999998631     2358899999999999999999999998765544332222110      


Q ss_pred             cccccccCCCCcCcccccccchhhhhccc-cCCCCcHHHHHHHHHhhhcCCCCC---cCHHhhhcCcccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVL-TSRKFSDSFHSIVELCLSRDVDKR---PLACNLLQHAFFKQTKK  310 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R---ps~~~~l~h~~~~~~~~  310 (622)
                                             .....+ ....+|+++++||++||+ ||.+|   |+++++++||||+...+
T Consensus       287 -----------------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          287 -----------------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             -----------------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             -----------------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence                                   000000 123579999999999999 99998   59999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.3e-45  Score=392.52  Aligned_cols=258  Identities=19%  Similarity=0.288  Sum_probs=206.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||++++++|.+.+.+++
T Consensus       148 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          148 NEFEYLKLLGK--GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             HHcEEeEEEee--CcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            57999999999  779999999999999999999987542 233445667899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      |||||++|+|.+++....  .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+++.|||.+.......
T Consensus       226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            999999999999987643  58899999999999999999998 999999999999999999999999999765322211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .    ......+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||.................+          
T Consensus       304 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------  367 (446)
T 4ejn_A          304 A----TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----------  367 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------
T ss_pred             c----ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence            1    1223467889999999975  45899999999999999999999999876554433333222110          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                             .+..+++++.+||..||+.||.+||     ++.++++||||....
T Consensus       368 -----------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          368 -----------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence                                   1234689999999999999999999     999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=376.11  Aligned_cols=287  Identities=21%  Similarity=0.291  Sum_probs=210.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++..... ......+.+|+.+|++++||||+++++++.+...+++|
T Consensus         2 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGE--GTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcC--CCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            57999999999  7799999999999999999999865432 22222455899999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |||++ |++.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||...........
T Consensus        79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             ecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            99998 58888887643 35889999999999999999999999999999999999999999999999987543322111


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~~p~~~~~~~~~~  246 (622)
                          .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.+......+  +....+.++.. .+.....
T Consensus       157 ----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~  230 (324)
T 3mtl_A          157 ----YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE-TWPGILS  230 (324)
T ss_dssp             ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT-TSTTGGG
T ss_pred             ----cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH-hchhhhc
Confidence                1223557889999998753 45899999999999999999999999876654333  22333332211 0100000


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ..  ............+  ........+++++.+|+.+||+.||.+|||+.|+++||||.....
T Consensus       231 ~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          231 NE--EFKTYNYPKYRAE--ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CH--HHHHTCCCCCCCC--CHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             ch--hhcccccccccch--hhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            00  0000000000000  001122457899999999999999999999999999999987654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.3e-45  Score=397.40  Aligned_cols=265  Identities=26%  Similarity=0.371  Sum_probs=219.7

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ...+.++|++.+.||+  |+||.||+|+++.+|+.||||++...... ....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus        21 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   98 (484)
T 3nyv_A           21 TAIFSDRYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK   98 (484)
T ss_dssp             CCCHHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CCcccCceEEeeEEec--CCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3455678999999999  77999999999999999999999765432 33456788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCceEEcCCccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYM  159 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl---~~~~~~~i~~~~~~  159 (622)
                      ..+++|||||.+|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+++.|||.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999999999998764  358899999999999999999999999999999999999   45678999999987


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  239 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~  239 (622)
                      ..........     ...+|+.|+|||++.+   .|+.++||||+||++|+|++|.+||..............+..+.  
T Consensus       177 ~~~~~~~~~~-----~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--  246 (484)
T 3nyv_A          177 THFEASKKMK-----DKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF--  246 (484)
T ss_dssp             HHBCCCCSHH-----HHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--
T ss_pred             EEcccccccc-----cCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            5543322111     2246788999999864   48999999999999999999999998776554444443332211  


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                 ..+.+..+|+++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       247 ---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          247 ---------------------------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             ---------------------------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             ---------------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence                                       0112345789999999999999999999999999999997643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-44  Score=395.15  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=216.3

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-----------HHHHHHHHHHHHHhhCCCCcce
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-----------EDLKSLHHEIVCMRHLRHPNII   73 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv   73 (622)
                      ..+.++|++++.||+  |+||+||+|+++.+++.||||++.......           ...+.+.+|+.+|++|+|||||
T Consensus        32 ~~i~~~Y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  109 (504)
T 3q5i_A           32 GKIGESYFKVRKLGS--GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII  109 (504)
T ss_dssp             SCGGGTEEEEEEEEC----CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred             CCcccceEEEeEecc--cCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            456789999999999  779999999999999999999997654321           2245688999999999999999


Q ss_pred             eEEEEEEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---c
Q psy15039         74 CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---K  150 (622)
Q Consensus        74 ~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~  150 (622)
                      +++++|.+...+++|||||++|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++.++   .
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999999999987653  589999999999999999999999999999999999999876   6


Q ss_pred             eEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH
Q psy15039        151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  230 (622)
Q Consensus       151 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~  230 (622)
                      +++.|||.+........     .....+|+.|+|||++.+   .|+.++||||+||++|+|++|..||.+......+...
T Consensus       188 ~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  259 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV  259 (504)
T ss_dssp             EEECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            89999998755433211     123457888999999863   4899999999999999999999999887665544444


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..+..+.                             ....+..+|+++.+||..||+.||.+|||+.++|+||||+...
T Consensus       260 ~~~~~~~-----------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          260 EKGKYYF-----------------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHCCCCC-----------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HcCCCCC-----------------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            3332211                             0112245789999999999999999999999999999997643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.7e-45  Score=377.49  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=209.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~   84 (622)
                      .+.++|++++.||+  |+||+||+|.++.+|+.||||+++.....      ..+|+++|.++ +|||||+++++|.+...
T Consensus        19 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           19 QFTDGYEVKEDIGV--GSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             CHHHHEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             CccccEEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            45678999999999  77999999999999999999999775432      23688888888 79999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-C---ceEEcCCcccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-G---KACLSGLRYMC  160 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~-~---~~~i~~~~~~~  160 (622)
                      +|+|||||++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||+..+ +   .+++.|||...
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999999998764  358999999999999999999999999999999999998543 3   48999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc--hHHHHHHHH-hCCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKL-AGATPH  237 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~--~~~~~~~~~-~~~~p~  237 (622)
                      ........    ..+..+|+.|+|||++.+.  .|+.++|||||||++|+|++|..||....  ....+...+ .+..+.
T Consensus       169 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  242 (342)
T 2qr7_A          169 QLRAENGL----LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL  242 (342)
T ss_dssp             ECBCTTCC----BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred             cCcCCCCc----eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence            44322111    1234668899999999753  47889999999999999999999997532  223333332 221110


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                   ....+..+|+++.+||..||..||++||++.++++||||....
T Consensus       243 -----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          243 -----------------------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             -----------------------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             -----------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                                         0011245789999999999999999999999999999997643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.9e-44  Score=361.92  Aligned_cols=260  Identities=22%  Similarity=0.381  Sum_probs=216.8

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe---
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD---   81 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~---   81 (622)
                      ++....|++.+.||+  |+||.||+|.+..++..||+|++..........+.+.+|+.+|++++||||++++++|..   
T Consensus        22 ~~~~~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CTTSCEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             ccCceeEEeeeeccC--CCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            455667999999999  789999999999999999999998776677778889999999999999999999999876   


Q ss_pred             -CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEc-CCCceEEcCCc
Q psy15039         82 -ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS-HNGKACLSGLR  157 (622)
Q Consensus        82 -~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~-~~~~~~i~~~~  157 (622)
                       ...+++||||+++|+|.+++....  .+++..+..++.||+.||.|||++|  |+||||||+|||++ .++.+++.|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             345899999999999999997643  4789999999999999999999999  99999999999998 78899999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  237 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~  237 (622)
                      .+........      ....+|+.|+|||++.+   .++.++||||+||++|+|++|..||............+......
T Consensus       178 ~~~~~~~~~~------~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (290)
T 1t4h_A          178 LATLKRASFA------KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             GGGGCCTTSB------EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             Cccccccccc------ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc
Confidence            8743322211      12346778999998863   48899999999999999999999998766555554444322110


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                                    .......++++.+++..||+.||.+|||+.++++||||++
T Consensus       249 ------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 ------------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                          0112345788999999999999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.3e-45  Score=399.05  Aligned_cols=262  Identities=20%  Similarity=0.301  Sum_probs=216.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..++|++.++||+  |+||.||+|+++.||+.||||++...... ......+.+|+.+|++++|||||+++++|.+.+.+
T Consensus       182 ~~~~f~~~~~LG~--G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          182 TKNTFRQYRVLGK--GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CGGGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            3568999999999  77999999999999999999998653221 11234577899999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.+|.++++|||.+......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999997655445899999999999999999999999999999999999999999999999987554322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch---HHHHHHHHhCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~---~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...     .+..+|+.|+|||++.+  ..|+.++|||||||++|||++|..||.....   ...+...+....+      
T Consensus       340 ~~~-----~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~------  406 (576)
T 2acx_A          340 QTI-----KGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE------  406 (576)
T ss_dssp             CCE-----ECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC------
T ss_pred             ccc-----cccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc------
Confidence            111     13367889999999975  3589999999999999999999999976432   1222222211110      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                                ..+..+|+++.+||..||+.||.+||     ++.++++||||+...
T Consensus       407 --------------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          407 --------------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             --------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             --------------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence                                      11245789999999999999999999     899999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=373.35  Aligned_cols=268  Identities=19%  Similarity=0.316  Sum_probs=213.8

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCC--CcceeEEEEE
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH--PNIICYISSF   79 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~~~~~~   79 (622)
                      |.++-...+|++++.||+  |+||.||+|.+. +++.||||+++.........+.+.+|+.+|++|+|  |||+++++++
T Consensus         2 e~i~~~~~~y~i~~~lG~--G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A            2 ECISVKGRIYSILKQIGS--GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             CCEESSSCEEEEEEEESC--CSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             ceeeeecCEEEEEEEEec--CCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            556667889999999999  789999999985 68999999998877777777889999999999987  9999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                      .+...+++||| +.+++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+++.|||.+
T Consensus        79 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           79 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             eeCCEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            99999999999 5778999999774  3588999999999999999999999999999999999997 688999999987


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhcc---------ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ---------NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  230 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~---------~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~  230 (622)
                      .........  .......+|+.|+|||++.+         ....|+.++|||||||++|+|++|..||............
T Consensus       155 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  232 (343)
T 3dbq_A          155 NQMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  232 (343)
T ss_dssp             CCC--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             cccCccccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence            554322111  11223467889999999864         1145788999999999999999999999865444333333


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      +.....                              ....+...++++.+|+..||+.||.+|||+.++++||||+..
T Consensus       233 ~~~~~~------------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          233 IIDPNH------------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HHCTTS------------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HhcCCc------------------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            221110                              001123356789999999999999999999999999999754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-44  Score=374.72  Aligned_cols=293  Identities=22%  Similarity=0.300  Sum_probs=219.1

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +...-++|++++.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+|++++||||+++++++.+..
T Consensus        20 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGE--GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             CCBCGGGEEEEEEGGG--GTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhhhhheeeeEEee--cCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            3455679999999999  77889999999999999999999877666666777889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++||||++++++.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||......
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            999999999999988876543  358999999999999999999999999999999999999999999999999875433


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCcc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDC  241 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~  241 (622)
                      .....    .....+++.|+|||++.+. ..++.++||||+||++|+|++|..||.............  .+..+.  ..
T Consensus       176 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~  248 (331)
T 4aaa_A          176 APGEV----YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP--RH  248 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH--HH
T ss_pred             CCccc----cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh--hh
Confidence            22111    1223567789999999753 357899999999999999999999998776544333222  121110  00


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ...+..... ........ +............+++++.+|+.+||+.||++|||+.++|+||||+...
T Consensus       249 ~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          249 QELFNKNPV-FAGVRLPE-IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             HHHHHHCGG-GTTCCCCC-CSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             hhHhhhccc-cccccCcc-ccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            000000000 00000000 0000000111235789999999999999999999999999999997643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.9e-45  Score=372.45  Aligned_cols=273  Identities=20%  Similarity=0.279  Sum_probs=218.4

Q ss_pred             CCCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEE
Q psy15039          1 METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSF   79 (622)
Q Consensus         1 ~~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   79 (622)
                      |.+-..+.++|++.+.||+  |+||.||+|+++.+|+.||||++..... .......+.+|+.++++++|||||++++++
T Consensus         4 ~~~~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A            4 MTTPSHLSDRYELGEILGF--GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             CCCCSEETTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             CCCcceecCcEEEEEEEcc--CCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            4566778899999999999  7799999999999999999999987543 345567788999999999999999999998


Q ss_pred             EeCCc----EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         80 LDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        80 ~~~~~----~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                      .....    .++||||+++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECC
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEee
Confidence            87654    499999999999999997653  588999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  235 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~  235 (622)
                      ||............ .......+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||.................
T Consensus       160 fg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~  236 (311)
T 3ork_A          160 FGIARAIADSGNSV-TQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP  236 (311)
T ss_dssp             CSCC-------------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred             ccCccccccccccc-ccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence            99875443221111 11123356788999999975  3589999999999999999999999987766554444443321


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..                             .......+++++.+++.+||+.||++||++.+++.|+|++...
T Consensus       237 ~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          237 IP-----------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CC-----------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CC-----------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            10                             0011245789999999999999999999999999999997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-44  Score=373.50  Aligned_cols=260  Identities=21%  Similarity=0.370  Sum_probs=205.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc---
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD---   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~---   84 (622)
                      .++|++++.||+  |+||.||+|+++.+|+.||||++.... .+...+.+.+|+.+|++|+|||||+++++|.....   
T Consensus         5 ~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            5 LTDFEPIQCMGR--GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHEEEEEEEEC--C-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhcCceeeEecC--CCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            457999999999  778899999999999999999997654 33445678899999999999999999999876542   


Q ss_pred             ------------------------------------------------------EEEEeecCCCCCHHHHHHhhcCC-CC
Q psy15039         85 ------------------------------------------------------LHLVSPLMGFGSCKDLINAHFNF-GL  109 (622)
Q Consensus        85 ------------------------------------------------------~~lv~e~~~~g~l~~~l~~~~~~-~l  109 (622)
                                                                            +++|||||++|+|.+++...... ..
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                  89999999999999999765322 24


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccc--------ccCCCCCCCcc
Q psy15039        110 PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH--------LFPPSTAYNLN  181 (622)
Q Consensus       110 ~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  181 (622)
                      ++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.............        .......+|+.
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            6677899999999999999999999999999999999999999999998765433221110        11223467889


Q ss_pred             ccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCCCccccccccCCCCcCccccccc
Q psy15039        182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCTTYYVDTGQDDGEENACSY  260 (622)
Q Consensus       182 y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (622)
                      |+|||++.+  ..|+.++||||+||++|+|++|..|+..   .......+.. ..|                        
T Consensus       242 y~aPE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~------------------------  292 (332)
T 3qd2_B          242 YMSPEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFP------------------------  292 (332)
T ss_dssp             GSCHHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCC------------------------
T ss_pred             ccChHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCC------------------------
Confidence            999999975  3589999999999999999999877532   1122222211 110                        


Q ss_pred             chhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       261 i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                              ......++++.+|+..||+.||++|||+.++++||||++
T Consensus       293 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          293 --------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             --------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             --------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence                    011234678899999999999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=377.84  Aligned_cols=260  Identities=22%  Similarity=0.279  Sum_probs=209.7

Q ss_pred             CCceE--EeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKI--CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~--~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +.|.+  .+.||+  |+||.||+|+++.+|+.||||+++...  ....+.+.+|+.+|++|+|||||++++++.+.+.++
T Consensus        87 ~~~~~~~~~~lG~--G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  162 (373)
T 2x4f_A           87 SFYTVSKTEILGG--GRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV  162 (373)
T ss_dssp             GTEEEEEEEECC-------CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cceeeecceEEec--CcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            44555  678999  778999999999999999999997653  345567889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE--cCCCceEEcCCccccccCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl--~~~~~~~i~~~~~~~~~~~  164 (622)
                      +||||+++|+|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||+  +.++.+++.|||.+.....
T Consensus       163 lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             EEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            9999999999999886532 348899999999999999999999999999999999999  4567899999998755432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ...     .....+|+.|+|||++..  ..++.++|||||||++|+|++|..||........+........+..      
T Consensus       242 ~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------  308 (373)
T 2x4f_A          242 REK-----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE------  308 (373)
T ss_dssp             TCB-----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC------
T ss_pred             ccc-----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC------
Confidence            211     123357888999999865  3588999999999999999999999987765554444433321100      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                             ......+++++.+||.+||+.||.+|||+.++++||||...+
T Consensus       309 -----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          309 -----------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             -----------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             -----------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                                   011235789999999999999999999999999999998754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.2e-44  Score=375.12  Aligned_cols=286  Identities=21%  Similarity=0.263  Sum_probs=213.9

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-----CCcceeEEEEEE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-----HPNIICYISSFL   80 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~~~~~~~   80 (622)
                      .+.++|++.+.||+  |+||+||+|+++.+|+.||||++..   .....+.+.+|+.+|+.++     |||||++++++.
T Consensus        32 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           32 LLNNAFLVIRKMGD--GTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             EETTTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             EecCEEEEEEEEcc--cCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            35679999999999  7799999999999999999999864   2445566778999999997     999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-------------
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-------------  147 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-------------  147 (622)
                      ..+.+++||||+ +++|.+++......++++..+..++.||+.||+|||++||+||||||+|||++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 899999998765556899999999999999999999999999999999999975             


Q ss_pred             ------------CCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCC
Q psy15039        148 ------------NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT  215 (622)
Q Consensus       148 ------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~  215 (622)
                                  ++.+++.|||.+......       .....+|+.|+|||++.+.  .|+.++|||||||++|+|++|+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCC
Confidence                        778999999987543221       1234568889999999763  5899999999999999999999


Q ss_pred             CCCCCCchHHHH--HHHHhCCCCCCCccc------cccccCCC-C-cCcccccc--cchhh-hhccccCCCCcHHHHHHH
Q psy15039        216 VPFAETPTTLML--IEKLAGATPHLLDCT------TYYVDTGQ-D-DGEENACS--YISEQ-QTQVLTSRKFSDSFHSIV  282 (622)
Q Consensus       216 ~Pf~~~~~~~~~--~~~~~~~~p~~~~~~------~~~~~~~~-~-~~~~~~~~--~i~~~-~~~~~~~~~~s~~~~~li  282 (622)
                      .||........+  +..+.+..|......      ..+..... . ........  ..... ..........++.+.+|+
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            999876544332  233333322100000      00000000 0 00000000  00000 000000112357889999


Q ss_pred             HHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        283 ELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       283 ~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                      ..||+.||.+|||+.++|+||||+
T Consensus       337 ~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          337 YSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHhcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999999995

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.7e-44  Score=362.33  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=216.8

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .++.++|++.+.||+  |+||.||+|.++.+++.||+|++......  ..+.+.+|+++|++++||||+++++++.+...
T Consensus         5 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            5 GDINQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             -CHHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhEEeeeEEee--cCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            456778999999999  77999999999999999999998764332  24567899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl---~~~~~~~i~~~~~~~~  161 (622)
                      .++||||+++++|.+.+....  .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+++.|||....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            999999999999999887643  47899999999999999999999999999999999999   7788999999998755


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ......     .....+|+.|+|||++.+   .++.++||||+||++|+|++|..||..............+..+..   
T Consensus       159 ~~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  227 (277)
T 3f3z_A          159 FKPGKM-----MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP---  227 (277)
T ss_dssp             CCTTSC-----BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             ccCccc-----hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            432221     123356788999999864   378999999999999999999999987665544444333321110   


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                ......+++++.+|+..||+.||++|||+.++++||||++..
T Consensus       228 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          228 --------------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             --------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             --------------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                      001234689999999999999999999999999999997643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-44  Score=365.87  Aligned_cols=257  Identities=19%  Similarity=0.304  Sum_probs=209.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~   84 (622)
                      .+.++|++++.||+  |+||.||+|+++.+|+.||||++............+.+|+..+.++ +||||+++++++.+.+.
T Consensus         8 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            8 RYTTEFHELEKIGS--GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             HHHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             cccchhhhhhhhcC--CCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            34568999999999  7789999999999999999999987655556667788999999999 99999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-------------
Q psy15039         85 LHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-------------  149 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-------------  149 (622)
                      .++||||+++++|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999999997642  13589999999999999999999999999999999999998544             


Q ss_pred             ------ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch
Q psy15039        150 ------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  223 (622)
Q Consensus       150 ------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~  223 (622)
                            .+++.|||........        ....+|+.|+|||++.+. ..++.++|||||||++|+|++|.+|+.....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred             ccCCceEEEEcccccccccCCc--------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence                  6899999976544321        123467889999999753 3466799999999999999999887754432


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                      ..   ....+..|.                                .+..+++++.+++..||+.||++|||+.++++||
T Consensus       237 ~~---~~~~~~~~~--------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          237 WH---EIRQGRLPR--------------------------------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             HH---HHHTTCCCC--------------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             HH---HHHcCCCCC--------------------------------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            21   111221111                                1235789999999999999999999999999999


Q ss_pred             ccccc
Q psy15039        304 FFKQT  308 (622)
Q Consensus       304 ~~~~~  308 (622)
                      ||...
T Consensus       282 ~~~~~  286 (289)
T 1x8b_A          282 VLLSA  286 (289)
T ss_dssp             TC---
T ss_pred             Hhhhh
Confidence            99764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-44  Score=371.40  Aligned_cols=264  Identities=18%  Similarity=0.253  Sum_probs=216.6

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      .+.++|++++.||+  |+||.||+|+++.+|+.||||.++......    ...+.+.+|+.+|++++||||+++++++.+
T Consensus         9 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A            9 KVEDFYDIGEELGS--GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             CHHHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhccEEEeeEeee--cCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45568999999999  779999999999999999999997654321    124568899999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----ceEEcCCc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLR  157 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~----~~~i~~~~  157 (622)
                      ...+++||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++    .+++.|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999999999763  3578999999999999999999999999999999999999887    79999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  237 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~  237 (622)
                      ..........     .....+|+.|+|||++.+  ..++.++|||||||++|+|++|..||.................+ 
T Consensus       165 ~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-  236 (321)
T 2a2a_A          165 LAHEIEDGVE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD-  236 (321)
T ss_dssp             TCEECCTTCC-----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-
T ss_pred             cceecCcccc-----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc-
Confidence            8754432211     123356788999999865  35889999999999999999999999876554433333222110 


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..                            ......+++.+.+|+..||..||++|||+.++++||||....
T Consensus       237 ~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          237 FD----------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             CC----------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             cC----------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            00                            001235688999999999999999999999999999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-44  Score=379.26  Aligned_cols=284  Identities=25%  Similarity=0.308  Sum_probs=205.3

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +..+++++|++++.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||+++++|...
T Consensus        23 ~~~~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           23 TIWEVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EEEEEETTEEEEEECC------CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cccCCCCceEEeeEEee--cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            34567789999999999  7788999999999999999999977655666777888999999999999999999999764


Q ss_pred             ------CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         83 ------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        83 ------~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                            ..+++|+|++ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeec
Confidence                  5689999998 5888888865   35899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHHHhCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEKLAGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~~~~~  234 (622)
                      |.+......       .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.+......+  +....+.
T Consensus       177 G~a~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  248 (367)
T 2fst_X          177 GLARHTADE-------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  248 (367)
T ss_dssp             ---------------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             ccccccccc-------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            986543211       1123567889999998753 45899999999999999999999999877654333  2233333


Q ss_pred             CCCCCccccccccCCCCcCcccccccchh---hhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISE---QQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~---~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ++. ..     ....   .......++..   ....  .......++++.+|+.+||..||++|||+.++|+||||....
T Consensus       249 p~~-~~-----~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          249 PGA-EL-----LKKI---SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             CCH-HH-----HTTC---CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCH-HH-----HHHh---hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence            211 00     0000   00000000000   0000  001134688999999999999999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.4e-44  Score=368.72  Aligned_cols=270  Identities=23%  Similarity=0.287  Sum_probs=206.3

Q ss_pred             CCCCCceEE-eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCC
Q psy15039          6 NVPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT   83 (622)
Q Consensus         6 ~~~~~y~~~-~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~   83 (622)
                      .+.+.|++. +.||+  |+||.||+|+++.+|+.||||++.....  ...+.+.+|+.+|+++ +||||+++++++.+.+
T Consensus         9 ~~~~~y~i~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGE--GAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CTTTSCEECCCCCCC--CSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ccceeEEecCceecC--CceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            467889995 78999  7799999999999999999999976532  2345678999999995 7999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---eEEcCCcccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLRYMC  160 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~---~~i~~~~~~~  160 (622)
                      .+++||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.   +++.|||...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999999999999997753  4789999999999999999999999999999999999998775   8999998764


Q ss_pred             ccCCCCcccc---ccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH----------
Q psy15039        161 PFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTT----------  224 (622)
Q Consensus       161 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~----------  224 (622)
                      ..........   .......+|+.|+|||++...   ...|+.++|||||||++|+|++|..||......          
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            4321111000   001123578899999998641   124788999999999999999999999764311          


Q ss_pred             ----HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhh
Q psy15039        225 ----LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL  300 (622)
Q Consensus       225 ----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l  300 (622)
                          ..+...+.......                            +......+++++.+|+.+||+.||.+|||+.+++
T Consensus       243 ~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEF----------------------------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCC----------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             hhHHHHHHHHHhccCccc----------------------------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                11111111100000                            0001235789999999999999999999999999


Q ss_pred             cCccccccc
Q psy15039        301 QHAFFKQTK  309 (622)
Q Consensus       301 ~h~~~~~~~  309 (622)
                      +||||+...
T Consensus       295 ~hp~~~~~~  303 (316)
T 2ac3_A          295 QHPWVQGCA  303 (316)
T ss_dssp             HSTTCC---
T ss_pred             cChhhcCCC
Confidence            999997643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=367.91  Aligned_cols=253  Identities=21%  Similarity=0.265  Sum_probs=204.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++.+.||+  |+||+||+|+++.+|+.||||++..............+|+..+.++ +|||||+++++|.+...+++
T Consensus        57 ~~y~~~~~LG~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGH--GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEE--ETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeheecc--CCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            57999999999  7799999999999999999999877655555555666777666655 99999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+ ++++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus       135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            99999 578888887653 4589999999999999999999999999999999999999999999999998654432211


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           .....+|+.|+|||++.+   .++.++|||||||++|||++|..||......    ..+....            
T Consensus       213 -----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~~~~------------  268 (311)
T 3p1a_A          213 -----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGW----QQLRQGY------------  268 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----HHHTTTC------------
T ss_pred             -----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHhccC------------
Confidence                 123356888999999864   4899999999999999999997776543221    1111100            


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                        .+......+++++.+|+..||+.||++|||+.++++||||++
T Consensus       269 ------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ------------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                              000012357899999999999999999999999999999975

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-44  Score=375.93  Aligned_cols=210  Identities=22%  Similarity=0.320  Sum_probs=174.2

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEE
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL  430 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~  430 (622)
                      ..+.+.|++.+.||+  |+||.||+|+++   .+++.||||++.....    ..++.+|+++|+.+ +|||||+++++|.
T Consensus        17 p~l~~~Y~i~~~lG~--G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGE--GTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             GGGGGTCEEEEEEEE--CSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             CCccCcEEEEEEEec--ccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            345678999999999  889999999885   4688999999865432    24678999999998 6999999999999


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CceEEcCcccc
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYM  509 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~-~~~~~~~~~~~  509 (622)
                      +.+.+|+|||||++|+|.+++.     .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.++++|||++
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            9999999999999999999884     37899999999999999999999999999999999999877 79999999987


Q ss_pred             cccCCCCCcee------------------------ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCC
Q psy15039        510 CPFSPTKKKVH------------------------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT  565 (622)
Q Consensus       510 ~~~~~~~~~~~------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~  565 (622)
                      ...........                        ....+.+||+.|||||++.+. ..|+.++||||+||++|||+||+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCC
Confidence            54332211100                        011235789999999999753 35899999999999999999999


Q ss_pred             CCCCCCCcHHH
Q psy15039        566 VPFAETPTTLM  576 (622)
Q Consensus       566 ~Pf~~~~~~~~  576 (622)
                      +||....+...
T Consensus       245 ~Pf~~~~~~~~  255 (361)
T 4f9c_A          245 YPFYKASDDLT  255 (361)
T ss_dssp             SSSSCCSSHHH
T ss_pred             CCCCCCCCHHH
Confidence            99976655433

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7e-44  Score=377.21  Aligned_cols=262  Identities=19%  Similarity=0.312  Sum_probs=209.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR--HPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~   86 (622)
                      .+|++++.||+  |+||+||+|.++. |+.||||+++.........+.+.+|+.+|++|+  |||||++++++...+.++
T Consensus        56 ~~y~~~~~LG~--G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           56 RIYSILKQIGS--GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             EEEEEEEEEEC--CSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CceEEEEEEcc--CCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            46999999999  7899999999875 999999999887767777788999999999997  599999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||| +.+++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+++.|||.+.......
T Consensus       133 lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9999 67899999997643  578889999999999999999999999999999999995 5899999999875543221


Q ss_pred             ccccccCCCCCCCccccChhhhccc---------cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCC
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQN---------LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  237 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~---------~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~  237 (622)
                      ..  .......+|+.|+|||++.+.         ...|+.++|||||||++|+|++|..||............+......
T Consensus       209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          209 TS--VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             cc--ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            11  112244678899999998641         1358899999999999999999999998654433333332211100


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                    ...+...++++.+||..||..||++||++.++++||||....
T Consensus       287 ------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          287 ------------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             ------------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ------------------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                                          001223478899999999999999999999999999997643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.9e-44  Score=362.70  Aligned_cols=266  Identities=25%  Similarity=0.378  Sum_probs=204.5

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .-..++|++.+.||+  |+||.||+|+++.+|+.||||++..........+.+.+|...++.++||||+++++++.+...
T Consensus         3 ~i~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            3 EVKADDLEPIMELGR--GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCCGGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             cccHHhhhhHHhcCC--CCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            445679999999999  779999999999999999999997765444444555566677899999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      .++||||++ |++.+++...  ....+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+++.|||.+..
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            999999998 5887776542  234589999999999999999999998 999999999999999999999999997654


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhcc--ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-HHHHHHHhCCCCCC
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKLAGATPHL  238 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-~~~~~~~~~~~p~~  238 (622)
                      ......     .....+|+.|+|||++..  ....++.++||||+||++|+|++|..||...... ......+....+. 
T Consensus       160 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  233 (290)
T 3fme_A          160 LVDDVA-----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-  233 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-
T ss_pred             cccccc-----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-
Confidence            332211     112356778999999731  1245788999999999999999999999864333 2222333222111 


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                    .....+++++.+++..||+.||++|||+.++++||||+...
T Consensus       234 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          234 ------------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             ------------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ------------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                                          12235789999999999999999999999999999997643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.6e-44  Score=361.88  Aligned_cols=257  Identities=22%  Similarity=0.385  Sum_probs=211.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -++|++.+.||+  |+||.||+|+++.+++.||||++........ ....+.+|+.++++++||||+++++++.+....+
T Consensus         8 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            8 LEDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccEEEeeEEec--CCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            358999999999  7799999999999999999999865322111 1356789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+.+....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.........
T Consensus        86 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            9999999999999987653  48899999999999999999999999999999999999999999999999764332211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                            .....+++.|+|||++.+  ..++.++||||+||++|+|++|..||.................           
T Consensus       164 ------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  224 (279)
T 3fdn_A          164 ------RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------  224 (279)
T ss_dssp             ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred             ------ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------
Confidence                  122356778999999875  3578899999999999999999999987654433322221110           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                            ..+..+++++.+|+..||+.||.+|||+.++++||||....
T Consensus       225 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          225 ----------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                                  11234688999999999999999999999999999997754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.8e-45  Score=370.57  Aligned_cols=201  Identities=24%  Similarity=0.344  Sum_probs=162.1

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC----c
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----D  434 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~----~  434 (622)
                      .+|.+.+.||+  |+||.||+|+.  +|+.||||++....   .......+|+..+..++|||||++++++.+.+    .
T Consensus         3 r~i~L~~~iG~--G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGK--GRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEE--CSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEee--CCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            46889999999  88999999987  68999999986432   11223456777778899999999999998764    5


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCceEEcCc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK--------GFIHRAVKASHILISHNGKACLSGL  506 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~--------~iiHRDlKp~NILl~~~~~~~~~~~  506 (622)
                      +|+|||||++|+|.++++..   ++++..+..++.|++.||+|||++        +||||||||+||||+.++.+||+||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            89999999999999999764   478888999999999999999987        9999999999999999999999999


Q ss_pred             ccccccCCCCCceeccCCCCCCCCccccccccccCc----cCCCchhhHHHHHHHHHHHHcCCCCCC
Q psy15039        507 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL----DGYDERSDIYSVGISCCELANGTVPFA  569 (622)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~~DiwSlGvil~e~ltg~~Pf~  569 (622)
                      |++...............+.+||+.|||||++.+..    ..|+.++|||||||++|||+||++||.
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            986544333222222334567999999999996421    136789999999999999999987764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-44  Score=392.38  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=215.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ..++|++.++||+  |+||+||+|+++.||+.||||++++..... ...+.+.+|+.+|++++|||||+++++|.+...+
T Consensus       183 ~~~~f~~~~~LG~--G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          183 GEDWFLDFRVLGR--GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEee--CCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            3468999999999  778899999999999999999996542211 2245678999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         86 HLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      |+||||+++|+|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||......
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999999987643  3358999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch---HHHHHHHHhCCCCCCCc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLLD  240 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~---~~~~~~~~~~~~p~~~~  240 (622)
                      .....    ..+..+|+.|+|||++.+  ..|+.++|||||||++|||++|..||.....   ...+...+....+    
T Consensus       341 ~~~~~----~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~----  410 (543)
T 3c4z_A          341 AGQTK----TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV----  410 (543)
T ss_dssp             TTCCC----BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC----
T ss_pred             CCCcc----cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc----
Confidence            22211    123367889999999975  4689999999999999999999999976421   2222222211110    


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCcccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTKK  310 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~~  310 (622)
                                                  ..+..+++++.+||.+||+.||.+||+     +.++++||||+...+
T Consensus       411 ----------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          411 ----------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ----------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                                        112457899999999999999999995     589999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-44  Score=374.12  Aligned_cols=270  Identities=19%  Similarity=0.253  Sum_probs=217.8

Q ss_pred             CCCCCCCceEE-eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe
Q psy15039          4 LDNVPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD   81 (622)
Q Consensus         4 ~~~~~~~y~~~-~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~   81 (622)
                      .+++...|.+. +.||+  |+||.||+|+++.+|+.||||++............+.+|+.+|+++ +||||++++++|.+
T Consensus        23 ~~~~~~~y~~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           23 MENFNNFYILTSKELGR--GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             HHHHHHHEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHhhhhEEeeccceeCC--CCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            34566788888 88999  7799999999999999999999987554444456788999999999 56999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcCCcc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRY  158 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~~~~  158 (622)
                      ...+++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+++.|||.
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            999999999999999999886544456899999999999999999999999999999999999987   78999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      .........     .....+|+.|+|||++.+  ..++.++|||||||++|+|++|..||.................+. 
T Consensus       181 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-  252 (327)
T 3lm5_A          181 SRKIGHACE-----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY-  252 (327)
T ss_dssp             CEEC--------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-
T ss_pred             ccccCCccc-----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc-
Confidence            755432211     112356788999999975  358899999999999999999999998766544433332221110 


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                                                  .......+++.+.+|+..||+.||.+|||+.++++||||+.....
T Consensus       253 ----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          253 ----------------------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             ----------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             ----------------------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence                                        001223578899999999999999999999999999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.8e-43  Score=370.94  Aligned_cols=262  Identities=25%  Similarity=0.400  Sum_probs=214.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC--CCHH----HHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR--MTDE----DLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~--~~~~----~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||++....  ....    ..+.+.+|+.+|+++ +||||+++++++.
T Consensus        93 ~~~y~~~~~lg~--G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           93 YQKYDPKDVIGR--GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhcccceEEec--CCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            357999999999  778999999999999999999987653  2222    245678999999999 8999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                      .....++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+++.|||.+.
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            9999999999999999999997643  58899999999999999999999999999999999999999999999999775


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccc----cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN----LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~----~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      .......     .....+|+.|+|||++.+.    ...|+.++|||||||++|+|++|..||..............+..+
T Consensus       249 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          249 HLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             ECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            5433221     1234668889999998642    235788999999999999999999999876554433333332211


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      .                             ..+.....++++.+|+.+||+.||++|||+.++++||||++
T Consensus       324 ~-----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          324 F-----------------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             C-----------------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             C-----------------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            0                             00112356889999999999999999999999999999963

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-43  Score=359.33  Aligned_cols=269  Identities=27%  Similarity=0.362  Sum_probs=217.7

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC---CH----HHHHHHHHHHHHHhhCC-CCccee
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---TD----EDLKSLHHEIVCMRHLR-HPNIIC   74 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~---~~----~~~~~~~~Ei~il~~l~-HpnIv~   74 (622)
                      +...+.++|++.+.||+  |+||.||+|+++.+|+.||||+++....   ..    ...+.+.+|+.+|+++. ||||++
T Consensus        11 ~~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A           11 STHGFYENYEPKEILGR--GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             ----CTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             CCcchhhccceeeeecC--CCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            45678899999999999  7799999999999999999999976531   22    23456789999999995 999999


Q ss_pred             EEEEEEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEc
Q psy15039         75 YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  154 (622)
Q Consensus        75 ~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~  154 (622)
                      +++++.+....++||||+++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+++.
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEe
Confidence            9999999999999999999999999997643  58899999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCccccccCCCCCCCccccChhhhcc----ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH
Q psy15039        155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ----NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  230 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~----~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~  230 (622)
                      |||..........     .....+++.|+|||++..    ....++.++|||||||++|+|++|..||............
T Consensus       167 dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  241 (298)
T 1phk_A          167 DFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI  241 (298)
T ss_dssp             CCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccchhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence            9998755432221     112356778999999852    1245788999999999999999999999876554433333


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ..+..+.                             .......+++++.+++..||+.||.+|||+.++++||||++..
T Consensus       242 ~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          242 MSGNYQF-----------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             HHTCCCC-----------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             hcCCccc-----------------------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            3222110                             0011235788999999999999999999999999999997643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4e-44  Score=376.82  Aligned_cols=289  Identities=20%  Similarity=0.242  Sum_probs=208.6

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC--
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--   83 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--   83 (622)
                      .+.++|++++.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+|+.++|||||+++++|....  
T Consensus        22 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           22 TVLKRYQNLKPIGS--GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EEETTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred             chhhheeEeeeeEe--cCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence            35579999999999  77999999999999999999999876666677788899999999999999999999998765  


Q ss_pred             ----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         84 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        84 ----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                          .+++||||+++ ++.+.+..    .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus       100 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          100 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence                68999999984 67777742    4789999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  239 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~  239 (622)
                      .......     ......+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||.+..........+.......+
T Consensus       175 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          175 RTAGTSF-----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             --------------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             ccccccc-----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            5433211     1123356788999999975  35899999999999999999999999887665544443322111100


Q ss_pred             ccccc-------cccCCCCcCcccccccchhhhhcc--ccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        240 DCTTY-------YVDTGQDDGEENACSYISEQQTQV--LTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       240 ~~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      +....       +....+................+.  ......++++.+|+++||+.||++|||+.++|+||||...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            00000       000000000000000000000000  0001136789999999999999999999999999999753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-44  Score=378.15  Aligned_cols=284  Identities=17%  Similarity=0.246  Sum_probs=209.4

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      +....+|++++.||+  |+||+||+|+++.+|+.||||++..+...      ..+|+++|+.|+|||||+++++|...  
T Consensus         3 ~~~~~~y~~~~~lG~--G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGT--GSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ---CTTEEEEEEEEC--C-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             ccccceEEEEEEEEe--ccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence            445679999999999  77999999999999999999998654321      23799999999999999999998543  


Q ss_pred             ------------------------------------CcEEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHH
Q psy15039         83 ------------------------------------TDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNG  124 (622)
Q Consensus        83 ------------------------------------~~~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~a  124 (622)
                                                          ..+++||||++ |+|.+.+...  ....+++..++.++.||+.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                                33899999999 5877777542  23458999999999999999


Q ss_pred             HHHHHhCCcccCCCCCCCEEEc-CCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHH
Q psy15039        125 LEYIHGKGFIHRAVKASHILIS-HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYS  203 (622)
Q Consensus       125 L~ylH~~~IvHrDiKp~NiLl~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWS  203 (622)
                      |+|||++||+||||||+|||++ .++.++++|||.+........     .....+|+.|+|||++.+. ..|+.++||||
T Consensus       154 L~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Diws  227 (383)
T 3eb0_A          154 VGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGA-TEYTPSIDLWS  227 (383)
T ss_dssp             HHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHH
T ss_pred             HHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-----CcCcccCCCccCHHHhcCC-CCCCcchhhhh
Confidence            9999999999999999999998 578999999998754432221     1233557789999998753 35899999999


Q ss_pred             HHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHH
Q psy15039        204 VGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSI  281 (622)
Q Consensus       204 lG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l  281 (622)
                      +||++|+|++|+.||.+......+...+  .+.++ .....    ...........+... ........+...++++.+|
T Consensus       228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~-~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  301 (383)
T 3eb0_A          228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT-KEQMI----RMNPHYTEVRFPTLK-AKDWRKILPEGTPSLAIDL  301 (383)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-HHHHH----HHCTTC--CCCCCCC-CCCHHHHSCTTCCHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHHH----HhCcccccccCCccC-cccHHhhCCCCCCHHHHHH
Confidence            9999999999999998876554443332  22211 00000    000000000000000 0011111234578999999


Q ss_pred             HHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        282 VELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       282 i~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      +.+||+.||.+|||+.|+++||||+...
T Consensus       302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          302 LEQILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             HHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             HHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence            9999999999999999999999998754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.9e-44  Score=369.85  Aligned_cols=259  Identities=22%  Similarity=0.361  Sum_probs=192.6

Q ss_pred             CCCceEE---eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCC
Q psy15039          8 PSNYKIC---SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~---~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~   83 (622)
                      -++|++.   +.||+  |+||.||+|.++.+|+.||||+++..     ....+.+|+.+|+.+. |||||+++++|.+..
T Consensus         7 ~~~y~~~~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGE--GSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHEEECTTSCCSEE--ETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhccccccCCCcccc--CCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            3567775   78999  77999999999999999999998653     2345678999999997 999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCcccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMC  160 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~~~~  160 (622)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++   .+++.|||...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999999999774  3589999999999999999999999999999999999998766   79999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch------HHHHHHHHhCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT------TLMLIEKLAGA  234 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~------~~~~~~~~~~~  234 (622)
                      ........    .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||.....      .......+...
T Consensus       158 ~~~~~~~~----~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          158 LKPPDNQP----LKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             ECCC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             ecCCCCCc----ccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            43322111    123356788999999865  4589999999999999999999999975432      12222222211


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ....                            .......+++++.+|+..||+.||.+|||+.++++||||+...
T Consensus       232 ~~~~----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          232 DFSF----------------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             CCCC----------------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             CCCC----------------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            1000                            0001234789999999999999999999999999999998754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-44  Score=397.29  Aligned_cols=215  Identities=21%  Similarity=0.309  Sum_probs=186.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.++|++++.||+  |+||.||+|+++.+|+.||||++....  ....+.+.+|+.+|+.|+|||||+++++|.+.+.+|
T Consensus       155 il~~Y~i~~~lG~--G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          155 VLDHYDIHEELGT--GAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEee--ccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3468999999999  789999999999999999999987643  444577899999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC--CceEEcCcccccccCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFSP  514 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~--~~~~~~~~~~~~~~~~  514 (622)
                      +|||||++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+  +.+||.|||++..+..
T Consensus       231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            9999999999999886432 358899999999999999999999999999999999999865  7999999998766543


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ....     .+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+....+..+..+
T Consensus       310 ~~~~-----~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~  371 (573)
T 3uto_A          310 KQSV-----KVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC  371 (573)
T ss_dssp             TSEE-----EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred             CCce-----eeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC
Confidence            3211     23468999999999976  56999999999999999999999999988766655444444

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-44  Score=379.92  Aligned_cols=259  Identities=19%  Similarity=0.276  Sum_probs=201.3

Q ss_pred             CCCCCceEE-eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHH-hhCCCCcceeEEEEEEe--
Q psy15039          6 NVPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM-RHLRHPNIICYISSFLD--   81 (622)
Q Consensus         6 ~~~~~y~~~-~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~~~~~~~~--   81 (622)
                      .+.++|++. ++||+  |+||+||+|+++.+|+.||||+++..       ..+.+|+.++ +.++|||||+++++|..  
T Consensus        58 ~~~~~y~~~~~~LG~--G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             CGGGTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccccceeccceeee--ccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            345678887 68999  77899999999999999999998632       2456788887 45589999999999876  


Q ss_pred             --CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcCC
Q psy15039         82 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGL  156 (622)
Q Consensus        82 --~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~~  156 (622)
                        ...+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+++.||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              567999999999999999997654445899999999999999999999999999999999999997   688999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH----HHHHHHh
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL----MLIEKLA  232 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~----~~~~~~~  232 (622)
                      |..........     ..+..+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||.......    .......
T Consensus       209 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          209 GFAKETTSHNS-----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             TTCEECC----------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             ccccccCCCCc-----cccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            98754332111     123456888999999865  468999999999999999999999997543210    1111111


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      +...                             ........+++++.+||..||+.||++|||+.++++||||.+..
T Consensus       282 ~~~~-----------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          282 GQYE-----------------------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TCCC-----------------------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             Cccc-----------------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            1100                             00112245789999999999999999999999999999997643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5e-44  Score=375.19  Aligned_cols=291  Identities=20%  Similarity=0.247  Sum_probs=218.3

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ++.++..+|++++.||+  |+||.||+|+++.+++.||||++.... .....+.+.+|+++|++++||||+++++++...
T Consensus        21 ~~~~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           21 QVFDVGPRYTNLSYIGE--GAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             CBCCCTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             EeccccccEEEEEEeec--CCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            35567789999999999  789999999999999999999997543 455567788999999999999999999999765


Q ss_pred             -----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCc
Q psy15039         83 -----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  157 (622)
Q Consensus        83 -----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~  157 (622)
                           ..+++||||++ |+|.++++..   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||
T Consensus        98 ~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A           98 TIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             STTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCc
Confidence                 36899999998 5898888652   48899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGAT  235 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~  235 (622)
                      .+.......... .......+|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.+......+..  ...+.+
T Consensus       174 ~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  251 (364)
T 3qyz_A          174 LARVADPDHDHT-GFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  251 (364)
T ss_dssp             TCEECCGGGCBC-CTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred             ceEecCCCCCcc-ccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence            875443221111 112234678899999998654 4589999999999999999999999987654333322  222222


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhh--hccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQ--TQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      +. ....     ..................  ........+++++.+|+..||+.||++|||+.++|+||||++.
T Consensus       252 ~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          252 SQ-EDLN-----CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CH-HHHH-----TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             CH-HHHH-----HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            11 0000     000000000000000000  0000123578999999999999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.8e-43  Score=356.42  Aligned_cols=260  Identities=19%  Similarity=0.266  Sum_probs=217.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ...++|++.+.||+  |+||.||+|+++.+++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           12 RSRRRYVRGRFLGK--GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TTTEEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcccceEEEEEEee--cCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence            35568999999999  7799999999999999999999876543 45566778899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.......
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999999999987643  588999999999999999999999999999999999999999999999998754432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....    .....+++.|+|||++.+  ..++.++||||+||++|+|++|..||..............+..         
T Consensus       168 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  232 (294)
T 2rku_A          168 DGER----KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------  232 (294)
T ss_dssp             TTCC----BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------
T ss_pred             Cccc----cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---------
Confidence            2111    112356778999999865  3578899999999999999999999987654433322221110         


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                              ..+..+++.+.+++.+||+.||++|||+.++++||||...
T Consensus       233 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          233 ------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             ------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence                                    1123468899999999999999999999999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-43  Score=362.70  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=213.0

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..++.++|++.+.||+  |+||.||+|+++.+|+.||||+++....  ...+.+.+|+.+|++++||||+++++++.+..
T Consensus         4 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGS--GAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTT   79 (304)
T ss_dssp             --CHHHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccchhccceeeeeccC--CCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence            4567889999999999  7799999999999999999999976432  23356789999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCceEEcCCcccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMC  160 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl---~~~~~~~i~~~~~~~  160 (622)
                      .+++||||+++++|.+.+....  .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+++.|||...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999999999999987643  47899999999999999999999999999999999999   677899999999764


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ......      .....+++.|+|||++.+  ..|+.++||||+||++|+|++|..||..............+..+.   
T Consensus       158 ~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---  226 (304)
T 2jam_A          158 MEQNGI------MSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF---  226 (304)
T ss_dssp             CCCCBT------THHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC---
T ss_pred             ecCCCc------cccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence            322111      111245778999999875  358899999999999999999999998765543333332222110   


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                .......+++++.+|+..||+.||++||++.++++||||....
T Consensus       227 --------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          227 --------------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             --------------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             --------------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                                      0011235789999999999999999999999999999997643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=369.22  Aligned_cols=285  Identities=21%  Similarity=0.282  Sum_probs=209.4

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      .....+|++++.||+  |+||.||+|+++.+|+.||||++.......   ...+.+.+|+.+|++++||||++++++|.+
T Consensus         6 ~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGE--GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             -------CEEEEEEE--ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             HHHhcccEEEeEEee--cCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            345678999999999  779999999999999999999987643221   123467799999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ....++||||+++ ++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+++.|||....
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            9999999999985 7888876532 3578889999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCC
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLL  239 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~  239 (622)
                      .......    .....+|+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+......+....  .+.++ ..
T Consensus       162 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~-~~  235 (346)
T 1ua2_A          162 FGSPNRA----YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EE  235 (346)
T ss_dssp             TTSCCCC----CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-TT
T ss_pred             ccCCccc----CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCC-hh
Confidence            4322211    1234567889999998653 458899999999999999999999998766544433322  22211 11


Q ss_pred             ccccccccCCCCcCcccccccchhhhhc----cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQ----VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .+...    .      ..+.++.....+    ......+++++.+||..||..||++|||+.|+++||||....
T Consensus       236 ~~~~~----~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          236 QWPDM----C------SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TSSST----T------SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hhhhh----c------cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence            11000    0      000000000000    001245789999999999999999999999999999997753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=372.99  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=209.7

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHH------HHHHHHHHHHHHhhCCCCcceeEEEEE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE------DLKSLHHEIVCMRHLRHPNIICYISSF   79 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~   79 (622)
                      ++..+|++.+.||+  |+||.||+|+++.+|+.||||+++.......      ..+.+.+|+.+|++++||||++++++|
T Consensus        21 ~~~~~y~~~~~lG~--G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           21 EYSQKYSTMSPLGS--GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             HHHHHEEEEEECSS--SSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceEEEeEEEe--cCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34568999999999  7788999999999999999999987643221      234566899999999999999999999


Q ss_pred             EeCCcEEEEeecCCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         80 LDATDLHLVSPLMGFG-SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g-~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                      .+...+++||||+..| ++.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999999776 999998764  3589999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      ..........     ....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.......             
T Consensus       177 a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------  237 (335)
T 3dls_A          177 AAYLERGKLF-----YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------  237 (335)
T ss_dssp             CEECCTTCCB-----CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------
T ss_pred             ceECCCCCce-----eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------
Confidence            7544322111     123567889999999753 234789999999999999999999996421100             


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                ......+..+++++.+|+..||+.||++|||+.++++||||++.
T Consensus       238 --------------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          238 --------------------------EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             --------------------------TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             --------------------------hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                                      00011223478999999999999999999999999999999764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.9e-44  Score=364.96  Aligned_cols=278  Identities=32%  Similarity=0.545  Sum_probs=198.2

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      -..++|++.+.||+  |+||.||+|+++.+|+.||||+++.... ....+.+.+|+.+|++++||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGS--GATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC-----CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheecc--ccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            34679999999999  7788999999999999999999876432 23455678999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         86 HLVSPLMGFGSCKDLINAH------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~------~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                      ++||||+++++|.+++...      ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999999998742      1234889999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCccc-cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        160 CPFSPTKKKV-HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       160 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      .......... ........+|+.|+|||++... ..++.++|||||||++|+|++|..||.................+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            5433211100 0111233567889999998643 3478999999999999999999999987665544444444333221


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ....                       ........+++++.+++.+||+.||.+||++.++++||||.+.+.
T Consensus       248 ~~~~-----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          248 ETGV-----------------------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             TC----------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             cccc-----------------------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            1100                       001122457899999999999999999999999999999987543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=363.69  Aligned_cols=268  Identities=27%  Similarity=0.476  Sum_probs=213.8

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      +.+.+...+|++.+.||+  |+||.||+|+++.+|+.||||++......   ...+.+|+.+|+++ +||||+++++++.
T Consensus        17 ~~l~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGN--GTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hhccCCCCcEEEEEEecc--CCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            345667789999999999  77999999999999999999999765432   24577899999999 8999999999998


Q ss_pred             e------CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEc
Q psy15039         81 D------ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  154 (622)
Q Consensus        81 ~------~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~  154 (622)
                      .      ...+++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence            7      4679999999999999999987544468999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCccccccCCCCCCCccccChhhhccc---cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH
Q psy15039        155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~  231 (622)
                      |||..........    ......+++.|+|||++...   ...++.++|||||||++|+|++|..||.............
T Consensus       172 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (326)
T 2x7f_A          172 DFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  247 (326)
T ss_dssp             CCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             eCcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence            9997654322111    11223567889999998621   2457899999999999999999999998765544333332


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ....|.                               .....+++++.+|+..||..||.+||++.++++||||....
T Consensus       248 ~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          248 RNPAPR-------------------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HSCCCC-------------------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             cCcccc-------------------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            222211                               12345789999999999999999999999999999997643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-43  Score=360.13  Aligned_cols=264  Identities=22%  Similarity=0.326  Sum_probs=214.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .+.++|++++.||+  |+||.||+|+++.+|+.||||.+.... ......+.+.+|+.++++++||||+++++++.+.+.
T Consensus         8 ~~~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            8 IINERYKIVDKLGG--GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             CEETTEEEEEEEEE--ETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             HhhccEEEEEEEcc--CCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            35678999999999  779999999999999999999987644 345556788999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999999997753  588999999999999999999999999999999999999999999999998754432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....   ......+|+.|+|||++.+  ..++.++||||+||++|+|++|+.||.+..........+....|...     
T Consensus       164 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  233 (294)
T 4eqm_A          164 TSLT---QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT-----  233 (294)
T ss_dssp             --------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHH-----
T ss_pred             cccc---ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcc-----
Confidence            2111   1123356788999999975  35789999999999999999999999877665555555443322110     


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                             ......+++.+.+++.+||+.||.+||+..+.+.+.|..
T Consensus       234 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          234 -----------------------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             -----------------------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             -----------------------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence                                   012245789999999999999999999777777766653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.8e-44  Score=363.56  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=213.7

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .+..++|++.+.||+  |+||.||+|+++.+|+.||+|++....  ....+.+.+|+.+|++++||||+++++++.+...
T Consensus        15 ~~~~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           15 LDPNEVWEIVGELGD--GAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             SCGGGTEEEEEEEEC--STTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             cCCccceeecceecc--CCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            356679999999999  778899999999999999999986543  2335678899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||.......
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999999999887643 3589999999999999999999999999999999999999999999999996532111


Q ss_pred             CCccccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      .    ........+++.|+|||++..   ....++.++|||||||++|+|++|..||..............+..|..   
T Consensus       170 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  242 (302)
T 2j7t_A          170 T----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL---  242 (302)
T ss_dssp             H----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---
T ss_pred             c----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc---
Confidence            0    001122356778999999842   124578899999999999999999999987665544444433322211   


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                 .....++.++.+++..||+.||++|||+.++++||||....
T Consensus       243 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          243 ---------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             ---------------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             ---------------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                                       12345788999999999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.4e-43  Score=362.50  Aligned_cols=260  Identities=19%  Similarity=0.263  Sum_probs=217.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ...+|++++.||+  |+||.||+++++.+++.||+|++.... ......+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus        39 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           39 SRRRYVRGRFLGK--GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTEEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEee--CCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            4568999999999  779999999999999999999987653 3455667788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||........
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999999987643  5889999999999999999999999999999999999999999999999987544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...    .....++..|+|||++.+  ..++.++|||||||++|+|++|..||..............+..          
T Consensus       195 ~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  258 (335)
T 2owb_A          195 GER----KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------  258 (335)
T ss_dssp             TCC----BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----------
T ss_pred             ccc----ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC----------
Confidence            111    122356778999999975  3578999999999999999999999987654433322222111          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                             .....+++++.+|+.+||+.||++||++.++++||||....
T Consensus       259 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          259 -----------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             -----------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence                                   01234688999999999999999999999999999997643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-43  Score=378.26  Aligned_cols=288  Identities=18%  Similarity=0.259  Sum_probs=212.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC------CCCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL------RHPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~   80 (622)
                      +..+|++++.||+  |+||.||+|+++.+|+.||||++...   ....+.+.+|+.+|+.+      +|+||++++++|.
T Consensus        95 ~~~ry~~~~~LG~--G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           95 VAYRYEVLKVIGK--GSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             ETTTEEEEEEEEE--SSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             ccCcEEEEEEccc--CccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            4567999999999  77999999999999999999999653   44456677899998887      5779999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--eEEcCCcc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--ACLSGLRY  158 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~--~~i~~~~~  158 (622)
                      ....+++||||++ ++|.+++......++++..++.++.||+.||+|||++||+||||||+|||++.++.  +++.|||.
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999997 68999987765456899999999999999999999999999999999999999887  99999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p  236 (622)
                      +......       ..+..+|+.|+|||++.+.  .|+.++|||||||++|||++|.+||........+..  ...+.+|
T Consensus       249 a~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          249 SCYEHQR-------VYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             CEETTCC-------CCSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ceecCCc-------ccccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            6543211       1234667889999999763  589999999999999999999999987765443332  2233222


Q ss_pred             CC-Cccc----cccccCCC---------CcCcc------cccccchh----hhhccccCCCCcHHHHHHHHHhhhcCCCC
Q psy15039        237 HL-LDCT----TYYVDTGQ---------DDGEE------NACSYISE----QQTQVLTSRKFSDSFHSIVELCLSRDVDK  292 (622)
Q Consensus       237 ~~-~~~~----~~~~~~~~---------~~~~~------~~~~~i~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~  292 (622)
                      .. .+..    .++...+.         .+...      ........    ...........++++.+||.+||+.||++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence            10 0000    00000000         00000      00000000    00000011234788999999999999999


Q ss_pred             CcCHHhhhcCccccccc
Q psy15039        293 RPLACNLLQHAFFKQTK  309 (622)
Q Consensus       293 Rps~~~~l~h~~~~~~~  309 (622)
                      |||+.|+|+||||++..
T Consensus       400 Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          400 RMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             SCCHHHHHTSTTTC---
T ss_pred             CCCHHHHhCChhhccCC
Confidence            99999999999998743

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-44  Score=384.25  Aligned_cols=263  Identities=22%  Similarity=0.304  Sum_probs=202.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC------CHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM------TDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      +.++|++.+.||+  |+||.||+|.++.+++.||||++.....      .......+.+|+.+|++|+|||||++++++.
T Consensus       133 ~~~~y~~~~~LG~--G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHTTEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhccEEEEeEEee--CCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3578999999999  7789999999999999999999876432      1122334779999999999999999999975


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLR  157 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~  157 (622)
                      . +.+++|||||++|+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++   .+++.|||
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             c-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            4 5689999999999998887653  3589999999999999999999999999999999999997655   49999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-AT  235 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~  235 (622)
                      .+.......     ......+|+.|+|||++.. +...|+.++|||||||++|+|++|..||........+...+.. ..
T Consensus       288 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          288 HSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             TTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             cceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            875543221     1123456788999999853 2245788999999999999999999999764432222222211 11


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      +..                             ......+++++.+|+.+||+.||++||++.++++||||+..
T Consensus       363 ~~~-----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NFI-----------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CCC-----------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CCC-----------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            100                             00123578999999999999999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=368.38  Aligned_cols=286  Identities=19%  Similarity=0.292  Sum_probs=214.1

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      -+-..+..+|++.+.||+  |+||.||+|+++.+|+.||||+++.... ....+.+.+|+++|++++||||+++++++..
T Consensus         2 ~~~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            2 GSQSTSNHLWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             CEEECSSEEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CcccCCCCCEEEEEEecC--CCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            344567889999999999  7899999999999999999999875432 1224556799999999999999999999987


Q ss_pred             CC--cEEEEeecCCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCceEEc
Q psy15039         82 AT--DLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLS  154 (622)
Q Consensus        82 ~~--~~~lv~e~~~~g~l~~~l~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl----~~~~~~~i~  154 (622)
                      ..  ..++||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+++.
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence            65  78999999999999999976532 238999999999999999999999999999999999999    677789999


Q ss_pred             CCccccccCCCCccccccCCCCCCCccccChhhhccc------cCCCCCcchHHHHHHHHHHHhcCCCCCCCCc---h-H
Q psy15039        155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN------LDGYDERSDIYSVGISCCELANGTVPFAETP---T-T  224 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~------~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~---~-~  224 (622)
                      |||.+.........     ....+|+.|+|||++...      ...|+.++|||||||++|||++|..||....   . .
T Consensus       159 Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          159 DFGAARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             CCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             cCCCceecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            99987554332211     133567889999998621      2457899999999999999999999996422   1 2


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                      ......+.+.++..........        .....|.............+++.+.+++..||+.||++|||++|+|+||
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAE--------NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECST--------TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhccc--------CCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            3333333433332211110000        0000011010111111234577889999999999999999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=362.28  Aligned_cols=262  Identities=19%  Similarity=0.328  Sum_probs=193.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +..++|++.+.||+  |+||.||+|+++.+|+.||||.+....... ...+.+.+|+.++++++||||+++++++.+...
T Consensus         8 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A            8 EKIEDFKVGNLLGK--GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY   85 (278)
T ss_dssp             SSGGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred             cccccceeeeeecC--CCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence            34568999999999  779999999999999999999986432111 123568899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999999997643 3589999999999999999999999999999999999999999999999997654432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....    .....+|+.|+|||++.+  ..++.++||||+||++|+|++|+.||..............            
T Consensus       165 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          165 PHEK----HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             CCCc----ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            2111    112356778999999875  3578899999999999999999999975432211110000            


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                           .....+..++.++.+++.+||+.||++|||+.++++||||....
T Consensus       227 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 ---------------------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             ---------------------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             ---------------------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                                 00011234788999999999999999999999999999997643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-44  Score=373.85  Aligned_cols=291  Identities=23%  Similarity=0.349  Sum_probs=217.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||+|++.... .....+.+.+|+.+|++++||||+++++++.+...++
T Consensus        31 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           31 KDDDFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceeeeeecC--CCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            3568999999999  778899999999999999999997753 4566678899999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+++.|||.+......
T Consensus       108 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999997753  478999999999999999999996 9999999999999999999999999976432111


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH---HHhCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE---KLAGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~---~~~~~~p~~~~~~  242 (622)
                            ......+|+.|+|||++.+  ..|+.++|||||||++|+|++|..||...........   ...+..+......
T Consensus       186 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          186 ------MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             ------C----CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             ------cccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence                  1123356788999999975  3588999999999999999999999987554322111   0111100000000


Q ss_pred             c---cccc-----CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        243 T---YYVD-----TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       243 ~---~~~~-----~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .   ....     .............+............++.++.+|+..||+.||.+|||+.++++||||+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence            0   0000     000000000001111111222233457999999999999999999999999999999987544

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=363.08  Aligned_cols=267  Identities=18%  Similarity=0.287  Sum_probs=210.9

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--   81 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--   81 (622)
                      .+.++|++++.||+  |+||.||+|.++.+|+.||||+++....  .......+.+|+++|++++||||+++++++..  
T Consensus         2 ~l~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (305)
T 2wtk_C            2 KLIGKYLMGDLLGE--GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE   79 (305)
T ss_dssp             ---CCBCCCCEEEE--CSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred             ccccceeEeeEEec--CCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            35679999999999  7789999999999999999999865321  12334678899999999999999999999854  


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ....++||||++++ +.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||....
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            45799999999977 77777665455689999999999999999999999999999999999999999999999998754


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ........  ......+++.|+|||++.+....++.++|||||||++|+|++|..||..............+..      
T Consensus       159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------  230 (305)
T 2wtk_C          159 LHPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------  230 (305)
T ss_dssp             CCTTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC------
T ss_pred             cCcccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC------
Confidence            43211111  1123356788999999875333346799999999999999999999987654433222222111      


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                                 .....+++++.+|+.+||..||.+|||+.++++||||+....
T Consensus       231 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          231 ---------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             ---------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ---------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                                       112346889999999999999999999999999999987543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-43  Score=358.60  Aligned_cols=257  Identities=21%  Similarity=0.354  Sum_probs=212.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||||++....... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus        13 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           13 IDDFDIGRPLGK--GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeheecC--CCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            468999999999  779999999999999999999986532111 11356789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.........
T Consensus        91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            9999999999999997653  47899999999999999999999999999999999999999999999999764432211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                            .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||.................           
T Consensus       169 ------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------  229 (284)
T 2vgo_A          169 ------RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-----------  229 (284)
T ss_dssp             ------BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------
T ss_pred             ------cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-----------
Confidence                  123356788999999975  3578999999999999999999999987654433222221110           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                            ..+..+++++.+++..||+.||.+||++.++++||||+...
T Consensus       230 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          230 ----------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                                  01234688999999999999999999999999999998654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.8e-44  Score=376.23  Aligned_cols=284  Identities=22%  Similarity=0.321  Sum_probs=215.0

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .+++.+|.+.+.||+  |+||.||+|.++.+|+.||||++......+...+.+.+|+.+|+.++||||++++++|.....
T Consensus        38 ~~l~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           38 WELPKTYVSPTHVGS--GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             EEEETTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ecccccEEEEeEEec--CCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            356789999999999  779999999999999999999998766666667888999999999999999999999988765


Q ss_pred             E------EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         85 L------HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        85 ~------~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                      .      ++||||++ +++.+.+.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus       116 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             STTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             cccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            4      99999998 67776653    2488999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~~p  236 (622)
                      +......       .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+......+...  ..+.++
T Consensus       191 a~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          191 ARHADAE-------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             C---------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccC-------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            6543221       1233567889999998753 45889999999999999999999999877654443332  222221


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhh--ccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQT--QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .  +.    ...............+.....  .......+++++.+||..||+.||++|||+.++++||||+...
T Consensus       263 ~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          263 T--EF----VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             H--HH----HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             H--HH----HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            1  00    000000000000000000000  0001235789999999999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-43  Score=357.35  Aligned_cols=264  Identities=18%  Similarity=0.316  Sum_probs=212.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++++.||+  |+||.||+|+++.+|+.||||+++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus         6 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecceEEEEEeec--CCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            357999999999  7788999999999999999999976443 2344678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||..........
T Consensus        83 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999999999888543  3588999999999999999999999999999999999999999999999997654322111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .  .......+++.|+|||++.+. ..++.++||||+||++|+|++|..||..................           
T Consensus       161 ~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  226 (276)
T 2yex_A          161 E--RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----------  226 (276)
T ss_dssp             E--CCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-----------
T ss_pred             h--hcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-----------
Confidence            1  111234567889999998753 23467899999999999999999999765432222222211100           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                         .......+++++.+|+..||..||++|||+.++++||||++..
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          227 -------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                               0111235788999999999999999999999999999997653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-43  Score=400.18  Aligned_cols=260  Identities=18%  Similarity=0.267  Sum_probs=216.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      .++|+++++||+  |+||+||+|+++.+|+.||||++++... .....+.+.+|..+|..+ +||||++++++|.+.+.+
T Consensus       340 ~~~f~~~~~LG~--G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          340 LTDFNFLMVLGK--GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             CTTEEEEEESSB--TTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccceEEEEEEcc--CCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            358999999999  7789999999999999999999875321 112345677899999988 799999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+++.|||.+......
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999998753  5889999999999999999999999999999999999999999999999976532221


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...    ..+..+|+.|+|||++.+  ..|+.++|||||||++|||++|..||.+.+........+.+..          
T Consensus       496 ~~~----~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----------  559 (674)
T 3pfq_A          496 GVT----TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------  559 (674)
T ss_dssp             TCC----BCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------
T ss_pred             Ccc----cccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence            111    224467889999999975  4689999999999999999999999987665544433332211          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCH-----HhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA-----CNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-----~~~l~h~~~~~~~~  310 (622)
                                             ..+..+++++.+||+.||+.||.+||++     +++++||||+...+
T Consensus       560 -----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          560 -----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             -----------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence                                   0123578999999999999999999997     99999999987643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=358.14  Aligned_cols=263  Identities=31%  Similarity=0.514  Sum_probs=211.1

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ....++|++.+.||+  |+||.||+|.++.+|+.||||++.....    .+.+.+|+.+|++++||||+++++++.....
T Consensus        25 ~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGE--GSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             -----CEEEEEECC------CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             hcchhhhhhheeecc--CCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            455678999999999  7788999999999999999999976542    2457789999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+++.|||.......
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999999999987532 4589999999999999999999999999999999999999999999999997654332


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....    .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||.................+..      
T Consensus       178 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------  245 (314)
T 3com_A          178 TMAK----RNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF------  245 (314)
T ss_dssp             TBSC----BCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred             hccc----cCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc------
Confidence            2111    123356788999999975  3588999999999999999999999987655443332222221110      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                              .....+++++.+|+..||..||.+|||+.++++||||.....
T Consensus       246 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          246 ------------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             ------------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             ------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence                                    112346889999999999999999999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.3e-43  Score=355.79  Aligned_cols=263  Identities=19%  Similarity=0.317  Sum_probs=215.5

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--CC
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--AT   83 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~   83 (622)
                      ...++|++++.||+  |+||.||+|+++.+|+.||+|++......+...+.+.+|+.+|++++||||+++++++.+  ..
T Consensus         3 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            3 SRAEDYEVLYTIGT--GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CCGGGEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             CchhheeeehhccC--CCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            34579999999999  778899999999999999999998877777778889999999999999999999998865  46


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEEcCCCceEEcCC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKG-----FIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~-----IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                      .+++||||+++++|.+++....  ...+++..+..++.|++.||+|||++|     |+||||||+|||++.++.+++.||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            7999999999999999987542  234889999999999999999999999     999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      |............    ....+++.|+|||++.+.  .++.++|||||||++|+|++|..||..............+..+
T Consensus       161 g~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  234 (279)
T 2w5a_A          161 GLARILNHDTSFA----KTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR  234 (279)
T ss_dssp             CHHHHC---CHHH----HHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             chheeeccccccc----cccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence            9865433221111    012456789999998753  5889999999999999999999999876544332222222211


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      .                                ....+++++.+++.+||+.||++||++.++++|+|+...
T Consensus       235 ~--------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          235 R--------------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             C--------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             c--------------------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            1                                123478899999999999999999999999999999763

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.1e-43  Score=363.16  Aligned_cols=289  Identities=21%  Similarity=0.314  Sum_probs=215.2

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEc-cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCcceeEEEEEE-
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHK-VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFL-   80 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~-~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~~~~~~~-   80 (622)
                      ...++|++++.||+  |+||.||+|+++ .+|+.||||++............+.+|+.+++.+   +||||+++++++. 
T Consensus         8 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            8 RADQQYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CGGGTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             Cchhceeeeeeecc--cccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            34578999999999  778999999995 7889999999875433222223455787777766   8999999999987 


Q ss_pred             ----eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         81 ----DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        81 ----~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                          ....+++||||++ |+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence                4567999999998 69999998765555899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~  234 (622)
                      |.........     ......++..|+|||++.+.  .++.++|||||||++|+|++|+.||........+...+  .+.
T Consensus       165 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          165 GLARIYSFQM-----ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             CSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccCCC-----CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9865443211     11234567789999999753  58899999999999999999999998766544333222  222


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCC
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS  312 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~  312 (622)
                      ++ ..++..... .    ....... .. ..........+++++.+|+.+||..||++|||+.++++||||.....+.
T Consensus       238 ~~-~~~~~~~~~-~----~~~~~~~-~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          238 PG-EEDWPRDVA-L----PRQAFHS-KS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             CC-GGGSCTTCS-S----CGGGSCC-CC-CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             CC-cccCccccc-c----chhhhcc-cC-cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            11 111100000 0    0000000 00 0000112245789999999999999999999999999999998876654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-43  Score=358.08  Aligned_cols=264  Identities=21%  Similarity=0.318  Sum_probs=213.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +.++|++++.||+  |+||.||+|+++.+|+.||||.++......    ...+.+.+|+.+|++++||||+++++++.+.
T Consensus         3 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            3 VEDHYEMGEELGS--GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK   80 (283)
T ss_dssp             HHHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhHHhhcc--cCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence            3467999999999  779999999999999999999987654321    1246688999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----ceEEcCCcc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLRY  158 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~----~~~i~~~~~  158 (622)
                      ...++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++    .+++.|||.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             CeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999999997643  588999999999999999999999999999999999998877    799999997


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      .........     .....+++.|+|||++..  ..++.++|||||||++|+|++|..||................... 
T Consensus       159 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  230 (283)
T 3bhy_A          159 AHKIEAGNE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF-  230 (283)
T ss_dssp             CEECC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-
T ss_pred             ceeccCCCc-----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC-
Confidence            654432211     112346778999999865  358899999999999999999999998765543333222211100 


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                                  ........++.+.+|+.+||..||++||++.++++||||+....
T Consensus       231 ----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          231 ----------------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             ----------------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             ----------------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence                                        00012346889999999999999999999999999999987543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.5e-43  Score=359.09  Aligned_cols=261  Identities=28%  Similarity=0.517  Sum_probs=217.2

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      +..+.|++++.||+  |+||.||+|+++.+|+.||||.++.... ....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        19 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           19 DPEELFTKLEKIGK--GSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CGGGTEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             ChHHHHHHhhhhcc--cCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            44567999999999  7788999999999999999999976543 23456788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+++++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+++.|||........
T Consensus        96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999999999864   35889999999999999999999999999999999999999999999999976544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...    .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||..............+..+.        
T Consensus       173 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  238 (303)
T 3a7i_A          173 QIK----RNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT--------  238 (303)
T ss_dssp             BCC----BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             ccc----cCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC--------
Confidence            111    123356788999999975  357899999999999999999999998765443333222222111        


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                              ....++.++.+|+..||+.||.+|||+.++++||||.....
T Consensus       239 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          239 ------------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             ------------------------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             ------------------------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence                                    12357889999999999999999999999999999976544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-43  Score=373.08  Aligned_cols=283  Identities=21%  Similarity=0.290  Sum_probs=206.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc---
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD---   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~---   84 (622)
                      ..+|++++.||+  |+||+||+|+++.+++ ||+|++......      ..+|+++|+.++|||||+++++|.....   
T Consensus        39 ~~~Y~~~~~lG~--G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           39 EIAYTNCKVIGN--GSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             EEEEEEEEEEEE--ETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             cceEEEeEEEee--CCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            447999999999  7799999999998876 899987553321      2369999999999999999999976543   


Q ss_pred             ---EEEEeecCCCCCHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCceEEcCCccc
Q psy15039         85 ---LHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKACLSGLRYM  159 (622)
Q Consensus        85 ---~~lv~e~~~~g~l~~~l~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~-~~~~~~i~~~~~~  159 (622)
                         +++||||++++.+..+.... ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.++++|||.+
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence               88999999975544433221 234589999999999999999999999999999999999999 7899999999987


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPH  237 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~  237 (622)
                      ........     .....+|+.|+|||++.+. ..|+.++||||+||++|||++|+.||.+......+...+  .+.++ 
T Consensus       190 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~-  262 (394)
T 4e7w_A          190 KILIAGEP-----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS-  262 (394)
T ss_dssp             EECCTTCC-----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-
T ss_pred             ccccCCCC-----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-
Confidence            54432221     1234567889999998753 458999999999999999999999998876554443332  22221 


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                      .......    .........+ .+.............++++.+|+.+||+.||.+|||+.++++||||+.....
T Consensus       263 ~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          263 REQIKTM----NPNYMEHKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHHHHH----CGGGSSSCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HHHHHhh----Chhhhhhccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            1000000    0000000000 0000011111233578999999999999999999999999999999876543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.7e-43  Score=376.43  Aligned_cols=280  Identities=19%  Similarity=0.241  Sum_probs=205.3

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC------C
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA------T   83 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~------~   83 (622)
                      +|++++.||+  |+||.||+|+++.+|+.||||++.....      ...+|+++|++|+|||||+++++|...      .
T Consensus        55 ~y~~~~~lG~--G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           55 SYTDTKVIGN--GSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             eEEeeeEEee--CCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            6999999999  7799999999999999999999865432      133799999999999999999998653      1


Q ss_pred             cEEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CceEEcCCcccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYMC  160 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~-~~~~i~~~~~~~  160 (622)
                      .+++||||+++ ++.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.++++|||...
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            37799999985 566655432  23458999999999999999999999999999999999999965 568999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHL  238 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~  238 (622)
                      .......     .....+|+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+......+...+  .+.++ .
T Consensus       206 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~-~  278 (420)
T 1j1b_A          206 QLVRGEP-----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT-R  278 (420)
T ss_dssp             ECCTTCC-----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC-H
T ss_pred             hcccCCC-----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-H
Confidence            4432211     1234567889999998753 358999999999999999999999998876544443332  22211 0


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ....    ...........+. +.............++++.+||.+||..||.+||++.++++||||.....
T Consensus       279 ~~~~----~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          279 EQIR----EMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHH----HHCSCCCCCCCCC-CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHH----hhChhhhhhccCc-cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            0000    0000000000000 00000001122356899999999999999999999999999999987544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.7e-43  Score=354.69  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=205.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .++|++++.||+  |+||.||+|+++.+|+.||||+++..... ....+.+.+|+.+|+.++||||+++++++.+....+
T Consensus        10 ~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A           10 IGHYVLGDTLGV--GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             ETTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             eccEEEEeeecC--CCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            468999999999  77899999999999999999998653211 112456789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||.........
T Consensus        88 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999999997653  47899999999999999999999999999999999999999999999999875443221


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      .     .....+++.|+|||++.+. ..++.++|||||||++|+|++|..||..............+..           
T Consensus       166 ~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  228 (276)
T 2h6d_A          166 F-----LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-----------  228 (276)
T ss_dssp             ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred             c-----eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Confidence            1     1123567789999998753 2236799999999999999999999987654433222211110           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                            ..+..+++++.+++..||+.||++|||+.++++||||++.
T Consensus       229 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 ----------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ----------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                                  0123467889999999999999999999999999999764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4e-43  Score=362.00  Aligned_cols=269  Identities=20%  Similarity=0.378  Sum_probs=194.5

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      ..-..++|++++.||+  |+||.||+|+++.++.   .||||+++.........+.+.+|+.+|++++||||+++++++.
T Consensus        18 ~~i~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGK--GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             TBCC---CEEEEEEEE--ETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             cccChhHeEEeceecc--cCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3445678999999999  7799999999988876   8999999876555666788999999999999999999999998


Q ss_pred             eCCcE------EEEeecCCCCCHHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc
Q psy15039         81 DATDL------HLVSPLMGFGSCKDLINAHFN----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK  150 (622)
Q Consensus        81 ~~~~~------~lv~e~~~~g~l~~~l~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~  150 (622)
                      .....      ++||||+++|+|.+++.....    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence            87655      999999999999999865431    24889999999999999999999999999999999999999999


Q ss_pred             eEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHH
Q psy15039        151 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIE  229 (622)
Q Consensus       151 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~  229 (622)
                      +++.|||.+.........  .......+++.|+|||++.+  ..|+.++|||||||++|+|++ |..||...........
T Consensus       176 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~  251 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYY--RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY  251 (323)
T ss_dssp             EEECCCCC-------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             EEEeeccccccccccccc--cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence            999999987544322111  11122344668999999976  358999999999999999999 9999987654433333


Q ss_pred             HHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-------HHhhhcC
Q psy15039        230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-------ACNLLQH  302 (622)
Q Consensus       230 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-------~~~~l~h  302 (622)
                      ...+..+                                .....+++++.+|+..||+.||++|||       .+++++|
T Consensus       252 ~~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          252 LIGGNRL--------------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHTTCCC--------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCCC--------------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            3222111                                122357889999999999999999999       6678889


Q ss_pred             cccccccc
Q psy15039        303 AFFKQTKK  310 (622)
Q Consensus       303 ~~~~~~~~  310 (622)
                      +|+.....
T Consensus       300 ~~~~~~~~  307 (323)
T 3qup_A          300 LSVLSTSQ  307 (323)
T ss_dssp             --------
T ss_pred             hhhcCCCC
Confidence            99976543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.1e-43  Score=362.98  Aligned_cols=280  Identities=21%  Similarity=0.303  Sum_probs=207.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEe--CC
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLD--AT   83 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~   83 (622)
                      ..++|++++.||+  |+||.||+|+++.+|+.||||+++...     .+.+.+|+.+|++|+ ||||+++++++.+  ..
T Consensus        34 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           34 NQDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             EGGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCCceEEEEEecc--cCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            3568999999999  789999999999999999999986432     355779999999997 9999999999998  56


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCcccccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPF  162 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~  162 (622)
                      ..++||||++++++.+++..     +++..+..++.||+.||+|||++||+||||||+|||++.++ .+++.|||.+...
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            79999999999999988743     78899999999999999999999999999999999999777 8999999987544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH---HhCCCCCCC
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK---LAGATPHLL  239 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~---~~~~~p~~~  239 (622)
                      .....     .....++..|+|||++.+. ..++.++|||||||++|+|++|..||............   ..+.. ...
T Consensus       182 ~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~-~~~  254 (330)
T 3nsz_A          182 HPGQE-----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE-DLY  254 (330)
T ss_dssp             CTTCC-----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH-HHH
T ss_pred             CCCCc-----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc-hhh
Confidence            32211     1233567789999998653 45889999999999999999999999654332221111   11100 000


Q ss_pred             ccccccccCCCCcCcccccccch-------hhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYIS-------EQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      +.    .................       ...........+++++.+||..||+.||.+|||+.++|+||||+...
T Consensus       255 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          255 DY----IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HH----HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hH----HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            00    00000000000000000       00000111223789999999999999999999999999999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-42  Score=361.96  Aligned_cols=291  Identities=20%  Similarity=0.224  Sum_probs=218.1

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-   82 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-   82 (622)
                      ..++.++|++.+.||+  |+||.||+|+++.+|+.||||+++... .......+.+|+.+|++++||||+++++++... 
T Consensus         6 ~~~i~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CCCSCTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             ccccccceEEeeEEcC--CCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            4578899999999999  779999999999999999999996543 455566788999999999999999999988764 


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ...++||||++ |+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence                67999999998 688888865   2588999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCcccc------ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH--HHH
Q psy15039        159 MCPFSPTKKKVH------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML--IEK  230 (622)
Q Consensus       159 ~~~~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~--~~~  230 (622)
                      +...........      .......+|+.|+|||++..+ ..++.++|||||||++|+|++|..||.+......+  +..
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            754432211100      011123568889999998643 45889999999999999999999999877654332  223


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhh-----hhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ-----QTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      ..+.++.......        ........++...     .........+++++.+|+.+||+.||++|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (353)
T 2b9h_A          238 IIGTPHSDNDLRC--------IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL  309 (353)
T ss_dssp             HHCCCCSTTTTTT--------CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HhCCCchhccccc--------cccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            3333221110000        0000000000000     00000123578999999999999999999999999999999


Q ss_pred             ccccc
Q psy15039        306 KQTKK  310 (622)
Q Consensus       306 ~~~~~  310 (622)
                      +....
T Consensus       310 ~~~~~  314 (353)
T 2b9h_A          310 QTYHD  314 (353)
T ss_dssp             TTTCC
T ss_pred             cccCC
Confidence            87554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.6e-43  Score=356.87  Aligned_cols=255  Identities=22%  Similarity=0.353  Sum_probs=204.6

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      -...+|++.+.||+  |+||+||+|++  +|+.||||++..........+.+.+|+.+|++++|||||++++++.+...+
T Consensus        34 i~~~~y~i~~~lG~--G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           34 IPWCDLNIKEKIGA--GSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             CCGGGEEEEEEEEE--CSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             CChhHceeeeEeec--CCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            34568999999999  78999999987  588999999988777777778899999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+++.|||.....
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999975321 12789999999999999999999999  999999999999999999999999976432


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ....    .......+|+.|+|||++.+  ..++.++|||||||++|+|++|..||.................       
T Consensus       190 ~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------  256 (309)
T 3p86_A          190 ASTF----LSSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------  256 (309)
T ss_dssp             ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------
T ss_pred             cccc----cccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Confidence            2111    11223456788999999975  3578999999999999999999999987655433322211110       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              ....+..+++++.+||..||+.||.+|||+.++++
T Consensus       257 ------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          257 ------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             ------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                    01123457899999999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-43  Score=373.17  Aligned_cols=267  Identities=13%  Similarity=0.159  Sum_probs=191.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC--CCCcceeEE-------EE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL--RHPNIICYI-------SS   78 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l--~HpnIv~~~-------~~   78 (622)
                      .+|++++.||+  |+||.||+|+++.+|+.||||++...... ....+.+.+|+.+++.|  +|||||+++       ++
T Consensus        62 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           62 RKLKLVEPLRV--GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             eeeeeeeeccC--CCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            46999999999  77999999999999999999999886653 34456677885544444  699988866       44


Q ss_pred             EEeC-----------------CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCccc
Q psy15039         79 FLDA-----------------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVI------CHILQDVLNGLEYIHGKGFIH  135 (622)
Q Consensus        79 ~~~~-----------------~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~------~~i~~qi~~aL~ylH~~~IvH  135 (622)
                      +...                 ..+++|||||+ |+|.+++..... .+++...      ..++.||+.||+|||++||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            4433                 23899999999 899999976432 2333444      566699999999999999999


Q ss_pred             CCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCC
Q psy15039        136 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT  215 (622)
Q Consensus       136 rDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~  215 (622)
                      |||||+|||++.+|.++++|||.+........       ...+|+.|+|||++.+....|+.++|||||||++|+|++|+
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEEE-------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCcc-------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999998764432110       22345789999999753346899999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC
Q psy15039        216 VPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL  295 (622)
Q Consensus       216 ~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps  295 (622)
                      .||........             .   .+... ..       ...............+++++.+||.+||+.||++|||
T Consensus       291 ~Pf~~~~~~~~-------------~---~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  346 (371)
T 3q60_A          291 LPFGLVTPGIK-------------G---SWKRP-SL-------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL  346 (371)
T ss_dssp             CSTTBCCTTCT-------------T---CCCBC-CT-------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred             CCCCCcCcccc-------------c---chhhh-hh-------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC
Confidence            99975422100             0   00000 00       0000001111223467999999999999999999999


Q ss_pred             HHhhhcCcccccccc
Q psy15039        296 ACNLLQHAFFKQTKK  310 (622)
Q Consensus       296 ~~~~l~h~~~~~~~~  310 (622)
                      +.++++||||++...
T Consensus       347 ~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          347 PLEAMETPEFLQLQN  361 (371)
T ss_dssp             HHHHTTSHHHHHHHH
T ss_pred             HHHHhcCHHHHHHHH
Confidence            999999999987544

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=370.40  Aligned_cols=262  Identities=20%  Similarity=0.351  Sum_probs=209.5

Q ss_pred             CCceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~   82 (622)
                      .+|++++.||+  |+||.||+|++.   .+|+.||||+++....  .....+.+.+|+++|+++ +||||+++++++...
T Consensus        54 ~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           54 ENFELLKVLGT--GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             GGEEEEEEEEE--TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cceEEEEEecc--CCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            58999999999  789999999984   5899999999865321  112234466799999999 699999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+++||||+++|+|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||....+
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             ceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            99999999999999999997653  4889999999999999999999999999999999999999999999999987544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCc---hHHHHHHHHhCCCCCCC
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP---TTLMLIEKLAGATPHLL  239 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~---~~~~~~~~~~~~~p~~~  239 (622)
                      .......   .....+|+.|+|||++.++...++.++|||||||++|+|++|..||....   ....+...+....|   
T Consensus       210 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---  283 (355)
T 1vzo_A          210 VADETER---AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---  283 (355)
T ss_dssp             CGGGGGG---GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC---
T ss_pred             ccCCCCc---ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC---
Confidence            3221111   11235678899999997644557899999999999999999999997432   12222222211111   


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                                   ..+..+++.+.+||.+||..||.+||     ++.++++||||....
T Consensus       284 -----------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          284 -----------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             -----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -----------------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence                                         11235788999999999999999999     999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-42  Score=365.67  Aligned_cols=256  Identities=18%  Similarity=0.300  Sum_probs=208.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc-------cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK-------VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF   79 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~-------~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~   79 (622)
                      .++|++++.||+  |+||.||+|++.       .++..||||+++.. ......+.+.+|+.+|+++ +|||||++++++
T Consensus        80 ~~~~~~~~~LG~--G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGE--GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESC--CSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHHCEeeeEEee--CCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            368999999999  778899999975       45678999999765 3456677899999999999 899999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      .+...+|+||||+++|+|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            999999999999999999999976431              247889999999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.+++.|||...........  .......+++.|+|||++.+  ..|+.++|||||||++|||++ |..||...+..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             CCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999987544322111  11122345678999999975  358999999999999999999 99999876544


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ........+..+                                ..+..+++++.+++..||+.||.+||++.+++++
T Consensus       313 ~~~~~~~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ELFKLLKEGHRM--------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GHHHHHHTTCCC--------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC--------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332222221111                                1123568899999999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.6e-43  Score=363.37  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=205.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC------HHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      +.++|++.+.||+  |+||.||+|+++.+|+.||||.+......      ......+.+|+.+|++++||||+++++++.
T Consensus         8 l~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            8 LRDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhceeEeeEEec--CCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            4568999999999  77999999999999999999999764321      122345789999999999999999999987


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---eEEcCCc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLR  157 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~---~~i~~~~  157 (622)
                      ... .++||||+++++|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.   +++.|||
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             CCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            654 89999999999999988653  35889999999999999999999999999999999999987664   9999999


Q ss_pred             cccccCCCCccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH-hCCC
Q psy15039        158 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGAT  235 (622)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~-~~~~  235 (622)
                      ...........     ....+|+.|+|||++.. +...|+.++|||||||++|+|++|..||........+...+ .+..
T Consensus       163 ~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          163 HSKILGETSLM-----RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             TCEECCCCHHH-----HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             cceeccccccc-----ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            86544322110     01245778999999842 22458899999999999999999999997543321111111 1111


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      +..                       .      .....+++++.+|+.+||..||++||++.++++||||...
T Consensus       238 ~~~-----------------------~------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 NFI-----------------------P------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CCC-----------------------H------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ccC-----------------------c------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            100                       0      0123478999999999999999999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8e-43  Score=364.48  Aligned_cols=283  Identities=22%  Similarity=0.324  Sum_probs=213.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc-
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-   84 (622)
                      +++++|++.+.||+  |+||.||+|+++.+|+.||||++......+...+.+.+|+.+|++++||||+++++++..... 
T Consensus        21 ~l~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGS--GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEec--CCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence            45789999999999  779999999999999999999998766666667788999999999999999999999987654 


Q ss_pred             -----EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         85 -----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        85 -----~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                           +++||||++ ++|.+++.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             ccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence                 599999998 57766653    24889999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATPH  237 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~~p~  237 (622)
                      ......       .....+|+.|+|||++.+. ..++.++||||+||++|+|++|..||.+......+...  ..+.++.
T Consensus       174 ~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          174 RHADAE-------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT  245 (353)
T ss_dssp             TC---------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred             cCCCCC-------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            543211       1123567889999998753 45889999999999999999999999876654333222  2222211


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      -  .    ...............+......  ......+++++.+|+.+||+.||++|||+.++++||||....
T Consensus       246 ~--~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          246 E--F----VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             H--H----HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             H--H----HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            0  0    0000000000000000000000  001235789999999999999999999999999999997654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7e-43  Score=354.02  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=214.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +.++|++.+.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+|++++||||+++++++.+...++
T Consensus        20 ~~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           20 FAERYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HhhcceeeEEEcC--CCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            3468999999999  77899999999999999999999765443444567889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEcCCccccccC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPFS  163 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~~~~~~~~~~  163 (622)
                      +||||+++++|.+.+....  .+++..+..++.||+.||.|||++||+||||||+||+++.++   .+++.|||......
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999999999886643  488999999999999999999999999999999999997644   69999999765443


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ....     .....+++.|+|||++.+   .++.++|||||||++|+|++|..||..............+..+.      
T Consensus       176 ~~~~-----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  241 (287)
T 2wei_A          176 QNTK-----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------  241 (287)
T ss_dssp             CCSS-----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred             CCCc-----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            2211     112245678999999864   37899999999999999999999998765544333333332111      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                             .......+++++.+++..||..||++|||+.++++||||++.
T Consensus       242 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          242 -----------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             -----------------------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             -----------------------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence                                   011224578999999999999999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=354.09  Aligned_cols=257  Identities=21%  Similarity=0.361  Sum_probs=206.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +++|++++.||+  |+||+||+|+++.+|+.||+|++..  ......+.+.+|+.+|++++||||+++++++.++...++
T Consensus         9 ~~~~~~~~~lG~--G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGK--GCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEEC--CSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecC--CCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            579999999999  7899999999999999999999854  346667889999999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||..........
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999999997743 3589999999999999999999999999999999999999999999999998754432211


Q ss_pred             ccc----------ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCC
Q psy15039        168 KVH----------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  237 (622)
Q Consensus       168 ~~~----------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~  237 (622)
                      ...          .......+|+.|+|||++.+  ..++.++|||||||++|+|++|..||........           
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~-----------  230 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-----------  230 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT-----------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH-----------
Confidence            110          00113467888999999975  4589999999999999999999999864211000           


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                        +            .     ............+..+++++.+++.+||+.||++|||+.++++
T Consensus       231 --~------------~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          231 --D------------F-----GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             --T------------S-----SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --H------------H-----hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              0            0     0000001111123457889999999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.9e-43  Score=370.10  Aligned_cols=287  Identities=24%  Similarity=0.337  Sum_probs=208.4

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC--------CCcceeEEE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR--------HPNIICYIS   77 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~~~~   77 (622)
                      .+..+|++++.||+  |+||+||+|+++.+|+.||||+++..   ....+.+.+|+.+|++++        ||||+++++
T Consensus        34 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           34 LFNGRYHVIRKLGW--GHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             EETTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hcCCeEEEEEEeee--cCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            34678999999999  77999999999999999999999643   445667889999999996        788999999


Q ss_pred             EEE----eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCC---
Q psy15039         78 SFL----DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNG---  149 (622)
Q Consensus        78 ~~~----~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~---  149 (622)
                      +|.    ....+++||||++ +++.+.+.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            998    4567999999994 5666666554334689999999999999999999999 999999999999999775   


Q ss_pred             ----------------------------------------------ceEEcCCccccccCCCCccccccCCCCCCCcccc
Q psy15039        150 ----------------------------------------------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL  183 (622)
Q Consensus       150 ----------------------------------------------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  183 (622)
                                                                    .+++.|||.+......       .....+|+.|+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~  260 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYR  260 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGC
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCccc
Confidence                                                          7999999987544321       12335688899


Q ss_pred             ChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--------HHHHHHHHhCCCCCCCccc-----cccccCCC
Q psy15039        184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--------TLMLIEKLAGATPHLLDCT-----TYYVDTGQ  250 (622)
Q Consensus       184 aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--------~~~~~~~~~~~~p~~~~~~-----~~~~~~~~  250 (622)
                      |||++.+.  .|+.++|||||||++|+|++|..||.....        ....+..+.+..|......     .++...+.
T Consensus       261 aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  338 (397)
T 1wak_A          261 SLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD  338 (397)
T ss_dssp             CHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred             CChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence            99999763  589999999999999999999999975331        1222333344333210000     00000000


Q ss_pred             CcCccc--ccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        251 DDGEEN--ACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       251 ~~~~~~--~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      ......  .+................++++.+||.+||+.||++|||+.++|+||||++
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000000  000000000001112234678899999999999999999999999999963

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=358.37  Aligned_cols=256  Identities=19%  Similarity=0.323  Sum_probs=208.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcE---EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL---IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~---vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..+|++.+.||+  |+||.||+|+++.+|+.   ||||+++... .....+.+.+|+.+|++|+|||||++++++.+...
T Consensus        48 ~~~y~i~~~lG~--G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGS--GDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEE--TTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEe--CCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            458999999999  88999999999876665   9999997643 45666788999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999997643 3589999999999999999999999999999999999999999999999998765433


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ...... ......+|+.|+|||++.+.  .|+.++|||||||++|+|++ |..||..............+..        
T Consensus       204 ~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--------  272 (325)
T 3kul_A          204 DPDAAY-TTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR--------  272 (325)
T ss_dssp             ---CCE-ECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------
T ss_pred             Ccccee-eccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC--------
Confidence            222111 12233446789999999753  58899999999999999998 9999987655443333222211        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ......+++++.+|+..||..||++||++.++++.
T Consensus       273 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          273 ------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    11234578899999999999999999999998874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.4e-44  Score=377.45  Aligned_cols=256  Identities=14%  Similarity=0.199  Sum_probs=199.2

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHH---HHHhhCCCCcceeEE-----
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEI---VCMRHLRHPNIICYI-----   76 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei---~il~~l~HpnIv~~~-----   76 (622)
                      ...++|++.+.||+  |+||.||+|+++.+|+.||||++.... ......+.+.+|+   ++|++++|||||+++     
T Consensus        70 ~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           70 ERPRTLVRGTVLGQ--EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             CCCEEEEEEEEEEE--ETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             CCCceEEEcceeec--CCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            34578999999999  779999999999999999999997643 2344567788999   556666899999998     


Q ss_pred             --EEEEeCC-----------------cEEEEeecCCCCCHHHHHHhhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCC
Q psy15039         77 --SSFLDAT-----------------DLHLVSPLMGFGSCKDLINAHFNFG-----LPELVICHILQDVLNGLEYIHGKG  132 (622)
Q Consensus        77 --~~~~~~~-----------------~~~lv~e~~~~g~l~~~l~~~~~~~-----l~e~~~~~i~~qi~~aL~ylH~~~  132 (622)
                        +++.+.+                 ..++||||+ +|+|.+++.......     +++..+..++.||+.||+|||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence              7766653                 288999999 589999997643211     224788889999999999999999


Q ss_pred             cccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccc---------cCCCCCcchHHH
Q psy15039        133 FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---------LDGYDERSDIYS  203 (622)
Q Consensus       133 IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---------~~~~~~~~DiWS  203 (622)
                      |+||||||+|||++.++.+++.|||.+......   .    ....+ +.|+|||++.+.         ...|+.++||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~----~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS  298 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---V----VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA  298 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---E----ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCCc---c----cCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence            999999999999999999999999987543211   1    12234 679999999753         014899999999


Q ss_pred             HHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHH
Q psy15039        204 VGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVE  283 (622)
Q Consensus       204 lG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~  283 (622)
                      |||++|||++|+.||.......            .                   ...+      ......+++++.+||.
T Consensus       299 lG~il~elltg~~Pf~~~~~~~------------~-------------------~~~~------~~~~~~~~~~~~~li~  341 (377)
T 3byv_A          299 LGLVIYWIWCADLPITKDAALG------------G-------------------SEWI------FRSCKNIPQPVRALLE  341 (377)
T ss_dssp             HHHHHHHHHHSSCCC------C------------C-------------------SGGG------GSSCCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCccccccc------------c-------------------hhhh------hhhccCCCHHHHHHHH
Confidence            9999999999999996432110            0                   0000      0112457899999999


Q ss_pred             HhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        284 LCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       284 ~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      +||+.||++|||+.++++||||+...
T Consensus       342 ~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          342 GFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHcCCCchhCCCHHHHhhChHHHHHH
Confidence            99999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=367.13  Aligned_cols=261  Identities=19%  Similarity=0.299  Sum_probs=209.3

Q ss_pred             CCCceEEeecccccCCceeEEEEE-----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~-----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .++|++++.||+  |+||+||+|+     +..+++.||||+++.. ........+.+|+.+|++++|||||++++++.+.
T Consensus        70 ~~~~~~~~~LG~--G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           70 RKNITLIRGLGH--GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             GGGEEEEEECCC--CSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEeee--CCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            368999999999  7788999999     5678899999999654 3455566788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEEc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFN-----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLS  154 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i~  154 (622)
                      ...++|||||++|+|.+++.....     ..+++..+..++.||+.||+|||++||+||||||+|||++.+|   .+++.
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999999976532     2478999999999999999999999999999999999999665   49999


Q ss_pred             CCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhC
Q psy15039        155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAG  233 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~  233 (622)
                      |||.+........  ........+|+.|+|||++.+.  .|+.++|||||||++|||++ |..||..............+
T Consensus       227 DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          227 DFGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             CCHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             CCccccccccccc--cccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9997643211110  0111223457789999999753  58999999999999999998 99999876654443333322


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      ..+                                .....+++++.+|+..||+.||.+||++.+++++.++..
T Consensus       303 ~~~--------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRM--------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCC--------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC--------------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            211                                112346888999999999999999999999999987643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-42  Score=347.88  Aligned_cols=252  Identities=18%  Similarity=0.320  Sum_probs=207.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--Cc
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TD   84 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~   84 (622)
                      ..++|++.+.||+  |+||.||+|+++  |+.||||++..........+.+.+|+.+|++++||||+++++++.+.  ..
T Consensus         8 ~~~~y~~~~~lg~--G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNE--NHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEE--ETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcC--CCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            3469999999999  778999999985  88999999988777777778899999999999999999999999887  77


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+++.+++.....
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999999998755445899999999999999999999999  999999999999999998888766654221


Q ss_pred             CCCCccccccCCCCCCCccccChhhhcccc-CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      .         .....+|+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.................+     
T Consensus       164 ~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  229 (271)
T 3kmu_A          164 Q---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-----  229 (271)
T ss_dssp             S---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             c---------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence            1         12345678899999987532 12334799999999999999999999876655444333322111     


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                ...+..+++++.+++..||+.||++|||+.++++.
T Consensus       230 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          230 --------------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      01123578899999999999999999999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=352.35  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEee
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP   90 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e   90 (622)
                      |....+||+  |+||.||+|+++.+++.||||.+....  ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        24 ~~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGK--GTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEE--CSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEee--cCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            334458999  778899999999999999999997653  2345668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCceEEcCCccccccCCCCcc
Q psy15039         91 LMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        91 ~~~~g~l~~~l~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+++.|||.......... 
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999999976532 24678999999999999999999999999999999999987 88999999997654432111 


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~~p~~~~~~~~~~  246 (622)
                         ......+++.|+|||++.+....++.++|||||||++|+|++|..||............  .....|          
T Consensus       179 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  245 (295)
T 2clq_A          179 ---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP----------  245 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC----------
T ss_pred             ---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc----------
Confidence               11233567889999999764445789999999999999999999999754332221111  111111          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                            ..+..+++++.+++..||+.||++||++.++++||||+....
T Consensus       246 ----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          246 ----------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             ----------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                                  112357889999999999999999999999999999987543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.7e-43  Score=372.56  Aligned_cols=291  Identities=20%  Similarity=0.284  Sum_probs=197.4

Q ss_pred             CCCCCceE-EeecccccCCceeEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-
Q psy15039          6 NVPSNYKI-CSILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-   81 (622)
Q Consensus         6 ~~~~~y~~-~~~lG~g~g~~~~V~~~~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-   81 (622)
                      .+.+.|++ +++||+  |+||.||+|+++  .+++.||||++......    ..+.+|+.+|++|+|||||+++++|.. 
T Consensus        17 ~~~~~y~~~g~~lG~--G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGR--GTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             CHHHHEECSSCCCC-------EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             hhhhhhhhcCcEeee--cCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            34456877 557999  779999999976  67899999999765443    346689999999999999999999976 


Q ss_pred             -CCcEEEEeecCCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCC
Q psy15039         82 -ATDLHLVSPLMGFGSCKDLINAHF-------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNG  149 (622)
Q Consensus        82 -~~~~~lv~e~~~~g~l~~~l~~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl----~~~~  149 (622)
                       ...+++||||++ |++.+++....       ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence             567999999998 57777765321       1238899999999999999999999999999999999999    6678


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch------
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT------  223 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~------  223 (622)
                      .+++.|||.+.......... .......+|+.|+|||++.+. ..|+.++|||||||++|+|++|..||.....      
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPL-ADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             CEEECCTTCCC-----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             cEEEEECCCceecCCCCccc-ccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            99999999876543221111 111234668889999999753 3589999999999999999999999975432      


Q ss_pred             -----HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhh--------hhccccCCCCcHHHHHHHHHhhhcCC
Q psy15039        224 -----TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQ--------QTQVLTSRKFSDSFHSIVELCLSRDV  290 (622)
Q Consensus       224 -----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP  290 (622)
                           ....+....+.++.. .+...    ................        ..........++++.+||..||+.||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP  322 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADK-DWEDI----KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP  322 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTT-TCGGG----GGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSG
T ss_pred             cchHHHHHHHHHhhCCCChh-hcchh----hcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCc
Confidence                 111222223322211 11000    0000000000000000        00000112347889999999999999


Q ss_pred             CCCcCHHhhhcCcccccccc
Q psy15039        291 DKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       291 ~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .+|||+.|+|+||||.....
T Consensus       323 ~~R~ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          323 IKRITSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             GGSCCHHHHHTSGGGTSSSC
T ss_pred             ccCCCHHHHhcChhhccCCC
Confidence            99999999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=356.55  Aligned_cols=286  Identities=19%  Similarity=0.217  Sum_probs=208.5

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE----
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL----   80 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~----   80 (622)
                      .++.++|++++.||+  |+||.||+|.++.+|+.||||++...  .....+.+.+|+.+|++++||||+++++++.    
T Consensus         7 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGC--GGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EEETTTEEEEEECC-------CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             CccCCceeEEEEecc--CCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            457789999999999  77899999999999999999998754  3566678889999999999999999999873    


Q ss_pred             ----------eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCC
Q psy15039         81 ----------DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNG  149 (622)
Q Consensus        81 ----------~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~-~~~  149 (622)
                                ....+++||||++ |+|.+++..   ..+++..+..++.|++.||+|||++||+||||||+|||++ .++
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence                      3467899999998 689988854   3588999999999999999999999999999999999997 456


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  229 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~  229 (622)
                      .+++.|||............ .......++..|+|||++... ..++.++|||||||++|+|++|+.||...........
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL  236 (320)
T ss_dssp             EEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             eEEEccCccccccCCCcccc-cccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            89999999765432211100 111223456789999998653 4588999999999999999999999987765443333


Q ss_pred             HHhCCCCCCCccc-cccccCCCCcCcccccccchhhhh-----ccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        230 KLAGATPHLLDCT-TYYVDTGQDDGEENACSYISEQQT-----QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       230 ~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                      ..... |...... .....        ....++.....     .......+++++.+|+.+||+.||++|||+.++++||
T Consensus       237 ~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (320)
T 2i6l_A          237 ILESI-PVVHEEDRQELLS--------VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP  307 (320)
T ss_dssp             HHHHS-CCCCHHHHHHHHT--------TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred             HHHhc-CCCchhhhhhhhh--------cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence            32221 1100000 00000        00000000000     0001235789999999999999999999999999999


Q ss_pred             cccccc
Q psy15039        304 FFKQTK  309 (622)
Q Consensus       304 ~~~~~~  309 (622)
                      ||+...
T Consensus       308 ~~~~~~  313 (320)
T 2i6l_A          308 YMSIYS  313 (320)
T ss_dssp             HHHTTC
T ss_pred             cccccc
Confidence            998654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-42  Score=353.30  Aligned_cols=264  Identities=22%  Similarity=0.366  Sum_probs=204.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-----
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-----   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----   81 (622)
                      +.++|++++.||+  |+||.||+|+++.+|+.||||++..   .....+.+.+|+.+|++++||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheecc--CCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            3468999999999  7899999999999999999999854   34556778899999999999999999999875     


Q ss_pred             --------CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEE
Q psy15039         82 --------ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        82 --------~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                              ...+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence                    346899999999999999997642 34688899999999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCccc----------cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch
Q psy15039        154 SGLRYMCPFSPTKKKV----------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  223 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~  223 (622)
                      .|||............          ........+++.|+|||++.+. ..++.++||||+||++|+|++   ||.....
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999765443211000          0011233567789999998743 358899999999999999998   6654333


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                      .......+....+..+                            .......++.+.+++..||+.||.+|||+.++++||
T Consensus       234 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFP----------------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             HHHHHHHHHSTTCCCC----------------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             HHHHHHhccccccccC----------------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            3333333332211100                            001234577899999999999999999999999999


Q ss_pred             ccccc
Q psy15039        304 FFKQT  308 (622)
Q Consensus       304 ~~~~~  308 (622)
                      ||...
T Consensus       286 ~~~~~  290 (303)
T 1zy4_A          286 WLPVK  290 (303)
T ss_dssp             CSCCC
T ss_pred             CcCCC
Confidence            99764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.9e-42  Score=345.03  Aligned_cols=252  Identities=21%  Similarity=0.347  Sum_probs=207.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .+++|++.+.||+  |+||.||+|++. +++.||||++.......   +.+.+|+.+|++++||||+++++++.+....+
T Consensus         8 ~~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             ChhhceeeheecC--CCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            4578999999999  778899999988 57789999998765443   45778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.........
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999999997643 358899999999999999999999999999999999999999999999999875433211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                         ........+++.|+|||++.+  ..++.++||||+||++|+|++ |..||..............+..          
T Consensus       161 ---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (269)
T 4hcu_A          161 ---YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  225 (269)
T ss_dssp             ---HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             ---cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence               112223455678999999975  358999999999999999999 9999987655443332222211          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                            ...+..+++++.+++..||+.||++||++.++++|
T Consensus       226 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ----------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                  11223468899999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.1e-42  Score=357.18  Aligned_cols=290  Identities=19%  Similarity=0.261  Sum_probs=215.8

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEE-ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc------ceeEEE
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKH-KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN------IICYIS   77 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~-~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~~~~   77 (622)
                      +.+.++|++.+.||+  |+||.||+|.+ +.+|+.||||+++..   ....+.+.+|+.+|+.++|+|      |+++++
T Consensus        10 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A           10 DVLSARYEIVDTLGE--GAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             CEETTTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             CCccCceEEEEEEec--CCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            446689999999999  77999999998 668999999998643   445667889999999997765      999999


Q ss_pred             EEEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC----------
Q psy15039         78 SFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH----------  147 (622)
Q Consensus        78 ~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~----------  147 (622)
                      +|.+...+++||||+ ++++.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.          
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999999 799999997765446889999999999999999999999999999999999987          


Q ss_pred             ---------CCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy15039        148 ---------NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF  218 (622)
Q Consensus       148 ---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf  218 (622)
                               ++.+++.|||.+......       .....+|+.|+|||++.+  ..|+.++|||||||++|||++|..||
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf  234 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVF  234 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                     567999999976443211       123456788999999975  35899999999999999999999999


Q ss_pred             CCCchHH--HHHHHHhCCCCCCCccc---cccccCCC--CcCcccccccchhhhh----ccccCCCCcHHHHHHHHHhhh
Q psy15039        219 AETPTTL--MLIEKLAGATPHLLDCT---TYYVDTGQ--DDGEENACSYISEQQT----QVLTSRKFSDSFHSIVELCLS  287 (622)
Q Consensus       219 ~~~~~~~--~~~~~~~~~~p~~~~~~---~~~~~~~~--~~~~~~~~~~i~~~~~----~~~~~~~~s~~~~~li~~~L~  287 (622)
                      .......  ..+..+.+..|......   ..+.....  .........++.....    ........++++.+|+.+||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            8765433  23344444333210000   00000000  0000000000000000    011122346789999999999


Q ss_pred             cCCCCCcCHHhhhcCccccccc
Q psy15039        288 RDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       288 ~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .||.+|||+.++++||||+..+
T Consensus       315 ~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          315 YDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             SSTTTSCCHHHHTTSGGGGGGG
T ss_pred             cCcccccCHHHHhcCHHHHHHh
Confidence            9999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=355.88  Aligned_cols=265  Identities=27%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -.++|++++.||+  |+||.||+|+++.+|+.||||++..........+.+..+..+++.++||||+++++++.+.+.++
T Consensus        23 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           23 EINDLENLGEMGS--GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             CGGGEEEEEEC--------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhccccccceeee--cCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            3468999999999  77899999999999999999999876544444444556667889999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +||||+ ++.+..+.... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+++.|||........
T Consensus       101 lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999999 45555555432 34689999999999999999999995 9999999999999999999999999976543322


Q ss_pred             CccccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH-HHHhCCCCCCCcc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI-EKLAGATPHLLDC  241 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~-~~~~~~~p~~~~~  241 (622)
                      ..     .....+++.|+|||++..   ....++.++|||||||++|+|++|..||.......... ....+..+..   
T Consensus       179 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  250 (318)
T 2dyl_A          179 KA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL---  250 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC---
T ss_pred             cc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC---
Confidence            11     112356778999999853   12457889999999999999999999998754433333 3333322211   


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                                 +....+++++.+++..||+.||.+||++.++++||||+....
T Consensus       251 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          251 ---------------------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             ---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             ---------------------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence                                       112357899999999999999999999999999999987544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-42  Score=363.26  Aligned_cols=258  Identities=19%  Similarity=0.299  Sum_probs=208.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEE-----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~-----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      ..++|++++.||+  |+||.||+|+     ++.+++.||||+++.. ......+.+.+|+++|+++ +|||||++++++.
T Consensus        20 ~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           20 PRDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccceeeceeecC--CCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            3578999999999  7899999999     6778899999999764 3455667789999999999 8899999999998


Q ss_pred             eCCc-EEEEeecCCCCCHHHHHHhhcC-----------------------------------------------------
Q psy15039         81 DATD-LHLVSPLMGFGSCKDLINAHFN-----------------------------------------------------  106 (622)
Q Consensus        81 ~~~~-~~lv~e~~~~g~l~~~l~~~~~-----------------------------------------------------  106 (622)
                      .... +++|||||++|+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            8654 9999999999999999976431                                                     


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCC
Q psy15039        107 -----------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  175 (622)
Q Consensus       107 -----------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  175 (622)
                                 ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.........  .....
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC--EEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc--hhccc
Confidence                       11789999999999999999999999999999999999999999999999987544322211  11223


Q ss_pred             CCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCc
Q psy15039        176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGE  254 (622)
Q Consensus       176 ~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  254 (622)
                      ..+|+.|+|||++.+  ..|+.++|||||||++|+|++ |..||............+....+                  
T Consensus       255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------  314 (359)
T 3vhe_A          255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------  314 (359)
T ss_dssp             CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC------------------
T ss_pred             cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC------------------
Confidence            456778999999875  458999999999999999998 99999876543333333221110                  


Q ss_pred             ccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        255 ENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       255 ~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                   ...+..+++++.+++..||+.||.+|||+.++++|
T Consensus       315 -------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          315 -------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                         01123468899999999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.2e-42  Score=359.82  Aligned_cols=285  Identities=19%  Similarity=0.236  Sum_probs=197.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc----
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD----   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~----   84 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||||++..+...   .....+|++.++.++|||||+++++|.....    
T Consensus        23 ~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           23 DRFQVERMAGQ--GTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             TTEEEC------------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             cceEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            58999999999  77899999999999999999998654321   2235578888999999999999999976543    


Q ss_pred             ---EEEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEEcC-CCceEEcCC
Q psy15039         85 ---LHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIH--GKGFIHRAVKASHILISH-NGKACLSGL  156 (622)
Q Consensus        85 ---~~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH--~~~IvHrDiKp~NiLl~~-~~~~~i~~~  156 (622)
                         +++||||+++ ++.+.+...  ....+++..+..++.|++.||.|||  ++||+||||||+|||++. ++.+++.||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence               8999999996 444443321  2335789999999999999999999  999999999999999996 899999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~  234 (622)
                      |.+........     .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+...+  .+.
T Consensus       177 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          177 GSAKKLSPSEP-----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             TTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             CCceecCCCCC-----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            98765433221     1233567889999998653 458999999999999999999999998766544333222  222


Q ss_pred             CCCCCccccccccCCCCcCccccc--ccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENAC--SYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~--~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ++.-  .   ..............  ..+.-...........++++.+|+.+||+.||.+|||+.++|+||||+....
T Consensus       251 ~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          251 PSRE--V---LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CCHH--H---HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             CCHH--H---HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            1100  0   00000000000000  0000000000112336789999999999999999999999999999988654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.2e-42  Score=351.97  Aligned_cols=257  Identities=18%  Similarity=0.317  Sum_probs=209.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      ..++|++.+.||+  |+||.||+|.+     +.+++.||||++.... .....+.+.+|+.+|++|+|||||++++++.+
T Consensus        21 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGE--GEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             chhheeeeeeecc--cCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            4569999999999  77889999998     4566899999997543 46667888999999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFN----------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVK  139 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~----------------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiK  139 (622)
                      ....++||||+++|+|.+++.....                      ..+++..+..++.||+.||+|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            9999999999999999999976432                      237899999999999999999999999999999


Q ss_pred             CCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCC
Q psy15039        140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF  218 (622)
Q Consensus       140 p~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf  218 (622)
                      |+|||++.++.+++.|||............  ......+++.|+|||++.+.  .++.++|||||||++|+|++ |..||
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYV--KRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEE--CSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hheEEEcCCCCEEEccccccccccccccce--eccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999875443222111  12233456789999998753  47899999999999999999 99999


Q ss_pred             CCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHh
Q psy15039        219 AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN  298 (622)
Q Consensus       219 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  298 (622)
                      ..............+..+                                .....+++++.+++..||+.||++||++.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  301 (314)
T 2ivs_A          254 PGIPPERLFNLLKTGHRM--------------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFAD  301 (314)
T ss_dssp             TTCCGGGHHHHHHTTCCC--------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCHHHHHHHhhcCCcC--------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            876543322222111111                                122357899999999999999999999999


Q ss_pred             hhcC
Q psy15039        299 LLQH  302 (622)
Q Consensus       299 ~l~h  302 (622)
                      ++++
T Consensus       302 l~~~  305 (314)
T 2ivs_A          302 ISKD  305 (314)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.8e-42  Score=363.56  Aligned_cols=254  Identities=19%  Similarity=0.298  Sum_probs=207.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||.++.. ..+...+.+.+|+.+|++++|||||++++++.....+++
T Consensus       113 ~~~~~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGR--GNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEecc--CCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            468999999999  77999999999999999999998754 345556678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||.+....... 
T Consensus       190 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~-  267 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-  267 (377)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE-
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc-
Confidence            999999999999997643 247899999999999999999999999999999999999999999999999865432211 


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                       ..........++.|+|||++..+  .|+.++|||||||++|||++ |..||..............+..           
T Consensus       268 -~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------  333 (377)
T 3cbl_A          268 -YAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-----------  333 (377)
T ss_dssp             -EECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-----------
T ss_pred             -eeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence             11111122335679999999753  47899999999999999998 9999987654433222221111           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           ...+..+++++.+|+..||+.||++|||+.++++
T Consensus       334 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ---------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                 1112346789999999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.5e-42  Score=342.68  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=207.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..++|++.+.||+  |+||.||+|+++ ++..||||++.......   +.+.+|+++|++++||||+++++++.+....+
T Consensus         6 ~~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGS--GQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeecc--CCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            4578999999999  778999999877 56789999997765443   44778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.........
T Consensus        80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999999997653 248899999999999999999999999999999999999999999999999875443222


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..   ......+++.|+|||++.+.  .++.++||||+||++|+|++ |..||..............+..+         
T Consensus       159 ~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (268)
T 3sxs_A          159 YV---SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------  224 (268)
T ss_dssp             EE---ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred             hh---cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence            11   12234556789999999753  47899999999999999998 99999876554443333222111         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                             ..+...++++.+++..||+.||++|||+.+++++
T Consensus       225 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 -----------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   1223468899999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.8e-43  Score=363.64  Aligned_cols=278  Identities=19%  Similarity=0.328  Sum_probs=213.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH---------------HHHHHHHHHHHHHhhCCCCcc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---------------EDLKSLHHEIVCMRHLRHPNI   72 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnI   72 (622)
                      .++|++++.||+  |+||.||+|++  +|+.||||++.......               ...+.+.+|+.+|++|+||||
T Consensus        30 ~~~y~~~~~lg~--G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           30 INDYRIIRTLNQ--GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             ETTEEEEEEEEC--CSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cCceEEEEEEcC--CCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            469999999999  77889999999  99999999986432111               112668899999999999999


Q ss_pred             eeEEEEEEeCCcEEEEeecCCCCCHHHH------HHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEE
Q psy15039         73 ICYISSFLDATDLHLVSPLMGFGSCKDL------INAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILI  145 (622)
Q Consensus        73 v~~~~~~~~~~~~~lv~e~~~~g~l~~~------l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl  145 (622)
                      +++++++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||+|||+ +||+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999988      544324468999999999999999999999 999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCC-cchHHHHHHHHHHHhcCCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE-RSDIYSVGISCCELANGTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~-~~DiWSlG~il~el~~g~~Pf~~~~~~  224 (622)
                      +.++.+++.|||........      ......++..|+|||++.+. ..++. ++||||+||++|+|++|..||......
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             cCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999999987543222      11234567889999999753 24555 999999999999999999999876653


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                      ......+....+..+........           ...  ..........+++++.+|+..||+.||.+|||+.++++|||
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~-----------~~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLY-----------PLT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTT-----------TTC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHhccCcCCccchhhhhc-----------ccc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            44444444332221110000000           000  00001122457899999999999999999999999999999


Q ss_pred             ccccc
Q psy15039        305 FKQTK  309 (622)
Q Consensus       305 ~~~~~  309 (622)
                      |....
T Consensus       326 f~~~~  330 (348)
T 2pml_X          326 LADTN  330 (348)
T ss_dssp             GTTCC
T ss_pred             ccCCC
Confidence            97743

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.1e-42  Score=360.37  Aligned_cols=288  Identities=19%  Similarity=0.241  Sum_probs=209.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CC-----cceeEEEEE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HP-----NIICYISSF   79 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~~~~~~   79 (622)
                      .+.++|++.+.||+  |+||+||+|+++.+|+.||||+++..   ......+.+|+.+++.++ |+     +|++++++|
T Consensus        51 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           51 KWMDRYEIDSLIGK--GSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             EETTTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             EeeeeEEEEEEEee--cCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            34578999999999  77999999999999999999999643   344566778999999885 55     499999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEEcC--CCceEEcC
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--GKGFIHRAVKASHILISH--NGKACLSG  155 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH--~~~IvHrDiKp~NiLl~~--~~~~~i~~  155 (622)
                      ...+.+++||||++ |+|.+++......++++..+..++.|++.||.|||  +.||+||||||+|||++.  ++.+++.|
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999999997 59999998764446899999999999999999999  579999999999999954  67899999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AG  233 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~  233 (622)
                      ||.+......       .....+|+.|+|||++.+.  .|+.++|||||||++|||++|+.||.+......+...+  .+
T Consensus       205 FG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~  275 (382)
T 2vx3_A          205 FGSSCQLGQR-------IYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG  275 (382)
T ss_dssp             CTTCEETTCC-------CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ccCceecccc-------cccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9987554321       1234567889999999763  58999999999999999999999998766544333222  23


Q ss_pred             CCCCCC-c----cccccccCCCCc------------Ccccccccchhhh--------hccccCC----CCcHHHHHHHHH
Q psy15039        234 ATPHLL-D----CTTYYVDTGQDD------------GEENACSYISEQQ--------TQVLTSR----KFSDSFHSIVEL  284 (622)
Q Consensus       234 ~~p~~~-~----~~~~~~~~~~~~------------~~~~~~~~i~~~~--------~~~~~~~----~~s~~~~~li~~  284 (622)
                      .+|... +    ...++.......            ........+....        .......    ..++++.+||.+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            222100 0    000000000000            0000000000000        0000000    012478999999


Q ss_pred             hhhcCCCCCcCHHhhhcCcccccc
Q psy15039        285 CLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       285 ~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                      ||+.||++|||+.|+|+||||++.
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             hcCCChhhCCCHHHHhcCcccccC
Confidence            999999999999999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.9e-42  Score=362.89  Aligned_cols=290  Identities=18%  Similarity=0.252  Sum_probs=208.3

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC---------CHHHHHHHHHHHHHHhhCCCCccee
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---------TDEDLKSLHHEIVCMRHLRHPNIIC   74 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~   74 (622)
                      +..+.++|++.+.||+  |+||.||+|.+.. |+.||||++.....         .....+.+.+|+.+|++++||||++
T Consensus        17 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISS--GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHTTCSCEEEEEEEE--ETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHhccceEEeEEecc--CCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            3456789999999999  7799999999875 99999999864322         2334577889999999999999999


Q ss_pred             EEEEEEeC-----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q psy15039         75 YISSFLDA-----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG  149 (622)
Q Consensus        75 ~~~~~~~~-----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~  149 (622)
                      +++++...     ..+++||||++ |++.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  171 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN  171 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence            99998653     35899999998 6888887653 23589999999999999999999999999999999999999999


Q ss_pred             ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH
Q psy15039        150 KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  229 (622)
Q Consensus       150 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~  229 (622)
                      .+++.|||.+........     .....+|+.|+|||++.+. ..++.++||||+||++|+|++|+.||.+.........
T Consensus       172 ~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          172 DITICDFNLAREDTADAN-----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             CEEECCTTC--------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CEEEEecCcccccccccc-----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999998753322111     1223567789999998753 4588999999999999999999999987654433322


Q ss_pred             H--HhCCCCCCCccccccccCCCCcCcccccccchh--hhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        230 K--LAGATPHLLDCTTYYVDTGQDDGEENACSYISE--QQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       230 ~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                      .  ..+.+ ...+.... ..   .............  ...........++.+.+|+..||+.||.+|||+.++++||||
T Consensus       246 i~~~~~~~-~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  320 (362)
T 3pg1_A          246 IVEVVGTP-KIEDVVMF-SS---PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF  320 (362)
T ss_dssp             HHHHHCCC-CHHHHHHT-SC---HHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHcCCC-ChHHhhhc-cc---hhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence            2  22221 11000000 00   0000000000000  000011223568899999999999999999999999999999


Q ss_pred             cccc
Q psy15039        306 KQTK  309 (622)
Q Consensus       306 ~~~~  309 (622)
                      +...
T Consensus       321 ~~~~  324 (362)
T 3pg1_A          321 ESLF  324 (362)
T ss_dssp             TTTC
T ss_pred             hhcc
Confidence            8753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9e-42  Score=354.79  Aligned_cols=257  Identities=17%  Similarity=0.292  Sum_probs=209.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      ..++|++.+.||+  |+||.||+|+++     .+++.||||.++... .....+.+.+|+.+|++++||||+++++++.+
T Consensus        45 ~~~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           45 PRNNIEYVRDIGE--GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CGGGCEEEEEEEE--CSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cHHHCeeeeeeee--cCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            4578999999999  778999999998     466999999997643 45566788999999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFN----------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVK  139 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~----------------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiK  139 (622)
                      .+.+++||||+++|+|.+++.....                      ..+++..+..++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999999999999976421                      358899999999999999999999999999999


Q ss_pred             CCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCC
Q psy15039        140 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF  218 (622)
Q Consensus       140 p~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf  218 (622)
                      |+|||++.++.+++.|||..........  ........+++.|+|||++.+.  .++.++|||||||++|+|++ |..||
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cceEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999997654322111  1112234557789999998753  58999999999999999999 99999


Q ss_pred             CCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHh
Q psy15039        219 AETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN  298 (622)
Q Consensus       219 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~  298 (622)
                      ..............+..+.                                .+..+++++.+++..||+.||++||++.+
T Consensus       278 ~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~  325 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNILA--------------------------------CPENCPLELYNLMRLCWSKLPADRPSFCS  325 (343)
T ss_dssp             TTSCHHHHHHHHHTTCCCC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCChHHHHHHHhCCCcCC--------------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            8765544333322222111                                12356889999999999999999999999


Q ss_pred             hhcC
Q psy15039        299 LLQH  302 (622)
Q Consensus       299 ~l~h  302 (622)
                      ++++
T Consensus       326 ~~~~  329 (343)
T 1luf_A          326 IHRI  329 (343)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-41  Score=342.46  Aligned_cols=254  Identities=19%  Similarity=0.317  Sum_probs=206.0

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .-..++|++++.||+  |+||.||+|+++ ++..||||++.......   +.+.+|+.+|++++||||+++++++.+...
T Consensus        20 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           20 EIDPKDLTFLKELGT--GQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cCCHHHHHhHhhcCC--CCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            345679999999999  779999999887 67789999998765443   457789999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.......
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999999999997643 3589999999999999999999999999999999999999999999999998754432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ..   ........+++.|+|||++.+.  .++.++||||+||++|+|++ |+.||..............+..        
T Consensus       173 ~~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------  239 (283)
T 3gen_A          173 DE---YTSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------  239 (283)
T ss_dssp             HH---HHSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--------
T ss_pred             cc---cccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--------
Confidence            21   1112234556789999999753  58899999999999999998 9999987654433332222211        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ...+...++++.+++..||+.||.+|||+.++++|
T Consensus       240 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 ------------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                    11223457899999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-41  Score=348.34  Aligned_cols=267  Identities=18%  Similarity=0.308  Sum_probs=209.6

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCcceeEEEEEEe
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR--HPNIICYISSFLD   81 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~   81 (622)
                      +.-...+|++++.||+  |+||.||+|+++ +|+.||||+++.........+.+.+|+.+|++++  ||||+++++++..
T Consensus        23 ~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           23 MSVKGRIYSILKQIGS--GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             EEETTEEEEEEEEEEC--CSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeccceEEEEEEecC--CCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            3445668999999999  779999999986 5899999999887667777788999999999997  5999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ...+++||| +.+++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+++.|||....
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence            999999999 6778999999764  3578999999999999999999999999999999999996 48999999998754


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccc---------cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---------LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---------~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~  232 (622)
                      .......  .......+++.|+|||++.+.         ...++.++|||||||++|+|++|..||............+.
T Consensus       176 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          176 MQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccCcccc--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            4322111  111233567889999998641         13578899999999999999999999986544333332222


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ....                              ........++++.+++..||+.||.+||++.++++||||....
T Consensus       254 ~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          254 DPNH------------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CTTS------------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             hccc------------------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            1100                              0011223578899999999999999999999999999997643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=356.90  Aligned_cols=256  Identities=20%  Similarity=0.304  Sum_probs=209.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccC-------CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVT-------NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF   79 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~   79 (622)
                      .++|++++.||+  |+||.||+|++..+       +..||||+++.. ......+.+.+|+++|+++ +|||||++++++
T Consensus        68 ~~~y~i~~~LG~--G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           68 RDRLVLGKPLGE--GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEeeeEEec--CCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            468999999999  78999999997643       467999999765 3466677889999999999 999999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      .....+++||||+++|+|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            999999999999999999999987531              248999999999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.++++|||.+.........  .......+|+.|+|||++.+  ..++.++|||||||++|+|++ |..||......
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             cCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999987544322111  11223345678999999975  458999999999999999999 99999876544


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ........+..+                                .....+++++.+|+..||+.||++|||+.+++++
T Consensus       301 ~~~~~~~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          301 ELFKLLKEGHRM--------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHTTCCC--------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC--------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333222222111                                1123578899999999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-41  Score=343.92  Aligned_cols=252  Identities=18%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC--HHHH---HHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT--DEDL---KSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~--~~~~---~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      ..++|++.+.||+  |+||.||+|+++.+++.||||++......  ....   +.+.+|+.+|++++||||+++++++.+
T Consensus        17 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           17 ADNEIEYEKQIGK--GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CSTTEEEEEECCC--CSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhccceehhcccc--CCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            4579999999999  77889999999999999999998765432  1211   678899999999999999999999866


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCc-----eEEc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGK-----ACLS  154 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~~~~-----~~i~  154 (622)
                      ..  ++||||+++|+|.+.+.... ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.     +++.
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            54  79999999999998886543 35899999999999999999999999  999999999999988776     8999


Q ss_pred             CCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH-HHHHH-h
Q psy15039        155 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM-LIEKL-A  232 (622)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~-~~~~~-~  232 (622)
                      |||........       .....+|+.|+|||++......++.++||||+||++|+|++|..||........ ....+ .
T Consensus       172 Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  244 (287)
T 4f0f_A          172 DFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE  244 (287)
T ss_dssp             CCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred             CCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence            99976533221       112356788999999854444578899999999999999999999976543222 11111 1


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ...                               .......+++++.+++..||+.||.+|||+.++++
T Consensus       245 ~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          245 EGL-------------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             SCC-------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCC-------------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            110                               00122357889999999999999999999999886

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.5e-41  Score=343.02  Aligned_cols=257  Identities=17%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      +....++|++.+.||+  |+||.||+|.++.+   +..||||.+.... .+...+.+.+|+.+|++++||||+++++++ 
T Consensus        10 ~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-   85 (281)
T 1mp8_A           10 YEIQRERIELGRCIGE--GQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVI-   85 (281)
T ss_dssp             CBCCGGGEEEEEEEEE--CSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             eEEehHHeEEEeEeee--cCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence            3455679999999999  77889999998754   5679999986543 455667789999999999999999999997 


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                      ..+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||...
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             ccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            4567899999999999999997643 358899999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLL  239 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~  239 (622)
                      ........   ......+++.|+|||++..  ..++.++|||||||++|+|++ |..||..............+..+   
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---  236 (281)
T 1mp8_A          165 YMEDSTYY---KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---  236 (281)
T ss_dssp             -----------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ccCccccc---ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---
Confidence            44322111   1112234567999999975  358899999999999999996 99999876544332222221111   


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                   .....+++++.+++..||..||++|||+.+++++
T Consensus       237 -----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 -----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                         1223578899999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-41  Score=354.41  Aligned_cols=289  Identities=16%  Similarity=0.225  Sum_probs=213.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCC-cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc------ceeEEEE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTN-QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN------IICYISS   78 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~~~~~   78 (622)
                      -+.++|++.+.||+  |+||+||+|.++.++ +.||||+++..   ....+.+.+|+.+|++++|+|      |+.++++
T Consensus        16 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           16 WLQERYEIVGNLGE--GTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             EETTTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             eecccEEEEEEeec--cCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            35689999999999  779999999998887 68999998643   445567889999999998876      9999999


Q ss_pred             EEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-------------
Q psy15039         79 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI-------------  145 (622)
Q Consensus        79 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl-------------  145 (622)
                      +.....+++||||+ ++++.+.+.......+++..+..++.||+.||+|||++||+||||||+|||+             
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            99999999999999 5677777765443468999999999999999999999999999999999999             


Q ss_pred             ------cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCC
Q psy15039        146 ------SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA  219 (622)
Q Consensus       146 ------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~  219 (622)
                            +.++.+++.|||.+......       .....+|+.|+|||++.+  ..|+.++|||||||++|||++|..||.
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                  56788999999976432211       123456888999999975  358999999999999999999999998


Q ss_pred             CCchHH--HHHHHHhCCCCCCCccc----cccccC-CCCcCcccccccchhh----hhccccCCCCcHHHHHHHHHhhhc
Q psy15039        220 ETPTTL--MLIEKLAGATPHLLDCT----TYYVDT-GQDDGEENACSYISEQ----QTQVLTSRKFSDSFHSIVELCLSR  288 (622)
Q Consensus       220 ~~~~~~--~~~~~~~~~~p~~~~~~----~~~~~~-~~~~~~~~~~~~i~~~----~~~~~~~~~~s~~~~~li~~~L~~  288 (622)
                      ......  ..+..+.+..|......    .++... ...........+....    ..........++++.+|+.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            765433  23344444443210000    000000 0000000000000000    001112223467899999999999


Q ss_pred             CCCCCcCHHhhhcCccccccc
Q psy15039        289 DVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       289 dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      ||.+|||+.++++||||....
T Consensus       321 dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          321 DPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             STTTSCCHHHHTTSGGGGGCC
T ss_pred             ChhhCcCHHHHhcChhhcCCC
Confidence            999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-41  Score=343.69  Aligned_cols=257  Identities=18%  Similarity=0.340  Sum_probs=211.1

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..-..++|++.+.||+  |+||.||+|.++.+++.||||.+..+.   ...+.+.+|+.+|++++||||+++++++.+..
T Consensus         8 ~~~~~~~~~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            8 WEMERTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             TBCCGGGEEEEEESGG--GTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccccccceeEEeecCC--CCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            3445678999999999  778899999999999999999997643   34566889999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++||||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||......
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999999999999987555568999999999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......   .....+++.|+|||++.+.  .++.++|||||||++|+|++ |..||.......... .+....       
T Consensus       163 ~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-~~~~~~-------  229 (288)
T 3kfa_A          163 GDTYTA---HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDY-------  229 (288)
T ss_dssp             SSSSEE---ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTC-------
T ss_pred             CCcccc---ccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhccC-------
Confidence            222111   1223446679999999753  58899999999999999999 999997654432222 211110       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ....+..+++++.+|+..||..||.+||++.++++.
T Consensus       230 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          230 ------------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence                                    011224578899999999999999999999999773

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-41  Score=346.83  Aligned_cols=272  Identities=21%  Similarity=0.363  Sum_probs=204.1

Q ss_pred             CCCCceEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ...+|++++.||+  |+||+||+|+    +..+|+.||||++...  .....+.+.+|+.+|++++||||+++++++...
T Consensus         8 ~~~~~~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGK--GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeec--cCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4579999999999  7799999999    6789999999998654  456667889999999999999999999998654


Q ss_pred             --CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         83 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        83 --~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                        ..+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              56999999999999999997643 248899999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ......... .......++..|+|||++.+.  .++.++|||||||++|+|++|..||.......  .... +..+....
T Consensus       163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~  236 (295)
T 3ugc_A          163 VLPQDKEFF-KVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MRMI-GNDKQGQM  236 (295)
T ss_dssp             --------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--HHHH-CTTCCTHH
T ss_pred             cccCCccee-eeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHH--Hhhh-cCccccch
Confidence            543222111 111223445679999999753  58999999999999999999999987533221  1111 11100000


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                  ........+ ........+..+++++.+++..||+.||++|||+.++++.
T Consensus       237 ------------~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          237 ------------IVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             ------------HHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ------------hHHHHHHHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                        000000000 0011122344678999999999999999999999998863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.4e-42  Score=354.72  Aligned_cols=256  Identities=20%  Similarity=0.320  Sum_probs=208.9

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCC--CCcceeEEE
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLR--HPNIICYIS   77 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~~~~   77 (622)
                      .+.+.++|++++.||+  |+||.||+|+++.+|+.||||++.......    ...+.+.+|+.+|++++  ||||+++++
T Consensus        38 ~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           38 KEPLESQYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             --CCTTTEEEEEECSS--SSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cCCccCceEEEEEEee--CCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            4567889999999999  778999999999999999999997653321    12234567999999996  599999999


Q ss_pred             EEEeCCcEEEEeecCCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCceEEcC
Q psy15039         78 SFLDATDLHLVSPLMGF-GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKACLSG  155 (622)
Q Consensus        78 ~~~~~~~~~lv~e~~~~-g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~-~~~~~~i~~  155 (622)
                      ++...+..++|||++.+ ++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+++.|
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            99999999999999986 89999987643  588999999999999999999999999999999999999 678999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  235 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~  235 (622)
                      ||.........      .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.....      ...+. 
T Consensus       194 fg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~-  259 (320)
T 3a99_A          194 FGSGALLKDTV------YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ-  259 (320)
T ss_dssp             CTTCEECCSSC------BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC-
T ss_pred             Ccccccccccc------ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccc-
Confidence            99765443211      1123567889999998753 3346789999999999999999999964321      11111 


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                                      ......+++++.+|+.+||..||++|||+.++++||||....
T Consensus       260 --------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          260 --------------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             --------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                                            011235788999999999999999999999999999997643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.5e-42  Score=358.63  Aligned_cols=254  Identities=19%  Similarity=0.338  Sum_probs=197.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~---~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      .+|++.+.||+  |+||.||+|+++   .++..||||+++... .....+.+.+|+.+|++++|||||++++++.+...+
T Consensus        45 ~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           45 TNISIDKVVGA--GEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGCCCCEEEEE--CSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhceeeeEEee--CCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            48999999999  778999999987   578889999997643 456667899999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||........
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999997643 35889999999999999999999999999999999999999999999999987544322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ..... ......+++.|+|||++.+  ..|+.++|||||||++|||++ |..||.......... .+...          
T Consensus       201 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~-~i~~~----------  266 (373)
T 2qol_A          201 PEAAY-TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK-AVDEG----------  266 (373)
T ss_dssp             --------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH-HHHTT----------
T ss_pred             Cccce-eccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcC----------
Confidence            11111 1112234567999999975  358999999999999999997 999998765443322 22111          


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           ........++.++.+++..||+.||.+||++.++++
T Consensus       267 ---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          267 ---------------------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                 011123356889999999999999999999999887

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.9e-41  Score=347.53  Aligned_cols=257  Identities=18%  Similarity=0.288  Sum_probs=210.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~   81 (622)
                      .++|++++.||+  |+||.||+|++     ..+++.||||++.... .....+.+.+|+.+|++| +||||+++++++.+
T Consensus        22 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           22 RNRLSFGKTLGA--GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhhhhHHHhhCc--cCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            468999999999  77999999994     5688999999997653 345567788999999999 99999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFN----------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~----------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      ....++||||+++|+|.+++.....                ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            9999999999999999999976532                137899999999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.+++.|||...........  .......+++.|+|||++.+  ..++.++|||||||++|+|++ |..||......
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cCCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999987654332211  11223345678999999875  358899999999999999998 99999876543


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ......+....                               .......+++++.+++..||..||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          255 SKFYKMIKEGF-------------------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHHTC-------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHhccCC-------------------------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            33333222111                               011234568899999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-41  Score=351.65  Aligned_cols=254  Identities=19%  Similarity=0.340  Sum_probs=196.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEE----EEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLI----AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~v----AiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      .++|++.+.||+  |+||+||+|+++.+|+.+    |+|.+.... .....+.+.+|+.+|++++|||||++++++.+..
T Consensus        14 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             HHHcccceEEee--CCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            468999999999  779999999999888765    777765432 2334567889999999999999999999998754


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                       .++++||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             -eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence             788999999999999997643 358999999999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......  ......+|+.|+|||++.+  ..|+.++|||||||++|||++ |..||..............+..       
T Consensus       169 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------  237 (327)
T 3poz_A          169 AEEKEY--HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------  237 (327)
T ss_dssp             TTCC---------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------
T ss_pred             CCcccc--cccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-------
Confidence            322211  1122344678999999975  458999999999999999999 9999986554332221111110       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               ......++.++.+++..||+.||.+||++.+++++
T Consensus       238 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 -------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                     11233468899999999999999999999999876

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.7e-42  Score=352.66  Aligned_cols=266  Identities=26%  Similarity=0.418  Sum_probs=191.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHH-HHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV-CMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .++|++++.||+  |+||.||+|.++.+|+.||||++..... ......+.+|+. +++.++||||+++++++...+..+
T Consensus        21 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           21 AEDLKDLGEIGR--GAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             SCSEEC-CEEEE--CSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhehheecc--CCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            468999999999  7799999999999999999999976543 444455666666 788899999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         87 LVSPLMGFGSCKDLINAH---FNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      +||||+++ ++.+++...   ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+++.|||.....
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99999985 777776532   234588999999999999999999999 9999999999999999999999999987544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhcc--ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH-hCCCCCCC
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLL  239 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~-~~~~p~~~  239 (622)
                      .....     .....+|+.|+|||++..  ....++.++|||||||++|+|++|..||............+ .+..|.  
T Consensus       177 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--  249 (327)
T 3aln_A          177 VDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ--  249 (327)
T ss_dssp             ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC--
T ss_pred             ccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC--
Confidence            32211     112256778999999842  12457899999999999999999999997543211111000 000000  


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                                ........+++++.+|+..||..||++||++.++++||||.....
T Consensus       250 --------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          250 --------------------------LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             --------------------------CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             --------------------------CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence                                      001112457899999999999999999999999999999976543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-41  Score=360.24  Aligned_cols=236  Identities=46%  Similarity=0.776  Sum_probs=195.2

Q ss_pred             cCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        354 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       354 ~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      .....++|++.+.||+|+++||.||+|+++.+|+.||||++..........+.+.+|+.+++.++|||||++++++.+.+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            34456789999999995448999999999999999999999877767777788999999999999999999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      .+++|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999999999987655568999999999999999999999999999999999999999999999998754332


Q ss_pred             CCC---CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCC
Q psy15039        514 PTK---KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  589 (622)
Q Consensus       514 ~~~---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~  589 (622)
                      ...   ...........+|+.|+|||++.+....|+.++|||||||++|||++|++||.+.+....+...+.+..|.+.
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            111   1122233445778899999999764456899999999999999999999999888777666666665555443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.6e-41  Score=345.74  Aligned_cols=261  Identities=20%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEcc---CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      +.-..++|++++.||+  |+||.||+|++..   +++.||||.++.........+.+.+|+.+|++++||||+++++++.
T Consensus        29 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           29 VVIDRNLLILGKILGE--GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TBCCGGGEEEEEEEEC---CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             cccCHHHeeeccceee--cCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            3444578999999999  7788999998765   6678999999877667777788999999999999999999999998


Q ss_pred             eCC-----cEEEEeecCCCCCHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         81 DAT-----DLHLVSPLMGFGSCKDLINAH----FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        81 ~~~-----~~~lv~e~~~~g~l~~~l~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      ...     ..++||||+++|+|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence            765     359999999999999998542    12358999999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  230 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~  230 (622)
                      ++.|||...........  .......+++.|+|||++.+  ..++.++|||||||++|+|++ |..||............
T Consensus       187 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             EECSCSCC------------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             EEeecCcceeccccccc--CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            99999976543322110  11112244667999999975  458899999999999999999 99999866544333222


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ..+..+                                .....+++++.+++..||..||.+||++.+++++
T Consensus       263 ~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          263 LHGHRL--------------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HTTCCC--------------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCC--------------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222111                                1123568899999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.5e-41  Score=348.96  Aligned_cols=216  Identities=22%  Similarity=0.388  Sum_probs=187.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..++|++.+.||+  |+||.||+|++..+|+.||||++.....+....+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus        13 ~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           13 HIGNYRLLKTIGK--GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             EETTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            3568999999999  88999999999999999999999877667777788999999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        91 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999999987653  47899999999999999999999999999999999999999999999999865443321


Q ss_pred             CceeccCCCCCCCCccccccccccCccCC-CchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .     ....++|+.|+|||++.+.  .+ +.++|||||||++|||++|++||.+.+..........+
T Consensus       169 ~-----~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  229 (328)
T 3fe3_A          169 K-----LDAFCGAPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG  229 (328)
T ss_dssp             G-----GGTTSSSGGGCCHHHHHTC--CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             c-----cccccCCcceeCcccccCC--CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            1     1235688999999999753  34 47899999999999999999999887655544444443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=353.54  Aligned_cols=258  Identities=19%  Similarity=0.280  Sum_probs=205.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~   81 (622)
                      .++|++++.||+  |+||.||+|++     ..+++.||||++.... .....+.+.+|+.+|++| +||||+++++++..
T Consensus        44 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           44 RENLEFGKVLGS--GAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHceeeeeecC--CCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            468999999999  77999999997     3467789999997543 334456788999999999 99999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFN---------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA  140 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~---------------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp  140 (622)
                      ...+++||||+++|+|.+++.....                     ..+++..+..++.||+.||+|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            9999999999999999999976432                     1278899999999999999999999999999999


Q ss_pred             CCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCC
Q psy15039        141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFA  219 (622)
Q Consensus       141 ~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~  219 (622)
                      +|||++.++.+++.|||...........  .......+|+.|+|||++.+  ..++.++|||||||++|+|++ |..||.
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999987544322111  11223345678999999875  358999999999999999998 999998


Q ss_pred             CCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhh
Q psy15039        220 ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL  299 (622)
Q Consensus       220 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~  299 (622)
                      ...........+.....                               ...+..+++++.+|+..||..||.+|||+.++
T Consensus       277 ~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  325 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFK-------------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  325 (344)
T ss_dssp             TCCCSHHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCcHHHHHHHHhcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            76544333333322110                               01123468899999999999999999999999


Q ss_pred             hcCc
Q psy15039        300 LQHA  303 (622)
Q Consensus       300 l~h~  303 (622)
                      ++|.
T Consensus       326 ~~~l  329 (344)
T 1rjb_A          326 TSFL  329 (344)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.7e-41  Score=342.02  Aligned_cols=255  Identities=18%  Similarity=0.284  Sum_probs=203.3

Q ss_pred             CCCCceEEe-ecccccCCceeEEEE--EEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          7 VPSNYKICS-ILGQCFNNLSSVYLS--KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         7 ~~~~y~~~~-~lG~g~g~~~~V~~~--~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ...+|++.+ .||+  |+||.||+|  .++.+++.||||+++.....+...+.+.+|+.+|++++||||+++++++ ..+
T Consensus        14 ~~~~y~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           14 DRKLLTLEDKELGS--GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             CGGGEEEEEEEEEE--CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             cchhhhhccCcccc--ccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            456899999 9999  779999999  5577889999999987655555567889999999999999999999998 567


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            799999999999999999764  348899999999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...... .......+++.|+|||++.+.  .++.++|||||||++|+|++ |..||..............+..+      
T Consensus       169 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------  239 (291)
T 1xbb_A          169 ADENYY-KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------  239 (291)
T ss_dssp             TTCSEE-EC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             cCCCcc-cccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            322211 111123446789999999653  47889999999999999999 99999876544332222222111      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                ..+..+++++.+++..||+.||++||++.++++
T Consensus       240 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 --------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      112357889999999999999999999999886

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.1e-41  Score=347.64  Aligned_cols=259  Identities=15%  Similarity=0.263  Sum_probs=209.7

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEE
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSF   79 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   79 (622)
                      .-..++|++.+.||+  |+||.||+|+++     .+++.||||.++... .......+.+|+.+|++++||||+++++++
T Consensus        21 ~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           21 EVAREKITMSRELGQ--GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             BCCGGGEEEEEEEEE--CSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cchhhheeeeeEecc--CCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            334568999999999  778899999987     578899999997543 445566788999999999999999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFN--------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      .+....++||||+++|+|.+++.....        ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            999999999999999999999875321        246889999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  230 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~  230 (622)
                      ++.|||...........  .......+++.|+|||++.+  ..++.++||||+||++|+|++ |..||............
T Consensus       178 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             EECCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             EECcCcccccccccccc--ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            99999976543221111  11122344678999999875  358899999999999999999 89999876554433333


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ..+..+                                .....+++++.+++..||..||++|||+.+++++
T Consensus       254 ~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          254 MEGGLL--------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HTTCCC--------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCcC--------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            222211                                1123568899999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-41  Score=368.61  Aligned_cols=252  Identities=19%  Similarity=0.359  Sum_probs=208.0

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||||.++.....   .+.+.+|+.+|++|+|||||++++++.+...+++
T Consensus       219 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGG--GTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecC--CCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            457999999999  77889999999999999999999765433   4567899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999999999875445588999999999999999999999999999999999999999999999998754432211


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                         .......+++.|+|||++...  .|+.++|||||||++|||++ |..||.+....... ..+....           
T Consensus       374 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~-----------  436 (495)
T 1opk_A          374 ---TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDY-----------  436 (495)
T ss_dssp             ---ECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTC-----------
T ss_pred             ---eecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCC-----------
Confidence               112233456789999999753  58899999999999999998 99999875543222 2221110           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                          ....+..+++++.+||..||+.||++|||+.++++
T Consensus       437 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 --------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                01123357889999999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.7e-41  Score=355.44  Aligned_cols=287  Identities=22%  Similarity=0.298  Sum_probs=208.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-----------CCcceeEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-----------HPNIICYI   76 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~~~   76 (622)
                      ..+|++++.||+  |+||.||+|+++.+|+.||||++..+   ......+.+|+.+|++++           ||||++++
T Consensus        18 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           18 DARYILVRKLGW--GHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCeEEEEEeeee--cCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            468999999999  77999999999999999999998643   344566789999999887           89999999


Q ss_pred             EEEEeCC----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcC----
Q psy15039         77 SSFLDAT----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH----  147 (622)
Q Consensus        77 ~~~~~~~----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~IvHrDiKp~NiLl~~----  147 (622)
                      +++....    .+++|||++ +++|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||++.    
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            9998754    789999999 89999999875555689999999999999999999998 9999999999999953    


Q ss_pred             --CCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--
Q psy15039        148 --NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--  223 (622)
Q Consensus       148 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--  223 (622)
                        .+.+++.|||.+......       .....+|+.|+|||++.+.  .|+.++|||||||++|+|++|..||.....  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence              347899999987544321       1233567889999999763  589999999999999999999999975431  


Q ss_pred             ------HHHHHHHHhCCCCCCCcccc-----ccccCCCCcCcccccccchh--hhhccccCCCCcHHHHHHHHHhhhcCC
Q psy15039        224 ------TLMLIEKLAGATPHLLDCTT-----YYVDTGQDDGEENACSYISE--QQTQVLTSRKFSDSFHSIVELCLSRDV  290 (622)
Q Consensus       224 ------~~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~li~~~L~~dP  290 (622)
                            ....+....+..|.......     ++..............+-.+  ...........++++.+||..||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence                  11122233333332100000     00000000000000000000  000111123457889999999999999


Q ss_pred             CCCcCHHhhhcCccccccc
Q psy15039        291 DKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       291 ~~Rps~~~~l~h~~~~~~~  309 (622)
                      ++|||+.++++||||++..
T Consensus       323 ~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          323 RKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             TTCBCHHHHHTCGGGTTCT
T ss_pred             cccCCHHHHhhChhhhccc
Confidence            9999999999999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.7e-41  Score=340.32  Aligned_cols=261  Identities=21%  Similarity=0.347  Sum_probs=200.0

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      +-...+|++++.||+  |+||.||+|++..   .||||+++.........+.+.+|+.+|++++||||++++++ .....
T Consensus        20 ei~~~~y~~~~~lG~--G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~   93 (289)
T 3og7_A           20 EIPDGQITVGQRIGS--GSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQ   93 (289)
T ss_dssp             BCCTTSCEEEEEEEE--CSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSS
T ss_pred             ccCccceeeeeEecC--CCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCc
Confidence            345568999999999  7899999998654   59999998877777778889999999999999999999995 45667


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.......
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             cEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            899999999999999986543 3588999999999999999999999999999999999999999999999997654322


Q ss_pred             CCccccccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC-CCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~  242 (622)
                      .....  ......+|+.|+|||++.. ....++.++|||||||++|+|++|+.||............+.. ..+...   
T Consensus       173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  247 (289)
T 3og7_A          173 WSGSH--QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---  247 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT---
T ss_pred             ccccc--cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch---
Confidence            11111  1122356788999999852 1245788999999999999999999999876554444433321 111000   


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               ......+++++.+|+..||+.||++|||+.++++.
T Consensus       248 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          248 -------------------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             -------------------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                                     00123568899999999999999999999998863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.4e-42  Score=353.80  Aligned_cols=261  Identities=18%  Similarity=0.286  Sum_probs=185.1

Q ss_pred             CCCCCCceEEe-ecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--
Q psy15039          5 DNVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--   81 (622)
Q Consensus         5 ~~~~~~y~~~~-~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--   81 (622)
                      ..+.++|++.+ +||+  |+||+||+|+++.+|+.||||++...   ....+   +....++.++||||++++++|..  
T Consensus        24 ~~~~~~y~i~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGL--GVNGKVLECFHRRTGQKCALKLLYDS---PKARQ---EVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             SCGGGTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEESS---HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeEecceeeee--CCCeEEEEEEECCCCCEEEEEEecCc---HHHHH---HHHHHHHhcCCCChHHHHHHHhhcc
Confidence            35678999965 6999  77999999999999999999998653   22222   23334677799999999999977  


Q ss_pred             --CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CceEEcCC
Q psy15039         82 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---GKACLSGL  156 (622)
Q Consensus        82 --~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~---~~~~i~~~  156 (622)
                        ...+++|||||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+++.||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              4458999999999999999987654468999999999999999999999999999999999999864   45999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH---HHHHhC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML---IEKLAG  233 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~---~~~~~~  233 (622)
                      |.........      .....+|+.|+|||++..  ..|+.++|||||||++|+|++|..||.........   ...+..
T Consensus       176 g~~~~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          176 GFAKETTQNA------LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             TTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             ccceeccccc------cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            9765432211      123356788999999864  35788999999999999999999999754322110   000000


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .                            ....+......+++++.+|+..||+.||.+|||+.++++||||.+..
T Consensus       248 ~----------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          248 G----------------------------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             -------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             c----------------------------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            0                            00001112345789999999999999999999999999999998743

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.5e-41  Score=349.71  Aligned_cols=256  Identities=18%  Similarity=0.199  Sum_probs=202.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      +.++|++++.||+  |+||.||+|+++.+|+.||||.+......    +.+.+|+.+|++| +||||+++++++.+....
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            7 VGPNFRVGKKIGC--GNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             ETTTEEEEEECCC---CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EcCCeEEEEEeec--cCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            5679999999999  77889999999999999999998765332    3467899999999 999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-----eEEcCCcccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-----ACLSGLRYMC  160 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~-----~~i~~~~~~~  160 (622)
                      ++||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.     +++.|||.+.
T Consensus        81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            9999999 89999999764 246899999999999999999999999999999999999998887     9999999876


Q ss_pred             ccCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHHHhC-C
Q psy15039        161 PFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAG-A  234 (622)
Q Consensus       161 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~~~~-~  234 (622)
                      ..........   .......+|+.|+|||++.+  ..|+.++|||||||++|||++|..||.....  .......+.. .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            5432221111   01234567889999999976  4589999999999999999999999986432  1122222110 0


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      .+.                           . .......++ ++.+++..||..||.+||++.++.+
T Consensus       237 ~~~---------------------------~-~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          237 RAT---------------------------P-IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHS---------------------------C-HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccC---------------------------C-HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            000                           0 000011234 8999999999999999999998876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-41  Score=363.54  Aligned_cols=267  Identities=21%  Similarity=0.278  Sum_probs=195.5

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~   83 (622)
                      ..+.+.|.+.++||+  |+||+||.+ .+.+|+.||||++..+.     .+.+.+|+.+|+++ +|||||++++++.+..
T Consensus        11 ~~l~~~~~~~~~LG~--G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           11 QSLKNLVVSEKILGY--GSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             CSCSSCEEEEEEEEE--CSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhhheeeccCeEee--CCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            456667888899999  778899874 56689999999986532     24567899999986 8999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----------
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFG-----LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN----------  148 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~-----l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~----------  148 (622)
                      .+++|||||+ |+|.+++.......     .++..+..++.||+.||+|||++||+||||||+|||++.+          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 69999997643211     1233456799999999999999999999999999999754          


Q ss_pred             ---CceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccc-----cCCCCCcchHHHHHHHHHHHhc-CCCCCC
Q psy15039        149 ---GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN-----LDGYDERSDIYSVGISCCELAN-GTVPFA  219 (622)
Q Consensus       149 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-----~~~~~~~~DiWSlG~il~el~~-g~~Pf~  219 (622)
                         +.++++|||.+..................+|+.|+|||++.+.     ...++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               3789999998765443222111112234678899999999651     2458899999999999999998 999997


Q ss_pred             CCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhh
Q psy15039        220 ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL  299 (622)
Q Consensus       220 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~  299 (622)
                      .......  ..+.+.... .                         .........+++++.+||..||+.||.+|||+.++
T Consensus       242 ~~~~~~~--~i~~~~~~~-~-------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  293 (434)
T 2rio_A          242 DKYSRES--NIIRGIFSL-D-------------------------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV  293 (434)
T ss_dssp             STTTHHH--HHHHTCCCC-C-------------------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CchhhHH--HHhcCCCCc-c-------------------------cccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence            6543322  122221100 0                         00011122457889999999999999999999999


Q ss_pred             hcCcccccc
Q psy15039        300 LQHAFFKQT  308 (622)
Q Consensus       300 l~h~~~~~~  308 (622)
                      ++||||...
T Consensus       294 l~hp~f~~~  302 (434)
T 2rio_A          294 LRHPLFWPK  302 (434)
T ss_dssp             HTSGGGSCH
T ss_pred             HhCCccCCc
Confidence            999999654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-42  Score=350.49  Aligned_cols=257  Identities=18%  Similarity=0.284  Sum_probs=198.9

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhC----CCCcceeE
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHL----RHPNIICY   75 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~~   75 (622)
                      ...+.++|++.+.||+  |+||.||+|+++.+|+.||||+++......    .....+.+|+.+++++    +||||+++
T Consensus        26 ~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGK--GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             -------CEEEEEEEE--ETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             hhhhhhceEEeeEEEc--CCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            3456789999999999  779999999999999999999997654322    2233456899999999    89999999


Q ss_pred             EEEEEeCCcEEEEeec-CCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCceEE
Q psy15039         76 ISSFLDATDLHLVSPL-MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKACL  153 (622)
Q Consensus        76 ~~~~~~~~~~~lv~e~-~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~-~~~~~~i  153 (622)
                      ++++...+..++|||+ +.+++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+++
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence            9999999999999999 78999999997743  488999999999999999999999999999999999999 7889999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  233 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~  233 (622)
                      .|||.........      .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.....      ....
T Consensus       182 ~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~  248 (312)
T 2iwi_A          182 IDFGSGALLHDEP------YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA  248 (312)
T ss_dssp             CCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT
T ss_pred             EEcchhhhcccCc------ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh
Confidence            9999765443221      1123567789999998753 2234589999999999999999999964311      1111


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .                                 ......+++++.+++.+||+.||++||++.++++||||+....
T Consensus       249 ~---------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 E---------------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             C---------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             c---------------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            0                                 0012346889999999999999999999999999999987543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-41  Score=345.09  Aligned_cols=248  Identities=15%  Similarity=0.238  Sum_probs=198.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCC-------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTN-------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      .++|++.+.||+  |+||.||+|+++.++       ..||+|.+....  ....+.+.+|+.+|++++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQ--GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeecc--CCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            469999999999  779999999999988       469999986532  334567889999999999999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--------eE
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--------AC  152 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~--------~~  152 (622)
                      +.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999999997643 23789999999999999999999999999999999999998886        89


Q ss_pred             EcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHh
Q psy15039        153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       153 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~  232 (622)
                      +.|||.........        ...+++.|+|||++.+. ..++.++|||||||++|+|++|..|+..............
T Consensus       162 l~Dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  232 (289)
T 4fvq_A          162 LSDPGISITVLPKD--------ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE  232 (289)
T ss_dssp             ECCCCSCTTTSCHH--------HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             eccCcccccccCcc--------ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence            99998764332111        11345679999999752 3588999999999999999995544443322222222221


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ...                                 ..+...++++.+|+..||+.||++|||+.++++|
T Consensus       233 ~~~---------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          233 DRH---------------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TTC---------------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccC---------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            110                                 0112346789999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.9e-41  Score=347.87  Aligned_cols=262  Identities=19%  Similarity=0.299  Sum_probs=205.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEE-----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~-----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      ...+|++++.||+  |+||.||+|+     +..+++.||||.+... ........+.+|+.+|++++||||+++++++..
T Consensus        28 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGH--GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC----CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcC--CCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            3469999999999  7788999999     6678999999999654 345566778899999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---ceEE
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFN-----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACL  153 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~---~~~i  153 (622)
                      ....++||||+++|+|.+++.....     ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+++
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999999986532     2478999999999999999999999999999999999999544   5999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHh
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~  232 (622)
                      .|||...........  .......+++.|+|||++.+.  .++.++|||||||++|+|++ |..||..............
T Consensus       185 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          185 GDFGMARDIYRASYY--RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             CCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             Ccccccccccccccc--ccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            999976432211110  111223456789999998753  58899999999999999998 9999987654433322222


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      +..+                                .....+++++.+++..||..||.+||++.++++|.++-.
T Consensus       261 ~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          261 GGRM--------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TCCC--------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC--------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            2111                                112346889999999999999999999999999988643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-41  Score=338.99  Aligned_cols=258  Identities=20%  Similarity=0.309  Sum_probs=207.2

Q ss_pred             CCCCceEEe-ecccccCCceeEEEEEE--ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          7 VPSNYKICS-ILGQCFNNLSSVYLSKH--KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         7 ~~~~y~~~~-~lG~g~g~~~~V~~~~~--~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..++|.+.+ .||+  |+||.||+|.+  ..+++.||||+++... .....+.+.+|+.+|++++||||+++++++ ..+
T Consensus         7 ~~~~~~i~~~~lg~--G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            7 KRDNLLIADIELGC--GNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CGGGEEEEEEEEEC--CTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             cHHHhhhhhccccc--cCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            456788887 9999  77999999985  4578899999997653 456677899999999999999999999998 556


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+++.|||......
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            799999999999999998653 2358999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...... .......+|+.|+|||++.+  ..++.++|||||||++|+|++ |..||..............+..+      
T Consensus       162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~------  232 (287)
T 1u59_A          162 ADDSYY-TARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------  232 (287)
T ss_dssp             TCSCEE-CCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC------
T ss_pred             cCccee-eccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC------
Confidence            322211 11223345678999999965  347899999999999999998 99999876544333222222111      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                                                ..+..+++++.+++..||..||++||++.+++++.+
T Consensus       233 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          233 --------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             --------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                                      112357899999999999999999999999998743

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.7e-41  Score=334.55  Aligned_cols=252  Identities=21%  Similarity=0.347  Sum_probs=206.3

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .+++|++.+.||+  |+||.||+|++. +++.||||++.......   +.+.+|+.++++++||||+++++++.+....+
T Consensus         6 ~~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            6 DPSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CGGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             chhheeeeeEecC--CCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            3578999999999  778999999997 67889999998765433   45778999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.........
T Consensus        80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999999997643 357899999999999999999999999999999999999999999999999865432211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                         ........++..|+|||++.+  ..++.++||||+||++|+|++ |..||..............+..+         
T Consensus       159 ---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---------  224 (267)
T 3t9t_A          159 ---YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------  224 (267)
T ss_dssp             ---HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred             ---ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---------
Confidence               111223345678999999975  357899999999999999999 89999876544333222221110         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                             ..+..+++++.+++..||+.||++||++.+++++
T Consensus       225 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          225 -----------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                   1123468899999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.2e-41  Score=348.42  Aligned_cols=258  Identities=17%  Similarity=0.286  Sum_probs=208.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCc-----EEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQ-----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      ..++|++++.||+  |+||.||+|.+..+++     .||+|.+.... .....+.+.+|+.+|++| +||||+++++++.
T Consensus        44 ~~~~~~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           44 PRNNLQFGKTLGA--GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             CTTSEEEEEEEEE--CSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHceeeeEecc--CCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3568999999999  7899999999987775     79999997653 455667789999999999 8999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHF------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN  148 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~  148 (622)
                      +...+++||||+++|+|.+++....            ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            9999999999999999999987542            2347899999999999999999999999999999999999999


Q ss_pred             CceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHH
Q psy15039        149 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLML  227 (622)
Q Consensus       149 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~  227 (622)
                      +.+++.|||.+.........  .......+++.|+|||++.+  ..++.++|||||||++|+|++ |..||.........
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CeEEECccccccccccccce--eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            99999999987543222111  11223345678999999875  358899999999999999998 99999865443333


Q ss_pred             HHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       228 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ...+....+                               ...+...++++.+++..||+.||.+|||+.+++++
T Consensus       277 ~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          277 YKLVKDGYQ-------------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCC-------------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            322221110                               01123457889999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-40  Score=341.05  Aligned_cols=257  Identities=26%  Similarity=0.430  Sum_probs=200.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ...+|++.+.||+  |+||.||+|.++.+|+.||||++.... ........+.+|+.+|++++||||+++++++.....+
T Consensus        30 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGR--GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEEC--C--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecC--CCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            4468999999999  778899999999999999999997643 3456677888999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         86 HLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ++||||+++++|.+++...  ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+++.|||......
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999999998653  23358899999999999999999999999999999999999999999999999765432


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-HHHHHHHhC-CCCCCCcc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKLAG-ATPHLLDC  241 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-~~~~~~~~~-~~p~~~~~  241 (622)
                      .....    .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||...... ......+.. ..|     
T Consensus       188 ~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  256 (310)
T 2wqm_A          188 SKTTA----AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-----  256 (310)
T ss_dssp             ---------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC-----
T ss_pred             CCCcc----ccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC-----
Confidence            22111    112345778999999875  35889999999999999999999999754322 222222211 111     


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                ......+++++.+++..||..||++||++.+++++
T Consensus       257 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          257 --------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             --------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                      11224578899999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-40  Score=345.65  Aligned_cols=257  Identities=18%  Similarity=0.299  Sum_probs=207.1

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEc-------cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHK-------VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISS   78 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~-------~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~   78 (622)
                      ..++|++++.||+  |+||.||+|++.       .+++.||||+++... .....+.+.+|+.+|+++ +||||++++++
T Consensus        33 ~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           33 PRDKLTLGKPLGE--GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CHhHeEEeeEEee--cCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3468999999999  778899999986       578899999997643 456677889999999999 99999999999


Q ss_pred             EEeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q psy15039         79 FLDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL  144 (622)
Q Consensus        79 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiL  144 (622)
                      +.....+++||||+++|+|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            9999999999999999999999976431              23789999999999999999999999999999999999


Q ss_pred             EcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCch
Q psy15039        145 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT  223 (622)
Q Consensus       145 l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~  223 (622)
                      ++.++.+++.|||...........  .......+++.|+|||++.+.  .++.++|||||||++|+|++ |..||.....
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSE--ECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EcCCCCEEEccccccccccccccc--cccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            999999999999987544322111  111223456789999998753  47899999999999999999 9999987654


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .........+..+                                .....+++++.+++..||..||.+||++.+++++
T Consensus       266 ~~~~~~~~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 EELFKLLKEGHRM--------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTCCC--------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCC--------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4332222222111                                1123468899999999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=343.47  Aligned_cols=257  Identities=18%  Similarity=0.303  Sum_probs=202.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCC----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .+.+|++.+.||+  |+||.||+|+++.++    ..||||.+.... .......+.+|+.+|++++||||+++++++.+.
T Consensus        42 ~~~~~~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGA--GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             CTTTEEEEEEEEE--CSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ChHHhhcccEEec--CCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            4568999999999  778899999987664    459999997543 455667788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||.....
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999997642 35889999999999999999999999999999999999999999999999987544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ....... .......+++.|+|||++.+  ..++.++|||||||++|+|++ |..||..............+..      
T Consensus       198 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~------  268 (333)
T 1mqb_A          198 EDDPEAT-YTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------  268 (333)
T ss_dssp             --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------
T ss_pred             ccccccc-cccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc------
Confidence            3221111 11112234667999999965  358899999999999999998 9999987654433222222111      


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                ......+++++.+++..||+.||++||++.+++++
T Consensus       269 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 --------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             --------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      11223568899999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-41  Score=350.43  Aligned_cols=254  Identities=17%  Similarity=0.293  Sum_probs=199.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcE----EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL----IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~----vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      .++|++.+.||+  |+||+||+|+++.+|+.    ||+|.+..... ....+.+.+|+.++++++|||||++++++. ..
T Consensus        12 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           12 ETELRKLKVLGS--GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTTEEEEEEEEC--CSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             HhHceeeeeeee--cCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            468999999999  77899999999999887    77777654321 222345668999999999999999999876 46


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      ..++||||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            7899999999999999987642 357888999999999999999999999999999999999999999999999876543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......  ......++..|+|||++.+.  .|+.++|||||||++|+|++ |..||..............+..       
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  235 (325)
T 3kex_A          167 PDDKQL--LYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-------  235 (325)
T ss_dssp             CCTTCC--C-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-------
T ss_pred             cccccc--cccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------
Confidence            322211  11223445689999999753  58999999999999999999 9999986544332222221111       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               ......++.++.+++..||+.||.+||++.+++++
T Consensus       236 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 -------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     11123357788999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.7e-41  Score=336.24  Aligned_cols=250  Identities=23%  Similarity=0.375  Sum_probs=195.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT--DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ..++|++.+.||+  |+||.||+|++.  |+.||||++......  ....+.+.+|+.++++++||||+++++++.+...
T Consensus         5 ~~~~~~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            5 DFAELTLEEIIGI--GGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             CTTSEEEEEEEEE--ETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             chhheeeeeeecc--CCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            4579999999999  779999999975  889999998764322  2234678899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCCEEEcC--------CCceEE
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG---FIHRAVKASHILISH--------NGKACL  153 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---IvHrDiKp~NiLl~~--------~~~~~i  153 (622)
                      .++||||+++++|.+++..   ..+++..+..++.|++.||+|||++|   |+||||||+|||++.        ++.+++
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            9999999999999998853   35889999999999999999999999   899999999999986        677999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhC
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  233 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~  233 (622)
                      .|||.........      .....+++.|+|||++.+  ..++.++||||+||++|+|++|+.||...............
T Consensus       158 ~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          158 TDFGLAREWHRTT------KMSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             CCCCC-------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             ccCCccccccccc------ccCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            9999765433221      112356788999999875  35889999999999999999999999876554443333222


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ..+                               ......+++++.+++..||+.||++|||+.+++++
T Consensus       230 ~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 KLA-------------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-------------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            111                               11224568899999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-42  Score=361.95  Aligned_cols=286  Identities=20%  Similarity=0.298  Sum_probs=211.7

Q ss_pred             CCCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          1 METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         1 ~~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      |.+...+..+|++.+.||+  |+||.||+|+++.+|+.||||+++.... ....+.+.+|+.+|++++|||||++++++.
T Consensus         1 m~~~~~~~~~y~i~~~LG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   77 (396)
T 4eut_A            1 MGSQSTSNHLWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (396)
T ss_dssp             -CEEECSSEEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCCCCCCceEEEEEEEc--CCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence            4455667889999999999  7899999999999999999999875332 122455678999999999999999999998


Q ss_pred             eCC--cEEEEeecCCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCceEE
Q psy15039         81 DAT--DLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACL  153 (622)
Q Consensus        81 ~~~--~~~lv~e~~~~g~l~~~l~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl----~~~~~~~i  153 (622)
                      ...  ..++|||||++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+++
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (396)
T 4eut_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL  157 (396)
T ss_dssp             CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred             cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEE
Confidence            765  78999999999999999876432 238999999999999999999999999999999999999    66778999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccc------cCCCCCcchHHHHHHHHHHHhcCCCCCCCC----ch
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN------LDGYDERSDIYSVGISCCELANGTVPFAET----PT  223 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~------~~~~~~~~DiWSlG~il~el~~g~~Pf~~~----~~  223 (622)
                      .|||.+........     .....+|+.|+|||++...      ...|+.++|||||||++|||++|..||...    ..
T Consensus       158 ~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          158 TDFGAARELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             CCGGGCEECCCGGG-----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             ecCCCceEccCCCc-----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            99998755433221     1234567889999998641      024678999999999999999999999642    22


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .......+.+.++...........        ....|.............+++.+.+++..||+.||++||++.+++++
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAEN--------GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTT--------CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhheeccC--------CCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            333344444444332211100000        00001100001111123356788999999999999999999998654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=346.48  Aligned_cols=254  Identities=19%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEE----EEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLI----AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~v----AiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..+|++++.||+  |+||.||+|+++.+|+.|    |+|.+.... .....+.+.+|+.+|++++||||+++++++....
T Consensus        14 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEE--CSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeee--CCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            478999999999  779999999999998876    666664432 2234466889999999999999999999998764


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                       .++++|++.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             -ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence             888999999999999997643 358899999999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ......  ......+|+.|+|||++.+  ..|+.++|||||||++|+|++ |..||..............+..       
T Consensus       169 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-------  237 (327)
T 3lzb_A          169 AEEKEY--HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------  237 (327)
T ss_dssp             -------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------
T ss_pred             Cccccc--cccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            222111  1223345678999999975  458999999999999999999 9999987654332222211111       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               ......++.++.+++..||+.||.+||++.++++.
T Consensus       238 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          238 -------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                     11234478899999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.3e-41  Score=347.66  Aligned_cols=272  Identities=22%  Similarity=0.327  Sum_probs=197.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   83 (622)
                      .++|++++.||+  |+||+||+|++.  ++.||||++...   ........+|+.+|++++|||||++++++....    
T Consensus        23 ~~~y~~~~~lg~--G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           23 SMPLQLLEVKAR--GRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TEEEEEEEEEEC--STTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             hhhchhhheecc--cCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            458999999999  778999999876  789999998653   233445667999999999999999999998854    


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCCEEEcCCCceEE
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK----------GFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~----------~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                      .+++|||||++|+|.++++..   .+++..+..++.|++.||+|||++          ||+||||||+|||++.++.+++
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             eEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            379999999999999999763   488999999999999999999999          9999999999999999999999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhcccc---CCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH-HHH
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL---DGYDERSDIYSVGISCCELANGTVPFAETPTTLM-LIE  229 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~-~~~  229 (622)
                      .|||.+.........  .......+|+.|+|||++.+..   ..++.++|||||||++|||++|+.||.+...... ...
T Consensus       173 ~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          173 ADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             CCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             ccCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            999987554332211  1122346788999999997521   1345688999999999999999999975322100 000


Q ss_pred             HHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        230 KLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       230 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ...+..|...+.........           ..+...........++++.+|+.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKK-----------KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSC-----------CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhccc-----------CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            00000000000000000000           000000011112235669999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-40  Score=340.13  Aligned_cols=256  Identities=17%  Similarity=0.222  Sum_probs=200.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      .-++|++.+.||+  |+||.||+|+++.+|+.||||++..... .+...+.+.+|+.++++++||||+++++++.....+
T Consensus        32 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           32 QFGPYRLRRLVGR--GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             --CCEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             EeccEEEEEEEcC--CCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            4568999999999  7788999999999999999999876533 344457788999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||........
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999997653  4889999999999999999999999999999999999999999999999976443222


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ...   ......+++.|+|||++.+  ..++.++|||||||++|+|++|..||...... .....+....+..       
T Consensus       188 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-------  254 (309)
T 2h34_A          188 KLT---QLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRP-------  254 (309)
T ss_dssp             ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCG-------
T ss_pred             ccc---cccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCc-------
Confidence            111   1123356788999999875  35789999999999999999999999876543 2223332221110       


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-CHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-LACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-s~~~~l~  301 (622)
                                            ......+++++.+++.+||..||++|| +++++++
T Consensus       255 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          255 ----------------------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ----------------------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ----------------------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                  012345788999999999999999999 7777765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.3e-41  Score=340.66  Aligned_cols=248  Identities=19%  Similarity=0.372  Sum_probs=204.0

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe------
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD------   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~------   81 (622)
                      ..+|++.+.||+  |+||.||+|+++.+|+.||||++....      ..+.+|+++|++++||||+++++++..      
T Consensus        10 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B           10 GMDFKEIELIGS--GGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHEEEEEEEEC--SSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             ccccceeeeecc--CCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            458999999999  778899999999999999999997653      245689999999999999999998865      


Q ss_pred             ----------CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         82 ----------ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        82 ----------~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                                ...+++||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                      3458999999999999999976544568999999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~  231 (622)
                      ++.|||.+........     .....+++.|+|||++.+  ..++.++|||||||++|+|++|..||....   .....+
T Consensus       162 kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~  231 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDL  231 (284)
T ss_dssp             EECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHH
T ss_pred             EECcchhheecccccc-----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHh
Confidence            9999997654432211     123356788999999975  358899999999999999999998875321   111111


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      ...                                  .....+++++.+++..||+.||.+||++.++++|.+.-.
T Consensus       232 ~~~----------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          232 RDG----------------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HTT----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             hcc----------------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            110                                  012346888999999999999999999999999987643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-40  Score=335.82  Aligned_cols=257  Identities=18%  Similarity=0.260  Sum_probs=203.3

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEcc---CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~---t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      +.-..++|++.+.||+  |+||.||+|++..   ++..||||.+.... .....+.+.+|+.+|++++||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            7 YGIAREDVVLNRILGE--GFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CSCCGGGEEEEEEEEE--CSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ceecccceEEEEEEEe--cCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3445678999999999  7788999999653   45679999987653 4556678899999999999999999999976


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                      + ...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||...
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence            5 45789999999999999997653 358899999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLL  239 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~  239 (622)
                      ........   ......+++.|+|||++.+  ..++.++|||||||++|+|++ |+.||..............+..    
T Consensus       162 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~----  232 (281)
T 3cc6_A          162 YIEDEDYY---KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR----  232 (281)
T ss_dssp             CC------------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC----
T ss_pred             cccccccc---ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC----
Confidence            44322111   1122344678999999965  358899999999999999998 9999976543322222111111    


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                  ......+++++.+++..||..||++||++.+++++
T Consensus       233 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 ----------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                        11223468899999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.8e-41  Score=346.56  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=202.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEE--EEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLI--AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~v--AiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.+  |||.+.... .....+.+.+|+.+|+++ +||||+++++++.+...+
T Consensus        25 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           25 NDIKFQDVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGCEEEEEEEC--GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHccceeeeec--CCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            58999999999  778899999999999866  999987532 344456788999999999 999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         86 HLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      ++||||+++|+|.+++....              ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence            99999999999999997642              1358999999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  230 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~  230 (622)
                      ++.|||.........     ......+++.|+|||++.+  ..++.++|||||||++|+|++ |..||......... ..
T Consensus       182 kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-~~  253 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EK  253 (327)
T ss_dssp             EECCTTCEESSCEEC-----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HH
T ss_pred             EEcccCcCccccccc-----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH-HH
Confidence            999999764322111     1112234667999999865  357899999999999999998 99999876543322 22


Q ss_pred             HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        231 LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       231 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      +....                               .......+++++.+|+.+||..||.+||++.+++++
T Consensus       254 ~~~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          254 LPQGY-------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGGTC-------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcCC-------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            21100                               001223568899999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-40  Score=339.86  Aligned_cols=259  Identities=18%  Similarity=0.298  Sum_probs=201.8

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE-e
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL-D   81 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~   81 (622)
                      ....+|++.+.||+  |+||.||+|++..+   +..||+|.++... .....+.+.+|+.+|++++||||+++++++. .
T Consensus        22 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (298)
T 3f66_A           22 PSSLIVHFNEVIGR--GHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS   98 (298)
T ss_dssp             GGGEEEEEEEEEEE--ETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             ccceehhhcceeee--cCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence            34457999999999  77999999997543   4469999987643 4566678899999999999999999999864 4


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      +...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence            567899999999999999997643 3578999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ................+|+.|+|||++.+  ..++.++||||+||++|+|++ |.+||..............+..     
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----  250 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-----  250 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-----
T ss_pred             ccccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-----
Confidence            43322111112223455678999999975  358899999999999999999 6666665443332222222211     


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                 ...+..+++++.+++..||..||++||++.++++.
T Consensus       251 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          251 ---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       11223468899999999999999999999999873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-40  Score=359.03  Aligned_cols=245  Identities=23%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-cEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-DLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~   86 (622)
                      .++|++.+.||+  |+||.||+|+++  |+.||||+++...    ..+.+.+|+.+|++++|||||++++++.... .++
T Consensus       192 ~~~~~~~~~lG~--G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             hHHeEEEeeecC--cCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            468999999999  779999999886  7799999997653    2356789999999999999999999987765 799


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.........
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            99999999999999987654447899999999999999999999999999999999999999999999999765332111


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                             ....+++.|+|||++.+  ..|+.++|||||||++|||++ |..||...+..........+..          
T Consensus       344 -------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  404 (450)
T 1k9a_A          344 -------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------  404 (450)
T ss_dssp             ----------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC----------
T ss_pred             -------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence                   11244667999999975  358999999999999999998 9999986544332222222111          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                            ...+..+++++.++|..||+.||.+|||+.++++
T Consensus       405 ----------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 ----------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  1122457889999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-40  Score=359.68  Aligned_cols=250  Identities=17%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|+++ +++.||||+++.....   .+.+.+|+.+|++|+|||||++++++. .+.+++
T Consensus       187 ~~~~~~~~~lG~--G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          187 RESLKLEKKLGA--GQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             GGGEEEEEEEEC--CSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEEEccc--CCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            457999999999  789999999986 4678999999765432   456889999999999999999999876 567999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+....... 
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-  338 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  338 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence            9999999999999976433357888999999999999999999999999999999999999999999999875543211 


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                        ........+++.|+|||++..  ..|+.++|||||||++|||++ |..||.+............+..           
T Consensus       339 --~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------  403 (454)
T 1qcf_A          339 --YTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-----------  403 (454)
T ss_dssp             --HHTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-----------
T ss_pred             --eeccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence              111223345678999999975  358999999999999999999 9999987655443332222211           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           ...+..+++++.+||..||..||++|||+.+++.
T Consensus       404 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          404 ---------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                 1122356889999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-40  Score=338.85  Aligned_cols=261  Identities=15%  Similarity=0.149  Sum_probs=205.6

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~   83 (622)
                      .-+.++|++.+.||+  |+||.||+|+++.+|+.||||++......    +.+.+|+.+++++ +|+||+++++++....
T Consensus         6 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            6 NVVGVHYKVGRRIGE--GSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             CEETTTEEEEEEEEE--CSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             cccccceEEEEEEee--cCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            446678999999999  77889999999999999999998754322    3466899999999 8999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-----eEEcCCcc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-----ACLSGLRY  158 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~-----~~i~~~~~  158 (622)
                      ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.     +++.|||.
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             eeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            999999999 899999997643 35899999999999999999999999999999999999987775     99999998


Q ss_pred             ccccCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHHHhC
Q psy15039        159 MCPFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAG  233 (622)
Q Consensus       159 ~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~~~~  233 (622)
                      +...........   .......+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||.....  .......+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            754432211110   11234467889999999875  3589999999999999999999999986421  2222221110


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ...                           ..........+++++.+++..||+.||++||++.++++.
T Consensus       236 ~~~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          236 KKQ---------------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHH---------------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             hcc---------------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            000                           000000123578999999999999999999999998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5e-41  Score=344.95  Aligned_cols=258  Identities=19%  Similarity=0.298  Sum_probs=207.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~-----~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~   80 (622)
                      ..++|++++.||+  |+||.||+|++     ..+++.||||++.... .....+.+.+|+.+|+++ +||||+++++++.
T Consensus        25 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           25 PRDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheeeeeEEcC--CCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            3568999999999  77999999994     5688999999997653 455567788999999999 7999999999988


Q ss_pred             eCC-cEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         81 DAT-DLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        81 ~~~-~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      ..+ .+++||||+++|+|.+++.....              ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            764 49999999999999999976432              127899999999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.+++.|||.+..........  ......+|+.|+|||++.+  ..++.++|||||||++|+|++ |..||......
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             CCCCCEEECCCccccccccCccce--eccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999999999999875543222111  1123345678999999975  358899999999999999998 99999865543


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      ......+....+                               ......+++++.+++..||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTR-------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCcc-------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333332211100                               01123468899999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-40  Score=336.42  Aligned_cols=257  Identities=19%  Similarity=0.262  Sum_probs=201.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      -.|++.+.||+  |+||.||+|++..+++   .||+|.++.. ......+.+.+|+.+|++++||||+++++++.+.+..
T Consensus        21 ~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           21 VVTHSDRVIGK--GHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEE--ETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eEEccCceecc--CCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            36778899999  7799999999766655   7999998753 3455667889999999999999999999999877665


Q ss_pred             -EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         86 -HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        86 -~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                       +++|||+.+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             cEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence             99999999999999997633 3578999999999999999999999999999999999999999999999998754432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      .............++..|+|||.+.+  ..++.++|||||||++|+|++|..|+............+....         
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---------  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC---------
T ss_pred             CcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC---------
Confidence            21111111223355678999999975  3588999999999999999995555443322222222221111         


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                            .......+++++.+++..||+.||.+|||+.++++.
T Consensus       246 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          246 ----------------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                  011234568899999999999999999999998874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-41  Score=348.82  Aligned_cols=269  Identities=18%  Similarity=0.279  Sum_probs=206.5

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .+....++|++.+.||+  |+||.||+|+++ +|+.||||++....  ....+.+.+|+.+|++++||||+++++++...
T Consensus        33 ~~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGH--GVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCCCCCSCCCCSCB--CSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHHHhccCccceeec--CCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34556789999999999  778899999965 78999999987653  23456788999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                      +.+++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||...
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999998865322  247899999999999999999999999999999999999999999999999765


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH-----HH-HHHH-hC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL-----ML-IEKL-AG  233 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~-----~~-~~~~-~~  233 (622)
                      .........  ......+|+.|+|||++.+.  .++.++|||||||++|+|++|+.||.......     .. .... .+
T Consensus       188 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          188 KGTELDQTH--LSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             ECSSSSCCC--CBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccc--cccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            432211110  11223467889999998753  58999999999999999999999997532210     00 0000 00


Q ss_pred             CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                      ..+..                      +.. ..........+.++.+++.+||+.||++|||+.+++++.
T Consensus       264 ~~~~~----------------------~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          264 QLEQI----------------------VDP-NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CCCSS----------------------SSS-SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHh----------------------cCh-hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            00000                      000 000011223567899999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-40  Score=344.44  Aligned_cols=270  Identities=20%  Similarity=0.307  Sum_probs=207.2

Q ss_pred             CCCceEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--   81 (622)
                      .++|++++.||+  |+||.||+|+    +..+++.||||++...  .....+.+.+|+++|++++||||+++++++..  
T Consensus        22 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccC--CCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            368999999999  7789999999    6789999999998764  35556778999999999999999999999874  


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ...+++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||....
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            456999999999999999997643 2488999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ........ .......++..|+|||++.+.  .++.++|||||||++|+|++|..||.................+.    
T Consensus       177 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----  249 (327)
T 3lxl_A          177 LPLDKDYY-VVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA----  249 (327)
T ss_dssp             CCTTCSEE-ECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCH----
T ss_pred             cccCCccc-eeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccccc----
Confidence            43322211 122233556789999998753  47889999999999999999999997533221100000000000    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                  .......+ ...........+++++.+|+..||+.||.+|||+.+++++
T Consensus       250 ------------~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          250 ------------LSRLLELL-EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ------------HHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------HHHHHHHh-hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                        00000000 0111122345678999999999999999999999999765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-40  Score=338.94  Aligned_cols=269  Identities=18%  Similarity=0.283  Sum_probs=203.0

Q ss_pred             CCceEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC--
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--   82 (622)
                      ..|++++.||+  |+||.||+|+    +..+|+.||||++.... .....+.+.+|+.+|++++||||+++++++...  
T Consensus        21 ~~~~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGE--GHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhccCC--CCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            46999999999  7799999999    68899999999997643 223346688999999999999999999999887  


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+...
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            67999999999999999996643 35899999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ....... .......+|..|+|||++.+.  .++.++||||+||++|+|++|..|+.....   ......+.......  
T Consensus       177 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--  248 (302)
T 4e5w_A          177 ETDKEYY-TVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMA---LFLKMIGPTHGQMT--  248 (302)
T ss_dssp             CTTCCEE-ECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHCSCCGGGH--
T ss_pred             cCCCcce-eccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhh---HHhhccCCcccccC--
Confidence            4332211 122334567789999998753  478899999999999999999998753211   11111111100000  


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                 .......+ ........+..+++++.+|+..||+.||.+|||+.++++
T Consensus       249 -----------~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          249 -----------VTRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             -----------HHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -----------HHHHHHHH-hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                       00000000 001112234567899999999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-41  Score=351.64  Aligned_cols=256  Identities=18%  Similarity=0.303  Sum_probs=194.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-CCc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-ATD   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~   84 (622)
                      ..|++.+.||+  |+||.||+|++..++   ..||||.++... .....+.+.+|+.+|++++|||||++++++.. ...
T Consensus        89 ~~~~~~~~LG~--G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGR--GHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEEC--CSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeee--CCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            35889999999  778899999986543   468999987543 34566788999999999999999999998654 467


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.......
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             eEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            899999999999999997643 3478899999999999999999999999999999999999999999999998754432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .............+++.|+|||++.+  ..|+.++|||||||++|||++ |.+||..............+..        
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--------  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--------
T ss_pred             cccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--------
Confidence            21111111123345678999999975  358999999999999999999 7788865443222222222211        


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ...+..+++++.+++..||+.||++||++.+++++
T Consensus       315 ------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 ------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    11223468899999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-40  Score=339.44  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=194.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh--CCCCcceeEEEEEEeC-
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH--LRHPNIICYISSFLDA-   82 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~~~~~~~~~-   82 (622)
                      .+.++|++++.||+  |+||+||+|++  +|+.||||++...     ....+.+|.+++..  ++||||+++++++... 
T Consensus         5 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGK--GRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEE--CSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeecc--CCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            46779999999999  78999999987  6899999998543     22344556666665  8999999999987653 


Q ss_pred             ---CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEEcCCCce
Q psy15039         83 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--------GKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        83 ---~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH--------~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                         ..+++||||+++|+|.++++.   ..+++..+..++.||+.||+|||        ++||+||||||+|||++.++.+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence               458999999999999999954   35889999999999999999999        9999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccC----CCCCcchHHHHHHHHHHHhcC----------CCC
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVGISCCELANG----------TVP  217 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~----~~~~~~DiWSlG~il~el~~g----------~~P  217 (622)
                      ++.|||.+..................+|+.|+|||++.+...    .++.++|||||||++|||++|          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999865433322222222233467889999999975321    234689999999999999999          888


Q ss_pred             CCCCch----HHHHHHHHhC--CCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCC
Q psy15039        218 FAETPT----TLMLIEKLAG--ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVD  291 (622)
Q Consensus       218 f~~~~~----~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  291 (622)
                      |.....    ..........  ..|.++                           ........++++.+|+..||+.||+
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~  285 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNIP---------------------------NRWFSDPTLTSLAKLMKECWYQNPS  285 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCC---------------------------GGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCCC---------------------------hhhccCccHHHHHHHHHHHhhcChh
Confidence            864221    1111111111  000000                           0011223567899999999999999


Q ss_pred             CCcCHHhhhcC
Q psy15039        292 KRPLACNLLQH  302 (622)
Q Consensus       292 ~Rps~~~~l~h  302 (622)
                      +|||+.++++.
T Consensus       286 ~Rps~~~i~~~  296 (301)
T 3q4u_A          286 ARLTALRIKKT  296 (301)
T ss_dssp             GSCCHHHHHHH
T ss_pred             hCCCHHHHHHH
Confidence            99999998863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.7e-40  Score=333.35  Aligned_cols=252  Identities=17%  Similarity=0.342  Sum_probs=202.9

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      -..++|++.+.||+  |+||.||+|+++ +++.||||.+......   .+.+.+|+++|++++||||+++++++. .+..
T Consensus        10 v~~~~y~~~~~lg~--G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   82 (279)
T 1qpc_A           10 VPRETLKLVERLGA--GQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI   82 (279)
T ss_dssp             CCGGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHhhhheeeecC--CCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence            44578999999999  778999999976 5678999999765433   345778999999999999999999876 4568


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      ++||||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||........
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999999986543235889999999999999999999999999999999999999999999999987554322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ..   .......++..|+|||++.+.  .++.++|||||||++|+|++ |..||..............+..         
T Consensus       163 ~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------  228 (279)
T 1qpc_A          163 EY---TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------  228 (279)
T ss_dssp             CE---ECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred             cc---ccccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------
Confidence            11   112233456789999999753  47899999999999999999 9999987654433222221111         


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                             ......+++++.+++..||..||++|||+.++++
T Consensus       229 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 -----------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                   0122356889999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-40  Score=348.79  Aligned_cols=267  Identities=15%  Similarity=0.194  Sum_probs=199.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccC-----CcEEEEEEecCCCCCH-HHH--------HHHHHHHHHHhhCCCCcc
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVT-----NQLIAVKKFNLDRMTD-EDL--------KSLHHEIVCMRHLRHPNI   72 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t-----~~~vAiK~~~~~~~~~-~~~--------~~~~~Ei~il~~l~HpnI   72 (622)
                      ...+|++.+.||+  |+||.||+|.++.+     ++.||||.+....... .+.        ....+|+..++.++||||
T Consensus        33 ~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           33 AAAAWKVGLPIGQ--GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             TCCEEEEEEECCC--C-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             CCCeEEEEEEEec--CCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            4568999999999  77899999998775     6889999987653110 111        123456778888999999


Q ss_pred             eeEEEEEEeC----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc--
Q psy15039         73 ICYISSFLDA----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS--  146 (622)
Q Consensus        73 v~~~~~~~~~----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~--  146 (622)
                      +++++++...    ...++||||| +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++  
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            9999999875    4489999999 999999997642 3589999999999999999999999999999999999999  


Q ss_pred             CCCceEEcCCccccccCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch
Q psy15039        147 HNGKACLSGLRYMCPFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  223 (622)
Q Consensus       147 ~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~  223 (622)
                      .++.+++.|||.+..+........   .......+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||.....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            789999999998754432211111   01123347889999999975  3589999999999999999999999975322


Q ss_pred             HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        224 TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       224 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ............                      ...+.......+....+++++.+++..||..||++||++.++++
T Consensus       267 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          267 DPKYVRDSKIRY----------------------RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CHHHHHHHHHHH----------------------HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHh----------------------hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            211111110000                      00000111112223567899999999999999999999999876

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.5e-41  Score=348.32  Aligned_cols=216  Identities=21%  Similarity=0.324  Sum_probs=179.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||++..... .....+.+.+|..+++.+ +|||||++++++.+.+.+
T Consensus        22 ~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           22 IDNFEFIRVLGK--GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             -CCEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEee--CCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            568999999999  7899999999999999999999874321 112245678999999988 799999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+......
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999987654  4789999999999999999999999999999999999999999999999976532211


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                          .....+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||...+.......+..+
T Consensus       178 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~  239 (353)
T 3txo_A          178 ----GVTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND  239 (353)
T ss_dssp             ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             ----CccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence                112234578999999999976  46899999999999999999999999887666554444444

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-40  Score=343.61  Aligned_cols=215  Identities=18%  Similarity=0.291  Sum_probs=180.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            357999999999  8899999999999999999999864311 1112456889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+.......
T Consensus        82 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999999999987653  47899999999999999999999999999999999999999999999999765322111


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      .    ...+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||...+..........
T Consensus       160 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~  219 (337)
T 1o6l_A          160 A----TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM  219 (337)
T ss_dssp             C----CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             C----cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            1    1234568899999999975  4689999999999999999999999987765544333333

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.1e-40  Score=356.11  Aligned_cols=250  Identities=19%  Similarity=0.345  Sum_probs=198.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|+++.+ ..||||+++.....   .+.+.+|+.+|++|+|||||++++++.+ +.+++
T Consensus       183 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~-~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          183 RESLRLEVKLGQ--GCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hhHceeeeeecC--CCCeEEEEEEECCC-ceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            457999999999  77899999999864 56999999765543   3457899999999999999999999866 67899


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999999999754333588999999999999999999999999999999999999999999999998754332111


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                         .......++..|+|||++..+  .|+.++|||||||++|||++ |..||.+............+..           
T Consensus       336 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------  399 (452)
T 1fmk_A          336 ---TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  399 (452)
T ss_dssp             ----------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             ---ecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence               111223446789999998753  58999999999999999999 9999987655443332222211           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           ...+..+++++.++|..||+.||++|||+.++++
T Consensus       400 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          400 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                 0122356889999999999999999999999886

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.2e-41  Score=347.71  Aligned_cols=263  Identities=14%  Similarity=0.155  Sum_probs=197.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEcc---CCcEEEEEEecCCCCCH-HH--------HHHHHHHHHHHhhCCCCccee
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTD-ED--------LKSLHHEIVCMRHLRHPNIIC   74 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~---t~~~vAiK~~~~~~~~~-~~--------~~~~~~Ei~il~~l~HpnIv~   74 (622)
                      ..++|++++.||+  |+||.||+|+++.   ++..||||++....... .+        ...+.+|+.+++.++||||++
T Consensus        35 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           35 EGNQWVLGKKIGS--GGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             TSCEEEEEEEC--------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cCceEEEEeeEee--cCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            4578999999999  7789999999988   89999999987654211 11        123568999999999999999


Q ss_pred             EEEEEEe----CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-
Q psy15039         75 YISSFLD----ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-  149 (622)
Q Consensus        75 ~~~~~~~----~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-  149 (622)
                      +++++..    ...+++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            9999988    67899999999 999999987643  588999999999999999999999999999999999999877 


Q ss_pred             -ceEEcCCccccccCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch-H
Q psy15039        150 -KACLSGLRYMCPFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT-T  224 (622)
Q Consensus       150 -~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~-~  224 (622)
                       .+++.|||.+...........   .......+|+.|+|||++.+.  .|+.++|||||||++|||++|..||..... .
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence             999999998755432211100   001234567889999999753  589999999999999999999999964221 1


Q ss_pred             HHHH---HHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        225 LMLI---EKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       225 ~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ....   .......|                          ...........+++++.+++..||..||++||++.++++
T Consensus       268 ~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          268 VAVQTAKTNLLDELP--------------------------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHHTTT--------------------------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhccccc--------------------------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1111   11111111                          000111122367899999999999999999999999887


Q ss_pred             C
Q psy15039        302 H  302 (622)
Q Consensus       302 h  302 (622)
                      .
T Consensus       322 ~  322 (345)
T 2v62_A          322 I  322 (345)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=351.90  Aligned_cols=218  Identities=24%  Similarity=0.302  Sum_probs=186.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.++|++.+.||+  |+||.||+|.++.+|+.+|+|++.....+....+.+.+|+.+|+.++|||||++++++.+.+..|
T Consensus         9 ~~~~Y~i~~~LG~--G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGK--GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEE--C--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccCCeEEEEEecc--CCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            4567999999999  88999999999999999999999887776667788999999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~---~~~~~~~~~~~~~~~~~  513 (622)
                      +||||+++|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++   .++.+++.|||.+....
T Consensus        87 lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            9999999999999987653  478999999999999999999999999999999999998   45789999999875443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....    ...+..||+.|||||++.+  ..|+.++|||||||++|+|++|.+||.+.+..........+.
T Consensus       165 ~~~~----~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  229 (444)
T 3soa_A          165 GEQQ----AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA  229 (444)
T ss_dssp             TTCC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             CCCc----eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Confidence            3221    1234578999999999975  468999999999999999999999998876665554444443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.8e-40  Score=343.09  Aligned_cols=217  Identities=27%  Similarity=0.367  Sum_probs=187.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.++|++.+.||+  |+||.||+|.++.+|+.||+|++..........+.+.+|+.+++.++|||||++++++.+.+..|
T Consensus        27 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           27 FSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCeEEeeEEec--CCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3467999999999  78999999999999999999999887777777788999999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~~~~~~~~~~  513 (622)
                      +||||+++|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++.++   .+++.|||.+....
T Consensus       105 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            9999999999999887543  478999999999999999999999999999999999998754   59999999875443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ...     ......||+.|+|||++.+  ..|+.++|||||||++|||++|++||...+..........+.
T Consensus       183 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~  246 (362)
T 2bdw_A          183 DSE-----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  246 (362)
T ss_dssp             TCC-----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CCc-----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            221     1224568899999999975  468999999999999999999999998876655544444443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-40  Score=346.04  Aligned_cols=217  Identities=21%  Similarity=0.293  Sum_probs=184.9

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH----HHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      .+.+.|++.+.||+  |+||.||+|+++.+|+.||+|++........    ..+.+.+|+.+|+.++|||||+++++|.+
T Consensus         9 ~~~~~y~~~~~LG~--G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            9 KVEDFYDIGEELGS--GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CGGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ChhhceEEeeEEee--CcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            45678999999999  7899999999999999999999976543221    24578899999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----ceEEcCcc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLR  507 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~----~~~~~~~~  507 (622)
                      .+..++||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++    .+++.|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999999987543  578999999999999999999999999999999999998877    79999999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .+.......     ......||+.|+|||++.+  ..|+.++|||||||++|+|++|.+||.+.+....+.....+
T Consensus       165 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~  233 (361)
T 2yab_A          165 LAHEIEDGV-----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV  233 (361)
T ss_dssp             SCEECCTTC-----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred             CceEcCCCC-----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            876543321     1234568899999999975  46899999999999999999999999887666554444443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=355.88  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=193.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+|++.++||+  |+||+|+. +...+|+.||||++.....     ..+.+|+++|+++ +|||||++++++.+...+|+
T Consensus        24 ~~y~~~~~LG~--G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           24 ISFCPKDVLGH--GAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEEEEEEEEEE--CGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEecCCeeec--CcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            36999999999  77889763 5567899999999965432     2245799999999 89999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CC--ceEEcCCcccccc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NG--KACLSGLRYMCPF  162 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~--~~~i~~~~~~~~~  162 (622)
                      |||||+ |+|.+++.... ...++..+..++.||+.||+|||++||+||||||+|||++.   ++  +++++|||.+...
T Consensus        96 v~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999997 69999987643 23455566789999999999999999999999999999953   23  5779999987554


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccc-cCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ....... ....+..+|+.|+|||++.+. ...++.++||||+||++|||++ |..||.........  .+.+..+.   
T Consensus       174 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~--~~~~~~~~---  247 (432)
T 3p23_A          174 AVGRHSF-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSL---  247 (432)
T ss_dssp             -------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH--HHTTCCCC---
T ss_pred             cCCCcce-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH--HHhccCCc---
Confidence            3221111 112234678899999998642 2356789999999999999999 99999654333221  11111100   


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                               .........+..+.+||.+||+.||.+|||+.++++||||....
T Consensus       248 -------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          248 -------------------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             -------------------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             -------------------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                                     00001123466789999999999999999999999999997643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.9e-40  Score=333.11  Aligned_cols=245  Identities=22%  Similarity=0.385  Sum_probs=193.8

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-CcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-TDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~   86 (622)
                      .++|++.+.||+  |+||.||+|+++  |+.||||+++...    ..+.+.+|+.+|++++||||+++++++... ..++
T Consensus        20 ~~~y~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEec--CCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence            468999999999  778899999875  8899999986543    345678999999999999999999987654 4799


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.........
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  171 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  171 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence            99999999999999976533237899999999999999999999999999999999999999999999999765432211


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                             ....+++.|+|||++.+  ..++.++|||||||++|+|++ |..||...+..... ..+....          
T Consensus       172 -------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~~~----------  231 (278)
T 1byg_A          172 -------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGY----------  231 (278)
T ss_dssp             -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTTTC----------
T ss_pred             -------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCC----------
Confidence                   12244667999999875  358899999999999999998 99999865443222 2221110          


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           .......+++++.+++..||+.||.+||++.++++
T Consensus       232 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ---------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                                 00122356889999999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.9e-41  Score=347.62  Aligned_cols=272  Identities=20%  Similarity=0.283  Sum_probs=203.9

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ...++|++.+.||+  |+||.||+|+++ +|+.||||++..... ......+.+|+.+|++++||||+++++++.+....
T Consensus        27 ~~~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           27 VASDNFSNKNILGR--GGFGKVYKGRLA-DGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             TTTTSSCSTTEEEC--CSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHhhccccceeEec--CCCcEEEEEEec-CCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            45679999999999  778899999854 699999999876432 12223578999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGK---GFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+++.|||.+.
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            999999999999999976532  2388999999999999999999999   99999999999999999999999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCC----chHHHHHHHHhCCCC
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET----PTTLMLIEKLAGATP  236 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~----~~~~~~~~~~~~~~p  236 (622)
                      .........   .....+|+.|+|||++.+.  .++.++||||+||++|+|++|..||...    .........+.+...
T Consensus       183 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          183 LMDYKDTHV---TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             ECCSSSSCE---ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             ccCcccccc---cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            443222211   1223467889999999753  4789999999999999999999999521    000111111111100


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                      ..                 .. ..+.............++++.+++..||+.||.+|||+.++++|-.
T Consensus       258 ~~-----------------~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          258 EK-----------------KL-EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SC-----------------CS-TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ch-----------------hh-hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            00                 00 0000000000112234678999999999999999999999999854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.3e-40  Score=348.09  Aligned_cols=203  Identities=20%  Similarity=0.333  Sum_probs=175.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||+|++....... ...+.+.+|..+++.+ +|||||+++++|.+.+.+
T Consensus        51 ~~~y~~~~~LG~--G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           51 LQDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             hhHcEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            467999999999  889999999999999999999998654333 3345688999999876 899999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|.|||.+......
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999999987653  4789999999999999999999999999999999999999999999999976532211


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      .    ....+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||..
T Consensus       207 ~----~~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          207 G----DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             T----CCBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             C----CccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            1    11234578999999999976  5689999999999999999999999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.3e-40  Score=333.91  Aligned_cols=244  Identities=18%  Similarity=0.270  Sum_probs=191.8

Q ss_pred             CCCCCCceEE-eecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHH-hhCCCCcceeEEEEEEe-
Q psy15039          5 DNVPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM-RHLRHPNIICYISSFLD-   81 (622)
Q Consensus         5 ~~~~~~y~~~-~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~~~~~~~~-   81 (622)
                      ..+.++|.+. ++||+  |+||.||+|.++.+|+.||||+++..       ..+.+|+.++ +.++||||++++++|.. 
T Consensus        13 ~~~~~~y~~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             SCGGGTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccccchhhcCccccc--CCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            3456789888 78999  77899999999999999999998642       3456799888 66699999999999987 


Q ss_pred             ---CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcC
Q psy15039         82 ---ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSG  155 (622)
Q Consensus        82 ---~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~  155 (622)
                         ...+++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+++.|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               677999999999999999998765446899999999999999999999999999999999999998   77899999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCC
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  235 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~  235 (622)
                      ||.+....                            ...|+.++||||+||++|+|++|..||........    .    
T Consensus       164 fg~a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----~----  207 (299)
T 3m2w_A          164 FGFAKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----S----  207 (299)
T ss_dssp             CTTCEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------
T ss_pred             cccccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----h----
Confidence            98642211                            02367899999999999999999999975432110    0    


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      +.....    ..    ..         ....+......+++++.+|+.+||+.||.+|||+.++++||||.+...
T Consensus       208 ~~~~~~----~~----~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          208 PGMKTR----IR----MG---------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             CCSCCS----SC----TT---------CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             HHHHHH----Hh----hc---------cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            000000    00    00         000011112457999999999999999999999999999999987654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.3e-40  Score=340.77  Aligned_cols=270  Identities=21%  Similarity=0.322  Sum_probs=203.3

Q ss_pred             CCCCCc-eEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          6 NVPSNY-KICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         6 ~~~~~y-~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      .+..+| ++++.||+  |+||+||++.    +..+|+.||||+++.. ......+.+.+|+.+|++++||||+++++++.
T Consensus        27 ~~~~r~~~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGE--GHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE  103 (318)
T ss_dssp             BCCGGGEEEEEEEEE--CSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eecHHHHhhhheecC--CCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence            355666 99999999  7799997775    5668999999999765 34566778899999999999999999999998


Q ss_pred             eC--CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         81 DA--TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        81 ~~--~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                      +.  ..+++||||+++|+|.+++...   ++++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence            84  5789999999999999998653   488999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      +.......... .......++..|+|||++.+.  .++.++|||||||++|+|++|..||..........   .+.....
T Consensus       181 a~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~---~~~~~~~  254 (318)
T 3lxp_A          181 AKAVPEGHEYY-RVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL---IGIAQGQ  254 (318)
T ss_dssp             CEECCTTCSEE-EC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH---HCSCCHH
T ss_pred             ccccccccccc-ccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh---hcccccc
Confidence            76544322211 112233456779999999753  47889999999999999999999997532211100   0000000


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                  . ....... .............+++++.+|+..||+.||.+|||+.++++
T Consensus       255 ------------~-~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          255 ------------M-TVLRLTE-LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             ------------H-HHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------h-hHHHHHH-HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                        0 0000000 00001112233567899999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=344.63  Aligned_cols=259  Identities=17%  Similarity=0.251  Sum_probs=200.8

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccC--------CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccee---
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVT--------NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC---   74 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t--------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~---   74 (622)
                      ....+|++.+.||+  |+||.||+|+++.|        ++.||||.+...       +.+.+|+.+|++++|||||+   
T Consensus        39 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           39 KSGRQWKLKSFQTR--DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             TTSCEEEEEEEEEE--ETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ccCCeEEEEEEecC--CCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhh
Confidence            34679999999999  77899999999985        889999998754       34678999999999999998   


Q ss_pred             ------------EEEEEEe-CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy15039         75 ------------YISSFLD-ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS  141 (622)
Q Consensus        75 ------------~~~~~~~-~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~  141 (622)
                                  +++++.. ....++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                        6677776 67899999999 999999998753346899999999999999999999999999999999


Q ss_pred             CEEEcCCC--ceEEcCCccccccCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCC
Q psy15039        142 HILISHNG--KACLSGLRYMCPFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTV  216 (622)
Q Consensus       142 NiLl~~~~--~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~  216 (622)
                      |||++.++  .+++.|||.+...........   .......+|+.|+|||++.+  ..++.++|||||||++|+|++|+.
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999988  899999998755433221111   11123367889999999975  358899999999999999999999


Q ss_pred             CCCCCc-hHHHHHHH---HhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC
Q psy15039        217 PFAETP-TTLMLIEK---LAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK  292 (622)
Q Consensus       217 Pf~~~~-~~~~~~~~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  292 (622)
                      ||.... ....+...   .....+.+.+                          .......+++++.+|+..||+.||++
T Consensus       267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~  320 (352)
T 2jii_A          267 PWTNCLPNTEDIMKQKQKFVDKPGPFVG--------------------------PCGHWIRPSETLQKYLKVVMALTYEE  320 (352)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHSCCCEEC--------------------------TTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred             CcccCCcCHHHHHHHHHhccCChhhhhh--------------------------hccccCCCcHHHHHHHHHHHhCChhh
Confidence            997643 22111111   1111111000                          00112356899999999999999999


Q ss_pred             CcCHHhhhcC
Q psy15039        293 RPLACNLLQH  302 (622)
Q Consensus       293 Rps~~~~l~h  302 (622)
                      ||++.++++.
T Consensus       321 Rps~~~l~~~  330 (352)
T 2jii_A          321 KPPYAMLRNN  330 (352)
T ss_dssp             CCCHHHHHHH
T ss_pred             CCCHHHHHHH
Confidence            9999998874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.6e-40  Score=334.40  Aligned_cols=217  Identities=26%  Similarity=0.493  Sum_probs=185.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ....|++.+.||+  |+||.||+|++..+|+.||||++.......  .+.+.+|+.+++.++|||||++++++...+..+
T Consensus        18 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           18 PKKKYTRFEKIGQ--GASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGGTBCCCEEEEE--ETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhceeeeeeecc--CCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            4567999999999  789999999999999999999987544332  356889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            999999999999998764   47899999999999999999999999999999999999999999999999865544322


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  586 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p  586 (622)
                      ..    .....+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||...+....+........|
T Consensus       171 ~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  234 (297)
T 3fxz_A          171 SK----RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP  234 (297)
T ss_dssp             CC----BCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC
T ss_pred             cc----cCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            11    223567889999999976  46899999999999999999999999888766655555444433

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=344.33  Aligned_cols=260  Identities=22%  Similarity=0.293  Sum_probs=200.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe----CC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----AT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~   83 (622)
                      ..+|++++.||+  |+||.||+|+++.+|+.||||++...  .....+.+.+|+.++++++||||+++++++..    ..
T Consensus        28 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGE--GGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC----CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecC--CCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            468999999999  77999999999999999999998653  35566778899999999999999999999873    34


Q ss_pred             cEEEEeecCCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                      ..++||||+++|+|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||....
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            7899999999999999987642  23589999999999999999999999999999999999999999999999997543


Q ss_pred             cCCCCcccc-----ccCCCCCCCccccChhhhcccc-CCCCCcchHHHHHHHHHHHhcCCCCCCCCchH-HHHHHHHhCC
Q psy15039        162 FSPTKKKVH-----LFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKLAGA  234 (622)
Q Consensus       162 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~-~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~-~~~~~~~~~~  234 (622)
                      .........     .......+|+.|+|||++.... ..++.++|||||||++|+|++|..||...... ......+.. 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence            321100000     0000123467899999986431 13678999999999999999999999531100 000011110 


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                    ....+....+++++.+++..||+.||.+||++.+++++
T Consensus       263 ------------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 ------------------------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ------------------------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                                          00112234578999999999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-40  Score=338.21  Aligned_cols=213  Identities=22%  Similarity=0.356  Sum_probs=182.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||+|++....... ...+.+.+|+.+++.++|||||++++++.+...+|
T Consensus         5 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            467999999999  889999999999999999999986431111 12456789999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+...... 
T Consensus        83 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            9999999999999998643  4789999999999999999999999999999999999999999999999976543221 


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                            ..+.+||+.|+|||++.+  ..|+.++|||||||++|||++|++||...+........+.+
T Consensus       160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  218 (318)
T 1fot_A          160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA  218 (318)
T ss_dssp             ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred             ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence                  224568899999999975  46899999999999999999999999887665554444444

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-39  Score=339.11  Aligned_cols=203  Identities=21%  Similarity=0.333  Sum_probs=177.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||+|++..... .....+.+.+|+.+++.+ +|||||++++++.+.+.+
T Consensus         8 ~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGR--GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEEe--cCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            467999999999  8899999999999999999999986543 345567789999999987 899999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+......
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999987653  4789999999999999999999999999999999999999999999999976532211


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      .    ....+.+||+.|+|||++.+  ..|+.++|||||||++|||++|++||..
T Consensus       164 ~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          164 G----DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             T----CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C----CcccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            1    11234578999999999976  4689999999999999999999999965

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.5e-40  Score=365.51  Aligned_cols=247  Identities=19%  Similarity=0.284  Sum_probs=196.9

Q ss_pred             eecccccCCceeEEEEE--EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSK--HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~--~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||.||+|.  .+.+++.||||+++.........+.+.+|+++|++|+|||||++++++.+ +.+++|||||
T Consensus       375 ~~LG~--G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGS--GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEE--CSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEecc--CCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence            47999  8899999994  56778999999997655455556778999999999999999999999864 5689999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......... ..
T Consensus       452 ~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~  528 (635)
T 4fl3_A          452 ELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KA  528 (635)
T ss_dssp             TTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc-cc
Confidence            999999999764  358899999999999999999999999999999999999999999999999875443222111 11


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCC
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQD  251 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  251 (622)
                      .....+++.|+|||++..  ..|+.++|||||||++|||++ |+.||.+............+..+               
T Consensus       529 ~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------------  591 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------------  591 (635)
T ss_dssp             ------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred             ccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence            122344678999999965  358999999999999999998 99999876654433332222111               


Q ss_pred             cCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        252 DGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                       ..+..+++++.+||..||+.||++||++.++++
T Consensus       592 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                             112357899999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=362.21  Aligned_cols=254  Identities=20%  Similarity=0.314  Sum_probs=198.8

Q ss_pred             CCCceEEe-ecccccCCceeEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICS-ILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~-~lG~g~g~~~~V~~~~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .++|.+.+ .||+  |+||.||+|.++  .++..||||+++... .....+.+.+|+++|++|+|||||++++++.+ +.
T Consensus       334 ~~~~~~~~~~LG~--G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          334 RDNLLIADIELGC--GNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TTSEEEEEEEEEE--CSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             ccceeEcCcEEec--CCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            34566666 7999  778999999876  466779999997653 23345678899999999999999999999876 56


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++|||||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            99999999999999998654 23589999999999999999999999999999999999999999999999998755432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ..... .......+++.|+|||++..  ..|+.++|||||||++|||++ |..||..............+..+       
T Consensus       489 ~~~~~-~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-------  558 (613)
T 2ozo_A          489 DDSYY-TARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------  558 (613)
T ss_dssp             --------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-------
T ss_pred             CCcee-eeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            21111 11112234578999999975  358999999999999999998 99999876554433222222111       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                               ..+..+++++.++|..||..||++||++.++++
T Consensus       559 -------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          559 -------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             -------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     122357899999999999999999999999754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.6e-40  Score=334.33  Aligned_cols=244  Identities=20%  Similarity=0.378  Sum_probs=192.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|+++  ++.||||++...    ...+.+.+|+++|++++|||||++++++.  +..++
T Consensus         7 ~~~~~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGR--GAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCL   76 (307)
T ss_dssp             GGGEEEEEEEEC--CSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEE
T ss_pred             HhHeeeeeEeec--CCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEE
Confidence            358999999999  778899999875  789999998543    34567889999999999999999999876  45899


Q ss_pred             EeecCCCCCHHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCCEEEcCCCc-eEEcCCcccccc
Q psy15039         88 VSPLMGFGSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHG---KGFIHRAVKASHILISHNGK-ACLSGLRYMCPF  162 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~-~l~e~~~~~i~~qi~~aL~ylH~---~~IvHrDiKp~NiLl~~~~~-~~i~~~~~~~~~  162 (622)
                      ||||+++|+|.+++...... .+++..+..++.|++.||+|||+   +||+||||||+|||++.++. +++.|||.....
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            99999999999999764321 36788999999999999999999   89999999999999998886 799999986543


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch-HHHHHHH-HhCCCCCCCc
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT-TLMLIEK-LAGATPHLLD  240 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~-~~~~~~~-~~~~~p~~~~  240 (622)
                      ...       .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||..... ....... ..+..|    
T Consensus       157 ~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----  223 (307)
T 2eva_A          157 QTH-------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP----  223 (307)
T ss_dssp             ---------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC----
T ss_pred             ccc-------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC----
Confidence            221       112346788999999975  3589999999999999999999999975432 2112211 111111    


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                  .....+++++.+++.+||+.||++|||+.+++++
T Consensus       224 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          224 ----------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             ----------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                                        1123468899999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.7e-40  Score=332.00  Aligned_cols=257  Identities=18%  Similarity=0.325  Sum_probs=196.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEcc-CCc--EEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKV-TNQ--LIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~-t~~--~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..+|++++.||+  |+||.||+|++.. +++  .||||+++.... .+...+.+.+|+.+|++++||||+++++++.+..
T Consensus        17 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           17 EKDLRLLEKLGD--GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             GGGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhHeeeeeeecC--CCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            468999999999  7788999999654 333  699999876543 2345677889999999999999999999988765


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                       .++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+++.|||......
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence             899999999999999987643 347899999999999999999999999999999999999999999999999875543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...... .......++..|+|||++.+.  .++.++|||||||++|+|++ |..||.................+      
T Consensus       173 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------  243 (291)
T 1u46_A          173 QNDDHY-VMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------  243 (291)
T ss_dssp             C-CCEE-EC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC------
T ss_pred             ccccch-hhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC------
Confidence            322211 112233456679999998753  47889999999999999999 99999876554433332221110      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               ......+++++.+++..||..||++||++.+++++
T Consensus       244 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          244 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                     11223578999999999999999999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.8e-40  Score=340.79  Aligned_cols=216  Identities=19%  Similarity=0.324  Sum_probs=180.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~  434 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++...... ......+.+|..+++.+ +|||||++++++.+.+.
T Consensus        15 ~~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             -CTTEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChHHeEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            4578999999999  88999999999999999999998743210 11235678899999876 99999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+.....
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            999999999999999998653  478999999999999999999999999999999999999999999999997653322


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      ...    ...+.+||+.|+|||++.+  ..|+.++|||||||++|||++|++||...+..........
T Consensus       171 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~  232 (345)
T 1xjd_A          171 GDA----KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM  232 (345)
T ss_dssp             TTC----CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCC----cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            111    1234578999999999976  4689999999999999999999999988765544333333

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.5e-41  Score=369.27  Aligned_cols=284  Identities=20%  Similarity=0.240  Sum_probs=206.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-----
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-----   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----   81 (622)
                      ..++|++.+.||+  |+||.||+|.++.+|+.||||++... ......+.+.+|+.+|++++|||||++++++..     
T Consensus        12 ~~grY~i~~~LG~--G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           12 TCGPWEMKERLGT--GGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             -----CCCCCCCB--CSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCCeEEEEEEee--CCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            3478999999999  77889999999999999999998764 356667788999999999999999999998765     


Q ss_pred             -CCcEEEEeecCCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---eEEcCC
Q psy15039         82 -ATDLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGL  156 (622)
Q Consensus        82 -~~~~~lv~e~~~~g~l~~~l~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~---~~i~~~  156 (622)
                       ....++|||||++|+|.+++..... .++++..+..++.|++.||+|||++||+||||||+|||++.++.   +++.||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             5678999999999999999976432 24788899999999999999999999999999999999997765   889999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      |..........     .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|..||............+....+
T Consensus       169 G~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGEL-----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCCC-----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             ccccccccccc-----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            98755432211     123456788999999865  45899999999999999999999999765332211110000000


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .    ......  ......   .+-.....+......+++.+.+++..||..||++|||+.++++||||....
T Consensus       242 ~----~~~~~~--~l~g~~---~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          242 E----HIVVYD--DLTGAV---KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             ------CCSCC--CCSSSC---CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             h----hhhhhh--hhcccc---ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            0    000000  000000   000000001112234688999999999999999999999999999998643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-39  Score=330.89  Aligned_cols=257  Identities=19%  Similarity=0.250  Sum_probs=200.1

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEE-EeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSF-LDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~   84 (622)
                      .+.++|++.+.||+  |+||.||+|+++.+|+.||||++......    +.+.+|+.+++.++|+|++..+..+ .....
T Consensus         6 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            6 RVGNRYRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             EETTTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             eeccEEEEEEEEcc--CCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            45789999999999  77899999999999999999998765433    2467899999999998877665554 56678


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~---~~~~~~i~~~~~~~~  161 (622)
                      .++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++   .++.+++.|||....
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            89999999 899999997543 3589999999999999999999999999999999999994   788999999998754


Q ss_pred             cCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCCC
Q psy15039        162 FSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATP  236 (622)
Q Consensus       162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~p  236 (622)
                      .........   .......+|+.|+|||++.+.  .++.++|||||||++|+|++|+.||......  ......+     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----  230 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-----  230 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH-----
T ss_pred             ccccccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh-----
Confidence            432221110   112344678889999999753  5889999999999999999999999753211  0000000     


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhc---cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQ---VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               ......   ......+++++.+++..||+.||++||++.++++.
T Consensus       231 -------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          231 -------------------------SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             -------------------------HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             -------------------------cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence                                     000000   00124578999999999999999999999998763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-39  Score=331.42  Aligned_cols=222  Identities=25%  Similarity=0.368  Sum_probs=186.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      +.+.|++.+.||+  |+||.||+|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         9 ~~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            9 INERYKIVDKLGG--GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             EETTEEEEEEEEE--ETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hhccEEEEEEEcc--CCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            4567999999999  789999999999999999999986543 3445567899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999999998754  4789999999999999999999999999999999999999999999999986544322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  587 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~  587 (622)
                      ..   .......+|+.|+|||++.+  ..++.++|||||||++|||++|++||...+........+....|.
T Consensus       165 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  231 (294)
T 4eqm_A          165 SL---TQTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN  231 (294)
T ss_dssp             -------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC
T ss_pred             cc---cccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC
Confidence            11   11223457889999999976  468899999999999999999999999887776666667666554

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.6e-39  Score=328.80  Aligned_cols=257  Identities=18%  Similarity=0.246  Sum_probs=195.3

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEE-EeCC
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSF-LDAT   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~   83 (622)
                      ..+.++|++.+.||+  |+||.||+|+++.+|+.||||++......    ..+.+|+.++++++|+|++..+..+ ...+
T Consensus         5 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            5 LRVGNRYRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ------CEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cccCCceEEeeeecC--CCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            356789999999999  77889999999999999999987654322    3467899999999998877666555 6677


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCceEEcCCcccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMC  160 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl---~~~~~~~i~~~~~~~  160 (622)
                      ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+++.|||.+.
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             ceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            889999999 899999997543 358999999999999999999999999999999999999   788899999999875


Q ss_pred             ccCCCCcccc---ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCC
Q psy15039        161 PFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGAT  235 (622)
Q Consensus       161 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~  235 (622)
                      ..........   .......+|+.|+|||++.+.  .++.++|||||||++|+|++|+.||......  ......+.   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---  231 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---  231 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh---
Confidence            4432221110   112244668899999999753  5889999999999999999999999753211  00000000   


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhc---cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQ---VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                 .....   ......+++++.+++..||+.||++||++.++++
T Consensus       232 ---------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          232 ---------------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ---------------------------HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ---------------------------cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                       00000   0112457899999999999999999999999887

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=339.18  Aligned_cols=260  Identities=19%  Similarity=0.376  Sum_probs=202.4

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .-..++|++.+.||+  |+||.||+|+++.   .||+|+++.........+.+.+|+.+|++++||||+++++++.+...
T Consensus        29 ~i~~~~~~~~~~lg~--G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           29 DIPFEQLEIGELIGK--GRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             SSCCSCEECCCBCCC--SSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cCCHHHeEEeeEecc--CCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            334579999999999  7788999999864   49999998765444444567789999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+++.|||.......
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            999999999999999986642 3588999999999999999999999999999999999998 68999999997543221


Q ss_pred             CCcc-ccccCCCCCCCccccChhhhccc-------cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        165 TKKK-VHLFPPSTAYNLNWLSPEVLEQN-------LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       165 ~~~~-~~~~~~~~~~~~~y~aPE~l~~~-------~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      .... .........+++.|+|||++...       ...|+.++|||||||++|+|++|..||..............+..|
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence            1110 00111223467789999998642       234788999999999999999999999876654443333322221


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .                               .....+++++.+++..||..||++|||+.++++.
T Consensus       262 ~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          262 N-------------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             C-------------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             C-------------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            1                               1123467889999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=357.60  Aligned_cols=251  Identities=19%  Similarity=0.339  Sum_probs=203.1

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++.+.||+  |+||.||+|+++.+ ..||||+++.....   .+.+.+|+++|++|+|||||++++++.+ ..+++
T Consensus       266 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~-~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQ--GCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTT-EEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hhhhhhheeccc--CCCeEEEEEEECCC-ceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            457999999999  78999999999864 57999999875543   2457899999999999999999999866 67999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||........  
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  416 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--  416 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH--
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC--
Confidence            999999999999997543335789999999999999999999999999999999999999999999999987544321  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                       .........++..|+|||++...  .|+.++|||||||++|||++ |..||.+......+.....+..           
T Consensus       417 -~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------  482 (535)
T 2h8h_A          417 -EYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  482 (535)
T ss_dssp             -HHHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             -ceecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence             11112233456789999998753  58999999999999999999 9999987654433322222110           


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                           ......+++++.+||..||+.||++|||+.++++.
T Consensus       483 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          483 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                 01223578899999999999999999999998864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.8e-40  Score=341.32  Aligned_cols=217  Identities=18%  Similarity=0.267  Sum_probs=181.9

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~  434 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++....... ...+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus        18 ~~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGK--GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             -CTTEEEEEEEEE--ETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             chHHcEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            4578999999999  789999999999999999999987432111 1245678999999988 89999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+.....
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999999998654  478999999999999999999999999999999999999999999999997653221


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ..    ....+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||...+..........+
T Consensus       174 ~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~  236 (353)
T 2i0e_A          174 DG----VTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH  236 (353)
T ss_dssp             TT----CCBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CC----cccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence            11    11234578999999999975  46899999999999999999999999887655544444443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=334.48  Aligned_cols=216  Identities=18%  Similarity=0.257  Sum_probs=184.0

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .+.++|++.+.||+  |+||.||+|+++.+++.+|+|.+...   ......+.+|+.+|+.++|||||++++++.+.+..
T Consensus         2 ~~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGR--GEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEec--CCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            35678999999999  88999999999999999999998743   23446788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCceEEcCcccccccC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFS  513 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~--~~~~~~~~~~~~~~~~  513 (622)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.  ++.+++.|||.+..+.
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999999999986542 35889999999999999999999999999999999999987  7899999999876543


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      .....     ....+|+.|+|||++.+  ..++.++|||||||++|||++|.+||...+....+.....+.
T Consensus       156 ~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  219 (321)
T 1tki_A          156 PGDNF-----RLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE  219 (321)
T ss_dssp             TTCEE-----EEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             CCCcc-----ccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC
Confidence            32211     12356888999999976  457899999999999999999999998876665554444443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=334.67  Aligned_cols=270  Identities=21%  Similarity=0.373  Sum_probs=204.0

Q ss_pred             CCCceEEeecccccCCceeEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~----~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      ..+|++++.||+  |+||.||+|+    +..+|+.||||++...  .....+.+.+|+.+|++++||||+++++++....
T Consensus        40 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGK--GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEEC--CSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHHceeeeeecc--CCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            457999999999  7799999999    5779999999999764  3455677899999999999999999999987654


Q ss_pred             --cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccc
Q psy15039         84 --DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  161 (622)
Q Consensus        84 --~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~  161 (622)
                        .+++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+..
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence              7899999999999999997643 3588999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      ......... ......++..|+|||++.+.  .++.++|||||||++|+|++|..||......  ..... +..+.. ..
T Consensus       195 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~~~~-~~~~~~-~~  267 (326)
T 2w1i_A          195 LPQDKEYYK-VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMI-GNDKQG-QM  267 (326)
T ss_dssp             CCSSCSEEE-CSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HHHHH-CTTCCT-HH
T ss_pred             ccccccccc-cccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HHHhh-ccccch-hh
Confidence            443322111 11223446679999998753  4788999999999999999999998643211  11111 100000 00


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                 ........+. ..........+++++.+++..||..||++|||+.++++
T Consensus       268 -----------~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 -----------IVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             -----------HHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----------hHHHHHHHhh-cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0000000000 00111223457899999999999999999999999886

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-39  Score=332.40  Aligned_cols=264  Identities=24%  Similarity=0.304  Sum_probs=202.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCC--CCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR--MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..|..++.||+  |+||.||+|++  +++.||||++....  ......+.+.+|+.+|++++||||+++++++.+.+..+
T Consensus        31 ~~~~~~~~lg~--G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  106 (307)
T 2nru_A           31 PISVGGNKMGE--GGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC  106 (307)
T ss_dssp             BTTTTCCEEEE--CSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cccccCCcccc--CCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceE
Confidence            34666799999  78999999987  58899999987543  23345677889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +||||+++|+|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||........
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence            9999999999999987543 235889999999999999999999999999999999999999999999999976543322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH---HHHHHHHhCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~---~~~~~~~~~~~p~~~~~~  242 (622)
                      ....  ......+|+.|+|||++.+   .++.++|||||||++|+|++|..||......   ..+...+....+.+.   
T Consensus       187 ~~~~--~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  258 (307)
T 2nru_A          187 AQTV--MTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIE---  258 (307)
T ss_dssp             SSCE--ECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHH---
T ss_pred             cccc--cccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhh---
Confidence            1111  1223456788999999864   3788999999999999999999999764321   111122211111100   


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                      .++...  ........++.+.+++..||+.||.+||++.+++++
T Consensus       259 ----------------~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          259 ----------------DYIDKK--MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             ----------------HHSCSS--CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------hhcccc--ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                            000000  000122346789999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=342.15  Aligned_cols=248  Identities=15%  Similarity=0.157  Sum_probs=193.3

Q ss_pred             CCCceEEeecccccCCceeEEEE-----EEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC---CCcceeEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLS-----KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNIICYISSF   79 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~-----~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~~~~~~   79 (622)
                      ..+|++.+.||+  |+||.||+|     .+..+++.||||+++...     ...+.+|+++++.|+   |+||+++++++
T Consensus        64 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           64 SKLVYVHHLLGE--GAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSEEEEEEEEEE--CSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CEEEEEEEEeec--cCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            467999999999  789999999     578899999999996542     234567888888776   99999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---------
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHF---NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---------  147 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---------  147 (622)
                      ...+..++|||||++|+|.+++....   ...+++..+..++.||+.||+|||++||+||||||+|||++.         
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence            99999999999999999999997532   235899999999999999999999999999999999999998         


Q ss_pred             --CCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHH
Q psy15039        148 --NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL  225 (622)
Q Consensus       148 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~  225 (622)
                        ++.++++|||.+..........  ......+|+.|+|||++.+.  .|+.++|||||||++|||++|+.||.......
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGT--IFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTE--EECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccCCEEEeeCchhhhhhccCCCc--eeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence              8999999999875432111111  11234678899999999763  58999999999999999999999995321100


Q ss_pred             HHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       226 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                                        .                .   ..........++.+.+++..||..+|.+|++..+.+.+.
T Consensus       293 ------------------~----------------~---~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          293 ------------------C----------------K---PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ------------------E----------------E---ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ------------------e----------------e---echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                              0                0   000011112467889999999999999997766655543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.2e-40  Score=338.44  Aligned_cols=257  Identities=17%  Similarity=0.260  Sum_probs=186.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEe-----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLD-----   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~-----   81 (622)
                      ..+|++.+.||+  |+||.||+|+++.+|+.||||++...  .....+.+.+|+.+|+++. ||||+++++++..     
T Consensus        27 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           27 ELRLRVRRVLAE--GGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TEEEEEEEEEEC--CSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             CceEEEEEEEcc--CCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            458999999999  77999999999999999999998554  3455677889999999996 9999999999953     


Q ss_pred             ---CCcEEEEeecCCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCceEEcC
Q psy15039         82 ---ATDLHLVSPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        82 ---~~~~~lv~e~~~~g~l~~~l~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                         ...++++|||+. |+|.+++.... ...+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+++.|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence               234899999997 78888886532 335899999999999999999999999  99999999999999999999999


Q ss_pred             CccccccCCCCccc--------cccCCCCCCCccccChhhhcc-ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH
Q psy15039        156 LRYMCPFSPTKKKV--------HLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  226 (622)
Q Consensus       156 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~l~~-~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~  226 (622)
                      ||............        ........+|+.|+|||++.. ....++.++|||||||++|+|++|+.||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            99875543221110        001113346788999999832 224578899999999999999999999965322111


Q ss_pred             HHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcc
Q psy15039        227 LIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF  304 (622)
Q Consensus       227 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~  304 (622)
                      .    .+.                               .........++.+.+|+..||+.||.+||++.++++|-.
T Consensus       262 ~----~~~-------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          262 V----NGK-------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             h----cCc-------------------------------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            0    000                               011122345677999999999999999999999999853

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.6e-40  Score=340.45  Aligned_cols=214  Identities=19%  Similarity=0.293  Sum_probs=182.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++....... ...+.+.+|+.+|+.++|||||++++++.+...+
T Consensus        39 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           39 QLDQFDRIKTLGT--GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHCEEEEEeec--CcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            3467999999999  889999999999999999999986432111 1245788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+......
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999999998754  4789999999999999999999999999999999999999999999999986544321


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                             ..+.+||+.|+|||++.+  ..|+.++|||||||++|||++|++||...+..........+
T Consensus       195 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  253 (350)
T 1rdq_E          195 -------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG  253 (350)
T ss_dssp             -------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             -------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC
Confidence                   123567899999999976  46899999999999999999999999887655544444444

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-39  Score=334.23  Aligned_cols=257  Identities=21%  Similarity=0.354  Sum_probs=189.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHh--hCCCCcceeEEEEEEeC--
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR--HLRHPNIICYISSFLDA--   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~--~l~HpnIv~~~~~~~~~--   82 (622)
                      +.++|++.+.||+  |+||.||+|+++  |+.||||++....   .  ....+|.+++.  .++||||+++++++...  
T Consensus        35 ~~~~y~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~~---~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           35 IAKQIQMVKQIGK--GRYGEVWMGKWR--GEKVAVKVFFTTE---E--ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHHCEEEEEEEE--ETTEEEEEEEET--TEEEEEEEEEGGG---H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccceEEEeEeec--CCCeEEEEEEEC--CceEEEEEEeccc---c--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3468999999999  779999999886  8999999985432   2  22334555554  45999999999999887  


Q ss_pred             --CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEEcCCCceE
Q psy15039         83 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK--------GFIHRAVKASHILISHNGKAC  152 (622)
Q Consensus        83 --~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--------~IvHrDiKp~NiLl~~~~~~~  152 (622)
                        ..+++||||+++|+|.++++..   .+++..+..++.|++.||+|||++        ||+||||||+|||++.++.++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence              6799999999999999999663   488999999999999999999999        999999999999999999999


Q ss_pred             EcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCC------cchHHHHHHHHHHHhcC----------CC
Q psy15039        153 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE------RSDIYSVGISCCELANG----------TV  216 (622)
Q Consensus       153 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~------~~DiWSlG~il~el~~g----------~~  216 (622)
                      +.|||....................+|+.|+|||++.+.  .++.      ++|||||||++|||++|          ..
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999998755443322222222344678899999999754  2333      38999999999999999          56


Q ss_pred             CCCCCch----HHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCC
Q psy15039        217 PFAETPT----TLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK  292 (622)
Q Consensus       217 Pf~~~~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  292 (622)
                      ||.....    .......+....                         .............+++++.+|+..||+.||.+
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  315 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKK-------------------------LRPSFPNRWSSDECLRQMGKLMTECWAHNPAS  315 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSC-------------------------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred             cHhhhcCCCCchhhhHHHHhhhc-------------------------cCccccccchhhHHHHHHHHHHHHhhhhChhh
Confidence            6643211    111111110000                         00000001112346778999999999999999


Q ss_pred             CcCHHhhhcC
Q psy15039        293 RPLACNLLQH  302 (622)
Q Consensus       293 Rps~~~~l~h  302 (622)
                      |||+.++++|
T Consensus       316 Rps~~ell~~  325 (337)
T 3mdy_A          316 RLTALRVKKT  325 (337)
T ss_dssp             SCCHHHHHHH
T ss_pred             CCCHHHHHHH
Confidence            9999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-39  Score=341.58  Aligned_cols=217  Identities=21%  Similarity=0.322  Sum_probs=175.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHH-HhhCCCCccceeEEEEEeCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVC-MRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~-l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ..++|++.+.||+  |+||.||+|+++.+++.||||++...... ......+.+|..+ ++.++|||||+++++|.+.+.
T Consensus        36 ~~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           36 KPSDFHFLKVIGK--GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             CGGGEEEEEEEEC--CTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             ChhheEEEEEEee--CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            3567999999999  88999999999999999999999765433 2334567778776 577899999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+.....
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999999987654  468889999999999999999999999999999999999999999999997653221


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ..    ....+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||...+........+.+
T Consensus       192 ~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~  254 (373)
T 2r5t_A          192 HN----STTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK  254 (373)
T ss_dssp             CC----CCCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS
T ss_pred             CC----CccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence            11    12234578999999999976  46899999999999999999999999887655544444443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=340.71  Aligned_cols=205  Identities=20%  Similarity=0.396  Sum_probs=176.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||+|++....... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus        14 ~~~y~i~~~LG~--G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           14 FDHFEILRAIGK--GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             GGGEEEEEEEEC--CTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999  889999999999999999999986432111 12467889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+.......
T Consensus        92 lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            9999999999999987643  47899999999999999999999999999999999999999999999999876443221


Q ss_pred             CceeccCCCCCCCCccccccccccC-ccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                           ...+.+||+.|+|||++... ...|+.++|||||||++|||++|++||...
T Consensus       170 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          170 -----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             -----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             -----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence                 12345688999999999642 235889999999999999999999999743

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9e-40  Score=349.23  Aligned_cols=219  Identities=20%  Similarity=0.273  Sum_probs=182.3

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ...++|++.+.||+  |+||.||+|+++.+++.||+|++....... .....+.+|+.+++.++|||||+++++|.+.+.
T Consensus        71 ~~~~~y~~~~~LG~--G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           71 LHREDFEILKVIGR--GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             CCGGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEEe--CCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            34578999999999  889999999999999999999986421111 012237889999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+|||||++|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.++|+|||.+.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            999999999999999997632 3588999999999999999999999999999999999999999999999998654433


Q ss_pred             CCCceeccCCCCCCCCcccccccccc---CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ....   .....+||+.|||||++..   +...|+.++|||||||++|||++|++||...+.......+
T Consensus       228 ~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          228 DGTV---QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             TSCE---ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             CCCc---ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            2211   1233578999999999962   1245899999999999999999999999887665554443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.2e-40  Score=347.83  Aligned_cols=218  Identities=23%  Similarity=0.333  Sum_probs=181.1

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ...++|++.+.||+  |+||.||+|+++.+++.||+|++....... .....+.+|+.+++.++|||||+++++|.+...
T Consensus        66 ~~~~~y~~~~~LG~--G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           66 MKAEDYEVVKVIGR--GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             CCGGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEc--CCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            34578999999999  889999999999999999999986421100 012347799999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+|||||++|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|.|||.+.....
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            99999999999999998753   478999999999999999999999999999999999999999999999998754433


Q ss_pred             CCCceeccCCCCCCCCccccccccccCcc--CCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLD--GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ...   ....+.+||+.|||||++.....  .|+.++|||||||++|||++|++||...+.......++
T Consensus       221 ~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  286 (410)
T 3v8s_A          221 EGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  286 (410)
T ss_dssp             TSE---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CCc---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence            211   11234678999999999965321  27889999999999999999999998876555444433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=345.38  Aligned_cols=219  Identities=21%  Similarity=0.279  Sum_probs=182.9

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++...... ....+.+.+|..++..++|||||+++++|.+.+.+
T Consensus        59 ~~~~f~~~~~lG~--G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGR--GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            4578999999999  88999999999999999999998642211 11234578999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.++++|||.+......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999999999997653 25789999999999999999999999999999999999999999999999987554332


Q ss_pred             CCceeccCCCCCCCCccccccccccC-----ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQN-----LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ...   .....+||+.|||||++...     ...|+.++|||||||++|||++|++||...+.......++
T Consensus       216 ~~~---~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          216 GTV---RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             SCE---ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             Ccc---ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            211   12235789999999999631     1358999999999999999999999998876655444433

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.4e-39  Score=330.69  Aligned_cols=217  Identities=19%  Similarity=0.313  Sum_probs=174.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMT--DEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ..++|++.+.||+  |+||.||++++.   .+|+.||+|++......  ......+.+|+.+|+.++|||||++++++..
T Consensus        15 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           15 RPECFELLRVLGK--GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CGGGEEEEEEEEE--ETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CHHHeEEEEEEEe--CCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            3567999999999  789999999985   68999999999765432  2234567899999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                      .+..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+..
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999999987653  468888999999999999999999999999999999999999999999997643


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .....    .......||+.|+|||++.+  ..++.++|||||||++|||++|++||...+....+......
T Consensus       171 ~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  236 (327)
T 3a62_A          171 SIHDG----TVTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC  236 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred             cccCC----ccccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            22111    11234567899999999975  46899999999999999999999999887665554444443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.4e-39  Score=336.79  Aligned_cols=249  Identities=18%  Similarity=0.268  Sum_probs=194.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc-------cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK-------VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF  429 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~  429 (622)
                      .++|++.+.||+  |+||.||+|++.       .++..||||++... ......+.+.+|+.+|+.+ +|||||++++++
T Consensus        80 ~~~~~~~~~LG~--G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGE--GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESC--CSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHHCEeeeEEee--CCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            467999999999  889999999975       35668999998654 3455677899999999999 899999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  495 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl  495 (622)
                      ...+.+|+||||+++|+|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            999999999999999999999986432              246888899999999999999999999999999999999


Q ss_pred             cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcH
Q psy15039        496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  574 (622)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~  574 (622)
                      +.++.+++.|||.+.........  .......+|+.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             CCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999987544322111  11123345778999999975  468999999999999999999 99999887766


Q ss_pred             HHHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhh
Q psy15039        575 LMLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       575 ~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      ........+..+.... ++....+....|...+..++.+-
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  352 (370)
T 2psq_A          313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF  352 (370)
T ss_dssp             GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            5544444444433332 33333334444444444444443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-38  Score=356.47  Aligned_cols=253  Identities=17%  Similarity=0.301  Sum_probs=202.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .++|++++.||+  |+||.||+|.++.+   +..||||.+.... .+...+.+.+|+.+|++++|||||++++++. .+.
T Consensus       389 ~~~y~i~~~LG~--G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          389 RERIELGRCIGE--GQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             GGGEEEEEEEEC--CSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             cccEEEeeEEee--CCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            457999999999  77889999998654   5679999986543 4555678899999999999999999999984 467


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            899999999999999997643 3588999999999999999999999999999999999999999999999998755432


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      ....   ......+++.|+|||++.+  ..|+.++|||||||++|||++ |..||.+............+..+       
T Consensus       544 ~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-------  611 (656)
T 2j0j_A          544 STYY---KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------  611 (656)
T ss_dssp             -------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-------
T ss_pred             Ccce---eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            2111   1112344678999999975  368999999999999999997 99999876654443333222211       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                               ..+..+++++.+++..||..||.+||++.++++.
T Consensus       612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                     1123568899999999999999999999998864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.7e-39  Score=329.67  Aligned_cols=215  Identities=20%  Similarity=0.311  Sum_probs=182.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      +.+.|++.+.||+  |+||.||+|+++.+|+.||+|++.......    ...+.+.+|+.+|+.++|||||++++++.+.
T Consensus         9 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            9 VDDYYDTGEELGS--GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             HHHHEEEEEEEEC--CSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cccceEeceEEee--CCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3456999999999  889999999999999999999997654321    1246788999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----ceEEcCccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLRY  508 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~----~~~~~~~~~  508 (622)
                      ...++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++    .+++.|||.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999998754  3578999999999999999999999999999999999999887    799999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      +........     .....+|+.|+|||++..  ..|+.++|||||||++|||++|.+||...+....+.....
T Consensus       165 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  231 (326)
T 2y0a_A          165 AHKIDFGNE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA  231 (326)
T ss_dssp             CEECCTTSC-----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred             CeECCCCCc-----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence            755432211     123567889999999965  4689999999999999999999999988766555444433

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-39  Score=331.69  Aligned_cols=223  Identities=22%  Similarity=0.305  Sum_probs=181.3

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..+.+.|++.+.||+  |+||.||+|++..+++.||||++...... ......+.+|+.+++.++|||||++++++....
T Consensus         8 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            8 SHLSDRYELGEILGF--GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             SEETTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             ceecCcEEEEEEEcc--CCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            445678999999999  88999999999999999999999865433 344678899999999999999999999988765


Q ss_pred             c----EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        434 D----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       434 ~----~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                      .    .|+||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            4    499999999999999997653  4789999999999999999999999999999999999999999999999986


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      .......... .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||................
T Consensus       164 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~  235 (311)
T 3ork_A          164 RAIADSGNSV-TQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED  235 (311)
T ss_dssp             -------------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred             cccccccccc-ccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence            5443322111 11223457889999999975  468999999999999999999999998887766655555553

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-38  Score=323.87  Aligned_cols=209  Identities=23%  Similarity=0.357  Sum_probs=176.1

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++.+.||+  |+||.||+|+++.+++.||||++..........+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGE--GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecC--CCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            47999999999  8899999999999999999999987665555567889999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||+++ ++.+.+... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........ 
T Consensus        80 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             EECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred             EecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence            999986 555555443 23588999999999999999999999999999999999999999999999998755432211 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  576 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~  576 (622)
                         ......+|+.|+|||++.+. ..|+.++|||||||++|||++|..||........
T Consensus       157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~  210 (292)
T 3o0g_A          157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD  210 (292)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred             ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence               12334678899999999653 3489999999999999999998888654444433

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-38  Score=321.09  Aligned_cols=230  Identities=13%  Similarity=0.156  Sum_probs=184.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      +..+|++.+.||+  |+||.||+|+++.+|+.||||++..... .+...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~~y~i~~~lg~--G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGG--VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTTTEEEEEEEEB--STTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ecCcEEEEEEEcc--cCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            4578999999999  7788999999999999999999987654 355667889999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+||||+++++|.++++.    +..+..+..++.||+.||+|||++||+||||||+|||++.+|.+++.+.         
T Consensus       107 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~---------  173 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---------  173 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC---------
T ss_pred             EEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec---------
Confidence            999999999999999854    2345667889999999999999999999999999999999998877521         


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                                     .|++|         ++.++|||||||++|+|++|+.||.+......           + ...   
T Consensus       174 ---------------~~~~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-----------~-~~~---  214 (286)
T 3uqc_A          174 ---------------ATMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-----------L-APA---  214 (286)
T ss_dssp             ---------------CCCTT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-----------S-EEC---
T ss_pred             ---------------cccCC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-----------h-HHH---
Confidence                           23443         67899999999999999999999975432100           0 000   


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .....  ..         ..........+++++.+++.+||+.||++| |+.++++.
T Consensus       215 ~~~~~--~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          215 ERDTA--GQ---------PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             CBCTT--SC---------BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHhc--cC---------CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            00000  00         000001124578999999999999999999 99999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.9e-39  Score=351.02  Aligned_cols=220  Identities=22%  Similarity=0.330  Sum_probs=183.9

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++....... .....+.+|+.+|+.++|||||+++++|.+...+
T Consensus       183 ~~~~f~~~~~LG~--G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          183 GEDWFLDFRVLGR--GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEee--CCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            4567999999999  889999999999999999999986432111 1135688999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        436 HLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      |+||||+++|+|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+..+.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999999987643  3358899999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC---cHHHHHHHHcCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP---TTLMLIEKLAGA  584 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~---~~~~~~~~~~~~  584 (622)
                      .....    ..+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||....   ....+...+...
T Consensus       341 ~~~~~----~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~  408 (543)
T 3c4z_A          341 AGQTK----TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ  408 (543)
T ss_dssp             TTCCC----BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred             CCCcc----cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence            32211    123478999999999976  468999999999999999999999997653   234444444433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-39  Score=336.18  Aligned_cols=206  Identities=23%  Similarity=0.390  Sum_probs=174.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      .+.|++.+.||+  |+||.||+|+++.+|+.||||++.....   .....+.+.+|+.+++.++|||||++++++.+.+.
T Consensus        23 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           23 EDVYELCEVIGK--GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             HHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEEeeEEee--CCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            456999999999  8899999999999999999999863211   11124578899999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---eEEcCcccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLRYM  509 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~---~~~~~~~~~  509 (622)
                      +|+||||+++|+|.+.+....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.   +++.|||.+
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999999998775432  334789999999999999999999999999999999999987664   999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ........    ......+|+.|+|||++.+  ..|+.++|||||||++|||++|++||...
T Consensus       181 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          181 IQLGESGL----VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             EECCTTSC----BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             eEecCCCe----eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            65443221    1234568899999999976  46899999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.7e-39  Score=327.48  Aligned_cols=215  Identities=23%  Similarity=0.366  Sum_probs=177.6

Q ss_pred             ccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       353 ~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ....+.++|++.+.||+  |+||.||+|++. +|+.||+|++..........+.+.+|+.+++.++|||||++++++.+.
T Consensus        15 ~~q~l~~~y~~~~~lG~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGE--GTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             CEECSSCEEEEEEEEEE--CSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             eecchHhhhHhhhhccC--CCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            34456788999999999  889999999996 599999999976554444457789999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  512 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~  512 (622)
                      +..++||||+++ ++.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+...
T Consensus        92 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           92 RCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             SCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             CEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            999999999995 7888776543 35889999999999999999999999999999999999999999999999987654


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ......    .....+|+.|+|||++.+. ..|+.++|||||||++|||++|++||........+
T Consensus       170 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  229 (311)
T 3niz_A          170 GIPVRS----YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL  229 (311)
T ss_dssp             TSCCC-------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH
T ss_pred             CCCccc----ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            322211    1234568889999998653 35899999999999999999999999876655443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-39  Score=337.89  Aligned_cols=217  Identities=22%  Similarity=0.305  Sum_probs=173.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCccceeEEEEEeCC--
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDAT--  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~--  433 (622)
                      +.++|++.+.||+  |+||.||+|.++.+|+.||||++..........+++.+|+.+|+.+. |||||++++++...+  
T Consensus         7 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            7 VLRKYELVKKLGK--GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHTTEEEEEC---------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             ccCceEEEEEeee--CCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            3568999999999  78999999999999999999999766666677788999999999997 999999999998654  


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      .+|+|||||+ |+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+..+.
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            6899999998 5898888763   47888899999999999999999999999999999999999999999999875443


Q ss_pred             CCCCc-----------------eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH
Q psy15039        514 PTKKK-----------------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM  576 (622)
Q Consensus       514 ~~~~~-----------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~  576 (622)
                      .....                 ........++|+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            21100                 01112335689999999999653 4689999999999999999999999998877665


Q ss_pred             HHHH
Q psy15039        577 LIEK  580 (622)
Q Consensus       577 ~~~~  580 (622)
                      +...
T Consensus       240 ~~~i  243 (388)
T 3oz6_A          240 LERI  243 (388)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            5443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.3e-39  Score=331.13  Aligned_cols=274  Identities=19%  Similarity=0.275  Sum_probs=188.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-----   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----   82 (622)
                      .++|++++.||+  |+||.||+|++  +|+.||||+++...   .......+|+..++.++||||+++++.+...     
T Consensus        12 ~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGR--GRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEE--CSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeeccc--CCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            468999999999  77999999976  68999999986532   2222233556566679999999999866532     


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCEEEcCCCceEE
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK---------GFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---------~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                      ..+++|||||++|+|.+++...   ..++..+..++.||+.||+|||++         ||+||||||+|||++.++.+++
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             ceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            2578999999999999999763   357888999999999999999999         9999999999999999999999


Q ss_pred             cCCccccccCCCCcc----ccccCCCCCCCccccChhhhcccc-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCchH
Q psy15039        154 SGLRYMCPFSPTKKK----VHLFPPSTAYNLNWLSPEVLEQNL-----DGYDERSDIYSVGISCCELANGTVPFAETPTT  224 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~l~~~~-----~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~  224 (622)
                      .|||.+.........    .........+|+.|+|||++.+..     ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            999987544322110    011122346788999999986521     23557899999999999999998776532110


Q ss_pred             ---HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        225 ---LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       225 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                         ........+..|...+..........   ..    .+   ..........++++.+||..||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQ---RP----KF---PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCC---CC----CC---CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhccccc---CC----CC---CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence               00000001111100000000000000   00    00   0000111235668999999999999999999999965

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.7e-39  Score=327.09  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=189.2

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...++|++.+.||+  |+||.||+|++  +|+.||||++..........+.+.+|+.+++.++|||||++++++...+..
T Consensus        34 i~~~~y~i~~~lG~--G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           34 IPWCDLNIKEKIGA--GSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             CCGGGEEEEEEEEE--CSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             CChhHceeeeEeec--CCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            34568999999999  88999999976  588999999987777777778899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~~qi~~gL~ylH~~~--iiHRDlKp~NILl~~~~~~~~~~~~~~~~~  512 (622)
                      ++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+++.|||.+...
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999875321 13788899999999999999999999  999999999999999999999999976432


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH-cCCCCCCCC-
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLD-  590 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~-~~~~p~~~~-  590 (622)
                      ...    ........+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...+......... ....+.+.+ 
T Consensus       190 ~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 3p86_A          190 AST----FLSSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN  263 (309)
T ss_dssp             ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             ccc----ccccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            211    111234567889999999976  458899999999999999999999998876655544432 223232222 


Q ss_pred             CCcccccCCCCcCcccccchhhh
Q psy15039        591 CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       591 ~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      .+..+.+....+...+..++++-
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rps~  286 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRPSF  286 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHccCChhhCcCH
Confidence            22233333344444444444443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-38  Score=322.42  Aligned_cols=212  Identities=24%  Similarity=0.366  Sum_probs=176.0

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++.+.||+  |+||.||+|++ .+|+.||+|++..........+.+.+|+.+++.++|||||++++++...+..++|
T Consensus         2 ~~y~~~~~lg~--G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGE--GTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEE--ETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhccc--CCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47999999999  78999999999 6799999999976543333346788999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.........
T Consensus        79 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            999995 8988887542 35789999999999999999999999999999999999999999999999986544322111


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                          .....+|+.|+|||++.+. ..++.++|||||||++|||++|++||...+....+...
T Consensus       157 ----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  213 (288)
T 1ob3_A          157 ----YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI  213 (288)
T ss_dssp             ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ----cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                1234568889999999643 35899999999999999999999999887766555443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.9e-38  Score=317.65  Aligned_cols=217  Identities=27%  Similarity=0.373  Sum_probs=187.7

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .+.++|++.+.||+  |+||.||+|.++.+|+.||+|++.....+....+.+.+|+.+++.++||||+++++++...+..
T Consensus         3 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            3 KFSDNYDVKEELGK--GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhhcC--cCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            45688999999999  7899999999999999999999987777777778899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---eEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~---~~~~~~~~~~~~  512 (622)
                      ++||||+++++|.+.+....  .+++..+..++.|++.||+|||++||+||||||+||+++.++.   +++.|||.+...
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999999998887653  4789999999999999999999999999999999999987665   999999987544


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .....     .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||..............+
T Consensus       159 ~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  222 (284)
T 3kk8_A          159 NDSEA-----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  222 (284)
T ss_dssp             CSSCB-----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ccCcc-----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc
Confidence            33211     123567889999999976  46899999999999999999999999887666554444444

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.8e-39  Score=335.73  Aligned_cols=204  Identities=24%  Similarity=0.343  Sum_probs=173.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|++..+++.||||++........ ....+.+|+.+++.++|||||++++++.+.+..
T Consensus         7 ~i~~Y~i~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            7 HIGPYIIRETLGE--GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             EETTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccCCEEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3568999999999  7899999999999999999999864321111 124688999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+ +|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999999 689999887653  4789999999999999999999999999999999999999999999999976543322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGY-DERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      .     .....+||+.|+|||++.+.  .+ +.++|||||||++|+|++|++||....
T Consensus       162 ~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~  212 (336)
T 3h4j_B          162 N-----FLKTSCGSPNYAAPEVINGK--LYAGPEVDVWSCGIVLYVMLVGRLPFDDEF  212 (336)
T ss_dssp             B-----TTCCCTTSTTTSCGGGSCCS--GGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred             c-----ccccccCCcCcCCHHHHcCC--CCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence            1     12345688999999999753  34 689999999999999999999997653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.2e-38  Score=328.55  Aligned_cols=218  Identities=28%  Similarity=0.488  Sum_probs=185.3

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ..|++.+.||+  |+||.||+|++..+|+.||||++....... ...+.+.+|+.+++.++|||||++++++...+..++
T Consensus        54 ~~y~~~~~lG~--G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeeEEcc--CCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            45899999999  889999999999999999999998664433 445788999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+. |++.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......  
T Consensus       132 v~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            999998 68888876543 35789999999999999999999999999999999999999999999999976543221  


Q ss_pred             ceeccCCCCCCCCcccccccccc-CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                            ....+|+.|+|||++.. ....|+.++|||||||++|||++|++||...+....+.....+..|.+
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  273 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL  273 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence                  23467889999999852 124689999999999999999999999988877766666666655544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-38  Score=330.31  Aligned_cols=256  Identities=21%  Similarity=0.342  Sum_probs=197.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh--CCCCcceeEEEEEEeCC--
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH--LRHPNIICYISSFLDAT--   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~~~~~~~~~~--   83 (622)
                      .++|++.+.||+  |+||.||+|++  +|+.||||+++..     ....+.+|+++++.  ++||||+++++++....  
T Consensus        41 ~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           41 ARTIVLQESIGK--GRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHCEEEEEEEE--ETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccEEEEeeecC--CCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            358999999999  77899999998  5899999998543     23456788888887  79999999999998876  


Q ss_pred             --cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEEcCCCceEE
Q psy15039         84 --DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--------GKGFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        84 --~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH--------~~~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                        .+++||||+++|+|.+++...   .+++..+..++.|++.||.|||        ++||+||||||+|||++.++.+++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence              799999999999999999753   4789999999999999999999        899999999999999999999999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccC----CCCCcchHHHHHHHHHHHhcC----------CCCCC
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVGISCCELANG----------TVPFA  219 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~----~~~~~~DiWSlG~il~el~~g----------~~Pf~  219 (622)
                      .|||....................+|+.|+|||++.+...    .++.++|||||||++|+|++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999875443322222112234467889999999975321    122689999999999999999          77886


Q ss_pred             CCch----HHHHHHHHhCC--CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCC
Q psy15039        220 ETPT----TLMLIEKLAGA--TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR  293 (622)
Q Consensus       220 ~~~~----~~~~~~~~~~~--~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  293 (622)
                      ....    .......+...  .|.++                           ........++.+.+|+..||+.||++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNIP---------------------------NRWQSCEALRVMAKIMRECWYANGAAR  321 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCC---------------------------GGGGTSHHHHHHHHHHHHHCCSSGGGS
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCCc---------------------------ccccchhHHHHHHHHHHHHhccChhhC
Confidence            5321    12222222110  00000                           001122345689999999999999999


Q ss_pred             cCHHhhhcC
Q psy15039        294 PLACNLLQH  302 (622)
Q Consensus       294 ps~~~~l~h  302 (622)
                      ||+.++++|
T Consensus       322 ps~~~i~~~  330 (342)
T 1b6c_B          322 LTALRIKKT  330 (342)
T ss_dssp             CCHHHHHHH
T ss_pred             CCHHHHHHH
Confidence            999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-39  Score=351.35  Aligned_cols=219  Identities=19%  Similarity=0.296  Sum_probs=184.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++....... .....+.+|+.+|+.++|||||++++++.+.+.+
T Consensus       182 ~~~~f~~~~~LG~--G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          182 TKNTFRQYRVLGK--GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CGGGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            4567999999999  789999999999999999999986432111 1134678999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.+|.+++.|||.+......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999988655556899999999999999999999999999999999999999999999999987654332


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC---cHHHHHHHHcCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP---TTLMLIEKLAGA  584 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~---~~~~~~~~~~~~  584 (622)
                      ..     ..+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||....   ....+...+...
T Consensus       340 ~~-----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~  404 (576)
T 2acx_A          340 QT-----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV  404 (576)
T ss_dssp             CC-----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC
T ss_pred             cc-----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc
Confidence            21     123478999999999976  468999999999999999999999998753   233444444443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-38  Score=332.30  Aligned_cols=215  Identities=20%  Similarity=0.323  Sum_probs=182.3

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.+.|++.+.||+  |+||.||+|.++.+|+.||+|++....  ......+.+|+.+|+.++|||||++++++.+....+
T Consensus        49 ~~~~y~i~~~LG~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  124 (387)
T 1kob_A           49 VYDYYDILEELGS--GAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  124 (387)
T ss_dssp             GGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEec--CCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence            4568999999999  789999999999999999999987542  334567899999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCceEEcCcccccccCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSP  514 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~--~~~~~~~~~~~~~~~~~  514 (622)
                      +||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.  ++.+++.|||.+.....
T Consensus       125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999999988653 235789999999999999999999999999999999999974  46799999998765433


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ....     ....+|+.|+|||++.+  ..++.++|||||||++|||++|++||...+....+......
T Consensus       204 ~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~  265 (387)
T 1kob_A          204 DEIV-----KVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC  265 (387)
T ss_dssp             TSCE-----EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred             Ccce-----eeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            2211     12357889999999975  46899999999999999999999999887665554444433

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=328.60  Aligned_cols=250  Identities=18%  Similarity=0.275  Sum_probs=194.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcE---EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL---IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~---vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      .+.|++.+.||+  |+||.||+|++..+++.   ||||++... ......+.+.+|+.+++.++|||||++++++.+.+.
T Consensus        48 ~~~y~i~~~lG~--G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGS--GDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEE--TTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEe--CCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            467999999999  88999999999876654   999998754 345556789999999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999997543 3578999999999999999999999999999999999999999999999998765443


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCC-CCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLL-DCT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~-~~~  592 (622)
                      ..... .......+|+.|+|||++.+  ..++.++|||||||++|||++ |..||..............+..++.. .++
T Consensus       204 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          204 DPDAA-YTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             ---CC-EECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             Cccce-eeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            22111 11223445778999999975  468999999999999999999 99999887766655544444333322 233


Q ss_pred             cccccCCCCcCcccccchhhhh
Q psy15039        593 TYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ....+....+...+..++.+-.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~  302 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFS  302 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHccCChhhCcCHH
Confidence            3333444444444444444443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-38  Score=327.60  Aligned_cols=213  Identities=25%  Similarity=0.351  Sum_probs=166.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||+|++..... ....+.+.+|+.+++.++|||||++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGN--GTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             -----------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECC--CCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            467999999999  7899999999999999999999875432 2223567899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        438 VSPLMGFGSCKDLINAHF----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ||||++ |+|.+++....    ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+..+.
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999999 69999886542    1347899999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      ....    ......+|+.|+|||++.+. ..|+.++|||||||++|||++|++||...+....+..
T Consensus       160 ~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  220 (317)
T 2pmi_A          160 IPVN----TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL  220 (317)
T ss_dssp             SCCC----CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCcc----cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            2211    12234678899999999643 3589999999999999999999999988876655433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.1e-38  Score=339.74  Aligned_cols=259  Identities=19%  Similarity=0.230  Sum_probs=200.8

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCC-cceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP-NIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~~~~~~~~~~~   84 (622)
                      .+.++|++++.||+  |+||.||+|+++.+|+.||||+++.....    ..+.+|+.+++.|+|+ +|..+..++...+.
T Consensus         4 ~i~~~y~i~~~LG~--G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            4 RVGNKFRLGRKIGS--GSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             EETTTEECCCCCEE--CSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             CcCCcEEEEEEEee--CCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            45689999999999  77899999999999999999998765432    2366899999999884 55566666677888


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl---~~~~~~~i~~~~~~~~  161 (622)
                      .++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||   +.++.+++.|||....
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            99999999 899999997543 358999999999999999999999999999999999999   5788999999998754


Q ss_pred             cCCCCccc---cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHHHhCCCC
Q psy15039        162 FSPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATP  236 (622)
Q Consensus       162 ~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~~~~~~p  236 (622)
                      ........   ........+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||.....  ....+..+.... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-  232 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-  232 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-
Confidence            43322111   111224567889999999975  3588999999999999999999999986432  122222111000 


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              +.  .........+++++.+|+..||..||++||++.++++
T Consensus       233 ------------------------~~--~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          233 ------------------------VA--TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             ------------------------HH--SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ------------------------cc--ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                    00  0000011357899999999999999999999998765

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8e-39  Score=344.83  Aligned_cols=216  Identities=19%  Similarity=0.282  Sum_probs=173.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||++..... .......+.+|+.+++.++|||||++++++...+.++
T Consensus       147 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          147 MNEFEYLKLLGK--GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             hHHcEEeEEEee--CcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            467999999999  7899999999999999999999874321 2233467789999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      +|||||++|+|.+++....  .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.++|.|||.+......
T Consensus       225 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999999987653  47899999999999999999998 99999999999999999999999999976432221


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .    ......+||+.|||||++.+  ..|+.++|||||||++|||++|++||...+...........
T Consensus       303 ~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  364 (446)
T 4ejn_A          303 G----ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME  364 (446)
T ss_dssp             --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             C----cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence            1    11234578999999999965  46899999999999999999999999887655544333333

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9e-39  Score=329.45  Aligned_cols=210  Identities=21%  Similarity=0.382  Sum_probs=175.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..++|++.+.||+  |+||.||+|+++.+++.||||++...... ...+.+.+|+.+++.++|||||++++++.+.+..+
T Consensus         5 ~~~~y~i~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEec--CCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            4578999999999  78999999999999999999998755332 22356889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+..+....
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999999987653  347899999999999999999999999999999999999999999999999865432211


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                        .........||+.|+|||++.+. ..++.++|||||||++|||++|+.||......
T Consensus       160 --~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  214 (323)
T 3tki_A          160 --RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS  214 (323)
T ss_dssp             --EECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred             --cccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence              11112345688999999999753 22477899999999999999999999866554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-38  Score=344.03  Aligned_cols=214  Identities=23%  Similarity=0.367  Sum_probs=180.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|.+.+.||+  |+||.||+|++..+|+.||||++....... .....+.+|+.+|+.++|||||++++++.+.+.++
T Consensus        15 ~~~Y~l~~~LG~--G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           15 IGHYILGDTLGV--GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             ETTEEEEEEEEC--CSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            568999999999  789999999999999999999986432111 12457889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        93 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999998754  347899999999999999999999999999999999999999999999999865443221


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                           ...+.+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+...........
T Consensus       171 -----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  229 (476)
T 2y94_A          171 -----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC  229 (476)
T ss_dssp             -----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred             -----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence                 12345688999999999753 223689999999999999999999998776555433333

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-38  Score=335.40  Aligned_cols=249  Identities=18%  Similarity=0.235  Sum_probs=195.3

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.||||++... ......+.+.+|+.+|+.++|||||++++++...+..++
T Consensus       113 ~~~~~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGR--GNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEecc--CCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            457999999999  78999999999999999999998643 345555678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||.+......  
T Consensus       190 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~--  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG--  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS--
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC--
Confidence            999999999999997643 24788889999999999999999999999999999999999999999999986543221  


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                      ..........+++.|+|||++..  ..|+.++|||||||++|||+| |..||...+..........+..++.++ ++...
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  344 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV  344 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            11111122334677999999975  458999999999999999998 999998876655444444444333333 33333


Q ss_pred             ccCCCCcCcccccchhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~  614 (622)
                      .+....|...++.++++-.
T Consensus       345 ~~li~~cl~~dP~~Rps~~  363 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFS  363 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHcCCCchhCcCHH
Confidence            3444444444555444433

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=323.30  Aligned_cols=210  Identities=20%  Similarity=0.367  Sum_probs=171.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH------------------------HHHHHHHHHHHH
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD------------------------EDLKSLHHEIVC  413 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~------------------------~~~~~~~~E~~~  413 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||||++.......                        ...+.+.+|+.+
T Consensus        12 ~~~y~~~~~lG~--G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           12 LNQYTLKDEIGK--GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             ETTEEEEEEEEC----CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             ecceEEEeEEee--cCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            467999999999  889999999999999999999997653211                        123568899999


Q ss_pred             HhhCCCCccceeEEEEEe--CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy15039        414 MRHLRHPNIICYISSFLD--ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS  491 (622)
Q Consensus       414 l~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~  491 (622)
                      |+.++||||+++++++.+  ....++||||+++++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            999999999999999987  4579999999999998875432   35889999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccC-CCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDG-YDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       492 NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      |||++.++.+++.|||.+..+......    .....+|+.|+|||++.+.... ++.++|||||||++|||++|+.||..
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDAL----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCE----ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HEEECCCCCEEEecCCCcccccccccc----ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999987654332211    1234678899999999753221 36789999999999999999999987


Q ss_pred             CCcHHH
Q psy15039        571 TPTTLM  576 (622)
Q Consensus       571 ~~~~~~  576 (622)
                      ......
T Consensus       243 ~~~~~~  248 (298)
T 2zv2_A          243 ERIMCL  248 (298)
T ss_dssp             SSHHHH
T ss_pred             ccHHHH
Confidence            755443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.6e-38  Score=338.48  Aligned_cols=211  Identities=21%  Similarity=0.342  Sum_probs=164.7

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC---
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA---  432 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~---  432 (622)
                      .+.++|++.+.||+  |+||.||+|+++.+|+.||||++..........+++.+|+.+|+.++|||||++++++...   
T Consensus        50 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           50 QIPDRYEIRHLIGT--GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CSCTTEEECCC---------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             ccCCCeEEeeEeee--cCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            45688999999999  7899999999999999999999977666666778899999999999999999999999544   


Q ss_pred             --CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        433 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       433 --~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                        ..+|+||||++ |+|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++.++.++|.|||.+.
T Consensus       128 ~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          128 KFDELYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cCceEEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence              46999999986 6898888753  347899999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCCCce-----------------------eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc----
Q psy15039        511 PFSPTKKKV-----------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN----  563 (622)
Q Consensus       511 ~~~~~~~~~-----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt----  563 (622)
                      .........                       .....+.++|+.|||||++... ..|+.++|||||||++|||++    
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccc
Confidence            543211100                       0112345679999999987433 468999999999999999999    


Q ss_pred             -------CCCCCCCCC
Q psy15039        564 -------GTVPFAETP  572 (622)
Q Consensus       564 -------g~~Pf~~~~  572 (622)
                             |++||.+..
T Consensus       284 ~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSS  299 (458)
T ss_dssp             TCSSGGGCCCSCC---
T ss_pred             cccccccccccCCCCc
Confidence                   778886653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=327.72  Aligned_cols=214  Identities=24%  Similarity=0.336  Sum_probs=170.6

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...+.|++.+.||+  |+||.||+|++..+++.||||++....    ..+.+.+|+.+|+.++|||||++++++...+..
T Consensus        50 ~~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  123 (349)
T 2w4o_A           50 ALSDFFEVESELGR--GATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI  123 (349)
T ss_dssp             CGGGTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccCcEEEeeEEee--CCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence            34577999999999  889999999999999999999987532    235678999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~---~~~~~~~~~~~~~~~  512 (622)
                      ++||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.   ++.+++.|||.+...
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999999987643  4789999999999999999999999999999999999976   789999999976543


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ...     .......+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||........+...+...
T Consensus       202 ~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~  266 (349)
T 2w4o_A          202 EHQ-----VLMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC  266 (349)
T ss_dssp             ----------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT
T ss_pred             Ccc-----cccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC
Confidence            221     11223467889999999975  468999999999999999999999998877766566655543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=333.36  Aligned_cols=250  Identities=18%  Similarity=0.255  Sum_probs=192.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEE-----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      .++|++.+.||+  |+||.||+|+     +..+++.||||++... ........+.+|+.+++.++|||||++++++...
T Consensus        70 ~~~~~~~~~LG~--G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           70 RKNITLIRGLGH--GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             GGGEEEEEECCC--CSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEeee--CCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            467999999999  8899999999     5667889999998643 3455556789999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFN-----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLS  504 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~  504 (622)
                      ...++||||+++|+|.+++.....     ..+++..++.++.||+.||+|||++||+||||||+|||++.+|   .+++.
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999999986532     2478889999999999999999999999999999999999655   49999


Q ss_pred             CcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcC
Q psy15039        505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~  583 (622)
                      |||.+........  ........+|+.|+|||++.+  ..|+.++|||||||++|||++ |.+||........+.....+
T Consensus       227 DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          227 DFGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             CCHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             CCccccccccccc--cccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9998653321110  111223456788999999976  468999999999999999998 99999888766655555555


Q ss_pred             CCCCCCC-CCcccccCCCCcCcccccchhhhh
Q psy15039        584 ATPHLLD-CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       584 ~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ..+.... ++..+.+....+...+..++++-.
T Consensus       303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            4333322 333344444444445555554433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.6e-38  Score=325.92  Aligned_cols=252  Identities=19%  Similarity=0.346  Sum_probs=181.1

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ....++|++.+.||+  |+||.||+|++..+++   .||||++..........+.+.+|+.+++.++||||+++++++..
T Consensus        19 ~i~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           19 LIPEQQFTLGRMLGK--GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             BCC---CEEEEEEEE--ETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             ccChhHeEEeceecc--cCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            345678999999999  7899999999988776   89999997665555567889999999999999999999999988


Q ss_pred             CCcE------EEEeeccCCCCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCce
Q psy15039        432 ATDL------HLVSPLMGFGSCKDLINAHF----NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  501 (622)
Q Consensus       432 ~~~~------~lv~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~  501 (622)
                      ....      ++||||+++|+|.+++....    ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7655      99999999999999986532    1247899999999999999999999999999999999999999999


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHH
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEK  580 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~  580 (622)
                      ++.|||.+........  ........+++.|+|||++.+  ..++.++|||||||++|||++ |++||............
T Consensus       177 kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  252 (323)
T 3qup_A          177 CVADFGLSRKIYSGDY--YRQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL  252 (323)
T ss_dssp             EECCCCC-------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             EEeecccccccccccc--ccccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            9999998654432211  111223445678999999976  468999999999999999999 99999887766655555


Q ss_pred             HcCCCCCCCC-CCcccccCCCCcCcccccchhh
Q psy15039        581 LAGATPHLLD-CTTYYVDTGQDDGEENACSYIS  612 (622)
Q Consensus       581 ~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~  612 (622)
                      ..+..+...+ .+....+....+...+..++++
T Consensus       253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  285 (323)
T 3qup_A          253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPS  285 (323)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred             hcCCCCCCCCccCHHHHHHHHHHccCChhhCcC
Confidence            5554333322 3333344444455555555554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-39  Score=341.68  Aligned_cols=253  Identities=15%  Similarity=0.198  Sum_probs=188.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCC-Ccce-------------
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRH-PNII-------------   73 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv-------------   73 (622)
                      .+|++.++||+  |+||+||+|+++.+|+.||||++..... .....+.+.+|+.+++.|+| +|+.             
T Consensus        78 ~~~~~~~~LG~--G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           78 RTLVRGTVLGQ--EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             eeEEEeccccc--CCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            35889999999  7799999999999999999999874432 22335678899999999987 3221             


Q ss_pred             --------eEEEEEEe-----CCcEEEEeecCCCCCHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy15039         74 --------CYISSFLD-----ATDLHLVSPLMGFGSCKDLINAH-----FNFGLPELVICHILQDVLNGLEYIHGKGFIH  135 (622)
Q Consensus        74 --------~~~~~~~~-----~~~~~lv~e~~~~g~l~~~l~~~-----~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvH  135 (622)
                              .+..++..     ...++++|+++ +++|.++++..     ....+++..+..++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                    11112222     22467777754 58999988532     1223678888999999999999999999999


Q ss_pred             CCCCCCCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhcc--------ccCCCCCcchHHHHHHH
Q psy15039        136 RAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--------NLDGYDERSDIYSVGIS  207 (622)
Q Consensus       136 rDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~~~~~~~~DiWSlG~i  207 (622)
                      |||||+|||++.++.+++.|||.+......       .....+ +.|+|||++..        ....|+.++|||||||+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999986543321       112344 78999999842        11347789999999999


Q ss_pred             HHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhh
Q psy15039        208 CCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLS  287 (622)
Q Consensus       208 l~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~  287 (622)
                      +|||++|+.||........                               ...+      ......+++++.+||..||+
T Consensus       307 l~elltg~~Pf~~~~~~~~-------------------------------~~~~------~~~~~~~~~~~~~li~~~l~  349 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG-------------------------------SEWI------FRSCKNIPQPVRALLEGFLR  349 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC-------------------------------SGGG------GSSCCCCCHHHHHHHHHHTC
T ss_pred             HHHHHHCCCCCCCcchhhh-------------------------------HHHH------HhhcccCCHHHHHHHHHHcc
Confidence            9999999999975432100                               0000      11123578999999999999


Q ss_pred             cCCCCCcCHHhhhcCccccccc
Q psy15039        288 RDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       288 ~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .||++||++.++++||||+...
T Consensus       350 ~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          350 YPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             SSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CChhhCcCHHHHHhCHHHHHHH
Confidence            9999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.6e-38  Score=343.26  Aligned_cols=216  Identities=25%  Similarity=0.381  Sum_probs=178.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.+.|++.+.||+  |+||.||+|+++.+++.||||++............+.+|+.+|+.++|||||+++++|.+....|
T Consensus        35 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           35 LSEMYQRVKKLGS--GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             HHHHEEEEEEEEC--C---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcCeEEeeEEec--CCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3457999999999  88999999999999999999999865544444567899999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---GKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~---~~~~~~~~~~~~~~~  513 (622)
                      +|||||++|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++..   +.+++.|||.+..+.
T Consensus       113 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999999887653  47899999999999999999999999999999999999764   459999999865443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....     .....+|+.|+|||++.+   .|+.++||||+||++|+|++|.+||...+....+.....+.
T Consensus       191 ~~~~-----~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  253 (494)
T 3lij_A          191 NQKK-----MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK  253 (494)
T ss_dssp             TTBC-----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CCcc-----ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            2211     123568889999999863   58999999999999999999999999887666555544443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-38  Score=328.61  Aligned_cols=212  Identities=24%  Similarity=0.304  Sum_probs=177.5

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-  433 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-  433 (622)
                      ..+.+.|++.+.||+  |+||.||+|++..+|+.||||++..........+++.+|+.+|+.++|||||++++++.... 
T Consensus        21 ~~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             ECCBSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eeecceEEEeEEeee--cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            456788999999999  78999999999999999999999766556666788999999999999999999999998763 


Q ss_pred             -----cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        434 -----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       434 -----~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                           .+|+||||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence                 469999999 78999998762   478999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      +......       .....+|+.|+|||++.+. ..|+.++||||+||++|||++|++||.+.+...++..+
T Consensus       175 a~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i  238 (367)
T 1cm8_A          175 ARQADSE-------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI  238 (367)
T ss_dssp             CEECCSS-------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccccccc-------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            6543221       2335678899999998653 35899999999999999999999999988766555443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-37  Score=319.79  Aligned_cols=214  Identities=26%  Similarity=0.443  Sum_probs=180.9

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      .|+..+.||+  |+||.||+|+++.+|+.||||++......  ..+.+.+|+.+++.++|||||++++++...+..++||
T Consensus        46 ~~~~~~~lg~--G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGE--GSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEecc--CCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            3677789999  78999999999999999999998765432  2356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      ||+++++|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......... 
T Consensus       122 e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  197 (321)
T 2c30_A          122 EFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-  197 (321)
T ss_dssp             CCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred             ecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-
Confidence            999999999988642   4789999999999999999999999999999999999999999999999986554332211 


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCC
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  586 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p  586 (622)
                         .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||........+........|
T Consensus       198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  259 (321)
T 2c30_A          198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP  259 (321)
T ss_dssp             ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC
T ss_pred             ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence               123567889999999975  46899999999999999999999999877665544444444433

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=317.96  Aligned_cols=207  Identities=21%  Similarity=0.404  Sum_probs=177.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||+|++..  .+....+.+.+|+.+++.++|||||++++++.+.+..++
T Consensus         9 ~~~~~~~~~lG~--G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGK--GCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEEC--CSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecC--CCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            467999999999  8899999999999999999999854  355667889999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999999998743 3578999999999999999999999999999999999999999999999998765433221


Q ss_pred             cee----------ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        518 KVH----------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       518 ~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ...          .......||+.|+|||++.+  ..++.++|||||||++|||++|..||...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            110          01114568899999999976  56899999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-38  Score=327.70  Aligned_cols=251  Identities=15%  Similarity=0.227  Sum_probs=196.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ..++|++.+.||+  |+||.||+|++.     .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus        45 ~~~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           45 PRNNIEYVRDIGE--GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CGGGCEEEEEEEE--CSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cHHHCeeeeeeee--cCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            4568999999999  889999999997     456899999987543 45556789999999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFN----------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVK  489 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~----------------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlK  489 (622)
                      .+..++||||+++|+|.+++.....                      ..+++..+..++.||+.||+|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999999999999976421                      357889999999999999999999999999999


Q ss_pred             CCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCC
Q psy15039        490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF  568 (622)
Q Consensus       490 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf  568 (622)
                      |+|||++.++.+++.|||.+........  ........+|+.|+|||++.+  ..++.++|||||||++|||+| |..||
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cceEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999998654432111  111223456788999999975  458999999999999999999 99999


Q ss_pred             CCCCcHHHHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhh
Q psy15039        569 AETPTTLMLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       569 ~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ...+..........+..+...+ ++....+....+...+..++++-.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            8887666555555554443333 233333344444444444444433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.2e-38  Score=313.54  Aligned_cols=245  Identities=19%  Similarity=0.272  Sum_probs=192.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|++. +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             hhhceeeheecC--CCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            467999999999  889999999987 57789999998665443   468899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+......  
T Consensus        83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  159 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--  159 (269)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH--
T ss_pred             EEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc--
Confidence            999999999999997643 35789999999999999999999999999999999999999999999999976543321  


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                       .........+|+.|+|||++..  ..++.++|||||||++|||++ |++||..............+..+.... .+...
T Consensus       160 -~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T 4hcu_A          160 -QYTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  236 (269)
T ss_dssp             -HHHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             -ccccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHH
Confidence             1122334556778999999975  468999999999999999999 999998876665544444443332222 12222


Q ss_pred             ccCCCCcCcccccchhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~  614 (622)
                      .+....+...++.++++..
T Consensus       237 ~~li~~~l~~~p~~Rps~~  255 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFS  255 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHccCCcccCcCHH
Confidence            2333334444444444433

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-38  Score=343.63  Aligned_cols=217  Identities=25%  Similarity=0.394  Sum_probs=182.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.+.|++.+.||+  |+||.||+|+++.+++.||||++............+.+|+.+|+.++|||||++++++.+...++
T Consensus        20 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           20 FAERYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHHEEEEEEEEC--CSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceEEeEEEee--cCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            3467999999999  88999999999999999999998643222222467889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~---~~~~~~~~~~~~~~~~~  513 (622)
                      +||||+++|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++   .++.+++.|||.+..+.
T Consensus        98 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            9999999999999887653  478999999999999999999999999999999999995   45579999999865443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ...     ......+|+.|+|||++.+   .|+.++|||||||++|+|++|++||.+.+....+.....+..
T Consensus       176 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  239 (486)
T 3mwu_A          176 QNT-----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY  239 (486)
T ss_dssp             CC---------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             CCC-----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            221     1223567899999999964   489999999999999999999999998877666555555543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.9e-38  Score=327.89  Aligned_cols=216  Identities=23%  Similarity=0.313  Sum_probs=179.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC-----
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-----  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-----  432 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        16 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSS--CSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEec--CCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            467999999999  8899999999999999999999876554433345678999999999999999999999874     


Q ss_pred             ---CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        433 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       433 ---~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                         +.+++||||+++ ++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence               468999999995 7777665432 35789999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                      ..+...............+|+.|+|||++.+. ..|+.++|||||||++|||++|++||.+......+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  239 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA  239 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            65543222222223345678999999998653 358999999999999999999999999877655443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.2e-38  Score=325.37  Aligned_cols=215  Identities=21%  Similarity=0.319  Sum_probs=173.1

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...++|++.+.||+  |+||.||+|++..+++.||||++..........+.+.+|+.+++.++|||||++++++.+.+..
T Consensus        31 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           31 TSIDRYRRITKLGE--GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             -CGGGEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhEEEEEEEEe--cCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            34567999999999  8899999999999999999999987655555566788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-----CCCceEEcCccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-----HNGKACLSGLRYMC  510 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~-----~~~~~~~~~~~~~~  510 (622)
                      ++||||++ |+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++     .++.+++.|||.+.
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999999 49999987653  478999999999999999999999999999999999995     44559999999876


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      .+......    .....+|+.|+|||++.+. ..|+.++|||||||++|||++|++||........+...
T Consensus       186 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  250 (329)
T 3gbz_A          186 AFGIPIRQ----FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI  250 (329)
T ss_dssp             HHC---------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccCCcccc----cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence            54322111    1234568889999999653 35899999999999999999999999888766655444

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-38  Score=329.48  Aligned_cols=228  Identities=24%  Similarity=0.373  Sum_probs=182.0

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ...++|++.+.||+  |+||.||+|++..+++.||+|++....   .+....+.+.+|+.+++.++|||||++++++.+.
T Consensus        23 ~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           23 ELQKKYHLKGAIGQ--GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhheeecceeee--cCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            34567999999999  889999999999999999999986431   2334457899999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhcc--------------------------------------CCCCCHHHHHHHHHHHHHH
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHF--------------------------------------NFGLPELVICHILQDVLNG  474 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~--------------------------------------~~~~~~~~~~~~~~qi~~g  474 (622)
                      +..++||||+++|+|.+++....                                      ...+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                      1113567788899999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEcCCC--ceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHH
Q psy15039        475 LEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY  552 (622)
Q Consensus       475 L~ylH~~~iiHRDlKp~NILl~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw  552 (622)
                      |+|||+++|+||||||+|||++.++  .+++.|||.+..+...............+|+.|+|||++.+....|+.++|||
T Consensus       181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            9999999999999999999998777  89999999865443211111112234567889999999965435689999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        553 SVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       553 SlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ||||++|||++|+.||........+...+.+..
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL  293 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc
Confidence            999999999999999998877766666555543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.1e-38  Score=316.48  Aligned_cols=244  Identities=17%  Similarity=0.281  Sum_probs=193.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC--CcE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--TDL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--~~~  435 (622)
                      .++|++.+.||+  |+||.||+|++.  ++.||||++.....+....+.+.+|+.+++.++||||+++++++.+.  +..
T Consensus         9 ~~~y~~~~~lg~--G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            9 FKQLNFLTKLNE--NHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGGCEEEEEEEE--ETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             HHHhHHHHHhcC--CCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            467999999999  789999999985  88999999988777777778899999999999999999999999887  778


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~--iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ++||||+++|+|.+++.......+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+++.++++.....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999999998765556899999999999999999999999  9999999999999999998888776543211


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCc-cCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC-CCCCCC-
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA-TPHLLD-  590 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~-~p~~~~-  590 (622)
                               .....+|+.|+|||++.+.. ..++.++|||||||++|||++|+.||...+............ .|.+.+ 
T Consensus       165 ---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3kmu_A          165 ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG  235 (271)
T ss_dssp             ---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             ---------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence                     12346788999999996531 123348999999999999999999998887766655554443 333332 


Q ss_pred             CCcccccCCCCcCcccccchhhhh
Q psy15039        591 CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       591 ~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      .+....+....+...+..++++-.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~  259 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFD  259 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHH
Confidence            222333333344444444444433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.1e-38  Score=329.56  Aligned_cols=202  Identities=26%  Similarity=0.411  Sum_probs=165.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..+.|++.+.||+  |+||.||+++++.+++.||||++.......   +.+.+|+.+++.++|||||++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGS--GNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESS--STTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCcEEEEEEecc--CCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            4568999999999  889999999999999999999997654322   45789999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--eEEcCcccccccCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--ACLSGLRYMCPFSP  514 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~--~~~~~~~~~~~~~~  514 (622)
                      +||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.  +++.|||.+.....
T Consensus        93 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             EEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999999987643  4789999999999999999999999999999999999987765  99999997542211


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCch-hhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDER-SDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                           ........+|+.|+|||++.+  ..++.+ +|||||||++|||++|++||....
T Consensus       171 -----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          171 -----HSQPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             ---------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             -----cCCCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence                 111234567899999999965  345544 899999999999999999997653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=326.86  Aligned_cols=210  Identities=23%  Similarity=0.299  Sum_probs=173.8

Q ss_pred             EeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeecc
Q psy15039        363 ICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM  442 (622)
Q Consensus       363 ~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~  442 (622)
                      ..+.||+  |+||.||+|++..+|+.||+|++....  ....+.+.+|+.+|+.++|||||++++++.+.+..++||||+
T Consensus        93 ~~~~lG~--G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           93 KTEILGG--GRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEECC-------CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEec--CcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3668999  889999999999999999999987643  344567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCCceEEcCcccccccCCCCCcee
Q psy15039        443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI--SHNGKACLSGLRYMCPFSPTKKKVH  520 (622)
Q Consensus       443 ~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl--~~~~~~~~~~~~~~~~~~~~~~~~~  520 (622)
                      ++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+  +.++.+++.|||.+........   
T Consensus       169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9999999886542 247889999999999999999999999999999999999  5667899999998765433211   


Q ss_pred             ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        521 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       521 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                        .....+|+.|+|||++..  ..++.++|||||||++|||++|+.||...+....+...+...
T Consensus       245 --~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  304 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR  304 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             --cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence              123457889999999965  468999999999999999999999999887766655555543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.8e-38  Score=320.43  Aligned_cols=251  Identities=17%  Similarity=0.255  Sum_probs=194.9

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ...+|++.+.||+  |+||.||+|.+     +.+++.||||++... ......+.+.+|+.+++.++|||||++++++..
T Consensus        21 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGE--GEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             chhheeeeeeecc--cCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3567999999999  88999999998     345689999998754 345667889999999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFN----------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVK  489 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~----------------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlK  489 (622)
                      .+..++||||+++|+|.+++.....                      ..+++..+..++.||+.||+|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            9999999999999999999976432                      237888999999999999999999999999999


Q ss_pred             CCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCC
Q psy15039        490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF  568 (622)
Q Consensus       490 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf  568 (622)
                      |+|||++.++.+++.|||.+..........  ......+|+.|+|||++.+  ..++.++|||||||++|||++ |..||
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYV--KRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEE--CSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hheEEEcCCCCEEEccccccccccccccce--eccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999875543322211  1223445778999999975  458999999999999999999 99999


Q ss_pred             CCCCcHHHHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhh
Q psy15039        569 AETPTTLMLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       569 ~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ...+..........+..+...+ .+....+....+...+..++++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            8876655443333333333322 233333333444444444444433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-37  Score=333.82  Aligned_cols=207  Identities=26%  Similarity=0.334  Sum_probs=172.3

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC--
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--  432 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--  432 (622)
                      ..+.++|++.+.||+  |+||.||+|+++.+++.||||++..........+++.+|+.+|+.++|||||++++++...  
T Consensus        22 ~~i~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGR--GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCCTTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             ceecCCEEEEEEEee--cCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            456789999999999  7899999999999999999999987655666778899999999999999999999999876  


Q ss_pred             ---CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        433 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       433 ---~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                         ..+|+||||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|.|||.+
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence               56999999998 5999988753  34789999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCce------------------eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCC
Q psy15039        510 CPFSPTKKKV------------------HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVP  567 (622)
Q Consensus       510 ~~~~~~~~~~------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~P  567 (622)
                      ..........                  .....+.++|+.|+|||++... ..|+.++|||||||++|||++|..|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccc
Confidence            6543221100                  0112345779999999987533 4689999999999999999984333

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6e-38  Score=321.07  Aligned_cols=214  Identities=21%  Similarity=0.338  Sum_probs=175.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH---HHHHHHHHHHHHHhhC---CCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHHEIVCMRHL---RHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~E~~~l~~l---~HpnIv~~~~~~~  430 (622)
                      ..++|++.+.||+  |+||.||+|++..+|+.||||++.......   .....+.+|+.+++.+   +||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            7 ATSRYEPVAEIGV--GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             ---CCEEEEEECC--SSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccceEEEEEEec--CCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            4578999999999  889999999999999999999986432211   1123456777777766   4999999999998


Q ss_pred             eCC-----cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcC
Q psy15039        431 DAT-----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  505 (622)
Q Consensus       431 ~~~-----~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~  505 (622)
                      ...     ..++||||++ |+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            765     4899999998 5999999876555589999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ||.+........     .....+|+.|+|||++.+  ..|+.++|||||||++|||++|++||...+....+...
T Consensus       164 fg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  231 (308)
T 3g33_A          164 FGLARIYSYQMA-----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI  231 (308)
T ss_dssp             CSCTTTSTTCCC-----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred             CccccccCCCcc-----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            998654432211     123467889999999975  45899999999999999999999999888766555443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-37  Score=341.22  Aligned_cols=217  Identities=24%  Similarity=0.362  Sum_probs=181.6

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-----------HHHHHHHHHHHHHhhCCCCccce
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-----------EDLKSLHHEIVCMRHLRHPNIIC  424 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-----------~~~~~~~~E~~~l~~l~HpnIv~  424 (622)
                      .+.+.|++.+.||+  |+||.||+|+++.+++.||||++.......           ...+.+.+|+.+|+.++|||||+
T Consensus        33 ~i~~~Y~~~~~lG~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           33 KIGESYFKVRKLGS--GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CGGGTEEEEEEEEC----CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CcccceEEEeEecc--cCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            45678999999999  889999999999999999999997654322           22467889999999999999999


Q ss_pred             eEEEEEeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ce
Q psy15039        425 YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KA  501 (622)
Q Consensus       425 ~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~  501 (622)
                      +++++.+....++|||||++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++   .+
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999999887653  478999999999999999999999999999999999999876   68


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ++.|||.+..+.....     .....+|+.|+|||++.+   .|+.++||||+||++|+|++|.+||.+.+....+....
T Consensus       189 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  260 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE  260 (504)
T ss_dssp             EECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999998765433211     123567889999999864   58999999999999999999999999887666555555


Q ss_pred             cCC
Q psy15039        582 AGA  584 (622)
Q Consensus       582 ~~~  584 (622)
                      .+.
T Consensus       261 ~~~  263 (504)
T 3q5i_A          261 KGK  263 (504)
T ss_dssp             HCC
T ss_pred             cCC
Confidence            443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.4e-38  Score=338.60  Aligned_cols=210  Identities=23%  Similarity=0.306  Sum_probs=175.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC---
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT---  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~---  433 (622)
                      +.++|++.+.||+  |+||.||+|++..+|+.||||++..........+++.+|+.+|+.++|||||++++++....   
T Consensus        60 ~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           60 VLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EETTEEEEEEEEE--CSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeec--CCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            4578999999999  88999999999999999999999866556666788999999999999999999999997653   


Q ss_pred             ---cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        434 ---DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       434 ---~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                         .+|+|||||+++ +.+.+..    .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|.|||.+.
T Consensus       138 ~~~~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          138 EFQDVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             TCCEEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             cCCeEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence               579999999865 5555532    37889999999999999999999999999999999999999999999999865


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      .....     .......+|+.|+|||++.+  ..|+.++|||||||++|||++|++||.+.+...++...
T Consensus       213 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i  275 (464)
T 3ttj_A          213 TAGTS-----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  275 (464)
T ss_dssp             ----C-----CCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ecCCC-----cccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            43321     11233567899999999976  46999999999999999999999999988776665444

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=318.23  Aligned_cols=211  Identities=23%  Similarity=0.352  Sum_probs=177.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGE--GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEee--cCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence            357999999999  889999999999999999999998776666666788999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus        80 v~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            99999999999887654  3478999999999999999999999999999999999999999999999998654432211


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                          ......+|+.|+|||++.+. ..++.++|||||||++|||++|++||........+
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  212 (311)
T 4agu_A          158 ----YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL  212 (311)
T ss_dssp             ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ----ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                11234578889999999643 35899999999999999999999999887665544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=324.64  Aligned_cols=207  Identities=24%  Similarity=0.389  Sum_probs=174.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC--c
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--D  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~--~  434 (622)
                      ....|++.+.||+  |+||.||+|++..+|+.||||++...... ...+.+.+|+.+++.++|||||++++++....  .
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            7 SNHLWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             SSEEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCEEEEEEecC--CCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            4567999999999  88999999999999999999998743221 12456789999999999999999999998765  7


Q ss_pred             EEEEeeccCCCCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCceEEcCcccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYM  509 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl----~~~~~~~~~~~~~~  509 (622)
                      .++||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+++.|||.+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            8999999999999999976432 348899999999999999999999999999999999999    77778999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccC------ccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN------LDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ........     ..+..+|+.|+|||++...      ...|+.++|||||||++|||++|+.||...
T Consensus       164 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          164 RELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             EECCTTCC-----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             eecCCCCc-----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            65433221     1234578899999998521      246889999999999999999999999643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.2e-38  Score=354.54  Aligned_cols=217  Identities=18%  Similarity=0.267  Sum_probs=182.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~  434 (622)
                      ..++|++.+.||+  |+||.||+|+++.+++.||||++...... ....+.+.+|..+|..+ +||||++++++|.+.+.
T Consensus       339 ~~~~f~~~~~LG~--G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGK--GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             -CTTEEEEEESSB--TTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccceEEEEEEcc--CCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            3568999999999  88999999999999999999998743111 11235678899999987 79999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+||||+++|+|.+++....  .+++..+..|+.||+.||+|||++|||||||||+|||++.+|.++|.|||.+.....
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999999998754  478999999999999999999999999999999999999999999999997653222


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ...    ...+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+..+....++.+
T Consensus       495 ~~~----~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  557 (674)
T 3pfq_A          495 DGV----TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH  557 (674)
T ss_dssp             TTC----CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS
T ss_pred             CCc----ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence            111    1234578999999999975  56999999999999999999999999887665544444443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8e-38  Score=324.64  Aligned_cols=211  Identities=27%  Similarity=0.418  Sum_probs=174.3

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      +.++|++.+.||+  |+||.||+|+++.+|+.||||++.....      ...+|+.++.++ +|||||++++++.+....
T Consensus        20 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           20 FTDGYEVKEDIGV--GSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHHEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEEee--CCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            4567999999999  8899999999999999999999976532      234688888877 799999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-C---ceEEcCcccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-G---KACLSGLRYMCP  511 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~-~---~~~~~~~~~~~~  511 (622)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||+.++ +   .+++.|||.+..
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999999987643  47899999999999999999999999999999999998543 3   599999998654


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC--CcHHHHHHHHcC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET--PTTLMLIEKLAG  583 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~--~~~~~~~~~~~~  583 (622)
                      ......    ...+.++|+.|+|||++.+  ..|+.++|||||||++|||++|.+||...  .....+...+..
T Consensus       170 ~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  237 (342)
T 2qr7_A          170 LRAENG----LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS  237 (342)
T ss_dssp             CBCTTC----CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH
T ss_pred             CcCCCC----ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc
Confidence            432211    1234567899999999975  45889999999999999999999999763  233444444433

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.5e-38  Score=328.42  Aligned_cols=219  Identities=19%  Similarity=0.309  Sum_probs=181.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEE-----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~  430 (622)
                      ..++|++.+.||+  |+||.||+|+     +..+++.||||++... ......+.+.+|+.+++.+ +|||||++++++.
T Consensus        20 ~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           20 PRDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccceeeceeecC--CCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            3567999999999  8899999999     6677899999999754 3455567899999999999 8999999999998


Q ss_pred             eCCc-EEEEeeccCCCCHHHHHHhccC-----------------------------------------------------
Q psy15039        431 DATD-LHLVSPLMGFGSCKDLINAHFN-----------------------------------------------------  456 (622)
Q Consensus       431 ~~~~-~~lv~e~~~~g~l~~~l~~~~~-----------------------------------------------------  456 (622)
                      ..+. .++||||+++|+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            8654 8999999999999999976432                                                     


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCC
Q psy15039        457 -----------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS  525 (622)
Q Consensus       457 -----------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (622)
                                 ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.........  .....
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC--EEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc--hhccc
Confidence                       11788889999999999999999999999999999999999999999999987644332221  11233


Q ss_pred             CCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHc
Q psy15039        526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       526 ~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~  582 (622)
                      ..+|+.|+|||++.+  ..|+.++|||||||++|||+| |++||........+...+.
T Consensus       255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  310 (359)
T 3vhe_A          255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  310 (359)
T ss_dssp             CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred             cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH
Confidence            456788999999975  468999999999999999998 9999988765555544443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-37  Score=330.12  Aligned_cols=200  Identities=21%  Similarity=0.318  Sum_probs=163.8

Q ss_pred             CCCCceEe-eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHH-hhCCCCccceeEEEEEe---
Q psy15039        357 VPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM-RHLRHPNIICYISSFLD---  431 (622)
Q Consensus       357 ~~~~y~~~-~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~~~~~~~~---  431 (622)
                      ..++|.+. +.||+  |+||.||+|+++.+|+.||||++...       ..+.+|+.++ +.++|||||+++++|..   
T Consensus        59 ~~~~y~~~~~~LG~--G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           59 IIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             GGGTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeccceeee--ccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            45678877 68999  78999999999999999999998632       3467888887 45689999999999876   


Q ss_pred             -CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCceEEcCcc
Q psy15039        432 -ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLR  507 (622)
Q Consensus       432 -~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~---~~~~~~~~~~  507 (622)
                       ...+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.   ++.++|.|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             567899999999999999998754446899999999999999999999999999999999999998   7889999999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      .+.......     ...+.+||+.|+|||++.+  ..|+.++|||||||++|||++|++||....
T Consensus       210 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          210 FAKETTSHN-----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             TCEECC----------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             cccccCCCC-----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            865433211     1234567889999999965  568999999999999999999999997654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=326.81  Aligned_cols=250  Identities=20%  Similarity=0.274  Sum_probs=194.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccC-------CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVT-------NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF  429 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~  429 (622)
                      .+.|.+.+.||+  |+||.||+|++..+       ++.||||++... ......+.+.+|+.+++.+ +|||||++++++
T Consensus        68 ~~~y~i~~~LG~--G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           68 RDRLVLGKPLGE--GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEeeeEEec--CCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            457999999999  88999999997643       358999998754 3455667899999999999 999999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  495 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl  495 (622)
                      ...+..++||||+++|+|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            999999999999999999999986542              247899999999999999999999999999999999999


Q ss_pred             cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcH
Q psy15039        496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  574 (622)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~  574 (622)
                      +.++.+++.|||.+.........  .......+|+.|+|||++.+  ..++.++|||||||++|||++ |..||...+..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             cCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999987644322111  11223456778999999975  468999999999999999999 99999887665


Q ss_pred             HHHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhh
Q psy15039        575 LMLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       575 ~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ........+..+...+ ++..+.+....+...+..++++-+
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  341 (382)
T 3tt0_A          301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  341 (382)
T ss_dssp             HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            5444444443333322 233333333444444444444433

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-37  Score=314.50  Aligned_cols=208  Identities=25%  Similarity=0.434  Sum_probs=175.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||+|++........ ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus         8 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            8 LEDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccEEEeeEEec--CCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            467999999999  8899999999999999999999864322111 1356889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        86 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            9999999999999987653  47889999999999999999999999999999999999999999999999764332211


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                            .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||...+.....
T Consensus       164 ------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  216 (279)
T 3fdn_A          164 ------RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY  216 (279)
T ss_dssp             ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             ------ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH
Confidence                  123457888999999975  45788999999999999999999999877655443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.8e-38  Score=340.79  Aligned_cols=216  Identities=28%  Similarity=0.423  Sum_probs=184.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      +.+.|++.+.||+  |+||.||+|+++.+|+.||||++...... ......+.+|+.+|+.++|||||++++++.+.+..
T Consensus        24 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           24 FSDRYKGQRVLGK--GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             HHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccCceEEeeEEec--CCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4567999999999  78999999999999999999999765433 23356789999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl---~~~~~~~~~~~~~~~~~  512 (622)
                      ++||||+.+|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+++.|||.+..+
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999999887643  47899999999999999999999999999999999999   46789999999987654


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ......     ....+|+.|+|||++.+   .|+.++|||||||++|+|++|++||...+....+.....+.
T Consensus       180 ~~~~~~-----~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  243 (484)
T 3nyv_A          180 EASKKM-----KDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK  243 (484)
T ss_dssp             CCCCSH-----HHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cccccc-----ccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            432211     12457889999999964   48999999999999999999999999887666555555554

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-38  Score=330.02  Aligned_cols=248  Identities=20%  Similarity=0.327  Sum_probs=182.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ..+|++.+.||+  |+||.||+|+++   .+++.||||++.... .....+.+.+|+.+|+.++|||||++++++...+.
T Consensus        44 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGA--GEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEE--CSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEee--CCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            457999999999  889999999987   567889999987543 45566789999999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             eEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999999997643 3578899999999999999999999999999999999999999999999998654432


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCC-CCCCCCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGAT-PHLLDCT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~-p~~~~~~  592 (622)
                      ..... .......+|+.|+|||++..  ..++.++|||||||++|||++ |+.||...+..........+.. |....++
T Consensus       200 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          200 DPEAA-YTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             ---------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred             CCccc-eeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            21111 11122234678999999975  468999999999999999998 9999988766554433333322 2222334


Q ss_pred             cccccCCCCcCcccccchhh
Q psy15039        593 TYYVDTGQDDGEENACSYIS  612 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~  612 (622)
                      ....+....|...+..++.+
T Consensus       277 ~~l~~li~~cl~~dp~~RPs  296 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPK  296 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHhCcChhhCcC
Confidence            33434444444444444443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.4e-39  Score=333.75  Aligned_cols=249  Identities=14%  Similarity=0.163  Sum_probs=188.8

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC------CHHHHHHHHHHHHHHhhCC---------CCcce
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM------TDEDLKSLHHEIVCMRHLR---------HPNII   73 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~------~~~~~~~~~~Ei~il~~l~---------HpnIv   73 (622)
                      ++|++++.||+  |+||+||+|++  +|+.||||++.....      .....+.+.+|+.+|+.|+         |||||
T Consensus        20 ~~y~~~~~lG~--G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           20 EKLQRCEKIGE--GVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HHHHTCEEEEE--ETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccchheeeecc--cCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            57999999999  77899999998  789999999986532      2223466788999999886         88888


Q ss_pred             eEEEEEE------------------------------eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHH
Q psy15039         74 CYISSFL------------------------------DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN  123 (622)
Q Consensus        74 ~~~~~~~------------------------------~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~  123 (622)
                      ++.+++.                              +...+|+|||||++|++.+.+..   ..+++..++.++.||+.
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence            8887754                              26789999999999976655533   35789999999999999


Q ss_pred             HHHHHH-hCCcccCCCCCCCEEEcCCC--------------------ceEEcCCccccccCCCCccccccCCCCCCCccc
Q psy15039        124 GLEYIH-GKGFIHRAVKASHILISHNG--------------------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW  182 (622)
Q Consensus       124 aL~ylH-~~~IvHrDiKp~NiLl~~~~--------------------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  182 (622)
                      ||+||| ++||+||||||+|||++.++                    .+++.|||.+.....         ....+|+.|
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------~~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------TEEECCCCT
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------CcEEEeecc
Confidence            999999 99999999999999999887                    899999998754321         123567889


Q ss_pred             cChhhhccccCCCCCcchHHHHHHH-HHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccc
Q psy15039        183 LSPEVLEQNLDGYDERSDIYSVGIS-CCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI  261 (622)
Q Consensus       183 ~aPE~l~~~~~~~~~~~DiWSlG~i-l~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i  261 (622)
                      +|||++.+.   .+.++||||+|++ .+++.+|..||............+......           .            
T Consensus       244 ~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~------------  297 (336)
T 2vuw_A          244 MDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-----------K------------  297 (336)
T ss_dssp             TCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC-----------S------------
T ss_pred             cChhhhcCC---CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc-----------C------------
Confidence            999999753   3789999998877 777889999995321111122222100000           0            


Q ss_pred             hhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhh-cCcccc
Q psy15039        262 SEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL-QHAFFK  306 (622)
Q Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l-~h~~~~  306 (622)
                        ..........+++++.+||++||++|     |+.|+| +||||+
T Consensus       298 --~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          298 --TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             --SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             --cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence              00000112346889999999999987     999999 999995

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.2e-37  Score=320.15  Aligned_cols=208  Identities=20%  Similarity=0.256  Sum_probs=180.6

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-----CCccceeEEEE
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-----HPNIICYISSF  429 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~~~~~~  429 (622)
                      ....+.|++.+.||+  |+||.||+|++..+++.||||++..   .....+.+.+|+.+++.++     |||||++++++
T Consensus        31 ~~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           31 MLLNNAFLVIRKMGD--GTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CEETTTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eEecCEEEEEEEEcc--cCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            345678999999999  8899999999999999999999863   2444567888999999996     99999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC------------
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH------------  497 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~------------  497 (622)
                      ...+..++||||+ +++|.+++......++++..+..++.||+.||+|||++||+||||||+|||++.            
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence            9999999999999 899999998765556889999999999999999999999999999999999975            


Q ss_pred             -------------CCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcC
Q psy15039        498 -------------NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG  564 (622)
Q Consensus       498 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg  564 (622)
                                   ++.+++.|||.+.....       ......+|+.|+|||++.+  ..|+.++|||||||++|||++|
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD-------YHGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTS-------CCCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccCCCCEEEEeccCceecCC-------CCcCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHC
Confidence                         78899999997653322       1234567889999999976  4689999999999999999999


Q ss_pred             CCCCCCCCcHHHH
Q psy15039        565 TVPFAETPTTLML  577 (622)
Q Consensus       565 ~~Pf~~~~~~~~~  577 (622)
                      ++||...+....+
T Consensus       256 ~~pf~~~~~~~~~  268 (360)
T 3llt_A          256 SLLFRTHEHMEHL  268 (360)
T ss_dssp             SCSCCCSSHHHHH
T ss_pred             CCCCCCCcHHHHH
Confidence            9999887665544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.9e-37  Score=317.94  Aligned_cols=215  Identities=20%  Similarity=0.297  Sum_probs=182.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH----HHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      +.+.|++.+.||+  |+||.||+|++..+|+.||+|++........    ..+.+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A           10 VEDFYDIGEELGS--GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             HHHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhccEEEeeEeee--cCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3467999999999  8899999999999999999999976533211    246788999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----ceEEcCccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLRY  508 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~----~~~~~~~~~  508 (622)
                      +..++||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++    .+++.|||.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999999764  3478999999999999999999999999999999999999888    799999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      +........     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...+....+.....
T Consensus       166 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  232 (321)
T 2a2a_A          166 AHEIEDGVE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS  232 (321)
T ss_dssp             CEECCTTCC-----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred             ceecCcccc-----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            654433211     123457889999999965  4689999999999999999999999988766555444433

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.8e-37  Score=309.43  Aligned_cols=216  Identities=20%  Similarity=0.344  Sum_probs=182.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++ +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGS--GQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             hhheeeeeeecc--CCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            467999999999  789999999876 57789999997665443   468899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            999999999999997653 2478999999999999999999999999999999999999999999999998654433221


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                         ....+..+|+.|+|||++.+  ..++.++|||||||++|||++ |++||..............+..
T Consensus       160 ---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~  223 (268)
T 3sxs_A          160 ---VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR  223 (268)
T ss_dssp             ---EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ---hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC
Confidence               12234556778999999975  458899999999999999999 9999988776665555444443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-37  Score=312.57  Aligned_cols=214  Identities=26%  Similarity=0.356  Sum_probs=182.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.+.|++.+.||+  |+||.||+|++..+++.+|+|++.......  .+.+.+|+.+++.++||||+++++++.+....+
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            7 INQYYTLENTIGR--GSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhEEeeeEEee--cCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            4567999999999  789999999999999999999987543322  457889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl---~~~~~~~~~~~~~~~~~~  513 (622)
                      +||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+++.|||.+....
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999999999887643  47899999999999999999999999999999999999   778899999999875543


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....     .....+|+.|+|||++.+   .++.++|||||||++|||++|+.||..............+.
T Consensus       161 ~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (277)
T 3f3z_A          161 PGKM-----MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT  223 (277)
T ss_dssp             TTSC-----BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             Cccc-----hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            3221     123457888999999864   38899999999999999999999998877666555555443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-37  Score=314.33  Aligned_cols=249  Identities=18%  Similarity=0.251  Sum_probs=194.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe--CCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--ATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~  434 (622)
                      ..++|++.+.||+  |+||.||+++++.+|+.||+|++.....+....+.+.+|+.+++.++||||+++++++..  ...
T Consensus         4 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            4 RAEDYEVLYTIGT--GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             chhheeeehhccC--CCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            3468999999999  889999999999999999999998877777777889999999999999999999998865  567


Q ss_pred             EEEEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCceEEcCcc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKG-----FIHRAVKASHILISHNGKACLSGLR  507 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~~~-----iiHRDlKp~NILl~~~~~~~~~~~~  507 (622)
                      .++||||+++++|.+++....  ...+++..+..++.|++.||+|||+++     |+||||||+|||++.++.+++.|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999999987542  234789999999999999999999999     9999999999999999999999999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  587 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~  587 (622)
                      .+.........    .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...+..........+..+.
T Consensus       162 ~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~  235 (279)
T 2w5a_A          162 LARILNHDTSF----AKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR  235 (279)
T ss_dssp             HHHHC---CHH----HHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             hheeecccccc----ccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc
Confidence            86544322111    112346788999999975  468899999999999999999999998876555444444554443


Q ss_pred             CCC-CCcccccCCCCcCcccccchhhh
Q psy15039        588 LLD-CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       588 ~~~-~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      +.. .+....+....+...+..++++.
T Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~  262 (279)
T 2w5a_A          236 IPYRYSDELNEIITRMLNLKDYHRPSV  262 (279)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCcccCHHHHHHHHHHcCCCcccCCCH
Confidence            332 22222333333344444444433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-37  Score=339.77  Aligned_cols=247  Identities=17%  Similarity=0.294  Sum_probs=194.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ..+|++.+.||+  |+||.||+|+++.+++.||||++......   .+.+.+|+.+|+.++|||||++++++.....+++
T Consensus       219 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGG--GTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecC--CCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            467999999999  78999999999999999999998765433   4578999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|.|||.+....... 
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            9999999999999987555568899999999999999999999999999999999999999999999999865443221 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                        .....+..+++.|+|||++..  ..|+.++|||||||++|||+| |..||...+..........+..+..++ ++...
T Consensus       373 --~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  448 (495)
T 1opk_A          373 --YTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  448 (495)
T ss_dssp             --EECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             --eeecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence              112233456778999999975  468999999999999999999 999998876554333223332222222 33333


Q ss_pred             ccCCCCcCcccccchhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~  614 (622)
                      .+....|...+..++++-.
T Consensus       449 ~~li~~cl~~dP~~RPs~~  467 (495)
T 1opk_A          449 YELMRACWQWNPSDRPSFA  467 (495)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHcCcChhHCcCHH
Confidence            3334444444444444433

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-36  Score=308.59  Aligned_cols=215  Identities=21%  Similarity=0.373  Sum_probs=184.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe----C
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----A  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~  432 (622)
                      ....|++.+.||+  |+||.||+|.+..++..||+|++.....+....+.+.+|+.+++.++||||+++++++..    .
T Consensus        24 ~~~~~~~~~~lg~--G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           24 DGRFLKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TSCEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             CceeEEeeeeccC--CCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            3455899999999  889999999999999999999998777777778889999999999999999999999876    3


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCceEEcCcccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS-HNGKACLSGLRYM  509 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~--iiHRDlKp~NILl~-~~~~~~~~~~~~~  509 (622)
                      ..+++||||+++|+|.+++....  .+++..+..++.|++.||+|||+++  |+||||||+|||++ .++.+++.|||.+
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            45899999999999999997653  4788899999999999999999999  99999999999997 7889999999976


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      .......      .....+|+.|+|||++.+   .++.++|||||||++|+|++|+.||........+...+...
T Consensus       180 ~~~~~~~------~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (290)
T 1t4h_A          180 TLKRASF------AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  245 (290)
T ss_dssp             GGCCTTS------BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             ccccccc------cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc
Confidence            5332211      112457888999999864   48999999999999999999999999877776666666554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.6e-37  Score=310.65  Aligned_cols=213  Identities=19%  Similarity=0.267  Sum_probs=182.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..+.|++.+.||+  |+||.||++++..+++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        13 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGK--GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEee--cCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            4567999999999  7899999999999999999999876533 345567889999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999999887643  4789999999999999999999999999999999999999999999999986544322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      ...    .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...........
T Consensus       169 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  226 (294)
T 2rku_A          169 GER----KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR  226 (294)
T ss_dssp             TCC----BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             ccc----cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            111    123457888999999965  4588899999999999999999999987765544433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.3e-37  Score=310.60  Aligned_cols=246  Identities=17%  Similarity=0.248  Sum_probs=190.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..++|++.+.||+  |+||.||++++. +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        22 ~~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           22 DPKDLTFLKELGT--GQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CHHHHHhHhhcCC--CCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            4568999999999  889999999887 67789999998665443   46889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            9999999999999987633 247899999999999999999999999999999999999999999999999865443211


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCcc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTY  594 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~  594 (622)
                         ........+|+.|+|||++..  ..++.++|||||||++|||+| |++||...+..........+..+.... .+..
T Consensus       175 ---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T 3gen_A          175 ---YTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK  249 (283)
T ss_dssp             ---HHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ---cccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence               122334556788999999975  458999999999999999998 999998876655544444443332222 1222


Q ss_pred             cccCCCCcCcccccchhhhh
Q psy15039        595 YVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ..+....+...+..++.+-+
T Consensus       250 l~~li~~~l~~~p~~Rps~~  269 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFK  269 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHH
T ss_pred             HHHHHHHHccCChhHCcCHH
Confidence            23333444444444444433

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-38  Score=356.65  Aligned_cols=243  Identities=17%  Similarity=0.212  Sum_probs=198.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEcc-CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc-
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKV-TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-   84 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~-t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-   84 (622)
                      +.++|++.+.||+  |+||.||+|.++. +|+.||||++.... .......+.+|+.+|++++|||||++++++...+. 
T Consensus        78 ~~~~y~i~~~lg~--G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           78 VAGQYEVKGCIAH--GGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             ETTTEEEEEEEEE--ETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             eCCceEEEEEEee--CCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            4579999999999  8899999999986 89999999986543 45556678899999999999999999999988765 


Q ss_pred             ----EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         85 ----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        85 ----~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                          .|+||||+++++|.+++..    .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+++.|||...
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence                7999999999999887643    58899999999999999999999999999999999999874 89999999865


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      .....        ....+|+.|+|||++.++   ++.++|||||||++|+|++|..||......         ..|    
T Consensus       230 ~~~~~--------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~----  285 (681)
T 2pzi_A          230 RINSF--------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP----  285 (681)
T ss_dssp             ETTCC--------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC----
T ss_pred             hcccC--------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc----
Confidence            43221        234567889999998753   588999999999999999999888632100         000    


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                            .    .......++.+.++|.+||+.||.+||+..+.+.|+|+..
T Consensus       286 ----------------------~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 ----------------------E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ----------------------T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----------------------c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                                  0    0001124678999999999999999999999999998854

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=321.84  Aligned_cols=211  Identities=23%  Similarity=0.328  Sum_probs=171.9

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++.+.||+  |+||.||+|++..+++.||||++..... ......+.+|+.+++.++|||||++++++...+..++|
T Consensus         2 ~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGE--GTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcC--CCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            57999999999  8899999999999999999999875432 11223456899999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||++ |+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+........ 
T Consensus        79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             EECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             ecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence            99998 58988887653 3578899999999999999999999999999999999999999999999998654332211 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                         ......+|+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+....+..
T Consensus       156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  212 (324)
T 3mtl_A          156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF  212 (324)
T ss_dssp             ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               11234568899999998653 3589999999999999999999999998876655433

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.7e-37  Score=319.17  Aligned_cols=206  Identities=20%  Similarity=0.380  Sum_probs=170.1

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc----
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD----  434 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~----  434 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+...    
T Consensus         6 ~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            6 TDFEPIQCMGR--GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHEEEEEEEEC--C-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hcCceeeEecC--CCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            56999999999  889999999999999999999997654 23345678999999999999999999999876542    


Q ss_pred             -----------------------------------------------------EEEEeeccCCCCHHHHHHhccCC-CCC
Q psy15039        435 -----------------------------------------------------LHLVSPLMGFGSCKDLINAHFNF-GLP  460 (622)
Q Consensus       435 -----------------------------------------------------~~lv~e~~~~g~l~~~l~~~~~~-~~~  460 (622)
                                                                           .++||||+++|+|.+++...... ..+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                 89999999999999999865332 245


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCcee--------ccCCCCCCCCcc
Q psy15039        461 ELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVH--------LFPPSTAYNLNW  532 (622)
Q Consensus       461 ~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~t~~y  532 (622)
                      +..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+...........        .......+|+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            667889999999999999999999999999999999999999999998765543221110        122345688999


Q ss_pred             ccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCC
Q psy15039        533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA  569 (622)
Q Consensus       533 ~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~  569 (622)
                      +|||++.+  ..|+.++|||||||++|||++|..|+.
T Consensus       243 ~aPE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          243 MSPEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             SCHHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             cChHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            99999976  468999999999999999999988763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.3e-37  Score=316.92  Aligned_cols=214  Identities=19%  Similarity=0.262  Sum_probs=183.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ....|.+.+.||+  |+||.||++++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        39 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           39 SRRRYVRGRFLGK--GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTEEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEee--CCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            4567999999999  789999999999999999999987553 3445567889999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999999887643  4789999999999999999999999999999999999999999999999986544322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ...    .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||............
T Consensus       195 ~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  253 (335)
T 2owb_A          195 GER----KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  253 (335)
T ss_dssp             TCC----BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             ccc----ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence            111    123457888999999975  45889999999999999999999999877655444333

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.2e-37  Score=312.60  Aligned_cols=248  Identities=15%  Similarity=0.242  Sum_probs=183.0

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ...+.|++.+.||+  |+||.||+|++..+   +..||+|++... ......+.+.+|+.+++.++||||+++++++. .
T Consensus        12 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           12 IQRERIELGRCIGE--GQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCGGGEEEEEEEEE--CSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EehHHeEEEeEeee--cCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            34568999999999  88999999998654   457999998653 34555678999999999999999999999874 5


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  512 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~  512 (622)
                      +..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             CccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            67899999999999999997643 35789999999999999999999999999999999999999999999999976544


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-  590 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-  590 (622)
                      ......   ......+|+.|+|||++..  ..++.++|||||||++|||++ |.+||........+.....+..+++.+ 
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  241 (281)
T 1mp8_A          167 EDSTYY---KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN  241 (281)
T ss_dssp             ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             Cccccc---ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCC
Confidence            322111   1122345678999999975  468999999999999999997 999998877665554444444333332 


Q ss_pred             CCcccccCCCCcCcccccchhhh
Q psy15039        591 CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       591 ~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      ++..+.+....+...+..++++.
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rps~  264 (281)
T 1mp8_A          242 CPPTLYSLMTKCWAYDPSRRPRF  264 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHHccCChhhCcCH
Confidence            23333333344444444444443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=323.34  Aligned_cols=203  Identities=16%  Similarity=0.177  Sum_probs=169.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEE-----EEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC---CCccceeEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLS-----KHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR---HPNIICYISS  428 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~-----~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~  428 (622)
                      ....|++.+.||+  |+||.||+|     .+..+++.||||++....     ...+.+|+.+++.++   ||||++++++
T Consensus        63 ~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           63 GSKLVYVHHLLGE--GAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             SSSEEEEEEEEEE--CSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             CCEEEEEEEEeec--cCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            3567999999999  889999999     578899999999987532     245677888888886   9999999999


Q ss_pred             EEeCCcEEEEeeccCCCCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--------
Q psy15039        429 FLDATDLHLVSPLMGFGSCKDLINAH---FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--------  497 (622)
Q Consensus       429 ~~~~~~~~lv~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~--------  497 (622)
                      +...+..++|||||++|+|.+++...   ....+++..+..++.||+.||+|||++|||||||||+|||++.        
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            99999999999999999999999753   2345899999999999999999999999999999999999998        


Q ss_pred             ---CCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        498 ---NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       498 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                         ++.+++.|||.+..........  .....+||+.|||||++.+  ..|+.++|||||||++|||+||++||..
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGT--IFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTE--EECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccCCEEEeeCchhhhhhccCCCc--eeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence               8999999999875432211111  1234568899999999976  4589999999999999999999999853

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.7e-37  Score=319.57  Aligned_cols=215  Identities=21%  Similarity=0.310  Sum_probs=181.4

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...++|++.+.||+  |+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   99 (331)
T 4aaa_A           22 QSMEKYENLGLVGE--GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW   99 (331)
T ss_dssp             BCGGGEEEEEEGGG--GTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhhhheeeeEEee--cCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence            34567999999999  7899999999999999999999987766666667889999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus       100 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999999998876543  35789999999999999999999999999999999999999999999999976543322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      ..    ......+|+.|+|||++.+. ..++.++|||||||++|||++|++||...+....+..
T Consensus       178 ~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  236 (331)
T 4aaa_A          178 GE----VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH  236 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cc----ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            11    12234578889999999653 3588999999999999999999999988876655444

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.9e-38  Score=317.34  Aligned_cols=207  Identities=23%  Similarity=0.417  Sum_probs=171.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ...+|++.+.||+  |+||.||+|+    +..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~~~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGK--GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeec--cCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3467999999999  8899999999    6778999999998743  455567899999999999999999999998654


Q ss_pred             --CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        433 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       433 --~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                        ..+++||||+++|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              458999999999999999976532 47889999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ........ ........+++.|+|||++.+  ..++.++|||||||++|||+||..||...
T Consensus       163 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          163 VLPQDKEF-FKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             --------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             cccCCcce-eeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            44332211 111222345677999999976  46899999999999999999999998643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-37  Score=319.09  Aligned_cols=192  Identities=25%  Similarity=0.419  Sum_probs=150.0

Q ss_pred             eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCccceeEEEEEeCCcEEEEeeccC
Q psy15039        365 SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHLVSPLMG  443 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~  443 (622)
                      +.||+  |+||.||+|+++.+|+.||||++...     ....+.+|+.+++.+. |||||++++++.+....|+||||++
T Consensus        17 ~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           17 KPLGE--GSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             CCSEE--ETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             Ccccc--CCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            67999  78999999999999999999998642     2356789999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEcCcccccccCCCCCcee
Q psy15039        444 FGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPFSPTKKKVH  520 (622)
Q Consensus       444 ~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~~~~~~~~~~~~~~~~~  520 (622)
                      +|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++   .+++.|||.+........   
T Consensus        90 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---  164 (325)
T 3kn6_A           90 GGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---  164 (325)
T ss_dssp             SCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence            999999998743  578999999999999999999999999999999999998776   799999997654332211   


Q ss_pred             ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        521 LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       521 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                       ......+|+.|+|||++.+  ..|+.++|||||||++|||++|++||...
T Consensus       165 -~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          165 -PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             -cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence             1223457889999999975  46899999999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-37  Score=334.20  Aligned_cols=247  Identities=16%  Similarity=0.286  Sum_probs=193.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..++|++.+.||+  |+||.||+|++. +++.||||++......   .+.+.+|+.+|+.++|||||++++++. ...++
T Consensus       186 ~~~~~~~~~~lG~--G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGA--GQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEEC--CSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             chHHeEEEEEccc--CCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            3467999999999  889999999986 4778999999765433   467899999999999999999999886 56789


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +|||||++|+|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||.+.......
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999999999975433347888899999999999999999999999999999999999999999999875443211


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCC-CCCcc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLL-DCTTY  594 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~-~~~~~  594 (622)
                         .....+..+|+.|+|||++..  ..|+.++|||||||++|||+| |++||.+.+..+.+.....+..++.+ .++..
T Consensus       339 ---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  413 (454)
T 1qcf_A          339 ---YTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE  413 (454)
T ss_dssp             ---HHTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             ---eeccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence               111233456778999999975  468999999999999999999 99999988766655444444333322 23444


Q ss_pred             cccCCCCcCcccccchhhhhh
Q psy15039        595 YVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      ..+....|...++.++.+-++
T Consensus       414 l~~li~~cl~~dp~~RPt~~~  434 (454)
T 1qcf_A          414 LYNIMMRCWKNRPEERPTFEY  434 (454)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHccCChhHCcCHHH
Confidence            444445555555555554433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-37  Score=320.36  Aligned_cols=211  Identities=18%  Similarity=0.378  Sum_probs=168.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEE----EEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLI----AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~v----avK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..+|++.+.||+  |+||.||+|++..+++.+    |+|.+.... .....+.+.+|+.+++.++|||||++++++... 
T Consensus        14 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           14 ETEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred             HHHcccceEEee--CCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            456999999999  789999999998888765    777765322 223356789999999999999999999999875 


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++++||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            4789999999999999997753 357899999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHH
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLML  577 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~  577 (622)
                      ......  ......+|+.|+|||++.+  ..|+.++|||||||++|||+| |+.||...+.....
T Consensus       169 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  229 (327)
T 3poz_A          169 AEEKEY--HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  229 (327)
T ss_dssp             TTCC---------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             CCcccc--cccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence            322211  1223445778999999976  468999999999999999999 99999887665443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-37  Score=326.42  Aligned_cols=211  Identities=24%  Similarity=0.320  Sum_probs=166.9

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC--
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--  432 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--  432 (622)
                      ..+.+.|++.+.||+  |+||.||+|++..+|+.||||++.....+....+++.+|+.+|+.++|||||++++++...  
T Consensus        25 ~~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           25 WEVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             EEEETTEEEEEECC------CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cCCCCceEEeeEEee--cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            445688999999999  7899999999999999999999977655666678899999999999999999999999764  


Q ss_pred             ----CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        433 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       433 ----~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                          ...++++|++ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence                5689999999 5889888765   2478999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      +......       .....+|+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+...++..
T Consensus       179 a~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  241 (367)
T 2fst_X          179 ARHTADE-------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  241 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccc-------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            6543211       1234678899999998653 3689999999999999999999999998876655443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-37  Score=311.21  Aligned_cols=217  Identities=21%  Similarity=0.326  Sum_probs=177.9

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .+.+.|.+.+.||+  |+||.||+|+++.+++.+|+|++...... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus        19 ~i~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           19 TIDDLFIFKRKLGS--GAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             CHHHHEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             Chhhheeecceecc--CCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            34567999999999  88999999999999999999998754322 2246788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCceEEcCccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMC  510 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl---~~~~~~~~~~~~~~~  510 (622)
                      ++||||+++|+|.+++...  ....+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+++.|||.+.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999988543  23458899999999999999999999999999999999999   445789999999765


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .+....     ......+|+.|+|||++.+   .++.++|||||||++|||++|+.||...+...........
T Consensus       176 ~~~~~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~  240 (285)
T 3is5_A          176 LFKSDE-----HSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK  240 (285)
T ss_dssp             C---------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             ecCCcc-----cCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC
Confidence            433211     1223457889999999864   5789999999999999999999999887665544444333

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.9e-37  Score=331.75  Aligned_cols=240  Identities=23%  Similarity=0.356  Sum_probs=189.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-cE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-DL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-~~  435 (622)
                      ..++|++.+.||+  |+||.||+++..  |+.||||++....    ..+.+.+|+.+|+.++|||||++++++.... .+
T Consensus       191 ~~~~~~~~~~lG~--G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             ChHHeEEEeeecC--cCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            3567999999999  889999999875  7899999997543    2357899999999999999999999987765 79


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++|||||++|+|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||.+......
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            99999999999999998765445788899999999999999999999999999999999999999999999976532211


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCc
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTT  593 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~  593 (622)
                             .....+++.|+|||++..  ..|+.++|||||||++|||+| |+.||...+..........+..+..++ ++.
T Consensus       343 -------~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~  413 (450)
T 1k9a_A          343 -------QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  413 (450)
T ss_dssp             -----------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred             -------ccCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence                   112245678999999975  468999999999999999998 999998876655544444444433333 344


Q ss_pred             ccccCCCCcCcccccchhhh
Q psy15039        594 YYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~  613 (622)
                      ...+....|...++.++.+-
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~  433 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTF  433 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCChhHCcCH
Confidence            44444444444444444443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.9e-37  Score=318.30  Aligned_cols=206  Identities=20%  Similarity=0.232  Sum_probs=176.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      +.++|++.+.||+  |+||.||+|++..+|+.||||++......    +.+.+|+.+++.| +||||+++++++...+..
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            7 VGPNFRVGKKIGC--GNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             ETTTEEEEEECCC---CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EcCCeEEEEEeec--cCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            4578999999999  88999999999999999999998754322    3578999999999 999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-----eEEcCccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-----ACLSGLRYMC  510 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~-----~~~~~~~~~~  510 (622)
                      ++||||+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.     +++.|||.+.
T Consensus        81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            9999999 89999999864 235889999999999999999999999999999999999999887     9999999876


Q ss_pred             ccCCCCCcee---ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        511 PFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       511 ~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      .+........   .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            5433221111   11234578999999999976  468999999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-37  Score=318.58  Aligned_cols=215  Identities=19%  Similarity=0.315  Sum_probs=175.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCC--CccceeEEEEEeCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH--PNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~  434 (622)
                      ....|++.+.||+  |+||.||++.+. +++.||||++..........+.+.+|+.+|+.++|  |||+++++++.+.+.
T Consensus         7 ~~~~y~i~~~lG~--G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            7 KGRIYSILKQIGS--GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSCEEEEEEEESC--CSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ecCEEEEEEEEec--CCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            4567999999999  889999999985 69999999998877777777889999999999976  999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +++||| +.+++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+++.|||.+..+..
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEEEEe-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            999999 67789999998743  478889999999999999999999999999999999997 68899999998754432


Q ss_pred             CCCceeccCCCCCCCCcccccccccc---------CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQ---------NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ...  ........||+.|+|||++.+         ....|+.++|||||||++|||++|++||............
T Consensus       160 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  232 (343)
T 3dbq_A          160 DTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  232 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             ccc--cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence            211  111234568899999999853         1135788999999999999999999999876555433333

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.1e-37  Score=310.71  Aligned_cols=248  Identities=16%  Similarity=0.270  Sum_probs=189.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH--HHH---HHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDL---KSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~--~~~---~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ..++|++.+.||+  |+||.||+|++..+++.||+|++.......  ...   +.+.+|+.+++.++||||+++++++.+
T Consensus        17 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           17 ADNEIEYEKQIGK--GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CSTTEEEEEECCC--CSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhccceehhcccc--CCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            3578999999999  889999999999999999999987543322  211   678999999999999999999999866


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCc-----eEEc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGK-----ACLS  504 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~--iiHRDlKp~NILl~~~~~-----~~~~  504 (622)
                      ..  ++||||+++|+|.+.+.... ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.     +++.
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            54  79999999999998886543 35789999999999999999999999  999999999999988876     9999


Q ss_pred             CcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHH--HHHHH-
Q psy15039        505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM--LIEKL-  581 (622)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~--~~~~~-  581 (622)
                      |||.+......       .....+|+.|+|||++......++.++|||||||++|||++|+.||........  ..... 
T Consensus       172 Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  244 (287)
T 4f0f_A          172 DFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE  244 (287)
T ss_dssp             CCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred             CCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence            99976532221       123457888999999954335678899999999999999999999987654332  22222 


Q ss_pred             cCCCCCCCC-CCcccccCCCCcCcccccchhhhhhh
Q psy15039        582 AGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQT  616 (622)
Q Consensus       582 ~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  616 (622)
                      .+..|.+.+ ++....+....+...+..++++-.+.
T Consensus       245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  280 (287)
T 4f0f_A          245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI  280 (287)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            233333322 23333444444455555555554443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.1e-37  Score=311.49  Aligned_cols=211  Identities=18%  Similarity=0.372  Sum_probs=181.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ...+|++.+.||+  |+||.||+|.+..+++.||+|++..+.   ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        11 ~~~~~~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGG--GTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCC--CCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            4567999999999  789999999999999999999987543   23567889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+.......
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999999987655568899999999999999999999999999999999999999999999999876543322


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHH
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLML  577 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~  577 (622)
                      ..   ......+|+.|+|||++.+  ..++.++|||||||++|+|++ |.+||...+.....
T Consensus       166 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~  222 (288)
T 3kfa_A          166 YT---AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  222 (288)
T ss_dssp             SE---EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             cc---cccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            11   1123445778999999975  468999999999999999999 99999877655433

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.2e-37  Score=313.03  Aligned_cols=249  Identities=17%  Similarity=0.221  Sum_probs=189.0

Q ss_pred             CCCCceEee-ecccccCCeeEEEEEE--EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        357 VPSNYKICS-ILGQCFNNLSSVYLSK--HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       357 ~~~~y~~~~-~lg~g~g~~~~V~~~~--~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ....|++.+ .||+  |+||.||+|.  +..+++.||||++..........+.+.+|+.+++.++||||+++++++ ..+
T Consensus        14 ~~~~y~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           14 DRKLLTLEDKELGS--GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             CGGGEEEEEEEEEE--CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             cchhhhhccCcccc--ccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            346789988 9999  8899999994  467789999999976544444567899999999999999999999998 567


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            7899999999999999998743  47899999999999999999999999999999999999999999999999876544


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-C
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-C  591 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~  591 (622)
                      ...... .......+|+.|+|||++.+  ..++.++|||||||++|||++ |+.||..............+..+.... +
T Consensus       169 ~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1xbb_A          169 ADENYY-KAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC  245 (291)
T ss_dssp             TTCSEE-EC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             cCCCcc-cccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            332221 11222345678999999965  458889999999999999999 999998876655444444444443332 2


Q ss_pred             CcccccCCCCcCcccccchhhh
Q psy15039        592 TTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       592 ~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      +....+....+...+..++.+-
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~  267 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGF  267 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CHHHHHHHHHHcCCChhhCcCH
Confidence            3333333444444444444443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-37  Score=321.57  Aligned_cols=220  Identities=19%  Similarity=0.297  Sum_probs=179.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~  430 (622)
                      ..++|++.+.||+  |+||.||+|++     ..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        43 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           43 PRENLEFGKVLGS--GAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHceeeeeecC--CCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3578999999999  88999999997     3467789999997542 233456889999999999 9999999999999


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHFN---------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVK  489 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~~---------------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlK  489 (622)
                      ..+..++||||+++|+|.+++.....                     ..+++..+..++.||+.||+|||++||+|||||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            99999999999999999999976432                     136888899999999999999999999999999


Q ss_pred             CCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCC
Q psy15039        490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPF  568 (622)
Q Consensus       490 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf  568 (622)
                      |+|||++.++.+++.|||.+..........  ......+|+.|+|||++.+  ..++.++|||||||++|||+| |..||
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccce--eccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999876443222111  1223456778999999975  468999999999999999998 99999


Q ss_pred             CCCCcHHHHHHHHcC
Q psy15039        569 AETPTTLMLIEKLAG  583 (622)
Q Consensus       569 ~~~~~~~~~~~~~~~  583 (622)
                      ...+....+...+..
T Consensus       276 ~~~~~~~~~~~~~~~  290 (344)
T 1rjb_A          276 PGIPVDANFYKLIQN  290 (344)
T ss_dssp             TTCCCSHHHHHHHHT
T ss_pred             ccCCcHHHHHHHHhc
Confidence            887766555555444

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.5e-37  Score=315.03  Aligned_cols=220  Identities=17%  Similarity=0.278  Sum_probs=183.9

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~  430 (622)
                      ..++|++.+.||+  |+||.||+|++     ..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        21 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           21 PRNRLSFGKTLGA--GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ChhhhhHHHhhCc--cCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            3467999999999  88999999984     5678999999997543 344567899999999999 9999999999999


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHFN----------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHIL  494 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~~----------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NIL  494 (622)
                      ..+..++||||+++|+|.+++.....                ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  177 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence            99999999999999999999976532                14789999999999999999999999999999999999


Q ss_pred             EcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCc
Q psy15039        495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPT  573 (622)
Q Consensus       495 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~  573 (622)
                      ++.++.+++.|||.+.........  .......+|+.|+|||++.+  ..++.++|||||||++|||+| |++||...+.
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EcCCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999987654433221  11223456778999999975  468999999999999999999 9999988776


Q ss_pred             HHHHHHHHcC
Q psy15039        574 TLMLIEKLAG  583 (622)
Q Consensus       574 ~~~~~~~~~~  583 (622)
                      ...+...+..
T Consensus       254 ~~~~~~~~~~  263 (313)
T 1t46_A          254 DSKFYKMIKE  263 (313)
T ss_dssp             SHHHHHHHHH
T ss_pred             hhHHHHHhcc
Confidence            5555444433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-37  Score=311.78  Aligned_cols=208  Identities=24%  Similarity=0.425  Sum_probs=177.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||||++........ ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        13 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           13 IDDFDIGRPLGK--GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeheecC--CCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            467999999999  7899999999999999999999864321111 1356889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++....  .+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+.......
T Consensus        91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            9999999999999987654  47899999999999999999999999999999999999999999999999764432211


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                            .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.........
T Consensus       169 ------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  221 (284)
T 2vgo_A          169 ------RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH  221 (284)
T ss_dssp             ------BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             ------cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH
Confidence                  123457889999999975  45889999999999999999999999876554443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.3e-37  Score=322.95  Aligned_cols=215  Identities=19%  Similarity=0.311  Sum_probs=176.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCccceeEEEEEeCCcE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR--HPNIICYISSFLDATDL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~~~~  435 (622)
                      ...|++.+.||+  |+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.|+  |||||++++++...+.+
T Consensus        55 ~~~y~~~~~LG~--G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGS--GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             TEEEEEEEEEEC--CSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CCceEEEEEEcc--CCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            346999999999  8899999999875 999999999877777777788999999999996  59999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||| +.+++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+++.|||.+..+...
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            99999 67889999998754  578888999999999999999999999999999999995 589999999987544322


Q ss_pred             CCceeccCCCCCCCCccccccccccC---------ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQN---------LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ..  .......+||+.|||||++.+.         ...|+.++|||||||++|||++|++||............+
T Consensus       208 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~  280 (390)
T 2zmd_A          208 TT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  280 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             Cc--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence            11  1112345689999999998641         1258899999999999999999999998765543333333

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.5e-37  Score=309.10  Aligned_cols=243  Identities=18%  Similarity=0.234  Sum_probs=188.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||||++............+.+|+..+..+ +||||+++++++.+.+..+
T Consensus        10 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGS--GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhhhcC--CCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            467999999999  7899999999999999999999987655555567888999999999 9999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---------------
Q psy15039        437 LVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---------------  499 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---------------  499 (622)
                      +||||+++++|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++               
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999999987642  23578999999999999999999999999999999999998544               


Q ss_pred             ----ceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHH
Q psy15039        500 ----KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL  575 (622)
Q Consensus       500 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~  575 (622)
                          .+++.|||.+......        ....+|+.|+|||++.+. ..++.++|||||||++|||++|.+|+.....  
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             CCceEEEEcccccccccCCc--------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                7899999976544321        223578889999999753 3467899999999999999999988755432  


Q ss_pred             HHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhh
Q psy15039        576 MLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       576 ~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                       ......+..|.+.+ .+....+....+...++.++++..
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  275 (289)
T 1x8b_A          237 -WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM  275 (289)
T ss_dssp             -HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             -HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHH
Confidence             23334444444433 222333333344444444444433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-37  Score=315.28  Aligned_cols=227  Identities=26%  Similarity=0.436  Sum_probs=182.1

Q ss_pred             ccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe
Q psy15039        353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD  431 (622)
Q Consensus       353 ~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~  431 (622)
                      .+....+.|++.+.||+  |+||.||+|++..+|+.||||++......   ...+.+|+.+++.+ +||||+++++++..
T Consensus        18 ~l~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGN--GTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCTTTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             hccCCCCcEEEEEEecc--CCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            34456788999999999  78999999999999999999998755332   35678999999998 89999999999987


Q ss_pred             ------CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcC
Q psy15039        432 ------ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSG  505 (622)
Q Consensus       432 ------~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~  505 (622)
                            .+..++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                  45789999999999999999875445688999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCceeccCCCCCCCCccccccccccC---ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      ||.+........    ......+|+.|+|||++...   ...++.++|||||||++|||++|+.||........+.....
T Consensus       173 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  248 (326)
T 2x7f_A          173 FGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  248 (326)
T ss_dssp             CTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence            997654332111    12234578899999998621   24578899999999999999999999988776666555555


Q ss_pred             CCCCCC
Q psy15039        583 GATPHL  588 (622)
Q Consensus       583 ~~~p~~  588 (622)
                      ...|.+
T Consensus       249 ~~~~~~  254 (326)
T 2x7f_A          249 NPAPRL  254 (326)
T ss_dssp             SCCCCC
T ss_pred             CccccC
Confidence            544443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=314.09  Aligned_cols=210  Identities=20%  Similarity=0.360  Sum_probs=159.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|++..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         9 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            9 KIEDFKVGNLLGK--GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             SGGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccceeeeeecC--CCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            4467999999999  889999999999999999999986432111 1136788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999987642 35789999999999999999999999999999999999999999999999976544322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL  575 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~  575 (622)
                      ...    .....+|+.|+|||++.+  ..++.++|||||||++|||++|++||.......
T Consensus       166 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  219 (278)
T 3cok_A          166 HEK----HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN  219 (278)
T ss_dssp             --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-
T ss_pred             CCc----ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH
Confidence            111    123457888999999975  457889999999999999999999998765433

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-36  Score=319.85  Aligned_cols=212  Identities=23%  Similarity=0.310  Sum_probs=175.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC---
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT---  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~---  433 (622)
                      +.++|++.+.||+  |+||.||+|++..+++.||||++..........+.+.+|+.+++.++|||||++++++....   
T Consensus        23 ~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           23 VLKRYQNLKPIGS--GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EETTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hhhheeEeeeeEe--cCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            4578999999999  88999999999999999999999876666666788999999999999999999999998765   


Q ss_pred             ---cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        434 ---DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       434 ---~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                         ..++||||+++ +|.+++..    .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             cccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence               68999999985 67777753    37888899999999999999999999999999999999999999999999865


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      ......     ......+|+.|+|||++.+  ..|+.++|||||||++|||++|++||.+.+....+...+.
T Consensus       176 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  240 (371)
T 2xrw_A          176 TAGTSF-----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE  240 (371)
T ss_dssp             -------------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred             cccccc-----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            433211     1123467889999999976  4689999999999999999999999998876665555444

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.8e-37  Score=310.09  Aligned_cols=224  Identities=24%  Similarity=0.333  Sum_probs=171.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..++|++.+.||+  |+||.||+|++..+|+.||||++..........+.+.++...++.++||||+++++++.+.+..+
T Consensus         5 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            5 KADDLEPIMELGR--GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cHHhhhhHHhcCC--CCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            3567999999999  88999999999999999999999765444444455566666788899999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      +||||++ |+|.+++...  ....+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+++.|||.+....
T Consensus        83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9999998 5888877542  234688999999999999999999998 99999999999999999999999999765433


Q ss_pred             CCCCceeccCCCCCCCCcccccccccc--CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHcCCCCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDGYDERSDIYSVGISCCELANGTVPFAETPTT-LMLIEKLAGATPHL  588 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~-~~~~~~~~~~~p~~  588 (622)
                      ...     ......+|+.|+|||++..  ....++.++|||||||++|||++|+.||...... ..+...+....|..
T Consensus       162 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (290)
T 3fme_A          162 DDV-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL  234 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred             ccc-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence            221     1122357888999999731  1245888999999999999999999999864443 44444455544443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.8e-37  Score=316.18  Aligned_cols=211  Identities=23%  Similarity=0.300  Sum_probs=170.8

Q ss_pred             CCCCCceEe-eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCC
Q psy15039        356 NVPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDAT  433 (622)
Q Consensus       356 ~~~~~y~~~-~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~  433 (622)
                      ...+.|++. +.||+  |+||.||+|++..+++.||||++......  ....+.+|+.+++.+ +||||+++++++.+.+
T Consensus         9 ~~~~~y~i~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGE--GAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CTTTSCEECCCCCCC--CSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ccceeEEecCceecC--CceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            456779885 78999  88999999999999999999999765322  245788999999884 7999999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---eEEcCccccc
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLRYMC  510 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~---~~~~~~~~~~  510 (622)
                      ..++||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.   +++.|||.+.
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999999999999997653  4789999999999999999999999999999999999998876   8999999765


Q ss_pred             ccCCCCCce---eccCCCCCCCCccccccccccC---ccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        511 PFSPTKKKV---HLFPPSTAYNLNWLSPEVLEQN---LDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       511 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      .........   ........+|+.|+|||++...   ...|+.++|||||||++|||++|++||....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            433211100   0111234578999999998631   1247889999999999999999999997654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.4e-37  Score=314.09  Aligned_cols=252  Identities=19%  Similarity=0.331  Sum_probs=187.2

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEcc---CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ...++|++.+.||+  |+||.||+|+...   +++.||+|++..........+.+.+|+.+++.++||||+++++++...
T Consensus        31 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           31 IDRNLLILGKILGE--GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CCGGGEEEEEEEEC---CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cCHHHeeeccceee--cCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34578999999999  7899999998765   566899999987776777778899999999999999999999999876


Q ss_pred             C-----cEEEEeeccCCCCHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEE
Q psy15039        433 T-----DLHLVSPLMGFGSCKDLINAH----FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL  503 (622)
Q Consensus       433 ~-----~~~lv~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~  503 (622)
                      .     ..++||||+++|+|.+++...    ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+++
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            5     359999999999999998542    2245889999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHc
Q psy15039        504 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~  582 (622)
                      .|||.+........  ........+++.|+|||++.+  ..++.++|||||||++|||++ |.+||..............
T Consensus       189 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  264 (313)
T 3brb_A          189 ADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH  264 (313)
T ss_dssp             CSCSCC------------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             eecCcceecccccc--cCcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence            99997654432211  111122345678999999975  468999999999999999999 9999988776655555555


Q ss_pred             CCCCCCCC-CCcccccCCCCcCcccccchhhh
Q psy15039        583 GATPHLLD-CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       583 ~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      +..+.... ++....+....+...+..++++-
T Consensus       265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  296 (313)
T 3brb_A          265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF  296 (313)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             CCCCCCCccccHHHHHHHHHHcCCChhhCcCH
Confidence            54443332 23333333444444444444443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.7e-37  Score=317.06  Aligned_cols=248  Identities=19%  Similarity=0.276  Sum_probs=191.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc-------cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK-------VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF  429 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~  429 (622)
                      .++|++.+.||+  |+||.||+|++.       .+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus        34 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           34 RDKLTLGKPLGE--GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhHeEEeeEEee--cCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            467999999999  889999999986       467899999987543 455677899999999999 999999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  495 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl  495 (622)
                      ...+..++||||+++|+|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            999999999999999999999976432              237888899999999999999999999999999999999


Q ss_pred             cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcH
Q psy15039        496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  574 (622)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~  574 (622)
                      +.++.+++.|||.+.........  .......+|+.|+|||++.+  ..++.++|||||||++|||++ |..||...+..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSE--ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             cCCCCEEEccccccccccccccc--cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999987654332211  11223345778999999975  458899999999999999999 99999887665


Q ss_pred             HHHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhh
Q psy15039        575 LMLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYIS  612 (622)
Q Consensus       575 ~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~  612 (622)
                      ........+..+.... ++..+.+....+...+..++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  305 (334)
T 2pvf_A          267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPT  305 (334)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            5444444443333322 2333333333344444444443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.6e-37  Score=316.44  Aligned_cols=251  Identities=16%  Similarity=0.216  Sum_probs=193.9

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL  430 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~  430 (622)
                      ...++|++.+.||+  |+||.||+|+++     .+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           22 VAREKITMSRELGQ--GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             CCGGGEEEEEEEEE--CSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             chhhheeeeeEecc--CCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34567999999999  889999999887     468899999987543 4455567899999999999999999999999


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceE
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHF--------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKAC  502 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~  502 (622)
                      +.+..++||||+++|+|.+++....        ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            9999999999999999999987532        13467888999999999999999999999999999999999999999


Q ss_pred             EcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHH
Q psy15039        503 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~  581 (622)
                      +.|||.+........  ........+|+.|+|||++.+  ..++.++|||||||++|||++ |.+||...+.........
T Consensus       179 l~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          179 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             ECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             ECcCccccccccccc--cccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            999997654322211  111122345778999999975  458999999999999999999 899998876665554445


Q ss_pred             cCCCCCCCC-CCcccccCCCCcCcccccchhhh
Q psy15039        582 AGATPHLLD-CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       582 ~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      .+..+...+ ++....+....+...+..++++.
T Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (322)
T 1p4o_A          255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF  287 (322)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            554433322 23333333344444444444443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-37  Score=319.97  Aligned_cols=215  Identities=24%  Similarity=0.345  Sum_probs=173.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..+.|++.+.||+  |+||.||+|++..+|+.||||++.......   ...+.+.+|+.+++.++|||||++++++.+.+
T Consensus         8 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            8 RAKRYEKLDFLGE--GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -----CEEEEEEE--ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HhcccEEEeEEee--cCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            3567999999999  789999999999999999999987543222   11346789999999999999999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..+.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            99999999996 8888876542 346778889999999999999999999999999999999999999999999876543


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ....    ......+|+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+....+...
T Consensus       164 ~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i  225 (346)
T 1ua2_A          164 SPNR----AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI  225 (346)
T ss_dssp             SCCC----CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCcc----cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            2211    12335678899999999643 35889999999999999999999999888766655444

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-36  Score=306.49  Aligned_cols=212  Identities=22%  Similarity=0.355  Sum_probs=178.1

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH----HHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ++|++.+.||+  |+||.||+|++..+|+.||+|++........    ..+.+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            5 DHYEMGEELGS--GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhHHhhcc--cCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            46999999999  8899999999999999999999876543221    24678999999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----ceEEcCccccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLRYMC  510 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~----~~~~~~~~~~~  510 (622)
                      .++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+||+++.++    .+++.|||.+.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            999999999999999997643  478999999999999999999999999999999999998887    79999999765


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      .......     .....+|+.|+|||++..  ..++.++|||||||++|+|++|+.||........+....
T Consensus       161 ~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  224 (283)
T 3bhy_A          161 KIEAGNE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS  224 (283)
T ss_dssp             ECC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             eccCCCc-----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH
Confidence            4432211     123457888999999965  468999999999999999999999998876655444333

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-37  Score=314.52  Aligned_cols=216  Identities=19%  Similarity=0.315  Sum_probs=174.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCccceeEEEEE--eC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT--DEDLKSLHHEIVCMRHLRHPNIICYISSFL--DA  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~--~~  432 (622)
                      ..++|++.+.||+  |+||.||++++..+++.||+|++......  ......+.+|+.+++.++||||+++++++.  ..
T Consensus         3 l~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            3 LIGKYLMGDLLGE--GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             --CCBCCCCEEEE--CSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred             cccceeEeeEEec--CCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence            4578999999999  88999999999999999999998643211  123467899999999999999999999985  34


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  512 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~  512 (622)
                      ...++||||++++ +.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+...
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            5789999999977 778777655556889999999999999999999999999999999999999999999999986554


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      .......  ......+|+.|+|||++.+....++.++|||||||++|||++|+.||...+.....
T Consensus       160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  222 (305)
T 2wtk_C          160 HPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF  222 (305)
T ss_dssp             CTTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             Ccccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Confidence            3221111  11234578899999999753233477999999999999999999999877654443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-36  Score=307.11  Aligned_cols=249  Identities=20%  Similarity=0.276  Sum_probs=192.0

Q ss_pred             CCCceEee-ecccccCCeeEEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICS-ILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~-~lg~g~g~~~~V~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      .++|.+.+ .||+  |+||.||+|.++  .+++.||||++.... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus         8 ~~~~~i~~~~lg~--G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            8 RDNLLIADIELGC--GNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGGEEEEEEEEEC--CTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHHhhhhhccccc--cCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            45677777 9999  889999999854  578899999997643 455667899999999999999999999998 5567


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+.....
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999999998653 23578999999999999999999999999999999999999999999999998765543


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~  592 (622)
                      .... ........+|+.|+|||++..  ..++.++|||||||++|||++ |+.||..............+..+...+ ++
T Consensus       163 ~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          163 DDSY-YTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  239 (287)
T ss_dssp             CSCE-ECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             Ccce-eeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence            2221 112233456788999999965  458899999999999999999 999998877665544444444443332 23


Q ss_pred             cccccCCCCcCcccccchhhhh
Q psy15039        593 TYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ....+....+...+..++++-.
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~  261 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFL  261 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHH
Confidence            3333334444444444444433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.8e-36  Score=317.58  Aligned_cols=218  Identities=26%  Similarity=0.430  Sum_probs=182.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCC--CCHH----HHHHHHHHHHHHhhC-CCCccceeEEEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR--MTDE----DLKSLHHEIVCMRHL-RHPNIICYISSFL  430 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~--~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~  430 (622)
                      ..+|++.+.||+  |+||.||+|+++.+|+.||||++....  ....    ..+.+.+|+.+++.+ +||||+++++++.
T Consensus        93 ~~~y~~~~~lg~--G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           93 YQKYDPKDVIGR--GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhcccceEEec--CCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            456999999999  789999999999999999999987543  2222    245678999999999 8999999999999


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                      ..+..++||||+++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+.
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            9999999999999999999987643  47899999999999999999999999999999999999999999999999866


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccC----ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN----LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      .+.....     .....+|+.|+|||++.+.    ...|+.++|||||||++|||++|++||........+.....+.
T Consensus       249 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  321 (365)
T 2y7j_A          249 HLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ  321 (365)
T ss_dssp             ECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            5443221     1235678899999998632    1257889999999999999999999998876655544444443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-36  Score=304.44  Aligned_cols=214  Identities=21%  Similarity=0.362  Sum_probs=180.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||++++. +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecC--CCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            467999999999  789999999987 67899999998665443   468899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+....... 
T Consensus        81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-  158 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  158 (267)
T ss_dssp             EECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             EEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence            999999999999997643 347889999999999999999999999999999999999999999999999765433211 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~  583 (622)
                        ........+|+.|+|||++..  ..++.++|||||||++|||++ |++||..............+
T Consensus       159 --~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~  221 (267)
T 3t9t_A          159 --YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG  221 (267)
T ss_dssp             --HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             --ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Confidence              112233456778999999975  458899999999999999999 89999887655544444444

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.4e-37  Score=316.46  Aligned_cols=220  Identities=18%  Similarity=0.297  Sum_probs=182.7

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCc-----EEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQ-----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF  429 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~-----~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~  429 (622)
                      ...++|++.+.||+  |+||.||+|++..+++     .||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus        43 ~~~~~~~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           43 FPRNNLQFGKTLGA--GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             CCTTSEEEEEEEEE--CSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHHHceeeeEecc--CCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34678999999999  8899999999987765     79999987543 445567899999999999 899999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHF------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH  497 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~  497 (622)
                      ...+..++||||+++|+|.+++....            ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence            99999999999999999999987542            234688999999999999999999999999999999999999


Q ss_pred             CCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHH
Q psy15039        498 NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLM  576 (622)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~  576 (622)
                      ++.+++.|||.+.........  .......+|+.|+|||++.+  ..++.++|||||||++|||+| |.+||........
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CCeEEECccccccccccccce--eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            999999999987544322211  11223455778999999975  458999999999999999999 9999987766555


Q ss_pred             HHHHHc
Q psy15039        577 LIEKLA  582 (622)
Q Consensus       577 ~~~~~~  582 (622)
                      +...+.
T Consensus       276 ~~~~~~  281 (333)
T 2i1m_A          276 FYKLVK  281 (333)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            444433

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-36  Score=315.03  Aligned_cols=249  Identities=17%  Similarity=0.264  Sum_probs=186.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCC----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~----~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ....|++.+.||+  |+||.||+|++..++    ..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus        42 ~~~~~~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGA--GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             CTTTEEEEEEEEE--CSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ChHHhhcccEEec--CCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            3567999999999  889999999987654    459999987543 455567899999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  512 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~  512 (622)
                      +..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999997643 35789999999999999999999999999999999999999999999999986544


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCC-C
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLL-D  590 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~-~  590 (622)
                      ...... ........+|+.|+|||++..  ..++.++|||||||++|||++ |+.||..............+..++.. .
T Consensus       198 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  274 (333)
T 1mqb_A          198 EDDPEA-TYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD  274 (333)
T ss_dssp             --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             cccccc-ccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCccc
Confidence            322111 111122345678999999965  468999999999999999999 99999887665544444444333322 2


Q ss_pred             CCcccccCCCCcCcccccchhh
Q psy15039        591 CTTYYVDTGQDDGEENACSYIS  612 (622)
Q Consensus       591 ~~~~~~~~~~~~~~~~~~~~~~  612 (622)
                      ++..+.+....+...+..++.+
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps  296 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPK  296 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCHHHHHHHHHHcCCChhhCcC
Confidence            3333333334444444444443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-37  Score=323.88  Aligned_cols=224  Identities=20%  Similarity=0.346  Sum_probs=178.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc---cCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK---VTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~---~~~~~vavK~i~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~  431 (622)
                      .++|++.+.||+  |+||.||++++.   .+++.||||++.....  .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus        53 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           53 IENFELLKVLGT--GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             GGGEEEEEEEEE--TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccceEEEEEecc--CCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            468999999999  889999999984   5899999999864321  111234567899999999 79999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                      .+..++||||+++|+|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+..
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             CceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            999999999999999999997653  478999999999999999999999999999999999999999999999998754


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC---cHHHHHHHHcCCCCCC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP---TTLMLIEKLAGATPHL  588 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~---~~~~~~~~~~~~~p~~  588 (622)
                      +......   ......+|+.|+|||++.+....++.++|||||||++|||++|+.||....   ....+...+....|+.
T Consensus       209 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  285 (355)
T 1vzo_A          209 FVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  285 (355)
T ss_dssp             CCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             cccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC
Confidence            4322111   122346788999999997543457889999999999999999999997432   2334444444444433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-36  Score=309.57  Aligned_cols=219  Identities=27%  Similarity=0.499  Sum_probs=185.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ...|++.+.||+  |+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++......++
T Consensus        21 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           21 EELFTKLEKIGK--GSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GGTEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHHHHhhhhcc--cCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            356999999999  88999999999999999999999765432 235678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++++|.+++..   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+........
T Consensus        98 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999999998864   2478999999999999999999999999999999999999999999999997654432211


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                          ......+|+.|+|||++.+  ..++.++|||||||++|||++|++||..............+..|.+
T Consensus       175 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  239 (303)
T 3a7i_A          175 ----KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL  239 (303)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             ----ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC
Confidence                1123467888999999975  4688999999999999999999999988766655544444444433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-36  Score=310.15  Aligned_cols=250  Identities=17%  Similarity=0.246  Sum_probs=187.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEE-eCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL-DAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~  433 (622)
                      ...|++.+.||+  |+||.||+|++..++   ..+|+|++... ......+.+.+|+.+++.++||||+++++++. ..+
T Consensus        24 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGR--GHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEE--ETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeee--cCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            456999999999  789999999975443   46899998753 34555678999999999999999999999865 455


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             ceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            7899999999999999997543 347888899999999999999999999999999999999999999999999876543


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-C
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-C  591 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~  591 (622)
                      ...........+..+|+.|+|||++.+  ..++.++|||||||++|||++ |.+||...+..........+..+.... +
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC  257 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             ccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence            322211222334556788999999965  468999999999999999999 677887766555554555554433322 2


Q ss_pred             CcccccCCCCcCcccccchhhh
Q psy15039        592 TTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       592 ~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      +..+.+....+...+..++++-
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~  279 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSF  279 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHcCCChhhCcCH
Confidence            3333333444444444444443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.4e-37  Score=318.03  Aligned_cols=217  Identities=18%  Similarity=0.322  Sum_probs=173.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcE----EEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL----IAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~----vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..+|++.+.||+  |+||.||+|++..+++.    ||+|++..... ....+.+.+|+.+++.++|||||++++++. .+
T Consensus        12 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           12 ETELRKLKVLGS--GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTTEEEEEEEEC--CSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             HhHceeeeeeee--cCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            467999999999  88999999999988876    77777653321 122345778999999999999999999876 56


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            7899999999999999987642 246778889999999999999999999999999999999999999999999876544


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .....  .......+|+.|+|||++.+  ..|+.++|||||||++|||+| |+.||..............+
T Consensus       167 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  233 (325)
T 3kex_A          167 PDDKQ--LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG  233 (325)
T ss_dssp             CCTTC--CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred             ccccc--ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence            32211  11223455678999999975  468999999999999999999 99999887655544333433

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.1e-37  Score=311.68  Aligned_cols=202  Identities=17%  Similarity=0.286  Sum_probs=169.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCC-------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTN-------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL  430 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~-------~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~  430 (622)
                      .++|++.+.||+  |+||.||+|+++.++       +.||+|++....  ....+.+.+|+.+++.++|||||++++++.
T Consensus         7 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQ--GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeecc--CCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            457999999999  789999999999888       479999986432  233467899999999999999999999999


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--------eE
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--------AC  502 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~--------~~  502 (622)
                      +.+..++||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999976532 3788889999999999999999999999999999999999887        89


Q ss_pred             EcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcC-CCCCCCCCc
Q psy15039        503 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPT  573 (622)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg-~~Pf~~~~~  573 (622)
                      +.|||.+......        ....+|+.|+|||++.+. ..++.++|||||||++|||++| .+||.....
T Consensus       162 l~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          162 LSDPGISITVLPK--------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             ECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eccCcccccccCc--------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence            9999975432211        112356779999999642 3589999999999999999995 555555443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-37  Score=331.10  Aligned_cols=217  Identities=24%  Similarity=0.345  Sum_probs=170.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC------HHHHHHHHHHHHHHhhCCCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHHEIVCMRHLRHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~  430 (622)
                      ..++|.+.+.||+  |+||.||+|.++.+++.||||++......      ......+.+|+.+|+.++|||||++++++.
T Consensus       133 ~~~~y~~~~~LG~--G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHTTEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhccEEEEeEEee--CCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4578999999999  88999999999999999999998754211      112335789999999999999999999875


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEcCcc
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLR  507 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~~~~  507 (622)
                       ....++||||+++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++   .+++.|||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             -cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence             45689999999999999887653  3578999999999999999999999999999999999997655   59999999


Q ss_pred             cccccCCCCCceeccCCCCCCCCcccccccccc-CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      .+.......     ......||+.|+|||++.. ....|+.++|||||||++|||++|++||........+...+..
T Consensus       288 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~  359 (419)
T 3i6u_A          288 HSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS  359 (419)
T ss_dssp             TTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred             cceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence            875443211     1223567889999999853 2245788999999999999999999999876554444444444

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.5e-36  Score=308.41  Aligned_cols=213  Identities=24%  Similarity=0.373  Sum_probs=177.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.+.|++.+.||+  |+||.||+|++..+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            7 IRKTFIFMEVLGS--GAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             HHHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhccceeeeeccC--CCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            4467999999999  8899999999999999999999975432  22356889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl---~~~~~~~~~~~~~~~~~~  513 (622)
                      +||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+++.|||.+....
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999999999987653  47899999999999999999999999999999999999   778899999999754322


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                      ..      ......+|+.|+|||++.+  ..++.++|||||||++|||++|++||..............+
T Consensus       161 ~~------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  222 (304)
T 2jam_A          161 NG------IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG  222 (304)
T ss_dssp             CB------TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred             CC------ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence            11      1112346888999999975  46899999999999999999999999887655544333433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.9e-37  Score=313.81  Aligned_cols=228  Identities=32%  Similarity=0.521  Sum_probs=167.9

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..++|++.+.||+  |+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        13 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           13 NRDDYELQEVIGS--GATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             CCCCCEEEEECC-----CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             chhhhhhhheecc--ccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            4578999999999  7899999999999999999999865432 233567889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        437 LVSPLMGFGSCKDLINAH------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~------~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                      +||||+++++|.+++...      ....+++..+..++.||+.||+|||++||+||||||+||+++.++.+++.|||.+.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999999998642      12347899999999999999999999999999999999999999999999999765


Q ss_pred             ccCCCCCc-eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        511 PFSPTKKK-VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       511 ~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                      ........ .........+|+.|+|||++.+. ..++.++|||||||++|||++|+.||...+....+........|.+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            44322111 01112234678899999998642 3578999999999999999999999988877666655555554443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.1e-37  Score=316.30  Aligned_cols=203  Identities=24%  Similarity=0.389  Sum_probs=169.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC---
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT---  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~---  433 (622)
                      ..++|++.+.||+  |+||.||+|++.  ++.||||++...   ........+|+.+++.++|||||++++++....   
T Consensus        22 ~~~~y~~~~~lg~--G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           22 QSMPLQLLEVKAR--GRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             TTEEEEEEEEEEC--STTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             chhhchhhheecc--cCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            4567999999999  889999999875  899999998643   233445677999999999999999999998754   


Q ss_pred             -cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEcCCCceE
Q psy15039        434 -DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK----------GFIHRAVKASHILISHNGKAC  502 (622)
Q Consensus       434 -~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~----------~iiHRDlKp~NILl~~~~~~~  502 (622)
                       .+++||||+++|+|.+++...   .+++..+..++.|++.||+|||++          +|+||||||+|||++.++.++
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             ceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence             379999999999999999763   378999999999999999999999          999999999999999999999


Q ss_pred             EcCcccccccCCCCCceeccCCCCCCCCccccccccccCc---cCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        503 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL---DGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      +.|||.+..+......  .......+|+.|+|||++.+..   ..++.++|||||||++|||+||++||...
T Consensus       172 L~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          172 IADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             ECCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             EccCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            9999987554332211  1123356789999999996521   23567899999999999999999999754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6e-36  Score=304.47  Aligned_cols=220  Identities=27%  Similarity=0.395  Sum_probs=183.0

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCC---CCH----HHHHHHHHHHHHHhhCC-CCccceeE
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR---MTD----EDLKSLHHEIVCMRHLR-HPNIICYI  426 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~---~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~  426 (622)
                      ....++|++.+.||+  |+||.||+|+++.+|+.||||++....   ...    ...+.+.+|+.+++.+. ||||++++
T Consensus        13 ~~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           13 HGFYENYEPKEILGR--GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             --CTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             cchhhccceeeeecC--CCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            345688999999999  789999999999999999999997653   222    22457889999999995 99999999


Q ss_pred             EEEEeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCc
Q psy15039        427 SSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  506 (622)
Q Consensus       427 ~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~  506 (622)
                      +++...+..++||||+++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+++.||
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999999997653  4789999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCceeccCCCCCCCCcccccccccc----CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        507 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ----NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      |.+........     .....+|+.|+|||++..    ....++.++|||||||++|||++|+.||...+..........
T Consensus       169 g~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          169 GFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             TTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cchhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            98665433221     123457889999999852    123578899999999999999999999988766554444444


Q ss_pred             C
Q psy15039        583 G  583 (622)
Q Consensus       583 ~  583 (622)
                      +
T Consensus       244 ~  244 (298)
T 1phk_A          244 G  244 (298)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=319.97  Aligned_cols=205  Identities=23%  Similarity=0.319  Sum_probs=174.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH------HHHHHHHHHHHHhhCCCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE------DLKSLHHEIVCMRHLRHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~~~~  430 (622)
                      ..++|++.+.||+  |+||.||+|+++.+++.||||++........      ..+.+.+|+.+|+.++|||||++++++.
T Consensus        22 ~~~~y~~~~~lG~--G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           22 YSQKYSTMSPLGS--GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             HHHHEEEEEECSS--SSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceEEEeEEEe--cCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4567999999999  8899999999999999999999986543221      2345778999999999999999999999


Q ss_pred             eCCcEEEEeeccCCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        431 DATDLHLVSPLMGFG-SCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g-~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                      +.+..++||||+.+| +|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            999999999999776 9999987643  4789999999999999999999999999999999999999999999999986


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ........     ..+..+|+.|+|||++.+. ..++.++|||||||++|||++|+.||...
T Consensus       178 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~  233 (335)
T 3dls_A          178 AYLERGKL-----FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCEL  233 (335)
T ss_dssp             EECCTTCC-----BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred             eECCCCCc-----eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence            54433221     1234578899999999753 22378999999999999999999999753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-36  Score=314.67  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=187.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEE--EEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLI--AVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~v--avK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~  434 (622)
                      .++|++.+.||+  |+||.||+|+++.+++.+  |+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        24 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           24 WNDIKFQDVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             GGGCEEEEEEEC--GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHHccceeeeec--CCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            367999999999  789999999999999866  999886432 333456789999999999 99999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK  500 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~--------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~  500 (622)
                      .++||||+++|+|.+++....              ...+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence            999999999999999987542              235789999999999999999999999999999999999999999


Q ss_pred             eEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHH
Q psy15039        501 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIE  579 (622)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~  579 (622)
                      +++.|||.+.....     ........+++.|+|||++..  ..++.++|||||||++|||+| |++||...........
T Consensus       181 ~kL~Dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~  253 (327)
T 1fvr_A          181 AKIADFGLSRGQEV-----YVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  253 (327)
T ss_dssp             EEECCTTCEESSCE-----ECCC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             EEEcccCcCccccc-----cccccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence            99999997643221     111122345678999999965  458899999999999999998 9999988765544333


Q ss_pred             HHcCCCCCCC-CCCcccccCCCCcCcccccchhhhh
Q psy15039        580 KLAGATPHLL-DCTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       580 ~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ...+..+... ..+....+....+...+..++++..
T Consensus       254 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  289 (327)
T 1fvr_A          254 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA  289 (327)
T ss_dssp             GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            3333222222 2233333334444444444444433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=316.42  Aligned_cols=247  Identities=18%  Similarity=0.295  Sum_probs=183.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEE----EEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLI----AVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~v----avK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..+|++.+.||+  |+||.||+|++..+++.+    |+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEE--CSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeee--CCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            567999999999  889999999999888765    666664332 2223467899999999999999999999998754


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                       .+++++++++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             -ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence             789999999999999997653 357899999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-C
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-C  591 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~  591 (622)
                      .....  .......+|+.|+|||++.+  ..|+.++|||||||++|||++ |++||...+..........+..++..+ +
T Consensus       169 ~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3lzb_A          169 AEEKE--YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             -------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             Ccccc--ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            32211  11223445778999999976  468999999999999999999 999998876655443333333333222 2


Q ss_pred             CcccccCCCCcCcccccchhhh
Q psy15039        592 TTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       592 ~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      +..+.+....+...+..++++-
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~  266 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKF  266 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CHHHHHHHHHHcCCChhHCcCH
Confidence            3233333334444444444443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-36  Score=306.39  Aligned_cols=216  Identities=24%  Similarity=0.397  Sum_probs=172.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|++..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A           10 IGHYVLGDTLGV--GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             ETTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             eccEEEEeeecC--CCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            468999999999  889999999999999999999986432111 11457889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+.......
T Consensus        88 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999999997653  47889999999999999999999999999999999999999999999999765443221


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                           ......+|+.|+|||++.+. ...+.++|||||||++|+|++|+.||....... +...+...
T Consensus       166 -----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~  226 (276)
T 2h6d_A          166 -----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGG  226 (276)
T ss_dssp             ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC
T ss_pred             -----ceecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcC
Confidence                 11234578889999999753 223679999999999999999999998765544 34444433

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-36  Score=309.94  Aligned_cols=219  Identities=18%  Similarity=0.220  Sum_probs=175.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|++..+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus        32 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           32 QFGPYRLRRLVGR--GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             --CCEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             EeccEEEEEEEcC--CCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            4578999999999  7899999999999999999999875433 334457889999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999998653  4788999999999999999999999999999999999999999999999976543321


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ..   .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...... .+...+....
T Consensus       188 ~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~  251 (309)
T 2h34_A          188 KL---TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI  251 (309)
T ss_dssp             ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC
T ss_pred             cc---ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC
Confidence            11   11123457888999999975  46888999999999999999999999876443 3444454443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.1e-36  Score=317.23  Aligned_cols=215  Identities=23%  Similarity=0.314  Sum_probs=180.3

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-  433 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-  433 (622)
                      ..+.+.|++.+.||+  |+||.||+|++..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.... 
T Consensus        23 ~~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           23 FDVGPRYTNLSYIGE--GAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             CCCTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccccccEEEEEEeec--CCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            345678999999999  889999999999999999999987533 4455678899999999999999999999997653 


Q ss_pred             ----cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        434 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       434 ----~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                          ..++||||++ |+|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence                6899999998 5899988753   4789999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                      ......... ........+|+.|+|||++.+. ..++.++|||||||++|||++|++||.+......+.
T Consensus       176 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  242 (364)
T 3qyz_A          176 RVADPDHDH-TGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN  242 (364)
T ss_dssp             EECCGGGCB-CCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH
T ss_pred             EecCCCCCc-cccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence            644332211 1112345788999999987543 458999999999999999999999998876554443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-37  Score=322.37  Aligned_cols=248  Identities=17%  Similarity=0.250  Sum_probs=179.3

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe-CCc
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-ATD  434 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~  434 (622)
                      ..|++.+.||+  |+||.||+|+...++   ..||+|.+.... .....+.+.+|+.+++.++|||||++++++.. .+.
T Consensus        89 ~~~~~~~~LG~--G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGR--GHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEEC--CSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeee--CCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            45889999999  889999999976543   468999986533 33456789999999999999999999998754 457


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+.....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             eEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            899999999999999997543 3467888999999999999999999999999999999999999999999998754432


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~  592 (622)
                      .............+|+.|+|||++.+  ..++.++|||||||++|||+| |.+||...+..........+..+..++ ++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            21111111233456778999999975  468999999999999999999 788998776555444444444333222 33


Q ss_pred             cccccCCCCcCcccccchhh
Q psy15039        593 TYYVDTGQDDGEENACSYIS  612 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~  612 (622)
                      ..+.+....|...+..++.+
T Consensus       323 ~~l~~li~~cl~~dp~~RPs  342 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPS  342 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHcCCChhhCcC
Confidence            33333334444444444443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.3e-37  Score=316.27  Aligned_cols=217  Identities=19%  Similarity=0.270  Sum_probs=179.7

Q ss_pred             CCCCceEe-eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCc
Q psy15039        357 VPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATD  434 (622)
Q Consensus       357 ~~~~y~~~-~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~  434 (622)
                      +.+.|.+. +.||+  |+||.||+|+++.+++.||+|++............+.+|+.+++.+ +||||+++++++...+.
T Consensus        26 ~~~~y~~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           26 FNNFYILTSKELGR--GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhEEeeccceeCC--CCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            34557777 88999  7899999999999999999999976544443456789999999998 56999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCceEEcCcccccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCP  511 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~---~~~~~~~~~~~~~~  511 (622)
                      .++||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.   ++.+++.|||.+..
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            999999999999999886544456889999999999999999999999999999999999988   78999999998754


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                      ......     .....+|+.|+|||++..  ..++.++|||||||++|||++|+.||..............
T Consensus       184 ~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  247 (327)
T 3lm5_A          184 IGHACE-----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ  247 (327)
T ss_dssp             C--------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCCccc-----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence            432211     123467889999999975  4689999999999999999999999988776655444433

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.6e-36  Score=322.08  Aligned_cols=209  Identities=19%  Similarity=0.250  Sum_probs=180.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC------CCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL------RHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~~~~~  430 (622)
                      +...|++.+.||+  |+||.||+|++..+++.||||++...   ....+.+.+|+.+++.+      +||||+++++++.
T Consensus        95 ~~~ry~~~~~LG~--G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           95 VAYRYEVLKVIGK--GSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             ETTTEEEEEEEEE--SSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             ccCcEEEEEEccc--CccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            4567999999999  88999999999999999999998643   34456778899888887      6789999999999


Q ss_pred             eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--eEEcCccc
Q psy15039        431 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK--ACLSGLRY  508 (622)
Q Consensus       431 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~--~~~~~~~~  508 (622)
                      ..+.+++||||++ ++|.+++......++++..+..++.||+.||+|||+++||||||||+|||++.++.  +++.|||.
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999997 69999988765556899999999999999999999999999999999999999987  99999997


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ++....       ...+..+|+.|||||++.+  ..|+.++|||||||++|||++|++||...+....+...
T Consensus       249 a~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i  311 (429)
T 3kvw_A          249 SCYEHQ-------RVYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM  311 (429)
T ss_dssp             CEETTC-------CCCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ceecCC-------cccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            654322       1223567889999999976  46899999999999999999999999988776655443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-36  Score=313.66  Aligned_cols=250  Identities=18%  Similarity=0.255  Sum_probs=186.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEE-----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ..++|++.+.||+  |+||.||+|+     +..+++.||||++... ........+.+|+.+++.++||||+++++++..
T Consensus        28 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGH--GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC----CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcC--CCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            4578999999999  8899999999     6678999999998643 345556688999999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEE
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFN-----FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACL  503 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~  503 (622)
                      ....++||||+++|+|.+++.....     ..+++..+..++.|++.||+|||++||+||||||+|||++.++   .+++
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999999986532     2478888999999999999999999999999999999998544   6999


Q ss_pred             cCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHc
Q psy15039        504 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~  582 (622)
                      .|||.+........  ........+|+.|+|||++.+  ..++.++|||||||++|||+| |+.||..............
T Consensus       185 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          185 GDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             CCCHHHHHHHC--------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             Cccccccccccccc--cccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            99997653322111  111223456788999999975  468999999999999999998 9999988766554444444


Q ss_pred             CCCCCCCC-CCcccccCCCCcCcccccchhhh
Q psy15039        583 GATPHLLD-CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       583 ~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      +..+.... ++....+....+...+..++++.
T Consensus       261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  292 (327)
T 2yfx_A          261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF  292 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence            44333222 23333333344444444444443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-36  Score=308.33  Aligned_cols=216  Identities=22%  Similarity=0.367  Sum_probs=171.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..+.|++.+.||+  |+||.||+|++..   .+|+|++..........+.+.+|+.+++.++||||++++++ ......+
T Consensus        22 ~~~~y~~~~~lG~--G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~   95 (289)
T 3og7_A           22 PDGQITVGQRIGS--GSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLA   95 (289)
T ss_dssp             CTTSCEEEEEEEE--CSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSSCE
T ss_pred             CccceeeeeEecC--CCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCccE
Confidence            4667999999999  8899999998643   59999998777777778889999999999999999999995 4566789


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus        96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999999986543 357888999999999999999999999999999999999999999999999765433211


Q ss_pred             CceeccCCCCCCCCcccccccccc-CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      .  ........+|+.|+|||++.. ....++.++|||||||++|||++|+.||........+...+
T Consensus       175 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  238 (289)
T 3og7_A          175 G--SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV  238 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred             c--cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence            1  111123457889999999852 12457889999999999999999999998877666655544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-36  Score=306.74  Aligned_cols=248  Identities=17%  Similarity=0.223  Sum_probs=185.5

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE-
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL-  435 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~-  435 (622)
                      .|++.+.||+  |+||.||+|++..+++   .+|+|++... ......+.+.+|+.+++.++|||||++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGK--GHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEE--ETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceecc--CCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            4778899999  7899999999766555   7999998653 3445567899999999999999999999999877665 


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      +++|||+.+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999999999987632 35788889999999999999999999999999999999999999999999987544332


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHcCCCCCCCC-CCc
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPTTLMLIEKLAGATPHLLD-CTT  593 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg-~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~  593 (622)
                      ............+|+.|+|||++.+  ..++.++|||||||++|||++| .+||...+..........+..++... .+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD  255 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             cccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence            2111122233456788999999975  4689999999999999999995 55555554444333333333322222 233


Q ss_pred             ccccCCCCcCcccccchhhh
Q psy15039        594 YYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~  613 (622)
                      ...+....+...+..++++-
T Consensus       256 ~l~~li~~~l~~~p~~Rps~  275 (298)
T 3pls_A          256 SLYQVMQQCWEADPAVRPTF  275 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHccCChhhCcCH
Confidence            33333344444444444443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.7e-37  Score=330.09  Aligned_cols=246  Identities=17%  Similarity=0.276  Sum_probs=188.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|++.. ++.||||++......   .+.+.+|+.+|+.++|||||++++++.. +..++
T Consensus       183 ~~~~~~~~~lG~--G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          183 RESLRLEVKLGQ--GCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hhHceeeeeecC--CCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            467999999999  8899999999875 467999999765444   3568999999999999999999998876 67899


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+++.|||.+....... 
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  334 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  334 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence            9999999999999975433457888999999999999999999999999999999999999999999999865433211 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                        .....+..+++.|+|||++..  ..|+.++|||||||++|||+| |++||.+....+.+.....+..++.++ ++...
T Consensus       335 --~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          335 --YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  410 (452)
T ss_dssp             ----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             --eecccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence              111223445678999999975  468999999999999999999 999998877665554444443333222 34434


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....|...++.++++-++
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~  430 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEY  430 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHccCChhhCcCHHH
Confidence            44445555555555554443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=308.32  Aligned_cols=201  Identities=21%  Similarity=0.287  Sum_probs=169.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||||++..............+|+..+..+ +|||||++++++.+.+.+++
T Consensus        57 ~~y~~~~~LG~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGH--GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEE--ETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeheecc--CCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            56999999999  7899999999999999999999876655565555666666666555 99999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+++.|||.+....... 
T Consensus       135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            99999 578988887653 358999999999999999999999999999999999999999999999999865443221 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                          ......||+.|+|||++.+   .++.++|||||||++|||++|..||...
T Consensus       212 ----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~  258 (311)
T 3p1a_A          212 ----AGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGG  258 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred             ----CCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                1223457889999999864   5899999999999999999997766543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-36  Score=317.40  Aligned_cols=210  Identities=19%  Similarity=0.292  Sum_probs=172.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC---
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT---  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~---  433 (622)
                      ...+|++.+.||+  |+||.||+|++..+|+.||||++..+..      ...+|+.+|+.++|||||+++++|....   
T Consensus         5 ~~~~y~~~~~lG~--G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGT--GSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEEC--C-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEe--ccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            4568999999999  8899999999999999999999865421      2347999999999999999999986533   


Q ss_pred             -----------------------------------cEEEEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHH
Q psy15039        434 -----------------------------------DLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLE  476 (622)
Q Consensus       434 -----------------------------------~~~lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~  476 (622)
                                                         .+++||||++ |+|.+.+...  ....+++..+..++.||+.||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                               3889999999 5888777542  2346889999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEc-CCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHH
Q psy15039        477 YIHGKGFIHRAVKASHILIS-HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVG  555 (622)
Q Consensus       477 ylH~~~iiHRDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG  555 (622)
                      |||++||+||||||+|||++ .++.+++.|||.+........     .....+|+.|+|||++.+. ..|+.++||||+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG  229 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHH
Confidence            99999999999999999998 688999999998754433221     1234568889999998653 3589999999999


Q ss_pred             HHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        556 ISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       556 vil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      |++|||++|++||.+.+...++...+
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~  255 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRII  255 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999999999887776665543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-36  Score=305.88  Aligned_cols=244  Identities=17%  Similarity=0.293  Sum_probs=187.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|++. +++.||||++......   .+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        12 ~~~y~~~~~lg~--G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (279)
T 1qpc_A           12 RETLKLVERLGA--GQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (279)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHhhhheeeecC--CCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence            467999999999  789999999976 5778999999765433   356889999999999999999999876 456899


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....... 
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  163 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence            9999999999999875433357889999999999999999999999999999999999999999999999876543321 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                        ........+++.|+|||++..  ..++.++|||||||++|||++ |++||........+.....+..+...+ .+...
T Consensus       164 --~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (279)
T 1qpc_A          164 --YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL  239 (279)
T ss_dssp             --EECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             --cccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHH
Confidence              111233456778999999965  458899999999999999999 999998876655444433333322222 22333


Q ss_pred             ccCCCCcCcccccchhhh
Q psy15039        596 VDTGQDDGEENACSYISE  613 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~  613 (622)
                      .+....+...+..++++-
T Consensus       240 ~~li~~~l~~~p~~Rps~  257 (279)
T 1qpc_A          240 YQLMRLCWKERPEDRPTF  257 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHhccChhhCCCH
Confidence            333344444444444443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-36  Score=308.45  Aligned_cols=204  Identities=25%  Similarity=0.424  Sum_probs=166.3

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh--CCCCccceeEEEEEeC-
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH--LRHPNIICYISSFLDA-  432 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~~-  432 (622)
                      .+.++|++.+.||+  |+||.||+|++  +++.||||++...     ....+.+|.+++..  ++||||+++++++... 
T Consensus         5 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGK--GRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEE--CSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeecc--CCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            34678999999999  88999999987  6999999998643     22445566666665  8999999999987653 


Q ss_pred             ---CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCce
Q psy15039        433 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--------GKGFIHRAVKASHILISHNGKA  501 (622)
Q Consensus       433 ---~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH--------~~~iiHRDlKp~NILl~~~~~~  501 (622)
                         ...++||||+++|+|.++++..   .+++..+..++.|++.||+|||        +++|+||||||+|||++.++.+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence               4589999999999999998542   5789999999999999999999        9999999999999999999999


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCcc----CCCchhhHHHHHHHHHHHHcC----------CCC
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVGISCCELANG----------TVP  567 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~~~DiwSlGvil~e~ltg----------~~P  567 (622)
                      ++.|||.+..................+|+.|+|||++.+...    .++.++|||||||++|||+||          ++|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999865444333332222334578999999999975321    345789999999999999999          899


Q ss_pred             CCCC
Q psy15039        568 FAET  571 (622)
Q Consensus       568 f~~~  571 (622)
                      |...
T Consensus       233 f~~~  236 (301)
T 3q4u_A          233 FYDV  236 (301)
T ss_dssp             TTTT
T ss_pred             cccc
Confidence            9654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.9e-36  Score=323.49  Aligned_cols=209  Identities=22%  Similarity=0.306  Sum_probs=170.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC----
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~----  433 (622)
                      ...|++.+.||+  |+||.||+|++..+|+.||||++....      +...+|+.+|+.++|||||+++++|....    
T Consensus        53 ~~~y~~~~~lG~--G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           53 EVSYTDTKVIGN--GSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             cceEEeeeEEee--CCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            346999999999  889999999999999999999986542      12347999999999999999999986532    


Q ss_pred             --cEEEEeeccCCCCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CceEEcCccc
Q psy15039        434 --DLHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRY  508 (622)
Q Consensus       434 --~~~lv~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~-~~~~~~~~~~  508 (622)
                        .+++||||+++ ++.+++..  .....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|.|||.
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence              37799999996 56665543  223468899999999999999999999999999999999999965 5689999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      +..+.....     .....+|+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+...++.+.+
T Consensus       204 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~  270 (420)
T 1j1b_A          204 AKQLVRGEP-----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII  270 (420)
T ss_dssp             CEECCTTCC-----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             hhhcccCCC-----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            754432211     1234678899999999653 368999999999999999999999999887666655543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.1e-36  Score=306.39  Aligned_cols=208  Identities=26%  Similarity=0.415  Sum_probs=168.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR-MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus        30 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGR--GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEEC--C--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecC--CCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            4467999999999  889999999999999999999997643 3455567899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        436 HLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ++||||+++++|.+++...  ....+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999999998652  23457899999999999999999999999999999999999999999999999765433


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      ....    ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       188 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  240 (310)
T 2wqm_A          188 SKTT----AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDK  240 (310)
T ss_dssp             ---------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             CCCc----cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            2111    1123456788999999975  468999999999999999999999997654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.2e-36  Score=303.35  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=181.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .++|++.+.||+  |+||.||+|++.  ++.||||++.......  ...+.+.+|+.+++.++||||+++++++...+..
T Consensus         6 ~~~~~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            6 FAELTLEEIIGI--GGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             TTSEEEEEEEEE--ETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             hhheeeeeeecc--CCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            568999999999  789999999974  8999999987543222  2246788999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcC--------CCceEEc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG---FIHRAVKASHILISH--------NGKACLS  504 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~---iiHRDlKp~NILl~~--------~~~~~~~  504 (622)
                      ++||||+++++|.+++..   ..+++..+..++.|++.||+|||++|   |+||||||+|||++.        ++.+++.
T Consensus        82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999999998853   25789999999999999999999999   899999999999986        6789999


Q ss_pred             CcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      |||.+.......      .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...+............
T Consensus       159 Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          159 DFGLAREWHRTT------KMSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CCCC-------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             cCCccccccccc------ccCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            999765433211      123467889999999975  458999999999999999999999998877665554444443


Q ss_pred             C-CCCCC-CCcccccCCCCcCcccccchhhhhhh
Q psy15039        585 T-PHLLD-CTTYYVDTGQDDGEENACSYISEQQT  616 (622)
Q Consensus       585 ~-p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  616 (622)
                      . ++..+ ++..+.+....+...+..++++-.+.
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  264 (271)
T 3dtc_A          231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNI  264 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            2 22222 23333444444555555555554443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-36  Score=316.51  Aligned_cols=205  Identities=24%  Similarity=0.381  Sum_probs=177.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..++|++.+.||+  |+||.||+|++..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        31 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           31 KDDDFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceeeeeecC--CCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            3567999999999  889999999999999999999987653 4555678999999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      +||||+++++|.+++....  .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+++.|||.+..... 
T Consensus       108 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             EEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            9999999999999997754  478899999999999999999996 999999999999999999999999997543211 


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                           .......+|+.|+|||++.+  ..|+.++|||||||++|||++|+.||......
T Consensus       185 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  236 (360)
T 3eqc_A          185 -----SMANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  236 (360)
T ss_dssp             -----HC----CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred             -----ccccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 11223467889999999976  46899999999999999999999999876543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-37  Score=326.63  Aligned_cols=222  Identities=22%  Similarity=0.365  Sum_probs=179.6

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC--c
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT--D  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~--~  434 (622)
                      ....|++.+.||+  |+||.||+|++..+|+.||||++...... ...+.+.+|+.+++.++|||||++++++...+  .
T Consensus         7 ~~~~y~i~~~LG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            7 SNHLWLLSDILGQ--GATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             SSEEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEEEc--CCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            3567999999999  88999999999999999999998743221 12456789999999999999999999998765  6


Q ss_pred             EEEEeeccCCCCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCceEEcCcccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKACLSGLRYM  509 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl----~~~~~~~~~~~~~~  509 (622)
                      .++||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+++.|||.+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            899999999999999987543 2348899999999999999999999999999999999999    77778999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccC------ccCCCchhhHHHHHHHHHHHHcCCCCCCCC----CcHHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN------LDGYDERSDIYSVGISCCELANGTVPFAET----PTTLMLIE  579 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~----~~~~~~~~  579 (622)
                      .......     ...+..+|+.|+|||++...      ...|+.++|||||||++|||++|+.||...    .....+..
T Consensus       164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  238 (396)
T 4eut_A          164 RELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (396)
T ss_dssp             EECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred             eEccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence            5543321     12235678899999998531      124778999999999999999999999642    23344444


Q ss_pred             HHcCCCC
Q psy15039        580 KLAGATP  586 (622)
Q Consensus       580 ~~~~~~p  586 (622)
                      .+.+.++
T Consensus       239 ~~~~~p~  245 (396)
T 4eut_A          239 IITGKPS  245 (396)
T ss_dssp             HHHSCCT
T ss_pred             HhcCCCc
Confidence            5555443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-36  Score=312.17  Aligned_cols=219  Identities=20%  Similarity=0.310  Sum_probs=180.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEE-----ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKH-----KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFL  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~  430 (622)
                      ..++|++.+.||+  |+||.||+|++     ..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        25 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           25 PRDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheeeeeEEcC--CCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            3567999999999  88999999985     4678999999987543 455567899999999999 7999999999988


Q ss_pred             eCC-cEEEEeeccCCCCHHHHHHhccCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy15039        431 DAT-DLHLVSPLMGFGSCKDLINAHFNF--------------GLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  495 (622)
Q Consensus       431 ~~~-~~~lv~e~~~~g~l~~~l~~~~~~--------------~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl  495 (622)
                      ..+ ..++||||+++|+|.+++......              .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            765 489999999999999999764321              26788899999999999999999999999999999999


Q ss_pred             cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcH
Q psy15039        496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  574 (622)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~  574 (622)
                      +.++.+++.|||.+..........  ......+|+.|+|||++.+  ..++.++|||||||++|||+| |+.||......
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSE--EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             CCCCCEEECCCccccccccCccce--eccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999999999999876543322111  1123456778999999975  468999999999999999998 99999877655


Q ss_pred             HHHHHHHc
Q psy15039        575 LMLIEKLA  582 (622)
Q Consensus       575 ~~~~~~~~  582 (622)
                      ..+...+.
T Consensus       258 ~~~~~~~~  265 (316)
T 2xir_A          258 EEFCRRLK  265 (316)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHhc
Confidence            55444433

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=304.01  Aligned_cols=216  Identities=31%  Similarity=0.495  Sum_probs=177.6

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .....|++.+.||+  |+||.||+|++..+|+.||||++.....    .+.+.+|+.+++.++||||+++++++...+..
T Consensus        26 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           26 QPEEVFDVLEKLGE--GSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ----CEEEEEECC------CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhheeecc--CCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            34567999999999  7899999999999999999999976432    35688999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+......
T Consensus       100 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999999998743 235789999999999999999999999999999999999999999999999986544322


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ..    ......+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||................
T Consensus       179 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  241 (314)
T 3com_A          179 MA----KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP  241 (314)
T ss_dssp             BS----CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             cc----ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence            11    1123457888999999975  458899999999999999999999998876655544444443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.8e-36  Score=303.26  Aligned_cols=215  Identities=20%  Similarity=0.374  Sum_probs=178.2

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++.+.||+  |+||.||+|+++.+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         7 ~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            7 EDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEeec--CCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            56999999999  88999999999999999999998754332 2346789999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+..+..... 
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  160 (276)
T 2yex_A           84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-  160 (276)
T ss_dssp             EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred             EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-
Confidence            9999999999887643  3478999999999999999999999999999999999999999999999997654322111 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                       ........+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.............
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  221 (276)
T 2yex_A          161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW  221 (276)
T ss_dssp             -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH
T ss_pred             -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh
Confidence             1112335678899999999753 224678999999999999999999998765443333333

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.3e-36  Score=303.00  Aligned_cols=219  Identities=18%  Similarity=0.276  Sum_probs=176.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEcc---CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..++|++.+.||+  |+||.||+|++..   ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+ +
T Consensus        10 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A           10 AREDVVLNRILGE--GFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             cccceEEEEEEEe--cCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            4568999999999  8899999998654   34569999987543 44556789999999999999999999998765 5


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            5799999999999999997653 347899999999999999999999999999999999999999999999999865443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ....   .......+|+.|+|||++..  ..++.++|||||||++|||++ |+.||..............+..
T Consensus       165 ~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~  232 (281)
T 3cc6_A          165 DEDY---YKASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR  232 (281)
T ss_dssp             -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC
T ss_pred             cccc---cccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC
Confidence            2211   11123345778999999965  468999999999999999998 9999987665554444444433

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.4e-36  Score=306.91  Aligned_cols=223  Identities=25%  Similarity=0.360  Sum_probs=180.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..+.|++.+.||+  |+||.||+|++..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        17 ~~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           17 PNEVWEIVGELGD--GAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             GGGTEEEEEEEEC--STTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             Cccceeecceecc--CCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            4567999999999  889999999999999999999986542  223567889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+...... 
T Consensus        93 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             EEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            9999999999999887643 35789999999999999999999999999999999999999999999999975321110 


Q ss_pred             CceeccCCCCCCCCcccccccccc---CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                         ........+|+.|+|||++..   ....++.++|||||||++|||++|++||...+....+.....+..|..
T Consensus       171 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  242 (302)
T 2j7t_A          171 ---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL  242 (302)
T ss_dssp             ---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             ---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc
Confidence               011123457888999999841   124578899999999999999999999988776666555555554443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-36  Score=311.27  Aligned_cols=211  Identities=19%  Similarity=0.309  Sum_probs=177.4

Q ss_pred             ccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       353 ~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      .+....++|++.+.||+  |+||.||+|+++ +++.||||++.....  ...+.+.+|+.+++.++|||||++++++...
T Consensus        33 ~~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGH--GVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCCCCCSCCCCSCB--CSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHHHhccCccceeec--CCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34556789999999999  889999999965 689999999876533  3356789999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHF--NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                      +..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999999886543  2247899999999999999999999999999999999999999999999999765


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      ........  .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       188 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          188 KGTELDQT--HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             ECSSSSCC--CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             cccccccc--ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            43221111  11123457889999999975  468999999999999999999999997653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-36  Score=318.42  Aligned_cols=209  Identities=22%  Similarity=0.348  Sum_probs=177.2

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .+.++|.+.+.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus        39 ~l~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           39 ELPKTYVSPTHVGS--GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EEETTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred             cccccEEEEeEEec--CCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence            45678999999999  8899999999999999999999987666666678899999999999999999999999887654


Q ss_pred             ------EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        436 ------HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       436 ------~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                            ++||||++ ++|.+++..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus       117 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          117 RNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             TTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             ccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence                  99999998 577766532    4789999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                      ......       .....+|+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+....+..
T Consensus       192 ~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          192 RHADAE-------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             ---------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccC-------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            533211       2234678899999998653 3588999999999999999999999988765554444

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5e-36  Score=303.55  Aligned_cols=216  Identities=25%  Similarity=0.407  Sum_probs=181.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ..+.|++.+.||+  |+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++...+..+
T Consensus        20 ~~~~y~i~~~lg~--G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           20 FAERYNIVCMLGK--GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HhhcceeeEEEcC--CCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            3467999999999  78999999999999999999998755433334567899999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---ceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG---KACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~---~~~~~~~~~~~~~~  513 (622)
                      +||||+++++|.+++....  .+++..+..++.|++.||+|||++||+||||||+||+++.++   .+++.|||.+....
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999999999887643  478999999999999999999999999999999999997644   69999999765443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....     .....+|+.|+|||++.+   .++.++|||||||++|+|++|++||...+....+.....+.
T Consensus       176 ~~~~-----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (287)
T 2wei_A          176 QNTK-----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK  238 (287)
T ss_dssp             CCSS-----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             CCCc-----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            2211     122346788999999864   48899999999999999999999998876655544444443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-37  Score=328.23  Aligned_cols=206  Identities=14%  Similarity=0.208  Sum_probs=162.4

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHH---HHHhhCCCCccceeE-----
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEI---VCMRHLRHPNIICYI-----  426 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~E~---~~l~~l~HpnIv~~~-----  426 (622)
                      ...++|++.+.||+  |+||.||+|+++.+|+.||||++..... .....+.+.+|+   .+|+.++|||||+++     
T Consensus        70 ~~~~~y~~~~~lG~--G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           70 ERPRTLVRGTVLGQ--EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             CCCEEEEEEEEEEE--ETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             CCCceEEEcceeec--CCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            34578999999999  7899999999999999999999975422 334457889999   555566899999998     


Q ss_pred             --EEEEeCCc-----------------EEEEeeccCCCCHHHHHHhccCCC-----CCHHHHHHHHHHHHHHHHHHHhCC
Q psy15039        427 --SSFLDATD-----------------LHLVSPLMGFGSCKDLINAHFNFG-----LPELVICHILQDVLNGLEYIHGKG  482 (622)
Q Consensus       427 --~~~~~~~~-----------------~~lv~e~~~~g~l~~~l~~~~~~~-----~~~~~~~~~~~qi~~gL~ylH~~~  482 (622)
                        +++.+.+.                 .|+||||+ +|+|.+++.......     +++..+..++.||+.||+|||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence              66665532                 89999999 589999997643221     224777789999999999999999


Q ss_pred             ceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccC---------ccCCCchhhHHH
Q psy15039        483 FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN---------LDGYDERSDIYS  553 (622)
Q Consensus       483 iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~~~DiwS  553 (622)
                      |+||||||+|||++.++.+++.|||.+.....   ..    ....+ +.|+|||++.+.         ...|+.++||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~----~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS  298 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RV----VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA  298 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EE----ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC---cc----cCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence            99999999999999999999999998654221   11    12345 789999999752         015899999999


Q ss_pred             HHHHHHHHHcCCCCCCCCC
Q psy15039        554 VGISCCELANGTVPFAETP  572 (622)
Q Consensus       554 lGvil~e~ltg~~Pf~~~~  572 (622)
                      |||++|||++|+.||....
T Consensus       299 lG~il~elltg~~Pf~~~~  317 (377)
T 3byv_A          299 LGLVIYWIWCADLPITKDA  317 (377)
T ss_dssp             HHHHHHHHHHSSCCC----
T ss_pred             HHHHHHHHHHCCCCCcccc
Confidence            9999999999999997654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.4e-36  Score=311.09  Aligned_cols=215  Identities=21%  Similarity=0.269  Sum_probs=177.5

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC--
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA--  432 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--  432 (622)
                      ..+.++|++.+.||+  |+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++...  
T Consensus         7 ~~i~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            7 YNISSDFQLKSLLGE--GAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCSCTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             cccccceEEeeEEcC--CCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            356789999999999  889999999999999999999986432 344556788999999999999999999988764  


Q ss_pred             ---CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        433 ---TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       433 ---~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                         ...++||||++ |+|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence               67899999998 5899888763   4789999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCcee------ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        510 CPFSPTKKKVH------LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       510 ~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ...........      .......+|+.|+|||++... ..++.++|||||||++|||++|++||...+....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  232 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL  232 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            65443211110      011234678899999988543 45889999999999999999999999887655443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.2e-36  Score=306.27  Aligned_cols=205  Identities=20%  Similarity=0.303  Sum_probs=171.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC-
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-  432 (622)
                      ...|++.+.||+  |+||.||+|+    +..+++.||||++.... .....+.+.+|+.+++.++||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGE--GHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCC--CCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            345899999999  8899999999    67899999999987543 222346789999999999999999999999877 


Q ss_pred             -CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        433 -TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       433 -~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                       ..+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence             66899999999999999996543 3478999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA  569 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~  569 (622)
                      ....... ........+|+.|+|||++.+  ..++.++|||||||++|||++|..|+.
T Consensus       176 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          176 IETDKEY-YTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CCTTCCE-EECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccCCCcc-eeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            5433221 122334567788999999976  457889999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2e-36  Score=304.98  Aligned_cols=239  Identities=23%  Similarity=0.353  Sum_probs=179.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC-CcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-TDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-~~~~  436 (622)
                      .++|++.+.||+  |+||.||++++.  |+.||||++....    ..+.+.+|+.+++.++||||+++++++... +..+
T Consensus        20 ~~~y~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEec--CCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence            467999999999  889999999874  8899999987543    346788999999999999999999987655 4789


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+++.|||.+...... 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            9999999999999997654333678889999999999999999999999999999999999999999999976433221 


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCcc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTY  594 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~  594 (622)
                            .....+++.|+|||++.+  ..++.++|||||||++|||+| |++||...+..........+..+...+ ++..
T Consensus       171 ------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (278)
T 1byg_A          171 ------QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA  242 (278)
T ss_dssp             -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred             ------ccCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHH
Confidence                  112345678999999965  468999999999999999998 999998876555443333333332222 2333


Q ss_pred             cccCCCCcCcccccchhhh
Q psy15039        595 YVDTGQDDGEENACSYISE  613 (622)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~  613 (622)
                      ..+....+...++..+++-
T Consensus       243 l~~li~~~l~~~p~~Rps~  261 (278)
T 1byg_A          243 VYEVMKNCWHLDAAMRPSF  261 (278)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHhcCChhhCCCH
Confidence            3333333444444444433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-35  Score=302.04  Aligned_cols=205  Identities=17%  Similarity=0.177  Sum_probs=174.7

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|++..+|+.||||++......    +.+.+|+.+++.+ +||||+++++++......
T Consensus         8 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            8 VGVHYKVGRRIGE--GSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             ETTTEEEEEEEEE--CSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccceEEEEEEee--cCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            4578999999999  88999999999999999999998654322    3578899999999 899999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-----eEEcCccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK-----ACLSGLRYMC  510 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~-----~~~~~~~~~~  510 (622)
                      ++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.     +++.|||.+.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999999 999999998643 35889999999999999999999999999999999999988776     9999999876


Q ss_pred             ccCCCCCcee---ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        511 PFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       511 ~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ..........   .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~  221 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGL  221 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence            5433221110   11234568899999999975  45899999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.1e-36  Score=310.20  Aligned_cols=206  Identities=21%  Similarity=0.328  Sum_probs=175.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe--
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--  431 (622)
                      ..+|++.+.||+  |+||.||+|+    +..+++.||||++...  .....+.+.+|+.+++.++||||+++++++..  
T Consensus        22 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGK--GNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccC--CCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            457999999999  7899999999    6788999999998754  34556789999999999999999999999874  


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                      ....++||||+++++|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            4568999999999999999976432 478999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ....... ........+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       177 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          177 LPLDKDY-YVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             CCTTCSE-EECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cccCCcc-ceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            5433222 122233456788999999976  45889999999999999999999998654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=335.77  Aligned_cols=248  Identities=20%  Similarity=0.274  Sum_probs=187.0

Q ss_pred             CCCceEee-ecccccCCeeEEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICS-ILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~-~lg~g~g~~~~V~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ..++.+.+ .||+  |+||.||+|..+  .++..||||++.... .....+.+.+|+.+|+.++|||||++++++.. +.
T Consensus       334 ~~~~~~~~~~LG~--G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          334 RDNLLIADIELGC--GNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TTSEEEEEEEEEE--CSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             ccceeEcCcEEec--CCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            45566666 7999  889999999875  456779999987543 22345679999999999999999999999876 56


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +++|||||++|+|.+++... ...+++..+..++.||+.||+|||+++||||||||+|||++.++.++|.|||.+.....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            99999999999999998654 33578999999999999999999999999999999999999999999999998754432


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~  592 (622)
                      ..... .......+|+.|||||++..  ..|+.++|||||||++|||++ |+.||...+..+.......+..+..++ ++
T Consensus       489 ~~~~~-~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  565 (613)
T 2ozo_A          489 DDSYY-TARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  565 (613)
T ss_dssp             --------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred             CCcee-eeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence            22111 11122345678999999975  468999999999999999998 999999887766555555554443333 44


Q ss_pred             cccccCCCCcCcccccchhhh
Q psy15039        593 TYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      ..+.+....|...+..++.+-
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~  586 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDF  586 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCH
T ss_pred             HHHHHHHHHHcCCChhHCcCH
Confidence            444444444444444444443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8e-36  Score=303.02  Aligned_cols=206  Identities=25%  Similarity=0.423  Sum_probs=171.2

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEee
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSP  440 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e  440 (622)
                      |.....||+  |+||.||+|++..+++.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        24 ~~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGK--GTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEE--CSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEee--cCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            444458999  889999999999999999999987653  2334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCceEEcCcccccccCCCCCc
Q psy15039        441 LMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       441 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |+++++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+++. ++.+++.|||.+.......  
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            999999999997653 234678888899999999999999999999999999999987 8999999999765443211  


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                        .......+|+.|+|||++.+....++.++|||||||++|||++|+.||......
T Consensus       178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  231 (295)
T 2clq_A          178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP  231 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred             --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence              112234678899999999754334789999999999999999999999765443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4e-36  Score=315.06  Aligned_cols=209  Identities=16%  Similarity=0.233  Sum_probs=168.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccC-----CcEEEEEEecCCCCCH-HHH--------HHHHHHHHHHhhCCCCcc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVT-----NQLIAVKKFNLDRMTD-EDL--------KSLHHEIVCMRHLRHPNI  422 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~-----~~~vavK~i~~~~~~~-~~~--------~~~~~E~~~l~~l~HpnI  422 (622)
                      ..++|++.+.||+  |+||.||+|.+..+     ++.||||++....... .+.        ....+|+..++.++||||
T Consensus        33 ~~~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           33 AAAAWKVGLPIGQ--GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             TCCEEEEEEECCC--C-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             CCCeEEEEEEEec--CCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            4568999999999  88999999998775     5889999987543110 001        123456777888899999


Q ss_pred             ceeEEEEEeC----CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--
Q psy15039        423 ICYISSFLDA----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS--  496 (622)
Q Consensus       423 v~~~~~~~~~----~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~--  496 (622)
                      |++++++...    ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++  
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            9999998875    3489999999 999999997642 3589999999999999999999999999999999999999  


Q ss_pred             CCCceEEcCcccccccCCCCCcee---ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        497 HNGKACLSGLRYMCPFSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      .++.++|.|||.+..+........   .......||+.|||||++.+  ..++.++|||||||++|||+||+.||.+.
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            889999999998755433221111   11123458999999999976  45899999999999999999999999854

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6e-36  Score=316.89  Aligned_cols=209  Identities=23%  Similarity=0.358  Sum_probs=169.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc---
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD---  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~---  434 (622)
                      ...|++.+.||+  |+||.||+|++..+++ +|+|++.....      ...+|+.+|+.++|||||+++++|.....   
T Consensus        39 ~~~Y~~~~~lG~--G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           39 EIAYTNCKVIGN--GSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             EEEEEEEEEEEE--ETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             cceEEEeEEEee--CCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            456999999999  7899999999988776 88888764321      22479999999999999999999976543   


Q ss_pred             ---EEEEeeccCCCCHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCceEEcCcccc
Q psy15039        435 ---LHLVSPLMGFGSCKDLINA-HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKACLSGLRYM  509 (622)
Q Consensus       435 ---~~lv~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~-~~~~~~~~~~~~~  509 (622)
                         +++||||++++.+..+... .....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+++.|||.+
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence               8899999997544443321 1234588999999999999999999999999999999999999 7899999999986


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~  581 (622)
                      ........     .....+|+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+...++...+
T Consensus       190 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~  255 (394)
T 4e7w_A          190 KILIAGEP-----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII  255 (394)
T ss_dssp             EECCTTCC-----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccccCCCC-----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            54432211     2235678899999998653 358999999999999999999999999887766665543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-36  Score=338.12  Aligned_cols=241  Identities=18%  Similarity=0.227  Sum_probs=183.3

Q ss_pred             eecccccCCeeEEEEEEE--ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeecc
Q psy15039        365 SILGQCFNNLSSVYLSKH--KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM  442 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~  442 (622)
                      +.||+  |+||.||+|.+  +.+++.||||++..........+.+.+|+.+|+.++|||||++++++. .+..++|||||
T Consensus       375 ~~LG~--G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGS--GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMA  451 (635)
T ss_dssp             EEEEE--CSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECC
T ss_pred             CEecc--CCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEcc
Confidence            47999  88999999954  567789999999765444444678999999999999999999999886 45689999999


Q ss_pred             CCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceecc
Q psy15039        443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  522 (622)
Q Consensus       443 ~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (622)
                      ++|+|.+++....  .+++..+..++.||+.||+|||++|||||||||+|||++.++.++|.|||.+..+...... ...
T Consensus       452 ~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~  528 (635)
T 4fl3_A          452 ELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKA  528 (635)
T ss_dssp             TTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-ccc
Confidence            9999999997643  4789999999999999999999999999999999999999999999999987654332211 111


Q ss_pred             CCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCcccccCCC
Q psy15039        523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYYVDTGQ  600 (622)
Q Consensus       523 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~  600 (622)
                      .....+|+.|+|||++..  ..|+.++|||||||++|||++ |+.||.+.+..........+..+...+ ++..+.+...
T Consensus       529 ~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             ------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            222345778999999965  468999999999999999998 999998887665554445554443332 3333333444


Q ss_pred             CcCcccccchhhh
Q psy15039        601 DDGEENACSYISE  613 (622)
Q Consensus       601 ~~~~~~~~~~~~~  613 (622)
                      .|...+..++++-
T Consensus       607 ~cl~~dP~~RPs~  619 (635)
T 4fl3_A          607 LCWTYDVENRPGF  619 (635)
T ss_dssp             HHTCSSTTTSCCH
T ss_pred             HHcCCCHhHCcCH
Confidence            4444444444443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-36  Score=331.27  Aligned_cols=245  Identities=18%  Similarity=0.280  Sum_probs=190.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|++.. ++.||||++......   .+.+.+|+.+|+.|+|||||++++++.. ..+++
T Consensus       266 ~~~~~~~~~lG~--G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQ--GCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hhhhhhheeccc--CCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            467999999999  8899999999875 467999999865544   3568999999999999999999998866 67899


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||+++||||||||+|||++.++.++|.|||.+......  
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  416 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--  416 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH--
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC--
Confidence            999999999999997543345788899999999999999999999999999999999999999999999986543321  


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCC-CCCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLL-DCTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~-~~~~~~  595 (622)
                       .........+++.|||||++..  ..|+.++|||||||++|||++ |+.||.+....+.+.....+..++.. .++..+
T Consensus       417 -~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          417 -EYTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  493 (535)
T ss_dssp             -HHHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             -ceecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence             1112233456778999999975  468999999999999999999 99999887666554444444333222 233333


Q ss_pred             ccCCCCcCcccccchhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~  614 (622)
                      .+....|...+..++.+-+
T Consensus       494 ~~li~~cl~~dP~~RPt~~  512 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFE  512 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHcCCChhHCcCHH
Confidence            3444444444444444433

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-36  Score=306.98  Aligned_cols=238  Identities=19%  Similarity=0.315  Sum_probs=178.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||++++.  ++.||||++...    ...+.+.+|+.+++.++|||||++++++.  +..++
T Consensus         7 ~~~~~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGR--GAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCL   76 (307)
T ss_dssp             GGGEEEEEEEEC--CSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEE
T ss_pred             HhHeeeeeEeec--CCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEE
Confidence            357999999999  889999999874  789999998632    23567899999999999999999999876  45799


Q ss_pred             EeeccCCCCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEcCCCc-eEEcCccccccc
Q psy15039        438 VSPLMGFGSCKDLINAHFNF-GLPELVICHILQDVLNGLEYIHG---KGFIHRAVKASHILISHNGK-ACLSGLRYMCPF  512 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~-~~~~~~~~~~~~qi~~gL~ylH~---~~iiHRDlKp~NILl~~~~~-~~~~~~~~~~~~  512 (622)
                      ||||+++|+|.+++...... .+++..+..++.|++.||+|||+   +||+||||||+|||++.++. +++.|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            99999999999999754321 36788889999999999999999   89999999999999998886 799999976543


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH--HHHHHHHcCCCCCCCC
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLD  590 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~--~~~~~~~~~~~p~~~~  590 (622)
                      ...       .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||......  ........+..|+...
T Consensus       157 ~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  227 (307)
T 2eva_A          157 QTH-------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK  227 (307)
T ss_dssp             ---------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBT
T ss_pred             ccc-------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccc
Confidence            221       122357888999999975  46899999999999999999999999865432  2222334444444433


Q ss_pred             -CCcccccCCCCcCcccccchhhhh
Q psy15039        591 -CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       591 -~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                       ++....+....+...+..++++-.
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~  252 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSME  252 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHH
Confidence             333333344444444444444433

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.5e-36  Score=312.09  Aligned_cols=208  Identities=22%  Similarity=0.347  Sum_probs=175.2

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc-
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-  434 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~-  434 (622)
                      .+..+|.+.+.||+  |+||.||+|+++.+|+.||||++..........+.+.+|+.+++.++||||+++++++..... 
T Consensus        21 ~l~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGS--GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEec--CCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence            35678999999999  889999999999999999999998766666667789999999999999999999999987654 


Q ss_pred             -----EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        435 -----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       435 -----~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                           .++||||++ ++|.+++.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             ccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence                 499999998 57766553    24789999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                      ......       .....+|+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+....+.
T Consensus       174 ~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  234 (353)
T 3coi_A          174 RHADAE-------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT  234 (353)
T ss_dssp             TC---------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred             cCCCCC-------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            533211       1234668889999998653 358899999999999999999999998876555443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.4e-36  Score=311.14  Aligned_cols=207  Identities=24%  Similarity=0.338  Sum_probs=168.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC------HHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT------DEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||||++......      ......+.+|+.+|+.++||||+++++++..
T Consensus         9 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            9 RDEYIMSKTLGS--GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhceeEeeEEec--CCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            357999999999  88999999999999999999998754321      1223458899999999999999999999876


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---eEEcCccc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLRY  508 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~---~~~~~~~~  508 (622)
                      . ..++||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.   +++.|||.
T Consensus        87 ~-~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           87 E-DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             S-SEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             C-ceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            5 489999999999999988654  35789999999999999999999999999999999999987664   99999997


Q ss_pred             ccccCCCCCceeccCCCCCCCCcccccccccc-CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                      +........     .....+|+.|+|||++.. ....++.++|||||||++|||++|.+||......
T Consensus       164 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          164 SKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             CEECCCCHH-----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             ceecccccc-----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            654432111     012346788999999842 1246889999999999999999999999766544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.1e-36  Score=316.77  Aligned_cols=204  Identities=14%  Similarity=0.192  Sum_probs=155.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhC--CCCccceeE-------E
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHL--RHPNIICYI-------S  427 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l--~HpnIv~~~-------~  427 (622)
                      ..+|++.+.||+  |+||.||+|++..+|+.||||++....... ...+.+.+|+.+++.|  +|||||+++       +
T Consensus        61 ~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           61 ERKLKLVEPLRV--GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             ceeeeeeeeccC--CCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            445999999999  889999999999999999999998766533 4456778885544444  699988865       4


Q ss_pred             EEEeCC-----------------cEEEEeeccCCCCHHHHHHhccCCCCCHHHH------HHHHHHHHHHHHHHHhCCce
Q psy15039        428 SFLDAT-----------------DLHLVSPLMGFGSCKDLINAHFNFGLPELVI------CHILQDVLNGLEYIHGKGFI  484 (622)
Q Consensus       428 ~~~~~~-----------------~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~------~~~~~qi~~gL~ylH~~~ii  484 (622)
                      ++...+                 .+|+|||||+ |+|.+++..... .+++...      ..++.||+.||+|||++||+
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence            554432                 3899999999 899999976422 1233333      56779999999999999999


Q ss_pred             ecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcC
Q psy15039        485 HRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG  564 (622)
Q Consensus       485 HRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg  564 (622)
                      ||||||+|||++.+|.+++.|||.+...+...       ....+|+.|+|||++.+....|+.++|||||||++|||++|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEE-------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCc-------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            99999999999999999999999876443211       12345578999999965334689999999999999999999


Q ss_pred             CCCCCCCC
Q psy15039        565 TVPFAETP  572 (622)
Q Consensus       565 ~~Pf~~~~  572 (622)
                      ++||....
T Consensus       290 ~~Pf~~~~  297 (371)
T 3q60_A          290 FLPFGLVT  297 (371)
T ss_dssp             SCSTTBCC
T ss_pred             CCCCCCcC
Confidence            99998763

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=317.16  Aligned_cols=207  Identities=14%  Similarity=0.180  Sum_probs=166.3

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEcc---CCcEEEEEEecCCCCCH-HH--------HHHHHHHHHHHhhCCCCccce
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKV---TNQLIAVKKFNLDRMTD-ED--------LKSLHHEIVCMRHLRHPNIIC  424 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~---~~~~vavK~i~~~~~~~-~~--------~~~~~~E~~~l~~l~HpnIv~  424 (622)
                      ..++|++.+.||+  |+||.||+|++..   +++.+|||++....... .+        ...+.+|+..++.++||||++
T Consensus        35 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           35 EGNQWVLGKKIGS--GGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             TSCEEEEEEEC--------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cCceEEEEeeEee--cCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3567999999999  8899999999987   88999999987653211 11        123668899999999999999


Q ss_pred             eEEEEEe----CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-
Q psy15039        425 YISSFLD----ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-  499 (622)
Q Consensus       425 ~~~~~~~----~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~-  499 (622)
                      +++++..    ....++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            9999988    67899999999 999999987654  578999999999999999999999999999999999999887 


Q ss_pred             -ceEEcCcccccccCCCCCce---eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        500 -KACLSGLRYMCPFSPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       500 -~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                       .+++.|||.+..+.......   ........+|+.|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence             99999999876543221110   011123467889999999976  4689999999999999999999999954

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=315.08  Aligned_cols=203  Identities=20%  Similarity=0.284  Sum_probs=169.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccC--------CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccce-----
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVT--------NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC-----  424 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-----  424 (622)
                      .++|++.+.||+  |+||.||+|++..|        ++.||||++...       +.+.+|+.+++.++|||||+     
T Consensus        41 ~~~y~~~~~lg~--G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTR--DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEE--ETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             CCeEEEEEEecC--CCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence            578999999999  78999999999884        899999998754       35789999999999999998     


Q ss_pred             ----------eEEEEEe-CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q psy15039        425 ----------YISSFLD-ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHI  493 (622)
Q Consensus       425 ----------~~~~~~~-~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NI  493 (622)
                                +++++.. ....++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      5677766 67789999999 99999999875334689999999999999999999999999999999999


Q ss_pred             EEcCCC--ceEEcCcccccccCCCCCce---eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCC
Q psy15039        494 LISHNG--KACLSGLRYMCPFSPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF  568 (622)
Q Consensus       494 Ll~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf  568 (622)
                      |++.++  .+++.|||.+..+.......   ........+|+.|+|||++.+  ..++.++|||||||++|||++|+.||
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999998  89999999876544322111   111233467899999999976  46899999999999999999999999


Q ss_pred             CCCC
Q psy15039        569 AETP  572 (622)
Q Consensus       569 ~~~~  572 (622)
                      ....
T Consensus       269 ~~~~  272 (352)
T 2jii_A          269 TNCL  272 (352)
T ss_dssp             GGGT
T ss_pred             ccCC
Confidence            8764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.7e-36  Score=315.75  Aligned_cols=221  Identities=21%  Similarity=0.367  Sum_probs=182.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH---------------HHHHHHHHHHHHHhhCCCCc
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---------------EDLKSLHHEIVCMRHLRHPN  421 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~---------------~~~~~~~~E~~~l~~l~Hpn  421 (622)
                      ..++|++.+.||+  |+||.||+|++  +|+.||||++.......               ...+.+.+|+.+++.++|||
T Consensus        29 ~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           29 YINDYRIIRTLNQ--GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             EETTEEEEEEEEC--CSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccCceEEEEEEcC--CCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            3578999999999  88999999999  89999999986431110               01167899999999999999


Q ss_pred             cceeEEEEEeCCcEEEEeeccCCCCHHHH------HHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEE
Q psy15039        422 IICYISSFLDATDLHLVSPLMGFGSCKDL------INAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHIL  494 (622)
Q Consensus       422 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~------l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NIL  494 (622)
                      |+++++++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||+|||+ +||+||||||+|||
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999988      554334568899999999999999999999 99999999999999


Q ss_pred             EcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        495 ISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE-RSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       495 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      ++.++.+++.|||.+......      ......+|+.|+|||++.+. ..++. ++|||||||++|||++|+.||.....
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             EcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999976543221      11234678889999999753 24666 99999999999999999999988776


Q ss_pred             HHHHHHHHcCCCCCC
Q psy15039        574 TLMLIEKLAGATPHL  588 (622)
Q Consensus       574 ~~~~~~~~~~~~p~~  588 (622)
                      ...+...+....+..
T Consensus       258 ~~~~~~~i~~~~~~~  272 (348)
T 2pml_X          258 LVELFNNIRTKNIEY  272 (348)
T ss_dssp             SHHHHHHHTSCCCCC
T ss_pred             HHHHHHHHhccCcCC
Confidence            455556655544433

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5e-35  Score=302.26  Aligned_cols=198  Identities=24%  Similarity=0.362  Sum_probs=170.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCccceeEEEEEe--CCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLD--ATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~--~~~  434 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||||++....     .+.+.+|+.+++.++ ||||+++++++.+  ...
T Consensus        35 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           35 QDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCceEEEEEecc--cCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            467999999999  889999999999999999999986432     356889999999997 9999999999998  567


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-ceEEcCcccccccC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPFS  513 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~-~~~~~~~~~~~~~~  513 (622)
                      .++||||+++++|.+++..     +++..+..++.|++.||+|||++||+||||||+|||++.++ .+++.|||.+....
T Consensus       108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            8999999999999988753     67888999999999999999999999999999999999777 89999999865443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      ....     .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.....
T Consensus       183 ~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~  236 (330)
T 3nsz_A          183 PGQE-----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  236 (330)
T ss_dssp             TTCC-----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             CCCc-----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            2211     1234677889999998643 3589999999999999999999999965543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=303.25  Aligned_cols=212  Identities=20%  Similarity=0.271  Sum_probs=169.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEE------
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFL------  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------  430 (622)
                      +.+.|++.+.||+  |+||.||+|++..+|+.||||++...  +....+.+.+|+.+++.++||||+++++++.      
T Consensus         9 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A            9 LGSRYMDLKPLGC--GGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             ETTTEEEEEECC-------CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             cCCceeEEEEecc--CCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            4678999999999  88999999999999999999998754  3555678999999999999999999999874      


Q ss_pred             --------eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCce
Q psy15039        431 --------DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKA  501 (622)
Q Consensus       431 --------~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~-~~~~~  501 (622)
                              .....++||||++ |+|.+++..   ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence                    3467899999998 699998864   3478899999999999999999999999999999999997 56789


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                      ++.|||.+......... ........+|+.|+|||++... ..++.++|||||||++|||++|+.||........+.
T Consensus       161 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  235 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ  235 (320)
T ss_dssp             EECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEccCccccccCCCccc-ccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999976544321111 1112234567889999998643 358899999999999999999999998876655443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-35  Score=304.45  Aligned_cols=214  Identities=22%  Similarity=0.347  Sum_probs=176.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEc-cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCccceeEEEEE--
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHK-VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFL--  430 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~~~~~~~--  430 (622)
                      ..++|++.+.||+  |+||.||+|++. .+|+.||+|++............+.+|+.+++.+   +||||+++++++.  
T Consensus         9 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            9 ADQQYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGGTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             chhceeeeeeecc--cccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            4568999999999  789999999995 7789999999875433222223456777777766   8999999999987  


Q ss_pred             ---eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcc
Q psy15039        431 ---DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLR  507 (622)
Q Consensus       431 ---~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~  507 (622)
                         .....++||||++ |+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence               4567899999999 699999987655568899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      .+.......     ......+|+.|+|||++.+  ..++.++|||||||++|||++|++||........+...
T Consensus       166 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i  231 (326)
T 1blx_A          166 LARIYSFQM-----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI  231 (326)
T ss_dssp             SCCCCCGGG-----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ccccccCCC-----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            765433211     1223467888999999976  45899999999999999999999999887766554443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.6e-35  Score=312.21  Aligned_cols=201  Identities=26%  Similarity=0.370  Sum_probs=170.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC--------CCccceeEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR--------HPNIICYISS  428 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~~~~~  428 (622)
                      +.++|++.+.||+  |+||.||+|++..+++.||||++...   ....+.+.+|+.+++.++        ||||++++++
T Consensus        35 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           35 FNGRYHVIRKLGW--GHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             ETTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             cCCeEEEEEEeee--cCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            4578999999999  88999999999999999999998643   445677899999999985        8889999999


Q ss_pred             EE----eCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCC----
Q psy15039        429 FL----DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNG----  499 (622)
Q Consensus       429 ~~----~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~~~----  499 (622)
                      +.    ....+++||||+ ++++.+.+.......+++..+..++.||+.||+|||++ ||+||||||+|||++.++    
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            98    455799999999 56676666554444689999999999999999999998 999999999999999776    


Q ss_pred             ---------------------------------------------ceEEcCcccccccCCCCCceeccCCCCCCCCcccc
Q psy15039        500 ---------------------------------------------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS  534 (622)
Q Consensus       500 ---------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~a  534 (622)
                                                                   .+++.|||.+......       .....+|+.|+|
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~a  261 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCC
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccC
Confidence                                                         7999999986544321       233467889999


Q ss_pred             ccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       535 PE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      ||++.+  ..|+.++|||||||++|||+||++||...+
T Consensus       262 PE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          262 LEVLIG--SGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             HHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             ChhhcC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            999976  458999999999999999999999997654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-35  Score=301.29  Aligned_cols=217  Identities=23%  Similarity=0.401  Sum_probs=170.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe------
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD------  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------  431 (622)
                      .++|++.+.||+  |+||.||+|++..+++.||||++..   +....+.+.+|+.+++.++||||+++++++.+      
T Consensus         5 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            5 ASDFEEIAVLGQ--GAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccchhhheecc--CCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            356999999999  8899999999999999999999864   34556788999999999999999999999875      


Q ss_pred             -------CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEc
Q psy15039        432 -------ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  504 (622)
Q Consensus       432 -------~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~  504 (622)
                             ....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence                   346899999999999999997643 346788889999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCc----------eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        505 GLRYMCPFSPTKKK----------VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       505 ~~~~~~~~~~~~~~----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                      |||.+.........          .........+|+.|+|||++.+. ..++.++|||||||++|||++   ||......
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~  234 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMER  234 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence            99986544321100          00111234578899999999743 358899999999999999998   66543333


Q ss_pred             HHHHHHHcCC
Q psy15039        575 LMLIEKLAGA  584 (622)
Q Consensus       575 ~~~~~~~~~~  584 (622)
                      ..+...+...
T Consensus       235 ~~~~~~~~~~  244 (303)
T 1zy4_A          235 VNILKKLRSV  244 (303)
T ss_dssp             HHHHHHHHST
T ss_pred             HHHHHhcccc
Confidence            4444554443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.7e-36  Score=306.15  Aligned_cols=206  Identities=23%  Similarity=0.352  Sum_probs=171.2

Q ss_pred             CCCCc-eEeeecccccCCeeEEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNY-KICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y-~~~~~lg~g~g~~~~V~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      +...| ++.+.||+  |+||.||++.    +..+++.||||++... ......+.+.+|+.+++.++||||+++++++.+
T Consensus        28 ~~~r~~~~~~~lG~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGE--GHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             CCGGGEEEEEEEEE--CSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ecHHHHhhhheecC--CCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            34455 99999999  8899997764    4568999999999765 345556789999999999999999999999988


Q ss_pred             C--CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        432 A--TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       432 ~--~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                      .  ..+++||||+++|+|.+++...   ++++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence            4  5689999999999999998754   3788999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ......... ........+|+.|+|||++.+  ..++.++|||||||++|||+||+.||...
T Consensus       182 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          182 KAVPEGHEY-YRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             EECCTTCSE-EEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccccccccc-cccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            655433221 122233456778999999975  45788999999999999999999999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=304.55  Aligned_cols=221  Identities=24%  Similarity=0.393  Sum_probs=165.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||++..........+.+.++..+++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           24 INDLENLGEMGS--GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             GGGEEEEEEC--------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccceeee--cCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            467999999999  889999999999999999999998765444444555666678888999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      ||||+ ++.+..+.... ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+++.|||.+.......
T Consensus       102 v~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             EECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            99999 45555555443 34588999999999999999999995 99999999999999999999999999765433221


Q ss_pred             CceeccCCCCCCCCcccccccccc---CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH-HHcCCCCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE-KLAGATPH  587 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~-~~~~~~p~  587 (622)
                      .     .....+|+.|+|||++..   ....++.++|||||||++|||++|+.||........... .+.+..|.
T Consensus       180 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (318)
T 2dyl_A          180 A-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL  249 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred             c-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence            1     123457888999999952   124578899999999999999999999987555444444 44444433

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.8e-36  Score=308.10  Aligned_cols=210  Identities=24%  Similarity=0.319  Sum_probs=170.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe----C
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----A  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~  432 (622)
                      ..++|++.+.||+  |+||.||++++..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++..    .
T Consensus        27 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           27 DNKHYLFIQKLGE--GGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TTEEEEEEEEEEC----CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CCeEEEEEEEecC--CCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            3567999999999  88999999999999999999998653  34556788999999999999999999999873    3


Q ss_pred             CcEEEEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                      ...++||||+++|+|.+++...  ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            4689999999999999998763  23458899999999999999999999999999999999999999999999999754


Q ss_pred             ccCCCCCcee-----ccCCCCCCCCccccccccccCc-cCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        511 PFSPTKKKVH-----LFPPSTAYNLNWLSPEVLEQNL-DGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       511 ~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      ..........     .......+|+.|+|||++.... ..++.++|||||||++|||++|+.||..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            3321100000     0001124578899999986421 2368899999999999999999999953

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-35  Score=297.82  Aligned_cols=198  Identities=19%  Similarity=0.391  Sum_probs=171.3

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe------
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD------  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------  431 (622)
                      ..+|++.+.||+  |+||.||+|++..+|+.||+|++....      ..+.+|+.+++.++||||+++++++..      
T Consensus        10 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B           10 GMDFKEIELIGS--GGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHEEEEEEEEC--SSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             ccccceeeeecc--CCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            456999999999  889999999999999999999987542      356789999999999999999998865      


Q ss_pred             ----------CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCce
Q psy15039        432 ----------ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  501 (622)
Q Consensus       432 ----------~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~  501 (622)
                                ....++||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                      3458999999999999999986554568899999999999999999999999999999999999999999


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      ++.|||.+........     .....+|+.|+|||++.+  ..++.++|||||||++|||++|..||..
T Consensus       162 kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             EECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             EECcchhheecccccc-----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence            9999997654433211     223457889999999975  4689999999999999999999999854

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-35  Score=308.08  Aligned_cols=203  Identities=20%  Similarity=0.315  Sum_probs=148.9

Q ss_pred             CCCCCCceEee-ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe--
Q psy15039        355 DNVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--  431 (622)
Q Consensus       355 ~~~~~~y~~~~-~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--  431 (622)
                      ..+.++|++.+ .||+  |+||.||+|+++.+|+.||||++...   ...   ..+....++.++||||+++++++..  
T Consensus        24 ~~~~~~y~i~~~~lG~--G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGL--GVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             SCGGGTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeEecceeeee--CCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            34567899965 6999  78999999999999999999998642   222   1222334567799999999999876  


Q ss_pred             --CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CceEEcCc
Q psy15039        432 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN---GKACLSGL  506 (622)
Q Consensus       432 --~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~---~~~~~~~~  506 (622)
                        ...+++||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.+   +.+++.||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              3458999999999999999987655568999999999999999999999999999999999999864   45999999


Q ss_pred             ccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        507 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      |.+......      ......+|+.|+|||++..  ..|+.++|||||||++|+|++|+.||.....
T Consensus       176 g~~~~~~~~------~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (336)
T 3fhr_A          176 GFAKETTQN------ALQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTG  234 (336)
T ss_dssp             TTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             ccceecccc------ccccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence            976543221      1123456888999999965  4688899999999999999999999976544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-35  Score=300.15  Aligned_cols=217  Identities=20%  Similarity=0.346  Sum_probs=167.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEcc-CCc--EEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKV-TNQ--LIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~-~~~--~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      .++|++.+.||+  |+||.||+|++.. +++  .||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus        17 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           17 EKDLRLLEKLGD--GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             GGGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhHeeeeeeecC--CCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            467999999999  7899999998643 333  68999987654322 44678999999999999999999999988754


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                       .++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence             899999999999999987643 247889999999999999999999999999999999999999999999999876554


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHH
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKL  581 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~  581 (622)
                      ..... ........+|+.|+|||++.+  ..++.++|||||||++|||++ |+.||...+....+....
T Consensus       173 ~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  238 (291)
T 1u46_A          173 QNDDH-YVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  238 (291)
T ss_dssp             C-CCE-EEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             ccccc-hhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence            32221 112233456778999999975  458899999999999999999 999998876655444433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=313.78  Aligned_cols=207  Identities=22%  Similarity=0.371  Sum_probs=156.5

Q ss_pred             CCCceE-eeecccccCCeeEEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe--C
Q psy15039        358 PSNYKI-CSILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--A  432 (622)
Q Consensus       358 ~~~y~~-~~~lg~g~g~~~~V~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~  432 (622)
                      .+.|++ ++.||+  |+||.||+|+++  .+++.||||++......    ..+.+|+.+|+.|+|||||++++++..  .
T Consensus        19 ~~~y~~~g~~lG~--G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           19 EDLFEYEGCKVGR--GTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHHEECSSCCCC-------EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhhcCcEeee--cCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            344665 447999  889999999976  57899999999765444    357789999999999999999999965  5


Q ss_pred             CcEEEEeeccCCCCHHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCce
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHF-------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI----SHNGKA  501 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~-------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl----~~~~~~  501 (622)
                      ..+++||||++ |+|.+++....       ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+
T Consensus        93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            67999999998 47887775321       1247899999999999999999999999999999999999    677899


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      +|.|||.+..+....... .......+|+.|+|||++.+. ..|+.++|||||||++|||++|++||.....
T Consensus       172 kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPL-ADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             EECCTTCCC-----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             EEEECCCceecCCCCccc-ccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            999999876543221111 112335678899999999753 3589999999999999999999999976543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-35  Score=301.24  Aligned_cols=205  Identities=19%  Similarity=0.230  Sum_probs=170.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEE-EeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSF-LDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~  435 (622)
                      +.++|++.+.||+  |+||.||+|++..+|+.||||++......    +.+.+|+.+++.++|+|++..+..+ ......
T Consensus         7 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            7 VGNRYRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ETTTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             eccEEEEEEEEcc--CCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            4678999999999  78999999999999999999998765432    3578999999999998877766655 556678


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl---~~~~~~~~~~~~~~~~~  512 (622)
                      ++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+++.|||.+...
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            9999999 899999997543 358899999999999999999999999999999999999   47889999999986554


Q ss_pred             CCCCCcee---ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        513 SPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       513 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ........   .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            33221110   11234567889999999976  45899999999999999999999999764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.4e-35  Score=304.41  Aligned_cols=208  Identities=24%  Similarity=0.382  Sum_probs=155.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHH-HHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV-CMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ..++|++.+.||+  |+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++...+..
T Consensus        20 ~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGR--GAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CSCSEEC-CEEEE--CSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHhhehheecc--CCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            3578999999999  889999999999999999999997654 3344455666666 77888999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        436 HLVSPLMGFGSCKDLINA---HFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                      ++||||+++ +|.+++..   .....+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+++.|||.+..
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999999995 78777653   2234578999999999999999999999 999999999999999999999999997654


Q ss_pred             cCCCCCceeccCCCCCCCCcccccccccc--CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--NLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      ......     .....+|+.|+|||++..  ....++.++|||||||++|||++|+.||.....
T Consensus       176 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (327)
T 3aln_A          176 LVDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS  234 (327)
T ss_dssp             -----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--
T ss_pred             cccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence            432211     122357888999999842  114588999999999999999999999987543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=304.67  Aligned_cols=206  Identities=23%  Similarity=0.410  Sum_probs=173.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEE----EccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSK----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      ...+|++.+.||+  |+||.||+|+    +..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        39 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           39 EERHLKFLQQLGK--GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CGGGEEEEEEEEC--CSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             CHHHceeeeeecc--CCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            3467999999999  8899999998    5678999999998754  334567899999999999999999999998765


Q ss_pred             C--cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        433 T--DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       433 ~--~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                      +  ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            4  6899999999999999998753 347899999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      ......... .......+++.|+|||++.+  ..++.++|||||||++|||+||..||..
T Consensus       194 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          194 VLPQDKEYY-KVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             ECCSSCSEE-ECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             hcccccccc-ccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            554332211 11223345677999999975  4588999999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-35  Score=300.69  Aligned_cols=205  Identities=25%  Similarity=0.311  Sum_probs=171.4

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCC--CCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDR--MTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .|..++.||+  |+||.||+|+.  +++.||||++....  ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        32 ~~~~~~~lg~--G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  107 (307)
T 2nru_A           32 ISVGGNKMGE--GGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL  107 (307)
T ss_dssp             TTTTCCEEEE--CSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ccccCCcccc--CCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEE
Confidence            3455688999  88999999986  68899999987542  223345678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHF-NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      ||||+++|+|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence            999999999999987432 3458899999999999999999999999999999999999999999999999765443222


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      ..  .......+|+.|+|||++.+   .++.++|||||||++|+|++|++||.....
T Consensus       188 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          188 QT--VMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             SC--EECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             cc--ccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            11  11223467889999999864   478899999999999999999999976543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.2e-35  Score=300.92  Aligned_cols=205  Identities=18%  Similarity=0.232  Sum_probs=175.9

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEE-ccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc------cceeEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKH-KVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN------IICYISSF  429 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~~~~~~  429 (622)
                      +.++|++.+.||+  |+||.||+|.+ ..+++.||||++...   ....+.+.+|+.+++.++|+|      |+++++++
T Consensus        12 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           12 LSARYEIVDTLGE--GAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             ETTTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             ccCceEEEEEEec--CCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            4578999999999  78999999998 668999999998642   445577889999999987765      99999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC------------
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH------------  497 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~------------  497 (622)
                      ...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 899999998765556889999999999999999999999999999999999987            


Q ss_pred             -------CCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        498 -------NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       498 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                             ++.+++.|||.+......       .....+|+.|+|||++.+  ..++.++|||||||++|||++|++||..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                   667999999976533221       223567889999999975  4689999999999999999999999988


Q ss_pred             CCcHHH
Q psy15039        571 TPTTLM  576 (622)
Q Consensus       571 ~~~~~~  576 (622)
                      .+....
T Consensus       237 ~~~~~~  242 (339)
T 1z57_A          237 HDSKEH  242 (339)
T ss_dssp             SCHHHH
T ss_pred             CChHHH
Confidence            766543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.9e-36  Score=308.96  Aligned_cols=227  Identities=19%  Similarity=0.368  Sum_probs=178.3

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      ...++|++.+.||+  |+||.||+|++..   .+|+|++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus        30 i~~~~~~~~~~lg~--G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           30 IPFEQLEIGELIGK--GRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SCCSCEECCCBCCC--SSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             CCHHHeEEeeEecc--CCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            34678999999999  8899999999864   499999876544433345678899999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++ ++.+++.|||.+......
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             EEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999999987543 3578888999999999999999999999999999999998 689999999975433221


Q ss_pred             CCc-eeccCCCCCCCCccccccccccC-------ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCC
Q psy15039        516 KKK-VHLFPPSTAYNLNWLSPEVLEQN-------LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH  587 (622)
Q Consensus       516 ~~~-~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~  587 (622)
                      ... .........+|+.|+|||++...       ...++.++|||||||++|||++|+.||...+..........+..|.
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence            111 11112234578899999999641       1347889999999999999999999998877666555555555444


Q ss_pred             CC
Q psy15039        588 LL  589 (622)
Q Consensus       588 ~~  589 (622)
                      +.
T Consensus       263 ~~  264 (319)
T 2y4i_B          263 LS  264 (319)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.3e-35  Score=304.12  Aligned_cols=211  Identities=18%  Similarity=0.272  Sum_probs=156.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCccceeEEEEEe-----
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLD-----  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-----  431 (622)
                      ..+|++.+.||+  |+||.||+|++..+++.||||++...  .....+.+.+|+.+++.+. |||||++++++..     
T Consensus        27 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           27 ELRLRVRRVLAE--GGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TEEEEEEEEEEC--CSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             CceEEEEEEEcc--CCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            457999999999  88999999999999999999998544  3455677899999999995 9999999999953     


Q ss_pred             ---CCcEEEEeeccCCCCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCceEEcC
Q psy15039        432 ---ATDLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISHNGKACLSG  505 (622)
Q Consensus       432 ---~~~~~lv~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~~qi~~gL~ylH~~~--iiHRDlKp~NILl~~~~~~~~~~  505 (622)
                         ...++++|||+. |+|.+++... ....+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+++.|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence               334899999997 7999988653 2335889999999999999999999999  99999999999999999999999


Q ss_pred             cccccccCCCCCce--------eccCCCCCCCCcccccccccc-CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        506 LRYMCPFSPTKKKV--------HLFPPSTAYNLNWLSPEVLEQ-NLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       506 ~~~~~~~~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      ||.+..........        ........+|+.|+|||++.. ....++.++|||||||++|||++|+.||.....
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99876543321110        001123457889999999831 124578899999999999999999999976544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-34  Score=305.97  Aligned_cols=211  Identities=19%  Similarity=0.247  Sum_probs=178.1

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CC-----ccceeEEE
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HP-----NIICYISS  428 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~~~~~  428 (622)
                      ....++|++.+.||+  |+||.||+|++..+++.||||++..   .......+.+|+.+++.++ |+     +|++++++
T Consensus        50 ~~~~~~y~~~~~lG~--G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGK--GSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             CEETTTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             CEeeeeEEEEEEEee--cCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            345678999999999  7899999999999999999999864   2444567888999998885 55     49999999


Q ss_pred             EEeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEc--CCCceEEc
Q psy15039        429 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--GKGFIHRAVKASHILIS--HNGKACLS  504 (622)
Q Consensus       429 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH--~~~iiHRDlKp~NILl~--~~~~~~~~  504 (622)
                      +...+..++||||++ |+|.+++......++++..+..++.|++.||+|||  ++|||||||||+|||++  .++.+++.
T Consensus       125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999999997 59999998765456889999999999999999999  57999999999999995  46789999


Q ss_pred             CcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      |||.+......       .....+|+.|+|||++.+  ..|+.++|||||||++|||+||++||...+....+...
T Consensus       204 DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i  270 (382)
T 2vx3_A          204 DFGSSCQLGQR-------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI  270 (382)
T ss_dssp             CCTTCEETTCC-------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eccCceecccc-------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99987654321       123567889999999976  46899999999999999999999999988766555443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.5e-35  Score=306.10  Aligned_cols=216  Identities=20%  Similarity=0.279  Sum_probs=171.5

Q ss_pred             ccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC---------CHHHHHHHHHHHHHHhhCCCCccc
Q psy15039        353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM---------TDEDLKSLHHEIVCMRHLRHPNII  423 (622)
Q Consensus       353 ~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~---------~~~~~~~~~~E~~~l~~l~HpnIv  423 (622)
                      .+....+.|++.+.||+  |+||.||+|.+.. |+.||||++.....         .....+.+.+|+.+++.++||||+
T Consensus        16 ~~~~~~~~y~~~~~lg~--G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISS--GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHTTCSCEEEEEEEE--ETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHhccceEEeEEecc--CCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            34456788999999999  7899999999865 99999999864322         223357899999999999999999


Q ss_pred             eeEEEEEeC-----CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q psy15039        424 CYISSFLDA-----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN  498 (622)
Q Consensus       424 ~~~~~~~~~-----~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~  498 (622)
                      ++++++...     ..+++||||++ |+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  170 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN  170 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence            999998653     35899999999 6888877653 3357899999999999999999999999999999999999999


Q ss_pred             CceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        499 GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                      +.+++.|||.+.......     ......+|+.|+|||++.+. ..++.++|||||||++|||++|++||........+.
T Consensus       171 ~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          171 NDITICDFNLAREDTADA-----NKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             CCEEECCTTC--------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCEEEEecCccccccccc-----ccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999765322211     12234567889999998653 358899999999999999999999998876555443


Q ss_pred             H
Q psy15039        579 E  579 (622)
Q Consensus       579 ~  579 (622)
                      .
T Consensus       245 ~  245 (362)
T 3pg1_A          245 K  245 (362)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-35  Score=306.86  Aligned_cols=208  Identities=23%  Similarity=0.332  Sum_probs=174.0

Q ss_pred             ccCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        353 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       353 ~~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      .+....++|++.+.||+  |+||.||+|++. +|+.||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~~~~~~y~~~~~lg~--G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           24 ELQVASDNFSNKNILGR--GGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             HHHTTTTSSCSTTEEEC--CSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             HHHHHhhccccceeEec--CCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            34456788999999999  889999999854 6899999998754322 1123688999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCceEEcCcc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFN--FGLPELVICHILQDVLNGLEYIHGK---GFIHRAVKASHILISHNGKACLSGLR  507 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~~qi~~gL~ylH~~---~iiHRDlKp~NILl~~~~~~~~~~~~  507 (622)
                      +..++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+++.|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  179 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG  179 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence            999999999999999999976432  3478999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCC
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA  569 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~  569 (622)
                      .+..........   .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       180 ~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          180 LAKLMDYKDTHV---TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             SCEECCSSSSCE---ECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             cccccCcccccc---cccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCccc
Confidence            875443322211   123457889999999965  458999999999999999999999995

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.2e-35  Score=295.98  Aligned_cols=207  Identities=18%  Similarity=0.224  Sum_probs=167.6

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEE-EeCCc
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSF-LDATD  434 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~  434 (622)
                      .+.++|++.+.||+  |+||.||+|++..+++.||||++.....    ...+.+|+.+++.++|+|++..+..+ ...+.
T Consensus         6 ~~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecC--CCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            35678999999999  8899999999999999999998764432    23578899999999998877776655 56677


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCceEEcCcccccc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCP  511 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl---~~~~~~~~~~~~~~~~  511 (622)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+++.|||.+..
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            89999999 999999987543 358899999999999999999999999999999999999   7889999999998765


Q ss_pred             cCCCCCcee---ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        512 FSPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       512 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      .........   .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            433221110   11234567899999999976  458999999999999999999999997643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1e-34  Score=326.09  Aligned_cols=249  Identities=16%  Similarity=0.256  Sum_probs=191.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVT---NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..++|++.+.||+  |+||.||+|++..+   +..||||++... ......+.+.+|+.+|+.++|||||++++++. .+
T Consensus       388 ~~~~y~i~~~LG~--G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGE--GQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CGGGEEEEEEEEC--CSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             ccccEEEeeEEee--CCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            3567999999999  88999999998654   467999988643 34555678999999999999999999999884 56


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            789999999999999999764 3357899999999999999999999999999999999999999999999999865443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-C
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-C  591 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~  591 (622)
                      .....   ......+|+.|||||++..  ..|+.++|||||||++|||++ |.+||.+......+.....+..+++.+ +
T Consensus       543 ~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  617 (656)
T 2j0j_A          543 DSTYY---KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  617 (656)
T ss_dssp             C-------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTC
T ss_pred             CCcce---eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            22111   1122345678999999965  468999999999999999997 999999887766555555555444433 3


Q ss_pred             CcccccCCCCcCcccccchhhhhh
Q psy15039        592 TTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       592 ~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      +....+....+...++.++++-.+
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~e  641 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTE  641 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHH
Confidence            333344444444445545544433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-34  Score=302.01  Aligned_cols=212  Identities=22%  Similarity=0.291  Sum_probs=162.3

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc--
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD--  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~--  434 (622)
                      ..++|++.+.||+  |+||.||+|+++.+|+.||||++..+...   .....+|++.++.++|||||+++++|.....  
T Consensus        21 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           21 EMDRFQVERMAGQ--GTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHTTEEEC------------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hccceEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            3467999999999  88999999999999999999998654322   2346678888899999999999999977544  


Q ss_pred             -----EEEEeeccCCCCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEcC-CCceEEc
Q psy15039        435 -----LHLVSPLMGFGSCKDLINA--HFNFGLPELVICHILQDVLNGLEYIH--GKGFIHRAVKASHILISH-NGKACLS  504 (622)
Q Consensus       435 -----~~lv~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~~qi~~gL~ylH--~~~iiHRDlKp~NILl~~-~~~~~~~  504 (622)
                           +++||||+++ ++.+.+..  .....+++..+..++.|++.||+|||  ++||+||||||+|||++. ++.+++.
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence                 8999999996 45444432  12345788889999999999999999  999999999999999997 8999999


Q ss_pred             CcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      |||.+........     .....+|+.|+|||++.+. ..++.++|||||||++|||++|++||...+....+...
T Consensus       175 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          175 DFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             CCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eCCCceecCCCCC-----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            9998765433221     1234678899999998653 35899999999999999999999999988766555443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3e-34  Score=294.25  Aligned_cols=216  Identities=19%  Similarity=0.303  Sum_probs=174.6

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCccceeEEEEEeCC
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR--HPNIICYISSFLDAT  433 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~~  433 (622)
                      .....|++.+.||+  |+||.||++++. +++.||||++..........+.+.+|+.+++.++  ||||+++++++...+
T Consensus        25 ~~~~~y~~~~~lg~--G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           25 VKGRIYSILKQIGS--GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             ETTEEEEEEEEEEC--CSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eccceEEEEEEecC--CCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            34567999999999  889999999986 5999999999877767777788999999999997  599999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      ..++||| +.+++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+++.|||.+....
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred             EEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence            9999999 67789999998743  578888999999999999999999999999999999996 4899999999865443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccC---------ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQN---------LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      ....  ........+|+.|+|||++...         ...++.++|||||||++|||++|+.||............
T Consensus       178 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (313)
T 3cek_A          178 PDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  251 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             Cccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence            2211  1112234678899999998641         135788999999999999999999999876554333333

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=300.56  Aligned_cols=201  Identities=23%  Similarity=0.433  Sum_probs=161.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh--CCCCccceeEEEEEeC--
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH--LRHPNIICYISSFLDA--  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~~--  432 (622)
                      +.++|++.+.||+  |+||.||+|++.  ++.||||++....     .....+|..++..  ++||||+++++++...  
T Consensus        35 ~~~~y~~~~~lg~--G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           35 IAKQIQMVKQIGK--GRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHHCEEEEEEEE--ETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccceEEEeEeec--CCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3467999999999  789999999875  8999999986421     2334455555554  4999999999999987  


Q ss_pred             --CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCceE
Q psy15039        433 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK--------GFIHRAVKASHILISHNGKAC  502 (622)
Q Consensus       433 --~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~--------~iiHRDlKp~NILl~~~~~~~  502 (622)
                        ...++||||+++|+|.+++...   .+++..+..++.|++.||+|||++        ||+||||||+|||++.++.++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence              6799999999999999999763   478999999999999999999999        999999999999999999999


Q ss_pred             EcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCc------hhhHHHHHHHHHHHHcC----------CC
Q psy15039        503 LSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDE------RSDIYSVGISCCELANG----------TV  566 (622)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~------~~DiwSlGvil~e~ltg----------~~  566 (622)
                      +.|||.+..+...............+|+.|+|||++.+.  .++.      ++|||||||++|||+||          +.
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999998765543332222223345788999999999753  2333      49999999999999999          77


Q ss_pred             CCCCC
Q psy15039        567 PFAET  571 (622)
Q Consensus       567 Pf~~~  571 (622)
                      ||...
T Consensus       261 p~~~~  265 (337)
T 3mdy_A          261 PYHDL  265 (337)
T ss_dssp             TTTTT
T ss_pred             cHhhh
Confidence            77643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.7e-34  Score=297.67  Aligned_cols=215  Identities=16%  Similarity=0.240  Sum_probs=178.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCC-cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc------cceeEEEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTN-QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN------IICYISSF  429 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~-~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~~~~~~  429 (622)
                      +.++|++.+.||+  |+||.||+|++..++ +.||+|++...   ....+.+.+|+.+++.++|+|      ++.+++++
T Consensus        17 ~~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           17 LQERYEIVGNLGE--GTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             ETTTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             ecccEEEEEEeec--cCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            4678999999999  789999999998887 78999998642   344567889999999998776      89999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--------------
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI--------------  495 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl--------------  495 (622)
                      ...+..++||||+ ++++.+.+.......+++..+..++.||+.||+|||++||+||||||+|||+              
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999999 5677777766544468899999999999999999999999999999999999              


Q ss_pred             -----cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        496 -----SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       496 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                           +.++.+++.|||.+......       .....+|+.|+|||++.+  ..|+.++|||||||++|||++|++||..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                 56789999999976532211       233567889999999975  4689999999999999999999999988


Q ss_pred             CCcHHHH--HHHHcCCCC
Q psy15039        571 TPTTLML--IEKLAGATP  586 (622)
Q Consensus       571 ~~~~~~~--~~~~~~~~p  586 (622)
                      ......+  +..+.+..|
T Consensus       242 ~~~~~~~~~~~~~~~~~p  259 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIP  259 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCC
T ss_pred             CCHHHHHHHHHHHcCCCc
Confidence            7655443  334444443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.4e-35  Score=313.53  Aligned_cols=209  Identities=21%  Similarity=0.276  Sum_probs=158.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      ..+.|...+.||+  |+||+||.+ +..+|+.||||++..+.     .+.+.+|+.+|+.+ +|||||++++++.+.+.+
T Consensus        13 l~~~~~~~~~LG~--G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           13 LKNLVVSEKILGY--GSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             CSSCEEEEEEEEE--CSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             hhheeeccCeEee--CCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            3455677789999  889999864 56689999999986431     34578899999876 899999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCC-----CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC------------
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGL-----PELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN------------  498 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~-----~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~------------  498 (622)
                      ++|||||+ |+|.+++........     ++..+..++.||+.||+|||++||+||||||+|||++.+            
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            99999996 699999976432111     222356799999999999999999999999999999764            


Q ss_pred             -CceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccC-----ccCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q psy15039        499 -GKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQN-----LDGYDERSDIYSVGISCCELAN-GTVPFAET  571 (622)
Q Consensus       499 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~  571 (622)
                       +.++++|||.+..................||+.|+|||++.+.     ...++.++|||||||++|||+| |++||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             3799999998765543222211122345688999999999641     2458899999999999999999 99999766


Q ss_pred             CcH
Q psy15039        572 PTT  574 (622)
Q Consensus       572 ~~~  574 (622)
                      ...
T Consensus       244 ~~~  246 (434)
T 2rio_A          244 YSR  246 (434)
T ss_dssp             TTH
T ss_pred             hhh
Confidence            443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-34  Score=290.42  Aligned_cols=178  Identities=13%  Similarity=0.174  Sum_probs=156.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      +.+.|++.+.||+  |+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++|||||++++++...+..
T Consensus        29 ~~~~y~i~~~lg~--G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGG--VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTTTEEEEEEEEB--STTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ecCcEEEEEEEcc--cCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            3467999999999  88999999999999999999999866443 45567899999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCC
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~  515 (622)
                      |+||||+++++|.+++...    ..+..+..++.|++.||+|||++||+||||||+|||++.+|.+++.+.         
T Consensus       107 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~---------  173 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---------  173 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC---------
T ss_pred             EEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec---------
Confidence            9999999999999998542    345567889999999999999999999999999999999998887522         


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                                     .|++|         ++.++|||||||++|||+||+.||.+.+.
T Consensus       174 ---------------~~~~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          174 ---------------ATMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             ---------------CCCTT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             ---------------cccCC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                           24543         67899999999999999999999987654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-34  Score=299.49  Aligned_cols=202  Identities=24%  Similarity=0.412  Sum_probs=168.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh--CCCCccceeEEEEEeCC--
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH--LRHPNIICYISSFLDAT--  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~~~--  433 (622)
                      .++|++.+.||+  |+||.||+|++  +|+.||||++...     ..+.+.+|+.+++.  ++||||+++++++....  
T Consensus        41 ~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           41 ARTIVLQESIGK--GRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHCEEEEEEEE--ETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccEEEEeeecC--CCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            457999999999  78999999988  5899999998632     23567788888887  79999999999998876  


Q ss_pred             --cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCceEE
Q psy15039        434 --DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--------GKGFIHRAVKASHILISHNGKACL  503 (622)
Q Consensus       434 --~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH--------~~~iiHRDlKp~NILl~~~~~~~~  503 (622)
                        ..++||||+++|+|.+++...   .+++..+..++.|++.||+|||        +++|+||||||+|||++.++.+++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence              799999999999999999763   4788999999999999999999        899999999999999999999999


Q ss_pred             cCcccccccCCCCCceeccCCCCCCCCccccccccccCcc----CCCchhhHHHHHHHHHHHHcC----------CCCCC
Q psy15039        504 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVGISCCELANG----------TVPFA  569 (622)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~~~DiwSlGvil~e~ltg----------~~Pf~  569 (622)
                      .|||.+..................+|+.|+|||++.+...    .++.++|||||||++|||+||          +.||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999875544333222223345578899999999965311    233689999999999999999          88997


Q ss_pred             CC
Q psy15039        570 ET  571 (622)
Q Consensus       570 ~~  571 (622)
                      ..
T Consensus       269 ~~  270 (342)
T 1b6c_B          269 DL  270 (342)
T ss_dssp             TT
T ss_pred             cc
Confidence            65

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=300.05  Aligned_cols=203  Identities=20%  Similarity=0.314  Sum_probs=158.3

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC----
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA----  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~----  432 (622)
                      ..++|++.+.||+  |+||.||+|+.  +++.||||++....   ........|+..++.++||||+++++.+...    
T Consensus        11 ~~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           11 DLDNLKLLELIGR--GRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             CTTSEEEEEEEEE--CSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             ChHHhheeeeccc--CCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            4578999999999  88999999976  68999999986432   1111223445455568999999999866532    


Q ss_pred             -CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEcCCCceE
Q psy15039        433 -TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK---------GFIHRAVKASHILISHNGKAC  502 (622)
Q Consensus       433 -~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~---------~iiHRDlKp~NILl~~~~~~~  502 (622)
                       ..+++||||+++|+|.+++....   .++..+..++.||+.||+|||++         ||+||||||+|||++.++.++
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence             25789999999999999997643   47888899999999999999999         999999999999999999999


Q ss_pred             EcCcccccccCCCCCc----eeccCCCCCCCCccccccccccCc-----cCCCchhhHHHHHHHHHHHHcCCCCCC
Q psy15039        503 LSGLRYMCPFSPTKKK----VHLFPPSTAYNLNWLSPEVLEQNL-----DGYDERSDIYSVGISCCELANGTVPFA  569 (622)
Q Consensus       503 ~~~~~~~~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~~DiwSlGvil~e~ltg~~Pf~  569 (622)
                      +.|||.+..+......    .........+|+.|+|||++.+..     ..++.++|||||||++|||++|..||.
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            9999987654322110    111223456889999999996421     235678999999999999999977764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.1e-35  Score=300.48  Aligned_cols=207  Identities=21%  Similarity=0.306  Sum_probs=172.6

Q ss_pred             cCCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCC--CCccceeEE
Q psy15039        354 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLR--HPNIICYIS  427 (622)
Q Consensus       354 ~~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~----~~~~~~~~E~~~l~~l~--HpnIv~~~~  427 (622)
                      .....++|++.+.||+  |+||.||+|++..+++.||||++.......    ...+.+.+|+.+++.++  ||||+++++
T Consensus        38 ~~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           38 KEPLESQYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             --CCTTTEEEEEECSS--SSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cCCccCceEEEEEEee--CCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            3456788999999999  889999999999999999999987543221    11235678999999996  599999999


Q ss_pred             EEEeCCcEEEEeeccCC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCceEEcC
Q psy15039        428 SFLDATDLHLVSPLMGF-GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKACLSG  505 (622)
Q Consensus       428 ~~~~~~~~~lv~e~~~~-g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~-~~~~~~~~~  505 (622)
                      ++...+..++|+|++.+ ++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+++.|
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            99999999999999986 89999987643  478899999999999999999999999999999999999 788999999


Q ss_pred             cccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        506 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ||.+.......      .....+|+.|+|||++... ..++.++|||||||++|||++|+.||...
T Consensus       194 fg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          194 FGSGALLKDTV------YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             CTTCEECCSSC------BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             Ccccccccccc------ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            99765443211      1234578899999999653 23467899999999999999999999653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-34  Score=302.58  Aligned_cols=200  Identities=23%  Similarity=0.344  Sum_probs=169.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-----------CCccceeE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-----------HPNIICYI  426 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~~~  426 (622)
                      ..+|++.+.||+  |+||.||+|++..+++.||||++..+   ......+.+|+.+++.++           ||||++++
T Consensus        18 ~~~y~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           18 DARYILVRKLGW--GHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCeEEEEEeeee--cCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            467999999999  88999999999999999999998643   344567889999999886           89999999


Q ss_pred             EEEEeCC----cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcC----
Q psy15039        427 SSFLDAT----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGK-GFIHRAVKASHILISH----  497 (622)
Q Consensus       427 ~~~~~~~----~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~-~iiHRDlKp~NILl~~----  497 (622)
                      +++...+    ..+++||++ +++|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||++.    
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            9998654    689999999 89999999876555689999999999999999999998 9999999999999953    


Q ss_pred             --CCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        498 --NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       498 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                        .+.+++.|||.+......       .....+|+.|+|||++.+  ..|+.++|||||||++|||++|++||...+
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence              347999999986544321       223467889999999976  458999999999999999999999997653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-34  Score=310.81  Aligned_cols=207  Identities=19%  Similarity=0.233  Sum_probs=171.1

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCC-ccceeEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP-NIICYISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~~~~~~~~~~~~  435 (622)
                      +.++|++.+.||+  |+||.||+|++..+++.||||++......    ..+.+|+.+++.|+|+ +|..+..++......
T Consensus         5 i~~~y~i~~~LG~--G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            5 VGNKFRLGRKIGS--GSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             ETTTEECCCCCEE--CSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             cCCcEEEEEEEee--CCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4578999999999  88999999999999999999988754332    2478899999999875 555556666777888


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI---SHNGKACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl---~~~~~~~~~~~~~~~~~  512 (622)
                      ++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||+   +.++.++|.|||.+..+
T Consensus        79 ~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999999 899999997543 358899999999999999999999999999999999999   68899999999987654


Q ss_pred             CCCCCcee---ccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        513 SPTKKKVH---LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       513 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      ........   .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            33221111   11224568899999999976  4689999999999999999999999987543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=296.87  Aligned_cols=205  Identities=19%  Similarity=0.293  Sum_probs=163.9

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhC----CCCccceeE
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHL----RHPNIICYI  426 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~----~~~~~~~~E~~~l~~l----~HpnIv~~~  426 (622)
                      ....++|++.+.||+  |+||.||+|++..+++.||||++.......    .....+.+|+.+++.+    +||||++++
T Consensus        27 ~~~~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGK--GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             ------CEEEEEEEE--ETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhhhhceEEeeEEEc--CCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            345678999999999  789999999999999999999997654332    1233466899999998    899999999


Q ss_pred             EEEEeCCcEEEEeec-cCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCceEEc
Q psy15039        427 SSFLDATDLHLVSPL-MGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS-HNGKACLS  504 (622)
Q Consensus       427 ~~~~~~~~~~lv~e~-~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~-~~~~~~~~  504 (622)
                      +++...+..++|+|+ +++++|.+++....  .+++..+..++.||+.||+|||++||+||||||+||+++ .++.+++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence            999999999999999 78999999998753  478999999999999999999999999999999999999 78999999


Q ss_pred             CcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      |||.+.......      .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus       183 dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          183 DFGSGALLHDEP------YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             CCSSCEECCSSC------BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EcchhhhcccCc------ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            999765443221      1234578889999998653 2234589999999999999999999965

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.3e-34  Score=303.18  Aligned_cols=205  Identities=21%  Similarity=0.315  Sum_probs=158.6

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ..|++.+.||+  |+||.|+ .+...+|+.||||++.....     ..+.+|+.+|+.+ +|||||++++++.+....|+
T Consensus        24 ~~y~~~~~LG~--G~~G~V~-~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           24 ISFCPKDVLGH--GAEGTIV-YRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEEEEEEEEEE--CGGGCEE-EEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEecCCeeec--CcCEEEE-EEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            45899999999  7899976 35567899999999865432     2356899999999 89999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CC--ceEEcCccccccc
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NG--KACLSGLRYMCPF  512 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~---~~--~~~~~~~~~~~~~  512 (622)
                      |||||+ |+|.+++..... ..++..+..++.||+.||+|||++||+||||||+|||++.   ++  ++++.|||.+...
T Consensus        96 v~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999997 599999876432 3444456789999999999999999999999999999953   23  5779999987654


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccC-ccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcH
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  574 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~  574 (622)
                      ....... ....+..||+.|||||++.+. ...++.++|||||||++|||++ |.+||......
T Consensus       174 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~  236 (432)
T 3p23_A          174 AVGRHSF-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR  236 (432)
T ss_dssp             -------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH
T ss_pred             cCCCcce-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH
Confidence            3322111 112345688999999999632 2356789999999999999999 99999765443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.1e-33  Score=286.06  Aligned_cols=180  Identities=21%  Similarity=0.301  Sum_probs=154.5

Q ss_pred             CCCCCceEe-eecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHH-hhCCCCccceeEEEEEe--
Q psy15039        356 NVPSNYKIC-SILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM-RHLRHPNIICYISSFLD--  431 (622)
Q Consensus       356 ~~~~~y~~~-~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~~~~~~~~--  431 (622)
                      .+.++|.+. +.||+  |+||.||+|.+..+++.||+|++...       ..+.+|+.++ +.++||||+++++++..  
T Consensus        14 ~~~~~y~~~~~~lg~--G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             CGGGTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccchhhcCccccc--CCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            455678887 78999  78999999999999999999998632       3567888887 66799999999999987  


Q ss_pred             --CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCceEEcCc
Q psy15039        432 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGL  506 (622)
Q Consensus       432 --~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~---~~~~~~~~~  506 (622)
                        ....++||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.   ++.+++.||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence              667899999999999999998765556899999999999999999999999999999999999998   788999999


Q ss_pred             ccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        507 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      |.+....                          +  ..|+.++|||||||++|||++|++||....
T Consensus       165 g~a~~~~--------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~  202 (299)
T 3m2w_A          165 GFAKETT--------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH  202 (299)
T ss_dssp             TTCEECT--------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred             ccccccc--------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            8642110                          1  247889999999999999999999997654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-33  Score=319.42  Aligned_cols=195  Identities=18%  Similarity=0.245  Sum_probs=166.3

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEcc-CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc-
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKV-TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~-  434 (622)
                      +.++|++.+.||+  |+||.||++++.. +|+.||||++... ........+.+|+.+++.++|||||++++++...+. 
T Consensus        78 ~~~~y~i~~~lg~--G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           78 VAGQYEVKGCIAH--GGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             ETTTEEEEEEEEE--ETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             eCCceEEEEEEee--CCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            4578999999999  8899999999976 7999999998653 244556778999999999999999999999988766 


Q ss_pred             ----EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        435 ----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       435 ----~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                          .|+||||+++++|.+++..    .+++..+..++.||+.||+|||++|||||||||+|||++.+ .+++.|||.+.
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence                7999999999999887654    47899999999999999999999999999999999999875 89999999765


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      .....        ....||+.|||||++.+   .++.++|||||||++|||++|.+||..
T Consensus       230 ~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          230 RINSF--------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             ETTCC--------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hcccC--------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcc
Confidence            43321        23467889999999965   358899999999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.9e-34  Score=312.94  Aligned_cols=206  Identities=24%  Similarity=0.325  Sum_probs=173.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe------
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD------  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------  431 (622)
                      .++|++.+.||+  |+||.||+|++..+|+.||||++... ......+.+.+|+.+++.++|||||++++++..      
T Consensus        13 ~grY~i~~~LG~--G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGT--GGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCB--CSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEee--CCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            467999999999  88999999999999999999998654 355667789999999999999999999998765      


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---eEEcCcc
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFN-FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK---ACLSGLR  507 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~---~~~~~~~  507 (622)
                      .+..++||||+++|+|.+++..... .++++..+..++.|++.||+|||++||+||||||+|||++.++.   +++.|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            5678999999999999999976432 24778888999999999999999999999999999999998775   8899999


Q ss_pred             cccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        508 YMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      .+.......     ......+|+.|+|||++.+  ..++.++|||||||++|||++|..||.....
T Consensus       170 ~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~  228 (676)
T 3qa8_A          170 YAKELDQGE-----LCTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQ  228 (676)
T ss_dssp             CCCBTTSCC-----CCCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred             ccccccccc-----ccccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence            876543221     1233567889999999975  4689999999999999999999999976543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-34  Score=305.55  Aligned_cols=207  Identities=16%  Similarity=0.208  Sum_probs=155.0

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCC-Cccce---------
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRH-PNIIC---------  424 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~H-pnIv~---------  424 (622)
                      ....+|+..+.||+  |+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++| +|...         
T Consensus        75 ~~~~~~~~~~~LG~--G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~  152 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQ--EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  152 (413)
T ss_dssp             SCCEEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred             CCceeEEEeccccc--CCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence            34556889999999  88999999999999999999998744322 2335778999999999987 32211         


Q ss_pred             ------------eEEEEEe-----CCcEEEEeeccCCCCHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy15039        425 ------------YISSFLD-----ATDLHLVSPLMGFGSCKDLINAH-----FNFGLPELVICHILQDVLNGLEYIHGKG  482 (622)
Q Consensus       425 ------------~~~~~~~-----~~~~~lv~e~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~~qi~~gL~ylH~~~  482 (622)
                                  +..++..     ....+++|+++ +++|.+++...     ....+++..+..++.||+.||+|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  231 (413)
T 3dzo_A          153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  231 (413)
T ss_dssp             CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                        1111111     22456777655 58999988522     1223567788889999999999999999


Q ss_pred             ceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCcccccccccc--------CccCCCchhhHHHH
Q psy15039        483 FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ--------NLDGYDERSDIYSV  554 (622)
Q Consensus       483 iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~~DiwSl  554 (622)
                      ||||||||+|||++.++.++|.|||.+......       ....+| +.|||||++..        ....|+.++|||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence            999999999999999999999999986543321       123345 78999999931        11357889999999


Q ss_pred             HHHHHHHHcCCCCCCCCCc
Q psy15039        555 GISCCELANGTVPFAETPT  573 (622)
Q Consensus       555 Gvil~e~ltg~~Pf~~~~~  573 (622)
                      ||++|||++|+.||.....
T Consensus       304 Gvil~elltg~~Pf~~~~~  322 (413)
T 3dzo_A          304 GLAIYWIWCADLPNTDDAA  322 (413)
T ss_dssp             HHHHHHHHHSSCCCCTTGG
T ss_pred             HHHHHHHHHCCCCCCCcch
Confidence            9999999999999976543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.4e-35  Score=301.54  Aligned_cols=194  Identities=13%  Similarity=0.147  Sum_probs=158.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCC------CHHHHHHHHHHHHHHhhCC---------CCcc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM------TDEDLKSLHHEIVCMRHLR---------HPNI  422 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~------~~~~~~~~~~E~~~l~~l~---------HpnI  422 (622)
                      .++|++.+.||+  |+||.||+|++  +|+.||||++.....      .....+.+.+|+.+|+.++         ||||
T Consensus        19 ~~~y~~~~~lG~--G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           19 TEKLQRCEKIGE--GVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             HHHHHTCEEEEE--ETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccchheeeecc--cCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            356999999999  78999999998  789999999976532      1222467889999999886         7777


Q ss_pred             ceeEEEEE-----------------e-------------CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHH
Q psy15039        423 ICYISSFL-----------------D-------------ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL  472 (622)
Q Consensus       423 v~~~~~~~-----------------~-------------~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~  472 (622)
                      |++.+++.                 +             .+.+|+||||+++|++.+.+..   ..+++..++.++.||+
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence            77776643                 2             6789999999999976655533   3478999999999999


Q ss_pred             HHHHHHH-hCCceecCCCCCcEEEcCCC--------------------ceEEcCcccccccCCCCCceeccCCCCCCCCc
Q psy15039        473 NGLEYIH-GKGFIHRAVKASHILISHNG--------------------KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN  531 (622)
Q Consensus       473 ~gL~ylH-~~~iiHRDlKp~NILl~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~  531 (622)
                      .||+||| ++|||||||||+|||++.++                    .++|+|||.+.....         ....||+.
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------~~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------GIVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------TEEECCCC
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------CcEEEeec
Confidence            9999999 99999999999999999987                    899999997653321         23467889


Q ss_pred             cccccccccCccCCCchhhHHHHHHH-HHHHHcCCCCCCC
Q psy15039        532 WLSPEVLEQNLDGYDERSDIYSVGIS-CCELANGTVPFAE  570 (622)
Q Consensus       532 y~aPE~~~~~~~~~~~~~DiwSlGvi-l~e~ltg~~Pf~~  570 (622)
                      |||||++.+.   .+.++||||++++ .+++++|..||..
T Consensus       243 y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          243 SMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             TTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             ccChhhhcCC---CccceehhhhhCCCCcccccccCCCcc
Confidence            9999999753   3789999998877 7889999999954

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	622
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-36
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-36
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-36
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-41
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-36
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-40
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-35
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-32
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-37
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-29
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-27
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-31
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-31
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-26
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-31
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-28
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-31
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-29
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-27
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-23
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-26
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-29
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-25
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-28
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-27
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-27
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-28
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-27
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-27
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-24
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-20
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-25
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-21
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-23
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-09
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-09

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-49
 Identities = 79/338 (23%), Positives = 138/338 (40%), Gaps = 28/338 (8%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHE 60
           ME  D+   +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E
Sbjct: 1   MELKDD---DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRE 54

Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  +     P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112

Query: 121 VLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
           V+ GL Y+  K   +HR VK S+IL++  G+  L      C F  + + +     S    
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGT 166

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATP 236
            +++SPE L+     Y  +SDI+S+G+S  E+A G  P          LM   ++ G   
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224

Query: 237 HL--------LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSR 288
                        ++Y +D+           YI  +    L S  FS  F   V  CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284

Query: 289 DVDKRPLACNLLQHAFFKQTKKCSVMLPELLRPALSLN 326
           +  +R     L+ HAF K++    V     L   + LN
Sbjct: 285 NPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLN 322

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 4e-36
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 14/210 (6%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +++  S LG    N   V+   HK +  ++A K  +L+ +       +  E+  +     
Sbjct: 7   DFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           P I+ +  +F    ++ +    M  GS   ++       +PE ++  +   V+ GL Y+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121

Query: 480 GK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
            K   +HR VK S+IL++  G+  L      C F  + + +     S     +++SPE L
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKL------CDFGVSGQLIDSMANSFVGTRSYMSPERL 175

Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +     Y  +SDI+S+G+S  E+A G  P 
Sbjct: 176 QGT--HYSVQSDIWSMGLSLVEMAVGRYPI 203

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 7e-48
 Identities = 80/320 (25%), Positives = 136/320 (42%), Gaps = 44/320 (13%)

Query: 3   TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
           ++ +    Y     +GQ      +VY +    T Q +A+++ NL +   ++L  + +EI+
Sbjct: 14  SVGDPKKKYTRFEKIGQ--GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEIL 69

Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
            MR  ++PNI+ Y+ S+L   +L +V   +  GS  D++       + E  I  + ++ L
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 126

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
             LE++H    IHR +K+ +IL+  +G   L+   +    +P + K      +      W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYW 182

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           ++PEV+ +    Y  + DI+S+GI   E+  G  P+        L       TP L +  
Sbjct: 183 MAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-- 238

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                                         K S  F   +  CL  DV+KR  A  LLQH
Sbjct: 239 ----------------------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270

Query: 303 AFFKQTKKCSVMLPELLRPA 322
            F K  K  S + P L+  A
Sbjct: 271 QFLKIAKPLSSLTP-LIAAA 289

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-39
 Identities = 60/239 (25%), Positives = 112/239 (46%), Gaps = 13/239 (5%)

Query: 350 SVETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHH 409
           S+ ++ +    Y     +GQ      +VY +    T Q +A+++ NL +   ++L  + +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQ--GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IIN 66

Query: 410 EIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQ 469
           EI+ MR  ++PNI+ Y+ S+L   +L +V   +  GS  D++       + E  I  + +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCR 123

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
           + L  LE++H    IHR +K+ +IL+  +G   L+   +    +P + K      +    
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGT 179

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 588
             W++PEV+ +    Y  + DI+S+GI   E+  G  P+        L       TP L
Sbjct: 180 PYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (403), Expect = 1e-44
 Identities = 77/325 (23%), Positives = 128/325 (39%), Gaps = 45/325 (13%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVC 63
           D+    +     +G    +  +VY ++    ++++A+KK +       E  + +  E+  
Sbjct: 11  DDPEKLFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           ++ LRHPN I Y   +L      LV       +   L        L E+ I  +    L 
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQ 126

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           GL Y+H    IHR VKA +IL+S  G   L         +P    V      T Y   W+
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPY---WM 178

Query: 184 SPEVLEQNLDG-YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           +PEV+    +G YD + D++S+GI+C ELA    P         L       +P L    
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--- 235

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                                       S  +S+ F + V+ CL +    RP +  LL+H
Sbjct: 236 ----------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267

Query: 303 AFFKQTKKCSVMLPELLRPALSLNE 327
            F  + +  +V++  + R   ++ E
Sbjct: 268 RFVLRERPPTVIMDLIQRTKDAVRE 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 1e-36
 Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 14/238 (5%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVC 413
           D+    +     +G    +  +VY ++    ++++A+KK +       E  + +  E+  
Sbjct: 11  DDPEKLFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           ++ LRHPN I Y   +L      LV       +   L        L E+ I  +    L 
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQ 126

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           GL Y+H    IHR VKA +IL+S  G   L         +P    V      T Y   W+
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPY---WM 178

Query: 534 SPEVLEQNLDG-YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD 590
           +PEV+    +G YD + D++S+GI+C ELA    P         L       +P L  
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 7e-44
 Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 42/301 (13%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            ++I   LG        VY +++K T+ L A K   +D  ++E+L+    EI  +    H
Sbjct: 13  FWEIIGELGD--GAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEIDILASCDH 68

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  + +F    +L ++      G+   ++       L E  I  + +  L+ L Y+H
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH 127

Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL- 188
               IHR +KA +IL + +G   L+        + T ++      S      W++PEV+ 
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD----SFIGTPYWMAPEVVM 183

Query: 189 --EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 246
                   YD ++D++S+GI+  E+A    P  E     +L++      P L        
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ------ 237

Query: 247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
                                     ++S +F   ++ CL ++VD R     LLQH F  
Sbjct: 238 ------------------------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

Query: 307 Q 307
            
Sbjct: 274 V 274

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 1e-37
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 12/232 (5%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            ++I   LG        VY +++K T+ L A K   +D  ++E+L+    EI  +    H
Sbjct: 13  FWEIIGELGD--GAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEIDILASCDH 68

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  + +F    +L ++      G+   ++       L E  I  + +  L+ L Y+H
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH 127

Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL- 538
               IHR +KA +IL + +G   L+        + T ++      S      W++PEV+ 
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD----SFIGTPYWMAPEVVM 183

Query: 539 --EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 588
                   YD ++D++S+GI+  E+A    P  E     +L++      P L
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 7e-43
 Identities = 51/298 (17%), Positives = 113/298 (37%), Gaps = 38/298 (12%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D   +++  EI   + L H
Sbjct: 6   DWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 62

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
            N++ +     +    +L       G   D I    + G+PE         ++ G+ Y+H
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 189
           G G  HR +K  ++L+       +S       F    ++  L        L +++PE+L 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPELL- 177

Query: 190 QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG 249
           +  + + E  D++S GI    +  G +P+ +   +                         
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------------- 218

Query: 250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
                        E++T +   +K   +  +++   L  +   R    ++ +  ++ +
Sbjct: 219 -----------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-37
 Identities = 47/229 (20%), Positives = 95/229 (41%), Gaps = 8/229 (3%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           ++ +   LG+       V L+ ++VT + +AVK  ++ R  D   +++  EI   + L H
Sbjct: 6   DWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 62

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
            N++ +     +    +L       G   D I    + G+PE         ++ G+ Y+H
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 539
           G G  HR +K  ++L+       +S       F    ++  L        L +++PE+L 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPELL- 177

Query: 540 QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 588
           +  + + E  D++S GI    +  G +P+ +   +            +L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (384), Expect = 1e-41
 Identities = 53/305 (17%), Positives = 101/305 (33%), Gaps = 43/305 (14%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           D+V  +Y I   LG        V+    + T    A K       +D+  +++  EI  M
Sbjct: 22  DHVLDHYDIHEELGT--GAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTM 77

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             LRHP ++    +F D  ++ ++   M  G   + +    N  + E      ++ V  G
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKG 136

Query: 125 LEYIHGKGFIHRAVKASHILIS--HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
           L ++H   ++H  +K  +I+ +   + +  L          P +         T     +
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-----KVTTGTAEF 191

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
            +PEV E         +D++SVG+    L +G  PF         +  +     ++ D  
Sbjct: 192 AAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDD-- 246

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                                           S+     +   L  D + R      L+H
Sbjct: 247 --------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280

Query: 303 AFFKQ 307
            +   
Sbjct: 281 PWLTP 285

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  136 bits (343), Expect = 6e-36
 Identities = 46/216 (21%), Positives = 85/216 (39%), Gaps = 14/216 (6%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           D+V  +Y I   LG        V+    + T    A K       +D+  +++  EI  M
Sbjct: 22  DHVLDHYDIHEELGT--GAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTM 77

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             LRHP ++    +F D  ++ ++   M  G   + +    N  + E      ++ V  G
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKG 136

Query: 475 LEYIHGKGFIHRAVKASHILIS--HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
           L ++H   ++H  +K  +I+ +   + +  L          P +         T     +
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-----KVTTGTAEF 191

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            +PEV E         +D++SVG+    L +G  PF
Sbjct: 192 AAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPF 225

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 6e-41
 Identities = 53/306 (17%), Positives = 108/306 (35%), Gaps = 49/306 (16%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
             +Y++   +G    +       + K   +++  K+ +   MT+ + + L  E+  +R L
Sbjct: 3   AEDYEVLYTIGT--GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 68  RHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLN 123
           +HPNI+ Y    +D T+  L++V      G    +I         L E  +  ++  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 124 GLEYIHGKG-----FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
            L+  H +       +HR +K +++ +       L         +        F  +  Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 238
               +SPE + +    Y+E+SDI+S+G    EL     PF       +  +   G    +
Sbjct: 181 ----MSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234

Query: 239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                                             ++SD  + I+   L+     RP    
Sbjct: 235 --------------------------------PYRYSDELNEIITRMLNLKDYHRPSVEE 262

Query: 299 LLQHAF 304
           +L++  
Sbjct: 263 ILENPL 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-36
 Identities = 46/240 (19%), Positives = 93/240 (38%), Gaps = 17/240 (7%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
             +Y++   +G    +       + K   +++  K+ +   MT+ + + L  E+  +R L
Sbjct: 3   AEDYEVLYTIGT--GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 418 RHPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFG--LPELVICHILQDVLN 473
           +HPNI+ Y    +D T+  L++V      G    +I         L E  +  ++  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 474 GLEYIHGKG-----FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
            L+  H +       +HR +K +++ +       L         +        F  +  Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 588
               +SPE + +    Y+E+SDI+S+G    EL     PF       +  +   G    +
Sbjct: 181 ----MSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  147 bits (372), Expect = 5e-40
 Identities = 52/306 (16%), Positives = 107/306 (34%), Gaps = 47/306 (15%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
           +V   Y I   LG        V+    K T ++   K  N     D+   ++ +EI  M 
Sbjct: 26  SVYDYYDILEELGS--GAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMN 81

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
            L HP +I    +F D  ++ L+   +  G   D I A  ++ + E  + + ++    GL
Sbjct: 82  QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGL 140

Query: 126 EYIHGKGFIHRAVKASHILIS--HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           +++H    +H  +K  +I+          +         +P +         T     + 
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-----TTATAEFA 195

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA--ETPTTLMLIEKLAGATPHLLDC 241
           +PE++++        +D++++G+    L +G  PFA  +   TL  +++           
Sbjct: 196 APEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF- 252

Query: 242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                                            S      ++  L ++  KR    + L+
Sbjct: 253 ------------------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

Query: 302 HAFFKQ 307
           H + K 
Sbjct: 283 HPWLKG 288

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  133 bits (335), Expect = 7e-35
 Identities = 43/216 (19%), Positives = 87/216 (40%), Gaps = 14/216 (6%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
           +V   Y I   LG        V+    K T ++   K  N     D+   ++ +EI  M 
Sbjct: 26  SVYDYYDILEELGS--GAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMN 81

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
            L HP +I    +F D  ++ L+   +  G   D I A  ++ + E  + + ++    GL
Sbjct: 82  QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGL 140

Query: 476 EYIHGKGFIHRAVKASHILIS--HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           +++H    +H  +K  +I+          +         +P +         T     + 
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-----TTATAEFA 195

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA 569
           +PE++++        +D++++G+    L +G  PFA
Sbjct: 196 APEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFA 229

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 7e-40
 Identities = 61/299 (20%), Positives = 117/299 (39%), Gaps = 46/299 (15%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 67
            +++I   LG+      +VYL++ K +  ++A+K     ++    +   L  E+    HL
Sbjct: 6   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           RHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L Y
Sbjct: 64  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSY 121

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
            H K  IHR +K  ++L+   G+  +        F  +         +    L++L PE+
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKI------ADFGWSVHAPSSRRTTLCGTLDYLPPEM 175

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           +E     +DE+ D++S+G+ C E   G  PF E  T     ++++       D       
Sbjct: 176 IEGR--MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPD------- 225

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK 306
                                      ++    ++   L  +  +RP+   +L+H +  
Sbjct: 226 -------------------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 7e-35
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 15/235 (6%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL-KSLHHEIVCMRHL 417
            +++I   LG+      +VYL++ K +  ++A+K     ++    +   L  E+    HL
Sbjct: 6   EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           RHPNI+     F DAT ++L+      G+    +     F   E      + ++ N L Y
Sbjct: 64  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSY 121

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
            H K  IHR +K  ++L+   G+  +        F  +         +    L++L PE+
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKI------ADFGWSVHAPSSRRTTLCGTLDYLPPEM 175

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETP--TTLMLIEKLAGATPHLLD 590
           +E     +DE+ D++S+G+ C E   G  PF       T   I ++    P  + 
Sbjct: 176 IEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 228

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-39
 Identities = 57/298 (19%), Positives = 115/298 (38%), Gaps = 41/298 (13%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
                +   +G    +  +VY  K       +AVK  N+   T + L++  +E+  +R  
Sbjct: 7   DGQITVGQRIGS--GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           RH NI+ ++  +  A  L +V+      S    ++         + +  I +    G++Y
Sbjct: 62  RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDY 119

Query: 128 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           +H K  IHR +K+++I +  +    +   GL  +        +        + ++ W++P
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE----QLSGSILWMAP 175

Query: 186 EVLE-QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY 244
           EV+  Q+ + Y  +SD+Y+ GI   EL  G +P++       +I  +             
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG---------- 225

Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
           Y+         N                    +   ++  CL +  D+RPL   +L  
Sbjct: 226 YLSPDLSKVRSN-----------------CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 1e-36
 Identities = 48/229 (20%), Positives = 99/229 (43%), Gaps = 14/229 (6%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
                +   +G    +  +VY  K       +AVK  N+   T + L++  +E+  +R  
Sbjct: 7   DGQITVGQRIGS--GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           RH NI+ ++  +  A  L +V+      S    ++         + +  I +    G++Y
Sbjct: 62  RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDY 119

Query: 478 IHGKGFIHRAVKASHILISHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           +H K  IHR +K+++I +  +    +   GL  +        +        + ++ W++P
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE----QLSGSILWMAP 175

Query: 536 EVLE-QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG 583
           EV+  Q+ + Y  +SD+Y+ GI   EL  G +P++       +I  +  
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-39
 Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 16/303 (5%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 189
               +HR +K  ++LI+  G   L+       F    +       +  Y     +PE+L 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY----RAPEILL 175

Query: 190 QNLDGYDERSDIYSVGISCCELANGTVPFA--ETPTTLMLIEKLAGATPHLLDCTTYYVD 247
                Y    DI+S+G    E+      F        L  I +  G    ++      + 
Sbjct: 176 GC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
             +    + A    S+            +   S++   L  D +KR  A   L H FF+ 
Sbjct: 235 DYKPSFPKWARQDFSK------VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

Query: 308 TKK 310
             K
Sbjct: 289 VTK 291

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 7e-32
 Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 10/232 (4%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           N++    +G+       VY +++K+T +++A+KK  LD  T+    +   EI  ++ L H
Sbjct: 3   NFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
           PNI+  +        L+LV   +     K  ++A    G+P  +I   L  +L GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 539
               +HR +K  ++LI+  G   L+       F    +       +  Y     +PE+L 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY----RAPEILL 175

Query: 540 QNLDGYDERSDIYSVGISCCELANGTVPFA--ETPTTLMLIEKLAGATPHLL 589
                Y    DI+S+G    E+      F        L  I +  G    ++
Sbjct: 176 GC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-38
 Identities = 60/305 (19%), Positives = 115/305 (37%), Gaps = 54/305 (17%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
            K    +G+   +  +VY      T   +A  +    ++T  + +    E   ++ L+HP
Sbjct: 11  LKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 71  NIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           NI+ +  S+         + LV+ LM  G+ K  +       +   V+    + +L GL+
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQ 126

Query: 127 YIH--GKGFIHRAVKASHILI-SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           ++H      IHR +K  +I I    G   +   GL  +   S  K        +      
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--------AVIGTPE 178

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC 241
           +++PE+ E+    YDE  D+Y+ G+   E+A    P++E      +  +           
Sbjct: 179 FMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----------- 224

Query: 242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                              ++         +        I+E C+ ++ D+R    +LL 
Sbjct: 225 -------------------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

Query: 302 HAFFK 306
           HAFF+
Sbjct: 266 HAFFQ 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-31
 Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 24/230 (10%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
            K    +G+   +  +VY      T   +A  +    ++T  + +    E   ++ L+HP
Sbjct: 11  LKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 421 NIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           NI+ +  S+         + LV+ LM  G+ K  +       +   V+    + +L GL+
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQ 126

Query: 477 YIH--GKGFIHRAVKASHILI-SHNGKACLS--GLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           ++H      IHR +K  +I I    G   +   GL  +   S  K        +      
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--------AVIGTPE 178

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           +++PE+ E+    YDE  D+Y+ G+   E+A    P++E      +  ++
Sbjct: 179 FMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-38
 Identities = 61/316 (19%), Positives = 109/316 (34%), Gaps = 28/316 (8%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           +Y    ++G    +   VY +K   + +L+A+KK   D+      +  + E+  MR L H
Sbjct: 21  SYTDTKVIGN--GSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDH 72

Query: 70  PNIICYISSFLDATD------LHLVSPLMGFGSCKDLIN-AHFNFGLPELVICHILQDVL 122
            NI+     F  + +      L+LV   +     +   + +     LP + +   +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
             L YIH  G  HR +K  ++L+  +          +C F   K+ V   P  +     +
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVL-----KLCDFGSAKQLVRGEPNVSYICSRY 187

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATPHLLD 240
                L      Y    D++S G    EL  G   F        L+ I K+ G       
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG------T 241

Query: 241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL 300
            T   +     +  E     I       +   +      ++    L      R       
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

Query: 301 QHAFFKQTKKCSVMLP 316
            H+FF + +  +V LP
Sbjct: 302 AHSFFDELRDPNVKLP 317

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 3e-29
 Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 22/237 (9%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +Y    ++G    +   VY +K   + +L+A+KK   D+      +  + E+  MR L H
Sbjct: 21  SYTDTKVIGN--GSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDH 72

Query: 420 PNIICYISSFLDATD------LHLVSPLMGFGSCKDLIN-AHFNFGLPELVICHILQDVL 472
            NI+     F  + +      L+LV   +     +   + +     LP + +   +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
             L YIH  G  HR +K  ++L+  +          +C F   K+ V   P  +     +
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVL-----KLCDFGSAKQLVRGEPNVSYICSRY 187

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATPH 587
                L      Y    D++S G    EL  G   F        L+ I K+ G    
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-38
 Identities = 65/306 (21%), Positives = 111/306 (36%), Gaps = 48/306 (15%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 66
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 7   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 67  LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALE 122

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN--SFVGTAQYVSPE 180

Query: 187 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 246
           +L +      + SD++++G    +L  G  PF      L+  + +               
Sbjct: 181 LLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--------- 229

Query: 247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA------CNLL 300
                                     KF      +VE  L  D  KR           L 
Sbjct: 230 ------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265

Query: 301 QHAFFK 306
            H FF+
Sbjct: 266 AHPFFE 271

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 1e-34
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 9/221 (4%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRH 416
           P ++K   ILG+   + S+V L++   T++  A+K      +  E+ +  +  E   M  
Sbjct: 7   PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 417 LRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           L HP  +    +F D   L+        G     I    +F   E        ++++ LE
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALE 122

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+HGKG IHR +K  +IL++ +    ++        SP  K+      S      ++SPE
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN--SFVGTAQYVSPE 180

Query: 537 VLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 577
           +L +      + SD++++G    +L  G  PF      L+ 
Sbjct: 181 LLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  140 bits (352), Expect = 5e-38
 Identities = 65/300 (21%), Positives = 116/300 (38%), Gaps = 18/300 (6%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y     +G+       VY +++    +  A+KK  L++  +    +   EI  ++ L+H
Sbjct: 3   KYHGLEKIGE--GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
            NI+           L LV   +     K L       GL  +     L  +LNG+ Y H
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 189
            +  +HR +K  ++LI+  G+  ++       F    +K           L + +P+VL 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT----HEIVTLWYRAPDVLM 173

Query: 190 QNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGATPHLLDCTTYYVD 247
            +   Y    DI+SVG    E+ NGT  F        LM I ++ G         +    
Sbjct: 174 GS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG------TPNSKNWP 226

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
              +  + +    + E        +   +S   ++   L  D ++R  A   L+HA+FK+
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  115 bits (289), Expect = 2e-29
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 12/226 (5%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y     +G+       VY +++    +  A+KK  L++  +    +   EI  ++ L+H
Sbjct: 3   KYHGLEKIGE--GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
            NI+           L LV   +     K L       GL  +     L  +LNG+ Y H
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 539
            +  +HR +K  ++LI+  G+  ++       F    +K           L + +P+VL 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT----HEIVTLWYRAPDVLM 173

Query: 540 QNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAG 583
            +   Y    DI+SVG    E+ NGT  F        LM I ++ G
Sbjct: 174 GS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  139 bits (352), Expect = 6e-38
 Identities = 68/310 (21%), Positives = 113/310 (36%), Gaps = 50/310 (16%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-------EDLKSLHHEIV 62
           NY+   ILG+     S V    HK T +  AVK  ++            E  ++   E+ 
Sbjct: 4   NYEPKEILGR--GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 63  CMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 121
            +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ +
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRAL 119

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L  +  +H    +HR +K  +IL+  +    L+   + C   P +K             +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPS 174

Query: 182 WLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH 237
           +L+PE++E     N  GY +  D++S G+    L  G+ PF      ++++  +      
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQ 233

Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
                                               +SD+   +V   L     KR  A 
Sbjct: 234 FGS----------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265

Query: 298 NLLQHAFFKQ 307
             L H FF+Q
Sbjct: 266 EALAHPFFQQ 275

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (308), Expect = 7e-32
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 21/230 (9%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-------EDLKSLHHEIV 412
           NY+   ILG+     S V    HK T +  AVK  ++            E  ++   E+ 
Sbjct: 4   NYEPKEILGR--GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 413 CMRHLR-HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDV 471
            +R +  HPNII    ++   T   LV  LM  G   D +       L E     I++ +
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRAL 119

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L  +  +H    +HR +K  +IL+  +    L+   + C   P +K             +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPS 174

Query: 532 WLSPEVLE----QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 577
           +L+PE++E     N  GY +  D++S G+    L  G+ PF      LML
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (348), Expect = 4e-37
 Identities = 62/327 (18%), Positives = 119/327 (36%), Gaps = 44/327 (13%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 64
           +++   Y    +LG      S V L++ K T +L+A+K      +  ++  S+ +EI  +
Sbjct: 5   EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVL 61

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 119

Query: 125 LEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           ++Y+H  G +HR +K  ++L      + K  +S         P          +      
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-----STACGTPG 174

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC 241
           +++PEVL Q    Y +  D +S+G+    L  G  PF +     +  + L          
Sbjct: 175 YVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------- 224

Query: 242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                                E +         SDS    +   + +D +KR      LQ
Sbjct: 225 ---------------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

Query: 302 HAFFKQTKKCSVMLPELLRPALSLNES 328
           H +          + + +   +  N +
Sbjct: 264 HPWIAGDTALDKNIHQSVSEQIKKNFA 290

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (301), Expect = 1e-30
 Identities = 50/226 (22%), Positives = 95/226 (42%), Gaps = 15/226 (6%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCM 414
           +++   Y    +LG      S V L++ K T +L+A+K      +  ++  S+ +EI  +
Sbjct: 5   EDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVL 61

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
             ++HPNI+     +     L+L+  L+  G   D I     +   E     ++  VL+ 
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDA 119

Query: 475 LEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           ++Y+H  G +HR +K  ++L      + K  +S         P          +      
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-----STACGTPG 174

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 577
           +++PEVL Q    Y +  D +S+G+    L  G  PF +     + 
Sbjct: 175 YVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 5e-37
 Identities = 56/323 (17%), Positives = 103/323 (31%), Gaps = 49/323 (15%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y I   LG+       V+      + +    K   +       +K    EI  +   RH
Sbjct: 6   KYMIAEDLGR--GEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARH 60

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
            NI+    SF    +L ++   +      + IN    F L E  I   +  V   L+++H
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH 119

Query: 130 GKGFIHRAVKASHILISHNGKACLS----GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
                H  ++  +I+      + +     G           + +   P        + +P
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE-------YYAP 172

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 245
           EV +   D     +D++S+G     L +G  PF    T   +IE +  A     +     
Sbjct: 173 EVHQH--DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDE----- 224

Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF 305
                                     ++ S      V+  L ++   R  A   LQH + 
Sbjct: 225 -----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

Query: 306 KQ-TKKCSVMLPELLRPALSLNE 327
           KQ  ++ S  +   L+     + 
Sbjct: 262 KQKIERVSTKVIRTLKHRRYYHT 284

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 3e-30
 Identities = 40/213 (18%), Positives = 73/213 (34%), Gaps = 19/213 (8%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y I   LG+       V+      + +    K   +       +K    EI  +   RH
Sbjct: 6   KYMIAEDLGR--GEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARH 60

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
            NI+    SF    +L ++   +      + IN    F L E  I   +  V   L+++H
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH 119

Query: 480 GKGFIHRAVKASHILISHNGKACLS----GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
                H  ++  +I+      + +     G           + +   P        + +P
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE-------YYAP 172

Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           EV +   D     +D++S+G     L +G  PF
Sbjct: 173 EVHQH--DVVSTATDMWSLGTLVYVLLSGINPF 203

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 73/316 (23%), Positives = 125/316 (39%), Gaps = 30/316 (9%)

Query: 2   ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           +T   V + Y+    +G       +V  +    T   +A+KK      ++   K  + E+
Sbjct: 11  KTAWEVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 62  VCMRHLRHPNIICYISSF------LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
             ++H+RH N+I  +  F       D TD +LV P MG      L+       L E  I 
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHE---KLGEDRIQ 124

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 175
            ++  +L GL YIH  G IHR +K  ++ ++ + +  +                 +    
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 183

Query: 176 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAG 233
                 + +PEV+  N   Y +  DI+SVG    E+  G   F  ++    L  I K+ G
Sbjct: 184 ------YRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 234 ATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTS--RKFSDSFHSIVELCLSRDVD 291
             P        +V   Q D  +N    + E + +   S     S    +++E  L  D +
Sbjct: 237 TPPA------EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290

Query: 292 KRPLACNLLQHAFFKQ 307
           +R  A   L H +F+ 
Sbjct: 291 QRVTAGEALAHPYFES 306

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-29
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 20/223 (8%)

Query: 352 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 411
           +T   V + Y+    +G       +V  +    T   +A+KK      ++   K  + E+
Sbjct: 11  KTAWEVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 412 VCMRHLRHPNIICYISSF------LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
             ++H+RH N+I  +  F       D TD +LV P MG      L+       L E  I 
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHE---KLGEDRIQ 124

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPS 525
            ++  +L GL YIH  G IHR +K  ++ ++ + +  +                 +    
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 183

Query: 526 TAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                 + +PEV+  N   Y +  DI+SVG    E+  G   F
Sbjct: 184 ------YRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLF 219

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 1e-36
 Identities = 60/309 (19%), Positives = 106/309 (34%), Gaps = 20/309 (6%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
           +V   Y   S +G+       V  +   V    +A+KK +         +    EI  + 
Sbjct: 5   DVGPRYTNLSYIGE--GAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILL 61

Query: 66  HLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
             RH NII         +     D++LV+ LMG      L+       L    IC+ L  
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQ---HLSNDHICYFLYQ 117

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           +L GL+YIH    +HR +K S++L++      +          P       F        
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG-FLTEYVATR 176

Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHL 238
            + +PE++  +  GY +  DI+SVG    E+ +    F        L  I  + G+    
Sbjct: 177 WYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN 298
                  +            + +   +               +++  L+ +  KR     
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNR----LFPNADSKALDLLDKMLTFNPHKRIEVEQ 291

Query: 299 LLQHAFFKQ 307
            L H + +Q
Sbjct: 292 ALAHPYLEQ 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-29
 Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 14/218 (6%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
           +V   Y   S +G+       V  +   V    +A+KK +         +    EI  + 
Sbjct: 5   DVGPRYTNLSYIGE--GAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILL 61

Query: 416 HLRHPNII-----CYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
             RH NII         +     D++LV+ LMG      L+       L    IC+ L  
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQ---HLSNDHICYFLYQ 117

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           +L GL+YIH    +HR +K S++L++      +          P       F        
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG-FLTEYVATR 176

Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
            + +PE++  +  GY +  DI+SVG    E+ +    F
Sbjct: 177 WYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIF 213

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 58/297 (19%), Positives = 103/297 (34%), Gaps = 51/297 (17%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
               K+   +G+       V L  ++     +AVK        D   ++   E   M  L
Sbjct: 6   MKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQL 57

Query: 68  RHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 126
           RH N++  +   ++    L++V+  M  GS  D + +     L    +     DV   +E
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 127 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 186
           Y+ G  F+HR + A ++L+S +  A +S        S T+    L          W +PE
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-------KWTAPE 170

Query: 187 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY 245
            L +    +  +SD++S GI   E  + G VP+   P   ++     G      D     
Sbjct: 171 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD----- 223

Query: 246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                                          + + +++ C   D   RP    L + 
Sbjct: 224 ---------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-33
 Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 19/235 (8%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
               K+   +G+       V L  ++     +AVK        D   ++   E   M  L
Sbjct: 6   MKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQL 57

Query: 418 RHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLE 476
           RH N++  +   ++    L++V+  M  GS  D + +     L    +     DV   +E
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 477 YIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPE 536
           Y+ G  F+HR + A ++L+S +  A +S        S T+    L          W +PE
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-------KWTAPE 170

Query: 537 VLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHLLD 590
            L +    +  +SD++S GI   E  + G VP+   P   ++     G      D
Sbjct: 171 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-36
 Identities = 53/295 (17%), Positives = 91/295 (30%), Gaps = 43/295 (14%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           PS       +G        V+L         +A+K      M++ED      E   M  L
Sbjct: 4   PSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---EEAEVMMKL 57

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP ++      L+   + LV   M  G   D +            +  +  DV  G+ Y
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAY 116

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +     IHR + A + L+  N    +S           +             + W SPEV
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP---VKWASPEV 173

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
              +   Y  +SD++S G+   E+ +      E  +   ++E +                
Sbjct: 174 FSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---------------- 215

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                              ++   R  S   + I+  C     + RP    LL+ 
Sbjct: 216 ---------------STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-33
 Identities = 45/224 (20%), Positives = 77/224 (34%), Gaps = 12/224 (5%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           PS       +G        V+L         +A+K      M++ED      E   M  L
Sbjct: 4   PSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---EEAEVMMKL 57

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP ++      L+   + LV   M  G   D +            +  +  DV  G+ Y
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAY 116

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +     IHR + A + L+  N    +S           +             + W SPEV
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP---VKWASPEV 173

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
              +   Y  +SD++S G+   E+ +      E  +   ++E +
Sbjct: 174 FSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-36
 Identities = 59/298 (19%), Positives = 110/298 (36%), Gaps = 12/298 (4%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
            Y+    +G+      +V+ +K++ T++++A+K+  LD   +    S   EI  ++ L+H
Sbjct: 3   KYEKLEKIGE--GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
            NI+           L LV                 N  L   ++   L  +L GL + H
Sbjct: 61  KNIVRLHDVLHSDKKLTLV--FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 130 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 189
            +  +HR +K  ++LI+ NG+  L+       F    +       +  Y      P+VL 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY----RPPDVLF 174

Query: 190 QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTG 249
                Y    D++S G    ELAN   P          ++++      L   T     + 
Sbjct: 175 GA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL---LGTPTEEQWPSM 230

Query: 250 QDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
               +           + V    K + +   +++  L  +  +R  A   LQH +F  
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-27
 Identities = 48/222 (21%), Positives = 88/222 (39%), Gaps = 9/222 (4%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
            Y+    +G+      +V+ +K++ T++++A+K+  LD   +    S   EI  ++ L+H
Sbjct: 3   KYEKLEKIGE--GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
            NI+           L LV                 N  L   ++   L  +L GL + H
Sbjct: 61  KNIVRLHDVLHSDKKLTLV--FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 480 GKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLE 539
            +  +HR +K  ++LI+ NG+  L+       F    +       +  Y      P+VL 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY----RPPDVLF 174

Query: 540 QNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
                Y    D++S G    ELAN   P          ++++
Sbjct: 175 GA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (337), Expect = 2e-35
 Identities = 56/305 (18%), Positives = 115/305 (37%), Gaps = 52/305 (17%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHL 67
            +++I   LG    +   V+L + +   +  A+K    + +   + ++  + E + +  +
Sbjct: 4   QDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP II    +F DA  + ++   +  G    L+    +   P  V      +V   LEY
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEY 119

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +H K  I+R +K  +IL+  NG   ++   +          +   P       ++++PEV
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP-------DYIAPEV 172

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           +      Y++  D +S GI   E+  G  PF +   T+   EK+  A             
Sbjct: 173 VSTK--PYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPP------- 222

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR-----PLACNLLQH 302
                                     F++    ++   ++RD+ +R         ++  H
Sbjct: 223 -------------------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257

Query: 303 AFFKQ 307
            +FK+
Sbjct: 258 PWFKE 262

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 47/226 (20%), Positives = 94/226 (41%), Gaps = 14/226 (6%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHL 417
            +++I   LG    +   V+L + +   +  A+K    + +   + ++  + E + +  +
Sbjct: 4   QDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP II    +F DA  + ++   +  G    L+    +   P  V      +V   LEY
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEY 119

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +H K  I+R +K  +IL+  NG   ++   +          +   P       ++++PEV
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP-------DYIAPEV 172

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG 583
           +      Y++  D +S GI   E+  G  PF ++ T     + L  
Sbjct: 173 VSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 57/312 (18%), Positives = 114/312 (36%), Gaps = 27/312 (8%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVT-NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL- 67
            Y+  + +G+       V+ ++      + +A+K+  +    +    S   E+  +RHL 
Sbjct: 8   QYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 68  --RHPNIICYISSFLDATDLHLVSPLMGF----GSCKDLINAHFNFGLPELVICHILQDV 121
              HPN++        +         + F          ++     G+P   I  ++  +
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L GL+++H    +HR +K  +IL++ +G+  L+       +S       +        L 
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT-----LW 180

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA--ETPTTLMLIEKLAGATPHLL 239
           + +PEVL Q+   Y    D++SVG    E+      F        L  I  + G      
Sbjct: 181 YRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE- 237

Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL 299
                  D  +D        +    Q          +    ++  CL+ +  KR  A + 
Sbjct: 238 -------DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

Query: 300 LQHAFFKQTKKC 311
           L H +F+  ++C
Sbjct: 291 LSHPYFQDLERC 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 42/217 (19%), Positives = 86/217 (39%), Gaps = 17/217 (7%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVT-NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL- 417
            Y+  + +G+       V+ ++      + +A+K+  +    +    S   E+  +RHL 
Sbjct: 8   QYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 418 --RHPNIICYISSFLDATDLHLVSPLMGF----GSCKDLINAHFNFGLPELVICHILQDV 471
              HPN++        +         + F          ++     G+P   I  ++  +
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L GL+++H    +HR +K  +IL++ +G+  L+       +S       +        L 
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT-----LW 180

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           + +PEVL Q+   Y    D++SVG    E+      F
Sbjct: 181 YRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLF 215

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 14/307 (4%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 68
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 10  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67

Query: 69  HPNIICYISSFLDAT--------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           H N++  I                ++LV           L N    F L E  I  ++Q 
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQM 125

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 180
           +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        +    L
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 181 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD 240
            +  PE+L      Y    D++  G    E+   +       T    +  ++     +  
Sbjct: 186 WYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITP 243

Query: 241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL 300
                VD  +   +         +    L +         +++  L  D  +R  + + L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

Query: 301 QHAFFKQ 307
            H FF  
Sbjct: 304 NHDFFWS 310

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-27
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 15/238 (6%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR 418
           S Y+  + +GQ       V+ ++H+ T Q +A+KK  ++   +    +   EI  ++ L+
Sbjct: 10  SKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67

Query: 419 HPNIICYISSFLDAT--------DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
           H N++  I                ++LV           L N    F L E  I  ++Q 
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQM 125

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNL 530
           +LNGL YIH    +HR +KA+++LI+ +G   L+       FS  K        +    L
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 531 NWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET--PTTLMLIEKLAGATP 586
            +  PE+L      Y    D++  G    E+   +           L LI +L G+  
Sbjct: 186 WYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-35
 Identities = 58/340 (17%), Positives = 116/340 (34%), Gaps = 47/340 (13%)

Query: 5   DNVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-V 62
           + +  +YK+ S +LG        V    +K T +  A+K          D      E+ +
Sbjct: 7   NAIIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL 57

Query: 63  CMRHLRHPNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 118
             R  + P+I+  +  + +       L +V   +  G     I    +    E     I+
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 119 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTA 177
           + +   ++Y+H     HR VK  ++L +       + +  +  F   K+   H    +  
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRP---NAILKLTDFGFAKETTSHNSLTTPC 174

Query: 178 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPH 237
           Y   +++PEVL      YD+  D++S+G+    L  G  PF                   
Sbjct: 175 YTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------------A 220

Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC 297
           +       +  GQ +      S +SE+                ++   L  +  +R    
Sbjct: 221 ISPGMKTRIRMGQYEFPNPEWSEVSEE-------------VKMLIRNLLKTEPTQRMTIT 267

Query: 298 NLLQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNEL 337
             + H +  Q+ K     P      L  ++    ++  E+
Sbjct: 268 EFMNHPWIMQSTKVP-QTPLHTSRVLKEDKERWEDVKEEM 306

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 4e-29
 Identities = 45/221 (20%), Positives = 86/221 (38%), Gaps = 21/221 (9%)

Query: 355 DNVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI-V 412
           + +  +YK+ S +LG        V    +K T +  A+K          D      E+ +
Sbjct: 7   NAIIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVEL 57

Query: 413 CMRHLRHPNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHIL 468
             R  + P+I+  +  + +       L +V   +  G     I    +    E     I+
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 469 QDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV-HLFPPSTA 527
           + +   ++Y+H     HR VK  ++L +       + +  +  F   K+   H    +  
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRP---NAILKLTDFGFAKETTSHNSLTTPC 174

Query: 528 YNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           Y   +++PEVL      YD+  D++S+G+    L  G  PF
Sbjct: 175 YTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPF 213

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (333), Expect = 1e-34
 Identities = 69/363 (19%), Positives = 138/363 (38%), Gaps = 55/363 (15%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSL----HHEIVCMR 65
           ++ +  I+G+       VY  +   T ++ A+K  +  R+  +  ++L       +  + 
Sbjct: 5   DFSVHRIIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 66  HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
               P I+C   +F     L  +  LM  G     ++ H  F   E  +     +++ GL
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGL 120

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
           E++H +  ++R +K ++IL+  +G   +S L   C FS  K      P ++     +++P
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGTHGYMAP 174

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLMLIEKLAGATPHLLDCTTY 244
           EVL++ +  YD  +D +S+G    +L  G  PF          I+++       L     
Sbjct: 175 EVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 229

Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNL 299
                                        FS    S++E  L RDV++R       A  +
Sbjct: 230 ---------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262

Query: 300 LQHAFFKQTKKCSVMLPELLRPALSLNESNVCEINNELECMFNINDTFNSSVETLDNVPS 359
            +  FF+      V L +   P +            ++    + ++     ++ LD+   
Sbjct: 263 KESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG---SFDEEDTKGIKLLDSDQE 319

Query: 360 NYK 362
            Y+
Sbjct: 320 LYR 322

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  121 bits (304), Expect = 1e-30
 Identities = 50/218 (22%), Positives = 98/218 (44%), Gaps = 15/218 (6%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSL----HHEIVCMR 415
           ++ +  I+G+       VY  +   T ++ A+K  +  R+  +  ++L       +  + 
Sbjct: 5   DFSVHRIIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 416 HLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
               P I+C   +F     L  +  LM  G     ++ H  F   E  +     +++ GL
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGL 120

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
           E++H +  ++R +K ++IL+  +G   +S L   C FS  K      P ++     +++P
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGTHGYMAP 174

Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT 573
           EVL++    YD  +D +S+G    +L  G  PF +  T
Sbjct: 175 EVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-34
 Identities = 59/288 (20%), Positives = 107/288 (37%), Gaps = 19/288 (6%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDED---LKSLHHEIVCMRHLRHPNIICYISSFLD 81
           ++VY ++ K TNQ++A+KK  L   ++      ++   EI  ++ L HPNII  + +F  
Sbjct: 12  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71

Query: 82  ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 141
            +++ LV   M   +  ++I    +  L    I   +   L GLEY+H    +HR +K +
Sbjct: 72  KSNISLVFDFM--ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN 129

Query: 142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 201
           ++L+  NG   L+       F    +       +  Y     +PE+L      Y    D+
Sbjct: 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY----RAPELLFGA-RMYGVGVDM 184

Query: 202 YSVGISCCELANGTVPFA--ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACS 259
           ++VG    EL               L  I +  G           + D           S
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE-----EQWPDMCSLPDYVTFKS 239

Query: 260 YISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ 307
           +       +       D    +++     +   R  A   L+  +F  
Sbjct: 240 FPGIPLHHIF--SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 10/197 (5%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDED---LKSLHHEIVCMRHLRHPNIICYISSFLD 431
           ++VY ++ K TNQ++A+KK  L   ++      ++   EI  ++ L HPNII  + +F  
Sbjct: 12  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71

Query: 432 ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS 491
            +++ LV   M   +  ++I    +  L    I   +   L GLEY+H    +HR +K +
Sbjct: 72  KSNISLVFDFM--ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN 129

Query: 492 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDI 551
           ++L+  NG   L+       F    +       +  Y     +PE+L      Y    D+
Sbjct: 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY----RAPELLFGA-RMYGVGVDM 184

Query: 552 YSVGISCCELANGTVPF 568
           ++VG    EL       
Sbjct: 185 WAVGCILAELLLRVPFL 201

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-34
 Identities = 69/312 (22%), Positives = 120/312 (38%), Gaps = 22/312 (7%)

Query: 2   ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           +T+  VP  Y+  S +G       SV  +    T   +AVKK +    +    K  + E+
Sbjct: 11  KTIWEVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68

Query: 62  VCMRHLRHPNIICYISSFLDATDLHLVSP--LMGFGSCKDLINAHFNFGLPELVICHILQ 119
             ++H++H N+I  +  F  A  L   +   L+      DL N      L +  +  ++ 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128

Query: 120 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 179
            +L GL+YIH    IHR +K S++ ++ + +  +                          
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW----- 183

Query: 180 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPH 237
             + +PE++  N   Y++  DI+SVG    EL  G   F   +    L LI +L G    
Sbjct: 184 --YRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTS--RKFSDSFHSIVELCLSRDVDKRPL 295
                   +     +   N    +++       +     +     ++E  L  D DKR  
Sbjct: 241 ------ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

Query: 296 ACNLLQHAFFKQ 307
           A   L HA+F Q
Sbjct: 295 AAQALAHAYFAQ 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-27
 Identities = 56/239 (23%), Positives = 97/239 (40%), Gaps = 14/239 (5%)

Query: 352 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 411
           +T+  VP  Y+  S +G       SV  +    T   +AVKK +    +    K  + E+
Sbjct: 11  KTIWEVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68

Query: 412 VCMRHLRHPNIICYISSFLDATDLHLVSP--LMGFGSCKDLINAHFNFGLPELVICHILQ 469
             ++H++H N+I  +  F  A  L   +   L+      DL N      L +  +  ++ 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128

Query: 470 DVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYN 529
            +L GL+YIH    IHR +K S++ ++ + +  +                          
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW----- 183

Query: 530 LNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATP 586
             + +PE++  N   Y++  DI+SVG    EL  G   F   +    L LI +L G   
Sbjct: 184 --YRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 47/304 (15%), Positives = 102/304 (33%), Gaps = 45/304 (14%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
               K+   LG        V++  +   +  +AVK      M+ +       E   M+ L
Sbjct: 12  RETLKLVERLGA--GQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMKQL 65

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           +H  ++   +       +++++  M  GS  D +       L    +  +   +  G+ +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           I  + +IHR ++A++IL+S      ++           +           + + W +PE 
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR---EGAKFPIKWTAPEA 181

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           +      +  +SD++S GI   E+           T   +I+ L                
Sbjct: 182 INYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------------- 223

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ--HAFF 305
                          E+  +++      +  + ++ LC     + RP    L      FF
Sbjct: 224 ---------------ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

Query: 306 KQTK 309
             T+
Sbjct: 269 TATE 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-31
 Identities = 38/224 (16%), Positives = 83/224 (37%), Gaps = 12/224 (5%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
               K+   LG        V++  +   +  +AVK      M+ +       E   M+ L
Sbjct: 12  RETLKLVERLGA--GQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMKQL 65

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           +H  ++   +       +++++  M  GS  D +       L    +  +   +  G+ +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           I  + +IHR ++A++IL+S      ++           +           + + W +PE 
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR---EGAKFPIKWTAPEA 181

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           +      +  +SD++S GI   E+           T   +I+ L
Sbjct: 182 INYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 48/294 (16%), Positives = 103/294 (35%), Gaps = 41/294 (13%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
            ++  +   LG        VY    K  +  +AVK    D M  E+      E   M+ +
Sbjct: 16  RTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEI 70

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           +HPN++  +         ++++  M +G+  D +       +  +V+ ++   + + +EY
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +  K FIHR + A + L+  N    ++        +      H       + + W +PE 
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---GAKFPIKWTAPES 187

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L  N   +  +SD+++ G+   E+A   +          + E L                
Sbjct: 188 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------------- 229

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                          E+  ++       +  + ++  C   +   RP    + Q
Sbjct: 230 ---------------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 10/224 (4%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
            ++  +   LG        VY    K  +  +AVK    D M  E+      E   M+ +
Sbjct: 16  RTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEI 70

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           +HPN++  +         ++++  M +G+  D +       +  +V+ ++   + + +EY
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +  K FIHR + A + L+  N    ++        +      H       + + W +PE 
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---GAKFPIKWTAPES 187

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           L  N   +  +SD+++ G+   E+A   +          + E L
Sbjct: 188 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-34
 Identities = 47/296 (15%), Positives = 97/296 (32%), Gaps = 45/296 (15%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
           P +      LG        V   K +     +A+K      M++++      E   M +L
Sbjct: 3   PKDLTFLKELGT--GQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNL 56

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            H  ++           + +++  M  G   + +            +  + +DV   +EY
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 115

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +  K F+HR + A + L++  G   +S           +    +          W  PEV
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR---WSPPEV 172

Query: 188 LEQNLDGYDERSDIYSVGISCCEL-ANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV 246
           L  +   +  +SDI++ G+   E+ + G +P+     +                    ++
Sbjct: 173 LMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHI 214

Query: 247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
             G      +                  S+  ++I+  C     D+RP    LL +
Sbjct: 215 AQGLRLYRPHLA----------------SEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-31
 Identities = 38/216 (17%), Positives = 78/216 (36%), Gaps = 13/216 (6%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
           P +      LG        V   K +     +A+K      M++++      E   M +L
Sbjct: 3   PKDLTFLKELGT--GQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNL 56

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            H  ++           + +++  M  G   + +            +  + +DV   +EY
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 115

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +  K F+HR + A + L++  G   +S           +    +          W  PEV
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR---WSPPEV 172

Query: 538 LEQNLDGYDERSDIYSVGISCCEL-ANGTVPFAETP 572
           L  +   +  +SDI++ G+   E+ + G +P+    
Sbjct: 173 LMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 8e-34
 Identities = 55/301 (18%), Positives = 106/301 (35%), Gaps = 46/301 (15%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL--KSLHHEIVCMRHL 67
           ++ +  +LG+   +   V+L++ K TNQ  A+K    D +  +D    ++  + V     
Sbjct: 3   DFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
            HP +     +F    +L  V   +  G     I +   F L          +++ GL++
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR--ATFYAAEIILGLQF 118

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +H KG ++R +K  +IL+  +G   ++             K + F  +  Y    ++PE+
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY----IAPEI 174

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
           L      Y+   D +S G+   E+  G  PF        L   +    P           
Sbjct: 175 LLGQ--KYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFY--------- 222

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN-LLQHAFFK 306
                                   R        ++     R+ +KR      + QH  F+
Sbjct: 223 -----------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

Query: 307 Q 307
           +
Sbjct: 260 E 260

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 9e-30
 Identities = 46/211 (21%), Positives = 89/211 (42%), Gaps = 12/211 (5%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDL--KSLHHEIVCMRHL 417
           ++ +  +LG+   +   V+L++ K TNQ  A+K    D +  +D    ++  + V     
Sbjct: 3   DFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
            HP +     +F    +L  V   +  G     I +   F L          +++ GL++
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR--ATFYAAEIILGLQF 118

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +H KG ++R +K  +IL+  +G   ++             K + F  +  Y    ++PE+
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY----IAPEI 174

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           L      Y+   D +S G+   E+  G  PF
Sbjct: 175 LLGQ--KYNHSVDWWSFGVLLYEMLIGQSPF 203

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  126 bits (318), Expect = 2e-33
 Identities = 55/302 (18%), Positives = 102/302 (33%), Gaps = 43/302 (14%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRH 69
           Y++  ILG     +S V+L++    ++ +AVK    D   D         E      L H
Sbjct: 9   YELGEILGF--GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 70  PNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 125
           P I+    +    T      ++V   +   + +D++  H    +       ++ D    L
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQAL 124

Query: 126 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 185
            + H  G IHR VK ++I+IS      +         + +   V     +      +LSP
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-AVIGTAQYLSP 183

Query: 186 EVLEQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLMLIEKLAGATPHLLDCTTY 244
           E    +    D RSD+YS+G    E+  G  PF  ++P ++          P        
Sbjct: 184 EQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---- 237

Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAF 304
                                         S    ++V   L+++ + R      ++   
Sbjct: 238 --------------------------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

Query: 305 FK 306
            +
Sbjct: 272 VR 273

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (293), Expect = 5e-30
 Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 12/228 (5%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLRH 419
           Y++  ILG     +S V+L++    ++ +AVK    D   D         E      L H
Sbjct: 9   YELGEILGF--GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 420 PNIICYISSFLDATD----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGL 475
           P I+    +    T      ++V   +   + +D++  H    +       ++ D    L
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQAL 124

Query: 476 EYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSP 535
            + H  G IHR VK ++I+IS      +         + +   V     +      +LSP
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT-AAVIGTAQYLSP 183

Query: 536 EVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG 583
           E    +    D RSD+YS+G    E+  G  PF       +  + +  
Sbjct: 184 EQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (320), Expect = 6e-33
 Identities = 52/305 (17%), Positives = 104/305 (34%), Gaps = 52/305 (17%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLR 68
            +     LG    +   V L KHK +    A+K  +  ++   + ++   +E   ++ + 
Sbjct: 42  QFDRIKTLGT--GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
            P ++    SF D ++L++V   +  G     +     F   E         ++   EY+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--SEPHARFYAAQIVLTFEYL 157

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H    I+R +K  ++LI   G   ++   +          +   P         L+PE++
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-------EALAPEII 210

Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT 248
                GY++  D +++G+   E+A G  PF                              
Sbjct: 211 LSK--GYNKAVDWWALGVLIYEMAAGYPPF------------------------------ 238

Query: 249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKR-----PLACNLLQHA 303
                ++    Y      +V     FS     ++   L  D+ KR         ++  H 
Sbjct: 239 ---FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295

Query: 304 FFKQT 308
           +F  T
Sbjct: 296 WFATT 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  118 bits (297), Expect = 7e-30
 Identities = 43/219 (19%), Positives = 88/219 (40%), Gaps = 15/219 (6%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLR 418
            +     LG    +   V L KHK +    A+K  +  ++   + ++   +E   ++ + 
Sbjct: 42  QFDRIKTLGT--GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
            P ++    SF D ++L++V   +  G     +     F   E         ++   EY+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--SEPHARFYAAQIVLTFEYL 157

Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H    I+R +K  ++LI   G   ++   +          +   P         L+PE++
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-------EALAPEII 210

Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPF-AETPTTLM 576
                GY++  D +++G+   E+A G  PF A+ P  + 
Sbjct: 211 LSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 7e-32
 Identities = 53/304 (17%), Positives = 104/304 (34%), Gaps = 49/304 (16%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 68
           ++    +LG+       V L + K T +  A+K    + +  +D +     E   +++ R
Sbjct: 6   DFDYLKLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
           HP +     +F     L  V      G     ++    F   E        ++++ LEY+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--TEERARFYGAEIVSALEYL 121

Query: 129 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 188
           H +  ++R +K  ++++  +G   ++              +  F  +      +L+PEVL
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT----PEYLAPEVL 177

Query: 189 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT 248
           E N   Y    D + +G+   E+  G +PF        L E +                 
Sbjct: 178 EDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRF---------- 224

Query: 249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHA 303
                                  R  S    S++   L +D  +R       A  +++H 
Sbjct: 225 ----------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262

Query: 304 FFKQ 307
           FF  
Sbjct: 263 FFLS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-27
 Identities = 41/219 (18%), Positives = 85/219 (38%), Gaps = 11/219 (5%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-LKSLHHEIVCMRHLR 418
           ++    +LG+       V L + K T +  A+K    + +  +D +     E   +++ R
Sbjct: 6   DFDYLKLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
           HP +     +F     L  V      G     ++    F   E        ++++ LEY+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--TEERARFYGAEIVSALEYL 121

Query: 479 HGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVL 538
           H +  ++R +K  ++++  +G   ++              +  F  +      +L+PEVL
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT----PEYLAPEVL 177

Query: 539 EQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 577
           E N   Y    D + +G+   E+  G +PF       + 
Sbjct: 178 EDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  123 bits (310), Expect = 8e-32
 Identities = 63/314 (20%), Positives = 112/314 (35%), Gaps = 27/314 (8%)

Query: 6   NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 65
               +Y++   LG+     S V+ + +   N+ + VK      +     K +  EI  + 
Sbjct: 32  GNQDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKREIKILE 84

Query: 66  HLR-HPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 122
           +LR  PNII       D       LV   +     K L        L +  I   + ++L
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEIL 139

Query: 123 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 182
             L+Y H  G +HR VK  +++I H  +        +  F    ++ ++   S  +    
Sbjct: 140 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF---- 195

Query: 183 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLL 239
             PE+   +   YD   D++S+G     +     PF         L+ I K+ G T  L 
Sbjct: 196 KGPEL-LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG-TEDLY 253

Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSR---KFSDSFHSIVELCLSRDVDKRPLA 296
           D    Y         +    +  ++  + + S      S      ++  L  D   R  A
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313

Query: 297 CNLLQHAFFKQTKK 310
              ++H +F    K
Sbjct: 314 REAMEHPYFYTVVK 327

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  100 bits (250), Expect = 7e-24
 Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 20/230 (8%)

Query: 356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMR 415
               +Y++   LG+     S V+ + +   N+ + VK      +     K +  EI  + 
Sbjct: 32  GNQDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKREIKILE 84

Query: 416 HLR-HPNIICYISSFLDATD--LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVL 472
           +LR  PNII       D       LV   +     K L        L +  I   + ++L
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEIL 139

Query: 473 NGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNW 532
             L+Y H  G +HR VK  +++I H  +        +  F    ++ ++   S  +    
Sbjct: 140 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF---- 195

Query: 533 LSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA 582
             PE+   +   YD   D++S+G     +     PF         + ++A
Sbjct: 196 KGPEL-LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 55/325 (16%), Positives = 103/325 (31%), Gaps = 48/325 (14%)

Query: 5   DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHE 60
           +NV   Y     LG      + V   + K T    A K     R          + +  E
Sbjct: 6   ENVDDYYDTGEELGS--GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 61  IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 120
           +  ++ ++HPN+I     + + TD+ L+  L+  G   D +       L E      L+ 
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQ 121

Query: 121 VLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLRYMCPFSPTKKKVHLFPPST 176
           +LNG+ Y+H     H  +K  +I++        +  +             +  ++F    
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP- 180

Query: 177 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP 236
                +++PE++    +     +D++S+G+    L +G  PF        L    A    
Sbjct: 181 ----EFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234

Query: 237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA 296
              +                                  S      +   L +D  KR   
Sbjct: 235 FEDEY-----------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 265

Query: 297 CNLLQHAFFKQTKKCSVMLPELLRP 321
            + LQH + K       +      P
Sbjct: 266 QDSLQHPWIKPKDTQQALSSAWSHP 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-26
 Identities = 43/222 (19%), Positives = 85/222 (38%), Gaps = 19/222 (8%)

Query: 355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE----DLKSLHHE 410
           +NV   Y     LG      + V   + K T    A K     R          + +  E
Sbjct: 6   ENVDDYYDTGEELGS--GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 411 IVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQD 470
           +  ++ ++HPN+I     + + TD+ L+  L+  G   D +       L E      L+ 
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQ 121

Query: 471 VLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLRYMCPFSPTKKKVHLFPPST 526
           +LNG+ Y+H     H  +K  +I++        +  +             +  ++F    
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP- 180

Query: 527 AYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                +++PE++    +     +D++S+G+    L +G  PF
Sbjct: 181 ----EFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPF 216

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 4e-31
 Identities = 47/304 (15%), Positives = 107/304 (35%), Gaps = 45/304 (14%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 67
             + ++   LGQ       V++     T + +A+K      M+ E       E   M+ L
Sbjct: 16  RESLRLEVKLGQ--GCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKL 69

Query: 68  RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 127
           RH  ++   +  +    +++V+  M  GS  D +       L    +  +   + +G+ Y
Sbjct: 70  RHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 128 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 187
           +    ++HR ++A++IL+  N    ++           +           + + W +PE 
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR---QGAKFPIKWTAPEA 185

Query: 188 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD 247
                  +  +SD++S GI   EL               +++++                
Sbjct: 186 ALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------------- 227

Query: 248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ--HAFF 305
                          E+  ++    +  +S H ++  C  ++ ++RP    L      +F
Sbjct: 228 ---------------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

Query: 306 KQTK 309
             T+
Sbjct: 273 TSTE 276

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 38/224 (16%), Positives = 85/224 (37%), Gaps = 12/224 (5%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL 417
             + ++   LGQ       V++     T + +A+K      M+ E       E   M+ L
Sbjct: 16  RESLRLEVKLGQ--GCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKL 69

Query: 418 RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEY 477
           RH  ++   +  +    +++V+  M  GS  D +       L    +  +   + +G+ Y
Sbjct: 70  RHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 478 IHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEV 537
           +    ++HR ++A++IL+  N    ++           +           + + W +PE 
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR---QGAKFPIKWTAPEA 185

Query: 538 LEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
                  +  +SD++S GI   EL               +++++
Sbjct: 186 ALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (301), Expect = 9e-31
 Identities = 49/300 (16%), Positives = 103/300 (34%), Gaps = 43/300 (14%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCM 64
            S  KI  ++G        V     K+  +    +A+K       T++  +    E   M
Sbjct: 25  ISCVKIEQVIGA--GEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 81

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
               HPN+I        +T + +++  M  GS    +  +       + +  +L+ +  G
Sbjct: 82  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIAAG 140

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY-NLNWL 183
           ++Y+    ++HR + A +IL++ N    +S                          + W 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHLLDCT 242
           +PE ++     +   SD++S GI   E ++ G  P+ +  T   +I  +           
Sbjct: 201 APEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDM-TNQDVINAI----------- 246

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                               EQ  ++        + H ++  C  +D + RP    ++  
Sbjct: 247 --------------------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  114 bits (287), Expect = 6e-29
 Identities = 40/218 (18%), Positives = 83/218 (38%), Gaps = 11/218 (5%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCM 414
            S  KI  ++G        V     K+  +    +A+K       T++  +    E   M
Sbjct: 25  ISCVKIEQVIGA--GEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 81

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
               HPN+I        +T + +++  M  GS    +  +       + +  +L+ +  G
Sbjct: 82  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIAAG 140

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY-NLNWL 533
           ++Y+    ++HR + A +IL++ N    +S                          + W 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAE 570
           +PE ++     +   SD++S GI   E ++ G  P+ +
Sbjct: 201 APEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWD 236

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 44/292 (15%), Positives = 96/292 (32%), Gaps = 44/292 (15%)

Query: 25  SSVYLSKHKV--TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
            +V    +++    + +AVK    +         L  E   M+ L +P I+  I    +A
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 79

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
               LV  +   G     +  + +  + +  I  ++  V  G++Y+    F+HR + A +
Sbjct: 80  ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 137

Query: 143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
           +L+     A +S           +           + + W +PE +      +  +SD++
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQ-THGKWPVKWYAPECINYY--KFSSKSDVW 194

Query: 203 SVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI 261
           S G+   E  + G  P+     + +      G                            
Sbjct: 195 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA--------------------- 233

Query: 262 SEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA---CNLLQHAFFKQTKK 310
                            + ++ LC + DV+ RP        L++ ++    +
Sbjct: 234 -----------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-27
 Identities = 36/199 (18%), Positives = 76/199 (38%), Gaps = 9/199 (4%)

Query: 375 SSVYLSKHKV--TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
            +V    +++    + +AVK    +         L  E   M+ L +P I+  I    +A
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 79

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
               LV  +   G     +  + +  + +  I  ++  V  G++Y+    F+HR + A +
Sbjct: 80  ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 137

Query: 493 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
           +L+     A +S           +           + + W +PE +      +  +SD++
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQ-THGKWPVKWYAPECINYY--KFSSKSDVW 194

Query: 553 SVGISCCE-LANGTVPFAE 570
           S G+   E  + G  P+  
Sbjct: 195 SFGVLMWEAFSYGQKPYRG 213

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-30
 Identities = 48/292 (16%), Positives = 96/292 (32%), Gaps = 44/292 (15%)

Query: 25  SSVYLSKHKVTN--QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 82
            SV    +++      +A+K          D + +  E   M  L +P I+  I     A
Sbjct: 23  GSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 80

Query: 83  TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 142
             L LV  + G G     +       +P   +  +L  V  G++Y+  K F+HR + A +
Sbjct: 81  EALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 139

Query: 143 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 202
           +L+ +   A +S                    +  + L W +PE +      +  RSD++
Sbjct: 140 VLLVNRHYAKISDFGLSKALGADDSYYTAR-SAGKWPLKWYAPECINFR--KFSSRSDVW 196

Query: 203 SVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYI 261
           S G++  E L+ G  P+ +     ++     G                            
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP--------------------- 235

Query: 262 SEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA---CNLLQHAFFKQTKK 310
                      +     ++++  C     + RP        ++  ++    K
Sbjct: 236 -----------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 2e-27
 Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 11/211 (5%)

Query: 375 SSVYLSKHKVTN--QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA 432
            SV    +++      +A+K          D + +  E   M  L +P I+  I     A
Sbjct: 23  GSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 80

Query: 433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASH 492
             L LV  + G G     +       +P   +  +L  V  G++Y+  K F+HR + A +
Sbjct: 81  EALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 139

Query: 493 ILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIY 552
           +L+ +   A +S                    +  + L W +PE +      +  RSD++
Sbjct: 140 VLLVNRHYAKISDFGLSKALGADDSYYTAR-SAGKWPLKWYAPECINFR--KFSSRSDVW 196

Query: 553 SVGISCCE-LANGTVPFAET--PTTLMLIEK 580
           S G++  E L+ G  P+ +   P  +  IE+
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 3e-30
 Identities = 60/311 (19%), Positives = 120/311 (38%), Gaps = 51/311 (16%)

Query: 10  NYKICSILGQCFNNLSSVYLSKH---KVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCM 64
           N+++  +LG        V+L +      T +L A+K      +    +  +    E   +
Sbjct: 25  NFELLKVLGT--GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 65  RHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
            H+R  P ++    +F   T LHL+   +  G     ++    F   E  +   + +++ 
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVL 140

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
            LE++H  G I+R +K  +IL+  NG   L+       F   + +       T     ++
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE---YM 197

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 243
           +P+++     G+D+  D +S+G+   EL  G  PF                         
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF------------------------- 232

Query: 244 YYVDTGQDDGEENACSYISEQQTQVLTS--RKFSDSFHSIVELCLSRDVDKRPLACN--- 298
                   DGE+N+ + IS +  +      ++ S     +++  L +D  KR        
Sbjct: 233 ------TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286

Query: 299 --LLQHAFFKQ 307
             + +H FF++
Sbjct: 287 DEIKEHLFFQK 297

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 2e-26
 Identities = 46/215 (21%), Positives = 91/215 (42%), Gaps = 13/215 (6%)

Query: 360 NYKICSILGQCFNNLSSVYLSKH---KVTNQLIAVKKFNLDRMTD--EDLKSLHHEIVCM 414
           N+++  +LG        V+L +      T +L A+K      +    +  +    E   +
Sbjct: 25  NFELLKVLGT--GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 415 RHLRH-PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
            H+R  P ++    +F   T LHL+   +  G     ++    F   E  +   + +++ 
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVL 140

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
            LE++H  G I+R +K  +IL+  NG   L+       F   + +       T     ++
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE---YM 197

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +P+++     G+D+  D +S+G+   EL  G  PF
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 9e-30
 Identities = 54/316 (17%), Positives = 101/316 (31%), Gaps = 61/316 (19%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCM 64
           S Y++  +LG       SVY       N  +A+K    DR++D     +   +  E+V +
Sbjct: 4   SQYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 65  RHLR--HPNIICYISSFLDATDLHLVSPLM-GFGSCKDLINAHFNFGLPELVICHILQDV 121
           + +      +I  +  F       L+           D I       L E +       V
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQV 119

Query: 122 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           L  + + H  G +HR +K  +ILI  N          +  F                   
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGEL-----KLIDFGSGALLKDTVYTDFDGTRV 174

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC 241
           +  PE +  +   +   + ++S+GI   ++  G +PF                       
Sbjct: 175 YSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPF----------------------- 210

Query: 242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                     + +E         + QV   ++ S     ++  CL+     RP    +  
Sbjct: 211 ----------EHDEEI------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254

Query: 302 HAFFKQTKKCSVMLPE 317
           H + +      V+LP+
Sbjct: 255 HPWMQ-----DVLLPQ 265

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-24
 Identities = 42/217 (19%), Positives = 76/217 (35%), Gaps = 17/217 (7%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCM 414
           S Y++  +LG       SVY       N  +A+K    DR++D     +   +  E+V +
Sbjct: 4   SQYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 415 RHLR--HPNIICYISSFLDATDLHLVSPLM-GFGSCKDLINAHFNFGLPELVICHILQDV 471
           + +      +I  +  F       L+           D I       L E +       V
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQV 119

Query: 472 LNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           L  + + H  G +HR +K  +ILI  N          +  F                   
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGEL-----KLIDFGSGALLKDTVYTDFDGTRV 174

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           +  PE +  +   +   + ++S+GI   ++  G +PF
Sbjct: 175 YSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPF 210

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-29
 Identities = 66/356 (18%), Positives = 125/356 (35%), Gaps = 36/356 (10%)

Query: 2   ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 61
           ++   V   Y+    +G        V  +   V ++ +A+KK +         K  + E+
Sbjct: 10  DSTFTVLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 62  VCMRHLRHPNIICYISSFL------DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 115
           V M+ + H NII  ++ F       +  D++LV  LM    C+ +             + 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMS 122

Query: 116 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFP 173
           ++L  +L G++++H  G IHR +K S+I++  +   K    GL      S       +  
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182

Query: 174 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKL 231
                   + +PEV+     GY E  DI+SVG    E+    + F   +       + + 
Sbjct: 183 -------YYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Query: 232 AGATP-----HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLT--SRKFSDSFHSIVEL 284
            G         L      YV+               +      +  ++  +     ++  
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293

Query: 285 CLSRDVDKRPLACNLLQHAFFKQT---KKCSVMLPELLRPALSLNESNVCEINNEL 337
            L  D  KR    + LQH +        +     P++    L   E  + E    +
Sbjct: 294 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 3e-23
 Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 24/225 (10%)

Query: 352 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEI 411
           ++   V   Y+    +G        V  +   V ++ +A+KK +         K  + E+
Sbjct: 10  DSTFTVLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 412 VCMRHLRHPNIICYISSFL------DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVIC 465
           V M+ + H NII  ++ F       +  D++LV  LM    C+ +             + 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMS 122

Query: 466 HILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFP 523
           ++L  +L G++++H  G IHR +K S+I++  +   K    GL      S       +  
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182

Query: 524 PSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                   + +PEV+     GY E  DI+SVG    E+    + F
Sbjct: 183 -------YYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILF 218

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-29
 Identities = 48/323 (14%), Positives = 105/323 (32%), Gaps = 66/323 (20%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQL-----IAVKKFNLDRMTDEDLKSLHHEIV 62
             N +   +LG        V  +     ++      +AVK    ++    + ++L  E+ 
Sbjct: 36  RENLEFGKVLGS--GAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELK 92

Query: 63  CMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG------------- 108
            M  L  H NI+  + +   +  ++L+     +G   + + +                  
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 109 --------LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC 160
                   L    +      V  G+E++  K  +HR + A ++L++H     +       
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 219
                    ++   +    + W++PE L +    Y  +SD++S GI   E  + G  P+ 
Sbjct: 213 DIMSDSN--YVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 220 ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFH 279
             P      +                               + +   ++      ++  +
Sbjct: 269 GIPVDANFYK-------------------------------LIQNGFKMDQPFYATEEIY 297

Query: 280 SIVELCLSRDVDKRPLACNLLQH 302
            I++ C + D  KRP   NL   
Sbjct: 298 IIMQSCWAFDSRKRPSFPNLTSF 320

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 1e-26
 Identities = 40/254 (15%), Positives = 88/254 (34%), Gaps = 35/254 (13%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL-----IAVKKFNLDRMTDEDLKSLHHEIV 412
             N +   +LG        V  +     ++      +AVK    ++    + ++L  E+ 
Sbjct: 36  RENLEFGKVLGS--GAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELK 92

Query: 413 CMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG------------- 458
            M  L  H NI+  + +   +  ++L+     +G   + + +                  
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 459 --------LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC 510
                   L    +      V  G+E++  K  +HR + A ++L++H     +       
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFA 569
                    ++   +    + W++PE L +    Y  +SD++S GI   E  + G  P+ 
Sbjct: 213 DIMSDSN--YVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 570 ETPTTLMLIEKLAG 583
             P      + +  
Sbjct: 269 GIPVDANFYKLIQN 282

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 55/293 (18%), Positives = 104/293 (35%), Gaps = 35/293 (11%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--- 81
             V+  K     + +AVK F+         ++   EI     LRH NI+ +I++      
Sbjct: 17  GEVWRGKW--RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIAADNKDNG 71

Query: 82  -ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--------GKG 132
             T L LVS     GS  D +N +    +    +  +     +GL ++H           
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128

Query: 133 FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL 192
             HR +K+ +IL+  NG  C++ L            + + P        +++PEVL+ ++
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188

Query: 193 DG----YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDT 248
           +       +R+DIY++G+   E+A             +    L  + P + +      + 
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248

Query: 249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                  N              S +       I+  C   +   R  A  + +
Sbjct: 249 KLRPNIPNRWQ-----------SCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 1e-25
 Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 24/230 (10%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--- 431
             V+  K     + +AVK F+         ++   EI     LRH NI+ +I++      
Sbjct: 17  GEVWRGKW--RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIAADNKDNG 71

Query: 432 -ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH--------GKG 482
             T L LVS     GS  D +N +    +    +  +     +GL ++H           
Sbjct: 72  TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128

Query: 483 FIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNL 542
             HR +K+ +IL+  NG  C++ L            + + P        +++PEVL+ ++
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188

Query: 543 DG----YDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL 588
           +       +R+DIY++G+   E+A             +    L  + P +
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-28
 Identities = 49/302 (16%), Positives = 93/302 (30%), Gaps = 47/302 (15%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDED-LKSLHHEIVC 63
             + ++   LG    +   V   +    +     +AVK    D ++  + +     E+  
Sbjct: 7   EKDLRLLEKLGD--GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           M  L H N+I      L    + +V+ L   GS  D +  H         +      V  
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAE 122

Query: 124 GLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 181
           G+ Y+  K FIHR + A ++L++     K    GL    P +     +            
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA--- 179

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETPTTLMLIEKLAGATPHLLD 240
           W +PE L+     +   SD +  G++  E    G  P+                      
Sbjct: 180 WCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPW---------------------- 215

Query: 241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL 300
                               I ++  ++          ++++  C +   + RP    L 
Sbjct: 216 ---------IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

Query: 301 QH 302
             
Sbjct: 267 DF 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 9e-27
 Identities = 44/222 (19%), Positives = 78/222 (35%), Gaps = 16/222 (7%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDED-LKSLHHEIVC 413
             + ++   LG    +   V   +    +     +AVK    D ++  + +     E+  
Sbjct: 7   EKDLRLLEKLGD--GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           M  L H N+I      L    + +V+ L   GS  D +  H         +      V  
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAE 122

Query: 474 GLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLN 531
           G+ Y+  K FIHR + A ++L++     K    GL    P +     +            
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA--- 179

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETP 572
           W +PE L+     +   SD +  G++  E    G  P+    
Sbjct: 180 WCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-28
 Identities = 41/298 (13%), Positives = 95/298 (31%), Gaps = 42/298 (14%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQ----LIAVKKFNLDRMTDEDLKSLHHEIVC 63
           PS      ++G        VY    K ++      +A+K       T++       E   
Sbjct: 6   PSCVTRQKVIGA--GEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGI 62

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           M    H NII           + +++  M  G+    +          L +  +L+ +  
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAA 121

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           G++Y+    ++HR + A +IL++ N    +S            +  +         + W 
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-GGKIPIRWT 180

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 243
           +PE +      +   SD++S GI   E+           +   +++ +            
Sbjct: 181 APEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------ 226

Query: 244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                                  ++ T      + + ++  C  ++  +RP   +++ 
Sbjct: 227 -------------------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 4e-27
 Identities = 37/228 (16%), Positives = 79/228 (34%), Gaps = 11/228 (4%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ----LIAVKKFNLDRMTDEDLKSLHHEIVC 413
           PS      ++G        VY    K ++      +A+K       T++       E   
Sbjct: 6   PSCVTRQKVIGA--GEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGI 62

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           M    H NII           + +++  M  G+    +          L +  +L+ +  
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAA 121

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           G++Y+    ++HR + A +IL++ N    +S            +  +         + W 
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-SGGKIPIRWT 180

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           +PE +      +   SD++S GI   E+           +   +++ +
Sbjct: 181 APEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 56/310 (18%), Positives = 100/310 (32%), Gaps = 56/310 (18%)

Query: 9   SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL 67
           ++ K   ++G+   N   V  ++ K     +      +    + +D +    E+  +  L
Sbjct: 10  NDIKFQDVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 68  -RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF--------------GLPEL 112
             HPNII  + +      L+L       G+  D +                     L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 113 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 172
            + H   DV  G++Y+  K FIHR + A +IL+  N  A ++            KK    
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA 232
            P     + W++ E L  +   Y   SD++S G+   E+ +         T   L EKL 
Sbjct: 188 LP-----VRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL- 239

Query: 233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDK 292
                                          Q  ++       D  + ++  C      +
Sbjct: 240 ------------------------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYE 269

Query: 293 RPLACNLLQH 302
           RP    +L  
Sbjct: 270 RPSFAQILVS 279

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 8e-26
 Identities = 50/239 (20%), Positives = 87/239 (36%), Gaps = 25/239 (10%)

Query: 359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHL 417
           ++ K   ++G+   N   V  ++ K     +      +    + +D +    E+  +  L
Sbjct: 10  NDIKFQDVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 418 -RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNF--------------GLPEL 462
             HPNII  + +      L+L       G+  D +                     L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 463 VICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF 522
            + H   DV  G++Y+  K FIHR + A +IL+  N  A ++            KK    
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
            P     + W++ E L  +   Y   SD++S G+   E+ +         T   L EKL
Sbjct: 188 LP-----VRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (281), Expect = 3e-28
 Identities = 47/308 (15%), Positives = 95/308 (30%), Gaps = 47/308 (15%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 70
           Y++   +G    +   +YL       + +A+K   +     +    LH E    + ++  
Sbjct: 9   YRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 62

Query: 71  NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 130
             I  I       D +++   +   S +DL N   +       +  +   +++ +EYIH 
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 121

Query: 131 KGFIHRAVKASHILIS---HNGKACLSGLRYMCPFSPTKKKVHLFPPST---AYNLNWLS 184
           K FIHR VK  + L+          +        +   +   H+             + S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--AETPTTLMLIEKLAGATPHLLDCT 242
                        R D+ S+G        G++P+   +  T     E+            
Sbjct: 182 INTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------------ 227

Query: 243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLA---CNL 299
                           S         +  + +   F + +  C S   D +P       L
Sbjct: 228 ---------------ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272

Query: 300 LQHAFFKQ 307
            ++ F +Q
Sbjct: 273 FRNLFHRQ 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (254), Expect = 1e-24
 Identities = 36/214 (16%), Positives = 73/214 (34%), Gaps = 15/214 (7%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHP 420
           Y++   +G    +   +YL       + +A+K   +     +    LH E    + ++  
Sbjct: 9   YRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 62

Query: 421 NIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG 480
             I  I       D +++   +   S +DL N   +       +  +   +++ +EYIH 
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 121

Query: 481 KGFIHRAVKASHILIS---HNGKACLSGLRYMCPFSPTKKKVHLFPPST---AYNLNWLS 534
           K FIHR VK  + L+          +        +   +   H+             + S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
                        R D+ S+G        G++P+
Sbjct: 182 INTHLGI--EQSRRDDLESLGYVLMYFNLGSLPW 213

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 5e-27
 Identities = 44/282 (15%), Positives = 86/282 (30%), Gaps = 39/282 (13%)

Query: 25  SSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 81
             VY   L  +       AVK  N       ++     E + M+   HPN++  +   L 
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99

Query: 82  ATD-LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 140
           +     +V P M  G  ++ I            +      V  G++++  K F+HR + A
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 158

Query: 141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 200
            + ++       ++           +             + W++ E L+     +  +SD
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSD 216

Query: 201 IYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSY 260
           ++S G+   EL     P      T  +   L                             
Sbjct: 217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYL----------------------------- 247

Query: 261 ISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
              Q  ++L      D  + ++  C     + RP    L+  
Sbjct: 248 --LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 4e-24
 Identities = 37/211 (17%), Positives = 72/211 (34%), Gaps = 8/211 (3%)

Query: 375 SSVY---LSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD 431
             VY   L  +       AVK  N       ++     E + M+   HPN++  +   L 
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99

Query: 432 ATD-LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA 490
           +     +V P M  G  ++ I            +      V  G++++  K F+HR + A
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 158

Query: 491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSD 550
            + ++       ++           +             + W++ E L+     +  +SD
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSD 216

Query: 551 IYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           ++S G+   EL     P      T  +   L
Sbjct: 217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 8e-27
 Identities = 49/328 (14%), Positives = 111/328 (33%), Gaps = 46/328 (14%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQL----IAVKKFNLDRMTDEDLKSLHHEIVC 63
            + +K   +LG       +VY        +     +A+K+   +  + +  K +  E   
Sbjct: 8   ETEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64

Query: 64  MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 123
           M  + +P++   +   L +  + L++ LM FG   D +  H +       + +    +  
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAK 122

Query: 124 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 183
           G+ Y+  +  +HR + A ++L+       ++           +K+ H         + W+
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWM 180

Query: 184 SPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT 243
           + E +      Y  +SD++S G++  EL        +      +   L            
Sbjct: 181 ALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------------ 226

Query: 244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH- 302
                              E+  ++      +   + I+  C   D D RP    L+   
Sbjct: 227 -------------------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

Query: 303 -AFFKQTKKCSVMLPELLRPALSLNESN 329
               +  ++  V+  +      S  +SN
Sbjct: 268 SKMARDPQRYLVIQGDERMHLPSPTDSN 295

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 39/220 (17%), Positives = 88/220 (40%), Gaps = 14/220 (6%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQL----IAVKKFNLDRMTDEDLKSLHHEIVC 413
            + +K   +LG       +VY        +     +A+K+   +  + +  K +  E   
Sbjct: 8   ETEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64

Query: 414 MRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLN 473
           M  + +P++   +   L +  + L++ LM FG   D +  H +       + +    +  
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAK 122

Query: 474 GLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWL 533
           G+ Y+  +  +HR + A ++L+       ++           +K+ H         + W+
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWM 180

Query: 534 SPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETP 572
           + E +      Y  +SD++S G++  EL   G+ P+   P
Sbjct: 181 ALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 1e-26
 Identities = 51/318 (16%), Positives = 100/318 (31%), Gaps = 62/318 (19%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQ-------LIAVKKFNLDRMTDEDLKSLHHE 60
                +   LG+       V L++    ++        +AVK    D  T++DL  L  E
Sbjct: 12  RDRLVLGKPLGE--GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISE 68

Query: 61  IVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG----------- 108
           +  M+ + +H NII  + +      L+++      G+ ++ + A    G           
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 109 ---LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT 165
              L    +      V  G+EY+  K  IHR + A ++L++ +    ++           
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETPTT 224
                           W++PE L      Y  +SD++S G+   E    G  P+   P  
Sbjct: 189 DYYKKTTNGRLPV--KWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244

Query: 225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVEL 284
            +      G                                         ++  + ++  
Sbjct: 245 ELFKLLKEGHRMDKPS--------------------------------NCTNELYMMMRD 272

Query: 285 CLSRDVDKRPLACNLLQH 302
           C      +RP    L++ 
Sbjct: 273 CWHAVPSQRPTFKQLVED 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 9e-25
 Identities = 46/238 (19%), Positives = 86/238 (36%), Gaps = 30/238 (12%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ-------LIAVKKFNLDRMTDEDLKSLHHE 410
                +   LG+       V L++    ++        +AVK    D  T++DL  L  E
Sbjct: 12  RDRLVLGKPLGE--GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISE 68

Query: 411 IVCMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG----------- 458
           +  M+ + +H NII  + +      L+++      G+ ++ + A    G           
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 459 ---LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT 515
              L    +      V  G+EY+  K  IHR + A ++L++ +    ++           
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE-LANGTVPFAETP 572
                           W++PE L      Y  +SD++S G+   E    G  P+   P
Sbjct: 189 DYYKKTTNGRLPV--KWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 2e-26
 Identities = 41/319 (12%), Positives = 93/319 (29%), Gaps = 57/319 (17%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
                +   LGQ   +   VY    K          +A+K  N    +  +     +E  
Sbjct: 19  REKITMSRELGQ--GSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEAS 75

Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--------LPELVI 114
            M+     +++  +          ++  LM  G  K  + +                  +
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 115 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 174
             +  ++ +G+ Y++   F+HR + A + +++ +    +           T         
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 175 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA 234
                  W+SPE L+     +   SD++S G+   E+A       +  +   ++  +   
Sbjct: 196 LLPV--RWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--M 249

Query: 235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP 294
              LLD                                   D    ++ +C   +   RP
Sbjct: 250 EGGLLDK-----------------------------PDNCPDMLFELMRMCWQYNPKMRP 280

Query: 295 LACNLLQ------HAFFKQ 307
               ++          F++
Sbjct: 281 SFLEIISSIKEEMEPGFRE 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 5e-24
 Identities = 33/237 (13%), Positives = 77/237 (32%), Gaps = 20/237 (8%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
                +   LGQ   +   VY    K          +A+K  N    +  +     +E  
Sbjct: 19  REKITMSRELGQ--GSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEAS 75

Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG--------LPELVI 464
            M+     +++  +          ++  LM  G  K  + +                  +
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 465 CHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPP 524
             +  ++ +G+ Y++   F+HR + A + +++ +    +           T         
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 525 STAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
                  W+SPE L+     +   SD++S G+   E+A       +  +   ++  +
Sbjct: 196 LLPV--RWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-26
 Identities = 41/298 (13%), Positives = 90/298 (30%), Gaps = 44/298 (14%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCM 64
               ++   +G+       V+   +         +A+K    +  +D   +    E + M
Sbjct: 6   RERIELGRCIGE--GQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTM 62

Query: 65  RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 124
           R   HP+I+  I    +   + ++  L   G  +  +     + L    +      +   
Sbjct: 63  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 120

Query: 125 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 184
           L Y+  K F+HR + A ++L+S N    L           +                W++
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---WMA 177

Query: 185 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY 244
           PE +      +   SD++  G+   E+    V   +      +I ++       +     
Sbjct: 178 PESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---- 231

Query: 245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH 302
                                           + +S++  C + D  +RP    L   
Sbjct: 232 ---------------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 6e-24
 Identities = 35/227 (15%), Positives = 77/227 (33%), Gaps = 13/227 (5%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCM 414
               ++   +G+       V+   +         +A+K    +  +D   +    E + M
Sbjct: 6   RERIELGRCIGE--GQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTM 62

Query: 415 RHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNG 474
           R   HP+I+  I    +   + ++  L   G  +  +     + L    +      +   
Sbjct: 63  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTA 120

Query: 475 LEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLS 534
           L Y+  K F+HR + A ++L+S N    L           +                W++
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---WMA 177

Query: 535 PEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL 581
           PE +      +   SD++  G+   E+    V   +      +I ++
Sbjct: 178 PESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (268), Expect = 4e-26
 Identities = 63/335 (18%), Positives = 122/335 (36%), Gaps = 33/335 (9%)

Query: 11  YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-------LKSLHH-EIV 62
           Y +   LG    + S+V+L+K  V N  +A+K    D++  E        L+ ++  +  
Sbjct: 15  YILVRKLGW--GHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72

Query: 63  CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGS---CKDLINAHFNFGLPELVICHILQ 119
               +   +I+  +  F       +   ++          LI  + + G+P + +  I +
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 120 DVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 178
            +L GL+Y+H + G IH  +K  ++L+        + ++                 ++  
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 179 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF--------AETPTTLMLIEK 230
              + SPEVL      +   +DI+S      EL  G   F         +    +  I +
Sbjct: 192 TREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 231 LAGATP-HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKF------SDSFHSIVE 283
           L G  P +LL    Y        G     S +     + + + K+      +      + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 284 LCLSRDVDKRPLACNLLQHAFFKQTKKCS-VMLPE 317
             L  D  KR  A  L+ H + K T     + +P+
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 89.3 bits (220), Expect = 8e-20
 Identities = 43/220 (19%), Positives = 86/220 (39%), Gaps = 17/220 (7%)

Query: 361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDED-------LKSLHH-EIV 412
           Y +   LG    + S+V+L+K  V N  +A+K    D++  E        L+ ++  +  
Sbjct: 15  YILVRKLGW--GHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72

Query: 413 CMRHLRHPNIICYISSFLDATDLHLVSPLMGFGS---CKDLINAHFNFGLPELVICHILQ 469
               +   +I+  +  F       +   ++          LI  + + G+P + +  I +
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 470 DVLNGLEYIHGK-GFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAY 528
            +L GL+Y+H + G IH  +K  ++L+        + ++                 ++  
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 529 NLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
              + SPEVL      +   +DI+S      EL  G   F
Sbjct: 192 TREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLF 229

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (264), Expect = 6e-26
 Identities = 45/328 (13%), Positives = 103/328 (31%), Gaps = 65/328 (19%)

Query: 1   METLDNVPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLK 55
           + +L+   +N +    +G+       V+ ++           ++AVK    +   D    
Sbjct: 5   LLSLEYPRNNIEYVRDIGE--GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QA 61

Query: 56  SLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG------- 108
               E   M    +PNI+  +        + L+   M +G   + + +            
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 109 ---------------LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL 153
                          L       I + V  G+ Y+  + F+HR +   + L+  N    +
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181

Query: 154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN 213
           +   +    +      +    + A  + W+ PE +  N   Y   SD+++ G+   E+ +
Sbjct: 182 AD--FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 237

Query: 214 GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRK 273
             +          +I  +     ++L C                                
Sbjct: 238 YGLQPYYGMAHEEVIYYV--RDGNILAC-----------------------------PEN 266

Query: 274 FSDSFHSIVELCLSRDVDKRPLACNLLQ 301
                ++++ LC S+    RP  C++ +
Sbjct: 267 CPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 38/261 (14%), Positives = 86/261 (32%), Gaps = 34/261 (13%)

Query: 348 NSSVETLDNVPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDE 402
           N  + +L+   +N +    +G+       V+ ++           ++AVK    +   D 
Sbjct: 2   NPKLLSLEYPRNNIEYVRDIGE--GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM 59

Query: 403 DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFG---- 458
                  E   M    +PNI+  +        + L+   M +G   + + +         
Sbjct: 60  -QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 459 ------------------LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGK 500
                             L       I + V  G+ Y+  + F+HR +   + L+  N  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 178

Query: 501 ACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCE 560
             ++   +    +      +    + A  + W+ PE +  N   Y   SD+++ G+   E
Sbjct: 179 VKIAD--FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWE 234

Query: 561 LANGTVPFAETPTTLMLIEKL 581
           + +  +          +I  +
Sbjct: 235 IFSYGLQPYYGMAHEEVIYYV 255

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  105 bits (263), Expect = 8e-26
 Identities = 42/311 (13%), Positives = 95/311 (30%), Gaps = 49/311 (15%)

Query: 10  NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 69
           +YK+   +G+   +   ++   + + NQ +A+K          D   L  E    + L  
Sbjct: 6   HYKVGRRIGE--GSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAG 59

Query: 70  PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 129
              I  +  F      +++   +   S +DL++           +    + +L  ++ IH
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH 118

Query: 130 GKGFIHRAVKASHILIS-----HNGKACLS--GLRYMCPFSPTKKKVHLFPPST-AYNLN 181
            K  ++R +K  + LI      +     +   G+        TK+ +        +    
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 182 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFA--ETPTTLMLIEKLAGATPHLL 239
           ++S             R D+ ++G        G++P+   +  T     E++        
Sbjct: 179 YMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------- 229

Query: 240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP---LA 296
                  +  Q       C+   E+             F+  +    +   D  P     
Sbjct: 230 -------EKKQSTPLRELCAGFPEE-------------FYKYMHYARNLAFDATPDYDYL 269

Query: 297 CNLLQHAFFKQ 307
             L      + 
Sbjct: 270 QGLFSKVLERL 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  102 bits (255), Expect = 8e-25
 Identities = 33/217 (15%), Positives = 76/217 (35%), Gaps = 17/217 (7%)

Query: 360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH 419
           +YK+   +G+   +   ++   + + NQ +A+K          D   L  E    + L  
Sbjct: 6   HYKVGRRIGE--GSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAG 59

Query: 420 PNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIH 479
              I  +  F      +++   +   S +DL++           +    + +L  ++ IH
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH 118

Query: 480 GKGFIHRAVKASHILIS-----HNGKACLS--GLRYMCPFSPTKKKVHLFPPST-AYNLN 531
            K  ++R +K  + LI      +     +   G+        TK+ +        +    
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 532 WLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPF 568
           ++S             R D+ ++G        G++P+
Sbjct: 179 YMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPW 213

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 5e-24
 Identities = 45/316 (14%), Positives = 93/316 (29%), Gaps = 59/316 (18%)

Query: 8   PSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
            +       LG        V  +             +AVK         E  ++L  E+ 
Sbjct: 22  RNRLSFGKTLGA--GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELK 78

Query: 63  CMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN--------------- 106
            + +L  H NI+  + +        +++    +G   + +    +               
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 107 -FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT 165
              L    +      V  G+ ++  K  IHR + A +IL++H     +            
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL 225
               ++   +    + W++PE +      Y   SD++S GI   EL +            
Sbjct: 199 SN--YVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 226 MLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELC 285
               K                              + ++  ++L+        + I++ C
Sbjct: 255 SKFYK------------------------------MIKEGFRMLSPEHAPAEMYDIMKTC 284

Query: 286 LSRDVDKRPLACNLLQ 301
              D  KRP    ++Q
Sbjct: 285 WDADPLKRPTFKQIVQ 300

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 1e-21
 Identities = 38/255 (14%), Positives = 77/255 (30%), Gaps = 29/255 (11%)

Query: 358 PSNYKICSILGQCFNNLSSVYLSK-----HKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
            +       LG        V  +             +AVK         E  ++L  E+ 
Sbjct: 22  RNRLSFGKTLGA--GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELK 78

Query: 413 CMRHL-RHPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFN--------------- 456
            + +L  H NI+  + +        +++    +G   + +    +               
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 457 -FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT 515
              L    +      V  G+ ++  K  IHR + A +IL++H     +            
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTL 575
               ++   +    + W++PE +      Y   SD++S GI   EL +            
Sbjct: 199 SN--YVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 576 MLIEKLAGATPHLLD 590
               K+      +L 
Sbjct: 255 SKFYKMIKEGFRMLS 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 6e-23
 Identities = 43/315 (13%), Positives = 89/315 (28%), Gaps = 56/315 (17%)

Query: 8   PSNYKICSILGQCFNNLSSVYL-----SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 62
               K+   LG+       V            T + +AVK         E    +    +
Sbjct: 12  RDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 63  CMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFG------------- 108
            +    H N++  + +       L ++     FG+    + +  N               
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 109 -LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 167
            L    +      V  G+E++  +  IHR + A +IL+S      +              
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 227
            V          L W++PE +      Y  +SD++S G+   E+ +              
Sbjct: 190 YVRKG--DARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 228 IEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLS 287
             +                                ++ T++      +   +  +  C  
Sbjct: 246 FCR------------------------------RLKEGTRMRAPDYTTPEMYQTMLDCWH 275

Query: 288 RDVDKRPLACNLLQH 302
            +  +RP    L++H
Sbjct: 276 GEPSQRPTFSELVEH 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 4e-20
 Identities = 37/244 (15%), Positives = 72/244 (29%), Gaps = 26/244 (10%)

Query: 358 PSNYKICSILGQCFNNLSSVYL-----SKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIV 412
               K+   LG+       V            T + +AVK         E    +    +
Sbjct: 12  RDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 413 CMRHLRHPNIICYISSFLDATD-LHLVSPLMGFGSCKDLINAHFNFG------------- 458
            +    H N++  + +       L ++     FG+    + +  N               
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 459 -LPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK 517
            L    +      V  G+E++  +  IHR + A +IL+S      +              
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML 577
            V          L W++PE +      Y  +SD++S G+   E+ +              
Sbjct: 190 YVRKG--DARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 578 IEKL 581
             + 
Sbjct: 246 FCRR 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.6 bits (128), Expect = 7e-09
 Identities = 15/141 (10%), Positives = 43/141 (30%), Gaps = 30/141 (21%)

Query: 25  SSVYLSKHKVTNQLIAVKKFNLD----------------RMTDEDLKSLHHEIVCMRHLR 68
           S+V+    +       VK   +                   +   ++S  +E   ++ L+
Sbjct: 14  SAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72

Query: 69  HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 128
              +              ++  L+       +   + +          +L  +L  +   
Sbjct: 73  GLAVPKVY----AWEGNAVLMELIDAKELYRVRVENPD---------EVLDMILEEVAKF 119

Query: 129 HGKGFIHRAVKASHILISHNG 149
           + +G +H  +   ++L+S  G
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEG 140

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.6 bits (128), Expect = 7e-09
 Identities = 15/141 (10%), Positives = 43/141 (30%), Gaps = 30/141 (21%)

Query: 375 SSVYLSKHKVTNQLIAVKKFNLD----------------RMTDEDLKSLHHEIVCMRHLR 418
           S+V+    +       VK   +                   +   ++S  +E   ++ L+
Sbjct: 14  SAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72

Query: 419 HPNIICYISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYI 478
              +              ++  L+       +   + +          +L  +L  +   
Sbjct: 73  GLAVPKVY----AWEGNAVLMELIDAKELYRVRVENPD---------EVLDMILEEVAKF 119

Query: 479 HGKGFIHRAVKASHILISHNG 499
           + +G +H  +   ++L+S  G
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEG 140

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	622
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.72
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.45
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.08
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.14
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.74
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	92.85
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	92.79
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	90.22
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	85.49

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-57  Score=455.25  Aligned_cols=263  Identities=29%  Similarity=0.509  Sum_probs=222.4

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .+...+|++++.||+  |+||+||+|+++.||+.||||+++......  .+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus        16 ~dp~~~Y~~~~~iG~--G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   91 (293)
T d1yhwa1          16 GDPKKKYTRFEKIGQ--GASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (293)
T ss_dssp             SCTTTTBCSCEECCC--SSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCcccccEEEEEEec--CcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCE
Confidence            345678999999999  779999999999999999999998654332  3568899999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+|||||++|+|.+++...   ++++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+..+..
T Consensus        92 ~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            99999999999999987652   589999999999999999999999999999999999999999999999998765543


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....    .....+|+.|+|||++.+  ..|+.++||||+||++|+|++|+.||.+......+...+....|.+      
T Consensus       169 ~~~~----~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~------  236 (293)
T d1yhwa1         169 EQSK----RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL------  236 (293)
T ss_dssp             TTCC----BCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC------
T ss_pred             cccc----ccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            2211    123467889999999976  4689999999999999999999999987766555444443322211      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                              ..+..+|+++++||.+||+.||++|||+.|+|+||||+..+.
T Consensus       237 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         237 ------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             ------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence                                    122457899999999999999999999999999999976443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-58  Score=454.63  Aligned_cols=263  Identities=18%  Similarity=0.319  Sum_probs=214.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +.++|++++.||+  |+||+||+|+++.||+.||||+++.... .+..+.+.+|+.+|++|+|||||+++++|.+++.+|
T Consensus         3 f~~dy~~~~~lG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence            5678999999999  7799999999999999999999987543 233456889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.+++...  ..+++..++.++.||++||+|||++||+||||||+|||++.+|.++++|||.+.......
T Consensus        80 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999999998653  358999999999999999999999999999999999999999999999999875443222


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..  ....+.++|+.|||||++.+. ..++.++||||+||++|||++|++||.................+.         
T Consensus       158 ~~--~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------  225 (271)
T d1nvra_         158 RE--RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------  225 (271)
T ss_dssp             EE--CCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------
T ss_pred             cc--ccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Confidence            11  112245788999999999753 334678999999999999999999997654433333222221110         


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                           ......+|+++.+|+.+||+.||++|||++|+|+||||++
T Consensus       226 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 ---------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ---------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ---------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                                 1122457899999999999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=447.54  Aligned_cols=254  Identities=22%  Similarity=0.391  Sum_probs=215.0

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||++.+....+ ...+.+.+|+++|++++|||||+++++|.+++.+|+
T Consensus         6 ~dy~i~~~iG~--G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEec--CCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            57999999999  779999999999999999999986543211 224567899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++....  .+++..++.++.||++||+|||++||+||||||+|||++.+|.++++|||.+....... 
T Consensus        84 vmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             EEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            999999999999997653  58999999999999999999999999999999999999999999999999875443221 


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           .....+|+.|||||++.+  ..|+.++|||||||++|||++|+.||.+............+. +.          
T Consensus       161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~----------  222 (263)
T d2j4za1         161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FT----------  222 (263)
T ss_dssp             -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CC----------
T ss_pred             -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC----------
Confidence                 113467889999999976  468999999999999999999999998765544333322221 11          


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                            .+..+|+++.+|+.+||+.||++|||++|+|+||||..
T Consensus       223 ----------------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         223 ----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                                  12347899999999999999999999999999999965

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=450.46  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=219.7

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .+.|++++.||+  |+||+||+|+++.||+.||||+++...  ....+.+.+|+++|++|+|||||+++++|.+++.+|+
T Consensus        11 ~d~Y~i~~~iG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          11 EDFWEIIGELGD--GAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEeEEEee--CCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            357999999999  779999999999999999999997653  3345678899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+........
T Consensus        87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            999999999999876543 3589999999999999999999999999999999999999999999999998643321111


Q ss_pred             cccccCCCCCCCccccChhhhcc---ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~---~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                          ...+..+|+.|+|||++..   ....|+.++||||+||++|||++|+.||.+......+.....+..|.+      
T Consensus       166 ----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~------  235 (288)
T d2jfla1         166 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL------  235 (288)
T ss_dssp             ----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC------
T ss_pred             ----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence                1123467889999999852   234689999999999999999999999987766555555555443321      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                                              ..+..+|+++.+||.+||+.||++|||+.|+++||||+.
T Consensus       236 ------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         236 ------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ------------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ------------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                    112357899999999999999999999999999999965

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=444.70  Aligned_cols=257  Identities=20%  Similarity=0.323  Sum_probs=209.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe--CCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--ATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~   86 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||+++....++.+.+.+.+|+++|++|+|||||++++++.+  ...+|
T Consensus         4 edy~~~~~iG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGT--GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEec--CCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            68999999999  779999999999999999999999887778888889999999999999999999999976  45699


Q ss_pred             EEeecCCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         87 LVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKG-----FIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~-----IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                      +|||||++|+|.+++...  ....+++..+..++.||+.||+|||++|     |+||||||+|||++.+|.++++|||.+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            999999999999998653  2345899999999999999999999976     999999999999999999999999987


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  239 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~  239 (622)
                      .........    ..+..+|+.|||||++.+  ..|+.++|||||||++|||++|+.||.+.+..........+..+.  
T Consensus       162 ~~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~--  233 (269)
T d2java1         162 RILNHDTSF----AKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--  233 (269)
T ss_dssp             HHC---------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--
T ss_pred             eecccCCCc----cccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            654332211    123467889999999965  468999999999999999999999998766554333333332221  


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFF  305 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~  305 (622)
                                                    .+..+|+++.+|+.+||+.||++|||++|+++|||+
T Consensus       234 ------------------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 ------------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ------------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                          123578999999999999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-56  Score=449.68  Aligned_cols=257  Identities=27%  Similarity=0.455  Sum_probs=220.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      .|++++.||+  |+||+||+|+++.||+.||||+++..... ....+.+.+|+.+|++|+|||||+++++|.+++.+|+|
T Consensus        16 ~y~~l~~lG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEeeEEEec--CCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            5999999999  77899999999999999999999876654 34467789999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||||.+|++..++...  .++++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+......   
T Consensus        94 ~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             EECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            9999999987666543  35899999999999999999999999999999999999999999999999987543221   


Q ss_pred             ccccCCCCCCCccccChhhhccc-cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           ....+|+.|||||++.+. ...|+.++|||||||++|||++|..||.+......+.....+..|.+         
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------  234 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---------  234 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence                 234678899999998642 24589999999999999999999999987766655555554443321         


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                            ....+|+++.+||.+||+.||++|||++++|+||||.+..
T Consensus       235 ----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         235 ----------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             ----------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             ----------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence                                  2345789999999999999999999999999999997644

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=459.75  Aligned_cols=292  Identities=23%  Similarity=0.335  Sum_probs=218.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .+++|++++.||+  |+||+||+|+++.||+.||||+++.+. .+...+.+.+|+.+|++|+|||||+++++|.+.+.+|
T Consensus         4 ~~d~y~~~~~iG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           4 KDDDFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CGGGEEEEEEEEC--CSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEec--CCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3568999999999  778899999999999999999998754 3444567889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      +|||||++|+|.+++....  .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.++++|||.+......
T Consensus        81 iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            9999999999999997653  48999999999999999999997 59999999999999999999999999987543211


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH---HHHHhCCCCCCCccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML---IEKLAGATPHLLDCT  242 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~---~~~~~~~~p~~~~~~  242 (622)
                            ...+.++|+.|||||++.+  ..|+.++||||+||++|||++|+.||.........   ...+.+.........
T Consensus       159 ------~~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         159 ------MANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             ------TC---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             ------ccccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence                  1224578899999999986  46999999999999999999999999865432221   111111111000000


Q ss_pred             cc---cc-----cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccC
Q psy15039        243 TY---YV-----DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKC  311 (622)
Q Consensus       243 ~~---~~-----~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~  311 (622)
                      ..   ..     ..............+.....+......+|.++.+|+.+||+.||++|||++|+|+||||++....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence            00   00     00000000000001111111222334578999999999999999999999999999999875543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=436.72  Aligned_cols=255  Identities=22%  Similarity=0.387  Sum_probs=215.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe----CCc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----ATD   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~   84 (622)
                      ..|++.+.||+  |+||+||+|+++.|++.||+|++......+...+.+.+|+++|++|+|||||+++++|.+    ...
T Consensus         9 ry~~~~~~iG~--G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           9 RFLKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             CEEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CEEEeeeEEec--CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            34588889999  789999999999999999999998877777778889999999999999999999999976    345


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcC-CCceEEcCCccccc
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILISH-NGKACLSGLRYMCP  161 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--IvHrDiKp~NiLl~~-~~~~~i~~~~~~~~  161 (622)
                      +|+|||||++|+|.+++....  .+++..++.++.||+.||+|||+++  |+||||||+|||++. ++.++++|||.+..
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            899999999999999997753  5889999999999999999999998  999999999999974 78999999998754


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcc
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC  241 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~  241 (622)
                      .....      ..+..+|+.|||||++.+   .|+.++||||+||++|||++|+.||.+......+...+....+.    
T Consensus       165 ~~~~~------~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~----  231 (270)
T d1t4ha_         165 KRASF------AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----  231 (270)
T ss_dssp             CCTTS------BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----
T ss_pred             ccCCc------cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC----
Confidence            32211      113467889999999864   48999999999999999999999998766655555555332111    


Q ss_pred             ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        242 TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                                .......++++.+||.+||+.||++|||++|+|+||||+
T Consensus       232 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 --------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             --------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             --------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                      011234688999999999999999999999999999995

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=446.79  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=215.9

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      .+++|++++.||+  |+||+||+|+++.||+.||||++++... .+...+.+.+|+++|++|+|||||+++++|.+++.+
T Consensus         6 ~p~dy~i~~~lG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   83 (288)
T d1uu3a_           6 RPEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL   83 (288)
T ss_dssp             CGGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred             CCCCCEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence            3578999999999  7789999999999999999999975432 122345688999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|+|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.+|.++++|||.+......
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999999999987653  5899999999999999999999999999999999999999999999999987654332


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ....  ...+.+||+.|+|||++.+  ..|+.++||||+||++|||++|+.||.+.+..........+.. .        
T Consensus       162 ~~~~--~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~--------  228 (288)
T d1uu3a_         162 SKQA--RANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-D--------  228 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-C--------
T ss_pred             Cccc--ccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-C--------
Confidence            2211  1123467899999999975  4689999999999999999999999987655444333332221 1        


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHh------hhcCccccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN------LLQHAFFKQTK  309 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~------~l~h~~~~~~~  309 (622)
                                              .+..+|+++++||++||+.||++|||++|      +++||||+...
T Consensus       229 ------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         229 ------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             ------------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence                                    12347899999999999999999999998      47899997754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-55  Score=447.01  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=208.0

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      -+++.+.|++++.||+  |+||+||+|+++.||+.||||+++..... .....+.+|+.+|++|+|||||+++++|.+++
T Consensus         4 ~edi~d~Y~~~~~lG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             CSCGGGTEEEEEESBS--GGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCccceEEEEEEee--ccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4578889999999999  77999999999999999999999876543 23356779999999999999999999999999


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCceEEcCCcccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMC  160 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~---~~~~~~i~~~~~~~  160 (622)
                      .+|+|||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+.   .++.++++|||.+.
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999999999999763  3589999999999999999999999999999999999995   46889999999875


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      .......     ..+.++|+.|||||++.+  ..|+.++||||+||++|||++|+.||.+............+..+.   
T Consensus       159 ~~~~~~~-----~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~---  228 (307)
T d1a06a_         159 MEDPGSV-----LSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF---  228 (307)
T ss_dssp             -------------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC---
T ss_pred             EccCCCe-----eeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC---
Confidence            4332211     123467889999999975  468999999999999999999999998766554443333332211   


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                .......+|+++.+||.+||+.||++|||+.|+++||||+..
T Consensus       229 --------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         229 --------------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             --------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             --------------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                                      011234578999999999999999999999999999999764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-55  Score=441.31  Aligned_cols=265  Identities=20%  Similarity=0.279  Sum_probs=220.0

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCCCCcceeEEEEEE
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLRHPNIICYISSFL   80 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   80 (622)
                      .|+.+.|++++.||+  |+||+||+|+++.||+.||||++++.....    ...+.+.+|+.+|++|+|||||+++++|.
T Consensus         6 ~~i~d~Y~~~~~lG~--G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   83 (293)
T d1jksa_           6 ENVDDYYDTGEELGS--GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE   83 (293)
T ss_dssp             SCGGGTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCcccCEEEeEEEec--CCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            467788999999999  779999999999999999999997654322    23467889999999999999999999999


Q ss_pred             eCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----ceEEcCC
Q psy15039         81 DATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGL  156 (622)
Q Consensus        81 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~----~~~i~~~  156 (622)
                      +++.+|+|||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++    .++++||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             ECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999999997753  589999999999999999999999999999999999998776    4899999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      |.+........     ..+..+|+.|+|||++.+  ..|+.++||||+||++|||++|+.||.+.+..........+..+
T Consensus       162 G~a~~~~~~~~-----~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~  234 (293)
T d1jksa_         162 GLAHKIDFGNE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE  234 (293)
T ss_dssp             TTCEECTTSCB-----CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred             hhhhhcCCCcc-----ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence            98755432221     123456788999999975  45899999999999999999999999877655444333332211


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .                             +......+|+++++||++||+.||++|||++|+++||||+...
T Consensus       235 ~-----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         235 F-----------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             C-----------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             C-----------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            0                             0011245789999999999999999999999999999997643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=443.95  Aligned_cols=258  Identities=19%  Similarity=0.298  Sum_probs=218.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|+++++||+  |+||+||+|+++.||+.||||+++++.. .....+.+.+|+.+|++++|||||+++++|.+.+.+|+
T Consensus         5 ~dy~~~~~lG~--G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           5 NDFDYLKLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhcEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            47999999999  7799999999999999999999976432 12235667899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++....  .++|..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+........
T Consensus        83 v~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          83 VMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999999988754  589999999999999999999999999999999999999999999999998764432221


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .    ..+.++|+.|+|||++.+  ..|+.++||||+||++|||++|++||.+............+..+           
T Consensus       161 ~----~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~-----------  223 (337)
T d1o6la_         161 T----MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-----------  223 (337)
T ss_dssp             C----BCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             c----cccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC-----------
Confidence            1    224567899999999976  46899999999999999999999999887655443333332211           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTK  309 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~  309 (622)
                                            .+..+|+++++||+.||++||.+||+     ++++++||||+...
T Consensus       224 ----------------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         224 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                                  12357999999999999999999995     89999999998754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-53  Score=426.19  Aligned_cols=263  Identities=27%  Similarity=0.371  Sum_probs=220.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC---H----HHHHHHHHHHHHHhhCC-CCcceeEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---D----EDLKSLHHEIVCMRHLR-HPNIICYISS   78 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~---~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~   78 (622)
                      |.++|++++.||+  |+||+||+|+++.+|+.||||++++....   .    ...+.+.+|+.+|++|+ |||||+++++
T Consensus         1 f~~~y~~~~~iG~--G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~   78 (277)
T d1phka_           1 FYENYEPKEILGR--GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   78 (277)
T ss_dssp             CTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CcccCEEceEEec--CcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee
Confidence            5789999999999  77999999999999999999999875432   1    22346789999999997 9999999999


Q ss_pred             EEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         79 FLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        79 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                      |.+++.+|+|||||++|+|.++++...  ++++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.
T Consensus        79 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          79 YETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999999997653  589999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhcc----ccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ----NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  234 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~----~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  234 (622)
                      .........     .....+|..|+|||.+..    ....|+.++||||+||++|+|++|+.||.+.+..........+.
T Consensus       157 a~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         157 SCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             eeEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            765543322     123467888999999863    22357889999999999999999999999876655444444332


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      ...                             .......+|+++++|+.+||+.||++|||++|+|+||||++
T Consensus       232 ~~~-----------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         232 YQF-----------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CCC-----------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCC-----------------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            110                             01122458999999999999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.7e-54  Score=444.70  Aligned_cols=261  Identities=20%  Similarity=0.280  Sum_probs=219.0

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +-++|++++.||+  |+||+||+|+++.||+.||||+++...  ..+.+.+.+|+.+|++|+|||||+++++|.+++.+|
T Consensus        27 ~~d~Y~i~~~lG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          27 VYDYYDILEELGS--GAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEec--CCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3457999999999  779999999999999999999997653  344567889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc--CCCceEEcCCccccccCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS--HNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~--~~~~~~i~~~~~~~~~~~  164 (622)
                      +|||||++|+|.+.+.... .+++|..++.++.||+.||+|||++||+||||||+||||+  .+|.++++|||.+.....
T Consensus       103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            9999999999998875532 3589999999999999999999999999999999999998  568999999998765543


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....     .+..+|+.|+|||++.+  ..|+.++||||+||++|+|++|+.||.+......+.....+..+..      
T Consensus       182 ~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------  248 (352)
T d1koba_         182 DEIV-----KVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------  248 (352)
T ss_dssp             TSCE-----EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred             CCce-----eeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            2211     12356788999999975  4689999999999999999999999987766554444443322110      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                             ......+|+++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       249 -----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 -----------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                                   01224579999999999999999999999999999999764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.9e-54  Score=442.81  Aligned_cols=262  Identities=19%  Similarity=0.269  Sum_probs=218.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      +-++|++++.||+  |+||+||+|+++.||+.||||++....  ..+.+.+.+|+.+|++|+|||||+++++|.+++.+|
T Consensus        24 il~~Y~i~~~lG~--G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGT--GAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGGTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CccCeEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3458999999999  779999999999999999999997643  445677889999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCceEEcCCccccccCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSP  164 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~--~~~~~i~~~~~~~~~~~  164 (622)
                      +|||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.  ++.++++|||.+.....
T Consensus       100 ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            9999999999999985432 35899999999999999999999999999999999999964  57899999998765443


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....     .+..+|+.|||||++.+  ..|+.++||||+||++|+|++|+.||.+......+.....+....       
T Consensus       179 ~~~~-----~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-------  244 (350)
T d1koaa2         179 KQSV-----KVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-------  244 (350)
T ss_dssp             TSCE-----EEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-------
T ss_pred             cccc-----ceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence            2221     12356889999999976  458999999999999999999999998766554444433332110       


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                                            .......+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus       245 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         245 ----------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             ----------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             ----------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                  0011235789999999999999999999999999999998653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.6e-54  Score=437.27  Aligned_cols=256  Identities=21%  Similarity=0.344  Sum_probs=217.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||+++++... ....+.+.+|+.+|++++|||||+++++|.+.+.+|+
T Consensus         4 ~dy~i~~~lG~--G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEec--CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            47999999999  77899999999999999999998754221 1234668899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|++.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+......  
T Consensus        82 vmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999999999987643  4789999999999999999999999999999999999999999999999987544321  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           ..+.++|+.|||||++.+  ..|+.++||||+||++|+|++|+.||.+.+..........+..+           
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----------  219 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-----------  219 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-----------
T ss_pred             -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-----------
Confidence                 123467889999999975  46899999999999999999999999887665544444433211           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                            .+..+|+++.+++.+||+.||.+|+     |++++++||||++..+
T Consensus       220 ----------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         220 ----------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ----------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence                                  1234789999999999999999996     8999999999987643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=428.22  Aligned_cols=288  Identities=23%  Similarity=0.330  Sum_probs=215.7

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||+||+|+++.+|+.||||+++.....+...+.+.+|+++|++++|||||+++++|.++..+|+|
T Consensus         2 d~Y~~~~~lG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEec--CcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            68999999999  7789999999999999999999977654444457788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||||.++ +.+++......++++..++.++.||+.||+|||++|||||||||+|||++.++.+++.|||.+.........
T Consensus        80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            9999854 445554444456999999999999999999999999999999999999999999999999987544322211


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH--hCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL--AGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~~~~~  246 (622)
                          .....+|+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+....+....  .+.++...... .  
T Consensus       159 ----~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~--  230 (298)
T d1gz8a_         159 ----YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG-V--  230 (298)
T ss_dssp             ----TTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT-G--
T ss_pred             ----ceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc-c--
Confidence                2234667889999998754 456889999999999999999999998776554443332  22222111000 0  


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .. ..........+.....  ......+|+++.+|+++||+.||++|||+.|+|+||||++..+
T Consensus       231 ~~-~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         231 TS-MPDYKPSFPKWARQDF--SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GG-STTCCTTSCCCCCCCH--HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cc-ccccccccccccccch--hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            00 0000000000000000  0112357899999999999999999999999999999987543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=433.17  Aligned_cols=261  Identities=18%  Similarity=0.247  Sum_probs=217.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ++-++|++++.||+  |+||+||+|.++.||+.||||+++...   .+...+.+|+++|++++|||||+++++|.+++.+
T Consensus         2 ~~~~rY~i~~~lG~--G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGR--GEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEec--CCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            45678999999999  779999999999999999999997653   3345678999999999999999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC--CceEEcCCccccccC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN--GKACLSGLRYMCPFS  163 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~--~~~~i~~~~~~~~~~  163 (622)
                      |+|||||++|+|.+++.... ..++|..++.++.||+.||+|||++||+||||||+|||++.+  +.++++|||......
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999999997642 358999999999999999999999999999999999999854  478999999876543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .....     ....+|+.|+|||++.+.  .|+.++||||+||++|+|++|..||..............+....      
T Consensus       156 ~~~~~-----~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------  222 (321)
T d1tkia_         156 PGDNF-----RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF------  222 (321)
T ss_dssp             TTCEE-----EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------
T ss_pred             cCCcc-----cccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence            32211     123557789999998753  58999999999999999999999998776554444443332110      


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                             .......+|+++++||.+||..||++|||+.|+++||||++.
T Consensus       223 -----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         223 -----------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -----------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -----------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                                   001123579999999999999999999999999999999753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-53  Score=437.95  Aligned_cols=256  Identities=19%  Similarity=0.292  Sum_probs=217.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||++++.... ....+.+.+|+++|++++|||||+++++|.+...+++
T Consensus        41 d~y~i~~~lG~--G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGT--GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEEEEeec--CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            57999999999  77899999999999999999998754321 1234568899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      ||||+.+|++.+.+....  .+++..++.++.||+.||+|||++|||||||||+|||++.+|.++++|||.+......  
T Consensus       119 v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999999999987653  5899999999999999999999999999999999999999999999999987554321  


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                           ..+..+|+.|||||++.+  ..|+.++|||||||++|||++|+.||.+............+..+           
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----------  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----------  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             -----cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC-----------
Confidence                 123467889999999976  46899999999999999999999999876554443333332211           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCcccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTKK  310 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~~  310 (622)
                                            .+..+|+++.+||++||+.||.+|+     |++++++||||+...+
T Consensus       257 ----------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         257 ----------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ----------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ----------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                                  1235789999999999999999995     9999999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=430.63  Aligned_cols=258  Identities=20%  Similarity=0.342  Sum_probs=214.3

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHh-hCCCCcceeEEEEEEeCCcEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMR-HLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||+++++.. .+...+.+.+|+.+|. .++|||||+++++|.+++.+|
T Consensus         2 ddy~i~~~iG~--G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCeEEeeEEec--CCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence            68999999999  7788999999999999999999975321 1223455667777765 689999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.|||.+.......
T Consensus        80 ivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999999999997754  58899999999999999999999999999999999999999999999999876443322


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..    .....+|+.|+|||++.+  ..|+.++||||+||++|||++|+.||.+............+. |.         
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~---------  221 (320)
T d1xjda_         158 AK----TNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PF---------  221 (320)
T ss_dssp             CC----BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CC---------
T ss_pred             cc----ccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CC---------
Confidence            21    123467889999999976  468999999999999999999999998766544333332222 11         


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHH-hhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLAC-NLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~-~~l~h~~~~~~~  309 (622)
                                             .+..+|+++.+||++||+.||++||++. ++++||||++..
T Consensus       222 -----------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         222 -----------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -----------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                                   1234789999999999999999999995 899999998753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=428.51  Aligned_cols=282  Identities=20%  Similarity=0.246  Sum_probs=210.0

Q ss_pred             eEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039         12 KICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus        12 ~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      |.+++||+  |+||+||+|+++.+|+.||||+++......   ...+.+.+|+.+|++++|||||+++++|.+++.+|+|
T Consensus         1 E~l~~lG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~iv   78 (299)
T d1ua2a_           1 EKLDFLGE--GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   78 (299)
T ss_dssp             CEEEEEEE--ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             CcceEecc--CcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeeh
Confidence            46789999  779999999999999999999997654322   2235688999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||||.++++..+...  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+.........
T Consensus        79 mE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          79 FDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             hhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            999998877665533  335889999999999999999999999999999999999999999999999987654433221


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p~~~~~~~~~~  246 (622)
                          ..+..+|+.|+|||++... ..|+.++||||+||++|||++|.+||.+......+..  ...+.++. ..+... .
T Consensus       157 ----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~-~~~~~~-~  229 (299)
T d1ua2a_         157 ----YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE-EQWPDM-C  229 (299)
T ss_dssp             ----CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT-TTSSST-T
T ss_pred             ----ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCCh-hhccch-h
Confidence                2234678899999998754 4689999999999999999999999987665444332  23332211 111000 0


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .........    ....... .......|+++.+|+++||+.||++||||.|+|+||||++..
T Consensus       230 ~~~~~~~~~----~~~~~~~-~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         230 SLPDYVTFK----SFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             SSTTCCCCC----CCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccchhhhhc----cCCCCCh-HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            000000000    0000000 001235789999999999999999999999999999998643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-52  Score=435.10  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=213.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM----TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ++|++++.||+  |+||+||+|+++.||+.||||++++...    .........+|+.+|+.++|||||+++++|.+.+.
T Consensus         4 ddy~i~~~lG~--G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           4 NDFSVHRIIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             TTEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             HhCeeeeEEec--CCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            57999999999  7799999999999999999999865432    12223334456888899999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +|+|||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.+..+..
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999999997753  478999999999999999999999999999999999999999999999998765543


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH--HHHHHHHhCCCCCCCccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~--~~~~~~~~~~~p~~~~~~  242 (622)
                      ..      .....+|+.|+|||++..+ ..|+.++|||||||++|||++|+.||......  ..+........       
T Consensus       160 ~~------~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-------  225 (364)
T d1omwa3         160 KK------PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-------  225 (364)
T ss_dssp             SC------CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC-------
T ss_pred             Cc------ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-------
Confidence            22      2244678999999999753 46899999999999999999999999764322  22222211111       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcC-----HHhhhcCccccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPL-----ACNLLQHAFFKQTK  309 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~~~l~h~~~~~~~  309 (622)
                                               ...+..+|+++.+||.+||+.||.+|||     |+++++||||+...
T Consensus       226 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         226 -------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             -------------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence                                     1123457999999999999999999999     79999999998754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.3e-52  Score=417.78  Aligned_cols=283  Identities=23%  Similarity=0.316  Sum_probs=213.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||+||+|+++ +|+.||||+++.....+...+.+.+|+.+|++++|||||+++++|.+.+..+++
T Consensus         2 ~~Y~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGE--GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEE--ETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEec--CCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            58999999999  779999999986 889999999977654444457788999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ||++.++.+..+....  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+.........
T Consensus        79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            9999877766665442  46899999999999999999999999999999999999999999999999987554322211


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCCCCCCCccccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATPHLLDCTTYYV  246 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~~p~~~~~~~~~~  246 (622)
                          .....+++.|+|||++.+. ..++.++||||+||++|||++|+.||.+......+...  ..+.++ ...+... .
T Consensus       157 ----~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~-~  229 (286)
T d1ob3a_         157 ----YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN-SKNWPNV-T  229 (286)
T ss_dssp             ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTG-G
T ss_pred             ----cceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC-hhhccch-h
Confidence                1233457789999999754 46789999999999999999999999876654443332  222221 1111100 0


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      ........  ....  ...........+|+++.+||++||+.||++|||+.|+|+||||++
T Consensus       230 ~~~~~~~~--~~~~--~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         230 ELPKYDPN--FTVY--EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             GSTTCCTT--CCCC--CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhhcccc--cccc--cCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            00000000  0000  000011123457899999999999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=421.12  Aligned_cols=287  Identities=21%  Similarity=0.299  Sum_probs=212.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccC-CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCcceeEEEEEEeC-
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVT-NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFLDA-   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~~~~~~~~~-   82 (622)
                      .++|++++.||+  |+||+||+|+++.+ ++.||||+++.....+.....+.+|+.+|+.|   +|||||+++++|... 
T Consensus         6 ~~~Y~i~~~LG~--G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEec--ccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            468999999999  77999999999766 67799999876543333334466788887766   899999999998642 


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ..++++||||+++.+...... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence                468999999998776544433 344689999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p  236 (622)
                      ........     ......+|+.|+|||++.+  ..|+.++||||+||++|||++|++||.+......+..  ...+.++
T Consensus       163 ~~~~~~~~-----~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         163 ARIYSFQM-----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             CCCCCGGG-----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhhcccc-----cCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            64332111     1234567889999999976  4689999999999999999999999987765443332  2233221


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccccCC
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKKCS  312 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~~~  312 (622)
                       ..++...     ............  ..........+|+++.+||.+||++||++|||+.|+|+||||++.++|.
T Consensus       236 -~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         236 -EEDWPRD-----VALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             -GGGSCTT-----CSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             -hhccccc-----ccchhhhhcccc--ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence             1111000     000000000000  0001112345789999999999999999999999999999999877663

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-51  Score=413.63  Aligned_cols=254  Identities=18%  Similarity=0.313  Sum_probs=211.1

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      ..++|++++.||+  |+||+||+|+++.+|+.||||+++.+...   .+.+.+|+++|++|+|||||+++++|.+++.++
T Consensus        15 ~~~~~~~~~~iG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTT--TTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cHHHeEEeeEEee--CCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            3468999999999  77999999999999999999999765443   346789999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|++.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+|++|||.+.......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            99999999999999977555568999999999999999999999999999999999999999999999999876543322


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ...   ..+..+++.|+|||++..+  .|+.++|||||||++|||++|..||........+...+.....          
T Consensus       170 ~~~---~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~----------  234 (287)
T d1opja_         170 YTA---HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------  234 (287)
T ss_dssp             SEE---ETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cee---eccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC----------
Confidence            211   1234567889999999763  5899999999999999999977776554444444444432211          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                           ...+..+++++.+|+..||+.||++|||+.++++
T Consensus       235 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         235 ---------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                 0122357899999999999999999999999976

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=417.90  Aligned_cols=252  Identities=20%  Similarity=0.324  Sum_probs=207.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCC--CCcceeEEEEEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLR--HPNIICYISSFL   80 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~   80 (622)
                      +.++|++++.||+  |+||+||+|+++.||+.||||+++.....+    .....+.+|+.+|++++  |||||+++++|.
T Consensus         2 l~~~Y~i~~~lG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~   79 (273)
T d1xwsa_           2 LESQYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE   79 (273)
T ss_dssp             CTTTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCCeEEEeEEEee--CCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence            5789999999999  779999999999999999999997643321    11233568999999997  899999999999


Q ss_pred             eCCcEEEEeecCCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCceEEcCCcc
Q psy15039         81 DATDLHLVSPLMGF-GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-NGKACLSGLRY  158 (622)
Q Consensus        81 ~~~~~~lv~e~~~~-g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-~~~~~i~~~~~  158 (622)
                      +++.+++||||+.+ +++.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++. ++.++++|||.
T Consensus        80 ~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          80 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence            99999999999975 67888886643  5899999999999999999999999999999999999985 47899999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  238 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~  238 (622)
                      +.......      ..+..+|+.|+|||++.+. ..++.++||||+||++|||++|+.||.....      ...+.    
T Consensus       158 a~~~~~~~------~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~----  220 (273)
T d1xwsa_         158 GALLKDTV------YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ----  220 (273)
T ss_dssp             CEECCSSC------BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC----
T ss_pred             ceeccccc------ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhhcc----
Confidence            75432221      1234678899999999754 3456789999999999999999999975321      11111    


Q ss_pred             CccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccc
Q psy15039        239 LDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQT  308 (622)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~  308 (622)
                                                   ......+|+++.+||++||+.||++|||++|+++||||++.
T Consensus       221 -----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         221 -----------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             -----------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             -----------------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                                         01224578999999999999999999999999999999764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=427.19  Aligned_cols=264  Identities=19%  Similarity=0.271  Sum_probs=206.9

Q ss_pred             CCCCCceEEe-ecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh-CCCCcceeEEEEEEe--
Q psy15039          6 NVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH-LRHPNIICYISSFLD--   81 (622)
Q Consensus         6 ~~~~~y~~~~-~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~~~~~~~~--   81 (622)
                      .+-++|++++ +||+  |+||+||+|+++.||+.||||+++..       ..+.+|+.++.+ ++|||||+++++|.+  
T Consensus         8 ~i~~~y~i~~~~lG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             CGGGTEEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccCEEEeeEEeee--ccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            4567999875 6999  77899999999999999999998642       346689998765 489999999999976  


Q ss_pred             --CCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcCC
Q psy15039         82 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGL  156 (622)
Q Consensus        82 --~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~~  156 (622)
                        ...+|+|||||++|+|.+++.......++|..++.|+.||+.||+|||++||+||||||+|||++.   ++.++++||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              356999999999999999998754446899999999999999999999999999999999999986   456999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATP  236 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p  236 (622)
                      |.+........     .....+|+.|||||++.+  ..|+.++|||||||++|+|++|++||.+............. . 
T Consensus       159 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~-i-  229 (335)
T d2ozaa1         159 GFAKETTSHNS-----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-I-  229 (335)
T ss_dssp             TTCEECCCCCC-----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C-C-
T ss_pred             ceeeeccCCCc-----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH-H-
Confidence            98754433221     224467889999999875  35899999999999999999999999754322111000000 0 


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                                ....             ...+......+|+++.+||++||+.||++|||+.|+++||||.+...
T Consensus       230 ----------~~~~-------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         230 ----------RMGQ-------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             ----------CSCS-------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             ----------hcCC-------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence                      0000             00011112357999999999999999999999999999999976443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=411.68  Aligned_cols=257  Identities=21%  Similarity=0.361  Sum_probs=206.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +++|++++.||+  |+||+||+|+.+   ..||||+++....++...+.+.+|+.+|++++|||||++++++. .+.+++
T Consensus         7 ~~~~~~~~~lG~--G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGS--GSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEE--CSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEEEEEee--CCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence            568999999999  779999999864   35999999877666777888999999999999999999999764 567899


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.... ..+++..+..++.||++||+|||++|||||||||+|||++.++.+|++|||.+........
T Consensus        81 v~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999997643 3589999999999999999999999999999999999999999999999998754432211


Q ss_pred             cccccCCCCCCCccccChhhhccc-cCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCC-C-CCCCccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA-T-PHLLDCTTY  244 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~-~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~-~-p~~~~~~~~  244 (622)
                      .  ....+..+|+.|||||++... ...|+.++|||||||++|||++|+.||.+......+...+... . |.+      
T Consensus       160 ~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~------  231 (276)
T d1uwha_         160 S--HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL------  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG------
T ss_pred             c--ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc------
Confidence            1  112234678899999999643 2358899999999999999999999998766554444443221 1 110      


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                             ......+++++.+|+.+||+.||++|||+.+++++
T Consensus       232 -----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         232 -----------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             -----------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   01234578999999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.6e-51  Score=410.03  Aligned_cols=265  Identities=19%  Similarity=0.274  Sum_probs=210.3

Q ss_pred             CCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          6 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         6 ~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .+.++|++++.||+  |+||+||+|+++.||+.||||+++.+.. ++...+.+.+|+++|++++|||||++++++...+.
T Consensus         4 ~l~drY~i~~~lG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           4 HLSDRYELGEILGF--GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             EETTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CccceeEEeEEEee--CCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            45678999999999  7899999999999999999999987654 45556778999999999999999999999987643


Q ss_pred             ----EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccc
Q psy15039         85 ----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  160 (622)
Q Consensus        85 ----~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~  160 (622)
                          +|+|||||++|+|.+.+....  .+++..++.++.||+.||+|||++||+||||||+|||++.++..++.+|+...
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             CCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhh
Confidence                899999999999999887653  58999999999999999999999999999999999999999999999998764


Q ss_pred             ccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCc
Q psy15039        161 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD  240 (622)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~  240 (622)
                      ........ .....+..+|+.|+|||++.+  ..|+.++||||+||++|||++|++||.+..........+......   
T Consensus       160 ~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~---  233 (277)
T d1o6ya_         160 AIADSGNS-VTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---  233 (277)
T ss_dssp             ECC-----------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred             hhcccccc-ccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC---
Confidence            43322111 112234567889999999975  468999999999999999999999998776665555555432211   


Q ss_pred             cccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccc
Q psy15039        241 CTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFK  306 (622)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~  306 (622)
                                                +......+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus       234 --------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 --------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             --------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             --------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                      0112345789999999999999999999555555566653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=425.20  Aligned_cols=286  Identities=23%  Similarity=0.293  Sum_probs=215.3

Q ss_pred             CCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC-
Q psy15039          5 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-   83 (622)
Q Consensus         5 ~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   83 (622)
                      .+++++|++++.||+  |+||+||+|+++.||+.||||+++....++...+.+.+|+++|++|+|||||+++++|...+ 
T Consensus        14 ~~~~~~Y~~i~~lG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~   91 (346)
T d1cm8a_          14 WEVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   91 (346)
T ss_dssp             ECCBSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eecCCcEEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence            368999999999999  77999999999999999999999887677777888999999999999999999999998754 


Q ss_pred             -----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         84 -----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        84 -----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                           .+|+||||| ++++..+.+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        92 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          92 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence                 479999999 4667777654   3589999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH--HHHhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI--EKLAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~p  236 (622)
                      +......       ..+..+|+.|+|||++.+. ..++.++||||+||++|+|++|++||.+......+.  ....+.+|
T Consensus       168 a~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         168 ARQADSE-------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CEECCSS-------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeccCCc-------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            7544321       1234678899999998753 457899999999999999999999998776543332  22333222


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      .-      ..................+....  .......|+++.+||++||+.||++|||+.|+|+||||+....
T Consensus       240 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         240 AE------FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HH------HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HH------HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence            10      00000000000000000000000  0112357899999999999999999999999999999987543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=401.71  Aligned_cols=250  Identities=21%  Similarity=0.358  Sum_probs=198.0

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      +++|++++.||+  |+||.||+|+++ +++.||||+++.+....   +.+.+|+++|++++|||||++++++...+.+++
T Consensus         4 p~~~~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           4 PSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CSCEEEEEEEEC--CSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hHHcEEEEEEee--CCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            679999999999  778999999987 56789999998755443   457899999999999999999999999999999


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|++|||.+........
T Consensus        78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999999987643 3578999999999999999999999999999999999999999999999998754432221


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcC-CCCCCCCchHHHHHHHH-hCCCCCCCcccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPTTLMLIEKL-AGATPHLLDCTTYY  245 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g-~~Pf~~~~~~~~~~~~~-~~~~p~~~~~~~~~  245 (622)
                      .   ......+|+.|+|||++.+  ..|+.++|||||||++|||+++ .+||....... +...+ .+..+         
T Consensus       157 ~---~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~~---------  221 (263)
T d1sm2a_         157 T---SSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRL---------  221 (263)
T ss_dssp             -----------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-HHHHHHHTCCC---------
T ss_pred             e---eecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-HHHHHHhcCCC---------
Confidence            1   1223456788999999976  3589999999999999999995 55565444333 33332 22111         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                             ..+...++++.+|+..||+.||++|||++++++|
T Consensus       222 -----------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 -----------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                   1223467899999999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-51  Score=416.75  Aligned_cols=293  Identities=21%  Similarity=0.235  Sum_probs=212.5

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC----
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA----   82 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----   82 (622)
                      -.++|++++.||+  |+||+||+|+++.+|+.||||++......+...+.+.+|+++|++|+||||+++++++...    
T Consensus         8 ~~~rY~i~~~LG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           8 EVSKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             BGGGEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             ccCCEEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            3479999999999  7788999999999999999999977655555567788999999999999999999998653    


Q ss_pred             ----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                          ..+|+|||||+++.+......  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||.
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence                458999999997766544332  23578999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHH--HHHHHhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLM--LIEKLAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~--~~~~~~~~~p  236 (622)
                      ...+............+..+|+.|+|||++.+. ..|+.++||||+||++|||++|+.||.+......  .+....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            765543332222233445788999999998754 4689999999999999999999999987654433  2333344332


Q ss_pred             CCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      .-.....  ........... ...........+.....++++.+||.+||++||++|||++|+|+||||+.
T Consensus       243 ~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         243 PEVWPNV--DNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTTSTTC--CCC-------C-CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhhcccc--chhhhhhhhcc-cccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            1110000  00000000000 00000000011111234788999999999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-50  Score=408.19  Aligned_cols=257  Identities=18%  Similarity=0.315  Sum_probs=200.4

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      .++|++.++||+  |+||+||+|+++.+|+   .||||++.... .+...+.+.+|+++|++|+|||||++++++.+.+.
T Consensus        25 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGA--GEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEE--CSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEee--CCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            468999999999  7799999999988775   58999986543 45667789999999999999999999999999999


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      +++|||||++|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+||||+.++.+|++|||.+.....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999887643 3589999999999999999999999999999999999999999999999998754432


Q ss_pred             CCcccc-ccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        165 TKKKVH-LFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       165 ~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...... ....+..+|+.|||||++..  ..|+.++|||||||++|||+| |..||.+............+..+      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------  252 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL------  252 (299)
T ss_dssp             ---------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------
T ss_pred             CCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            221111 11122345788999999875  468999999999999999998 89999876654433332222111      


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                                +.+..+++++.+|+..||+.||++|||+.+++++
T Consensus       253 --------------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         253 --------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                      1223468899999999999999999999998875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-51  Score=405.96  Aligned_cols=258  Identities=17%  Similarity=0.320  Sum_probs=207.4

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      -.++|++++.||+  |+||+||+|+++ +++.||||+++......   +.+.+|+.+|++++|||||++++++. .+.++
T Consensus        11 ~~~~~~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGA--GQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY   83 (272)
T ss_dssp             CGGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHHeEEeEEEec--CCCcEEEEEEEC-CCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeec-cCCeE
Confidence            3469999999999  779999999986 67889999997655433   45789999999999999999999765 46689


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +|||||++|+|.+++.......+++..+..++.||++||+|||+++|+||||||+||||+.++.++++|||.+.......
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            99999999999998755443458999999999999999999999999999999999999999999999999876543322


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCccccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYV  246 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~  246 (622)
                      ..   ...+..+|+.|+|||++..+  .|+.++|||||||++|||+||..|+........+...+.....          
T Consensus       164 ~~---~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----------  228 (272)
T d1qpca_         164 YT---AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------  228 (272)
T ss_dssp             EE---CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cc---cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence            11   12344667889999999753  5899999999999999999965554443333333333322110          


Q ss_pred             cCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc--Cccccc
Q psy15039        247 DTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ--HAFFKQ  307 (622)
Q Consensus       247 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~--h~~~~~  307 (622)
                                           ...+..+++++.+|+.+||+.||++|||++++++  |+||..
T Consensus       229 ---------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 ---------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                                 1122457889999999999999999999999998  788864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=406.39  Aligned_cols=284  Identities=21%  Similarity=0.284  Sum_probs=218.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV   88 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   88 (622)
                      ++|++++.||+  |+||+||+|+++.+|+.||||+++.....+...+.+.+|+.+|++++|||||+++++|.+...++++
T Consensus         2 ~ry~~i~~LG~--G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGE--GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEec--CcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            47999999999  7789999999999999999999987766666678899999999999999999999999999999999


Q ss_pred             eecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcc
Q psy15039         89 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  168 (622)
Q Consensus        89 ~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~  168 (622)
                      ++++.++++..++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||.+.........
T Consensus        80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            9999999988887653  35789999999999999999999999999999999999999999999999987654432221


Q ss_pred             ccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH---HHHhCCCCCCCcccccc
Q psy15039        169 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI---EKLAGATPHLLDCTTYY  245 (622)
Q Consensus       169 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~---~~~~~~~p~~~~~~~~~  245 (622)
                          ......+..|+|||++... ..++.++||||+||++|||++|+.||..........   ....+.++.. ......
T Consensus       158 ----~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  231 (292)
T d1unla_         158 ----YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE-QWPSMT  231 (292)
T ss_dssp             ----CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT-TCTTGG
T ss_pred             ----ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh-hhhhhh
Confidence                1122345679999998754 457899999999999999999999976544333222   2233322211 000000


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                       .....    ..................+|+++.+|+.+||+.||.+||||+|+|+||||++
T Consensus       232 -~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         232 -KLPDY----KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             -GSTTC----CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             -hcccc----cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence             00000    0000000001111123457899999999999999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=403.12  Aligned_cols=261  Identities=20%  Similarity=0.332  Sum_probs=210.5

Q ss_pred             CCCCceEEee-cccccCCceeEEEEEEcc--CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          7 VPSNYKICSI-LGQCFNNLSSVYLSKHKV--TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         7 ~~~~y~~~~~-lG~g~g~~~~V~~~~~~~--t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      -.++|.+.++ ||+  |+||+||+|.++.  ++..||||+++... .+...+.+.+|+++|++|+|||||++++++.+ +
T Consensus         6 ~~~~~~~~~~~iG~--G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           6 KRDNLLIADIELGC--GNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   81 (285)
T ss_dssp             CGGGEEEEEEEEEC--CTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             cccCeEECCcEEec--ccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence            3468999996 999  7899999998764  45579999997653 46667889999999999999999999999865 5


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+|+|||||++|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+|||++.++.++++|||.+....
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            6899999999999999886532 358999999999999999999999999999999999999999999999999876554


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...... .......+|+.|+|||++..+  .|+.++|||||||++|||+| |..||.+............+..|.     
T Consensus       161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~-----  232 (285)
T d1u59a_         161 ADDSYY-TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-----  232 (285)
T ss_dssp             TCSCEE-CCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC-----
T ss_pred             cccccc-ccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            332211 222344567889999999754  58999999999999999998 999998765443332222222211     


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhh---hcCccccc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL---LQHAFFKQ  307 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~---l~h~~~~~  307 (622)
                                                 .+..+++++.+||..||..||++|||+.++   |+|+|+..
T Consensus       233 ---------------------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         233 ---------------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------------------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                       123578999999999999999999999887   56777643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=403.99  Aligned_cols=252  Identities=18%  Similarity=0.306  Sum_probs=199.4

Q ss_pred             eecccccCCceeEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEEEeecC
Q psy15039         15 SILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM   92 (622)
Q Consensus        15 ~~lG~g~g~~~~V~~~~~~--~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~   92 (622)
                      +.||+  |+||+||+|.++  .+++.||||+++....++...+.+.+|+.+|++|+|||||++++++.+ +..++|||||
T Consensus        13 k~iG~--G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGS--GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEE--CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCccc--CCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence            36999  779999999854  567889999997765555666789999999999999999999999865 5689999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCcccccc
Q psy15039         93 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  172 (622)
Q Consensus        93 ~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~  172 (622)
                      ++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+.......... ..
T Consensus        90 ~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KA  166 (277)
T ss_dssp             TTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE-EC
T ss_pred             CCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc-cc
Confidence            999999998764  358999999999999999999999999999999999999999999999999875543322211 12


Q ss_pred             CCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccccccCCCC
Q psy15039        173 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVDTGQD  251 (622)
Q Consensus       173 ~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  251 (622)
                      .....+|+.|||||++...  .|+.++|||||||++|||++ |+.||.+............+..|.              
T Consensus       167 ~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------------  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------------
T ss_pred             ccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence            2234567889999999753  58899999999999999997 899998765543322222222111              


Q ss_pred             cCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhh---hcCcccc
Q psy15039        252 DGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL---LQHAFFK  306 (622)
Q Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~---l~h~~~~  306 (622)
                                        .+..+++++.+|+.+||+.||++|||++++   |+|+|+.
T Consensus       231 ------------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         231 ------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                              123578999999999999999999999998   4566653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-50  Score=395.25  Aligned_cols=252  Identities=19%  Similarity=0.316  Sum_probs=209.6

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH   86 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   86 (622)
                      .+++|++++.||+  |+||+||+|+++ +++.||||+++.....+   +.+.+|+.+|++++|||||++++++.++..++
T Consensus         2 ~~~~~~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           2 DPKDLTFLKELGT--GQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCCE--ETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             ChHHCEEeEEEec--CCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            3689999999999  779999999985 78899999998866544   35779999999999999999999999999999


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|++.+++.... ..+++..+..++.|+++||+|||++||+||||||+|||+++++.+|++|||.+.......
T Consensus        76 iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             EEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999999999976643 357899999999999999999999999999999999999999999999999875443221


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                      ..   ......+|+.|+|||++..+  .|+.++|||||||++|||+| |+.||..............+..+         
T Consensus       155 ~~---~~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---------  220 (258)
T d1k2pa_         155 YT---SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---------  220 (258)
T ss_dssp             CC---CCCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred             ce---eecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            11   12234567889999999763  58999999999999999998 89999877654433322222111         


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                             ..+...++++.+|+++||+.||++|||++++++|
T Consensus       221 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 -----------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                   1223467899999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=413.95  Aligned_cols=256  Identities=19%  Similarity=0.286  Sum_probs=207.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCc-----EEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQ-----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~   82 (622)
                      ++|++++.||+  |+||+||+|+++.+++     .||||++.... .......+.+|+.+|+++ +|||||++++++.+.
T Consensus        37 ~~~~l~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          37 ENLEFGKVLGS--GAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEee--CCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            68999999999  7899999999987654     69999986543 334456788999999998 899999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFN---------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKAS  141 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~---------------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~  141 (622)
                      +.+|+|||||++|+|.++++....                     ..+++..+..++.||++||+|||++||+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            999999999999999999976421                     24789999999999999999999999999999999


Q ss_pred             CEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCC
Q psy15039        142 HILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAE  220 (622)
Q Consensus       142 NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~  220 (622)
                      |||++.++.++++|||.+.........  ....+..+|+.|||||++.+  ..|+.++|||||||++|||++ |..||.+
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ccccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999987543322211  11223456888999999976  358999999999999999997 8999987


Q ss_pred             CchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhh
Q psy15039        221 TPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLL  300 (622)
Q Consensus       221 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l  300 (622)
                      .+....+...+....+                               ...+..+++++.+||..||+.||++|||++|++
T Consensus       270 ~~~~~~~~~~~~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~  318 (325)
T d1rjba_         270 IPVDANFYKLIQNGFK-------------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT  318 (325)
T ss_dssp             CCCSHHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCHHHHHHHHHhcCCC-------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            6655544444433211                               012235689999999999999999999999999


Q ss_pred             cC
Q psy15039        301 QH  302 (622)
Q Consensus       301 ~h  302 (622)
                      +|
T Consensus       319 ~~  320 (325)
T d1rjba_         319 SF  320 (325)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=416.33  Aligned_cols=291  Identities=20%  Similarity=0.224  Sum_probs=215.7

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      +..++.++|++++.||+  |+||+||+|+++.||+.||||++++.. .+...+.+.+|+.+|++|+|||||++++++...
T Consensus         2 ~~~~i~~rY~~~~~LG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~   78 (345)
T d1pmea_           2 QVFDVGPRYTNLSYIGE--GAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAP   78 (345)
T ss_dssp             CCCCCCTTEEEEEECC-----CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             CccCcCCCeEEEEEEee--ccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence            45788899999999999  778899999999999999999997654 455667888999999999999999999998765


Q ss_pred             C----cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcc
Q psy15039         83 T----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  158 (622)
Q Consensus        83 ~----~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~  158 (622)
                      .    ..+++++++.+|+|.+++...   ++++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||.
T Consensus        79 ~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          79 TIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             STTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence            3    234445567789999999753   589999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCCCC
Q psy15039        159 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATP  236 (622)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~~p  236 (622)
                      +......... ........+|+.|+|||++..+ ..|+.++||||+||++|+|++|+.||............  +...++
T Consensus       156 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~  233 (345)
T d1pmea_         156 ARVADPDHDH-TGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  233 (345)
T ss_dssp             CEECCGGGCB-CCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             eeeccCCCcc-ceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence            7543322211 1122345678899999998654 46889999999999999999999999876543333222  112111


Q ss_pred             CCCccccccccCCCCcCcccccccchh---hhh--ccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        237 HLLDCTTYYVDTGQDDGEENACSYISE---QQT--QVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~---~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      . ....    .    ......+.....   ...  .......+|+++.+|+..||+.||++|||+.|+|+||||+....
T Consensus       234 ~-~~~~----~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         234 Q-EDLN----C----IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             H-HHHH----T----CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             h-hhhh----h----hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            0 0000    0    000000000000   000  00012357889999999999999999999999999999986543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=420.50  Aligned_cols=289  Identities=22%  Similarity=0.256  Sum_probs=217.3

Q ss_pred             CCCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          2 ETLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         2 ~~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      +++.+++++|++++.||+  |+||+||+|+++.||+.||||+++....+....+.+.+|+++|++|+|||||+++++|..
T Consensus        11 ~~~~~~~~rY~i~~~LG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~   88 (348)
T d2gfsa1          11 KTIWEVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   88 (348)
T ss_dssp             SSEEEEETTEEEEEECGG--GTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CccccCCCCeEEEEEEec--CCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            456788999999999999  778899999999999999999998876677777889999999999999999999999864


Q ss_pred             C-----CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         82 A-----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        82 ~-----~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                      .     ...+++|+++.+|+|.+++..   .++++..++.++.||+.||+|||++||+||||||+|||++.+|.+++.||
T Consensus        89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          89 ARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccccc
Confidence            3     234666777889999999854   35899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGA  234 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~  234 (622)
                      |.+......       ..+..+++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+........  ..+.
T Consensus       166 g~a~~~~~~-------~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         166 GLARHTDDE-------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  237 (348)
T ss_dssp             ----CCTGG-------GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             chhcccCcc-------cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            976443211       1234667889999998754 45789999999999999999999999876654333222  2222


Q ss_pred             CCCCCccccccccCCCCcCcccccccchhhhhc--cccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        235 TPHLLDCTTYYVDTGQDDGEENACSYISEQQTQ--VLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      .+.-.      ......................  .......|+++.+||++||+.||.+|||+.|+|+||||++..
T Consensus       238 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         238 PGAEL------LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CCHHH------HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CChHH------hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            11000      0000000000000000000000  001235789999999999999999999999999999998754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-50  Score=414.49  Aligned_cols=281  Identities=19%  Similarity=0.233  Sum_probs=209.1

Q ss_pred             CceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC------C
Q psy15039         10 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA------T   83 (622)
Q Consensus        10 ~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~------~   83 (622)
                      +|+.+++||+  |+||+||+|+++.+|+.||||++..+...      ..+|+++|++|+|||||+++++|...      .
T Consensus        21 ~Y~~~k~LG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGN--GSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEee--CcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            6999999999  77999999999999999999999765421      23799999999999999999998653      2


Q ss_pred             cEEEEeecCCCCCHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCccccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAH-FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCP  161 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~  161 (622)
                      .+|+|||||+++.+..+.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .++++|||.+..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            489999999976555444322 234689999999999999999999999999999999999999876 889999998755


Q ss_pred             cCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHH--HhCCCCCCC
Q psy15039        162 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK--LAGATPHLL  239 (622)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~--~~~~~p~~~  239 (622)
                      ......     ..+..+|+.|+|||++.+. ..|+.++||||+||++|||++|+.||........+...  ..+.++. .
T Consensus       173 ~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~-~  245 (350)
T d1q5ka_         173 LVRGEP-----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR-E  245 (350)
T ss_dssp             CCTTSC-----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH-H
T ss_pred             ccCCcc-----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH-H
Confidence            433221     2234667889999998754 46899999999999999999999999876654443332  2232210 0


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCcccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTKK  310 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~~  310 (622)
                      ...    ............ ...............++++.+|+.+||+.||++|||+.|+|+||||++...
T Consensus       246 ~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         246 QIR----EMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHH----HHCC---CCCCC-CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhh----hhccchhhcccc-ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            000    000000000000 000001111223457999999999999999999999999999999987654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=392.85  Aligned_cols=260  Identities=16%  Similarity=0.262  Sum_probs=202.9

Q ss_pred             CCCCCCCceEEeecccccCCceeEEEEEEccCC----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEE
Q psy15039          4 LDNVPSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSF   79 (622)
Q Consensus         4 ~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   79 (622)
                      +.--++.|++.++||+  |+||+||+|+++.++    ..||||+++... .+.....+.+|+++|++|+|||||++++++
T Consensus         2 ~ei~~~~~~~~~~iG~--G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~   78 (283)
T d1mqba_           2 TEIHPSCVTRQKVIGA--GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI   78 (283)
T ss_dssp             CBCCTTTEEEEEEEEE--CSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcCCHHHeEeeeEEee--CCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence            3344668999999999  778999999988765    479999997653 455566789999999999999999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccc
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  159 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~  159 (622)
                      .+...+++|||||.+|++.+.+.... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+|++|||.+
T Consensus        79 ~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          79 SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchh
Confidence            99999999999999999999886643 35889999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCC
Q psy15039        160 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  239 (622)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~  239 (622)
                      .......... .......+|+.|||||++.+  ..|+.++|||||||++|||++|..|+........+...+....    
T Consensus       158 ~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----  230 (283)
T d1mqba_         158 RVLEDDPEAT-YTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----  230 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----
T ss_pred             hcccCCCccc-eEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC----
Confidence            5443222111 11223456788999999975  4689999999999999999996666554434444444433211    


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                 ....+..+++++.+|+.+||+.||++|||+.++++
T Consensus       231 ---------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         231 ---------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                       01122346889999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=408.26  Aligned_cols=279  Identities=22%  Similarity=0.297  Sum_probs=208.7

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeC--C
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA--T   83 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~--~   83 (622)
                      ..++|++++.||+  |+||+||+|+++.+|+.||||+++...     .+.+.+|+++|++|+ |||||+++++|...  .
T Consensus        33 ~~d~y~i~~~LG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          33 NQDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             CGGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCcCeEEEEEEec--CcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            3468999999999  779999999999999999999996532     345778999999995 99999999999854  4


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-ceEEcCCcccccc
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPF  162 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~-~~~i~~~~~~~~~  162 (622)
                      .+++|||||++++|.++.     ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++++|||.+...
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec
Confidence            699999999999987653     2489999999999999999999999999999999999999765 5899999987544


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHH---HHHHhCCCCCCC
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML---IEKLAGATPHLL  239 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~---~~~~~~~~p~~~  239 (622)
                      .....     .....+|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.........   +..+.+.. ...
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~-~~~  253 (328)
T d3bqca1         181 HPGQE-----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE-DLY  253 (328)
T ss_dssp             CTTCC-----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH-HHH
T ss_pred             cCCCc-----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc-hhh
Confidence            32221     1234567889999998764 45899999999999999999999999765432221   12222210 000


Q ss_pred             cc--------ccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccccc
Q psy15039        240 DC--------TTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~--------~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~~~  309 (622)
                      +.        ...+..........     .............+|+++.+||++||+.||.+|||++|+|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRK-----RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCC-----CGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             hhhhhcccccCcccchhccccccc-----chhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            00        00000000000000     0000111122345789999999999999999999999999999998754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-50  Score=414.12  Aligned_cols=293  Identities=20%  Similarity=0.258  Sum_probs=209.0

Q ss_pred             CCCCCCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          3 TLDNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         3 ~~~~~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      ++.++..+|+++++||+  |+||+||+|+++.||+.||||+++....++...+.+.+|+.+|++++|||||+++++|...
T Consensus        11 ~~f~i~~~Y~i~~~LG~--G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~   88 (355)
T d2b1pa1          11 STFTVLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ   88 (355)
T ss_dssp             EEEEEETTEEEEEECSC--C--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cceeecCCeEEEEEeec--CcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence            34456678999999999  7789999999999999999999988777777778899999999999999999999999643


Q ss_pred             ------CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCC
Q psy15039         83 ------TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGL  156 (622)
Q Consensus        83 ------~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~  156 (622)
                            ..+|+|||||.++.+. .+.    ..+++..++.++.||+.||+|||++||+||||||+|||++.++..++.||
T Consensus        89 ~~~~~~~~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          89 KTLEEFQDVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             CSTTTCCEEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             cccccCceeEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeech
Confidence                  6799999999865544 332    35789999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHH---HHHhC
Q psy15039        157 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI---EKLAG  233 (622)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~---~~~~~  233 (622)
                      +.........     ......+|+.|+|||++.+  ..|+.++||||+||++|+|++|++||.+........   ....+
T Consensus       164 ~~~~~~~~~~-----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         164 GLARTAGTSF-----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             CC--------------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             hhhhcccccc-----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence            8754433221     1223456788999999976  468999999999999999999999998765443322   22222


Q ss_pred             CCCCCCcccccc----ccCCCCcCcccccccchhhh--hccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCccccc
Q psy15039        234 ATPHLLDCTTYY----VDTGQDDGEENACSYISEQQ--TQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHAFFKQ  307 (622)
Q Consensus       234 ~~p~~~~~~~~~----~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~~~~~  307 (622)
                      ..|.........    .................+..  .........|+++.+||++||..||++||||+|+|+||||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            211110000000    00000000000000000000  000011235788999999999999999999999999999986


Q ss_pred             cc
Q psy15039        308 TK  309 (622)
Q Consensus       308 ~~  309 (622)
                      ..
T Consensus       317 ~~  318 (355)
T d2b1pa1         317 WY  318 (355)
T ss_dssp             GC
T ss_pred             CC
Confidence            43

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=393.06  Aligned_cols=252  Identities=17%  Similarity=0.304  Sum_probs=198.2

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   85 (622)
                      ++|++++.||+  |+||+||+|+++.++   ..||||+++... .+...+.+.+|+.+|++++|||||++++++. .+.+
T Consensus         7 ~~~~l~~~iG~--G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           7 ERIELGRCIGE--GQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGEEEEEEEEE--CSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHeEEEEEEee--CCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            69999999999  778999999987654   569999986543 4556678999999999999999999999985 4678


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCC
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPT  165 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~  165 (622)
                      |+|||||++|++.+++.... ..+++..+..++.||++||+|||+++|+||||||+|||++.++.+|++|||.+..+...
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999999876543 46899999999999999999999999999999999999999999999999987554322


Q ss_pred             CccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccccc
Q psy15039        166 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTY  244 (622)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~  244 (622)
                      ....   .....+|+.|+|||++..  ..|+.++|||||||++|||++ |.+||..............+..+        
T Consensus       162 ~~~~---~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~--------  228 (273)
T d1mp8a_         162 TYYK---ASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--------  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred             ccee---ccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            2111   122345778999999975  468999999999999999997 89999876554433333332211        


Q ss_pred             cccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        245 YVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       245 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              ..+..+++++.+||..||..||++|||+.++++|
T Consensus       229 ------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                    1234578999999999999999999999999886

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=394.09  Aligned_cols=258  Identities=17%  Similarity=0.312  Sum_probs=203.5

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCcEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL   87 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   87 (622)
                      .++|++++.||+  |+||+||+|+++.+ +.||||+++......   +.+.+|+.+|++++|||||++++++. .+.+|+
T Consensus        16 ~~~~~i~~~iG~--G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQ--GCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEeeEEee--CCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEE
Confidence            468999999999  77999999999866 569999997665443   45789999999999999999999985 466899


Q ss_pred             EeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCc
Q psy15039         88 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  167 (622)
Q Consensus        88 v~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~  167 (622)
                      |||||++|++..++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.++++|||.+........
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999999999888665444589999999999999999999999999999999999999999999999998754432221


Q ss_pred             cccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHHhCCCCCCCcccccccc
Q psy15039        168 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDCTTYYVD  247 (622)
Q Consensus       168 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  247 (622)
                      .   ......+|+.|+|||++..  ..|+.++|||||||++|||++|..||........+...+.....           
T Consensus       169 ~---~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-----------  232 (285)
T d1fmka3         169 T---ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  232 (285)
T ss_dssp             ----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             e---eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            1   1123456788999999975  45899999999999999999966555444443333333322110           


Q ss_pred             CCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc--Ccccccc
Q psy15039        248 TGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ--HAFFKQT  308 (622)
Q Consensus       248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~--h~~~~~~  308 (622)
                                          ...+..+++++.+|+.+||+.||++|||++++++  ++||...
T Consensus       233 --------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         233 --------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                                1123457889999999999999999999999987  7888654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-50  Score=408.03  Aligned_cols=262  Identities=20%  Similarity=0.344  Sum_probs=211.0

Q ss_pred             CCceEEeecccccCCceeEEEEEE---ccCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHhhCCC-CcceeEEEEEEeC
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKH---KVTNQLIAVKKFNLDRM--TDEDLKSLHHEIVCMRHLRH-PNIICYISSFLDA   82 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~---~~t~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~   82 (622)
                      ++|++++.||+  |+||+||+|++   +.||+.||||++++...  +....+.+.+|+++|++++| |||+++++++.+.
T Consensus        24 ~~y~~~~~IG~--G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          24 ENFELLKVLGT--GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGEEEEEEEEE--TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hceEEEEEEec--CCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            57999999999  77999999997   55899999999876432  11223557789999999977 8999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCcccccc
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  162 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~  162 (622)
                      ..++++||||.+|+|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.++++|||.+..+
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999997754  4689999999999999999999999999999999999999999999999987554


Q ss_pred             CCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchH---HHHHHHHhCCCCCCC
Q psy15039        163 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT---LMLIEKLAGATPHLL  239 (622)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~---~~~~~~~~~~~p~~~  239 (622)
                      ......   ...+..+++.|+|||++.++...|+.++||||+||+||+|++|+.||......   ..+........    
T Consensus       180 ~~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~----  252 (322)
T d1vzoa_         180 VADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----  252 (322)
T ss_dssp             CGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred             cccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC----
Confidence            322211   12234667889999999866556788999999999999999999999754321   11222111111    


Q ss_pred             ccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCc-----CHHhhhcCccccccc
Q psy15039        240 DCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRP-----LACNLLQHAFFKQTK  309 (622)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~~l~h~~~~~~~  309 (622)
                                                  ...+..+|+++.+|+++||++||++||     |++|+++||||+...
T Consensus       253 ----------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         253 ----------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                                        112245799999999999999999999     589999999998754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=391.68  Aligned_cols=218  Identities=23%  Similarity=0.420  Sum_probs=185.2

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDE-DLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++.+.||+  |+||.||+|+++.+|+.||+|++......+. ..+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         6 ~dy~i~~~iG~--G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGK--GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEec--CCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            57999999999  8899999999999999999999864322221 24568899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++....  .+++..+..++.||+.||+|||++|||||||||+|||++.+|.+++.|||.+....... 
T Consensus        84 vmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             EEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            999999999999998654  47899999999999999999999999999999999999999999999999865433221 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  589 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~  589 (622)
                           .....||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+... +...+....+.++
T Consensus       161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~p  224 (263)
T d2j4za1         161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEFTFP  224 (263)
T ss_dssp             -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCCCCC
T ss_pred             -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCC
Confidence                 123568999999999976  468999999999999999999999998775554 4455555444443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=392.55  Aligned_cols=223  Identities=20%  Similarity=0.329  Sum_probs=181.4

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe--CCcEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD--ATDLH  436 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~  436 (622)
                      ++|++.+.||+  |+||.||+|+++.||+.||||++.....++...+.+.+|+.+|++++|||||++++++.+  .+.+|
T Consensus         4 edy~~~~~iG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGT--GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEec--CCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            57999999999  889999999999999999999999888788778889999999999999999999999975  45689


Q ss_pred             EEeeccCCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        437 LVSPLMGFGSCKDLINAH--FNFGLPELVICHILQDVLNGLEYIHGKG-----FIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~~qi~~gL~ylH~~~-----iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                      +|||||++|+|.+++...  ....+++..++.++.||+.||+|||+++     ||||||||+|||++.++.++++|||.+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            999999999999998643  2346899999999999999999999876     999999999999999999999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  589 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~  589 (622)
                      ..+.....    ...+..||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+..+.......+..+.++
T Consensus       162 ~~~~~~~~----~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~  235 (269)
T d2java1         162 RILNHDTS----FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP  235 (269)
T ss_dssp             HHC---------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC
T ss_pred             eecccCCC----ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            65433221    1234578999999999975  46999999999999999999999999887666555555555554443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=391.38  Aligned_cols=219  Identities=26%  Similarity=0.495  Sum_probs=190.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ....|++.+.||+  |+||.||+|+++.+|+.||||++.......  .+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus        18 p~~~Y~~~~~iG~--G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQ--GASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCC--SSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEec--CcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            3457999999999  889999999999999999999997654332  357899999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +|||||++|+|.+++...   ++++..++.++.||+.||+|||++|||||||||+|||++.+|.+++.|||.+..+....
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999999999987653   48899999999999999999999999999999999999999999999999876554322


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                      ..    ....+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+...+....|.+
T Consensus       171 ~~----~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~  236 (293)
T d1yhwa1         171 SK----RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL  236 (293)
T ss_dssp             CC----BCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC
T ss_pred             cc----ccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            11    234578999999999976  4689999999999999999999999998877777766666655443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=397.08  Aligned_cols=254  Identities=18%  Similarity=0.330  Sum_probs=200.1

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCc----EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCCc
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQ----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD   84 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   84 (622)
                      ++|+++++||+  |+||+||+|+++.+|+    .||||+++... +....+.+.+|+.+|++|+|||||++++++.++ .
T Consensus         9 ~dy~~~~~lG~--G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEE--CSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEec--CCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            57999999999  7899999999998887    58888886532 233456788999999999999999999999875 5


Q ss_pred             EEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCC
Q psy15039         85 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  164 (622)
Q Consensus        85 ~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~  164 (622)
                      .++++|++.+|++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+.....
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            788899999999999887643 3589999999999999999999999999999999999999999999999998765433


Q ss_pred             CCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccc
Q psy15039        165 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTT  243 (622)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~  243 (622)
                      .....  ......+|+.|+|||++.++  .|+.++|||||||++|||+| |.+||.+.+..........+..+       
T Consensus       164 ~~~~~--~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-------  232 (317)
T d1xkka_         164 EEKEY--HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------  232 (317)
T ss_dssp             TCC----------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-------
T ss_pred             ccccc--cccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            22211  12233567899999999764  58999999999999999998 88999876543322222222211       


Q ss_pred             ccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcCc
Q psy15039        244 YYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQHA  303 (622)
Q Consensus       244 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h~  303 (622)
                                               ..+..+++++.+|+.+||..||++|||+.++++|.
T Consensus       233 -------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         233 -------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                                     12245788999999999999999999999999883

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=395.30  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +++|++++.||+  |+||.||+|+++.+|+.||||++......+ ...+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus         7 p~dy~i~~~lG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           7 PEDFKFGKILGE--GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            467999999999  889999999999999999999987432211 12467899999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +|||||++|+|.+++....  .+++..++.++.|++.||+|||++|||||||||+|||++++|.+++.|||.+..+....
T Consensus        85 ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999999887654  47899999999999999999999999999999999999999999999999876544322


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                      ..  ....+.+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+.... ...+....+.+++ .....
T Consensus       163 ~~--~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~  237 (288)
T d1uu3a_         163 KQ--ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-FQKIIKLEYDFPEKFFPKA  237 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTTCCCCCTTCCHHH
T ss_pred             cc--cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-HHHHHcCCCCCCccCCHHH
Confidence            11  11234578999999999976  4689999999999999999999999988765554 4444444443332 22222


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....+...+..++++.++
T Consensus       238 ~~li~~~L~~dP~~R~t~~e  257 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGCEE  257 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTSGG
T ss_pred             HHHHHHHccCCHhHCcCHHH
Confidence            33344455555555555443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=392.96  Aligned_cols=219  Identities=20%  Similarity=0.355  Sum_probs=181.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||++...... ...+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         4 ~~dy~~~~~lG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGE--GAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcceEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence            567999999999  78999999999999999999999865432 234678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+|++|||.+..+.... 
T Consensus        81 vmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-  157 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-  157 (271)
T ss_dssp             EEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred             EEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC-
Confidence            99999999999988653  358899999999999999999999999999999999999999999999999876443221 


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                       ......+.+||+.|||||++.+. ..++.++|||||||++|||+||++||...+............
T Consensus       158 -~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~  222 (271)
T d1nvra_         158 -RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  222 (271)
T ss_dssp             -EECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT
T ss_pred             -ccccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence             11223346789999999999753 224678999999999999999999998765544444444443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=383.58  Aligned_cols=246  Identities=23%  Similarity=0.376  Sum_probs=195.0

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe-CCcEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD-ATDLH   86 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~   86 (622)
                      .++|++++.||+  |+||.||+|+++  |..||||+++.+.    ..+.+.+|+++|++++|||||++++++.+ .+.+|
T Consensus         6 ~~~~~~~~~lG~--G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             HHHeEEeEEEec--CCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            357999999999  778899999985  7799999996543    23567899999999999999999999865 46689


Q ss_pred             EEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCC
Q psy15039         87 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  166 (622)
Q Consensus        87 lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~  166 (622)
                      +||||+++|+|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||++.+|.++++|||........ 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999999997654334789999999999999999999999999999999999999999999999976543221 


Q ss_pred             ccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCcccccc
Q psy15039        167 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCTTYY  245 (622)
Q Consensus       167 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~~~~  245 (622)
                            .....++..|+|||++.++  .|+.++|||||||++|||++ |++||...+..........+..|.        
T Consensus       157 ------~~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~--------  220 (262)
T d1byga_         157 ------QDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD--------  220 (262)
T ss_dssp             -----------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC--------
T ss_pred             ------CccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence                  1123456789999999763  58999999999999999998 788887654443322221221111        


Q ss_pred             ccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        246 VDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       246 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                              .+..+++++.+|+++||..||++|||+.+++++
T Consensus       221 ------------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         221 ------------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                                    123468899999999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-48  Score=389.74  Aligned_cols=244  Identities=24%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      .|+.++.||+  |+||.||+|+++.+|+.||||++....... ...+.+.+|+.+|+.|+|||||++++++.+.+.+|+|
T Consensus        16 ~y~~l~~lG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGH--GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEeeEEEec--CCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            4899999999  889999999999999999999998766544 4457899999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      ||||++|++..++...  .++++..++.++.||+.||+|||++|||||||||+|||++.++.++++|||.+.....    
T Consensus        94 ~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             EECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             EEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            9999999987666543  3589999999999999999999999999999999999999999999999997654322    


Q ss_pred             eeccCCCCCCCCccccccccccC-ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCCC--Cccc
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLDC--TTYY  595 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~~--~~~~  595 (622)
                          .....||+.|||||++.+. ...|+.++|||||||++|||++|++||.+.+....+.....+..|.+.+.  +...
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~  243 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF  243 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHH
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHH
Confidence                1235689999999999642 23589999999999999999999999998887777777777776655442  2223


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....+...++..+++-++
T Consensus       244 ~~li~~~L~~dP~~Rpt~~e  263 (309)
T d1u5ra_         244 RNFVDSCLQKIPQDRPTSEV  263 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHCcCChhHCcCHHH
Confidence            33344444444444444433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=379.71  Aligned_cols=212  Identities=22%  Similarity=0.390  Sum_probs=183.8

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe----CCcEE
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD----ATDLH  436 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~~~~~  436 (622)
                      |++.+.||+  |+||.||+|+++.+++.||+|++.....+....+.+.+|+++|++++|||||+++++|.+    ...+|
T Consensus        11 ~~~~~~iG~--G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGR--GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEec--CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            578889999  889999999999999999999998777777777889999999999999999999999876    34589


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCceEEcCcccccccC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKG--FIHRAVKASHILIS-HNGKACLSGLRYMCPFS  513 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~--iiHRDlKp~NILl~-~~~~~~~~~~~~~~~~~  513 (622)
                      +|||||++|+|.+++.+..  .+++..+..++.||+.||+|||+++  ||||||||+|||++ +++.+|++|||.+....
T Consensus        89 ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999999998753  4789999999999999999999998  99999999999996 47899999999875322


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ...      ..+.+||+.|||||++.+   .|+.++|||||||++|||++|++||.+..+...+.+.+....
T Consensus       167 ~~~------~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~  229 (270)
T d1t4ha_         167 ASF------AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV  229 (270)
T ss_dssp             TTS------BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred             CCc------cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC
Confidence            211      123568999999999964   589999999999999999999999988777777777766543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=390.07  Aligned_cols=222  Identities=25%  Similarity=0.366  Sum_probs=188.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .+.|++.+.||+  |+||.||+|+++.+|+.||||++....  ....+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus        11 ~d~Y~i~~~iG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          11 EDFWEIIGELGD--GAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEeEEEee--CCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            356999999999  789999999999999999999997643  2345678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.... .++++..+..++.||+.||+|||++|||||||||+|||++.+|.+|++|||.+......  
T Consensus        87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--  163 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred             EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence            999999999999876543 35899999999999999999999999999999999999999999999999976433211  


Q ss_pred             ceeccCCCCCCCCcccccccccc---CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQ---NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHL  588 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~  588 (622)
                        .....+..||+.|||||++..   ....|+.++|||||||++|||+||++||.+.+..+.+.....+..|.+
T Consensus       164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~  235 (288)
T d2jfla1         164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL  235 (288)
T ss_dssp             --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred             --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence              111234578999999999842   124589999999999999999999999998887777766666655443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=385.23  Aligned_cols=254  Identities=20%  Similarity=0.326  Sum_probs=204.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCC-------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEE
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTN-------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF   79 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~   79 (622)
                      .++|++++.||+  |+||.||+|++..++       ..||||+++.+. .......+.+|...++++ +|||||++++++
T Consensus        12 ~~~~~l~~~iG~--G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGE--GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-------CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEee--cCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            469999999999  889999999987665       479999997654 456667788999999888 899999999999


Q ss_pred             EeCCcEEEEeecCCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         80 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        80 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      .++...++|||||++|++.+++.....              ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            999999999999999999999975531              247999999999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.++++|||...........  .......+++.|+|||++.+  ..|+.++|||||||++|||++ |.+||...+..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             cCCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999987654322211  11233456788999999976  469999999999999999998 78888766554


Q ss_pred             HHHHHHH-hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        225 LMLIEKL-AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       225 ~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      .. ...+ .+..|                                ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       245 ~~-~~~i~~~~~~--------------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 EL-FKLLKEGHRM--------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HH-HHHHHTTCCC--------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH-HHHHHcCCCC--------------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            33 3333 22111                                122457899999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-47  Score=386.69  Aligned_cols=255  Identities=16%  Similarity=0.284  Sum_probs=206.9

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA   82 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   82 (622)
                      .++|++++.||+  |+||+||+|+++     .+++.||||+++... .++..+.+.+|+++|++++|||||++++++...
T Consensus        12 ~~~~~~~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGE--GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEE--CSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEee--CCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            357999999999  779999999976     467899999997643 456677899999999999999999999999999


Q ss_pred             CcEEEEeecCCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q psy15039         83 TDLHLVSPLMGFGSCKDLINAHF----------------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA  140 (622)
Q Consensus        83 ~~~~lv~e~~~~g~l~~~l~~~~----------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp  140 (622)
                      ..++++|||+++|+|.+++....                      ...+++..+..++.|++.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999986532                      12378889999999999999999999999999999


Q ss_pred             CCEEEcCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCC-CCCC
Q psy15039        141 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT-VPFA  219 (622)
Q Consensus       141 ~NiLl~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~-~Pf~  219 (622)
                      +|||++.++.+|++|||.+.........  ....+..+++.|+|||.+.+  ..|+.++|||||||++|||++|. +||.
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cceEECCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999986543222111  11223456788999999976  35899999999999999999985 6777


Q ss_pred             CCchHHHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhh
Q psy15039        220 ETPTTLMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNL  299 (622)
Q Consensus       220 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~  299 (622)
                      +.+..........+..|.                                .+..+++++.+|+..||+.||++|||+.|+
T Consensus       245 ~~~~~e~~~~v~~~~~~~--------------------------------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev  292 (301)
T d1lufa_         245 GMAHEEVIYYVRDGNILA--------------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSI  292 (301)
T ss_dssp             TSCHHHHHHHHHTTCCCC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHHHHHHHHHcCCCCC--------------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            665554443333332221                                123468899999999999999999999998


Q ss_pred             hc
Q psy15039        300 LQ  301 (622)
Q Consensus       300 l~  301 (622)
                      ++
T Consensus       293 ~~  294 (301)
T d1lufa_         293 HR  294 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=389.20  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcE--EEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEeCCcE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQL--IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL   85 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~--vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   85 (622)
                      ++|+++++||+  |+||+||+|+++.||..  ||||+++... .++..+.+.+|+++|+++ +|||||++++++.+.+.+
T Consensus        10 ~~~~~~~~iG~--G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          10 NDIKFQDVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGCEEEEEEEC--GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHcEEEEEEee--CCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            58999999999  77899999999999875  6778875433 344566789999999999 799999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCce
Q psy15039         86 HLVSPLMGFGSCKDLINAH--------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  151 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~--------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~  151 (622)
                      ++|||||++|+|.+++...              ....+++..+..++.||+.||.|+|+++|+||||||+|||++.++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence            9999999999999998643              12458999999999999999999999999999999999999999999


Q ss_pred             EEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCC-CCCCCCchHHHHHHH
Q psy15039        152 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT-VPFAETPTTLMLIEK  230 (622)
Q Consensus       152 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~-~Pf~~~~~~~~~~~~  230 (622)
                      +++|||.+........     .....+|..|+|||.+.++  .|+.++|||||||++|||++|. +||...+... +...
T Consensus       167 kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEK  238 (309)
T ss_dssp             EECCTTCEESSCEECC-----C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHH
T ss_pred             EEcccccccccccccc-----ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-HHHH
Confidence            9999998754322111     1223467789999999764  5899999999999999999965 5676554433 3333


Q ss_pred             H-hCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        231 L-AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       231 ~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      + .+..|                                ..+..+++++.+||.+||+.||++|||+.++++|
T Consensus       239 i~~~~~~--------------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         239 LPQGYRL--------------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGGTCCC--------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCC--------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2 22111                                1234578999999999999999999999999987

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-47  Score=388.46  Aligned_cols=217  Identities=24%  Similarity=0.378  Sum_probs=171.7

Q ss_pred             CCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcE
Q psy15039        356 NVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDL  435 (622)
Q Consensus       356 ~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~  435 (622)
                      .+.+.|++.+.||+  |+||.||+|+++.+|+.||||++....... ....+.+|+.+|+.++|||||++++++.+.+.+
T Consensus         6 di~d~Y~~~~~lG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           6 DIRDIYDFRDVLGT--GAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             CGGGTEEEEEESBS--GGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCccceEEEEEEee--ccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45567999999999  789999999999999999999998655433 235688999999999999999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS---HNGKACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~---~~~~~~~~~~~~~~~~  512 (622)
                      |+|||||++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||+.   .++.++++|||++...
T Consensus        83 ~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999999999764  3589999999999999999999999999999999999995   4789999999986543


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....     ...+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+............+.
T Consensus       161 ~~~~-----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~  225 (307)
T d1a06a_         161 DPGS-----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE  225 (307)
T ss_dssp             -----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC
T ss_pred             cCCC-----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence            2211     1234578999999999976  469999999999999999999999998876665544444443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=381.68  Aligned_cols=256  Identities=18%  Similarity=0.323  Sum_probs=196.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEcc-CC--cEEEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKV-TN--QLIAVKKFNLDRM-TDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~-t~--~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   83 (622)
                      +.+|++++.||+  |+||.||+|+++. ++  ..||||+++.... .++..+.+.+|+.+|++|+|||||++++++.+ .
T Consensus         7 ~~d~~~~~~iG~--G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           7 EKDLRLLEKLGD--GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hHHeEEEEEEec--CCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            467999999999  7799999998653 33  4689999987544 33446778999999999999999999999966 4


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  163 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~  163 (622)
                      .+++|||||++|++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            6889999999999999876643 358999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchHHHHHHHHhCCCCCCCccc
Q psy15039        164 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLDCT  242 (622)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  242 (622)
                      ...... .......++..|+|||++.+  ..|+.++|||||||++|||++ |..||.+.+.............       
T Consensus       163 ~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~-------  232 (273)
T d1u46a_         163 QNDDHY-VMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-------  232 (273)
T ss_dssp             C-CCEE-EC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-------
T ss_pred             cCCCcc-eecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC-------
Confidence            332221 11222345678999999976  358899999999999999998 8999987765554433322211       


Q ss_pred             cccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        243 TYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                              ....+..+++++.+|+..||..||++|||+.+++.
T Consensus       233 ------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         233 ------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    01123457889999999999999999999999863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=392.72  Aligned_cols=215  Identities=18%  Similarity=0.290  Sum_probs=184.5

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++++.||+  |+||.||+|+++.||+.||||++.++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus         5 ~dy~~~~~lG~--G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           5 NDFDYLKLLGK--GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhcEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            57999999999  789999999999999999999997532211 124678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++.+|.++++|||.+........
T Consensus        83 v~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          83 VMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999999988754  478999999999999999999999999999999999999999999999998754332211


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~  583 (622)
                          ...+.+||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+..........+
T Consensus       161 ----~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~  220 (337)
T d1o6la_         161 ----TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME  220 (337)
T ss_dssp             ----CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             ----ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC
Confidence                1234678999999999976  56999999999999999999999999988665544434443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=385.69  Aligned_cols=256  Identities=18%  Similarity=0.279  Sum_probs=197.3

Q ss_pred             CCCceEEeecccccCCceeEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~-----t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~   81 (622)
                      .++|++++.||+  |+||+||+|+++.     +++.||||+++... .....+.+.+|+.++.++ +|||||.+++++..
T Consensus        12 ~~~y~~~~~iG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          12 RDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHEEEeeEEee--cCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            368999999999  7789999999754     55789999987543 445566778888888777 68999999998776


Q ss_pred             C-CcEEEEeecCCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q psy15039         82 A-TDLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS  146 (622)
Q Consensus        82 ~-~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~  146 (622)
                      . ..+++|||||++|+|.+++....              ...+++..+..++.||++||+|||++||+||||||+||||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence            4 46899999999999999997542              12478999999999999999999999999999999999999


Q ss_pred             CCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcC-CCCCCCCchHH
Q psy15039        147 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPTTL  225 (622)
Q Consensus       147 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g-~~Pf~~~~~~~  225 (622)
                      .++.+|++|||.+.........  ....+..+|+.|+|||++.+  ..|+.++|||||||++|||++| .+||.......
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             GGGCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             CCCcEEEccCcchhhccccccc--cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999987543322211  12234467889999999976  4689999999999999999986 56787655444


Q ss_pred             HHHHHHh-CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        226 MLIEKLA-GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       226 ~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .+...+. +..|.                                .+..+++++.+|+.+||+.||++|||+.++++|
T Consensus       245 ~~~~~~~~~~~~~--------------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRMR--------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCCC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC--------------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433332 21111                                123468899999999999999999999999987

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-47  Score=387.32  Aligned_cols=213  Identities=22%  Similarity=0.360  Sum_probs=183.8

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++..+.... ...+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         4 ~dy~i~~~lG~--G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGT--GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEec--CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            57999999999  789999999999999999999986432211 224678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|++.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||.+......  
T Consensus        82 vmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999999999887644  4678888999999999999999999999999999999999999999999986543321  


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                           ..+.+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+.....+.
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC
T ss_pred             -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence                 234678999999999976  468999999999999999999999998887666555555543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=381.88  Aligned_cols=256  Identities=18%  Similarity=0.284  Sum_probs=209.2

Q ss_pred             CCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCcceeEEEEEEe
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD   81 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~   81 (622)
                      +++|++++.||+  |+||.||+|+++     .+++.||||+++... ...+...+.+|+.+++++ +|||||++++++.+
T Consensus        22 ~~~~~l~~~iG~--G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          22 RNRLSFGKTLGA--GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEee--cCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            478999999999  779999999863     577899999998754 455667788999999999 69999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHF----------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  145 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~----------------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl  145 (622)
                      ...+++|||||++|++.+++....                ...+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence            999999999999999999987542                1247899999999999999999999999999999999999


Q ss_pred             cCCCceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhc-CCCCCCCCchH
Q psy15039        146 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  224 (622)
Q Consensus       146 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~-g~~Pf~~~~~~  224 (622)
                      +.++.+++.|||...........  .......+|+.|+|||++..  ..|+.++|||||||++|||++ |.+||...+..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999987654332221  12234466889999999975  458999999999999999998 66666665554


Q ss_pred             HHHHHHHhCCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        225 LMLIEKLAGATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       225 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      ..+...+....+                               ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       255 ~~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEGFR-------------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHTCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCC-------------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            443333322111                               1123457899999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=389.69  Aligned_cols=203  Identities=24%  Similarity=0.383  Sum_probs=178.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||+||+|+++.+|+.||+|++..+. .......+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus         5 ~d~y~~~~~iG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGA--GNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEEC--CSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEec--CCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            467999999999  889999999999999999999997653 33445678999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      |||||++|+|.+++.+..  .+++..+..++.|++.||+|||+ +|||||||||+|||++.+|.+|++|||.+..+..  
T Consensus        82 VmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  157 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  157 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             EEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence            999999999999998754  47899999999999999999997 5999999999999999999999999998654321  


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                          ....+.+||+.|||||++.+  ..|+.++||||+||++|||++|+.||...+.
T Consensus       158 ----~~~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         158 ----SMANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             ----HTC---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             ----CccccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence                12234678999999999976  4699999999999999999999999976654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=380.27  Aligned_cols=256  Identities=16%  Similarity=0.263  Sum_probs=208.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEe
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD   81 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~-----~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   81 (622)
                      .+++|++++.||+  |+||+||+|.++     .+++.||||+++... .......+.+|+++|++++|||||++++++..
T Consensus        18 ~~~~~~l~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQ--GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEE--CSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEee--CCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3579999999999  779999999986     356789999997643 45566778999999999999999999999999


Q ss_pred             CCcEEEEeecCCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEE
Q psy15039         82 ATDLHLVSPLMGFGSCKDLINAHF--------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACL  153 (622)
Q Consensus        82 ~~~~~lv~e~~~~g~l~~~l~~~~--------~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i  153 (622)
                      .+..++|||||++|+|.+++....        ...+++..+..++.|+++||+|||+++|+||||||+|||++.++.+|+
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            999999999999999999876431        123688899999999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcC-CCCCCCCchHHHHHHHHh
Q psy15039        154 SGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPTTLMLIEKLA  232 (622)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g-~~Pf~~~~~~~~~~~~~~  232 (622)
                      +|||.+.........  .......+|+.|+|||.+.++  .|+.++|||||||++|||++| .+||.+.+....+.....
T Consensus       175 ~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         175 GDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             CCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eecccceeccCCcce--eeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            999986543222211  112233567889999999764  588999999999999999998 577776655444433333


Q ss_pred             CCCCCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        233 GATPHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                      +..+.                                .+..+++.+.++|..||+.||++|||+.++++
T Consensus       251 ~~~~~--------------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         251 GGLLD--------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TCCCC--------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCC--------------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            32221                                12346889999999999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=378.84  Aligned_cols=217  Identities=20%  Similarity=0.303  Sum_probs=185.8

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      +.+.|++++.||+  |+||.||+|+++.+|+.||||++.......    ...+.+.+|+.+|+.++|||||+++++|.+.
T Consensus         8 i~d~Y~~~~~lG~--G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           8 VDDYYDTGEELGS--GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             GGGTEEEEEEEEE--CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cccCEEEeEEEec--CCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            4567999999999  889999999999999999999997654322    1246789999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----ceEEcCccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG----KACLSGLRY  508 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~----~~~~~~~~~  508 (622)
                      +.+|+|||||++|+|.+++....  .+++..++.++.|++.||+|||+++||||||||+|||++.++    .+++.|||.
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             CEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999999997654  488999999999999999999999999999999999998877    489999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      +........     ..+..+|+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+..+.+.....+.
T Consensus       164 a~~~~~~~~-----~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~  232 (293)
T d1jksa_         164 AHKIDFGNE-----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN  232 (293)
T ss_dssp             CEECTTSCB-----CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred             hhhcCCCcc-----ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence            655432211     234567889999999976  468999999999999999999999999887666655554443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-46  Score=387.20  Aligned_cols=247  Identities=19%  Similarity=0.264  Sum_probs=198.4

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.++|++.+.||+  |+||.||+|+++.+|+.||||++....  ..+.+.+.+|+.+|+.|+|||||+++++|.+.+.+|
T Consensus        27 ~~d~Y~i~~~lG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          27 VYDYYDILEELGS--GAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGGTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEec--CCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3467999999999  789999999999999999999987643  344567889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCceEEcCcccccccCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS--HNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~--~~~~~~~~~~~~~~~~~~  514 (622)
                      +|||||++|+|.+++... ..++++..++.++.||+.||+|||++|||||||||+|||++  .++.++|+|||.+..+..
T Consensus       103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999999999877653 33589999999999999999999999999999999999998  578999999998765543


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCCC----
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLLD----  590 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~~----  590 (622)
                      ....     .+..+|+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+.....+..+...+    
T Consensus       182 ~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  254 (352)
T d1koba_         182 DEIV-----KVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS  254 (352)
T ss_dssp             TSCE-----EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred             CCce-----eeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence            2211     22457889999999976  569999999999999999999999998887766655555554322111    


Q ss_pred             CCcccccCCCCcCcccccchhhhhh
Q psy15039        591 CTTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       591 ~~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....+....+...++..+++.++
T Consensus       255 ~s~~~~~li~~~L~~dp~~R~s~~e  279 (352)
T d1koba_         255 VSPEAKDFIKNLLQKEPRKRLTVHD  279 (352)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHH
Confidence            2222333444555555555555444

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-46  Score=378.33  Aligned_cols=248  Identities=17%  Similarity=0.274  Sum_probs=199.9

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++.+|+.||||++..+...   .+.+.+|+.+|+.++|||||+++++|.+.+.+++
T Consensus        16 ~~~~~~~~~iG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGG--GQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTT--TTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHeEEeeEEee--CCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            457999999999  88999999999999999999999765443   3568999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||.+........
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999999999876556789999999999999999999999999999999999999999999999998764433222


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcC-CCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAG-ATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~-~~p~~~~-~~~~~  595 (622)
                      .   ...+..+|+.|||||++.+  ..|+.++|||||||++|||++|..||....+...+.+.+.. ..|+.++ ++...
T Consensus       171 ~---~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  245 (287)
T d1opja_         171 T---AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  245 (287)
T ss_dssp             E---EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             e---eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence            1   1233557889999999976  46999999999999999999977666555555556665544 3344433 33334


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....|...++.+++|-.+
T Consensus       246 ~~li~~cl~~dP~~Rps~~e  265 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAE  265 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHH
Confidence            44455555555555555443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=377.12  Aligned_cols=251  Identities=18%  Similarity=0.286  Sum_probs=199.5

Q ss_pred             EeecccccCCceeEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeC-CcEEEEe
Q psy15039         14 CSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-TDLHLVS   89 (622)
Q Consensus        14 ~~~lG~g~g~~~~V~~~~~~~t~---~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lv~   89 (622)
                      .++||+  |+||+||+|++..++   ..||||+++.. ..+...+.+.+|+++|++|+|||||++++++... ..+++||
T Consensus        32 ~~~iG~--G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGR--GHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEE--ETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEee--cCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            678999  779999999987654   36999999753 3566778899999999999999999999998764 5799999


Q ss_pred             ecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEcCCccccccCCCCccc
Q psy15039         90 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  169 (622)
Q Consensus        90 e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~~~~~~~~~~~~~~~~  169 (622)
                      |||++|++.+++.... ..+++..+..++.|++.||.|+|+++|+||||||+|||+++++.++++|||.+..........
T Consensus       109 E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999999987643 356788889999999999999999999999999999999999999999999876544333222


Q ss_pred             cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH-hCCCCCCCccccccccC
Q psy15039        170 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLDCTTYYVDT  248 (622)
Q Consensus       170 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~  248 (622)
                      ........+|..|+|||++..  ..|+.++|||||||++|||++|..||........+...+ .+..|            
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~------------  253 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------------  253 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC------------
T ss_pred             ceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence            222334566888999999875  358999999999999999999888876543332222222 22211            


Q ss_pred             CCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        249 GQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       249 ~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                                          ..+...++++.+||.+||+.||++||++.|+++|
T Consensus       254 --------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 --------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                1223468899999999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-46  Score=386.67  Aligned_cols=215  Identities=20%  Similarity=0.304  Sum_probs=184.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      -++|++++.||+  |+||.||+|+++.+|+.||||++....  ....+.+.+|+.+|+.|+|||||+++++|.+.+.+|+
T Consensus        25 l~~Y~i~~~lG~--G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          25 LDHYDIHEELGT--GAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGTEEEEEEEEE--ETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            457999999999  789999999999999999999997543  4456788999999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCceEEcCcccccccCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH--NGKACLSGLRYMCPFSPT  515 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~--~~~~~~~~~~~~~~~~~~  515 (622)
                      |||||++|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.  ++.++|+|||.+..+...
T Consensus       101 vmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999999886432 35899999999999999999999999999999999999964  578999999987655432


Q ss_pred             CCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        516 KKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       516 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ...     .+..||+.|||||++.+  ..|+.++|||||||++|||++|++||.+.+..+.+..+..+.
T Consensus       180 ~~~-----~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  241 (350)
T d1koaa2         180 QSV-----KVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD  241 (350)
T ss_dssp             SCE-----EEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccc-----ceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            221     23467889999999976  468999999999999999999999998876666555554443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-46  Score=374.45  Aligned_cols=222  Identities=21%  Similarity=0.293  Sum_probs=182.2

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc-
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD-  434 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~-  434 (622)
                      +.+.|++.+.||+  |+||.||+|+++.+|+.||||++..+... ....+.+.+|+.+|+.++|||||++++++...+. 
T Consensus         5 l~drY~i~~~lG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           5 LSDRYELGEILGF--GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             ETTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred             ccceeEEeEEEee--CCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence            4567999999999  88999999999999999999999876543 4456789999999999999999999999987543 


Q ss_pred             ---EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccc
Q psy15039        435 ---LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCP  511 (622)
Q Consensus       435 ---~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~  511 (622)
                         +|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++.++..++.|||....
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence               899999999999999887654  478999999999999999999999999999999999999999999999987544


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCC
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGAT  585 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~  585 (622)
                      ...... ......+.+||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+...+....
T Consensus       161 ~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~  231 (277)
T d1o6ya_         161 IADSGN-SVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP  231 (277)
T ss_dssp             CC-----------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred             hccccc-cccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC
Confidence            332221 1122344678999999999975  4689999999999999999999999998877777666666643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-46  Score=378.49  Aligned_cols=252  Identities=17%  Similarity=0.276  Sum_probs=189.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ---LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      .++|++.+.||+  |+||.||+|+++.+++   .||||++... .+....+.+.+|+.+|++++|||||++++++...+.
T Consensus        25 ~~~~~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGA--GEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEE--CSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEee--CCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            467999999999  8899999999987775   5889987643 345566789999999999999999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +++|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||.+..+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999887643 3578999999999999999999999999999999999999999999999998754433


Q ss_pred             CCCce-eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCC-CCC
Q psy15039        515 TKKKV-HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHL-LDC  591 (622)
Q Consensus       515 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~-~~~  591 (622)
                      ..... .....+..+|+.|||||++..  ..|+.++|||||||++|||+| |++||.+.+....+.....+..++. .++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC  258 (299)
T ss_dssp             ---------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            22211 111223456889999999975  469999999999999999998 8999998876665544445544333 334


Q ss_pred             CcccccCCCCcCcccccchhhhhh
Q psy15039        592 TTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       592 ~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      +....+....|...++.++.+-.+
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~e  282 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQ  282 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHH
Confidence            544555555555555555554433

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-46  Score=370.93  Aligned_cols=249  Identities=20%  Similarity=0.279  Sum_probs=198.4

Q ss_pred             CCCceEeee-cccccCCeeEEEEEEEcc--CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSI-LGQCFNNLSSVYLSKHKV--TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~-lg~g~g~~~~V~~~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      .++|.+.+. ||+  |+||.||+|.++.  ++..||||++... ..+...+.+.+|+.+|+.++|||||++++++.+ +.
T Consensus         7 ~~~~~~~~~~iG~--G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           7 RDNLLIADIELGC--GNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGGEEEEEEEEEC--CTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             ccCeEECCcEEec--ccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            356778885 999  8899999998754  4557999999754 345667889999999999999999999999865 56


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+|++|||.+..+..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            899999999999999876543 3588999999999999999999999999999999999999999999999998765543


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~  592 (622)
                      ... .........+|+.|||||++..  ..|+.++|||||||++|||+| |++||.+.+..+.+.....+..|..++ ++
T Consensus       162 ~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  238 (285)
T d1u59a_         162 DDS-YYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  238 (285)
T ss_dssp             CSC-EECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccc-ccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence            322 2222334567889999999976  468999999999999999998 999999887666555555665555544 44


Q ss_pred             cccccCCCCcCcccccchhhhh
Q psy15039        593 TYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      ....+....|...++.++.+-.
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~  260 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFL  260 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHH
Confidence            4455556666666666665443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-46  Score=386.28  Aligned_cols=213  Identities=19%  Similarity=0.295  Sum_probs=184.0

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++......+ ...+.+.+|+.+|+.++|||||++++++.+....++
T Consensus        41 d~y~i~~~lG~--G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGT--GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEEEEeec--CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            57999999999  889999999999999999999986432111 224678899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+.+|+|.+++....  .+++..++.++.||+.||.|||++|||||||||+|||++.+|.++|+|||.+.....   
T Consensus       119 v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---  193 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             ccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence            999999999999987754  478999999999999999999999999999999999999999999999998754432   


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                          ...+..||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+....+..+..+.
T Consensus       194 ----~~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~  254 (350)
T d1rdqe_         194 ----RTWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK  254 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             ----ccccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Confidence                1234578999999999976  568999999999999999999999998876655544444443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=371.17  Aligned_cols=216  Identities=21%  Similarity=0.347  Sum_probs=178.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+.+   ..||||++.....+....+.+.+|+.+|++++|||||++++++. .+.+++
T Consensus         7 ~~~~~~~~~lG~--G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGS--GSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEE--CSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEEEEEee--CCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence            567999999999  889999999754   46999999877666667788999999999999999999999764 467899


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||++........
T Consensus        81 v~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999997643 3588999999999999999999999999999999999999999999999998654332211


Q ss_pred             ceeccCCCCCCCCccccccccccC-ccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQN-LDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLA  582 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~  582 (622)
                        .....+..||+.|||||++... ...|+.++|||||||++|||+||+.||.+.+....+...+.
T Consensus       160 --~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~  223 (276)
T d1uwha_         160 --SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG  223 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             --cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence              1122345789999999999642 23589999999999999999999999998877666655543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.6e-45  Score=365.87  Aligned_cols=218  Identities=28%  Similarity=0.385  Sum_probs=186.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC---H----HHHHHHHHHHHHHhhCC-CCccceeEEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT---D----EDLKSLHHEIVCMRHLR-HPNIICYISSF  429 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~---~----~~~~~~~~E~~~l~~l~-HpnIv~~~~~~  429 (622)
                      .++|++.+.||+  |+||+||+|+++.+|+.||||++......   .    ...+++.+|+.+|+.++ |||||++++++
T Consensus         2 ~~~y~~~~~iG~--G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~   79 (277)
T d1phka_           2 YENYEPKEILGR--GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   79 (277)
T ss_dssp             TTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             cccCEEceEEec--CcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence            468999999999  78999999999999999999999765432   1    22356889999999997 99999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                      .+.+.+|+|||||++|+|.++++...  ++++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||.+
T Consensus        80 ~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          80 ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999999997654  5899999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCcccccccccc----CccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQ----NLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ..++....     .....||+.|+|||++..    ....|+.++||||+||++|||++|++||.+.+..........+.
T Consensus       158 ~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         158 CQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             EECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             eEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            65543221     233568899999999853    12347889999999999999999999999887766555555554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=368.59  Aligned_cols=246  Identities=19%  Similarity=0.278  Sum_probs=187.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      +++|++.+.||+  |+||.||+|+++ +++.||||++.......   +.+.+|+.+++.++|||||++++++...+..++
T Consensus         4 p~~~~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           4 PSELTFVQEIGS--GQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CSCEEEEEEEEC--CSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hHHcEEEEEEee--CCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            568999999999  889999999986 57889999998655444   468899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||.+........
T Consensus        78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999999987643 3478888999999999999999999999999999999999999999999998654432211


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                         .......||+.|||||++.+  ..|+.++|||||||++|||+| |.+||...+....+.....+..+..++ ++...
T Consensus       157 ---~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  231 (263)
T d1sm2a_         157 ---TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  231 (263)
T ss_dssp             -----------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             ---eeecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence               11233567889999999976  469999999999999999999 566676655544444444444444333 33334


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....|...++..+.+-.+
T Consensus       232 ~~li~~cl~~~p~~Rps~~~  251 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRPAFSR  251 (263)
T ss_dssp             HHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHccCCHhHCcCHHH
Confidence            44455555555555555444

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-46  Score=378.54  Aligned_cols=220  Identities=20%  Similarity=0.343  Sum_probs=182.7

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHh-hCCCCccceeEEEEEeCCcEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT-DEDLKSLHHEIVCMR-HLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++.++... +...+.+.+|+.++. .++|||||++++++.+.+.+|
T Consensus         2 ddy~i~~~iG~--G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGK--GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCeEEeeEEec--CCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence            57999999999  78999999999999999999999743211 122455677777765 689999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +|||||++|+|.+++....  .+++..+..++.||+.||+|||++|||||||||+|||++++|.+++.|||.+.......
T Consensus        80 ivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999999999998754  47899999999999999999999999999999999999999999999999875443222


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCCCCCCC
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGATPHLL  589 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~~p~~~  589 (622)
                      .    ......||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+.... ...+....|..+
T Consensus       158 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~p  223 (320)
T d1xjda_         158 A----KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNPFYP  223 (320)
T ss_dssp             C----CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCC
T ss_pred             c----cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCC
Confidence            1    1233568899999999976  4699999999999999999999999988765554 444444444443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=371.94  Aligned_cols=242  Identities=17%  Similarity=0.220  Sum_probs=187.5

Q ss_pred             eecccccCCeeEEEEEEEc--cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEeecc
Q psy15039        365 SILGQCFNNLSSVYLSKHK--VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVSPLM  442 (622)
Q Consensus       365 ~~lg~g~g~~~~V~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~e~~  442 (622)
                      +.||+  |+||.||+|..+  .+++.||||++.....+....+.+.+|+.+|++++|||||++++++.+ +..++|||||
T Consensus        13 k~iG~--G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGS--GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEE--CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCccc--CCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence            46999  889999999864  456889999997655444556789999999999999999999999865 5679999999


Q ss_pred             CCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCceecc
Q psy15039        443 GFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKVHLF  522 (622)
Q Consensus       443 ~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (622)
                      ++|+|.+++....  .+++..+..++.||+.||+|||+++||||||||+|||++.++.++++|||++..+...... ...
T Consensus        90 ~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKA  166 (277)
T ss_dssp             TTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-EEC
T ss_pred             CCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-ccc
Confidence            9999999987643  4789999999999999999999999999999999999999999999999987654433222 222


Q ss_pred             CCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCcccccCCC
Q psy15039        523 PPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYYVDTGQ  600 (622)
Q Consensus       523 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~  600 (622)
                      .....||+.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+..+.......+..|+.++ ++....+...
T Consensus       167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~  244 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  244 (277)
T ss_dssp             ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence            334567889999999976  468999999999999999998 899999887665444445555555544 3444444555


Q ss_pred             CcCcccccchhhhh
Q psy15039        601 DDGEENACSYISEQ  614 (622)
Q Consensus       601 ~~~~~~~~~~~~~~  614 (622)
                      .|...++.+++|-.
T Consensus       245 ~cl~~dp~~RPs~~  258 (277)
T d1xbba_         245 LCWTYDVENRPGFA  258 (277)
T ss_dssp             HHTCSSTTTSCCHH
T ss_pred             HHcCCCHhHCcCHH
Confidence            55555555555443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.7e-45  Score=380.13  Aligned_cols=219  Identities=22%  Similarity=0.372  Sum_probs=180.9

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC----HHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----DEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ++|++.+.||+  |+||.||+|+++.||+.||||++......    ........+|+.+++.++|||||+++++|.+.+.
T Consensus         4 ddy~i~~~lG~--G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           4 NDFSVHRIIGR--GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             TTEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             HhCeeeeEEec--CCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            57999999999  88999999999999999999998643221    1222233455778888899999999999999999


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+|||||++|+|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++.+|.++++|||.+..+..
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999999998754  468999999999999999999999999999999999999999999999998765543


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH--HHHHHHHcCCCCCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT--LMLIEKLAGATPHL  588 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~--~~~~~~~~~~~p~~  588 (622)
                      ..      ....+||+.|||||++..+ ..|+.++|||||||++|||+||++||...+..  ..+........+..
T Consensus       160 ~~------~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  228 (364)
T d1omwa3         160 KK------PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL  228 (364)
T ss_dssp             SC------CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCC
T ss_pred             Cc------ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence            22      2345789999999999643 46899999999999999999999999765432  23344444444333

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=366.64  Aligned_cols=246  Identities=16%  Similarity=0.281  Sum_probs=191.3

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++ +++.||||++.......   +.+.+|+.+|++++|||||++++++. .+.+++
T Consensus        12 ~~~~~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGA--GQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEE--ETTEEEEEEEET-TTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEeEEEec--CCCcEEEEEEEC-CCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEE
Confidence            357999999999  889999999986 67889999997655443   56899999999999999999999775 466899


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|+|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||.+........
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999999999987654434588999999999999999999999999999999999999999999999998765433221


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg-~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                         ....+..+|+.|||||++..  ..|+.++|||||||++|||+|| .+||...+....+.....+..|..++ ++...
T Consensus       165 ---~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (272)
T d1qpca_         165 ---TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL  239 (272)
T ss_dssp             ---ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ---ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHH
Confidence               12234567889999999975  4689999999999999999996 45555554444444444444454443 33344


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....|...++.++.+-++
T Consensus       240 ~~li~~cl~~~P~~Rpt~~e  259 (272)
T d1qpca_         240 YQLMRLCWKERPEDRPTFDY  259 (272)
T ss_dssp             HHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHH
Confidence            44555555556655555433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-45  Score=373.08  Aligned_cols=215  Identities=18%  Similarity=0.252  Sum_probs=183.3

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLH  436 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~  436 (622)
                      +.+.|++.+.||+  |+||.||+|+++.+|+.||||++....   .+...+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus         3 ~~~rY~i~~~lG~--G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           3 LYEKYMIAEDLGR--GEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             CccceEEEEEEec--CCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            4678999999999  889999999999999999999997643   23356889999999999999999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--ceEEcCcccccccCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG--KACLSGLRYMCPFSP  514 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~--~~~~~~~~~~~~~~~  514 (622)
                      +|||||++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++  +++++|||.+.....
T Consensus        78 lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999999987543 3589999999999999999999999999999999999998654  789999998765433


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHcCC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKLAGA  584 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~~~~  584 (622)
                      ....     ....+|+.|||||++.+  ..|+.++|||||||++|||++|++||...+....+..+..+.
T Consensus       157 ~~~~-----~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~  219 (321)
T d1tkia_         157 GDNF-----RLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE  219 (321)
T ss_dssp             TCEE-----EEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             CCcc-----cccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            2211     22456788999999976  468999999999999999999999998887666555555443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-45  Score=358.82  Aligned_cols=246  Identities=17%  Similarity=0.251  Sum_probs=198.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      +++|++.+.||+  |+||.||+|+++ +++.||||++.......   +.+.+|+.++++++|||||++++++.+.+.+++
T Consensus         3 ~~~~~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           3 PKDLTFLKELGT--GQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCE--ETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             hHHCEEeEEEec--CCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            578999999999  789999999985 78899999998766554   468899999999999999999999999999999


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      ||||+++|++.+++..... .+++..+..++.|+++||+|||++||+||||||+|||+++++.+|++|||.+........
T Consensus        77 v~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999999999998765433 478888999999999999999999999999999999999999999999998754433211


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                         .......+|+.|||||++..  ..|+.++|||||||++|||+| |+.||.+.+..+.......+..++.++ ++...
T Consensus       156 ---~~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  230 (258)
T d1k2pa_         156 ---TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV  230 (258)
T ss_dssp             ---CCCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ---eeecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHH
Confidence               12234567889999999976  468999999999999999998 899998887665444444443433333 23334


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+....|...++..+++-++
T Consensus       231 ~~li~~cl~~dP~~RPt~~e  250 (258)
T d1k2pa_         231 YTIMYSCWHEKADERPTFKI  250 (258)
T ss_dssp             HHHHHHTTCSSGGGSCCHHH
T ss_pred             HHHHHHHccCCHhHCcCHHH
Confidence            45555666666666665443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=376.47  Aligned_cols=202  Identities=21%  Similarity=0.308  Sum_probs=172.3

Q ss_pred             CCCCCceEee-ecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhh-CCCCccceeEEEEEe--
Q psy15039        356 NVPSNYKICS-ILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRH-LRHPNIICYISSFLD--  431 (622)
Q Consensus       356 ~~~~~y~~~~-~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~--  431 (622)
                      .+.++|++.+ .||+  |+||.||+|+++.+|+.||||++...       ..+.+|+.++.+ ++|||||+++++|.+  
T Consensus         8 ~i~~~y~i~~~~lG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGL--GINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             CGGGTEEEEEEEEEE--CSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccCEEEeeEEeee--ccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            3457899875 6999  88999999999999999999998642       356789998654 589999999999976  


Q ss_pred             --CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCceEEcCc
Q psy15039        432 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGL  506 (622)
Q Consensus       432 --~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~---~~~~~~~~~  506 (622)
                        ...+|+|||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.   ++.++++||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              356899999999999999998765556899999999999999999999999999999999999986   457999999


Q ss_pred             ccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        507 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      |++.......     ......||+.|||||++.+  ..|+.++|||||||++|||+||++||.+.+.
T Consensus       159 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~  218 (335)
T d2ozaa1         159 GFAKETTSHN-----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  218 (335)
T ss_dssp             TTCEECCCCC-----CCCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred             ceeeeccCCC-----ccccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence            9875443321     1234578999999999976  5699999999999999999999999976654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=374.62  Aligned_cols=250  Identities=17%  Similarity=0.220  Sum_probs=194.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCc-----EEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQ-----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~-----~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~  431 (622)
                      .++|++++.||+  |+||.||+|+++.+++     .||+|++.... .......+.+|+.+|+++ +|||||++++++.+
T Consensus        36 ~~~~~l~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          36 RENLEFGKVLGS--GAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEee--CCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            367999999999  8899999999877654     69999986543 233456789999999998 89999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHFN---------------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKA  490 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~~---------------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp  490 (622)
                      .+.+|+|||||++|+|.++++....                     ..+++..++.++.||+.||+|||+++||||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence            9999999999999999999975431                     2478889999999999999999999999999999


Q ss_pred             CcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCC
Q psy15039        491 SHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFA  569 (622)
Q Consensus       491 ~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~  569 (622)
                      +|||++.++.+||+|||.+.........  ....+..+|+.|||||++.+  ..|+.++|||||||++|||+| |++||.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hccccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999987543322211  11234567889999999976  469999999999999999998 899999


Q ss_pred             CCCcHHHHHHHHcCC-CCCCCC-CCcccccCCCCcCcccccchhhhh
Q psy15039        570 ETPTTLMLIEKLAGA-TPHLLD-CTTYYVDTGQDDGEENACSYISEQ  614 (622)
Q Consensus       570 ~~~~~~~~~~~~~~~-~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  614 (622)
                      +.+....+.+.+... .|+.++ ++....+....|...++.+++|-+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~  315 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP  315 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            887777666666553 233322 333334444455555555555433

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=364.83  Aligned_cols=214  Identities=24%  Similarity=0.372  Sum_probs=178.5

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++++.||+  |+||.||+|+++.+|+.||||++......+...+++.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus         2 d~Y~~~~~lG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGE--GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEec--CcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            58999999999  7899999999999999999999976554444457889999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      |||+.++ +.+++......++++..+..++.||+.||+|||++|||||||||+|||++.++.+++.|||.+.......  
T Consensus        80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            9999864 4455544445568999999999999999999999999999999999999999999999999875443221  


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                        .......+|+.|+|||++... ..++.++||||+||++|||++|++||.+.+....+...
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i  215 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI  215 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             --ccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH
Confidence              122345678899999998653 34578999999999999999999999988776665554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=373.79  Aligned_cols=269  Identities=22%  Similarity=0.284  Sum_probs=191.6

Q ss_pred             CCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcceeEEEEEEeCC----
Q psy15039          8 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----   83 (622)
Q Consensus         8 ~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----   83 (622)
                      -.+|.+.+.||+  |+||.||+|+.  +|+.||||+++.+.   .......+|+..+++++|||||++++++.+.+    
T Consensus         2 ~~~~~l~~~iG~--G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGK--GRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEC--CSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEee--CCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            457899999999  77899999986  68999999986532   22222346777778899999999999998754    


Q ss_pred             cEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCCEEEcCCCceEEcC
Q psy15039         84 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG--------KGFIHRAVKASHILISHNGKACLSG  155 (622)
Q Consensus        84 ~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~--------~~IvHrDiKp~NiLl~~~~~~~i~~  155 (622)
                      .+|+|||||++|+|.++++..   ++++.....++.|++.||+|+|+        +||+||||||+||||+.+|.+|++|
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            589999999999999999763   47889999999999999999996        6999999999999999999999999


Q ss_pred             CccccccCCCCccccccCCCCCCCccccChhhhccccC----CCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHHHH
Q psy15039        156 LRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL  231 (622)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~----~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~~~  231 (622)
                      ||....................+|+.|+|||++.+...    .|+.++|||||||++|||++|..||.............
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            99765443332222222334578899999999865321    24668999999999999999988875322110000000


Q ss_pred             hCCCCCCCccccccccCCCCcCcccccccchhhh-----hccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhcC
Q psy15039        232 AGATPHLLDCTTYYVDTGQDDGEENACSYISEQQ-----TQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQH  302 (622)
Q Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~h  302 (622)
                      .                ............+....     ...+........+.+|+.+||+.||.+|||+.|++++
T Consensus       232 ~----------------~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         232 V----------------PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             S----------------CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             c----------------cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0                00000000000000000     0011112234568899999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=366.95  Aligned_cols=209  Identities=24%  Similarity=0.327  Sum_probs=172.6

Q ss_pred             EeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEEe
Q psy15039        363 ICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD---EDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLVS  439 (622)
Q Consensus       363 ~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  439 (622)
                      .+++||+  |+||+||+|+++.+|+.||||++.......   ...+.+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus         2 ~l~~lG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm   79 (299)
T d1ua2a_           2 KLDFLGE--GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   79 (299)
T ss_dssp             EEEEEEE--ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             cceEecc--CcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence            4678999  789999999999999999999997654322   12357889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCce
Q psy15039        440 PLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKKV  519 (622)
Q Consensus       440 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~  519 (622)
                      ||++++++..+...  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.+........  
T Consensus        80 E~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          80 DFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             ECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            99998877665443  33578888999999999999999999999999999999999999999999998765433221  


Q ss_pred             eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        520 HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       520 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                        ...+.++|+.|||||++... ..|+.++|||||||++|||+||++||.+.+..+++..+
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i  213 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI  213 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH
Confidence              12345688999999998653 45899999999999999999999999988776665443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=360.30  Aligned_cols=248  Identities=16%  Similarity=0.226  Sum_probs=187.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCC----cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTN----QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~----~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ++.|++.++||+  |+||.||+|+.+.++    ..||||++... .++.....+.+|+.+|++++|||||++++++.+.+
T Consensus         6 ~~~~~~~~~iG~--G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           6 PSCVTRQKVIGA--GEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTTEEEEEEEEE--CSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEeeeEEee--CCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            567999999999  889999999987665    47999999654 34555667999999999999999999999999999


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      .+++|||||.+|++.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||++....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999999877643 357899999999999999999999999999999999999999999999999865433


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHH-cCCCCCCCC-C
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEKL-AGATPHLLD-C  591 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~~-~~~~p~~~~-~  591 (622)
                      ..... .....+..||+.|||||++.+  ..|+.++|||||||++|||++|..||....+...+...+ .+..|+.++ +
T Consensus       162 ~~~~~-~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  238 (283)
T d1mqba_         162 DDPEA-TYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  238 (283)
T ss_dssp             -------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CCCcc-ceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhh
Confidence            22211 112234567889999999976  469999999999999999999655544444444455544 444444433 4


Q ss_pred             CcccccCCCCcCcccccchhh
Q psy15039        592 TTYYVDTGQDDGEENACSYIS  612 (622)
Q Consensus       592 ~~~~~~~~~~~~~~~~~~~~~  612 (622)
                      +....+...+|...++.++.+
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt  259 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPK  259 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHHHHHCcCCHhHCcC
Confidence            444445555555555555544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-44  Score=360.47  Aligned_cols=264  Identities=17%  Similarity=0.245  Sum_probs=196.8

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcce-eEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII-CYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~~~~~~~~~~~~   85 (622)
                      +.++|++++.||+  |+||+||+|+++.+|+.||||++..+...    +.+.+|+++|++++|+|+| .+.+++.+.+..
T Consensus         5 vg~rY~l~~~iG~--G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           5 VGNRYRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             ETTTEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             ECCEEEEeEEEee--CCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            4468999999999  77899999999999999999998765432    2366899999999887655 555666778889


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCceEEcCCcccccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCPF  162 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~---~~~~~i~~~~~~~~~  162 (622)
                      ++|||||+ +++.+.+... ...+++..+..++.|++.||+|||++||+||||||+|||++.   +..++++|||.+..+
T Consensus        79 ~ivme~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEcC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999986 5565555443 345899999999999999999999999999999999999864   446999999987654


Q ss_pred             CCCCccc---cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCchHHHHHH--HHhCCCCC
Q psy15039        163 SPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE--KLAGATPH  237 (622)
Q Consensus       163 ~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~p~  237 (622)
                      .......   .....+..+|+.|||||++.+  ..|+.++|||||||++|||++|+.||...........  .....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~---  231 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---  231 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc---
Confidence            3322111   112234567899999999975  3589999999999999999999999976433221111  10000   


Q ss_pred             CCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHh---hhcCccccc
Q psy15039        238 LLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACN---LLQHAFFKQ  307 (622)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~---~l~h~~~~~  307 (622)
                                            ..  ..........+++++.+++..||+.||++||++.+   +|+|+|.+.
T Consensus       232 ----------------------~~--~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         232 ----------------------KM--STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----------------------HH--HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------cC--CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                                  00  00000112457899999999999999999999874   567776543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=361.98  Aligned_cols=246  Identities=17%  Similarity=0.290  Sum_probs=187.5

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCc----EEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQ----LIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~----~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      .+|++++.||+  |+||.||+|++..+|+    .||+|++.... +....+.+.+|+.+|+.++|||||++++++.+ +.
T Consensus         9 ~dy~~~~~lG~--G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~   84 (317)
T d1xkka_           9 TEFKKIKVLGS--GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-ST   84 (317)
T ss_dssp             TTEEEEEEEEE--CSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             HHCEEeeEEec--CCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            46999999999  8899999999988887    57888876432 23335689999999999999999999999986 46


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      .++++|++.+|+|.+.+.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+|++|||++.....
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            788899999999999887653 3588999999999999999999999999999999999999999999999998765443


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~  592 (622)
                      ....  .......||+.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+..+.......+..|+.++ ++
T Consensus       164 ~~~~--~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~  239 (317)
T d1xkka_         164 EEKE--YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  239 (317)
T ss_dssp             TCC----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBC
T ss_pred             cccc--ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence            2221  12233457889999999976  469999999999999999999 899998876665444444555454443 34


Q ss_pred             cccccCCCCcCcccccchhhh
Q psy15039        593 TYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      ....+....|...++.++++-
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~  260 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKF  260 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHhCCCChhhCcCH
Confidence            444444555555555555443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-44  Score=355.11  Aligned_cols=248  Identities=15%  Similarity=0.252  Sum_probs=188.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      .++|++.+.||+  |+||.||+|++..++   ..||||++... ..+...+.+.+|+.+|+.++|||||++++++. .+.
T Consensus         6 ~~~~~l~~~iG~--G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGE--GQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEE--CSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEee--CCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            357999999999  889999999987654   46899988543 34555678999999999999999999999985 567


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSP  514 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~  514 (622)
                      +|+||||+++|++.+++.... .++++..++.++.||+.||+|||+++||||||||+|||++.++.+|++|||.+..+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            899999999999999876543 3588999999999999999999999999999999999999999999999998754432


Q ss_pred             CCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CC
Q psy15039        515 TKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CT  592 (622)
Q Consensus       515 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~  592 (622)
                      ....   ......+|+.|||||++..  ..|+.++|||||||++|||+| |.+||...+..+.+.....+..+++++ ++
T Consensus       161 ~~~~---~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  235 (273)
T d1mp8a_         161 STYY---KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP  235 (273)
T ss_dssp             -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             Ccce---eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            2211   1223456788999999976  468999999999999999998 899999887776666666665555444 33


Q ss_pred             cccccCCCCcCcccccchhhhhh
Q psy15039        593 TYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      ....+....|...++.+++|-.+
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~e  258 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTE  258 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHH
Confidence            44444445555555555555443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=353.89  Aligned_cols=246  Identities=17%  Similarity=0.246  Sum_probs=186.7

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHL  437 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l  437 (622)
                      .++|++.+.||+  |+||.||+|+++.+ +.||||++.......   +.+.+|+.+|++++|||||++++++. .+..++
T Consensus        16 ~~~~~i~~~iG~--G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQ--GCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEeeEEee--CCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEE
Confidence            457999999999  88999999999765 569999997665443   56899999999999999999999985 466899


Q ss_pred             EeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCC
Q psy15039        438 VSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKK  517 (622)
Q Consensus       438 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~  517 (622)
                      |||||++|++..++.......+++..++.++.||+.||+|||++||+||||||+|||+++++.++|+|||.+........
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999999999988755444589999999999999999999999999999999999999999999999998754432221


Q ss_pred             ceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCC-CCCCCcHHHHHHHHcCCCCCCCC-CCccc
Q psy15039        518 KVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVP-FAETPTTLMLIEKLAGATPHLLD-CTTYY  595 (622)
Q Consensus       518 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~P-f~~~~~~~~~~~~~~~~~p~~~~-~~~~~  595 (622)
                         .......+|+.|||||++..  ..++.++|||||||++|||+||..| |......+.+.....+..++..+ ++...
T Consensus       169 ---~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  243 (285)
T d1fmka3         169 ---TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  243 (285)
T ss_dssp             ----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             ---eeeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHH
Confidence               11233567889999999976  4689999999999999999996555 55544444443344444444333 34444


Q ss_pred             ccCCCCcCcccccchhhhhh
Q psy15039        596 VDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+...+|...++.++++-++
T Consensus       244 ~~li~~cl~~dP~~Rps~~~  263 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEY  263 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHcccCHhHCcCHHH
Confidence            45555555555555555444

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-43  Score=357.38  Aligned_cols=254  Identities=15%  Similarity=0.212  Sum_probs=202.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD  431 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~  431 (622)
                      ..++|++.+.||+  |+||.||+|+.+     .+++.||||++... ..+...+++.+|+.+|+.++|||||++++++..
T Consensus        11 p~~~~~~~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          11 PRNNIEYVRDIGE--GAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             CGGGCEEEEEEEE--CSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CHHHcEEeEEEee--CCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3567999999999  889999999975     35689999998754 345556789999999999999999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHF----------------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVK  489 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~----------------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlK  489 (622)
                      .+..+++|||+++|+|.+++....                      ...+++..+..++.|++.||+|||+++|||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            999999999999999999986432                      1236788899999999999999999999999999


Q ss_pred             CCcEEEcCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCC-CCC
Q psy15039        490 ASHILISHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT-VPF  568 (622)
Q Consensus       490 p~NILl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~-~Pf  568 (622)
                      |+|||++.++.+||+|||++........  .....+..+|+.|||||++.+  ..|+.++|||||||++|||++|. +||
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ccceEECCCCcEEEccchhheeccCCcc--ccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999998653322111  112234567889999999976  46999999999999999999985 788


Q ss_pred             CCCCcHHHHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhhhhh
Q psy15039        569 AETPTTLMLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQTQ  617 (622)
Q Consensus       569 ~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  617 (622)
                      ...+..+.+.....+..|..++ ++..+.+....|...++.++++-++..
T Consensus       244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~  293 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH  293 (301)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            8877666666666666665553 455555566666666666666554443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-44  Score=353.04  Aligned_cols=241  Identities=23%  Similarity=0.352  Sum_probs=187.2

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC-CcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-TDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|+.+  |+.||||++..+.    ..+.+.+|+.+|++++|||||++++++.+. +.++
T Consensus         6 ~~~~~~~~~lG~--G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGK--GEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             HHHeEEeEEEec--CCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            356899999999  889999999984  7899999997543    235788999999999999999999998654 5689


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCC
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTK  516 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~  516 (622)
                      +||||+++|+|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||++.+|.+++.|||.+...... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999999997654335789999999999999999999999999999999999999999999999976433221 


Q ss_pred             CceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCCCCCCCC-CCcc
Q psy15039        517 KKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGATPHLLD-CTTY  594 (622)
Q Consensus       517 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~~p~~~~-~~~~  594 (622)
                            .....+|+.|||||++.+  ..|+.++|||||||++|||+| |++||...+..+.......+..|+.++ +++.
T Consensus       157 ------~~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (262)
T d1byga_         157 ------QDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA  228 (262)
T ss_dssp             -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred             ------CccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence                  123356778999999976  468999999999999999998 799998876666555555556665554 3444


Q ss_pred             cccCCCCcCcccccchhhhhh
Q psy15039        595 YVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      +.+....|...++.++++-.+
T Consensus       229 ~~~li~~cl~~dP~~Rps~~~  249 (262)
T d1byga_         229 VYEVMKNCWHLDAAMRPSFLQ  249 (262)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHcccCHhHCcCHHH
Confidence            444455555555555554433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.2e-42  Score=346.35  Aligned_cols=258  Identities=15%  Similarity=0.144  Sum_probs=200.2

Q ss_pred             CCCCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CcceeEEEEEEeCCcE
Q psy15039          7 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH-PNIICYISSFLDATDL   85 (622)
Q Consensus         7 ~~~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~   85 (622)
                      +..+|++++.||+  |+||+||+|+++.+|+.||||+++.....    ..+.+|+++++.|+| +||+.+++++......
T Consensus         3 ig~~Y~i~~~iG~--G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           3 VGVHYKVGRRIGE--GSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             ETTTEEEEEEEEE--CSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCCceEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            4578999999999  77999999999999999999998765332    235678999999976 8999999999999999


Q ss_pred             EEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-----CCceEEcCCcccc
Q psy15039         86 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-----NGKACLSGLRYMC  160 (622)
Q Consensus        86 ~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~-----~~~~~i~~~~~~~  160 (622)
                      ++||||| +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.     ++.++++|||.+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9999998 589998886643 35889999999999999999999999999999999999974     5689999999876


Q ss_pred             ccCCCCccc---cccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch--HHHHHHHHhCCC
Q psy15039        161 PFSPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT--TLMLIEKLAGAT  235 (622)
Q Consensus       161 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~--~~~~~~~~~~~~  235 (622)
                      .+.......   .....+..||+.|||||++.+  ..|+.++|||||||++|||++|..||.+...  .......+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            543222111   112234578999999999975  4589999999999999999999999975432  221222111000


Q ss_pred             CCCCccccccccCCCCcCcccccccchhhhhccccCCCCcHHHHHHHHHhhhcCCCCCcCHHhhhc
Q psy15039        236 PHLLDCTTYYVDTGQDDGEENACSYISEQQTQVLTSRKFSDSFHSIVELCLSRDVDKRPLACNLLQ  301 (622)
Q Consensus       236 p~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  301 (622)
                                                 ......-....+++++.+++..|+..+|++||+.+.+.+
T Consensus       233 ---------------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 ---------------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             ---------------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ---------------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                       000000012346889999999999999999998776543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=354.11  Aligned_cols=203  Identities=22%  Similarity=0.313  Sum_probs=170.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHhhCC--CCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTD----EDLKSLHHEIVCMRHLR--HPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~----~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~  431 (622)
                      .+.|++.+.||+  |+||.||+|+++.+|+.||||++......+    ....++.+|+.+|+.++  |||||+++++|.+
T Consensus         3 ~~~Y~i~~~lG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~   80 (273)
T d1xwsa_           3 ESQYQVGPLLGS--GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER   80 (273)
T ss_dssp             TTTEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CCeEEEeEEEee--CCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence            467999999999  789999999999999999999997543321    11234678999999986  9999999999999


Q ss_pred             CCcEEEEeeccCC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CceEEcCcccc
Q psy15039        432 ATDLHLVSPLMGF-GSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHN-GKACLSGLRYM  509 (622)
Q Consensus       432 ~~~~~lv~e~~~~-g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~-~~~~~~~~~~~  509 (622)
                      .+..++||||+.+ +++.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+++.|||.+
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999999975 68888887643  47899999999999999999999999999999999999854 79999999986


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                      ......      ...+..||+.|||||++.+. ..++.++|||||||++|||+||++||...
T Consensus       159 ~~~~~~------~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         159 ALLKDT------VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             EECCSS------CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             eecccc------cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCc
Confidence            543221      12345789999999999753 23467899999999999999999999753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-43  Score=354.11  Aligned_cols=213  Identities=23%  Similarity=0.341  Sum_probs=173.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccC-CcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC---CCCccceeEEEEEeC-
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVT-NQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL---RHPNIICYISSFLDA-  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~-  432 (622)
                      .++|++++.||+  |+||.||+|++..+ ++.||||++......+.....+.+|+.+|+.|   +|||||+++++|... 
T Consensus         6 ~~~Y~i~~~LG~--G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGE--GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEE--ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEec--ccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            367999999999  78999999999766 67799999875443333334566788877766   899999999998642 


Q ss_pred             ----CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        433 ----TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       433 ----~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                          ..++++||+++++.+..... .....+++..++.++.|++.||+|||+++||||||||+|||+++++.+++.|||.
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence                46899999999877654433 3344689999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      +......     .......||+.|||||++.+  ..|+.++||||+||++|||+||++||.+.+....+...
T Consensus       163 ~~~~~~~-----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  227 (305)
T d1blxa_         163 ARIYSFQ-----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI  227 (305)
T ss_dssp             CCCCCGG-----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             hhhhccc-----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            5432211     12245678999999999976  46999999999999999999999999988776665443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.1e-43  Score=350.86  Aligned_cols=212  Identities=24%  Similarity=0.340  Sum_probs=177.3

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      ++|++++.||+  |+||.||+|+++ +|+.||||++.....++...+++.+|+.+|+.++|||||+++++|...+..+++
T Consensus         2 ~~Y~~~~~iG~--G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGE--GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEE--ETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEec--CCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            47999999999  779999999996 789999999976654444457899999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      +|++.++.+..+....  ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+++.|||.+........ 
T Consensus        79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            9999987776665433  4589999999999999999999999999999999999999999999999998765433221 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                         ......+++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++.+.
T Consensus       156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i  213 (286)
T d1ob3a_         156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI  213 (286)
T ss_dssp             ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH
Confidence               12234567889999999753 45789999999999999999999999888766665543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=357.17  Aligned_cols=210  Identities=23%  Similarity=0.305  Sum_probs=176.3

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-  433 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-  433 (622)
                      ..+.+.|++++.||+  |+||+||+|+++.+|+.||||++.....++...+.+.+|+.+|+.++|||||+++++|...+ 
T Consensus        14 ~~~~~~Y~~i~~lG~--G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~   91 (346)
T d1cm8a_          14 WEVRAVYRDLQPVGS--GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   91 (346)
T ss_dssp             ECCBSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eecCCcEEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence            346788999999999  88999999999999999999999877777777888999999999999999999999998765 


Q ss_pred             -----cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccc
Q psy15039        434 -----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRY  508 (622)
Q Consensus       434 -----~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~  508 (622)
                           .+|+||||+ +.+|..+.+..   .+++..++.++.||+.||+|||++|||||||||+|||++.++.+++.|||.
T Consensus        92 ~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          92 LDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence                 479999999 46777776542   489999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        509 MCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                      +......       ..+..+|+.|||||++.+. ..++.++||||+||++|||++|++||.+.+....+.
T Consensus       168 a~~~~~~-------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~  229 (346)
T d1cm8a_         168 ARQADSE-------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK  229 (346)
T ss_dssp             CEECCSS-------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eeccCCc-------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence            6543321       2345678899999998653 357889999999999999999999998876655543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=351.34  Aligned_cols=252  Identities=20%  Similarity=0.279  Sum_probs=193.1

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCC-------cEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTN-------QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSF  429 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~-------~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~  429 (622)
                      .++|++++.||+  |+||.||+|++..++       ..||||++..+. .......+.+|...+.++ +|||||+++++|
T Consensus        12 ~~~~~l~~~iG~--G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGE--GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-------CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEee--cCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            467999999999  889999999987665       379999987544 455567888999999888 899999999999


Q ss_pred             EeCCcEEEEeeccCCCCHHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy15039        430 LDATDLHLVSPLMGFGSCKDLINAHFN--------------FGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  495 (622)
Q Consensus       430 ~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl  495 (622)
                      .+.+.+++|||||++|+|.+++.....              ..+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            999999999999999999999975432              247899999999999999999999999999999999999


Q ss_pred             cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcH
Q psy15039        496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  574 (622)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~  574 (622)
                      +.++.+++.|||.+.........  .......+|+.|||||++.+  ..|+.++|||||||++|||++ |.+||.+.+..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             cCCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999986654332211  12334567889999999976  469999999999999999998 78999877665


Q ss_pred             HHHHHHHcCCCCCCCC-CCcccccCCCCcCcccccchhhhhhh
Q psy15039        575 LMLIEKLAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQT  616 (622)
Q Consensus       575 ~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  616 (622)
                      ........+..|..+. ++....+...+|...++..++|-.+.
T Consensus       245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei  287 (299)
T d1fgka_         245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  287 (299)
T ss_dssp             HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence            4433334444444433 23334445555555555555554443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-42  Score=360.06  Aligned_cols=286  Identities=22%  Similarity=0.314  Sum_probs=197.6

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-----------CCcceeEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-----------HPNIICYIS   77 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~~~~   77 (622)
                      .+|+++++||+  |+||+||+|+++.+|+.||||+++.+   ....+.+.+|+++|+.++           |||||++++
T Consensus        13 ~rY~i~~~LG~--G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          13 ARYILVRKLGW--GHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CcEEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            46999999999  77999999999999999999999754   333456778999998886           578999998


Q ss_pred             EEEeC--CcEEEEeecCCCCCH-HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCC----
Q psy15039         78 SFLDA--TDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNG----  149 (622)
Q Consensus        78 ~~~~~--~~~~lv~e~~~~g~l-~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~IvHrDiKp~NiLl~~~~----  149 (622)
                      ++...  ...+++++++..+.. ...........+++..++.++.||+.||+|||+ .||+||||||+|||++.++    
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            88653  556777777655443 333334344568899999999999999999998 8999999999999998665    


Q ss_pred             --ceEEcCCccccccCCCCccccccCCCCCCCccccChhhhccccCCCCCcchHHHHHHHHHHHhcCCCCCCCCch----
Q psy15039        150 --KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT----  223 (622)
Q Consensus       150 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~DiWSlG~il~el~~g~~Pf~~~~~----  223 (622)
                        .+++.|||.+.....       ......+|+.|+|||++..  ..|+.++||||+||++++|++|+.||.....    
T Consensus       168 ~~~~kl~dfg~s~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             EEEEEECCCTTCEETTB-------CCCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cceeeEeeccccccccc-------ccccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence              488889987654321       1234467889999999875  4689999999999999999999999974321    


Q ss_pred             ----HHHHHHHHhCCCCCCCccccc----ccc-CCCCcCcccccc-cchhh-hhccccCCCCcHHHHHHHHHhhhcCCCC
Q psy15039        224 ----TLMLIEKLAGATPHLLDCTTY----YVD-TGQDDGEENACS-YISEQ-QTQVLTSRKFSDSFHSIVELCLSRDVDK  292 (622)
Q Consensus       224 ----~~~~~~~~~~~~p~~~~~~~~----~~~-~~~~~~~~~~~~-~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~  292 (622)
                          .......+.+..|.-......    +.. ............ ..... ..........++++.+|+.+||+.||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence                111112233332211000000    000 000000000000 00000 0011122346789999999999999999


Q ss_pred             CcCHHhhhcCcccccc
Q psy15039        293 RPLACNLLQHAFFKQT  308 (622)
Q Consensus       293 Rps~~~~l~h~~~~~~  308 (622)
                      ||||.|+|+||||++.
T Consensus       319 Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         319 RADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CBCHHHHHTCGGGTTC
T ss_pred             CcCHHHHhcCcccCCC
Confidence            9999999999999854

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=346.72  Aligned_cols=249  Identities=18%  Similarity=0.284  Sum_probs=183.0

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEcc-CC--cEEEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCccceeEEEEEeCC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKV-TN--QLIAVKKFNLDRMTD-EDLKSLHHEIVCMRHLRHPNIICYISSFLDAT  433 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~-~~--~~vavK~i~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~  433 (622)
                      ..+|++.+.||+  |+||.||+|+... ++  ..||||++....... ...+.+.+|+.+|+.++|||||++++++.+ +
T Consensus         7 ~~d~~~~~~iG~--G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           7 EKDLRLLEKLGD--GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hHHeEEEEEEec--CCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            467999999999  8899999998643 33  368999987654433 345789999999999999999999999976 5


Q ss_pred             cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccC
Q psy15039        434 DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFS  513 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~  513 (622)
                      .+++|||||++|++.+.+..... .+++..++.++.||+.||+|||+++|+||||||+|||++.++.++++|||.+..+.
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             chheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            67999999999999998765432 48899999999999999999999999999999999999999999999999876554


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHcCC-CCCCCC-
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTTLMLIEKLAGA-TPHLLD-  590 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~~~~~~~~~~~-~p~~~~-  590 (622)
                      ...... .......+++.|||||++.+  ..|+.++|||||||++|||+| |++||.+.+..+.+....... .|+.++ 
T Consensus       163 ~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         163 QNDDHY-VMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED  239 (273)
T ss_dssp             C-CCEE-EC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             cCCCcc-eecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence            433221 22223456778999999976  468999999999999999998 899999887766655444332 333322 


Q ss_pred             CCcccccCCCCcCcccccchhhh
Q psy15039        591 CTTYYVDTGQDDGEENACSYISE  613 (622)
Q Consensus       591 ~~~~~~~~~~~~~~~~~~~~~~~  613 (622)
                      .+....+....|...++.+++|-
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~  262 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTF  262 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCH
Confidence            33334444555555555555543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=353.76  Aligned_cols=215  Identities=23%  Similarity=0.301  Sum_probs=175.6

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEe------
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLD------  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------  431 (622)
                      .++|++.+.||+  |+||+||+|+++.+|+.||||++......+...+++.+|+.+|+.++||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~--G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQ--GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEec--CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            467999999999  789999999999999999999997765555555778999999999999999999999865      


Q ss_pred             --CCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        432 --ATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       432 --~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                        .+.+|++|||++++.+......  ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+++.|||.+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence              3468999999998766544332  335788889999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ..++...........+.++|+.|+|||++... ..|+.++||||+||++|||++|++||.+.+....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~  231 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL  231 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH
Confidence            65554333333334456789999999998653 36899999999999999999999999887665543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=349.95  Aligned_cols=248  Identities=21%  Similarity=0.263  Sum_probs=190.8

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcE--EEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEeCCcE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQL--IAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLDATDL  435 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~--vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~  435 (622)
                      ++|++.+.||+  |+||.||+|+++.+|..  ||||++.... +....+.+.+|+++|+++ +|||||++++++.+.+.+
T Consensus        10 ~~~~~~~~iG~--G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          10 NDIKFQDVIGE--GNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGCEEEEEEEC--GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHcEEEEEEee--CCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            57999999999  78999999999999875  6777775432 333456799999999998 799999999999999999


Q ss_pred             EEEeeccCCCCHHHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCce
Q psy15039        436 HLVSPLMGFGSCKDLINAH--------------FNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKA  501 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~--------------~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~  501 (622)
                      ++||||+++|+|.+++...              ....+++..+..++.||+.||.|||+++||||||||+|||++.++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence            9999999999999998643              12458899999999999999999999999999999999999999999


Q ss_pred             EEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHH
Q psy15039        502 CLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGT-VPFAETPTTLMLIEK  580 (622)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~-~Pf~~~~~~~~~~~~  580 (622)
                      ||+|||.+.......     ......+|+.|+|||.+.+  ..|+.++|||||||++|||++|. +||.+.+..+.....
T Consensus       167 kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         167 KIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             EECCTTCEESSCEEC-----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             EEccccccccccccc-----cccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999865432211     1223457888999999976  46899999999999999999965 677766555544333


Q ss_pred             HcCCCCCCCC-CCcccccCCCCcCcccccchhhhhhh
Q psy15039        581 LAGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQT  616 (622)
Q Consensus       581 ~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  616 (622)
                      ..+..|..+. ++....+....|...++.+++|-.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei  276 (309)
T d1fvra_         240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  276 (309)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            4454554433 34444555555655566555554443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-42  Score=347.18  Aligned_cols=251  Identities=18%  Similarity=0.238  Sum_probs=184.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~  431 (622)
                      .++|++.+.||+  |+||.||+|++..     +++.||||++.... .....+.+.+|+.++.++ +|||||.+++++..
T Consensus        12 ~~~y~~~~~iG~--G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          12 RDRLKLGKPLGR--GAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGGEEEEEEEEE--CSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHEEEeeEEee--cCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            357999999999  8899999999754     45789999986543 344556788888877776 78999999998876


Q ss_pred             CC-cEEEEeeccCCCCHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q psy15039        432 AT-DLHLVSPLMGFGSCKDLINAHF--------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILIS  496 (622)
Q Consensus       432 ~~-~~~lv~e~~~~g~l~~~l~~~~--------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~  496 (622)
                      .+ .+++|||||++|+|.+++....              ...+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence            54 6899999999999999997532              12478889999999999999999999999999999999999


Q ss_pred             CCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcHH
Q psy15039        497 HNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPTTL  575 (622)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg-~~Pf~~~~~~~  575 (622)
                      +++.+||+|||.+.........  ....+..||+.|||||++.+  ..|+.++|||||||++|||+|| .+||...+...
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             GGGCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             CCCcEEEccCcchhhccccccc--cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999987543322211  12234568899999999976  4689999999999999999996 67888776665


Q ss_pred             HHHHHH-cCCCCCCCC-CCcccccCCCCcCcccccchhhhhh
Q psy15039        576 MLIEKL-AGATPHLLD-CTTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       576 ~~~~~~-~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      .+...+ .+..|..++ ++....+....|...++.++++-.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e  286 (299)
T d1ywna1         245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  286 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            555543 344454444 3333444444455555555554433

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-42  Score=348.72  Aligned_cols=253  Identities=16%  Similarity=0.217  Sum_probs=200.3

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEc-----cCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCccceeEEEEEe
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHK-----VTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHL-RHPNIICYISSFLD  431 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~  431 (622)
                      .++|++.+.||+  |+||.||+|+.+     .+++.||||++.... .......+.+|+.+++.+ +|||||++++++.+
T Consensus        22 ~~~~~l~~~iG~--G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          22 RNRLSFGKTLGA--GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEee--cCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            468999999999  889999999863     567899999997654 345567899999999999 79999999999999


Q ss_pred             CCcEEEEeeccCCCCHHHHHHhcc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy15039        432 ATDLHLVSPLMGFGSCKDLINAHF----------------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILI  495 (622)
Q Consensus       432 ~~~~~lv~e~~~~g~l~~~l~~~~----------------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl  495 (622)
                      .+..++|||||++|+|.+++....                ...+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence            999999999999999999987542                1247889999999999999999999999999999999999


Q ss_pred             cCCCceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcH
Q psy15039        496 SHNGKACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELAN-GTVPFAETPTT  574 (622)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~lt-g~~Pf~~~~~~  574 (622)
                      +.++.+++.|||.+.........  .......+|+.|||||++..  ..++.++|||||||++|||+| |.+||...+..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999987654432221  22334677899999999976  468999999999999999998 67777777666


Q ss_pred             HHHHHHHcC-CCCCCCC-CCcccccCCCCcCcccccchhhhhhhh
Q psy15039        575 LMLIEKLAG-ATPHLLD-CTTYYVDTGQDDGEENACSYISEQQTQ  617 (622)
Q Consensus       575 ~~~~~~~~~-~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  617 (622)
                      ..+.+.+.. ..|..++ .+....+...+|...++..+++-.+..
T Consensus       255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il  299 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV  299 (311)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            655555443 3333332 334444555666666666666655443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=348.88  Aligned_cols=215  Identities=22%  Similarity=0.266  Sum_probs=176.6

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCc
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATD  434 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~  434 (622)
                      ..+.+.|++++.||+  |+||+||+|+++.+|+.||||++.... .....+++.+|+.+|+.|+|||||++++++.....
T Consensus         4 ~~i~~rY~~~~~LG~--G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           4 FDVGPRYTNLSYIGE--GAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCTTEEEEEECC-----CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cCcCCCeEEEEEEee--ccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            456678999999999  789999999999999999999997544 35556789999999999999999999999976532


Q ss_pred             ----EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        435 ----LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       435 ----~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                          .+++++++.+|+|.+++...   ++++..++.++.||+.||+|||++|||||||||+|||++.++.+++.|||.+.
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence                24445567789999998753   48899999999999999999999999999999999999999999999999865


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      ....... ........++|+.|+|||++... ..|+.++||||+||++|||++|++||...+.....
T Consensus       158 ~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~  222 (345)
T d1pmea_         158 VADPDHD-HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL  222 (345)
T ss_dssp             ECCGGGC-BCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eccCCCc-cceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH
Confidence            4433221 11223446788999999998643 46789999999999999999999999887665444

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=341.71  Aligned_cols=246  Identities=17%  Similarity=0.230  Sum_probs=185.5

Q ss_pred             EeeecccccCCeeEEEEEEEccCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC-CcEEEE
Q psy15039        363 ICSILGQCFNNLSSVYLSKHKVTN---QLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA-TDLHLV  438 (622)
Q Consensus       363 ~~~~lg~g~g~~~~V~~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-~~~~lv  438 (622)
                      +.++||+  |+||+||+|+...++   ..||||++... .+....+++.+|+.+|++++|||||++++++... +..++|
T Consensus        31 ~~~~iG~--G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGR--GHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEE--ETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEee--cCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            3578999  889999999986654   36899998643 3556678899999999999999999999998764 579999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      ||||++|+|.+++.... ...++..+..++.|++.||.|||+++|+||||||+|||+++++.++++|||.+.........
T Consensus       108 ~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999887543 34678888899999999999999999999999999999999999999999987654433222


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH-HHcCCCCCCCC-CCcccc
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE-KLAGATPHLLD-CTTYYV  596 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~-~~~~~~p~~~~-~~~~~~  596 (622)
                      ......+..+|+.|+|||++..  ..|+.++|||||||++|||+||..||....+...+.. ...+..|..++ ++..+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence            2222334567889999999976  4689999999999999999998777765544444333 45555555444 333444


Q ss_pred             cCCCCcCcccccchhhhh
Q psy15039        597 DTGQDDGEENACSYISEQ  614 (622)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~  614 (622)
                      +...+|...++.++++-+
T Consensus       265 ~li~~cl~~dP~~RPs~~  282 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFS  282 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCCHhHCcCHH
Confidence            444555555555544443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=348.69  Aligned_cols=207  Identities=22%  Similarity=0.283  Sum_probs=171.2

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC------C
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA------T  433 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~  433 (622)
                      .|+.+++||+  |+||+||+|+++.+|+.||||++..+..      ...+|+.+|+.++|||||+++++|...      .
T Consensus        21 ~Y~~~k~LG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGN--GSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEE--ETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEee--CcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            5999999999  7899999999999999999999976432      234799999999999999999998653      2


Q ss_pred             cEEEEeeccCCCCHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-ceEEcCcccccc
Q psy15039        434 DLHLVSPLMGFGSCKDLINA-HFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCP  511 (622)
Q Consensus       434 ~~~lv~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~-~~~~~~~~~~~~  511 (622)
                      .+|+|||||+++.+..+... .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.+..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            47999999997755554432 2334689999999999999999999999999999999999999876 889999998654


Q ss_pred             cCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q psy15039        512 FSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIEK  580 (622)
Q Consensus       512 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~~  580 (622)
                      +....     ...+..+|+.|+|||++.+. ..|+.++||||+||++|||++|++||...+...++...
T Consensus       173 ~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i  235 (350)
T d1q5ka_         173 LVRGE-----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI  235 (350)
T ss_dssp             CCTTS-----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred             ccCCc-----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH
Confidence            43322     12345678899999998653 46899999999999999999999999887766655443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=342.77  Aligned_cols=251  Identities=16%  Similarity=0.211  Sum_probs=198.8

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEcc-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKV-----TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA  432 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~  432 (622)
                      .++|++.+.||+  |+||.||+|.+..     +++.||||+++... .......+.+|+.++++++|||||++++++...
T Consensus        19 ~~~~~l~~~lG~--G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          19 REKITMSRELGQ--GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             GGGEEEEEEEEE--CSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEee--CCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            468999999999  8899999998753     46789999997543 455567799999999999999999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHF--------NFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  504 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~--------~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~  504 (622)
                      +..++|||||++|+|.+++....        ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999999876431        1236788899999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHcC
Q psy15039        505 GLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANG-TVPFAETPTTLMLIEKLAG  583 (622)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg-~~Pf~~~~~~~~~~~~~~~  583 (622)
                      |||.+........  ........+|+.|||||.+.+  ..|+.++|||||||++|||+|| ++||.+.+..+.+.....+
T Consensus       176 DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         176 DFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             CTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             ecccceeccCCcc--eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9998654332221  122233457899999999976  4689999999999999999998 5888877666655555666


Q ss_pred             CCCCCCC-CCcccccCCCCcCcccccchhhhhh
Q psy15039        584 ATPHLLD-CTTYYVDTGQDDGEENACSYISEQQ  615 (622)
Q Consensus       584 ~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  615 (622)
                      ..|..++ ++....+....|...++.++.|-.+
T Consensus       252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~  284 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE  284 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            6555544 4444555555555556655555433

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=349.81  Aligned_cols=247  Identities=19%  Similarity=0.307  Sum_probs=189.9

Q ss_pred             CCceEeeecccccCCeeEEEEEEE---ccCCcEEEEEEecCCCCC--HHHHHHHHHHHHHHhhCCC-CccceeEEEEEeC
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKH---KVTNQLIAVKKFNLDRMT--DEDLKSLHHEIVCMRHLRH-PNIICYISSFLDA  432 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~---~~~~~~vavK~i~~~~~~--~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~~  432 (622)
                      ++|++++.||+  |+||.||+|++   +.+|+.||||++......  ....+.+.+|+.+|++++| |||+++++++.+.
T Consensus        24 ~~y~~~~~IG~--G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          24 ENFELLKVLGT--GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGEEEEEEEEE--TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hceEEEEEEec--CCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            67999999999  88999999987   557999999998654321  1123567899999999976 8999999999999


Q ss_pred             CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccccc
Q psy15039        433 TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPF  512 (622)
Q Consensus       433 ~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~  512 (622)
                      ...+++||||.+|+|.+++.....  +++..+..++.||+.||+|||+++||||||||+|||++.+|.+++.|||.+..+
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999999887643  578889999999999999999999999999999999999999999999986544


Q ss_pred             CCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc---HHHHHHHHcCCCCCCC
Q psy15039        513 SPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT---TLMLIEKLAGATPHLL  589 (622)
Q Consensus       513 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~---~~~~~~~~~~~~p~~~  589 (622)
                      ....   .....+..|++.|+|||++..+...++.++|||||||++|||+||+.||...+.   ...+........|+.+
T Consensus       180 ~~~~---~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~  256 (322)
T d1vzoa_         180 VADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP  256 (322)
T ss_dssp             CGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred             cccc---cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence            3221   112234567889999999976544678899999999999999999999976543   2334444434444433


Q ss_pred             C-CCcccccCCCCcCcccccchhh
Q psy15039        590 D-CTTYYVDTGQDDGEENACSYIS  612 (622)
Q Consensus       590 ~-~~~~~~~~~~~~~~~~~~~~~~  612 (622)
                      . ......+....+...++..++|
T Consensus       257 ~~~s~~~~~li~~~l~~dP~~R~s  280 (322)
T d1vzoa_         257 QEMSALAKDLIQRLLMKDPKKRLG  280 (322)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred             ccCCHHHHHHHHHHcccCHHHcCC
Confidence            3 2333333444444445555543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=335.54  Aligned_cols=212  Identities=23%  Similarity=0.335  Sum_probs=181.0

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCCcEEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDATDLHLV  438 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv  438 (622)
                      +.|++++.||+  |+||+||+|+++.+|+.||||++......+....++.+|+.+|+.++|||||+++++|.+....+++
T Consensus         2 ~ry~~i~~LG~--G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGE--GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEE--CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEec--CcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            46999999999  8899999999999999999999987666666678899999999999999999999999999999999


Q ss_pred             eeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccccccCCCCCc
Q psy15039        439 SPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMCPFSPTKKK  518 (622)
Q Consensus       439 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  518 (622)
                      ++++.++++..++...  ..+++..++.++.|++.||+|||++|||||||||+|||++.++.+++.|||.+........ 
T Consensus        80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            9999999988877654  3578899999999999999999999999999999999999999999999998765543222 


Q ss_pred             eeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q psy15039        519 VHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLIE  579 (622)
Q Consensus       519 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~~  579 (622)
                         ......+++.|+|||++... ..++.++||||+||++|||++|+.||....+......
T Consensus       157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~  213 (292)
T d1unla_         157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK  213 (292)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred             ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence               12223456789999998753 3478999999999999999999999766555444333

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-41  Score=347.12  Aligned_cols=210  Identities=22%  Similarity=0.286  Sum_probs=177.1

Q ss_pred             CCCCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC-
Q psy15039        355 DNVPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT-  433 (622)
Q Consensus       355 ~~~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-  433 (622)
                      .++++.|++++.||+  |+||+||+|+++.+|+.||||++.....+....+++.+|+.+|+.|+|||||++++++.... 
T Consensus        14 ~~~~~rY~i~~~LG~--G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          14 WEVPERYQNLSPVGS--GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEEETTEEEEEECGG--GTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccCCCCeEEEEEEec--CCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            345678999999999  78999999999999999999999877777777788999999999999999999999987432 


Q ss_pred             ----cEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCcccc
Q psy15039        434 ----DLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYM  509 (622)
Q Consensus       434 ----~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~  509 (622)
                          ..+++++++.+|+|.+++...   .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+++.|||.+
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             cccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence                346667788899999988542   5899999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q psy15039        510 CPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLML  577 (622)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~  577 (622)
                      .....       ...+..+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.....
T Consensus       169 ~~~~~-------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~  228 (348)
T d2gfsa1         169 RHTDD-------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL  228 (348)
T ss_dssp             -CCTG-------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccCc-------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence            53321       12345678899999998653 34688999999999999999999999887655443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-40  Score=341.50  Aligned_cols=208  Identities=23%  Similarity=0.327  Sum_probs=170.0

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeC----
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDA----  432 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~----  432 (622)
                      +...|++++.||+  |+||+||+|+++.||+.||||++.....+....+++.+|+.+|+.++|||||+++++|...    
T Consensus        15 i~~~Y~i~~~LG~--G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          15 VLKRYQNLKPIGS--GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             EETTEEEEEECSC--C--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeec--CcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            3467999999999  7899999999999999999999988777777778899999999999999999999999743    


Q ss_pred             --CcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        433 --TDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       433 --~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                        +.+|+|||||.++.+..+ .    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.|||...
T Consensus        93 ~~~~~~iv~Ey~~~~l~~~~-~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLCQVI-Q----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TCCEEEEEEECCSEEHHHHH-T----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cCceeEEEEeccchHHHHhh-h----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence              578999999987655433 2    247899999999999999999999999999999999999999999999998754


Q ss_pred             ccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcHHHHH
Q psy15039        511 PFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTTLMLI  578 (622)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~~~~~  578 (622)
                      ..+..     .......+|+.|+|||++.+  ..|+.++||||+||++|||++|++||.+.+....+.
T Consensus       168 ~~~~~-----~~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~  228 (355)
T d2b1pa1         168 TAGTS-----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN  228 (355)
T ss_dssp             ------------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ccccc-----cccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH
Confidence            33321     12234467889999999976  468999999999999999999999998876655443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.8e-40  Score=336.07  Aligned_cols=199  Identities=24%  Similarity=0.343  Sum_probs=169.4

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCccceeEEEEEeC--Cc
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDA--TD  434 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~--~~  434 (622)
                      .++|++++.||+  |+||+||+|+++.+|+.||||++....     .+++.+|+.+|+.++ ||||++++++|...  ..
T Consensus        34 ~d~y~i~~~LG~--G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          34 QDDYQLVRKLGR--GKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             GGGEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CcCeEEEEEEec--CcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            357999999999  789999999999999999999986432     356889999999995 99999999999854  46


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-ceEEcCcccccccC
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNG-KACLSGLRYMCPFS  513 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~-~~~~~~~~~~~~~~  513 (622)
                      +++|||||++++|.++.     ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+++.|||.+....
T Consensus       107 ~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence            99999999999987653     2478999999999999999999999999999999999998766 58999999865443


Q ss_pred             CCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCcH
Q psy15039        514 PTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPTT  574 (622)
Q Consensus       514 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~~  574 (622)
                      ...     .....++|+.|+|||++.+. ..|+.++||||+||++|||++|+.||....+.
T Consensus       182 ~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~  236 (328)
T d3bqca1         182 PGQ-----EYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  236 (328)
T ss_dssp             TTC-----CCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             CCC-----cccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence            321     12345678899999998753 35899999999999999999999999876554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-41  Score=338.03  Aligned_cols=202  Identities=24%  Similarity=0.346  Sum_probs=161.8

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccceeEEEEEeCC----c
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIICYISSFLDAT----D  434 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~----~  434 (622)
                      ..|.+.+.||+  |+||.||+|+.  +|+.||||++..+.   ......++|+..++.++|||||++++++.+.+    .
T Consensus         3 ~~~~l~~~iG~--G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGK--GRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEC--CSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEee--CCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            46788999999  88999999986  68999999986432   11122345666667889999999999998754    5


Q ss_pred             EEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEcCCCceEEcCc
Q psy15039        435 LHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHG--------KGFIHRAVKASHILISHNGKACLSGL  506 (622)
Q Consensus       435 ~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~--------~~iiHRDlKp~NILl~~~~~~~~~~~  506 (622)
                      +|+|||||++|+|.+++++.   ++++..+..++.|++.||+|||+        +|||||||||+|||++.++.+||+||
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            89999999999999999864   47888889999999999999996        69999999999999999999999999


Q ss_pred             ccccccCCCCCceeccCCCCCCCCccccccccccCcc----CCCchhhHHHHHHHHHHHHcCCCCCCC
Q psy15039        507 RYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLD----GYDERSDIYSVGISCCELANGTVPFAE  570 (622)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~~~DiwSlGvil~e~ltg~~Pf~~  570 (622)
                      |.+..................||+.|||||++.....    .++.++|||||||++|||+||.+||..
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            9765443333222223345678999999999864211    257789999999999999999988743

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-39  Score=326.58  Aligned_cols=205  Identities=16%  Similarity=0.156  Sum_probs=172.5

Q ss_pred             CCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CccceeEEEEEeCCcEE
Q psy15039        358 PSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRH-PNIICYISSFLDATDLH  436 (622)
Q Consensus       358 ~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~~~~~~  436 (622)
                      .++|++.+.||+  |+||.||+|++..+|+.||||++......    ..+.+|++.++.|+| +||+.+++++......+
T Consensus         4 g~~Y~i~~~iG~--G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           4 GVHYKVGRRIGE--GSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTTEEEEEEEEE--CSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCceEEEEEEec--CCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            468999999999  88999999999999999999998654322    346788999999965 89999999999999999


Q ss_pred             EEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-----CCceEEcCcccccc
Q psy15039        437 LVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH-----NGKACLSGLRYMCP  511 (622)
Q Consensus       437 lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~-----~~~~~~~~~~~~~~  511 (622)
                      +||||+ +++|.+++.... ..+++..+..++.|++.||+|||++|||||||||+|||++.     ++.+++.|||.+..
T Consensus        78 ~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999998 589999886543 35788999999999999999999999999999999999974     57899999998765


Q ss_pred             cCCCCCce---eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q psy15039        512 FSPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETP  572 (622)
Q Consensus       512 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~  572 (622)
                      +.......   .....+..||+.|||||++.+  ..|+.++|||||||++|||+||++||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence            44322111   112334578999999999976  469999999999999999999999997543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-38  Score=322.66  Aligned_cols=207  Identities=18%  Similarity=0.221  Sum_probs=166.5

Q ss_pred             CCCCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccce-eEEEEEeCCcE
Q psy15039        357 VPSNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNIIC-YISSFLDATDL  435 (622)
Q Consensus       357 ~~~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-~~~~~~~~~~~  435 (622)
                      +.+.|++.+.||+  |+||.||+|++..+|+.||||++..+...    ..+.+|+++++.++|+|+|. +.+++.+.+..
T Consensus         5 vg~rY~l~~~iG~--G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           5 VGNRYRLGRKIGS--GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             ETTTEEEEEEEEE--CSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             ECCEEEEeEEEee--CCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            3457999999999  88999999999999999999998764322    34788999999998776554 55666777888


Q ss_pred             EEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCceEEcCccccccc
Q psy15039        436 HLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISH---NGKACLSGLRYMCPF  512 (622)
Q Consensus       436 ~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~---~~~~~~~~~~~~~~~  512 (622)
                      ++||||++ +++.+.+... ...+++..+..++.|++.||+|||++|||||||||+|||++.   +..++++|||.+..+
T Consensus        79 ~ivme~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEcC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999995 5666655443 335889999999999999999999999999999999999864   446999999987655


Q ss_pred             CCCCCce---eccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q psy15039        513 SPTKKKV---HLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAETPT  573 (622)
Q Consensus       513 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~~~  573 (622)
                      .......   .....+..||+.|||||++.+  ..|+.++|||||||++|||+||++||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~  218 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  218 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence            4322111   112234578999999999976  4689999999999999999999999976544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-33  Score=293.60  Aligned_cols=198  Identities=24%  Similarity=0.371  Sum_probs=158.4

Q ss_pred             CceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-----------CCccceeEEE
Q psy15039        360 NYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-----------HPNIICYISS  428 (622)
Q Consensus       360 ~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~~~~~  428 (622)
                      .|++++.||+  |+||+||+|+++.+|+.||||+++.+   ....+.+.+|+.+++.++           |||||+++++
T Consensus        14 rY~i~~~LG~--G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          14 RYILVRKLGW--GHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TEEEEEEEEE--CSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cEEEEEEEee--CCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            4999999999  78999999999999999999999753   333467788999998875           4789999988


Q ss_pred             EEeC--CcEEEEeeccCCCCH-HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCC-----
Q psy15039        429 FLDA--TDLHLVSPLMGFGSC-KDLINAHFNFGLPELVICHILQDVLNGLEYIHG-KGFIHRAVKASHILISHNG-----  499 (622)
Q Consensus       429 ~~~~--~~~~lv~e~~~~g~l-~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~-~~iiHRDlKp~NILl~~~~-----  499 (622)
                      +...  ...+++++++..+.. ...........+++..+..++.||+.||+|||+ +||+||||||+|||++.++     
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            7653  456677776665443 333344444567899999999999999999997 8999999999999998765     


Q ss_pred             -ceEEcCcccccccCCCCCceeccCCCCCCCCccccccccccCccCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q psy15039        500 -KACLSGLRYMCPFSPTKKKVHLFPPSTAYNLNWLSPEVLEQNLDGYDERSDIYSVGISCCELANGTVPFAET  571 (622)
Q Consensus       500 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlGvil~e~ltg~~Pf~~~  571 (622)
                       .+++.|||.+.....       .....++|+.|+|||++..  ..|+.++||||+||+++||++|++||...
T Consensus       169 ~~~kl~dfg~s~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEECCCTTCEETTB-------CCCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeeEeeccccccccc-------ccccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCC
Confidence             388999987543321       2234678899999999975  46899999999999999999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=3.8e-23  Score=193.31  Aligned_cols=135  Identities=12%  Similarity=0.111  Sum_probs=105.3

Q ss_pred             ceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCC----------------HHHHHHHHHHHHHHhhCCCCccee
Q psy15039         11 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----------------DEDLKSLHHEIVCMRHLRHPNIIC   74 (622)
Q Consensus        11 y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~   74 (622)
                      |.+++.||+  |+||+||+|++. +|+.||||++......                ......+.+|...|.++.|+|++.
T Consensus         2 ~~vg~~IG~--G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~   78 (191)
T d1zara2           2 DAIGKLMGE--GKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK   78 (191)
T ss_dssp             SEEEEEEEE--CSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred             chhCCEeee--CcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcce
Confidence            678999999  889999999985 7999999987532110                111234567999999999999999


Q ss_pred             EEEEEEeCCcEEEEeecCCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCceEEc
Q psy15039         75 YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  154 (622)
Q Consensus        75 ~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~IvHrDiKp~NiLl~~~~~~~i~  154 (622)
                      .+++.    .-+++|||+++....+         +++..+..++.|++.||+|||++||+||||||+|||++.+ .+++.
T Consensus        79 ~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          79 VYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             EEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence            87652    2378999999765432         3344456799999999999999999999999999999864 58888


Q ss_pred             CCcccccc
Q psy15039        155 GLRYMCPF  162 (622)
Q Consensus       155 ~~~~~~~~  162 (622)
                      |||.+...
T Consensus       145 DFG~a~~~  152 (191)
T d1zara2         145 DFPQSVEV  152 (191)
T ss_dssp             CCTTCEET
T ss_pred             ECCCcccC
Confidence            99976544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=7.1e-23  Score=191.47  Aligned_cols=135  Identities=12%  Similarity=0.111  Sum_probs=104.4

Q ss_pred             ceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCC----------------HHHHHHHHHHHHHHhhCCCCccce
Q psy15039        361 YKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMT----------------DEDLKSLHHEIVCMRHLRHPNIIC  424 (622)
Q Consensus       361 y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~----------------~~~~~~~~~E~~~l~~l~HpnIv~  424 (622)
                      +.+++.||+  |+||.||+|++. +|+.||||+++.....                ........+|...+..+.|+|++.
T Consensus         2 ~~vg~~IG~--G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~   78 (191)
T d1zara2           2 DAIGKLMGE--GKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK   78 (191)
T ss_dssp             SEEEEEEEE--CSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred             chhCCEeee--CcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcce
Confidence            467889999  889999999985 6999999987532110                111234567999999999999999


Q ss_pred             eEEEEEeCCcEEEEeeccCCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCceEEc
Q psy15039        425 YISSFLDATDLHLVSPLMGFGSCKDLINAHFNFGLPELVICHILQDVLNGLEYIHGKGFIHRAVKASHILISHNGKACLS  504 (622)
Q Consensus       425 ~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~~qi~~gL~ylH~~~iiHRDlKp~NILl~~~~~~~~~  504 (622)
                      .+++.    ..+++|||+++..+.+         +++..+..++.|++.||+|||++||+||||||+|||++++ .+++.
T Consensus        79 ~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          79 VYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             EEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence            87653    2379999999865432         2233356789999999999999999999999999999865 47888


Q ss_pred             Cccccccc
Q psy15039        505 GLRYMCPF  512 (622)
Q Consensus       505 ~~~~~~~~  512 (622)
                      |||.+...
T Consensus       145 DFG~a~~~  152 (191)
T d1zara2         145 DFPQSVEV  152 (191)
T ss_dssp             CCTTCEET
T ss_pred             ECCCcccC
Confidence            99976543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.72  E-value=0.00015  Score=68.38  Aligned_cols=85  Identities=12%  Similarity=-0.028  Sum_probs=55.7

Q ss_pred             CCceEeeecccccCCeeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCccceeEEEEEeCCcEEE
Q psy15039        359 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHL  437 (622)
Q Consensus       359 ~~y~~~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~l  437 (622)
                      ..|++.+..+.  ++-+.||+..  ..++.+.+|........  ....+.+|...++.|. +--+-+++.+....+..++
T Consensus        14 ~~~~~~~~~~G--~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          14 EKYRCVKDTEG--MSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TTSEEEECSCC--CSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hceEEEEcCCC--CCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            34555554443  3457899875  35677889987533211  1234678888888774 3334566777777888999


Q ss_pred             EeeccCCCCHHH
Q psy15039        438 VSPLMGFGSCKD  449 (622)
Q Consensus       438 v~e~~~~g~l~~  449 (622)
                      ||++++|.++.+
T Consensus        88 v~~~l~G~~~~~   99 (263)
T d1j7la_          88 LMSEADGVLCSE   99 (263)
T ss_dssp             EEECCSSEEHHH
T ss_pred             EEEecccccccc
Confidence            999999987754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.45  E-value=0.00043  Score=65.13  Aligned_cols=86  Identities=12%  Similarity=-0.048  Sum_probs=55.4

Q ss_pred             CCceEEeecccccCCceeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCcceeEEEEEEeCCcEEE
Q psy15039          9 SNYKICSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLR-HPNIICYISSFLDATDLHL   87 (622)
Q Consensus         9 ~~y~~~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~l   87 (622)
                      ..|.+.+..+-++  .+.||+..  ..++.+.+|+.......  ....+.+|...|+.|. +--+-+++.+..++...++
T Consensus        14 ~~~~~~~~~~G~s--~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          14 EKYRCVKDTEGMS--PAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TTSEEEECSCCCS--SSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hceEEEEcCCCCC--CCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            4566666544322  24899875  45667888987543211  1223567888888773 3224566777777888999


Q ss_pred             EeecCCCCCHHHH
Q psy15039         88 VSPLMGFGSCKDL  100 (622)
Q Consensus        88 v~e~~~~g~l~~~  100 (622)
                      ||+++++..+.+.
T Consensus        88 v~~~l~G~~~~~~  100 (263)
T d1j7la_          88 LMSEADGVLCSEE  100 (263)
T ss_dssp             EEECCSSEEHHHH
T ss_pred             EEEeccccccccc
Confidence            9999998776543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.08  E-value=0.00073  Score=67.83  Aligned_cols=79  Identities=14%  Similarity=0.129  Sum_probs=47.6

Q ss_pred             eeecccccCCeeEEEEEEEccCCcEEEEEEecCC-CC-C---HHHHHHHHHHHHHHhhCC-C-C-ccceeEEEEEeCCcE
Q psy15039        364 CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD-RM-T---DEDLKSLHHEIVCMRHLR-H-P-NIICYISSFLDATDL  435 (622)
Q Consensus       364 ~~~lg~g~g~~~~V~~~~~~~~~~~vavK~i~~~-~~-~---~~~~~~~~~E~~~l~~l~-H-p-nIv~~~~~~~~~~~~  435 (622)
                      ++.+|.  |....||+..+..+++.++||.-... +. .   .....+..+|...|+.+. + | .+.+++.  .+....
T Consensus        31 ~~eig~--G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~  106 (392)
T d2pula1          31 CQEIGD--GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMA  106 (392)
T ss_dssp             EEECCS--SSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTT
T ss_pred             EEEeCC--CceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCC
Confidence            446777  67889999998888899999975421 00 0   011345667888887662 3 3 3444543  355566


Q ss_pred             EEEeeccCCCC
Q psy15039        436 HLVSPLMGFGS  446 (622)
Q Consensus       436 ~lv~e~~~~g~  446 (622)
                      ++|||++++..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            89999998643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.99  E-value=0.0045  Score=57.45  Aligned_cols=68  Identities=12%  Similarity=0.033  Sum_probs=47.1

Q ss_pred             eeEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc--cceeEEEEEeCCcEEEEeeccCCCCH
Q psy15039        374 LSSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN--IICYISSFLDATDLHLVSPLMGFGSC  447 (622)
Q Consensus       374 ~~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~~~~~~lv~e~~~~g~l  447 (622)
                      -+.||+.... ++..+.+|.......     ..+.+|+..|+.|....  +.+++.+..+.+..++||++++|.++
T Consensus        24 ~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          24 DAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CCeEEEEEeC-CCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4678988754 466688887654322     24677888888774333  45567777778889999999987543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.70  E-value=0.0023  Score=64.10  Aligned_cols=79  Identities=13%  Similarity=0.088  Sum_probs=47.4

Q ss_pred             EeecccccCCceeEEEEEEccCCcEEEEEEecCC-CC----CHHHHHHHHHHHHHHhhC-CC--CcceeEEEEEEeCCcE
Q psy15039         14 CSILGQCFNNLSSVYLSKHKVTNQLIAVKKFNLD-RM----TDEDLKSLHHEIVCMRHL-RH--PNIICYISSFLDATDL   85 (622)
Q Consensus        14 ~~~lG~g~g~~~~V~~~~~~~t~~~vAiK~~~~~-~~----~~~~~~~~~~Ei~il~~l-~H--pnIv~~~~~~~~~~~~   85 (622)
                      .+.||.  |+...||+.....+|+.|.||.-... +.    -+....+..+|...|+.+ .+  ..+.+++.  .+.+..
T Consensus        31 ~~eig~--G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~  106 (392)
T d2pula1          31 CQEIGD--GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMA  106 (392)
T ss_dssp             EEECCS--SSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTT
T ss_pred             EEEeCC--CceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCC
Confidence            456887  66669999998888899999974321 00    011122345688888776 23  23455543  456667


Q ss_pred             EEEeecCCCCC
Q psy15039         86 HLVSPLMGFGS   96 (622)
Q Consensus        86 ~lv~e~~~~g~   96 (622)
                      .+|||++++..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            88999997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.14  E-value=0.015  Score=53.58  Aligned_cols=66  Identities=12%  Similarity=0.061  Sum_probs=45.8

Q ss_pred             eeEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCc--ceeEEEEEEeCCcEEEEeecCCCCC
Q psy15039         25 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPN--IICYISSFLDATDLHLVSPLMGFGS   96 (622)
Q Consensus        25 ~~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~~~~~~~~~~~~~lv~e~~~~g~   96 (622)
                      +.||+.... .|..+.+|.-.....     ..+.+|...|+.|....  +.+++.+..+....+++|+++++-.
T Consensus        25 ~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          25 AAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             CeEEEEEeC-CCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            478988754 566688887644322     23567888888774433  4567777777888999999998644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.74  E-value=0.038  Score=53.19  Aligned_cols=67  Identities=16%  Similarity=0.151  Sum_probs=42.5

Q ss_pred             eEEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccc--eeE-----EEEEeCCcEEEEeeccCCC
Q psy15039        375 SSVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII--CYI-----SSFLDATDLHLVSPLMGFG  445 (622)
Q Consensus       375 ~~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv--~~~-----~~~~~~~~~~lv~e~~~~g  445 (622)
                      -.||+++.. +|+.|++|+.+....+.   +.+..|...|..|...+|.  ...     ..+...+..+.++++++|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            468888764 57889999887655554   3466788888887533321  111     1223345678888888763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=92.85  E-value=0.14  Score=50.34  Aligned_cols=72  Identities=13%  Similarity=0.088  Sum_probs=45.1

Q ss_pred             EeecccccCCceeEEEEEEcc-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcce-eEEEEEEeCCcE
Q psy15039         14 CSILGQCFNNLSSVYLSKHKV-------TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII-CYISSFLDATDL   85 (622)
Q Consensus        14 ~~~lG~g~g~~~~V~~~~~~~-------t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~~~~~~~~~~~~   85 (622)
                      ++.|+-|..|  .+|++....       .++.|.+++... .....   ...+|..+++.|.-.++. ++++++.+    
T Consensus        47 v~~l~GGltN--~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~i---dr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          47 ISRIKGGMSN--MLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETES---HLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEECCCTTE--EEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHH---HHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEcCCcccc--ceEEEEeCCCCccccCCCCcEEEEecCC-cchhh---HHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            3456655555  899998653       345677777652 22222   345799999988544443 67666532    


Q ss_pred             EEEeecCCCC
Q psy15039         86 HLVSPLMGFG   95 (622)
Q Consensus        86 ~lv~e~~~~g   95 (622)
                      .+|+||+++.
T Consensus       117 g~I~efi~g~  126 (395)
T d1nw1a_         117 GRLEEYIPSR  126 (395)
T ss_dssp             EEEECCCCEE
T ss_pred             ceEEEEeccc
Confidence            5789998763

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=92.79  E-value=0.19  Score=47.92  Aligned_cols=65  Identities=17%  Similarity=0.171  Sum_probs=42.0

Q ss_pred             eEEEEEEccCCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCcce--eEE-----EEEEeCCcEEEEeecCCC
Q psy15039         26 SVYLSKHKVTNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII--CYI-----SSFLDATDLHLVSPLMGF   94 (622)
Q Consensus        26 ~V~~~~~~~t~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv--~~~-----~~~~~~~~~~lv~e~~~~   94 (622)
                      .||+++.. +|+.|++|.......+..+   +..|...|..|...+|-  ...     ..+......+.++++++|
T Consensus        37 ~vy~v~~~-dg~~~VlK~~rp~~~s~~~---i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          37 RVYQFQDE-DRRRFVVKFYRPERWTADQ---ILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             EEEEECCT-TCCCEEEEEECTTTSCHHH---HHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eeEEEEcC-CCCEEEEEEeCCCCCCHHH---HHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            79999874 7888999998776655443   45688888887533321  111     122334567777888765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=90.22  E-value=0.51  Score=46.12  Aligned_cols=70  Identities=10%  Similarity=0.069  Sum_probs=42.8

Q ss_pred             ecccccCCeeEEEEEEEcc-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCccc-eeEEEEEeCCcEEE
Q psy15039        366 ILGQCFNNLSSVYLSKHKV-------TNQLIAVKKFNLDRMTDEDLKSLHHEIVCMRHLRHPNII-CYISSFLDATDLHL  437 (622)
Q Consensus       366 ~lg~g~g~~~~V~~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~l  437 (622)
                      .|+.  |---.+|++....       ..+.|.+++.. .....   -...+|..+++.+.-.+++ ++++++.  +  .+
T Consensus        49 ~l~G--GltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~  118 (395)
T d1nw1a_          49 RIKG--GMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE---SHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  118 (395)
T ss_dssp             EECC--CTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EcCC--ccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh---hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ce
Confidence            4543  3345688877543       34667777765 22222   2356899999988544554 6666553  2  67


Q ss_pred             EeeccCCC
Q psy15039        438 VSPLMGFG  445 (622)
Q Consensus       438 v~e~~~~g  445 (622)
                      |+||++|-
T Consensus       119 I~efi~g~  126 (395)
T d1nw1a_         119 LEEYIPSR  126 (395)
T ss_dssp             EECCCCEE
T ss_pred             EEEEeccc
Confidence            89999874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=85.49  E-value=0.12  Score=49.10  Aligned_cols=30  Identities=17%  Similarity=0.388  Sum_probs=25.6

Q ss_pred             CCceecCCCCCcEEEcCCCceEEcCccccc
Q psy15039        481 KGFIHRAVKASHILISHNGKACLSGLRYMC  510 (622)
Q Consensus       481 ~~iiHRDlKp~NILl~~~~~~~~~~~~~~~  510 (622)
                      .|+||.|+.++||+++.++...+.||+.++
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988776788988654